Citrus Sinensis ID: 019901
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | 2.2.26 [Sep-21-2011] | |||||||
| Q940H6 | 362 | Serine/threonine-protein | no | no | 0.913 | 0.842 | 0.898 | 1e-157 | |
| Q75H77 | 362 | Serine/threonine-protein | yes | no | 0.910 | 0.839 | 0.862 | 1e-151 | |
| Q75V57 | 361 | Serine/threonine-protein | no | no | 0.910 | 0.842 | 0.842 | 1e-148 | |
| Q39193 | 361 | Serine/threonine-protein | no | no | 0.910 | 0.842 | 0.806 | 1e-144 | |
| Q39192 | 362 | Serine/threonine-protein | no | no | 0.901 | 0.831 | 0.775 | 1e-140 | |
| Q7Y0B9 | 371 | Serine/threonine-protein | no | no | 0.799 | 0.719 | 0.857 | 1e-137 | |
| A2YNT8 | 339 | Serine/threonine-protein | N/A | no | 0.835 | 0.823 | 0.771 | 1e-128 | |
| Q0D4J7 | 339 | Serine/threonine-protein | no | no | 0.835 | 0.823 | 0.767 | 1e-128 | |
| Q75LR7 | 342 | Serine/threonine-protein | no | no | 0.787 | 0.769 | 0.794 | 1e-127 | |
| Q02066 | 332 | Abscisic acid-inducible p | N/A | no | 0.826 | 0.831 | 0.757 | 1e-124 |
| >sp|Q940H6|SRK2E_ARATH Serine/threonine-protein kinase SRK2E OS=Arabidopsis thaliana GN=SRK2E PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 553 bits (1426), Expect = e-157, Method: Compositional matrix adjust.
Identities = 275/306 (89%), Positives = 289/306 (94%), Gaps = 1/306 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 57 KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 117 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 176
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+V
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV 236
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QY+IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT QF+
Sbjct: 237 QYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFD 296
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEM-DEDIDTDPDLDIDSSG 328
E DQP QSI+EIMQIIAEAT+P AGTQ+LN L GSLDIDD+M ++ DLDIDSSG
Sbjct: 297 ESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSG 356
Query: 329 EIVYAM 334
EIVYAM
Sbjct: 357 EIVYAM 362
|
Activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as stomata closure in response to drought, plant pathogens, or decreases in atmospheric relative humidity (RH). Involved in the resistance to drought by avoiding water loss. Required for the stomata closure mediated by pathogen-associated molecular pattern (PAMPs) (e.g. flg22 and LPS) of pathogenic bacteria such as P.syringae pv. tomato (Pst) and E.coli O157:H7. As a plant defense process, stomata are closed transiently in order to limit invaders, but actively reopened by bacteria after a few hours; virulent strains (e.g. Pst DC3000) are more efficient than avirulent strains (e.g. Pst DC3000 AvrRpt2) in reopening stomata. Mediates the phosphorylation and activation of the S-type anion efflux channel SLAC1, and thus promotes stomata closure. Essential for stomatal closure in response to reactive oxygen species (ROS). Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q75H77|SAPKA_ORYSJ Serine/threonine-protein kinase SAPK10 OS=Oryza sativa subsp. japonica GN=SAPK10 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 535 bits (1378), Expect = e-151, Method: Compositional matrix adjust.
Identities = 263/305 (86%), Positives = 283/305 (92%), Gaps = 1/305 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EPKNFRKTI RIL V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPKNFRKTIQRILGV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECR LI+RIFVA+PA RISIPEIRNH WFLKNLPADL+ D+ ++Q+E
Sbjct: 239 QYSIPDYVHISPECRDLIARIFVANPATRISIPEIRNHPWFLKNLPADLMDDSKMSSQYE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EP+QPMQS+DEIMQI+AEATIPAAG+ +NQ D+ ED+D+DPDLD++SSGE
Sbjct: 299 EPEQPMQSMDEIMQILAEATIPAAGSGGINQ-FLNDGLDLDDDMEDLDSDPDLDVESSGE 357
Query: 330 IVYAM 334
IVYAM
Sbjct: 358 IVYAM 362
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75V57|SAPK9_ORYSJ Serine/threonine-protein kinase SAPK9 OS=Oryza sativa subsp. japonica GN=SAPK9 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 526 bits (1354), Expect = e-148, Method: Compositional matrix adjust.
Identities = 257/305 (84%), Positives = 281/305 (92%), Gaps = 1/305 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERIC+AGRFSEDE
Sbjct: 58 KIDENVQREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICSAGRFSEDE 117
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKST
Sbjct: 118 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSTAPRLKICDFGYSKSSVLHSQPKST 177
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE+PKNFRKTI +IL V
Sbjct: 178 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEDPKNFRKTIQKILGV 237
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECR LI+RIFV +PA RI++PEI+NH WF+KN+PADL+ D +NQ+E
Sbjct: 238 QYSIPDYVHISPECRDLITRIFVGNPASRITMPEIKNHPWFMKNIPADLMDDGMVSNQYE 297
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EPDQPMQ+++EIMQI+AEATIPAAGT +NQ L D+ ED+D+D DLDI+SSGE
Sbjct: 298 EPDQPMQNMNEIMQILAEATIPAAGTSGINQFLT-DSLDLDDDMEDMDSDLDLDIESSGE 356
Query: 330 IVYAM 334
IVYAM
Sbjct: 357 IVYAM 361
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39193|SRK2I_ARATH Serine/threonine-protein kinase SRK2I OS=Arabidopsis thaliana GN=SRK2I PE=1 SV=1 | Back alignment and function description |
|---|
Score = 509 bits (1312), Expect = e-144, Method: Compositional matrix adjust.
Identities = 246/305 (80%), Positives = 277/305 (90%), Gaps = 1/305 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDE
Sbjct: 58 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE 117
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+YSIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+
Sbjct: 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQ 297
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EP+QPMQS+D IMQII+EATIPA + L+ + D+ +D D++ ++DIDSSGE
Sbjct: 298 EPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMT-DNLDLDDDMDDFDSESEIDIDSSGE 356
Query: 330 IVYAM 334
IVYA+
Sbjct: 357 IVYAL 361
|
Together with SRK2D, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39192|SRK2D_ARATH Serine/threonine-protein kinase SRK2D OS=Arabidopsis thaliana GN=SRK2D PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 239/308 (77%), Positives = 276/308 (89%), Gaps = 7/308 (2%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTP+HLAIVMEYA+GGEL+ERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPSHLAIVMEYAAGGELYERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPE+LL++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+++RKTI RILSV
Sbjct: 179 VGTPAYIAPEILLRQEYDGKLADVWSCGVTLYVMLVGAYPFEDPQEPRDYRKTIQRILSV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
YSIP+ +H+SPECRHLISRIFVADPA RI+IPEI + +WFLKNLP DL+ +N +QF+
Sbjct: 239 TYSIPEDLHLSPECRHLISRIFVADPATRITIPEITSDKWFLKNLPGDLMDENRMGSQFQ 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLN---GSLDIDDEMDEDIDTDPDLDIDS 326
EP+QPMQS+D IMQII+EATIP N+CL+ D+ +D D++ ++D+DS
Sbjct: 299 EPEQPMQSLDTIMQIISEATIPTVR----NRCLDDFMADNLDLDDDMDDFDSESEIDVDS 354
Query: 327 SGEIVYAM 334
SGEIVYA+
Sbjct: 355 SGEIVYAL 362
|
Together with SRK2I, key component and activator of the abscisic acid (ABA) signaling pathway that regulates numerous ABA responses, such as seed germination, Pro accumulation, root growth inhibition, dormancy and seedling growth, and, to a lesser extent, stomatal closure. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7Y0B9|SAPK8_ORYSJ Serine/threonine-protein kinase SAPK8 OS=Oryza sativa subsp. japonica GN=SAPK8 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 488 bits (1256), Expect = e-137, Method: Compositional matrix adjust.
Identities = 229/267 (85%), Positives = 252/267 (94%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+ID+NVQREIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELFERIC RFSEDE
Sbjct: 69 KIDDNVQREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFERICKNVRFSEDE 128
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR+FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 129 ARYFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 188
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGK ADVWSCGVTLYVM+VGAYPFEDPEEPKNFRKTI RIL+V
Sbjct: 189 VGTPAYIAPEVLLKKEYDGKTADVWSCGVTLYVMVVGAYPFEDPEEPKNFRKTIQRILNV 248
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIP+ V ISPECRHLISRIFV DP+ RI+IPEIR+H WFLKNLPADL+ D++ ++Q+E
Sbjct: 249 QYSIPENVDISPECRHLISRIFVGDPSLRITIPEIRSHGWFLKNLPADLMDDDSMSSQYE 308
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQ 296
EPDQPMQ++D+IMQI+ EATIP A ++
Sbjct: 309 EPDQPMQTMDQIMQILTEATIPPACSR 335
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A2YNT8|SAPK2_ORYSI Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. indica GN=SAPK2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 459 bits (1182), Expect = e-128, Method: Compositional matrix adjust.
Identities = 216/280 (77%), Positives = 246/280 (87%), Gaps = 1/280 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREI+NHRSLRHPNIVRFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDE
Sbjct: 40 KIDENVQREIMNHRSLRHPNIVRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKST
Sbjct: 100 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSVLHSQPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSV
Sbjct: 160 VGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QY +PDYV +S ECRHL+SRIFVA+P +RI+IPEI+NH WFLKNLP ++ + + Q
Sbjct: 220 QYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMN 279
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLN-GSLDI 308
+ + P Q ++EIM II EA P G++ Q GS+++
Sbjct: 280 DINTPSQGLEEIMAIIQEARKPGDGSKFSGQIPGLGSMEL 319
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0D4J7|SAPK2_ORYSJ Serine/threonine-protein kinase SAPK2 OS=Oryza sativa subsp. japonica GN=SAPK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 458 bits (1178), Expect = e-128, Method: Compositional matrix adjust.
Identities = 215/280 (76%), Positives = 246/280 (87%), Gaps = 1/280 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREI+NHRSLRHPNIVRFKEV+LTPTHLAIVMEYA+GGELFERIC+AGRFSEDE
Sbjct: 40 KIDENVQREIMNHRSLRHPNIVRFKEVVLTPTHLAIVMEYAAGGELFERICSAGRFSEDE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCHSMQ+CHRDLKLENTLLDGS APRLKICDFGYSKSS+LHSQPKST
Sbjct: 100 ARFFFQQLISGVSYCHSMQICHRDLKLENTLLDGSIAPRLKICDFGYSKSSLLHSQPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSV
Sbjct: 160 VGTPAYIAPEVLARKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QY +PDYV +S ECRHL+SRIFVA+P +RI+IPEI+NH WFLKNLP ++ + + Q
Sbjct: 220 QYMVPDYVRVSMECRHLLSRIFVANPEQRITIPEIKNHPWFLKNLPIEMTDEYQMSVQMN 279
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLN-GSLDI 308
+ + P Q ++EIM II EA P G++ Q GS+++
Sbjct: 280 DINTPSQGLEEIMAIIQEARKPGDGSKFSGQIPGLGSMEL 319
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q75LR7|SAPK1_ORYSJ Serine/threonine-protein kinase SAPK1 OS=Oryza sativa subsp. japonica GN=SAPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-127, Method: Compositional matrix adjust.
Identities = 209/263 (79%), Positives = 237/263 (90%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDE+VQREI+NHRSL+HPNI+RFKEV+LTPTHLAIVMEYA+GGELFERICNAGRFSEDE
Sbjct: 40 KIDEHVQREIMNHRSLKHPNIIRFKEVVLTPTHLAIVMEYAAGGELFERICNAGRFSEDE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS PRLKICDFGYSKSSVLHSQPKST
Sbjct: 100 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVTPRLKICDFGYSKSSVLHSQPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL +KEYDGK+ADVWSCGVTLYVMLVGAYPFEDP++P+NFRKTI RILSV
Sbjct: 160 VGTPAYIAPEVLSRKEYDGKVADVWSCGVTLYVMLVGAYPFEDPDDPRNFRKTITRILSV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYV +S +CRHL+SRIFV +P +RI+IPEI+NH WFLKNLP ++ + + Q
Sbjct: 220 QYSIPDYVRVSADCRHLLSRIFVGNPEQRITIPEIKNHPWFLKNLPIEMTDEYQRSMQLA 279
Query: 270 EPDQPMQSIDEIMQIIAEATIPA 292
+ + P QS++E+M II EA P
Sbjct: 280 DMNTPSQSLEEVMAIIQEARKPG 302
|
May play a role in signal transduction of hyperosmotic response. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q02066|AAIP_WHEAT Abscisic acid-inducible protein kinase (Fragment) OS=Triticum aestivum PE=2 SV=1 | Back alignment and function description |
|---|
Score = 446 bits (1147), Expect = e-124, Method: Compositional matrix adjust.
Identities = 212/280 (75%), Positives = 241/280 (86%), Gaps = 4/280 (1%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDE+VQREI+NHRSL+HPNI+RFKEV+LTPTHLAIVMEYASGGELF+RICNAGRFSEDE
Sbjct: 30 KIDEHVQREIMNHRSLKHPNIIRFKEVVLTPTHLAIVMEYASGGELFQRICNAGRFSEDE 89
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKST
Sbjct: 90 GRFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSVAPRLKICDFGYSKSSVLHSQPKST 149
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL ++EYDGK+ADVWSCGVTLYVMLVGAYPFEDP+EP+NFRKTI RILSV
Sbjct: 150 VGTPAYIAPEVLSRREYDGKVADVWSCGVTLYVMLVGAYPFEDPDEPRNFRKTITRILSV 209
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYS+PDYV +S +C HL+SRIFV +P +RI+IPEI+NH WFLK LP ++ + + Q
Sbjct: 210 QYSVPDYVRVSMDCIHLLSRIFVGNPQQRITIPEIKNHPWFLKRLPVEMTDEYQRSMQLA 269
Query: 270 EPDQPMQSIDEIMQIIAEATIP---AAGTQSLNQCLNGSL 306
+ + P QS++E M II EA P A G CL GS+
Sbjct: 270 DMNTPSQSLEEAMAIIQEAQKPGDNALGVAGQVACL-GSM 308
|
Involved in water-stress responses. Triticum aestivum (taxid: 4565) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| 388491244 | 363 | unknown [Medicago truncatula] | 0.913 | 0.840 | 0.927 | 1e-167 | |
| 255561655 | 363 | Serine/threonine-protein kinase SAPK10, | 0.913 | 0.840 | 0.918 | 1e-166 | |
| 224123434 | 363 | predicted protein [Populus trichocarpa] | 0.913 | 0.840 | 0.911 | 1e-166 | |
| 225428695 | 363 | PREDICTED: serine/threonine-protein kina | 0.913 | 0.840 | 0.914 | 1e-165 | |
| 147788088 | 363 | hypothetical protein VITISV_025025 [Viti | 0.913 | 0.840 | 0.908 | 1e-164 | |
| 224105505 | 362 | predicted protein [Populus trichocarpa] | 0.910 | 0.839 | 0.911 | 1e-163 | |
| 359475222 | 371 | PREDICTED: serine/threonine-protein kina | 0.913 | 0.822 | 0.891 | 1e-163 | |
| 356575154 | 364 | PREDICTED: serine/threonine-protein kina | 0.913 | 0.837 | 0.934 | 1e-161 | |
| 404435147 | 362 | sucrose non-fermenting 1-related protein | 0.910 | 0.839 | 0.927 | 1e-160 | |
| 356521207 | 364 | PREDICTED: serine/threonine-protein kina | 0.913 | 0.837 | 0.924 | 1e-159 |
| >gi|388491244|gb|AFK33688.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 593 bits (1528), Expect = e-167, Method: Compositional matrix adjust.
Identities = 283/305 (92%), Positives = 296/305 (97%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLR PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRRPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+M+VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMEVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI+RIL+V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTINRILNV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
YSIPDYVHISPEC+HLISRIFVADPAKRISIPEIRNHEWFLKNLP DL+ DN TNNQFE
Sbjct: 239 HYSIPDYVHISPECQHLISRIFVADPAKRISIPEIRNHEWFLKNLPTDLMDDNGTNNQFE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EPDQP QS++EIMQIIAEAT+PAAGTQSLN L GSLDIDD+M+ED+DTDPDLDIDSSGE
Sbjct: 299 EPDQPTQSVEEIMQIIAEATVPAAGTQSLNPYLTGSLDIDDDMEEDLDTDPDLDIDSSGE 358
Query: 330 IVYAM 334
IVYAM
Sbjct: 359 IVYAM 363
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255561655|ref|XP_002521837.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] gi|223538875|gb|EEF40473.1| Serine/threonine-protein kinase SAPK10, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 590 bits (1520), Expect = e-166, Method: Compositional matrix adjust.
Identities = 280/305 (91%), Positives = 298/305 (97%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPEC+HLISRIFVADPAKRISIPEI+NHEWFLKNLPADL+ D T NNQF+
Sbjct: 239 QYSIPDYVHISPECQHLISRIFVADPAKRISIPEIKNHEWFLKNLPADLMDDKTINNQFD 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EP+QP+QSIDEIMQII+EATIPAAGT + NQ L GSLDIDD+M+ED+++DP+LD+DSSGE
Sbjct: 299 EPEQPVQSIDEIMQIISEATIPAAGTGNPNQYLTGSLDIDDDMEEDLESDPELDMDSSGE 358
Query: 330 IVYAM 334
IVYAM
Sbjct: 359 IVYAM 363
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224123434|ref|XP_002330314.1| predicted protein [Populus trichocarpa] gi|222871349|gb|EEF08480.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 589 bits (1518), Expect = e-166, Method: Compositional matrix adjust.
Identities = 278/305 (91%), Positives = 295/305 (96%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN+GRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNSGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP ST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPTST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP+NFR TIHRIL+V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPRNFRSTIHRILNV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPEC+HLISRIFVADPAKRI+IPEIRNH+WFLKN PADL+V+N NNQFE
Sbjct: 239 QYSIPDYVHISPECQHLISRIFVADPAKRITIPEIRNHDWFLKNFPADLMVENNMNNQFE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EPDQPMQSIDEIMQII EATIPAAGT SLN L GSLDIDDEM+ED+++DP+LD+DSSGE
Sbjct: 299 EPDQPMQSIDEIMQIITEATIPAAGTPSLNHYLTGSLDIDDEMEEDLESDPELDLDSSGE 358
Query: 330 IVYAM 334
IVYAM
Sbjct: 359 IVYAM 363
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225428695|ref|XP_002284959.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 1 [Vitis vinifera] gi|297741336|emb|CBI32467.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 587 bits (1514), Expect = e-165, Method: Compositional matrix adjust.
Identities = 279/305 (91%), Positives = 292/305 (95%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ + +NQ+E
Sbjct: 239 QYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDETKMDNQYE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EP+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGE
Sbjct: 299 EPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGE 358
Query: 330 IVYAM 334
IVYAM
Sbjct: 359 IVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147788088|emb|CAN62745.1| hypothetical protein VITISV_025025 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 583 bits (1504), Expect = e-164, Method: Compositional matrix adjust.
Identities = 277/305 (90%), Positives = 291/305 (95%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGS APRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSSAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF KTI RIL V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHKTIQRILKV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECRHLISRIFVADPA RI+I EIRNH+WFLKNLPADL+ + +NQ+E
Sbjct: 239 QYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHDWFLKNLPADLMDETKMDNQYE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EP+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPDLDIDSSGE
Sbjct: 299 EPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPDLDIDSSGE 358
Query: 330 IVYAM 334
IVYAM
Sbjct: 359 IVYAM 363
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224105505|ref|XP_002313835.1| predicted protein [Populus trichocarpa] gi|222850243|gb|EEE87790.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 581 bits (1497), Expect = e-163, Method: Compositional matrix adjust.
Identities = 278/305 (91%), Positives = 296/305 (97%), Gaps = 1/305 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC AGRFSEDE
Sbjct: 59 KIDENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICIAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP+EP NFR TIHRIL+V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPDEPMNFRNTIHRILNV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPEC+HLISRIFVADPA RI+IPEIRNHEWFLKNLPADL+V+NT NN+FE
Sbjct: 239 QYSIPDYVHISPECQHLISRIFVADPAMRITIPEIRNHEWFLKNLPADLMVENTMNNEFE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EPDQPMQSI+EIMQII+EATIPAAGT SLNQ L GSLDIDD+M ED+++DP+LD+DSSGE
Sbjct: 299 EPDQPMQSIEEIMQIISEATIPAAGTPSLNQYLTGSLDIDDDM-EDLESDPELDLDSSGE 357
Query: 330 IVYAM 334
IVYAM
Sbjct: 358 IVYAM 362
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359475222|ref|XP_003631617.1| PREDICTED: serine/threonine-protein kinase SAPK10 isoform 3 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 580 bits (1496), Expect = e-163, Method: Compositional matrix adjust.
Identities = 279/313 (89%), Positives = 292/313 (93%), Gaps = 8/313 (2%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 --------ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
ARFFFQQL+SGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV
Sbjct: 119 VLMQLAHLARFFFQQLVSGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 178
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 201
LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF K
Sbjct: 179 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFHK 238
Query: 202 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
TI RIL VQYSIPDYVHISPECRHLISRIFVADPA RI+I EIRNHEWFLKNLPADL+ +
Sbjct: 239 TIQRILKVQYSIPDYVHISPECRHLISRIFVADPATRITIAEIRNHEWFLKNLPADLMDE 298
Query: 262 NTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPD 321
+NQ+EEP+QPMQSIDEIM+II EA IPAAGTQSLNQ L GSLDIDDEM+ED++TDPD
Sbjct: 299 TKMDNQYEEPEQPMQSIDEIMRIIGEAMIPAAGTQSLNQYLTGSLDIDDEMEEDLETDPD 358
Query: 322 LDIDSSGEIVYAM 334
LDIDSSGEIVYAM
Sbjct: 359 LDIDSSGEIVYAM 371
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356575154|ref|XP_003555707.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 574 bits (1479), Expect = e-161, Method: Compositional matrix adjust.
Identities = 286/306 (93%), Positives = 298/306 (97%), Gaps = 1/306 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVRREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECRHLISRIFVADPA+RISIPEIRNHEWFL+NLPADL+V+NT NNQFE
Sbjct: 239 QYSIPDYVHISPECRHLISRIFVADPAQRISIPEIRNHEWFLRNLPADLMVENTMNNQFE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSG 328
EPDQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSG
Sbjct: 299 EPDQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSG 358
Query: 329 EIVYAM 334
EIVYAM
Sbjct: 359 EIVYAM 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|404435147|gb|AFR68940.1| sucrose non-fermenting 1-related protein kinase 2 family member [Solanum tuberosum] | Back alignment and taxonomy information |
|---|
Score = 569 bits (1467), Expect = e-160, Method: Compositional matrix adjust.
Identities = 283/305 (92%), Positives = 296/305 (97%), Gaps = 1/305 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVME+ASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEFASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI RIL+V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIQRILNV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHISPECRHLISRIFVADPAKRISIPEI+NHEWFLKNLPADL +DNTTNNQFE
Sbjct: 239 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIKNHEWFLKNLPADL-MDNTTNNQFE 297
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGE 329
EPDQ MQSIDEIMQII EATIPAAGT SLN L GSLDIDD+++ED+++DPDLDIDS GE
Sbjct: 298 EPDQRMQSIDEIMQIITEATIPAAGTNSLNHYLTGSLDIDDDIEEDLESDPDLDIDSGGE 357
Query: 330 IVYAM 334
IVYAM
Sbjct: 358 IVYAM 362
|
Source: Solanum tuberosum Species: Solanum tuberosum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356521207|ref|XP_003529248.1| PREDICTED: serine/threonine-protein kinase SRK2E-like isoform 1 [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 568 bits (1463), Expect = e-159, Method: Compositional matrix adjust.
Identities = 283/306 (92%), Positives = 296/306 (96%), Gaps = 1/306 (0%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKE+ILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 59 KIDENVRREIINHRSLRHPNIVRFKEIILTPTHLAIVMEYASGGELFERICNAGRFSEDE 118
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 119 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 178
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL V
Sbjct: 179 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILKV 238
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QYSIPDYVHIS ECRHLISRIFVADPA+RISIPEIRNHEWFLKNLPADL+V+NT N QFE
Sbjct: 239 QYSIPDYVHISSECRHLISRIFVADPAQRISIPEIRNHEWFLKNLPADLMVENTMNRQFE 298
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS-LDIDDEMDEDIDTDPDLDIDSSG 328
EPDQPMQSI+EIMQII+EATIPAAGTQSLNQ L GS DD+MDED++TDPDLDIDSSG
Sbjct: 299 EPDQPMQSIEEIMQIISEATIPAAGTQSLNQYLTGSLDIDDDDMDEDLETDPDLDIDSSG 358
Query: 329 EIVYAM 334
EIVYA+
Sbjct: 359 EIVYAI 364
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 334 | ||||||
| TAIR|locus:2118929 | 362 | OST1 "OPEN STOMATA 1" [Arabido | 0.913 | 0.842 | 0.866 | 2.4e-140 | |
| TAIR|locus:2174999 | 361 | SNRK2.3 "sucrose nonfermenting | 0.910 | 0.842 | 0.790 | 5.2e-129 | |
| TAIR|locus:2159597 | 353 | SNRK2.1 "SNF1-related protein | 0.826 | 0.781 | 0.728 | 1.8e-110 | |
| TAIR|locus:2206046 | 361 | SNRK2.10 "SNF1-related protein | 0.805 | 0.745 | 0.744 | 1.8e-110 | |
| TAIR|locus:2160559 | 360 | SNRK2.5 "SNF1-related protein | 0.805 | 0.747 | 0.748 | 2.3e-110 | |
| TAIR|locus:2140104 | 350 | SNRK2.7 "SNF1-related protein | 0.802 | 0.765 | 0.735 | 2.4e-108 | |
| TAIR|locus:2032075 | 343 | SNRK2-8 "SNF1-RELATED PROTEIN | 0.823 | 0.801 | 0.719 | 7.2e-107 | |
| TAIR|locus:2045319 | 339 | SNRK2.9 "SNF1-related protein | 0.865 | 0.852 | 0.649 | 1.5e-99 | |
| TAIR|locus:2102132 | 535 | KIN10 "AT3G01090" [Arabidopsis | 0.667 | 0.416 | 0.497 | 4e-51 | |
| DICTYBASE|DDB_G0277905 | 727 | snfA "AMP-activated protein ki | 0.676 | 0.310 | 0.485 | 2.2e-50 |
| TAIR|locus:2118929 OST1 "OPEN STOMATA 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1373 (488.4 bits), Expect = 2.4e-140, P = 2.4e-140
Identities = 265/306 (86%), Positives = 276/306 (90%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV+REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE
Sbjct: 57 KIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 116
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQLISGVSYCH+MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 117 ARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 176
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLLKKEYDGK+ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL+V
Sbjct: 177 VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNV 236
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QY+IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL+ DNT QF+
Sbjct: 237 QYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFD 296
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXX-SSG 328
E DQP QSI+EIMQIIAEAT+P AGTQ+LN L GSL SSG
Sbjct: 297 ESDQPGQSIEEIMQIIAEATVPPAGTQNLNHYLTGSLDIDDDMEEDLESDLDDLDIDSSG 356
Query: 329 EIVYAM 334
EIVYAM
Sbjct: 357 EIVYAM 362
|
|
| TAIR|locus:2174999 SNRK2.3 "sucrose nonfermenting 1(SNF1)-related protein kinase 2.3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1266 (450.7 bits), Expect = 5.2e-129, P = 5.2e-129
Identities = 241/305 (79%), Positives = 267/305 (87%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDE
Sbjct: 58 KIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE 117
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
ARFFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST
Sbjct: 118 ARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 177
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV
Sbjct: 178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV 237
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+YSIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+
Sbjct: 238 KYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQ 297
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLXXXXXXXXXXXXXXXXXXXSSGE 329
EP+QPMQS+D IMQII+EATIPA + L+ + +L SSGE
Sbjct: 298 EPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSESEIDID-SSGE 356
Query: 330 IVYAM 334
IVYA+
Sbjct: 357 IVYAL 361
|
|
| TAIR|locus:2159597 SNRK2.1 "SNF1-related protein kinase 2.1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
Identities = 201/276 (72%), Positives = 235/276 (85%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV REIINHRSL+HPNI+RFKEVILTPTHLAIVMEYASGGELF+RIC AGRFSE E
Sbjct: 40 KIDENVAREIINHRSLKHPNIIRFKEVILTPTHLAIVMEYASGGELFDRICTAGRFSEAE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR+FFQQLI GV YCHS+Q+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKST
Sbjct: 100 ARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSILHSRPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL ++EYDGK ADVWSCGVTLYVMLVGAYPFEDP +PKNFRKTI RI++V
Sbjct: 160 VGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVGAYPFEDPNDPKNFRKTIQRIMAV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
QY IPDYVHIS EC+HL+SRIFV + AKRI++ EI+NH W+LKNLP +L+
Sbjct: 220 QYKIPDYVHISQECKHLLSRIFVTNSAKRITLKEIKNHPWYLKNLPKELLESAQAAYYKR 279
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS 305
+ +QS+++IM+I+ EA PA T ++ +G+
Sbjct: 280 DTSFSLQSVEDIMKIVGEARNPAPSTSAVKSSGSGA 315
|
|
| TAIR|locus:2206046 SNRK2.10 "SNF1-related protein kinase 2.10" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1091 (389.1 bits), Expect = 1.8e-110, P = 1.8e-110
Identities = 201/270 (74%), Positives = 236/270 (87%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV REIINHRSLRHPNI+RFKEV+LTPTH+AI MEYA+GGELFERIC+AGRFSEDE
Sbjct: 40 KIDENVAREIINHRSLRHPNIIRFKEVVLTPTHIAIAMEYAAGGELFERICSAGRFSEDE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR+FFQQLISGVSYCH+MQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSS+LHS PKST
Sbjct: 100 ARYFFQQLISGVSYCHAMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSLLHSMPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL + EYDGK+ADVWSCGVTLYVMLVGAYPFED E+PKNF+KTI RI++V
Sbjct: 160 VGTPAYIAPEVLSRGEYDGKMADVWSCGVTLYVMLVGAYPFEDQEDPKNFKKTIQRIMAV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV-VDNTTNNQF 268
+Y IPDYVHIS +C+HL+SRIFV + KRI+I +I+ H WFLKNLP +L + +
Sbjct: 220 KYKIPDYVHISQDCKHLLSRIFVTNSNKRITIGDIKKHPWFLKNLPRELTEIAQAAYFRK 279
Query: 269 EEPDQPMQSIDEIMQIIAEATIPAAGTQSL 298
E P +QS++EIM+I+ EA PA ++S+
Sbjct: 280 ENPTFSLQSVEEIMKIVEEAKTPARVSRSI 309
|
|
| TAIR|locus:2160559 SNRK2.5 "SNF1-related protein kinase 2.5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1090 (388.8 bits), Expect = 2.3e-110, P = 2.3e-110
Identities = 202/270 (74%), Positives = 233/270 (86%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDENV REIINHRSLRHPNI+RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE E
Sbjct: 40 KIDENVAREIINHRSLRHPNIIRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEAE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR+FFQQLI GV YCHS+Q+CHRDLKLENTLLDGSPAP LKICDFGYSKSS+LHS+PKST
Sbjct: 100 ARYFFQQLICGVDYCHSLQICHRDLKLENTLLDGSPAPLLKICDFGYSKSSLLHSRPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAYIAPEVL ++EYDGK ADVWSCGVTLYVMLVG YPFEDP++P+NFRKTI RI++V
Sbjct: 160 VGTPAYIAPEVLSRREYDGKHADVWSCGVTLYVMLVGGYPFEDPDDPRNFRKTIQRIMAV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD-NTTNNQF 268
QY IPDYVHIS ECRHL+SRIFV + AKRI++ EI+ H W+LKNLP +L +
Sbjct: 220 QYKIPDYVHISQECRHLLSRIFVTNSAKRITLKEIKKHPWYLKNLPKELTEPAQAAYYKR 279
Query: 269 EEPDQPMQSIDEIMQIIAEATIPAAGTQSL 298
E P +QS+++IM+I+ EA PA + ++
Sbjct: 280 ETPSFSLQSVEDIMKIVGEARNPAPSSNAV 309
|
|
| TAIR|locus:2140104 SNRK2.7 "SNF1-related protein kinase 2.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1071 (382.1 bits), Expect = 2.4e-108, P = 2.4e-108
Identities = 200/272 (73%), Positives = 231/272 (84%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+IDE+VQREIINHR L+HPNI+RFKEV +TPTHLAIVMEYA+GGELFERICNAGRFSEDE
Sbjct: 40 KIDEHVQREIINHRDLKHPNIIRFKEVFVTPTHLAIVMEYAAGGELFERICNAGRFSEDE 99
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
R++F+QLISGVSYCH+MQ+CHRDLKLENTLLDGSP+ LKICDFGYSKSSVLHSQPKST
Sbjct: 100 GRYYFKQLISGVSYCHAMQICHRDLKLENTLLDGSPSSHLKICDFGYSKSSVLHSQPKST 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTPAY+APEVL +KEY+GKIADVWSCGVTLYVMLVGAYPFEDPE+P+N R TI RILSV
Sbjct: 160 VGTPAYVAPEVLSRKEYNGKIADVWSCGVTLYVMLVGAYPFEDPEDPRNIRNTIQRILSV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL----PADLVVDNTTN 265
Y+IPDYV IS EC+HL+SRIFVADP KRI++PEI H WFLK P + DN
Sbjct: 220 HYTIPDYVRISSECKHLLSRIFVADPDKRITVPEIEKHPWFLKGPLVVPPEEEKCDNGVE 279
Query: 266 NQFEEPDQPMQSIDEIMQIIAEATIPAAGTQS 297
+ EE ++ QS++EI++II EA GT +
Sbjct: 280 EEEEEEEKCRQSVEEIVKIIEEARKGVNGTDN 311
|
|
| TAIR|locus:2032075 SNRK2-8 "SNF1-RELATED PROTEIN KINASE 2-8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1057 (377.1 bits), Expect = 7.2e-107, P = 7.2e-107
Identities = 203/282 (71%), Positives = 235/282 (83%)
Query: 10 RCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 69
R +S +LF + + +IDE+VQREI+NHRSL HPNI+RFKEV+LT THLA+VMEY
Sbjct: 22 RDKFSKELFA--VKFIERGQKIDEHVQREIMNHRSLIHPNIIRFKEVLLTATHLALVMEY 79
Query: 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 129
A+GGELF RIC+AGRFSEDEARFFFQQLISGV+YCHS+Q+CHRDLKLENTLLDGS APR+
Sbjct: 80 AAGGELFGRICSAGRFSEDEARFFFQQLISGVNYCHSLQICHRDLKLENTLLDGSEAPRV 139
Query: 130 KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 189
KICDFGYSKS VLHSQPK+TVGTPAYIAPEVL KEYDGKIADVWSCGVTLYVMLVGAYP
Sbjct: 140 KICDFGYSKSGVLHSQPKTTVGTPAYIAPEVLSTKEYDGKIADVWSCGVTLYVMLVGAYP 199
Query: 190 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
FEDP +PK+FRKTI RIL QY+IPDYV +S ECRHL+SRIFVA+P KRI+I EI+NH W
Sbjct: 200 FEDPSDPKDFRKTIGRILKAQYAIPDYVRVSDECRHLLSRIFVANPEKRITIEEIKNHSW 259
Query: 250 FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 291
FLKNLP ++ + N P Q+++EI+ II EA P
Sbjct: 260 FLKNLPVEMYEGSLMMNG---PST--QTVEEIVWIIEEARKP 296
|
|
| TAIR|locus:2045319 SNRK2.9 "SNF1-related protein kinase 2.9" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
Identities = 193/297 (64%), Positives = 228/297 (76%)
Query: 2 LGFHNFYDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVIL 58
LGF NF + N ++ V + ++IDENV REIINHR+L HPNIVRFKEV+L
Sbjct: 10 LGFGNF-GLARLMRNKQTNELVAVKFIDRGYKIDENVAREIINHRALNHPNIVRFKEVVL 68
Query: 59 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 118
TPTHL IVMEYA+GGELFERI + GRFSE EAR+FFQQLI GV Y H++Q+CHRDLKLEN
Sbjct: 69 TPTHLGIVMEYAAGGELFERISSVGRFSEAEARYFFQQLICGVHYLHALQICHRDLKLEN 128
Query: 119 TLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGV 178
TLLDGSPAPRLKICDFGYSKSSVLHS PKSTVGTPAYIAPEV + EYDGK DVWSCGV
Sbjct: 129 TLLDGSPAPRLKICDFGYSKSSVLHSNPKSTVGTPAYIAPEVFCRSEYDGKSVDVWSCGV 188
Query: 179 TLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238
LYVMLVGAYPFEDP++P+NFRKT+ +I++V Y IP YVHIS +CR L+SRIFVA+P R
Sbjct: 189 ALYVMLVGAYPFEDPKDPRNFRKTVQKIMAVNYKIPGYVHISEDCRKLLSRIFVANPLHR 248
Query: 239 ISIPEIRNHEWFLKNLPADLVVDNTT---NNQFEEPDQPMQSIDEIMQIIAEA-TIP 291
++ EI++H WFLKNLP +L + Q ++EIM+I+ EA TIP
Sbjct: 249 STLKEIKSHAWFLKNLPRELKEPAQAIYYQRNVNLINFSPQRVEEIMKIVGEARTIP 305
|
|
| TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 531 (192.0 bits), Expect = 4.0e-51, P = 4.0e-51
Identities = 115/231 (49%), Positives = 141/231 (61%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+++E V+REI R HP+I+R EVI TPT + +VMEY + GELF+ I GR EDE
Sbjct: 82 EMEEKVRREIKILRLFMHPHIIRLYEVIETPTDIYLVMEYVNSGELFDYIVEKGRLQEDE 141
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR FFQQ+ISGV YCH V HRDLK EN LLD +KI DFG S K++
Sbjct: 142 ARNFFQQIISGVEYCHRNMVVHRDLKPENLLLDSKC--NVKIADFGLSNIMRDGHFLKTS 199
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
G+P Y APEV+ K Y G DVWSCGV LY +L G PF+D P F+K I
Sbjct: 200 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--- 256
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 260
Y++P H+SP R LI R+ V DP KR++IPEIR H WF +LP L V
Sbjct: 257 -YTLPS--HLSPGARDLIPRMLVVDPMKRVTIPEIRQHPWFQAHLPRYLAV 304
|
|
| DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 524 (189.5 bits), Expect = 2.2e-50, P = 2.2e-50
Identities = 114/235 (48%), Positives = 143/235 (60%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
++DE ++REI N + RHP+I++ EVI T T + +VMEY +GGELFE I G+ EDE
Sbjct: 71 KMDEKIRREIQNMKLFRHPHIIKLYEVIETTTDIFMVMEYVTGGELFEYIVKNGKLLEDE 130
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR-LKICDFGYSKSSVLHSQPKS 148
+R FQQ+ISGV YCH V HRDLK EN LLD P + +KI DFG S K+
Sbjct: 131 SRRLFQQMISGVDYCHHHMVVHRDLKPENLLLD--PINKCIKIADFGLSNMMQDGDFLKT 188
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
+ G+P Y APEV+ K Y G DVWSCGV LY L PF+D P F+K +
Sbjct: 189 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGV-- 246
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 263
+SIPD+V SP C LI ++ V DP KRI+I EIRNH WF LP L +T
Sbjct: 247 --FSIPDFV--SPSCADLIKKMLVVDPVKRITIHEIRNHPWFQVKLPKYLSSPHT 297
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| A2ZAB5 | SAPK3_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7064 | 0.8652 | 0.8652 | N/A | no |
| P0C5D6 | SAPK3_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7064 | 0.8652 | 0.8652 | no | no |
| Q0D4J7 | SAPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7678 | 0.8353 | 0.8230 | no | no |
| Q02066 | AAIP_WHEAT | 2, ., 7, ., 1, 1, ., 1 | 0.7571 | 0.8263 | 0.8313 | N/A | no |
| Q9M9E9 | SRK2C_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7163 | 0.8233 | 0.8017 | no | no |
| Q39193 | SRK2I_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8065 | 0.9101 | 0.8421 | no | no |
| Q39192 | SRK2D_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.7759 | 0.9011 | 0.8314 | no | no |
| A2YNT8 | SAPK2_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7714 | 0.8353 | 0.8230 | N/A | no |
| Q940H6 | SRK2E_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8986 | 0.9131 | 0.8425 | no | no |
| Q75H77 | SAPKA_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8622 | 0.9101 | 0.8397 | yes | no |
| Q75V57 | SAPK9_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.8426 | 0.9101 | 0.8421 | no | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.979 |
| 3rd Layer | 2.7.11 | 0.983 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 334 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-87 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-76 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-57 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 7e-55 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-54 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-50 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-46 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-45 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-43 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-40 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-39 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-38 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 7e-38 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-38 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-37 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-37 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-37 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-37 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 7e-37 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 9e-37 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-36 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-35 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-35 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 5e-35 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-35 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-34 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-34 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-34 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-34 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-34 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 4e-34 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-34 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 5e-34 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-34 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 7e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-34 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 9e-34 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-33 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-33 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-33 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-33 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-32 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-31 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-31 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-31 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-31 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 8e-31 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-30 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-30 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-30 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 4e-30 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 4e-30 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-30 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 8e-30 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-29 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-29 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-29 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 7e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-28 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-28 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-28 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-28 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 5e-28 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 5e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-27 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-27 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-27 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-27 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 5e-27 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-27 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-26 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 5e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-26 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 7e-26 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 9e-26 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-25 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 6e-25 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 8e-25 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-25 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-25 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-25 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-24 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 2e-24 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-24 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-24 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-23 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-23 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 2e-23 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-23 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-23 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-23 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 7e-23 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-22 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-22 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-22 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-22 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-22 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-22 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 8e-22 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-22 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 9e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-21 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-21 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-21 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-21 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-21 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-21 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 4e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-21 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-21 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-21 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-21 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-20 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-20 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-20 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-20 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-20 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-20 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 8e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-20 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-19 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-19 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-19 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-19 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 8e-19 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-19 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-18 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-18 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-18 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-18 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-18 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-18 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 7e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-17 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-17 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-17 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-17 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 6e-17 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-17 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-16 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-16 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-16 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-16 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-16 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 1e-15 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-15 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-15 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-15 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-15 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 6e-15 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-14 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-14 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 5e-14 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-14 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 6e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 6e-14 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-13 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 4e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-13 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-13 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 8e-13 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-13 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-12 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-12 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-12 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 5e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-11 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 2e-11 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-11 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-11 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-11 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-10 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-10 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-10 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-10 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 3e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 8e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-10 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-09 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 5e-09 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 6e-09 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-09 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-08 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-08 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 4e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 8e-08 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-07 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 2e-07 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 6e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 6e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-07 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-06 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-06 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 2e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 8e-06 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 8e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 9e-06 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-05 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-05 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 9e-05 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-04 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-04 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-04 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-04 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 3e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 0.001 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.001 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 0.003 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 1e-87
Identities = 90/230 (39%), Positives = 128/230 (55%), Gaps = 7/230 (3%)
Query: 22 IIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81
+I + + E + REI + L+HPNIVR +V L +VMEY GG+LF+ +
Sbjct: 31 VIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKK 90
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
GR SEDEARF+ +Q++S + Y HS + HRDLK EN LLD +K+ DFG ++
Sbjct: 91 RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDED--GHVKLADFGLARQLD 148
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 201
+ + VGTP Y+APEVLL K Y + D+WS GV LY +L G PF ++ +
Sbjct: 149 PGEKLTTFVGTPEYMAPEVLLGKGYGKAV-DIWSLGVILYELLTGKPPFPGDDQLL---E 204
Query: 202 TIHRILSVQYSIP-DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+I + P ISPE + LI ++ V DP KR++ E H +F
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 235 bits (602), Expect = 1e-76
Identities = 96/235 (40%), Positives = 127/235 (54%), Gaps = 6/235 (2%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78
V I+ + D+ +REI R L HPNIVR + HL +VMEY GG+LF+
Sbjct: 29 VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88
Query: 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
+ G SEDEA+ Q++ G+ Y HS + HRDLK EN LLD + +KI DFG +K
Sbjct: 89 LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDEN--GVVKIADFGLAK 146
Query: 139 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
+ S +T VGTP Y+APEVLL G DVWS GV LY +L G PF E
Sbjct: 147 KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSG-ENIL 205
Query: 198 NFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ + I RIL +++ P + S E + LI + DP+KR + EI H WF
Sbjct: 206 DQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (493), Expect = 2e-60
Identities = 88/224 (39%), Positives = 119/224 (53%), Gaps = 17/224 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+ E + HP IV+ T L +V+EYA GGELF + GRFSE+ ARF
Sbjct: 38 EHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF 97
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLH-SQPKST 149
+ +++ + Y HS+ + +RDLK EN LLD G +K+ DFG +K S+ +
Sbjct: 98 YAAEIVLALEYLHSLGIIYRDLKPENILLDADG----HIKLTDFGLAKELSSEGSRTNTF 153
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
GTP Y+APEVLL K Y GK D WS GV LY ML G PF + + +IL
Sbjct: 154 CGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRK----EIYEKILKD 208
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 250
P+++ SPE R LIS + DP KR+ EI+ H +F
Sbjct: 209 PLRFPEFL--SPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 4e-57
Identities = 83/217 (38%), Positives = 107/217 (49%), Gaps = 40/217 (18%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEAR 91
E + REI + L HPNIV+ V HL +VMEY GG L + + N G+ SEDE
Sbjct: 36 EELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL 95
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTV 150
Q++ G+ Y HS + HRDLK EN LLD S ++K+ DFG SK + S K+ V
Sbjct: 96 RILLQILEGLEYLHSNGIIHRDLKPENILLD-SDNGKVKLADFGLSKLLTSDKSLLKTIV 154
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTPAY+APEVLL K Y + +D+WS GV LY +
Sbjct: 155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------- 187
Query: 211 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
PE + LI ++ DP KR S EI H
Sbjct: 188 ----------PELKDLIRKMLQKDPEKRPSAKEILEH 214
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 179 bits (457), Expect = 7e-55
Identities = 73/223 (32%), Positives = 111/223 (49%), Gaps = 15/223 (6%)
Query: 35 VQREIINHRSLRHPNIVRFK--EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++REI SL+HPNIVR+ E L I +EY SGG L + G+ E R
Sbjct: 46 LEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKST 149
+ +Q++ G++Y HS + HRD+K N L+D +K+ DFG +K S
Sbjct: 106 YTRQILEGLAYLHSNGIVHRDIKGANILVDSD--GVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
GTP ++APEV+ +EY AD+WS G T+ M G P+ + P +++I S
Sbjct: 164 RGTPYWMAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMAA---LYKIGSS 219
Query: 210 QYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
IP+ H+S E + + + DP KR + E+ H +
Sbjct: 220 GEPPEIPE--HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 9e-54
Identities = 83/244 (34%), Positives = 128/244 (52%), Gaps = 20/244 (8%)
Query: 10 RCSYSSDLFVNIIIIVFHLWQID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 68
R L+V I + ++ + + E+ E+ + L HPNI+++ E L IVME
Sbjct: 20 RRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79
Query: 69 YASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS 124
YA GG+L ++I + F E++ +F QL + Y HS ++ HRD+K +N L
Sbjct: 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT-- 137
Query: 125 PAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 181
+K+ DFG SK S+V + K+ VGTP Y++PE+ K Y+ K +D+WS G LY
Sbjct: 138 SNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYK-SDIWSLGCVLY 194
Query: 182 VMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKRIS 240
+ +PFE +N + +IL QY IP S E R+L+S + DP +R S
Sbjct: 195 ELCTLKHPFEG----ENLLELALKILKGQYPPIPS--QYSSELRNLVSSLLQKDPEERPS 248
Query: 241 IPEI 244
I +I
Sbjct: 249 IAQI 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 168 bits (429), Expect = 2e-50
Identities = 85/242 (35%), Positives = 130/242 (53%), Gaps = 33/242 (13%)
Query: 25 VFHLWQIDENVQRE-IINHR----SLRHPNIVR----FKEVILTPTHLAIVMEYASGGEL 75
+ +I + Q E ++N + S+RHP +V F++ ++L +VMEY GGEL
Sbjct: 33 ILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD----DSNLYLVMEYVPGGEL 88
Query: 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICD 133
F + +GRF E ARF+ Q++ + Y HS+ + +RDLK EN LLD G +KI D
Sbjct: 89 FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY----IKITD 144
Query: 134 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 193
FG++K + + + GTP Y+APE++L K Y GK D W+ G+ +Y ML G PF D
Sbjct: 145 FGFAK--RVKGRTYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFD- 200
Query: 194 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHE 248
+ P + +IL + P SP+ + LI + D KR+ + +I+NH
Sbjct: 201 DNP---IQIYEKILEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHP 255
Query: 249 WF 250
WF
Sbjct: 256 WF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 4e-46
Identities = 83/229 (36%), Positives = 119/229 (51%), Gaps = 21/229 (9%)
Query: 34 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF 93
+R+I++ + P +V+ +L +VMEY GG+L + N G ED AR +
Sbjct: 41 LTERDILSQ--AQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIY 98
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---------SSVLHS 144
+++ + Y HS + HRDLK +N L+D + LK+ DFG SK +
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSN--GHLKLTDFGLSKVGLVRRQINLNDDEK 156
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ K VGTP YIAPEV+L + + K D WS G LY LVG PF E P +
Sbjct: 157 EDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHG-ETP---EEIFQ 211
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 250
IL+ + P+ V +S E LIS++ V DP KR+ SI EI+NH +F
Sbjct: 212 NILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-45
Identities = 75/246 (30%), Positives = 117/246 (47%), Gaps = 43/246 (17%)
Query: 34 NVQREIINHRSLRHPNIVR----FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+++E++ R HP I++ F++ +L V+EYA GEL + I G E
Sbjct: 49 KIEKEVL-TRLNGHPGIIKLYYTFQD----EENLYFVLEYAPNGELLQYIRKYGSLDEKC 103
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----------- 138
RF+ +++ + Y HS + HRDLK EN LLD +KI DFG +K
Sbjct: 104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD--MHIKITDFGTAKVLDPNSSPESN 161
Query: 139 ----------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 188
+ S VGT Y++PE+L +K GK +D+W+ G +Y ML G
Sbjct: 162 KGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKP 220
Query: 189 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI----PEI 244
PF E T +IL ++YS P + P+ + LI ++ V DP R+ + E+
Sbjct: 221 PFRGSNEY----LTFQKILKLEYSFPP--NFPPDAKDLIEKLLVLDPQDRLGVNEGYDEL 274
Query: 245 RNHEWF 250
+ H +F
Sbjct: 275 KAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 3e-43
Identities = 66/224 (29%), Positives = 110/224 (49%), Gaps = 13/224 (5%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSED 88
+ E + EI + +HPNIV++ L L IVME+ SGG L + + + + +E
Sbjct: 39 EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTES 98
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQP 146
+ + ++L+ G+ Y HS + HRD+K N LL DG +K+ DFG S
Sbjct: 99 QIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE----VKLIDFGLSAQLSDTKAR 154
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+ VGTP ++APEV+ K YD K AD+WS G+T + G P+ + K + +I
Sbjct: 155 NTMVGTPYWMAPEVINGKPYDYK-ADIWSLGITAIELAEGKPPYSEL----PPMKALFKI 209
Query: 207 L-SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ + + S E + + + +P KR + ++ H +
Sbjct: 210 ATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 73/226 (32%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA-- 90
+ + E+ L+HPN+V++ V + + I MEY SGG L E + GR DE
Sbjct: 44 KEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL-EELLEHGRI-LDEHVI 101
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 145
R + QL+ G++Y HS + HRD+K N LD + +K+ DFG + ++ + +
Sbjct: 102 RVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEE 159
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
+S GTPAY+APEV+ + G AD+WS G + M G P+ E F+
Sbjct: 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW--SELDNEFQIMF 217
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
H + IPD + +SPE + + R +DP KR + E+ H +
Sbjct: 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 144 bits (362), Expect = 7e-40
Identities = 81/241 (33%), Positives = 115/241 (47%), Gaps = 21/241 (8%)
Query: 30 QIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVMEYASGGELFERICN---AGRF 85
+ E REI SL HP NIV+ + L +VMEY GG L + + G
Sbjct: 39 KEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPL 98
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------- 138
SE EA F Q++S + Y HS + HRD+K EN LLD +K+ DFG +K
Sbjct: 99 SESEALFILAQILSALEYLHSKGIIHRDIKPENILLD-RDGRVVKLIDFGLAKLLPDPGS 157
Query: 139 SSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 196
+S + + P ++VGTP Y+APEVLL Y +D+WS G+TLY +L G PFE +
Sbjct: 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS 217
Query: 197 -------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
K + L+ S + IS L+ ++ DP R+S +H+
Sbjct: 218 SATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDL 277
Query: 250 F 250
Sbjct: 278 L 278
|
Length = 384 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 74/230 (32%), Positives = 116/230 (50%), Gaps = 16/230 (6%)
Query: 29 WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
E++ E HP IV+ ++ ++MEY GGEL+ + + G F E
Sbjct: 34 TGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEY 93
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
ARF+ ++ Y H+ + +RDLK EN LLD + +K+ DFG++K + +
Sbjct: 94 TARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSN--GYVKLVDFGFAKKLKSGQKTWT 151
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRIL 207
GTP Y+APE++L K YD D WS G+ LY +L G PF ED E+P + + IL
Sbjct: 152 FCGTPEYVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDP---MEIYNDIL 207
Query: 208 SVQYSI--PDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ P+Y I + LI ++ +P +R+ I +I+ H+WF
Sbjct: 208 KGNGKLEFPNY--IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 3e-38
Identities = 84/238 (35%), Positives = 118/238 (49%), Gaps = 20/238 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++ RHP + K T L VMEYA+GGELF + FSED ARF+ +++S +
Sbjct: 50 QNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALG 109
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 161
Y HS V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 110 YLHSCDVVYRDLKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVL 167
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
+Y G+ D W GV +Y M+ G PF + + K F IL + P +SP
Sbjct: 168 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFPR--TLSP 220
Query: 222 ECRHLISRIFVADPAKRI-----SIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 274
E + L++ + DP +R+ EI H +F A + + + E P +P
Sbjct: 221 EAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF-----ASINWQDVVQKKLEPPFKP 273
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 71/220 (32%), Positives = 111/220 (50%), Gaps = 15/220 (6%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+ +EI ++L+HPNIV++ I T L I++EYA G L + I G F E +
Sbjct: 46 IMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYV 105
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKSTVG 151
Q++ G++Y H V HRD+K N L DG +K+ DFG + K + + S VG
Sbjct: 106 YQVLQGLAYLHEQGVIHRDIKAANILTTKDGV----VKLADFGVATKLNDVSKDDASVVG 161
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP ++APEV+ +D+WS G T+ +L G P+ D N + RI+ +
Sbjct: 162 TPYWMAPEVIEMSGASTA-SDIWSLGCTVIELLTGNPPYYD----LNPMAALFRIVQDDH 216
Query: 212 S-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+P+ ISPE + + + F DP R + ++ H W
Sbjct: 217 PPLPE--GISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 77/231 (33%), Positives = 118/231 (51%), Gaps = 17/231 (7%)
Query: 25 VFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 84
V L Q ++V E + + HP I+R L ++MEY GGELF + N+GR
Sbjct: 39 VIRLKQE-QHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR 97
Query: 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144
FS F+ +++ + Y HS ++ +RDLK EN LLD +K+ DFG++K L
Sbjct: 98 FSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKE--GHIKLTDFGFAKK--LRD 153
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ + GTP Y+APEV+ K + K D W+ G+ +Y MLVG PF D N
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFD----DNPFGIYE 208
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+IL+ + P H+ + LI ++ V D +R+ +++NH WF
Sbjct: 209 KILAGKLEFPR--HLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 7e-38
Identities = 83/227 (36%), Positives = 122/227 (53%), Gaps = 17/227 (7%)
Query: 31 IDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
D++V+ ++ R L HP + T HL VMEY +GG+L I ++GRF
Sbjct: 35 EDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD 94
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E ARF+ ++I G+ + H + +RDLKL+N LLD +KI DFG K ++
Sbjct: 95 EARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKD--GHIKIADFGMCKENMNGEGK 152
Query: 147 KST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
ST GTP YIAPE+L ++Y+ + D WS GV LY ML+G PF +E + F
Sbjct: 153 ASTFCGTPDYIAPEILKGQKYNESV-DWWSFGVLLYEMLIGQSPFHGEDEDELFD----- 206
Query: 206 ILSVQYSIPDY-VHISPECRHLISRIFVADPAKRISIP-EIRNHEWF 250
S+ P + IS E + +S++F DP KR+ + +IR H +F
Sbjct: 207 --SILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 1e-37
Identities = 77/249 (30%), Positives = 112/249 (44%), Gaps = 41/249 (16%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFF 93
++EI+ +L HP + T T+L +VM+Y GGELF + SE+ ARF+
Sbjct: 51 EQEIL--ATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFY 108
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGY 136
+++ + Y H + + +RDLK EN LL S P P K G
Sbjct: 109 AAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGS 168
Query: 137 SKSSVLHSQP-----------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 185
+SSV S VGT YIAPEV+ + + D W+ G+ LY ML
Sbjct: 169 RRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLY 227
Query: 186 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----SI 241
G PF+ N +T IL + + P +S R LI ++ V DP+KR+
Sbjct: 228 GTTPFKG----SNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGA 283
Query: 242 PEIRNHEWF 250
EI+ H +F
Sbjct: 284 AEIKQHPFF 292
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (341), Expect = 2e-37
Identities = 72/243 (29%), Positives = 104/243 (42%), Gaps = 36/243 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQ 95
REI + L+HPNIV+ +VI T L +V EY +L + + G S + +
Sbjct: 47 REISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMY 105
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 151
QL+ G++YCHS ++ HRDLK +N L++ LK+ DFG +++ P T V
Sbjct: 106 QLLRGLAYCHSHRILHRDLKPQNILINRD--GVLKLADFGLARA---FGIPLRTYTHEVV 160
Query: 152 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFE------------------D 192
T Y APE+LL K Y + D+WS G M+ G F
Sbjct: 161 TLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPT 219
Query: 193 PEEPKNFRK--TIHRILSVQYSIPDYVHIS---PECRHLISRIFVADPAKRISIPEIRNH 247
E K + PE L+S++ +PAKRIS E H
Sbjct: 220 EESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279
Query: 248 EWF 250
+F
Sbjct: 280 PYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 78/228 (34%), Positives = 114/228 (50%), Gaps = 19/228 (8%)
Query: 34 NVQREIINHRS-----LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
Q+ I+ R+ ++HP +V T L V++Y +GGELF + F E
Sbjct: 37 KEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP 96
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
ARF+ ++ S + Y HS+ + +RDLK EN LLD L DFG K + HS+ S
Sbjct: 97 RARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLT--DFGLCKEGIEHSKTTS 154
Query: 149 T-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
T GTP Y+APEVL K+ YD + D W G LY ML G PF + + + +++ L
Sbjct: 155 TFCGTPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL 213
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRI----SIPEIRNHEWFL 251
++ + IS RHL+ + D KR+ EI+NH +F
Sbjct: 214 RLKPN------ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 75/211 (35%), Positives = 107/211 (50%), Gaps = 15/211 (7%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
+HP + + T L VMEY +GG+L I +GRF E ARF+ +++ G+ + H
Sbjct: 54 KHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLH 113
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKK 164
+ +RDLKL+N LLD +KI DFG K +L ST GTP YIAPE+L +
Sbjct: 114 ERGIIYRDLKLDNVLLDSE--GHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ 171
Query: 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224
Y G D W+ GV LY ML G PFE +E + F IL + P +S E +
Sbjct: 172 PY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAK 224
Query: 225 HLISRIFVADPAKRISIP-----EIRNHEWF 250
++ +P KR+ +I+ H +F
Sbjct: 225 SILKSFLTKNPEKRLGCLPTGEQDIKGHPFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 7e-37
Identities = 74/222 (33%), Positives = 103/222 (46%), Gaps = 41/222 (18%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
HL +VMEY GG+L + F E+ ARF+ +L+ + H + HRD+K +N L+
Sbjct: 75 HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134
Query: 122 DGSPAPRLKICDFGYSK--------------------------SSVLHSQPK----STVG 151
D +K+ DFG K H Q + STVG
Sbjct: 135 DADG--HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVG 192
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP YIAPEVL Y + D WS GV LY ML G PF ++T ++I++ +
Sbjct: 193 TPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSD----TLQETYNKIINWKE 247
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRI-SIPEIRNHEWF 250
S P +SPE LI R + DP R+ S EI++H +F
Sbjct: 248 SLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFF 288
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 9e-37
Identities = 80/232 (34%), Positives = 120/232 (51%), Gaps = 21/232 (9%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSED 88
Q E + EI+ + +HPNIV + + L L +VMEY GG L + I N R +E
Sbjct: 57 QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEP 116
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQ 145
+ + ++++ G+ Y HS V HRD+K +N LL DGS +K+ DFG++ + + S+
Sbjct: 117 QIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS----VKLADFGFAAQLTKEKSK 172
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIH 204
S VGTP ++APEV+ +K+Y K+ D+WS G+ M G P +P P I
Sbjct: 173 RNSVVGTPYWMAPEVIKRKDYGPKV-DIWSLGIMCIEMAEGEPPYLREP--PLRALFLI- 228
Query: 205 RILSVQYSIPDYVHI---SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
IP + SPE + +++ V DP KR S E+ H FLK
Sbjct: 229 ----TTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP-FLKK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 81/249 (32%), Positives = 126/249 (50%), Gaps = 32/249 (12%)
Query: 28 LWQIDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83
L++++E R ++ R + + +V+ +L + MEY GG+ + N G
Sbjct: 39 LFKLNE--VRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG 96
Query: 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143
SED ARF+ ++ V H + HRDLK EN L+D S +K+ DFG SK V
Sbjct: 97 VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDAS--GHIKLTDFGLSKGIV-- 152
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEP----K 197
+ S VG+P Y+APEVL K YD + D WS G LY L G PF P E K
Sbjct: 153 TYANSVVGSPDYMAPEVLRGKGYDFTV-DYWSLGCMLYEFLCGFPPFSGSTPNETWENLK 211
Query: 198 NFRKTIHRILSVQYSIPDYV----HISPECRHLISRIFVADPAKRI-SIPEIRNHEWFLK 252
+++T+ R P Y ++S E LI+++ + DP++R S+ +I+NH +F K
Sbjct: 212 YWKETLQR--------PVYDDPRFNLSDEAWDLITKL-INDPSRRFGSLEDIKNHPFF-K 261
Query: 253 NLPADLVVD 261
+ + + +
Sbjct: 262 EVDWNELRE 270
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 131 bits (330), Expect = 1e-35
Identities = 78/227 (34%), Positives = 119/227 (52%), Gaps = 17/227 (7%)
Query: 31 IDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
ID++V+ ++ R L +P + T HL VME+ +GG+L I + GRF
Sbjct: 35 IDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD 94
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
A F+ +++ G+ + HS + +RDLKL+N +LD +KI DFG K +V
Sbjct: 95 LYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRD--GHIKIADFGMCKENVFGDNR 152
Query: 147 KST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
ST GTP YIAPE+L +Y + D WS GV LY ML+G PF +E + F
Sbjct: 153 ASTFCGTPDYIAPEILQGLKYTFSV-DWWSFGVLLYEMLIGQSPFHGDDEDELFE----- 206
Query: 206 ILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIP-EIRNHEWF 250
S++ P Y I+ E + ++ ++F DP +R+ + IR H +F
Sbjct: 207 --SIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 2e-35
Identities = 70/212 (33%), Positives = 106/212 (50%), Gaps = 12/212 (5%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
R P +V T T L ++++Y +GGELF + F+E E R + +++ + + H
Sbjct: 63 RCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLH 122
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLK 163
+ + +RD+KLEN LLD + + DFG SK + + + S GT Y+APEV+
Sbjct: 123 QLGIIYRDIKLENILLDSE--GHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRG 180
Query: 164 KEYD-GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-HRILSVQYSIPDYVHISP 221
K D WS GV + +L GA PF E +N + I RIL + P +S
Sbjct: 181 GSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILKSKPPFPK--TMSA 237
Query: 222 ECRHLISRIFVADPAKRI---SIPEIRNHEWF 250
E R I ++ DP KR+ EI+NH +F
Sbjct: 238 EARDFIQKLLEKDPKKRLGANGADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 76/212 (35%), Positives = 111/212 (52%), Gaps = 15/212 (7%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y H
Sbjct: 53 RHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 112
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLKK 164
S V +RD+KLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 113 SRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 170
Query: 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224
+Y G+ D W GV +Y M+ G PF + + + F IL + P +SPE +
Sbjct: 171 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPR--TLSPEAK 223
Query: 225 HLISRIFVADPAKRI-----SIPEIRNHEWFL 251
L++ + DP +R+ E+ H +FL
Sbjct: 224 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 5e-35
Identities = 77/231 (33%), Positives = 109/231 (47%), Gaps = 18/231 (7%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 107
P IV K +P L +V+ + +GGELF + GRF ARF+ +L+ + H
Sbjct: 53 PFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKF 112
Query: 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEY 166
V +RDLK EN LLD + +CDFG K ++ +T GTP Y+APE+LL Y
Sbjct: 113 NVIYRDLKPENILLD--YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY 170
Query: 167 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226
K D W+ GV LY ML G PF D + +RK IL PD + + L
Sbjct: 171 T-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRK----ILQEPLRFPD--GFDRDAKDL 223
Query: 227 ISRIFVADPAKRISI---PEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQP 274
+ + DP +R+ EI+NH +F + L + P +P
Sbjct: 224 LIGLLSRDPTRRLGYNGAQEIKNHPFF-----SQLSWKKLLMKGIQPPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-34
Identities = 70/249 (28%), Positives = 109/249 (43%), Gaps = 34/249 (13%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDE 89
I REI ++ +HP +V+ +V + +VMEY +L E + + R E +
Sbjct: 42 IPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQ 100
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPK 147
+ + + L+ GV+Y H+ + HRDLK N L+ S LKI DFG ++ S
Sbjct: 101 VKSYMRMLLKGVAYMHANGIMHRDLKPANLLI--SADGVLKIADFGLARLFSEEEPRLYS 158
Query: 148 STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
V T Y APE+L ++YD + D+W+ G +L G+ P E + R
Sbjct: 159 HQVATRWYRAPELLYGARKYDPGV-DLWAVGCIFAELLNGS-PLFPGENDIEQLAIVFRT 216
Query: 207 LSVQ--------YSIPDYVHIS-------------PECR----HLISRIFVADPAKRISI 241
L S+PDY I+ P+ L+ + V DP+KR+S
Sbjct: 217 LGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSA 276
Query: 242 PEIRNHEWF 250
E H +F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 2e-34
Identities = 71/222 (31%), Positives = 112/222 (50%), Gaps = 12/222 (5%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R ++ H + P +V T L ++++Y SGGE+F + FSEDE RF+
Sbjct: 54 ERNVLEHVR-QSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSG 112
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTP 153
++I + + H + + +RD+KLEN LLD + + DFG SK + + + S GT
Sbjct: 113 EIILALEHLHKLGIVYRDIKLENILLDSE--GHVVLTDFGLSKEFLSEEKERTYSFCGTI 170
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213
Y+APE++ K GK D WS G+ ++ +L GA PF E + RIL
Sbjct: 171 EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF 230
Query: 214 PDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
P + I PE + L+ ++ DP KR+ EI+ H +F
Sbjct: 231 PSF--IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 72/210 (34%), Positives = 96/210 (45%), Gaps = 12/210 (5%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCH 105
IV T L +VM +GG+L I N G F E A F+ Q+I G+ + H
Sbjct: 53 RFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLH 112
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 165
++ +RDLK EN LLD R I D G + + K GTP Y+APEVL +
Sbjct: 113 QRRIVYRDLKPENVLLDDHGNVR--ISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV 170
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225
YD D ++ G TLY M+ G PF +E + R L + PD SPE +
Sbjct: 171 YDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPD--KFSPEAKD 227
Query: 226 LISRIFVADPAKRI-----SIPEIRNHEWF 250
L + DP KR+ S E+R H F
Sbjct: 228 LCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 3e-34
Identities = 81/212 (38%), Positives = 111/212 (52%), Gaps = 16/212 (7%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
RHP + K T L VMEYA+GGELF + FSED ARF+ +++S + Y H
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 112
Query: 106 S-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVLLK 163
S V +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 113 SEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 170
Query: 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223
+Y G+ D W GV +Y M+ G PF + + K F IL + P +SPE
Sbjct: 171 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFPRT--LSPEA 223
Query: 224 RHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ L+S + DP +R+ EI H++F
Sbjct: 224 KSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-34
Identities = 76/215 (35%), Positives = 106/215 (49%), Gaps = 9/215 (4%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARF 92
Q E + L HPNI+ + E L L IVMEYA GG L E I ED
Sbjct: 46 AQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILH 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
FF Q++ + + H+ + HRDLK +N LLD +KI DFG SK S+ + VGT
Sbjct: 106 FFVQILLALHHVHTKLILHRDLKTQNILLDKHKMV-VKIGDFGISKILSSKSKAYTVVGT 164
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P YI+PE+ K Y+ K +D+W+ G LY + F E N + +I+S ++
Sbjct: 165 PCYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAF----EAANLPALVLKIMSGTFA 219
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
P SP+ R LI + DP+KR + +I
Sbjct: 220 -PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 4e-34
Identities = 77/227 (33%), Positives = 124/227 (54%), Gaps = 17/227 (7%)
Query: 31 IDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
+D++V+ ++ R L HP + T +L VMEY +GG+L I + +F
Sbjct: 35 MDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFD 94
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
A F+ ++I G+ + HS + +RDLKL+N LLD +KI DFG K ++L
Sbjct: 95 LPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD--GHIKIADFGMCKENMLGDAK 152
Query: 147 KST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
T GTP YIAPE+LL ++Y+ + D WS GV LY ML+G PF +E + F+
Sbjct: 153 TCTFCGTPDYIAPEILLGQKYNTSV-DWWSFGVLLYEMLIGQSPFHGHDEEELFQ----- 206
Query: 206 ILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIP-EIRNHEWF 250
S++ P Y ++ E + ++ ++FV +P +R+ + +IR H +F
Sbjct: 207 --SIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF 251
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 4e-34
Identities = 71/211 (33%), Positives = 108/211 (51%), Gaps = 16/211 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 104
L HP IV + ++E+ GGELF + AGRF D A+F+ +L+ Y
Sbjct: 75 LSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYL 134
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 164
HS + +RDLK EN LLD +K+ DFG++K + + + GTP Y+APEV+ K
Sbjct: 135 HSKDIIYRDLKPENLLLDNK--GHVKVTDFGFAKK--VPDRTFTLCGTPEYLAPEVIQSK 190
Query: 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224
+ GK D W+ GV LY + G PF D + P FR +IL+ + P++ R
Sbjct: 191 GH-GKAVDWWTMGVLLYEFIAGYPPFFD-DTP--FR-IYEKILAGRLKFPNWF--DGRAR 243
Query: 225 HLISRIFVADPAKRI-----SIPEIRNHEWF 250
L+ + D KR+ + +++NH +F
Sbjct: 244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 5e-34
Identities = 77/214 (35%), Positives = 110/214 (51%), Gaps = 15/214 (7%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++ RHP + K T L VMEY +GGELF + FSED RF+ +++S +
Sbjct: 50 KNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVL 161
Y HS ++ +RDLKLEN +LD +KI DFG K + + K+ GTP Y+APEVL
Sbjct: 110 YLHSGKIVYRDLKLENLMLDKD--GHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVL 167
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
+Y G+ D W GV +Y M+ G PF + + K F IL P +S
Sbjct: 168 EDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEDIKFPRT--LSA 220
Query: 222 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ + L+S + + DP KR+ EI H +F
Sbjct: 221 DAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 6e-34
Identities = 65/228 (28%), Positives = 109/228 (47%), Gaps = 16/228 (7%)
Query: 31 IDENVQREIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
+++ R ++N R L HP +V ++ +V++ GG+L + +FS
Sbjct: 39 VEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS 98
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E++ +F+ +++ + Y HS + HRD+K +N LLD + I DF + +
Sbjct: 99 EEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQ--GHVHITDFNIATKVTPDTLT 156
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
ST GTP Y+APEVL ++ Y D WS GVT Y L G P+ + R +I
Sbjct: 157 TSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYR-----GHSRTIRDQI 210
Query: 207 LSVQ-YSIPDY-VHISPECRHLISRIFVADPAKRISIP--EIRNHEWF 250
+ Q + Y S E I+++ DP KR+ +++NH +F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 7e-34
Identities = 70/218 (32%), Positives = 99/218 (45%), Gaps = 22/218 (10%)
Query: 43 RSLRHPNIVRF--KEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQ 96
R L+HPNIVR+ + + + L IVMEY GG+L + I E+ Q
Sbjct: 54 RELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQ 113
Query: 97 LISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 150
L+ + CH V HRDLK N LD + +K+ DFG +K S T V
Sbjct: 114 LLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYV 171
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP Y++PE L YD K +D+WS G +Y + + PF +N + +I +
Sbjct: 172 GTPYYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPF----TARNQLQLASKIKEGK 226
Query: 211 YS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ IP S E +I + DP KR S E+
Sbjct: 227 FRRIPY--RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 8e-34
Identities = 72/221 (32%), Positives = 125/221 (56%), Gaps = 17/221 (7%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R+I+ + HP IV+ T L +++++ GG+LF R+ F+E++ +F+
Sbjct: 48 ERDILAE--VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 105
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 154
+L + + HS+ + +RDLK EN LLD +K+ DFG SK S+ H + S GT
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILLDEE--GHIKLTDFGLSKESIDHEKKAYSFCGTVE 163
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
Y+APEV+ ++ + + AD WS GV ++ ML G+ PF+ K+ ++T+ IL + +P
Sbjct: 164 YMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQG----KDRKETMTMILKAKLGMP 218
Query: 215 DYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ +SPE + L+ +F +PA R+ + EI+ H +F
Sbjct: 219 QF--LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 9e-34
Identities = 83/255 (32%), Positives = 138/255 (54%), Gaps = 23/255 (9%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R I+ +++HP IV T L +++EY SGGELF + G F ED A F+
Sbjct: 50 ERNIL--EAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
++ + + H + +RDLK EN LLD +K+ DFG K S+ T GT
Sbjct: 108 EISLALEHLHQQGIIYRDLKPENILLDAQ--GHVKLTDFGLCKESIHEGTVTHTFCGTIE 165
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
Y+APE+L++ + GK D WS G +Y ML GA PF +N +KTI +IL + ++P
Sbjct: 166 YMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPF----TAENRKKTIDKILKGKLNLP 220
Query: 215 DYVHISPECRHLISRIFVADPAKRI-SIPE----IRNHEWFLKNLPADLVVDNTTNNQFE 269
Y ++PE R L+ ++ +P+ R+ + P +++H +F +++ D ++ + E
Sbjct: 221 PY--LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFF-RHVNWDDLL----ARKVE 273
Query: 270 EPDQP-MQSIDEIMQ 283
P +P +QS +++ Q
Sbjct: 274 PPFKPLLQSEEDVSQ 288
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 73/219 (33%), Positives = 113/219 (51%), Gaps = 15/219 (6%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
EI ++L+H IV++ + L+I MEY GG + +++ G +E R + +Q+
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI 113
Query: 98 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQ---PKSTVGTP 153
+ GV Y HS + HRD+K N L D A +K+ DFG SK + S KS GTP
Sbjct: 114 LEGVEYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQY 211
+++PEV+ + Y G+ ADVWS G T+ ML P+ + E I +I +
Sbjct: 172 YWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQPTNP 226
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+P H+SP+ R+ + R FV + KR S E+ H +
Sbjct: 227 QLPS--HVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 72/208 (34%), Positives = 106/208 (50%), Gaps = 15/208 (7%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 107
P + + + +L +VMEY +GG+ I G ED A+ + +++ GV H
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 167
+ HRD+K EN L+D LK+ DFG S++ + K VGTP Y+APE +L D
Sbjct: 117 GIIHRDIKPENLLIDQ--TGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVG-D 170
Query: 168 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--ISPECRH 225
K++D WS G ++ L G PF E P ILS + + P+ V SPE
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFH-AETPD---AVFDNILSRRINWPEEVKEFCSPEAVD 226
Query: 226 LISRIFVADPAKRIS---IPEIRNHEWF 250
LI+R+ DPAKR+ EI++H +F
Sbjct: 227 LINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 70/213 (32%), Positives = 107/213 (50%), Gaps = 6/213 (2%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+++EI L+HPNIV++ +L I +E GG L + + G F E R +
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
+Q++ G+ Y H HRD+K N L+D + +K+ DFG +K V S KS G+P
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPY 166
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
++APEV+ ++ G AD+WS G T+ M G P+ E K I R + IP
Sbjct: 167 WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK-IGRSKELP-PIP 224
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
D H+S E + I + DP+ R + E+ H
Sbjct: 225 D--HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-33
Identities = 71/220 (32%), Positives = 124/220 (56%), Gaps = 21/220 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDE 89
E ++E+ +++HPNIV+++E +L IVM+Y GG+L+++I NA R F ED+
Sbjct: 44 EESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKI-NAQRGVLFPEDQ 102
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ-- 145
+F Q+ + + H ++ HRD+K +N L DG+ +K+ DFG ++ VL+S
Sbjct: 103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT----IKLGDFGIAR--VLNSTVE 156
Query: 146 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
++ +GTP Y++PE+ + Y+ K +D+W+ G LY M + F E N + +
Sbjct: 157 LARTCIGTPYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAF----EAGNMKNLVL 211
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+I+ Y P H S + R+L+S++F +P R S+ I
Sbjct: 212 KIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSI 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 82/272 (30%), Positives = 124/272 (45%), Gaps = 65/272 (23%)
Query: 60 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 119
+L ++MEY GG++ + F+E+E RF+ + I + H + HRD+K +N
Sbjct: 73 ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL 132
Query: 120 LLDGSPAPRLKICDFGYSK---------------------SSVLHSQPK----------- 147
LLD +K+ DFG S+P
Sbjct: 133 LLDAKG--HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKR 190
Query: 148 -------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKN 198
STVGTP YIAPEV L+ Y K D WS GV +Y MLVG PF ++P+E
Sbjct: 191 NRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQE--T 247
Query: 199 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF----- 250
+RK I+ ++Q PD V +SPE + LI R + +R+ + EI++H +F
Sbjct: 248 YRKIINWKETLQ--FPDEVPLSPEAKDLIKR-LCCEAERRLGNNGVNEIKSHPFFKGVDW 304
Query: 251 --LKNLPADLVV-----DNTTN-NQFEEPDQP 274
++ PA ++ +T+N + FEE D
Sbjct: 305 EHIRERPAPIIPELKSITDTSNFDDFEEIDLD 336
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 70/232 (30%), Positives = 103/232 (44%), Gaps = 10/232 (4%)
Query: 22 IIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81
I V + + + RE+ RS P +V+ ++IV+EY GG L + +
Sbjct: 33 KIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKK 92
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLL--DGSPAPRLKICDFGYSK 138
G+ E + +Q++ G+ Y H+ + HRD+K N L+ G KI DFG SK
Sbjct: 93 VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEV----KIADFGISK 148
Query: 139 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
+T VGT Y++PE ++ E AD+WS G+TL +G +PF P +P
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPE-RIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS 207
Query: 198 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
F I SPE R IS DP KR S E+ H +
Sbjct: 208 FFELMQA-ICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF 258
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 73/223 (32%), Positives = 110/223 (49%), Gaps = 17/223 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ + REI + L+H NIV++ L HL I +EY GG + + N G F E R
Sbjct: 51 DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQ 145
F +Q++ G++Y H+ + HRD+K N L+D +KI DFG SK S+ +
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTKTNGA 168
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
S G+ ++APEV+ + Y K AD+WS G + ML G +PF D + + I +
Sbjct: 169 RPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQ----LQAIFK 223
Query: 206 ILS-VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
I IP +IS E + + F D KR + E+ H
Sbjct: 224 IGENASPEIPS--NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 82/251 (32%), Positives = 126/251 (50%), Gaps = 18/251 (7%)
Query: 36 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+R I+ L P IV K T + L +V +Y SGGELF + GRFSED A+F+
Sbjct: 43 ERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYI 102
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
+L+ + + H + +RDLK EN LLD + + +CDFG SK+++ ++ +T GT
Sbjct: 103 AELVLALEHLHKYDIVYRDLKPENILLDAT--GHIALCDFGLSKANLTDNKTTNTFCGTT 160
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213
Y+APEVLL ++ K D WS GV ++ M G PF + + +R I +
Sbjct: 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN----IAFGKVRF 216
Query: 214 PDYVHISPECRHLISRIFVADPAKRI----SIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
P V +S E R + + +P R+ E++ H +F AD+ D + Q
Sbjct: 217 PKNV-LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFF-----ADIDWDLLSKKQIT 270
Query: 270 EPDQPMQSIDE 280
P +P+ DE
Sbjct: 271 PPFKPIVDSDE 281
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 4e-31
Identities = 70/197 (35%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
S RHP +V T H+ VMEYA+GG+L I + FSE A F+ ++ G+ Y
Sbjct: 58 SERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQY 116
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLL 162
H ++ +RDLKL+N LLD +KI DFG K + ST GTP ++APEVL
Sbjct: 117 LHENKIVYRDLKLDNLLLD--TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174
Query: 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222
+ Y + D W GV +Y MLVG PF +E + F ++ V+Y +S E
Sbjct: 175 ETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND--EVRYPR----FLSRE 227
Query: 223 CRHLISRIFVADPAKRI 239
++ R+ +P +R+
Sbjct: 228 AISIMRRLLRRNPERRL 244
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 6e-31
Identities = 71/207 (34%), Positives = 101/207 (48%), Gaps = 17/207 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLIS 99
S+ HPNI+ +KE L L IVMEYA G+L + I + E E F QL+
Sbjct: 55 SVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLR 114
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAP 158
G+ H ++ HRDLK N LL +KI D G SK VL K+ +GTP Y+AP
Sbjct: 115 GLQALHEQKILHRDLKSANILL--VANDLVKIGDLGISK--VLKKNMAKTQIGTPHYMAP 170
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYV 217
EV + Y K +D+WS G LY M A PF E ++ + +++ +Y IP
Sbjct: 171 EVWKGRPYSYK-SDIWSLGCLLYEMATFAPPF----EARSMQDLRYKVQRGKYPPIPP-- 223
Query: 218 HISPECRHLISRIFVADPAKRISIPEI 244
S + ++ I + P R + +I
Sbjct: 224 IYSQDLQNFIRSMLQVKPKLRPNCDKI 250
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-31
Identities = 74/229 (32%), Positives = 114/229 (49%), Gaps = 19/229 (8%)
Query: 32 DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D++V+ ++ R L + P + + T L VMEY +GG+L I G+F E
Sbjct: 41 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKE 100
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
A F+ ++ G+ + HS + +RDLKL+N +LD +KI DFG K ++ +
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE--GHIKIADFGMCKENIFGGKTT 158
Query: 148 ST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
T GTP YIAPE++ + Y GK D W+ GV LY ML G PF+ +E + F+ +
Sbjct: 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-----PEIRNHEWF 250
+S S +S E + + PAKR+ +IR H +F
Sbjct: 218 VSYPKS------LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF 260
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 8e-31
Identities = 70/249 (28%), Positives = 110/249 (44%), Gaps = 43/249 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAI--VMEYA----SGGELFERICNAGRFSEDEA 90
REI + LRHPNIVR KE++ + +I V EY +G L + +F+E +
Sbjct: 47 REIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQI 102
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
+ + +QL+ G+ Y HS + HRD+K N L++ LK+ DFG ++ + T
Sbjct: 103 KCYMKQLLEGLQYLHSNGILHRDIKGSNILINND--GVLKLADFGLARPYTKRNSADYTN 160
Query: 150 -VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI- 206
V T Y PE+LL Y ++ D+WS G L + +G F+ E + K I +
Sbjct: 161 RVITLWYRPPELLLGATRYGPEV-DMWSVGCILAELFLGKPIFQGSTELEQLEK-IFELC 218
Query: 207 -------------------LSVQYSIP----DYVH--ISPECRHLISRIFVADPAKRISI 241
L + ++ I P L+ ++ DP KRIS
Sbjct: 219 GSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278
Query: 242 PEIRNHEWF 250
+ HE+F
Sbjct: 279 DQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-30
Identities = 69/229 (30%), Positives = 107/229 (46%), Gaps = 27/229 (11%)
Query: 33 ENVQREIINHRSLRH---PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
++QRE+ LR PNI ++ L L I+MEYA GG + + AG +E
Sbjct: 44 SDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKY 102
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
++++ + Y H + V HRD+K N L+ + +K+CDFG + +S +ST
Sbjct: 103 ISVIIREVLVALKYIHKVGVIHRDIKAANILV--TNTGNVKLCDFGVAALLNQNSSKRST 160
Query: 150 -VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
VGTP ++APEV+ + K YD K AD+WS G+T+Y M G P+ D
Sbjct: 161 FVGTPYWMAPEVITEGKYYDTK-ADIWSLGITIYEMATGNPPYSD-----------VDAF 208
Query: 208 SVQYSIPDYV-------HISPECRHLISRIFVADPAKRISIPEIRNHEW 249
IP S R ++ +P +R+S E+ +W
Sbjct: 209 RAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKW 257
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 2e-30
Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 12/227 (5%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
E++ R +HPNIV L L +VME+ GG L + I R +E++ +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124
Query: 98 ISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPA 154
+ +S+ H+ V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPY 180
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
++APEV+ + Y G D+WS G+ + M+ G P+ + E P K I L + +
Sbjct: 181 WMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFN-EPPLQAMKRIRDNLPPK--LK 236
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
+ +SP R + R+ V DPA+R + E+ NH + K P +V
Sbjct: 237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPPSSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 73/233 (31%), Positives = 110/233 (47%), Gaps = 21/233 (9%)
Query: 32 DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D++V + R L +HP + T L VMEY +GG+L +I + +F E
Sbjct: 36 DDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDE 95
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+RF+ ++ + + H V +RDLKL+N LLD K+ DFG K +L+
Sbjct: 96 PRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAE--GHCKLADFGMCKEGILNGVTT 153
Query: 148 ST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+T GTP YIAPE+L + EY + D W+ GV +Y M+ G PFE E F +H
Sbjct: 154 TTFCGTPDYIAPEILQELEYGPSV-DWWALGVLMYEMMAGQPPFEADNEDDLFESILHD- 211
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-------PEIRNHEWFLK 252
V Y V +S E ++ +P KR+ I+ H +F +
Sbjct: 212 -DVLYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 4e-30
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 28/231 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++Q+EI R P I ++ L + L I+MEY GG + + G+ E F
Sbjct: 44 EDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLL-KPGKLDETYIAF 102
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKS-SVLHSQPKST 149
++++ G+ Y H HRD+K N LL +G +K+ DFG S + S+ +
Sbjct: 103 ILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD----VKLADFGVSGQLTSTMSKRNTF 158
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKT 202
VGTP ++APEV+ + YD K AD+WS G+T + G P D PKN +
Sbjct: 159 VGTPFWMAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPS 217
Query: 203 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ S + +S DP +R S E+ H+ F+K
Sbjct: 218 LEG-----------NKFSKPFKDFVSLCLNKDPKERPSAKELLKHK-FIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-30
Identities = 72/234 (30%), Positives = 112/234 (47%), Gaps = 31/234 (13%)
Query: 62 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120
+L +VMEY GG+L + +F ED A+F+ +L+ + H M HRD+K EN L
Sbjct: 75 NLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVL 134
Query: 121 LDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-----DV 173
+D + +K+ DFG + ++ K VGTP YIAPEVL DGK D
Sbjct: 135 IDRT--GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDW 192
Query: 174 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIF 231
WS GV Y M+ G PF + KT + I++ Q + P+ +S + LI +
Sbjct: 193 WSLGVIAYEMIYGRSPFHE----GTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSL- 247
Query: 232 VADPAKRISIPEIRNHEWF-------LKNLPADLV-----VDNTTNNQFEEPDQ 273
+ +R+ + H +F ++N V D+T+N F+EP++
Sbjct: 248 LCGQKERLGYEGLCCHPFFSKIDWNNIRNSLPPFVPTLKSDDDTSN--FDEPEK 299
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 7e-30
Identities = 69/243 (28%), Positives = 107/243 (44%), Gaps = 35/243 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQ 95
REI + L HPNI++ +V L +V E+ +L++ I + R E + +
Sbjct: 47 REIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLY 105
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---STVGT 152
QL+ G+++CHS + HRDLK EN L++ LK+ DFG ++S S + V T
Sbjct: 106 QLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARS--FGSPVRPYTHYVVT 161
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL----- 207
Y APE+LL + D+WS G +L F E K I R L
Sbjct: 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFK-IFRTLGTPDP 220
Query: 208 -----------SVQYSIPDYVHI---------SPECRHLISRIFVADPAKRISIPEIRNH 247
+ ++S P + SP+ L+S++ DP KRI+ + H
Sbjct: 221 EVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280
Query: 248 EWF 250
+F
Sbjct: 281 PYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 71/213 (33%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++L+HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 51 KNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIG 110
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 161
Y HS+ + +RDLK EN LLD + + DFG K V + ST GTP Y+APEVL
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQ--GHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVL 168
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
K+ YD + D W G LY ML G PF + + + +H+ L +
Sbjct: 169 RKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAA---- 223
Query: 222 ECRHLISRIFVADPAKRI----SIPEIRNHEWF 250
C L+ + D +R+ EI+NH +F
Sbjct: 224 -CDLLVG-LLHKDQRRRLGAKADFLEIKNHVFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 73/213 (34%), Positives = 111/213 (52%), Gaps = 14/213 (6%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 51 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 110
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 161
Y HS+ + +RDLK EN LLD + + DFG K ++ H+ ST GTP Y+APEVL
Sbjct: 111 YLHSLNIVYRDLKPENILLDSQ--GHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVL 168
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
K+ YD + D W G LY ML G PF + + +++ L ++ P+ I+
Sbjct: 169 HKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK---PN---ITN 221
Query: 222 ECRHLISRIFVADPAKRISIP----EIRNHEWF 250
RHL+ + D KR+ EI+NH +F
Sbjct: 222 SARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 71/215 (33%), Positives = 105/215 (48%), Gaps = 31/215 (14%)
Query: 59 TPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 118
T HL +VMEY GG+ + N G D AR +F + + + Y H+ + HRDLK +N
Sbjct: 72 TKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDN 131
Query: 119 TLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKSTVGTPAYIAPEVLL 162
L+ + +K+ DFG SK ++ K GTP YIAPEV+L
Sbjct: 132 LLI--TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVIL 189
Query: 163 KKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRILSVQYSIPDYVH-I 219
++ Y GK D W+ G+ LY LVG PF + PEE F + I S P+ +
Sbjct: 190 RQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVI----SDDIEWPEGDEAL 242
Query: 220 SPECRHLISRIFVADPAKRI---SIPEIRNHEWFL 251
+ + LISR+ +P +R+ E++ H +FL
Sbjct: 243 PADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 4e-29
Identities = 75/218 (34%), Positives = 114/218 (52%), Gaps = 17/218 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGR-FSEDEA 90
E+ ++E + ++HPNIV FKE HL IVMEY GG+L ++I G+ F ED
Sbjct: 43 EDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI 102
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-- 148
+F Q+ GV + H +V HRD+K +N L + ++K+ DFG S+ L + P +
Sbjct: 103 LQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL--TQNGKVKLGDFG---SARLLTSPGAYA 157
Query: 149 --TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
VGTP Y+ PE+ Y+ K +D+WS G LY + +PF + +++ I ++
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPF----QANSWKNLILKV 212
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
Y P H S E R LI ++F +P R S I
Sbjct: 213 CQGSYK-PLPSHYSYELRSLIKQMFKRNPRSRPSATTI 249
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 7e-29
Identities = 73/227 (32%), Positives = 110/227 (48%), Gaps = 18/227 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ ++ EI + L H NIV++ T +L+I +EY GG + + GRF E RF
Sbjct: 53 KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKST 149
F +Q++ G++Y HS + HRDLK +N L+D KI DFG SK S + Q S
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDNDQNMSM 170
Query: 150 VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
G+ ++APEV + Y K+ D+WS G + M G P+ D E K L
Sbjct: 171 QGSVFWMAPEVIHSYSQGYSAKV-DIWSLGCVVLEMFAGRRPWSDEEAIAAMFK-----L 224
Query: 208 SVQYS---IPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ S IP V ++SP ++ F +P R + E+ H +
Sbjct: 225 GNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 1e-28
Identities = 69/226 (30%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 28 LWQIDENVQREIINHRS----LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--N 81
L ++ E +R+ +N L+HPNI+ + + L I MEYA+GG L+++I
Sbjct: 35 LTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK 94
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--- 138
F E+ ++ Q++S VSY H + HRD+K N L + A +K+ DFG SK
Sbjct: 95 GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL--TKAGLIKLGDFGISKILG 152
Query: 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 198
S ++ + VGTP Y++PE+ +Y+ K +D+W+ G LY +L F + N
Sbjct: 153 SEYSMAE--TVVGTPYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTF----DATN 205
Query: 199 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ +I+ Y+ V+ S E L+ + DP KR + E+
Sbjct: 206 PLNLVVKIVQGNYTPVVSVY-SSELISLVHSLLQQDPEKRPTADEV 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 73/224 (32%), Positives = 109/224 (48%), Gaps = 18/224 (8%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R+I+ H + IV+ +L +VMEY GG+L + N E ARF+
Sbjct: 93 ERDIMAHAN--SEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-DIPEKWARFYTA 149
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPKSTVG 151
+++ + HSM HRD+K +N LLD S LK+ DFG + ++ + VG
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMDANGMVRCD--TAVG 205
Query: 152 TPAYIAPEVLLKKEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
TP YI+PEVL + D G+ D WS GV LY MLVG PF + K + S
Sbjct: 206 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS 265
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAK--RISIPEIRNHEWF 250
+ + PD + IS + + LI + R + EI++H +F
Sbjct: 266 LTF--PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-28
Identities = 75/229 (32%), Positives = 115/229 (50%), Gaps = 19/229 (8%)
Query: 32 DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D++V+ ++ R L + P + + T L VMEY +GG+L +I GRF E
Sbjct: 41 DDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKE 100
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QP 146
A F+ ++ G+ + HS + +RDLKL+N +LD +KI DFG K ++
Sbjct: 101 PHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSE--GHIKIADFGMCKENMWDGVTT 158
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
K+ GTP YIAPE++ + Y GK D W+ GV LY ML G PFE +E + F+ +
Sbjct: 159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN 217
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-PE----IRNHEWF 250
++ S +S E + + P KR+ PE I+ H +F
Sbjct: 218 VAYPKS------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 260
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-28
Identities = 78/253 (30%), Positives = 123/253 (48%), Gaps = 24/253 (9%)
Query: 32 DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D++V+ ++ R L + P + + T L VMEY +GG+L I G+F E
Sbjct: 41 DDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKE 100
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+A F+ ++ G+ + H + +RDLKL+N +LD +KI DFG K ++
Sbjct: 101 PQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSE--GHIKIADFGMCKEHMVDGVTT 158
Query: 148 ST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
T GTP YIAPE++ + Y GK D W+ GV LY ML G PF+ +E + F+ +
Sbjct: 159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN 217
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-PE----IRNHEWFLKNLPADLVVD 261
+S S +S E + + P+KR+ PE IR H +F + + D
Sbjct: 218 VSYPKS------LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR-----IDWD 266
Query: 262 NTTNNQFEEPDQP 274
N + + P +P
Sbjct: 267 KLENREIQPPFKP 279
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 73/241 (30%), Positives = 98/241 (40%), Gaps = 65/241 (26%)
Query: 63 LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD 122
L VM+Y GG++ + G F ED ARF+ +L + H M HRD+K +N L+D
Sbjct: 76 LYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILID 135
Query: 123 GSPAPRLKICDFG-------------YSK---------------SSVLHSQPK------- 147
+K+ DFG Y K S + + K
Sbjct: 136 RDG--HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRK 193
Query: 148 ---------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE---- 194
S VGTP YIAPEVLL+ Y ++ D WS GV LY MLVG PF
Sbjct: 194 RQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFLADTPAET 252
Query: 195 --EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEW 249
+ N+ T+H IP +S E LI R+ R+ EI+ H +
Sbjct: 253 QLKVINWETTLH--------IPSQAKLSREASDLILRL-CCGAEDRLGKNGADEIKAHPF 303
Query: 250 F 250
F
Sbjct: 304 F 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 5e-28
Identities = 75/220 (34%), Positives = 114/220 (51%), Gaps = 20/220 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDE 89
E ++E+I ++HPNIV F L IVMEY GG+L +RI N R FSED+
Sbjct: 44 EASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQ 102
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ-- 145
+F Q+ G+ + H ++ HRD+K +N L +G A K+ DFG ++ L+
Sbjct: 103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVA---KLGDFGIAR--QLNDSME 157
Query: 146 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ VGTP Y++PE+ + Y+ K D+WS G LY + +PFE N + +
Sbjct: 158 LAYTCVGTPYYLSPEICQNRPYNNK-TDIWSLGCVLYELCTLKHPFEG----NNLHQLVL 212
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+I ++ P + S + R LIS++F P R SI I
Sbjct: 213 KICQGYFA-PISPNFSRDLRSLISQLFKVSPRDRPSITSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 5e-28
Identities = 64/221 (28%), Positives = 90/221 (40%), Gaps = 17/221 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEA 90
E RE R L HPNIV+ V L IVMEY GG+L + R S +
Sbjct: 46 EEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDL 105
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQ 145
F Q+ G+ Y S HRDL N L+ + +KI DFG Y
Sbjct: 106 LSFALQIARGMEYLESKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYKVKG 163
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
K + ++APE L + ++ K +DVWS GV L+ + E N +
Sbjct: 164 GKLPI---RWMAPESLKEGKFTSK-SDVWSFGVLLWEIF--TLGEEPYPGMSNAE--VLE 215
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246
L Y +P + PE L+ + + DP R + E+
Sbjct: 216 YLKKGYRLPKPPNCPPELYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-28
Identities = 70/213 (32%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 32 DENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D++V+ + R L HP + + TP L VME+ +GG+L I + RF E
Sbjct: 36 DDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE 95
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
ARF+ ++ S + + H + +RDLKL+N LLD K+ DFG K + + +
Sbjct: 96 ARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGIFNGKTT 153
Query: 148 ST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
ST GTP YIAPE+L + Y G D W+ GV LY ML G PFE E F I
Sbjct: 154 STFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----I 208
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239
L+ + P ++ + ++ +P R+
Sbjct: 209 LNDEVVYPTWLS--QDAVDILKAFMTKNPTMRL 239
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 1e-27
Identities = 70/220 (31%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R+I+N+ + HP V ++L +V+E+ GGE F + RF D F+
Sbjct: 81 ERKILNY--INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAA 138
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155
Q++ Y S+ + +RDLK EN LLD +K+ DFG++K V+ ++ + GTP Y
Sbjct: 139 QIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAK--VVDTRTYTLCGTPEY 194
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 215
IAPE+LL + GK AD W+ G+ +Y +LVG PF E ++K + I+ P
Sbjct: 195 IAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII----YFPK 249
Query: 216 YVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ + C+HL+ ++ D KR ++ H WF
Sbjct: 250 F--LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 62/165 (37%), Positives = 86/165 (52%), Gaps = 16/165 (9%)
Query: 32 DENV----QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRF 85
DE+V RE+ R LRH NIV KE L +V EY EL E + G
Sbjct: 40 DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEA--SPGGL 97
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145
D R + QL+ ++YCHS + HRD+K EN L+ S + LK+CDFG++++ L ++
Sbjct: 98 PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV--SESGVLKLCDFGFARA--LRAR 153
Query: 146 PKST----VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186
P S V T Y APE+L+ GK DVW+ G + +L G
Sbjct: 154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 68/226 (30%), Positives = 114/226 (50%), Gaps = 15/226 (6%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+R+++ H + P +V T T L ++++Y +GGELF + RF E E + +
Sbjct: 54 ERQVLEHIR-QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSG 112
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTP 153
+++ + + H + + +RD+KLEN LLD + + + DFG SK + S GT
Sbjct: 113 EIVLALEHLHKLGIIYRDIKLENILLDSN--GHVVLTDFGLSKEFHEDEVERAYSFCGTI 170
Query: 154 AYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
Y+AP+++ + +D K D WS GV +Y +L GA PF E + + RIL +
Sbjct: 171 EYMAPDIVRGGDGGHD-KAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP 229
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWFLK 252
P +S + +I R+ + DP KR+ EI+ H +F K
Sbjct: 230 PYPQ--EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQK 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-27
Identities = 65/222 (29%), Positives = 93/222 (41%), Gaps = 22/222 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR 91
E RE R L HPN+V+ V L IVMEY GG+L + N + S +
Sbjct: 46 EEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLL 105
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSKSSVLHSQP 146
F Q+ G+ Y S HRDL N L+ + +KI DFG Y
Sbjct: 106 SFALQIARGMEYLESKNFIHRDLAARNCLVGEN--LVVKISDFGLSRDLYDDDYYRKRGG 163
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA---YPFEDPEEPKNFRKTI 203
K + ++APE L + ++ K +DVWS GV L+ + YP EE + K
Sbjct: 164 KLPI---RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG 219
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245
+R+ P PE L+ + + DP R + E+
Sbjct: 220 YRL-----PQPPNCP--PELYDLMLQCWAEDPEDRPTFSELV 254
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 72/227 (31%), Positives = 111/227 (48%), Gaps = 16/227 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E +++EI L HP+I+R +H + +E+ +GG + + G F E
Sbjct: 48 EALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIIN 107
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 149
+ +QL+ G+SY H Q+ HRD+K N L+D S RL+I DFG ++ L ++
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLID-STGQRLRIADFG--AAARLAAKGTGAGEF 164
Query: 150 ----VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
+GT A++APEVL ++Y G+ DVWS G + M P+ + E+ N I +
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPW-NAEKHSNHLALIFK 222
Query: 206 ILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
I S SIP+ H+SP R + R P R E+ H F
Sbjct: 223 IASATTAPSIPE--HLSPGLRDVTLRCLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-27
Identities = 67/229 (29%), Positives = 106/229 (46%), Gaps = 26/229 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEA 90
+ + +EI + P IV++ T L IVMEY G + + +I N +E+E
Sbjct: 43 QEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEI 101
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKST 149
Q + G+ Y HS + HRD+K N LL+ K+ DFG S + + ++ +
Sbjct: 102 AAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQA--KLADFGVSGQLTDTMAKRNTV 159
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
+GTP ++APEV+ + Y+ K AD+WS G+T M G P+ D IH +
Sbjct: 160 IGTPFWMAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSD----------IHPM-RA 207
Query: 210 QYSIP--------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ IP D SPE + + V DP +R S ++ H +
Sbjct: 208 IFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 76/269 (28%), Positives = 113/269 (42%), Gaps = 65/269 (24%)
Query: 26 FHLWQIDENVQ-REIINHRSLR----HPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80
F+ W +E + RE+ +SLR HPNIV+ KEV L V EY G L++ +
Sbjct: 36 FYSW--EECMNLREV---KSLRKLNEHPNIVKLKEVFRENDELYFVFEYME-GNLYQLMK 89
Query: 81 --NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
FSE R Q++ G+++ H HRDLK EN L+ S +KI DFG ++
Sbjct: 90 DRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV--SGPEVVKIADFGLAR 147
Query: 139 SSVLHSQPKST--VGTPAYIAPEVLLK-KEYDGKIADVWSCG------VTLYVMLVGAYP 189
+ S+P T V T Y APE+LL+ Y + D+W+ G TL + G+
Sbjct: 148 E--IRSRPPYTDYVSTRWYRAPEILLRSTSYSSPV-DIWALGCIMAELYTLRPLFPGSSE 204
Query: 190 FEDPEEPKNFRKTIHRILSV-------------------QYSIPDYVHI---------SP 221
+ +++I SV + P + SP
Sbjct: 205 ID----------QLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASP 254
Query: 222 ECRHLISRIFVADPAKRISIPEIRNHEWF 250
E LI + DP KR + + H +F
Sbjct: 255 EAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 76/244 (31%), Positives = 110/244 (45%), Gaps = 17/244 (6%)
Query: 19 VNIIIIVFHLWQID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77
V I I Q + +++E+ HPN+V++ + L +VM Y SGG L +
Sbjct: 29 VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLD 88
Query: 78 ---RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKIC 132
G E ++++ G+ Y HS HRD+K N LL DGS +KI
Sbjct: 89 IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS----VKIA 144
Query: 133 DFGYSKS-----SVLHSQPKSTVGTPAYIAPEVL-LKKEYDGKIADVWSCGVTLYVMLVG 186
DFG S S K+ VGTP ++APEV+ YD K AD+WS G+T + G
Sbjct: 145 DFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFK-ADIWSFGITAIELATG 203
Query: 187 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246
A P+ K T+ + DY S R +IS DP+KR + E+
Sbjct: 204 AAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263
Query: 247 HEWF 250
H++F
Sbjct: 264 HKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 3e-26
Identities = 68/234 (29%), Positives = 112/234 (47%), Gaps = 21/234 (8%)
Query: 31 IDENVQREI-----INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAG 83
I+E +Q++I I H+ P IV F ++I MEY GG L + G
Sbjct: 38 INEAIQKQILRELDILHKC-NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ-G 95
Query: 84 RFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
R E ++ G++Y H ++ HRD+K N L++ ++K+CDFG S V
Sbjct: 96 RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG--QIKLCDFGVSGQLV- 152
Query: 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202
+S K+ VGT +Y+APE + +Y K +D+WS G++L + G +P+ +P +
Sbjct: 153 NSLAKTFVGTSSYMAPERIQGNDYSVK-SDIWSLGLSLIELATGRFPYPPENDPPD---G 208
Query: 203 IHRILS--VQYSIPDY-VHI-SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
I +L V P SP+ + ++ + DP +R S E+ H + K
Sbjct: 209 IFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 78/255 (30%), Positives = 108/255 (42%), Gaps = 55/255 (21%)
Query: 37 REIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGGE-----LFERICNAGRFSEDE 89
REI L+HPNIV KEV++ + +VMEY E L E + F + E
Sbjct: 53 REINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV---EHDLKSLMETM--KQPFLQSE 107
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPK 147
+ QL+SGV++ H + HRDLK N LL + LKICDFG ++ S L +
Sbjct: 108 VKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL--NNRGILKICDFGLAREYGSPLKPYTQ 165
Query: 148 STVGTPAYIAPEVLL-KKEYDGKIADVWSCG------VTLYVMLVGA------------- 187
V T Y APE+LL KEY I D+WS G +T + G
Sbjct: 166 LVV-TLWYRAPELLLGAKEYSTAI-DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLL 223
Query: 188 -YPFED--PEEPKNFRKTIHRILSVQYSIPDYVHISPECRH---------LISRIFVADP 235
P E P F + ++ Y + + L++R+ DP
Sbjct: 224 GTPTEKIWPG----FSELPG-AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDP 278
Query: 236 AKRISIPEIRNHEWF 250
AKRIS + H +F
Sbjct: 279 AKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 6e-26
Identities = 69/211 (32%), Positives = 101/211 (47%), Gaps = 15/211 (7%)
Query: 50 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGVSYCH 105
IV T T L +VM +GG+L I N F E A F+ Q+ISG+ + H
Sbjct: 55 IVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-KSSVLHSQPKSTVGTPAYIAPEVLLKK 164
++ +RDLK EN LLD ++I D G + + S+ K GTP ++APE+L +
Sbjct: 115 QRRIIYRDLKPENVLLDN--DGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE 172
Query: 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224
EYD + D ++ GVTLY M+ PF E ++ RIL+ + PD SP +
Sbjct: 173 EYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPD--KFSPASK 229
Query: 225 HLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ DP KR+ + +R H F
Sbjct: 230 SFCEALLAKDPEKRLGFRDGNCDGLRTHPLF 260
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 7e-26
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEARFFFQQLISGV 101
L I+R+ E L L IVMEYA G+L + + ED+ FF Q++ G+
Sbjct: 55 KLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAP 158
++ HS ++ HRD+K N LD +KI D G +K +L + VGTP Y++P
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAY--DNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSP 170
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 218
E+ K Y+ K +DVW+ GV LY G +PF + N I +I+ + P
Sbjct: 171 ELCEDKPYNEK-SDVWALGVVLYECCTGKHPF----DANNQGALILKIIRGVFP-PVSQM 224
Query: 219 ISPECRHLISRIFVADPAKR 238
S + LI + D +R
Sbjct: 225 YSQQLAQLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 65/213 (30%), Positives = 104/213 (48%), Gaps = 14/213 (6%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++++HP +V T L V+++ +GGELF + F E ARF+ ++ S +
Sbjct: 51 KNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALG 110
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 161
Y HS+ + +RDLK EN LLD + + DFG K + S +T GTP Y+APEV+
Sbjct: 111 YLHSINIVYRDLKPENILLDSQ--GHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI 168
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
K+ YD + D W G LY ML G PF + + + +H+ L ++ S
Sbjct: 169 RKQPYDNTV-DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPG------ASL 221
Query: 222 ECRHLISRIFVADPAKRI----SIPEIRNHEWF 250
++ + D +R+ EI+ H +F
Sbjct: 222 TAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-25
Identities = 72/243 (29%), Positives = 107/243 (44%), Gaps = 49/243 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
REI R + HPN+V+ ++ + +++E+ GG L +F D AR Q
Sbjct: 121 REIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVAR----Q 176
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAY 155
++SG++Y H + HRD+K N L++ A +KI DFG S+ P S+VGT AY
Sbjct: 177 ILSGIAYLHRRHIVHRDIKPSNLLINS--AKNVKIADFGVSRILAQTMDPCNSSVGTIAY 234
Query: 156 IAPEV----LLKKEYDGKIADVWSCGVTLYVMLVGAYPF------------------EDP 193
++PE L YDG D+WS GV++ +G +PF + P
Sbjct: 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPP 294
Query: 194 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
E P S E RH IS +PAKR S ++ H + L+
Sbjct: 295 EAPAT--------------------ASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334
Query: 254 LPA 256
P
Sbjct: 335 QPG 337
|
Length = 353 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 6e-25
Identities = 71/262 (27%), Positives = 103/262 (39%), Gaps = 65/262 (24%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYA---------SGGELFERICNA 82
REI R LRH NI+ +++ P+ + IV E S L
Sbjct: 48 REIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPL------- 100
Query: 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
++D ++F Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++
Sbjct: 101 ---TDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD--LKICDFGLARGVDP 155
Query: 143 HSQPKST----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVML------------- 184
K V T Y APE+LL Y I D+WS G +L
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYID 214
Query: 185 --------VGAYPFEDPEEPKNFRKTIHRILSVQYS--------IPDYVHISPECRHLIS 228
+G ED + + K + + S+ P SPE L+
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITS-EKARNYLKSLPKKPKKPLSKLFPG---ASPEAIDLLE 270
Query: 229 RIFVADPAKRISIPEIRNHEWF 250
++ V DP KRI+ E H +
Sbjct: 271 KMLVFDPKKRITADEALAHPYL 292
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-25
Identities = 61/220 (27%), Positives = 91/220 (41%), Gaps = 25/220 (11%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS- 99
+ L HPN+VR V L +V+EY GG+L + R S +++ + L+S
Sbjct: 51 KKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 100 ------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153
G+ Y S + HRDL N L+ +KI DFG S+ + G
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLVGED--LVVKISDFGLSRDVYDDDYYRKKTGGK 168
Query: 154 AYI---APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFRKTIHRIL 207
I APE L + K +DVWS GV L+ + +GA P+ EE + L
Sbjct: 169 LPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEE-------VLEYL 220
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
Y +P + E L+ + DP R + E+
Sbjct: 221 RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 70/215 (32%), Positives = 109/215 (50%), Gaps = 15/215 (6%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL---FERICNAGRFSEDEARFFF 94
EI H L+H NIV++ I ME GG L + +E F+
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 153
+Q++ G+ Y H Q+ HRD+K +N L++ + + +KI DFG SK + ++ ++ GT
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVN-TYSGVVKISDFGTSKRLAGINPCTETFTGTL 173
Query: 154 AYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--FRKTIHRILSV 209
Y+APEV+ K + Y G AD+WS G T+ M G PF + EP+ F+ + +I
Sbjct: 174 QYMAPEVIDKGPRGY-GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKI--- 229
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
IP+ +S E ++ I R F DP KR S ++
Sbjct: 230 HPEIPE--SLSAEAKNFILRCFEPDPDKRASAHDL 262
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-25
Identities = 64/186 (34%), Positives = 106/186 (56%), Gaps = 17/186 (9%)
Query: 63 LAIVMEYASGGELFERICN---AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLEN 118
+A+V++YA+ G+L + I + R F E EA F Q++ V + HS + HRD+K N
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSAN 173
Query: 119 TLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 175
LL + +K+ DFG+SK ++V ++ GTP Y+APE+ +K Y K AD++S
Sbjct: 174 ILLCSNGL--VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFS 230
Query: 176 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVAD 234
GV LY +L PF+ +N + +H+ L+ +Y +P ISPE + +++ + +D
Sbjct: 231 LGVLLYELLTLKRPFDG----ENMEEVMHKTLAGRYDPLPP--SISPEMQEIVTALLSSD 284
Query: 235 PAKRIS 240
P +R S
Sbjct: 285 PKRRPS 290
|
Length = 496 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-25
Identities = 71/235 (30%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEAR 91
E +Q+EI + RHPNIV + L L IVMEY GG L + G SE +
Sbjct: 45 EIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIA 104
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS---KSSVLHSQP 146
+ ++ + G++Y H HRD+K N LL DG +K+ DFG S +++ ++
Sbjct: 105 YVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD----VKLADFGVSAQLTATI--AKR 158
Query: 147 KSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
KS +GTP ++APEV K YDGK D+W+ G+T + P D +
Sbjct: 159 KSFIGTPYWMAPEVAAVERKGGYDGK-CDIWALGITAIELAELQPPMFD----------L 207
Query: 204 HRILSVQYSIP----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHE 248
H + + I D SP I + DP KR + ++ H
Sbjct: 208 H-PMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 78/246 (31%), Positives = 112/246 (45%), Gaps = 41/246 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FF 94
REI + L HPNIVR +V+ + L +V E+ +L + + ++ D +
Sbjct: 47 REISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYL 105
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----V 150
QL+ G++YCHS +V HRDLK +N L+D A LK+ DFG +++ P T V
Sbjct: 106 YQLLQGIAYCHSHRVLHRDLKPQNLLIDREGA--LKLADFGLARA---FGVPVRTYTHEV 160
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILS- 208
T Y APE+LL D+WS G M+ F D E + FR I R L
Sbjct: 161 VTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFR--IFRTLGT 218
Query: 209 --------VQYSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEI 244
V S+PDY ++ + L+S++ V DPAKRIS
Sbjct: 219 PDEDVWPGVT-SLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277
Query: 245 RNHEWF 250
H +F
Sbjct: 278 LQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 66/219 (30%), Positives = 100/219 (45%), Gaps = 18/219 (8%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 92
+EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 51 KEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 147
+F QL S + + HS ++ HRD+K N + + +K+ D G SK++ HS
Sbjct: 111 YFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL-- 166
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
VGTP Y++PE + + Y+ K +D+WS G LY M PF + N +I
Sbjct: 167 --VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFY--GDKMNLYSLCKKIE 221
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246
Y H S E R L+SR DP KR I +
Sbjct: 222 KCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 2e-24
Identities = 71/246 (28%), Positives = 106/246 (43%), Gaps = 40/246 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFF 94
REI + L+H NIVR +VI T L +V EY + + G + + F
Sbjct: 47 REISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFT 106
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 153
QL+ G+++CH +V HRDLK +N L++ LK+ DFG +++ + + + V T
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINKR--GELKLADFGLARAFGIPVNTFSNEVVTL 164
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF-----ED--------------- 192
Y AP+VLL + Y I D+WS G + M+ G F ED
Sbjct: 165 WYRAPDVLLGSRTYSTSI-DIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223
Query: 193 --------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
PE F + + +Q P H P L+ R+ +P RIS +
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQ--DLQQLFP---HADPLGIDLLHRLLQLNPELRISAHDA 278
Query: 245 RNHEWF 250
H WF
Sbjct: 279 LQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 2e-24
Identities = 74/244 (30%), Positives = 108/244 (44%), Gaps = 37/244 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQ 95
REI + L HPNIV+ +VI T L +V E+ + F + +
Sbjct: 48 REISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLF 107
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST----VG 151
QL+ G+++CHS +V HRDLK +N L++ A +K+ DFG +++ + P T V
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGV---PVRTYTHEVV 162
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQ 210
T Y APE+LL +Y D+WS G M+ F D E + FR I R L
Sbjct: 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR--IFRTLGTP 220
Query: 211 --------YSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRN 246
S+PDY + + R L+S++ DP KRIS
Sbjct: 221 DEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280
Query: 247 HEWF 250
H +F
Sbjct: 281 HPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 9e-24
Identities = 69/245 (28%), Positives = 103/245 (42%), Gaps = 39/245 (15%)
Query: 37 REIINHRSLR-HPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGR-FSEDEARF 92
REI R L HPNI+R EV+ LA+V E L+E I R E +
Sbjct: 46 REIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKGRKRPLPEKRVKS 104
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 150
+ QL+ + + H + HRD+K EN L+ LK+ DFG + ++S+P T +
Sbjct: 105 YMYQLLKSLDHMHRNGIFHRDIKPENILIKDD---ILKLADFGSCRG--IYSKPPYTEYI 159
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPKNFRKTIHRILSV 209
T Y APE LL Y G D+W+ G + +L +P F E K IH +L
Sbjct: 160 STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEIL-SLFPLFPGTNELDQIAK-IHDVLGT 217
Query: 210 ----------QYSIPDY--------------VHISPECRHLISRIFVADPAKRISIPEIR 245
+ +Y + S E L+ ++ DP +RI+ +
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277
Query: 246 NHEWF 250
H +F
Sbjct: 278 RHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 77/255 (30%), Positives = 127/255 (49%), Gaps = 17/255 (6%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARFFFQQLISGV 101
H IV+ + + L ++MEY SGG+L ++I + F E E F Q++ +
Sbjct: 123 DHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLAL 182
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAP 158
HS ++ HRDLK N L P +K+ DFG+SK SV S GTP Y+AP
Sbjct: 183 DEVHSRKMMHRDLKSANIFL--MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAP 240
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 218
E+ +K Y K AD+WS GV LY +L PF+ P + R+ + ++L +Y P
Sbjct: 241 ELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQ----REIMQQVLYGKYD-PFPCP 294
Query: 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSI 278
+S + L+ + +PA R + ++ + E FLK + A+L D +++ P + +
Sbjct: 295 VSSGMKALLDPLLSKNPALRPTTQQLLHTE-FLKYV-ANLFQDIVRHSETISPHDREEIL 352
Query: 279 DEIMQIIAEATIPAA 293
++ + A P++
Sbjct: 353 RQLQESGERAPPPSS 367
|
Length = 478 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 72/226 (31%), Positives = 114/226 (50%), Gaps = 19/226 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ R +HPNIV + + L L +VMEY +GG L + + E +
Sbjct: 61 ELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAA 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST- 149
++ + + + HS QV HRD+K +N LL DGS +K+ DFG+ +ST
Sbjct: 120 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTM 175
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTP ++APEV+ +K Y K+ D+WS G+ M+ G P+ + +N + ++ I +
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLN----ENPLRALYLIAT- 229
Query: 210 QYSIPDYVH---ISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
P+ + +S R ++R D KR S E+ H FLK
Sbjct: 230 -NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 2e-23
Identities = 68/212 (32%), Positives = 101/212 (47%), Gaps = 19/212 (8%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 107
P IV TP L +++ +GG+L + G FSE E RF+ ++I G+ + H+
Sbjct: 57 PFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNR 116
Query: 108 QVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 163
V +RDLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169
Query: 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223
AD +S G L+ +L G PF + K+ + L+V +PD SPE
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTVNVELPD--SFSPEL 226
Query: 224 RHLISRIFVADPAKRISI-----PEIRNHEWF 250
+ L+ + D +KR+ E++ H +F
Sbjct: 227 KSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-23
Identities = 70/218 (32%), Positives = 109/218 (50%), Gaps = 14/218 (6%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
EI ++L+H IV++ + L I MEY GG + +++ G +E R + +
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVG 151
Q++ G+SY HS + HRD+K N L D A +K+ DFG SK ++ S +S G
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP +++PEV+ + Y G+ ADVWS G T+ ML P+ + E I +I +
Sbjct: 172 TPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQPT 226
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ HIS R + IFV + R S E+ H +
Sbjct: 227 NPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 3e-23
Identities = 71/217 (32%), Positives = 112/217 (51%), Gaps = 16/217 (7%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
EI ++L H IV++ + P L+I ME+ GG + +++ + G +E+ R + +
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKSTVG 151
Q++ GVSY HS + HRD+K N L D +K+ DFG SK + + KS G
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANILRDS--VGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP +++PEV+ + Y G+ AD+WS G T+ ML P+ + E K ++ Q
Sbjct: 172 TPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFK-----IATQP 225
Query: 212 SIPDY-VHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ P H+S CR + RIFV + R S E+ H
Sbjct: 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 5e-23
Identities = 69/236 (29%), Positives = 118/236 (50%), Gaps = 33/236 (13%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
E++ R +H N+V + L L ++ME+ GG L + I + R +E++ + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESV 126
Query: 98 ISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPA 154
+ + Y HS V HRD+K ++ L LDG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSLVGTPY 182
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDP--------EEPKNFRKTIH 204
++APEV+ + Y ++ D+WS G+ + M+ G P+ + P + P K H
Sbjct: 183 WMAPEVISRTPYGTEV-DIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAH 241
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV 259
+ ISP R + R+ +P +R + E+ +H + L+ LP LV
Sbjct: 242 K-------------ISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGLPECLV 284
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 6e-23
Identities = 75/225 (33%), Positives = 115/225 (51%), Gaps = 17/225 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ + L++PNIV F + L L +VMEY +GG L + + DEA+
Sbjct: 61 ELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQI 117
Query: 93 --FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS 148
++ + + + H+ QV HRD+K +N LL DGS +K+ DFG+ +S
Sbjct: 118 AAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS----VKLTDFGFCAQITPEQSKRS 173
Query: 149 T-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
T VGTP ++APEV+ +K Y K+ D+WS G+ M+ G P+ + E P I
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNG 231
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ + P+ +SP R ++R D KR S E+ H FLK
Sbjct: 232 TPELQNPE--KLSPIFRDFLNRCLEMDVEKRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 7e-23
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 17/216 (7%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 106
HP +V T + L V+E+ SGG+L + + E+ ARF+ ++ +++ H
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHE 114
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 165
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++
Sbjct: 115 RGIIYRDLKLDNVLLDAE--GHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
Y + D W+ GV ++ M+ G PF+ D + IL Q IP +S
Sbjct: 173 YGFSV-DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRS--LS 229
Query: 221 PECRHLISRIFVADPAKRI------SIPEIRNHEWF 250
+ ++ DP +R+ +I++H +F
Sbjct: 230 VKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFF 265
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 1e-22
Identities = 79/276 (28%), Positives = 129/276 (46%), Gaps = 64/276 (23%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+L ++ME+ GG++ + SE+ +F+ + + + H + HRD+K +N LL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL 134
Query: 122 DGSPAPRLKICDFGYSKS-----------SVLHSQPK----------------------- 147
D +K+ DFG ++ H+ P
Sbjct: 135 DAKG--HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQL 192
Query: 148 --STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTI 203
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E P+E +RK +
Sbjct: 193 AYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQE--TYRKVM 249
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKN 253
+ ++ + P V IS + + LI R F D RI + EI++H +F ++
Sbjct: 250 NWKETLVF--PPEVPISEKAKDLILR-FCTDSENRIGSNGVEEIKSHPFFEGVDWGHIRE 306
Query: 254 LPADL-----VVDNTTN-NQFEEPD--QPMQSIDEI 281
PA + +D+T+N ++F E D QP ++ E
Sbjct: 307 RPAAIPIEIKSIDDTSNFDEFPESDILQPAENTIEP 342
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 1e-22
Identities = 70/214 (32%), Positives = 103/214 (48%), Gaps = 23/214 (10%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 107
P IV TP L+ +++ +GG+L + G FSE E RF+ ++I G+ + H+
Sbjct: 57 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNR 116
Query: 108 QVCHRDLKLENTLLDGSPAPRLK----ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 163
V +RDLK N LLD R+ CDF K P ++VGT Y+APEVL K
Sbjct: 117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-------PHASVGTHGYMAPEVLQK 169
Query: 164 K-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-ILSVQYSIPDYVHISP 221
YD AD +S G L+ +L G PF + + I R L++ +PD SP
Sbjct: 170 GVAYDSS-ADWFSLGCMLFKLLRGHSPFR--QHKTKDKHEIDRMTLTMAVELPD--SFSP 224
Query: 222 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
E R L+ + D +R+ E++ H +F
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFF 258
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 1e-22
Identities = 68/201 (33%), Positives = 105/201 (52%), Gaps = 13/201 (6%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
EI ++LRH IV++ + P L+I +EY GG + +++ G +E+ R + +
Sbjct: 54 EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP--KSTVG 151
Q++ GVSY HS + HRD+K N L D A +K+ DFG SK ++ S KS G
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANILRDS--AGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP +++PEV+ + Y G+ ADVWS T+ ML P+ + E K +
Sbjct: 172 TPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPM- 229
Query: 212 SIPDYVHISPECRHLISRIFV 232
+PD +S CR + +IFV
Sbjct: 230 -LPD--GVSDACRDFLKQIFV 247
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 24/231 (10%)
Query: 37 REIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERI-----CNAGRFSEDE 89
RE+ ++S + P IV++ L + + I MEY GG L + I GR E
Sbjct: 48 RELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKV 106
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
+ ++ G+SY HS ++ HRD+K N LL +K+CDFG S V S +
Sbjct: 107 LGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVN-SLAGTF 163
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS- 208
GT Y+APE + K Y +DVWS G+TL + +PF PE +LS
Sbjct: 164 TGTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFP-PEGEPPLGPI--ELLSY 219
Query: 209 -VQYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251
V P + + S E + I + DP +R + ++ H W
Sbjct: 220 IVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 95.3 bits (238), Expect = 1e-22
Identities = 64/249 (25%), Positives = 101/249 (40%), Gaps = 38/249 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFF 94
REI + L+HPNI+ +V +++ +V E+ E++ + + + +
Sbjct: 51 REIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMETD--LEKVIKDKSIVLTPADIKSYM 108
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----STV 150
+ G+ Y HS + HRDLK N L+ LK+ DFG ++S P V
Sbjct: 109 LMTLRGLEYLHSNWILHRDLKPNNLLIA--SDGVLKLADFGLARS---FGSPNRKMTHQV 163
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-- 208
T Y APE+L + G D+WS G +L+ PF + + I L
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTP 222
Query: 209 ------VQYSIPDYVHISP---------------ECRHLISRIFVADPAKRISIPEIRNH 247
S+PDYV P + L+ R+ +P KRI+ + H
Sbjct: 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282
Query: 248 EWFLKNLPA 256
+F N PA
Sbjct: 283 PYF-SNDPA 290
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-22
Identities = 69/226 (30%), Positives = 115/226 (50%), Gaps = 12/226 (5%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
E++ R +H N+V L L +VME+ GG L + I R +E++ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125
Query: 98 ISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPA 154
+ +S H+ V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLTHDG----RVKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
++APE++ + Y G D+WS G+ + M+ G P+ + E P K I L + +
Sbjct: 182 WMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLPPK--LK 237
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 260
+ +SP + + R+ V DPA+R + E+ H + K P +V
Sbjct: 238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPSCIV 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 2e-22
Identities = 69/206 (33%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISG 100
L HP IV+F L I+ EY G +L ++ SE++ +F QL+ G
Sbjct: 59 LDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG 118
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 159
V Y H ++ HRDLK +N L + LKI DFG S+ + +T GTP Y++PE
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPE 175
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVH 218
L + YD K +D+WS G LY M A+ FE +NF + RI+ S+P+
Sbjct: 176 ALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEG----QNFLSVVLRIVEGPTPSLPE--T 228
Query: 219 ISPECRHLISRIFVADPAKRISIPEI 244
S + ++ + DP+ R S EI
Sbjct: 229 YSRQLNSIMQSMLNKDPSLRPSAAEI 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 65/220 (29%), Positives = 100/220 (45%), Gaps = 25/220 (11%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQQLISGVS 102
+HPNIV E L I++E+ GG L + R +E + R+ +Q++ ++
Sbjct: 58 ECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALN 117
Query: 103 YCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPE 159
+ HS +V HRDLK N LL DG +K+ DFG S + Q + T +GTP ++APE
Sbjct: 118 FLHSHKVIHRDLKAGNILLTLDGD----VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPE 173
Query: 160 VLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
V+ YD K AD+WS G+TL + E P + + +L + S P
Sbjct: 174 VVACETFKDNPYDYK-ADIWSLGITLIELAQM-------EPPHHELNPMRVLLKILKSEP 225
Query: 215 DYV----HISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ S + V DP R + E+ H +
Sbjct: 226 PTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 5e-22
Identities = 55/165 (33%), Positives = 87/165 (52%), Gaps = 10/165 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E +Q E+ +SL+H NIV++ L ++I ME+ GG + + G E
Sbjct: 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCK 106
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQP 146
+ +Q++ GV+Y H+ V HRD+K N +L P +K+ DFG ++ HS
Sbjct: 107 YTKQILDGVAYLHNNCVVHRDIKGNNVML--MPNGIIKLIDFGCARRLAWVGLHGTHSNM 164
Query: 147 -KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 190
KS GTP ++APEV+ + Y G+ +D+WS G T++ M G P
Sbjct: 165 LKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPL 208
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 7e-22
Identities = 78/259 (30%), Positives = 124/259 (47%), Gaps = 44/259 (16%)
Query: 28 LWQIDENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83
L Q DE V REI + ++H NIVR ++V+ + L +V EY +L + + ++
Sbjct: 37 LEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP 95
Query: 84 RFSEDE--ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
F+++ + + Q++ G++YCHS +V HRDLK +N L+D LK+ DFG +++
Sbjct: 96 DFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRR-TNALKLADFGLARAFG 154
Query: 142 LHSQPKST----VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEE 195
+ P T V T Y APE+LL + D+WS G ++ +V P D E
Sbjct: 155 I---PVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC-IFAEMVNQKPLFPGDSEI 210
Query: 196 PKNFRKTIHRILSVQY--------SIPDYVH----------------ISPECRHLISRIF 231
+ F+ I RIL S+PDY + P L+S++
Sbjct: 211 DELFK--IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKML 268
Query: 232 VADPAKRISIPEIRNHEWF 250
DP+KRI+ HE+F
Sbjct: 269 RLDPSKRITARAALEHEYF 287
|
Length = 294 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 8e-22
Identities = 60/225 (26%), Positives = 91/225 (40%), Gaps = 23/225 (10%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEA 90
E E + L HPNIVR V L IV EY GG+L F R + + + +
Sbjct: 46 EEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK-HGEKLTLKDL 104
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
Q+ G+ Y S HRDL N L+ + +KI DFG S+ ++
Sbjct: 105 LQMALQIAKGMEYLESKNFVHRDLAARNCLVTEN--LVVKISDFGLSR--DIYEDDYYRK 160
Query: 151 GTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED--PEEPKNFRKT 202
+ APE L ++ K +DVWS GV L+ + +G P+ EE +
Sbjct: 161 RGGGKLPIKWMAPESLKDGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLED 219
Query: 203 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+R+ P+ E L+ + + DP R + E+
Sbjct: 220 GYRLP-----RPENCP--DELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-22
Identities = 76/275 (27%), Positives = 122/275 (44%), Gaps = 36/275 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
RE+ + LRH NI+ ++ ++P + V E G R+ + + ++F
Sbjct: 58 RELKLLKHLRHENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLY 115
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155
Q++ G+ Y HS V HRDLK N L++ + LKICDFG ++ + Q V T Y
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINEN--CDLKICDFGLAR--IQDPQMTGYVSTRYY 171
Query: 156 IAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDP------------EEPKNFR 200
APE++L ++YD ++ D+WS G ML G +P +D P +
Sbjct: 172 RAPEIMLTWQKYDVEV-DIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVI 230
Query: 201 KTI--HRILSVQYSIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
TI L S+P + + P L+ ++ V DP KRIS E H +
Sbjct: 231 NTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 250 F-LKNLPADL-VVDNTTNNQFEEPDQPMQSIDEIM 282
+ P D V + + F + D P+ + +M
Sbjct: 291 LAPYHDPTDEPVAEEKFDWSFNDADLPVDTWKVMM 325
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 9e-22
Identities = 77/265 (29%), Positives = 114/265 (43%), Gaps = 62/265 (23%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA---IVMEYASG--GELFERICNAGRFSEDEAR 91
REI +LRHPNIV KEV+ HL +VMEY L + + FSE + +
Sbjct: 55 REITLLLNLRHPNIVELKEVV-VGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVK 111
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TV 150
QL+ G+ Y H + HRDLK+ N LL LKI DFG +++ L ++P + V
Sbjct: 112 CLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKV 169
Query: 151 GTPAYIAPEVLL-KKEYDGKIADVWSCG---------------------VTLYVMLVGA- 187
T Y APE+LL Y I D+W+ G + L + L+G
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228
Query: 188 ----YP----------FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233
+P F P++P N K H+ + +S L++ + +
Sbjct: 229 NESIWPGFSDLPLVGKFTLPKQPYNNLK--HK----------FPWLSEAGLRLLNFLLMY 276
Query: 234 DPAKRISIPEIRNHEWFLKN-LPAD 257
DP KR + E +F + LP +
Sbjct: 277 DPKKRATAEEALESSYFKEKPLPCE 301
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 1e-21
Identities = 68/251 (27%), Positives = 102/251 (40%), Gaps = 47/251 (18%)
Query: 37 REIINHRSLR---HPNIVRFKEVILTP-----THLAIVMEYASGG-ELFERICNAGRFSE 87
REI + L HPNIVR +V P L +V E+ + C
Sbjct: 47 REIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPP 106
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ 145
+ + +QL+ GV + HS ++ HRDLK +N L+ DG ++KI DFG ++
Sbjct: 107 ETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG----QVKIADFGLARIYSFEMA 162
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM---------------------L 184
S V T Y APEVLL+ Y + D+WS G + +
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATPV-DMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDV 221
Query: 185 VGAYPFED-PEE----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239
+G E+ P +F S + +P+ I E L+ ++ +P KRI
Sbjct: 222 IGLPSEEEWPRNVSLPRSSFPSY--TPRSFKSFVPE---ICEEGLDLLKKMLTFNPHKRI 276
Query: 240 SIPEIRNHEWF 250
S E H +F
Sbjct: 277 SAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 92.2 bits (230), Expect = 1e-21
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 106
+PN ++ + T ++M+Y G+LF+ + G+ SE E + +QL+ ++ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEY 166
+ H D+KLEN L D + R+ +CD+G K P GT Y +PE + Y
Sbjct: 128 HNIIHNDIKLENVLYDRA-KDRIYLCDYGLCKII---GTPSCYDGTLDYFSPEKIKGHNY 183
Query: 167 DGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225
D D W+ GV Y +L G +PF+ D +E + + R Q +P ++S
Sbjct: 184 DVSF-DWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNAND 239
Query: 226 LISRIFVADPAKR-ISIPEIRNHEWFLKN 253
+ + + R + EI H FLK
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHP-FLKI 267
|
Length = 267 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 1e-21
Identities = 85/282 (30%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH------LAIVMEYASGGELFERICNAGRFSEDEA 90
REI R L H N++ K+ I+ P H + IV E +L + I ++ S+D
Sbjct: 53 REIKLLRHLDHENVIAIKD-IMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHC 110
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST 149
++F QL+ G+ Y HS V HRDLK N LL+ + LKICDFG ++ +S
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLARTTSEKGDFMTEY 168
Query: 150 VGTPAYIAPEVLLK-KEYDGKIADVWSCG---------------------VTLYVMLVGA 187
V T Y APE+LL EY I DVWS G + L L+G+
Sbjct: 169 VVTRWYRAPELLLNCSEYTTAI-DVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGS 227
Query: 188 YPFEDPE--EPKNFRKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIP 242
ED + R+ I R L + H +P L+ ++ V DP+KRI++
Sbjct: 228 PSEEDLGFIRNEKARRYI-RSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVE 286
Query: 243 EIRNHEWF--LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 282
E H + L + + V + FEE + I E++
Sbjct: 287 EALAHPYLASLHDPSDEPVCQTPFSFDFEEDALTEEDIKELI 328
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.4 bits (232), Expect = 2e-21
Identities = 80/297 (26%), Positives = 126/297 (42%), Gaps = 78/297 (26%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+L ++ME+ GG+L + FSED RF+ + + + H + HRD+K +N L+
Sbjct: 75 YLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI 134
Query: 122 DGSPAPRLKICDFG-------------YSK----------------------SSVLHSQP 146
D +K+ DFG Y K + + S+
Sbjct: 135 DRGG--HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKD 192
Query: 147 K-------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--E 191
+ STVGTP YIAPE+ L++ Y G+ D WS G ++ L+G PF E
Sbjct: 193 QIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSE 251
Query: 192 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHE 248
+ E +RK I+ ++ + PD +H+S E LI R+ + + R+ EI++H
Sbjct: 252 NSHE--TYRKIINWRETLYF--PDDIHLSVEAEDLIRRL-ITNAENRLGRGGAHEIKSHP 306
Query: 249 WFLKNLPADLVVDNTTNNQFEEPDQP-MQSI--------DEIMQIIAEATIPAAGTQ 296
+F VD T Q P P ++SI DE+ Q+ EA
Sbjct: 307 FFRG-------VDWDTIRQIRAPFIPQLKSITDTSYFPTDELEQVP-EAPALKQAAP 355
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 3e-21
Identities = 71/223 (31%), Positives = 115/223 (51%), Gaps = 13/223 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ R ++PNIV + + L L +VMEY +GG L + + E +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 120
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKST 149
++ + + + HS QV HRD+K +N LL DGS +K+ DFG+ ++ + S+ +
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTM 176
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTP ++APEV+ +K Y K+ D+WS G+ M+ G P+ + E P I +
Sbjct: 177 VGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMIEGEPPYLN-ENPLRALYLIATNGTP 234
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ P+ +S R ++R D KR S E+ H+ FLK
Sbjct: 235 ELQNPE--KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQ-FLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-21
Identities = 70/229 (30%), Positives = 109/229 (47%), Gaps = 24/229 (10%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++Q+EI P + ++ L T L I+MEY GG + + AG F E +
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIAT 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STV 150
++++ G+ Y HS + HRD+K N LL S +K+ DFG + + +Q K + V
Sbjct: 106 MLKEILKGLDYLHSEKKIHRDIKAANVLL--SEQGDVKLADFGVA-GQLTDTQIKRNTFV 162
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APEV+ + YD K AD+WS G+T + G EP N R+L
Sbjct: 163 GTPFWMAPEVIQQSAYDSK-ADIWSLGITAIELAKG--------EPPNSDMHPMRVL--- 210
Query: 211 YSIPDYV------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ IP S + I DP+ R + E+ H++ +KN
Sbjct: 211 FLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 72/199 (36%), Positives = 103/199 (51%), Gaps = 18/199 (9%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+L +VMEY GG+L + N E ARF+ +++ + HSM HRD+K +N LL
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175
Query: 122 DGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVW 174
D S LK+ DFG +K ++ + VGTP YI+PEVL + Y G+ D W
Sbjct: 176 DKS--GHLKLADFGTCMKMNKEGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 175 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234
S GV LY MLVG PF + K ++ S+ + PD IS E ++LI F+ D
Sbjct: 232 SVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTF--PDDNDISKEAKNLIC-AFLTD 288
Query: 235 PAKRI---SIPEIRNHEWF 250
R+ + EI+ H +F
Sbjct: 289 REVRLGRNGVEEIKRHLFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-21
Identities = 65/224 (29%), Positives = 103/224 (45%), Gaps = 20/224 (8%)
Query: 32 DENVQREIINH-----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----A 82
D+++ +I++ LRHPNIVR+ + L L IVM+ G L E +
Sbjct: 49 DKSI-GDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKK 107
Query: 83 GRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
RF+E+ F Q++ + Y H ++ HRDL N +L ++ I DFG +K
Sbjct: 108 QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML--GEDDKVTITDFGLAKQKQ 165
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 201
S+ S VGT Y PE++ + Y G+ ADVW+ G LY M PF N
Sbjct: 166 PESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYS----TNMLS 220
Query: 202 TIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+I+ Y +P+ ++ S + +I+ D R I ++
Sbjct: 221 LATKIVEAVYEPLPEGMY-SEDVTDVITSCLTPDAEARPDIIQV 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 4e-21
Identities = 66/242 (27%), Positives = 107/242 (44%), Gaps = 33/242 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARFFF 94
REI + L+H NIVR +V+ + L +V EY + ++ ++ G + + F
Sbjct: 48 REICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD--QDLKKYFDSCNGDIDPEIVKSFM 105
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 153
QL+ G+++CHS V HRDLK +N L++ + LK+ DFG +++ + + V T
Sbjct: 106 FQLLKGLAFCHSHNVLHRDLKPQNLLINKN--GELKLADFGLARAFGIPVRCYSAEVVTL 163
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-- 210
Y P+VL K Y I D+WS G + P + + K I R+L
Sbjct: 164 WYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 222
Query: 211 ------YSIPDYV----------------HISPECRHLISRIFVADPAKRISIPEIRNHE 248
+PDY ++ R L+ + V +P +RIS E H
Sbjct: 223 ESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHP 282
Query: 249 WF 250
+F
Sbjct: 283 YF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 5e-21
Identities = 63/214 (29%), Positives = 105/214 (49%), Gaps = 15/214 (7%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 106
+P +V T + L +V+EY +GG+L + + E+ ARF+ ++ +++ H
Sbjct: 55 NPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 165
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L +E
Sbjct: 115 RGIIYRDLKLDNVLLDAD--GHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE 172
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPFE---DPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222
Y G D W+ GV ++ M+ G PF+ D + IL IP + +S +
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRF--LSVK 229
Query: 223 CRHLISRIFVADPAKRI------SIPEIRNHEWF 250
H++ DP +R+ +I++H +F
Sbjct: 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF 263
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 5e-21
Identities = 71/223 (31%), Positives = 111/223 (49%), Gaps = 13/223 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ R ++PNIV + + L L +VMEY +GG L + + E +
Sbjct: 61 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAA 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST- 149
++ + + + HS QV HRD+K +N LL DGS +K+ DFG+ +ST
Sbjct: 120 VCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFCAQITPEQSKRSTM 175
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTP ++APEV+ +K Y K+ D+WS G+ M+ G P+ + E P I +
Sbjct: 176 VGTPYWMAPEVVTRKAYGPKV-DIWSLGIMAIEMVEGEPPYLN-ENPLRALYLIATNGTP 233
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ P+ +S R ++R D +R S E+ H FLK
Sbjct: 234 ELQNPE--RLSAVFRDFLNRCLEMDVDRRGSAKELLQHP-FLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 6e-21
Identities = 67/199 (33%), Positives = 102/199 (51%), Gaps = 18/199 (9%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+L +VMEY GG+L + N E A+F+ +++ + HSM + HRD+K +N LL
Sbjct: 117 YLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 175
Query: 122 DGSPAPRLKICDFG----YSKSSVLHSQPKSTVGTPAYIAPEVLLKK---EYDGKIADVW 174
D LK+ DFG ++ ++ + VGTP YI+PEVL + Y G+ D W
Sbjct: 176 D--KHGHLKLADFGTCMKMDETGMVRCD--TAVGTPDYISPEVLKSQGGDGYYGRECDWW 231
Query: 175 SCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234
S GV L+ MLVG PF + K + S+ + P+ V IS ++LI F+ D
Sbjct: 232 SVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNF--PEDVEISKHAKNLIC-AFLTD 288
Query: 235 PAKRI---SIPEIRNHEWF 250
R+ + EI+ H +F
Sbjct: 289 REVRLGRNGVEEIKQHPFF 307
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 8e-21
Identities = 75/271 (27%), Positives = 119/271 (43%), Gaps = 34/271 (12%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS 106
HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++Y H
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHE 114
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 165
+ +RDLKL+N LLD +K+ D+G K + ST GTP YIAPE+L ++
Sbjct: 115 RGIIYRDLKLDNVLLDSE--GHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGED 172
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPFE-----DPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
Y G D W+ GV ++ M+ G PF+ D + IL Q IP +S
Sbjct: 173 Y-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLS 229
Query: 221 PECRHLISRIFVADPAKRISI------------PEIRNHEW-----------FLKNLPAD 257
+ ++ DP +R+ P RN +W F N+ +
Sbjct: 230 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGE 289
Query: 258 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEA 288
+DN EP Q D+I++ I ++
Sbjct: 290 FGLDNFDAQFTNEPVQLTPDDDDIVRKIDQS 320
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 1e-20
Identities = 72/254 (28%), Positives = 106/254 (41%), Gaps = 49/254 (19%)
Query: 37 REIINHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFSEDEARF 92
RE+ R +H NI+ ++++ P + +VM+ +L I + +E+ R+
Sbjct: 53 RELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRY 111
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQ-PK 147
F QL+ G+ Y HS V HRDLK N L++ L+I DFG S S H
Sbjct: 112 FLYQLLRGLKYIHSANVIHRDLKPSNLLVNED--CELRIGDFGMARGLSSSPTEHKYFMT 169
Query: 148 STVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHR 205
V T Y APE+LL EY I D+WS G ML F P KN+ +
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAI-DMWSVGCIFAEMLGRRQLF-----PGKNYVHQLKL 223
Query: 206 ILSVQYSIPD-----------------------------YVHISPECRHLISRIFVADPA 236
ILSV S + + SPE L+S++ DP
Sbjct: 224 ILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPE 283
Query: 237 KRISIPEIRNHEWF 250
+RI++ + H +
Sbjct: 284 ERITVEQALQHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 1e-20
Identities = 73/241 (30%), Positives = 104/241 (43%), Gaps = 59/241 (24%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL- 120
+L VM+Y GG++ + F E ARF+ +L + H M HRD+K +N L
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI 134
Query: 121 -LDGSPAPRLKICDFG-------------YSKSSVLHS---QPK---------------- 147
LDG +K+ DFG Y K S + +P
Sbjct: 135 DLDG----HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLK 190
Query: 148 ----------------STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 191
S VGTP YIAPEVLL+K Y ++ D WS GV L+ MLVG PF
Sbjct: 191 TLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQPPFL 249
Query: 192 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA--DPAKRISIPEIRNHEW 249
P + K I+ ++ IP V +SPE LI+++ + + R +I+ H +
Sbjct: 250 APTPTETQLKVINWENTLH--IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 250 F 250
F
Sbjct: 308 F 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-20
Identities = 65/214 (30%), Positives = 99/214 (46%), Gaps = 18/214 (8%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 92
+EI + L HPN++++ + + L IV+E A G+L + I + E
Sbjct: 51 KEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 147
+F QL S V + HS +V HRD+K N + + +K+ D G SK++ H
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + N +I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLFSLCQKIE 221
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241
Y H S + R L+S DP +R I
Sbjct: 222 QCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-20
Identities = 71/248 (28%), Positives = 114/248 (45%), Gaps = 44/248 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFF 94
REI + L+HPNIV ++V++ + L ++ E+ S + + + + + +
Sbjct: 48 REISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS------SVLHSQPKS 148
Q++ G+ +CHS +V HRDLK +N L+D +K+ DFG +++ H
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHE---- 161
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHRI 206
V T Y APEVLL D+WS G T++ + P D E + FR I RI
Sbjct: 162 -VVTLWYRAPEVLLGSPRYSTPVDIWSIG-TIFAEMATKKPLFHGDSEIDQLFR--IFRI 217
Query: 207 LSVQ--------YSIPDYVHISPECR----------------HLISRIFVADPAKRISIP 242
L S+PDY + P+ + L+ ++ + DPAKRIS
Sbjct: 218 LGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277
Query: 243 EIRNHEWF 250
+ NH +F
Sbjct: 278 KALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 4e-20
Identities = 73/238 (30%), Positives = 107/238 (44%), Gaps = 29/238 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++Q+EI P I R+ L T L I+MEY GG + + G E
Sbjct: 47 EDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIAT 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 151
++++ G+ Y HS + HRD+K N LL S +K+ DFG + ++T VG
Sbjct: 106 ILREILKGLDYLHSERKIHRDIKAANVLL--SEQGDVKLADFGVAGQLTDTQIKRNTFVG 163
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIH 204
TP ++APEV+ + YD K AD+WS G+T + G P D PKN T
Sbjct: 164 TPFWMAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT-- 220
Query: 205 RILSVQYSIP--DYVH--------ISPECRHLISRIFVADPAKRIS-IPEI--RNHEW 249
L QYS P ++V P + L+ F+ K+ S + E+ R W
Sbjct: 221 --LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRW 276
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 5e-20
Identities = 74/265 (27%), Positives = 124/265 (46%), Gaps = 62/265 (23%)
Query: 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+L ++ME+ GG++ + +E+E +F+ + + + H + HRD+K +N LL
Sbjct: 75 NLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL 134
Query: 122 DGSPAPRLKICDFGYSKS-----------SVLHSQPK----------------------- 147
D +K+ DFG ++ HS P
Sbjct: 135 DSKG--HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQL 192
Query: 148 --STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTI 203
STVGTP YIAPEV ++ Y+ K+ D WS GV +Y ML+G PF E P+E ++K +
Sbjct: 193 AFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETPQE--TYKKVM 249
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP---EIRNHEWF-------LKN 253
+ ++ + P V IS + + LI R F + RI P EI+ + +F ++
Sbjct: 250 NWKETLIF--PPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFFEGVDWEHIRE 306
Query: 254 LPADL-----VVDNTTN-NQFEEPD 272
PA + +D+T+N ++F + D
Sbjct: 307 RPAAIPIEIKSIDDTSNFDEFPDSD 331
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 8e-20
Identities = 65/230 (28%), Positives = 105/230 (45%), Gaps = 26/230 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 47 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIAT 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 150
++++ G+ Y HS + HRD+K N LL S +K+ DFG + + +Q K V
Sbjct: 106 ILREILKGLDYLHSEKKIHRDIKAANVLL--SEHGEVKLADFGVA-GQLTDTQIKRNTFV 162
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTI 203
GTP ++APEV+ + YD K AD+WS G+T + G P + PKN T
Sbjct: 163 GTPFWMAPEVIKQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT- 220
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
L YS P + + +P+ R + E+ H++ ++
Sbjct: 221 ---LEGNYSKP--------LKEFVEACLNKEPSFRPTAKELLKHKFIVRF 259
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 8e-20
Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 10/209 (4%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR--FFFQQLISGVSYCH 105
P IV + THL +VM +GG+L I N G + R + Q+ G+ + H
Sbjct: 53 PFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 165
SM + +RD+K EN LLD RL D G + GT Y+APE+L ++
Sbjct: 113 SMDIVYRDMKPENVLLDDQGNCRLS--DLGLAVELKDGKTITQRAGTNGYMAPEILKEEP 170
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225
Y + D ++ G ++Y M+ G PF+D +E + R L + ++ + + E +
Sbjct: 171 YSYPV-DWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF-EHQNFTEESKD 228
Query: 226 LISRIFVADPAKRISIPEI----RNHEWF 250
+ P R+ E R HE+F
Sbjct: 229 ICRLFLAKKPEDRLGSREKNDDPRKHEFF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 9e-20
Identities = 68/218 (31%), Positives = 111/218 (50%), Gaps = 13/218 (5%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
E++ R H N+V L L +VME+ GG L + I R +E++ +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127
Query: 98 ISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTPA 154
+ +SY H+ V HRD+K ++ LL DG R+K+ DFG+ ++ S + KS VGTP
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLTSDG----RIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
++APEV+ + Y G D+WS G+ + M+ G P+ + E P + I L + +
Sbjct: 184 WMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR--VK 239
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
D +S R + + V +P++R + E+ H FLK
Sbjct: 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHP-FLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 62 HLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120
+L +VM+Y GG+L + R ED ARF+ +++ + H + HRD+K +N L
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVL 134
Query: 121 LDGSPAPRLKICDFGYSKSSVLHSQPKST------VGTPAYIAPEVLLKKEYDGK----- 169
LD + RL DFG S L T VGTP YI+PE+L E DGK
Sbjct: 135 LDKNGHIRL--ADFG----SCLRLLADGTVQSNVAVGTPDYISPEILQAME-DGKGRYGP 187
Query: 170 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229
D WS GV +Y ML G PF + + K ++ Q+ PD +S E + LI R
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP-PDVTDVSEEAKDLIRR 246
Query: 230 IFVADPAK--RISIPEIRNHEWF 250
+ + + R + + ++H +F
Sbjct: 247 LICSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 67/206 (32%), Positives = 97/206 (47%), Gaps = 40/206 (19%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNA----GR 84
I+ NV RE L+H NIVR+ + L + L I+ME+ G+L I G+
Sbjct: 61 IEVNVMRE------LKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK 114
Query: 85 FSEDEARFFFQQLISGVSYCHSMQ-------VCHRDLKLENTLLDG-------------- 123
E +QL+ ++YCH+++ V HRDLK +N L
Sbjct: 115 IEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANN 174
Query: 124 -SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTL 180
+ P KI DFG SK+ + S S VGTP Y +PE+LL K YD K +D+W+ G +
Sbjct: 175 LNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDK-SDMWALGCII 233
Query: 181 YVMLVGAYPFEDPEEPKNFRKTIHRI 206
Y + G PF + NF + I +
Sbjct: 234 YELCSGKTPF---HKANNFSQLISEL 256
|
Length = 1021 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 2e-19
Identities = 74/258 (28%), Positives = 103/258 (39%), Gaps = 56/258 (21%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA-----------IVMEYASG---GELFERICNA 82
REI R L H NIV KE I+T A +V EY G L + +
Sbjct: 55 REIKILRQLNHRNIVNLKE-IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH- 112
Query: 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
FSED + F +QL+ G++YCH HRD+K N LL+ ++K+ DFG ++
Sbjct: 113 --FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNK--GQIKLADFGLARLYNS 168
Query: 143 HSQPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE----- 195
T V T Y PE+LL +E G DVWSCG L + F+ +E
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLE 228
Query: 196 ----------PKNF--------------RKTIHRILSVQYSIPDYVHISPECRHLISRIF 231
P + +K R L ++S I L+ +
Sbjct: 229 LISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS-----FIPTPALDLLDHML 283
Query: 232 VADPAKRISIPEIRNHEW 249
DP+KR + E N W
Sbjct: 284 TLDPSKRCTAEEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 65/269 (24%), Positives = 98/269 (36%), Gaps = 58/269 (21%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVM--EYASGGEL----FERICNAGRFSEDEA 90
REI R L+H N+V EV L ++ + +YA F R
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKS 148
+ Q+++GV Y HS V HRDLK N L+ +G +KI D G ++ + ++ K
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR--LFNAPLKP 168
Query: 149 ------TVGTPAYIAPEVLLKKEYDGKIADVWSCG------VTLYVMLVGA--------- 187
V T Y APE+LL + K D+W+ G +TL + G
Sbjct: 169 LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNP 228
Query: 188 --------------YPFED--------PEEPKNFRKTIHRILSVQYSIPDYVHI----SP 221
P E PE K S+ ++
Sbjct: 229 FQRDQLERIFEVLGTPTEKDWPDIKKMPEYDT-LMKDFKTKTYPSNSLAKWMEKHKKPDS 287
Query: 222 ECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ L+ ++ DP KRI+ E H +F
Sbjct: 288 QGFDLLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 42/192 (21%)
Query: 29 WQIDENVQREIINHRSLR----HPNIVRFKEVILTPTH------LAIVMEYASGG---EL 75
+E ++ E LR HPNI F + L +VME GG +L
Sbjct: 43 EDEEEEIKEEY---NILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDL 99
Query: 76 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKIC 132
+ + G R E+ + ++ + G++Y H +V HRD+K +N LL + +K+
Sbjct: 100 VKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA----EVKLV 155
Query: 133 DFGYSKSSVLHSQPKST-------VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTL 180
DFG S +Q ST +GTP ++APEV+ E YD + +DVWS G+T
Sbjct: 156 DFGVS------AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDAR-SDVWSLGITA 208
Query: 181 YVMLVGAYPFED 192
+ G P D
Sbjct: 209 IELADGKPPLCD 220
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-19
Identities = 65/210 (30%), Positives = 106/210 (50%), Gaps = 24/210 (11%)
Query: 45 LRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERIC-NAGRF-SEDEARFFFQQLISGV 101
L+HPNIV ++E L IVM + GG+L+ ++ G+ E++ +F Q+ +
Sbjct: 56 LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAP 158
Y H + HRDLK +N L + +K+ D G ++ VL +Q + +GTP Y++P
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIAR--VLENQCDMASTLIGTPYYMSP 171
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---- 214
E+ K Y+ K +DVW+ G +Y M + F K+ ++RI ++ +P
Sbjct: 172 ELFSNKPYNYK-SDVWALGCCVYEMATLKHAF----NAKDMNSLVYRI--IEGKLPPMPK 224
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEI 244
DY SPE LI+ + P KR S+ I
Sbjct: 225 DY---SPELGELIATMLSKRPEKRPSVKSI 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 8e-19
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 59 TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 116
T L +V+ +GG+L I N G F E+ A F+ ++ G+ H ++ +RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKP 130
Query: 117 ENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWS 175
EN LLD ++I D G + + + + VGT Y+APEV+ + Y D W
Sbjct: 131 ENILLDDY--GHIRISDLGLA-VEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWG 186
Query: 176 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235
G +Y M+ G PF +E + R+ Q + S R + ++ DP
Sbjct: 187 LGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE--KFSEAARSICRQLLTKDP 244
Query: 236 AKRI-----SIPEIRNHEWF----LKNLPADLV 259
R+ E++ H +F K L A ++
Sbjct: 245 GFRLGCRGEGAEEVKAHPFFRTANFKRLEAGML 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 9e-19
Identities = 56/156 (35%), Positives = 82/156 (52%), Gaps = 16/156 (10%)
Query: 29 WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFS 86
WQ ++ +E+ + LRHPN + +K L +VMEY S ++ E +
Sbjct: 59 WQ---DIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQ 113
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E E + G++Y HS + HRD+K N LL + +K+ DFG S+ L S
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL--TEPGTVKLADFG---SASLVSPA 168
Query: 147 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVT 179
S VGTP ++APEV+L + +YDGK DVWS G+T
Sbjct: 169 NSFVGTPYWMAPEVILAMDEGQYDGK-VDVWSLGIT 203
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 74/244 (30%), Positives = 105/244 (43%), Gaps = 34/244 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQ 95
RE + L+H NIV ++I T L +V EY +L + + + G S R F
Sbjct: 52 REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
QL+ G++YCH +V HRDLK +N L+ S LK+ DFG +++ + S+ S V T
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLI--SERGELKLADFGLARAKSVPSKTYSNEVVTLW 168
Query: 155 YIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----- 208
Y P+VLL EY + D+W G Y M G F + ++ I R+L
Sbjct: 169 YRPPDVLLGSTEYSTSL-DMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEE 227
Query: 209 -----------VQYSIPDY------VHIS-----PECRHLISRIFVADPAKRISIPEIRN 246
YS P Y H P L + +P KRIS E
Sbjct: 228 TWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287
Query: 247 HEWF 250
H +F
Sbjct: 288 HPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-18
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 18/214 (8%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSEDEARF 92
+EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 51 KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWK 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-----SKSSVLHSQPK 147
+F QL S + + HS +V HRD+K N + + +K+ D G SK++ H
Sbjct: 111 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAH---- 164
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + N +I
Sbjct: 165 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIE 221
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241
Y H S E R L++ DP KR I
Sbjct: 222 QCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 1e-18
Identities = 74/256 (28%), Positives = 104/256 (40%), Gaps = 65/256 (25%)
Query: 50 IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQV 109
+VR +L VM+Y GG++ + G F ED ARF+ +L V H M
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122
Query: 110 CHRDLKLENTLLD--------------------------GSPAPRLKICDFGYS------ 137
HRD+K +N L+D R DF
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 138 ------------KSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 183
+++ H + S VGTP YIAPEVLL+ Y ++ D WS GV LY M
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 241
Query: 184 LVGAYPF--EDPEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237
LVG PF + P E + N++ ++H IP +SPE LI ++ P
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLH--------IPPQAKLSPEASDLIIKL-CRGPED 292
Query: 238 RI---SIPEIRNHEWF 250
R+ EI+ H +F
Sbjct: 293 RLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 55/155 (35%), Positives = 78/155 (50%), Gaps = 9/155 (5%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNAGRFSE 87
++ E RE+ R+L+ NIV KE L +V EY EL E + N
Sbjct: 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PP 99
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
++ R + QLI + +CH + HRD+K EN L+ S LK+CDFG++++ S
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI--SHNDVLKLCDFGFARNLSEGSNAN 157
Query: 148 ST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 180
T V T Y +PE+LL Y GK D+WS G L
Sbjct: 158 YTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCIL 191
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-18
Identities = 50/148 (33%), Positives = 78/148 (52%), Gaps = 5/148 (3%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
VQ+EII + +H NIV + L L I ME+ GG L + G SE + +
Sbjct: 53 VQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVS 112
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGTP 153
++ + G+ Y HS HRD+K N LL + +K+ DFG S + ++ KS +GTP
Sbjct: 113 RETLQGLYYLHSKGKMHRDIKGANILL--TDNGHVKLADFGVSAQITATIAKRKSFIGTP 170
Query: 154 AYIAPEVLLKKEYDG--KIADVWSCGVT 179
++APEV + G ++ D+W+ G+T
Sbjct: 171 YWMAPEVAAVERKGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-18
Identities = 54/234 (23%), Positives = 105/234 (44%), Gaps = 20/234 (8%)
Query: 32 DENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
+V+++I+ + H P IV F L ++ + ME+ G L G
Sbjct: 43 KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPV 102
Query: 88 DEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+ ++ G++Y +++ ++ HRD+K N L++ ++K+CDFG S +++S
Sbjct: 103 EILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNS--RGQIKLCDFGVS-GELINSIA 159
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNF 199
+ VGT Y++PE + +Y K +DVWS G+++ + +G +PF P
Sbjct: 160 DTFVGTSTYMSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGI 218
Query: 200 RKTIHRILSVQYSIPDY--VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251
+ +I VQ P + R + + DP +R + ++ F+
Sbjct: 219 LDLLQQI--VQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 66/223 (29%), Positives = 105/223 (47%), Gaps = 33/223 (14%)
Query: 62 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120
+L +VM+Y GG+L + R ED ARF+ +++ + H + HRD+K +N L
Sbjct: 75 YLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL 134
Query: 121 LDGSPAPR-------LKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD----GK 169
LD + R LK+ G +SSV VGTP YI+PE+L E G
Sbjct: 135 LDMNGHIRLADFGSCLKMNQDGTVQSSV-------AVGTPDYISPEILQAMEDGMGKYGP 187
Query: 170 IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HISPECRHLIS 228
D WS GV +Y ML G PF + + K ++ ++ P ++ +S E + LI
Sbjct: 188 ECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITDVSEEAKDLIQ 245
Query: 229 RIFVADPAKRI---SIPEIRNHEWF-------LKNLPADLVVD 261
R+ + +R+ I + + H +F ++NL A + D
Sbjct: 246 RL-ICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 60/242 (24%), Positives = 110/242 (45%), Gaps = 20/242 (8%)
Query: 30 QIDENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNA 82
++DE+ +II + H P IV F + + MEY G +L+
Sbjct: 37 ELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVAT 96
Query: 83 GRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
ED R ++ G+ + + HRD+K N L++G+ ++K+CDFG S ++
Sbjct: 97 EGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVS-GNL 153
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKI-----ADVWSCGVTLYVMLVGAYPFEDPEEP 196
+ S K+ +G +Y+APE + + +DVWS G+++ M +G YP+ PE
Sbjct: 154 VASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETY 212
Query: 197 KNFRKTIHRIL-SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
N + I+ ++P S + + +++ P +R + ++ H W +K
Sbjct: 213 ANIFAQLSAIVDGDPPTLPS--GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270
Query: 256 AD 257
AD
Sbjct: 271 AD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 56/168 (33%), Positives = 72/168 (42%), Gaps = 21/168 (12%)
Query: 37 REIINHRSLRHPNIVRFKEVILT-----------PTHLA---IVMEYASGGELFERICNA 82
REI R L H NIV+ EV+ T L IV EY +
Sbjct: 51 REIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQ 108
Query: 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
G SE+ AR F QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++
Sbjct: 109 GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN-TEDLVLKIGDFGLARIVDP 167
Query: 143 HSQPKS----TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186
H K + T Y +P +LL K D+W+ G ML G
Sbjct: 168 HYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 8e-18
Identities = 72/248 (29%), Positives = 112/248 (45%), Gaps = 43/248 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQ 95
RE+ + L+H NIV ++I T L +V EY +L + + + G + + F
Sbjct: 53 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S V T
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINER--GELKLADFGLARAKSIPTKTYSNEVVTLW 169
Query: 155 YIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILS--- 208
Y P++LL +Y +I D+W G Y M G +P EE +F I RIL
Sbjct: 170 YRPPDILLGSTDYSTQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHF---IFRILGTPT 225
Query: 209 -------------VQYSIPDYVHISPECRH------------LISRIFVADPAKRISIPE 243
Y+ P Y +C H L+S++ + KRIS E
Sbjct: 226 EETWPGILSNEEFKSYNYPKY---RADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEE 282
Query: 244 IRNHEWFL 251
H +F
Sbjct: 283 AMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 67/243 (27%), Positives = 105/243 (43%), Gaps = 34/243 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 94
REI + LRH N+V EV L +V E+ L E+ N E R +
Sbjct: 49 REIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LDESRVRKYL 106
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGT 152
Q++ G+ +CHS + HRD+K EN L+ S + +K+CDFG+++ ++ T V T
Sbjct: 107 FQILRGIEFCHSHNIIHRDIKPENILV--SQSGVVKLCDFGFAR-TLAAPGEVYTDYVAT 163
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------------------PE 194
Y APE+L+ G+ D+W+ G + ML G F P
Sbjct: 164 RWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPR 223
Query: 195 EPKNFRKT----IHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ F+K R+ V+ P + +S L + DP R S ++ +H
Sbjct: 224 HQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283
Query: 248 EWF 250
E+F
Sbjct: 284 EFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 55/153 (35%), Positives = 82/153 (53%), Gaps = 7/153 (4%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF-SEDEARFFFQ 95
RE+ ++L+H NIV ++I T L +V EY +L + + N G S + F
Sbjct: 52 REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
QL+ G+SYCH ++ HRDLK +N L++ LK+ DFG +++ + ++ S V T
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEK--GELKLADFGLARAKSVPTKTYSNEVVTLW 168
Query: 155 YIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVG 186
Y P+VLL EY I D+W G LY M G
Sbjct: 169 YRPPDVLLGSTEYSTPI-DMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 71/264 (26%), Positives = 107/264 (40%), Gaps = 63/264 (23%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGGELFERICNAG-RFSE 87
REI + L+H N+V E+ T +V E+ +L + N +F+
Sbjct: 60 REIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTL 118
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQ 145
E + + L++G+ Y H ++ HRD+K N L+ DG LK+ DFG +++ L
Sbjct: 119 SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI----LKLADFGLARAFSLSKN 174
Query: 146 PKST-----VGTPAYIAPEVLLKKEYDGKIADVWSCG---------------------VT 179
K V T Y PE+LL + G D+W G +T
Sbjct: 175 SKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT 234
Query: 180 LYVMLVGA-----YP-------FEDPEEPKN-FRKTIHRILSVQYSIPDYVHISPECRHL 226
L L G+ +P F+ E P+ RK R+ YV P L
Sbjct: 235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKP-------YVK-DPHALDL 286
Query: 227 ISRIFVADPAKRISIPEIRNHEWF 250
I ++ V DPAKRI NH++F
Sbjct: 287 IDKLLVLDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 3e-17
Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 18/202 (8%)
Query: 59 TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 116
T L +V+ +GG+L I + G F E A F+ ++ G+ H ++ +RDLK
Sbjct: 71 TKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKP 130
Query: 117 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSC 176
EN LLD ++I D G + K VGT Y+APEV+ + Y D W+
Sbjct: 131 ENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFS-PDWWAL 187
Query: 177 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRHLISRIFVA 233
G LY M+ G PF+ + K R+ + R++ +YS SP+ R L +
Sbjct: 188 GCLLYEMIAGQSPFQQ-RKKKIKREEVERLVKEVQEEYS----EKFSPDARSLCKMLLCK 242
Query: 234 DPAKRI-----SIPEIRNHEWF 250
DP +R+ E++ H F
Sbjct: 243 DPKERLGCQGGGAREVKEHPLF 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 4e-17
Identities = 55/191 (28%), Positives = 99/191 (51%), Gaps = 15/191 (7%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGV 101
+++ HP+++R K+ +++ +V+ + S +L+ + + D+A +Q++ G+
Sbjct: 112 QNVNHPSVIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGL 170
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161
Y H+ ++ HRD+K EN ++ ++ I D G ++ V+ GT APEVL
Sbjct: 171 RYLHAQRIIHRDVKTENIFIND--VDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVL 228
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYP---FEDP----EEP-KNFRKTIHRILSVQYSI 213
+ +Y+ K AD+WS G+ L+ ML AYP FEDP EE K+ + +I+S
Sbjct: 229 ARDKYNSK-ADIWSAGIVLFEML--AYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVH 285
Query: 214 PDYVHISPECR 224
P+ P R
Sbjct: 286 PEEFPRDPGSR 296
|
Length = 357 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 55/175 (31%), Positives = 81/175 (46%), Gaps = 12/175 (6%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARF 92
+REI R+L H NIV++K V P L ++MEY G L + + + + +
Sbjct: 54 EREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLL 113
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149
F Q+ G+ Y S + HRDL N L++ +KI DFG +K K
Sbjct: 114 FSSQICKGMDYLGSQRYIHRDLAARNILVESE--DLVKISDFGLAKVLPEDKDYYYVKEP 171
Query: 150 VGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
+P + APE L ++ +DVWS GVTLY + P + P P F + I
Sbjct: 172 GESPIFWYAPECLRTSKFSSA-SDVWSFGVTLYELFTYGDPSQSP--PAEFLRMI 223
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 55/156 (35%), Positives = 83/156 (53%), Gaps = 16/156 (10%)
Query: 29 WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFS 86
WQ ++ +E+ + L+HPN + +K L +VMEY S +L E +
Sbjct: 65 WQ---DIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLE--VHKKPLQ 119
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E E + G++Y HS + HRD+K N LL + ++K+ DFG S+ S
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASKSSPA 174
Query: 147 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVT 179
S VGTP ++APEV+L + +YDGK+ DVWS G+T
Sbjct: 175 NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGIT 209
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-17
Identities = 68/238 (28%), Positives = 110/238 (46%), Gaps = 20/238 (8%)
Query: 29 WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFS 86
WQ ++ +E+ + LRHPN ++++ L +VMEY S +L E +
Sbjct: 59 WQ---DIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQ 113
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E E + G++Y HS + HRD+K N LL S +K+ DFG S+ + +
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL--SEPGLVKLGDFG---SASIMAPA 168
Query: 147 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
VGTP ++APEV+L + +YDGK+ DVWS G+T + L P P N +
Sbjct: 169 NXFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSAL 223
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
+ I + H S R+ + P R + + H + L+ P +++D
Sbjct: 224 YHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (197), Expect = 7e-17
Identities = 53/159 (33%), Positives = 72/159 (45%), Gaps = 13/159 (8%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEARF 92
REI R +H NI+ + I+ P + EL E ++ S D ++
Sbjct: 52 REIKILRRFKHENIIGILD-IIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQY 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 149
F Q++ G+ Y HS V HRDLK N LL+ LKICDFG ++ +
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNT--NCDLKICDFGLARIADPEHDHTGFLTE 168
Query: 150 -VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG 186
V T Y APE++L K Y I D+WS G L ML
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAI-DIWSVGCILAEMLSN 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 60/199 (30%), Positives = 96/199 (48%), Gaps = 14/199 (7%)
Query: 62 HLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120
+L +VM+Y GG+L + R ED ARF+ +++ + H + HRD+K +N L
Sbjct: 75 NLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 134
Query: 121 LDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLKKEYDGK-----IADV 173
+D + RL DFG + +S+ VGTP YI+PE+L E DGK D
Sbjct: 135 MDMNGHIRL--ADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAME-DGKGKYGPECDW 191
Query: 174 WSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233
WS GV +Y ML G PF + + K ++ Q+ +S + + LI R+ +
Sbjct: 192 WSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFP-AQVTDVSEDAKDLIRRLICS 250
Query: 234 DPAK--RISIPEIRNHEWF 250
+ + I + + H +F
Sbjct: 251 REHRLGQNGIEDFKQHPFF 269
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 1e-16
Identities = 68/238 (28%), Positives = 111/238 (46%), Gaps = 20/238 (8%)
Query: 29 WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFS 86
WQ ++ +E+ + ++HPN + +K L +VMEY S +L E +
Sbjct: 69 WQ---DIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLE--VHKKPLQ 123
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
E E + G++Y HS + HRD+K N LL + ++K+ DFG S+ + S
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL--TEPGQVKLADFG---SASIASPA 178
Query: 147 KSTVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
S VGTP ++APEV+L + +YDGK+ DVWS G+T + L P P N +
Sbjct: 179 NSFVGTPYWMAPEVILAMDEGQYDGKV-DVWSLGITC-IELAERKP---PLFNMNAMSAL 233
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
+ I + S R+ + P R + E+ H + L+ P +++D
Sbjct: 234 YHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLID 291
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-16
Identities = 69/242 (28%), Positives = 105/242 (43%), Gaps = 32/242 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
REI + L+HPN+V EV L +V EY L E N E + Q
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQ 108
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---TVGTP 153
+ V++CH HRD+K EN L+ + ++K+CDFG+++ +L V T
Sbjct: 109 TLQAVNFCHKHNCIHRDVKPENILI--TKQGQIKLCDFGFAR--ILTGPGDDYTDYVATR 164
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFE-DPEEPKNFRKTI------H 204
Y APE+L+ G DVW+ G +L G +P + D ++ RKT+ H
Sbjct: 165 WYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRH 224
Query: 205 R-ILSVQ-----YSIPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHE 248
+ I S SIP+ + +IS + DP +R+S E+ H
Sbjct: 225 QQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHP 284
Query: 249 WF 250
+F
Sbjct: 285 YF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 49/148 (33%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+Q+EI + +H NIV + L+ L I MEY GG L + G SE + +
Sbjct: 53 IQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVC 112
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY-SKSSVLHSQPKSTVGTP 153
++ + G++Y HS HRD+K N LL + +K+ DFG +K + ++ KS +GTP
Sbjct: 113 RETLQGLAYLHSKGKMHRDIKGANILL--TDNGDVKLADFGVAAKITATIAKRKSFIGTP 170
Query: 154 AYIAPEVLLKKEYDG--KIADVWSCGVT 179
++APEV ++ G ++ D+W+ G+T
Sbjct: 171 YWMAPEVAAVEKNGGYNQLCDIWAVGIT 198
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-16
Identities = 54/185 (29%), Positives = 76/185 (41%), Gaps = 32/185 (17%)
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG 151
F QL+ GV++CH V HRDLK +N L+D LKI D G ++ S+ +
Sbjct: 115 FMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG-LLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL---- 207
T Y APEVLL + D+WS G M F E + I ++L
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH-IFKLLGTPT 232
Query: 208 ----------------------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245
+ ++PD +SPE L+ ++ DPAKRIS
Sbjct: 233 EQVWPGVSKLRDWHEFPQWKPQDLSRAVPD---LSPEGLDLLQKMLRYDPAKRISAKAAL 289
Query: 246 NHEWF 250
H +F
Sbjct: 290 THPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 2e-16
Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 14/160 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEAR 91
E+ EI S HPNIV+ + +L I++E+ +GG + + R +E + R
Sbjct: 47 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIR 106
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYSKSSVLHSQPK-S 148
+Q + ++Y H ++ HRDLK N L LDG +K+ DFG S + Q + S
Sbjct: 107 VVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD----IKLADFGVSAKNTRTIQRRDS 162
Query: 149 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVM 183
+GTP ++APEV++ + YD K ADVWS G+TL M
Sbjct: 163 FIGTPYWMAPEVVMCETSKDRPYDYK-ADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 3e-16
Identities = 56/161 (34%), Positives = 85/161 (52%), Gaps = 16/161 (9%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEA 90
D V+ EI+ + HP IV+ L I++E+ GG + + R +E +
Sbjct: 55 DYMVEIEIL--ATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI 112
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPK- 147
+ +Q++ + Y HSM++ HRDLK N LL DG +K+ DFG S +V Q +
Sbjct: 113 QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD----IKLADFGVSAKNVKTLQRRD 168
Query: 148 STVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVM 183
S +GTP ++APEV++ YD K AD+WS G+TL M
Sbjct: 169 SFIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 77.4 bits (190), Expect = 5e-16
Identities = 55/175 (31%), Positives = 89/175 (50%), Gaps = 10/175 (5%)
Query: 25 VFHLWQIDENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80
+ HL +I ++ +II + H P IV F + ++I ME+ GG L + +
Sbjct: 37 LIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 95
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139
AGR E +I G++Y ++ HRD+K N L++ +K+CDFG S
Sbjct: 96 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVS-G 152
Query: 140 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
++ S S VGT +Y++PE L Y + +D+WS G++L M +G YP P+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 6e-16
Identities = 52/176 (29%), Positives = 93/176 (52%), Gaps = 22/176 (12%)
Query: 31 IDENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNA-- 82
I +Q++I++ + + P I+ F ++I E+ GG L + +I
Sbjct: 38 ITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYRKIPEHVL 97
Query: 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
GR + ++ G++Y S+++ HRD+K N L++ ++K+CDFG S V
Sbjct: 98 GRIA--------VAVVKGLTYLWSLKILHRDVKPSNMLVNTRG--QVKLCDFGVSTQLV- 146
Query: 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 198
+S K+ VGT AY+APE + ++Y G +DVWS G++ + +G +P+ P+ KN
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPY--PQIQKN 199
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 8e-16
Identities = 57/203 (28%), Positives = 89/203 (43%), Gaps = 13/203 (6%)
Query: 59 TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 116
T L +V+ +GG+L I N G F E+ A F+ +++ G+ H +RDLK
Sbjct: 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKP 130
Query: 117 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSC 176
EN LLD ++I D G + + VGT Y+APEVL + Y D W
Sbjct: 131 ENILLDDY--GHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGL 187
Query: 177 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236
G +Y M+ G PF +E + R+L + S E + + + DP
Sbjct: 188 GCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYS--AKFSEEAKSICKMLLTKDPK 245
Query: 237 KRISIP-----EIRNHEWFLKNL 254
+R+ E++ H F +N+
Sbjct: 246 QRLGCQEEGAGEVKRHP-FFRNM 267
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 68/244 (27%), Positives = 112/244 (45%), Gaps = 37/244 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFFQ 95
RE+ + L+H NIV +++ T L +V EY +L + + + G S + F
Sbjct: 53 REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
Q++ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ S V T
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLIN--ERGELKLADFGLARAKSVPTKTYSNEVVTLW 169
Query: 155 YIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEEPKNFRKTIHRILSV-- 209
Y P+VLL EY +I D+W G + M G +P E+ + I R+L
Sbjct: 170 YRPPDVLLGSSEYSTQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHL---IFRLLGTPT 225
Query: 210 --------------QYSIPDY-----VHISP----ECRHLISRIFVADPAKRISIPEIRN 246
Y+ P Y ++ +P E L+++ + KRIS E
Sbjct: 226 EETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285
Query: 247 HEWF 250
H +F
Sbjct: 286 HAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 1e-15
Identities = 67/253 (26%), Positives = 102/253 (40%), Gaps = 37/253 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
RE + L+H NIV ++I T L +V EY + G + + F Q
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 155
L+ G+SY H + HRDLK +N L+ S LK+ DFG +++ + S S V T Y
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLI--SDTGELKLADFGLARAKSVPSHTYSNEVVTLWY 169
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----- 210
P+VLL D+W G M+ G F ++ ++ + I +L
Sbjct: 170 RPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTW 229
Query: 211 ---YSIPDYVHISPE----------------------CRHLISRIFVADPAKRISIPEIR 245
+S+P H PE L S++ P R+S
Sbjct: 230 PGVHSLP---HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAAL 286
Query: 246 NHEWFLKNLPADL 258
+HE+F +LP L
Sbjct: 287 SHEYF-SDLPPRL 298
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 1e-15
Identities = 53/175 (30%), Positives = 89/175 (50%), Gaps = 10/175 (5%)
Query: 25 VFHLWQIDENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80
+ HL +I ++ +II + H P IV F + ++I ME+ GG L + +
Sbjct: 37 LIHL-EIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 95
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139
A R E+ ++ G++Y Q+ HRD+K N L++ +K+CDFG S
Sbjct: 96 EAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG--EIKLCDFGVS-G 152
Query: 140 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
++ S S VGT +Y++PE L Y + +D+WS G++L + +G YP P+
Sbjct: 153 QLIDSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 70/240 (29%), Positives = 110/240 (45%), Gaps = 27/240 (11%)
Query: 31 IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLA-----IVMEYASGG---ELFERICN 81
+DE ++ E +SL HPN+V+F + L +V+E +GG EL + +
Sbjct: 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLI 120
Query: 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS- 139
G R E + + G+ + H+ ++ HRD+K N LL +K+ DFG S
Sbjct: 121 CGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQL 178
Query: 140 SVLHSQPKSTVGTPAYIAPEVL-LKKEYDGKI---ADVWSCGVTLYVMLVGAYPFEDPEE 195
+ + ++VGTP ++APEV+ +++YD DVWS G+T + G P D
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238
Query: 196 PKNFRKTIHRILSVQYSIPDYVHISPECR---HLISRIFVADPAKRISIPEIRNHEWFLK 252
K K I R P +H CR H IS+ + D R S+ + H F+K
Sbjct: 239 VKTLFK-IPRNPP-----PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHP-FIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 2e-15
Identities = 66/243 (27%), Positives = 98/243 (40%), Gaps = 32/243 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
RE + L+H NIV ++I T L V EY I + G R F Q
Sbjct: 52 REASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAY 155
L+ G++Y H + HRDLK +N L+ S LK+ DFG +++ + SQ S+ V T Y
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLI--SYLGELKLADFGLARAKSIPSQTYSSEVVTLWY 169
Query: 156 IAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----- 209
P+VLL +Y + D+W G ML G F + + I +L V
Sbjct: 170 RPPDVLLGATDYSSAL-DIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDT 228
Query: 210 ---------------QYSIPDYVHI-------SPECRHLISRIFVADPAKRISIPEIRNH 247
P + + P+ L S++ + P RIS + H
Sbjct: 229 WPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288
Query: 248 EWF 250
+F
Sbjct: 289 PYF 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 70/257 (27%), Positives = 104/257 (40%), Gaps = 38/257 (14%)
Query: 25 VFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER-----I 79
VF + V RE+ +H N++ + IL P H+ E EL + I
Sbjct: 36 VFQNLVSCKRVFRELKMLCFFKHDNVLSALD-ILQPPHIDPFEEIYVVTELMQSDLHKII 94
Query: 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139
+ S D + F Q++ G+ Y HS + HRD+K N L++ + LKICDFG ++
Sbjct: 95 VSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN--CVLKICDFGLARV 152
Query: 140 SVLHSQPKST--VGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFE----- 191
T V T Y APE+L+ + Y + D+WS G +L F+
Sbjct: 153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAV-DIWSVGCIFAELLGRRILFQAQSPI 211
Query: 192 -----------DP--EEPKNFRK-TIHRILSVQYSIPD----YVHISP---ECRHLISRI 230
P E ++ + IL + P Y S E HL+ R+
Sbjct: 212 QQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRM 271
Query: 231 FVADPAKRISIPEIRNH 247
V DP KRIS + H
Sbjct: 272 LVFDPDKRISAADALAH 288
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 5e-15
Identities = 68/294 (23%), Positives = 119/294 (40%), Gaps = 57/294 (19%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDE 89
RE++ + + H NI+ V TP + +VME +C D
Sbjct: 69 RELVLLKCVNHKNIISLLNV-FTPQKSLEEFQDVYLVMELMDAN-----LCQVIHMELDH 122
Query: 90 AR--FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
R + Q++ G+ + HS + HRDLK N ++ LKI DFG ++++ +
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMT 180
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI- 206
V T Y APEV+L Y + D+WS G + ++ G+ F+ + + K I ++
Sbjct: 181 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLG 239
Query: 207 -------LSVQYSIPDYVHISP----------------------------ECRHLISRIF 231
+Q ++ +YV P + R L+S++
Sbjct: 240 TPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKML 299
Query: 232 VADPAKRISIPEIRNHEW---FLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIM 282
V DP KRIS+ E H + + A+ + Q EE + ++ E++
Sbjct: 300 VIDPDKRISVDEALRHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEEWKELI 353
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 6e-15
Identities = 66/263 (25%), Positives = 114/263 (43%), Gaps = 42/263 (15%)
Query: 27 HLWQIDENVQREIINHRSLRH----PNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82
HL +I ++ +II + H P IV F + ++I ME+ GG L + + A
Sbjct: 35 HL-EIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 93
Query: 83 GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
GR E+ ++ G++Y ++ HRD+K N L++ +K+CDFG S +
Sbjct: 94 GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG--EIKLCDFGVS-GQL 150
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-------- 193
+ S S VGT +Y++PE L Y + +D+WS G++L M +G YP P
Sbjct: 151 IDSMANSFVGTRSYMSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAKELEAM 209
Query: 194 ---EEPKNFRKTIHRILSVQ----------YSIPDYV-----------HISPECRHLISR 229
+ K HR +S + + DY+ S E + + +
Sbjct: 210 FGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDK 269
Query: 230 IFVADPAKRISIPEIRNHEWFLK 252
+P +R + E+ H + +
Sbjct: 270 CLKKNPKERADLKELTKHPFIKR 292
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-15
Identities = 60/212 (28%), Positives = 96/212 (45%), Gaps = 27/212 (12%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVS 102
LRHPN+V+ V+L L IV EY + G L + + + GR + + F + G+
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGME 116
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVL 161
Y HRDL N L+ K+ DFG +K + SQ + + P + APE L
Sbjct: 117 YLEEKNFVHRDLAARNVLVSEDLVA--KVSDFGLAKEA---SQGQDSGKLPVKWTAPEAL 171
Query: 162 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI------P 214
+K++ K +DVWS G+ L+ + G P+ P P K + + Y + P
Sbjct: 172 REKKFSTK-SDVWSFGILLWEIYSFGRVPY--PRIP---LKDVVPHVEKGYRMEAPEGCP 225
Query: 215 DYVHISPECRHLISRIFVADPAKRISIPEIRN 246
V+ ++ + DPAKR + ++R
Sbjct: 226 PEVY------KVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 74.1 bits (183), Expect = 6e-15
Identities = 69/247 (27%), Positives = 100/247 (40%), Gaps = 42/247 (17%)
Query: 37 REIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSEDEAR 91
REI+ + L HPNIV+ VI I + + E E + A + R
Sbjct: 55 REIMFLQELGDHPNIVKLLNVIKAENDKDIYLVF----EYMETDLHAVIRANILEDVHKR 110
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 149
+ QL+ + Y HS V HRDLK N LL+ R+K+ DFG ++S +
Sbjct: 111 YIMYQLLKALKYIHSGNVIHRDLKPSNILLNS--DCRVKLADFGLARSLSELEENPENPV 168
Query: 150 ----VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------- 190
V T Y APE+LL K D+WS G L ML+G F
Sbjct: 169 LTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228
Query: 191 ------EDPEEPK-NFRKTIHRILSV--QYSIPDYV-HISPECRHLISRIFVADPAKRIS 240
ED E K F T+ L + + + + S + L+ ++ V +P KR++
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT 288
Query: 241 IPEIRNH 247
E H
Sbjct: 289 AEEALEH 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 60/209 (28%), Positives = 87/209 (41%), Gaps = 42/209 (20%)
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----------------YS 137
F ++ + + Y HS V HRDLK +N LL + I D+G
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 138 KSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
+ ++ +S P VGTP Y+APE LL D+++ GV LY ML ++P+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRR-- 233
Query: 195 EPKNFRKTI--HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRNH 247
K RK ILS P Y I P + + DPA+R S ++ H
Sbjct: 234 --KKGRKISYRDVILSPIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPH 290
Query: 248 -----EWFLKNLPADLVVDNTTNNQFEEP 271
EW +K A L+ + +F EP
Sbjct: 291 LQGSPEWTVK---ATLMTKKKSCWKFYEP 316
|
Length = 932 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-14
Identities = 52/161 (32%), Positives = 77/161 (47%), Gaps = 15/161 (9%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEAR 91
REI R LRHP+IV K ++L P+ + +V E +L + I + + +
Sbjct: 48 REIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQ 106
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---- 147
FF QL+ + Y H+ V HRDLK +N L + +LKICDFG ++ + +
Sbjct: 107 FFLYQLLRALKYIHTANVFHRDLKPKNILANAD--CKLKICDFGLARVAFNDTPTAIFWT 164
Query: 148 STVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVG 186
V T Y APE+ +Y I D+WS G +L G
Sbjct: 165 DYVATRWYRAPELCGSFFSKYTPAI-DIWSIGCIFAEVLTG 204
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 3e-14
Identities = 66/273 (24%), Positives = 115/273 (42%), Gaps = 40/273 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE+ + ++H N++ +V L +VM + G ++ + SED
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRI 120
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
+F Q++ G+ Y H+ + HRDLK N L + LKI DFG ++ + S+ V
Sbjct: 121 QFLVYQMLKGLKYIHAAGIIHRDLKPGN--LAVNEDCELKILDFGLARQT--DSEMTGYV 176
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------- 191
T Y APEV+L + + D+WS G + ML G F+
Sbjct: 177 VTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPS 236
Query: 192 -------DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
E+ KN+ K + R + + +P +++ ++ V D RI+ E
Sbjct: 237 KEFVQKLQSEDAKNYVKKLPRFRKKDFRSL-LPNANPLAVNVLEKMLVLDAESRITAAEA 295
Query: 245 RNHEWFLK-NLPADLVVDNTTNNQFEEPDQPMQ 276
H +F + + P D ++ F+E DQ ++
Sbjct: 296 LAHPYFEEFHDPEDETEAPPYDDSFDEVDQSLE 328
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 50/183 (27%), Positives = 81/183 (44%), Gaps = 7/183 (3%)
Query: 59 TPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL 116
T L +V+ +GG+L I N G F E A F+ +L G+ ++ +RDLK
Sbjct: 71 TKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKP 130
Query: 117 ENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSC 176
EN LLD ++I D G + + VGT Y+APEV+ ++Y D W
Sbjct: 131 ENILLDDR--GHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFS-PDWWGL 187
Query: 177 GVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236
G +Y M+ G PF +E + R+ Q + S + + + + +P
Sbjct: 188 GCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE--KFSEDAKSICRMLLTKNPK 245
Query: 237 KRI 239
+R+
Sbjct: 246 ERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-14
Identities = 67/243 (27%), Positives = 110/243 (45%), Gaps = 38/243 (15%)
Query: 31 IDENVQREIINHRSLR-HPNIVRF-----KEVILTPTHLAIVMEYASGG---ELFERICN 81
IDE ++ E ++L HPN+V+F K+ + L +V+E +GG +L +
Sbjct: 57 IDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLK 116
Query: 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-- 138
G R E + + + G+ + H + HRD+K N LL + +K+ DFG S
Sbjct: 117 RGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL--TTEGGVKLVDFGVSAQL 174
Query: 139 SSVLHSQPKSTVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 193
+S + ++VGTP ++APEV+ L YD + DVWS G+T + G P D
Sbjct: 175 TSTRLRR-NTSVGTPFWMAPEVIACEQQLDSTYDAR-CDVWSLGITAIELGDGDPPLADL 232
Query: 194 EE-------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246
P+N T+H+ P+ S E I + D KR ++ ++
Sbjct: 233 HPMRALFKIPRNPPPTLHQ--------PEL--WSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
Query: 247 HEW 249
H +
Sbjct: 283 HVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 6e-14
Identities = 84/310 (27%), Positives = 126/310 (40%), Gaps = 77/310 (24%)
Query: 36 QREIINHRSLR----------HPNIVRFKEV-ILTPTHLAIVMEYASGGELFE----RIC 80
++I+ R+LR H NI ++ I+ P + + Y EL E +I
Sbjct: 40 SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYE---ELMEADLHQII 96
Query: 81 NAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGYS 137
+G ++ + F Q++ G+ Y HS V HRDLK N L D LKICDFG +
Sbjct: 97 RSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC----ELKICDFGLA 152
Query: 138 KS-SVLH--SQPKST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE- 191
+ S + T V T Y APE++L + K DVWS G L +L F+
Sbjct: 153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKG 212
Query: 192 ---------------DPEEPKNFRKTIHRILSVQ-----YSIPDYVHI---------SPE 222
P+E +T+ RI S + S+P+ +P
Sbjct: 213 KDYVDQLNQILQVLGTPDE-----ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPL 267
Query: 223 CRHLISRIFVADPAKRISIPEIRNH----EWFLKNLPAD-LVVDNTTNNQFEEPDQPMQS 277
L+ ++ DP KRIS+ E H W + P D V + FE D S
Sbjct: 268 ALDLLEKLLAFDPTKRISVEEALEHPYLAIW---HDPDDEPVCQKPFDFSFESED----S 320
Query: 278 IDEIMQIIAE 287
++E+ +I E
Sbjct: 321 MEELRDMIIE 330
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 6e-14
Identities = 70/290 (24%), Positives = 117/290 (40%), Gaps = 57/290 (19%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE+ + + H N++ +V + L +V G +L I + S+D
Sbjct: 63 RELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL-NNIVKCQKLSDDHI 120
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
+F Q++ G+ Y HS + HRDLK N ++ LKI DFG ++ H+ + T
Sbjct: 121 QFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNED--CELKILDFGLAR----HTDDEMTG 174
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFEDP------------- 193
V T Y APE++L + + D+WS G + +L G +P D
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234
Query: 194 -----------EEPKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIFVADPAKR 238
E +N+ +++ Q D+ + +P L+ ++ V DP KR
Sbjct: 235 PDEELLQKISSESARNYIQSLP-----QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKR 289
Query: 239 ISIPEIRNHEWFLK-NLPADLVVDNTTNNQFEEPDQPMQ-----SIDEIM 282
I+ E H + + + P D V + FE D + EIM
Sbjct: 290 ITAAEALAHPYLAEYHDPEDEPVAPPYDQSFESRDLTVDEWKELVYKEIM 339
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 50/155 (32%), Positives = 75/155 (48%), Gaps = 14/155 (9%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNA-GRFSEDEARFFF 94
+E SL H N++R V+LT L +V E A G L +R+ +A G F +
Sbjct: 45 KEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYA 103
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKST 149
Q+ +G+ Y S + HRDL N LL + ++KI DFG ++ + +
Sbjct: 104 VQIANGMRYLESKRFIHRDLAARNILL--ASDDKVKIGDFGLMRALPQNEDHYVMEEHLK 161
Query: 150 VGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVM 183
V P A+ APE L + + +DVW GVTL+ M
Sbjct: 162 V--PFAWCAPESLRTRTFS-HASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 44/139 (31%), Positives = 74/139 (53%), Gaps = 11/139 (7%)
Query: 62 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 119
L +VME+ G + + + N ED + ++++ G+++ H+ +V HRD+K +N
Sbjct: 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNV 152
Query: 120 LLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE-----YDGKIADV 173
LL + +K+ DFG S ++T +GTP ++APEV+ E YD + +D+
Sbjct: 153 LL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYR-SDI 209
Query: 174 WSCGVTLYVMLVGAYPFED 192
WS G+T M GA P D
Sbjct: 210 WSLGITAIEMAEGAPPLCD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 17/171 (9%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEAR 91
+Q+EII R L+HPNI+ + + + L +V M Y S +L + G E
Sbjct: 46 LQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAIA 104
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVLH 143
F + +++ + Y HS HR +K + LL G ++ + YS + V+H
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGD--GKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 144 SQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 192
PKS+V +++PEVL + + Y+ K D++S G+T + G PF+D
Sbjct: 163 DFPKSSVKNLPWLSPEVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 2e-13
Identities = 58/181 (32%), Positives = 85/181 (46%), Gaps = 14/181 (7%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSE 87
Q ++EI ++L H NIV++K L ++MEY G L + + + +
Sbjct: 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNL 106
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHS 144
+ F QQ+ G++Y HS HRDL N LLD +KI DFG +K+ +
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYY 164
Query: 145 QPKSTVGTPAY-IAPEVLLKKEYDGKIA-DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202
+ + +P + A E L KE A DVWS GVTLY +L + P PK F +
Sbjct: 165 RVREDGDSPVFWYAVECL--KENKFSYASDVWSFGVTLYELLTHCDSKQSP--PKKFEEM 220
Query: 203 I 203
I
Sbjct: 221 I 221
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 68.9 bits (169), Expect = 2e-13
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 18/222 (8%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFFQQLISGVSYC- 104
P IV+ +T + + I ME S +L +RI G ED ++ + Y
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLK 131
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVGTPAYIAPEVL-- 161
V HRD+K N LLD S +K+CDFG S V S+ K+ + G AY+APE +
Sbjct: 132 EKHGVIHRDVKPSNILLDASG--NVKLCDFGISGRLV-DSKAKTRSAGCAAYMAPERIDP 188
Query: 162 --LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVH 218
+YD + ADVWS G++L + G +P+++ + F + + +IL + S+P
Sbjct: 189 PDPNPKYDIR-ADVWSLGISLVELATGQFPYKNCK--TEF-EVLTKILQEEPPSLPPNEG 244
Query: 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 260
SP+ + D KR E+ H + + A++ V
Sbjct: 245 FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 4e-13
Identities = 52/158 (32%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS----- 99
L H +V+ V + IV EY S G C E RF QL+
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNG------CLLNYLREHGKRFQPSQLLEMCKDV 109
Query: 100 --GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---A 154
G++Y S Q HRDL N L+D +K+ DFG S+ VL + S+VG+
Sbjct: 110 CEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSR-YVLDDEYTSSVGSKFPVR 166
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
+ PEVLL ++ K +DVW+ GV ++ V +G P+E
Sbjct: 167 WSPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 4e-13
Identities = 60/271 (22%), Positives = 102/271 (37%), Gaps = 46/271 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
RE+ ++H NI+ +V + + +VM+ + +L + + R +E + + Q
Sbjct: 69 RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----------HSQ 145
+++G++ H HRDL N ++ KI DFG ++ Q
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 146 PK----STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 201
+ S V T Y APE+L+ E D+WS G +L G F E +
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 202 TIHRILSV--------QYSIPDYVHISP---------------ECRHLISRIFVADPAKR 238
I +L +P Y +P + L+ + +P +R
Sbjct: 246 -IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304
Query: 239 ISIPEIRNHEWF----LKNLPADLVVDNTTN 265
IS E HE+F L P+ L + T
Sbjct: 305 ISAKEALKHEYFKSDPLPCDPSQLPFNFLTK 335
|
Length = 335 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-13
Identities = 61/205 (29%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF--FFQQLISGVS 102
L H N+VR VIL L IVME S G L + GR + F + G+
Sbjct: 56 LHHKNLVRLLGVILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGME 114
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-YIAPEVL 161
Y S ++ HRDL N L+ S K+ DFG ++ + S P + APE L
Sbjct: 115 YLESKKLVHRDLAARNILV--SEDGVAKVSDFGLAR---VGSMGVDNSKLPVKWTAPEAL 169
Query: 162 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
K++ K +DVWS GV L+ V G P+ PK K + + Y +
Sbjct: 170 KHKKFSSK-SDVWSYGVLLWEVFSYGRAPY-----PKMSLKEVKECVEKGYRMEPPEGCP 223
Query: 221 PECRHLISRIFVADPAKRISIPEIR 245
+ L++ + +P KR S ++R
Sbjct: 224 ADVYVLMTSCWETEPKKRPSFHKLR 248
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 8e-13
Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 20/224 (8%)
Query: 34 NVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC-NAGRFSEDEA 90
++++EI R+L H NIV++K + + ++ME+ G L E + N + + +
Sbjct: 52 DLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQ 111
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 147
+ Q+ G+ Y S Q HRDL N L++ ++KI DFG +K+ + K
Sbjct: 112 LKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH--QVKIGDFGLTKAIETDKEYYTVK 169
Query: 148 STVGTPAY-IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNF 199
+ +P + APE L++ ++ +DVWS GVTLY +L P P +
Sbjct: 170 DDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHG 228
Query: 200 RKTIHRILSV---QYSIPDYVHISPECRHLISRIFVADPAKRIS 240
+ T+ R++ V +P + E L+ + + P+KR +
Sbjct: 229 QMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTT 272
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 8e-13
Identities = 64/274 (23%), Positives = 104/274 (37%), Gaps = 76/274 (27%)
Query: 36 QREIINHRSLRHPNIVRFKEVIL--------TPTHLAIVMEYA----SGGELFE--RICN 81
REI + L+HPN+V ++ + + +V Y SG L E +
Sbjct: 55 LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSG--LLENPSV-- 110
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
+ +E + + + QL+ G++Y H + HRD+K N L+D LKI DFG ++
Sbjct: 111 --KLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLAR--P 164
Query: 142 LHSQPK--------------STVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVM--- 183
P + V T Y PE+LL ++ Y + D+W G M
Sbjct: 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTR 223
Query: 184 ------------------LVGAYPFED--PE-------EPKNFRKTIHRILSVQYSIPDY 216
L G P E+ P E + R L ++
Sbjct: 224 RPILQGKSDIDQLHLIFKLCGT-PTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG---- 278
Query: 217 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ PE L+S++ DP KR++ + H +F
Sbjct: 279 -KLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 2e-12
Identities = 63/270 (23%), Positives = 118/270 (43%), Gaps = 42/270 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHL-----AIVMEYASGGELFERICNAGRFSEDEAR 91
RE+ + ++H N++ +V L ++ + G +L I + ++D +
Sbjct: 65 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADL-NNIVKCQKLTDDHVQ 123
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 149
F Q++ G+ Y HS + HRDLK N L + LKI DFG ++ H+ + T
Sbjct: 124 FLIYQILRGLKYIHSADIIHRDLKPSN--LAVNEDCELKILDFGLAR----HTDDEMTGY 177
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFED--------------- 192
V T Y APE++L + + D+WS G + +L G +P D
Sbjct: 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 237
Query: 193 ---------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243
E +N+ +++ ++ + ++ ++ +P L+ ++ V D KRI+ +
Sbjct: 238 GAELLKKISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQ 296
Query: 244 IRNHEWFLK-NLPADLVVDNTTNNQFEEPD 272
H +F + + P D V + + FE D
Sbjct: 297 ALAHAYFAQYHDPDDEPVADPYDQSFESRD 326
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 2e-12
Identities = 46/139 (33%), Positives = 73/139 (52%), Gaps = 11/139 (7%)
Query: 62 HLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 119
L +VME+ G + + I N E+ + ++++ G+S+ H +V HRD+K +N
Sbjct: 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNV 142
Query: 120 LLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE-----YDGKIADV 173
LL + +K+ DFG S ++T +GTP ++APEV+ E YD K +D+
Sbjct: 143 LL--TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDL 199
Query: 174 WSCGVTLYVMLVGAYPFED 192
WS G+T M GA P D
Sbjct: 200 WSLGITAIEMAEGAPPLCD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 3e-12
Identities = 64/258 (24%), Positives = 104/258 (40%), Gaps = 54/258 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGRFSEDE 89
RE++ + + H NI+ V TP + IVME +C + D
Sbjct: 72 RELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELMDAN-----LCQVIQMELDH 125
Query: 90 AR--FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
R + Q++ G+ + HS + HRDLK N ++ LKI DFG ++++
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMT 183
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
V T Y APEV+L Y + D+WS G + M+ G F + + K I ++
Sbjct: 184 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 242
Query: 208 S--------VQYSIPDYVHISP----------------------------ECRHLISRIF 231
+ +Q ++ YV P + R L+S++
Sbjct: 243 TPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302
Query: 232 VADPAKRISIPEIRNHEW 249
V D +KRIS+ E H +
Sbjct: 303 VIDASKRISVDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 3e-12
Identities = 58/246 (23%), Positives = 104/246 (42%), Gaps = 40/246 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE+ + ++H N++ +V + +VM Y ++I SED+
Sbjct: 63 RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKI-MGHPLSEDKV 119
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
++ Q++ G+ Y HS + HRDLK N L + LKI DFG ++ + ++ V
Sbjct: 120 QYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCELKILDFGLARHA--DAEMTGYV 175
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------- 191
T Y APEV+L + + D+WS G + ML G F+
Sbjct: 176 VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235
Query: 192 -------DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ + K++ K++ + +S + SP+ L+ ++ D KR++ E
Sbjct: 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTL-FPKASPQAVDLLEKMLELDVDKRLTATEA 294
Query: 245 RNHEWF 250
H +F
Sbjct: 295 LEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 3e-12
Identities = 64/264 (24%), Positives = 107/264 (40%), Gaps = 59/264 (22%)
Query: 37 REIINHRSLRHPNIVRFKEVILTP-------THLAIVMEY--ASGGELFERICNAGRFSE 87
RE++ + + H NI+ V TP + +VME A+ ++ + + R S
Sbjct: 64 RELVLMKLVNHKNIIGLLNV-FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS- 121
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+ Q++ G+ + HS + HRDLK N ++ LKI DFG ++++
Sbjct: 122 ----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMT 175
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---- 203
V T Y APEV+L Y + D+WS G + M+ G F + + K I
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLG 234
Query: 204 ----HRILSVQYSIPDYVHISPEC-----------------------------RHLISRI 230
+ +Q ++ +YV P+ R L+S++
Sbjct: 235 TPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKM 294
Query: 231 FVADPAKRISIPEIRNHE----WF 250
V DP KRIS+ + H W+
Sbjct: 295 LVIDPEKRISVDDALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 4e-12
Identities = 49/162 (30%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 97 LISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPA 154
++ + Y HS + V HRD+K N L++ ++K+CDFG S V S K+ G
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLIN--RNGQVKLCDFGISGYLV-DSVAKTIDAGCKP 168
Query: 155 YIAPE----VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
Y+APE L +K YD K +DVWS G+T+ + G +P++ + P K + V+
Sbjct: 169 YMAPERINPELNQKGYDVK-SDVWSLGITMIELATGRFPYDSWKTPFQQLKQV-----VE 222
Query: 211 YSIPDYVH--ISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
P SPE + +++ + +R + PE+ H +F
Sbjct: 223 EPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFF 264
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (160), Expect = 4e-12
Identities = 62/252 (24%), Positives = 103/252 (40%), Gaps = 42/252 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEAR--FF 93
RE++ + + H NI+ V L + EL + +C + D R +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYL 124
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153
Q++ G+ + HS + HRDLK N ++ LKI DFG ++++ V T
Sbjct: 125 LYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPYVVTR 182
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----- 208
Y APEV+L Y + D+WS G + M+ F + + K I ++ +
Sbjct: 183 YYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241
Query: 209 ---VQYSIPDYVHISP----------------------------ECRHLISRIFVADPAK 237
+Q ++ +YV P + R L+S++ V DPAK
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301
Query: 238 RISIPEIRNHEW 249
RIS+ E H +
Sbjct: 302 RISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 5e-12
Identities = 52/159 (32%), Positives = 78/159 (49%), Gaps = 16/159 (10%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFER-ICNAGRFSEDE 89
+ +REI +SL+H NIV++K V + +L +VMEY G L + + R +
Sbjct: 50 RDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRK 109
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS- 148
+ Q+ G+ Y S + HRDL N L++ R+KI DFG +K + Q K
Sbjct: 110 LLLYASQICKGMEYLGSKRYVHRDLATRNILVESE--NRVKIGDFGLTK---VLPQDKEY 164
Query: 149 -TVGTPA-----YIAPEVLLKKEYDGKIADVWSCGVTLY 181
V P + APE L + ++ +DVWS GV LY
Sbjct: 165 YKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLY 202
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 52/208 (25%), Positives = 92/208 (44%), Gaps = 18/208 (8%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCH 105
H NI+R + V+ I+ EY G L + + + G FS + + + +G+ Y
Sbjct: 65 HHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLS 124
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAPE 159
M HRDL N L++ + K+ DFG S+ VL P+ T T + APE
Sbjct: 125 DMNYVHRDLAARNILVNSNLE--CKVSDFGLSR--VLEDDPEGTYTTSGGKIPIRWTAPE 180
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 218
+ +++ +DVWS G+ ++ VM G P+ D + + ++ + +P +
Sbjct: 181 AIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSN-----HEVMKAINDGFRLPAPMD 234
Query: 219 ISPECRHLISRIFVADPAKRISIPEIRN 246
L+ + + D A+R +I N
Sbjct: 235 CPSAVYQLMLQCWQQDRARRPRFVDIVN 262
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED-----E 89
++ EI+ L H NI++ +E++ + + ++ + +L+ + + +D +
Sbjct: 210 LENEILALGRLNHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQ 268
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
R +QL+ V Y H ++ HRD+KLEN L+ L DFG + +
Sbjct: 269 TRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLG--DFGTAMPFEKEREAFDY 326
Query: 150 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184
VGT A +PE+L Y +I D+WSCG+ L ML
Sbjct: 327 GWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 2e-11
Identities = 49/162 (30%), Positives = 76/162 (46%), Gaps = 30/162 (18%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI------ 98
HPNI+R + V+ + I+ EY G L F R E++ +F QL+
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR--------ENDGKFTVGQLVGMLRGI 115
Query: 99 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT----- 152
SG+ Y M HRDL N L++ + K+ DFG S+ L ++T T
Sbjct: 116 ASGMKYLSEMNYVHRDLAARNILVNSN--LVCKVSDFGLSR--RLED-SEATYTTKGGKI 170
Query: 153 PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
P + APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 171 PIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 2e-11
Identities = 40/136 (29%), Positives = 55/136 (40%), Gaps = 10/136 (7%)
Query: 36 QREIINHRSLRHPNIVRF-KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+RE L HPNIV P L V EY G L E + G E
Sbjct: 26 RRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRLM 85
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSK-----SSVLHSQPKS 148
Q++ ++ H+ + HRDLK +N ++ + P K+ DFG +
Sbjct: 86 LQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTR 145
Query: 149 T---VGTPAYIAPEVL 161
T +GTP Y APE L
Sbjct: 146 TTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 23/169 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYASGG-----ELFERICNAG 83
RE++ ++L H NI+ K+ T L +VME+ + + R N
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNH 165
Query: 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSS 140
+ + QL ++Y HS +CHRDLK +N L+D P LK+CDFG +K+
Sbjct: 166 ALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID----PNTHTLKLCDFGSAKNL 221
Query: 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 189
+ + S + + Y APE++L D+WS G + M++G YP
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG-YP 269
|
Length = 440 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 3e-11
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 15/155 (9%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 104
HPNI+ + V+ + IV EY G L F R + G+F+ + + + SG+ Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVGMLRGIASGMKYL 122
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA------YIAP 158
M HRDL N L++ + K+ DFG S+ VL P++ T + AP
Sbjct: 123 SDMGYVHRDLAARNILVNSNLV--CKVSDFGLSR--VLEDDPEAAYTTRGGKIPIRWTAP 178
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 179 EAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWE 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 48/153 (31%), Positives = 69/153 (45%), Gaps = 9/153 (5%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC 104
L HP IVR V L +VME A G L + + + + Q+ G++Y
Sbjct: 53 LDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYL 111
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVGT--P-AYIAPEV 160
S HRDL N LL + KI DFG S++ ++T P + APE
Sbjct: 112 ESKHFVHRDLAARNVLLVNR--HQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPEC 169
Query: 161 LLKKEYDGKIADVWSCGVTLYVML-VGAYPFED 192
+ ++ K +DVWS GVTL+ GA P+ +
Sbjct: 170 INYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 3e-11
Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 63/274 (22%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGEL----FERICNAGR----FS 86
REI R L+HPN++ ++V L+ + + ++ +YA F R A +
Sbjct: 47 REIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP 106
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHS 144
+ Q++ G+ Y H+ V HRDLK N L+ +G R+KI D G+++ L +
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFN 163
Query: 145 QP-------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML------------- 184
P V T Y APE+LL + K D+W+ G +L
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
Query: 185 ----------------VGAYP----FED----PEEP---KNFRKTIHRILS-VQYSIPDY 216
V +P +ED PE P K+FR+T + S ++Y
Sbjct: 224 KTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHK 283
Query: 217 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
V + L+ ++ DP KRI+ + +F
Sbjct: 284 VKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 3e-11
Identities = 47/148 (31%), Positives = 70/148 (47%), Gaps = 11/148 (7%)
Query: 44 SLRHPNIVRFKEVILTP-----THLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQ 96
+ HPN+VR +V T L +V E+ +++ G +E FQ
Sbjct: 60 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ- 118
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156
L+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ S V T Y
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIYSFQMALTSVVVTLWYR 176
Query: 157 APEVLLKKEYDGKIADVWSCGVTLYVML 184
APEVLL+ Y + D+WS G M
Sbjct: 177 APEVLLQSSYATPV-DLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 5e-11
Identities = 42/145 (28%), Positives = 67/145 (46%), Gaps = 11/145 (7%)
Query: 47 HPNIVRFKEVILT-----PTHLAIVMEYASGG--ELFERICNAGRFSEDEARFFFQQLIS 99
HPNIVR +V T T + +V E+ +++ G + + +Q +
Sbjct: 61 HPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQFLR 119
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159
G+ + H+ + HRDLK EN L+ + ++K+ DFG ++ V T Y APE
Sbjct: 120 GLDFLHANCIVHRDLKPENILV--TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE 177
Query: 160 VLLKKEYDGKIADVWSCGVTLYVML 184
VLL+ Y + D+WS G M
Sbjct: 178 VLLQSTYATPV-DMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 63/274 (22%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGEL----FERICNAGR----FS 86
REI R L+HPN++ ++V L+ + ++ +YA F R A +
Sbjct: 47 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLP 106
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHS 144
+ Q++ G+ Y H+ V HRDLK N L+ +G R+KI D G+++ L +
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR---LFN 163
Query: 145 QP-------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML------------- 184
P V T Y APE+LL + K D+W+ G +L
Sbjct: 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDI 223
Query: 185 ----------------VGAYP----FED----PEEP---KNFRKTIHRILS-VQYSIPDY 216
V +P +ED PE K+FR+ + S ++Y
Sbjct: 224 KTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHK 283
Query: 217 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
V + HL+ ++ DP KRI+ + +F
Sbjct: 284 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 6e-11
Identities = 64/219 (29%), Positives = 91/219 (41%), Gaps = 39/219 (17%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------- 98
HPNIV+ V + + IVME GG L + + + R ++L+
Sbjct: 50 DHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFL------RKKKNRLTVKKLLQMSLDAA 103
Query: 99 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG---------YSKSSVLHSQP-KS 148
+G+ Y S HRDL N L+ + LKI DFG Y+ S L P K
Sbjct: 104 AGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQIPIKW 161
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRIL 207
T APE L Y + +DVWS G+ L+ +G P+ + ++T RI
Sbjct: 162 T-------APEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPG----MSNQQTRERIE 209
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246
S Y +P E L+ + + DP R S EI N
Sbjct: 210 S-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 7e-11
Identities = 45/152 (29%), Positives = 66/152 (43%), Gaps = 9/152 (5%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 103
L HPN+V+ V + IV EY + G L + G+ + + + Y
Sbjct: 56 LSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEY 115
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APEV 160
S HRDL N L+ +K+ DFG ++ VL Q S+ GT + PEV
Sbjct: 116 LESNGFIHRDLAARNCLVGEDNV--VKVSDFGLAR-YVLDDQYTSSQGTKFPVKWAPPEV 172
Query: 161 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
+ K +DVWS GV ++ V G P+E
Sbjct: 173 FDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 9/153 (5%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 103
L HP +V+ V + + +V E+ G L + + G+FS++ + G++Y
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAY 115
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEV 160
S V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PEV
Sbjct: 116 LESSNVIHRDLAARNCLVGENQV--VKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEV 172
Query: 161 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+Y K +DVWS GV ++ V G P+E+
Sbjct: 173 FSFSKYSSK-SDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-10
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF-FQQLI--- 98
+ LRH +V+ V + IV EY S G L + + E + QL+
Sbjct: 56 KKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFL------KSGEGKKLRLPQLVDMA 109
Query: 99 ----SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVG 151
G++Y S HRDL N L+ + KI DFG ++ ++ +
Sbjct: 110 AQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLAR--LIEDDEYTAREGAK 165
Query: 152 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSV 209
P + APE + K +DVWS G+ L ++ G P+ R+ + ++
Sbjct: 166 FPIKWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPG----MTNREVLEQV-ER 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKR 238
Y +P + E L+ + + DP +R
Sbjct: 220 GYRMPRPPNCPEELYDLMLQCWDKDPEER 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 57/199 (28%), Positives = 84/199 (42%), Gaps = 13/199 (6%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCH 105
HPNIVR V + IVME GG+ + G R E + +G+ Y
Sbjct: 52 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLE 111
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV--LHSQPKSTVGTPA-YIAPEVLL 162
S HRDL N L+ LKI DFG S+ +++ P + APE L
Sbjct: 112 SKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALN 169
Query: 163 KKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
Y + +DVWS G+ L+ +GA P+ + + R+ I + V+ P+
Sbjct: 170 YGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAIEQ--GVRLPCPE--LCPD 223
Query: 222 ECRHLISRIFVADPAKRIS 240
L+ R + DP +R S
Sbjct: 224 AVYRLMERCWEYDPGQRPS 242
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 48/152 (31%), Positives = 68/152 (44%), Gaps = 9/152 (5%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVSY 103
L HP +V+ V L IV E+ G L + G+ S+D Q + G+ Y
Sbjct: 56 LSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEY 115
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIAPEV 160
HRDL N L+ S +K+ DFG ++ VL + S+ G + PEV
Sbjct: 116 LERNSFIHRDLAARNCLV--SSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEV 172
Query: 161 LLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
+Y K +DVWS GV ++ V G PFE
Sbjct: 173 FNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 2e-10
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 48/236 (20%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC---------------NAGRF 85
+ + HP++++ L +++EYA G L F R ++
Sbjct: 58 KQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 86 SEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYS 137
+ DE LIS G+ Y M++ HRDL N L+ +G ++KI DFG S
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR---KMKISDFGLS 174
Query: 138 K------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--Y 188
+ S V S+ + V ++A E L Y + +DVWS GV L+ ++ +G Y
Sbjct: 175 RDVYEEDSYVKRSKGRIPV---KWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 230
Query: 189 PFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
P PE N KT +R+ P+ + S E +L+ + +P KR + +I
Sbjct: 231 PGIAPERLFNLLKTGYRM-----ERPE--NCSEEMYNLMLTCWKQEPDKRPTFADI 279
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 45/154 (29%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
S+ HP++VR + L+ ++ + G L + + + + Q+ G+S
Sbjct: 65 SVDHPHVVRLLGICLSSQV-QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMS 123
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKSTVG-TP-AYIAPE 159
Y ++ HRDL N L+ +P +KI DFG +K V + + G P ++A E
Sbjct: 124 YLEEKRLVHRDLAARNVLVK-TPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALE 181
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+L + Y K +DVWS GVT++ +M GA P+E
Sbjct: 182 SILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 62/251 (24%), Positives = 103/251 (41%), Gaps = 45/251 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEAR 91
RE+ + ++H N++ +V T + E G +L I + S++ +
Sbjct: 63 RELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADL-NNIVKCQKLSDEHVQ 121
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
F QL+ G+ Y HS + HRDLK N ++ L+I DFG ++ + + V
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNED--CELRILDFGLARQA--DDEMTGYVA 177
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSV- 209
T Y APE++L + + D+WS G + +L G F P N + + RI+ V
Sbjct: 178 TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-----PGNDYIDQLKRIMEVV 232
Query: 210 -----------------QY--SIPDYVH---------ISPECRHLISRIFVADPAKRISI 241
+Y S+P +P L+ ++ V D KRIS
Sbjct: 233 GTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISA 292
Query: 242 PEIRNHEWFLK 252
E H +F +
Sbjct: 293 SEALAHPYFSQ 303
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 6e-10
Identities = 50/186 (26%), Positives = 76/186 (40%), Gaps = 32/186 (17%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAI--------VMEYASGGEL--FERIC------NAGRFS 86
L H NI L H+ I + Y + G L F + C N S
Sbjct: 63 YGLSHQNI-------LPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALS 115
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLH 143
+ Q+ G+SY H V H+D+ N ++D ++KI D S+ H
Sbjct: 116 TQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEE--LQVKITDNALSRDLFPMDYH 173
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE--DPEEPKNFR 200
+ ++A E L+ KEY +DVWS GV L+ +M +G P+ DP E +
Sbjct: 174 CLGDNENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYL 232
Query: 201 KTIHRI 206
K +R+
Sbjct: 233 KDGYRL 238
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 8e-10
Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 21/175 (12%)
Query: 33 ENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFS 86
E +R+ ++ S+ HPNI+ + V+ + I+ E+ G L F R N G+F+
Sbjct: 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQ-NDGQFT 104
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+ + + +G+ Y M HRDL N L++ + K+ DFG S+ L
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSR--FLEDDT 160
Query: 147 KSTVGTPA--------YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
T + + APE + +++ +DVWS G+ ++ VM G P+ D
Sbjct: 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 54/177 (30%), Positives = 79/177 (44%), Gaps = 23/177 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER---------ICN 81
E+ +E+ L PNI R V L ++MEY G+L F + CN
Sbjct: 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN 123
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
+ S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S++
Sbjct: 124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG--KNYTIKIADFGMSRN-- 179
Query: 142 LHSQPKSTVG--TPAYI---APEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPFE 191
L+S V P I A E +L ++ K +DVW+ GVTL+ + L P+E
Sbjct: 180 LYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTK-SDVWAFGVTLWEILTLCREQPYE 235
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 2e-09
Identities = 46/174 (26%), Positives = 78/174 (44%), Gaps = 23/174 (13%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AGRFSEDEARF 92
+Q E+ + HPNIV ++ + L +V + + G + IC SE +
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTL--LDGSPAPRLKICDFGY----------SKSS 140
Q ++ + Y H M HR +K + L +DG K+ G +
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILISVDG------KVYLSGLRSNLSMINHGQRLR 159
Query: 141 VLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFED 192
V+H PK +V +++PEVL + + YD K +D++S G+T + G PF+D
Sbjct: 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 25/163 (15%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISG 100
RS P IV+F + I ME S + ++ + + ++++
Sbjct: 58 RSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLK------SVIPEEILGK 111
Query: 101 VSYC---------HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 150
++ +++ HRD+K N LLD + +K+CDFG S V S K+
Sbjct: 112 IAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLV-DSIAKTRDA 168
Query: 151 GTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPF 190
G Y+APE + + YD + +DVWS G+TLY + G +P+
Sbjct: 169 GCRPYMAPERIDPSARDGYDVR-SDVWSLGITLYEVATGKFPY 210
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 3e-09
Identities = 52/217 (23%), Positives = 84/217 (38%), Gaps = 26/217 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++ Q+E+ + LRH +++ V + I+ E G L + + A
Sbjct: 47 QDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL 106
Query: 93 --FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSV-LHSQP 146
Q+ G++Y HRDL N L+ K+ DFG + K V L S
Sbjct: 107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDK 164
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 205
K + APE + K +DVWS G+ LY + G P+ N + +
Sbjct: 165 KIPY---KWTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPG----MNNHEVYDQ 216
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFV----ADPAKR 238
I + Y +P +C I +I + A+P R
Sbjct: 217 ITA-GYRMPC----PAKCPQEIYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 46/164 (28%), Positives = 71/164 (43%), Gaps = 18/164 (10%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL------------FERICNAGR 84
+EI L++PNI+R V ++ L ++ EY G+L F N
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSV 141
S + Q+ SG+ Y S+ HRDL N L+ +KI DFG S+ S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGD 183
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 185
+ V ++A E +L ++ +DVW+ GVTL+ M
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 15/155 (9%)
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 151
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K +
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGSAR 237
Query: 152 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSV 209
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 238 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD--GT 294
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ P+ +PE ++ + DP +R + +
Sbjct: 295 RMRAPENA--TPEIYRIMLACWQGDPKERPTFSAL 327
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 6e-09
Identities = 48/150 (32%), Positives = 67/150 (44%), Gaps = 30/150 (20%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI-------S 99
HPNIV+ V + IVME GG+ + R +DE + +QL+ +
Sbjct: 51 HPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFL----RKKKDELK--TKQLVKFALDAAA 104
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--------SSVLHSQPKSTVG 151
G++Y S HRDL N L+ + LKI DFG S+ SS L P
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPIK--- 159
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLY 181
+ APE L Y + +DVWS G+ L+
Sbjct: 160 ---WTAPEALNYGRYSSE-SDVWSYGILLW 185
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 9e-09
Identities = 61/216 (28%), Positives = 102/216 (47%), Gaps = 13/216 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR 91
E +E R HP+IV+ VI T + IVME A GEL + N
Sbjct: 52 EKFLQEAYIMRQFDHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLI 110
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ QL + ++Y S + HRD+ N L+ SP +K+ DFG S+ S K++ G
Sbjct: 111 LYSYQLSTALAYLESKRFVHRDIAARNVLV-SSPDC-VKLGDFGLSRYLEDESYYKASKG 168
Query: 152 T-P-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILS 208
P ++APE + + + +DVW GV ++ ++++G PF+ + I RI +
Sbjct: 169 KLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKN----NDVIGRIEN 223
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ +P + P L+++ + DP+KR E+
Sbjct: 224 GE-RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 1e-08
Identities = 40/160 (25%), Positives = 67/160 (41%), Gaps = 23/160 (14%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARF--------FFQ-- 95
++VR V+ T +VME + G+L + R R + F Q
Sbjct: 69 HHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR---RPEAENNPGLGPPTLQKFIQMA 125
Query: 96 -QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT-- 152
++ G++Y + + HRDL N ++ +KI DFG ++ +
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLL 183
Query: 153 PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPF 190
P ++APE L + K +DVWS GV L+ M + P+
Sbjct: 184 PVRWMAPESLKDGVFTTK-SDVWSFGVVLWEMATLAEQPY 222
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 1e-08
Identities = 32/112 (28%), Positives = 56/112 (50%), Gaps = 6/112 (5%)
Query: 31 IDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
I++N+ ++ R + P IV + + ++ +VMEY GG++ + G F
Sbjct: 43 INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
E+ A + ++ + Y H + HRDLK +N L+ S +K+ DFG SK
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI--SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 1e-08
Identities = 58/245 (23%), Positives = 98/245 (40%), Gaps = 36/245 (14%)
Query: 27 HLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE------RIC 80
++ + ++E L+HPNIV V ++ EY + G+L E
Sbjct: 47 AEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHS 106
Query: 81 NAGRFSED-------EARFFFQ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 130
+ G S D + F Q+ +G+ Y S HRDL N L+ +K
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLV--GEGLTVK 164
Query: 131 ICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVG 186
I DFG S+ S+ + ++ ++ PE +L ++ + +D+WS GV L+ + G
Sbjct: 165 ISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTE-SDIWSFGVVLWEIFSYG 223
Query: 187 AYP---FEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIP 242
P F + E + R +L P V+ + EC + I PA+R
Sbjct: 224 LQPYYGFSNQEVIEMIRSRQ--LLPCPEDCPARVYALMIECWNEI-------PARRPRFK 274
Query: 243 EIRNH 247
+I
Sbjct: 275 DIHTR 279
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 1e-08
Identities = 37/146 (25%), Positives = 64/146 (43%), Gaps = 13/146 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ--QLISG 100
+ ++HPN+V+ V I+ E+ + G L + + R + + Q+ S
Sbjct: 57 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA 116
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 155
+ Y HRDL N L+ +K+ DFG S+ + H+ K + +
Sbjct: 117 MEYLEKKNFIHRDLAARNCLV--GENHLVKVADFGLSRLMTGDTYTAHAGAKFPI---KW 171
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLY 181
APE L ++ K +DVW+ GV L+
Sbjct: 172 TAPESLAYNKFSIK-SDVWAFGVLLW 196
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 21/161 (13%)
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 151
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 242
Query: 152 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH---RI 206
P ++APE + + Y + +DVWS GV L+ + +GA P+ + + F + + R+
Sbjct: 243 LPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ Y+ P+ +C H +P++R + E+ H
Sbjct: 302 RAPDYTTPEMYQTMLDCWH-------GEPSQRPTFSELVEH 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 2e-08
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 38/224 (16%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF------------- 92
+H NI+ V L +V+EYA+ G L + + A R + A
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL-RARRPPGEYASPDDPRPPEETLTQK 132
Query: 93 ----FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-- 146
F Q+ G+ + S + HRDL N L+ + +KI DFG ++ +H
Sbjct: 133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLV--TEDHVMKIADFGLARD--IHHIDYY 188
Query: 147 -KSTVG-TPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFR 200
K+T G P ++APE L + Y + +DVWS GV L+ + +G YP EE
Sbjct: 189 RKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247
Query: 201 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
K +R+ Q + H+ +C H P++R + ++
Sbjct: 248 KEGYRMEKPQNCTQELYHLMRDCWH-------EVPSQRPTFKQL 284
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 4e-08
Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 20/208 (9%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM 107
PN+V + I++ + +V+++A GG+L+ I E+ + + +++ + H
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104
Query: 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD 167
+ RDL N LLD +L +S+ S + Y APEV E +
Sbjct: 105 GIVCRDLNPNNILLDDRGHIQLTY----FSRWSEVEDSCDGEAVENMYCAPEVGGISE-E 159
Query: 168 GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227
+ D WS G L+ +L G E N T+ +IP+ +S E R L+
Sbjct: 160 TEACDWWSLGAILFELLTGKTLVECHPSGINTHTTL--------NIPE--WVSEEARSLL 209
Query: 228 SRIFVADPAKRI-----SIPEIRNHEWF 250
++ +P +R+ + +I++H +F
Sbjct: 210 QQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 47/165 (28%), Positives = 74/165 (44%), Gaps = 23/165 (13%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----------NAGRF 85
+EI L+ PNI+R V +T L ++ EY G+L + + +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 144
S F Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++ L+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRN--LYSG 183
Query: 145 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184
Q ++ + +LL K +DVW+ GVTL+ +L
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLGKFTTA--SDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSEDEAR-----FFFQ 95
+H NI+ L +++EYAS G L E + A R +S D AR F+
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYL-RARRPPGMEYSYDIARVPDEQMTFK 137
Query: 96 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 146
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++ + +
Sbjct: 138 DLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKK 195
Query: 147 KSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPKNFRKT 202
+ P ++APE L + Y + +DVWS GV ++ + YP EE K
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKE 254
Query: 203 IHRILSVQYSIPDYVHISPECRHLIS 228
HR+ + + +C H I
Sbjct: 255 GHRMDKPANCTNELYMMMRDCWHAIP 280
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 8e-08
Identities = 49/161 (30%), Positives = 73/161 (45%), Gaps = 21/161 (13%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLIS------- 99
HPNIV+ V L I+ME GG+L + +A ++L+
Sbjct: 58 HPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAK 117
Query: 100 GVSYCHSMQVCHRDLKLENTLLD--GSPAPR-LKICDFGYSK---SSVLHSQPKSTVGTP 153
G Y M HRDL N L+ G A R +KI DFG ++ S + + +
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177
Query: 154 AYIAPEVLLKKEYDGKI---ADVWSCGVTLY-VMLVGAYPF 190
++APE LL DGK +DVWS GV ++ ++ +G P+
Sbjct: 178 RWMAPESLL----DGKFTTQSDVWSFGVLMWEILTLGQQPY 214
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 9e-08
Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 6/102 (5%)
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
+GTP Y+APE+LL K + G D W+ GV L+ L G PF D E P+ + IL+
Sbjct: 541 LGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFND-ETPQ---QVFQNILNR 595
Query: 210 QYSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
P+ +S ++ I + DP KR + E++ H F
Sbjct: 596 DIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 60/205 (29%), Positives = 88/205 (42%), Gaps = 27/205 (13%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 95
+H NI+ L +++EYAS G L E + A R +S D E + F+
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYL-RARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 96 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 147
L+S G+ Y S + HRDL N L+ +KI DFG ++ + K
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKK 192
Query: 148 STVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPKNFRKT 202
+T G P ++APE L + Y + +DVWS GV L+ + YP EE K
Sbjct: 193 TTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE 251
Query: 203 IHRILSVQYSIPDYVHISPECRHLI 227
HR+ + I EC H +
Sbjct: 252 GHRMDKPANCTHELYMIMRECWHAV 276
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 2e-07
Identities = 46/154 (29%), Positives = 66/154 (42%), Gaps = 15/154 (9%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 104
H NIVR + VI + IV EY S G L F R + G+ + L SG+ Y
Sbjct: 65 HSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRK-HEGQLVAGQLMGMLPGLASGMKYL 123
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFG---YSKSSVLHS--QPKSTVGTPAYIAPE 159
M H+ L L++ KI F KS +++ KS V + APE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPV---LWAAPE 178
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+ + +DVWS G+ ++ VM G P+ D
Sbjct: 179 AIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 2e-07
Identities = 54/234 (23%), Positives = 94/234 (40%), Gaps = 32/234 (13%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI------------- 79
++ +RE + +H NIV+F V +V EY G+L + +
Sbjct: 53 KDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112
Query: 80 -CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
G + + Q+ SG+ Y S HRDL N L+ +KI DFG S+
Sbjct: 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV--GYDLVVKIGDFGMSR 170
Query: 139 SSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP-FE 191
+++ VG ++ PE ++ +++ + +DVWS GV L+ + G P +
Sbjct: 171 D--VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYG 227
Query: 192 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245
E + I I + E ++ + DP +RI+I +I
Sbjct: 228 LSNE-----EVIECITQGRLLQRPRT-CPSEVYDIMLGCWKRDPQQRINIKDIH 275
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 2e-07
Identities = 44/146 (30%), Positives = 62/146 (42%), Gaps = 20/146 (13%)
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGY------SKSSVLHSQP 146
+QL+S + Y H + HRD+K EN L++G IC DFG S S+ H
Sbjct: 267 RQLLSAIDYIHGEGIIHRDIKTENVLVNGPE----DICLGDFGAACFARGSWSTPFHYGI 322
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKN--FRKTI 203
TV T APEVL Y + D+WS G+ ++ V A F + + I
Sbjct: 323 AGTVDTN---APEVLAGDPYTPSV-DIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQI 378
Query: 204 HRILSVQYSIPDYVHISPECRHLISR 229
RI+ D R L+S+
Sbjct: 379 LRIIRQAQVHVDEFPQHAGSR-LVSQ 403
|
Length = 461 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 43/139 (30%), Positives = 70/139 (50%), Gaps = 14/139 (10%)
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVG 151
Q+ G+ + S + HRDL N LL S +KICDFG ++ ++ P K
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILL--SENNVVKICDFGLARD--IYKDPDYVRKGDAR 236
Query: 152 TP-AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNF-RKTIH--RI 206
P ++APE + K Y + +DVWS GV L+ + +GA P+ + + F R+ R+
Sbjct: 237 LPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 207 LSVQYSIPDYVHISPECRH 225
+ +Y+ P+ I +C H
Sbjct: 296 RAPEYATPEIYSIMLDCWH 314
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 4e-07
Identities = 52/228 (22%), Positives = 89/228 (39%), Gaps = 31/228 (13%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRF 85
L H ++V+ V + ++ +V EY G L E+ + +
Sbjct: 44 DSLAFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHW 102
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-----DGSPAPRLKICDFGYSKSS 140
D A +QL S + Y ++ H ++ +N L+ + P +K+ D G +
Sbjct: 103 KLDVA----KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV 158
Query: 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA-DVWSCGVTLY-VMLVGAYPFE--DPEEP 196
+ + + +IAPE + + IA D WS G TL + G P E
Sbjct: 159 LSREERVERI---PWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEK 215
Query: 197 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ F + HR+ +PD E +LI++ + DP KR S I
Sbjct: 216 ERFYQDQHRL-----PMPD----CAELANLINQCWTYDPTKRPSFRAI 254
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 6e-07
Identities = 42/154 (27%), Positives = 73/154 (47%), Gaps = 10/154 (6%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
++L+H +VR V+ + I+ EY + G L F + G+ + F Q+ G
Sbjct: 56 KTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEG 115
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIA 157
++Y HRDL+ N L+ S + KI DFG ++ + ++ + G + A
Sbjct: 116 MAYIERKNYIHRDLRAANVLV--SESLMCKIADFGLAR-VIEDNEYTAREGAKFPIKWTA 172
Query: 158 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
PE + + K +DVWS G+ LY ++ G P+
Sbjct: 173 PEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPY 205
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 49.7 bits (118), Expect = 6e-07
Identities = 49/193 (25%), Positives = 89/193 (46%), Gaps = 28/193 (14%)
Query: 21 IIIIVFHLWQIDENVQREIINHR------SLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74
I++ V L +N +++ HR +L+H +IV+F V + L +V EY G+
Sbjct: 36 ILVAVKTLKDASDNARKDF--HREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93
Query: 75 LFERICNAG-------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
L + + G ++ + QQ+ +G+ Y S HRDL N L+
Sbjct: 94 LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV 153
Query: 122 DGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGV 178
+ +KI DFG S+ S+ + T+ ++ PE ++ +++ + +DVWS GV
Sbjct: 154 GENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGV 210
Query: 179 TLY-VMLVGAYPF 190
L+ + G P+
Sbjct: 211 VLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 6e-07
Identities = 54/204 (26%), Positives = 87/204 (42%), Gaps = 13/204 (6%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVSYC 104
H NIV + ++ EY G+L F R + ++ F Q+ G+++
Sbjct: 98 HENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFL 157
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA-YIAPEVL 161
S HRDL N LL + +KICDFG ++ + S K P ++APE +
Sbjct: 158 ASKNCIHRDLAARNVLL--THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI 215
Query: 162 LKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
Y + +DVWS G+ L+ + +G+ P+ F K I Y + H
Sbjct: 216 FNCVYTFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE----GYRMAQPEHAP 270
Query: 221 PECRHLISRIFVADPAKRISIPEI 244
E ++ + ADP KR + +I
Sbjct: 271 AEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (117), Expect = 9e-07
Identities = 46/163 (28%), Positives = 69/163 (42%), Gaps = 24/163 (14%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFE-----RIC-----------NAGRFSEDEA 90
HPNI+ +L + +EYA G L + R+ A S +
Sbjct: 55 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F + G+ Y Q HRDL N L+ + KI DFG S+ ++ K T+
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKTM 170
Query: 151 GT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
G P ++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 171 GRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 212
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 50/164 (30%), Positives = 73/164 (44%), Gaps = 24/164 (14%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA---------RFFFQQ 96
HPNI+ +L I +EYA G L + + + D A QQ
Sbjct: 61 HHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120
Query: 97 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+ +G+ Y Q HRDL N L+ + A KI DFG S+ ++ K T
Sbjct: 121 LLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS--KIADFGLSRGEEVYV--KKT 176
Query: 150 VGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+G P ++A E L Y K +DVWS GV L+ ++ +G P+
Sbjct: 177 MGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPY 219
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 11/168 (6%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIV---MEYASGGELFERICNAGRFSEDEAR 91
+Q E++ RHPNI+ V T + L ++ M Y S L + G SE
Sbjct: 46 LQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIG 104
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------KSSVLHSQ 145
+ G++Y H HR++K + L+ G L YS K+ V++
Sbjct: 105 NILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDF 164
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKI-ADVWSCGVTLYVMLVGAYPFED 192
P+ + +++PE+L + Y + +D++S G+T + G PF+D
Sbjct: 165 PQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 1e-06
Identities = 50/172 (29%), Positives = 78/172 (45%), Gaps = 11/172 (6%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEA 90
DE ++ I H+ L +P IVR V L +VME ASGG L + + +
Sbjct: 40 DEMMREAEIMHQ-LDNPYIVRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNV 97
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPK 147
Q+ G+ Y HRDL N LL KI DFG SK+ + + +
Sbjct: 98 VELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYA--KISDFGLSKALGADDSYYKAR 155
Query: 148 STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPK 197
S P + APE + +++ + +DVWS G+T++ G P++ + P+
Sbjct: 156 SAGKWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPE 206
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 46/166 (27%), Positives = 78/166 (46%), Gaps = 25/166 (15%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-----FSED-----EARFFFQ 95
+H NI+ V L +++EYA+ G L E + A R ++ D E + F+
Sbjct: 76 KHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFL-RARRPPGPDYTFDITKVPEEQLSFK 134
Query: 96 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQP 146
L+S G+ Y S + HRDL N L+ +KI DFG ++ + + +
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKK 192
Query: 147 KSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
S P ++APE L + Y + +DVWS G+ ++ + +G P+
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPY 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 43/157 (27%), Positives = 65/157 (41%), Gaps = 13/157 (8%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERIC--NAGRFSE---DEARFFFQQLI 98
H NIVR V I++E +GG+L F R R S + F + +
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 99 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKS---SVLHSQPKSTVGTPA 154
G Y HRD+ N LL R+ KI DFG ++ + + + +
Sbjct: 127 KGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK 186
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
++ PE L + K DVWS GV L+ + +G P+
Sbjct: 187 WMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPY 222
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 2e-06
Identities = 42/143 (29%), Positives = 65/143 (45%), Gaps = 15/143 (10%)
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149
F Q+ +G+ + S HRDL N L+ +KICDFG ++ + S ST
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLI--CEGKLVKICDFGLARDIMRDSNYISKGST 301
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKN--FRKTIHRI 206
++APE + Y ++DVWS G+ L+ + +G P+ PE P N F I R
Sbjct: 302 FLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPY--PELPMNEQFYNAIKR- 357
Query: 207 LSVQYSIPDYVHISPECRHLISR 229
Y + H S E ++ +
Sbjct: 358 ---GYRMAKPAHASDEIYEIMQK 377
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 48/169 (28%), Positives = 75/169 (44%), Gaps = 25/169 (14%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER------------ 78
++ QRE L+H +IVRF V L +V EY G+L F R
Sbjct: 52 QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG 111
Query: 79 -ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137
G+ + + Q+ SG+ Y S+ HRDL N L+ +KI DFG S
Sbjct: 112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMS 169
Query: 138 KSSVLHSQPKSTVGTPA-----YIAPEVLLKKEYDGKIADVWSCGVTLY 181
+ ++S VG ++ PE +L +++ + +D+WS GV L+
Sbjct: 170 RD--IYSTDYYRVGGRTMLPIRWMPPESILYRKFTTE-SDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 48/178 (26%), Positives = 78/178 (43%), Gaps = 23/178 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FER------------ 78
++ QRE +L+H +IV+F V L +V EY G+L F R
Sbjct: 52 KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG 111
Query: 79 --ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 136
G + Q+ SG+ Y S HRDL N L+ + +KI DFG
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGM 169
Query: 137 SK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
S+ S+ + T+ ++ PE ++ +++ + +DVWS GV L+ + G P+
Sbjct: 170 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPW 226
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 2e-06
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 13/153 (8%)
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
F Q+ G+ + S HRDL N LL + +KICDFG ++ ++H + G+
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLL--AQGKIVKICDFGLAR-DIMHDSNYVSKGS 298
Query: 153 P----AYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRIL 207
++APE + Y ++DVWS G+ L+ + +G P+ F I
Sbjct: 299 TFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKS-- 355
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240
+ + PD H + E ++ + + ++P KR S
Sbjct: 356 GYRMAKPD--HATQEVYDIMVKCWNSEPEKRPS 386
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 42/149 (28%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 48 PNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVSYCHS 106
P + R + LT T + +V + G L + + N R + + Q+ G+SY
Sbjct: 69 PYVCRLLGICLTST-VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---YIAPEVLLK 163
+++ HRDL N L+ SP +KI DFG ++ + G ++A E +L
Sbjct: 128 VRLVHRDLAARNVLVK-SPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILH 185
Query: 164 KEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
+ + + +DVWS GVT++ +M GA P++
Sbjct: 186 RRFTHQ-SDVWSYGVTVWELMTFGAKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 47/159 (29%), Positives = 72/159 (45%), Gaps = 17/159 (10%)
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTV 150
F Q+ G+S+ S HRDL N LL + KICDFG ++ S K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILL--THGRITKICDFGLARDIRNDSNYVVKGNA 276
Query: 151 GTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTI---HR 205
P ++APE + Y + +DVWS G+ L+ + +G+ P+ F K I +R
Sbjct: 277 RLPVKWMAPESIFNCVYTFE-SDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYR 335
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+LS + + + I C + ADP KR + +I
Sbjct: 336 MLSPECAPSEMYDIMKSC-------WDADPLKRPTFKQI 367
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 4e-06
Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 34/236 (14%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFS 86
E E + HPN+++ V + L +++ + G+L + R
Sbjct: 46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLL-YSRLG 104
Query: 87 EDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYS 137
+ Q L+ G+ Y + HRDL N +L + +C DFG S
Sbjct: 105 GLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLRED----MTVCVADFGLS 160
Query: 138 K---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDP 193
K S + Q + +IA E L + Y K +DVW+ GVT++ + G P+
Sbjct: 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGV 219
Query: 194 E--EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
E E ++ + +R L D ++ L+ + ADP R + ++R
Sbjct: 220 ENHEIYDYLRHGNR-LKQPEDCLDELY------DLMYSCWRADPKDRPTFTKLREV 268
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 47/165 (28%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 37 REIINHR----SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR 91
+EI +H SL H IVR + + L +V + + G L + + +
Sbjct: 54 QEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---- 147
+ Q+ G+ Y ++ HR+L N LL S + ++I DFG + +L+ K
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLK-SDS-IVQIADFGVA--DLLYPDDKKYFY 168
Query: 148 STVGTP-AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 190
S TP ++A E +L Y + +DVWS GVT++ M+ GA P+
Sbjct: 169 SEHKTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPY 212
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 5e-06
Identities = 42/166 (25%), Positives = 73/166 (43%), Gaps = 22/166 (13%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHL------AIVMEYASGGEL-----FERICN 81
E+ E + + HPN++R V L +++ + G+L + R+ +
Sbjct: 45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGD 104
Query: 82 AGRFSEDEARF-FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSK 138
++ + F + SG+ Y S HRDL N +L+ + + +C DFG SK
Sbjct: 105 CPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNEN----MNVCVADFGLSK 160
Query: 139 ---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 181
+ + Q + +IA E L + Y K +DVWS GVT++
Sbjct: 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMW 205
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 6e-06
Identities = 42/147 (28%), Positives = 66/147 (44%), Gaps = 18/147 (12%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE----DEARFFFQQLI 98
+ LRH +V+ V+ + + IV EY S G L + + G + + Q+
Sbjct: 56 KKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFL--KGEMGKYLRLPQLVDMAAQIA 112
Query: 99 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA---- 154
SG++Y M HRDL+ N L+ + K+ DFG ++ L + T A
Sbjct: 113 SGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLAR---LIEDNEYTARQGAKFPI 167
Query: 155 -YIAPEVLLKKEYDGKIADVWSCGVTL 180
+ APE L + K +DVWS G+ L
Sbjct: 168 KWTAPEAALYGRFTIK-SDVWSFGILL 193
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 8e-06
Identities = 42/160 (26%), Positives = 68/160 (42%), Gaps = 7/160 (4%)
Query: 34 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF 93
REI +++ H I+ + + +VM +LF + +G ++A
Sbjct: 132 TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITI 190
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST--V 150
++L+ ++Y H + HRD+K EN LD L DFG + H P+
Sbjct: 191 QRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLG--DFGAACKLDAHPDTPQCYGWS 248
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 190
GT +PE+L Y K D+WS G+ L+ M V
Sbjct: 249 GTLETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 8e-06
Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 32/219 (14%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA-IVMEYASGGELFERICNAGRF-SEDEARFFF 94
+E I + HPN++ + L +V+ Y G+L I + + + F
Sbjct: 45 KEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFG 104
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG-----YSK---SSVLHSQP 146
Q+ G+ Y S + HRDL N +LD S +K+ DFG Y K S H+
Sbjct: 105 LQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGA 162
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTI 203
K V ++A E L +++ K +DVWS GV L+ +M GA YP D + +
Sbjct: 163 KLPV---KWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG 218
Query: 204 HRILSVQYSIPDYV--------HISPECR----HLISRI 230
R+L +Y PD + H PE R L+SRI
Sbjct: 219 RRLLQPEYC-PDPLYEVMLSCWHPKPEMRPTFSELVSRI 256
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 42/159 (26%), Positives = 65/159 (40%), Gaps = 20/159 (12%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI---- 98
+ LRHP +++ V + IV E G L E + QLI
Sbjct: 56 KKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQG-----GAGRALKLPQLIDMAA 110
Query: 99 ---SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155
SG++Y + HRDL N L+ + K+ DFG ++ + ++ G
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLAR-VIKEDIYEAREGAKFP 167
Query: 156 I---APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
I APE L + K +DVWS G+ L ++ G P+
Sbjct: 168 IKWTAPEAALYNRFSIK-SDVWSFGILLTEIVTYGRMPY 205
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 1e-05
Identities = 40/171 (23%), Positives = 72/171 (42%), Gaps = 17/171 (9%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----FERICNAGRFSEDEAR 91
+E+ +R L HPN+++ + +V+E+ G+L R A +D +
Sbjct: 44 QEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQ 103
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKST 149
++ SG+ + H H DL L N L + +KI D+G + + K
Sbjct: 104 RMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDC 161
Query: 150 VGTP-AYIAPEVLLKKEYDGKIAD------VWSCGVTLYVML-VGAYPFED 192
P ++APE++ + D D +WS GVT++ + P+ D
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPD 212
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 53/183 (28%), Positives = 79/183 (43%), Gaps = 25/183 (13%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE----RICNAGRFSED-----EARFFFQQ 96
+H NI+ L +++EYAS G L E R + + E + F+
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 97 LIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 148
L+S G+ Y S + HRDL N L+ +KI DFG ++ + K+
Sbjct: 142 LVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKT 199
Query: 149 TVGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV---GAYPFEDPEEPKNFRKTI 203
T G P ++APE L + Y + +DVWS GV L+ + YP EE K
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258
Query: 204 HRI 206
HR+
Sbjct: 259 HRM 261
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 48/163 (29%), Positives = 75/163 (46%), Gaps = 14/163 (8%)
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQ 145
+D RF Q + G+ + S HRD+ N LL DG A KICDFG ++ + S
Sbjct: 212 DDLLRFSSQ-VAQGMDFLASKNCIHRDVAARNVLLTDGRVA---KICDFGLARDIMNDSN 267
Query: 146 --PKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 201
K P ++APE + Y + +DVWS G+ L+ + +G P+ F K
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326
Query: 202 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ R Q S PD+ PE ++ + +P +R + +I
Sbjct: 327 MVKR--GYQMSRPDFA--PPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 12/158 (7%)
Query: 32 DENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87
D ++ E++ + L +P IVR I +VME A G L + + +E
Sbjct: 36 DPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAELGPLNKFLQKNKHVTE 94
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHS 144
Q+ G+ Y HRDL N LL KI DFG SK + +
Sbjct: 95 KNITELVHQVSMGMKYLEETNFVHRDLAARNVLL--VTQHYAKISDFGLSKALGADENYY 152
Query: 145 QPKSTVGTPA-YIAPEVLLKKEYDGKIADVWSCGVTLY 181
+ K+ P + APE + ++ K +DVWS GV ++
Sbjct: 153 KAKTHGKWPVKWYAPECMNYYKFSSK-SDVWSFGVLMW 189
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 39/155 (25%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVS 102
S+ +P++ R + LT T + ++ + G L + + + + Q+ G++
Sbjct: 65 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 123
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIA 157
Y ++ HRDL N L+ +KI DFG +K +L + K ++A
Sbjct: 124 YLEERRLVHRDLAARNVLVKT--PQHVKITDFGLAK--LLGADEKEYHAEGGKVPIKWMA 179
Query: 158 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
E +L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 180 LESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYD 213
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 2e-05
Identities = 37/149 (24%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVM-EYASGGELFERICNAGRFSEDEARFFFQQLISGV 101
R++ HP+I++ K +++ Y + +L+ + + + + ++ +
Sbjct: 138 RAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERSVLRAI 195
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYSKSSVLHSQPK--STVGTPAYIA 157
Y H ++ HRD+K EN ++ P +C DFG + V + K GT A A
Sbjct: 196 QYLHENRIIHRDIKAENIFIN-HPG---DVCLGDFGAACFPVDINANKYYGWAGTIATNA 251
Query: 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVG 186
PE+L + Y G D+WS G+ L+ M
Sbjct: 252 PELLARDPY-GPAVDIWSAGIVLFEMATC 279
|
Length = 391 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 3e-05
Identities = 42/155 (27%), Positives = 75/155 (48%), Gaps = 13/155 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSEDEARFFFQQLISGVS 102
S+ HP++VR V L+PT + +V + G L + + + + Q+ G+
Sbjct: 65 SMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMM 123
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----YIA 157
Y ++ HRDL N L+ SP +KI DFG ++ +L K ++A
Sbjct: 124 YLEERRLVHRDLAARNVLVK-SPN-HVKITDFGLAR--LLEGDEKEYNADGGKMPIKWMA 179
Query: 158 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFE 191
E + +++ + +DVWS GVT++ +M G P++
Sbjct: 180 LECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYD 213
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 3e-05
Identities = 43/177 (24%), Positives = 72/177 (40%), Gaps = 28/177 (15%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE------------ 77
+ + QRE HPNIV+ V + ++ EY + G+L E
Sbjct: 50 DMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCS 109
Query: 78 --------RICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 127
R C S E +Q+ +G++Y + HRDL N L+ +
Sbjct: 110 LSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGEN--M 167
Query: 128 RLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY 181
+KI DFG S+ S+ + ++ ++ PE + Y + +DVW+ GV L+
Sbjct: 168 VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLW 223
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 3e-05
Identities = 48/164 (29%), Positives = 71/164 (43%), Gaps = 26/164 (15%)
Query: 47 HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF----------QQ 96
HPNI+ +L + +EYA G L + + R E + F QQ
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQ 125
Query: 97 LIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+ G+ Y Q HRDL N L+ + KI DFG S+ ++ K T
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA--KIADFGLSRGQEVYV--KKT 181
Query: 150 VGT-PA-YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+G P ++A E L Y +DVWS GV L+ ++ +G P+
Sbjct: 182 MGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPY 224
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-05
Identities = 44/173 (25%), Positives = 75/173 (43%), Gaps = 33/173 (19%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR------------- 91
L+ PNI+R V + L ++ EY G+L + ++ + E
Sbjct: 76 LKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPAHCLPA 134
Query: 92 -------FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144
Q+ SG+ Y S+ HRDL N L+ + +KI DFG S++ L++
Sbjct: 135 ISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRN--LYA 190
Query: 145 QPKSTVGTPA-----YIAPEVLLKKEYDGKIADVWSCGVTLY--VMLVGAYPF 190
+ A ++A E +L ++ +DVW+ GVTL+ +ML P+
Sbjct: 191 GDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKEQPY 242
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 9e-05
Identities = 48/144 (33%), Positives = 69/144 (47%), Gaps = 27/144 (18%)
Query: 62 HLAIVM-EYASGGELFERICNAGRFSEDE-ARFFFQQLISGVS--YCHS-MQVCHRDLKL 116
H+ IVM +Y G L + I G FS A+ FQ +GV+ Y H+ + + H DLK
Sbjct: 206 HMCIVMPKY--GPCLLDWIMKHGPFSHRHLAQIIFQ---TGVALDYFHTELHLMHTDLKP 260
Query: 117 ENTLLDGS-------------PAP-RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 162
EN L++ S P P R++ICD G HS+ + V T Y +PEV+L
Sbjct: 261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLG-GCCDERHSR-TAIVSTRHYRSPEVVL 318
Query: 163 KKEYDGKIADVWSCGVTLYVMLVG 186
+ D+WS G +Y + G
Sbjct: 319 GLGWMYS-TDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 42/178 (23%), Positives = 79/178 (44%), Gaps = 23/178 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC------NAGRFS 86
E + E + L+HPNIV V+ L+++ Y S +L E + + G
Sbjct: 53 EEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD 112
Query: 87 EDE--------ARFF--FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 136
+D+ A F Q+ +G+ + S V H+DL N L+ +KI D G
Sbjct: 113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLV--FDKLNVKISDLGL 170
Query: 137 SK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+ ++ + +++ +++PE ++ ++ +D+WS GV L+ V G P+
Sbjct: 171 FREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 1e-04
Identities = 43/168 (25%), Positives = 77/168 (45%), Gaps = 14/168 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
+ L+HP +VR V+ T + I+ EY G L F + + + ++ Q+ G
Sbjct: 56 KQLQHPRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEG 114
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP---AYIA 157
+++ HRDL+ N L+ S KI DFG ++ + ++ + G + A
Sbjct: 115 MAFIERKNYIHRDLRAANILV--SETLCCKIADFGLAR-LIEDNEYTAREGAKFPIKWTA 171
Query: 158 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF---EDPEEPKNFRK 201
PE + + K +DVWS G+ L ++ G P+ +PE +N +
Sbjct: 172 PEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER 218
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 1e-04
Identities = 42/180 (23%), Positives = 70/180 (38%), Gaps = 25/180 (13%)
Query: 32 DENVQ----REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRF 85
DEN+Q RE+ R L H N+VR + +++EY G+L F R +
Sbjct: 48 DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDE 107
Query: 86 SEDEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGS-----PAPRLKICD 133
+Q ++ G+ + + + HRDL N L+ L
Sbjct: 108 KLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL--SK 165
Query: 134 FGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
Y+ + ++APE + + ++ K +DVWS GV ++ V G PF
Sbjct: 166 DVYNSEYYKLRNALIPL---RWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 15/170 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
++L+H +V+ V+ T + I+ E+ + G L F + + + F Q+ G
Sbjct: 56 KTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 114
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQPKSTVGTPAY 155
+++ HRDL+ N L+ S + KI DFG ++ K + +
Sbjct: 115 MAFIEQRNYIHRDLRAANILV--SASLVCKIADFGLARVIEDNEYTAREGAKFPI---KW 169
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIH 204
APE + + K +DVWS G+ L ++ G P+ P+ R
Sbjct: 170 TAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 1e-04
Identities = 47/160 (29%), Positives = 73/160 (45%), Gaps = 23/160 (14%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSE-----DEARFFFQQ 96
+ LRH +V+ V+ + + IV EY S G L + + + GR + D A Q
Sbjct: 56 KKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA----AQ 110
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-- 154
+ +G++Y M HRDL+ N L+ KI DFG ++ L + T A
Sbjct: 111 VAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLAR---LIEDNEYTARQGAKF 165
Query: 155 ---YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 190
+ APE L + K +DVWS G+ L ++ G P+
Sbjct: 166 PIKWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 2e-04
Identities = 46/177 (25%), Positives = 77/177 (43%), Gaps = 26/177 (14%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI----------CNAG-- 83
Q+E L HPNIV V+ + ++ EY + G+L E + C++
Sbjct: 55 QQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDED 114
Query: 84 ---RFSEDEARFFFQ--QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
+ S D F Q+ +G+ Y S H+DL N L+ +KI D G S+
Sbjct: 115 GTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI--GEQLHVKISDLGLSR 172
Query: 139 ----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+ QPKS + ++ PE ++ ++ +D+WS GV L+ + G P+
Sbjct: 173 EIYSADYYRVQPKSLLPI-RWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPY 227
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 2e-04
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 25/170 (14%)
Query: 42 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ----QL 97
+R L+HPNI++ + +V EY G+L + + Q ++
Sbjct: 49 YRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEI 108
Query: 98 ISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS----KSSVLHSQPKSTVGTP 153
+GV++ H H DL L N L +K+ D+G K + ++ V
Sbjct: 109 AAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPL- 165
Query: 154 AYIAPEVLLKKEYDG-------KIADVWSCGVTLYVMLVGAYPFEDPEEP 196
++APE L+ + + G K ++VW+ GVTL+ + FE+ +P
Sbjct: 166 RWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWEL------FENAAQP 208
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 45/175 (25%), Positives = 75/175 (42%), Gaps = 31/175 (17%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 95
E +RSL+H N+++ T +VME+ G+L + R C + +
Sbjct: 45 EAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQR 104
Query: 96 ---QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
++ G+ + H H DL L N LL +KI D+G S H++ K
Sbjct: 105 MACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLS-----HNKYKEDYYV 157
Query: 153 PA--------YIAPEVLLKKEYDG--------KIADVWSCGVTLYVML-VGAYPF 190
+IAPE++ E G K ++VWS GVT++ + +G+ P+
Sbjct: 158 TPDQLWVPLRWIAPELV--DEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPY 210
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.001
Identities = 48/177 (27%), Positives = 74/177 (41%), Gaps = 25/177 (14%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVIL---TPTHLAIVM---EYASGGELFERICNAGRFS 86
E RE + HPN+++ V L L I M + G+L + R
Sbjct: 46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLL-MSRIG 104
Query: 87 EDEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC--DFGYS 137
E+ Q L+ SG+ Y S HRDL N +L+ + + +C DFG S
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNEN----MTVCVADFGLS 160
Query: 138 K---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
K S + Q ++ ++A E L Y +DVW+ GVT++ +M G P+
Sbjct: 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPY 216
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 22/164 (13%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQL 97
EI + L+HPNIV+ + + ++ EY G L E + N E R +++
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRNLSW----ERR---RKI 785
Query: 98 ISGVS------YCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
G++ +C S V +L E ++DG P L++ S +L + K +
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRL-----SLPGLLCTDTKCFI 840
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
+ AY+APE K+ K +D++ G+ L +L G P D E
Sbjct: 841 SS-AYVAPETRETKDITEK-SDIYGFGLILIELLTGKSP-ADAE 881
|
Length = 968 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.003
Identities = 42/156 (26%), Positives = 67/156 (42%), Gaps = 15/156 (9%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
+ LRH +V V+ + + IV E+ G L F + + + Q+ G
Sbjct: 56 KKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADG 114
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA-----Y 155
++Y M HRDL+ N L+ + KI DFG ++ L + T A +
Sbjct: 115 MAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLAR---LIEDNEYTARQGAKFPIKW 169
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPF 190
APE L + K +DVWS G+ L ++ G P+
Sbjct: 170 TAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.004
Identities = 27/83 (32%), Positives = 39/83 (46%), Gaps = 13/83 (15%)
Query: 104 CHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161
+++ HR K N LL DG G SV P+ + P ++APEV+
Sbjct: 27 LGALRELHRQAKSGNILLTWDGLLKL------DG----SVAFKTPEQSRPDPYFMAPEVI 76
Query: 162 LKKEYDGKIADVWSCGVTLYVML 184
+ Y K AD++S G+TLY L
Sbjct: 77 QGQSYTEK-ADIYSLGITLYEAL 98
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.88 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.87 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.86 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.83 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.75 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.74 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.63 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.61 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.6 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.58 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.54 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.36 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.36 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.33 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.32 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.16 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.15 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.1 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.02 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.95 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.82 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.63 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.61 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.58 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.58 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.55 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.33 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.18 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.15 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.14 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.94 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.86 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.85 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.85 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.71 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.65 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.52 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.38 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.29 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.23 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.0 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 96.81 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 96.63 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.54 | |
| PLN02236 | 344 | choline kinase | 96.49 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.47 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.34 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.34 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.3 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.22 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.1 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.63 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 95.47 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.07 | |
| PTZ00384 | 383 | choline kinase; Provisional | 94.76 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.71 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.34 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.24 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 94.22 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 93.9 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 93.55 | |
| PTZ00296 | 442 | choline kinase; Provisional | 93.11 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 92.92 |
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-61 Score=417.81 Aligned_cols=249 Identities=36% Similarity=0.532 Sum_probs=216.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc-------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~-------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|+| +|..++||+.| |||++.+..... ...+++|+++|++|+|||||+++++|......|+||||+
T Consensus 180 LGsGafg~Vkla~e~~tgk~v-AiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v 258 (475)
T KOG0615|consen 180 LGSGAFGLVKLAYEKKTGKQV-AIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYV 258 (475)
T ss_pred ecCCceeEEEEEEEcccCcEE-EeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEe
Confidence 688888 69999999999 999999876322 235789999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCCCCCc
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+||.|++.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+ ....+||+|||+|+.........+.
T Consensus 259 ~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~Tl 338 (475)
T KOG0615|consen 259 EGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTL 338 (475)
T ss_pred cCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccceehhhh
Confidence 999999999999999999999999999999999999999999999999999766 2235899999999987777778899
Q ss_pred cCCCccccchhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
||||.|.|||++.+... +..++|||||||++|-+++|.+||........+.+.+.+ ....+-.+.|..+|.++.+||
T Consensus 339 CGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~-G~y~f~p~~w~~Iseea~dlI 417 (475)
T KOG0615|consen 339 CGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK-GRYAFGPLQWDRISEEALDLI 417 (475)
T ss_pred cCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc-CcccccChhhhhhhHHHHHHH
Confidence 99999999999976543 344589999999999999999999887665534443322 122334467888999999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||..||++|||+.|+|+||||+.
T Consensus 418 ~~mL~VdP~~R~s~~eaL~hpW~~~ 442 (475)
T KOG0615|consen 418 NWMLVVDPENRPSADEALNHPWFKD 442 (475)
T ss_pred HHhhEeCcccCcCHHHHhcChhhhc
Confidence 9999999999999999999999964
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-58 Score=417.16 Aligned_cols=243 Identities=37% Similarity=0.637 Sum_probs=220.9
Q ss_pred CCCccee---e-eeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 1 MLGFHNF---Y-DRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 1 ~lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
+||.|+| + +++..+|+.| |+|++.+... ...+.+.+||+++++|+|||||+++++|++.+.+|||.|+|..+
T Consensus 25 ~LGkGgFA~cYe~~~~~tge~~-A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~ 103 (592)
T KOG0575|consen 25 FLGKGGFARCYEARDLDTGEVV-AVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRG 103 (592)
T ss_pred eeccCcceEEEEEEEcCCCcEE-EEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCc
Confidence 4788887 3 7888999999 9999998652 45689999999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
+|..+++++++++|.+++.+++||+.||.|||++||+|||||..|+|++.+.. |||+|||||...... ....+.|||
T Consensus 104 sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~--VKIgDFGLAt~le~~~Erk~TlCGT 181 (592)
T KOG0575|consen 104 SLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMN--VKIGDFGLATQLEYDGERKKTLCGT 181 (592)
T ss_pred cHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCc--EEecccceeeeecCcccccceecCC
Confidence 99999999999999999999999999999999999999999999999987765 999999999877644 667788999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|.|+|||++...+..-. +||||+|||||.|++|+|||.. ..+.++..++....+..|. .+|.++++||.+||+
T Consensus 182 PNYIAPEVl~k~gHsfE-vDiWSlGcvmYtLL~G~PPFet----k~vkety~~Ik~~~Y~~P~--~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 182 PNYIAPEVLNKSGHSFE-VDIWSLGCVMYTLLVGRPPFET----KTVKETYNKIKLNEYSMPS--HLSAEAKDLIRKLLR 254 (592)
T ss_pred CcccChhHhccCCCCCc-hhhhhhhhHHHhhhhCCCCccc----chHHHHHHHHHhcCccccc--ccCHHHHHHHHHHhc
Confidence 99999999997777655 9999999999999999999987 4456677778888888887 689999999999999
Q ss_pred cCCCCCCCHhHHhcCcccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~ 253 (334)
++|.+|||+.++|.|+||.+.
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g 275 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSG 275 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCC
Confidence 999999999999999999664
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-57 Score=390.66 Aligned_cols=243 Identities=28% Similarity=0.489 Sum_probs=211.1
Q ss_pred eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-eEEEEEeccCCCChHHHHHhcCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
.++|+.|+..+ |+|.+.... ....+++.+|+++++.++|||||++|+.|..++ .++|+||||++|+|...+...+++
T Consensus 97 kv~Hk~t~~i~-AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i 175 (364)
T KOG0581|consen 97 KVRHKPTGKIY-ALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRI 175 (364)
T ss_pred EEEEcCCCeEE-EEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCC
Confidence 59999999999 999995443 245678999999999999999999999999999 599999999999999999998999
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~ 164 (334)
+|.....++.++++||.|||. ++||||||||+|||++..|. |||||||.++..... ...+.+||..|||||.+.+.
T Consensus 176 ~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGe--VKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~ 252 (364)
T KOG0581|consen 176 PEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGE--VKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE 252 (364)
T ss_pred CHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCC--EEeccccccHHhhhh-hcccccccccccChhhhcCC
Confidence 999999999999999999995 99999999999999998776 999999999876544 66888999999999999999
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
.|+.+ +||||||++++|+++|+.||... .........+..+... ...+|.. .+|+++++||..||++||.+|||+.
T Consensus 253 ~Ys~~-sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~FV~~CL~Kdp~~R~s~~ 330 (364)
T KOG0581|consen 253 SYSVK-SDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSFVSCCLRKDPSERPSAK 330 (364)
T ss_pred cCCcc-cceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHHHHHHhcCCcccCCCHH
Confidence 99877 99999999999999999999874 2222333445555543 3334432 4899999999999999999999999
Q ss_pred HHhcCccccccCCC
Q 019901 243 EIRNHEWFLKNLPA 256 (334)
Q Consensus 243 ell~h~~~~~~~~~ 256 (334)
|+++|||+++....
T Consensus 331 qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 331 QLLQHPFIKKFEDP 344 (364)
T ss_pred HHhcCHHHhhcccc
Confidence 99999999875443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-55 Score=378.16 Aligned_cols=242 Identities=33% Similarity=0.574 Sum_probs=210.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .++.+.+++.| |+|+++|... ...+.+..|..+|..++||.||+++..|++++.+|+|+||+.||.
T Consensus 33 iGkG~fGkV~~Vrk~dt~kiY-AmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGe 111 (357)
T KOG0598|consen 33 IGKGSFGKVFQVRKKDTGKIY-AMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGE 111 (357)
T ss_pred eeccCCceEEEEEEcccCcee-ehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCcc
Confidence 566666 48888999999 9999999863 234688999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|+..|++.+.|++..++.|+.+|+.||.|||++|||||||||+|||++.+|. ++|+|||||+..... ....+.|||+
T Consensus 112 Lf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GH--i~LtDFgL~k~~~~~~~~t~tfcGT~ 189 (357)
T KOG0598|consen 112 LFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGH--IKLTDFGLCKEDLKDGDATRTFCGTP 189 (357)
T ss_pred HHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCc--EEEeccccchhcccCCCccccccCCc
Confidence 9999999999999999999999999999999999999999999999998876 999999999965444 4455679999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|||||++.+.+|+.. +|+||||+++|+|++|.+||.+.+.... ..++.......+ +..++.+++++|+++|..
T Consensus 190 eYmAPEil~~~gy~~~-vDWWsLGillYeML~G~pPF~~~~~~~~----~~~I~~~k~~~~-p~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 190 EYMAPEILLGKGYDKA-VDWWSLGILLYEMLTGKPPFYAEDVKKM----YDKILKGKLPLP-PGYLSEEARDLLKKLLKR 263 (357)
T ss_pred cccChHHHhcCCCCcc-cchHhHHHHHHHHhhCCCCCcCccHHHH----HHHHhcCcCCCC-CccCCHHHHHHHHHHhcc
Confidence 9999999999998755 9999999999999999999998665443 344444442211 223799999999999999
Q ss_pred CCCCCC----CHhHHhcCccccc
Q 019901 234 DPAKRI----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~----s~~ell~h~~~~~ 252 (334)
+|++|. .++++.+||||..
T Consensus 264 dp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CHHHhcCCCCChHHhhcCccccc
Confidence 999996 6899999999964
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-54 Score=377.70 Aligned_cols=248 Identities=34% Similarity=0.547 Sum_probs=216.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .++++.++..| |||.+.+.. ....+.+..||++|+.++|||||+++++++.++.+|+|||||+||+|
T Consensus 18 iG~GsfavVykg~h~~~~~~V-AIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDL 96 (429)
T KOG0595|consen 18 IGSGSFAVVYKGRHKKSGTEV-AIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDL 96 (429)
T ss_pred ccCcceEEEEEeEeccCCceE-EeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCH
Confidence 688887 48899999777 999999885 35567889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CC---CCEEEeccCCccCCCCCCCCCCccC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PA---PRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~---~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
..++.+.+.+++..++.++.||+.||++||+++||||||||+|||++.. .. ..+||+|||+|+.........+.||
T Consensus 97 s~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcG 176 (429)
T KOG0595|consen 97 SDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCG 176 (429)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhC
Confidence 9999999999999999999999999999999999999999999999764 22 4699999999999888888889999
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+|.|||||++..+.|+.+ +|+||+|+|+|++++|++||...+..+.+. .+++.......++ ..+++.+.+++...|
T Consensus 177 SplYMAPEV~~~~~YdAK-ADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~-~~~k~~~~~~~~~--~~~s~~~~~Ll~~ll 252 (429)
T KOG0595|consen 177 SPLYMAPEVIMSQQYDAK-ADLWSIGTILYQCLTGKPPFDAETPKELLL-YIKKGNEIVPVLP--AELSNPLRELLISLL 252 (429)
T ss_pred CccccCHHHHHhccccch-hhHHHHHHHHHHHHhCCCCccccCHHHHHH-HHhccccccCchh--hhccCchhhhhhHHH
Confidence 999999999999999888 899999999999999999999877644433 2222211111222 246778889999999
Q ss_pred ccCCCCCCCHhHHhcCccccccC
Q 019901 232 VADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..+|.+|.+..+-+.|+++..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 253 QRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred hcCccccCchHHhhhhhhcccCc
Confidence 99999999999999999997654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-54 Score=389.63 Aligned_cols=244 Identities=50% Similarity=0.814 Sum_probs=218.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc----c-cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL----W-QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~----~-~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| ++.+..+|..| |+|++.+.. . ...+.+.+|+.+++.++ ||||+++++++.....+|+|||||.
T Consensus 25 lG~GsfgkV~~a~~~~t~~~v-AiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~ 103 (370)
T KOG0583|consen 25 LGSGSFGKVKLAKHRLTGEKV-AIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCS 103 (370)
T ss_pred ecCCCCeeEEEeeeccCCCeE-EEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecC
Confidence 566666 58899999998 999887752 2 34568889999999999 9999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCC-CCCCCCCCcc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTV 150 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~-~~~~~~~~~~ 150 (334)
||+|++++.+.++++|.+++.+++|++.|++|+|++||+||||||+|||++.+. +++||+|||++... .......+.|
T Consensus 104 gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~-~~~Kl~DFG~s~~~~~~~~~l~t~c 182 (370)
T KOG0583|consen 104 GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNE-GNLKLSDFGLSAISPGEDGLLKTFC 182 (370)
T ss_pred CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCC-CCEEEeccccccccCCCCCcccCCC
Confidence 999999999999999999999999999999999999999999999999999872 35999999999977 4666778899
Q ss_pred CCCccccchhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 151 GTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 151 gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
|||.|+|||++.+.. |.++++||||+|++||.|++|+.||...+.. ....++....+.+|.+.. |++++.|+.+
T Consensus 183 Gsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~----~l~~ki~~~~~~~p~~~~-S~~~~~Li~~ 257 (370)
T KOG0583|consen 183 GSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP----NLYRKIRKGEFKIPSYLL-SPEARSLIEK 257 (370)
T ss_pred CCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH----HHHHHHhcCCccCCCCcC-CHHHHHHHHH
Confidence 999999999999988 9989999999999999999999999985544 344447777888887644 9999999999
Q ss_pred hcccCCCCCCCHhHHhcCccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||..+|.+|+|+.+++.||||+.
T Consensus 258 mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 258 MLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HcCCCcccCCCHHHHhhChhhcc
Confidence 99999999999999999999987
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-54 Score=392.46 Aligned_cols=245 Identities=37% Similarity=0.690 Sum_probs=225.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+- +|+|..||+.. |||++.+.. -.....+.+||.+|+.+.|||+++++++|++..++|+|.||++||.
T Consensus 20 LG~Gstg~vrlakh~~TGqla-aiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGE 98 (786)
T KOG0588|consen 20 LGKGSTGCVRLAKHAETGQLA-AIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGE 98 (786)
T ss_pred ccCCCCceehhhhccccccee-EEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCch
Confidence 566655 69999999999 999999873 1335789999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|++++.+.+++++.++..+++||+.|+.|+|..+|+||||||+|+|++..+. +||+|||+|..-.......+.||+|.
T Consensus 99 LFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n--IKIADFGMAsLe~~gklLeTSCGSPH 176 (786)
T KOG0588|consen 99 LFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN--IKIADFGMASLEVPGKLLETSCGSPH 176 (786)
T ss_pred hHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC--EeeeccceeecccCCccccccCCCcc
Confidence 9999999999999999999999999999999999999999999999998776 99999999998777888889999999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|.|||++.|.+|++.++||||.|||||.|++|+.||.+ ++++..+.++..+.+..|. .+|+++++||.+||..|
T Consensus 177 YA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdD----dNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~VD 250 (786)
T KOG0588|consen 177 YAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDD----DNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDVD 250 (786)
T ss_pred cCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCC----ccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhccC
Confidence 99999999999999999999999999999999999985 5567777788888888774 68999999999999999
Q ss_pred CCCCCCHhHHhcCccccccCC
Q 019901 235 PAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~~ 255 (334)
|.+|+|.+++++|||+.....
T Consensus 251 p~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 251 PSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred ccccccHHHHhhCchhhcCCC
Confidence 999999999999999987543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-53 Score=355.29 Aligned_cols=239 Identities=34% Similarity=0.611 Sum_probs=214.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+|..| |+|++.+.. ....+...+|..+|+.+.||+++++++.|.+.+.+|+||||++||.
T Consensus 52 lGtGSFGrV~LVr~k~~g~yY-AmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGE 130 (355)
T KOG0616|consen 52 LGTGSFGRVHLVREKHSGNYY-AMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGE 130 (355)
T ss_pred eccCccceEEEEEEccCCcee-ehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCcc
Confidence 566666 79999999999 999999886 2345778899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|+.++++.++|++..++.++.||+.||+|||+++|++|||||+|||++++|. +||+|||+|+.... ...+.||||.
T Consensus 131 lFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~--iKitDFGFAK~v~~--rT~TlCGTPe 206 (355)
T KOG0616|consen 131 LFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGH--IKITDFGFAKRVSG--RTWTLCGTPE 206 (355)
T ss_pred HHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCc--EEEEeccceEEecC--cEEEecCCcc
Confidence 9999999999999999999999999999999999999999999999998886 99999999986533 3567899999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++...++. +++|+|||||++|||++|.+||...+.. .+..++......+|.. +++++++||.++|+.|
T Consensus 207 YLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~----~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~vD 279 (355)
T KOG0616|consen 207 YLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPI----QIYEKILEGKVKFPSY--FSSDAKDLLKKLLQVD 279 (355)
T ss_pred ccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChH----HHHHHHHhCcccCCcc--cCHHHHHHHHHHHhhh
Confidence 9999999999885 5599999999999999999999987764 4455677778877764 7999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 019901 235 PAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~-----s~~ell~h~~~~~ 252 (334)
-.+|. ...++.+||||+.
T Consensus 280 ~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 280 LTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred hHhhhcCcCCCccccccCccccc
Confidence 99995 4789999999963
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-52 Score=376.01 Aligned_cols=241 Identities=32% Similarity=0.539 Sum_probs=211.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||-|+| +|+++.++..| |||++.|..+. -.+-+.+|-..|..| .||.|++++..|+++..+|+|+||+++|
T Consensus 81 lGeGSYStV~~A~~~~t~keY-AiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nG 159 (604)
T KOG0592|consen 81 LGEGSYSTVVLAREKATGKEY-AIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNG 159 (604)
T ss_pred eccccceeEEEeeecCCCcee-eHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCC
Confidence 788888 58999999999 99999887632 234677888999999 8999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---------
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------- 144 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--------- 144 (334)
+|.++|.+.+.|++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||-|+......
T Consensus 160 dll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmh--ikITDFGsAK~l~~~~~~~~~~~~~ 237 (604)
T KOG0592|consen 160 DLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGH--IKITDFGSAKILSPSQKSQENPVDP 237 (604)
T ss_pred cHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCc--EEEeeccccccCChhhccccCccCc
Confidence 99999999999999999999999999999999999999999999999988775 9999999987433211
Q ss_pred -----CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 145 -----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 145 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
...+.+||..|.+||++........ +|||+||||+|+|+.|.+||.+.++...++ ++....+.+|. .+
T Consensus 238 ~~a~s~~~SFVGTAeYVSPElL~~~~~~~~-sDiWAlGCilyQmlaG~PPFra~NeyliFq----kI~~l~y~fp~--~f 310 (604)
T KOG0592|consen 238 NQASSRRSSFVGTAEYVSPELLNDSPAGPS-SDLWALGCILYQMLAGQPPFRAANEYLIFQ----KIQALDYEFPE--GF 310 (604)
T ss_pred ccccCcccceeeeecccCHHHhcCCCCCcc-cchHHHHHHHHHHhcCCCCCccccHHHHHH----HHHHhcccCCC--CC
Confidence 1145789999999999987776544 999999999999999999999988765444 45666776665 57
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
++.+++||+++|..||++|+|+++|.+||||..
T Consensus 311 p~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 311 PEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred CHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 899999999999999999999999999999964
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-52 Score=368.93 Aligned_cols=249 Identities=28% Similarity=0.430 Sum_probs=214.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc-HHHHHHHHHHHcCC-CCCcccceEEEEcCC-eEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID-ENVQREIINHRSLR-HPNIVRFKEVILTPT-HLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~-~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~-~~~lv~e~~~~~~ 74 (334)
||=|+| +|+.+.+|+.| |||.+++...... ..-.||++.|++|+ ||||+++.+++.+.. .+|+||||| ..+
T Consensus 18 lGDGTfGsV~la~~~~~~~~V-AIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~N 95 (538)
T KOG0661|consen 18 LGDGTFGSVYLAKSKETGELV-AIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCN 95 (538)
T ss_pred hcCCcceeEEEeeecCCCcee-eHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhh
Confidence 566666 59999999998 9999988764433 45679999999999 999999999999887 999999999 469
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
|+++++.+ ..|++..++.|++||+.||+|+|.+|+.|||+||+|||+.++.. +||+|||+||.......-+..+.|.
T Consensus 96 LYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~--iKiaDFGLARev~SkpPYTeYVSTR 173 (538)
T KOG0661|consen 96 LYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDV--IKIADFGLAREVRSKPPYTEYVSTR 173 (538)
T ss_pred HHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccce--eEecccccccccccCCCcchhhhcc
Confidence 99999865 45999999999999999999999999999999999999986554 9999999999888777777889999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCCCC--
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPDY-- 216 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~~-- 216 (334)
||+|||++....+++.+.||||+|||++|+++-++.|.|.++.+++.++..-+.. ..+.+|..
T Consensus 174 WYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~ 253 (538)
T KOG0661|consen 174 WYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKP 253 (538)
T ss_pred cccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCC
Confidence 9999999998888888899999999999999999999999888777766543222 12233322
Q ss_pred -------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 217 -------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 217 -------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+..++++.++|.+||.+||.+||||.++|+||||+...
T Consensus 254 ~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 254 SPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred CChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 23689999999999999999999999999999997643
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=350.60 Aligned_cols=246 Identities=24% Similarity=0.401 Sum_probs=206.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+|-|+| .++++.||+.| |||.+.... ....+-..|||++|++++|||+|.++++|.....+++|+|||+. ++
T Consensus 10 vGEGSYGvV~KCrnk~TgqIV-AIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-Tv 87 (396)
T KOG0593|consen 10 VGEGSYGVVMKCRNKDTGQIV-AIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TV 87 (396)
T ss_pred cccCcceEEEEeccCCcccEE-EEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HH
Confidence 577776 48999999999 999987654 23345677999999999999999999999999999999999976 56
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
.+-+.+. ..++...++++++|++.|+.|+|+.++|||||||+||||+.++. +||||||+|+.....+. -+..+.|.
T Consensus 88 L~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv--vKLCDFGFAR~L~~pgd~YTDYVATR 165 (396)
T KOG0593|consen 88 LHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV--VKLCDFGFARTLSAPGDNYTDYVATR 165 (396)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc--EEeccchhhHhhcCCcchhhhhhhhh
Confidence 5666654 45999999999999999999999999999999999999988775 99999999997764333 34457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh----------c-----cccCCC---
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------V-----QYSIPD--- 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------~-----~~~~~~--- 215 (334)
||+|||.+.+...+++++||||+||++.||++|.+.|.+.++.+++..+...... . ...+|.
T Consensus 166 WYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~ 245 (396)
T KOG0593|consen 166 WYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEH 245 (396)
T ss_pred hccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCC
Confidence 9999999999666677799999999999999999999999887777655433211 1 112222
Q ss_pred -------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 216 -------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 216 -------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
++.++.-+.+|+++||..||.+|++.+++|.||||.
T Consensus 246 ~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 246 PEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred ccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 345688899999999999999999999999999994
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=342.34 Aligned_cols=247 Identities=34% Similarity=0.586 Sum_probs=214.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.| .+.+..||+.+ |+|++....+ ...+.+++|+++-+.|+|||||++++.+.+.+..|+|+|++.|++|
T Consensus 19 igkG~FSvVrRc~~~~tg~~f-a~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl 97 (355)
T KOG0033|consen 19 LGKGAFSVVRRCVHKTTGLEF-AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 97 (355)
T ss_pred HccCchHHHHHHHhccchHHH-HHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHH
Confidence 677777 36789999999 9999987654 3457899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
..-|-.+-.++|..+-.+++||+.||.|+|.+||||||+||+|+++-+... .-+||+|||+|.............|||.
T Consensus 98 ~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~ 177 (355)
T KOG0033|consen 98 FEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPG 177 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCc
Confidence 887776667999999999999999999999999999999999999954322 2499999999998776666777899999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||||++...+|..+ +|||+.|+|+|-|+.|++||++.+....+..++.. ...++.|.|..+++++++|+++||..|
T Consensus 178 fmaPEvvrkdpy~kp-vDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g--~yd~~~~~w~~is~~Ak~LvrrML~~d 254 (355)
T KOG0033|consen 178 YLSPEVLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAG--AYDYPSPEWDTVTPEAKSLIRRMLTVN 254 (355)
T ss_pred ccCHHHhhcCCCCCc-chhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhcc--ccCCCCcccCcCCHHHHHHHHHHhccC
Confidence 999999999988655 99999999999999999999986665544443322 234456678999999999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 019901 235 PAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~ 252 (334)
|.+|+|+.|+|+|||+.+
T Consensus 255 P~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 255 PKKRITADEALKHPWICN 272 (355)
T ss_pred hhhhccHHHHhCCchhcc
Confidence 999999999999999976
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-51 Score=368.56 Aligned_cols=244 Identities=32% Similarity=0.535 Sum_probs=212.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||-|.| +|+-+.||+.| |+|+++|... ...+.++.|-.+|...++|+||+++..|++...+||||||++||+
T Consensus 149 IgkGAfGeVrLarKk~Tg~iy-AmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD 227 (550)
T KOG0605|consen 149 IGKGAFGEVRLARKKDTGEIY-AMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGD 227 (550)
T ss_pred eccccceeEEEEEEccCCcEE-eeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCcc
Confidence 455554 69999999999 9999999873 345788999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC------------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------------ 142 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~------------ 142 (334)
+..+|.+.+.|++..++.++.+++.|++.||+.|+|||||||+|+|||..|. +||+||||++....
T Consensus 228 ~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GH--iKLSDFGLs~gl~~~~~~~~~~~~~~ 305 (550)
T KOG0605|consen 228 MMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGH--IKLSDFGLSTGLDKKHRIESYRLDEQ 305 (550)
T ss_pred HHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCC--Eeeccccccchhhhhhhhhhhcchhh
Confidence 9999999999999999999999999999999999999999999999998876 99999999852110
Q ss_pred ----------CCCC--------------------------CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC
Q 019901 143 ----------HSQP--------------------------KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186 (334)
Q Consensus 143 ----------~~~~--------------------------~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 186 (334)
.... .+++|||.|||||++.+.+|.-. +|+||||||+|||+.|
T Consensus 306 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~-cDwWSLG~ImyEmLvG 384 (550)
T KOG0605|consen 306 MQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKE-CDWWSLGCIMYEMLVG 384 (550)
T ss_pred hhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcc-ccHHHHHHHHHHHHhC
Confidence 0000 12479999999999999998655 9999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 019901 187 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 187 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~---s~~ell~h~~~~~ 252 (334)
.+||.+.+..+.+++++.. ...+.+|....+++++++||.+||. ||.+|. +++||..||||+.
T Consensus 385 yPPF~s~tp~~T~rkI~nw--r~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 385 YPPFCSETPQETYRKIVNW--RETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred CCCCCCCCHHHHHHHHHHH--hhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 9999998887777665532 2345667777889999999999999 999998 5999999999975
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-51 Score=359.13 Aligned_cols=247 Identities=30% Similarity=0.454 Sum_probs=201.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC--eEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L 75 (334)
||.|+| ++.++++|..+ |||.+........+.+.+|+.+|++++|||||++++...... .+++.|||+.+|+|
T Consensus 25 lG~Gs~G~V~l~~~~~~g~~~-AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL 103 (313)
T KOG0198|consen 25 LGRGSFGSVYLATNKKTGELM-AVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSL 103 (313)
T ss_pred ccCccceEEEEEEecCCCcce-eeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcH
Confidence 566666 57788889999 999998764222567999999999999999999999744433 69999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCC----CCCCCCc
Q 019901 76 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVL----HSQPKST 149 (334)
Q Consensus 76 ~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~----~~~~~~~ 149 (334)
.+++.+.+ .+++..++.+.+||+.||.|||++|||||||||+|||++. ++. +||+|||+++.... .......
T Consensus 104 ~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~--~KlaDFG~a~~~~~~~~~~~~~~~~ 181 (313)
T KOG0198|consen 104 SDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGD--VKLADFGLAKKLESKGTKSDSELSV 181 (313)
T ss_pred HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCe--EEeccCccccccccccccccccccc
Confidence 99999887 7999999999999999999999999999999999999987 454 99999999986553 2223456
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCC-CchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP-EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.|||.|||||++.......+++|||||||++.||+||++||... .... .+..+.......+.+..+|+++++||.
T Consensus 182 ~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~----~~~~ig~~~~~P~ip~~ls~~a~~Fl~ 257 (313)
T KOG0198|consen 182 QGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE----ALLLIGREDSLPEIPDSLSDEAKDFLR 257 (313)
T ss_pred cCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH----HHHHHhccCCCCCCCcccCHHHHHHHH
Confidence 79999999999986333334699999999999999999999863 2211 112222222222333458999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccccCC
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
+|+..+|.+|||+.++|+|||..++.+
T Consensus 258 ~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 258 KCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHhhcCcccCcCHHHHhhChhhhcccc
Confidence 999999999999999999999977654
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=367.56 Aligned_cols=240 Identities=28% Similarity=0.471 Sum_probs=209.6
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
+|+...+++.| |||.+........+.+.+|+.+|+..+|+|||.+++.|...+.+|+||||++||+|.+.+... .++|
T Consensus 291 ~A~~~~~~~~V-aiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E 368 (550)
T KOG0578|consen 291 VARKISTKQEV-AIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTE 368 (550)
T ss_pred eeeeccCCceE-EEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccH
Confidence 58888899998 999999887667789999999999999999999999999999999999999999998888664 4999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccCCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~ 166 (334)
.++..++++++.||+|||.+||+|||||.+|||++.++. +||+|||++....... ...+.+|||.|||||++....|
T Consensus 369 ~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~--vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~Y 446 (550)
T KOG0578|consen 369 GQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGS--VKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPY 446 (550)
T ss_pred HHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCc--EEEeeeeeeeccccccCccccccCCCCccchhhhhhccc
Confidence 999999999999999999999999999999999987776 9999999998765554 5567789999999999999999
Q ss_pred CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 167 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
..+ .||||||++++||+-|.+||-.......+. .+ ..+....+..+..+|+.+++||.+||+.|+.+|+|+.|||.
T Consensus 447 G~K-VDIWSLGIMaIEMveGEPPYlnE~PlrAly-LI--a~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 447 GPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALY-LI--ATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred Ccc-ccchhhhhHHHHHhcCCCCccCCChHHHHH-HH--hhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 777 999999999999999999998754432222 12 22344456666789999999999999999999999999999
Q ss_pred CccccccCC
Q 019901 247 HEWFLKNLP 255 (334)
Q Consensus 247 h~~~~~~~~ 255 (334)
||||+...+
T Consensus 523 HpFl~~a~p 531 (550)
T KOG0578|consen 523 HPFLKMAKP 531 (550)
T ss_pred ChhhhhcCC
Confidence 999965443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-51 Score=366.74 Aligned_cols=242 Identities=32% Similarity=0.560 Sum_probs=211.1
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
|||.|+| .++.+.+.+.| |||++.|.-.. .-..+.+|+++++.++||||+.++++|++..++|+|+|||.| +
T Consensus 9 ~iG~Gsfg~VYKgrrK~t~~~v-Aik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~ 86 (808)
T KOG0597|consen 9 MIGEGSFGRVYKGRRKYTIQVV-AIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-D 86 (808)
T ss_pred HhcCCccceeeecccccceeEE-EEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-h
Confidence 5788887 36677888888 99999887622 235799999999999999999999999999999999999976 9
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
|+.++...+.++|+.++.++.+++.||.|||+.+|+|||+||+|||+..++. +|+||||+|+....... .....|||
T Consensus 87 L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~--~KlcdFg~Ar~m~~~t~vltsikGtP 164 (808)
T KOG0597|consen 87 LFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGT--LKLCDFGLARAMSTNTSVLTSIKGTP 164 (808)
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCc--eeechhhhhhhcccCceeeeeccCcc
Confidence 9999999999999999999999999999999999999999999999987765 99999999997655433 34456999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|||||++.+..|+.. +|+||||||+|||++|++||.... +...+..+...+...|. ..|+.+.+|+..+|.+
T Consensus 165 lYmAPElv~e~pyd~~-sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~k 237 (808)
T KOG0597|consen 165 LYMAPELVEEQPYDHT-SDLWSLGCILYELYVGQPPFYARS----ITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIK 237 (808)
T ss_pred cccCHHHHcCCCccch-hhHHHHHHHHHHHhcCCCCchHHH----HHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhc
Confidence 9999999999999877 899999999999999999998633 34445556555555444 6899999999999999
Q ss_pred CCCCCCCHhHHhcCcccccc
Q 019901 234 DPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~~ 253 (334)
||.+|.|..+++.|||.+..
T Consensus 238 dP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 238 DPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred ChhhcccHHHHhcChHHhhh
Confidence 99999999999999999764
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=349.13 Aligned_cols=249 Identities=28% Similarity=0.414 Sum_probs=206.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEe--cCcccccHHHHHHHHHHHcCCCCCcccceEEEEc-----CCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIV--FHLWQIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~--~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~ 70 (334)
||.|.| .|.++.+|+.| |||.+. .......+...||+++|+.++|+||+.+.+++.. -+.+|+|+|++
T Consensus 30 iG~GAyGvVcsA~~~~t~~~V-AIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM 108 (359)
T KOG0660|consen 30 IGRGAYGVVCSAKDKRTGEKV-AIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM 108 (359)
T ss_pred ccCcceeeEEEEEEcCCCCEe-ehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH
Confidence 688887 37799999999 999998 3343445788999999999999999999999875 35699999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC---CCCCC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPK 147 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~---~~~~~ 147 (334)
+.+|...++..+.+++.+++.+++||+.||+|+|+.||+||||||+|+|++.+.. +||+|||+|+.... .+..+
T Consensus 109 -etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~--lKI~DFGLAR~~~~~~~~~~mT 185 (359)
T KOG0660|consen 109 -ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCD--LKICDFGLARYLDKFFEDGFMT 185 (359)
T ss_pred -hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCC--EEeccccceeeccccCcccchh
Confidence 6688888888777999999999999999999999999999999999999987776 99999999997653 23334
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-------------------h
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------S 208 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------~ 208 (334)
..+.|.||+|||++....-++++.||||+|||+.||++|++.|.+.+...++..++.-+. .
T Consensus 186 eYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~ 265 (359)
T KOG0660|consen 186 EYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIK 265 (359)
T ss_pred cceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHH
Confidence 567899999999998766667779999999999999999999998776555543332111 0
Q ss_pred ccccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 209 VQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 209 ~~~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.....| .++..++.+.+|+.+||..||.+|+|++|+|.|||+..-.
T Consensus 266 slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 266 SLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred hCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 001111 1346799999999999999999999999999999998753
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-50 Score=351.09 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=209.2
Q ss_pred CCcc----eeeeeecCCCCeeEEEEEEecCccccc-HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFH----NFYDRCSYSSDLFVNIIIIVFHLWQID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g----~~~~~~~~~~~~vvaiK~~~~~~~~~~-~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.| -+.|++..++..| |||++..+..... +.+.+|+..++.++||||++++..|..+..+|+||.||.+|++.
T Consensus 34 IG~G~sa~V~~A~c~p~~e~V-AIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~l 112 (516)
T KOG0582|consen 34 IGVGASAVVYLARCIPTNEVV-AIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLL 112 (516)
T ss_pred EeccceeEeeeeeecccCCEE-EEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHH
Confidence 4566 3369999999888 9999998774444 78999999999999999999999999999999999999999999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC-----CCc
Q 019901 77 ERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KST 149 (334)
Q Consensus 77 ~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~-----~~~ 149 (334)
+.+... ..++|..+..++++++.||.|||.+|.||||||+.||||+++|. |||+|||.+......+.. .+.
T Consensus 113 dIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~--VkLadFgvsa~l~~~G~R~~~rf~tf 190 (516)
T KOG0582|consen 113 DIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGT--VKLADFGVSASLFDSGDRQVTRFNTF 190 (516)
T ss_pred HHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCc--EEEcCceeeeeecccCceeeEeeccc
Confidence 999864 34999999999999999999999999999999999999998886 999999987654433321 455
Q ss_pred cCCCccccchhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc----cccCCCCCCCCHHH
Q 019901 150 VGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----QYSIPDYVHISPEC 223 (334)
Q Consensus 150 ~gt~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~ 223 (334)
.|||+|||||++. ..+|+.+ +|||||||+..||.+|..||....+.+.+...+++.... ..........+..+
T Consensus 191 vgtp~wmAPEvl~q~~~GYdfK-aDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf 269 (516)
T KOG0582|consen 191 VGTPCWMAPEVLMQQLHGYDFK-ADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSF 269 (516)
T ss_pred cCcccccChHHhhhcccCccch-hhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHH
Confidence 7999999999953 3556655 999999999999999999999877765554433321110 00111233567889
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccccCCCccc
Q 019901 224 RHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 259 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~~~~~ 259 (334)
+.+|..||++||.+|||++++|+|+||++....++.
T Consensus 270 ~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~~~~ 305 (516)
T KOG0582|consen 270 REMIALCLVKDPSKRPTASKLLKHAFFKKAKSKEYL 305 (516)
T ss_pred HHHHHHHhhcCcccCCCHHHHhccHHHhhccchhhc
Confidence 999999999999999999999999999887655543
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-51 Score=339.49 Aligned_cols=237 Identities=32% Similarity=0.545 Sum_probs=206.3
Q ss_pred eeecCCCCeeEEEEEEecCcc--------cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 9 DRCSYSSDLFVNIIIIVFHLW--------QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~--------~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+.++.+|+.+ |+|++....- ...+...+|+.+|+++ .||+|+++.++++++..+++|+|.|..|.|++++
T Consensus 36 ci~k~t~~e~-a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyL 114 (411)
T KOG0599|consen 36 CIHKETGKEF-AVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYL 114 (411)
T ss_pred hhhcccccce-eEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHh
Confidence 6688999999 9999876431 2235677899999998 5999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.-.+++...+.+++|++.|+.|||.++||||||||+|||++.+.. +||+|||+|.....+......||||.|.|||
T Consensus 115 ts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~--i~isDFGFa~~l~~GekLrelCGTPgYLAPE 192 (411)
T KOG0599|consen 115 TSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMN--IKISDFGFACQLEPGEKLRELCGTPGYLAPE 192 (411)
T ss_pred hhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccc--eEEeccceeeccCCchhHHHhcCCCcccChh
Confidence 99989999999999999999999999999999999999999987765 9999999999888888888899999999999
Q ss_pred hhccC-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhcc
Q 019901 160 VLLKK-----EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 160 ~~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.+.-. +-+++.+|+||+|+|+|.|+.|.+||+.....- .++.+..+ ++..|.|.++|...++||.+||+
T Consensus 193 tikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml----MLR~ImeGkyqF~speWadis~~~KdLIsrlLq 268 (411)
T KOG0599|consen 193 TIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML----MLRMIMEGKYQFRSPEWADISATVKDLISRLLQ 268 (411)
T ss_pred heeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH----HHHHHHhcccccCCcchhhccccHHHHHHHHHe
Confidence 98532 222455999999999999999999998643322 23334444 45678899999999999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
.||.+|.|++|+|.||||.+
T Consensus 269 Vdp~~Ritake~LaHpff~q 288 (411)
T KOG0599|consen 269 VDPTKRITAKEALAHPFFIQ 288 (411)
T ss_pred eCchhcccHHHHhcChHHHH
Confidence 99999999999999999965
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-50 Score=356.37 Aligned_cols=247 Identities=34% Similarity=0.564 Sum_probs=210.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--------------cccHHHHHHHHHHHcCCCCCcccceEEEEcC--C
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--------------QIDENVQREIINHRSLRHPNIVRFKEVILTP--T 61 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--------------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~ 61 (334)
||.|.| +|++..+++.| |||++.+..+ ...+.+.+||.+|++|+|||||+++++..+. +
T Consensus 105 iG~G~yGkVkLar~~~~~~l~-AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~ 183 (576)
T KOG0585|consen 105 IGSGQYGKVKLARDEVDGKLY-AIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESD 183 (576)
T ss_pred hcCCccceEEEEeecCCCcEE-EEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccC
Confidence 577776 69999999999 9999988651 1126899999999999999999999998764 5
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC
Q 019901 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141 (334)
Q Consensus 62 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~ 141 (334)
.+|||+|||..|.+.+.-.....+++.+++.|+++++.||+|||.+|||||||||+|+|++.++. |||+|||.+....
T Consensus 184 ~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~--VKIsDFGVs~~~~ 261 (576)
T KOG0585|consen 184 KLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGT--VKISDFGVSNEFP 261 (576)
T ss_pred ceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCc--EEeeccceeeecc
Confidence 79999999999988654333333999999999999999999999999999999999999988765 9999999887442
Q ss_pred CC------CCCCCccCCCccccchhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc
Q 019901 142 LH------SQPKSTVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212 (334)
Q Consensus 142 ~~------~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 212 (334)
.. .....++|||.|+|||.+.+ ..+.+++.||||+||+||-|+.|+.||.+... .....++.+....
T Consensus 262 ~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~----~~l~~KIvn~pL~ 337 (576)
T KOG0585|consen 262 QGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE----LELFDKIVNDPLE 337 (576)
T ss_pred cCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----HHHHHHHhcCccc
Confidence 22 11234789999999999987 55778889999999999999999999988554 4455667788888
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 213 ~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
+|..+.+...+++||.+||++||.+|+++.++..|||......
T Consensus 338 fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~ 380 (576)
T KOG0585|consen 338 FPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGD 380 (576)
T ss_pred CCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCC
Confidence 8888889999999999999999999999999999999987643
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=354.99 Aligned_cols=248 Identities=27% Similarity=0.431 Sum_probs=212.6
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCC
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~ 72 (334)
.||.|+| .|++..+|+.| |+|.+.... .+...-+.|||.+|++|+||||+++.++..+. +.+|+|+|||+.
T Consensus 124 kIGeGTyg~VYkAr~~~tgkiv-ALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh 202 (560)
T KOG0600|consen 124 KIGEGTYGQVYKARDLETGKIV-ALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH 202 (560)
T ss_pred HhcCcchhheeEeeecccCcEE-EEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc
Confidence 3788888 49999999999 999999877 34456789999999999999999999998776 789999999965
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCc
Q 019901 73 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKST 149 (334)
Q Consensus 73 ~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~ 149 (334)
+|.-++... -.|++.+++.+++||+.||.|+|++||+|||||.+||||+.+|. +||+|||||+...... ..+..
T Consensus 203 -DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~--LKiaDFGLAr~y~~~~~~~~T~r 279 (560)
T KOG0600|consen 203 -DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGV--LKIADFGLARFYTPSGSAPYTSR 279 (560)
T ss_pred -hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCC--EEeccccceeeccCCCCcccccc
Confidence 788877764 46999999999999999999999999999999999999998776 9999999999544433 34556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc------cCCC--------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------SIPD-------- 215 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------~~~~-------- 215 (334)
+-|.||+|||.+.|..-++.+.|+||+||||.||++|++.|.+.++.+++..+.+-+..... .+|.
T Consensus 280 VvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~ 359 (560)
T KOG0600|consen 280 VVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQ 359 (560)
T ss_pred eEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCC
Confidence 78999999999999887777799999999999999999999999998888877765433221 1111
Q ss_pred ---------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 ---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 ---------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...++..+.+|+..||..||.+|.|+.++|.|+||..
T Consensus 360 ~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 360 PYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 1246889999999999999999999999999999944
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-49 Score=326.03 Aligned_cols=248 Identities=25% Similarity=0.384 Sum_probs=211.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| +|++..||+.| |||.++.... .......|||+.|+.++||||+.+.++|...+.+.+|+||++ .+|
T Consensus 10 lGEG~~gvVyka~d~~t~~~V-AIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdL 87 (318)
T KOG0659|consen 10 LGEGTYGVVYKARDTETGKRV-AIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDL 87 (318)
T ss_pred hcCcceEEEEEEEecCCCcEE-EEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccH
Confidence 688887 59999999999 9999998763 346789999999999999999999999999999999999995 589
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC-CCccCCC
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~gt~ 153 (334)
...++.. ..+++.+++.|+.++++||+|||++.|+||||||.|+||+++|. +||+|||+|+........ ...+-|.
T Consensus 88 e~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~--lKiADFGLAr~f~~p~~~~~~~V~TR 165 (318)
T KOG0659|consen 88 EVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQ--LKIADFGLARFFGSPNRIQTHQVVTR 165 (318)
T ss_pred HHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCc--EEeecccchhccCCCCcccccceeee
Confidence 8888765 45999999999999999999999999999999999999988775 999999999975544333 3347899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cCCC-----------------
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD----------------- 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~----------------- 215 (334)
||+|||.+.|...++..+||||+|||+.||+-|.+-|.+.++-+++..+..-...... ..|.
T Consensus 166 WYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~ 245 (318)
T KOG0659|consen 166 WYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPP 245 (318)
T ss_pred eccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCc
Confidence 9999999998777777799999999999999999999999988887776654332211 1111
Q ss_pred ----CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 ----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 ----~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+...++++.+|+.+||..||.+|+|+.|+|+|+||+..
T Consensus 246 ~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 246 LNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred cccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 12357889999999999999999999999999999873
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=356.69 Aligned_cols=247 Identities=34% Similarity=0.563 Sum_probs=217.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|.| .++++.+|+.+ |+|++.+..... .+.+.+|+.+|+++. |||||.++++|++...+++|||+|.||
T Consensus 43 lG~G~Fg~v~~~~~~~tg~~~-A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GG 121 (382)
T KOG0032|consen 43 LGRGQFGVVYLCREKSTGKEV-ACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGG 121 (382)
T ss_pred hCCCCceEEEEEEecCCCcee-EEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCc
Confidence 677777 48889999999 999999987543 369999999999998 999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC--CCEEEeccCCccCCCCCCCCCCccC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~--~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
.|++.+.+. .+++..+..+++|++.|+.|||+.||+||||||+|+|+..... +.+|++|||+|............+|
T Consensus 122 eLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~G 200 (382)
T KOG0032|consen 122 ELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVG 200 (382)
T ss_pred hHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecC
Confidence 999999887 4999999999999999999999999999999999999976532 4699999999997766556677899
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
||.|+|||++....|... +||||+|+++|.|++|.+||.+.+....+..+... ...+..+.|..+|..+++||.+||
T Consensus 201 tp~y~APEvl~~~~y~~~-~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~--~~~f~~~~w~~is~~akd~i~~ll 277 (382)
T KOG0032|consen 201 TPEYVAPEVLGGRPYGDE-VDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG--DFDFTSEPWDDISESAKDFIRKLL 277 (382)
T ss_pred CccccCchhhcCCCCCcc-cchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--CCCCCCCCccccCHHHHHHHHHhc
Confidence 999999999988888766 99999999999999999999998876655543322 224456678889999999999999
Q ss_pred ccCCCCCCCHhHHhcCcccccc
Q 019901 232 VADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..||.+|+|+.++|+|||+...
T Consensus 278 ~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 278 EFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred ccCcccCCCHHHHhcCccccCC
Confidence 9999999999999999998764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-50 Score=338.29 Aligned_cols=231 Identities=31% Similarity=0.501 Sum_probs=195.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceE-EEEcCCe-EEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKE-VILTPTH-LAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~-~~~~~~~-~~lv~e~~~~~ 73 (334)
||-|+| .+.+..+|..+ |.|.+...... ....+..|+.+|++|+|||||++++ .|.+++. ++||||||++|
T Consensus 27 IG~GsFg~vykv~~~~~g~l~-a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~G 105 (375)
T KOG0591|consen 27 IGRGSFGEVYKVQCLLDGKLV-ALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAG 105 (375)
T ss_pred HcCCcchheEEeeeccCcchh-hhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhccc
Confidence 566666 48899999999 99999876532 3467889999999999999999998 4545544 99999999999
Q ss_pred ChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHH--CC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-
Q 019901 74 ELFERICNA----GRFSEDEARFFFQQLISGVSYCHS--MQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 144 (334)
Q Consensus 74 ~L~~~l~~~----~~~~~~~~~~~~~qil~~L~~LH~--~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~- 144 (334)
+|..+++.. +.++|..+|+++.|+|.||.++|+ .+ |+||||||.||+++.+|. |||+||||++......
T Consensus 106 DLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gv--vKLGDfGL~r~l~s~~t 183 (375)
T KOG0591|consen 106 DLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGV--VKLGDFGLGRFLSSKTT 183 (375)
T ss_pred CHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCc--eeeccchhHhHhcchhH
Confidence 999998753 459999999999999999999999 55 899999999999998775 9999999998654332
Q ss_pred CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-CCCCCCCCHHH
Q 019901 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPEC 223 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 223 (334)
...+.+|||.||+||++.+.+|+.+ |||||+||++|||+.-++||.+. ++.....++....++ +|. ..+|.++
T Consensus 184 fA~S~VGTPyYMSPE~i~~~~Y~~k-SDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qgd~~~~p~-~~YS~~l 257 (375)
T KOG0591|consen 184 FAHSLVGTPYYMSPERIHESGYNFK-SDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQGDYPPLPD-EHYSTDL 257 (375)
T ss_pred HHHhhcCCCcccCHHHHhcCCCCcc-hhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcCCCCCCcH-HHhhhHH
Confidence 3456689999999999999999766 99999999999999999999985 455666666666554 231 3579999
Q ss_pred HHHHHHhcccCCCCCCCH
Q 019901 224 RHLISRIFVADPAKRISI 241 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~ 241 (334)
..+|..|+..||.+||+.
T Consensus 258 ~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 258 RELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHccCCcccCCCc
Confidence 999999999999999985
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=334.66 Aligned_cols=243 Identities=33% Similarity=0.539 Sum_probs=209.5
Q ss_pred ceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEc----CCeEEEEEeccCCCChHHH
Q 019901 5 HNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILT----PTHLAIVMEYASGGELFER 78 (334)
Q Consensus 5 g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 78 (334)
|.++ +.++.||+.+ |+|++ .......+|+++.-.. .|||||.++++|+. ..++.+|||.++||.|+..
T Consensus 76 GkV~~C~~k~T~ekf-ALKvL-----~Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsr 149 (400)
T KOG0604|consen 76 GKVVQCVHKRTQEKF-ALKVL-----LDSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSR 149 (400)
T ss_pred CceEEEEeccchhhh-HHHHH-----hcCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHH
Confidence 3443 8899999999 99997 4566789999998776 59999999999864 3579999999999999999
Q ss_pred HHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 79 ICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+...+. |+|.++..|++||+.|+.|||+.+|.||||||+|+|..... +..+||+|||+|+.........+.|-||.|
T Consensus 150 iq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyY 229 (400)
T KOG0604|consen 150 IQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYY 229 (400)
T ss_pred HHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccc
Confidence 998766 99999999999999999999999999999999999996543 346899999999987777778889999999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhccc
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVA 233 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~ 233 (334)
.|||++....|+ +.+|+||+|+++|-|++|.+||.........-....++....+.+| +|..+|..++++|+++|..
T Consensus 230 vaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt 308 (400)
T KOG0604|consen 230 VAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKT 308 (400)
T ss_pred cCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcC
Confidence 999999888876 4499999999999999999999865543333344456666666655 5788999999999999999
Q ss_pred CCCCCCCHhHHhcCccccccC
Q 019901 234 DPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~~~ 254 (334)
+|.+|.|+.++++|||+.+..
T Consensus 309 ~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 309 EPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred CchhheeHHHhhcCchhcccc
Confidence 999999999999999998753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=343.59 Aligned_cols=241 Identities=36% Similarity=0.612 Sum_probs=216.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +|.....|..| |||.+.+...... -.+.+||++++.|+||||+++|++|+..+.+.|||||..+|.
T Consensus 61 LGkGTYGKVk~A~e~~sgR~V-AiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~Ge 139 (668)
T KOG0611|consen 61 LGKGTYGKVKLAYEHKSGREV-AIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGE 139 (668)
T ss_pred hcCCcccceeehhhccCCcEe-ehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCcc
Confidence 788888 57777888888 9999999875444 368899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|++++...+.+++.+++.+++||++|+.|+|.++++|||||.+|||++.+++ +||+||||+..........+.||+|.
T Consensus 140 LYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~N--iKIADFGLSNly~~~kfLqTFCGSPL 217 (668)
T KOG0611|consen 140 LYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNN--IKIADFGLSNLYADKKFLQTFCGSPL 217 (668)
T ss_pred HHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCC--eeeeccchhhhhccccHHHHhcCCcc
Confidence 9999999999999999999999999999999999999999999999998886 99999999987666666788999999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|.+||++++.+|..+.+|.||||++||.|..|..||.+.+- ...++.+....+.-|. -++++.-||++||..|
T Consensus 218 YASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh----k~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 218 YASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH----KRLVRQISRGAYREPE---TPSDASGLIRWMLMVN 290 (668)
T ss_pred cCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH----HHHHHHhhcccccCCC---CCchHHHHHHHHHhcC
Confidence 99999999999999999999999999999999999998654 3444556666665443 4788999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 019901 235 PAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~ 252 (334)
|.+|.|++++-.|=|++=
T Consensus 291 P~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 291 PERRATIEDIASHWWVNW 308 (668)
T ss_pred cccchhHHHHhhhheeec
Confidence 999999999999988864
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=321.21 Aligned_cols=241 Identities=35% Similarity=0.600 Sum_probs=215.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||-|.| +|+.++++..+ |+|++.++.. +....+.+|+++.+.|+||||+++|++|.+...+|+++||..+|+
T Consensus 30 LgkgkFG~vYlarekks~~Iv-alKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~ge 108 (281)
T KOG0580|consen 30 LGKGKFGNVYLAREKKSLFIV-ALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGE 108 (281)
T ss_pred ccCCccccEeEeeeccCCcEE-EEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCch
Confidence 555555 58899999999 9999999873 456789999999999999999999999999999999999999999
Q ss_pred hHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 75 LFERIC--NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 75 L~~~l~--~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
++..+. ...+|++..+..++.|++.||.|+|.++++||||||+|+|++..+. +||+|||.+.... .+...+.|||
T Consensus 109 l~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~--lkiAdfGwsV~~p-~~kR~tlcgt 185 (281)
T KOG0580|consen 109 LYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAP-SNKRKTLCGT 185 (281)
T ss_pred HHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCC--eeccCCCceeecC-CCCceeeecc
Confidence 999998 6678999999999999999999999999999999999999988776 9999999988655 6677888999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..|.+||...+..++.. +|+|++|++.||++.|.+||...+.. +..+++......+| ..++.+++++|++||.
T Consensus 186 ~dyl~pEmv~~~~hd~~-Vd~w~lgvl~yeflvg~ppFes~~~~----etYkrI~k~~~~~p--~~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 186 LDYLPPEMVEGRGHDKF-VDLWSLGVLCYEFLVGLPPFESQSHS----ETYKRIRKVDLKFP--STISGGAADLISRLLV 258 (281)
T ss_pred cccCCHhhcCCCCccch-hhHHHHHHHHHHHHhcCCchhhhhhH----HHHHHHHHccccCC--cccChhHHHHHHHHhc
Confidence 99999999999998877 99999999999999999999976643 44455666666666 4689999999999999
Q ss_pred cCCCCCCCHhHHhcCcccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~ 253 (334)
++|.+|.+..|++.|||+..+
T Consensus 259 ~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 259 KNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred cCccccccHHHHhhhHHHHhc
Confidence 999999999999999998653
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=359.73 Aligned_cols=240 Identities=32% Similarity=0.541 Sum_probs=209.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||-|+| ++..+.+++.| |||+++|... ...+....|.+++.... ||.++.++..|++..++|+||||+.||
T Consensus 376 LGkGsFGkV~lae~k~~~e~y-AIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Gg 454 (694)
T KOG0694|consen 376 LGRGSFGKVLLAELKGTNEYY-AIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGG 454 (694)
T ss_pred eccCcCceEEEEEEcCCCcEE-EEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCC
Confidence 666666 68899999999 9999999873 23467888999998875 999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-CCCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt 152 (334)
++ -.+...+.|++..++.|+..++.||+|||++||||||||.+|||+|..|. +||+|||+++... ......+.|||
T Consensus 455 dm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh--~kiADFGlcKe~m~~g~~TsTfCGT 531 (694)
T KOG0694|consen 455 DL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGH--VKIADFGLCKEGMGQGDRTSTFCGT 531 (694)
T ss_pred cE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCc--EEecccccccccCCCCCccccccCC
Confidence 94 44455678999999999999999999999999999999999999998876 9999999999766 45556778999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|.|||||++.+..|+.. +|+|||||+||||+.|..||.+.++.+.+. .+.......|.+ +|.++.++++++|.
T Consensus 532 pey~aPEil~e~~Yt~a-VDWW~lGVLlyeML~Gq~PF~gddEee~Fd----sI~~d~~~yP~~--ls~ea~~il~~ll~ 604 (694)
T KOG0694|consen 532 PEFLAPEVLTEQSYTRA-VDWWGLGVLLYEMLVGESPFPGDDEEEVFD----SIVNDEVRYPRF--LSKEAIAIMRRLLR 604 (694)
T ss_pred hhhcChhhhccCcccch-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHhcCCCCCCCc--ccHHHHHHHHHHhc
Confidence 99999999999999655 999999999999999999999988755544 456666666664 89999999999999
Q ss_pred cCCCCCCC-----HhHHhcCccccc
Q 019901 233 ADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s-----~~ell~h~~~~~ 252 (334)
++|++|.. +.++..||||+.
T Consensus 605 k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 605 KNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred cCcccccCCCCCCchhhhhCCcccc
Confidence 99999995 578999999964
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=344.45 Aligned_cols=239 Identities=32% Similarity=0.462 Sum_probs=199.6
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccc--cHHHHHHHHHHHcCCCCCcccceEEEEcCC-eEEEEEeccCCCChH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQI--DENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~--~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~ 76 (334)
+|.|+| +.+....|..+||||++....... .+.+.+|+.+|++++|||||++++++.++. .+++||||+.+|+|.
T Consensus 49 iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~ 128 (362)
T KOG0192|consen 49 LGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLS 128 (362)
T ss_pred cccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHH
Confidence 566666 567888888844999998766332 458999999999999999999999999887 799999999999999
Q ss_pred HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 77 ERICN--AGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 77 ~~l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~-ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
.++.+ .+.++...+..|+.||+.|+.|||+++ ||||||||+|||++... .++||+|||+++..... .......||
T Consensus 129 ~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~-~~~KI~DFGlsr~~~~~~~~~~~~~GT 207 (362)
T KOG0192|consen 129 VLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKG-KTLKIADFGLSREKVISKTSMTSVAGT 207 (362)
T ss_pred HHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCC-CEEEECCCccceeeccccccccCCCCC
Confidence 99988 577999999999999999999999999 99999999999998775 24999999999865544 333446899
Q ss_pred Cccccchhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 153 PAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 153 ~~y~aPE~~~--~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+.|||||++. ...|+.+ +||||||+++|||+||+.||.+........ .+.....+.+.+...++.+..++.+|
T Consensus 208 ~~wMAPEv~~~~~~~~~~K-~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~----~v~~~~~Rp~~p~~~~~~l~~l~~~C 282 (362)
T KOG0192|consen 208 YRWMAPEVLRGEKSPYTEK-SDVYSFGIVLWELLTGEIPFEDLAPVQVAS----AVVVGGLRPPIPKECPPHLSSLMERC 282 (362)
T ss_pred ccccChhhhcCCCCcCCcc-chhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcCCCCCCCccCCHHHHHHHHHh
Confidence 9999999999 4577666 999999999999999999999877622222 22223333333444899999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 019901 231 FVADPAKRISIPEIRN 246 (334)
Q Consensus 231 L~~~p~~R~s~~ell~ 246 (334)
|..+|.+||++.+++.
T Consensus 283 W~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 283 WLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCCcCCCHHHHHH
Confidence 9999999999999864
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=347.36 Aligned_cols=241 Identities=35% Similarity=0.584 Sum_probs=202.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+|+.| |||++.+... .....+.+|+.+++.++||||+++++++..++.+|+||||+.+++
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 3 LGKGTFGKVILVREKATGKYY-AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 566655 47788899999 9999987542 223467789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... ......+||+
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 82 LFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEeeCCCCcccccCCCcccceecCc
Confidence 9999998888999999999999999999999999999999999999987665 999999998753322 2234457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|+.||...+..... ..+......+| ..+++++.+||.+||+.
T Consensus 160 ~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~li~~~L~~ 232 (323)
T cd05571 160 EYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred cccChhhhcCCCCCcc-ccCcccchhhhhhhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHccC
Confidence 9999999988877655 99999999999999999999875543222 22333333333 35799999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 019901 234 DPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~-----s~~ell~h~~~~~ 252 (334)
+|.+|| ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 233 DPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=333.05 Aligned_cols=243 Identities=29% Similarity=0.471 Sum_probs=209.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|.+ ++..+.++..+ |+|++.+...... ..++.|-.+|+.++||.++.+|..|+++...|+|||||.||+
T Consensus 85 LG~GdiG~VyL~~l~~t~~~f-AmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGd 163 (459)
T KOG0610|consen 85 LGCGDIGTVYLVELRGTNCLF-AMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGD 163 (459)
T ss_pred cCCCCceeEEEEEecCCCceE-EEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCcc
Confidence 565544 58888888999 9999999875433 466779999999999999999999999999999999999999
Q ss_pred hHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC----------
Q 019901 75 LFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---------- 142 (334)
Q Consensus 75 L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~---------- 142 (334)
|..+.++. +.|++..++.++.+++.||+|||..|||+|||||+||||..+|. +.|+||.|+.....
T Consensus 164 L~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGH--IMLsDFDLS~~~~~~Pt~~~s~~~ 241 (459)
T KOG0610|consen 164 LHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGH--IMLSDFDLSLRCPVSPTLVKSSSP 241 (459)
T ss_pred HHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCc--EEeeeccccccCCCCCeeeccCCC
Confidence 99888765 45999999999999999999999999999999999999988876 99999998742100
Q ss_pred -----------------------C------------------------CCCCCccCCCccccchhhccCCCCCccchhhh
Q 019901 143 -----------------------H------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWS 175 (334)
Q Consensus 143 -----------------------~------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diws 175 (334)
. ....+.+||-.|.|||++.|.+.... +|+|+
T Consensus 242 ~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA-VDWWt 320 (459)
T KOG0610|consen 242 RSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA-VDWWT 320 (459)
T ss_pred CCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch-hhHHH
Confidence 0 00122469999999999999988655 99999
Q ss_pred hhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----HhHHhcCcccc
Q 019901 176 CGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----IPEIRNHEWFL 251 (334)
Q Consensus 176 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s----~~ell~h~~~~ 251 (334)
|||++|||+.|..||.+.+..+ ++.++......+|..+.++..+++||+++|.+||.+|.. ++||.+||||+
T Consensus 321 fGIflYEmLyG~TPFKG~~~~~----Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~ 396 (459)
T KOG0610|consen 321 FGIFLYEMLYGTTPFKGSNNKE----TLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFE 396 (459)
T ss_pred HHHHHHHHHhCCCCcCCCCchh----hHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcccc
Confidence 9999999999999999987754 445567778888888889999999999999999999997 99999999996
Q ss_pred c
Q 019901 252 K 252 (334)
Q Consensus 252 ~ 252 (334)
.
T Consensus 397 g 397 (459)
T KOG0610|consen 397 G 397 (459)
T ss_pred C
Confidence 4
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=325.52 Aligned_cols=248 Identities=27% Similarity=0.380 Sum_probs=207.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~ 73 (334)
|+.|+| .|++++|++.| |+|.++...- ...=.-.|||.+|.+++|||||.+.++.... +.+|+|||||+.
T Consensus 84 I~EGtyGiVYRakdk~t~eIV-ALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh- 161 (419)
T KOG0663|consen 84 IEEGTYGVVYRAKDKKTDEIV-ALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH- 161 (419)
T ss_pred cccCcceeEEEeccCCcceeE-EeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-
Confidence 455665 38999999999 9999988761 2234678999999999999999999987754 569999999965
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC-CCccC
Q 019901 74 ELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVG 151 (334)
Q Consensus 74 ~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~g 151 (334)
+|..++.+.+ +|+..+++.++.|++.|++|||...|+||||||+|+|++..|. +||+|||+|+........ +..+-
T Consensus 162 DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~--lKiaDFGLAR~ygsp~k~~T~lVV 239 (419)
T KOG0663|consen 162 DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGI--LKIADFGLAREYGSPLKPYTPLVV 239 (419)
T ss_pred hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCc--EEecccchhhhhcCCcccCcceEE
Confidence 8988888765 7999999999999999999999999999999999999987776 999999999976554433 34468
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------cCC--------C-
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SIP--------D- 215 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~--------~- 215 (334)
|.||+|||.+.+...++.+.|+||+|||+.||+++++.|.+..+..++.++......... .+| .
T Consensus 240 TLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~ 319 (419)
T KOG0663|consen 240 TLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEH 319 (419)
T ss_pred EeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCC
Confidence 999999999998877777799999999999999999999999998888887765432211 011 1
Q ss_pred --------C--CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 --------Y--VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 --------~--~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+ ..++....+|+..+|..||.+|.|+.++|+|+||.+.
T Consensus 320 pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 320 PYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET 367 (419)
T ss_pred CchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence 0 1146889999999999999999999999999999773
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-48 Score=343.72 Aligned_cols=243 Identities=35% Similarity=0.660 Sum_probs=219.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.| +|+|.-||..| |||++.+..+. ....+.+|++.|+.++|||||++|++..+...+|+|+|+-++|+|
T Consensus 26 lG~GHFAVVKLArHVFTGekV-AVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl 104 (864)
T KOG4717|consen 26 LGRGHFAVVKLARHVFTGEKV-AVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDL 104 (864)
T ss_pred hcCCceehhhhhhhhccccee-EEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchH
Confidence 788998 68999999999 99999988743 346899999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
+++|.+. ..++|..+++|+.||+.|+.|+|+..+|||||||+|+.+... .+-|||+|||++.....+....+.||+..
T Consensus 105 ~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEK-lGlVKLTDFGFSNkf~PG~kL~TsCGSLA 183 (864)
T KOG4717|consen 105 FDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEK-LGLVKLTDFGFSNKFQPGKKLTTSCGSLA 183 (864)
T ss_pred HHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeee-cCceEeeeccccccCCCcchhhcccchhh
Confidence 9999875 459999999999999999999999999999999999988643 34599999999998888888889999999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|.|||++.+..|+.+++||||||+|||.|.+|++||...++.+.+- .++.-.+..|. .+|.++++||.+||..+
T Consensus 184 YSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLT----mImDCKYtvPs--hvS~eCrdLI~sMLvRd 257 (864)
T KOG4717|consen 184 YSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLT----MIMDCKYTVPS--HVSKECRDLIQSMLVRD 257 (864)
T ss_pred ccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhh----hhhcccccCch--hhhHHHHHHHHHHHhcC
Confidence 9999999999999999999999999999999999999887765443 45555666665 58999999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 019901 235 PAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~ 252 (334)
|.+|.|.+++..|+|++.
T Consensus 258 PkkRAslEeI~s~~Wlq~ 275 (864)
T KOG4717|consen 258 PKKRASLEEIVSTSWLQA 275 (864)
T ss_pred chhhccHHHHhccccccC
Confidence 999999999999999975
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=343.66 Aligned_cols=239 Identities=30% Similarity=0.527 Sum_probs=202.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ +++++.+++.| |||++.+... ...+.+.+|+.+++.++||||+++++++..++.+|+||||+.+++
T Consensus 26 lg~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 104 (329)
T PTZ00263 26 LGTGSFGRVRIAKHKGTGEYY-AIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGE 104 (329)
T ss_pred EEecCCeEEEEEEECCCCCEE-EEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCCh
Confidence 455544 47888899998 9999986542 233578899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... .....+||+.
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~--~~~~~~gt~~ 180 (329)
T PTZ00263 105 LFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGH--VKVTDFGFAKKVPD--RTFTLCGTPE 180 (329)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCC--EEEeeccCceEcCC--CcceecCChh
Confidence 9999998888999999999999999999999999999999999999987765 99999999875432 2234679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+....... ..+......+|. .++..+++||.+||+.|
T Consensus 181 y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li~~~L~~d 253 (329)
T PTZ00263 181 YLAPEVIQSKGHGKA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIY----EKILAGRLKFPN--WFDGRARDLVKGLLQTD 253 (329)
T ss_pred hcCHHHHcCCCCCCc-ceeechHHHHHHHHcCCCCCCCCCHHHHH----HHHhcCCcCCCC--CCCHHHHHHHHHHhhcC
Confidence 999999988877654 99999999999999999999876543322 333334444443 47899999999999999
Q ss_pred CCCCCC-----HhHHhcCccccc
Q 019901 235 PAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s-----~~ell~h~~~~~ 252 (334)
|.+||+ ++++++||||..
T Consensus 254 P~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 254 HTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred HHHcCCCCCCCHHHHhcCCccCC
Confidence 999997 799999999975
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=340.38 Aligned_cols=241 Identities=31% Similarity=0.530 Sum_probs=201.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .+++..++..| |+|++.+... .....+.+|+.+++.++||||+++++++..++..|+||||+.+|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~-aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 79 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIY-ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGE 79 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence 455544 47788888888 9999976431 223567789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|.+++.+.+++++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+
T Consensus 80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~ 157 (312)
T cd05585 80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGH--IALCDFGLCKLNMKDDDKTNTFCGTP 157 (312)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCc--EEEEECcccccCccCCCccccccCCc
Confidence 9999988888999999999999999999999999999999999999987665 999999998753222 2234457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|+.||........+ ..+......+| ..+++++++||.+||..
T Consensus 158 ~y~aPE~~~~~~~~~~-~DvwslGvil~el~tg~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~L~~ 230 (312)
T cd05585 158 EYLAPELLLGHGYTKA-VDWWTLGVLLYEMLTGLPPFYDENVNEMY----RKILQEPLRFP--DGFDRDAKDLLIGLLSR 230 (312)
T ss_pred ccCCHHHHcCCCCCCc-cceechhHHHHHHHhCCCCcCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHcCC
Confidence 9999999988877655 89999999999999999999876543333 23333333333 35799999999999999
Q ss_pred CCCCCC---CHhHHhcCccccc
Q 019901 234 DPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~---s~~ell~h~~~~~ 252 (334)
+|.+|| ++.+++.||||.+
T Consensus 231 dp~~R~~~~~~~e~l~hp~~~~ 252 (312)
T cd05585 231 DPTRRLGYNGAQEIKNHPFFSQ 252 (312)
T ss_pred CHHHcCCCCCHHHHHcCCCcCC
Confidence 999997 5799999999975
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=338.01 Aligned_cols=239 Identities=31% Similarity=0.571 Sum_probs=201.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .++++.+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.+++
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 87 (291)
T cd05612 9 VGTGTFGRVHLVRDRISEHYY-ALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGE 87 (291)
T ss_pred eecCCCeEEEEEEEcCCCCEE-EEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCC
Confidence 555554 47788889998 9999976542 234568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+++.+.+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .....+||+.
T Consensus 88 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~--~kl~Dfg~~~~~~~--~~~~~~gt~~ 163 (291)
T cd05612 88 LFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGH--IKLTDFGFAKKLRD--RTWTLCGTPE 163 (291)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEEecCcchhccC--CcccccCChh
Confidence 9999998888999999999999999999999999999999999999987664 99999999875432 2234579999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ .+......+|. .+++.++++|.+||+.|
T Consensus 164 y~aPE~~~~~~~~~~-~DiwSlG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l~~d 236 (291)
T cd05612 164 YLAPEVIQSKGHNKA-VDWWALGILIYEMLVGYPPFFDDNPFGIYE----KILAGKLEFPR--HLDLYAKDLIKKLLVVD 236 (291)
T ss_pred hcCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCcCCCc--cCCHHHHHHHHHHcCCC
Confidence 999999988777654 999999999999999999998765533333 23333333333 46899999999999999
Q ss_pred CCCCCC-----HhHHhcCccccc
Q 019901 235 PAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s-----~~ell~h~~~~~ 252 (334)
|.+||+ +++++.||||..
T Consensus 237 p~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 237 RTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred HHHccCCccCCHHHHhcCccccC
Confidence 999995 999999999964
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=324.19 Aligned_cols=248 Identities=27% Similarity=0.409 Sum_probs=207.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCC-cccceEEEEcCC------eEEEEEe
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPN-IVRFKEVILTPT------HLAIVME 68 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~------~~~lv~e 68 (334)
||-|+| .|+++.+|+.| |+|.+....- .......+|+.+++.++|+| |+++++++.+.+ .+++|+|
T Consensus 19 lGeGtyg~Vykar~~~~g~~V-ALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe 97 (323)
T KOG0594|consen 19 LGEGTYGVVYKARSKRTGKFV-ALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFE 97 (323)
T ss_pred hCCCCceEEEEEEEecCCCEE-EEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEE
Confidence 677777 48999999998 9999988762 25678899999999999999 999999998877 8999999
Q ss_pred ccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC
Q 019901 69 YASGGELFERICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 69 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~ 144 (334)
|++ -+|..++...+ .++...++.+++||+.||+|||++||+||||||+||||+..+. +||+|||+|+......
T Consensus 98 ~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~--lKlaDFGlAra~~ip~ 174 (323)
T KOG0594|consen 98 FLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGV--LKLADFGLARAFSIPM 174 (323)
T ss_pred eec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCc--EeeeccchHHHhcCCc
Confidence 995 58999998765 4788899999999999999999999999999999999998665 9999999999655333
Q ss_pred C-CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc------------
Q 019901 145 Q-PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------ 211 (334)
Q Consensus 145 ~-~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------ 211 (334)
. ....++|.+|+|||++.+...++...||||+|||++||+++++.|.+..+..++..+.........
T Consensus 175 ~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~ 254 (323)
T KOG0594|consen 175 RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDY 254 (323)
T ss_pred ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccc
Confidence 3 455679999999999999865555599999999999999999999998887776666554322211
Q ss_pred --cCCCC----------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 --SIPDY----------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 --~~~~~----------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.++.+ ...+++..+++.+||+.+|.+|.|++.+|.||||...
T Consensus 255 k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~ 308 (323)
T KOG0594|consen 255 KAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL 308 (323)
T ss_pred cccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence 11111 1234689999999999999999999999999999764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=344.75 Aligned_cols=244 Identities=27% Similarity=0.404 Sum_probs=209.4
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
.||.|+| .+.+..+++.| |||++...... ..+.+++|+.+|.++++|||.++|+.+..+..++++||||.||++
T Consensus 20 ~IgrGsfG~Vyk~~d~~t~k~v-AiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv 98 (467)
T KOG0201|consen 20 LIGRGSFGEVYKAIDNKTKKVV-AIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV 98 (467)
T ss_pred hccccccceeeeeeeccccceE-EEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence 3788877 48899999999 99999887633 347899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~ 154 (334)
.+.++..+.+.+..+..++++++.||.|||..+.+|||||+.|||+...+. +||+|||++........ ..+.+|||.
T Consensus 99 ~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~--vkl~DfgVa~ql~~~~~rr~tfvGTPf 176 (467)
T KOG0201|consen 99 LDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGD--VKLADFGVAGQLTNTVKRRKTFVGTPF 176 (467)
T ss_pred hhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCc--EEEEecceeeeeechhhcccccccccc
Confidence 999988887899999999999999999999999999999999999987765 99999999876544433 367889999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||||++.+..|+.+ +||||||++.+||++|.+||....+...+. .+....++. -....|+.+++|+..||+++
T Consensus 177 wMAPEVI~~~~Y~~K-ADIWSLGITaiEla~GePP~s~~hPmrvlf----lIpk~~PP~-L~~~~S~~~kEFV~~CL~k~ 250 (467)
T KOG0201|consen 177 WMAPEVIKQSGYDTK-ADIWSLGITAIELAKGEPPHSKLHPMRVLF----LIPKSAPPR-LDGDFSPPFKEFVEACLDKN 250 (467)
T ss_pred ccchhhhccccccch-hhhhhhhHHHHHHhcCCCCCcccCcceEEE----eccCCCCCc-cccccCHHHHHHHHHHhhcC
Confidence 999999998889887 899999999999999999998766532211 111111111 11267999999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 019901 235 PAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~ 253 (334)
|+.||||.+||+|+|++..
T Consensus 251 P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 251 PEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred cccCcCHHHHhhhHHHHhc
Confidence 9999999999999999763
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=340.13 Aligned_cols=241 Identities=34% Similarity=0.576 Sum_probs=201.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| ++++..+|..| |||++.+... .....+.+|+.+++.++||||+++++++...+.+|+||||+.+|+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 3 LGKGTFGKVILVREKASGKYY-AMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 555555 47888899999 9999987542 223567789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH--IKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCc--EEEecCcCCccCCCcccccccccCCc
Confidence 9999988888999999999999999999999999999999999999987665 999999998753322 2233457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+......+| ..+++++.+||.+||++
T Consensus 160 ~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~Pf~~~~~~~~~----~~~~~~~~~~p--~~~~~~~~~li~~~L~~ 232 (328)
T cd05593 160 EYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEDIKFP--RTLSADAKSLLSGLLIK 232 (328)
T ss_pred CccChhhhcCCCCCcc-CCccccchHHHHHhhCCCCCCCCCHHHHH----HHhccCCccCC--CCCCHHHHHHHHHHcCC
Confidence 9999999988777655 99999999999999999999876543222 22333333333 35799999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 019901 234 DPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~-----s~~ell~h~~~~~ 252 (334)
+|.+|+ ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 233 DPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999997 8999999999964
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=332.22 Aligned_cols=245 Identities=23% Similarity=0.338 Sum_probs=200.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .+.+..+|+.| |||.+.+... .....+.+|+.+++.++||||+++++++.+++..++||||+.+|+
T Consensus 8 lg~G~~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~ 86 (285)
T cd05631 8 LGKGGFGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGD 86 (285)
T ss_pred EecCCCEEEEEEEEecCCceE-EEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCc
Confidence 455544 47788899999 9999876542 223467889999999999999999999999999999999999999
Q ss_pred hHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 75 LFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
|...+... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||+++............||
T Consensus 87 L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~ 164 (285)
T cd05631 87 LKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGH--IRISDLGLAVQIPEGETVRGRVGT 164 (285)
T ss_pred HHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeCCCcEEcCCCCeecCCCCC
Confidence 98887543 35899999999999999999999999999999999999987665 999999998764433333456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||...............+...... ....+++++.+||.+||+
T Consensus 165 ~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~l~ 241 (285)
T cd05631 165 VGYMAPEVINNEKYTFS-PDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE--YSEKFSEDAKSICRMLLT 241 (285)
T ss_pred CCccCHhhhcCCCCCcc-cCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccccc--CCccCCHHHHHHHHHHhh
Confidence 99999999988888665 899999999999999999998765433322322222222222 233579999999999999
Q ss_pred cCCCCCCC-----HhHHhcCccccc
Q 019901 233 ADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s-----~~ell~h~~~~~ 252 (334)
.+|.+||+ ++++++||||..
T Consensus 242 ~~P~~R~~~~~~~~~~~~~h~~~~~ 266 (285)
T cd05631 242 KNPKERLGCRGNGAAGVKQHPIFKN 266 (285)
T ss_pred cCHHHhcCCCCCCHHHHhcCHhhcC
Confidence 99999997 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=341.43 Aligned_cols=242 Identities=30% Similarity=0.432 Sum_probs=212.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCe-EEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTH-LAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-~~lv~e~~~~~~ 74 (334)
+|-|+| +++++..+..| ++|.+...... ..+...+|+.++++++|||||.+.+.|..+++ ++|||+||+||+
T Consensus 12 iG~GafG~a~lvrhk~~~~~~-vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~ 90 (426)
T KOG0589|consen 12 VGRGAFGSALLVRHKSDDKLY-VLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGD 90 (426)
T ss_pred cCccccchhhhhhhccCCceE-EEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCC
Confidence 677887 68899999999 99999887632 33578999999999999999999999999988 999999999999
Q ss_pred hHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccC
Q 019901 75 LFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 151 (334)
Q Consensus 75 L~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~g 151 (334)
+.+.+.+.+ .|+++.+..|+.|++.|+.|||+++|+|||||+.|||++.++. |||+|||+|+...... ...+.+|
T Consensus 91 l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~--VkLgDfGlaK~l~~~~~~a~tvvG 168 (426)
T KOG0589|consen 91 LAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKK--VKLGDFGLAKILNPEDSLASTVVG 168 (426)
T ss_pred HHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCc--eeecchhhhhhcCCchhhhheecC
Confidence 999998754 4999999999999999999999999999999999999988776 9999999999877665 6677889
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
||.||+||++.+.+|..+ +|||||||++|||++-+++|.+.+-.....+ +.... ..|.+...+.+++.+|..||
T Consensus 169 Tp~YmcPEil~d~pYn~K-SDiWsLGC~~yEm~~lk~aF~a~~m~~Li~k----i~~~~-~~Plp~~ys~el~~lv~~~l 242 (426)
T KOG0589|consen 169 TPYYMCPEILSDIPYNEK-SDIWSLGCCLYEMCTLKPAFKASNMSELILK----INRGL-YSPLPSMYSSELRSLVKSML 242 (426)
T ss_pred CCcccCHHHhCCCCCCcc-CcchhhcchHHHHHhcccccCccchHHHHHH----Hhhcc-CCCCCccccHHHHHHHHHHh
Confidence 999999999999999877 9999999999999999999998665444433 33333 23445568999999999999
Q ss_pred ccCCCCCCCHhHHhcCccccc
Q 019901 232 VADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~ 252 (334)
.++|..||++.+||.+|.++.
T Consensus 243 ~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 243 RKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred hcCCccCCCHHHHhhChhhhh
Confidence 999999999999999998874
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.51 Aligned_cols=241 Identities=34% Similarity=0.582 Sum_probs=201.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+|..| |+|++.+... .....+.+|+.+++.++||||++++++|...+.+|+||||+.+|+
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 3 LGKGTFGKVILVREKATGRYY-AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 566655 47788899999 9999987542 123456789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 82 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCC--EEecccHHhccccCCCCccccccCCc
Confidence 9999988888999999999999999999999999999999999999987665 999999998753222 2223457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...... .+......+| ..++++++++|.+||+.
T Consensus 160 ~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~g~~Pf~~~~~~~~~~----~~~~~~~~~p--~~~~~~~~~li~~~L~~ 232 (323)
T cd05595 160 EYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFE----LILMEEIRFP--RTLSPEAKSLLAGLLKK 232 (323)
T ss_pred CcCCcccccCCCCCch-hchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCCCCC--CCCCHHHHHHHHHHccC
Confidence 9999999988877655 999999999999999999998765433322 2223333333 35799999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 019901 234 DPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~-----s~~ell~h~~~~~ 252 (334)
+|.+|+ ++.++++||||..
T Consensus 233 dP~~R~~~~~~~~~~~l~h~~~~~ 256 (323)
T cd05595 233 DPKQRLGGGPSDAKEVMEHRFFLS 256 (323)
T ss_pred CHHHhCCCCCCCHHHHHcCCCcCC
Confidence 999998 8999999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=343.55 Aligned_cols=244 Identities=25% Similarity=0.417 Sum_probs=199.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.| |||++.+... .....+.+|+.+++.++||||+++++.+.+...+|+|||||+||+
T Consensus 9 LG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (363)
T cd05628 9 IGRGAFGEVRLVQKKDTGHVY-AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGD 87 (363)
T ss_pred EEeCCCEEEEEEEECCCCCEE-EEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCc
Confidence 455554 47788899999 9999987542 223567889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------- 144 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------- 144 (334)
|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~ 165 (363)
T cd05628 88 MMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGH--VKLSDFGLCTGLKKAHRTEFYRNLNH 165 (363)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCC--EEEeeccCcccccccccccccccccc
Confidence 9999998889999999999999999999999999999999999999987664 9999999987432110
Q ss_pred --------------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH
Q 019901 145 --------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 198 (334)
Q Consensus 145 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 198 (334)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-~DvwSlGvil~ell~G~~Pf~~~~~~~~ 244 (363)
T cd05628 166 SLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQET 244 (363)
T ss_pred cccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-hhhhhhHHHHHHHHhCCCCCCCCCHHHH
Confidence 0123579999999999988887655 9999999999999999999987665443
Q ss_pred HHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC---CCCCHhHHhcCccccc
Q 019901 199 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA---KRISIPEIRNHEWFLK 252 (334)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~---~R~s~~ell~h~~~~~ 252 (334)
+..+... .....+|....++++++++|.+|+. +|. .||+++++++||||..
T Consensus 245 ~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~ 298 (363)
T cd05628 245 YKKVMNW--KETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG 298 (363)
T ss_pred HHHHHcC--cCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence 3332211 1223445555689999999999775 444 4689999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=332.63 Aligned_cols=248 Identities=25% Similarity=0.416 Sum_probs=192.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .++++.+++.| |||++..... .....+.+|+.+++.++||||+++++++.++...++||||+. ++|.
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~ 90 (303)
T cd07869 13 LGEGSYATVYKGKSKVNGKLV-ALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLC 90 (303)
T ss_pred EEecCCEEEEEEEECCCCCEE-EEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHH
Confidence 455544 47788889998 9999976542 233567899999999999999999999999999999999995 5777
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCc
Q 019901 77 ERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~ 154 (334)
+++... +.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..... .......+|+.
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 168 (303)
T cd07869 91 QYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGE--LKLADFGLARAKSVPSHTYSNEVVTLW 168 (303)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECCCCcceeccCCCccCCCCcccCC
Confidence 777654 56899999999999999999999999999999999999987665 999999998743222 22234578999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--------cC------------C
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------SI------------P 214 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~------------~ 214 (334)
|+|||++.+....+.++|||||||++|+|++|..||.+..+.......+........ .. +
T Consensus 169 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (303)
T cd07869 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSP 248 (303)
T ss_pred CCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCC
Confidence 999999876554455599999999999999999999875443222111111110000 00 0
Q ss_pred -------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 -------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 -------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.....++.+.+||.+||+.+|.+|||++++++||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 249 KNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 001245789999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-45 Score=329.49 Aligned_cols=243 Identities=26% Similarity=0.440 Sum_probs=193.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .+++..++..| |+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+.+ +|.+++..
T Consensus 18 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 95 (288)
T cd07871 18 YATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDN 95 (288)
T ss_pred CEEEEEEEECCCCCEE-EEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHh
Confidence 3444 37788889998 9999976542 3345788999999999999999999999999999999999975 89888876
Q ss_pred cC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccch
Q 019901 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPE 159 (334)
Q Consensus 82 ~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE 159 (334)
.+ .+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||
T Consensus 96 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE 173 (288)
T cd07871 96 CGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGE--LKLADFGLARAKSVPTKTYSNEVVTLWYRPPD 173 (288)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEECcCcceeeccCCCccccCceecccccChH
Confidence 54 4799999999999999999999999999999999999987665 9999999987543222 223456899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc---------------cccCCC---------
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD--------- 215 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~--------- 215 (334)
++.+....+.++||||+||++|+|++|++||.+.+....+.......... ....|.
T Consensus 174 ~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (288)
T cd07871 174 VLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH 253 (288)
T ss_pred HhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHh
Confidence 98765433455999999999999999999998766544443332211100 000111
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 216 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 216 ~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...+++++++||.+||+.+|.+|||++|+++||||
T Consensus 254 ~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 254 APRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred CCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 13468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=335.74 Aligned_cols=241 Identities=31% Similarity=0.517 Sum_probs=200.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .++++.+++.| |||++.+... ...+.+.+|+.+++.+ +||||+++++++...+.+|+||||+.+|
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 3 LGKGSFGKVMLARLKESGRLY-AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeCCCeEEEEEEEcCCCCEE-EEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 566655 47788889998 9999986532 2234567788888766 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
+|..++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||
T Consensus 82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeeCCCCeecCcCCCcccccccC
Confidence 99999988888999999999999999999999999999999999999987765 999999998753322 223445799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ ..+.......|. .++++++++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~----~~i~~~~~~~~~--~~~~~~~~li~~~L~ 232 (320)
T cd05590 160 PDYIAPEILQEMLYGPS-VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPT--WLSQDAVDILKAFMT 232 (320)
T ss_pred ccccCHHHHcCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHH----HHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988777655 89999999999999999999876653333 233333333333 479999999999999
Q ss_pred cCCCCCCCH------hHHhcCccccc
Q 019901 233 ADPAKRISI------PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~------~ell~h~~~~~ 252 (334)
.+|.+||++ +++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 233 KNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred cCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 999999998 89999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-46 Score=336.08 Aligned_cols=245 Identities=27% Similarity=0.477 Sum_probs=199.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| +++++.++..| |||++++.... ....+.+|+.+++.+ +||||+++++++.+.+.+|+||||+++|
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~-aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 3 IGRGSYAKVLLVELKKTRRIY-AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 555555 47788889998 99999875422 234578899999888 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 82 DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEECcCccccccccCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987665 99999999875322 2233456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch----H-HHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----K-NFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
+.|+|||++.+..++.+ +|+|||||++|+|++|+.||...... . ........+......+|. .++..+.++|
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li 236 (329)
T cd05588 160 PNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVL 236 (329)
T ss_pred ccccCHHHHcCCCCCCc-cceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHH
Confidence 99999999988877655 99999999999999999999632111 1 111122223333334443 5789999999
Q ss_pred HHhcccCCCCCCC------HhHHhcCccccc
Q 019901 228 SRIFVADPAKRIS------IPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s------~~ell~h~~~~~ 252 (334)
.+||+.+|.+|+| ++++++||||..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999997 789999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=337.95 Aligned_cols=239 Identities=29% Similarity=0.478 Sum_probs=198.3
Q ss_pred CCccee---e-eeecCCC-CeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCSYSS-DLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~-~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| + |+++.++ ..| |+|++.+... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+.+|
T Consensus 38 ig~G~~g~Vy~a~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g 116 (340)
T PTZ00426 38 LGTGSFGRVILATYKNEDFPPV-AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGG 116 (340)
T ss_pred EeecCCeEEEEEEEECCCCeEE-EEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCC
Confidence 455544 3 5555555 456 9999976531 23356788999999999999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... ...+.+||+
T Consensus 117 ~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--ikL~DFG~a~~~~~--~~~~~~gt~ 192 (340)
T PTZ00426 117 EFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGF--IKMTDFGFAKVVDT--RTYTLCGTP 192 (340)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEecCCCCeecCC--CcceecCCh
Confidence 99999998889999999999999999999999999999999999999987664 99999999875432 234567999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+...... .+......+|. .+++.++++|++||+.
T Consensus 193 ~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~li~~~l~~ 265 (340)
T PTZ00426 193 EYIAPEILLNVGHGKA-ADWWTLGIFIYEILVGCPPFYANEPLLIYQ----KILEGIIYFPK--FLDNNCKHLMKKLLSH 265 (340)
T ss_pred hhcCHHHHhCCCCCcc-ccccchhhHHHHHhcCCCCCCCCCHHHHHH----HHhcCCCCCCC--CCCHHHHHHHHHHccc
Confidence 9999999988777554 999999999999999999998765533332 23333333333 4789999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 019901 234 DPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~-----s~~ell~h~~~~~ 252 (334)
+|.+|+ |++++++||||..
T Consensus 266 dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 266 DLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred CHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999996 8999999999964
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-46 Score=342.69 Aligned_cols=244 Identities=30% Similarity=0.525 Sum_probs=200.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| ++++..+|+.| |||++.+... .....+.+|+.+++.++||||+++++++.+++.+|+||||+.+|+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (364)
T cd05599 9 IGRGAFGEVRLVQKKDTGHIY-AMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGD 87 (364)
T ss_pred EEecCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcH
Confidence 455554 47888899998 9999987531 223567889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------- 144 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------- 144 (334)
|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||+++......
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~ 165 (364)
T cd05599 88 MMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGH--IKLSDFGLCTGLKKSHRTEFYRILSH 165 (364)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEeecccceeccccccccccccccc
Confidence 9999988888999999999999999999999999999999999999987765 9999999986432111
Q ss_pred -----------------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc
Q 019901 145 -----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 195 (334)
Q Consensus 145 -----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 195 (334)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|.+||.....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~G~~Pf~~~~~ 244 (364)
T cd05599 166 ALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKE-CDWWSLGVIMYEMLVGYPPFCSDNP 244 (364)
T ss_pred cccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCe-eeeecchhHHHHhhcCCCCCCCCCH
Confidence 0113469999999999988877655 9999999999999999999987665
Q ss_pred hHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC---HhHHhcCccccc
Q 019901 196 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK 252 (334)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s---~~ell~h~~~~~ 252 (334)
......... .......|....++++++++|.+||. +|.+|++ +++++.||||..
T Consensus 245 ~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~ 301 (364)
T cd05599 245 QETYRKIIN--WKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301 (364)
T ss_pred HHHHHHHHc--CCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 433332221 11223344445679999999999996 9999998 999999999964
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-46 Score=337.82 Aligned_cols=241 Identities=35% Similarity=0.577 Sum_probs=200.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| ++++..+|..| |+|++.+... .....+.+|+.+++.++||||+++++++..++.+|+||||+.+|+
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 3 LGKGTFGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 566655 47788899999 9999987542 223456789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+++..... .......||
T Consensus 82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 82 LFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCC--EEEecCCCCeecCCCCcccccccCC
Confidence 99999888889999999999999999999997 89999999999999987765 999999998753322 223345799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....... ..+......+| ..+++++.++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~~L~ 232 (325)
T cd05594 160 PEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLF----ELILMEEIRFP--RTLSPEAKSLLSGLLK 232 (325)
T ss_pred cccCCHHHHccCCCCCc-cccccccceeeeeccCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHhh
Confidence 99999999988877655 99999999999999999999876543222 22333333333 3579999999999999
Q ss_pred cCCCCCC-----CHhHHhcCccccc
Q 019901 233 ADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~-----s~~ell~h~~~~~ 252 (334)
.+|.+|+ ++.++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~~il~h~~~~~ 257 (325)
T cd05594 233 KDPKQRLGGGPDDAKEIMQHKFFAG 257 (325)
T ss_pred cCHHHhCCCCCCCHHHHhcCCCcCC
Confidence 9999997 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=319.40 Aligned_cols=255 Identities=30% Similarity=0.492 Sum_probs=214.2
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
.||.|.| -+++..+|..| |||++.|..-.....+.+|++++.+++ |+||++++++|+++...|+|||-+.||+|
T Consensus 85 ~LGeGAyasVqtcv~i~t~~EY-AVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 85 LLGEGAYASVQTCVSIQTGKEY-AVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HhcCccceeeeeeeeeccchhh-hhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 3788877 48889999999 999999998677889999999999985 99999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCC--------CCC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH--------SQP 146 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~--------~~~ 146 (334)
...|.+...|++.++..++++|+.||.|||.+||.||||||+|||....+ ..-||||||.|....... ...
T Consensus 164 LshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L 243 (463)
T KOG0607|consen 164 LSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPEL 243 (463)
T ss_pred HHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccc
Confidence 99999999999999999999999999999999999999999999986433 234899999987532221 122
Q ss_pred CCccCCCccccchhhc----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-------h---HH-HHHHHHHHhhccc
Q 019901 147 KSTVGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------P---KN-FRKTIHRILSVQY 211 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~---~~-~~~~~~~~~~~~~ 211 (334)
.+.+|+..|||||+.. ...++.+.+|.||||+|+|.|++|++||.+.-. . .. .......+....+
T Consensus 244 ~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkY 323 (463)
T KOG0607|consen 244 LTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY 323 (463)
T ss_pred cCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCC
Confidence 4567889999999863 334456669999999999999999999975321 1 11 2334455666777
Q ss_pred cCC--CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCC
Q 019901 212 SIP--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 212 ~~~--~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~~ 256 (334)
.+| .|..+|.+.+++|+.+|..++.+|.++.++++|||++...++
T Consensus 324 eFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 324 EFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred cCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 777 478899999999999999999999999999999999865443
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=336.14 Aligned_cols=243 Identities=30% Similarity=0.457 Sum_probs=201.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+++..+++.| |||++.+... .....+.+|+.+++.++||||+++++++..++..|+||||++|++
T Consensus 9 ig~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~ 87 (333)
T cd05600 9 VGQGGYGQVFLAKKKDTGEIV-ALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGD 87 (333)
T ss_pred EeecCCeEEEEEEECCCCCEE-EEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCC
Confidence 454544 47788889998 9999987542 233568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+||+.
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~a~~~~~--~~~~~~gt~~ 163 (333)
T cd05600 88 FRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGH--IKLTDFGLSKGIVT--YANSVVGSPD 163 (333)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEEEeCcCCccccc--ccCCcccCcc
Confidence 9999998888999999999999999999999999999999999999987665 99999999875433 3345679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCC----CCCCHHHHHHHHHh
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY----VHISPECRHLISRI 230 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~ 230 (334)
|+|||++.+..++.+ +|||||||++|+|++|..||...+........... ......|.. ..+++++.++|.+|
T Consensus 164 y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~s~~~~~li~~~ 240 (333)
T cd05600 164 YMAPEVLRGKGYDFT-VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYW--KETLQRPVYDDPRFNLSDEAWDLITKL 240 (333)
T ss_pred ccChhHhcCCCCCCc-cceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhc--cccccCCCCCccccccCHHHHHHHHHH
Confidence 999999988877655 99999999999999999999876654333322211 111111211 25689999999999
Q ss_pred cccCCCCCCCHhHHhcCccccc
Q 019901 231 FVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~ 252 (334)
|..+|.+|||++++++||||..
T Consensus 241 l~~~~~rr~s~~~ll~h~~~~~ 262 (333)
T cd05600 241 INDPSRRFGSLEDIKNHPFFKE 262 (333)
T ss_pred hhChhhhcCCHHHHHhCcccCC
Confidence 9999999999999999999965
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=327.38 Aligned_cols=245 Identities=25% Similarity=0.353 Sum_probs=194.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .++++.+++.| |||++..... ...+.+.+|+.+++.++||||+++++++...+..|+||||+.++.+
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 87 (287)
T cd07848 9 VGEGAYGVVLKCRHKETKEIV-AIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87 (287)
T ss_pred ecccCCEEEEEEEECCCCcEE-EEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHH
Confidence 455544 47788888888 9999986542 2346788999999999999999999999999999999999998777
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~ 153 (334)
..+......+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||+++...... ......||+
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 165 (287)
T cd07848 88 ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDV--LKLCDFGFARNLSEGSNANYTEYVATR 165 (287)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccCccccccccccccccccccc
Confidence 655555567999999999999999999999999999999999999987664 9999999998643322 123356899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCCC---
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD--- 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~--- 215 (334)
.|+|||++.+..++.+ +|||||||++|+|++|++||.+................ .....+.
T Consensus 166 ~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (287)
T cd07848 166 WYRSPELLLGAPYGKA-VDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244 (287)
T ss_pred ccCCcHHHcCCCCCCc-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccC
Confidence 9999999988777654 99999999999999999999876543332221111000 0000111
Q ss_pred --------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 216 --------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 216 --------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...+|+++.+||.+||+.+|.+|||++++|+||||
T Consensus 245 ~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=341.51 Aligned_cols=244 Identities=32% Similarity=0.503 Sum_probs=200.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| ++++..++..| |||++.+... .....+.+|+.+++.++||||+++++.+.+++.+|+|||||.+|+
T Consensus 9 LG~G~~g~Vy~a~~~~~~~~~-aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (382)
T cd05625 9 LGIGAFGEVCLARKVDTKALY-AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 87 (382)
T ss_pred EEeCCCEEEEEEEECCCCCEE-EEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCc
Confidence 556655 47888899998 9999986542 223578899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----------- 143 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----------- 143 (334)
|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~--~kL~DFGla~~~~~~~~~~~~~~~~~ 165 (382)
T cd05625 88 MMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQSGDH 165 (382)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEeECCCCccccccccccccccccc
Confidence 9999988888999999999999999999999999999999999999987665 999999997521100
Q ss_pred -------------------------------------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC
Q 019901 144 -------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186 (334)
Q Consensus 144 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 186 (334)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlGvil~elltG 244 (382)
T cd05625 166 VRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVG 244 (382)
T ss_pred cccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCe-eeEEechHHHHHHHhC
Confidence 00123469999999999988888755 9999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC---HhHHhcCccccc
Q 019901 187 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---IPEIRNHEWFLK 252 (334)
Q Consensus 187 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s---~~ell~h~~~~~ 252 (334)
++||.+.+.......... .......|....+++++.++|.+|+ .+|.+|++ ++++++||||..
T Consensus 245 ~~Pf~~~~~~~~~~~i~~--~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 310 (382)
T cd05625 245 QPPFLAQTPLETQMKVIN--WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT 310 (382)
T ss_pred CCCCCCCCHHHHHHHHHc--cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence 999987655433322221 1123344555678999999999986 59999997 999999999955
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=342.04 Aligned_cols=245 Identities=30% Similarity=0.459 Sum_probs=199.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.++..| |||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+
T Consensus 9 LG~G~~g~Vy~~~~~~~~~~~-aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~ 87 (381)
T cd05626 9 LGIGAFGEVCLACKVDTHALY-AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (381)
T ss_pred EeecCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCc
Confidence 566555 47888899999 9999987542 223568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----------- 143 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----------- 143 (334)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 88 L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~--~kL~DFGl~~~~~~~~~~~~~~~~~~ 165 (381)
T cd05626 88 MMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH--IKLTDFGLCTGFRWTHNSKYYQKGSH 165 (381)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC--EEEeeCcCCccccccccccccccccc
Confidence 9999998888999999999999999999999999999999999999987664 999999997532100
Q ss_pred -------------------------------------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC
Q 019901 144 -------------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186 (334)
Q Consensus 144 -------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 186 (334)
....+.+||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~DiwSlG~il~elltG 244 (381)
T cd05626 166 IRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQL-CDWWSVGVILFEMLVG 244 (381)
T ss_pred ccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCc-cceeehhhHHHHHHhC
Confidence 00123479999999999988877655 9999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc--cCCCCCCCHhHHhcCccccc
Q 019901 187 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV--ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 187 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~--~~p~~R~s~~ell~h~~~~~ 252 (334)
+.||...+.......... .......|....+++++.+||.+|+. .+|..|++++++++||||..
T Consensus 245 ~~Pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 245 QPPFLAPTPTETQLKVIN--WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred CCCCcCCCHHHHHHHHHc--cccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 999987665333322211 12233455555689999999999654 45556999999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=333.15 Aligned_cols=245 Identities=27% Similarity=0.485 Sum_probs=198.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| +++++.+++.| |+|++.+.... ....+.+|+.++.++ +||||+++++++..++..|+||||+.++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~ 81 (329)
T cd05618 3 IGRGSYAKVLLVRLKKTERIY-AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG 81 (329)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence 566655 47788889998 99999875422 234577888888776 8999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 82 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCC--EEEeeCCccccccCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987765 99999999875322 2223445799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-----hHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----PKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ..........+......+|. .++..+.++|
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll 236 (329)
T cd05618 160 PNYIAPEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVL 236 (329)
T ss_pred ccccCHHHHcCCCCCCc-cceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHH
Confidence 99999999988877655 9999999999999999999953111 11111122223333344443 5789999999
Q ss_pred HHhcccCCCCCCC------HhHHhcCccccc
Q 019901 228 SRIFVADPAKRIS------IPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s------~~ell~h~~~~~ 252 (334)
.+||+.+|.+||| ++++++||||..
T Consensus 237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9999999999998 579999999954
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=332.09 Aligned_cols=242 Identities=30% Similarity=0.502 Sum_probs=201.0
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
+||.|+| .++++.+++.| |||++.+... ...+.+..|+.+++.+ +||||+++++++..++.+|+||||+++
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVY-AIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEE-EEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3666665 47788888998 9999987542 2234566788888765 799999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~g 151 (334)
++|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH--CKLADFGMCKEGILNGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeecccceecccCCcccccccc
Confidence 999999988888999999999999999999999999999999999999987765 999999998753322 22344579
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||........+. .+.......|. .+++++.++|.+||
T Consensus 159 t~~y~aPE~~~~~~~~~~-~DvwslG~il~el~tg~~Pf~~~~~~~~~~----~i~~~~~~~p~--~~~~~~~~ll~~~L 231 (321)
T cd05591 159 TPDYIAPEILQELEYGPS-VDWWALGVLMYEMMAGQPPFEADNEDDLFE----SILHDDVLYPV--WLSKEAVSILKAFM 231 (321)
T ss_pred CccccCHHHHcCCCCCCc-cceechhHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 999999999988777655 999999999999999999998766543333 33333333333 47899999999999
Q ss_pred ccCCCCCC-------CHhHHhcCccccc
Q 019901 232 VADPAKRI-------SIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~-------s~~ell~h~~~~~ 252 (334)
+.+|.+|| +++++++||||..
T Consensus 232 ~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 232 TKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred ccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999999 8999999999954
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=341.39 Aligned_cols=244 Identities=28% Similarity=0.473 Sum_probs=198.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.| |||++.+... .....+.+|+.+++.++||||+++++++.+++.+|+||||+.||+
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (377)
T cd05629 9 IGKGAFGEVRLVQKKDTGKIY-AMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGD 87 (377)
T ss_pred EeecCCEEEEEEEECCCCCEE-EEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCc
Confidence 455544 47788899998 9999876431 223567889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------- 144 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------- 144 (334)
|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~~~ 165 (377)
T cd05629 88 LMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGH--IKLSDFGLSTGFHKQHDSAYYQKLLQ 165 (377)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEEeeccccccccccccccccccccc
Confidence 9999988888999999999999999999999999999999999999987665 9999999986321100
Q ss_pred --------------------------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC
Q 019901 145 --------------------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG 186 (334)
Q Consensus 145 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g 186 (334)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltG 244 (377)
T cd05629 166 GKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQE-CDWWSLGAIMFECLIG 244 (377)
T ss_pred ccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCc-eeeEecchhhhhhhcC
Confidence 0012469999999999988877655 9999999999999999
Q ss_pred CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC---CCHhHHhcCccccc
Q 019901 187 AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR---ISIPEIRNHEWFLK 252 (334)
Q Consensus 187 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R---~s~~ell~h~~~~~ 252 (334)
.+||........+...... .....+|....++.++++||.+||. +|.+| +|+.+++.||||..
T Consensus 245 ~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 245 WPPFCSENSHETYRKIINW--RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred CCCCCCCCHHHHHHHHHcc--CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 9999876554333322211 1223445555689999999999997 67765 59999999999964
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.17 Aligned_cols=242 Identities=32% Similarity=0.526 Sum_probs=204.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+++..+|+.| |||++.+... .....+.+|+.+++.++||||+++++++.+++.+|+||||+.+++
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (350)
T cd05573 9 IGRGAFGEVWLVRDKDTGQVY-AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGD 87 (350)
T ss_pred EEeCCcEEEEEEEECCCCCEE-EEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCC
Confidence 455544 47888889999 9999987542 234578899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------- 144 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------- 144 (334)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 88 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~ 165 (350)
T cd05573 88 LMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGH--IKLADFGLCKKMNKAKDREYYLNDSH 165 (350)
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEeecCCCCccCcccCcccccccccc
Confidence 9999998888999999999999999999999999999999999999987765 9999999987543332
Q ss_pred --------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 019901 145 --------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204 (334)
Q Consensus 145 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 204 (334)
......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...........
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~--- 241 (350)
T cd05573 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETYNK--- 241 (350)
T ss_pred cccccccccccccccccccccccccccCccccCHHHHcCCCCCCc-eeeEecchhhhhhccCCCCCCCCCHHHHHHH---
Confidence 2234569999999999988877655 9999999999999999999987664333332
Q ss_pred HHhh--ccccCCCCCCCCHHHHHHHHHhcccCCCCCCC-HhHHhcCccccc
Q 019901 205 RILS--VQYSIPDYVHISPECRHLISRIFVADPAKRIS-IPEIRNHEWFLK 252 (334)
Q Consensus 205 ~~~~--~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s-~~ell~h~~~~~ 252 (334)
+.. ....+|....+++++.+||.+||. +|.+||+ ++++++||||..
T Consensus 242 -i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~ 290 (350)
T cd05573 242 -IINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG 290 (350)
T ss_pred -HhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence 222 333455555579999999999997 9999999 999999999954
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=324.69 Aligned_cols=243 Identities=29% Similarity=0.392 Sum_probs=196.7
Q ss_pred cceee-eeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||+++ +.++.+|+.| |||.+.+.... ..+.+..|+.+++.++||||+++.+++..++..|+||||+++|+|...+
T Consensus 6 ~g~Vy~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~ 84 (280)
T cd05608 6 FGEVSACQMRATGKLY-ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHI 84 (280)
T ss_pred ceeEEEEEEccCCcEE-EEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHH
Confidence 44443 6788899999 99999765422 2245678999999999999999999999999999999999999998877
Q ss_pred Hh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 80 CN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 80 ~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|||+++...... ......||+.
T Consensus 85 ~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~g~~~ 162 (280)
T cd05608 85 YNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGN--VRISDLGLAVELKDGQSKTKGYAGTPG 162 (280)
T ss_pred HhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCccceecCCCCccccccCCCcC
Confidence 43 346999999999999999999999999999999999999987654 9999999987543322 2234578999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||...............+...... ....+++.+.+++.+||+.+
T Consensus 163 y~aPE~~~~~~~~~~-~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~ 239 (280)
T cd05608 163 FMAPELLQGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVT--YPDKFSPASKSFCEALLAKD 239 (280)
T ss_pred ccCHHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCC--CcccCCHHHHHHHHHHhcCC
Confidence 999999988887655 999999999999999999998654432222323333222222 23357999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 019901 235 PAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~-----s~~ell~h~~~~~ 252 (334)
|.+|| |++++++||||+.
T Consensus 240 P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 240 PEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred HHHhcCCCCCCHHHHhcChhhhc
Confidence 99999 7899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=331.85 Aligned_cols=241 Identities=30% Similarity=0.527 Sum_probs=199.0
Q ss_pred CCccee---e-eee---cCCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF---Y-DRC---SYSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~---~-~~~---~~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|+| + +++ ..+++.| |||++.+... .....+.+|+.+++.++||||+++++++..++.+|+||||+
T Consensus 4 lg~G~~g~V~~~~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 82 (323)
T cd05584 4 LGKGGYGKVFQVRKVTGADTGKIF-AMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYL 82 (323)
T ss_pred eeecCCeEEEEEEEcccCCCCCEE-EEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCC
Confidence 555655 3 433 3467777 9999986532 22346788999999999999999999999999999999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCc
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 149 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~ 149 (334)
.+++|.+.+.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .....
T Consensus 83 ~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 83 SGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH--VKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEeeCcCCeecccCCCccccc
Confidence 99999999998888999999999999999999999999999999999999987665 9999999987433222 23345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... ..+......+| ..+++.+.+||.+
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~G~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~ 233 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKA-VDWWSLGALMYDMLTGAPPFTAENRKKTI----DKILKGKLNLP--PYLTPEARDLLKK 233 (323)
T ss_pred CCCccccChhhccCCCCCCc-ceecccHHHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHH
Confidence 79999999999988777554 99999999999999999999876553332 33333333333 3578999999999
Q ss_pred hcccCCCCCC-----CHhHHhcCccccc
Q 019901 230 IFVADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
||+++|.+|| +++++++||||..
T Consensus 234 ~l~~~p~~R~~~~~~~~~~l~~h~~~~~ 261 (323)
T cd05584 234 LLKRNPSSRLGAGPGDAAEVQSHPFFRH 261 (323)
T ss_pred HcccCHhHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999 8999999999965
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=341.07 Aligned_cols=244 Identities=31% Similarity=0.480 Sum_probs=199.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.| |||++.+... .....+.+|+.+++.++||||+++++.+.+++.+|+|||||++|+
T Consensus 9 lG~G~~g~V~~a~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~ 87 (376)
T cd05598 9 IGIGAFGEVCLVRKVDTNALY-AMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGD 87 (376)
T ss_pred EEeCCCeEEEEEEECCCCCEE-EEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCc
Confidence 455555 47888899999 9999976431 223568899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----------- 143 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----------- 143 (334)
|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|......
T Consensus 88 L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--ikL~DFG~a~~~~~~~~~~~~~~~~~ 165 (376)
T cd05598 88 MMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQKGDH 165 (376)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCC--EEEEeCCCCccccccccccccccccc
Confidence 9999998888999999999999999999999999999999999999987665 999999997521100
Q ss_pred ---------------------------------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCC
Q 019901 144 ---------------------------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 190 (334)
Q Consensus 144 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 190 (334)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf 244 (376)
T cd05598 166 HRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQPPF 244 (376)
T ss_pred cccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc-eeeeeccceeeehhhCCCCC
Confidence 00113469999999999988887655 99999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 019901 191 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~---s~~ell~h~~~~~ 252 (334)
.+............ .......+....+++++.++|.+|+ .+|.+|+ |+.++++||||..
T Consensus 245 ~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 245 LADTPAETQLKVIN--WETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCHHHHHHHHhc--cCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 87665433322211 1122334445568999999999977 5999999 9999999999965
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=329.24 Aligned_cols=246 Identities=25% Similarity=0.426 Sum_probs=198.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+|..+ |+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+++++|.
T Consensus 13 lg~G~~g~V~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (331)
T cd06649 13 LGAGNGGVVTKVQHKPSGLIM-ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91 (331)
T ss_pred ecCCCCEEEEEEEECCCCcEE-EEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHH
Confidence 455554 47888889888 9999986531 23467899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+++.+...+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||+++.... .......||+.|
T Consensus 92 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~g~~~y 168 (331)
T cd06649 92 QVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSY 168 (331)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCc--EEEccCcccccccc-cccccCCCCcCc
Confidence 9998888899999999999999999999986 5999999999999987765 99999999875432 223445799999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHH-------------------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------------- 204 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------------------- 204 (334)
+|||++.+..++.+ +|||||||++|+|++|+.||....... +...+.
T Consensus 169 ~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (331)
T cd06649 169 MSPERLQGTHYSVQ-SDIWSMGLSLVELAIGRYPIPPPDAKE-LEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMD 246 (331)
T ss_pred CCHhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHhcccccccccCCccccCcccccccccccccccc
Confidence 99999988777655 999999999999999999997544311 111110
Q ss_pred ------------HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 205 ------------RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 205 ------------~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.+............+++++++||.+||++||++|||+.++++||||...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 247 SRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred cccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000000000112468899999999999999999999999999999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=329.33 Aligned_cols=241 Identities=32% Similarity=0.533 Sum_probs=198.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| +++++.+|..| |||++.+... ........|+.++.. ++||||+++++++.+.+.+|+||||+.++
T Consensus 3 lg~G~~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 81 (316)
T cd05620 3 LGKGSFGKVLLAELKGKGEYF-AVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGG 81 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCC
Confidence 555554 47888899999 9999987531 223456778888765 48999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 82 DLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH--IKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEeCccCCCeecccCCCceeccCCC
Confidence 99999988888999999999999999999999999999999999999987665 99999999874322 2223456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+...... .+.......|. .++.+++++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslGvil~el~~g~~Pf~~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~li~~~l~ 232 (316)
T cd05620 160 PDYIAPEILQGLKYTFS-VDWWSFGVLLYEMLIGQSPFHGDDEDELFE----SIRVDTPHYPR--WITKESKDILEKLFE 232 (316)
T ss_pred cCccCHHHHcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCC--CCCHHHHHHHHHHcc
Confidence 99999999988877655 999999999999999999998765433222 22222233333 478999999999999
Q ss_pred cCCCCCCCH-hHHhcCccccc
Q 019901 233 ADPAKRISI-PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~-~ell~h~~~~~ 252 (334)
.+|.+||++ +++++||||..
T Consensus 233 ~dP~~R~~~~~~~~~h~~f~~ 253 (316)
T cd05620 233 RDPTRRLGVVGNIRGHPFFKT 253 (316)
T ss_pred CCHHHcCCChHHHHcCCCcCC
Confidence 999999998 58899999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=329.92 Aligned_cols=242 Identities=32% Similarity=0.571 Sum_probs=201.0
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
+||.|+| .++++.+++.| |||++.+... .....+.+|+.+++.+ +||||+++++++...+.+|+||||+.+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELY-AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEE-EEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 3566655 47788888898 9999987542 2234567888888877 699999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~g 151 (334)
++|...+.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH--IKIADFGMCKEGILGGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCc--EEecccCCCeecCcCCCcccceec
Confidence 999999988888999999999999999999999999999999999999987765 999999998753222 22334579
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+....... ..+.......| ..++..+.+||.+||
T Consensus 159 ~~~y~aPE~~~~~~~~~~-~DiwslGvil~~l~~G~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l 231 (318)
T cd05570 159 TPDYIAPEILSYQPYGPA-VDWWALGVLLYEMLAGQSPFEGDDEDELF----QSILEDEVRYP--RWLSKEAKSILKSFL 231 (318)
T ss_pred CccccCHHHhcCCCCCcc-hhhhhHHHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CcCCHHHHHHHHHHc
Confidence 999999999988888655 99999999999999999999876543322 22333333333 357999999999999
Q ss_pred ccCCCCCCCH-----hHHhcCccccc
Q 019901 232 VADPAKRISI-----PEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~-----~ell~h~~~~~ 252 (334)
..+|.+|||+ .+++.||||..
T Consensus 232 ~~dP~~R~s~~~~~~~~ll~~~~~~~ 257 (318)
T cd05570 232 TKNPEKRLGCLPTGEQDIKGHPFFRE 257 (318)
T ss_pred cCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999999999 99999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=335.53 Aligned_cols=245 Identities=30% Similarity=0.457 Sum_probs=199.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ +++++.++..| |+|++.+... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+.||+
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05596 51 IGRGAFGEVQLVRHKSSKQVY-AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EeeCCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCc
Confidence 455544 47888899999 9999976431 223457789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt 152 (334)
|..++.+ ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||
T Consensus 130 L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~--~kL~DfG~~~~~~~~~~~~~~~~~gt 206 (370)
T cd05596 130 LVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMDANGMVRCDTAVGT 206 (370)
T ss_pred HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCC--EEEEeccceeeccCCCcccCCCCCCC
Confidence 9998865 46899999999999999999999999999999999999987765 9999999987543322 22345799
Q ss_pred CccccchhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 153 PAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 153 ~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
+.|+|||++.+.. ..+.++|||||||++|+|++|++||........+..+... .....+|....+|.++++||.+
T Consensus 207 ~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ 284 (370)
T cd05596 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH--KNSLTFPDDIEISKQAKDLICA 284 (370)
T ss_pred cCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--CCcCCCCCcCCCCHHHHHHHHH
Confidence 9999999986543 2345599999999999999999999876654333332211 1223455555689999999999
Q ss_pred hcccCCCC--CCCHhHHhcCccccc
Q 019901 230 IFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
||..+|.+ |+|++++++||||+.
T Consensus 285 ~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 285 FLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HccChhhccCCCCHHHHhcCcccCC
Confidence 99999988 999999999999965
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=341.66 Aligned_cols=246 Identities=28% Similarity=0.352 Sum_probs=205.2
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-C-----CCcccceEEEEcCCeEEEEEecc
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-H-----PNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-h-----p~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
+||.|+| .|.+..|++.| |||+++... .--.+...|+.+|..|+ | -|+|+++++|...+++|||+|.+
T Consensus 193 ~LGkGtFGQVvk~~d~~T~e~V-AIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL 270 (586)
T KOG0667|consen 193 VLGKGSFGQVVKAYDHKTGEIV-AIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL 270 (586)
T ss_pred EecccccceeEEEEecCCCcEE-EEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh
Confidence 4788888 47789999999 999998766 44567788999999987 3 38999999999999999999999
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCC
Q 019901 71 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 71 ~~~~L~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~ 148 (334)
+-+|+++++.++ .|+...++.++.||+.||.+||+.||||+||||+|||+...+..+|||+|||.|....... .+
T Consensus 271 -~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--yt 347 (586)
T KOG0667|consen 271 -STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YT 347 (586)
T ss_pred -hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcc--ee
Confidence 579999998764 4899999999999999999999999999999999999988777789999999987543333 36
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh-----------------c--
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-----------------V-- 209 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-----------------~-- 209 (334)
.+.+..|+|||++.|.+|+.+ .||||||||++||++|.+.|.+.++.+++..++.-... .
T Consensus 348 YiQSRfYRAPEVILGlpY~~~-IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~ 426 (586)
T KOG0667|consen 348 YIQSRFYRAPEVILGLPYDTA-IDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLK 426 (586)
T ss_pred eeeccccccchhhccCCCCCc-cceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccC
Confidence 778999999999999999877 89999999999999999999998887776655432100 0
Q ss_pred -----------------------------cccCC-CCC--------CCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 210 -----------------------------QYSIP-DYV--------HISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 210 -----------------------------~~~~~-~~~--------~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
....| ... .-...+.+||++||..||.+|+|+.++|+||||.
T Consensus 427 ~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 427 GFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLT 506 (586)
T ss_pred CceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccc
Confidence 00001 000 0125589999999999999999999999999998
Q ss_pred c
Q 019901 252 K 252 (334)
Q Consensus 252 ~ 252 (334)
.
T Consensus 507 ~ 507 (586)
T KOG0667|consen 507 G 507 (586)
T ss_pred c
Confidence 4
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=331.12 Aligned_cols=241 Identities=31% Similarity=0.543 Sum_probs=197.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHH-HHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .++++.+|+.| |||++.+.... ....+.+|.. +++.++||||+++++.+...+..|+||||+.+|
T Consensus 3 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 3 IGKGSFGKVLLAKHKADGKFY-AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 555554 47888899999 99999865421 1234445544 568899999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCc--EEEeccCCCcccccCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987765 999999998753322 223345799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|..||...+...... .+....... ...+++.+.++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~--~~~~~~~~~~li~~~l~ 232 (323)
T cd05575 160 PEYLAPEVLRKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDTAEMYD----NILNKPLRL--KPNISVSARHLLEGLLQ 232 (323)
T ss_pred hhhcChhhhcCCCCCcc-ccccccchhhhhhhcCCCCCCCCCHHHHHH----HHHcCCCCC--CCCCCHHHHHHHHHHhh
Confidence 99999999988877655 999999999999999999998765433322 233333322 23579999999999999
Q ss_pred cCCCCCCCH----hHHhcCccccc
Q 019901 233 ADPAKRISI----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~----~ell~h~~~~~ 252 (334)
.+|.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 233 KDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred cCHHhCCCCCCCHHHHHcCCCcCC
Confidence 999999987 69999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=330.97 Aligned_cols=236 Identities=30% Similarity=0.517 Sum_probs=192.7
Q ss_pred cCCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCC
Q 019901 12 SYSSDLFVNIIIIVFHLW----QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 86 (334)
..++..| |+|++.+... ...+.+.+|+.+++.+ +||||+++++++..++.+++||||+.+|+|..++.+.+.++
T Consensus 25 ~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~ 103 (332)
T cd05614 25 HDTGKLY-AMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS 103 (332)
T ss_pred CCCCCEE-EEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence 3467788 9999986431 2235678899999999 58999999999999999999999999999999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccchhhccC
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~ 164 (334)
+..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+.
T Consensus 104 ~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~ 181 (332)
T cd05614 104 EDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGH--VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181 (332)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCC--EEEeeCcCCccccccCCCccccccCCccccCHHHhcCC
Confidence 9999999999999999999999999999999999987765 9999999987543222 22345799999999999876
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC-----
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----- 239 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~----- 239 (334)
...+.++|||||||++|+|++|+.||...............+......+ ...+++.++++|.+||+.+|.+||
T Consensus 182 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~R~~~~~~ 259 (332)
T cd05614 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPF--PSFIGPEAQDLLHKLLRKDPKKRLGAGPQ 259 (332)
T ss_pred CCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCC--CCCCCHHHHHHHHHHcCCCHHHcCCCCCC
Confidence 5445569999999999999999999975433222222223333333333 335799999999999999999999
Q ss_pred CHhHHhcCccccc
Q 019901 240 SIPEIRNHEWFLK 252 (334)
Q Consensus 240 s~~ell~h~~~~~ 252 (334)
+++++++||||..
T Consensus 260 ~~~~~l~h~~~~~ 272 (332)
T cd05614 260 GASEIKEHPFFKG 272 (332)
T ss_pred CHHHHHcCCCcCC
Confidence 7889999999975
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=327.99 Aligned_cols=241 Identities=35% Similarity=0.583 Sum_probs=197.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .+++..+++.| |||++.+... ...+....|..++.. .+||||+++++++..++.+|+||||+.||
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 3 LGKGSFGKVMLAELKGTNEFF-AIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 566665 47778888888 9999987542 122345567777664 48999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH--IKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCC--EEEccCcCCeECCCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987665 99999999975332 2233455799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+. .+......+| ..++.++.++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DvwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~ll~~~l~ 232 (316)
T cd05592 160 PDYIAPEILKGQKYNES-VDWWSFGVLLYEMLIGQSPFHGEDEDELFD----SILNDRPHFP--RWISKEAKDCLSKLFE 232 (316)
T ss_pred ccccCHHHHcCCCCCCc-ccchhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHcc
Confidence 99999999988877655 999999999999999999998766533332 2222222233 3478999999999999
Q ss_pred cCCCCCCCH-hHHhcCccccc
Q 019901 233 ADPAKRISI-PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~-~ell~h~~~~~ 252 (334)
.+|.+||++ .+++.||||..
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05592 233 RDPTKRLGVDGDIRQHPFFRG 253 (316)
T ss_pred CCHHHcCCChHHHHcCcccCC
Confidence 999999986 48889999964
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=341.63 Aligned_cols=245 Identities=25% Similarity=0.387 Sum_probs=191.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC--------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP--------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~ 69 (334)
||.|+| .+.+..++..| |||.+.... ....+|+.+++.++||||+++++++... ..+++||||
T Consensus 74 LG~G~fg~Vy~~~~~~~~~~v-AiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~ 148 (440)
T PTZ00036 74 IGNGSFGVVYEAICIDTSEKV-AIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEF 148 (440)
T ss_pred EEeCCCEEEEEEEECCCCCEE-EEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEec
Confidence 455544 37788889998 999886443 3456899999999999999999887532 247899999
Q ss_pred cCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 70 ASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 70 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
+.+ +|...+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++ ..+||+|||+|+.......
T Consensus 149 ~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~-~~vkL~DFGla~~~~~~~~ 226 (440)
T PTZ00036 149 IPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNT-HTLKLCDFGSAKNLLAGQR 226 (440)
T ss_pred CCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCC-CceeeeccccchhccCCCC
Confidence 964 6766654 345699999999999999999999999999999999999997544 2499999999986554444
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------------ccc
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYS 212 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~ 212 (334)
.....||+.|+|||++.+....+.++|||||||++|+|++|.+||.+......+...+...... ...
T Consensus 227 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~ 306 (440)
T PTZ00036 227 SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIK 306 (440)
T ss_pred cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhccc
Confidence 4566789999999998765433455999999999999999999998876655555443321110 001
Q ss_pred CCC----------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 213 IPD----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 213 ~~~----------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+|. +...++++.+||.+||..+|.+|||+.|+|+||||...
T Consensus 307 ~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~ 357 (440)
T PTZ00036 307 FPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357 (440)
T ss_pred CCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence 111 12367899999999999999999999999999999753
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=318.81 Aligned_cols=241 Identities=36% Similarity=0.594 Sum_probs=211.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++.+.+|+.| |+|++++...... .....|-++|+..+||.+..+...|++..++|+||||..||.
T Consensus 176 LGkGTFGKVIL~rEKat~k~Y-AiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGe 254 (516)
T KOG0690|consen 176 LGKGTFGKVILCREKATGKLY-AIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGE 254 (516)
T ss_pred hcCCccceEEEEeecccCcee-ehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCce
Confidence 687877 79999999999 9999999874333 455678899999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|+..+.+...|++..++.+...|+.||.|||+++||+||||.+|.|++.+|. +||+|||+++..... ....+.||||
T Consensus 255 Lf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGH--IKitDFGLCKE~I~~g~t~kTFCGTP 332 (516)
T KOG0690|consen 255 LFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGH--IKITDFGLCKEEIKYGDTTKTFCGTP 332 (516)
T ss_pred EeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCc--eEeeecccchhcccccceeccccCCh
Confidence 9999999999999999999999999999999999999999999999998876 999999999865444 4456789999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|.|||++....|. +++|+|.+|+++|||++|+.||.+.+.... ..-++.....+|. .++++++.|+..+|.+
T Consensus 333 EYLAPEVleDnDYg-raVDWWG~GVVMYEMmCGRLPFyn~dh~kL----FeLIl~ed~kFPr--~ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 333 EYLAPEVLEDNDYG-RAVDWWGVGVVMYEMMCGRLPFYNKDHEKL----FELILMEDLKFPR--TLSPEAKTLLSGLLKK 405 (516)
T ss_pred hhcCchhhcccccc-ceeehhhhhHHHHHHHhccCcccccchhHH----HHHHHhhhccCCc--cCCHHHHHHHHHHhhc
Confidence 99999999998885 559999999999999999999998765433 3334555556665 5899999999999999
Q ss_pred CCCCCC-----CHhHHhcCccccc
Q 019901 234 DPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~-----s~~ell~h~~~~~ 252 (334)
+|.+|. .+.|+..|+||..
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhcc
Confidence 999998 4899999999964
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=336.65 Aligned_cols=244 Identities=27% Similarity=0.461 Sum_probs=199.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.| |||++.+... .....+.+|+.++..++||||+++++.+.+++.+|+||||++||+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~ 87 (360)
T cd05627 9 IGRGAFGEVRLVQKKDTGHIY-AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGD 87 (360)
T ss_pred EeeCCCEEEEEEEECCCCCEE-EEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCcc
Confidence 455544 47788899999 9999986431 234578889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------- 144 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------- 144 (334)
|.+++.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 88 L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~--vkL~DfG~~~~~~~~~~~~~~~~~~~ 165 (360)
T cd05627 88 MMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGH--VKLSDFGLCTGLKKAHRTEFYRNLTH 165 (360)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCC--EEEeeccCCccccccccccccccccc
Confidence 9999998888999999999999999999999999999999999999987665 9999999986432110
Q ss_pred --------------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH
Q 019901 145 --------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 198 (334)
Q Consensus 145 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 198 (334)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|++||...+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvilyel~tG~~Pf~~~~~~~~ 244 (360)
T cd05627 166 NPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETPQET 244 (360)
T ss_pred CCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCc-ceeccccceeeecccCCCCCCCCCHHHH
Confidence 0123479999999999988888655 9999999999999999999987665443
Q ss_pred HHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 019901 199 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~---s~~ell~h~~~~~ 252 (334)
....... .....+|....++++++++|.+|+ .+|.+|+ +++++++||||..
T Consensus 245 ~~~i~~~--~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~ 298 (360)
T cd05627 245 YRKVMNW--KETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEG 298 (360)
T ss_pred HHHHHcC--CCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCC
Confidence 3332211 122334444457999999999987 4999998 4799999999965
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=335.20 Aligned_cols=245 Identities=29% Similarity=0.440 Sum_probs=198.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.+ |+|++.+... .....+.+|+.+++.++||||+++++++.+++.+|+||||+.+|+
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (370)
T cd05621 51 IGRGAFGEVQLVRHKSSQKVY-AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGD 129 (370)
T ss_pred EEecCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCc
Confidence 455554 47888889998 9999976431 223467889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt 152 (334)
|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... ..+.+||
T Consensus 130 L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~gt 206 (370)
T cd05621 130 LVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGH--LKLADFGTCMKMDETGMVRCDTAVGT 206 (370)
T ss_pred HHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEEecccceecccCCceecccCCCC
Confidence 99988654 6899999999999999999999999999999999999987665 99999999976433222 2356799
Q ss_pred CccccchhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 153 PAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 153 ~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
+.|+|||++.+.. +.+.++|||||||++|+|++|+.||...+....+..+... .....+|....++..+++++.+
T Consensus 207 ~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~s~~~~~li~~ 284 (370)
T cd05621 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--KNSLNFPEDVEISKHAKNLICA 284 (370)
T ss_pred cccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CcccCCCCcccCCHHHHHHHHH
Confidence 9999999997643 2345599999999999999999999876654433332211 1223455555689999999999
Q ss_pred hcccCCCC--CCCHhHHhcCccccc
Q 019901 230 IFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
||..++.+ |+|++++++||||+.
T Consensus 285 ~L~~~~~r~~R~~~~e~l~hp~~~~ 309 (370)
T cd05621 285 FLTDREVRLGRNGVEEIKQHPFFKN 309 (370)
T ss_pred HccCchhccCCCCHHHHhcCcccCC
Confidence 99865543 889999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=326.32 Aligned_cols=241 Identities=32% Similarity=0.557 Sum_probs=197.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .+++..++..| |||++.+... ........|..+++. ++||||+++++++.+.+.+|+||||+.+|
T Consensus 3 lG~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 3 LGKGSFGKVFLAELKGTNQFF-AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 555555 47778888888 9999987532 223456677777775 58999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
+|...+.+...+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 82 DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGH--IKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCC--EEEccCCcceECCCCCCceeeecCC
Confidence 99999988888999999999999999999999999999999999999987765 999999998753222 223445799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|..||.+........ .+.......|. .++.+++++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~~~--~~~~~~~~li~~~l~ 232 (316)
T cd05619 160 PDYIAPEILLGQKYNTS-VDWWSFGVLLYEMLIGQSPFHGHDEEELFQ----SIRMDNPCYPR--WLTREAKDILVKLFV 232 (316)
T ss_pred ccccCHHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCCc--cCCHHHHHHHHHHhc
Confidence 99999999988877655 999999999999999999998765433222 22222223332 478999999999999
Q ss_pred cCCCCCCCHh-HHhcCccccc
Q 019901 233 ADPAKRISIP-EIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~-ell~h~~~~~ 252 (334)
.+|.+||++. +++.||||..
T Consensus 233 ~~P~~R~~~~~~l~~h~~~~~ 253 (316)
T cd05619 233 REPERRLGVKGDIRQHPFFRE 253 (316)
T ss_pred cCHhhcCCChHHHHcCcccCC
Confidence 9999999996 8999999965
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=328.17 Aligned_cols=241 Identities=26% Similarity=0.393 Sum_probs=189.2
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCChHHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERIC 80 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~ 80 (334)
.++++.+|..| |||.+..... .....+.+|+.+++.++||||+++++++... ..+|+||||| +++|.+.+.
T Consensus 18 ~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~ 95 (338)
T cd07859 18 SAIDTHTGEKV-AIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIK 95 (338)
T ss_pred EEEECCCCCEE-EEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHH
Confidence 47888899999 9999875431 2234688999999999999999999988643 3589999999 468999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccc
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYI 156 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~ 156 (334)
+...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....||+.|+
T Consensus 96 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~ 173 (338)
T cd07859 96 ANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCK--LKICDFGLARVAFNDTPTAIFWTDYVATRWYR 173 (338)
T ss_pred hcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEccCccccccccccCccccccCCCCCCCcC
Confidence 8888999999999999999999999999999999999999987665 99999999875432221 13457999999
Q ss_pred cchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------H---hhcccc
Q 019901 157 APEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------I---LSVQYS 212 (334)
Q Consensus 157 aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~---~~~~~~ 212 (334)
|||++.+ ..++ .++|||||||++|+|++|++||.+............. . ......
T Consensus 174 aPE~~~~~~~~~~-~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 252 (338)
T cd07859 174 APELCGSFFSKYT-PAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQP 252 (338)
T ss_pred CHHHHhccccccC-chhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCC
Confidence 9999865 4454 4499999999999999999999775543222111000 0 000000
Q ss_pred C---CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 213 I---PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 213 ~---~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
. .....+++.+.++|.+||+.+|.+|||++++++||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 253 VPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred CchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 0 1123468899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.18 Aligned_cols=244 Identities=27% Similarity=0.463 Sum_probs=199.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .++++.+|+.| |||++.+... .....+.+|+.+++.++||||+++++++...+..|+||||+++++
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (330)
T cd05601 9 VGRGHFGEVQVVREKATGDIY-AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87 (330)
T ss_pred EEeccCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCC
Confidence 444444 47888899999 9999987642 234568889999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|.+++.+. +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....|
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~~g 165 (330)
T cd05601 88 LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGH--IKLADFGSAARLTANKMVNSKLPVG 165 (330)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCC--EEeccCCCCeECCCCCceeeecccC
Confidence 99999876 67999999999999999999999999999999999999987665 99999999975433222 233469
Q ss_pred CCccccchhhcc------CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 152 TPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 152 t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
|+.|+|||++.. ..++ .++|||||||++|+|++|+.||........+...... .....+|....+++++.+
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~ 242 (330)
T cd05601 166 TPDYIAPEVLTTMNGDGKGTYG-VECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNF--QRFLKFPEDPKVSSDFLD 242 (330)
T ss_pred CccccCHHHhccccccccCCCC-CcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcC--CCccCCCCCCCCCHHHHH
Confidence 999999999863 3343 4599999999999999999999876654433332211 112234555568999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||.+||. +|.+|||++++++||||..
T Consensus 243 li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 243 LIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred HHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999998 9999999999999999965
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-45 Score=329.99 Aligned_cols=241 Identities=27% Similarity=0.496 Sum_probs=197.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHH-HHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .++++.+|+.+ |||++.+... .....+.+|.. +++.++||||+++++.+...+..|+||||+.+|
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 3 IGKGSFGKVLLAKRKLDGKCY-AVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 566665 47888899999 9999986531 12234555554 567899999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 82 ELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGH--VVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEEeecCCcccCCCCCCCcccccCC
Confidence 99999988888999999999999999999999999999999999999987765 99999999875322 2233455799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|..||...+....+.. +....... ....+..+.++|.+||.
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DvwslG~il~el~~G~~pf~~~~~~~~~~~----~~~~~~~~--~~~~~~~~~~ll~~ll~ 232 (325)
T cd05604 160 PEYLAPEVIRKQPYDNT-VDWWCLGAVLYEMLYGLPPFYCRDVAEMYDN----ILHKPLVL--RPGASLTAWSILEELLE 232 (325)
T ss_pred hhhCCHHHHcCCCCCCc-CccccccceehhhhcCCCCCCCCCHHHHHHH----HHcCCccC--CCCCCHHHHHHHHHHhc
Confidence 99999999988887655 9999999999999999999987655433333 22222222 23578999999999999
Q ss_pred cCCCCCCCH----hHHhcCccccc
Q 019901 233 ADPAKRISI----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~----~ell~h~~~~~ 252 (334)
.+|.+||++ .++++||||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 233 KDRQRRLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCHHhcCCCCCCHHHHhcCCCcCC
Confidence 999999976 58999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=333.78 Aligned_cols=240 Identities=18% Similarity=0.231 Sum_probs=189.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ ++++..+++.| |||... ...+.+|+.+++.++||||++++++|..+...++|+|++. ++|..
T Consensus 100 lg~G~~g~V~~~~d~~~~~~v-aiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~ 171 (391)
T PHA03212 100 FTPGAEGFAFACIDNKTCEHV-VIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYC 171 (391)
T ss_pred EcCCCCeEEEEEEECCCCCEE-EEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHH
Confidence 455554 48889999999 999743 3457899999999999999999999999999999999994 68999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC--CCCCCccCCCcc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y 155 (334)
++.....+++..++.++.||+.||.|||++||+||||||+|||++..+. +||+|||+|+..... ......+||+.|
T Consensus 172 ~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~gt~~y 249 (391)
T PHA03212 172 YLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGD--VCLGDFGAACFPVDINANKYYGWAGTIAT 249 (391)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCC--EEEEeCCcccccccccccccccccCccCC
Confidence 9888888999999999999999999999999999999999999987665 999999998643221 222345799999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHHh---------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRIL--------------------- 207 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~--------------------- 207 (334)
+|||++.+..++.+ +|||||||++|+|++|+.||..... ...+...+....
T Consensus 250 ~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~ 328 (391)
T PHA03212 250 NAPELLARDPYGPA-VDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGL 328 (391)
T ss_pred CChhhhcCCCCCcH-HHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHH
Confidence 99999988777655 9999999999999999988753221 111111111100
Q ss_pred -hcccc----CCC---CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 208 -SVQYS----IPD---YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 208 -~~~~~----~~~---~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
..... .+. ...++.++.+||.+||+.||.+|||++|+|+||||..
T Consensus 329 ~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~ 381 (391)
T PHA03212 329 AKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQD 381 (391)
T ss_pred HhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhcc
Confidence 00000 010 1135678999999999999999999999999999965
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=328.34 Aligned_cols=245 Identities=27% Similarity=0.486 Sum_probs=199.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| ++++..++..| |+|++.+.... ..+.+.+|+.++..+ +||||+++++++...+.+|+||||+.++
T Consensus 3 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 3 IGRGSYAKVLLVRLKKNDQIY-AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 566655 47788888888 99999876422 234577899998888 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 82 DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGH--IKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCC--EEEeccccceeccCCCCceecccCC
Confidence 99999988888999999999999999999999999999999999999987765 99999999875322 2233456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... .........+......+| ..++..+.++|.+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p--~~~~~~~~~li~~ 236 (327)
T cd05617 160 PNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP--RFLSVKASHVLKG 236 (327)
T ss_pred cccCCHHHHCCCCCCch-heeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC--CCCCHHHHHHHHH
Confidence 99999999988877655 99999999999999999999643211 111112222333333333 3578999999999
Q ss_pred hcccCCCCCCC------HhHHhcCccccc
Q 019901 230 IFVADPAKRIS------IPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~s------~~ell~h~~~~~ 252 (334)
||+.+|.+|++ ++++++||||..
T Consensus 237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~ 265 (327)
T cd05617 237 FLNKDPKERLGCQPQTGFSDIKSHTFFRS 265 (327)
T ss_pred HhccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence 99999999998 569999999965
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=318.81 Aligned_cols=245 Identities=24% Similarity=0.368 Sum_probs=196.2
Q ss_pred Cccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 3 GFHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 3 G~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
|||.+ +++++.+|+.| |+|.+...... ....+..|+.+++.++||||+++++++..+...|+||||+.|++|...
T Consensus 5 ~~g~Vy~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~ 83 (277)
T cd05607 5 GFGEVCAVQVKNTGKMY-ACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYH 83 (277)
T ss_pred CceEEEEEEEccCCcEE-EEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHH
Confidence 34444 36788889999 99999764421 234566799999999999999999999999999999999999999888
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
+...+ .+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||++.............|++.|+
T Consensus 84 ~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~ 161 (277)
T cd05607 84 IYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGN--CRLSDLGLAVELKDGKTITQRAGTNGYM 161 (277)
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCC--EEEeeceeeeecCCCceeeccCCCCCcc
Confidence 76543 4889999999999999999999999999999999999987664 9999999987654433334457899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|||||||++|+|++|+.||.......................+ ...++++++++|.+||+++|.
T Consensus 162 aPE~~~~~~~~~~-~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~ 239 (277)
T cd05607 162 APEILKEEPYSYP-VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPE 239 (277)
T ss_pred CHHHHccCCCCCc-hhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHh
Confidence 9999988876655 99999999999999999999765432222222233322222221 235799999999999999999
Q ss_pred CCCCH----hHHhcCccccc
Q 019901 237 KRISI----PEIRNHEWFLK 252 (334)
Q Consensus 237 ~R~s~----~ell~h~~~~~ 252 (334)
+||++ ++++.||||+.
T Consensus 240 ~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 240 DRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred hCCCCccchhhhhcChhhcC
Confidence 99999 66889999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.28 Aligned_cols=249 Identities=28% Similarity=0.459 Sum_probs=205.3
Q ss_pred CCCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC--C---eEEEEEeccC
Q 019901 1 MLGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP--T---HLAIVMEYAS 71 (334)
Q Consensus 1 ~lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~---~~~lv~e~~~ 71 (334)
++|.|+| + ++...+++.+ |||.+..+. +---+|+.+|+.++|||||++.-+|... + .+.+||||++
T Consensus 31 liG~GsFg~Vyq~~~~e~~~~v-AIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP 105 (364)
T KOG0658|consen 31 LIGSGSFGVVYQAKLRETEEEV-AIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP 105 (364)
T ss_pred EEeecccceEEEEEEcCCCcee-EEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence 3577776 3 6667778888 999986554 3335799999999999999999888643 2 4679999995
Q ss_pred CCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC
Q 019901 72 GGELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147 (334)
Q Consensus 72 ~~~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~ 147 (334)
-+|...++. +.+++...++-+.+||++||.|||+.||+||||||+|+|+|... +.+||||||.|+....+....
T Consensus 106 -~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~t-g~LKicDFGSAK~L~~~epni 183 (364)
T KOG0658|consen 106 -ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDT-GVLKICDFGSAKVLVKGEPNI 183 (364)
T ss_pred -HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCC-CeEEeccCCcceeeccCCCce
Confidence 589888874 56799999999999999999999999999999999999998653 469999999999888888878
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc----------c---ccCC
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------Q---YSIP 214 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~---~~~~ 214 (334)
+...|..|+|||.+.+...++.+.||||.||++.||+-|++.|.+.+...++..+++-.... . ..+|
T Consensus 184 SYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p 263 (364)
T KOG0658|consen 184 SYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFP 263 (364)
T ss_pred eEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCc
Confidence 88899999999999987766676999999999999999999999988877777666432111 1 1111
Q ss_pred C----------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCC
Q 019901 215 D----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 215 ~----------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~~ 256 (334)
. ....++++.+|+.++|..+|.+|.++.|++.||||......
T Consensus 264 ~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 264 QIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred ccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1 23568999999999999999999999999999999775433
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=330.15 Aligned_cols=241 Identities=31% Similarity=0.560 Sum_probs=199.0
Q ss_pred CCccee---e-eee---cCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---Y-DRC---SYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~---~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| + +++ ..+|..| |+|++.+.... ....+.+|+.++++++||||+++++++..++.+|+||||+.+
T Consensus 4 lg~G~~g~Vy~~~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~ 82 (318)
T cd05582 4 LGQGSFGKVFLVRKITGPDAGQLY-AMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRG 82 (318)
T ss_pred eeeCCCEEEEEEEEeccCCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCC
Confidence 555555 3 333 4577888 99999875422 234577899999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~g 151 (334)
++|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......|
T Consensus 83 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 83 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCc--EEEeeccCCcccCCCCCceecccC
Confidence 999999988888999999999999999999999999999999999999987665 999999998754333 22334579
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.......... .+.......| ..+++.+.++|.+||
T Consensus 161 ~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~tg~~p~~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~l 233 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMT----MILKAKLGMP--QFLSPEAQSLLRALF 233 (318)
T ss_pred ChhhcCHHHHcCCCCCCc-cceeccceEeeeeccCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHh
Confidence 999999999988777555 999999999999999999998765533332 2333333333 347899999999999
Q ss_pred ccCCCCCCC-----HhHHhcCccccc
Q 019901 232 VADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s-----~~ell~h~~~~~ 252 (334)
+.+|.+||| +.+++.||||..
T Consensus 234 ~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 234 KRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred hcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999999999 677999999965
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.38 Aligned_cols=241 Identities=32% Similarity=0.536 Sum_probs=198.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCC-CcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ ++++..+++.| |||++.+... ...+.+..|+.+++.+.|+ +|+++++++...+.+|+||||+.+|
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (324)
T cd05587 8 LGKGSFGKVMLAERKGTDELY-AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (324)
T ss_pred EeeccCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCC
Confidence 455555 47788888888 9999987542 2235677899999999764 6888999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~gt 164 (324)
T cd05587 87 DLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH--IKIADFGMCKENIFGGKTTRTFCGT 164 (324)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC--EEEeecCcceecCCCCCceeeecCC
Confidence 99999988888999999999999999999999999999999999999987665 99999999874322 2223345799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+. .+......+| ..+++++.+++.+||.
T Consensus 165 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~li~~~l~ 237 (324)
T cd05587 165 PDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYP--KSLSKEAVSICKGLLT 237 (324)
T ss_pred ccccChhhhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCC--CCCCHHHHHHHHHHhh
Confidence 99999999988877655 899999999999999999998766533332 2333333333 3579999999999999
Q ss_pred cCCCCCCCH-----hHHhcCccccc
Q 019901 233 ADPAKRISI-----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~-----~ell~h~~~~~ 252 (334)
++|.+|++. +++++||||..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 999999986 89999999965
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=327.54 Aligned_cols=241 Identities=31% Similarity=0.541 Sum_probs=196.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHH-HHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei-~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| ++++..+++.| |+|++.+... .....+.+|. .+++.++||||+++++++...+.+|+||||+.++
T Consensus 3 lg~G~fg~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 3 IGKGSFGKVLLARHKAEEKFY-AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeCCCeEEEEEEECCCCCEE-EEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 566655 47788888888 9999986541 1223444444 4568899999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|...+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~--~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCC--EEEccCCCCcccccCCCCcccccCC
Confidence 99999988888999999999999999999999999999999999999987664 99999999875332 2233455799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+.. +...... ....+++.+.++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~----i~~~~~~--~~~~~~~~~~~li~~~l~ 232 (325)
T cd05602 160 PEYLAPEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN----ILNKPLQ--LKPNITNSARHLLEGLLQ 232 (325)
T ss_pred ccccCHHHHcCCCCCCc-cccccccHHHHHHhcCCCCCCCCCHHHHHHH----HHhCCcC--CCCCCCHHHHHHHHHHcc
Confidence 99999999988877655 9999999999999999999987665433333 2222222 223579999999999999
Q ss_pred cCCCCCCCHh----HHhcCccccc
Q 019901 233 ADPAKRISIP----EIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~----ell~h~~~~~ 252 (334)
.+|.+|+++. ++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 233 KDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred cCHHHCCCCCCCHHHHhcCcccCC
Confidence 9999999876 8999999954
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=330.64 Aligned_cols=243 Identities=30% Similarity=0.481 Sum_probs=196.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcC---CCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSL---RHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .++++.+|..| |||++.+...... .....|..++..+ +||||+++++++...+.+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~ 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIY-AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEE-EEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC
Confidence 455544 47888899998 9999976542221 2344566666554 69999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCcc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTV 150 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~ 150 (334)
+|+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.... .......+
T Consensus 80 ~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 80 GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGH--IALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEecCCcCcCCCCCCCCccCcc
Confidence 9999999988888999999999999999999999999999999999999987665 99999999875332 22234567
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
||+.|+|||++.+....+.++|||||||++|+|++|+.||.+...... ...+......++.. .+++++++||.+|
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~-~~~~~~~~li~~~ 232 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQM----YRNIAFGKVRFPKN-VLSDEGRQFVKGL 232 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHH----HHHHHcCCCCCCCc-cCCHHHHHHHHHH
Confidence 999999999987655334559999999999999999999987654322 23333333344432 4789999999999
Q ss_pred cccCCCCCC----CHhHHhcCccccc
Q 019901 231 FVADPAKRI----SIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~----s~~ell~h~~~~~ 252 (334)
|+.+|.+|| ++.++++||||..
T Consensus 233 L~~~P~~R~~~~~~~~~ll~h~~~~~ 258 (330)
T cd05586 233 LNRNPQHRLGAHRDAVELKEHPFFAD 258 (330)
T ss_pred cCCCHHHCCCCCCCHHHHhcCccccC
Confidence 999999998 6899999999965
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=327.05 Aligned_cols=240 Identities=32% Similarity=0.536 Sum_probs=195.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHH---HcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l---~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|++ .+.+..+|+.| |||++.+... ...+.+.+|+.++ +.++||||+++++++...+..|+||||+.
T Consensus 7 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~ 85 (324)
T cd05589 7 LGRGHFGKVLLAEYKKTGELY-AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAA 85 (324)
T ss_pred EeecCCEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCC
Confidence 455554 47788889998 9999986541 2234567776655 56789999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCcc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV 150 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~ 150 (334)
+++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+++..... ......+
T Consensus 86 ~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~ 162 (324)
T cd05589 86 GGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF--VKIADFGLCKEGMGFGDRTSTFC 162 (324)
T ss_pred CCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCc--EEeCcccCCccCCCCCCcccccc
Confidence 9999888754 56999999999999999999999999999999999999987765 999999998753322 2234567
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
|++.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+...... .+.......| ..+++.+.++|.+|
T Consensus 163 g~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~G~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~ 235 (324)
T cd05589 163 GTPEFLAPEVLTETSYTRA-VDWWGLGVLIYEMLVGESPFPGDDEEEVFD----SIVNDEVRYP--RFLSREAISIMRRL 235 (324)
T ss_pred cCccccCHhHhcCCCCCcc-cchhhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHHHHHH
Confidence 9999999999988777655 999999999999999999998766543332 2333333333 35799999999999
Q ss_pred cccCCCCCC-----CHhHHhcCccccc
Q 019901 231 FVADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
|+.+|.+|| ++.++++||||..
T Consensus 236 L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 236 LRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred hhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 999999999 6899999999965
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=318.84 Aligned_cols=243 Identities=23% Similarity=0.353 Sum_probs=198.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+.+..++..| |||++..... .....+.+|+.+++.++||||+++++.+..++.+++||||+.+++|...+
T Consensus 13 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 91 (285)
T cd05605 13 FGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 91 (285)
T ss_pred CeEEEEEEEcCCCceE-EEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHH
Confidence 3444 36777888888 9999976542 22345778999999999999999999999999999999999999999887
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++............|++.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~y~a 169 (285)
T cd05605 92 YNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGH--IRISDLGLAVEIPEGETIRGRVGTVGYMA 169 (285)
T ss_pred HhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCC--EEEeeCCCceecCCCCccccccCCCCccC
Confidence 653 45999999999999999999999999999999999999987654 99999999876543333345578999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +||||+||++|+|++|+.||.+.............+....... +..+++.+.+||.+||..||.+
T Consensus 170 PE~~~~~~~~~~-~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~ 246 (285)
T cd05605 170 PEVVKNERYTFS-PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSICRQLLTKDPGF 246 (285)
T ss_pred cHHhcCCCCCcc-ccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHHHHHHccCCHHH
Confidence 999988777655 8999999999999999999987654333333322222222222 2347999999999999999999
Q ss_pred CC-----CHhHHhcCccccc
Q 019901 238 RI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 238 R~-----s~~ell~h~~~~~ 252 (334)
|| ++++++.||||..
T Consensus 247 R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 247 RLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred hcCCCCCCHHHHhcCcCccC
Confidence 99 8999999999964
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=318.40 Aligned_cols=245 Identities=27% Similarity=0.376 Sum_probs=190.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC---CCCCcccceEEEE-----cCCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL---RHPNIVRFKEVIL-----TPTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~-----~~~~~~lv~ 67 (334)
||.|++ .+++..++...||||.+..... .......+|+.+++.+ +||||+++++++. ....+++||
T Consensus 9 lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~ 88 (290)
T cd07862 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVF 88 (290)
T ss_pred eccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEE
Confidence 455554 3666555444349999876542 2234566788777665 6999999999885 245689999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 68 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 68 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
||+. ++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 89 e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~ 165 (290)
T cd07862 89 EHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMA 165 (290)
T ss_pred ccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCC--EEEccccceEeccCCcc
Confidence 9996 6898888754 34899999999999999999999999999999999999987665 99999999976544444
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccCC----------
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIP---------- 214 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~---------- 214 (334)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+..+........ ...+
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T cd07862 166 LTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAF 244 (290)
T ss_pred cccccccccccChHHHhCCCCCCc-cchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhc
Confidence 455679999999999988777655 9999999999999999999998776555554443211000 0000
Q ss_pred ----------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 215 ----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 215 ----------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
....+++.+++++.+||+.+|++|||+.++|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 245 HSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-45 Score=335.34 Aligned_cols=246 Identities=40% Similarity=0.644 Sum_probs=221.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc--cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI--DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~--~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.| ++++..+|..| |||++.+..... ...+.+|+++++.++|||||+++.+.+++..+|+||||+.+|.+
T Consensus 64 ig~g~f~~V~La~~~~t~~~V-aiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~ 142 (596)
T KOG0586|consen 64 IGKGNFAKVKLARHILTGTEV-AIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGEL 142 (596)
T ss_pred eccceeEEEEeeEecCCCceE-EEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchh
Confidence 677777 69999999999 999999987433 35689999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
++++.+.++..+..++.++.|+++|++|||+++|||||||++|||++.+.+ +||+|||++..........+.||+|.|
T Consensus 143 ~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mn--ikIaDfgfS~~~~~~~~lqt~cgsppy 220 (596)
T KOG0586|consen 143 FDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMN--IKIADFGFSTFFDYGLMLQTFCGSPPY 220 (596)
T ss_pred HHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccc--eeeeccccceeecccccccccCCCCCc
Confidence 999999999999999999999999999999999999999999999987765 999999999988888888999999999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
.|||++.+..|+.+.+|+||+|+++|-|+.|..||.+.+-. ..-.+.+...+.+|.+ ++.++.++|+++|.++|
T Consensus 221 AaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk----~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lvl~P 294 (596)
T KOG0586|consen 221 AAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLK----ELRPRVLRGKYRIPFY--MSCDCEDLLRKFLVLNP 294 (596)
T ss_pred cChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccc----cccchheeeeecccce--eechhHHHHHHhhccCc
Confidence 99999999999999999999999999999999999986542 2223345566666664 79999999999999999
Q ss_pred CCCCCHhHHhcCccccccCCC
Q 019901 236 AKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~~~ 256 (334)
.+|++.+++..|.|.......
T Consensus 295 skr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 295 SKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred cccCCHHHhhhhcccchhhhh
Confidence 999999999999999765544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=326.17 Aligned_cols=246 Identities=24% Similarity=0.370 Sum_probs=192.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~ 69 (334)
||.|+| .+.+..+|..| |||++..... .....+.+|+.+++.++||||+++++++...+ .+|+||||
T Consensus 29 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 107 (359)
T cd07876 29 IGSGAQGIVCAAFDTVLGINV-AVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107 (359)
T ss_pred eecCCCEEEEEEEEcCCCcee-EEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeC
Confidence 455555 47788889998 9999976531 23457789999999999999999999986543 57999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 108 ~~~-~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~ 182 (359)
T cd07876 108 MDA-NLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTACTNFMMTPY 182 (359)
T ss_pred CCc-CHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEecCCCccccccCccCCCC
Confidence 965 56666543 4889999999999999999999999999999999999987765 999999999765444444556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH------------------hhccc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI------------------LSVQY 211 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------------------~~~~~ 211 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+....... .....
T Consensus 183 ~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (359)
T cd07876 183 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRP 261 (359)
T ss_pred cccCCCCCchhccCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCC
Confidence 78999999999988888766 999999999999999999998765433332222110 00000
Q ss_pred cC---------C---------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 212 SI---------P---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 212 ~~---------~---------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.. + .....++.+++||.+||+.||++|||+.|+|+||||....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 262 QYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred CCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00 0 0112467899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=323.60 Aligned_cols=246 Identities=26% Similarity=0.421 Sum_probs=196.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ ++.+..++..+ |+|++..... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|.
T Consensus 13 lg~g~~g~V~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (333)
T cd06650 13 LGAGNGGVVFKVSHKPSGLIM-ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 91 (333)
T ss_pred ccCCCCEEEEEEEECCCCcEE-EEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHH
Confidence 455554 47788888888 9999876531 23457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+++.+.+.+++..+..++.|++.||.|||++ +|+||||||+|||++.++. +||+|||++..... .......|++.|
T Consensus 92 ~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~~~~~~~-~~~~~~~~~~~y 168 (333)
T cd06650 92 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSY 168 (333)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCC--EEEeeCCcchhhhh-hccccCCCCccc
Confidence 9999888899999999999999999999985 7999999999999987665 99999999875422 222345789999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHH--------------------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-------------------------------- 203 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-------------------------------- 203 (334)
+|||++.+..++.+ +|+|||||++|+|++|+.||....... .....
T Consensus 169 ~aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (333)
T cd06650 169 MSPERLQGTHYSVQ-SDIWSMGLSLVEMAIGRYPIPPPDAKE-LELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSR 246 (333)
T ss_pred cCHHHhcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcchhH-HHHHhcCcccCCccccccCcccCCccchhhhhccccc
Confidence 99999988777655 999999999999999999997543311 11100
Q ss_pred ---------HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 204 ---------HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 204 ---------~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..+............++.++++||.+||++||.+|||+.+++.||||+..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 305 (333)
T cd06650 247 PPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 305 (333)
T ss_pred ccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence 00000000000011357889999999999999999999999999999754
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=325.08 Aligned_cols=241 Identities=30% Similarity=0.510 Sum_probs=196.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHH-HHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+++..+|..| |||++.+... .....+.+|+. +++.++||||+++++++.+.+..|+||||+.++
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 3 IGKGSFGKVLLAKRKSDGSFY-AVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 566655 47888889998 9999986542 12234555554 678899999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|...+.+...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGH--VVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCC--EEEccCCCCccCCCCCCccccccCC
Confidence 99999988888999999999999999999999999999999999999987765 99999999875322 2233445799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|..||...+..... ..+......+| ...+..+.++|.+||+
T Consensus 160 ~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~----~~i~~~~~~~~--~~~~~~~~~li~~~l~ 232 (321)
T cd05603 160 PEYLAPEVLRKEPYDRT-VDWWCLGAVLYEMLYGLPPFYSRDVSQMY----DNILHKPLQLP--GGKTVAACDLLVGLLH 232 (321)
T ss_pred cccCCHHHhcCCCCCCc-CcccccchhhhhhhcCCCCCCCCCHHHHH----HHHhcCCCCCC--CCCCHHHHHHHHHHcc
Confidence 99999999988777655 99999999999999999999876543322 22333333333 3568999999999999
Q ss_pred cCCCCCCCH----hHHhcCccccc
Q 019901 233 ADPAKRISI----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~----~ell~h~~~~~ 252 (334)
.+|.+||++ .++++|+||..
T Consensus 233 ~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 233 KDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCHhhcCCCCCCHHHHhCCCCcCC
Confidence 999999975 59999999964
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-44 Score=325.91 Aligned_cols=244 Identities=27% Similarity=0.426 Sum_probs=192.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+++.| |||++..... .....+.+|+.+++.++||||+++++++..++.+++||||+.+++|.
T Consensus 82 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 160 (353)
T PLN00034 82 IGSGAGGTVYKVIHRPTGRLY-ALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE 160 (353)
T ss_pred ccCCCCeEEEEEEECCCCCEE-EEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccc
Confidence 555555 47778889998 9999976541 23467889999999999999999999999999999999999999985
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y 155 (334)
.. ...++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|
T Consensus 161 ~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt~~y 234 (353)
T PLN00034 161 GT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKN--VKIADFGVSRILAQTMDPCNSSVGTIAY 234 (353)
T ss_pred cc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEcccccceecccccccccccccCccc
Confidence 43 34578889999999999999999999999999999999987664 9999999987543322 22345799999
Q ss_pred ccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 156 IAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 156 ~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+|||++.. ..+.+.++|||||||++|+|++|+.||....... +......+. ..........++.++++||.+||
T Consensus 235 ~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 312 (353)
T PLN00034 235 MSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAIC-MSQPPEAPATASREFRHFISCCL 312 (353)
T ss_pred cCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHh-ccCCCCCCCccCHHHHHHHHHHc
Confidence 99998743 2334456999999999999999999997433221 122222221 11122223457899999999999
Q ss_pred ccCCCCCCCHhHHhcCccccccC
Q 019901 232 VADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..+|.+|||+.|+++||||.+..
T Consensus 313 ~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 313 QREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred cCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999998754
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=330.35 Aligned_cols=245 Identities=30% Similarity=0.450 Sum_probs=197.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.+ |+|++.+... .....+.+|+.+++.++||||+++++++..++.+|+||||+.||+
T Consensus 51 lG~G~fg~Vy~~~~~~~~~~~-aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~ 129 (371)
T cd05622 51 IGRGAFGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGD 129 (371)
T ss_pred EeecCCeEEEEEEECCCCcEE-EEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCc
Confidence 455554 47888899999 9999976431 223457789999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt 152 (334)
|..++... .+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||
T Consensus 130 L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~--ikL~DfG~a~~~~~~~~~~~~~~~gt 206 (371)
T cd05622 130 LVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGT 206 (371)
T ss_pred HHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCC--EEEEeCCceeEcCcCCcccccCcccC
Confidence 99988654 5899999999999999999999999999999999999987665 9999999997543322 22356799
Q ss_pred CccccchhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 153 PAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 153 ~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...+....+..+... .....+|....++..++++|.+
T Consensus 207 ~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~~~~li~~ 284 (371)
T cd05622 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--KNSLTFPDDNDISKEAKNLICA 284 (371)
T ss_pred ccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CCcccCCCcCCCCHHHHHHHHH
Confidence 9999999987543 2345599999999999999999999876654333332211 1223455556789999999999
Q ss_pred hcccCCCC--CCCHhHHhcCccccc
Q 019901 230 IFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
||..++.+ |++++++++||||.+
T Consensus 285 ~L~~~~~r~~r~~~~ei~~h~~~~~ 309 (371)
T cd05622 285 FLTDREVRLGRNGVEEIKRHLFFKN 309 (371)
T ss_pred HcCChhhhcCCCCHHHHhcCcccCC
Confidence 99854443 789999999999965
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=333.71 Aligned_cols=242 Identities=26% Similarity=0.367 Sum_probs=203.8
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN- 81 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 81 (334)
||.++ |+++.++-.. |-|++....-+.-+.+.-||.+|..++||+||++++.|..++.++|+.|||.||-+...+-.
T Consensus 45 FGKVyKA~nket~~lA-AaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL 123 (1187)
T KOG0579|consen 45 FGKVYKAVNKETKLLA-AAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLEL 123 (1187)
T ss_pred chhhhhhhcccchhhh-hhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHh
Confidence 44444 7788777777 99998877645567888999999999999999999999999999999999999988776655
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-CCCCCCCccCCCccccchh
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEV 160 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~aPE~ 160 (334)
...+++.++..+++|+|.||+|||+++|||||||..|||++.+|. ++|+|||.+.... ......+.+|||+|||||+
T Consensus 124 ~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGd--irLADFGVSAKn~~t~qkRDsFIGTPYWMAPEV 201 (1187)
T KOG0579|consen 124 GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGD--IRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEV 201 (1187)
T ss_pred ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCc--EeeecccccccchhHHhhhccccCCcccccchh
Confidence 456999999999999999999999999999999999999998876 9999999876432 2334567899999999998
Q ss_pred hc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 161 LL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 161 ~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+. ..+|+.+ +|||||||+|.+|..+.+|....+....+.++. ...+..+-.+...+..+.+|+.+||.+||
T Consensus 202 vmCET~KD~PYDyk-aDiWSlGITLIEMAqiEPPHhelnpMRVllKia---KSePPTLlqPS~Ws~~F~DfLk~cL~Knp 277 (1187)
T KOG0579|consen 202 VMCETFKDQPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA---KSEPPTLLQPSHWSRSFSDFLKRCLVKNP 277 (1187)
T ss_pred eeeccccCCCchhh-hhHHhhhhHHHHHhccCCCccccchHHHHHHHh---hcCCCcccCcchhhhHHHHHHHHHHhcCC
Confidence 74 5677766 899999999999999999998876654444332 22334455566789999999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
..||++++||+||||..
T Consensus 278 ~~Rp~aaqll~Hpfv~~ 294 (1187)
T KOG0579|consen 278 RNRPPAAQLLKHPFVQN 294 (1187)
T ss_pred ccCCCHHHHhhCccccc
Confidence 99999999999999954
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=323.99 Aligned_cols=234 Identities=25% Similarity=0.366 Sum_probs=200.9
Q ss_pred CCccee--eeeecCCCC-eeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF--YDRCSYSSD-LFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~-~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|.| +......+. .| |+|.++... -..+.+.+|+.+|++|+|+|||++++++..+..+||||||+..|+|.++
T Consensus 214 LG~G~FG~V~~g~~~~~~~v-avk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~y 291 (468)
T KOG0197|consen 214 LGSGQFGEVWLGKWNGSTKV-AVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDY 291 (468)
T ss_pred hcCCccceEEEEEEcCCCcc-cceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHH
Confidence 788888 556667776 66 999998876 4567888999999999999999999999998899999999999999999
Q ss_pred HHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 79 ICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 79 l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
|.. .+.+...+...++.|||+|++||+++++|||||-..||||+.+.. +||+|||||+....... .....-...
T Consensus 292 Lr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~--vKIsDFGLAr~~~d~~Y~~~~~~kfPIk 369 (468)
T KOG0197|consen 292 LRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLV--VKISDFGLARLIGDDEYTASEGGKFPIK 369 (468)
T ss_pred hhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCce--EEEcccccccccCCCceeecCCCCCCce
Confidence 987 456999999999999999999999999999999999999987765 99999999994322221 122223557
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|.|||.+....++.+ ||||||||+||||+| |+.||.+.+..+.+. .....+++|.+..+|+++.+++..||..
T Consensus 370 WtAPEa~~~~~FS~k-SDVWSFGVlL~E~fT~G~~py~~msn~ev~~-----~le~GyRlp~P~~CP~~vY~lM~~CW~~ 443 (468)
T KOG0197|consen 370 WTAPEALNYGKFSSK-SDVWSFGVLLWELFTYGRVPYPGMSNEEVLE-----LLERGYRLPRPEGCPDEVYELMKSCWHE 443 (468)
T ss_pred ecCHHHHhhCCcccc-cceeehhhhHHHHhccCCCCCCCCCHHHHHH-----HHhccCcCCCCCCCCHHHHHHHHHHhhC
Confidence 999999999999877 999999999999998 999999877654433 3456778888889999999999999999
Q ss_pred CCCCCCCHhHHh
Q 019901 234 DPAKRISIPEIR 245 (334)
Q Consensus 234 ~p~~R~s~~ell 245 (334)
+|++|||++.+.
T Consensus 444 ~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 444 DPEDRPTFETLR 455 (468)
T ss_pred CcccCCCHHHHH
Confidence 999999999765
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-44 Score=337.92 Aligned_cols=240 Identities=27% Similarity=0.410 Sum_probs=195.4
Q ss_pred ccee-eeeecCC-CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYS-SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~-~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ +|.+..+ +..+ |+|.+..........+.+|+.+++.++||||+++++++..++.+|+||||+.||+|.+++..
T Consensus 80 ~g~vy~a~~~~~~~~~v-v~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~ 158 (478)
T PTZ00267 80 TTAAFVATRGSDPKEKV-VAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQ 158 (478)
T ss_pred CcEEEEEEEcCCCCeEE-EEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHH
Confidence 4444 4666666 5666 88887655433345678899999999999999999999999999999999999999887753
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCc
Q 019901 82 ----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 154 (334)
Q Consensus 82 ----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~ 154 (334)
..++++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.
T Consensus 159 ~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~--~kL~DFgla~~~~~~~~~~~~~~~~gt~~ 236 (478)
T PTZ00267 159 RLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI--IKLGDFGFSKQYSDSVSLDVASSFCGTPY 236 (478)
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCc--EEEEeCcCceecCCccccccccccCCCcc
Confidence 356899999999999999999999999999999999999987665 9999999998543322 2344579999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+. .+...... +.+..++++++++|.+||..+
T Consensus 237 y~aPE~~~~~~~~~~-~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~----~~~~~~~~-~~~~~~s~~~~~li~~~L~~d 310 (478)
T PTZ00267 237 YLAPELWERKRYSKK-ADMWSLGVILYELLTLHRPFKGPSQREIMQ----QVLYGKYD-PFPCPVSSGMKALLDPLLSKN 310 (478)
T ss_pred ccCHhHhCCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCC-CCCccCCHHHHHHHHHHhccC
Confidence 999999988777655 999999999999999999998765433332 22222221 223457899999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 019901 235 PAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~ 252 (334)
|.+|||+++++.|+|+..
T Consensus 311 P~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 311 PALRPTTQQLLHTEFLKY 328 (478)
T ss_pred hhhCcCHHHHHhCHHHHH
Confidence 999999999999999964
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=323.61 Aligned_cols=241 Identities=32% Similarity=0.519 Sum_probs=198.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .++++.++..| |||++.+.... ..+....|..++..+ +||+|+++++++...+.+|+||||+.+|
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g 86 (323)
T cd05616 8 LGKGSFGKVMLAERKGTDELY-AIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 86 (323)
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCC
Confidence 455554 47788888898 99999875421 223466777887776 5899999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||
T Consensus 87 ~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kL~DfG~~~~~~~~~~~~~~~~gt 164 (323)
T cd05616 87 DLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENMWDGVTTKTFCGT 164 (323)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc--EEEccCCCceecCCCCCccccCCCC
Confidence 99999988888999999999999999999999999999999999999987765 99999999875332 2223456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ .+......+| ..++.++.+++.+||+
T Consensus 165 ~~y~aPE~~~~~~~~~~-~DiwSlGvil~elltg~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~li~~~l~ 237 (323)
T cd05616 165 PDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELFQ----SIMEHNVAYP--KSMSKEAVAICKGLMT 237 (323)
T ss_pred hhhcCHHHhcCCCCCCc-cchhchhHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CcCCHHHHHHHHHHcc
Confidence 99999999988887655 999999999999999999998766533332 3333333333 3579999999999999
Q ss_pred cCCCCCCCH-----hHHhcCccccc
Q 019901 233 ADPAKRISI-----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~-----~ell~h~~~~~ 252 (334)
.+|.+|++. .++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999999984 89999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=313.92 Aligned_cols=246 Identities=23% Similarity=0.361 Sum_probs=207.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||-|+| .|.|+.+|+.+ |||.+.... .-..+.+||.++++++.|++|++|+.+.....+++|||||..|++.+
T Consensus 41 LGEGSYGSV~KAIH~EsG~v~-AIK~VPV~s--DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSD 117 (502)
T KOG0574|consen 41 LGEGSYGSVHKAIHRESGHVL-AIKKVPVDT--DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISD 117 (502)
T ss_pred hcCCcchHHHHHHHhccCcEE-EEEecCccc--hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHH
Confidence 677777 48899999999 999987765 45678999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
.+.- ++++++.++..+++..+.||+|||...-+|||||..|||++..|. .||+|||.|-..... ....+.+|||.|
T Consensus 118 I~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~--AKLADFGVAGQLTDTMAKRNTVIGTPFW 195 (502)
T KOG0574|consen 118 IMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGI--AKLADFGVAGQLTDTMAKRNTVIGTPFW 195 (502)
T ss_pred HHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccch--hhhhhccccchhhhhHHhhCccccCccc
Confidence 8864 567999999999999999999999999999999999999987765 999999998754332 345677899999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
||||++..-+|+.. +||||||++..||..|++||....+.... .--..+.+..+..+...|+++.+|+++||.++|
T Consensus 196 MAPEVI~EIGY~~~-ADIWSLGITaIEMAEG~PPYsDIHPMRAI---FMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P 271 (502)
T KOG0574|consen 196 MAPEVIEEIGYDTK-ADIWSLGITAIEMAEGRPPYSDIHPMRAI---FMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP 271 (502)
T ss_pred ccHHHHHHhccchh-hhHhhhcchhhhhhcCCCCccccccccee---EeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence 99999999999888 89999999999999999999865442111 000112222334445679999999999999999
Q ss_pred CCCCCHhHHhcCccccccCCC
Q 019901 236 AKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~~~ 256 (334)
++|-|+-+|++|||++...+.
T Consensus 272 E~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 272 EERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred HHHHHHHHHhhhhhhcCCCcc
Confidence 999999999999999765443
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=329.01 Aligned_cols=248 Identities=25% Similarity=0.376 Sum_probs=196.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-----eEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~ 70 (334)
||.|++ .+.+..+|+.| |||.+.... ......+.+|+.+++.++||||+++++++...+ ..|+||||+
T Consensus 8 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~ 86 (372)
T cd07853 8 IGYGAFGVVWSVTDPRDGKRV-ALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELM 86 (372)
T ss_pred eeeCCCEEEEEEEECCCCCEE-EEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecc
Confidence 566555 47778889998 999986543 123357889999999999999999999998776 799999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKS 148 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~ 148 (334)
. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ....
T Consensus 87 ~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~--~kL~Dfg~a~~~~~~~~~~~~~ 163 (372)
T cd07853 87 Q-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCV--LKICDFGLARVEEPDESKHMTQ 163 (372)
T ss_pred c-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCC--EEeccccceeecccCccccCCC
Confidence 5 688888888888999999999999999999999999999999999999987664 9999999987543222 1233
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------Hhhc
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------ILSV 209 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~~~~ 209 (334)
..+|+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..+... +...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 243 (372)
T cd07853 164 EVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243 (372)
T ss_pred CCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhC
Confidence 468999999999987654455599999999999999999999876654433332211 0011
Q ss_pred cccCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 210 QYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 210 ~~~~~-------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+ .....++++.+||.+||+.||.+|||+.++++||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred CCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 11111 122458899999999999999999999999999999763
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=322.50 Aligned_cols=245 Identities=24% Similarity=0.350 Sum_probs=193.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|++ .+.+..++..| |||++..... .....+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 32 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~ 110 (364)
T cd07875 32 IGSGAQGIVCAAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110 (364)
T ss_pred eecCCCeEEEEEEECCCCcEE-EEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeC
Confidence 455555 36778888888 9999976431 2335678999999999999999999987643 357999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+.+ +|...+.. .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 111 ~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~ 185 (364)
T cd07875 111 MDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 185 (364)
T ss_pred CCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCc--EEEEeCCCccccCCCCcccCC
Confidence 965 67777653 4889999999999999999999999999999999999987665 999999999865444444556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc------------------cc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------QY 211 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------~~ 211 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+..++...... ..
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (364)
T cd07875 186 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 264 (364)
T ss_pred cccCCcCCHHHHhCCCCCch-hhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCC
Confidence 79999999999988887665 999999999999999999998776554444433211100 00
Q ss_pred c--------------C----CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 S--------------I----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 ~--------------~----~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
. . ......++.+++||.+||+.||.+|||+.++|+||||...
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 265 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred CcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 0 0 0011135689999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.98 Aligned_cols=241 Identities=31% Similarity=0.528 Sum_probs=198.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ +++++.+|+.| |||++.+... ...+.+..|+.+++.+. ||+|+++++++.+.+.+|+||||++||
T Consensus 8 lg~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g 86 (323)
T cd05615 8 LGKGSFGKVMLAERKGTDELY-AIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGG 86 (323)
T ss_pred EEecCCeEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCC
Confidence 455554 47888899999 9999987542 12245677888888886 577888999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt 152 (334)
+|..++.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||
T Consensus 87 ~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~--ikL~Dfg~~~~~~~~~~~~~~~~gt 164 (323)
T cd05615 87 DLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH--IKIADFGMCKEHMVDGVTTRTFCGT 164 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEeccccccccCCCCccccCccCC
Confidence 99999988888999999999999999999999999999999999999987765 9999999987543222 23445699
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ .+.......| ..++.++.+++.+||+
T Consensus 165 ~~y~aPE~~~~~~~~~~-~DiwslGvil~elltG~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~l~ 237 (323)
T cd05615 165 PDYIAPEIIAYQPYGKS-VDWWAYGVLLYEMLAGQPPFDGEDEDELFQ----SIMEHNVSYP--KSLSKEAVSICKGLMT 237 (323)
T ss_pred ccccCHHHHcCCCCCCc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHHHHHHHHcc
Confidence 99999999988777655 999999999999999999998765533333 3333333333 3578999999999999
Q ss_pred cCCCCCCC-----HhHHhcCccccc
Q 019901 233 ADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s-----~~ell~h~~~~~ 252 (334)
++|.+|++ .+++++||||..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~ 262 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRR 262 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCC
Confidence 99999997 478999999964
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=317.13 Aligned_cols=247 Identities=25% Similarity=0.428 Sum_probs=194.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .++++.+++.+ |||.+..... .....+.+|+.+++.++||||+++++++..++..++||||+.+ +|.
T Consensus 14 lg~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~ 91 (309)
T cd07872 14 LGEGTYATVFKGRSKLTENLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLK 91 (309)
T ss_pred ecccCCEEEEEEEecCCCCeE-EEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHH
Confidence 455544 37778888888 9999976542 2345678999999999999999999999999999999999975 788
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 77 ERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
.++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 169 (309)
T cd07872 92 QYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSVPTKTYSNEVVTLW 169 (309)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECccccceecCCCcccccccccccc
Confidence 877654 44899999999999999999999999999999999999987665 9999999987533222 2234568999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc---------------cccCC-----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIP----- 214 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~----- 214 (334)
|+|||++.+....+.++|||||||++|+|++|++||.+.+............... ....+
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (309)
T cd07872 170 YRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQ 249 (309)
T ss_pred ccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCC
Confidence 9999998765444555999999999999999999998766544333332211000 00111
Q ss_pred ----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 215 ----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 215 ----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
....++++++++|.+||..+|.+|||+++++.||||..
T Consensus 250 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~ 291 (309)
T cd07872 250 PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRS 291 (309)
T ss_pred chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhh
Confidence 12347889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=329.87 Aligned_cols=234 Identities=28% Similarity=0.410 Sum_probs=204.4
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.|.- +-..+..++.| |||.++ +.-+.+|+-|+.|+||||+.|.++|.....+|||||||..|.|...|
T Consensus 132 lGSGaQGAVF~Grl~netV-AVKKV~-------elkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VL 203 (904)
T KOG4721|consen 132 LGSGAQGAVFLGRLHNETV-AVKKVR-------ELKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVL 203 (904)
T ss_pred hccCcccceeeeeccCcee-hhHHHh-------hhhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHH
Confidence 566655 33345667788 999864 33467899999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
+..++++......|..+|+.|++|||...|||||||.-||||..+.. |||+|||-++..........++||..|||||
T Consensus 204 ka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~--VKIsDFGTS~e~~~~STkMSFaGTVaWMAPE 281 (904)
T KOG4721|consen 204 KAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDV--VKISDFGTSKELSDKSTKMSFAGTVAWMAPE 281 (904)
T ss_pred hccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccce--EEeccccchHhhhhhhhhhhhhhhHhhhCHH
Confidence 99999999999999999999999999999999999999999987765 9999999998776667777889999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++...+.+.+ +|||||||+||||+||..||...+.. .++..+....+.+|-+...|+.++-||+.||+-.|..||
T Consensus 282 vIrnePcsEK-VDIwSfGVVLWEmLT~EiPYkdVdss----AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRP 356 (904)
T KOG4721|consen 282 VIRNEPCSEK-VDIWSFGVVLWEMLTGEIPYKDVDSS----AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRP 356 (904)
T ss_pred HhhcCCcccc-cceehhHHHHHHHHhcCCCccccchh----eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCc
Confidence 9999888766 99999999999999999999876553 344455566667777778899999999999999999999
Q ss_pred CHhHHhcCccc
Q 019901 240 SIPEIRNHEWF 250 (334)
Q Consensus 240 s~~ell~h~~~ 250 (334)
|+.++|.|--+
T Consensus 357 SFrqil~HldI 367 (904)
T KOG4721|consen 357 SFRQILLHLDI 367 (904)
T ss_pred cHHHHHHHHhh
Confidence 99999998644
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=312.92 Aligned_cols=244 Identities=25% Similarity=0.363 Sum_probs=191.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC---CCCCcccceEEEEc-----CCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL---RHPNIVRFKEVILT-----PTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~-----~~~~~lv~ 67 (334)
||.|++ +++++.+|+.| |+|.+..... .....+.+|+.+++.+ +||||+++++++.. ...+++||
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~ 86 (288)
T cd07863 8 IGVGAYGTVYKARDPHSGHFV-ALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVF 86 (288)
T ss_pred EeecCCeEEEEEEECCCCcEE-EEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEE
Confidence 444544 47888899998 9999986542 2234567788777665 79999999998864 34689999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 68 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 68 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
||+. ++|..++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 87 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~--~kl~dfg~~~~~~~~~~ 163 (288)
T cd07863 87 EHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQ--VKLADFGLARIYSCQMA 163 (288)
T ss_pred cccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccCccccccCccc
Confidence 9997 4888888764 34899999999999999999999999999999999999987765 99999999886544434
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------cccC-----
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------QYSI----- 213 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------~~~~----- 213 (334)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+.+........ ....
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07863 164 LTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAF 242 (288)
T ss_pred CCCccccccccCchHhhCCCCCCc-chhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccccccc
Confidence 445678999999999988777655 999999999999999999998766544444433221100 0000
Q ss_pred ---------CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 214 ---------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 214 ---------~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.....++..++++|.+||+.||.+|||+.+++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 243 SPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred CCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0012467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=307.47 Aligned_cols=241 Identities=31% Similarity=0.443 Sum_probs=197.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-----ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-----~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ .+.+..++..+ |+|.+...... ....+.+|+.++++++||||+++++++..+...++|+||+.+
T Consensus 10 lg~g~~~~vy~~~~~~~~~~~-~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 88 (263)
T cd06625 10 LGQGAFGRVYLCYDVDTGREL-AVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88 (263)
T ss_pred ecCCCceEEEEEEEcCCCcEE-EEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCC
Confidence 566654 47778888998 99998765421 124688899999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----CC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 148 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~----~~ 148 (334)
++|.+.+.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++........ ..
T Consensus 89 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 166 (263)
T cd06625 89 GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICSSGTGMKS 166 (263)
T ss_pred CcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceeccccccccccccC
Confidence 999999988888999999999999999999999999999999999999987654 999999998754322111 23
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
..+++.|+|||++.+..++.+ +||||||+++|+|++|+.||........... ........+....+++.+.++|.
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~ 241 (263)
T cd06625 167 VTGTPYWMSPEVISGEGYGRK-ADVWSVGCTVVEMLTEKPPWAEFEAMAAIFK----IATQPTNPQLPSHVSPDARNFLR 241 (263)
T ss_pred CCcCccccCcceeccCCCCch-hhhHHHHHHHHHHHhCCCCccccchHHHHHH----HhccCCCCCCCccCCHHHHHHHH
Confidence 467889999999988776544 9999999999999999999987544332222 22222222233457899999999
Q ss_pred HhcccCCCCCCCHhHHhcCccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+||..+|.+|||+.++++||||
T Consensus 242 ~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 242 RTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHhhcCcccCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.45 Aligned_cols=246 Identities=26% Similarity=0.465 Sum_probs=193.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.+++.| |||++.+... .....+.+|+.+++.++||||+++++++.+++.+|+||||+.||+
T Consensus 9 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~ 87 (331)
T cd05597 9 IGRGAFGEVAVVKMKNTGQVY-AMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGD 87 (331)
T ss_pred EEecCCeEEEEEEECCCCCEE-EEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCc
Confidence 455554 47788889998 9999976431 223457889999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++........ ....+|
T Consensus 88 L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~g 165 (331)
T cd05597 88 LLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGH--IRLADFGSCLRLLADGTVQSNVAVG 165 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCC--EEEEECCceeecCCCCCccccceec
Confidence 9999976 456999999999999999999999999999999999999987665 99999999875433222 123469
Q ss_pred CCccccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC-CCCCCCHHHHHH
Q 019901 152 TPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHL 226 (334)
Q Consensus 152 t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 226 (334)
|+.|+|||++.. ....+.++|||||||++|+|++|+.||........+...... .....++ ....+++.++++
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~l 243 (331)
T cd05597 166 TPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--KEHFQFPPDVTDVSEEAKDL 243 (331)
T ss_pred cccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC--CCcccCCCccCCCCHHHHHH
Confidence 999999999863 222344599999999999999999999876543333332211 1111222 233579999999
Q ss_pred HHHhcccCCCC--CCCHhHHhcCccccc
Q 019901 227 ISRIFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
|.+||..++.+ |++++++++||||..
T Consensus 244 i~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 244 IRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 99999764443 789999999999954
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=311.22 Aligned_cols=243 Identities=24% Similarity=0.381 Sum_probs=195.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ ++.+..+++.| |||.+.+.... ....+.+|+.+++.++|++|+++++.+.+.+..++||||+.+++|.+++
T Consensus 13 ~g~v~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l 91 (285)
T cd05630 13 FGEVCACQVRATGKMY-ACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 91 (285)
T ss_pred CeEEEEEEEcCCCceE-EEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHH
Confidence 4444 47888899998 99998765422 2245778999999999999999999999999999999999999999888
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
... ..+++..+..++.|++.||.|||++||+||||||+||+++..+. ++|+|||++.............|++.|+|
T Consensus 92 ~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~g~~~y~a 169 (285)
T cd05630 92 YHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMA 169 (285)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCC--EEEeeccceeecCCCccccCCCCCccccC
Confidence 653 35899999999999999999999999999999999999987664 99999999875443333344579999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +||||+||++|+|++|+.||........... ...... .........+++++++|+.+||+.+|.+
T Consensus 170 PE~~~~~~~~~~-~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~ 246 (285)
T cd05630 170 PEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVK-EVQEEYSEKFSPDARSLCKMLLCKDPKE 246 (285)
T ss_pred hHHHcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhh-hhhhhcCccCCHHHHHHHHHHhhcCHHH
Confidence 999988877655 9999999999999999999986543211111 111111 0011122357899999999999999999
Q ss_pred CCC-----HhHHhcCccccc
Q 019901 238 RIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 238 R~s-----~~ell~h~~~~~ 252 (334)
||| ++++++||||.+
T Consensus 247 R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 247 RLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred ccCCCCCchHHHHcChhhhc
Confidence 999 899999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=316.28 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=182.7
Q ss_pred CCccee----eeeec--CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCS--YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~--~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~ 73 (334)
||.|+| +|+++ .++..| |+|.+.... ....+.+|+.+++.++||||+++++++.. +..+|+||||+. +
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~-aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07868 9 VGRGTYGHVYKAKRKDGKDDRDY-ALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-H 84 (317)
T ss_pred cccCCCeEEEEEEEccCCCCceE-EEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-C
Confidence 666665 35543 466777 999986543 34568899999999999999999999864 457899999995 5
Q ss_pred ChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCCccCCCC
Q 019901 74 ELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 142 (334)
Q Consensus 74 ~L~~~l~~~---------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgla~~~~~ 142 (334)
+|..++... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||+|+....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCC
Confidence 888877532 248999999999999999999999999999999999999532 224699999999975432
Q ss_pred CC----CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHh--
Q 019901 143 HS----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRIL-- 207 (334)
Q Consensus 143 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~-- 207 (334)
.. ......||+.|+|||++.+....+.++||||+||++|+|++|++||...... ..+........
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07868 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFP 244 (317)
T ss_pred CCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCC
Confidence 21 1234578999999999987654455699999999999999999999754321 11111111000
Q ss_pred ---------h-------------ccccC--------CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 208 ---------S-------------VQYSI--------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 208 ---------~-------------~~~~~--------~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
. ..... ......++.+.+||.+||+.||.+|||++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 245 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred ChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 00000 0011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=319.03 Aligned_cols=245 Identities=24% Similarity=0.354 Sum_probs=191.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|+| .+.+..+++.+ |||.+..... .....+.+|+.+++.++||||+++++++... ...|+||||
T Consensus 25 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~ 103 (355)
T cd07874 25 IGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103 (355)
T ss_pred eeecCCEEEEEEEecCCCceE-EEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhh
Confidence 455554 36778888888 9999876542 2235677899999999999999999988643 357999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+++ +|...+.. .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 104 ~~~-~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 178 (355)
T cd07874 104 MDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 178 (355)
T ss_pred hcc-cHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCC--EEEeeCcccccCCCccccCCc
Confidence 965 67676643 4889999999999999999999999999999999999987665 999999999865444444556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh------------------ccc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQY 211 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~ 211 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+...+..... ...
T Consensus 179 ~~t~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T cd07874 179 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_pred cccCCccCHHHHcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCC
Confidence 79999999999988877665 99999999999999999999876544333332221100 000
Q ss_pred -----cCC-------------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 -----SIP-------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 -----~~~-------------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..+ .....+.++++||.+||..||.+|||+.|+|+||||...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred ccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 000 011245788999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=305.87 Aligned_cols=239 Identities=29% Similarity=0.492 Sum_probs=198.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 84 (334)
.+++..+++.+ |+|++.+... ...+.+.+|+.+++.++||||+++++.+.+++..++|+||+.+++|.+++.+...
T Consensus 11 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 89 (262)
T cd05572 11 LVKVKSKNRTF-ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL 89 (262)
T ss_pred EEEECCCCcEE-EEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC
Confidence 47788889998 9999987542 2346789999999999999999999999999999999999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccC
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~ 164 (334)
+++..+..++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||+++............+++.|+|||.+.+.
T Consensus 90 l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~ 167 (262)
T cd05572 90 FDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY--VKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK 167 (262)
T ss_pred CCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCC--EEEeeCCcccccCcccccccccCCcCccChhHhcCC
Confidence 999999999999999999999999999999999999987664 999999998865444333445789999999998877
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---- 240 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s---- 240 (334)
.++.+ +|+||+|+++|+|++|..||....... ......+.......+.+...+++++++|.+||+.+|.+|||
T Consensus 168 ~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 244 (262)
T cd05572 168 GYDFS-VDYWSLGILLYELLTGRPPFGEDDEDP--MEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKG 244 (262)
T ss_pred CCCCh-hhhhhhHHHHHHHHhCCCCcCCCCCCH--HHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCccc
Confidence 77655 899999999999999999998765211 12222233212222223345899999999999999999999
Q ss_pred -HhHHhcCccccc
Q 019901 241 -IPEIRNHEWFLK 252 (334)
Q Consensus 241 -~~ell~h~~~~~ 252 (334)
++|+++||||..
T Consensus 245 ~~~~l~~~~~~~~ 257 (262)
T cd05572 245 GIKDIKKHKWFNG 257 (262)
T ss_pred CHHHHhcChhhhC
Confidence 999999999964
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=332.35 Aligned_cols=249 Identities=23% Similarity=0.329 Sum_probs=189.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC------CCcccceEEEEcC-CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH------PNIVRFKEVILTP-THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h------p~iv~~~~~~~~~-~~~~lv~e~~ 70 (334)
||.|+| ++.+..+++.| |||++.... ........|+.+++.++| +++++++++|..+ +++|+||+++
T Consensus 137 lG~G~fg~V~~a~~~~~~~~v-AvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~ 214 (467)
T PTZ00284 137 LGEGTFGKVVEAWDRKRKEYC-AVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY 214 (467)
T ss_pred EEeccCEEEEEEEEcCCCeEE-EEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc
Confidence 455554 47778888888 999997543 334456777777777654 4588888888765 5799999998
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCC--------------CCEEEeccC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA--------------PRLKICDFG 135 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~--------------~~~kl~Dfg 135 (334)
|++|.+++.+.+.+++..++.++.||+.||.|||+ .|||||||||+|||++..+. ..+||+|||
T Consensus 215 -g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG 293 (467)
T PTZ00284 215 -GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG 293 (467)
T ss_pred -CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCC
Confidence 78899999888889999999999999999999998 59999999999999976542 149999999
Q ss_pred CccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc------
Q 019901 136 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------ 209 (334)
Q Consensus 136 la~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 209 (334)
++.... ......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+..+.......
T Consensus 294 ~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~-~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~ 370 (467)
T PTZ00284 294 GCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYS-TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAG 370 (467)
T ss_pred ccccCc--cccccccCCccccCcHHhhcCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHh
Confidence 876422 22345679999999999998888655 999999999999999999998765533322211110000
Q ss_pred -------------ccc-CCC----------------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCC
Q 019901 210 -------------QYS-IPD----------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 210 -------------~~~-~~~----------------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~~ 256 (334)
... .+. ....++.+.+||.+||+.||.+|||++|+|+||||.+..+.
T Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~ 447 (467)
T PTZ00284 371 RCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPE 447 (467)
T ss_pred hccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCc
Confidence 000 000 00124668899999999999999999999999999876543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=309.30 Aligned_cols=244 Identities=24% Similarity=0.364 Sum_probs=198.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+.+..+++.+ |+|++.+.... ....+.+|+.+++.++|+||+++.+.+..++..++||||+.+++|...+
T Consensus 13 ~g~vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 91 (285)
T cd05632 13 FGEVCACQVRATGKMY-ACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHI 91 (285)
T ss_pred CeEEEEEEECCCCcEE-EEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHH
Confidence 4444 47788889988 99999765422 2245778999999999999999999999999999999999999998887
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||++.............|++.|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~g~~~~~a 169 (285)
T cd05632 92 YNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGH--IRISDLGLAVKIPEGESIRGRVGTVGYMA 169 (285)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCC--EEEecCCcceecCCCCcccCCCCCcCccC
Confidence 653 35999999999999999999999999999999999999987654 99999999875433333345578999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|+|||||++|+|++|..||...................... ....++..+.+|+.+||+.+|.+
T Consensus 170 PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~ 246 (285)
T cd05632 170 PEVLNNQRYTLS-PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEV--YSAKFSEEAKSICKMLLTKDPKQ 246 (285)
T ss_pred hHHhcCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccc--cCccCCHHHHHHHHHHccCCHhH
Confidence 999988777655 899999999999999999998765433333333333222222 22357899999999999999999
Q ss_pred CCC-----HhHHhcCcccccc
Q 019901 238 RIS-----IPEIRNHEWFLKN 253 (334)
Q Consensus 238 R~s-----~~ell~h~~~~~~ 253 (334)
||| +.+++.|+||...
T Consensus 247 R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 247 RLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred cCCCcccChHHHHcChhhhcC
Confidence 999 8899999999653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-43 Score=310.37 Aligned_cols=229 Identities=21% Similarity=0.221 Sum_probs=187.6
Q ss_pred eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccCCCChHHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~ 80 (334)
+.+.+.+|+.| |||.+.+..... .+.+.+|+.++++++||||+++++++.+ ...+++||||+.+|+|.+++.
T Consensus 36 v~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 114 (283)
T PHA02988 36 IYKGIFNNKEV-IIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLD 114 (283)
T ss_pred EEEEEECCEEE-EEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHh
Confidence 45556688888 999998765222 3567799999999999999999999876 357899999999999999999
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
+.+.++......++.|++.||.|||+. +++||||||+|||++.++. +||+|||+++.... ......|++.|+|||
T Consensus 115 ~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~--~kl~dfg~~~~~~~--~~~~~~~~~~y~aPE 190 (283)
T PHA02988 115 KEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYK--LKIICHGLEKILSS--PPFKNVNFMVYFSYK 190 (283)
T ss_pred hCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCc--EEEcccchHhhhcc--ccccccCcccccCHH
Confidence 888899999999999999999999984 9999999999999987765 99999999875432 223456899999999
Q ss_pred hhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 160 VLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 160 ~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
++.+ ..++.+ +|||||||++|+|++|+.||.+.+....... +.......+.....++.+++++.+||+.+|.+
T Consensus 191 ~~~~~~~~~~~k-~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~ 265 (283)
T PHA02988 191 MLNDIFSEYTIK-DDIYSLGVVLWEIFTGKIPFENLTTKEIYDL----IINKNNSLKLPLDCPLEIKCIVEACTSHDSIK 265 (283)
T ss_pred Hhhhccccccch-hhhhHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhcCCCCCCCCcCcHHHHHHHHHHhcCCccc
Confidence 9876 456544 9999999999999999999987654333322 22222233333357999999999999999999
Q ss_pred CCCHhHHhc
Q 019901 238 RISIPEIRN 246 (334)
Q Consensus 238 R~s~~ell~ 246 (334)
|||+.+++.
T Consensus 266 Rps~~ell~ 274 (283)
T PHA02988 266 RPNIKEILY 274 (283)
T ss_pred CcCHHHHHH
Confidence 999999985
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=320.88 Aligned_cols=240 Identities=25% Similarity=0.385 Sum_probs=185.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ ++++..++..| |+|+..+. ....|+.+++.++||||+++++++..++..++|||++. ++|..
T Consensus 74 lg~G~~g~Vy~~~~~~~~~~v-alK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~ 145 (357)
T PHA03209 74 LTPGSEGRVFVATKPGQPDPV-VLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYT 145 (357)
T ss_pred ecCCCCeEEEEEEECCCCceE-EEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHH
Confidence 455544 47777788888 99985433 34679999999999999999999999999999999995 57888
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++..+. +||+|||+++............||+.|+
T Consensus 146 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~gt~~y~ 223 (357)
T PHA03209 146 YLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ--VCIGDLGAAQFPVVAPAFLGLAGTVETN 223 (357)
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEecCccccccccCccccccccccccc
Confidence 7765 456999999999999999999999999999999999999987665 9999999987544333344567999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCC-CCCCCch---------HHHHHHHHHHhhccccCC------------
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEP---------KNFRKTIHRILSVQYSIP------------ 214 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p-f~~~~~~---------~~~~~~~~~~~~~~~~~~------------ 214 (334)
|||++.+..++.+ +|||||||++|+|+++..| |...... ..+...+.........++
T Consensus 224 aPE~~~~~~~~~~-~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (357)
T PHA03209 224 APEVLARDKYNSK-ADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFI 302 (357)
T ss_pred CCeecCCCCCCch-hhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHH
Confidence 9999988887665 9999999999999985444 4432211 011111111100000111
Q ss_pred ----------------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 215 ----------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 215 ----------------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
....++.++.+||.+||+.||.+|||+.|+|+||||++
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 303 EYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred hhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 11245778889999999999999999999999999964
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=316.61 Aligned_cols=241 Identities=22% Similarity=0.393 Sum_probs=188.1
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--C
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--G 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 83 (334)
++.++.+|+.| |+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++... .
T Consensus 18 ~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~ 96 (327)
T cd08227 18 LARYKPTGEYV-TVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMD 96 (327)
T ss_pred EEeecccCcEE-EEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccC
Confidence 47788899999 9999976542 23357888999999999999999999999999999999999999999998653 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--------CCCCccCCCcc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKSTVGTPAY 155 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--------~~~~~~gt~~y 155 (334)
.+++..++.++.|++.||.|||++||+||||||+|||++.++. ++++||+.+......+ ......++..|
T Consensus 97 ~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~--~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 174 (327)
T cd08227 97 GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPW 174 (327)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCc--EEEcccchhhccccccccccccccccccccceecc
Confidence 5899999999999999999999999999999999999987664 9999998654322111 11223567789
Q ss_pred ccchhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-----------------------
Q 019901 156 IAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------------- 210 (334)
Q Consensus 156 ~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------------- 210 (334)
+|||++.+. .++ .++|||||||++|+|++|+.||....................
T Consensus 175 ~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (327)
T cd08227 175 LSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSG 253 (327)
T ss_pred cChHHhhcccCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCC
Confidence 999999763 354 449999999999999999999976543322222111000000
Q ss_pred -----------------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 211 -----------------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 211 -----------------~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+....+++.+.+||.+||+.||++|||++++++||||++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~ 312 (327)
T cd08227 254 LGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ 312 (327)
T ss_pred CCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence 000111235788999999999999999999999999999965
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-44 Score=325.38 Aligned_cols=245 Identities=27% Similarity=0.423 Sum_probs=203.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +|++..+.+.| |||.+...-.+.. ..+.+|+++|++++|||++.+.++|..+...|+|||||- |+
T Consensus 34 IGHGSFGAVYfArd~~n~evV-AIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GS 111 (948)
T KOG0577|consen 34 IGHGSFGAVYFARDVRNSEVV-AIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GS 111 (948)
T ss_pred hcCCccceeEEeeccCcccee-eeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-cc
Confidence 577766 69999999999 9999876542332 579999999999999999999999999999999999995 57
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
-.+.+.- .+++.+.++..|+.+.+.||.|||+.+-||||||..|||++..+. |||+|||.|... ....+++|||
T Consensus 112 AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~--VKLaDFGSAsi~---~PAnsFvGTP 186 (948)
T KOG0577|consen 112 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGL--VKLADFGSASIM---APANSFVGTP 186 (948)
T ss_pred HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCe--eeeccccchhhc---CchhcccCCc
Confidence 7777653 356999999999999999999999999999999999999987775 999999987643 4557889999
Q ss_pred ccccchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 154 AYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 154 ~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+|||||++. .+.|+.+ +|||||||+..+|...++|+-+.+....+ ..+.....+.-.....|..+++|+..|
T Consensus 187 ywMAPEVILAMDEGqYdgk-vDvWSLGITCIELAERkPPlFnMNAMSAL----YHIAQNesPtLqs~eWS~~F~~Fvd~C 261 (948)
T KOG0577|consen 187 YWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSAL----YHIAQNESPTLQSNEWSDYFRNFVDSC 261 (948)
T ss_pred cccchhHheeccccccCCc-cceeeccchhhhhhhcCCCccCchHHHHH----HHHHhcCCCCCCCchhHHHHHHHHHHH
Confidence 999999985 5678888 89999999999999999998765543322 233332222222345799999999999
Q ss_pred cccCCCCCCCHhHHhcCccccccCCCcc
Q 019901 231 FVADPAKRISIPEIRNHEWFLKNLPADL 258 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~~~~~~ 258 (334)
|++-|..|||.+++|.|+|....-|...
T Consensus 262 LqKipqeRptse~ll~H~fv~R~Rp~tv 289 (948)
T KOG0577|consen 262 LQKIPQERPTSEELLKHRFVLRERPPTV 289 (948)
T ss_pred HhhCcccCCcHHHHhhcchhccCCCchH
Confidence 9999999999999999999987665544
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=308.64 Aligned_cols=244 Identities=36% Similarity=0.550 Sum_probs=195.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc--HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID--ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~--~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+++..+++.| |+|++........ ....+|+.++++++||||+++++++......++||||+.+++|
T Consensus 7 lg~G~~g~v~~~~~~~~~~~~-~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L 85 (260)
T PF00069_consen 7 LGSGGFGTVYKAKNKKNGQKV-AVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSL 85 (260)
T ss_dssp EEEESSEEEEEEEETTTTEEE-EEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBH
T ss_pred EEeCCCEEEEEEEECCCCeEE-EEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccc
Confidence 455544 48888888889 9999998763222 2345699999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCC-CCCCCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS-VLHSQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~-~~~~~~~~~~gt~~ 154 (334)
.+++.+.+.+++..+..++.|++.||.+||++||+|+||||+||+++.++. ++|+|||.+... ..........+++.
T Consensus 86 ~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 163 (260)
T PF00069_consen 86 QDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGE--VKLIDFGSSVKLSENNENFNPFVGTPE 163 (260)
T ss_dssp HHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSE--EEESSGTTTEESTSTTSEBSSSSSSGG
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence 999997788999999999999999999999999999999999999986654 999999998752 22333445678999
Q ss_pred cccchhhc-cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCCCHHHHHHHHHhc
Q 019901 155 YIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 155 y~aPE~~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L 231 (334)
|+|||++. +... +.++||||||+++|+|++|..||......... ........... ........+..+.++|.+||
T Consensus 164 y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 241 (260)
T PF00069_consen 164 YMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGKLPFEESNSDDQL-EIIEKILKRPLPSSSQQSREKSEELRDLIKKML 241 (260)
T ss_dssp GSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-HHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccchhhh-hhhhhcccccccccccccchhHHHHHHHHHHHc
Confidence 99999988 5555 45599999999999999999999976322222 22222221111 11111123489999999999
Q ss_pred ccCCCCCCCHhHHhcCccc
Q 019901 232 VADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~ 250 (334)
+.+|++|||+.++++||||
T Consensus 242 ~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 242 SKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp SSSGGGSTTHHHHHTSGGG
T ss_pred cCChhHCcCHHHHhcCCCC
Confidence 9999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=305.03 Aligned_cols=243 Identities=27% Similarity=0.396 Sum_probs=194.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+++..++..| |+|.+..........+.+|+.+++.++||||+++++.+...+..|+||||+.+++|.+
T Consensus 17 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06645 17 IGSGTYGDVYKARNVNTGELA-AIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95 (267)
T ss_pred hCCCCCeEEEEEEEcCCCcEE-EEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHH
Confidence 455554 47778888888 9999987653444568899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~ 156 (334)
++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++. ++|+|||++...... .......|++.|+
T Consensus 96 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 173 (267)
T cd06645 96 IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGH--VKLADFGVSAQITATIAKRKSFIGTPYWM 173 (267)
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEECcceeeeEccCcccccccccCccccc
Confidence 9988888999999999999999999999999999999999999987664 999999998654322 2223457899999
Q ss_pred cchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 157 APEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 157 aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|||++. ...++ .++|+|||||++|+|++|..||................ ...........++..+.++|.+||+.
T Consensus 174 aPE~~~~~~~~~~~-~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~ 251 (267)
T cd06645 174 APEVAAVERKGGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSN-FQPPKLKDKMKWSNSFHHFVKMALTK 251 (267)
T ss_pred ChhhhccccCCCCC-chhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccC-CCCCcccccCCCCHHHHHHHHHHccC
Confidence 999974 33344 45999999999999999999997554322221111110 01111112234688999999999999
Q ss_pred CCCCCCCHhHHhcCcc
Q 019901 234 DPAKRISIPEIRNHEW 249 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~ 249 (334)
+|.+|||++++++|||
T Consensus 252 ~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 252 NPKKRPTAEKLLQHPF 267 (267)
T ss_pred CchhCcCHHHHhcCCC
Confidence 9999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=317.67 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=191.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|+| .+.+..+++.| |||.+.+... .....+.+|+.+++.++||||+++++++... ...|+++++
T Consensus 23 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~ 101 (343)
T cd07878 23 VGSGAYGSVCSAYDTRLRQKV-AVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL 101 (343)
T ss_pred cccCCCeEEEEEEECCCCCEE-EEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeec
Confidence 566655 47778888888 9999876541 2235677899999999999999999987643 457999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+ +++|...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .....
T Consensus 102 ~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~--~kl~Dfg~~~~~~~--~~~~~ 175 (343)
T cd07878 102 M-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCE--LRILDFGLARQADD--EMTGY 175 (343)
T ss_pred C-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCC--EEEcCCccceecCC--CcCCc
Confidence 8 778887764 456999999999999999999999999999999999999987665 99999999985432 23445
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh-------------------cc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-------------------VQ 210 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-------------------~~ 210 (334)
.||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+......... ..
T Consensus 176 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07878 176 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSL 255 (343)
T ss_pred cccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhcc
Confidence 78999999999977444455599999999999999999999875543333322211000 00
Q ss_pred ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 211 YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 211 ~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+ .....++.+.+||.+||..+|.+|||+.++++||||.+.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 256 PHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred ccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0000 012357789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.09 Aligned_cols=247 Identities=26% Similarity=0.430 Sum_probs=194.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .++++.++..| |+|.+.... ......+.+|+.+++.++||||+++++++..++..++||||+. ++|.
T Consensus 14 lg~g~~g~vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~ 91 (301)
T cd07873 14 LGEGTYATVYKGRSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLK 91 (301)
T ss_pred eccCcCEEEEEEEEcCCCcEE-EEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHH
Confidence 455544 36778888888 999987654 2334567899999999999999999999999999999999996 5888
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 77 ERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
.++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||++....... ......+++.
T Consensus 92 ~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~ 169 (301)
T cd07873 92 QYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYSNEVVTLW 169 (301)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCc--EEECcCcchhccCCCCCcccccceeec
Confidence 887654 46899999999999999999999999999999999999987665 9999999987543222 2233467899
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc---------------cccCCC----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD---- 215 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---- 215 (334)
|+|||++.+....+.++|||||||++|+|++|++||...+............... ....+.
T Consensus 170 y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (301)
T cd07873 170 YRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRAD 249 (301)
T ss_pred ccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccc
Confidence 9999998765544556999999999999999999998766543333222111000 001111
Q ss_pred -----CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 -----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 -----~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+++.+++||.+||+.+|.+|||++++++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~ 291 (301)
T cd07873 250 CLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC 291 (301)
T ss_pred cHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 1247889999999999999999999999999999954
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=307.40 Aligned_cols=245 Identities=25% Similarity=0.413 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+.+..++..| |||.+..... .....+.+|+.+++.++||||+++++++..++..|+||||+. ++|
T Consensus 8 l~~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l 85 (285)
T cd07861 8 IGEGTYGVVYKGRNKKTGQIV-AMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDL 85 (285)
T ss_pred ecccCceEEEEEEECCCCcEE-EEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCH
Confidence 455544 46777888888 9999876542 233678899999999999999999999999999999999997 588
Q ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccC
Q 019901 76 FERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVG 151 (334)
Q Consensus 76 ~~~l~~~---~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~g 151 (334)
.+++... ..+++..++.++.||+.||.|||++|++||||+|+||+++.++. ++|+|||++........ .....+
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 163 (285)
T cd07861 86 KKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGV--IKLADFGLARAFGIPVRVYTHEVV 163 (285)
T ss_pred HHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCc--EEECcccceeecCCCcccccCCcc
Confidence 8887643 45899999999999999999999999999999999999987665 99999999875432221 233467
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--------------cccC----
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSI---- 213 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~---- 213 (334)
++.|+|||++.+....+.++|||||||++|+|++|++||.+................. ....
T Consensus 164 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd07861 164 TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWK 243 (285)
T ss_pred cccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccC
Confidence 8999999998765544455999999999999999999998765443332222111000 0000
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 214 -----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 214 -----~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.....++++++++|.+||+.+|.+|||+.+++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=320.64 Aligned_cols=244 Identities=33% Similarity=0.606 Sum_probs=211.6
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.| + ++++++|+.| |||++.|..+ .....+.+|+.+|+.+.||.||.+...|++.+.+++|||-+. |+.
T Consensus 572 LGSGQFG~VYgg~hRktGrdV-AvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDM 649 (888)
T KOG4236|consen 572 LGSGQFGTVYGGKHRKTGRDV-AVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDM 649 (888)
T ss_pred ccCCcceeeecceecccCcee-eeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chH
Confidence 566555 4 8899999999 9999998764 345789999999999999999999999999999999999995 566
Q ss_pred HHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 76 FERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 76 ~~~l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
..+|-. .+++++...+.++.||+.||.|||-+||+|+||||+|||+.+. .-+++||||||+|+.........+.+||
T Consensus 650 LEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGT 729 (888)
T KOG4236|consen 650 LEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGT 729 (888)
T ss_pred HHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCC
Confidence 666543 5789999999999999999999999999999999999999653 3357999999999998888888999999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|.|.|||+++.++|+.. .|+||+|+|+|--+.|..||....+- ...+++ ....++...|..+++++.+||..+|+
T Consensus 730 PAYLaPEVLrnkGyNrS-LDMWSVGVIiYVsLSGTFPFNEdEdI---ndQIQN-AaFMyPp~PW~eis~~AidlIn~LLq 804 (888)
T KOG4236|consen 730 PAYLAPEVLRNKGYNRS-LDMWSVGVIIYVSLSGTFPFNEDEDI---NDQIQN-AAFMYPPNPWSEISPEAIDLINNLLQ 804 (888)
T ss_pred ccccCHHHHhhcccccc-ccceeeeEEEEEEecccccCCCccch---hHHhhc-cccccCCCchhhcCHHHHHHHHHHHH
Confidence 99999999999999755 89999999999999999999865432 222222 34455666788999999999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
..-++|.|+.+.|.|||++.
T Consensus 805 Vkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 805 VKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred HHHHHhcchHhhccchhhhc
Confidence 99999999999999999975
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=315.99 Aligned_cols=244 Identities=28% Similarity=0.412 Sum_probs=212.2
Q ss_pred Ccceee-eeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 3 GFHNFY-DRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 3 G~g~~~-~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
|||.++ ++-+.||+.| |+|++.+... .......+|-.+|..++.|.||.+-..|++...+|+|+..|+||+|.-+
T Consensus 197 GFGEV~acqvraTGKMY-AcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfH 275 (591)
T KOG0986|consen 197 GFGEVCACQVRATGKMY-ACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFH 275 (591)
T ss_pred cccceeEEEEecchhhH-HHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEE
Confidence 566666 6678899999 9999987663 3446778899999999999999999999999999999999999999988
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
|.+.+ .|++..++.++.+|+.||.+||+.+||+|||||+|||+|..|+ ++|+|.|||............+||..||
T Consensus 276 iyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~Gh--vRISDLGLAvei~~g~~~~~rvGT~GYM 353 (591)
T KOG0986|consen 276 IYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGH--VRISDLGLAVEIPEGKPIRGRVGTVGYM 353 (591)
T ss_pred eeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCC--eEeeccceEEecCCCCccccccCccccc
Confidence 88766 6999999999999999999999999999999999999998776 9999999999877777777779999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..|+.. .|+|||||++|+|+.|+.||..........++-+.+.......+ ..+|++++++.+.+|++||+
T Consensus 354 APEvl~ne~Y~~s-~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~LL~Kdp~ 430 (591)
T KOG0986|consen 354 APEVLQNEVYDFS-PDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGLLTKDPE 430 (591)
T ss_pred CHHHHcCCcccCC-ccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHHHccCHH
Confidence 9999999998766 89999999999999999999866554433344445555555555 36899999999999999999
Q ss_pred CCC-----CHhHHhcCccccc
Q 019901 237 KRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 237 ~R~-----s~~ell~h~~~~~ 252 (334)
+|. +++++.+||||+.
T Consensus 431 ~RLGcrg~ga~evk~HpfFk~ 451 (591)
T KOG0986|consen 431 KRLGCRGEGAQEVKEHPFFKD 451 (591)
T ss_pred HhccCCCcCcchhhhCccccc
Confidence 998 5789999999975
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=316.83 Aligned_cols=246 Identities=25% Similarity=0.448 Sum_probs=193.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .++++.++..+ |+|++.+... .....+.+|+.++..++||+|+++++.+.+++.+|+||||+.+|+
T Consensus 9 lG~G~fg~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~ 87 (332)
T cd05623 9 IGRGAFGEVAVVKLKNADKVF-AMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGD 87 (332)
T ss_pred EEeCCCeEEEEEEECCCCCEE-EEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCc
Confidence 555554 46777888888 9999976431 223457889999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++........ ....+|
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~g 165 (332)
T cd05623 88 LLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVG 165 (332)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCC--EEEeecchheecccCCcceeccccc
Confidence 9999977 467999999999999999999999999999999999999987664 99999999875432222 223579
Q ss_pred CCccccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC-CCCCCCHHHHHH
Q 019901 152 TPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHL 226 (334)
Q Consensus 152 t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 226 (334)
|+.|+|||++.. ....+.++|||||||++|+|++|+.||...+....+....... ....+| ....+++++++|
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~s~~~~~l 243 (332)
T cd05623 166 TPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK--ERFQFPAQVTDVSEDAKDL 243 (332)
T ss_pred CccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--ccccCCCccccCCHHHHHH
Confidence 999999999863 2223445999999999999999999998765544333322111 111222 224579999999
Q ss_pred HHHhcccCCCC--CCCHhHHhcCccccc
Q 019901 227 ISRIFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
|.+||..++.+ |++++++++||||..
T Consensus 244 i~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 244 IRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 99999765444 689999999999964
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=306.66 Aligned_cols=233 Identities=35% Similarity=0.606 Sum_probs=196.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 84 (334)
.+++..+++.+ |+|++.+... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.+++|.+++.+.+.
T Consensus 19 ~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~ 97 (290)
T cd05580 19 LVRHKGSGKYY-ALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGR 97 (290)
T ss_pred EEEEcCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCC
Confidence 37788888888 9999976542 2346788999999999999999999999999999999999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccC
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~ 164 (334)
+++..+..++.|++.||.|||++|++||||+|.||+++.++. +||+|||+++..... .....+++.|+|||.+.+.
T Consensus 98 l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~ 173 (290)
T cd05580 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGY--IKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK 173 (290)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEeeCCCccccCCC--CCCCCCCccccChhhhcCC
Confidence 999999999999999999999999999999999999987664 999999998764333 3445789999999998777
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC-----
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----- 239 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~----- 239 (334)
..+.+ +||||||+++|+|++|..||.......... .+......+| ..+++.++++|.+||..+|.+|+
T Consensus 174 ~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~R~~~~~~ 246 (290)
T cd05580 174 GYGKA-VDWWALGILIYEMLAGYPPFFDDNPIQIYE----KILEGKVRFP--SFFSPDAKDLIRNLLQVDLTKRLGNLKN 246 (290)
T ss_pred CCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCccCC--ccCCHHHHHHHHHHccCCHHHccCcccC
Confidence 66544 999999999999999999998765322222 2223333333 34689999999999999999999
Q ss_pred CHhHHhcCccccc
Q 019901 240 SIPEIRNHEWFLK 252 (334)
Q Consensus 240 s~~ell~h~~~~~ 252 (334)
+++++++||||..
T Consensus 247 ~~~~l~~~~~~~~ 259 (290)
T cd05580 247 GVNDIKNHPWFAG 259 (290)
T ss_pred CHHHHHcCccccc
Confidence 8999999999954
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=302.20 Aligned_cols=240 Identities=32% Similarity=0.476 Sum_probs=196.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEe
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME 68 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 68 (334)
||.|++ .+.+..+++.+ |+|.+....... .+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus 8 ig~g~~~~v~~a~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (267)
T cd06628 8 IGSGSFGSVYLGMNASSGELM-AVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLE 86 (267)
T ss_pred eecCCCeEEEEEEecCCCcEE-EEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEE
Confidence 455554 46777788888 999987654221 2568899999999999999999999999999999999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----
Q 019901 69 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 144 (334)
Q Consensus 69 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---- 144 (334)
|+.+++|..++.+.+.+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++......
T Consensus 87 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~ 164 (267)
T cd06628 87 YVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGG--IKISDFGISKKLEANSLSTK 164 (267)
T ss_pred ecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCC--EEecccCCCcccccccccCC
Confidence 9999999999988888999999999999999999999999999999999999987664 9999999987543211
Q ss_pred ---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCH
Q 019901 145 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221 (334)
Q Consensus 145 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (334)
......|++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||........... ... .........++.
T Consensus 165 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~ 238 (267)
T cd06628 165 TNGARPSLQGSVFWMAPEVVKQTSYTRK-ADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK----IGE-NASPEIPSNISS 238 (267)
T ss_pred ccccccccCCCcCccChhHhccCCCCch-hhhHHHHHHHHHHhhCCCCCCCccHHHHHHH----Hhc-cCCCcCCcccCH
Confidence 1123458889999999987777655 8999999999999999999987654332221 111 111122235789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 222 ECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.+.++|.+||+++|.+||++.++++||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=304.46 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=195.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .++++.+|+.| |+|.+.... ....+.+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus 9 l~~g~~~~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l 87 (286)
T cd07847 9 IGEGSYGVVFKCRNRETGQIV-AIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVL 87 (286)
T ss_pred ecccCCeEEEEEEECCCCcEE-EEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHH
Confidence 455544 46777788888 999987653 12345678999999999999999999999999999999999999888
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
...+.....+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++....... ......++..
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 165 (286)
T cd07847 88 NELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQ--IKLCDFGFARILTGPGDDYTDYVATRW 165 (286)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCc--EEECccccceecCCCcccccCcccccc
Confidence 887777777999999999999999999999999999999999999987664 9999999987654333 2233457889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc---------------cccCCC----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD---- 215 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---- 215 (334)
|+|||++.+....+.++||||||+++|+|++|++||.+................. ....+.
T Consensus 166 ~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07847 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETR 245 (286)
T ss_pred cCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccc
Confidence 9999998765444455999999999999999999998766543332222111000 000111
Q ss_pred ------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 216 ------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 216 ------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...++..+.+|+.+||+.+|.+|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 246 EPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 13468889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=306.99 Aligned_cols=239 Identities=24% Similarity=0.411 Sum_probs=187.5
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~ 84 (334)
.+++..+|..+ |+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|+||+. ++|...+.+ .+.
T Consensus 18 ~~~~~~~g~~~-~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~ 95 (284)
T cd07839 18 KAKNRETHEIV-ALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGD 95 (284)
T ss_pred EEEECCCCcEE-EEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCC
Confidence 47888899998 9999976541 234578889999999999999999999999999999999996 578777765 567
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~ 163 (334)
+++..++.++.||+.||.|||++||+||||||+||+++.++. ++|+|||+++...... ......+++.|+|||++.+
T Consensus 96 ~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 173 (284)
T cd07839 96 IDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGE--LKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173 (284)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCc--EEECccchhhccCCCCCCcCCCccccCCcChHHHhC
Confidence 999999999999999999999999999999999999987664 9999999987543222 1233467899999999877
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-hHHHHHHHHHHhh-------------ccccCC----------CCCCC
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILS-------------VQYSIP----------DYVHI 219 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~-------------~~~~~~----------~~~~~ 219 (334)
....+.++|||||||++|+|++|..||..... ...+......... .....+ ....+
T Consensus 174 ~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07839 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKL 253 (284)
T ss_pred CcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccC
Confidence 65444559999999999999999888644333 2222222111000 000000 11246
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+++++++|.+||+.+|.+|||+++++.||||
T Consensus 254 ~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 254 NSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 8999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=304.74 Aligned_cols=243 Identities=29% Similarity=0.415 Sum_probs=196.8
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||+++ +.+..+|..| |+|.+.+... .....+.+|+.+++.++||||+++++.+...+..|+||||+++++|.+++
T Consensus 6 ~g~vy~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 84 (277)
T cd05577 6 FGEVCACQVKATGKMY-ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHI 84 (277)
T ss_pred ceeEEEEEEcCCCcEE-EEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHH
Confidence 44443 6778888888 9999976542 22345678999999999999999999999999999999999999999998
Q ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
.+.. .+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++.............++..|+|
T Consensus 85 ~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~~ 162 (277)
T cd05577 85 YNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGN--VRISDLGLAVELKGGKKIKGRAGTPGYMA 162 (277)
T ss_pred HHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEccCcchhhhccCCccccccCCCCcCC
Confidence 7765 6999999999999999999999999999999999999987665 99999999875443333344568889999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +||||||+++|+|++|+.||..................... +....+++.+.++|.+||+.+|.+
T Consensus 163 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~ 239 (277)
T cd05577 163 PEVLQGEVYDFS-VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAV--EYPDKFSPEAKDLCEALLQKDPEK 239 (277)
T ss_pred HHHhcCCCCCch-hhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccc--cCCccCCHHHHHHHHHHccCChhH
Confidence 999987776555 99999999999999999999765542222222222222222 223357999999999999999999
Q ss_pred CC-----CHhHHhcCccccc
Q 019901 238 RI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 238 R~-----s~~ell~h~~~~~ 252 (334)
|| ++.++++||||..
T Consensus 240 R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 240 RLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred ccCCCcccHHHHHhChhhhc
Confidence 99 8888999999954
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-42 Score=303.80 Aligned_cols=245 Identities=26% Similarity=0.365 Sum_probs=196.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+++..++..+ ++|.+........+.+.+|+.+++.++||||+++++.+..++..++|+||+.+++|..
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~ 91 (282)
T cd06643 13 LGDGAFGKVYKAQNKETGVLA-AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91 (282)
T ss_pred cccCCCeEEEEEEECCCCeEE-EEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHH
Confidence 555554 36677778887 9999876553445678889999999999999999999999999999999999999988
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
.+.+ ..++++..+..++.|++.||.|||+.|++||||||+|||++.++. ++|+|||++...... .......+++.|
T Consensus 92 ~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y 169 (282)
T cd06643 92 VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYW 169 (282)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCC--EEEccccccccccccccccccccccccc
Confidence 7765 456999999999999999999999999999999999999987664 999999998754322 122345689999
Q ss_pred ccchhhc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 156 IAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 156 ~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+|||++. +..++ .++|+||+||++|+|++|++||...+.......... ......+....++.++++||.+|
T Consensus 170 ~aPE~~~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 170 MAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPTLAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred cCHhhccccCCCCCCCC-ccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhh---cCCCCCCCccccCHHHHHHHHHH
Confidence 9999984 23343 459999999999999999999987554333222211 11112233345789999999999
Q ss_pred cccCCCCCCCHhHHhcCcccccc
Q 019901 231 FVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
|+.+|.+|||+.++++||||...
T Consensus 246 l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 246 LEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred ccCChhhCcCHHHHhcCCCEecc
Confidence 99999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=302.49 Aligned_cols=246 Identities=28% Similarity=0.451 Sum_probs=198.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc------cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW------QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|.+ .+.+..+++.+ |+|.+..... .....+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~-alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~ 86 (268)
T cd06630 8 LGTGAFSSCYQARDVKTGTLM-AVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMA 86 (268)
T ss_pred ecCcCceEEEEEEEcCCCcEE-EEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccC
Confidence 455555 46778889998 9999876441 123578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----C
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----P 146 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~ 146 (334)
+++|.+++.+.+++++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||++........ .
T Consensus 87 ~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 165 (268)
T cd06630 87 GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQ-RLRIADFGAAARLAAKGTGAGEFQ 165 (268)
T ss_pred CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEcccccccccccccccCCccc
Confidence 9999999988888999999999999999999999999999999999999976542 499999999875433211 1
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
....++..|+|||.+.+..++.+ +|+||||+++|+|++|..||.......... .................+++++.++
T Consensus 166 ~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (268)
T cd06630 166 GQLLGTIAFMAPEVLRGEQYGRS-CDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATTAPSIPEHLSPGLRDV 243 (268)
T ss_pred cccccccceeCHhHhccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCCCCCCchhhCHHHHHH
Confidence 23468889999999987776555 899999999999999999997544322222 2222222222222233578999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
+.+||..+|.+|||+.++++||||+
T Consensus 244 i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 244 TLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHcCCCcccCcCHHHHhcCcccC
Confidence 9999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=320.00 Aligned_cols=242 Identities=22% Similarity=0.291 Sum_probs=189.4
Q ss_pred CCccee---e-eee--cCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF---Y-DRC--SYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~---~-~~~--~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ + +.. ..++..+ |+|.+... ....+|+.+++.++||||+++++++...+.+|+|||++. ++|
T Consensus 100 Lg~G~~g~Vy~~~~~~~~~~~~v-~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l 172 (392)
T PHA03207 100 LTPGSEGEVFVCTKHGDEQRKKV-IVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDL 172 (392)
T ss_pred ecCCCCeEEEEEEEcCCccceeE-EEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCH
Confidence 555654 3 332 3445667 99987543 346789999999999999999999999999999999995 688
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt 152 (334)
..++...+.+++..++.++.||+.||.|||++||+||||||+|||++..+. ++|+|||+++....... .....||
T Consensus 173 ~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~--~~l~DfG~a~~~~~~~~~~~~~~~~gt 250 (392)
T PHA03207 173 FTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN--AVLGDFGAACKLDAHPDTPQCYGWSGT 250 (392)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEccCccccccCcccccccccccccc
Confidence 898877788999999999999999999999999999999999999987665 99999999875433222 2245699
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhhcc-------------------
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQ------------------- 210 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~------------------- 210 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... ..+..++.......
T Consensus 251 ~~y~aPE~~~~~~~~~~-~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (392)
T PHA03207 251 LETNSPELLALDPYCAK-TDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYA 329 (392)
T ss_pred cCccCHhHhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhc
Confidence 99999999988887655 99999999999999999999765421 22222221111000
Q ss_pred ------ccCCC---CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 211 ------YSIPD---YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 211 ------~~~~~---~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+..+. ...++.++.+||.+||..+|.+|||+.++|.||||.+.
T Consensus 330 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 330 IVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred ccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 01111 01346789999999999999999999999999999763
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=306.70 Aligned_cols=245 Identities=26% Similarity=0.440 Sum_probs=196.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| ++++..++..+ |+|.+..... .....+.+|+.++++++||||+++++++..++.+++||||+++++|.
T Consensus 9 lg~G~~g~v~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~ 87 (308)
T cd06615 9 LGAGNGGVVTKVLHRPSGLIM-ARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 87 (308)
T ss_pred ccCCCCeEEEEEEEcCCCeEE-EEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHH
Confidence 455554 47788888888 9999876531 23356889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+++.+.+.+++..+..++.|++.||.|||+ .|++||||||+|||++.++. +||+|||++..... .......|++.|
T Consensus 88 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~-~~~~~~~~~~~~ 164 (308)
T cd06615 88 QVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSY 164 (308)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCc--EEEccCCCcccccc-cccccCCCCcCc
Confidence 999888889999999999999999999998 59999999999999987664 99999999875422 223455789999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHH-------------------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH------------------------------- 204 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~------------------------------- 204 (334)
+|||++.+..++.+ +|+|||||++|+|++|+.||...+.. .......
T Consensus 165 ~aPE~~~~~~~~~~-~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (308)
T cd06615 165 MSPERLQGTHYTVQ-SDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242 (308)
T ss_pred cChhHhcCCCCCcc-chHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCCCccchhhHHHH
Confidence 99999887776555 99999999999999999999754321 1111110
Q ss_pred --HHhhc-cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 205 --RILSV-QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 205 --~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..... ....|. ..++.++++|+.+||..+|++|||+.+++.||||.+.
T Consensus 243 ~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 243 LDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred HHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00000 000111 1367889999999999999999999999999999653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=315.06 Aligned_cols=245 Identities=25% Similarity=0.446 Sum_probs=193.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +++++.++..| |+|++.+... .....+.+|+.+++.++||||+++++++.+++..|+||||+.||+
T Consensus 9 lG~G~fg~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~ 87 (331)
T cd05624 9 IGRGAFGEVAVVKMKHTERIY-AMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGD 87 (331)
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCc
Confidence 455544 57888888888 9999976431 223457789999999999999999999999999999999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|..++.+ ...+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... ....+|
T Consensus 88 L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~g 165 (331)
T cd05624 88 LLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGH--IRLADFGSCLKMNQDGTVQSSVAVG 165 (331)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCC--EEEEeccceeeccCCCceeeccccC
Confidence 9999987 467999999999999999999999999999999999999987665 99999999875433222 123569
Q ss_pred CCccccchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC-CCCCCHHHHH
Q 019901 152 TPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRH 225 (334)
Q Consensus 152 t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 225 (334)
|+.|+|||++.+ ..++ .++|||||||++|+|++|+.||........+...... .....+|. ...++.++++
T Consensus 166 t~~y~aPE~~~~~~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~--~~~~~~p~~~~~~~~~~~~ 242 (331)
T cd05624 166 TPDYISPEILQAMEDGMGKYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH--EERFQFPSHITDVSEEAKD 242 (331)
T ss_pred CcccCCHHHHhccccCCCCCC-CcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcC--CCcccCCCccccCCHHHHH
Confidence 999999999865 3343 4489999999999999999999876543333322211 11122222 2357899999
Q ss_pred HHHHhcccCCCC--CCCHhHHhcCccccc
Q 019901 226 LISRIFVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 226 li~~~L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
+|.+||...+.+ |++++++++||||..
T Consensus 243 li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 243 LIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999876554 468999999999954
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=308.43 Aligned_cols=243 Identities=33% Similarity=0.509 Sum_probs=200.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+.+..++..| |||.+.+.... ....+.+|+.+++.++||||+++++.+..++..|+||||+.+++
T Consensus 9 ig~g~~g~vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 87 (316)
T cd05574 9 LGKGDVGRVFLVRLKGTGKLF-ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGE 87 (316)
T ss_pred ecCCccEEEEEEEEcCCCcEE-EEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCC
Confidence 455554 47777788998 99999876532 23568889999999999999999999999999999999999999
Q ss_pred hHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-------
Q 019901 75 LFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------- 145 (334)
Q Consensus 75 L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~------- 145 (334)
|.+++.+. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++........
T Consensus 88 L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 165 (316)
T cd05574 88 LFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGH--IMLSDFDLSKQSDVEPPPVSKALR 165 (316)
T ss_pred HHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCC--EEEeecchhhcccccccccccccc
Confidence 99998764 46999999999999999999999999999999999999987664 99999999864322111
Q ss_pred -----------------------CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHH
Q 019901 146 -----------------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202 (334)
Q Consensus 146 -----------------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 202 (334)
.....||..|+|||++.+..++. ++||||||+++|+|++|..||.+......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~-~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~- 243 (316)
T cd05574 166 KGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGS-AVDWWTLGILLYEMLYGTTPFKGSNRDETFSN- 243 (316)
T ss_pred cccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCc-hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHH-
Confidence 11235788999999998777754 49999999999999999999987665444333
Q ss_pred HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC----HhHHhcCccccc
Q 019901 203 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----IPEIRNHEWFLK 252 (334)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s----~~ell~h~~~~~ 252 (334)
+.......+....+++.++++|.+||..+|.+||| ++++++||||..
T Consensus 244 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~ 294 (316)
T cd05574 244 ---ILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRG 294 (316)
T ss_pred ---HhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhc
Confidence 23333344444447999999999999999999999 999999999965
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=305.28 Aligned_cols=239 Identities=26% Similarity=0.389 Sum_probs=197.0
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.+++..+++.+ |+|.+........+.+.+|+.+++.+.||||+++++.+..+...|+||||+.+++|.+++.+ ..+++
T Consensus 38 ~~~~~~~~~~v-~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~ 115 (296)
T cd06654 38 TAMDVATGQEV-AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDE 115 (296)
T ss_pred EEEECCCCcEE-EEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCH
Confidence 36677888888 99999877655567888999999999999999999999999999999999999999998865 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhccCCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 166 (334)
.++..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++........ .....|++.|+|||.+.+..+
T Consensus 116 ~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 193 (296)
T cd06654 116 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 193 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEECccccchhccccccccCcccCCccccCHHHHcCCCC
Confidence 999999999999999999999999999999999987664 99999999875433222 233468999999999987766
Q ss_pred CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 167 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+.+ +|||||||++|+|++|+.||............ ........+....++..+.+++.+||..+|.+|||+.+++.
T Consensus 194 ~~~-~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred Ccc-chHHHHHHHHHHHHhCCCCCCCCCHHHhHHHH---hcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 555 99999999999999999999876543222211 11122222334457899999999999999999999999999
Q ss_pred CccccccC
Q 019901 247 HEWFLKNL 254 (334)
Q Consensus 247 h~~~~~~~ 254 (334)
||||....
T Consensus 270 ~~~~~~~~ 277 (296)
T cd06654 270 HQFLKIAK 277 (296)
T ss_pred ChhhhccC
Confidence 99997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=300.84 Aligned_cols=240 Identities=25% Similarity=0.382 Sum_probs=191.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcC------CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTP------THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~------~~~~lv~e~~ 70 (334)
||.|++ .+.+..++..+ |+|++.... .....+.+|+.+++.+ +||||+++++.+... ...|+||||+
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~-aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 91 (272)
T cd06637 14 VGNGTYGQVYKGRHVKTGQLA-AIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 91 (272)
T ss_pred eeecCCeEEEEEEEcCCCcEE-EEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcC
Confidence 455544 36777788888 999997765 4456789999999998 699999999998753 4689999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCC
Q 019901 71 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 147 (334)
Q Consensus 71 ~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~ 147 (334)
.+++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||+++..... ....
T Consensus 92 ~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~--~~l~Dfg~~~~~~~~~~~~~ 169 (272)
T cd06637 92 GAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRN 169 (272)
T ss_pred CCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCC--EEEccCCCceecccccccCC
Confidence 999999998864 45899999999999999999999999999999999999987765 999999998754322 2234
Q ss_pred CccCCCccccchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHH
Q 019901 148 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (334)
...|++.|+|||++.+ ..++. ++||||+||++|+|++|..||........... .............++.+
T Consensus 170 ~~~g~~~y~aPE~~~~~~~~~~~~~~-~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 244 (272)
T cd06637 170 TFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKWSKK 244 (272)
T ss_pred cccccccccCHhHhccccCcCCCCCc-hhhHHHHHHHHHHHHhCCCCccccCHHHHHHH----HhcCCCCCCCCCCcCHH
Confidence 4568999999999863 23444 49999999999999999999976543222211 11122222223357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+.+|+.+||..+|.+|||+.+++.||||
T Consensus 245 ~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 245 FQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=301.93 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=198.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+++.+ |+|++.... ......+.+|+.+++.++||||+++++.+..+...|+|+||+.+++|.
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~ 87 (274)
T cd06609 9 IGKGSFGEVYKAIDKRTNQVV-AIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCL 87 (274)
T ss_pred hcCCCCeEEEEEEECCCCeEE-EEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHH
Confidence 454544 47778888888 999997654 233457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
+++... ++++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++..... .......+++.|
T Consensus 88 ~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y 164 (274)
T cd06609 88 DLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGD--VKLADFGVSGQLTSTMSKRNTFVGTPFW 164 (274)
T ss_pred HHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCC--EEEcccccceeecccccccccccCCccc
Confidence 998765 7899999999999999999999999999999999999987665 999999998765433 223445688999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||.+.+..++.+ +||||||+++|+|++|.+||.......... .+..... ..+. ..++.++.+++.+||..+
T Consensus 165 ~~PE~~~~~~~~~~-sDv~slG~il~~l~tg~~p~~~~~~~~~~~----~~~~~~~~~~~~-~~~~~~~~~~l~~~l~~~ 238 (274)
T cd06609 165 MAPEVIKQSGYDEK-ADIWSLGITAIELAKGEPPLSDLHPMRVLF----LIPKNNPPSLEG-NKFSKPFKDFVSLCLNKD 238 (274)
T ss_pred cChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCcccCchHHHHH----HhhhcCCCCCcc-cccCHHHHHHHHHHhhCC
Confidence 99999988776555 999999999999999999997655322221 1111111 1121 127889999999999999
Q ss_pred CCCCCCHhHHhcCccccccC
Q 019901 235 PAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~ 254 (334)
|.+|||+++++.||||.+..
T Consensus 239 p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 239 PKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred hhhCcCHHHHhhChhhcCCC
Confidence 99999999999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=303.88 Aligned_cols=239 Identities=26% Similarity=0.409 Sum_probs=198.2
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.+.+..+|+.+ |||.+........+.+.+|+.+++.++||||+++++.+..++..|+|+||+.+++|..++.+ ..+++
T Consensus 37 ~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~ 114 (296)
T cd06655 37 TAIDVATGQEV-AIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDE 114 (296)
T ss_pred EEEEcCCCcEE-EEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCH
Confidence 36778899998 99999876545567889999999999999999999999999999999999999999988865 46899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhccCCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~ 166 (334)
.++..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++........ .....+++.|+|||.+.+..+
T Consensus 115 ~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 192 (296)
T cd06655 115 AQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY 192 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccchhcccccccCCCcCCCccccCcchhcCCCC
Confidence 999999999999999999999999999999999987664 99999999875433322 233468899999999987777
Q ss_pred CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 167 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+.+ +|+|||||++|+|++|+.||............. .........+..+++.+.++|.+||..+|.+|||+.+++.
T Consensus 193 ~~~-~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 193 GPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA---TNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred Cch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 655 999999999999999999998765533322211 1112222334467899999999999999999999999999
Q ss_pred CccccccC
Q 019901 247 HEWFLKNL 254 (334)
Q Consensus 247 h~~~~~~~ 254 (334)
||||....
T Consensus 269 ~~~~~~~~ 276 (296)
T cd06655 269 HPFLKLAK 276 (296)
T ss_pred ChHhhhcc
Confidence 99997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=299.49 Aligned_cols=237 Identities=29% Similarity=0.406 Sum_probs=194.4
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFS 86 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 86 (334)
.+++..++..+ ++|++..........+.+|+.+++.++||||+++++.+..++.+|++|||+.+++|..++... ..++
T Consensus 21 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~ 99 (262)
T cd06613 21 KARDIATGELV-AIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLS 99 (262)
T ss_pred EeEecCCCCEE-EEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCC
Confidence 47777788888 999998776455678999999999999999999999999999999999999999999988776 7899
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccC-
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK- 164 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~- 164 (334)
+..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++....... ......++..|+|||.+.+.
T Consensus 100 ~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~ 177 (262)
T cd06613 100 ELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGD--VKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVER 177 (262)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCC--EEECccccchhhhhhhhccccccCCccccCchhhcccc
Confidence 9999999999999999999999999999999999987665 9999999987543322 22345688899999998766
Q ss_pred --CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 165 --EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 165 --~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
.++. ++|+||||+++|+|++|.+||................. ..........++.++.+++.+||..+|..|||+.
T Consensus 178 ~~~~~~-~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~ 255 (262)
T cd06613 178 KGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF-PPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTAT 255 (262)
T ss_pred cCCcCc-hhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC-CCccccchhhhhHHHHHHHHHHcCCChhhCCCHH
Confidence 5654 49999999999999999999987654333222111100 0111112234578899999999999999999999
Q ss_pred HHhcCcc
Q 019901 243 EIRNHEW 249 (334)
Q Consensus 243 ell~h~~ 249 (334)
+++.|+|
T Consensus 256 ~il~~~~ 262 (262)
T cd06613 256 KLLQHPF 262 (262)
T ss_pred HHhcCCC
Confidence 9999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=302.54 Aligned_cols=234 Identities=26% Similarity=0.383 Sum_probs=189.8
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.++++.++..+ |+|++..........+.+|+.+++.++||||+++++.+..++..++||||+.+++|.+++...+++++
T Consensus 27 ~~~~~~~~~~~-aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~ 105 (267)
T cd06646 27 KARNLHTGELA-AVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSE 105 (267)
T ss_pred EEEECCCCeEE-EEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCH
Confidence 36777888888 99999766534446788999999999999999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc---
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK--- 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~--- 163 (334)
..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++...... ......|++.|+|||.+..
T Consensus 106 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~ 183 (267)
T cd06646 106 LQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGD--VKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183 (267)
T ss_pred HHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCC--EEECcCccceeecccccccCccccCccccCHhHcccccC
Confidence 999999999999999999999999999999999987665 9999999987543222 2234568899999998853
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc---CCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS---IPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
..++ .++|+||+||++|+|++|+.||........... ....... .+....++..+.+||.+||..+|.+|||
T Consensus 184 ~~~~-~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~ 258 (267)
T cd06646 184 GGYN-QLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPT 258 (267)
T ss_pred CCCc-chhhHHHHHHHHHHHHhCCCCccccchhhhhee----eecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcC
Confidence 2343 458999999999999999999965432211111 1111111 1222346899999999999999999999
Q ss_pred HhHHhcCcc
Q 019901 241 IPEIRNHEW 249 (334)
Q Consensus 241 ~~ell~h~~ 249 (334)
++++++|+|
T Consensus 259 ~~~il~~l~ 267 (267)
T cd06646 259 AERLLTHLF 267 (267)
T ss_pred HHHHhcCCC
Confidence 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=320.77 Aligned_cols=234 Identities=21% Similarity=0.269 Sum_probs=183.3
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFS 86 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 86 (334)
.+.+..+++.| |||... ...+.+|+.+++.++||||+++++++..++..++||+++. ++|..++... ..++
T Consensus 187 ~a~~~~~~~~v-avK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~ 258 (461)
T PHA03211 187 ESSHPDYPQRV-VVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLG 258 (461)
T ss_pred EEEECCCCCEE-EEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCC
Confidence 47888888888 999643 2346789999999999999999999999999999999995 6888887654 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccchhhcc
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~ 163 (334)
+..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+
T Consensus 259 ~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 336 (461)
T PHA03211 259 LAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED--ICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAG 336 (461)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCC--EEEcccCCceecccccccccccccCCCcCCcCHHHHcC
Confidence 9999999999999999999999999999999999987664 9999999987543221 1223569999999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-------hHHHHHHHHHHhhcc--------------------------
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------PKNFRKTIHRILSVQ-------------------------- 210 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~~~~~~~~~~~-------------------------- 210 (334)
..++.+ +|||||||++|+|++|..|+..... ...+...+.......
T Consensus 337 ~~~~~~-sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 415 (461)
T PHA03211 337 DPYTPS-VDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPA 415 (461)
T ss_pred CCCCch-HHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCc
Confidence 887655 9999999999999998765532211 112222222111000
Q ss_pred ccC---CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 211 YSI---PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 211 ~~~---~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
... .....++.++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 416 ~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 416 YTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 000 111245678999999999999999999999999999964
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=302.55 Aligned_cols=242 Identities=22% Similarity=0.411 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+++.| |+|.+.... ......+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (279)
T cd06619 9 LGHGNGGTVYKAYHLLTRRIL-AVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLD 87 (279)
T ss_pred eccCCCeEEEEEEEcCCCcEE-EEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChH
Confidence 555544 47788899998 999997653 123457889999999999999999999999999999999999999986
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
.+ ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++. ++|+|||++...... ......||+.|+
T Consensus 88 ~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~--~~l~dfg~~~~~~~~-~~~~~~~~~~y~ 160 (279)
T cd06619 88 VY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQ--VKLCDFGVSTQLVNS-IAKTYVGTNAYM 160 (279)
T ss_pred Hh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCC--EEEeeCCcceecccc-cccCCCCChhhc
Confidence 54 35789999999999999999999999999999999999987765 999999998754322 234457899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH---HHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN---FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|||++.+..++.+ +|+||||+++|+|++|+.||........ .......+.............++++.+++.+||+.
T Consensus 161 aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 239 (279)
T cd06619 161 APERISGEQYGIH-SDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRK 239 (279)
T ss_pred CceeecCCCCCCc-chHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhC
Confidence 9999988777655 9999999999999999999975332111 01111111111111111234688999999999999
Q ss_pred CCCCCCCHhHHhcCccccc
Q 019901 234 DPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~ 252 (334)
+|.+||++++++.||||..
T Consensus 240 ~P~~Rp~~~eil~~~~~~~ 258 (279)
T cd06619 240 QPKERPAPENLMDHPFIVQ 258 (279)
T ss_pred ChhhCCCHHHHhcCccccc
Confidence 9999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=301.33 Aligned_cols=242 Identities=26% Similarity=0.417 Sum_probs=200.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+++..+++.| |+|++.+... ...+.+.+|+.++++++||||+++++.+..+...++|+||+.|++
T Consensus 8 i~~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 86 (258)
T cd05578 8 IGKGAFGKVCIVQKRDTKKMF-AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGD 86 (258)
T ss_pred eccCCCceEEEEEEccCCcEE-EEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCC
Confidence 455554 47788889998 9999987542 234678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|...+....++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++.............|+..
T Consensus 87 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~ 164 (258)
T cd05578 87 LRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH--VHITDFNIATKVTPDTLTTSTSGTPG 164 (258)
T ss_pred HHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC--EEEeecccccccCCCccccccCCChh
Confidence 9999988778999999999999999999999999999999999999987665 99999999876544444445678899
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|+||||+++|+|++|..||...... .............. ..+..++..+.++|.+||..+
T Consensus 165 y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~ 240 (258)
T cd05578 165 YMAPEVLCRQGYSVA-VDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQETADV--LYPATWSTEAIDAINKLLERD 240 (258)
T ss_pred hcCHHHHcccCCCCc-ccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhccccc--cCcccCcHHHHHHHHHHccCC
Confidence 999999987776555 99999999999999999999876541 11111111111122 223357899999999999999
Q ss_pred CCCCCCH--hHHhcCccc
Q 019901 235 PAKRISI--PEIRNHEWF 250 (334)
Q Consensus 235 p~~R~s~--~ell~h~~~ 250 (334)
|.+||++ +++++||||
T Consensus 241 p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 241 PQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred hhHcCCccHHHHhcCCCC
Confidence 9999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=326.52 Aligned_cols=243 Identities=29% Similarity=0.425 Sum_probs=196.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC--------eEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT--------HLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--------~~~lv~ 67 (334)
||.|+| ++++..+|..| |||++..... .....+.+|+..+..++|+||+++++.+.... .+++||
T Consensus 40 LG~G~fG~Vy~a~~~~~g~~v-AvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~ 118 (496)
T PTZ00283 40 LGSGATGTVLCAKRVSDGEPF-AVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVL 118 (496)
T ss_pred EecCCCEEEEEEEEcCCCCEE-EEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEE
Confidence 455544 47788899998 9999977642 22356788999999999999999988775432 478999
Q ss_pred eccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-
Q 019901 68 EYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 142 (334)
Q Consensus 68 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~- 142 (334)
||+.+|+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 119 Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~--vkL~DFGls~~~~~~ 196 (496)
T PTZ00283 119 DYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL--VKLGDFGFSKMYAAT 196 (496)
T ss_pred eCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCC--EEEEecccCeecccc
Confidence 999999999988642 46899999999999999999999999999999999999987665 99999999875332
Q ss_pred --CCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCC
Q 019901 143 --HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 143 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (334)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+ ........ .+.+..++
T Consensus 197 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k-~DVwSlGvilyeLltG~~Pf~~~~~~~~~----~~~~~~~~-~~~~~~~~ 270 (496)
T PTZ00283 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKK-ADMFSLGVLLYELLTLKRPFDGENMEEVM----HKTLAGRY-DPLPPSIS 270 (496)
T ss_pred ccccccccccCCcceeCHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHH----HHHhcCCC-CCCCCCCC
Confidence 122345679999999999988877655 99999999999999999999875543322 22222222 12334679
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+++.+++.+||+.+|.+|||+.++++|||++..
T Consensus 271 ~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 271 PEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 999999999999999999999999999998653
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=306.01 Aligned_cols=246 Identities=25% Similarity=0.421 Sum_probs=199.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..++..+ |||.+........+.+.+|+..++.++||||+++++.+..++..|+||||+.+++|..
T Consensus 30 lg~g~~g~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~ 108 (292)
T cd06658 30 IGEGSTGIVCIATEKHTGKQV-AVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD 108 (292)
T ss_pred ccCCCCeEEEEEEECCCCCEE-EEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHH
Confidence 555554 36677788888 9999876554445678899999999999999999999999999999999999999988
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++. ++|+|||++....... ......|++.|+
T Consensus 109 ~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~ 185 (292)
T cd06658 109 IVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGR--IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185 (292)
T ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCC--EEEccCcchhhcccccccCceeecCcccc
Confidence 7754 56899999999999999999999999999999999999987654 9999999987432222 223456899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||.+.+..++.+ +|+||||+++|+|++|+.||........+.. +... .....+....++..+.+++.+||..+|.
T Consensus 186 aPE~~~~~~~~~~-~Dv~slGvil~el~~g~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~P~ 261 (292)
T cd06658 186 APEVISRLPYGTE-VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR-IRDN--LPPRVKDSHKVSSVLRGFLDLMLVREPS 261 (292)
T ss_pred CHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhc--CCCccccccccCHHHHHHHHHHccCChh
Confidence 9999987777655 9999999999999999999987654333222 1111 1222233335789999999999999999
Q ss_pred CCCCHhHHhcCccccccCC
Q 019901 237 KRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~~ 255 (334)
+|||++++++||||....+
T Consensus 262 ~Rpt~~~il~~~~~~~~~~ 280 (292)
T cd06658 262 QRATAQELLQHPFLKLAGP 280 (292)
T ss_pred HCcCHHHHhhChhhhccCC
Confidence 9999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=324.71 Aligned_cols=247 Identities=30% Similarity=0.457 Sum_probs=205.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| + +++..|.-+. |||-+.........-+..||.+.+.|+|.|||++++.+..++.+-|.||-++||+|..
T Consensus 583 LGKGTYG~VYA~RD~~tqvrI-aIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 583 LGKGTYGTVYAARDMDTQVRI-AIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred eecCceeEEEeeccccceeEE-EeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 566666 5 5556665565 9999987664555678899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-CCCCCCCccCCC
Q 019901 78 RICNA-GRF--SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~-~~~--~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~ 153 (334)
++... +++ ++..+-.+.+||++||.|||...|||||||-.|+||+.. .+.+||+|||-++... .+....+..||.
T Consensus 662 LLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTy-SGvlKISDFGTsKRLAginP~TETFTGTL 740 (1226)
T KOG4279|consen 662 LLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTY-SGVLKISDFGTSKRLAGINPCTETFTGTL 740 (1226)
T ss_pred HHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeec-cceEEecccccchhhccCCccccccccch
Confidence 99865 566 889999999999999999999999999999999999743 3569999999987643 344456778999
Q ss_pred ccccchhhcc-CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|||||++.. ..-+++++|||||||++.||.||++||.....+. ..+.++.......|.+..+|.++++||.+|+.
T Consensus 741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgspq---AAMFkVGmyKvHP~iPeelsaeak~FilrcFe 817 (1226)
T KOG4279|consen 741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQ---AAMFKVGMYKVHPPIPEELSAEAKNFILRCFE 817 (1226)
T ss_pred hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChh---HhhhhhcceecCCCCcHHHHHHHHHHHHHHcC
Confidence 9999999964 3334677999999999999999999998665543 23333444444455556789999999999999
Q ss_pred cCCCCCCCHhHHhcCcccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~ 253 (334)
++|.+||++.++|..||++.+
T Consensus 818 pd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 818 PDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred CCcccCccHHHhccCcccccC
Confidence 999999999999999999764
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-42 Score=337.50 Aligned_cols=246 Identities=28% Similarity=0.448 Sum_probs=195.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~ 73 (334)
||.|+| ++++..++..+ |+|++..... .....+.+|+.+++.++||||++++++|.. ...+||||||+.++
T Consensus 21 LG~GgFGtVYLAkdk~tg~~v-AlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gG 99 (1021)
T PTZ00266 21 IGNGRFGEVFLVKHKRTQEFF-CWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAG 99 (1021)
T ss_pred EecCCCeEEEEEEECCCCeEE-EEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCC
Confidence 455544 48888888888 9999976542 223578899999999999999999998854 45799999999999
Q ss_pred ChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-------CceeCCCCCCcEEEcCC---------------CCC
Q 019901 74 ELFERICN----AGRFSEDEARFFFQQLISGVSYCHSM-------QVCHRDLKLENTLLDGS---------------PAP 127 (334)
Q Consensus 74 ~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~-------~ivH~dlkp~NIli~~~---------------~~~ 127 (334)
+|..+|.. .+.+++..++.|+.||+.||.|||+. +||||||||+|||++.. +..
T Consensus 100 SL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~ 179 (1021)
T PTZ00266 100 DLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179 (1021)
T ss_pred cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCC
Confidence 99998875 25699999999999999999999984 59999999999999642 223
Q ss_pred CEEEeccCCccCCCCCCCCCCccCCCccccchhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHH
Q 019901 128 RLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205 (334)
Q Consensus 128 ~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 205 (334)
.+||+|||+++............||+.|+|||++.+. .++ .++||||||||+|+|++|..||........+...+.
T Consensus 180 iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s-~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk- 257 (1021)
T PTZ00266 180 IAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYD-DKSDMWALGCIIYELCSGKTPFHKANNFSQLISELK- 257 (1021)
T ss_pred ceEEccCCccccccccccccccCCCccccCHHHHhccCCCCC-chhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHh-
Confidence 4899999999865444444556799999999998653 344 449999999999999999999987655433322221
Q ss_pred HhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 206 ~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
....++ ....+.++.+||.+||..+|.+|||+.++|.|||+....
T Consensus 258 ---~~p~lp-i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 258 ---RGPDLP-IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred ---cCCCCC-cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 111222 234689999999999999999999999999999997543
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.51 Aligned_cols=240 Identities=25% Similarity=0.409 Sum_probs=194.3
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~ 84 (334)
.+.+..+|..+ |+|++..... .....+.+|+.+++.++||||+++++++..+...++|+||+ +++|.+++.. ...
T Consensus 18 ~~~~~~~~~~~-~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~ 95 (286)
T cd07832 18 KAKDRETGETV-ALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERP 95 (286)
T ss_pred EEEECCCCceE-EEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCC
Confidence 46777888888 9999987652 23467899999999999999999999999999999999999 9999998865 356
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchhhc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~ 162 (334)
+++..++.++.||+.||+|||+.|++|+||||+||+++.++. ++|+|||++........ .....|++.|+|||.+.
T Consensus 96 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 173 (286)
T cd07832 96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGV--LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLY 173 (286)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCc--EEEeeeeecccccCCCCCccccccCcccccCceeee
Confidence 999999999999999999999999999999999999987654 99999999876543321 23456899999999987
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc---------------ccCC---------CCCC
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIP---------DYVH 218 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~ 218 (334)
+....+.++||||+|+++|+|++|.+||.+......+........... ...+ ....
T Consensus 174 ~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (286)
T cd07832 174 GARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPD 253 (286)
T ss_pred ccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCC
Confidence 665545669999999999999999999977665444433332211100 0000 0124
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 219 ~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
.+..+.++|.+||..+|.+|||+++++.||||.
T Consensus 254 ~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 254 ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 578999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=301.26 Aligned_cols=238 Identities=26% Similarity=0.381 Sum_probs=193.6
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFS 86 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~ 86 (334)
.+.+..++..+ |+|++........+.+.+|+.+++.++||||+++++.+..+...|+||||+.+++|..++.+. ..++
T Consensus 23 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~ 101 (280)
T cd06611 23 KAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLT 101 (280)
T ss_pred EEEEcCCCcEE-EEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCC
Confidence 36677788888 999998665344467889999999999999999999999999999999999999999998764 4699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc--
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK-- 163 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~-- 163 (334)
+..++.++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++....... ......+++.|+|||.+..
T Consensus 102 ~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 179 (280)
T cd06611 102 EPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGD--VKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179 (280)
T ss_pred HHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCC--EEEccCccchhhcccccccceeecchhhcCHHHHhhcc
Confidence 9999999999999999999999999999999999987665 9999999886543222 2234468999999999853
Q ss_pred ---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 164 ---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 164 ---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
..++ .++|+||||+++|+|++|++||.......... .+.... ..+.....++.++.++|.+||+.+|.+||
T Consensus 180 ~~~~~~~-~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 254 (280)
T cd06611 180 FKDNPYD-YKADIWSLGITLIELAQMEPPHHELNPMRVLL----KILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP 254 (280)
T ss_pred cCCCCCC-ccccHHHHHHHHHHHHhCCCCcccCCHHHHHH----HHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCc
Confidence 2333 34999999999999999999998765433222 222221 12223345789999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
|+.++++||||.+.
T Consensus 255 s~~~il~~~~~~~~ 268 (280)
T cd06611 255 TAAELLKHPFVSDQ 268 (280)
T ss_pred CHHHHhcChhhccc
Confidence 99999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=300.00 Aligned_cols=244 Identities=28% Similarity=0.438 Sum_probs=194.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc----------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ----------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~----------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 67 (334)
||.|++ .+.+..+|+.+ |||.+...... ..+.+.+|+.+++.++|||++++++++...+..++||
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 87 (272)
T cd06629 9 IGKGTYGRVYLALNVTTGEMM-AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFL 87 (272)
T ss_pred ecccCceEEEEEeecCCCcee-eeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEE
Confidence 566665 36677788888 99998753211 1246788999999999999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---
Q 019901 68 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 144 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--- 144 (334)
||+.+++|.+++.+.+.+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++......
T Consensus 88 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~ 165 (272)
T cd06629 88 EYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGI--CKISDFGISKKSDDIYDND 165 (272)
T ss_pred ecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCe--EEEeecccccccccccccc
Confidence 99999999999988888999999999999999999999999999999999999987664 9999999987543211
Q ss_pred CCCCccCCCccccchhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCH
Q 019901 145 QPKSTVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISP 221 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 221 (334)
......|+..|+|||++.... ..+.++|+||||+++|+|++|..||..........+.... .....++. ...++.
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~ 243 (272)
T cd06629 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNK--RSAPPIPPDVSMNLSP 243 (272)
T ss_pred ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhcc--ccCCcCCccccccCCH
Confidence 122345888999999987654 2244599999999999999999999754433222221111 11111221 235689
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 222 ECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.+.++|.+||..+|.+|||++++++||||
T Consensus 244 ~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 244 VALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred HHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 99999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-43 Score=337.34 Aligned_cols=243 Identities=31% Similarity=0.465 Sum_probs=209.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||-|.| +++++.|++.| |+|++.|.. .....-+..|-.+|.-.+.+=|++++..|+++.++|+||||+.||+
T Consensus 83 IGrGaFGEV~lVr~k~t~~VY-AMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGD 161 (1317)
T KOG0612|consen 83 IGRGAFGEVALVRHKSTEKVY-AMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGD 161 (1317)
T ss_pred hcccccceeEEEEeeccccch-hHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCch
Confidence 566666 79999999999 999999854 2334667888899988899999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt 152 (334)
|..++.+..++++.-++.|+..|+.||..||+.|+|||||||.|||++..|. +||+|||-+-.....+. ....+||
T Consensus 162 lltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GH--ikLADFGsClkm~~dG~V~s~~aVGT 239 (1317)
T KOG0612|consen 162 LLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGH--IKLADFGSCLKMDADGTVRSSVAVGT 239 (1317)
T ss_pred HHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCc--EeeccchhHHhcCCCCcEEeccccCC
Confidence 9999999999999999999999999999999999999999999999998876 99999998876654443 3456899
Q ss_pred Cccccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--cccCCCCCCCCHHHHHH
Q 019901 153 PAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHL 226 (334)
Q Consensus 153 ~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l 226 (334)
|-|++||++.. ...+++.+|+||+||++|||+.|..||...+ +..+..+|+.. .+.+|....+|.++++|
T Consensus 240 PDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~~l~FP~~~~VSeeakdL 315 (1317)
T KOG0612|consen 240 PDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKESLSFPDETDVSEEAKDL 315 (1317)
T ss_pred CCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhhhcCCCcccccCHHHHHH
Confidence 99999999862 1334556999999999999999999999744 44555555554 56677777899999999
Q ss_pred HHHhcccCCCCCCC---HhHHhcCccccc
Q 019901 227 ISRIFVADPAKRIS---IPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~R~s---~~ell~h~~~~~ 252 (334)
|.+++. +|..|.. ++++.+||||..
T Consensus 316 I~~ll~-~~e~RLgrngiedik~HpFF~g 343 (1317)
T KOG0612|consen 316 IEALLC-DREVRLGRNGIEDIKNHPFFEG 343 (1317)
T ss_pred HHHHhc-ChhhhcccccHHHHHhCccccC
Confidence 999885 8899998 999999999964
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=300.65 Aligned_cols=244 Identities=28% Similarity=0.417 Sum_probs=189.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHH---HcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINH---RSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l---~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .+.+..++..+ |||++.+..... .....+|..++ ...+||||+.+++.+..++..++||||+.
T Consensus 2 lg~G~~g~Vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 2 IGRGGFGEVYGCRKADTGKMY-AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred cccCCCeEEEEEEECCCCcEE-EEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 565555 36777788888 999997754221 12334444433 34579999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
+++|..++...+.+++..+..++.|++.||.|||++||+||||||+|||++.++. ++|+|||++...... ......|
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~--~~l~dfg~~~~~~~~-~~~~~~~ 157 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCC--EEEccCCcceecccc-CccCcCC
Confidence 9999999988888999999999999999999999999999999999999987665 999999998644322 2234568
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
++.|+|||.+.+....+.++||||+||++|+|++|..||........ ............. .+..++++++++|.+||
T Consensus 158 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l 234 (279)
T cd05633 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTVNVE--LPDSFSPELKSLLEGLL 234 (279)
T ss_pred CcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH-HHHHHHhhcCCcC--CccccCHHHHHHHHHHh
Confidence 99999999986433333449999999999999999999975433211 1111111111222 22357899999999999
Q ss_pred ccCCCCCC-----CHhHHhcCccccc
Q 019901 232 VADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
..+|.+|| |++++++||||+.
T Consensus 235 ~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 235 QRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred cCCHHHhcCCCCCCHHHHHhCccccC
Confidence 99999999 6999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=304.65 Aligned_cols=246 Identities=25% Similarity=0.387 Sum_probs=199.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|.+ .+.+..+++.| |+|.+........+.+.+|+.+++.++||||+++++.+..++..|+||||+++++|.+
T Consensus 27 lg~g~~g~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (297)
T cd06656 27 IGQGASGTVYTAIDIATGQEV-AIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 105 (297)
T ss_pred eccCCCeEEEEEEECCCCCEE-EEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHH
Confidence 555544 46778889998 9999987664555778899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~ 156 (334)
++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++. ++|+|||++........ .....+++.|+
T Consensus 106 ~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~ 182 (297)
T cd06656 106 VVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182 (297)
T ss_pred HHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEECcCccceEccCCccCcCcccCCcccc
Confidence 8865 45899999999999999999999999999999999999987664 99999999875433222 23346889999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||.+.+..++.+ +|+|||||++|+|++|..||............ ..........+..++..+++++.+||..+|.
T Consensus 183 aPE~~~~~~~~~~-~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 258 (297)
T cd06656 183 APEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPERLSAVFRDFLNRCLEMDVD 258 (297)
T ss_pred CHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCcchheeee---ccCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence 9999987777544 99999999999999999999765542221111 1111112223345788999999999999999
Q ss_pred CCCCHhHHhcCccccccCC
Q 019901 237 KRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~~ 255 (334)
+|||+++++.||||....+
T Consensus 259 ~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 259 RRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred hCcCHHHHhcCchhccccc
Confidence 9999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=309.58 Aligned_cols=245 Identities=24% Similarity=0.380 Sum_probs=180.4
Q ss_pred CCccee---e-eeec--CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCS--YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~--~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~ 73 (334)
||.|+| + ++++ .++..| |+|.+.... ....+.+|+.+++.++||||+++++++.. +...++||||+. +
T Consensus 9 lG~G~~g~Vy~~~~~~~~~~~~~-a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~ 84 (317)
T cd07867 9 VGRGTYGHVYKAKRKDGKDEKEY-ALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-H 84 (317)
T ss_pred eccCCCeeEEEEEecCCCccceE-EEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-C
Confidence 565555 3 4433 355677 999986544 34568899999999999999999998854 567899999995 5
Q ss_pred ChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCCccCCCC
Q 019901 74 ELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVL 142 (334)
Q Consensus 74 ~L~~~l~~~---------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgla~~~~~ 142 (334)
+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..+++||+|||+++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~ 164 (317)
T cd07867 85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164 (317)
T ss_pred cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCC
Confidence 777776421 248899999999999999999999999999999999999532 223699999999975433
Q ss_pred CCC----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHh--
Q 019901 143 HSQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRIL-- 207 (334)
Q Consensus 143 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~-- 207 (334)
... .....||+.|+|||++.+....+.++|||||||++|+|++|++||...... ...........
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 221 233468999999999977554455599999999999999999999754321 11111110000
Q ss_pred ----------------------hcccc--------CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 208 ----------------------SVQYS--------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 208 ----------------------~~~~~--------~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
..... .......+..+.++|.+||+.||.+|||++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000 00011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=302.28 Aligned_cols=243 Identities=27% Similarity=0.374 Sum_probs=195.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+++..++..+ ++|++..........+.+|+.+++.++||||+++++.+..++..|+||||+.+++|..
T Consensus 20 lg~g~~g~vy~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~ 98 (292)
T cd06644 20 LGDGAFGKVYKAKNKETGALA-AAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDA 98 (292)
T ss_pred ecCCCCeEEEEEEECCCCceE-EEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHH
Confidence 455554 47778888988 9999987654445678899999999999999999999999999999999999999988
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
.+.+ ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++...... .......+++.|
T Consensus 99 ~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y 176 (292)
T cd06644 99 IMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGD--IKLADFGVSAKNVKTLQRRDSFIGTPYW 176 (292)
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCC--EEEccCccceeccccccccceecCCccc
Confidence 7754 456899999999999999999999999999999999999986654 999999988653222 122344688999
Q ss_pred ccchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccCCCCCCCCHHHHHHHHH
Q 019901 156 IAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 156 ~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ 229 (334)
+|||++.+ ..++ .++|+|||||++|+|++|.+||..........+ .... ....+....++.++.++|.+
T Consensus 177 ~aPE~~~~~~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~ 251 (292)
T cd06644 177 MAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLK----IAKSEPPTLSQPSKWSMEFRDFLKT 251 (292)
T ss_pred cCceeeccccccCCCCC-chhhhHhHHHHHHHHhcCCCCCccccHHHHHHH----HhcCCCccCCCCcccCHHHHHHHHH
Confidence 99999853 2333 348999999999999999999976553222221 1111 11223334578899999999
Q ss_pred hcccCCCCCCCHhHHhcCccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||..+|.+||+++++++||||..
T Consensus 252 ~l~~~p~~Rp~~~~il~~~~~~~ 274 (292)
T cd06644 252 ALDKHPETRPSAAQLLEHPFVSS 274 (292)
T ss_pred HhcCCcccCcCHHHHhcCccccc
Confidence 99999999999999999999944
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=297.98 Aligned_cols=237 Identities=26% Similarity=0.428 Sum_probs=188.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| ++.++.++..+ |+|.+........ |+..... .+||||+++++.+..++..|+||||+++++|.
T Consensus 24 lg~g~~g~v~~~~~~~~~~~~-~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (267)
T PHA03390 24 LIDGKFGKVSVLKHKPTQKLF-VQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF 97 (267)
T ss_pred ecCCCceEEEEEEEcCCCcEE-EEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHH
Confidence 355544 47778888888 9999876542211 2222222 27999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
+++.+...+++..++.++.|++.||.|||+.|++||||||+||+++.++ +.++|+|||+++.... .....+++.|+
T Consensus 98 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~---~~~~~~~~~y~ 173 (267)
T PHA03390 98 DLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAK-DRIYLCDYGLCKIIGT---PSCYDGTLDYF 173 (267)
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCC-CeEEEecCccceecCC---CccCCCCCccc
Confidence 9998888899999999999999999999999999999999999998766 2499999999875432 23446899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|+||+|+++|+|++|+.||............+.... ....+....+++.+.+||.+||+.+|.
T Consensus 174 aPE~~~~~~~~~~-~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~ 250 (267)
T PHA03390 174 SPEKIKGHNYDVS-FDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ--QKKLPFIKNVSKNANDFVQSMLKYNIN 250 (267)
T ss_pred ChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh--cccCCcccccCHHHHHHHHHHhccChh
Confidence 9999988777655 9999999999999999999985543221111111111 222233346899999999999999999
Q ss_pred CCCC-HhHHhcCcccc
Q 019901 237 KRIS-IPEIRNHEWFL 251 (334)
Q Consensus 237 ~R~s-~~ell~h~~~~ 251 (334)
+||+ ++++|+||||.
T Consensus 251 ~R~~~~~~~l~h~~~~ 266 (267)
T PHA03390 251 YRLTNYNEIIKHPFLK 266 (267)
T ss_pred hCCchHHHHhcCCccc
Confidence 9996 69999999995
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.74 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=197.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-----ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-----~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ .+.+..+|+.| |||.+...... ....+.+|+.+++.++||||+++++++.+++..++||||+ +
T Consensus 8 lg~g~~~~vy~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~ 85 (298)
T cd07841 8 LGEGTYAVVYKARDKETGRIV-AIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-E 85 (298)
T ss_pred eeeccccEEEEEEECCCCcEE-EEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-C
Confidence 455554 46777888888 99999876522 2356778999999999999999999999999999999999 8
Q ss_pred CChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCcc
Q 019901 73 GELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTV 150 (334)
Q Consensus 73 ~~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~ 150 (334)
++|..++.+.. .+++..+..++.||+.||.|||++||+||||+|+|||++.++. ++|+|||+++....... .....
T Consensus 86 ~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~ 163 (298)
T cd07841 86 TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGV--LKLADFGLARSFGSPNRKMTHQV 163 (298)
T ss_pred CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCC--EEEccceeeeeccCCCccccccc
Confidence 99999998766 7999999999999999999999999999999999999987665 99999999876443322 22345
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------cC---------C
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SI---------P 214 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~---------~ 214 (334)
+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+......+.+.......... .. +
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T cd07841 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFP 243 (298)
T ss_pred cceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccC
Confidence 7889999999866544455699999999999999999888876654443333221100000 00 0
Q ss_pred ------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 ------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 ------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.....+..+.++|.+||.++|++|||+.+++.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~ 288 (298)
T cd07841 244 PTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND 288 (298)
T ss_pred CcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence 012357889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=298.09 Aligned_cols=241 Identities=29% Similarity=0.444 Sum_probs=194.9
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.++ +.+..++..+ |+|++..... .....+.+|+..++.++||||+++++.+...+..++|+|++.+++|.+++.+
T Consensus 14 ~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~ 92 (267)
T cd06610 14 TAVVYAAICLPNNEKV-AIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKS 92 (267)
T ss_pred CeEEEEEEEcCCCcEE-EEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHH
Confidence 34443 5566677888 9999976542 2346789999999999999999999999999999999999999999999976
Q ss_pred c---CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----CCCccCCC
Q 019901 82 A---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTP 153 (334)
Q Consensus 82 ~---~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~ 153 (334)
. ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++. ++|+|||++........ .....|++
T Consensus 93 ~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~ 170 (267)
T cd06610 93 SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGS--VKIADFGVSASLADGGDRTRKVRKTFVGTP 170 (267)
T ss_pred hcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccchHHHhccCccccccccccccCCh
Confidence 4 45899999999999999999999999999999999999987654 99999999875433222 23346899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC---CCCCCHHHHHHHHHh
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHISPECRHLISRI 230 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~ 230 (334)
.|+|||++......+.++|+||||+++|+|++|+.||........+.+.... .....+. ...+++.+.+++.+|
T Consensus 171 ~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06610 171 CWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPPSLETGADYKKYSKSFRKMISLC 247 (267)
T ss_pred hhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCCCcCCccccccccHHHHHHHHHH
Confidence 9999999877633345599999999999999999999876554443333222 1111111 235789999999999
Q ss_pred cccCCCCCCCHhHHhcCccc
Q 019901 231 FVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~ 250 (334)
|..+|.+|||+++++.||||
T Consensus 248 l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 248 LQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred cCCChhhCcCHHHHhhCCCC
Confidence 99999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.90 Aligned_cols=244 Identities=25% Similarity=0.456 Sum_probs=199.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..+++.| |||++........+.+.+|+.+++.++||||+++++.+..++..|+|+||+.+++|..
T Consensus 29 ig~g~~g~v~~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~ 107 (297)
T cd06659 29 IGEGSTGIVCIAREKHSGRQV-AVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD 107 (297)
T ss_pred cCCCCceeEEEEEEcCCCCEE-EEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence 555554 46777888888 9999976554455678899999999999999999999999999999999999999988
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
.+.. ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....... ......|++.|+
T Consensus 108 ~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~ 184 (297)
T cd06659 108 IVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184 (297)
T ss_pred HHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc--EEEeechhHhhcccccccccceecCcccc
Confidence 7654 56899999999999999999999999999999999999987765 9999999986433222 223456899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|||||||++|+|++|+.||........... +.. ...........++..+.++|.+||+.+|.
T Consensus 185 aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~l~~~i~~~l~~~P~ 260 (297)
T cd06659 185 APEVISRTPYGTE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR-LRD--SPPPKLKNAHKISPVLRDFLERMLTREPQ 260 (297)
T ss_pred CHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-Hhc--cCCCCccccCCCCHHHHHHHHHHhcCCcc
Confidence 9999987777554 9999999999999999999986554333222 111 11111222345789999999999999999
Q ss_pred CCCCHhHHhcCcccccc
Q 019901 237 KRISIPEIRNHEWFLKN 253 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~ 253 (334)
+|||++++++||||.+.
T Consensus 261 ~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 261 ERATAQELLDHPFLLQT 277 (297)
T ss_pred cCcCHHHHhhChhhccC
Confidence 99999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=299.69 Aligned_cols=239 Identities=26% Similarity=0.479 Sum_probs=195.3
Q ss_pred eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 85 (334)
.+.++.+++.+ |+|.+..... .....+.+|+.+++.++||||+++++.+..++..++|+||+.+++|.+++... ..+
T Consensus 19 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 97 (265)
T cd06605 19 KVLHRPTGKIM-AVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRI 97 (265)
T ss_pred EEEEcCCCcEE-EEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCC
Confidence 47788889998 9999887642 33467889999999999999999999999999999999999999999999876 779
Q ss_pred CHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~ 164 (334)
++..+..++.|++.||.|||+ .|++||||+|+||+++.++. ++|+|||.+........ ....+++.|+|||.+.+.
T Consensus 98 ~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~ 174 (265)
T cd06605 98 PERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ--IKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGN 174 (265)
T ss_pred CHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCC--EEEeecccchhhHHHHh-hcccCChhccCHHHHcCC
Confidence 999999999999999999999 99999999999999987654 99999999865432221 226788999999999887
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCc-hHHHHHHHHHHhhccc-cCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
.++.+ +||||||+++|+|++|..||..... .......+........ ..+. ..+++++.++|.+||..+|.+|||+.
T Consensus 175 ~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~Rpt~~ 252 (265)
T cd06605 175 DYSVK-SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFVNLCLIKDPRERPSYK 252 (265)
T ss_pred CCCch-hhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHHHHHcCCCchhCcCHH
Confidence 77655 9999999999999999999975421 1122222333222221 1111 12789999999999999999999999
Q ss_pred HHhcCccccc
Q 019901 243 EIRNHEWFLK 252 (334)
Q Consensus 243 ell~h~~~~~ 252 (334)
+++.||||++
T Consensus 253 ~ll~~~~~~~ 262 (265)
T cd06605 253 ELLEHPFIKK 262 (265)
T ss_pred HHhhCchhhc
Confidence 9999999965
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=295.17 Aligned_cols=241 Identities=34% Similarity=0.456 Sum_probs=198.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.+ .+.++.+++.+ |||.+..... .....+.+|+.+++.++||||+++++.+..++..++||||+.+++|
T Consensus 8 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (256)
T cd08220 8 VGRGAFGIVHLCRRKADQKLV-IIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86 (256)
T ss_pred ecccCceEEEEEEEcCCCcEE-EEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCH
Confidence 455544 47788889998 9999987542 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 76 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
.+++... ..+++..+..++.|++.||+|||++|++||||+|+||+++.++. .++|+|||++.............+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 165 (256)
T cd08220 87 AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKM-VVKIGDFGISKILSSKSKAYTVVGTP 165 (256)
T ss_pred HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC-EEEEccCCCceecCCCccccccccCC
Confidence 9999764 34899999999999999999999999999999999999975442 48999999998655444444567899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...+........ .... ..+....+++++.+++.+||..
T Consensus 166 ~y~aPE~~~~~~~~~~-~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~l~~li~~~l~~ 239 (256)
T cd08220 166 CYISPELCEGKPYNQK-SDIWALGCVLYELASLKRAFEAANLPALVLKI----MSGT-FAPISDRYSPDLRQLILSMLNL 239 (256)
T ss_pred cccCchhccCCCCCcc-cchHHHHHHHHHHHhCCCCcccCchHHHHHHH----HhcC-CCCCCCCcCHHHHHHHHHHccC
Confidence 9999999987766544 99999999999999999999876554333222 1111 1122234789999999999999
Q ss_pred CCCCCCCHhHHhcCccc
Q 019901 234 DPAKRISIPEIRNHEWF 250 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~ 250 (334)
+|.+|||+.++++||||
T Consensus 240 ~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 240 DPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ChhhCCCHHHHhhCCCC
Confidence 99999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=296.07 Aligned_cols=240 Identities=27% Similarity=0.412 Sum_probs=195.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|.+ .+++..++..+ ++|.+.... . ...+.+|+.+++.++||||+++++.+......|+++||+.+++|.+
T Consensus 11 i~~g~~~~v~~~~~~~~~~~~-~~k~~~~~~-~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~ 87 (256)
T cd06612 11 LGEGSYGSVYKAIHKETGQVV-AIKVVPVEE-D-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSD 87 (256)
T ss_pred hcCCCCeEEEEEEEcCCCcEE-EEEEeecHH-H-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHH
Confidence 454544 46677778888 999987654 2 5789999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCcc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y 155 (334)
++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++....... ......++..|
T Consensus 88 ~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y 165 (256)
T cd06612 88 IMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQ--AKLADFGVSGQLTDTMAKRNTVIGTPFW 165 (256)
T ss_pred HHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCc--EEEcccccchhcccCccccccccCCccc
Confidence 9875 456899999999999999999999999999999999999987665 9999999988654333 23344588999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||++.+..++.+ +||||||+++|+|++|+.||............. ............++..+.++|.+||+.+|
T Consensus 166 ~~PE~~~~~~~~~~-~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 241 (256)
T cd06612 166 MAPEVIQEIGYNNK-ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIP---NKPPPTLSDPEKWSPEFNDFVKKCLVKDP 241 (256)
T ss_pred cCHHHHhcCCCCch-hhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhc---cCCCCCCCchhhcCHHHHHHHHHHHhcCh
Confidence 99999988777555 999999999999999999998654432211110 01111122233467899999999999999
Q ss_pred CCCCCHhHHhcCccc
Q 019901 236 AKRISIPEIRNHEWF 250 (334)
Q Consensus 236 ~~R~s~~ell~h~~~ 250 (334)
.+|||+.+++.||||
T Consensus 242 ~~Rps~~~il~~~~~ 256 (256)
T cd06612 242 EERPSAIQLLQHPFI 256 (256)
T ss_pred hhCcCHHHHhcCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=297.51 Aligned_cols=237 Identities=35% Similarity=0.555 Sum_probs=198.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 84 (334)
.+++..+|+.+ ++|++..... ...+.+.+|+.+++.++||||+++++.+..+...|+|+||+.+++|.+++.+.+.
T Consensus 11 ~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 89 (265)
T cd05579 11 LAKKKSTGDIY-AIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89 (265)
T ss_pred EEEECCCCCEE-EEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCC
Confidence 47777789998 9999977653 2346788999999999999999999999999999999999999999999988788
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---------CCCCccCCCcc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---------QPKSTVGTPAY 155 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---------~~~~~~gt~~y 155 (334)
+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++....... ......+++.|
T Consensus 90 ~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (265)
T cd05579 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGH--LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167 (265)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCC--EEEEecccchhcccCcccccccccccccCcccCccc
Confidence 999999999999999999999999999999999999987765 9999999987543321 12234578899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||.+.+...+. ++|+||||+++|+|++|..||......... ..........+....+++.+.+++.+||+.+|
T Consensus 168 ~~Pe~~~~~~~~~-~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 242 (265)
T cd05579 168 IAPEVILGQGHSK-TVDWWSLGCILYEFLVGIPPFHGETPEEIF----QNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242 (265)
T ss_pred cCHHHhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HHHhcCCcCCCccccCCHHHHHHHHHHhcCCH
Confidence 9999998777544 499999999999999999999876543322 22333333444443458999999999999999
Q ss_pred CCCCCH---hHHhcCccccc
Q 019901 236 AKRISI---PEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~---~ell~h~~~~~ 252 (334)
.+|||+ .++++||||.+
T Consensus 243 ~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 243 EKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred hhcCCCccHHHHhcCccccC
Confidence 999999 99999999953
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=299.25 Aligned_cols=245 Identities=27% Similarity=0.463 Sum_probs=198.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.++.++..+ ++|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+.+++|.+
T Consensus 27 lg~g~~g~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~ 105 (285)
T cd06648 27 IGEGSTGIVCIATDKSTGRQV-AVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD 105 (285)
T ss_pred eccCCCeEEEEEEECCCCCEE-EEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHH
Confidence 455544 36667788888 9999876553445678899999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
++.. +++++..+..++.|++.||++||++|++||||+|+||+++.++. ++|+|||++....... ......|++.|+
T Consensus 106 ~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~ 182 (285)
T cd06648 106 IVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWM 182 (285)
T ss_pred HHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc--EEEcccccchhhccCCcccccccCCcccc
Confidence 9877 67999999999999999999999999999999999999987664 9999999876433221 223346899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||.+.+..++.+ +|+||||+++|+|++|+.||...+....... .... .........++..+.+|+.+||+.+|
T Consensus 183 aPE~~~~~~~~~~-~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 183 APEVISRLPYGTE-VDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR----IRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred CHHHhcCCCCCCc-ccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence 9999988777655 9999999999999999999987554333222 2211 11222223478999999999999999
Q ss_pred CCCCCHhHHhcCccccccCC
Q 019901 236 AKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~~ 255 (334)
.+|||+.+++.||||.+..+
T Consensus 258 ~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 258 AQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred hhCcCHHHHccCcccccCCC
Confidence 99999999999999977543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=293.71 Aligned_cols=234 Identities=27% Similarity=0.396 Sum_probs=193.6
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--C
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--G 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 83 (334)
.+.++.++..| ++|.+..... .....+.+|+.+++.++||||+++++.+...+..|+||||+.+++|.+++... .
T Consensus 18 ~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 96 (256)
T cd08529 18 KVVRKADKRVY-AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGR 96 (256)
T ss_pred EEEEcCCCcEE-EEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCC
Confidence 47778889998 9999876532 23467889999999999999999999999999999999999999999998774 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~ 162 (334)
.+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++....... .....|++.|+|||++.
T Consensus 97 ~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 174 (256)
T cd08529 97 PLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN--VKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174 (256)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCC--EEEcccccceeccCccchhhccccCccccCHHHhc
Confidence 6899999999999999999999999999999999999987654 99999999875433322 23346889999999998
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
+..++.+ +|+||||+++|+|++|+.||.......... .+...... +....++..+.+++.+||+.+|++||++.
T Consensus 175 ~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~ 248 (256)
T cd08529 175 DKPYNEK-SDVWALGVVLYECCTGKHPFDANNQGALIL----KIIRGVFP-PVSQMYSQQLAQLIDQCLTKDYRQRPDTF 248 (256)
T ss_pred CCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCC-CCccccCHHHHHHHHHHccCCcccCcCHH
Confidence 8777655 999999999999999999998765432222 22222211 12225789999999999999999999999
Q ss_pred HHhcCccc
Q 019901 243 EIRNHEWF 250 (334)
Q Consensus 243 ell~h~~~ 250 (334)
+++.|||+
T Consensus 249 ~ll~~~~~ 256 (256)
T cd08529 249 QLLRNPSL 256 (256)
T ss_pred HHhhCCCC
Confidence 99999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=295.93 Aligned_cols=241 Identities=29% Similarity=0.397 Sum_probs=191.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~ 70 (334)
||.|++ .+.+..++..| |+|.+..... .....+.+|+.+++.++||||+++++++.. ...+++++||+
T Consensus 10 lg~g~~g~vy~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~ 88 (266)
T cd06651 10 LGQGAFGRVYLCYDVDTGREL-AAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYM 88 (266)
T ss_pred ecCCCCEEEEEEEEcCCCcEE-EEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCC
Confidence 555555 46778889998 9999876531 122468889999999999999999998875 36789999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC----CCC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQP 146 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----~~~ 146 (334)
.+++|.+.+.+.+.+++..++.++.|++.||+|||++||+||||+|+||+++.++. ++|+|||+++..... ...
T Consensus 89 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 166 (266)
T cd06651 89 PGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRLQTICMSGTGI 166 (266)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCCCccccccccccCCcc
Confidence 99999999988888999999999999999999999999999999999999987654 999999998754321 112
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
....++..|+|||.+.+..++.. +|+||+||++|+|++|+.||........... .............+++.++++
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 167 RSVTGTPYWMSPEVISGEGYGRK-ADVWSLGCTVVEMLTEKPPWAEYEAMAAIFK----IATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred ccCCccccccCHHHhCCCCCCch-hhhHHHHHHHHHHHHCCCCccccchHHHHHH----HhcCCCCCCCchhcCHHHHHH
Confidence 23458889999999987776555 9999999999999999999986544332222 111111111123468889999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
+ +||..+|.+|||++++++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 57778999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=294.00 Aligned_cols=234 Identities=26% Similarity=0.424 Sum_probs=190.6
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEeccCCCChHHHHHhc--
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNA-- 82 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-- 82 (334)
.++++.+++.+ |+|.+..... ...+.+.+|+.+++.++|||++++++.+.. .+.+|+||||+.+++|.+.+...
T Consensus 18 ~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~ 96 (257)
T cd08223 18 LVRHRTDGKQY-VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG 96 (257)
T ss_pred EEEEcCCCcEE-EEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcC
Confidence 47788888888 9999976542 233568899999999999999999998764 45689999999999999988763
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~ 161 (334)
..+++.+++.++.|++.||.+||++|++||||||+||+++.++. ++|+|||++...... .......+++.|+|||++
T Consensus 97 ~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 174 (257)
T cd08223 97 KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNI--IKVGDLGIARVLENQCDMASTLIGTPYYMSPELF 174 (257)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCc--EEEecccceEEecccCCccccccCCcCccChhHh
Confidence 45899999999999999999999999999999999999987664 999999998754322 223345689999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+..++.+ +|+||||+++|+|++|+.||...+....... +..... .+....+++.+.+++.+||+.+|.+|||+
T Consensus 175 ~~~~~~~~-~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 248 (257)
T cd08223 175 SNKPYNYK-SDVWALGCCVYEMATLKHAFNAKDMNSLVYR----IIEGKL-PPMPKDYSPELGELIATMLSKRPEKRPSV 248 (257)
T ss_pred cCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHhcCC-CCCccccCHHHHHHHHHHhccCcccCCCH
Confidence 88777655 8999999999999999999986554322222 222211 12223578999999999999999999999
Q ss_pred hHHhcCccc
Q 019901 242 PEIRNHEWF 250 (334)
Q Consensus 242 ~ell~h~~~ 250 (334)
.+++.||||
T Consensus 249 ~~~l~~~~~ 257 (257)
T cd08223 249 KSILRQPYI 257 (257)
T ss_pred HHHhcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=308.38 Aligned_cols=226 Identities=21% Similarity=0.360 Sum_probs=178.1
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcC-CeEEEEEeccCCCChHHHHHhc-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNA------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------- 82 (334)
.++..| |||++..... .....+.+|+.+++.+ +||||+++++++... +.+++||||+++|+|.+++...
T Consensus 35 ~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~ 113 (338)
T cd05102 35 SSCNTV-AVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPY 113 (338)
T ss_pred ccchhh-heeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccc
Confidence 344566 9999876441 2235788999999999 899999999988764 4689999999999999988652
Q ss_pred -------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHC
Q 019901 83 -------------------------------------------------------GRFSEDEARFFFQQLISGVSYCHSM 107 (334)
Q Consensus 83 -------------------------------------------------------~~~~~~~~~~~~~qil~~L~~LH~~ 107 (334)
.++++..+..++.||+.||.|||++
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 193 (338)
T cd05102 114 REKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR 193 (338)
T ss_pred cccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2377888999999999999999999
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHH
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 184 (334)
||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..++.+ +|||||||++|+|+
T Consensus 194 ~ivHrDiKp~Nil~~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sDiwslG~il~el~ 270 (338)
T cd05102 194 KCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIF 270 (338)
T ss_pred CEECCCCccceEEEcCCCc--EEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcc-cCHHHHHHHHHHHH
Confidence 9999999999999987654 9999999997542221 1123346788999999988877655 99999999999999
Q ss_pred h-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 185 V-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 185 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+ |..||.+......+...+. .....+....+++.+.+++.+||+.+|.+|||+.++++
T Consensus 271 ~~g~~pf~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 271 SLGASPYPGVQINEEFCQRLK----DGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred hCCCCCCCCCCccHHHHHHHh----cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 7 9999987554333322221 11122223457899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=295.87 Aligned_cols=241 Identities=26% Similarity=0.392 Sum_probs=193.2
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| +.....+|+.+ |+|.+...... ....+.+|+.+++.++||||+++++++.+.+..++|+||+.+
T Consensus 8 ig~g~~~~v~~~~~~~~~~~-avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (265)
T cd06631 8 LGKGAYGTVYCGLTNQGQLI-AVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPG 86 (265)
T ss_pred EeccCCeEEEEEEEcCCCeE-EEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCC
Confidence 455554 33233577777 99998754311 124688999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-------CCC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-------HSQ 145 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-------~~~ 145 (334)
++|.+++.+.+++++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||++..... ...
T Consensus 87 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 164 (265)
T cd06631 87 GSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGI--IKLIDFGCARRLAWVGLHGTHSNM 164 (265)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCe--EEeccchhhHhhhhcccccccccc
Confidence 999999988888999999999999999999999999999999999999987664 99999998874321 111
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccCCCCCCCCHHHH
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECR 224 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 224 (334)
.....|++.|+|||++.+..++.+ +|+||||+++|+|++|..||........... .... ....+....++.++.
T Consensus 165 ~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~ 239 (265)
T cd06631 165 LKSMHGTPYWMAPEVINESGYGRK-SDIWSIGCTVFEMATGKPPLASMDRLAAMFY----IGAHRGLMPRLPDSFSAAAI 239 (265)
T ss_pred ccccCCCccccChhhhcCCCCcch-hhHHHHHHHHHHHHhCCCccccCChHHHHHH----hhhccCCCCCCCCCCCHHHH
Confidence 223468899999999987777655 9999999999999999999986544322211 1111 111122335789999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 225 HLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
++|.+||..+|.+|||+.+++.||||
T Consensus 240 ~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 240 DFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=299.35 Aligned_cols=247 Identities=23% Similarity=0.364 Sum_probs=195.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+|..| |+|.+..... .....+.+|+.++++++||||+++++.+..++..|+||||+.+++|.
T Consensus 9 ig~g~~g~v~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 87 (286)
T cd06622 9 LGKGNYGSVYKVLHRPTGVTM-AMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87 (286)
T ss_pred hcccCCeEEEEEEEcCCCcEE-EEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHH
Confidence 445544 47788889998 9999876431 22357889999999999999999999999999999999999999998
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 77 ERICNA---GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 77 ~~l~~~---~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
.++... ..+++..+..++.|++.||.|||+ .||+||||||+||+++.++ .++|+|||++..... .......++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~--~~~l~dfg~~~~~~~-~~~~~~~~~ 164 (286)
T cd06622 88 KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG--QVKLCDFGVSGNLVA-SLAKTNIGC 164 (286)
T ss_pred HHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC--CEEEeecCCcccccC-CccccCCCc
Confidence 888763 369999999999999999999997 5999999999999998755 499999999875422 223345688
Q ss_pred CccccchhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 153 PAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 153 ~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
+.|+|||.+.+... .+.++|+|||||++|+|++|+.||......... ..+..+.... ..+.+..+++++.+||
T Consensus 165 ~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li 242 (286)
T cd06622 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF-AQLSAIVDGD-PPTLPSGYSDDAQDFV 242 (286)
T ss_pred cCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHH-HHHHHHhhcC-CCCCCcccCHHHHHHH
Confidence 89999999865432 234599999999999999999999765432222 2222222221 1122234799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccccC
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.+||..+|.+||+++++++||||....
T Consensus 243 ~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 243 AKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHcccCcccCCCHHHHhcChhhhhcc
Confidence 999999999999999999999996643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=294.06 Aligned_cols=240 Identities=29% Similarity=0.463 Sum_probs=198.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ ++++..+++.+ ++|.+..... .....+.+|+.++++++||||+++++++.+.+..++||||+.+++|
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L 86 (256)
T cd08221 8 LGKGAFGEATLYRRTEDDSLV-VWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTL 86 (256)
T ss_pred ecccCCceEEEEEEcCCCcEE-EEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcH
Confidence 455544 58888899998 9999876542 2345788999999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCC
Q 019901 76 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt 152 (334)
.+.+.+. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++. +||+|||+++...... ......++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08221 87 YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGL--IKLGDFGISKILGSEYSMAETVVGT 164 (256)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCC--EEECcCcceEEcccccccccccCCC
Confidence 9999775 45899999999999999999999999999999999999987664 9999999987543332 23445689
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||.+.+..++.+ +|+||||+++|+|++|..||........... +...... +....++.++.+++.+||.
T Consensus 165 ~~y~ape~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~i~~~l~ 238 (256)
T cd08221 165 PYYMSPELCQGVKYNFK-SDIWALGCVLYELLTLKRTFDATNPLNLVVK----IVQGNYT-PVVSVYSSELISLVHSLLQ 238 (256)
T ss_pred ccccCHhhcCCCCCCCc-chhHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCC-CCccccCHHHHHHHHHHcc
Confidence 99999999987776555 8999999999999999999987554333322 2222222 2224578999999999999
Q ss_pred cCCCCCCCHhHHhcCccc
Q 019901 233 ADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~ 250 (334)
.+|.+|||++++++|||+
T Consensus 239 ~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 239 QDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cCcccCCCHHHHhhCcCC
Confidence 999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=318.86 Aligned_cols=242 Identities=25% Similarity=0.408 Sum_probs=195.6
Q ss_pred CCcceee----eeecCCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCCCCcccceEEEEcCC--eEEEEEeccC
Q 019901 2 LGFHNFY----DRCSYSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~~----~~~~~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~ 71 (334)
||.|.|. |.+..+|-.| |=-.++...+ ...+.+..|+.+|+.|+||||+++++.|.+.. .+.+|+|++.
T Consensus 48 LGrGafKtVYka~De~~giEV-AWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~T 126 (632)
T KOG0584|consen 48 LGRGAFKTVYKAFDEEEGIEV-AWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFT 126 (632)
T ss_pred cccccceeeeeccccccchhh-HHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeeccc
Confidence 7888772 5566666555 5333322221 22368899999999999999999999998764 4899999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
.|+|..|+++.++++...++.|++||+.||.|||++. |||||||+.||||+++ .+.|||+|+|||+...... ....
T Consensus 127 SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~-~G~VKIGDLGLAtl~r~s~-aksv 204 (632)
T KOG0584|consen 127 SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGN-LGEVKIGDLGLATLLRKSH-AKSV 204 (632)
T ss_pred CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCC-cCceeecchhHHHHhhccc-ccee
Confidence 9999999999999999999999999999999999975 9999999999999865 4579999999998654433 3458
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHH-HHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-KTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
+|||.|||||++. ..|+.. +||||||+.+.||+|+..||.....+++.. ++...+.+..+. .--.+++++||.
T Consensus 205 IGTPEFMAPEmYE-E~YnE~-VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~----kV~dPevr~fIe 278 (632)
T KOG0584|consen 205 IGTPEFMAPEMYE-ENYNEL-VDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALS----KVKDPEVREFIE 278 (632)
T ss_pred ccCccccChHHHh-hhcchh-hhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhh----ccCCHHHHHHHH
Confidence 9999999999986 667666 999999999999999999998877665443 332222222111 112789999999
Q ss_pred HhcccCCCCCCCHhHHhcCcccccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+||.. .+.|+|+.|||.||||...
T Consensus 279 kCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 279 KCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHhcC-chhccCHHHHhhChhhccc
Confidence 99999 9999999999999999875
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=299.23 Aligned_cols=239 Identities=28% Similarity=0.417 Sum_probs=190.4
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh--cC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN--AG 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~ 83 (334)
.+++..+|+.| |||.+..... .....+.+|+.++++++||||+++++++.+++..++||||+. ++|..++.. ..
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~ 95 (284)
T cd07860 18 KARNKLTGEVV-ALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLS 95 (284)
T ss_pred EEEECCCCCEE-EEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCC
Confidence 47788889988 9999876542 233578899999999999999999999999999999999995 688888765 35
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~ 162 (334)
.+++..+..++.|++.||+|||+.|++||||+|+||+++.++. +||+|||++....... ......+++.|+|||++.
T Consensus 96 ~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 173 (284)
T cd07860 96 GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 173 (284)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEeeccchhhcccCccccccccccccccCCeEEe
Confidence 6899999999999999999999999999999999999987765 9999999987543221 122335788999999987
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--------------cccCCC---------CCCC
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSIPD---------YVHI 219 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~---------~~~~ 219 (334)
+....+.++||||||+++|+|+||+.||...+......+........ ...++. ...+
T Consensus 174 ~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07860 174 GCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPL 253 (284)
T ss_pred cCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccC
Confidence 76554556999999999999999999998766544333322211100 000110 1246
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+++++++|.+||+.+|.+|||++++++||||
T Consensus 254 ~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred CHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 8899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.04 Aligned_cols=237 Identities=30% Similarity=0.496 Sum_probs=193.7
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 84 (334)
.+.+..+++.| |||.+.+... .....+.+|+.+++.++||||+++++.+..++.+++||||++|++|.+++...+.
T Consensus 19 ~~~~~~~~~~v-~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~ 97 (305)
T cd05609 19 LVRHKETRQRF-AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA 97 (305)
T ss_pred EEEECCCCcEE-EEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCC
Confidence 47888899999 9999887642 2234677899999999999999999999999999999999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----------------CCCC
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------------QPKS 148 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----------------~~~~ 148 (334)
+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++...... ....
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (305)
T cd05609 98 LPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQ 175 (305)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCC--EEEeeCCCccccCcCccccccccccccchhhccccC
Confidence 999999999999999999999999999999999999987664 9999999986321110 0112
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC-CCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li 227 (334)
..+++.|+|||.+.+..++.+ +|+|||||++|+|++|..||.+........ .........|. ...+++++.++|
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~vl~el~~g~~pf~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li 250 (305)
T cd05609 176 VCGTPEYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFG----QVISDDIEWPEGDEALPADAQDLI 250 (305)
T ss_pred CccCccccCchhccCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcccCCCCccccCCHHHHHHH
Confidence 357889999999887777555 999999999999999999998765433222 22222222222 124789999999
Q ss_pred HHhcccCCCCCCC---HhHHhcCccccc
Q 019901 228 SRIFVADPAKRIS---IPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s---~~ell~h~~~~~ 252 (334)
.+||+.+|.+||+ +.++++||||..
T Consensus 251 ~~~l~~~P~~R~~~~~~~~ll~~~~~~~ 278 (305)
T cd05609 251 SRLLRQNPLERLGTGGAFEVKQHRFFLG 278 (305)
T ss_pred HHHhccChhhccCccCHHHHHhCccccC
Confidence 9999999999997 799999999954
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=293.32 Aligned_cols=243 Identities=29% Similarity=0.459 Sum_probs=198.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+.+..++..+ |+|.+...... ..+.+.+|+.+++.++||||+++++++...+..++|+||+.+++|
T Consensus 8 lg~G~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 86 (264)
T cd06626 8 IGGGTFGKVYTAVNLDTGELM-AVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL 86 (264)
T ss_pred eecCCCcEEEEEEECCCCcEE-EEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcH
Confidence 555555 35666788888 99999877632 456889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC-----CCcc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KSTV 150 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~-----~~~~ 150 (334)
.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||++......... ....
T Consensus 87 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~ 164 (264)
T cd06626 87 EELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV--IKLGDFGCAVKLKNNTTTMGEEVQSLA 164 (264)
T ss_pred HHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEcccccccccCCCCCcccccccCCc
Confidence 999988777999999999999999999999999999999999999987654 999999998754332221 1346
Q ss_pred CCCccccchhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 151 GTPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 151 gt~~y~aPE~~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
+++.|+|||++.+.. .. .++||||||+++|+|++|+.||............ ........+|....+++.+.++|
T Consensus 165 ~~~~~~~PE~~~~~~~~~~~-~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~li 241 (264)
T cd06626 165 GTPAYMAPEVITGGKGKGHG-RAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH--VGAGHKPPIPDSLQLSPEGKDFL 241 (264)
T ss_pred CCcCccChhhccCCCCCCCC-cccchHHHHHHHHHHHhCCCCccCCcchHHHHHH--HhcCCCCCCCcccccCHHHHHHH
Confidence 788999999987655 44 4499999999999999999999765432221111 11122334455555689999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.+||+.+|.+|||+.+++.|||+
T Consensus 242 ~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 242 DRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHccCCcccCCCHHHHhcCCCC
Confidence 99999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=298.41 Aligned_cols=244 Identities=27% Similarity=0.431 Sum_probs=190.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCC-CCCcccceEEEEcC--CeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~e~~~~~ 73 (334)
||.|++ .+.+..++..+ |+|.+.+... .......+|+..++++. |||++++++++.++ +..++||||+. +
T Consensus 7 lg~g~~~~v~~~~~~~~~~~~-aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 84 (282)
T cd07831 7 IGEGTFSEVLKAQSRKTGKYY-AIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-M 84 (282)
T ss_pred ccccccceEEEEEEcCCCcEE-EEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-c
Confidence 555554 46777888888 9999876531 12234457888888885 99999999999987 88999999996 5
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 74 ELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
+|.+.+.. ...+++..+..++.|++.||.|||++|++||||+|+||+++. + .+||+|||+++............++
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~--~~kl~dfg~~~~~~~~~~~~~~~~~ 161 (282)
T cd07831 85 NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D--ILKLADFGSCRGIYSKPPYTEYIST 161 (282)
T ss_pred cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C--CeEEEecccccccccCCCcCCCCCC
Confidence 78777765 356899999999999999999999999999999999999987 4 5999999999865444433445689
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh--------------ccccCCC---
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSIPD--- 215 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~--- 215 (334)
+.|+|||.+......+.++|||||||++|+|++|.+||.+.+.............. .....+.
T Consensus 162 ~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07831 162 RWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKG 241 (282)
T ss_pred cccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCccccc
Confidence 99999998765555455699999999999999999999876554333222211000 0111111
Q ss_pred ------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 216 ------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 216 ------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...++.++.++|.+||..+|.+|||+++++.||||
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 242 TGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 12468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-41 Score=296.82 Aligned_cols=248 Identities=22% Similarity=0.372 Sum_probs=198.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+.+..+|..| |+|++.... ....+.+.+|+.+++.++||||+++++.+...+..++||||+++++|.
T Consensus 13 ig~g~~g~v~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 91 (284)
T cd06620 13 LGAGNGGSVSKVKHIPTGTVM-AKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLD 91 (284)
T ss_pred cCCCCCeEEEEEEEcCCCcEE-EEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHH
Confidence 455554 36777788888 999987654 234568899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
.++.+.+.+++..+..++.+++.||.|||+ .|++||||+|+||+++.++. ++|+|||++..... .......|+..|
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~--~~l~d~gl~~~~~~-~~~~~~~~~~~~ 168 (284)
T cd06620 92 RIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQ--IKLCDFGVSGELIN-SIADTFVGTSTY 168 (284)
T ss_pred HHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCc--EEEccCCcccchhh-hccCccccCccc
Confidence 999888889999999999999999999997 59999999999999987654 99999999864322 222345789999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-------HHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-------KNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
+|||++.+..++.+ +|+|||||++|+|++|+.||...... .........+............++.++.+|+.
T Consensus 169 ~aPE~~~~~~~~~~-~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 247 (284)
T cd06620 169 MSPERIQGGKYTVK-SDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVD 247 (284)
T ss_pred CCHHHHccCCCCcc-chHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHH
Confidence 99999987766555 99999999999999999999864432 11112222222221111111236889999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccccC
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+||+.+|.+|||+.++++|+||.+..
T Consensus 248 ~~l~~dp~~Rpt~~e~~~~~~~~~~~ 273 (284)
T cd06620 248 ACLLKDPTERPTPQQLCAMPPFIQAL 273 (284)
T ss_pred HHhcCCcccCcCHHHHhcCccccccc
Confidence 99999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=291.79 Aligned_cols=235 Identities=29% Similarity=0.438 Sum_probs=194.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
.+.+..++..| ++|.+..... ...+.+.+|+.+++.++||||+++++++..+...++|+||+++++|.+++.+.
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 96 (258)
T cd06632 18 EGLNLDDGDFF-AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKY 96 (258)
T ss_pred EEEEcCCCcEE-EEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhc
Confidence 36677788888 9999876541 13357889999999999999999999999999999999999999999999888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhc
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~ 162 (334)
+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. +||+|||++.............|++.|+|||.+.
T Consensus 97 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~ 174 (258)
T cd06632 97 GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGV--VKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174 (258)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEccCccceeccccccccccCCCcceeCHHHhc
Confidence 88999999999999999999999999999999999999987664 9999999987654443344566899999999987
Q ss_pred cCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 163 KKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 163 ~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
... ++ .++|+||||+++|+|++|+.||........... .............+++.+.+++.+||+.+|.+|||+
T Consensus 175 ~~~~~~-~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 249 (258)
T cd06632 175 QQGGYG-LAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK----IGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTA 249 (258)
T ss_pred CCCCCC-chhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH----HHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCH
Confidence 666 54 449999999999999999999976553222211 111111111223578999999999999999999999
Q ss_pred hHHhcCccc
Q 019901 242 PEIRNHEWF 250 (334)
Q Consensus 242 ~ell~h~~~ 250 (334)
.+++.|||+
T Consensus 250 ~~~l~~~~~ 258 (258)
T cd06632 250 AELLEHPFV 258 (258)
T ss_pred HHHhcCCCC
Confidence 999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=298.60 Aligned_cols=240 Identities=25% Similarity=0.369 Sum_probs=190.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEc------CCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILT------PTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~------~~~~~lv~e~~ 70 (334)
||.|++ .+++..+++.+ |+|++.... .....+..|+.+++.+ +||||+++++++.. ....|+||||+
T Consensus 24 lg~g~~~~v~~~~~~~~~~~~-a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~ 101 (282)
T cd06636 24 VGNGTYGQVYKGRHVKTGQLA-AIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFC 101 (282)
T ss_pred eccCCCeEEEEEEEcCCCcEE-EEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeC
Confidence 455554 47788888888 999987665 3446788999999888 79999999999853 46789999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCC
Q 019901 71 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPK 147 (334)
Q Consensus 71 ~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~ 147 (334)
.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||+|+||+++.++. ++|+|||++...... ....
T Consensus 102 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~ 179 (282)
T cd06636 102 GAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRN 179 (282)
T ss_pred CCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCcchhhhhccccCCC
Confidence 999999988753 35889999999999999999999999999999999999987665 999999998754322 2234
Q ss_pred CccCCCccccchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHH
Q 019901 148 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (334)
...|++.|+|||++.. ..++. ++|+|||||++|+|++|..||........... .............++.+
T Consensus 180 ~~~~~~~y~aPE~l~~~~~~~~~~~~-~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 254 (282)
T cd06636 180 TFIGTPYWMAPEVIACDENPDATYDY-RSDIWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPPPKLKSKKWSKK 254 (282)
T ss_pred cccccccccCHhhcCcccCcCcCCCc-ccchhHHHHHHHHHHhCCCCccccCHHhhhhh----HhhCCCCCCcccccCHH
Confidence 4568999999999852 33444 48999999999999999999976543322221 11111111122357899
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+.+||.+||..+|.+|||+.++++||||
T Consensus 255 ~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=295.78 Aligned_cols=243 Identities=28% Similarity=0.456 Sum_probs=191.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---cHHHHHHH---HHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREI---INHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei---~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|++ .+++..+++.| |||++.+..... ......|. ..++...||+|+++++.+..++..++||||+.
T Consensus 2 ig~g~~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 2 IGRGGFGEVYGCRKADTGKMY-AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred cccCCCeEEEEEEEecCCCEE-EEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 555554 36778888998 999998754221 12233343 34455689999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
|++|..++.+.+.+++..++.++.|++.||.|||+++|+||||||+||+++.++. ++|+|||+++..... ......|
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~--~kl~dfg~~~~~~~~-~~~~~~~ 157 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 157 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCC--EEEccCcCccccCcc-CCcCcCC
Confidence 9999999988888999999999999999999999999999999999999987664 999999998754322 2334579
Q ss_pred CCccccchhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
++.|+|||++.+. .++ .++||||+|+++|+|++|+.||........ ..............| ..++.++.+++.+|
T Consensus 158 ~~~y~aPE~~~~~~~~~-~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~--~~~s~~~~~li~~~ 233 (278)
T cd05606 158 THGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELP--DSFSPELRSLLEGL 233 (278)
T ss_pred CcCCcCcHHhcCCCCCC-cccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhccCCCCC--CcCCHHHHHHHHHH
Confidence 9999999998754 354 448999999999999999999986532211 111111222222222 34689999999999
Q ss_pred cccCCCCCC-----CHhHHhcCccccc
Q 019901 231 FVADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
|..+|.+|| ++.++++||||..
T Consensus 234 l~~~p~~R~~~~~~~~~~ll~~~~~~~ 260 (278)
T cd05606 234 LQRDVNRRLGCLGRGAQEVKEHPFFRS 260 (278)
T ss_pred hhcCHHhccCCCCCCHHHHHhCccccC
Confidence 999999999 9999999999965
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=294.20 Aligned_cols=240 Identities=31% Similarity=0.462 Sum_probs=191.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHH-HHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .|.+..+|+.| |||.+.+..... ...+..|..+ ....+|||++++++++..++..|+|+||+.++
T Consensus 4 l~~g~~~~v~~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 82 (260)
T cd05611 4 ISKGAFGSVYLAKKRSTGDYF-AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGG 82 (260)
T ss_pred CCcCCCeeEEEEEecCCCCeE-EEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCC
Confidence 455554 46777888888 999987654221 1234445444 45568999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+|..++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++.... .....+++
T Consensus 83 ~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 83 DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGH--LKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCc--EEEeecccceeccc---cccCCCCc
Confidence 99999988888999999999999999999999999999999999999987654 99999999875332 33456889
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHHHhc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIF 231 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L 231 (334)
.|+|||.+.+..++. ++||||||+++|+|++|..||...+........ ....... .....+++.+.+++.+||
T Consensus 158 ~y~~pe~~~~~~~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l 232 (260)
T cd05611 158 DYLAPETILGVGDDK-MSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI----LSRRINWPEEVKEFCSPEAVDLINRLL 232 (260)
T ss_pred CccChhhhcCCCCcc-hhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH----HhcccCCCCcccccCCHHHHHHHHHHc
Confidence 999999998777554 499999999999999999999876553332222 2222111 122357899999999999
Q ss_pred ccCCCCCCC---HhHHhcCccccc
Q 019901 232 VADPAKRIS---IPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s---~~ell~h~~~~~ 252 (334)
+.+|.+||| ++|++.||||.+
T Consensus 233 ~~~p~~R~~~~~~~~~l~~~~~~~ 256 (260)
T cd05611 233 CMDPAKRLGANGYQEIKSHPFFKS 256 (260)
T ss_pred cCCHHHccCCCcHHHHHcChHhhc
Confidence 999999995 579999999955
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=302.69 Aligned_cols=242 Identities=23% Similarity=0.388 Sum_probs=190.8
Q ss_pred eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--C
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--G 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 83 (334)
++++..++..| |||++.... ......+.+|+.+++.++||||+++++++...+..+++|||+.+++|.+++.+. .
T Consensus 18 ~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~ 96 (314)
T cd08216 18 LAKHKPTNTLV-AVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPE 96 (314)
T ss_pred EEEecCCCCEE-EEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhccc
Confidence 68888899998 999998763 233468999999999999999999999999999999999999999999998763 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--------CCCccCCCcc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAY 155 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y 155 (334)
.+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||.+........ .....++..|
T Consensus 97 ~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~--~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 174 (314)
T cd08216 97 GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGK--VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174 (314)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCc--eEEecCccceeeccccccccccccccccccccccc
Confidence 5899999999999999999999999999999999999987664 99999998864332211 1233577889
Q ss_pred ccchhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc------------------------
Q 019901 156 IAPEVLLKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------------ 209 (334)
Q Consensus 156 ~aPE~~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------ 209 (334)
+|||++.+. .++ .++|+||+||++|+|++|+.||...................
T Consensus 175 ~aPE~~~~~~~~~~-~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (314)
T cd08216 175 LSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHP 253 (314)
T ss_pred cCHHHhcCCCCCCC-cchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccccc
Confidence 999998653 344 44999999999999999999998755433222211110000
Q ss_pred ----cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 210 ----QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 210 ----~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+....++.++.+|+.+||..+|.+|||+.++|+||||++.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~ 301 (314)
T cd08216 254 NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQC 301 (314)
T ss_pred chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhh
Confidence 00000011235788999999999999999999999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=293.86 Aligned_cols=239 Identities=29% Similarity=0.472 Sum_probs=198.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~ 86 (334)
.+.+..+++.+ +||++..... .....+.+|+..++.++||||+++++++..++..++||||+.+++|.+++.....++
T Consensus 19 ~~~~~~~~~~~-~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~ 97 (264)
T cd06623 19 KVRHKPTGKIY-ALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIP 97 (264)
T ss_pred EEEEcCCCcEE-EEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCC
Confidence 57888889999 9999987653 345689999999999999999999999999999999999999999999998888899
Q ss_pred HHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC-CccCCCccccchhhccC
Q 019901 87 EDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-STVGTPAYIAPEVLLKK 164 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~-~~~gt~~y~aPE~~~~~ 164 (334)
+..+..++.|++.||.|||+ +|++||||+|+||+++.++. ++|+|||++.......... ...++..|+|||.+.+.
T Consensus 98 ~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~ 175 (264)
T cd06623 98 EPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGE--VKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE 175 (264)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCC--EEEccCccceecccCCCcccceeecccccCHhhhCCC
Confidence 99999999999999999999 99999999999999987665 9999999987654333322 45688999999998877
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCC-CCHHHHHHHHHhcccCCCCCCCHhH
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRIFVADPAKRISIPE 243 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~~p~~R~s~~e 243 (334)
.++.+ +|+||||+++|+|++|..||...... ........+.... ..+.... ++..+.++|.+||..+|.+|||+.+
T Consensus 176 ~~~~~-~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ 252 (264)
T cd06623 176 SYSYA-ADIWSLGLTLLECALGKFPFLPPGQP-SFFELMQAICDGP-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252 (264)
T ss_pred CCCch-hhHHHHHHHHHHHHhCCCCCcccccc-CHHHHHHHHhcCC-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHH
Confidence 66554 99999999999999999999876421 1112222222211 1122223 7899999999999999999999999
Q ss_pred HhcCccccc
Q 019901 244 IRNHEWFLK 252 (334)
Q Consensus 244 ll~h~~~~~ 252 (334)
+++|||++.
T Consensus 253 ll~~~~~~~ 261 (264)
T cd06623 253 LLQHPFIKK 261 (264)
T ss_pred HHhCHHHHh
Confidence 999999954
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=294.09 Aligned_cols=237 Identities=30% Similarity=0.398 Sum_probs=187.7
Q ss_pred eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCC--
Q 019901 9 DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRF-- 85 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~-- 85 (334)
+.+..++..+ |+|.+........+.+.+|+.+++.++||||+++++++..++..++|+||+.+++|.+.+... ..+
T Consensus 27 ~~~~~~~~~v-~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 105 (268)
T cd06624 27 ARDLSTQVRI-AIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKD 105 (268)
T ss_pred eEecCCCcEE-EEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCC
Confidence 6667777788 999988765444568899999999999999999999999999999999999999999998764 445
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 164 (334)
++..+..++.||+.||.|||++||+||||||+||+++... +.++|+|||++....... ......|++.|+|||.+.+.
T Consensus 106 ~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 184 (268)
T cd06624 106 NEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYS-GVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184 (268)
T ss_pred cHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CeEEEecchhheecccCCCccccCCCCccccChhhhccc
Confidence 8888999999999999999999999999999999997532 259999999986543221 12234588999999998654
Q ss_pred C-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhH
Q 019901 165 E-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243 (334)
Q Consensus 165 ~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~e 243 (334)
. ..+.++|+||+|+++|+|++|+.||........... ........... +..+++++.+++.+||+.+|.+|||+.+
T Consensus 185 ~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~Rpt~~~ 261 (268)
T cd06624 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF-KVGMFKIHPEI--PESLSAEAKNFILRCFEPDPDKRASAHD 261 (268)
T ss_pred cccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh-hhhhhccCCCC--CcccCHHHHHHHHHHcCCCchhCCCHHH
Confidence 3 123459999999999999999999976443211110 00111111122 2357899999999999999999999999
Q ss_pred HhcCccc
Q 019901 244 IRNHEWF 250 (334)
Q Consensus 244 ll~h~~~ 250 (334)
++.||||
T Consensus 262 ll~~~~~ 268 (268)
T cd06624 262 LLQDPFL 268 (268)
T ss_pred HHhCCCC
Confidence 9999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-41 Score=300.80 Aligned_cols=247 Identities=28% Similarity=0.422 Sum_probs=192.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~ 73 (334)
||.|++ .+.++.+|+.| |+|.+..... .....+.+|+.+++.++||||+++++++... +.+++||||+. +
T Consensus 15 ig~g~~~~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~ 92 (309)
T cd07845 15 IGEGTYGIVYRARDTTSGEIV-ALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-Q 92 (309)
T ss_pred eeecCCEEEEEEEECCCCcEE-EEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-C
Confidence 455544 47788889998 9999976542 2234567899999999999999999998765 56899999996 4
Q ss_pred ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccC
Q 019901 74 ELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVG 151 (334)
Q Consensus 74 ~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~g 151 (334)
+|...+.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++........ .....+
T Consensus 93 ~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~ 170 (309)
T cd07845 93 DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGC--LKIADFGLARTYGLPAKPMTPKVV 170 (309)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECccceeeecCCccCCCCcccc
Confidence 78887765 356899999999999999999999999999999999999987664 99999999876543322 223346
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc---------------cccCCC-
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------QYSIPD- 215 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~- 215 (334)
++.|+|||++.+....+.++|||||||++|+|++|++||...+....+.......... ....+.
T Consensus 171 ~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (309)
T cd07845 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQ 250 (309)
T ss_pred cccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCC
Confidence 8889999998765444455999999999999999999998776655444433221100 000000
Q ss_pred --------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 --------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 --------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
....++.+.++|.+||+.||++|||+.+++.||||.+
T Consensus 251 ~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~ 295 (309)
T cd07845 251 PYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE 295 (309)
T ss_pred CCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence 1225889999999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=296.87 Aligned_cols=239 Identities=29% Similarity=0.469 Sum_probs=185.5
Q ss_pred eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 85 (334)
.+.++.++..| |||.+..... .....+.+|+.+++.++||||+++++++.+++..++||||+.+ +|.+++.+. ..+
T Consensus 23 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~ 100 (291)
T cd07844 23 KGRSKLTGQLV-ALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGL 100 (291)
T ss_pred EEEEcCCCcEE-EEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCCCC
Confidence 46777788888 9999876542 2235677899999999999999999999999999999999974 898888764 468
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 164 (334)
++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... ......+++.|+|||++.+.
T Consensus 101 ~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 178 (291)
T cd07844 101 SMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGE--LKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGS 178 (291)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCC--EEECccccccccCCCCccccccccccccCCcHHhhcC
Confidence 99999999999999999999999999999999999987765 9999999987543221 12233578899999998764
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc----------------ccC---------CCCCCC
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSI---------PDYVHI 219 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~---------~~~~~~ 219 (334)
...+.++||||+|+++|+|++|+.||............+....... ... .....+
T Consensus 179 ~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (291)
T cd07844 179 TEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRL 258 (291)
T ss_pred cccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCC
Confidence 4334559999999999999999999976653221111111110000 000 001123
Q ss_pred C--HHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 S--PECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~--~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+ .++.+++.+||+.+|.+|||+.+++.||||
T Consensus 259 ~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 259 DRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 4 889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=305.51 Aligned_cols=249 Identities=25% Similarity=0.386 Sum_probs=194.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~ 71 (334)
||.|++ .+.++.+|..| |+|.+.... ......+.+|+.+++.++||||+++++++.. ...+++||||+.
T Consensus 13 lg~g~~g~v~~~~~~~~~~~v-alK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 91 (334)
T cd07855 13 IGSGAYGVVCSAIDTRSGKKV-AIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME 91 (334)
T ss_pred eecCCCeEEEEEEEcCCCCEE-EEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh
Confidence 455544 47788899998 999987653 2334677889999999999999999998763 357899999995
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----C
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----P 146 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~ 146 (334)
++|.+.+...+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... .
T Consensus 92 -~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~ 168 (334)
T cd07855 92 -SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE--LRIGDFGMARGLSSSPTEHKYFM 168 (334)
T ss_pred -hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEecccccceeecccCcCCCccc
Confidence 689999887788999999999999999999999999999999999999987665 99999999875432221 1
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-------------------
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------------- 207 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------------- 207 (334)
....|+..|+|||.+.+....+.++|||||||++|+|++|++||.+.+....+........
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred ccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 2346889999999986644345559999999999999999999977554332221111100
Q ss_pred h-cc--ccCC---CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 208 S-VQ--YSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 208 ~-~~--~~~~---~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
. .. ...+ .....++++.++|.+||+.+|.+|||+++++.||||.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 0 00 0000 0134689999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.00 Aligned_cols=241 Identities=29% Similarity=0.507 Sum_probs=213.5
Q ss_pred Cccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 3 GFHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 3 G~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
|||++ +++-+.....+ |+|+++|... ...+.+..|-.+|..++.|.||++|..|.++..+|++||-|-||.|+..
T Consensus 432 gFGRVELV~~~~~~~~f-AlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTi 510 (732)
T KOG0614|consen 432 GFGRVELVKVNSQKATF-ALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTI 510 (732)
T ss_pred ccceEEEEEecccchHH-HHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhh
Confidence 55555 45544445578 9999998763 2346788999999999999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 158 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aP 158 (334)
+...+.|.+..++.++..+++|++|||++|||+|||||+|.|++..|. +||.|||+|+....+....+.||||.|.||
T Consensus 511 LrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy--~KLVDFGFAKki~~g~KTwTFcGTpEYVAP 588 (732)
T KOG0614|consen 511 LRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGY--LKLVDFGFAKKIGSGRKTWTFCGTPEYVAP 588 (732)
T ss_pred hhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCc--eEEeehhhHHHhccCCceeeecCCcccccc
Confidence 999999999999999999999999999999999999999999998876 999999999998888888899999999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++...+.+.. +|.||||+++|||++|.+||.+.++...+..+++.+-... +| ..++..+.++|+++...+|..|
T Consensus 589 EIILnKGHD~a-vDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~--~P--r~I~k~a~~Lik~LCr~~P~ER 663 (732)
T KOG0614|consen 589 EIILNKGHDRA-VDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE--FP--RRITKTATDLIKKLCRDNPTER 663 (732)
T ss_pred hhhhccCcchh-hHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh--cc--cccchhHHHHHHHHHhcCcHhh
Confidence 99999888755 8999999999999999999999998877776666554333 23 4689999999999999999999
Q ss_pred CC-----HhHHhcCcccc
Q 019901 239 IS-----IPEIRNHEWFL 251 (334)
Q Consensus 239 ~s-----~~ell~h~~~~ 251 (334)
.. +.++..|.||.
T Consensus 664 LG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 664 LGYQKGGINDIKKHRWFE 681 (732)
T ss_pred hccccCChHHHHhhhhhh
Confidence 85 89999999994
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=297.36 Aligned_cols=245 Identities=28% Similarity=0.397 Sum_probs=192.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~ 73 (334)
||.|.+ .+.+..++..+ |||.+...... ....+.+|+.+++.++||||+++++++... +..|+|+||+. +
T Consensus 13 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~ 90 (293)
T cd07843 13 IEEGTYGVVYRARDKKTGEIV-ALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-H 90 (293)
T ss_pred hcCCCCeEEEEEEECCCCcEE-EEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-c
Confidence 455544 47777788888 99999865522 234567899999999999999999998877 88999999996 5
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccC
Q 019901 74 ELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVG 151 (334)
Q Consensus 74 ~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~g 151 (334)
+|.+.+.... .+++..++.++.|++.||+|||++|++||||||+|||++.++. ++|+|||+++..... .......+
T Consensus 91 ~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~ 168 (293)
T cd07843 91 DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI--LKICDFGLAREYGSPLKPYTQLVV 168 (293)
T ss_pred CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCc--EEEeecCceeeccCCccccccccc
Confidence 8988887643 5899999999999999999999999999999999999987765 999999998865443 22233467
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-----------------ccc--
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-----------------QYS-- 212 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-----------------~~~-- 212 (334)
++.|+|||.+.+....+.++|+||||+++|+|++|.+||..........+........ ...
T Consensus 169 ~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (293)
T cd07843 169 TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKY 248 (293)
T ss_pred cccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccc
Confidence 8899999998765544455999999999999999999998776544443332211100 000
Q ss_pred -----CCCCCC--CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 213 -----IPDYVH--ISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 213 -----~~~~~~--~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...... +++.+.++|.+||+.+|++|||+.|++.||||
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 249 PYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 000111 48889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=305.41 Aligned_cols=247 Identities=24% Similarity=0.363 Sum_probs=192.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|++ .+++..+|..| |||.+.+.. ......+.+|+.+++.++||||++++++|... ...|+||||
T Consensus 24 lg~g~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 102 (353)
T cd07850 24 IGSGAQGIVCAAYDTVTGQNV-AIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL 102 (353)
T ss_pred eccCCCEEEEEEEECCCCCEE-EEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEec
Confidence 444444 47788899998 999987543 12335677899999999999999999988644 357999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+. ++|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...........
T Consensus 103 ~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~ 177 (353)
T cd07850 103 MD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 177 (353)
T ss_pred cC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEccCccceeCCCCCCCCCC
Confidence 95 5888887654 899999999999999999999999999999999999987765 999999999865444333445
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc------------------cc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------QY 211 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------~~ 211 (334)
.+++.|+|||++.+..++.+ +|||||||++|+|++|+.||...+....+.+........ ..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (353)
T cd07850 178 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRP 256 (353)
T ss_pred cccccccCHHHHhCCCCCCc-hhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCC
Confidence 68999999999988887655 899999999999999999998665433333322111000 00
Q ss_pred c--------------CCC-----CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 212 S--------------IPD-----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 212 ~--------------~~~-----~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
. .+. ....++.++++|.+||+.||.+|||+.++|.||||.....
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 257 KYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred CCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 0 000 1124667899999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=302.02 Aligned_cols=248 Identities=22% Similarity=0.332 Sum_probs=196.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc--------------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI--------------DENVQREIINHRSLRHPNIVRFKEVILTPTHL 63 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~--------------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~ 63 (334)
||.|++ .+.++.+++.| |||++....... ...+.+|+.+++.++||||+++++++..++..
T Consensus 17 ig~G~~g~vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 95 (335)
T PTZ00024 17 LGEGTYGKVEKAYDTLTGKIV-AIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFI 95 (335)
T ss_pred ccCCCceeEEEEEECCCCCeE-EEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcE
Confidence 566665 47778889998 999987654221 12578999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-
Q 019901 64 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL- 142 (334)
Q Consensus 64 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~- 142 (334)
++||||+. ++|.+++.....+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++....
T Consensus 96 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~--~kl~dfg~~~~~~~~ 172 (335)
T PTZ00024 96 NLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGI--CKIADFGLARRYGYP 172 (335)
T ss_pred EEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCC--EEECCccceeecccc
Confidence 99999996 689999988888999999999999999999999999999999999999987665 99999999875431
Q ss_pred --------------CCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh
Q 019901 143 --------------HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 143 --------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
........+++.|+|||.+.+....+.++|+|||||++|+|++|.+||.+.+....+.........
T Consensus 173 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~ 252 (335)
T PTZ00024 173 PYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252 (335)
T ss_pred cccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 111122346889999999876554455599999999999999999999877665444333322111
Q ss_pred cccc-CC---------------------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 209 VQYS-IP---------------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 209 ~~~~-~~---------------------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.... ++ .....+.++.++|.+||+.+|.+|||+++++.||||+..
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD 319 (335)
T ss_pred CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence 0000 00 012357889999999999999999999999999999764
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=298.42 Aligned_cols=246 Identities=25% Similarity=0.415 Sum_probs=194.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.+ .+.+..+++.| |+|.+.+... ...+.+.+|+.+++.++||||+++++++..++..|+|+||+.+++|
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l 87 (286)
T cd07846 9 VGEGSYGMVMKCKHKETGQIV-AIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVL 87 (286)
T ss_pred eccCCCeEEEEEEECCCCCEE-EEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHH
Confidence 455544 46777788888 9999876442 2345788999999999999999999999999999999999999988
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~ 154 (334)
..+......+++..++.++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||++........ .....++..
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 165 (286)
T cd07846 88 DDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYTDYVATRW 165 (286)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCc--EEEEeeeeeeeccCCccccCcccceee
Confidence 887766667999999999999999999999999999999999999987665 99999999875433222 223457889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCC-----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIP----- 214 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~----- 214 (334)
|+|||++.+....+.++||||||+++|+|++|++||.................. .....+
T Consensus 166 y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T cd07846 166 YRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEI 245 (286)
T ss_pred ccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCc
Confidence 999999876554455699999999999999999999765543322222210000 000011
Q ss_pred -----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 215 -----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 215 -----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
....++..+.+|+.+||..+|.+||++.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 246 EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 123568899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=292.34 Aligned_cols=240 Identities=28% Similarity=0.495 Sum_probs=196.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ ++++..+|+.| |+|.+..... .....+.+|+.+++.++||||+++++++...+..++|+||+.+++|
T Consensus 8 lg~g~~g~~~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l 86 (256)
T cd08218 8 IGEGSFGKAILVKSKEDGKQY-VIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL 86 (256)
T ss_pred eccCCceEEEEEEEcCCCCEE-EEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcH
Confidence 565655 57788888988 9999876532 2335789999999999999999999999999999999999999999
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCC
Q 019901 76 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt 152 (334)
.+.+.... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........ .....|+
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~ 164 (256)
T cd08218 87 YKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--IKLGDFGIARVLNSTVELARTCIGT 164 (256)
T ss_pred HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEEeeccceeecCcchhhhhhccCC
Confidence 99887643 5899999999999999999999999999999999999987665 99999999875433221 1234588
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|+|||||++|+|++|+.||........... +..... .+....++.++.++|.+||+
T Consensus 165 ~~~~~pe~~~~~~~~~~-~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~li~~~l~ 238 (256)
T cd08218 165 PYYLSPEICENRPYNNK-SDIWALGCVLYEMCTLKHAFEAGNMKNLVLK----IIRGSY-PPVSSHYSYDLRNLVSQLFK 238 (256)
T ss_pred ccccCHHHhCCCCCCCc-cchhHHHHHHHHHHcCCCCccCCCHHHHHHH----HhcCCC-CCCcccCCHHHHHHHHHHhh
Confidence 89999999987776555 8999999999999999999986554333322 222221 12234578999999999999
Q ss_pred cCCCCCCCHhHHhcCccc
Q 019901 233 ADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~ 250 (334)
.+|.+||++.+++.||||
T Consensus 239 ~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 239 RNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CChhhCcCHHHHhhCcCC
Confidence 999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=295.22 Aligned_cols=239 Identities=27% Similarity=0.407 Sum_probs=190.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC--
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-- 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 83 (334)
.+.++.+|..| |||.+..... .....+.+|+..++.++|||++++++++..++..|+||||+. ++|..++....
T Consensus 17 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~ 94 (283)
T cd07835 17 KARDKLTGEIV-ALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLT 94 (283)
T ss_pred EEEEcCCCCEE-EEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCC
Confidence 36777889988 9999986642 233578899999999999999999999999999999999995 68999887765
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~ 162 (334)
.+++..+..++.|++.||+|||++|++||||+|+||+++.++ .++|+|||+++....... .....+++.|+|||++.
T Consensus 95 ~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~--~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~ 172 (283)
T cd07835 95 GLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG--ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILL 172 (283)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC--cEEEeecccccccCCCccccCccccccCCCCCceee
Confidence 689999999999999999999999999999999999998755 499999999875432221 22345688999999887
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--------------cccC---------CCCCCC
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSI---------PDYVHI 219 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~~ 219 (334)
+....+.++|+||||+++|+|++|++||...+......+........ .... .....+
T Consensus 173 ~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd07835 173 GSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNL 252 (283)
T ss_pred cCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCC
Confidence 65443455999999999999999999998766544333322211000 0000 112356
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+..+.++|.+||+.+|.+|||+++++.||||
T Consensus 253 ~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 253 DEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 7899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=322.44 Aligned_cols=238 Identities=28% Similarity=0.472 Sum_probs=197.5
Q ss_pred Ccceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEE-c---CC---eEEEEEeccCCC
Q 019901 3 GFHNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVIL-T---PT---HLAIVMEYASGG 73 (334)
Q Consensus 3 G~g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~-~---~~---~~~lv~e~~~~~ 73 (334)
||+.|+ |++...|..| |+|.+...+-...+.+.+||.+|+.|+ |||||.+++... . .+ .++|.||||.||
T Consensus 49 GFa~VYla~~~~~~~~~-AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg 127 (738)
T KOG1989|consen 49 GFAQVYLAQDVKGGKKY-ALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGG 127 (738)
T ss_pred CcEEEEEEEecCCCcee-eeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCC
Confidence 666664 7777777899 999988776556688999999999997 999999999322 1 12 478999999999
Q ss_pred ChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC--
Q 019901 74 ELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-- 147 (334)
Q Consensus 74 ~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~-- 147 (334)
.|-+++..+ .+|++.++++|+.++++|+.+||... |||||||-+||||..++. .||||||-|..........
T Consensus 128 ~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~--~KLCDFGSatt~~~~~~~~~e 205 (738)
T KOG1989|consen 128 SLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGN--YKLCDFGSATTKILSPTSAQE 205 (738)
T ss_pred cHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCC--EEeCcccccccccCCCccHHH
Confidence 999999753 45999999999999999999999987 999999999999988775 9999999887543332111
Q ss_pred --------CccCCCccccchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCC
Q 019901 148 --------STVGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 216 (334)
Q Consensus 148 --------~~~gt~~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (334)
....|+.|+|||++. +.+.+.+ +|||+|||+||-|+....||+..... .|+...+.+|..
T Consensus 206 ~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eK-sDIWALGclLYkLCy~t~PFe~sg~l--------aIlng~Y~~P~~ 276 (738)
T KOG1989|consen 206 VNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEK-SDIWALGCLLYKLCYFTTPFEESGKL--------AILNGNYSFPPF 276 (738)
T ss_pred HHHHHHHHHhhCCccccChHHHhhhcCCCCcch-hHHHHHHHHHHHHHHhCCCcCcCcce--------eEEeccccCCCC
Confidence 234799999999874 5566555 99999999999999999999875432 366788899998
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
..++..+.+||..||+.+|.+||++-+++.+-+-..
T Consensus 277 p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~ 312 (738)
T KOG1989|consen 277 PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA 312 (738)
T ss_pred ccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence 899999999999999999999999999887655543
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=291.47 Aligned_cols=234 Identities=30% Similarity=0.439 Sum_probs=188.2
Q ss_pred eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERIC 80 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~ 80 (334)
.+.+..+|..| |||.+..... ...+.+.+|+.+++.++||||+++++++.+. ..+++||||+.+++|.+++.
T Consensus 20 ~~~~~~~~~~v-~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 98 (265)
T cd06652 20 LCYDADTGREL-AVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLK 98 (265)
T ss_pred EEEEcCCCcEE-EEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHH
Confidence 36777888888 9999865431 1124678899999999999999999998763 56889999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC----CCCCCccCCCccc
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQPKSTVGTPAYI 156 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----~~~~~~~gt~~y~ 156 (334)
+.+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++..... .......|+..|+
T Consensus 99 ~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 176 (265)
T cd06652 99 SYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN--VKLGDFGASKRLQTICLSGTGMKSVTGTPYWM 176 (265)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCC--EEECcCccccccccccccccccccCCCCcccc
Confidence 8788999999999999999999999999999999999999987664 999999998754321 1123346889999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|+|||||++|+|++|+.||.......... ...........+..++..+.++|.+||. +|.
T Consensus 177 aPE~~~~~~~~~~-~Dv~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~ 250 (265)
T cd06652 177 SPEVISGEGYGRK-ADIWSVGCTVVEMLTEKPPWAEFEAMAAIF----KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAK 250 (265)
T ss_pred ChhhhcCCCCCcc-hhHHHHHHHHHHHhhCCCCCCccchHHHHH----HHhcCCCCCCCchhhCHHHHHHHHHHhc-Chh
Confidence 9999987776544 999999999999999999998654333222 1221111222233568889999999995 999
Q ss_pred CCCCHhHHhcCccc
Q 019901 237 KRISIPEIRNHEWF 250 (334)
Q Consensus 237 ~R~s~~ell~h~~~ 250 (334)
+|||+++++.|||+
T Consensus 251 ~Rp~~~~il~~~~~ 264 (265)
T cd06652 251 LRPSADELLRHTFV 264 (265)
T ss_pred hCCCHHHHhcCccc
Confidence 99999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=296.50 Aligned_cols=237 Identities=25% Similarity=0.362 Sum_probs=188.1
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcC-----CeEEEEEeccCCCChHHHHHh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICN 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~ 81 (334)
.+.+..+++.+ |+|++.... .....+.+|+.+++.+ +|||++++++++... +..++||||+.+++|.+++..
T Consensus 40 ~~~~~~~~~~~-aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~ 117 (291)
T cd06639 40 KVTNKKDGSLA-AVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKG 117 (291)
T ss_pred EEEECCCCCEE-EEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHH
Confidence 36777888888 999987654 3456788999999998 799999999998753 468999999999999988753
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 82 ----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 82 ----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||+++...... ......|++.|+
T Consensus 118 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 195 (291)
T cd06639 118 LLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWM 195 (291)
T ss_pred hhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEeecccchhcccccccccCccCCcccc
Confidence 456899999999999999999999999999999999999987664 9999999987543322 223456889999
Q ss_pred cchhhccCCC----CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 157 APEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 157 aPE~~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|||++..... .+.++|||||||++|+|++|++||.............. ............+..+.++|.+||+
T Consensus 196 aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~ 272 (291)
T cd06639 196 APEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPR---NPPPTLLHPEKWCRSFNHFISQCLI 272 (291)
T ss_pred ChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhc---CCCCCCCcccccCHHHHHHHHHHhh
Confidence 9999864331 23459999999999999999999987654333322111 1111222233467889999999999
Q ss_pred cCCCCCCCHhHHhcCcccc
Q 019901 233 ADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~ 251 (334)
.+|.+|||+.++++||||+
T Consensus 273 ~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 273 KDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred cChhhCcCHHHHhcCcccC
Confidence 9999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=264.95 Aligned_cols=247 Identities=25% Similarity=0.448 Sum_probs=204.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .++++.+++.| |+|.+.... -....+..+||-+++.++|.|||+++++..+++.+.+|+|||. -+|
T Consensus 10 igegtygtvfkarn~~t~eiv-alkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdl 87 (292)
T KOG0662|consen 10 IGEGTYGTVFKARNRETHEIV-ALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDL 87 (292)
T ss_pred hcCCcceeeEecccCCccceE-EEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHH
Confidence 666665 48999999999 999998765 2445789999999999999999999999999999999999995 478
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 76 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
..+..+ ++.++.+.++.++.|++.||.++|+.++.|||+||+|.||+.+|. +||+|||+|+.....-. -...+-|.
T Consensus 88 kkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~nge--lkladfglarafgipvrcysaevvtl 165 (292)
T KOG0662|consen 88 KKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGE--LKLADFGLARAFGIPVRCYSAEVVTL 165 (292)
T ss_pred HHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCc--EEecccchhhhcCCceEeeeceeeee
Confidence 777765 567999999999999999999999999999999999999988776 99999999986543322 12345799
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccc-------cCCCC---------
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY-------SIPDY--------- 216 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~~~~--------- 216 (334)
+|++|.++.+...++.+.|+||.|||+.|+.. |++.|.+.+-..++.++.+....... .+|.+
T Consensus 166 wyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypat 245 (292)
T KOG0662|consen 166 WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPAT 245 (292)
T ss_pred eccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcccc
Confidence 99999999988777776899999999999985 88999988877777776654432211 11111
Q ss_pred -------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 217 -------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 217 -------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+.++..-+++++++|..+|.+|++++++++||||..
T Consensus 246 tswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d 288 (292)
T KOG0662|consen 246 TSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSD 288 (292)
T ss_pred chHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccc
Confidence 134566899999999999999999999999999964
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=295.37 Aligned_cols=240 Identities=28% Similarity=0.346 Sum_probs=188.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCe-----EEEEEeccCCCChHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLR-HPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI 79 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l 79 (334)
.+.+..+++.| |||.+..... .....+.+|+.+++.+. ||||+++++++..... .|+||||+.+ +|..++
T Consensus 19 ~~~~~~~~~~v-~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 96 (295)
T cd07837 19 KARDKNTGKLV-ALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFM 96 (295)
T ss_pred EEEECCCCcEE-EEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHH
Confidence 47777888888 9999876542 23467889999999995 6999999999887655 8999999975 788887
Q ss_pred Hhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 80 CNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 80 ~~~-----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
... ..+++..++.++.||+.||.|||++||+||||+|+||+++. ++ .+||+|||+++..... .......++
T Consensus 97 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~~ 174 (295)
T cd07837 97 DSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKG--LLKIADLGLGRAFSIPVKSYTHEIVT 174 (295)
T ss_pred HHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCC--eEEEeecccceecCCCccccCCcccc
Confidence 643 35799999999999999999999999999999999999986 43 5999999998754322 222334578
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-c------------CC-----
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------------IP----- 214 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------------~~----- 214 (334)
+.|+|||++.+....+.++||||||+++|+|++|..||.+.+......+.......... . .+
T Consensus 175 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (295)
T cd07837 175 LWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQ 254 (295)
T ss_pred cCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccch
Confidence 89999999876444445599999999999999999999877665554443332111000 0 00
Q ss_pred ----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 215 ----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 215 ----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
....+++.+.+||.+||..+|.+|||+.+++.||||+
T Consensus 255 ~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 255 DLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 0134789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=296.40 Aligned_cols=247 Identities=26% Similarity=0.439 Sum_probs=198.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..+++.+ |||.+..........+.+|+.+++.++||||+++++.+..++..++||||+++++|.+
T Consensus 28 lg~g~~g~v~~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 106 (292)
T cd06657 28 IGEGSTGIVCIATVKSSGKLV-AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 106 (292)
T ss_pred cCCCCCeEEEEEEEcCCCeEE-EEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHH
Confidence 566554 35677788888 9998865443445678899999999999999999999999999999999999999988
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
++. .+.+++..+..++.|++.||+|||+.|++||||+|+||+++.++. ++|+|||++....... ......|++.|+
T Consensus 107 ~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~ 183 (292)
T cd06657 107 IVT-HTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWM 183 (292)
T ss_pred HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCC--EEEcccccceecccccccccccccCcccc
Confidence 764 456899999999999999999999999999999999999987664 9999999886543222 223356889999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||.+.+..++.+ +|+||+|+++|+|++|..||.+......... +... ....++....+++.+.+++.+||+.+|.
T Consensus 184 ~pE~~~~~~~~~~-~Dv~slGvil~el~tg~~p~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 184 APELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM-IRDN--LPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred CHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHhh--CCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 9999877666544 9999999999999999999986554332221 1111 1122223345789999999999999999
Q ss_pred CCCCHhHHhcCccccccCCC
Q 019901 237 KRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~~~ 256 (334)
+||++.+++.||||.+..+.
T Consensus 260 ~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 260 QRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred cCcCHHHHhcChHHhccCCC
Confidence 99999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.83 Aligned_cols=243 Identities=27% Similarity=0.410 Sum_probs=186.2
Q ss_pred eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCChHHHHHh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICN 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~ 81 (334)
.+++..+|+.| |||++.... ......+.+|+.+++.++||||+++++++... ...|+|+||+. ++|...+.
T Consensus 23 ~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~- 99 (336)
T cd07849 23 SATHKPTGVKV-AIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK- 99 (336)
T ss_pred EEEEcCCCCeE-EEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-
Confidence 47788899998 999986532 12345678899999999999999999987643 35899999996 58877774
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCcccc
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIA 157 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~a 157 (334)
.+.+++..++.++.|++.||.|||+.||+||||||+|||++.++. +||+|||+++....... .....|++.|+|
T Consensus 100 ~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 177 (336)
T cd07849 100 TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD--LKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177 (336)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCC--EEECcccceeeccccccccCCcCCcCcCCCccC
Confidence 456999999999999999999999999999999999999987665 99999999875432221 123468999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH-----------h--------h---ccccCC-
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-----------L--------S---VQYSIP- 214 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-----------~--------~---~~~~~~- 214 (334)
||.+.+....+.++|||||||++|+|++|++||.+.............. . . .....+
T Consensus 178 PE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (336)
T cd07849 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPW 257 (336)
T ss_pred hHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccH
Confidence 9987654433455999999999999999999997654322221111000 0 0 000000
Q ss_pred --CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 215 --DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 215 --~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
....+++++.++|.+||+.+|.+|||+.++++||||.+...
T Consensus 258 ~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 258 NKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 01246888999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.62 Aligned_cols=246 Identities=27% Similarity=0.421 Sum_probs=194.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+.+..+++.| |||.+.... ......+.+|+.+++.++||||+++++++..++..++||||+.++.+
T Consensus 9 i~~g~~~~v~~~~~~~~~~~v-~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l 87 (288)
T cd07833 9 VGEGAYGVVLKCRNKATGEIV-AIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87 (288)
T ss_pred ecccCCeeEEEEEeCCCCcEE-EEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHH
Confidence 455544 47788888888 999987643 23447889999999999999999999999999999999999998777
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~ 153 (334)
.....+...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. +||+|||++....... ......+++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~ 165 (288)
T cd07833 88 ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGV--LKLCDFGFARALRARPASPLTDYVATR 165 (288)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEEeeecccccCCCccccccCccccc
Confidence 666666667999999999999999999999999999999999999987654 9999999987654433 223456789
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc------------c---cCC----
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------Y---SIP---- 214 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------~---~~~---- 214 (334)
.|+|||++.+....+.++|+||||+++|+|++|++||.+......+........... . ..+
T Consensus 166 ~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (288)
T cd07833 166 WYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQ 245 (288)
T ss_pred CCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCC
Confidence 999999998773444559999999999999999999987654333222111000000 0 000
Q ss_pred -------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 215 -------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 215 -------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
....++.++++||.+||..+|++|||+++++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 246 PESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 011248899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=304.42 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=187.7
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--C
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--G 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~ 83 (334)
++++..+|+.| |+|++..... ...+.+.+|+.+++.++||||++++++|..++..++|+||+.+++|.+++.+. .
T Consensus 18 ~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~ 96 (328)
T cd08226 18 LARHTPTGTLV-TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPE 96 (328)
T ss_pred EEEEcCCCcEE-EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhccc
Confidence 47888899999 9999876542 22367889999999999999999999999999999999999999999988764 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--------CCCccCCCcc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--------PKSTVGTPAY 155 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--------~~~~~gt~~y 155 (334)
.+++..+..++.|++.||+|||++||+||||||+|||++..+. ++++||+.+........ .....++..|
T Consensus 97 ~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y 174 (328)
T cd08226 97 GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGL--VSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPW 174 (328)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCc--EEEechHHHhhhhccCccccccccccccccCccCc
Confidence 4899999999999999999999999999999999999987654 99999986532211111 1112356679
Q ss_pred ccchhhccCCC-CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh---------------------------
Q 019901 156 IAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL--------------------------- 207 (334)
Q Consensus 156 ~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------------------- 207 (334)
+|||++.+... .+.++|||||||++|+|++|+.||............+....
T Consensus 175 ~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (328)
T cd08226 175 LSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI 254 (328)
T ss_pred cChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhccc
Confidence 99999876422 23459999999999999999999987554332222111000
Q ss_pred --------------hccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 208 --------------SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 208 --------------~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
......+.....++.+.+||.+||+.+|.+|||+.++++||||...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~ 314 (328)
T cd08226 255 GESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV 314 (328)
T ss_pred ccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence 0000111122356789999999999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=293.96 Aligned_cols=242 Identities=28% Similarity=0.415 Sum_probs=195.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+.+..++..+ |||++..... .....+.+|+.+++.+.||||+++++++.+++..|+||||+.+++|.
T Consensus 12 lg~g~~~~vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06640 12 IGKGSFGEVFKGIDNRTQQVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred cccCCCeEEEEEEEccCCEEE-EEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHH
Confidence 555555 36777788888 9999886542 23457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y 155 (334)
+++.. +++++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........ .....++..|
T Consensus 91 ~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y 167 (277)
T cd06640 91 DLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFW 167 (277)
T ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCC--EEEcccccceeccCCccccccccCcccc
Confidence 98865 56899999999999999999999999999999999999987664 99999999875433221 2234578899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||.+.+..++.+ +|+|||||++|+|++|.+||........... +.. .........++..+.+++.+||..+|
T Consensus 168 ~apE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 168 MAPEVIQQSAYDSK-ADIWSLGITAIELAKGEPPNSDMHPMRVLFL----IPK-NNPPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred cCHhHhccCCCccH-HHHHHHHHHHHHHHHCCCCCCCcChHhHhhh----hhc-CCCCCCchhhhHHHHHHHHHHcccCc
Confidence 99999987777555 9999999999999999999986554322211 111 11111223467899999999999999
Q ss_pred CCCCCHhHHhcCcccccc
Q 019901 236 AKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~ 253 (334)
.+||++.+++.|+||.+.
T Consensus 242 ~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06640 242 SFRPTAKELLKHKFIVKN 259 (277)
T ss_pred ccCcCHHHHHhChHhhhc
Confidence 999999999999999653
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.57 Aligned_cols=231 Identities=35% Similarity=0.500 Sum_probs=193.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
+|-|+| ++.++.+++.+ ++|++.+.. ....+|+.++.. -+||||+++++++.++.+.|+|||++.|+.+.
T Consensus 330 ~~~gs~s~~~~~~~~~t~~~~-~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell 404 (612)
T KOG0603|consen 330 LGEGSFSAVKYCESSPTDQEP-AVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELL 404 (612)
T ss_pred cCCCCccceeeeeccccccch-hheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHH
Confidence 466655 57889999999 999998763 446677755544 47999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc-CCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~-~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+.+...+.+. .++..|+.+|+.|+.|||++|+|||||||+|||++ +.+ +++|+|||.++..... ..+.+-|..|
T Consensus 405 ~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g--~lrltyFG~a~~~~~~--~~tp~~t~~y 479 (612)
T KOG0603|consen 405 RRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG--HLRLTYFGFWSELERS--CDTPALTLQY 479 (612)
T ss_pred HHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC--cEEEEEechhhhCchh--hcccchhhcc
Confidence 9887776666 78889999999999999999999999999999995 444 5999999998865444 3455778899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
.|||++....|+.. |||||||++||+|++|+.||........ +...+....+. ..+|..+++||++||+.+|
T Consensus 480 ~APEvl~~~~yt~a-cD~WSLGvlLy~ML~G~tp~~~~P~~~e---i~~~i~~~~~s----~~vS~~AKdLl~~LL~~dP 551 (612)
T KOG0603|consen 480 VAPEVLAIQEYTEA-CDWWSLGVLLYEMLTGRTLFAAHPAGIE---IHTRIQMPKFS----ECVSDEAKDLLQQLLQVDP 551 (612)
T ss_pred cChhhhccCCCCcc-hhhHHHHHHHHHHHhCCCccccCCchHH---HHHhhcCCccc----cccCHHHHHHHHHhccCCh
Confidence 99999998888655 9999999999999999999988766522 22333322222 4689999999999999999
Q ss_pred CCCCCHhHHhcCccc
Q 019901 236 AKRISIPEIRNHEWF 250 (334)
Q Consensus 236 ~~R~s~~ell~h~~~ 250 (334)
.+|+++.+++.||||
T Consensus 552 ~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 552 ALRLGADEIGAHPWF 566 (612)
T ss_pred hhCcChhhhccCcch
Confidence 999999999999999
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=295.00 Aligned_cols=235 Identities=25% Similarity=0.370 Sum_probs=185.8
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEE-----cCCeEEEEEeccCCCChHHHHHh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVIL-----TPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
.++++.++..+ |+|++.... .....+.+|+.+++.+ +||||+++++++. .++..++||||+++++|.+.+..
T Consensus 36 ~~~~~~~~~~~-~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 113 (286)
T cd06638 36 KVLNKKNGSKA-AVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKG 113 (286)
T ss_pred EEEECCCCcee-EEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHH
Confidence 47788888888 999986544 3456788999999999 6999999999874 34679999999999999987753
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 82 ----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 82 ----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
...+++..++.++.|++.||.|||+++++||||||+||+++.++. ++|+|||+++...... ......|++.|+
T Consensus 114 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~ 191 (286)
T cd06638 114 FLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGG--VKLVDFGVSAQLTSTRLRRNTSVGTPFWM 191 (286)
T ss_pred hhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCC--EEEccCCceeecccCCCccccccCCCccc
Confidence 356899999999999999999999999999999999999987665 9999999987543322 223456899999
Q ss_pred cchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 157 APEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 157 aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|||++.. ..++ .++||||+||++|+|++|+.||............. .............+..+.++|.+||
T Consensus 192 aPE~~~~~~~~~~~~~-~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~~~l 267 (286)
T cd06638 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP---RNPPPTLHQPELWSNEFNDFIRKCL 267 (286)
T ss_pred Chhhhchhhhcccccc-chhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcc---ccCCCcccCCCCcCHHHHHHHHHHc
Confidence 9999853 2243 45999999999999999999998654432221111 0111111222335788999999999
Q ss_pred ccCCCCCCCHhHHhcCccc
Q 019901 232 VADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~ 250 (334)
+.+|.+|||+.++++|+||
T Consensus 268 ~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 268 TKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCcccCCCHHHHhhcccC
Confidence 9999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=294.11 Aligned_cols=236 Identities=25% Similarity=0.393 Sum_probs=187.9
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCC------eEEEEEeccCCCChHHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPT------HLAIVMEYASGGELFERIC 80 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~ 80 (334)
.+.++.+++.+ ++|++.... ...+.+.+|+.+++.+ +||||+++++++.... .+++||||+.+++|.+++.
T Consensus 24 ~~~~~~~~~~~-~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 101 (275)
T cd06608 24 KARHKKTGQLV-AIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVK 101 (275)
T ss_pred EEEECCCCcEE-EEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHH
Confidence 57777888888 999988766 3456789999999998 7999999999997644 4899999999999998876
Q ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 81 N----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 81 ~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
. ...+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++...... .......|++.|
T Consensus 102 ~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y 179 (275)
T cd06608 102 GLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAE--VKLVDFGVSAQLDSTLGRRNTFIGTPYW 179 (275)
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCe--EEECCCccceecccchhhhcCccccccc
Confidence 5 347999999999999999999999999999999999999987654 999999998653322 223345689999
Q ss_pred ccchhhccCC----CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 156 IAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 156 ~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+|||++.... ..+.++|||||||++|+|++|++||.............. ............++.++++|.+||
T Consensus 180 ~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l 256 (275)
T cd06608 180 MAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR---NPPPTLKSPENWSKKFNDFISECL 256 (275)
T ss_pred cCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc---cCCCCCCchhhcCHHHHHHHHHHh
Confidence 9999885422 123448999999999999999999976544333222211 111122222336789999999999
Q ss_pred ccCCCCCCCHhHHhcCccc
Q 019901 232 VADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~ 250 (334)
..+|.+|||+.+++.|||+
T Consensus 257 ~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 257 IKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hcChhhCcCHHHHhcCCCC
Confidence 9999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=293.23 Aligned_cols=238 Identities=27% Similarity=0.418 Sum_probs=183.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~ 85 (334)
.+.+..+|+.| |||.+..... .....+.+|+.+++.++|+||+++++++..++..|+||||+. ++|...+.. ...+
T Consensus 23 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~ 100 (291)
T cd07870 23 KGISRINGQLV-ALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGL 100 (291)
T ss_pred EEEEcCCCcEE-EEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCC
Confidence 36778889998 9999976542 233567899999999999999999999999999999999995 677666654 3568
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~ 164 (334)
++..++.++.|++.||.|||+.||+||||||+|||++.++. ++|+|||+++...... ......+++.|+|||.+.+.
T Consensus 101 ~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 178 (291)
T cd07870 101 HPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGE--LKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGA 178 (291)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCc--EEEeccccccccCCCCCCCCCccccccccCCceeecC
Confidence 88999999999999999999999999999999999987664 9999999987533222 22334578999999998765
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH-HHHHHHHHhhcc----------------ccC----C-------CC
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQ----------------YSI----P-------DY 216 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~----------------~~~----~-------~~ 216 (334)
...+.++||||||+++|+|++|..||........ +.+.. ...... ... + ..
T Consensus 179 ~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (291)
T cd07870 179 TDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIW-TVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKR 257 (291)
T ss_pred CCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHH-HHcCCCChhhhhhhhhcccccchhccccCCcchhhhccc
Confidence 4333448999999999999999999986543211 11111 000000 000 0 00
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...++.+.+++.+||..+|++|||+.+++.||||
T Consensus 258 ~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 258 LSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 1236789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=299.01 Aligned_cols=247 Identities=25% Similarity=0.326 Sum_probs=186.9
Q ss_pred CCccee----eeeecC--CCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSY--SSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~--~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 70 (334)
||.|++ .+.+.. ++..| |||.+.... ....+.+.+|+.+++.++||||+++++++... ..+++||||+
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~~~-alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~ 86 (316)
T cd07842 8 IGRGTYGRVYKAKRKNGKDGKEY-AIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYA 86 (316)
T ss_pred eccCCcEEEEEEEecCCCCCCeE-EEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCC
Confidence 444544 466666 77888 999998743 23456788999999999999999999999988 8899999999
Q ss_pred CCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC--CCCEEEeccCCccCCCCC
Q 019901 71 SGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH 143 (334)
Q Consensus 71 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~--~~~~kl~Dfgla~~~~~~ 143 (334)
.+ +|...+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++ .+.+||+|||+++.....
T Consensus 87 ~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~ 165 (316)
T cd07842 87 EH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165 (316)
T ss_pred Cc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCC
Confidence 64 676666432 3689999999999999999999999999999999999998711 235999999998754332
Q ss_pred CC----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH---------HHHHHHHHHh---
Q 019901 144 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---------NFRKTIHRIL--- 207 (334)
Q Consensus 144 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---------~~~~~~~~~~--- 207 (334)
.. .....+++.|+|||++.+....+.++|||||||++|+|++|++||.+..... .+........
T Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 245 (316)
T cd07842 166 LKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPT 245 (316)
T ss_pred cccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCc
Confidence 22 2344688999999998775544455999999999999999999998654321 1111110000
Q ss_pred -------------------hccccCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 208 -------------------SVQYSIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 208 -------------------~~~~~~~---------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
......+ .....+..+.+++.+||+.+|++|||+.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 246 EKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0000000 011467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=282.82 Aligned_cols=246 Identities=24% Similarity=0.330 Sum_probs=197.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+- .++.+.+|... |||.+.... .+....+.+.+.++... ++|+||+++++|..+..+++.||.+. .-+
T Consensus 100 lGsGtcG~V~k~~~rs~~~ii-AVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ 177 (391)
T KOG0983|consen 100 LGSGTCGQVWKMRFRSTGHII-AVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCA 177 (391)
T ss_pred hcCCCccceEEEEEcccceEE-EEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHH
Confidence 577765 47778888988 999998765 23345666677666544 48999999999999999999999984 334
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 76 FERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
..++++ .++++|.-+-++...++.||.||..+ ||+|||+||+|||++..|. +||||||++-............|-+
T Consensus 178 ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~Gn--iKlCDFGIsGrlvdSkAhtrsAGC~ 255 (391)
T KOG0983|consen 178 EKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGN--IKLCDFGISGRLVDSKAHTRSAGCA 255 (391)
T ss_pred HHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCC--EEeecccccceeecccccccccCCc
Confidence 444443 46799999999999999999999975 8999999999999998776 9999999998776666667778999
Q ss_pred ccccchhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 154 AYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 154 ~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.|||||.+.- ..|+-+ +||||||++++||.||..||.+.... +.+.+++. ..+..+|....+|+++++|+..
T Consensus 256 ~YMaPERidp~~~~kYDiR-aDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln---~ePP~L~~~~gFSp~F~~fv~~ 331 (391)
T KOG0983|consen 256 AYMAPERIDPPDKPKYDIR-ADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN---EEPPLLPGHMGFSPDFQSFVKD 331 (391)
T ss_pred cccCccccCCCCCCccchh-hhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh---cCCCCCCcccCcCHHHHHHHHH
Confidence 9999999863 456666 89999999999999999999886543 33333322 2234455555689999999999
Q ss_pred hcccCCCCCCCHhHHhcCccccccCC
Q 019901 230 IFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
||.+|+.+||...+||+|||+....+
T Consensus 332 CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 332 CLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred HhhcCcccCcchHHHhcCcceeecch
Confidence 99999999999999999999976443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=301.87 Aligned_cols=248 Identities=27% Similarity=0.389 Sum_probs=197.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-----eEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~ 70 (334)
||.|++ .+++..+++.+ |||.+.... ....+.+.+|+.+++.++||||+++++++.... .+|+||+|+
T Consensus 8 ig~g~~~~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 86 (330)
T cd07834 8 IGSGAYGVVCSAVDKRTGRKV-AIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM 86 (330)
T ss_pred ecCCCCeEEEEEEeCCCCcEE-EEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecch
Confidence 455544 47777889998 999987654 234567899999999999999999999988765 789999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QP 146 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~ 146 (334)
. ++|...+.+..++++..++.++.||+.||++||++||+||||||.|||++.++ .++|+|||++....... ..
T Consensus 87 ~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~--~~~L~dfg~~~~~~~~~~~~~~~ 163 (330)
T cd07834 87 E-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC--DLKICDFGLARGVDPDEDEKGFL 163 (330)
T ss_pred h-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEcccCceEeecccccccccc
Confidence 6 58999998878899999999999999999999999999999999999998775 49999999988654432 12
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc---------------
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------- 211 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------- 211 (334)
....+++.|+|||++.+....+.++|+||||+++|+|++|++||.+......+..+.........
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHH
Confidence 34468899999999987733345599999999999999999999876654433333221100000
Q ss_pred -----c-----CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 -----S-----IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 -----~-----~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
. ......+++++.++|.+||+++|.+|||+++++.||||...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 295 (330)
T cd07834 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295 (330)
T ss_pred hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence 0 00012368899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=294.62 Aligned_cols=242 Identities=26% Similarity=0.398 Sum_probs=189.2
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC-
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~- 84 (334)
.++++.+|+.| |||.+..... ...+.+.+|+.++++++||||+++++++..++..|+||||+. ++|...+.....
T Consensus 20 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~ 97 (294)
T PLN00009 20 KARDRVTNETI-ALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDF 97 (294)
T ss_pred EEEecCCCcEE-EEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCC
Confidence 46777888998 9999876542 234678899999999999999999999999999999999995 578887765443
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhc
Q 019901 85 -FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 85 -~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~ 162 (334)
+++..++.++.||+.||+|||++|++||||+|+||+++..+. .+||+|||++....... ......+++.|+|||++.
T Consensus 98 ~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 176 (294)
T PLN00009 98 AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN-ALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176 (294)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCC-EEEEcccccccccCCCccccccCceeecccCHHHHh
Confidence 578889999999999999999999999999999999975432 48999999987532221 123346788999999987
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--------------ccCC---------CCCCC
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------YSIP---------DYVHI 219 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------~~~~---------~~~~~ 219 (334)
+....+.++|||||||++|+|++|++||...+......+......... ...+ ....+
T Consensus 177 ~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (294)
T PLN00009 177 GSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTL 256 (294)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCC
Confidence 654444559999999999999999999987655444333222110000 0000 01346
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
++.+.+++.+||+.+|.+||++.+++.||||..
T Consensus 257 ~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~ 289 (294)
T PLN00009 257 EPAGVDLLSKMLRLDPSKRITARAALEHEYFKD 289 (294)
T ss_pred ChHHHHHHHHHccCChhhCcCHHHHhcCchHhH
Confidence 889999999999999999999999999999964
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=296.58 Aligned_cols=243 Identities=22% Similarity=0.310 Sum_probs=189.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+++..++..+ |||.+.+... .....+.+|+.++.++. ||||+++++++..++..+++|||+.+ ++
T Consensus 12 lg~G~~g~vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l 89 (288)
T cd06616 12 IGRGAFGTVNKMLHKPSGTIM-AVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SL 89 (288)
T ss_pred hCCCCceEEEEEEECCCCCEE-EEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CH
Confidence 555554 47788889998 9999876542 23457889999999986 99999999999999999999999854 55
Q ss_pred HHHH---H--hcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 76 FERI---C--NAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 76 ~~~l---~--~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
.++. . ..+.+++..+..++.|++.||+|||+. |++||||||+||+++.++. ++|+|||+++...........
T Consensus 90 ~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 167 (288)
T cd06616 90 DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGN--IKLCDFGISGQLVDSIAKTRD 167 (288)
T ss_pred HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCc--EEEeecchhHHhccCCccccc
Confidence 4432 2 235699999999999999999999974 9999999999999987664 999999998754443333445
Q ss_pred cCCCccccchhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccC--CCCCCCCHHH
Q 019901 150 VGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI--PDYVHISPEC 223 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~ 223 (334)
.|++.|+|||++.+. .++ .++||||+||++|+|++|+.||..... . ...+....... ... .....++.++
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 168 AGCRPYMAPERIDPSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNS--V-FDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cCccCccCHHHhccccccCCc-chhhhhHHHHHHHHHHhCCCCchhcch--H-HHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 789999999999766 344 459999999999999999999976432 1 11222222111 111 1123478999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 224 RHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||.+||+.+|.+|||+++++.||||..
T Consensus 244 ~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 272 (288)
T cd06616 244 VNFINLCLIKDESKRPKYKELLEHPFIKD 272 (288)
T ss_pred HHHHHHHccCChhhCcCHHHHhcChhhhc
Confidence 99999999999999999999999999965
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=291.83 Aligned_cols=244 Identities=27% Similarity=0.453 Sum_probs=194.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCC---CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+.+..++..+ |+|.+..... .....+.+|+.+++.++ |||++++++++..+...++||||+.++
T Consensus 9 l~~g~~g~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~ 87 (277)
T cd06917 9 IGRGAYGAVYRGKHVPTGRVV-ALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87 (277)
T ss_pred eeccCCceEEEEEEcCCCcEE-EEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCC
Confidence 455544 46777888888 9999876542 23356889999999986 999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt 152 (334)
+|.+++.. +.+++..+..++.|++.||.|||+.||+||||+|+||+++..+. ++|+|||++........ .....|+
T Consensus 88 ~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~ 164 (277)
T cd06917 88 SVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGN--VKLCDFGVAALLNQNSSKRSTFVGT 164 (277)
T ss_pred cHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCC--EEEccCCceeecCCCccccccccCC
Confidence 99998865 47999999999999999999999999999999999999987654 99999999875443322 2334689
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccCCCCCCCCHHHHHHHHHhc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L 231 (334)
+.|+|||.+.+....+.++|+||||+++|+|++|..||.+........ ...... ..++ ....+.++.+++.+||
T Consensus 165 ~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~----~~~~~~~~~~~-~~~~~~~~~~~i~~~l 239 (277)
T cd06917 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM----LIPKSKPPRLE-DNGYSKLLREFVAACL 239 (277)
T ss_pred cceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh----ccccCCCCCCC-cccCCHHHHHHHHHHc
Confidence 999999998765444455999999999999999999998654322211 111111 1111 1136889999999999
Q ss_pred ccCCCCCCCHhHHhcCccccccC
Q 019901 232 VADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..+|.+||++.+++.|+||++..
T Consensus 240 ~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 240 DEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCcccCcCHHHHhhChHhhccc
Confidence 99999999999999999996643
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=301.38 Aligned_cols=248 Identities=28% Similarity=0.415 Sum_probs=192.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~ 70 (334)
||.|++ .+++..++..| |||.+.... ......+.+|+.+++.++||||+++++++... ...|+|+||+
T Consensus 13 lg~G~~~~vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~ 91 (337)
T cd07858 13 IGRGAYGIVCSAKNSETNEKV-AIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM 91 (337)
T ss_pred eccCCCeEEEEEEecCCCCeE-EEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC
Confidence 455544 47788899999 999987643 12335677899999999999999999987654 3589999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCc
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 149 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~ 149 (334)
. ++|.+++...+++++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++...... .....
T Consensus 92 ~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~ 168 (337)
T cd07858 92 D-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARTTSEKGDFMTEY 168 (337)
T ss_pred C-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECcCccccccCCCccccccc
Confidence 5 689999988888999999999999999999999999999999999999987664 9999999988654332 22344
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------hh--
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------LS-- 208 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------~~-- 208 (334)
.++..|+|||.+......+.++|||||||++|+|++|++||.+.+............ ..
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (337)
T cd07858 169 VVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248 (337)
T ss_pred ccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhc
Confidence 688999999998754334455999999999999999999997654322111111000 00
Q ss_pred -cccc---CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 209 -VQYS---IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 209 -~~~~---~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.... ......+++++.++|.+||+.+|.+|||++++++||||...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred CcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 0000 00123578999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=294.53 Aligned_cols=241 Identities=27% Similarity=0.388 Sum_probs=193.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|.+ .+.+..++..+ |+|++..... ...+.+.+|+.+++.++||||+++++++..++..|+||||+.+++|.
T Consensus 12 l~~g~~~~vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 90 (277)
T cd06642 12 IGKGSFGEVYKGIDNRTKEVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSAL 90 (277)
T ss_pred hcCCCCeeEEEEEEcCCCeEE-EEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHH
Confidence 455544 36677778887 9999875541 23457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y 155 (334)
+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||++........ .....++..|
T Consensus 91 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y 167 (277)
T cd06642 91 DLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGD--VKLADFGVAGQLTDTQIKRNTFVGTPFW 167 (277)
T ss_pred HHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCC--EEEccccccccccCcchhhhcccCcccc
Confidence 88754 56899999999999999999999999999999999999987664 99999999875433221 2234588899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||.+.+..++.+ +|+|||||++|+|++|+.||........... +.. ..........+..+.++|.+||..+|
T Consensus 168 ~aPE~~~~~~~~~~-~Dv~slG~il~el~tg~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06642 168 MAPEVIKQSAYDFK-ADIWSLGITAIELAKGEPPNSDLHPMRVLFL----IPK-NSPPTLEGQYSKPFKEFVEACLNKDP 241 (277)
T ss_pred cCHHHhCcCCCchh-hhHHHHHHHHHHHHhCCCCCcccchhhHHhh----hhc-CCCCCCCcccCHHHHHHHHHHccCCc
Confidence 99999988777655 9999999999999999999975543222111 111 11111122468899999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
.+|||+.+++.||||..
T Consensus 242 ~~Rp~~~~il~~~~~~~ 258 (277)
T cd06642 242 RFRPTAKELLKHKFITR 258 (277)
T ss_pred ccCcCHHHHHHhHHHHH
Confidence 99999999999999965
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=287.99 Aligned_cols=237 Identities=25% Similarity=0.382 Sum_probs=194.1
Q ss_pred CCccee----eeeecCC---CCeeEEEEEEecCcccc-cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYS---SDLFVNIIIIVFHLWQI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~---~~~vvaiK~~~~~~~~~-~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+.+... +..+ ++|++....... .+.+.+|+..++.++||||+++++++.....+++||||+.++
T Consensus 3 ig~g~~g~v~~~~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 3 LGEGAFGEVYKGKLKGKDGKTTEV-AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred cccCCceEEEEEEEecCCCCCceE-EeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 555555 3555544 7777 999998765222 578899999999999999999999999999999999999999
Q ss_pred ChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC
Q 019901 74 ELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 74 ~L~~~l~~~---------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~ 144 (334)
+|.+++... ..+++..++.++.|++.||.|||++|++||||+|+||+++.++. ++|+|||.+.......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLV--VKISDFGLSRDVYDDD 159 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCc--EEEccccccccccccc
Confidence 999999875 77999999999999999999999999999999999999987764 9999999998654432
Q ss_pred ---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCC
Q 019901 145 ---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 145 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (334)
......+++.|+|||.+....++.+ +||||||+++|+|++ |..||........... ... ....+....++
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~ 233 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEY----LRK-GYRLPKPEYCP 233 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchh-hccHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccCC
Confidence 2334567889999999987766555 999999999999999 6999987754333222 211 22333444679
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+++.+++.+||..+|.+|||+.+++++
T Consensus 234 ~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 234 DELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred hHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.53 Aligned_cols=239 Identities=28% Similarity=0.456 Sum_probs=191.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc---C
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---G 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~ 83 (334)
.+.+..+|..| |||.+..... .....+.+|+.+++.++||||+++++.+...+..++||||+.+ +|.+++... .
T Consensus 18 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~ 95 (284)
T cd07836 18 KGRNRTTGEIV-ALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRG 95 (284)
T ss_pred EEEECCCCeEE-EEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCC
Confidence 47788888888 9999987652 2346778899999999999999999999999999999999975 888887654 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~ 162 (334)
.+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||+++...... ......+++.|+|||++.
T Consensus 96 ~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~ 173 (284)
T cd07836 96 ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGE--LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173 (284)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCc--EEEeecchhhhhcCCccccccccccccccChHHhc
Confidence 5899999999999999999999999999999999999987665 9999999987543221 123345788999999987
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--------------cccCCC---------CCCC
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--------------QYSIPD---------YVHI 219 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------~~~~~~---------~~~~ 219 (334)
+....+.++|+||||+++|+|++|+.||.+.+............... ....+. ...+
T Consensus 174 ~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (284)
T cd07836 174 GSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHA 253 (284)
T ss_pred CCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhc
Confidence 65544555999999999999999999998776654444333211000 000010 1235
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
++.+++++.+||+.+|.+||++.++++||||
T Consensus 254 ~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 254 DPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred CcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 7889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-40 Score=286.38 Aligned_cols=240 Identities=30% Similarity=0.455 Sum_probs=198.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~ 78 (334)
+|.+ .+.+..++..+ ++|++..... ...+.+.+|+..+++++||||+++++.+... +..++|+||+.+++|.++
T Consensus 13 ~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (260)
T cd06606 13 FGSVYLALDKDTGELM-AVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSL 91 (260)
T ss_pred ceEEEEEEECCCCcEE-EEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHH
Confidence 4444 47777788888 9999977652 2356889999999999999999999999988 899999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCcc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y 155 (334)
+.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||.+........ .....++..|
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y 169 (260)
T cd06606 92 LKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGV--VKLADFGCAKRLGDIETGEGTGSVRGTPYW 169 (260)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCC--EEEcccccEEecccccccccccCCCCCccc
Confidence 988888999999999999999999999999999999999999987654 99999999876544432 3456789999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||.+.+...+.+ +|+||||+++|+|++|..||........ .................++..+.++|.+||+.+|
T Consensus 170 ~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p 245 (260)
T cd06606 170 MAPEVIRGEEYGRA-ADIWSLGCTVIEMATGKPPWSELGNPMA---ALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDP 245 (260)
T ss_pred cCHhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHH---HHHhccccCCCcCCCcccCHHHHHHHHHhCcCCh
Confidence 99999877766555 9999999999999999999987652221 1112221111222233568999999999999999
Q ss_pred CCCCCHhHHhcCccc
Q 019901 236 AKRISIPEIRNHEWF 250 (334)
Q Consensus 236 ~~R~s~~ell~h~~~ 250 (334)
.+||++.+++.||||
T Consensus 246 ~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 246 KKRPTADELLQHPFL 260 (260)
T ss_pred hhCCCHHHHhhCCCC
Confidence 999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=292.39 Aligned_cols=237 Identities=29% Similarity=0.465 Sum_probs=196.6
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-CCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFS 86 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~ 86 (334)
.+++..++..+ ++|++..... ..+.+.+|+..++.++|||++++++.+..++..|+|+||+.+++|.+++.... .++
T Consensus 37 ~~~~~~~~~~~-~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~ 114 (286)
T cd06614 37 KATDRATGKEV-AIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMN 114 (286)
T ss_pred EEEEccCCcEE-EEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCC
Confidence 47777788888 9999987663 45678899999999999999999999999999999999999999999998876 799
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhccCC
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKE 165 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~ 165 (334)
...+..++.|++.||.|||+.|++|+||+|+||+++.++. ++|+|||++....... ......+++.|+|||.+.+..
T Consensus 115 ~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~ 192 (286)
T cd06614 115 EPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGS--VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD 192 (286)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCC--EEECccchhhhhccchhhhccccCCcccCCHhHhcCCC
Confidence 9999999999999999999999999999999999987665 9999999876433222 123345788999999998777
Q ss_pred CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 166 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 166 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
++.+ +|+||||+++|+|++|+.||............. .......+....++..+.++|.+||+.+|.+|||+.+++
T Consensus 193 ~~~~-~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 193 YGPK-VDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT---TKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred CCCc-cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 7655 999999999999999999998655432222211 111122233334789999999999999999999999999
Q ss_pred cCccccc
Q 019901 246 NHEWFLK 252 (334)
Q Consensus 246 ~h~~~~~ 252 (334)
.|+||.+
T Consensus 269 ~~~~~~~ 275 (286)
T cd06614 269 QHPFLKK 275 (286)
T ss_pred hChHhhc
Confidence 9999977
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=287.87 Aligned_cols=225 Identities=21% Similarity=0.304 Sum_probs=183.9
Q ss_pred cee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC
Q 019901 5 HNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83 (334)
Q Consensus 5 g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 83 (334)
|++ +++++.+++.| |+|.+.+.. ...+|...+....||||+++++++......++||||+.|++|.+++.+..
T Consensus 7 ~~v~~~~~~~~~~~~-~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 80 (237)
T cd05576 7 DKVLLVMDTRTQQTF-ILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL 80 (237)
T ss_pred ceEEEEEEccCCcEE-EEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc
Confidence 344 58999999999 999987654 23345555556679999999999999999999999999999999998887
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhcc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~ 163 (334)
.+++..+..++.|++.||.|||++||+||||||+||+++.++. ++++|||.+...... .....++..|+|||.+.+
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGH--IQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGI 156 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCC--EEEecccchhccccc--cccCCcCccccCCcccCC
Confidence 8999999999999999999999999999999999999987765 999999987644322 234456778999999877
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH--
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI-- 241 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~-- 241 (334)
..++.+ +|+||+|+++|+|++|+.||....... . ......+| ..+++.++++|.+||+.||.+||++
T Consensus 157 ~~~~~~-~DvwslG~il~el~~g~~~~~~~~~~~------~--~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 157 SEETEA-CDWWSLGAILFELLTGKTLVECHPSGI------N--THTTLNIP--EWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CCCCch-hhHHHHHHHHHHHHHCcchhhcCchhc------c--cccccCCc--ccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 777555 899999999999999999886432110 0 00111222 3478999999999999999999986
Q ss_pred ---hHHhcCccc
Q 019901 242 ---PEIRNHEWF 250 (334)
Q Consensus 242 ---~ell~h~~~ 250 (334)
+++++||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=293.01 Aligned_cols=243 Identities=24% Similarity=0.385 Sum_probs=188.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHH-HHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .++++.+|..| |||.+.+... .....+..|+.. ++.++||||+++++.+..++..|+||||++ ++|
T Consensus 9 ig~g~~g~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l 86 (283)
T cd06617 9 LGRGAYGVVDKMRHVPTGTIM-AVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSL 86 (283)
T ss_pred ecccCCeEEEEEEEcCCCcEE-EEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccH
Confidence 455554 47888899999 9999987542 223455566665 677799999999999999999999999996 678
Q ss_pred HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 76 FERICN----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 76 ~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
...+.. ...+++..++.++.|++.||.|||++ +++||||||+||+++.++. +||+|||+++............
T Consensus 87 ~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 164 (283)
T cd06617 87 DKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQ--VKLCDFGISGYLVDSVAKTIDA 164 (283)
T ss_pred HHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeeccccccccccccccccc
Confidence 776654 24689999999999999999999997 9999999999999987665 9999999987654333333456
Q ss_pred CCCccccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 151 GTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 151 gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
++..|+|||++.+ ..++ .++|+|||||++|+|++|+.||...... ..+... ........+. ..+|.++.+
T Consensus 165 ~~~~y~aPE~~~~~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~-~~~~~~l~~ 239 (283)
T cd06617 165 GCKPYMAPERINPELNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQV---VEEPSPQLPA-EKFSPEFQD 239 (283)
T ss_pred CCccccChhhcCCcccccccC-ccccchhhHHHHHHHHhCCCCCCccccCHHHHHHH---HhcCCCCCCc-cccCHHHHH
Confidence 8899999998864 2333 4489999999999999999999754322 222111 1111112221 247899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+|.+||..+|.+|||+.+++.||||.+.
T Consensus 240 li~~~l~~~p~~Rp~~~~il~~~~~~~~ 267 (283)
T cd06617 240 FVNKCLKKNYKERPNYPELLQHPFFELH 267 (283)
T ss_pred HHHHHccCChhhCcCHHHHhcCchhhhc
Confidence 9999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=294.81 Aligned_cols=244 Identities=25% Similarity=0.406 Sum_probs=185.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC--------eEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT--------HLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--------~~~lv~ 67 (334)
||.|++ .+++..+++.| |||.+..... .....+.+|+.++++++||||+++++++.... ..++||
T Consensus 20 lg~g~~~~v~~~~~~~~~~~~-aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 98 (310)
T cd07865 20 IGQGTFGEVFKARHKKTKQIV-ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVF 98 (310)
T ss_pred eecCCCEEEEEEEECCCCcEE-EEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEE
Confidence 455554 47778889998 9999876541 22345678999999999999999999987543 469999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-
Q 019901 68 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 145 (334)
Q Consensus 68 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~- 145 (334)
||+. ++|...+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. +||+|||++........
T Consensus 99 e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~ 175 (310)
T cd07865 99 EFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGI--LKLADFGLARAFSLSKNS 175 (310)
T ss_pred cCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCc--EEECcCCCcccccCCccc
Confidence 9995 5787777654 36899999999999999999999999999999999999987664 99999999875433221
Q ss_pred ----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-c----------
Q 019901 146 ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-Q---------- 210 (334)
Q Consensus 146 ----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~---------- 210 (334)
.....++..|+|||.+.+....+.++||||||+++|+|++|++||.+......... +..+... .
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 254 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTL-ISQLCGSITPEVWPGVDKL 254 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCChhhcccccch
Confidence 12345788999999987654334559999999999999999999987654332221 1111100 0
Q ss_pred -----ccCCC-----------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 211 -----YSIPD-----------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 211 -----~~~~~-----------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...+. ....++.+.+||.+||..+|.+|||++++++||||
T Consensus 255 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 255 ELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 00000 01135778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=292.35 Aligned_cols=247 Identities=28% Similarity=0.446 Sum_probs=191.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~ 74 (334)
||.|.+ .+.+..+++.+ |+|.+..... .....+.+|+.+++.++||||+++++++.. .+.+|+||||+++++
T Consensus 9 lg~g~~~~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~ 87 (287)
T cd06621 9 LGEGAGGSVTKCRLKNTGMIF-ALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGS 87 (287)
T ss_pred eccCCceEEEEEEECCCCeEE-EEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCC
Confidence 455544 47777888888 9999986542 234678999999999999999999998865 347899999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 75 LFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 75 L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|.||+++.++. ++|+|||++....... .....
T Consensus 88 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~-~~~~~ 164 (287)
T cd06621 88 LDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQ--VKLCDFGVSGELVNSL-AGTFT 164 (287)
T ss_pred HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCe--EEEeeccccccccccc-ccccc
Confidence 9887653 345899999999999999999999999999999999999987665 9999999987543222 22345
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhcc-ccCC----CCCCCCHHHH
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQ-YSIP----DYVHISPECR 224 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~ 224 (334)
++..|+|||.+.+..++.+ +|||||||++|+|++|..||...... ....+......... ...+ .....++.++
T Consensus 165 ~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (287)
T cd06621 165 GTSFYMAPERIQGKPYSIT-SDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK 243 (287)
T ss_pred CCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHH
Confidence 7889999999988777665 89999999999999999999865210 00111111111111 1111 1123467899
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 225 HLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+||.+||..+|.+|||+.|++.||||++.
T Consensus 244 ~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 272 (287)
T cd06621 244 DFIKQCLEKDPTRRPTPWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence 99999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=287.67 Aligned_cols=235 Identities=21% Similarity=0.314 Sum_probs=189.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+..+.++..+ |+|++.... .....+.+|+.+++.++||||+++++++..++.+++||||+.+++|.+
T Consensus 14 ig~g~~~~v~~~~~~~~~~~~-~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (263)
T cd05052 14 LGGGQYGEVYEGVWKKYSLTV-AVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 91 (263)
T ss_pred cCCcccceEEEEEEecCCceE-EEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHH
Confidence 455544 36777788888 999987654 334578899999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~ 153 (334)
++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++........ ....+++
T Consensus 92 ~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~~~ 169 (263)
T cd05052 92 YLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI 169 (263)
T ss_pred HHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCc--EEeCCCccccccccceeeccCCCCCcc
Confidence 98754 35899999999999999999999999999999999999987664 999999998754332211 1123456
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+......... + ......+....+++++.++|.+||+
T Consensus 170 ~y~aPE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~cl~ 243 (263)
T cd05052 170 KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----L-EKGYRMERPEGCPPKVYELMRACWQ 243 (263)
T ss_pred ccCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-HCCCCCCCCCCCCHHHHHHHHHHcc
Confidence 7999999988777655 999999999999998 9999987554322222 1 1222333345678999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|++|||+.++++
T Consensus 244 ~~p~~Rp~~~~l~~ 257 (263)
T cd05052 244 WNPSDRPSFAEIHQ 257 (263)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=284.00 Aligned_cols=239 Identities=28% Similarity=0.453 Sum_probs=196.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
+|.+ .+.+..++..+ ++|++..........+.+|+.+++.++|||++++++++...+..++++||+.+++|.+.+...
T Consensus 13 ~~~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~ 91 (253)
T cd05122 13 FGEVYKARHKRTGKEV-AIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKST 91 (253)
T ss_pred ceEEEEEEECCCCcEE-EEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhc
Confidence 3444 36677788888 999998766445578999999999999999999999999999999999999999999998776
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 83 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 -~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
..+++..+..++.|++.||.+||++|++||||+|+||+++.++. ++|+|||.+.............++..|+|||.+
T Consensus 92 ~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 169 (253)
T cd05122 92 NQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGE--VKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVI 169 (253)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCe--EEEeeccccccccccccccceecCCcccCHHHH
Confidence 57999999999999999999999999999999999999987654 999999998765443323455788999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+...+.+ +|+||||+++|+|++|+.||...+.......... ......+....++..+.++|.+||+.+|.+|||+
T Consensus 170 ~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~ 245 (253)
T cd05122 170 NGKPYDYK-ADIWSLGITAIELAEGKPPYSELPPMKALFKIAT---NGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTA 245 (253)
T ss_pred cCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh---cCCCCcCcccccCHHHHHHHHHHccCChhhCCCH
Confidence 87766544 9999999999999999999987643332222111 1222233333358999999999999999999999
Q ss_pred hHHhcCcc
Q 019901 242 PEIRNHEW 249 (334)
Q Consensus 242 ~ell~h~~ 249 (334)
.+++.|||
T Consensus 246 ~~~l~~~~ 253 (253)
T cd05122 246 EQLLKHPF 253 (253)
T ss_pred HHHhcCCC
Confidence 99999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=305.60 Aligned_cols=223 Identities=22% Similarity=0.356 Sum_probs=178.1
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------- 82 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------- 82 (334)
..| |||++..... ...+.+.+|+.+++.+ +||||+++++.+...+.+++|||||.+|+|.+++...
T Consensus 69 ~~v-avK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~ 147 (374)
T cd05106 69 LRV-AVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMAL 147 (374)
T ss_pred cee-EEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccc
Confidence 467 9999976542 2235688999999999 8999999999999999999999999999999988542
Q ss_pred -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q 019901 83 -----------------------------------------------------------GRFSEDEARFFFQQLISGVSY 103 (334)
Q Consensus 83 -----------------------------------------------------------~~~~~~~~~~~~~qil~~L~~ 103 (334)
.++++..++.++.||+.||.|
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~y 227 (374)
T cd05106 148 PEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDF 227 (374)
T ss_pred cccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHH
Confidence 247888899999999999999
Q ss_pred HHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHH
Q 019901 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 180 (334)
Q Consensus 104 LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 180 (334)
||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..++.+ +|||||||++
T Consensus 228 LH~~giiHrDLkp~Nil~~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlGvil 304 (374)
T cd05106 228 LASKNCIHRDVAARNVLLTDGRV--AKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILL 304 (374)
T ss_pred HHHCCEEeccCchheEEEeCCCe--EEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCcc-ccHHHHHHHH
Confidence 99999999999999999986654 99999999875432221 112235668999999987777655 9999999999
Q ss_pred HHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 181 YVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 181 ~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
|+|++ |+.||............. ......+....+++++.+++.+||+.+|.+|||+.++++
T Consensus 305 ~ellt~G~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 305 WEIFSLGKSPYPGILVNSKFYKMV----KRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHhCCCCCCccccccHHHHHHH----HcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99997 999998654433222222 222222233346899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=295.00 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=197.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..+++.+ |+|.+........+.+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.+
T Consensus 27 lg~g~~g~v~~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (293)
T cd06647 27 IGQGASGTVYTAIDVATGQEV-AIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 105 (293)
T ss_pred ecCCCCeEEEEEEEcCCCCEE-EEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHH
Confidence 455544 35667788888 9999876553445678999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~ 156 (334)
++.+. .+++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++........ .....+++.|+
T Consensus 106 ~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~y~ 182 (293)
T cd06647 106 VVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 182 (293)
T ss_pred HHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCC--EEEccCcceecccccccccccccCChhhc
Confidence 88654 5889999999999999999999999999999999999987654 99999998865433222 23346889999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||.+.+..++.+ +|+||||+++|+|++|+.||............ ........+....++..++++|.+||..+|.
T Consensus 183 ~PE~~~~~~~~~~-~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 258 (293)
T cd06647 183 APEVVTRKAYGPK-VDIWSLGIMAIEMVEGEPPYLNENPLRALYLI---ATNGTPELQNPEKLSAIFRDFLNRCLEMDVE 258 (293)
T ss_pred CchhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCChhhheeeh---hcCCCCCCCCccccCHHHHHHHHHHccCChh
Confidence 9999987777555 99999999999999999999865442221111 1111222233345688999999999999999
Q ss_pred CCCCHhHHhcCccccccCC
Q 019901 237 KRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~~ 255 (334)
+||++.+++.|+||....+
T Consensus 259 ~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 259 KRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred hCcCHHHHhcCHHHhcCcc
Confidence 9999999999999976543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-40 Score=286.78 Aligned_cols=234 Identities=30% Similarity=0.434 Sum_probs=190.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCChHHHHHh--
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICN-- 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~-- 81 (334)
.+.+..++..+ |+|.+..... ...+.+.+|+.+++.++||||+++++.+.. +...+++|||+.+++|.+++.+
T Consensus 18 ~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~ 96 (265)
T cd08217 18 KVRRKSDGKIL-VWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96 (265)
T ss_pred EeeecCCCCEE-EEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHh
Confidence 47788889988 9999876542 223567889999999999999999997754 4578999999999999999875
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHH-----HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 82 --AGRFSEDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 82 --~~~~~~~~~~~~~~qil~~L~~LH-----~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
..++++..++.++.||+.||.||| +.+++||||+|+||+++.++. +||+|||++........ .....+++
T Consensus 97 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~ 174 (265)
T cd08217 97 KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNN--VKLGDFGLAKILGHDSSFAKTYVGTP 174 (265)
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCC--EEEecccccccccCCcccccccccCC
Confidence 356899999999999999999999 899999999999999987654 99999999886544332 33456899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|+||||+++|+|++|+.||...... .. ...+..... .+.....+..+.+++.+||+.
T Consensus 175 ~~~~pE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~-~~---~~~~~~~~~-~~~~~~~~~~~~~l~~~~l~~ 248 (265)
T cd08217 175 YYMSPEQLNHMSYDEK-SDIWSLGCLIYELCALSPPFTARNQL-QL---ASKIKEGKF-RRIPYRYSSELNEVIKSMLNV 248 (265)
T ss_pred CccChhhhcCCCCCch-hHHHHHHHHHHHHHHCCCcccCcCHH-HH---HHHHhcCCC-CCCccccCHHHHHHHHHHccC
Confidence 9999999987776544 99999999999999999999876532 22 222222221 122235789999999999999
Q ss_pred CCCCCCCHhHHhcCccc
Q 019901 234 DPAKRISIPEIRNHEWF 250 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~ 250 (334)
+|.+|||+.++++|||+
T Consensus 249 ~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 249 DPDKRPSTEELLQLPLI 265 (265)
T ss_pred CcccCCCHHHHhhCCCC
Confidence 99999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=286.48 Aligned_cols=236 Identities=26% Similarity=0.376 Sum_probs=187.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+.++.+++.+ |+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+.+++|.
T Consensus 3 lg~g~~g~vy~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 3 IGRGNFGEVFSGRLRADNTPV-AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred cCcccCccEEEEEEecCCceE-EEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 565555 36777788888 9999865431 23467899999999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC---CCccCC
Q 019901 77 ERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT 152 (334)
Q Consensus 77 ~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---~~~~gt 152 (334)
+++.+.+ .+++..++.++.|++.||.|||++|++||||||+|||++.++. +||+|||++......... ....++
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 82 TFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNV--LKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCc--EEECccccCcccccccccccCCCCCCc
Confidence 9987644 5899999999999999999999999999999999999987654 999999998753321111 111234
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
..|+|||.+.+..++.+ +||||||+++|+|++ |..||........ ...+ ......+.....+..+.+++.+||
T Consensus 160 ~~y~aPE~~~~~~~~~~-~Dv~slG~il~e~~~~~~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~li~~~l 233 (252)
T cd05084 160 VKWTAPEALNYGRYSSE-SDVWSFGILLWEAFSLGAVPYANLSNQQT-REAI----EQGVRLPCPELCPDAVYRLMERCW 233 (252)
T ss_pred eeecCchhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccCHHHH-HHHH----HcCCCCCCcccCCHHHHHHHHHHc
Confidence 56999999988777655 999999999999997 9999976544221 1111 112222333457899999999999
Q ss_pred ccCCCCCCCHhHHhc
Q 019901 232 VADPAKRISIPEIRN 246 (334)
Q Consensus 232 ~~~p~~R~s~~ell~ 246 (334)
+.+|.+|||+.++++
T Consensus 234 ~~~p~~Rps~~~~~~ 248 (252)
T cd05084 234 EYDPGQRPSFSTVHQ 248 (252)
T ss_pred CCChhhCcCHHHHHH
Confidence 999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=301.90 Aligned_cols=242 Identities=27% Similarity=0.390 Sum_probs=184.0
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+- +..-....+.| |+|.+.... ......+.+||.+|.+|+ |.+||+++++-..++.+|+||||- ..+|
T Consensus 369 iG~GGSSkV~kV~~s~~~iy-alkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL 446 (677)
T KOG0596|consen 369 IGSGGSSKVFKVLNSDKQIY-ALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDL 446 (677)
T ss_pred hcCCCcceeeeeecCCCcch-hhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccH
Confidence 566665 22222233455 666655433 233467899999999995 899999999999999999999976 5789
Q ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccC
Q 019901 76 FERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVG 151 (334)
Q Consensus 76 ~~~l~~~~~-~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~g 151 (334)
...|.+... .+...++.+..|++.|++++|..||||.||||.|+|+-. | ++||+|||+|........ ..+.+|
T Consensus 447 ~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G--~LKLIDFGIA~aI~~DTTsI~kdsQvG 523 (677)
T KOG0596|consen 447 NKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-G--RLKLIDFGIANAIQPDTTSIVKDSQVG 523 (677)
T ss_pred HHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-e--eEEeeeechhcccCccccceeeccccC
Confidence 999987765 344689999999999999999999999999999999963 3 499999999986544433 345689
Q ss_pred CCccccchhhccCCCC----------CccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCC
Q 019901 152 TPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHI 219 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~----------~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~ 219 (334)
|+.|||||.+....+. +++|||||||||||+|+.|++||.... +...-+..+..... .+|..+.
T Consensus 524 T~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~---n~~aKl~aI~~P~~~Iefp~~~~- 599 (677)
T KOG0596|consen 524 TVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII---NQIAKLHAITDPNHEIEFPDIPE- 599 (677)
T ss_pred cccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH---HHHHHHHhhcCCCccccccCCCC-
Confidence 9999999998754443 345999999999999999999997432 12222333333333 3333221
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
..++.++++.||+.||.+|||+.+||+|||++-
T Consensus 600 ~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 600 NDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred chHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 234999999999999999999999999999854
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=285.63 Aligned_cols=239 Identities=37% Similarity=0.586 Sum_probs=198.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+.+..+++.+ |+|++.+.... ....+.+|+.+++.++||||+++++.+..++..++||||+.+++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 79 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLY-AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGE 79 (250)
T ss_pred CCCCCceEEEEEEECCCCcEE-EEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence 355554 46677778888 99999876522 33578899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|.||+++.++. ++|+|||++...... .......++.
T Consensus 80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05123 80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGH--IKLTDFGLAKELSSEGSRTNTFCGTP 157 (250)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCc--EEEeecCcceecccCCCcccCCcCCc
Confidence 9999988888999999999999999999999999999999999999987664 999999998754333 2234456888
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||...+...+.+ +|+||||+++|+|++|..||........ ...+...... .+..++..+.+++.+||..
T Consensus 158 ~~~~Pe~~~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~----~~~~~~~~~~--~~~~~~~~l~~~i~~~l~~ 230 (250)
T cd05123 158 EYLAPEVLLGKGYGKA-VDWWSLGVLLYEMLTGKPPFYAEDRKEI----YEKILKDPLR--FPEFLSPEARDLISGLLQK 230 (250)
T ss_pred cccChHHhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHH----HHHHhcCCCC--CCCCCCHHHHHHHHHHhcC
Confidence 9999999987766544 9999999999999999999976654222 2222222333 3334689999999999999
Q ss_pred CCCCCCCH---hHHhcCccc
Q 019901 234 DPAKRISI---PEIRNHEWF 250 (334)
Q Consensus 234 ~p~~R~s~---~ell~h~~~ 250 (334)
+|.+|||+ +++++||||
T Consensus 231 ~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 231 DPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CHhhCCCcccHHHHHhCCCC
Confidence 99999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=303.34 Aligned_cols=227 Identities=23% Similarity=0.332 Sum_probs=180.2
Q ss_pred CCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-------
Q 019901 13 YSSDLFVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------- 83 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 83 (334)
.++..| |||+++... ....+.+.+|+.+++.+ +||||+++++++..++..++|||||++|+|.+++....
T Consensus 63 ~~~~~v-avK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~ 141 (375)
T cd05104 63 DAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPK 141 (375)
T ss_pred ccceeE-EEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccc
Confidence 345566 999987543 12345788999999999 89999999999999999999999999999999886432
Q ss_pred --------------------------------------------------------------------CCCHHHHHHHHH
Q 019901 84 --------------------------------------------------------------------RFSEDEARFFFQ 95 (334)
Q Consensus 84 --------------------------------------------------------------------~~~~~~~~~~~~ 95 (334)
.+++..+..++.
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 221 (375)
T cd05104 142 HEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSY 221 (375)
T ss_pred ccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHH
Confidence 367888999999
Q ss_pred HHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccch
Q 019901 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIAD 172 (334)
Q Consensus 96 qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~D 172 (334)
||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....++..|+|||++.+..++.+ +|
T Consensus 222 qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-sD 298 (375)
T cd05104 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SD 298 (375)
T ss_pred HHHHHHHHHHHCCeeccCCchhhEEEECCCc--EEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCC-CC
Confidence 9999999999999999999999999986654 99999999875433221 112335667999999988877655 99
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 173 VWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 173 iwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
||||||++|+|++ |..||..........+.+. .......+...+.++++++.+||+.+|++|||+.++++.
T Consensus 299 i~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 299 VWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIK----EGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHH----hCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9999999999998 8999987654333333222 222222233468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=280.38 Aligned_cols=240 Identities=28% Similarity=0.419 Sum_probs=194.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~ 72 (334)
||-|+| ++++..+++.| |+|.+.++..+..+...+|+...++++|||++++++....+ ...|++++|...
T Consensus 29 LgeGGfsfv~LV~~~s~~~~Y-AlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~ 107 (302)
T KOG2345|consen 29 LGEGGFSFVDLVKGLSTGHLY-ALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKR 107 (302)
T ss_pred ecCCCceeeeeecccCcccch-hhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhcc
Confidence 677777 58889999999 99999998867778999999999999999999998875433 359999999999
Q ss_pred CChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC
Q 019901 73 GELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146 (334)
Q Consensus 73 ~~L~~~l~~~----~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~ 146 (334)
|+|.+.+... ..+++.++.+|+.+|++||++||+.. +.||||||.|||+...+. .+|.|||.++.....-..
T Consensus 108 Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~--~vl~D~GS~~~a~i~i~~ 185 (302)
T KOG2345|consen 108 GSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGL--PVLMDLGSATQAPIQIEG 185 (302)
T ss_pred ccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCc--eEEEeccCccccceEeec
Confidence 9999988753 35999999999999999999999998 999999999999987655 999999988754322211
Q ss_pred C----------CccCCCccccchhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC
Q 019901 147 K----------STVGTPAYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213 (334)
Q Consensus 147 ~----------~~~gt~~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 213 (334)
. ....|..|+|||.+.- ...+++ +|||||||++|.|+.|..||........ ...-.+.+.++.+
T Consensus 186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~er-tDIWSLGCtLYa~mf~~sPfe~~~~~Gg--SlaLAv~n~q~s~ 262 (302)
T KOG2345|consen 186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITER-TDIWSLGCTLYAMMFGESPFERIYQQGG--SLALAVQNAQISI 262 (302)
T ss_pred hHHHHHHHHHHHHhCCCcccCchheecccCcccccc-cchhhhhHHHHHHHHcCCcchHHhhcCC--eEEEeeecccccc
Confidence 1 1236889999999863 334444 8999999999999999999963211000 0001133456778
Q ss_pred CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 214 PDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 214 ~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
|+...+|..+.++|++||+.||.+||++.+++.+
T Consensus 263 P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 263 PNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 8877899999999999999999999999999864
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=285.29 Aligned_cols=235 Identities=23% Similarity=0.290 Sum_probs=186.3
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|+| +....+.+..+ |+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+|+|.++
T Consensus 12 lg~G~~~~vy~~~~~~~~~~-a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~ 89 (256)
T cd05114 12 LGSGQFGVVHLGKWRAQIKV-AIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89 (256)
T ss_pred ecCCcCceEEEEEeccCceE-EEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHH
Confidence 455555 33333445567 999987554 3356789999999999999999999999999999999999999999999
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCCcc
Q 019901 79 ICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAY 155 (334)
Q Consensus 79 l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y 155 (334)
+... +.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++........ ....++..|
T Consensus 90 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd05114 90 LRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGV--VKVSDFGMTRYVLDDEYTSSSGAKFPVKW 167 (256)
T ss_pred HHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCe--EEECCCCCccccCCCceeccCCCCCchhh
Confidence 8753 46899999999999999999999999999999999999987664 999999998754322211 122355689
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||++.+..++.+ +|+||||+++|+|++ |+.||............ .... ..+.....+..+.+++.+||+.+
T Consensus 168 ~aPE~~~~~~~~~~-~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i----~~~~-~~~~~~~~~~~~~~li~~c~~~~ 241 (256)
T cd05114 168 SPPEVFNFSKYSSK-SDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI----SRGF-RLYRPKLASMTVYEVMYSCWHEK 241 (256)
T ss_pred CChhhcccCccchh-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH----HCCC-CCCCCCCCCHHHHHHHHHHccCC
Confidence 99999987777655 999999999999999 99999876554333322 2211 22223346889999999999999
Q ss_pred CCCCCCHhHHhc
Q 019901 235 PAKRISIPEIRN 246 (334)
Q Consensus 235 p~~R~s~~ell~ 246 (334)
|.+|||++++++
T Consensus 242 p~~Rps~~~l~~ 253 (256)
T cd05114 242 PEGRPTFAELLR 253 (256)
T ss_pred cccCcCHHHHHH
Confidence 999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=286.46 Aligned_cols=237 Identities=31% Similarity=0.464 Sum_probs=192.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ ++.++.+++.+ |+|.+.... ....+.+.+|+.+++.++||||+++++.+..++.+|+||||+++++|.
T Consensus 8 lg~g~~g~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~ 86 (255)
T cd08219 8 VGEGSFGRALLVQHVNSDQKY-AMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLM 86 (255)
T ss_pred eeccCCeEEEEEEEcCCCceE-EEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHH
Confidence 556654 58888899999 999987543 233467889999999999999999999999999999999999999999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 77 ERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 77 ~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
+++... ..+++..+..++.|++.||.+||++||+|+||||+||+++.++. ++|+|||+++....... .....|++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~ 164 (255)
T cd08219 87 QKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK--VKLGDFGSARLLTSPGAYACTYVGTP 164 (255)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCc--EEEcccCcceeecccccccccccCCc
Confidence 988653 45899999999999999999999999999999999999987665 99999999875433222 23456899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|+||||+++|+|++|..||...+..... ..+..... .+....++..+.++|.+||+.
T Consensus 165 ~~~aPE~~~~~~~~~~-~Dv~slG~i~~~l~~g~~p~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 238 (255)
T cd08219 165 YYVPPEIWENMPYNNK-SDIWSLGCILYELCTLKHPFQANSWKNLI----LKVCQGSY-KPLPSHYSYELRSLIKQMFKR 238 (255)
T ss_pred cccCHHHHccCCcCch-hhhhhhchhheehhhccCCCCCCCHHHHH----HHHhcCCC-CCCCcccCHHHHHHHHHHHhC
Confidence 9999999987776555 99999999999999999999865432222 22222222 122335789999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+.+++.-
T Consensus 239 ~P~~Rp~~~~il~~ 252 (255)
T cd08219 239 NPRSRPSATTILSR 252 (255)
T ss_pred CcccCCCHHHHhhc
Confidence 99999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=291.05 Aligned_cols=223 Identities=22% Similarity=0.342 Sum_probs=181.3
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc------------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA------------ 82 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------ 82 (334)
..+ |+|.+..... .....+.+|+.+++.++||||+++++++...+..+++|||+.+++|.+++...
T Consensus 36 ~~v-~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 114 (283)
T cd05048 36 TSV-AIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD 114 (283)
T ss_pred eeE-EEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence 456 9999875441 23356889999999999999999999999989999999999999999998764
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCcc
Q 019901 83 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 155 (334)
Q Consensus 83 ----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y 155 (334)
..+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++...... ......+++.|
T Consensus 115 ~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y 192 (283)
T cd05048 115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT--VKISDFGLSRDIYSADYYRVQSKSLLPVRW 192 (283)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc--EEECCCcceeeccccccccccCCCcccccc
Confidence 45788999999999999999999999999999999999987664 9999999987542221 22334568899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||.+.+..++.+ +|||||||++|+|++ |..||.+........ .+... ...+....+++++.+++.+||+.+
T Consensus 193 ~aPE~~~~~~~~~~-sDv~slG~il~el~~~g~~p~~~~~~~~~~~----~i~~~-~~~~~~~~~~~~~~~l~~~c~~~~ 266 (283)
T cd05048 193 MPPEAILYGKFTTE-SDIWSFGVVLWEIFSYGLQPYYGFSNQEVIE----MIRSR-QLLPCPEDCPARVYALMIECWNEI 266 (283)
T ss_pred cCHHHhccCcCchh-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHcC-CcCCCcccCCHHHHHHHHHHccCC
Confidence 99999887777655 999999999999998 999998765533222 22221 222333467999999999999999
Q ss_pred CCCCCCHhHHhcC
Q 019901 235 PAKRISIPEIRNH 247 (334)
Q Consensus 235 p~~R~s~~ell~h 247 (334)
|.+||++.+++++
T Consensus 267 p~~Rp~~~~i~~~ 279 (283)
T cd05048 267 PARRPRFKDIHTR 279 (283)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=289.19 Aligned_cols=224 Identities=23% Similarity=0.350 Sum_probs=182.8
Q ss_pred CCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---------
Q 019901 14 SSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 83 (334)
++..+ |||.+...... ....+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...+
T Consensus 34 ~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~ 112 (280)
T cd05049 34 DKELV-AVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP 112 (280)
T ss_pred CcceE-EEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccc
Confidence 34667 99998765522 34688999999999999999999999999999999999999999999997542
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCcc
Q 019901 84 -----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 155 (334)
Q Consensus 84 -----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y 155 (334)
.+++..+..++.|++.||.+||++|++||||||+||+++.++. ++|+|||+++...... ......+++.|
T Consensus 113 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05049 113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV--VKIGDFGMSRDVYTTDYYRVGGHTMLPIRW 190 (280)
T ss_pred ccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe--EEECCcccceecccCcceecCCCCccccee
Confidence 3788999999999999999999999999999999999987764 9999999987432221 12334567889
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||++.+..++.+ +|||||||++|+|++ |..||.......... .+...... +....++..+.+++.+||+.+
T Consensus 191 ~aPE~~~~~~~~~~-~Di~slG~il~e~~~~g~~p~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~li~~~l~~~ 264 (280)
T cd05049 191 MPPESIMYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE----CITQGRLL-QRPRTCPSEVYDIMLGCWKRD 264 (280)
T ss_pred cChhhhccCCcchh-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHcCCcC-CCCCCCCHHHHHHHHHHcCCC
Confidence 99999988887655 999999999999998 999998765533222 22222221 222357899999999999999
Q ss_pred CCCCCCHhHHhc
Q 019901 235 PAKRISIPEIRN 246 (334)
Q Consensus 235 p~~R~s~~ell~ 246 (334)
|.+|||+.|+++
T Consensus 265 p~~Rp~~~eil~ 276 (280)
T cd05049 265 PQQRINIKDIHE 276 (280)
T ss_pred cccCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=300.72 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=191.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC--------------CeE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP--------------THL 63 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--------------~~~ 63 (334)
||.|++ .+.++.+|+.| |+|.+........+.+.+|+.+++.++||||+++++++... ...
T Consensus 13 Lg~g~~g~vy~~~~~~~~~~v-~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 91 (342)
T cd07854 13 LGCGSNGLVFSAVDSDCDKRV-AVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSV 91 (342)
T ss_pred ecCCCCEEEEEEEECCCCcEE-EEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceE
Confidence 455554 47788899999 99999877655567899999999999999999999876543 357
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC
Q 019901 64 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143 (334)
Q Consensus 64 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~ 143 (334)
|+||||+. ++|...+.. +.+++..++.++.||+.||.|||+.||+||||||+||+++..+ ..++|+|||+++.....
T Consensus 92 ~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~-~~~kl~dfg~~~~~~~~ 168 (342)
T cd07854 92 YIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED-LVLKIGDFGLARIVDPH 168 (342)
T ss_pred EEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-ceEEECCcccceecCCc
Confidence 99999996 588887754 5699999999999999999999999999999999999997543 24899999998754322
Q ss_pred CC----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh------------
Q 019901 144 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL------------ 207 (334)
Q Consensus 144 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------------ 207 (334)
.. .....++..|+|||++.+....+.++|||||||++|+|++|+.||.................
T Consensus 169 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (342)
T cd07854 169 YSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLN 248 (342)
T ss_pred cccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 11 12235788999999876544445559999999999999999999987655443333221110
Q ss_pred ------h---ccccCC---CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 208 ------S---VQYSIP---DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 208 ------~---~~~~~~---~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
. .....+ ....++.++.+||.+||+.+|.+|||+.+++.||||+.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~ 305 (342)
T cd07854 249 VIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSC 305 (342)
T ss_pred hhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcccc
Confidence 0 000000 01246889999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=286.95 Aligned_cols=224 Identities=20% Similarity=0.295 Sum_probs=181.1
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHH
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 91 (334)
.+..| |+|.+..... .....+.+|+..++.++||||+++++++..++..++||||+.+|+|.+++.+. ..+++..++
T Consensus 32 ~~~~v-aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~ 110 (266)
T cd05064 32 RELPV-AIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM 110 (266)
T ss_pred ceeeE-EEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHH
Confidence 34556 9999876531 22357889999999999999999999999999999999999999999998764 568999999
Q ss_pred HHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCCccccchhhccCCCCCc
Q 019901 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYDGK 169 (334)
Q Consensus 92 ~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~ 169 (334)
.++.|++.||+|||++|++||||||+|||++.++. ++++|||.+......... ....+++.|+|||.+.+..++.+
T Consensus 111 ~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 188 (266)
T cd05064 111 GMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLV--CKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSA 188 (266)
T ss_pred HHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCc--EEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccch
Confidence 99999999999999999999999999999987664 999999987643222111 12235678999999988777655
Q ss_pred cchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 170 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 170 ~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+|||||||++|++++ |..||........... + ......+.+..++..+.+++.+||+.+|.+|||+.++++
T Consensus 189 -~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 189 -SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA----V-EDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----H-HCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 999999999999775 9999987655332222 1 222233445568999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=296.32 Aligned_cols=241 Identities=32% Similarity=0.545 Sum_probs=205.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccH---HHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDE---NVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~---~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| ++..+.+.+.| |||++++.....++ -...|-++|... +-|.+++++.+|++-+++|+||||+.||
T Consensus 357 lGKGSFGKVlLaerkgtdELy-AiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGG 435 (683)
T KOG0696|consen 357 LGKGSFGKVLLAERKGTDELY-AIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGG 435 (683)
T ss_pred eccCccceeeeecccCcchhh-hhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCc
Confidence 566666 58888899999 99999998743332 334566777666 4689999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt 152 (334)
+|.-.++.-++|.+..+..++..|+.||-+||++|||+||||..|||+++.|. +||+|||+++.....+ ...+.|||
T Consensus 436 DLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGH--iKi~DFGmcKEni~~~~TTkTFCGT 513 (683)
T KOG0696|consen 436 DLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIFDGVTTKTFCGT 513 (683)
T ss_pred hhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCc--eEeeecccccccccCCcceeeecCC
Confidence 99999999999999999999999999999999999999999999999998876 9999999998654443 35677999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|.|+|||++..++|. +++|+||+|++||||+.|.+||.+.++.+.++.+. ......|. .+|.++.++....|.
T Consensus 514 PdYiAPEIi~YqPYg-ksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~----ehnvsyPK--slSkEAv~ickg~lt 586 (683)
T KOG0696|consen 514 PDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM----EHNVSYPK--SLSKEAVAICKGLLT 586 (683)
T ss_pred CcccccceEEecccc-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH----HccCcCcc--cccHHHHHHHHHHhh
Confidence 999999999999985 55999999999999999999999988866665544 44444444 579999999999999
Q ss_pred cCCCCCCC-----HhHHhcCccccc
Q 019901 233 ADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s-----~~ell~h~~~~~ 252 (334)
+.|.+|.. -.++..||||+.
T Consensus 587 K~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 587 KHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred cCCccccCCCCccccchhhCcchhh
Confidence 99999985 367999999964
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=284.73 Aligned_cols=235 Identities=31% Similarity=0.465 Sum_probs=192.3
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC--
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-- 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-- 83 (334)
.+.++.+|..+ |+|.+..... ...+.+.+|+.+++.++||||+++++.+...+..++|+||+.+++|.+++.+..
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~ 96 (257)
T cd08225 18 LAKAKSDSEHC-VIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGV 96 (257)
T ss_pred EEEEcCCCceE-EEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCC
Confidence 37788888888 9999977542 234578899999999999999999999999999999999999999999987643
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~ 162 (334)
.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++. .+||+|||.+........ .....|++.|+|||++.
T Consensus 97 ~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~ 175 (257)
T cd08225 97 LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGM-VAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQ 175 (257)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCC-eEEecccccchhccCCcccccccCCCccccCHHHHc
Confidence 4799999999999999999999999999999999999986643 479999999875433222 22345889999999988
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
+..++.+ +|+||||+++|+|++|..||........... ..... ..+....++.++.++|.+||..+|++|||+.
T Consensus 176 ~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~ 249 (257)
T cd08225 176 NRPYNNK-TDIWSLGCVLYELCTLKHPFEGNNLHQLVLK----ICQGY-FAPISPNFSRDLRSLISQLFKVSPRDRPSIT 249 (257)
T ss_pred CCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----Hhccc-CCCCCCCCCHHHHHHHHHHhccChhhCcCHH
Confidence 7776555 9999999999999999999986544332222 22111 1122335788999999999999999999999
Q ss_pred HHhcCccc
Q 019901 243 EIRNHEWF 250 (334)
Q Consensus 243 ell~h~~~ 250 (334)
+++.||||
T Consensus 250 ~ll~~~~~ 257 (257)
T cd08225 250 SILKRPFL 257 (257)
T ss_pred HHhhCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=285.37 Aligned_cols=234 Identities=33% Similarity=0.485 Sum_probs=195.0
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc---
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--- 82 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--- 82 (334)
.+.+..++..+ |+|.+..... .....+.+|+.+++.++|||++++.+.+..+...++|+||+++++|.+.+.+.
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 96 (258)
T cd08215 18 LVRRKSDGKLY-VLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKE 96 (258)
T ss_pred EEEEcCCCcEE-EEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhcc
Confidence 47778888888 9999987653 34467889999999999999999999999999999999999999999998764
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchh
Q 019901 83 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEV 160 (334)
Q Consensus 83 -~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~ 160 (334)
..+++..+..++.+++.||.+||++|++|+||+|+||+++.++. ++|+|||++....... ......|++.|+|||.
T Consensus 97 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~ 174 (258)
T cd08215 97 GKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGL--VKLGDFGISKVLSSTVDLAKTVVGTPYYLSPEL 174 (258)
T ss_pred CCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCc--EEECCccceeecccCcceecceeeeecccChhH
Confidence 67999999999999999999999999999999999999987654 9999999987543332 2334568999999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
+.+..++.+ +|+||+|+++++|++|..||........... ..... ..+....++..+.+++.+||..+|.+|||
T Consensus 175 ~~~~~~~~~-~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 248 (258)
T cd08215 175 CQNKPYNYK-SDIWSLGCVLYELCTLKHPFEGENLLELALK----ILKGQ-YPPIPSQYSSELRNLVSSLLQKDPEERPS 248 (258)
T ss_pred hccCCCCcc-ccHHHHHHHHHHHHcCCCCCCCCcHHHHHHH----HhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 887776555 9999999999999999999977654322222 22211 11222357899999999999999999999
Q ss_pred HhHHhcCccc
Q 019901 241 IPEIRNHEWF 250 (334)
Q Consensus 241 ~~ell~h~~~ 250 (334)
+.++|+||||
T Consensus 249 ~~~ll~~~~~ 258 (258)
T cd08215 249 IAQILQSPFI 258 (258)
T ss_pred HHHHhcCCCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=283.22 Aligned_cols=234 Identities=29% Similarity=0.449 Sum_probs=195.2
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
.+.+..+++.| ++|.+..... ...+.+.+|+.+++.++|||++++++++..++..++||||+.+++|.+++.+.+.+
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l 96 (254)
T cd06627 18 KGLNLETGDFV-AIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPF 96 (254)
T ss_pred EEEEcCCCcEE-EEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCC
Confidence 36677788888 9999987763 24467899999999999999999999999999999999999999999999888889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhccC
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~ 164 (334)
++..+..++.|++.||.+||++||+||||+|+||+++.++ .++|+|||++........ .....+++.|+|||.+.+.
T Consensus 97 ~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~ 174 (254)
T cd06627 97 PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG--VVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS 174 (254)
T ss_pred CHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC--CEEEeccccceecCCCcccccccccchhhcCHhhhcCC
Confidence 9999999999999999999999999999999999998755 499999999875443322 2345688999999998777
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHH
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~el 244 (334)
..+ .++|+||||+++|+|++|..||..........+. .. ....+....+++.+++++.+||..+|++|||+.++
T Consensus 175 ~~~-~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 175 GAS-TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRI----VQ-DDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred CCC-cchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH----hc-cCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 654 4499999999999999999999865532222221 11 11122233578999999999999999999999999
Q ss_pred hcCccc
Q 019901 245 RNHEWF 250 (334)
Q Consensus 245 l~h~~~ 250 (334)
+.||||
T Consensus 249 l~~~~~ 254 (254)
T cd06627 249 LKHPWI 254 (254)
T ss_pred hcCCCC
Confidence 999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=291.85 Aligned_cols=225 Identities=23% Similarity=0.324 Sum_probs=176.2
Q ss_pred eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC------------
Q 019901 17 LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------------ 83 (334)
Q Consensus 17 ~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 83 (334)
.| |+|++..... .....+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++....
T Consensus 48 ~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 126 (304)
T cd05096 48 LV-AVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126 (304)
T ss_pred EE-EEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccccc
Confidence 46 9999876542 223578899999999999999999999999999999999999999999886532
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCC
Q 019901 84 -------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP 153 (334)
Q Consensus 84 -------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~ 153 (334)
.++...+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+++
T Consensus 127 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~DfG~~~~~~~~~~~~~~~~~~~~~ 204 (304)
T cd05096 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLT--IKIADFGMSRNLYAGDYYRIQGRAVLPI 204 (304)
T ss_pred ccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCcc--EEECCCccceecccCceeEecCcCCCCc
Confidence 3677889999999999999999999999999999999987664 99999999875432211 12334578
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCCCchHHHHHHHHHHhhc--cccCCCCCCCCHHHHHHHHH
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~ 229 (334)
.|+|||++.+..++.+ +|||||||++|+|++ +..||................... .........+++.+.+++.+
T Consensus 205 ~y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 283 (304)
T cd05096 205 RWMAWECILMGKFTTA-SDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQ 283 (304)
T ss_pred cccCHHHHhcCCCCch-hhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHH
Confidence 8999999987777655 999999999999986 567887665433332221111111 11112233578999999999
Q ss_pred hcccCCCCCCCHhHHh
Q 019901 230 IFVADPAKRISIPEIR 245 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell 245 (334)
||+.+|.+|||+.++.
T Consensus 284 cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 284 CWSRDCRERPSFSDIH 299 (304)
T ss_pred HccCCchhCcCHHHHH
Confidence 9999999999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=300.23 Aligned_cols=240 Identities=22% Similarity=0.354 Sum_probs=189.3
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCe------EEEEEeccCCCChHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTH------LAIVMEYASGGELFERI 79 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~------~~lv~e~~~~~~L~~~l 79 (334)
.+++..+++.| |||.+..... .....+.+|+.+++.++||||+++++++...+. .++|+||+ +++|.+++
T Consensus 33 ~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 110 (343)
T cd07851 33 SAFDTKTGRKV-AIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIV 110 (343)
T ss_pred EEEECCCCcEE-EEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHH
Confidence 47788888888 9999876431 233567789999999999999999998866544 89999999 67998888
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.. .++++..++.++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++...... .....+++.|+|||
T Consensus 111 ~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE 185 (343)
T cd07851 111 KC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCE--LKILDFGLARHTDDE--MTGYVATRWYRAPE 185 (343)
T ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC--EEEcccccccccccc--ccCCcccccccCHH
Confidence 65 56999999999999999999999999999999999999987664 999999998754322 33456889999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-------------------ccC------C
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------YSI------P 214 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~------~ 214 (334)
.+.+....+.++|||||||++|+|++|+.||.+......+........... ... .
T Consensus 186 ~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (343)
T cd07851 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKE 265 (343)
T ss_pred HHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHH
Confidence 986644444559999999999999999999987655443333222110000 000 0
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.....++.+.++|.+||+.+|.+|||+.+++.||||.+..
T Consensus 266 ~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 266 VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 0123589999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.92 Aligned_cols=236 Identities=26% Similarity=0.376 Sum_probs=187.4
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AG 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~ 83 (334)
.+.+..+++.| |+|++..... .....+.+|+.+++.++||||+++++++..++..|+|+||+. |++.+.+.. .+
T Consensus 33 ~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~ 110 (307)
T cd06607 33 FARDVRTNEVV-AIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK 110 (307)
T ss_pred EEEEcCCCcEE-EEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc
Confidence 46777788888 9999875432 122468899999999999999999999999999999999996 567676654 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhc-
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL- 162 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~- 162 (334)
.+++..+..++.|++.||.|||+.||+||||+|+||+++.++. ++|+|||++..... .....+++.|+|||++.
T Consensus 111 ~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~--~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 185 (307)
T cd06607 111 PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGT--VKLADFGSASLVSP---ANSFVGTPYWMAPEVILA 185 (307)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCC--EEEeecCcceecCC---CCCccCCccccCceeeec
Confidence 6999999999999999999999999999999999999987665 99999999864322 23456888999999874
Q ss_pred --cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 163 --KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 163 --~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
...++ .++||||||+++|+|++|.+||........... +.............+..+.++|.+||..+|.+|||
T Consensus 186 ~~~~~~~-~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 260 (307)
T cd06607 186 MDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS 260 (307)
T ss_pred cCCCCCC-cccchHHHHHHHHHHHcCCCCCCCccHHHHHHH----HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcC
Confidence 23344 449999999999999999999986554322211 11111111112236789999999999999999999
Q ss_pred HhHHhcCccccccCC
Q 019901 241 IPEIRNHEWFLKNLP 255 (334)
Q Consensus 241 ~~ell~h~~~~~~~~ 255 (334)
+.+++.||||....+
T Consensus 261 ~~~il~~~~~~~~~~ 275 (307)
T cd06607 261 SEELLKHRFVLRERP 275 (307)
T ss_pred HHHHhcChhhcccCC
Confidence 999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.43 Aligned_cols=250 Identities=27% Similarity=0.391 Sum_probs=194.3
Q ss_pred CCccee----eeeecCCCC----eeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSD----LFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~----~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~ 70 (334)
||.|+| .|+.++++. .+ |||.++-+. -....+.-||+.+++.++|||++.+..+|.+ +..+++++||.
T Consensus 32 Ig~GTYG~VykA~~~~~n~kr~k~y-AiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYA 110 (438)
T KOG0666|consen 32 IGRGTYGKVYKAVRKNTNDKRTKEY-AIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYA 110 (438)
T ss_pred ecccccceeeEeeeccCCcccchhh-HHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhh
Confidence 677777 354444443 56 999987653 2455788999999999999999999999988 78899999999
Q ss_pred CCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC--CCCEEEeccCCccCCCCC
Q 019901 71 SGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLH 143 (334)
Q Consensus 71 ~~~~L~~~l~~-----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~--~~~~kl~Dfgla~~~~~~ 143 (334)
+. +|++.|.- ...++...++.+++||+.|+.|||++=|+||||||.|||+..++ .++|||+|||+|+.....
T Consensus 111 Eh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~p 189 (438)
T KOG0666|consen 111 EH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNP 189 (438)
T ss_pred hh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcc
Confidence 65 78887753 24599999999999999999999999999999999999997662 257999999999865433
Q ss_pred CC----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHhhc-
Q 019901 144 SQ----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILSV- 209 (334)
Q Consensus 144 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~~- 209 (334)
-. ....+-|.+|+|||.+.|...++++.||||+|||+.||+|-.+.|.+.... .++..++.-....
T Consensus 190 lkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt 269 (438)
T KOG0666|consen 190 LKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPT 269 (438)
T ss_pred ccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCc
Confidence 22 234567999999999999988889899999999999999999999764321 2222222111100
Q ss_pred cc------cCCCC------------------------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 210 QY------SIPDY------------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 210 ~~------~~~~~------------------------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.. ..|.+ ..-++...+|+.+||..||.+|.|++++|+|+||++.
T Consensus 270 ~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d 343 (438)
T KOG0666|consen 270 DKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTED 343 (438)
T ss_pred cccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccC
Confidence 00 01111 1125668999999999999999999999999999886
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=284.34 Aligned_cols=240 Identities=29% Similarity=0.437 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-----ccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-----WQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-----~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~ 70 (334)
||.|.+ .+.++.++..+ |+|.+.... ......+++|+.+++.++||||+++++.+.+. +.+++|+||+
T Consensus 10 lg~g~~g~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~ 88 (264)
T cd06653 10 LGRGAFGEVYLCYDADTGREL-AVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYM 88 (264)
T ss_pred EccCCCeEEEEEEEcCCCCEE-EEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeC
Confidence 455544 47788889998 999986532 12235788999999999999999999998764 5689999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC----CCC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQP 146 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----~~~ 146 (334)
.+++|.+++.+.+.+++..++.++.|++.||.|||++|++|+||+|+||+++.++. ++|+|||+++..... ...
T Consensus 89 ~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 166 (264)
T cd06653 89 PGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGN--VKLGDFGASKRIQTICMSGTGI 166 (264)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCC--EEECccccccccccccccCccc
Confidence 99999999988788999999999999999999999999999999999999987664 999999998754321 111
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
....+++.|+|||.+.+..++.+ +|+|||||++|+|++|+.||.......... ...........+..+++.+.++
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~p~~~~~~~~~~ 241 (264)
T cd06653 167 KSVTGTPYWMSPEVISGEGYGRK-ADVWSVACTVVEMLTEKPPWAEYEAMAAIF----KIATQPTKPMLPDGVSDACRDF 241 (264)
T ss_pred cccCCcccccCHhhhcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCccCHHHHHH----HHHcCCCCCCCCcccCHHHHHH
Confidence 23468899999999988776555 899999999999999999998654433222 2222222222234578999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
|.+||. +|..|||+.+++.|||.
T Consensus 242 i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 242 LKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHhc-CcccCccHHHHhcCCCC
Confidence 999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=288.22 Aligned_cols=239 Identities=30% Similarity=0.471 Sum_probs=190.6
Q ss_pred eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHhc-
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA- 82 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~- 82 (334)
++.+..+|+.+ |+|.+.... ......+.+|+.+++.++|||++++++++... +..++|+||+. ++|...+.+.
T Consensus 17 ~~~~~~~~~~~-~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 94 (287)
T cd07840 17 KARNKKTGELV-ALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPE 94 (287)
T ss_pred EEEECCCCeEE-EEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccC
Confidence 46777788888 999998764 23346788999999999999999999999888 88999999996 4888888765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEV 160 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~ 160 (334)
..+++..++.++.||+.||+|||+.|++|+||+|+||+++.++. ++|+|||++........ .....++..|+|||.
T Consensus 95 ~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~ 172 (287)
T cd07840 95 VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGV--LKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172 (287)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCC--EEEccccceeeccCCCcccccccccccccCCcee
Confidence 57999999999999999999999999999999999999987665 99999999875543321 233457889999998
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccCCC-----------------------C
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPD-----------------------Y 216 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~-----------------------~ 216 (334)
+.+....+.++||||||+++|+|++|+.||........+........... ...+. .
T Consensus 173 ~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (287)
T cd07840 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFF 252 (287)
T ss_pred eEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHh
Confidence 77654444559999999999999999999987665444433322111000 00000 1
Q ss_pred CC-CCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 217 VH-ISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 217 ~~-~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.. .++.+.+++.+||..+|.+|||+++++.||||
T Consensus 253 ~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 253 KHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred cccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 12 38899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=291.40 Aligned_cols=239 Identities=28% Similarity=0.427 Sum_probs=187.5
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC----------eEEEEEeccCCCCh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT----------HLAIVMEYASGGEL 75 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----------~~~lv~e~~~~~~L 75 (334)
.+.++.+|+.| |||.+..... .....+.+|+.+++.++||||+++++++.+.. .+++|+||+.+ ++
T Consensus 25 ~~~~~~~~~~v-~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 102 (302)
T cd07864 25 KARDKDTGELV-ALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DL 102 (302)
T ss_pred EEEECCCCcEE-EEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cH
Confidence 47777888888 9999976541 23457789999999999999999999987654 79999999976 67
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCC
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt 152 (334)
...+.+. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. +||+|||++........ .....++
T Consensus 103 ~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 180 (302)
T cd07864 103 MGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQ--IKLADFGLARLYNSEESRPYTNKVIT 180 (302)
T ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCc--EEeCcccccccccCCcccccccceec
Confidence 7776653 46899999999999999999999999999999999999987665 99999999875433321 1223467
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-c------C------------
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-S------I------------ 213 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~------~------------ 213 (334)
+.|+|||.+.+....+.++|||||||++|+|++|++||........+............ . .
T Consensus 181 ~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (302)
T cd07864 181 LWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQY 260 (302)
T ss_pred cCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccccccccccccccc
Confidence 88999998875543345599999999999999999999876654444333322111000 0 0
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 214 -----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 214 -----~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.....++..+.+++.+||..+|.+|||+.+++.||||
T Consensus 261 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 261 RRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred ccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0122468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=283.42 Aligned_cols=235 Identities=23% Similarity=0.290 Sum_probs=185.4
Q ss_pred CCccee---e-e--eecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-D--RCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~--~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ + + +.+.++..+ |+|++..... ...+.+.+|+.+++.++||||+++++++. ....++||||+.++
T Consensus 3 lg~G~~g~v~~~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 3 LGSGNFGTVKKGMYKMKKSEKTV-AVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred CCCcCCcceEEeEEecCCCceEE-EEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 566665 2 3 235567777 9999875542 23467889999999999999999999875 45679999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCc
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 149 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~ 149 (334)
+|.+++.....+++..+..++.|++.||.|||++||+||||||.||+++.++. +||+|||+++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHY--AKISDFGLSKALGADENYYKAKTHG 158 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCe--EEECCCccccccCCCCCeeeecCCC
Confidence 99999988888999999999999999999999999999999999999987654 99999999875433221 1222
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+++.|+|||.+....++.+ +|+|||||++|+|++ |..||.......... .+.. ....+.+..+++++.++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~----~i~~-~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05116 159 KWPVKWYAPECMNYYKFSSK-SDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQ----MIES-GERMECPQRCPPEMYDLMK 232 (257)
T ss_pred CCCccccCHhHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHC-CCCCCCCCCCCHHHHHHHH
Confidence 34678999999877666555 999999999999998 999998755432222 2222 1222333458999999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||+.+|.+||++.++..
T Consensus 233 ~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 233 LCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHhccCchhCcCHHHHHH
Confidence 999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=282.72 Aligned_cols=235 Identities=21% Similarity=0.318 Sum_probs=186.9
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ + +++ .++..+ |+|++.... .....+.+|+.+++.++||||+++++++...+..|+||||+++++|.+
T Consensus 12 lg~G~~~~v~~~~~-~~~~~~-~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 88 (256)
T cd05059 12 LGSGQFGVVHLGKW-RGKIDV-AIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLN 88 (256)
T ss_pred hccCCCceEEEeEe-cCCccE-EEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHH
Confidence 555555 3 444 345567 999987654 344678899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCCc
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPA 154 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~ 154 (334)
++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++........ ....++..
T Consensus 89 ~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 166 (256)
T cd05059 89 YLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNV--VKVSDFGLARYVLDDQYTSSQGTKFPVK 166 (256)
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCc--EEECCcccceecccccccccCCCCCCcc
Confidence 98764 46899999999999999999999999999999999999987765 999999998754322111 11223457
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||.+.+..++.+ +||||||+++|+|++ |+.||........... +. .....+.....++.+.+++.+||..
T Consensus 167 y~~Pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05059 167 WAPPEVFDYSRFSSK-SDVWSFGVLMWEVFSEGKMPYERFSNSEVVES----VS-AGYRLYRPKLAPTEVYTIMYSCWHE 240 (256)
T ss_pred ccCHHHhccCCCCch-hhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHHHHHHHHHHhcC
Confidence 999999988777655 999999999999998 8999986554332222 21 2223333445799999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+.++++.
T Consensus 241 ~p~~Rpt~~~~l~~ 254 (256)
T cd05059 241 KPEDRPAFKKLLSQ 254 (256)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=288.88 Aligned_cols=239 Identities=28% Similarity=0.446 Sum_probs=190.8
Q ss_pred eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~ 84 (334)
.+.+..+++.+ ++|.+...... ....+.+|+.+++.++||||+++++++..++..++|+||+.+ +|...+.. ...
T Consensus 17 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~~~ 94 (283)
T cd05118 17 KARDKLTGEIV-AIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRG 94 (283)
T ss_pred EEEcCCCCcEE-EEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhccc
Confidence 46777788888 99998766522 356788999999999999999999999999999999999965 88777766 357
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~ 163 (334)
+++..+..++.|++.||.|||+.||+|+||+|+||+++.++. ++|+|||.+....... ......++..|+|||.+.+
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 172 (283)
T cd05118 95 LPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV--LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLG 172 (283)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc--EEEeeeeeeEecCCCcccccCccCcccccCcHHHhc
Confidence 999999999999999999999999999999999999987654 9999999987544332 2223457889999999877
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc---------------ccCC---------CCCCC
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIP---------DYVHI 219 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~---------~~~~~ 219 (334)
....+.++|+||||+++|+|++|+.||...+................ ...+ ....+
T Consensus 173 ~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (283)
T cd05118 173 DKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNA 252 (283)
T ss_pred CCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhh
Confidence 63344559999999999999999999987665444333322111100 0000 11236
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+.++++||.+||+++|.+||++.+++.||||
T Consensus 253 ~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 253 SPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred CHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 8899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=282.72 Aligned_cols=236 Identities=22% Similarity=0.303 Sum_probs=185.7
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|.+ +......+..+ |||.+.... ...+.+.+|+.+++.++||||+++++++......++||||+.+++|.++
T Consensus 12 lg~G~~~~vy~~~~~~~~~~-aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 89 (256)
T cd05113 12 LGTGQFGVVKYGKWRGQYDV-AIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNY 89 (256)
T ss_pred ecCcccceEEEEEecCCCcE-EEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHH
Confidence 455544 32222333456 999987654 3356789999999999999999999999988899999999999999999
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCcc
Q 019901 79 ICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAY 155 (334)
Q Consensus 79 l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y 155 (334)
+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++. +||+|||+++....... .....++..|
T Consensus 90 i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~y 167 (256)
T cd05113 90 LREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGC--VKVSDFGLSRYVLDDEYTSSVGSKFPVRW 167 (256)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCC--EEECCCccceecCCCceeecCCCccChhh
Confidence 8764 46899999999999999999999999999999999999987654 99999999875432221 1122355679
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||.+.+..++.+ +|||||||++|+|++ |..||........... +... ...+.....+..+++++.+||+.+
T Consensus 168 ~~pe~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05113 168 SPPEVLLYSKFSSK-SDVWAFGVLMWEVYSLGKMPYERFNNSETVEK----VSQG-LRLYRPHLASEKVYAIMYSCWHEK 241 (256)
T ss_pred CCHHHHhcCcccch-hHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH----HhcC-CCCCCCCCCCHHHHHHHHHHcCCC
Confidence 99999987777655 999999999999998 9999986654333222 2221 122223346899999999999999
Q ss_pred CCCCCCHhHHhcC
Q 019901 235 PAKRISIPEIRNH 247 (334)
Q Consensus 235 p~~R~s~~ell~h 247 (334)
|.+|||+.+++.+
T Consensus 242 p~~Rp~~~~ll~~ 254 (256)
T cd05113 242 AEERPTFQQLLSS 254 (256)
T ss_pred cccCCCHHHHHHh
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=289.41 Aligned_cols=239 Identities=33% Similarity=0.561 Sum_probs=197.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+.+..+|+.+ |+|++.+... .....+.+|+.+++.+. ||||+++++++..++..++||||+.++
T Consensus 9 lg~g~~~~vy~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 87 (280)
T cd05581 9 IGEGSFSTVVLAKEKETNKEY-AIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNG 87 (280)
T ss_pred ecCCCceEEEEEEEcCCCCEE-EEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCC
Confidence 455554 36677788988 9999987432 22467889999999998 999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---------
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------- 144 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--------- 144 (334)
+|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++. ++|+|||++.......
T Consensus 88 ~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~--~~l~df~~~~~~~~~~~~~~~~~~~ 165 (280)
T cd05581 88 ELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMH--IKITDFGTAKVLDPNSSPESNKGDA 165 (280)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCC--EEecCCccccccCCccccccCCCCC
Confidence 99999998888999999999999999999999999999999999999987664 9999999987543322
Q ss_pred ------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc
Q 019901 145 ------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212 (334)
Q Consensus 145 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 212 (334)
......++..|+|||++....++. ++|+||||++++++++|+.||........+.. .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~ 240 (280)
T cd05581 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGK-SSDLWALGCIIYQMLTGKPPFRGSNEYLTFQK----ILKLEYS 240 (280)
T ss_pred ccccccccccccccccccCCccccCHHHhCCCCCCh-hhhHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhcCCC
Confidence 112335788999999987766654 49999999999999999999987764333322 2222333
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCH----hHHhcCccc
Q 019901 213 IPDYVHISPECRHLISRIFVADPAKRISI----PEIRNHEWF 250 (334)
Q Consensus 213 ~~~~~~~~~~~~~li~~~L~~~p~~R~s~----~ell~h~~~ 250 (334)
.+ ..+++.+.+||.+||+.+|.+|||+ +++++||||
T Consensus 241 ~~--~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 241 FP--PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CC--CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 33 3568999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=334.21 Aligned_cols=245 Identities=27% Similarity=0.425 Sum_probs=204.9
Q ss_pred CCCccee---e-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 1 MLGFHNF---Y-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 1 ~lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
++|-|+| + |.+..+|... |+|-++.+.. ..-..+.+|..++..++|||+|+++++-.....++|.||||+||+
T Consensus 1242 ~Ig~G~fG~VYtavN~~tGell-AvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~Gs 1320 (1509)
T KOG4645|consen 1242 FIGGGTFGKVYTAVNLDTGELL-AVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGS 1320 (1509)
T ss_pred ccCCcceeeeEEeecCCccchh-hhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCc
Confidence 3666666 3 8899999999 9999988763 334688999999999999999999999888889999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKST 149 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~ 149 (334)
|.+.+...+-.++...+.+..|++.|+.|||+.|||||||||.||+++.+|. +|++|||.|....... .....
T Consensus 1321 La~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~--iK~~DFGsa~ki~~~~~~~~~el~~~ 1398 (1509)
T KOG4645|consen 1321 LASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL--IKYGDFGSAVKIKNNAQTMPGELQSM 1398 (1509)
T ss_pred HHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc--EEeecccceeEecCchhcCCHHHHhh
Confidence 9999988887888889999999999999999999999999999999998875 9999999997544332 12345
Q ss_pred cCCCccccchhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccCCCCCCCCHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSIPDYVHISPECRHL 226 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 226 (334)
.|||.|||||++.+... ...+.|||||||++.||+||+-||...+... .++.++..+. +.+|. .+|++.++|
T Consensus 1399 ~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~---aIMy~V~~gh~Pq~P~--~ls~~g~dF 1473 (1509)
T KOG4645|consen 1399 MGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEW---AIMYHVAAGHKPQIPE--RLSSEGRDF 1473 (1509)
T ss_pred cCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchh---HHHhHHhccCCCCCch--hhhHhHHHH
Confidence 79999999999976542 2445899999999999999999998765432 3333433332 33444 489999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
|..||..||++|+++.||++|.|-+..
T Consensus 1474 le~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1474 LEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred HHHHHhcCchhhhHHHHHHHhhccccc
Confidence 999999999999999999999986443
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=287.66 Aligned_cols=223 Identities=24% Similarity=0.361 Sum_probs=180.8
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------- 83 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 83 (334)
+..+ |+|.+..........+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...+
T Consensus 35 ~~~~-~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~ 113 (288)
T cd05093 35 KILV-AVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113 (288)
T ss_pred ceEE-EEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence 4456 9999876553345678999999999999999999999999999999999999999999987543
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccc
Q 019901 84 --RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAP 158 (334)
Q Consensus 84 --~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aP 158 (334)
.+++..+..++.|++.||+|||++|++||||||+|||++.++. ++|+|||+++...... ......+++.|+||
T Consensus 114 ~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 191 (288)
T cd05093 114 PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191 (288)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEeccCCccccccCCceeecCCCCCccccccCH
Confidence 3899999999999999999999999999999999999987664 9999999987543221 12233457789999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
|++.+..++.+ +|||||||++|+|++ |.+||.......... .+..... .+.....++++.+++.+||+.+|.+
T Consensus 192 E~~~~~~~~~~-sDiwslG~il~~l~t~g~~p~~~~~~~~~~~----~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~ 265 (288)
T cd05093 192 ESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIE----CITQGRV-LQRPRTCPKEVYDLMLGCWQREPHM 265 (288)
T ss_pred HHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHcCCc-CCCCCCCCHHHHHHHHHHccCChhh
Confidence 99987777655 999999999999998 999998765433222 2222221 2223357899999999999999999
Q ss_pred CCCHhHHhc
Q 019901 238 RISIPEIRN 246 (334)
Q Consensus 238 R~s~~ell~ 246 (334)
|||+.+++.
T Consensus 266 Rpt~~~v~~ 274 (288)
T cd05093 266 RLNIKEIHS 274 (288)
T ss_pred CCCHHHHHH
Confidence 999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=283.46 Aligned_cols=235 Identities=21% Similarity=0.311 Sum_probs=190.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.++. +..+ |+|++..........+.+|+.+++.++||||+++++++......++||||+.+++|.+
T Consensus 14 ig~g~~~~vy~~~~~~-~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 91 (261)
T cd05148 14 LGSGYFGEVWEGLWKN-RVRV-AIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLA 91 (261)
T ss_pred hccCCCccEEEeEecC-CCcE-EEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHH
Confidence 455555 355555 6777 9999987764456789999999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCc
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPA 154 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~ 154 (334)
++.+. ..++...+..++.||+.||.|||++|++||||+|+||+++.++. +||+|||++........ .....++..
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05148 92 FLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLV--CKVADFGLARLIKEDVYLSSDKKIPYK 169 (261)
T ss_pred HHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCce--EEEccccchhhcCCccccccCCCCceE
Confidence 99763 45899999999999999999999999999999999999987665 99999999875432221 122345678
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..+..+ +||||||+++|+|++ |+.||........+... . .....+.....++.+.+++.+||+.
T Consensus 170 ~~~PE~~~~~~~~~~-~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 170 WTAPEAASHGTFSTK-SDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI----T-AGYRMPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred ecCHHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH----H-hCCcCCCCCCCCHHHHHHHHHHcCC
Confidence 999999987777655 999999999999998 89999876543333322 2 2233344456799999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+.++++
T Consensus 244 ~p~~Rpt~~~l~~ 256 (261)
T cd05148 244 EPEDRPSFKALRE 256 (261)
T ss_pred CchhCcCHHHHHH
Confidence 9999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=285.93 Aligned_cols=239 Identities=25% Similarity=0.396 Sum_probs=192.5
Q ss_pred ceee-eeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 5 HNFY-DRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 5 g~~~-~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
|.++ +.+..++..+ |||++..... .....+.+|+.+++.++||||+++++.+..++..++||||+.+++|..++.+
T Consensus 18 ~~vy~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~- 95 (277)
T cd06641 18 GEVFKGIDNRTQKVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP- 95 (277)
T ss_pred eEEEEEEECCCCcEE-EEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-
Confidence 4443 5677788888 9999875542 2235788999999999999999999999999999999999999999988864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~ 161 (334)
+.+++..+..++.|++.|+.+||++|++|+||+|+||+++.++. ++|+|||++....... ......++..|+|||.+
T Consensus 96 ~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~ 173 (277)
T cd06641 96 GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 173 (277)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC--EEEeecccceecccchhhhccccCCccccChhhh
Confidence 56899999999999999999999999999999999999987664 9999999987543322 12234688899999998
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+..++.+ +|+|||||++|+|++|..||.......... .+.... .......++.++.+++.+||..+|.+||++
T Consensus 174 ~~~~~~~~-~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 247 (277)
T cd06641 174 KQSAYDSK-ADIWSLGITAIELAKGEPPHSELHPMKVLF----LIPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPTA 247 (277)
T ss_pred ccCCCCch-hhHHHHHHHHHHHHcCCCCCCccchHHHHH----HHhcCC-CCCCCcccCHHHHHHHHHHccCChhhCcCH
Confidence 77766555 899999999999999999997654322221 111111 111223468999999999999999999999
Q ss_pred hHHhcCcccccc
Q 019901 242 PEIRNHEWFLKN 253 (334)
Q Consensus 242 ~ell~h~~~~~~ 253 (334)
.+++.||||.+.
T Consensus 248 ~~~l~~~~~~~~ 259 (277)
T cd06641 248 KELLKHKFIVRF 259 (277)
T ss_pred HHHHhCHHHhhh
Confidence 999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=285.22 Aligned_cols=238 Identities=23% Similarity=0.310 Sum_probs=185.6
Q ss_pred CCCccee----eeeecCCCCe-eEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 1 MLGFHNF----YDRCSYSSDL-FVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~-vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
+||.|++ .++.+.++.. .+++|.+.... ....+.+.+|+.+++.+ +||||+++++++...+..++||||+.++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 3566665 3566666653 23888876432 12345788999999999 7999999999999999999999999999
Q ss_pred ChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCc
Q 019901 74 ELFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137 (334)
Q Consensus 74 ~L~~~l~~~~----------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla 137 (334)
+|.+++...+ .++...+..++.|++.||+|||++|++||||||+|||++.++. +||+|||++
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~--~kl~dfgl~ 159 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLS 159 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCe--EEECCCCCc
Confidence 9999987543 4788999999999999999999999999999999999987664 999999998
Q ss_pred cCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCC
Q 019901 138 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 216 (334)
Q Consensus 138 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (334)
..............++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+.+....... + ......+..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~-~Di~slG~il~el~~~g~~pf~~~~~~~~~~~----~-~~~~~~~~~ 233 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK----L-PQGYRLEKP 233 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCch-hhHHHHHHHHHHHHcCCCCCccccCHHHHHHH----H-hCCCCCCCC
Confidence 64332222222334567999999977776555 999999999999997 9999976554332222 2 122222333
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
..++.++.+++.+||..+|.+|||+.+++.
T Consensus 234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 234 LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=287.37 Aligned_cols=236 Identities=29% Similarity=0.484 Sum_probs=190.4
Q ss_pred CCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 13 YSSDLFVNIIIIVFHLW----QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.+|..| |+|++..... ...+.+.+|+.+++.+ +||||+++++.+..++..|+|+||+.+++|.+++....++++
T Consensus 26 ~~g~~~-aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~ 104 (290)
T cd05613 26 DSGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE 104 (290)
T ss_pred CCCceE-EEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCH
Confidence 477888 9999976431 2346788899999999 589999999999999999999999999999999988888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccchhhccCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKE 165 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~ 165 (334)
..+..++.|++.||.|||++|++||||+|+|||++.++. +||+|||+++...... ......|+..|+|||.+.+..
T Consensus 105 ~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (290)
T cd05613 105 QEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGD 182 (290)
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCC--EEEeeCccceecccccccccccccCCcccCChhhccCCC
Confidence 999999999999999999999999999999999987654 9999999987543322 122356899999999986532
Q ss_pred -CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC-----
Q 019901 166 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI----- 239 (334)
Q Consensus 166 -~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~----- 239 (334)
....++||||||+++|+|++|..||....................... ...+++.+.+++.+||+.+|.+||
T Consensus 183 ~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~~l~~~p~~R~~~~~~ 260 (290)
T cd05613 183 GGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDIIQRLLMKDPKKRLGCGPS 260 (290)
T ss_pred CCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHHHHHHHhcCCHHHhcCCCCC
Confidence 224458999999999999999999975433223333333333222222 335789999999999999999997
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
++++++.||||.+.
T Consensus 261 ~~~~l~~~~~~~~~ 274 (290)
T cd05613 261 DADEIKKHPFFQKI 274 (290)
T ss_pred CHHHHHcCcccccC
Confidence 89999999999653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=281.82 Aligned_cols=237 Identities=24% Similarity=0.354 Sum_probs=190.0
Q ss_pred CCCccee----eeeecC-CCC--eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 1 MLGFHNF----YDRCSY-SSD--LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~----~~~~~~-~~~--~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
+||.|++ .+.+.. .+. .+ |||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++||||+.+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPV-AVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEE-EEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 3566665 244433 332 46 9999988775 455688999999999999999999999988 889999999999
Q ss_pred CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----C
Q 019901 73 GELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 146 (334)
Q Consensus 73 ~~L~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~ 146 (334)
++|.+.+.+.. .+++..++.++.|++.||.|||++|++||||+|+||+++.++. +||+|||+++....... .
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 80 GSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK--VKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE--EEeccccccccccccccceecc
Confidence 99999998764 6899999999999999999999999999999999999987754 99999999876433221 1
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
....++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||............ .......+.....+..+.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~ 232 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI----DKEGERLERPEACPQDIYN 232 (257)
T ss_pred cCCCCCceecCHHHhcccCcCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH----HhcCCcCCCCccCCHHHHH
Confidence 23356788999999987777655 999999999999998 99999766554333222 2122223333457899999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 019901 226 LISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~ 246 (334)
++.+||+.+|++|||+.++++
T Consensus 233 li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 233 VMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HHHHHCCCCcccCCCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=292.60 Aligned_cols=247 Identities=28% Similarity=0.373 Sum_probs=190.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcC-CCCCcccceEEEEcC--CeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSL-RHPNIVRFKEVILTP--THLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~--~~~~lv~e~~~~ 72 (334)
||.|++ .+.+..+|..+ |||.+.+.. ......+.+|+.+++++ +||||+++++++... ...|+||||+.
T Consensus 15 lg~g~~~~v~~~~~~~~~~~~-~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~- 92 (337)
T cd07852 15 LGKGAYGIVWKAIDRRTKEVV-ALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME- 92 (337)
T ss_pred hcCCCCeeEEEEEEcCCCeEE-EEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-
Confidence 455544 46777788888 999886532 12335677899999999 999999999988653 46899999996
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC------CC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS------QP 146 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~------~~ 146 (334)
++|..++.+. .+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... ..
T Consensus 93 ~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~ 169 (337)
T cd07852 93 TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCR--VKLADFGLARSLSELEENPENPVL 169 (337)
T ss_pred cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCc--EEEeeccchhccccccccccCcch
Confidence 5898888765 7899999999999999999999999999999999999987765 9999999987543322 12
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH-------------------h
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI-------------------L 207 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-------------------~ 207 (334)
....|++.|+|||.+.+....+.++|+||||+++|+|++|++||.+.............. .
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred hcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 234589999999988765544556999999999999999999998665443332221110 0
Q ss_pred h----ccc-c-CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 208 S----VQY-S-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 208 ~----~~~-~-~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
. ... . ......++.++.++|.+||+.+|.+|||+.++++||||.+-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0 000 0 01122368999999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=290.39 Aligned_cols=248 Identities=25% Similarity=0.359 Sum_probs=188.4
Q ss_pred CCccee----eeeecCC--CCeeEEEEEEecCcc--cccHHHHHHHHHHHcC-CCCCcccceEEEEcC----CeEEEEEe
Q 019901 2 LGFHNF----YDRCSYS--SDLFVNIIIIVFHLW--QIDENVQREIINHRSL-RHPNIVRFKEVILTP----THLAIVME 68 (334)
Q Consensus 2 lG~g~~----~~~~~~~--~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~----~~~~lv~e 68 (334)
||.|++ .+++..+ +..| |||.+..... .....+.+|+.+++.+ +||||+++++.+... ..+|++++
T Consensus 8 lg~G~~g~vy~~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e 86 (332)
T cd07857 8 LGQGAYGIVCSARNAETSEEETV-AIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEE 86 (332)
T ss_pred ccccCCeEEEEEEeCCCCcCceE-EEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEe
Confidence 455554 3666666 7787 9999875431 2235678899999998 599999999875432 45889999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---
Q 019901 69 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 145 (334)
Q Consensus 69 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--- 145 (334)
|+. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 87 ~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~--~kl~Dfg~a~~~~~~~~~~~ 163 (332)
T cd07857 87 LME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCE--LKICDFGLARGFSENPGENA 163 (332)
T ss_pred ccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCC--EEeCcCCCceeccccccccc
Confidence 985 689999988888999999999999999999999999999999999999987665 99999999875432211
Q ss_pred --CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------
Q 019901 146 --PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------- 208 (334)
Q Consensus 146 --~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------- 208 (334)
.....||+.|+|||++.+....+.++||||+|+++|+|++|.+||........+...+.....
T Consensus 164 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (332)
T cd07857 164 GFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQ 243 (332)
T ss_pred ccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHH
Confidence 223468999999998866433345599999999999999999999875543322222211000
Q ss_pred -------c--cccCC-CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 209 -------V--QYSIP-DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 209 -------~--~~~~~-~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
. ...++ .....+..+.+|+.+||+.+|.+|||+.+++.||||.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~ 298 (332)
T cd07857 244 NYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298 (332)
T ss_pred HHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence 0 00000 122457899999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=283.72 Aligned_cols=240 Identities=27% Similarity=0.413 Sum_probs=188.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|.+ .++++.++..| |||.+..... .....+.+|+.+++.++||||+++++++...+..++|+||+.+++
T Consensus 10 l~~g~~~~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08228 10 IGRGQFSEVYRATCLLDRKPV-ALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGD 88 (267)
T ss_pred eccCCCeeEEEEEEeCCCCEE-EEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCc
Confidence 455554 47778889998 9998875431 223467889999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCc
Q 019901 75 LFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 149 (334)
Q Consensus 75 L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~ 149 (334)
|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||++........ ....
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~--~~l~d~g~~~~~~~~~~~~~~~ 166 (267)
T cd08228 89 LSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCC--EEECccccceeccchhHHHhcC
Confidence 9888753 345899999999999999999999999999999999999987665 99999999875432221 2234
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.|++.|+|||.+.+..++.+ +|+||+|+++|+|++|+.||...... .......+.............+..+.+++.+
T Consensus 167 ~~~~~~~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08228 167 VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LFSLCQKIEQCDYPPLPTEHYSEKLRELVSM 243 (267)
T ss_pred CCCccccChhhhccCCCCch-hhHHHHHHHHHHHhcCCCCCcccccc--HHHHHHHHhcCCCCCCChhhcCHHHHHHHHH
Confidence 68899999999988777655 99999999999999999999654321 1122222222121111122467899999999
Q ss_pred hcccCCCCCCCHhHHhcC
Q 019901 230 IFVADPAKRISIPEIRNH 247 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h 247 (334)
||..+|.+|||+.++++.
T Consensus 244 cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 244 CIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HCCCCcccCcCHHHHHHH
Confidence 999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=291.98 Aligned_cols=245 Identities=24% Similarity=0.392 Sum_probs=187.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcC--------CeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTP--------THLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~ 67 (334)
||.|++ ++.++.+++.+ |||.+...... ....+.+|+.+++.++||||+++++++... ..+++|+
T Consensus 16 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~ 94 (311)
T cd07866 16 LGEGTFGEVYKARQIKTGRVV-ALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT 94 (311)
T ss_pred eccCCCEEEEEEEECCCCcEE-EEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEE
Confidence 455554 47788889998 99998765422 234678999999999999999999987543 3579999
Q ss_pred eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-
Q 019901 68 EYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ- 145 (334)
Q Consensus 68 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~- 145 (334)
+|+.+ +|...+.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++.......
T Consensus 95 ~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~ 171 (311)
T cd07866 95 PYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGI--LKIADFGLARPYDGPPPN 171 (311)
T ss_pred ecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEECcCccchhccCCCcc
Confidence 99965 67666654 456999999999999999999999999999999999999987765 99999999875332211
Q ss_pred -----------CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc---
Q 019901 146 -----------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--- 211 (334)
Q Consensus 146 -----------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--- 211 (334)
.....+++.|+|||.+.+....+.++|||||||++|+|++|++||.+...................
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (311)
T cd07866 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW 251 (311)
T ss_pred cccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence 112356888999999876543345599999999999999999999876665444433321110000
Q ss_pred ----------------cCC-----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 212 ----------------SIP-----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 212 ----------------~~~-----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
..+ .....++.+.+||.+||..+|.+|||+.+++.||||
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 252 PGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 012345789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=290.99 Aligned_cols=238 Identities=23% Similarity=0.307 Sum_probs=185.4
Q ss_pred CCccee----eeeecCCCCe-eEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDL-FVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~-vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|.++.++.. .+|+|.+.... ......+.+|+.++..+ +||||+++++++..++..|+||||+++++
T Consensus 15 lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 94 (303)
T cd05088 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 94 (303)
T ss_pred ecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCc
Confidence 566655 4666667653 33666665432 12335788899999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 75 LFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 75 L~~~l~~~~----------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|.+++.+.+ .+++..++.++.|++.||+|||++|++||||||+|||++.++. +||+|||+++
T Consensus 95 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~--~kl~dfg~~~ 172 (303)
T cd05088 95 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSR 172 (303)
T ss_pred HHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc--EEeCccccCc
Confidence 999987542 4789999999999999999999999999999999999987664 9999999986
Q ss_pred CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 139 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
............++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.......... .. ......+...
T Consensus 173 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~ 246 (303)
T cd05088 173 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQGYRLEKPL 246 (303)
T ss_pred ccchhhhcccCCCcccccCHHHHhccCCccc-ccchhhhhHHHHHHhcCCCCcccCChHHHHH----HH-hcCCcCCCCC
Confidence 4322222222334667999999877766554 999999999999998 999997655433222 11 2222233334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.+++++.+++.+||+.+|.+|||+++++.+
T Consensus 247 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 247 NCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=285.63 Aligned_cols=239 Identities=20% Similarity=0.267 Sum_probs=187.0
Q ss_pred CCccee----eeeecC-----CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSY-----SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~-----~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|.+ .+.++. ++..| |+|.+..... .....+.+|+.+++.++||||+++++++.+.+..++||||+.
T Consensus 14 lg~g~~g~vy~~~~~~~~~~~~~~~v-~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 92 (277)
T cd05036 14 LGHGAFGEVYEGLYRGRDGDAVELQV-AVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMA 92 (277)
T ss_pred CCCCCCCcEEEEEEecCCCCCCceeE-EEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCC
Confidence 455544 355554 55666 9998865432 223568899999999999999999999999889999999999
Q ss_pred CCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCC
Q 019901 72 GGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH 143 (334)
Q Consensus 72 ~~~L~~~l~~~~-------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~ 143 (334)
|++|.+++.+.+ .+++..+..++.||+.||.|||++|++||||||+||+++.++. ..+||+|||+++.....
T Consensus 93 g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~ 172 (277)
T cd05036 93 GGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172 (277)
T ss_pred CCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCc
Confidence 999999987653 4899999999999999999999999999999999999986542 35899999998854222
Q ss_pred CC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 144 SQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 144 ~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
.. ......++.|+|||++.+..++.+ +|||||||++|+|++ |..||...+....... +. .....+....+
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~ 246 (277)
T cd05036 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSK-TDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF----VT-GGGRLDPPKGC 246 (277)
T ss_pred cceecCCCCCccHhhCCHHHHhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCC
Confidence 11 112234568999999988777655 999999999999997 9999987655332221 11 11122223457
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+..+.+++.+||+.+|.+|||+.++++|
T Consensus 247 ~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 247 PGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=281.22 Aligned_cols=224 Identities=20% Similarity=0.296 Sum_probs=181.9
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHHH
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEA 90 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~ 90 (334)
.+++.| |||.+.... ...+.+.+|+.++++++||||+++++++...+..++||||+.+++|.+++.... .++...+
T Consensus 28 ~~~~~v-~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 105 (261)
T cd05068 28 NNTTPV-AVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQL 105 (261)
T ss_pred cCCeEE-EEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHH
Confidence 344566 999987655 345678999999999999999999999999999999999999999999997654 6899999
Q ss_pred HHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCCccccchhhccCCCCC
Q 019901 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTPAYIAPEVLLKKEYDG 168 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~ 168 (334)
..++.|++.||.+||++|++||||||+||+++.++. ++|+|||+++........ .....+..|+|||.+.+..++.
T Consensus 106 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 183 (261)
T cd05068 106 IDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNI--CKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSI 183 (261)
T ss_pred HHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCC--EEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCc
Confidence 999999999999999999999999999999987765 999999998754322111 1122345799999988777765
Q ss_pred ccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 169 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 169 ~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+ +|+||||+++|+|++ |+.||.+......... + ......+.....+..+.+++.+||+.+|.+||++.+++.
T Consensus 184 ~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 184 K-SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQ----V-DQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred h-hhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----H-HcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 5 899999999999999 9999987654332222 2 122233344467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=295.23 Aligned_cols=245 Identities=23% Similarity=0.351 Sum_probs=191.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~ 69 (334)
||.|.+ .+.+..+|..| |||.+..... .....+.+|+.+++.++||||+++++++..+. ..++||+|
T Consensus 23 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~ 101 (343)
T cd07880 23 VGSGAYGTVCSALDRRTGAKV-AIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF 101 (343)
T ss_pred eeecCCeEEEEEEECCCCcEE-EEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEec
Confidence 455554 47788889998 9999865431 12356889999999999999999999987653 46999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+ +++|..++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++. ++|+|||++..... .....
T Consensus 102 ~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~--~~~~~ 175 (343)
T cd07880 102 M-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQTDS--EMTGY 175 (343)
T ss_pred C-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeeccccccccc--Ccccc
Confidence 9 7788877754 57999999999999999999999999999999999999987664 99999999875432 22344
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc----------------cccC
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------------QYSI 213 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------------~~~~ 213 (334)
.+++.|+|||.+.+....+.++|+||||+++|+|++|+.||..........+........ ....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (343)
T cd07880 176 VVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKL 255 (343)
T ss_pred ccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhc
Confidence 678999999998764434555999999999999999999998765433333322110000 0000
Q ss_pred C---------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 214 P---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 214 ~---------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+ ....+++.+.++|.+||+.+|.+|||+.+++.||||...
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~ 304 (343)
T cd07880 256 PRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF 304 (343)
T ss_pred cccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence 0 113568899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=281.93 Aligned_cols=235 Identities=21% Similarity=0.324 Sum_probs=186.7
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +.....++..+ |+|.+.... ...+.+.+|+.+++.++||||+++++.+...+..++||||+.+++|.++
T Consensus 14 lg~g~~g~v~~~~~~~~~~v-~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 91 (261)
T cd05072 14 LGAGQFGEVWMGYYNNSTKV-AVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91 (261)
T ss_pred cCCcCCceEEEEEecCCceE-EEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 455544 32233455667 999987654 3456889999999999999999999999999999999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 79 ICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 79 l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
+.+. ..++...+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++....... .....++..
T Consensus 92 l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 169 (261)
T cd05072 92 LKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM--CKIADFGLARVIEDNEYTAREGAKFPIK 169 (261)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCc--EEECCCccceecCCCceeccCCCcccee
Confidence 8653 45889999999999999999999999999999999999987664 99999999975432221 122335678
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||.+.+..++.+ +|||||||++|+|++ |..||........... + ......+....++.++.+++.+||..
T Consensus 170 y~aPE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~~ 243 (261)
T cd05072 170 WTAPEAINFGSFTIK-SDVWSFGILLYEIVTYGKIPYPGMSNSDVMSA----L-QRGYRMPRMENCPDELYDIMKTCWKE 243 (261)
T ss_pred cCCHHHhccCCCChh-hhhhhhHHHHHHHHccCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999987777555 899999999999998 9999976554332222 1 12233444456789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|++|||++++.+
T Consensus 244 ~p~~Rp~~~~i~~ 256 (261)
T cd05072 244 KAEERPTFDYLQS 256 (261)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=285.92 Aligned_cols=239 Identities=30% Similarity=0.459 Sum_probs=192.1
Q ss_pred eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GR 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~ 84 (334)
.+++..+++.+ |+|.+.... ......+.+|+.+++.++||||+++++++...+..++|+||+. ++|.+++.+. ..
T Consensus 17 ~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~ 94 (282)
T cd07829 17 KARDKKTGEIV-ALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGP 94 (282)
T ss_pred EeeecCCCcEE-EEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccC
Confidence 47788889999 999998764 2334678899999999999999999999999999999999997 5899999876 57
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~ 163 (334)
+++..+..++.|++.||.+||++||+||||+|+||+++.++. ++|+|||+++...... ......++..|+|||.+.+
T Consensus 95 ~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~ 172 (282)
T cd07829 95 LSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV--LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLG 172 (282)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC--EEEecCCcccccCCCccccCccccCcCcCChHHhcC
Confidence 999999999999999999999999999999999999987654 9999999987543332 2223456788999999877
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh--------------ccccCCC---------CCCCC
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--------------VQYSIPD---------YVHIS 220 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--------------~~~~~~~---------~~~~~ 220 (334)
....+.++|+|||||++|+|++|++||........+.+....... .....+. ...++
T Consensus 173 ~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (282)
T cd07829 173 SKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLD 252 (282)
T ss_pred CcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhccccc
Confidence 633345599999999999999999999876654443333221100 0000111 12357
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
..+.++|.+||..+|++||++.+++.||||
T Consensus 253 ~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 253 PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=317.44 Aligned_cols=237 Identities=25% Similarity=0.327 Sum_probs=185.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+.+..+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+++
T Consensus 15 fG~VYlA~d~~tg~~V-AIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL 93 (932)
T PRK13184 15 MGEVYLAYDPVCSRRV-ALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLL 93 (932)
T ss_pred CEEEEEEEECCCCcEE-EEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHH
Confidence 3444 47788899999 9999976532 12356889999999999999999999999999999999999999999988
Q ss_pred Hhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----
Q 019901 80 CNA-----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----- 143 (334)
Q Consensus 80 ~~~-----------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----- 143 (334)
.+. ..++...+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||+++.....
T Consensus 94 ~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~--vKLiDFGLAk~i~~~~~~~~ 171 (932)
T PRK13184 94 KSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGE--VVILDWGAAIFKKLEEEDLL 171 (932)
T ss_pred HHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCC--EEEEecCcceeccccccccc
Confidence 642 23556778899999999999999999999999999999987665 999999998754110
Q ss_pred --------------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc
Q 019901 144 --------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209 (334)
Q Consensus 144 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 209 (334)
......+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||........... .....
T Consensus 172 ~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~k-SDIWSLGVILyELLTG~~PF~~~~~~ki~~~---~~i~~ 247 (932)
T PRK13184 172 DIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASES-TDIYALGVILYQMLTLSFPYRRKKGRKISYR---DVILS 247 (932)
T ss_pred ccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcH-hHHHHHHHHHHHHHHCCCCCCCcchhhhhhh---hhccC
Confidence 01123469999999999988877655 9999999999999999999986443221111 11111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 210 ~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.........+++.+.+++.+||+.+|++||+..+.+.+
T Consensus 248 P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~ 285 (932)
T PRK13184 248 PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285 (932)
T ss_pred hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 11222334678999999999999999999876665543
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=284.53 Aligned_cols=231 Identities=24% Similarity=0.330 Sum_probs=178.9
Q ss_pred ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 11 CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
...++..+ |+|++..... .....+.+|+.+++.++||||+++++++... ..+++||||+.+++|.+++... .+++
T Consensus 29 ~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~ 106 (283)
T cd05080 29 NDGTGEMV-AVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNL 106 (283)
T ss_pred cCCCCceE-EEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCH
Confidence 34567777 9999976542 2346788999999999999999999987653 4689999999999999998764 5999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~ 163 (334)
..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+++....... .....++..|+|||.+.+
T Consensus 107 ~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~ 184 (283)
T cd05080 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE 184 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCc--EEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc
Confidence 999999999999999999999999999999999987654 99999999875432221 122345667999999987
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH--H--------HHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN--F--------RKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~--------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
..++.+ +||||||+++|+|++|+.||........ . ..............+.....+..+.+++.+||+.
T Consensus 185 ~~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~ 263 (283)
T cd05080 185 NKFSYA-SDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWET 263 (283)
T ss_pred cCCCcc-cccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhcc
Confidence 777655 9999999999999999999865432100 0 0000011111122233445789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|++|||+++++.
T Consensus 264 ~p~~Rps~~~i~~ 276 (283)
T cd05080 264 EAKFRPTFRSLIP 276 (283)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999884
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=281.99 Aligned_cols=239 Identities=27% Similarity=0.411 Sum_probs=189.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+.+..++..+ |||.+..... .....+.+|+.+++.++||||+++++++..++..+++|||+.+++
T Consensus 10 ig~g~~g~v~~~~~~~~~~~~-~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~ 88 (267)
T cd08229 10 IGRGQFSEVYRATCLLDGVPV-ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 88 (267)
T ss_pred hcccCCeEEEEEeecCCCceE-EEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCC
Confidence 455544 46777889998 9998876431 223577889999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCc
Q 019901 75 LFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKST 149 (334)
Q Consensus 75 L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~ 149 (334)
|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++. ++|+|||++........ ....
T Consensus 89 L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd08229 89 LSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred HHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEECcchhhhccccCCcccccc
Confidence 9998864 345899999999999999999999999999999999999987664 99999998875433222 2334
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.|++.|+|||.+.+..++.+ +|+||||+++|+|++|..||.+.... .......+............+++.+++++.+
T Consensus 167 ~~~~~~~ape~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 243 (267)
T cd08229 167 VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEQCDYPPLPSDHYSEELRQLVNM 243 (267)
T ss_pred cCCcCccCHHHhcCCCccch-hhHHHHHHHHHHHHhCCCCcccccch--HHHHhhhhhcCCCCCCCcccccHHHHHHHHH
Confidence 68899999999987777655 99999999999999999999754321 1122222222222211223478899999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 019901 230 IFVADPAKRISIPEIRN 246 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~ 246 (334)
||..+|.+|||+.++++
T Consensus 244 ~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 244 CINPDPEKRPDITYVYD 260 (267)
T ss_pred hcCCCcccCCCHHHHHH
Confidence 99999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=287.75 Aligned_cols=238 Identities=23% Similarity=0.309 Sum_probs=184.2
Q ss_pred CCccee---e-eeecCCCCe-eEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCSYSSDL-FVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~-vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ + +..+.++.. .+++|.++... ....+.+.+|+.+++++ +||||+++++++...+..++|+||+.+++
T Consensus 10 lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 89 (297)
T cd05089 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGN 89 (297)
T ss_pred ecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCc
Confidence 555555 3 555555542 23888876432 12335788999999999 79999999999999999999999999999
Q ss_pred hHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 75 LFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 75 L~~~l~~~~----------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|.+++.+.+ .+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||++.
T Consensus 90 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~ 167 (297)
T cd05089 90 LLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLA--SKIADFGLSR 167 (297)
T ss_pred HHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCe--EEECCcCCCc
Confidence 999987532 4788999999999999999999999999999999999987654 9999999986
Q ss_pred CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 139 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
.............+..|+|||++.+..++.+ +|||||||++|+|++ |..||........... +.. ....+...
T Consensus 168 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~----~~~-~~~~~~~~ 241 (297)
T cd05089 168 GEEVYVKKTMGRLPVRWMAIESLNYSVYTTK-SDVWSFGVLLWEIVSLGGTPYCGMTCAELYEK----LPQ-GYRMEKPR 241 (297)
T ss_pred cccceeccCCCCcCccccCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----Hhc-CCCCCCCC
Confidence 4322212222233557999999987777655 999999999999997 9999987655333322 221 22223334
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.++..+.+|+.+||+.+|.+|||++++++.
T Consensus 242 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 242 NCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 578999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=280.16 Aligned_cols=235 Identities=25% Similarity=0.320 Sum_probs=186.0
Q ss_pred CCccee----eeeecCCC---CeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSS---DLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~---~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .++...++ ..+ |+|.+...... ..+.+.+|+.+++.++||||+++++++. .+..++||||+.++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 80 (257)
T cd05060 3 LGHGNFGSVVKGVYLMKSGKEVEV-AVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLG 80 (257)
T ss_pred cCccCceeEEEeEeeccCCCcceE-EEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCC
Confidence 566655 24443333 566 99998876632 3467889999999999999999999876 45689999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----CCc
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KST 149 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~----~~~ 149 (334)
+|.+++.+.+.+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++........ ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~--~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 81 PLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQ--AKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred cHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCc--EEeccccccceeecCCcccccccCc
Confidence 99999988888999999999999999999999999999999999999987765 999999998754332221 111
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||........ ...+ ......+....++..++++|.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~~~~~~g~~p~~~~~~~~~-~~~~----~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05060 159 RWPLKWYAPECINYGKFSSK-SDVWSYGVTLWEAFSYGAKPYGEMKGAEV-IAML----ESGERLPRPEECPQEIYSIML 232 (257)
T ss_pred cccccccCHHHhcCCCCCcc-chHHHHHHHHHHHHcCCCCCcccCCHHHH-HHHH----HcCCcCCCCCCCCHHHHHHHH
Confidence 23467999999987777655 999999999999998 9999987654322 2221 122223444567899999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||..+|.+|||+.++++
T Consensus 233 ~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 233 SCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHhcCChhhCcCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=287.82 Aligned_cols=241 Identities=24% Similarity=0.376 Sum_probs=191.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+++..+|..+ +||.+...... ....+.+|+.+++.++|||++++++++.+....|+||||+. ++
T Consensus 29 lg~g~~g~v~~~~~~~~~~~v-~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~ 106 (313)
T cd06633 29 IGHGSFGAVYFATNSHTNEVV-AVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GS 106 (313)
T ss_pred eccCCCeEEEEEEECCCCcEE-EEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CC
Confidence 455544 46777888888 99999765422 22467889999999999999999999999999999999995 57
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+.+.+.. ..++++..+..++.|++.||.|||++|++||||+|+||+++.++. +||+|||++.... ......|++
T Consensus 107 l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~--~kL~dfg~~~~~~---~~~~~~~~~ 181 (313)
T cd06633 107 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASKSS---PANSFVGTP 181 (313)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCC--EEEeecCCCcccC---CCCCccccc
Confidence 7777755 456899999999999999999999999999999999999987664 9999999886432 223457889
Q ss_pred ccccchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 154 AYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 154 ~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
.|+|||++. ...++ .++|||||||++|+|++|..||............ ............++..+++|+.+|
T Consensus 182 ~y~aPE~~~~~~~~~~~-~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~ 256 (313)
T cd06633 182 YWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYHI----AQNDSPTLQSNEWTDSFRGFVDYC 256 (313)
T ss_pred cccChhhccccCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCCCCCccccCHHHHHHHHHH
Confidence 999999984 23444 4489999999999999999999876543333222 111111112234678899999999
Q ss_pred cccCCCCCCCHhHHhcCccccccC
Q 019901 231 FVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
|+.+|.+||++.+++.||||....
T Consensus 257 l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 257 LQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred ccCChhhCcCHHHHhcCcccCCCc
Confidence 999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=291.49 Aligned_cols=236 Identities=20% Similarity=0.322 Sum_probs=187.0
Q ss_pred CCccee---e-eeecCCCCe----eEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---Y-DRCSYSSDL----FVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~----vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| + +.+..++.. | |||.+.... ......+.+|+.+++.++||||+++++++... ..++|++|+.+
T Consensus 15 lg~G~~g~Vy~~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~ 92 (316)
T cd05108 15 LGSGAFGTVYKGLWIPEGEKVKIPV-AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPF 92 (316)
T ss_pred eecCCCceEEEEEEecCCCccceeE-EEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCC
Confidence 566655 2 455555554 6 999987543 13346788999999999999999999998765 56899999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC---CC
Q 019901 73 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KS 148 (334)
Q Consensus 73 ~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---~~ 148 (334)
|+|.+++... ..++...+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++........ ..
T Consensus 93 g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~ 170 (316)
T cd05108 93 GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGADEKEYHAEG 170 (316)
T ss_pred CCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCc--EEEccccccccccCCCcceeccC
Confidence 9999998874 45889999999999999999999999999999999999987665 999999999865433221 12
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..++..|+|||.+.+..++.+ +|||||||++|+|++ |+.||.+..... .. .+.......+.....+.++.+++
T Consensus 171 ~~~~~~y~apE~~~~~~~~~~-~Di~slGv~l~el~t~g~~p~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~~li 244 (316)
T cd05108 171 GKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE-IS----SILEKGERLPQPPICTIDVYMIM 244 (316)
T ss_pred CccceeecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHH-HH----HHHhCCCCCCCCCCCCHHHHHHH
Confidence 234668999999988877655 999999999999997 999998654322 22 22233334444556789999999
Q ss_pred HHhcccCCCCCCCHhHHhcC
Q 019901 228 SRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h 247 (334)
.+||..+|.+|||+.+++.+
T Consensus 245 ~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 245 VKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHccCChhhCcCHHHHHHH
Confidence 99999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-39 Score=285.95 Aligned_cols=224 Identities=24% Similarity=0.349 Sum_probs=180.9
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
++..+ ++|.+..........+.+|+..++.++||||+++++++......++||||+.+++|.+++...+
T Consensus 34 ~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (291)
T cd05094 34 DKMLV-AVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 112 (291)
T ss_pred cceee-EEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccc
Confidence 33445 8999876553444678999999999999999999999999999999999999999999987543
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCc
Q 019901 84 ------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 154 (334)
Q Consensus 84 ------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~ 154 (334)
.+++..++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||+++...... ......+++.
T Consensus 113 ~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~dfg~a~~~~~~~~~~~~~~~~~~~~ 190 (291)
T cd05094 113 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLL--VKIGDFGMSRDVYSTDYYRVGGHTMLPIR 190 (291)
T ss_pred cccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCc--EEECCCCcccccCCCceeecCCCCCccee
Confidence 3789999999999999999999999999999999999987664 9999999987543322 1233456788
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||.+.+..++.+ +|||||||++|+|++ |..||.......... .+.... ........+..+.+++.+||+.
T Consensus 191 y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~li~~~l~~ 264 (291)
T cd05094 191 WMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQPWFQLSNTEVIE----CITQGR-VLERPRVCPKEVYDIMLGCWQR 264 (291)
T ss_pred ecChHHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHhCCC-CCCCCccCCHHHHHHHHHHccc
Confidence 999999988777655 999999999999998 999997655433222 122211 1122234688999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+.++++
T Consensus 265 ~P~~Rpt~~~v~~ 277 (291)
T cd05094 265 EPQQRLNIKEIYK 277 (291)
T ss_pred ChhhCcCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=285.26 Aligned_cols=224 Identities=24% Similarity=0.367 Sum_probs=181.3
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
++..+ |+|.+..........+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.+.+
T Consensus 34 ~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 112 (280)
T cd05092 34 DKMLV-AVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGE 112 (280)
T ss_pred CceEE-EEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccc
Confidence 45566 9998876553445689999999999999999999999999999999999999999999987643
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCcc
Q 019901 84 -----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 155 (334)
Q Consensus 84 -----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y 155 (334)
.+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++....... .....+++.|
T Consensus 113 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y 190 (280)
T cd05092 113 DVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIRW 190 (280)
T ss_pred cCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC--EEECCCCceeEcCCCceeecCCCccccccc
Confidence 4789999999999999999999999999999999999987654 99999999874322211 1233457889
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||.+.+..++.+ +|||||||++|+|++ |.+||............ .. ....+....+++.+.++|.+||+.+
T Consensus 191 ~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~li~~cl~~~ 264 (280)
T cd05092 191 MPPESILYRKFTTE-SDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI----TQ-GRELERPRTCPPEVYAIMQGCWQRE 264 (280)
T ss_pred cCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH----Hc-CccCCCCCCCCHHHHHHHHHHccCC
Confidence 99999988877655 899999999999998 99999765543333222 11 1122233457899999999999999
Q ss_pred CCCCCCHhHHhc
Q 019901 235 PAKRISIPEIRN 246 (334)
Q Consensus 235 p~~R~s~~ell~ 246 (334)
|.+||++++++.
T Consensus 265 P~~Rp~~~~l~~ 276 (280)
T cd05092 265 PQQRMVIKDIHS 276 (280)
T ss_pred hhhCCCHHHHHH
Confidence 999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=286.85 Aligned_cols=242 Identities=25% Similarity=0.388 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+++..++..+ |+|.+...... ....+.+|+.+++.++|||++++++++..++..++||||+.| +
T Consensus 33 lg~G~~~~v~~~~~~~~~~~v-alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~ 110 (317)
T cd06635 33 IGHGSFGAVYFARDVRTNEVV-AIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-S 110 (317)
T ss_pred eccCCCeEEEEEEEcCCCcEE-EEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-C
Confidence 555554 46777888888 99998765422 234688899999999999999999999999999999999965 7
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
|.+.+.. ..++++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||++.... ......|++
T Consensus 111 l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~--~kl~dfg~~~~~~---~~~~~~~~~ 185 (317)
T cd06635 111 ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQ--VKLADFGSASIAS---PANSFVGTP 185 (317)
T ss_pred HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCC--EEEecCCCccccC---CcccccCCc
Confidence 7776654 456899999999999999999999999999999999999987654 9999999886432 223456889
Q ss_pred ccccchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 154 AYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 154 ~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
.|+|||.+. ...++ .++|||||||++|+|++|+.||........... +............+++.+++++.+|
T Consensus 186 ~y~aPE~~~~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~ 260 (317)
T cd06635 186 YWMAPEVILAMDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPTLQSNEWSDYFRNFVDSC 260 (317)
T ss_pred cccChhhhhcCCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhccCCCCCCccccHHHHHHHHHH
Confidence 999999974 23444 449999999999999999999976543332222 2222222222335788999999999
Q ss_pred cccCCCCCCCHhHHhcCccccccCC
Q 019901 231 FVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
|+.+|.+||++.+++.|+|+....+
T Consensus 261 l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 261 LQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred ccCCcccCcCHHHHHhChhhhccCc
Confidence 9999999999999999999966543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=283.92 Aligned_cols=238 Identities=29% Similarity=0.411 Sum_probs=188.5
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC---CCCCcccceEEEEcCCe-----EEEEEeccCCCChHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL---RHPNIVRFKEVILTPTH-----LAIVMEYASGGELFE 77 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~~~~-----~~lv~e~~~~~~L~~ 77 (334)
+++++.+++.| |+|.+..... .....+.+|+.+++.+ +||||+++++++..... ++++|||+. ++|.+
T Consensus 17 ~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~ 94 (287)
T cd07838 17 KARDLNTGRFV-ALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLAT 94 (287)
T ss_pred EEEECCCCCEE-EEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHH
Confidence 47777788888 9999976541 1234566788777655 69999999999987766 999999996 47888
Q ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 78 RICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
++.+.. .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.............+++.|
T Consensus 95 ~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 172 (287)
T cd07838 95 YLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG--QVKIADFGLARIYSFEMALTSVVVTLWY 172 (287)
T ss_pred HHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC--CEEEeccCcceeccCCcccccccccccc
Confidence 887643 489999999999999999999999999999999999998775 4999999998765444443445688899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccC-----------CC--------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSI-----------PD-------- 215 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-----------~~-------- 215 (334)
+|||++.+..++.+ +|+|||||++|+|++|++||..........+........ .... +.
T Consensus 173 ~~PE~~~~~~~~~~-~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (287)
T cd07838 173 RAPEVLLQSSYATP-VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKS 251 (287)
T ss_pred cChHHhccCCCCCc-chhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhh
Confidence 99999988777655 999999999999999999998776655554443321100 0000 00
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 216 -YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 216 -~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
...+++.+.++|.+||+.+|.+||++++++.||||
T Consensus 252 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 252 FVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 12356888999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=285.61 Aligned_cols=245 Identities=29% Similarity=0.427 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+....++..+ |||.+...... ......+|+..++.++ ||||+++++++..++..++||||+ +++|
T Consensus 7 ig~g~~g~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l 84 (283)
T cd07830 7 LGDGTFGSVYLARNKETGELV-AIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNL 84 (283)
T ss_pred eccCCceEEEEEEECCCCcEE-EEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCH
Confidence 454544 36667778888 99998765422 2234567999999999 999999999999999999999999 7899
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 76 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
.+.+.... .+++..+..++.|++.+|.|||++|++|+||+|.||+++.++. ++|+|||+++............++.
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~ 162 (283)
T cd07830 85 YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEV--VKIADFGLAREIRSRPPYTDYVSTR 162 (283)
T ss_pred HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCC--EEEeecccceeccCCCCcCCCCCcc
Confidence 99887764 6899999999999999999999999999999999999987665 9999999988654444444556889
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCC----
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIP---- 214 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~---- 214 (334)
.|+|||++.+....+.++|+||||+++++|++|++||..........+....... .....+
T Consensus 163 ~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07830 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAP 242 (283)
T ss_pred cccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccccc
Confidence 9999998865544455599999999999999999999876654443322211000 000000
Q ss_pred -----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 215 -----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 215 -----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.....+..+.++|.+||+.+|.+|||++|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 243 TSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 011236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=310.42 Aligned_cols=217 Identities=24% Similarity=0.359 Sum_probs=167.3
Q ss_pred HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC
Q 019901 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-----GRFSEDEARFFFQQLISGVSYCHSM 107 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qil~~L~~LH~~ 107 (334)
..+.+|+.+++.++||||+++++++...+..|+|++++. ++|..++... .......++.++.||+.||.|||++
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~ 286 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK 286 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 467899999999999999999999999999999999995 5777766542 2244677889999999999999999
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 185 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 185 (334)
|||||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+..++.+ +|||||||++|+|++
T Consensus 287 gIiHrDLKP~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlGvil~ell~ 363 (501)
T PHA03210 287 KLIHRDIKLENIFLNCDGK--IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDMLS 363 (501)
T ss_pred CeecCCCCHHHEEECCCCC--EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcH-HHHHHHHHHHHHHHH
Confidence 9999999999999987665 9999999997543322 2234579999999999988888655 999999999999999
Q ss_pred CCCC-CCCCC--chHHHHHHHHHHhhccccCC--------------------------CCCCCCHHHHHHHHHhcccCCC
Q 019901 186 GAYP-FEDPE--EPKNFRKTIHRILSVQYSIP--------------------------DYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 186 g~~p-f~~~~--~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|..+ |.... ....+.+.+..+......+| ....++.++.++|.+||+.||.
T Consensus 364 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~ 443 (501)
T PHA03210 364 HDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWH 443 (501)
T ss_pred CCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcc
Confidence 8754 43221 11222222221110000000 0123567888999999999999
Q ss_pred CCCCHhHHhcCcccccc
Q 019901 237 KRISIPEIRNHEWFLKN 253 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~ 253 (334)
+|||+.|+|.||||...
T Consensus 444 ~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 444 LRPGAAELLALPLFSAE 460 (501)
T ss_pred cCcCHHHHhhChhhhcC
Confidence 99999999999999654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=279.22 Aligned_cols=233 Identities=30% Similarity=0.409 Sum_probs=192.7
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh----
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---- 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---- 81 (334)
.+++..+++.+ |+|.+..... .....+.+|+.+++.++||||+++++++......++|+||+++++|..++.+
T Consensus 18 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~ 96 (256)
T cd08530 18 KVKRLSDNQFY-ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKK 96 (256)
T ss_pred EEEECCCCCEE-EEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhh
Confidence 47788899999 9999986542 2234677899999999999999999999999999999999999999998866
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
...+++..+..++.|++.||.|||+.|++||||+|.||+++.++. +||+|||+++..... ......+++.|+|||.+
T Consensus 97 ~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~--~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~ 173 (256)
T cd08530 97 RKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDL--VKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVW 173 (256)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCc--EEEeeccchhhhccC-CcccccCCccccCHHHH
Confidence 356899999999999999999999999999999999999987654 999999998765443 33445688999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+..++.+ +|+||||+++|+|++|+.||...+...... .+..... .+.....+.++++++.+||..+|.+|||+
T Consensus 174 ~~~~~~~~-~D~~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 247 (256)
T cd08530 174 KGRPYSYK-SDIWSLGCLLYEMATFAPPFEARSMQDLRY----KVQRGKY-PPIPPIYSQDLQNFIRSMLQVKPKLRPNC 247 (256)
T ss_pred CCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhcCCC-CCCchhhCHHHHHHHHHHcCCCcccCCCH
Confidence 88777555 899999999999999999998765432221 1222211 12223578999999999999999999999
Q ss_pred hHHhcCccc
Q 019901 242 PEIRNHEWF 250 (334)
Q Consensus 242 ~ell~h~~~ 250 (334)
.++++||++
T Consensus 248 ~~~l~~p~~ 256 (256)
T cd08530 248 DKILASPAV 256 (256)
T ss_pred HHHhcCCCC
Confidence 999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=278.87 Aligned_cols=244 Identities=28% Similarity=0.519 Sum_probs=206.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccccc---HHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQID---ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~---~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||-|+| +++.++|.+.| |+|++++.....+ +=++.|-.+..+. +||.+|.++.+|+++.++++|.||++||
T Consensus 258 igrgsyakvl~~~~~~t~qiy-amkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~gg 336 (593)
T KOG0695|consen 258 IGRGSYAKVLLVRLKKTDQIY-AMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGG 336 (593)
T ss_pred ecCcchhhhhheehcccceee-ehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCc
Confidence 688888 58899999999 9999999764433 3467788887666 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt 152 (334)
+|.-.+++.+++++++++.+...|+.||.|||++|||+||||..|+|++..+. +||+|+|+++.....+ ...+.|||
T Consensus 337 dlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaegh--ikltdygmcke~l~~gd~tstfcgt 414 (593)
T KOG0695|consen 337 DLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGH--IKLTDYGMCKEGLGPGDTTSTFCGT 414 (593)
T ss_pred ceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCc--eeecccchhhcCCCCCcccccccCC
Confidence 99999999999999999999999999999999999999999999999998876 9999999998654444 45567999
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC--CCch-HHH-HHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PEEP-KNF-RKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~--~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
|.|+|||++.+..|.-. +|+|+||++++||+.|+.||.- ...+ .+. ....+-++..+.++|. .+|-.+..+++
T Consensus 415 pnyiapeilrgeeygfs-vdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiripr--slsvkas~vlk 491 (593)
T KOG0695|consen 415 PNYIAPEILRGEEYGFS-VDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR--SLSVKASHVLK 491 (593)
T ss_pred CcccchhhhcccccCce-ehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccc--eeehhhHHHHH
Confidence 99999999999998655 9999999999999999999962 1111 111 2223345566666665 46788899999
Q ss_pred HhcccCCCCCC------CHhHHhcCcccc
Q 019901 229 RIFVADPAKRI------SIPEIRNHEWFL 251 (334)
Q Consensus 229 ~~L~~~p~~R~------s~~ell~h~~~~ 251 (334)
..|++||..|. .+.++..|+||+
T Consensus 492 gflnkdp~erlgc~~~~g~~dik~h~ffr 520 (593)
T KOG0695|consen 492 GFLNKDPKERLGCRPQTGFSDIKSHAFFR 520 (593)
T ss_pred HhhcCCcHHhcCCCcccchhhhhcchhhh
Confidence 99999999997 478999999997
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=294.03 Aligned_cols=239 Identities=23% Similarity=0.353 Sum_probs=184.8
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEeccCCCChHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERI 79 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l 79 (334)
.+++..+|+.| |||.+.+... .....+.+|+.+++.++||||+++++++... ...++|++|+. .+|...+
T Consensus 33 ~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 110 (342)
T cd07879 33 SAIDKRTGEKV-AIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM 110 (342)
T ss_pred EEEeCCCCcEE-EEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH
Confidence 36777889998 9999876431 2235688999999999999999999998754 34699999995 4676654
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
...+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++.... ......+++.|+|||
T Consensus 111 --~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~--~kL~dfg~~~~~~~--~~~~~~~~~~y~aPE 184 (342)
T cd07879 111 --GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRWYRAPE 184 (342)
T ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEeeCCCCcCCCC--CCCCceeeecccChh
Confidence 346899999999999999999999999999999999999987664 99999999875422 223446788999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-------------------hccccCC------
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------SVQYSIP------ 214 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~~~~~------ 214 (334)
++.+....+.++|||||||++|+|++|+.||.+......+...+.... ......+
T Consensus 185 ~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (342)
T cd07879 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST 264 (342)
T ss_pred hhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHH
Confidence 987644334559999999999999999999987654333332221000 0000000
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..+..++.+.+||.+||+.+|.+|||+++++.||||....
T Consensus 265 ~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 265 LFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred HhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 0124678899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=279.46 Aligned_cols=239 Identities=27% Similarity=0.424 Sum_probs=189.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+.+..+|+.+ |+|.+..... ...+.+.+|+.+++.++|+||+++++.+...+..++||||+.+++
T Consensus 10 lg~g~~~~v~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~ 88 (267)
T cd08224 10 IGKGQFSVVYKAICLLDGRVV-ALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGD 88 (267)
T ss_pred eccCCceEEEEEEEcCCCCEE-EEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCC
Confidence 455554 46777789998 9999875431 234678899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCc
Q 019901 75 LFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 149 (334)
Q Consensus 75 L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~ 149 (334)
|..++.+ ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++. ++|+|||+++...... .....
T Consensus 89 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 166 (267)
T cd08224 89 LSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL 166 (267)
T ss_pred HHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCc--EEEeccceeeeccCCCccccee
Confidence 9998864 245899999999999999999999999999999999999987665 9999999987543322 22334
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.+++.|+|||.+.+..++.+ +|+||||+++|+|++|+.||...... ....................++..+.++|.+
T Consensus 167 ~~~~~y~apE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 243 (267)
T cd08224 167 VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMN--LYSLCKKIEKCDYPPLPADHYSEELRDLVSR 243 (267)
T ss_pred cCCccccCHHHhccCCCCch-hcHHHHHHHHHHHHHCCCCcccCCcc--HHHHHhhhhcCCCCCCChhhcCHHHHHHHHH
Confidence 68899999999988777655 89999999999999999999654321 1122222222111111112568899999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 019901 230 IFVADPAKRISIPEIRN 246 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~ 246 (334)
||..+|.+|||+.++++
T Consensus 244 cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 244 CINPDPEKRPDISYVLQ 260 (267)
T ss_pred HcCCCcccCCCHHHHHH
Confidence 99999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=278.98 Aligned_cols=233 Identities=25% Similarity=0.385 Sum_probs=186.9
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.|.+ +.+....|+.+ |||.+.... .....+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++
T Consensus 14 ig~g~~g~v~~~~~~~~~v-~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 91 (256)
T cd05039 14 IGKGEFGDVMLGDYRGQKV-AVKCLKDDS-TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYL 91 (256)
T ss_pred eecCCCceEEEEEecCcEE-EEEEeccch-hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHH
Confidence 455544 23334457777 999997765 24567889999999999999999999999899999999999999999999
Q ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
.... .+++..++.++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++...... ....++..|+|
T Consensus 92 ~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~--~~l~d~g~~~~~~~~~--~~~~~~~~~~a 167 (256)
T cd05039 92 RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLV--AKVSDFGLAKEASQGQ--DSGKLPVKWTA 167 (256)
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCC--EEEccccccccccccc--ccCCCcccccC
Confidence 7765 6899999999999999999999999999999999999987665 9999999988653222 23344567999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
||.+....+..+ +|+||||+++|+|++ |..||....... ..... ...........+++.+.++|.+||..+|.
T Consensus 168 pe~~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 241 (256)
T cd05039 168 PEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKD-VVPHV----EKGYRMEAPEGCPPEVYKVMKDCWELDPA 241 (256)
T ss_pred chhhcCCcCCcH-HHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHH----hcCCCCCCccCCCHHHHHHHHHHhccChh
Confidence 999987777655 999999999999997 999997654322 22211 11122222335789999999999999999
Q ss_pred CCCCHhHHhc
Q 019901 237 KRISIPEIRN 246 (334)
Q Consensus 237 ~R~s~~ell~ 246 (334)
+|||+.++++
T Consensus 242 ~Rp~~~~l~~ 251 (256)
T cd05039 242 KRPTFKQLRE 251 (256)
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=283.62 Aligned_cols=226 Identities=21% Similarity=0.331 Sum_probs=180.5
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc---------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------- 82 (334)
.++..+ |+|.+..... .....+.+|+.+++.++||||+++++++..++..|+||||+.+++|.+++...
T Consensus 32 ~~~~~~-~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 110 (283)
T cd05090 32 DHAQLV-AIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCS 110 (283)
T ss_pred CCcceE-EEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccc
Confidence 355677 9999875431 22356889999999999999999999999999999999999999999988532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccC
Q 019901 83 --------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVG 151 (334)
Q Consensus 83 --------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~g 151 (334)
..+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++...... ......+
T Consensus 111 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 188 (283)
T cd05090 111 SDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH--VKISDLGLSREIYSADYYRVQPKSLL 188 (283)
T ss_pred cccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc--EEeccccccccccCCcceecccCCCc
Confidence 23788899999999999999999999999999999999987664 9999999987543221 1233446
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+..|+|||++.+..++.+ +|+|||||++|+|++ |..||.+....... . .+. .....+.+..+++.+.+++.+|
T Consensus 189 ~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~g~~p~~~~~~~~~~-~---~~~-~~~~~~~~~~~~~~~~~li~~c 262 (283)
T cd05090 189 PIRWMPPEAIMYGKFSSD-SDIWSFGVVLWEIFSFGLQPYYGFSNQEVI-E---MVR-KRQLLPCSEDCPPRMYSLMTEC 262 (283)
T ss_pred cceecChHHhccCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-H---HHH-cCCcCCCCCCCCHHHHHHHHHH
Confidence 778999999987777555 999999999999998 99999765432221 1 111 1222333446789999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 019901 231 FVADPAKRISIPEIRNH 247 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h 247 (334)
|+.+|.+||++.+++++
T Consensus 263 l~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 263 WQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cccCcccCcCHHHHHHH
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=292.93 Aligned_cols=246 Identities=21% Similarity=0.366 Sum_probs=189.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|++ .+.+..+|+.| |+|++.+... ...+.+.+|+.++++++||||+++++++... +..|+++++
T Consensus 25 lg~G~~g~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~ 103 (345)
T cd07877 25 VGSGAYGSVCAAFDTKTGLRV-AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 103 (345)
T ss_pred eeecCCeEEEEEEEcCCCeEE-EEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehh
Confidence 455544 46778889988 9999876431 2245688899999999999999999988643 347888888
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+ +++|.+.+.. ..+++..++.++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.... .....
T Consensus 104 ~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~--~kl~dfg~~~~~~~--~~~~~ 177 (345)
T cd07877 104 M-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD--EMTGY 177 (345)
T ss_pred c-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCC--EEEecccccccccc--ccccc
Confidence 7 7889877754 46999999999999999999999999999999999999987765 99999999875422 22345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHh-------------------hcc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL-------------------SVQ 210 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-------------------~~~ 210 (334)
.+++.|+|||++.+....+.++|||||||++|+|++|++||........+........ ...
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (345)
T cd07877 178 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 257 (345)
T ss_pred ccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHh
Confidence 6889999999987643334459999999999999999999976554333332221110 000
Q ss_pred ccCCC------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 YSIPD------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 ~~~~~------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
...+. ....++++.+||.+||+.+|.+|||+.+++.||||.+..
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 258 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred cccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 00010 123588899999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=309.35 Aligned_cols=221 Identities=26% Similarity=0.383 Sum_probs=190.0
Q ss_pred CeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------
Q 019901 16 DLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------- 83 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 83 (334)
..| |||.++...-. ...+|+||+.++..++|||||++++++..++.+|+|+|||..|+|.++|....
T Consensus 517 ~lV-AVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~ 595 (774)
T KOG1026|consen 517 QLV-AVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQD 595 (774)
T ss_pred eeh-hHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCC
Confidence 455 99999887633 56799999999999999999999999999999999999999999999996432
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCcccc
Q 019901 84 ---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIA 157 (334)
Q Consensus 84 ---~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~a 157 (334)
+++..+...++.||+.|+.||-++.+|||||-.+|+||..+-. |||+||||++....... .....-..+|||
T Consensus 596 ~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~--VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMp 673 (774)
T KOG1026|consen 596 TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLV--VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMP 673 (774)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceE--EEecccccchhhhhhhhhcccCCceeeeecCC
Confidence 2888999999999999999999999999999999999987665 99999999996443322 223445679999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
||.+....++++ |||||+||+|||+++ |+.||.+.+..+. +..+..... ++.+...|.++.+|+..||+.+|.
T Consensus 674 pEsIly~kFTte-SDVWs~GVvLWEIFsyG~QPy~glSn~EV----Ie~i~~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~ 747 (774)
T KOG1026|consen 674 PESILYGKFTTE-SDVWSFGVVLWEIFSYGKQPYYGLSNQEV----IECIRAGQL-LSCPENCPTEVYSLMLECWNENPK 747 (774)
T ss_pred HHHhhcCcccch-hhhhhhhhhhhhhhccccCcccccchHHH----HHHHHcCCc-ccCCCCCCHHHHHHHHHHhhcCcc
Confidence 999999999888 999999999999997 9999998877443 334444454 677778999999999999999999
Q ss_pred CCCCHhHHh
Q 019901 237 KRISIPEIR 245 (334)
Q Consensus 237 ~R~s~~ell 245 (334)
+|||+.||-
T Consensus 748 ~RPsF~eI~ 756 (774)
T KOG1026|consen 748 RRPSFKEIH 756 (774)
T ss_pred cCCCHHHHH
Confidence 999999974
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=282.16 Aligned_cols=235 Identities=19% Similarity=0.188 Sum_probs=183.0
Q ss_pred CCccee----eeeecCCCC-------eeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSD-------LFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~-------~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|+| .+.+..++. .+ |+|.+........+.+.+|+.+++.++||||+++++++..+...++||||+
T Consensus 3 lg~G~~~~Vy~~~~~~~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 3 LGQGTFTKIFKGIRREVGDYGELHKTEV-LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCcccchhheeeeecccccccccccchh-hHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 677766 245544333 36 888886655344567889999999999999999999999989999999999
Q ss_pred CCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC------CEEEeccCCccCCCCC
Q 019901 71 SGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVLH 143 (334)
Q Consensus 71 ~~~~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~------~~kl~Dfgla~~~~~~ 143 (334)
.+|+|..++...+ .+++..+..++.||+.||.|||++||+||||||+||+++.++.. .++++|||++.....
T Consensus 82 ~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~- 160 (258)
T cd05078 82 KFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP- 160 (258)
T ss_pred CCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC-
Confidence 9999999997654 58999999999999999999999999999999999999765431 379999998864322
Q ss_pred CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHH
Q 019901 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222 (334)
Q Consensus 144 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (334)
.....+++.|+|||++.+....+.++||||||+++|+|++| .+||......... . ........|. ..+.+
T Consensus 161 --~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~----~~~~~~~~~~--~~~~~ 231 (258)
T cd05078 161 --KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-Q----FYEDRHQLPA--PKWTE 231 (258)
T ss_pred --chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-H----HHHccccCCC--CCcHH
Confidence 23456888999999997654334559999999999999998 4666554432211 1 1111222222 35688
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 223 CRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+.+++.+||+.+|.+|||++++++.
T Consensus 232 ~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 232 LANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHhccChhhCCCHHHHHHh
Confidence 9999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=282.69 Aligned_cols=225 Identities=18% Similarity=0.227 Sum_probs=178.0
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---------
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 83 (334)
++..+ |||.+..... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++.+..
T Consensus 35 ~~~~~-aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 113 (277)
T cd05062 35 PETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ 113 (277)
T ss_pred ceeEE-EEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccc
Confidence 34566 9999865431 233468899999999999999999999999999999999999999999987532
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccch
Q 019901 84 -RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 159 (334)
Q Consensus 84 -~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE 159 (334)
.++...+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++....... .....+++.|+|||
T Consensus 114 ~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 191 (277)
T cd05062 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 191 (277)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCC--EEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence 2567889999999999999999999999999999999987664 99999999874322211 12234577899999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
++.+..++.+ +|||||||++|+|++ |..||.+......... ..... ..+.....++.+.+++.+||+.+|.+|
T Consensus 192 ~~~~~~~~~~-~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (277)
T cd05062 192 SLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF----VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMR 265 (277)
T ss_pred HhhcCCcCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcCC-cCCCCCCCCHHHHHHHHHHcCCChhhC
Confidence 9987777655 899999999999998 7899987654332221 11111 122234578899999999999999999
Q ss_pred CCHhHHhcC
Q 019901 239 ISIPEIRNH 247 (334)
Q Consensus 239 ~s~~ell~h 247 (334)
||+.+++++
T Consensus 266 ps~~e~l~~ 274 (277)
T cd05062 266 PSFLEIISS 274 (277)
T ss_pred cCHHHHHHH
Confidence 999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=279.10 Aligned_cols=237 Identities=22% Similarity=0.354 Sum_probs=187.2
Q ss_pred CCccee---e-eeecCC---CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCSYS---SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~~~---~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| + ++.+.+ ...+ |||.+..... .....+.+|+.+++.++||||+++++++...+..++||||+.++
T Consensus 12 lg~g~~g~vy~~~~~~~~~~~~~v-aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~ 90 (266)
T cd05033 12 IGGGEFGEVCRGRLKLPGKKEIDV-AIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENG 90 (266)
T ss_pred ecCCccceEEEEEEccCCCCcceE-EEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCC
Confidence 455554 3 444433 3355 9999876542 23356888999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+|.+++... +.+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++....... ....
T Consensus 91 ~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 168 (266)
T cd05033 91 SLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLV--CKVSDFGLSRRLEDSEATYTTKGG 168 (266)
T ss_pred CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCC--EEECccchhhcccccccceeccCC
Confidence 999998764 46899999999999999999999999999999999999987665 99999999986531111 1122
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+++.|+|||.+.+..++.+ +||||||+++|+|++ |..||.......... .+ ......+.....+..+.+++.
T Consensus 169 ~~~~~y~~Pe~~~~~~~~~~-~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~l~~li~ 242 (266)
T cd05033 169 KIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVIK----AV-EDGYRLPPPMDCPSALYQLML 242 (266)
T ss_pred CCCccccChhhhccCCCccc-cchHHHHHHHHHHHccCCCCCCCCCHHHHHH----HH-HcCCCCCCCCCCCHHHHHHHH
Confidence 34678999999987777655 899999999999998 999997655432222 22 122233444567999999999
Q ss_pred HhcccCCCCCCCHhHHhcC
Q 019901 229 RIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h 247 (334)
+||+.+|.+||++.+++++
T Consensus 243 ~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 243 DCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHcCCCcccCcCHHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.69 Aligned_cols=223 Identities=23% Similarity=0.368 Sum_probs=178.6
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------- 82 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------- 82 (334)
..| |||++..... ...+.+.+|+.+++.+. ||||+++++++...+..|+|||||.+|+|.+++...
T Consensus 68 ~~v-avK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~ 146 (400)
T cd05105 68 MKV-AVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK 146 (400)
T ss_pred eEE-EEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence 456 9999976542 23457889999999996 999999999999999999999999999999887642
Q ss_pred --------------------------------------------------------------------------------
Q 019901 83 -------------------------------------------------------------------------------- 82 (334)
Q Consensus 83 -------------------------------------------------------------------------------- 82 (334)
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 226 (400)
T cd05105 147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL 226 (400)
T ss_pred ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCc
Q 019901 83 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 154 (334)
Q Consensus 83 -----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~ 154 (334)
..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+++.
T Consensus 227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~--~kL~DfGla~~~~~~~~~~~~~~~~~~~~ 304 (400)
T cd05105 227 SDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI--VKICDFGLARDIMHDSNYVSKGSTFLPVK 304 (400)
T ss_pred HhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE--EEEEeCCcceeccccccccccCCcCCCcc
Confidence 23778888999999999999999999999999999999987654 9999999987543222 1223457788
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |..||............ .......+....+++++.+++.+||+.
T Consensus 305 y~aPE~~~~~~~~~~-~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~cl~~ 379 (400)
T cd05105 305 WMAPESIFDNLYTTL-SDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK----IKSGYRMAKPDHATQEVYDIMVKCWNS 379 (400)
T ss_pred eEChhhhcCCCCCch-hhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH----HhcCCCCCCCccCCHHHHHHHHHHCcc
Confidence 999999988777655 999999999999997 99999765433222221 222223344456789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|++|||+.++.+
T Consensus 380 dP~~RPt~~~l~~ 392 (400)
T cd05105 380 EPEKRPSFLHLSD 392 (400)
T ss_pred CHhHCcCHHHHHH
Confidence 9999999988764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=299.82 Aligned_cols=244 Identities=30% Similarity=0.445 Sum_probs=202.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|.| +++...|...| |.|.+.|... .....++.|-.||...+.+-||++|..|++...+|+||+|+.||+
T Consensus 637 iGvGAFGeV~Lv~KvDT~~lY-AmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD 715 (1034)
T KOG0608|consen 637 IGVGAFGEVCLVRKVDTRALY-AMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD 715 (1034)
T ss_pred ecccccceeEEEeecchhhHH-HHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence 566666 56666778888 9999988762 234678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC--------C---
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--------H--- 143 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~--------~--- 143 (334)
+..+|.+.+-|.|..++.++.++..|++++|..|+|||||||.|||||.+|. +||+||||++...- .
T Consensus 716 mMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGH--IKLTDFGLCTGfRWTHdskYYq~gdH 793 (1034)
T KOG0608|consen 716 MMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH--IKLTDFGLCTGFRWTHDSKYYQEGDH 793 (1034)
T ss_pred HHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCc--eeeeeccccccceeccccccccCCCc
Confidence 9999999999999999999999999999999999999999999999998876 99999999862110 0
Q ss_pred ----C----------------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019901 144 ----S----------------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 191 (334)
Q Consensus 144 ----~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 191 (334)
. .....+||+.|+|||++...+|+.. +|+||.|+|||+|+.|++||.
T Consensus 794 ~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~-cdwws~gvil~em~~g~~pf~ 872 (1034)
T KOG0608|consen 794 HRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQL-CDWWSVGVILYEMLVGQPPFL 872 (1034)
T ss_pred cccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcccc-chhhHhhHHHHHHhhCCCCcc
Confidence 0 0012369999999999999888655 999999999999999999998
Q ss_pred CCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC---CHhHHhcCccccc
Q 019901 192 DPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~---s~~ell~h~~~~~ 252 (334)
..+......+++ ....-+.++....+|.++.++|.++. ..++.|. .++++..||||+.
T Consensus 873 ~~tp~~tq~kv~--nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 873 ADTPGETQYKVI--NWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCCCcceeeee--ehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence 776654333222 11233456666789999999999965 5889998 3678999999964
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=273.64 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=199.3
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEc--------CCeEEEE
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILT--------PTHLAIV 66 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--------~~~~~lv 66 (334)
++|.|+| .|+++++|+.| |+|++.... ........+|+++|..++|+|++.+++++.+ ...+|+|
T Consensus 24 kigqGtfgeVFkAr~~n~~kkv-alkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV 102 (376)
T KOG0669|consen 24 KIGQGTFGEVFKARSKNTGKKV-ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV 102 (376)
T ss_pred hcCCchHHHHHHHhhcCccchh-HHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence 3677777 59999999998 998877644 2345678999999999999999999988753 2359999
Q ss_pred EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-
Q 019901 67 MEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 144 (334)
Q Consensus 67 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~- 144 (334)
|++|+. +|.-.+.+. .+|+..+++.++.+++.||.|+|+..|+|||+|++|+||+.++. +||+|||+++......
T Consensus 103 f~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgi--lklADFGlar~fs~~~n 179 (376)
T KOG0669|consen 103 FDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGI--LKLADFGLARAFSTSKN 179 (376)
T ss_pred HHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCce--EEeeccccccceecccc
Confidence 999965 788888765 67999999999999999999999999999999999999987776 9999999997433221
Q ss_pred ----CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cCCCC---
Q 019901 145 ----QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDY--- 216 (334)
Q Consensus 145 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 216 (334)
.-...+-|.+|++||.+.|..-++++.|||..|||+.+|+++.+.|.+.++..++..+..-..+... ..|..
T Consensus 180 ~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~l 259 (376)
T KOG0669|consen 180 VVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNL 259 (376)
T ss_pred cCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccc
Confidence 1233456999999999998777777799999999999999999999988876655443322111100 01110
Q ss_pred -------------------------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 217 -------------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 217 -------------------------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..-.+++.+|+.+||..||.+|+.+.++++|.||.+..
T Consensus 260 pL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 260 PLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred hHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 01246889999999999999999999999999997753
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=284.12 Aligned_cols=225 Identities=24% Similarity=0.347 Sum_probs=180.1
Q ss_pred EEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------CCC
Q 019901 19 VNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-----------RFS 86 (334)
Q Consensus 19 vaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~ 86 (334)
||+|.+..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+++|..++.+.. .++
T Consensus 49 va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ 128 (296)
T cd05051 49 VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128 (296)
T ss_pred EEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCC
Confidence 49999886542 234678899999999999999999999999999999999999999999997765 689
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccchhhcc
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~ 163 (334)
+..++.++.|++.||.|||++|++||||||+||+++..+. ++|+|||+++...... ......+++.|+|||++.+
T Consensus 129 ~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 206 (296)
T cd05051 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL 206 (296)
T ss_pred HHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCCCc--eEEccccceeecccCcceeecCcCCCCceecCHHHhhc
Confidence 9999999999999999999999999999999999987754 9999999987543222 1223456788999999887
Q ss_pred CCCCCccchhhhhhHHHHHHHh--CCCCCCCCCchHHHHHHHHHHh--hccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 164 KEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
..++.+ +|||||||++|+|++ +..||........+........ ......+....++.++.+++.+||+.+|.+||
T Consensus 207 ~~~~~~-~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp 285 (296)
T cd05051 207 GKFTTK-SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP 285 (296)
T ss_pred CCCCcc-chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC
Confidence 766555 999999999999998 7888876655433332221100 11112233345679999999999999999999
Q ss_pred CHhHHhc
Q 019901 240 SIPEIRN 246 (334)
Q Consensus 240 s~~ell~ 246 (334)
|+.++++
T Consensus 286 t~~el~~ 292 (296)
T cd05051 286 TFREIHL 292 (296)
T ss_pred CHHHHHH
Confidence 9999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=276.48 Aligned_cols=236 Identities=26% Similarity=0.360 Sum_probs=187.6
Q ss_pred CCCccee---e-eeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 1 MLGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 1 ~lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+||.|++ + +.+.. ++.| |+|.+...... ....+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~-~~~v-~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 2 KIGKGNFGDVYKGVLKG-NTEV-AVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred ccccCCCceEEEEEEeC-CCcE-EEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 3565554 3 55555 8888 99998776532 346789999999999999999999999999999999999999999
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC---CCccC
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVG 151 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---~~~~g 151 (334)
.+++.+. ..++...+..++.+++.||.|||++|++||||+|+|||++.++. ++|+|||+++........ ....+
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCc--EEEeeccccccccCCcceeccccCcc
Confidence 9998663 46899999999999999999999999999999999999987664 999999998754321111 12234
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+..|+|||.+.+..++.+ +|+||||+++|+|++ |..||........... + ......+.....+..+.+++.+|
T Consensus 158 ~~~y~~PE~~~~~~~~~~-~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~ 231 (251)
T cd05041 158 PIKWTAPEALNYGRYTSE-SDVWSYGILLWETFSLGDTPYPGMSNQQTRER----I-ESGYRMPAPQLCPEEIYRLMLQC 231 (251)
T ss_pred eeccCChHhhccCCCCcc-hhHHHHHHHHHHHHhccCCCCccCCHHHHHHH----H-hcCCCCCCCccCCHHHHHHHHHH
Confidence 567999999887776555 999999999999998 8999977654322221 1 11222333345789999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 019901 231 FVADPAKRISIPEIRN 246 (334)
Q Consensus 231 L~~~p~~R~s~~ell~ 246 (334)
|..+|.+|||+.++++
T Consensus 232 l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 232 WAYDPENRPSFSEIYN 247 (251)
T ss_pred hccChhhCcCHHHHHH
Confidence 9999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=285.45 Aligned_cols=223 Identities=31% Similarity=0.452 Sum_probs=175.1
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHH
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEAR 91 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~ 91 (334)
+..| +||.+..... ...+.+.+|+..+++++||||+++++++...+..++|+||+.+|+|.+++... ..++...+.
T Consensus 28 ~~~V-~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~ 106 (259)
T PF07714_consen 28 NQPV-AVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRL 106 (259)
T ss_dssp EEEE-EEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHH
T ss_pred CEEE-EEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 4555 9999965431 23578999999999999999999999999888899999999999999999886 679999999
Q ss_pred HHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCC
Q 019901 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDG 168 (334)
Q Consensus 92 ~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~ 168 (334)
.|+.||+.||.|||+++++|++|+++||+++.++. +||+|||+++....... .....+...|+|||.+.+..++.
T Consensus 107 ~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~--~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ 184 (259)
T PF07714_consen 107 SIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQ--VKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTK 184 (259)
T ss_dssp HHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTE--EEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESH
T ss_pred ccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999999999999999999997764 99999999876522211 22344677899999998877654
Q ss_pred ccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 169 KIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 169 ~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+ +||||||+++||+++ |+.||......... ..+ ......+....++..+.++|.+||..+|.+|||+.++++
T Consensus 185 k-sDVysfG~~l~ei~~~~~~p~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 185 K-SDVYSFGMLLYEILTLGKFPFSDYDNEEII----EKL-KQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp H-HHHHHHHHHHHHHHTTSSGTTTTSCHHHHH----HHH-HTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred c-cccccccccccccccccccccccccccccc----ccc-cccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 4 999999999999999 78999876543322 222 222233444467999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=277.50 Aligned_cols=233 Identities=22% Similarity=0.309 Sum_probs=183.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ ++++..+ ..+ |||++.... ...+.+.+|+.+++.++||||+++++.+. ....++||||+.+++|.+
T Consensus 14 lg~g~~~~v~~~~~~~~-~~v-alK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~ 89 (262)
T cd05071 14 LGQGCFGEVWMGTWNGT-TRV-AIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD 89 (262)
T ss_pred cCCCCCCcEEEEEecCC-ceE-EEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHH
Confidence 455554 3544443 456 999998655 34567899999999999999999999875 456799999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
++.+. ..+++..+..++.|++.||.|||++|++||||||+||+++.++. ++|+|||+++....... .....++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~--~~L~dfg~~~~~~~~~~~~~~~~~~~~ 167 (262)
T cd05071 90 FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 167 (262)
T ss_pred HHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCc--EEeccCCceeeccccccccccCCcccc
Confidence 99763 34889999999999999999999999999999999999987654 99999999875432221 12234667
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||+..+..++.+ +|||||||++|+|++ |.+||.+......... +. .....+....++..+.+++.+||+
T Consensus 168 ~y~~PE~~~~~~~~~~-~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~ 241 (262)
T cd05071 168 KWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VE-RGYRMPCPPECPESLHDLMCQCWR 241 (262)
T ss_pred eecCHhHhccCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH----Hh-cCCCCCCccccCHHHHHHHHHHcc
Confidence 8999999887777655 999999999999999 8999987654332222 21 122233344678999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
++|.+|||++++++
T Consensus 242 ~~p~~Rp~~~~~~~ 255 (262)
T cd05071 242 KEPEERPTFEYLQA 255 (262)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=283.78 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=188.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+++..+++.| |||.+.+... .....+.+|+.++... .||||+++++++.+.+..|+||||+. +++
T Consensus 23 lg~g~~~~v~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l 100 (296)
T cd06618 23 IGSGTCGQVYKMRFKKTGHVM-AVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCL 100 (296)
T ss_pred eeccCCeEEEEEEECCCCeEE-EEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCH
Confidence 455544 47777778888 9999986542 2234566777766666 59999999999999999999999984 567
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 76 FERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
...+.. ...+++..+..++.|++.||.|||+ .||+||||+|+||+++.++. +||+|||++.............+++
T Consensus 101 ~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~--~kL~dfg~~~~~~~~~~~~~~~~~~ 178 (296)
T cd06618 101 DKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGN--VKLCDFGISGRLVDSKAKTRSAGCA 178 (296)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCC--EEECccccchhccCCCcccCCCCCc
Confidence 666655 4568999999999999999999997 59999999999999987654 9999999987544333334446788
Q ss_pred ccccchhhccCC----CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccCCCCCCCCHHHHHHHH
Q 019901 154 AYIAPEVLLKKE----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 154 ~y~aPE~~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~ 228 (334)
.|+|||.+.+.. ++. ++||||||+++|+|++|+.||....... ......... ....+....++.++.+|+.
T Consensus 179 ~y~aPE~~~~~~~~~~~~~-~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 254 (296)
T cd06618 179 AYMAPERIDPPDPNPKYDI-RADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQEEPPSLPPNEGFSPDFCSFVD 254 (296)
T ss_pred cccCHhhcCCCCCcccccc-chhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhcCCCCCCCCCCCCCHHHHHHHH
Confidence 999999987553 444 4899999999999999999997543221 112222222 2223333357899999999
Q ss_pred HhcccCCCCCCCHhHHhcCcccccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+||..+|.+|||+++++.||||...
T Consensus 255 ~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 255 LCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred HHccCChhhCCCHHHHhcChhhhcc
Confidence 9999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=284.13 Aligned_cols=225 Identities=24% Similarity=0.363 Sum_probs=181.3
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC--CCCHHH
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDE 89 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~ 89 (334)
++..+ |||++..... ...+.+.+|+.+++++ +||||+++++.+...+..++||||+.+++|..++.... .+++.+
T Consensus 64 ~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~ 142 (302)
T cd05055 64 AVMKV-AVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED 142 (302)
T ss_pred ceeEE-EEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHH
Confidence 44566 9999876541 2335788999999999 79999999999999999999999999999999987643 389999
Q ss_pred HHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCC
Q 019901 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~ 166 (334)
+..++.|++.||.|||++||+|+||||+|||++.++ .++|+|||+++....... .....+++.|+|||.+.+..+
T Consensus 143 ~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~--~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 220 (302)
T cd05055 143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK--IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY 220 (302)
T ss_pred HHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC--eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC
Confidence 999999999999999999999999999999998655 499999999875432221 122346778999999988777
Q ss_pred CCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 167 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
+.+ +||||+||++|+|++ |..||........+.+.. ......+.....++.+.+++.+||..+|.+|||+.+++
T Consensus 221 ~~~-~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell 295 (302)
T cd05055 221 TFE-SDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLI----KEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIV 295 (302)
T ss_pred CcH-hHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHH----HcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHH
Confidence 655 999999999999998 999998765543333222 22222233345789999999999999999999999997
Q ss_pred c
Q 019901 246 N 246 (334)
Q Consensus 246 ~ 246 (334)
.
T Consensus 296 ~ 296 (302)
T cd05055 296 Q 296 (302)
T ss_pred H
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=277.24 Aligned_cols=235 Identities=24% Similarity=0.331 Sum_probs=181.3
Q ss_pred CCccee---e-eeec--CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCS--YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~--~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| + +... ..+..+ |+|++..... ...+.+.+|+.++++++||||+++++++. ....++||||+.+++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~v-avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDV-AIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeE-EEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 455655 2 3333 334456 9999876542 22356889999999999999999999875 457899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCc
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 149 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~ 149 (334)
|.+++.. ...+++..++.++.|++.||.|||++|++||||||+|||++.++. +||+|||+++....... ....
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHY--AKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCc--EEeccCCccccccCCccceeccCCC
Confidence 9998875 456899999999999999999999999999999999999987654 99999999874322211 1112
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.......... . + ......+.....++++.+++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~-~---~-~~~~~~~~~~~~~~~l~~li~ 232 (257)
T cd05115 159 KWPLKWYAPECINFRKFSSR-SDVWSYGITMWEAFSYGQKPYKKMKGPEVMS-F---I-EQGKRLDCPAECPPEMYALMK 232 (257)
T ss_pred CCCcccCCHHHHccCCCCch-hhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH-H---H-HCCCCCCCCCCCCHHHHHHHH
Confidence 23578999999887776555 999999999999996 999998765433221 1 1 111222233456899999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||..+|++||++.++.+
T Consensus 233 ~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 233 DCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHcCCChhhCcCHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=276.79 Aligned_cols=232 Identities=24% Similarity=0.354 Sum_probs=182.8
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEE-cCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +.+....|..+ |+|.+.... ..+.+.+|+.+++.++|||++++++++. .++..++||||+.+++|.++
T Consensus 14 lg~g~~~~v~~~~~~~~~~-~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 90 (256)
T cd05082 14 IGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 90 (256)
T ss_pred ecccCCCeEEEEEEcCCcE-EEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHH
Confidence 455554 33334567888 999986543 3457889999999999999999999754 55679999999999999999
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
+.+.+ .+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||+++..... .....++..|+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~--~kl~dfg~~~~~~~~--~~~~~~~~~y~ 166 (256)
T cd05082 91 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWT 166 (256)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCc--EEecCCccceecccc--CCCCccceeec
Confidence 87653 3889999999999999999999999999999999999987664 999999998754322 22334567899
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||++.+..++.+ +|||||||++|+|++ |+.||......... ..+. ..........+++.+.+++.+||+.+|
T Consensus 167 aPE~~~~~~~~~~-~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p 240 (256)
T cd05082 167 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVV----PRVE-KGYKMDAPDGCPPVVYDVMKQCWHLDA 240 (256)
T ss_pred CHHHHccCCCCch-hhhHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHh-cCCCCCCCCCCCHHHHHHHHHHhcCCh
Confidence 9999987777655 999999999999997 99999765432221 1111 122222234578999999999999999
Q ss_pred CCCCCHhHHhc
Q 019901 236 AKRISIPEIRN 246 (334)
Q Consensus 236 ~~R~s~~ell~ 246 (334)
.+|||+.++++
T Consensus 241 ~~Rpt~~~l~~ 251 (256)
T cd05082 241 ATRPSFLQLRE 251 (256)
T ss_pred hhCcCHHHHHH
Confidence 99999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=274.75 Aligned_cols=237 Identities=22% Similarity=0.334 Sum_probs=186.1
Q ss_pred CCCccee---eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 1 MLGFHNF---YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 1 ~lG~g~~---~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
+||.|++ +.....++..+ |+|.+..... .....+.+|+.+++.++||||+++++++...+..++||||+.+++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEE-EEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 3566665 32234466777 9999876542 22346889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccCCC
Q 019901 77 ERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVGTP 153 (334)
Q Consensus 77 ~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~gt~ 153 (334)
+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||++......... ....+++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNV--LKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCe--EEECCCccceeccccccccCCCCCCcc
Confidence 988754 45899999999999999999999999999999999999987664 999999998743322211 1223456
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +||||||+++|++++ |..||.......... .+. ..........++..+.+++.+||+
T Consensus 159 ~y~aPE~~~~~~~~~~-~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l~ 232 (250)
T cd05085 159 KWTAPEALNYGRYSSE-SDVWSYGILLWETFSLGVCPYPGMTNQQARE----QVE-KGYRMSCPQKCPDDVYKVMQRCWD 232 (250)
T ss_pred cccCHHHhccCCCCch-hHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH----HHH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 7999999987776555 999999999999998 999998665432222 111 122223334578999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 233 ~~p~~Rp~~~~l~~ 246 (250)
T cd05085 233 YKPENRPKFSELQK 246 (250)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=280.42 Aligned_cols=235 Identities=20% Similarity=0.349 Sum_probs=184.5
Q ss_pred CCccee---e-eeecCCCCe----eEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---Y-DRCSYSSDL----FVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~----vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ + +.+..++.. | |+|++..... .....+.+|+.+++.++||||+++++++... ..+++++|+++
T Consensus 15 lg~G~~g~vy~~~~~~~~~~~~~~v-a~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~ 92 (279)
T cd05109 15 LGSGAFGTVYKGIWIPDGENVKIPV-AIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPY 92 (279)
T ss_pred cCCCCCceEEEEEEecCCCccceEE-EEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCC
Confidence 555555 3 555566653 5 9999876442 2345788999999999999999999998754 46899999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC---CC
Q 019901 73 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KS 148 (334)
Q Consensus 73 ~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---~~ 148 (334)
|+|.+.+... +.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++........ ..
T Consensus 93 g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~--~kL~dfG~~~~~~~~~~~~~~~~ 170 (279)
T cd05109 93 GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH--VKITDFGLARLLDIDETEYHADG 170 (279)
T ss_pred CCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCCCceeecccccceeecCC
Confidence 9999998764 56999999999999999999999999999999999999976654 999999998755332221 12
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..+++.|+|||.+.+..++.+ +|||||||++|+|++ |..||....... .... .......+.....+.++.+++
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05109 171 GKVPIKWMALESILHRRFTHQ-SDVWSYGVTVWELMTFGAKPYDGIPARE-IPDL----LEKGERLPQPPICTIDVYMIM 244 (279)
T ss_pred CccchhhCCHHHhccCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCccCCHHHHHHH
Confidence 234678999999988777655 999999999999998 999997654322 2222 222223344456789999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
.+||..+|.+|||+.+++.
T Consensus 245 ~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 245 VKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HHHcCCChhhCcCHHHHHH
Confidence 9999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=279.52 Aligned_cols=219 Identities=21% Similarity=0.222 Sum_probs=172.8
Q ss_pred EEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHH
Q 019901 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQL 97 (334)
Q Consensus 19 vaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi 97 (334)
|++|.+..........+.+|+.+++.++||||+++++++......++||||+.+++|..++.+. ..+++..+..++.||
T Consensus 35 v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi 114 (262)
T cd05077 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQL 114 (262)
T ss_pred EEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 3888876655344457888999999999999999999999988999999999999998888753 568999999999999
Q ss_pred HHHHHHHHHCCceeCCCCCCcEEEcCCCC-----CCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccch
Q 019901 98 ISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 172 (334)
Q Consensus 98 l~~L~~LH~~~ivH~dlkp~NIli~~~~~-----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 172 (334)
+.||.|||++||+||||||+|||++.++. ..++++|||++..... .....++..|+|||++......+.++|
T Consensus 115 ~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~D 191 (262)
T cd05077 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAAD 191 (262)
T ss_pred HHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhH
Confidence 99999999999999999999999975442 1389999998864322 233467889999999874443345599
Q ss_pred hhhhhHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 173 VWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 173 iwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
||||||++|+|+ +|..||........ .. ....... .....++++.+++.+||+.+|.+||++.+|+.+
T Consensus 192 iwslG~~l~el~~~~~~p~~~~~~~~~-~~----~~~~~~~--~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 192 KWSFGTTLWEICYNGEIPLKDKTLAEK-ER----FYEGQCM--LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHHHHHHHHHHHhCCCCCCCCcchhHH-HH----HHhcCcc--CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 999999999997 58888876433211 11 1111111 122346889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=279.95 Aligned_cols=227 Identities=18% Similarity=0.293 Sum_probs=172.5
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-----CCCHH
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-----RFSED 88 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~ 88 (334)
...+ |+|.+..... .....+.+|+..++.++||||+++++.+......++||||+.+|+|.+++.... .+++.
T Consensus 22 ~~~~-~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 100 (269)
T cd05042 22 KARV-VVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD 100 (269)
T ss_pred CeEE-EEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHH
Confidence 3455 8887765431 223467889999999999999999999999999999999999999999987643 24677
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccchhhccC-
Q 019901 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKK- 164 (334)
Q Consensus 89 ~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~- 164 (334)
.+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++...
T Consensus 101 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 178 (269)
T cd05042 101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLS--VKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178 (269)
T ss_pred HHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCc--EEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence 88999999999999999999999999999999987665 9999999986432221 11233466789999997532
Q ss_pred -----CCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCC-CCCCCCHHHHHHHHHhcccCCCC
Q 019901 165 -----EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIP-DYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 165 -----~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
...+.++|||||||++|+|++ |..||........+........ .....| ....+++.+.+++..|+ .+|.+
T Consensus 179 ~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~ 256 (269)
T cd05042 179 QDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQD-IKLPKPQLDLKYSDRWYEVMQFCW-LDPET 256 (269)
T ss_pred ccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccC-ccCCCCcccccCCHHHHHHHHHHh-cCccc
Confidence 122455999999999999999 8889987655443333322211 111111 12357888999999998 59999
Q ss_pred CCCHhHHhc
Q 019901 238 RISIPEIRN 246 (334)
Q Consensus 238 R~s~~ell~ 246 (334)
|||++++++
T Consensus 257 Rpt~~~v~~ 265 (269)
T cd05042 257 RPTAEEVHE 265 (269)
T ss_pred ccCHHHHHH
Confidence 999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.84 Aligned_cols=235 Identities=30% Similarity=0.499 Sum_probs=187.8
Q ss_pred CCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 13 YSSDLFVNIIIIVFHLW----QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.++..+ |||++.+... .....+.+|+.+++.+ +||||+++++.+..+...++||||+.+++|...+.+...+++
T Consensus 26 ~~~~~~-avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 104 (288)
T cd05583 26 DAGKLY-AMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE 104 (288)
T ss_pred cCCcEE-EEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCH
Confidence 456777 9999976431 2335678899999999 599999999999999999999999999999999988788999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchhhccCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKE 165 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~ 165 (334)
..++.++.|++.||.|||++|++||||+|.||+++.++. ++|+|||+++....... .....|++.|+|||.+.+..
T Consensus 105 ~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 182 (288)
T cd05583 105 SEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGH--VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGS 182 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC--EEEEECccccccccccccccccccCCccccCHHHhcCCC
Confidence 999999999999999999999999999999999987654 99999999875433222 22346899999999987654
Q ss_pred -CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC---H
Q 019901 166 -YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS---I 241 (334)
Q Consensus 166 -~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s---~ 241 (334)
..+.++|+||||+++|+|++|..||..................... +....+++.+.++|.+||+.+|++||| +
T Consensus 183 ~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~ 260 (288)
T cd05583 183 GGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARDFIQKLLEKDPKKRLGANGA 260 (288)
T ss_pred CCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence 2234589999999999999999999654332222222233333222 233357899999999999999999998 5
Q ss_pred hHHhcCccccc
Q 019901 242 PEIRNHEWFLK 252 (334)
Q Consensus 242 ~ell~h~~~~~ 252 (334)
.++|+||||+.
T Consensus 261 ~~~l~~~~~~~ 271 (288)
T cd05583 261 DEIKNHPFFQG 271 (288)
T ss_pred HHHhcCccccc
Confidence 67899999955
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=283.36 Aligned_cols=235 Identities=25% Similarity=0.359 Sum_probs=186.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AG 83 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~ 83 (334)
.++++.++..+ |||.+..... .....+.+|+.+++.++|||++++++++......++||||+. |++.+.+.. ..
T Consensus 33 ~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~ 110 (308)
T cd06634 33 FARDVRNSEVV-AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKK 110 (308)
T ss_pred EEEEcCCCcEE-EEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCC
Confidence 47788888888 9999875431 123467789999999999999999999999999999999996 577776654 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhcc
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~ 163 (334)
++++..+..++.|++.||.|||++|++||||+|+||+++.++. ++|+|||++..... .....+++.|+|||.+.+
T Consensus 111 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~--~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~ 185 (308)
T cd06634 111 PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANXFVGTPYWMAPEVILA 185 (308)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCc--EEECCcccceeecC---cccccCCccccCHHHHhh
Confidence 6899999999999999999999999999999999999987654 99999999865322 234568899999999753
Q ss_pred ---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 164 ---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 164 ---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
..++ .++|||||||++|+|++|..||........... ..............+..+.++|.+||..+|.+||+
T Consensus 186 ~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~ 260 (308)
T cd06634 186 MDEGQYD-GKVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT 260 (308)
T ss_pred cccCCCC-cccchHHHHHHHHHHHcCCCCCccccHHHHHHH----HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCC
Confidence 3344 449999999999999999999976543222221 11111111122357889999999999999999999
Q ss_pred HhHHhcCccccccC
Q 019901 241 IPEIRNHEWFLKNL 254 (334)
Q Consensus 241 ~~ell~h~~~~~~~ 254 (334)
+++++.|||+....
T Consensus 261 ~~~ll~~~~~~~~~ 274 (308)
T cd06634 261 SEVLLKHRFVLRER 274 (308)
T ss_pred HHHHhhCccccccC
Confidence 99999999997643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=281.13 Aligned_cols=219 Identities=22% Similarity=0.255 Sum_probs=174.3
Q ss_pred EEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHH
Q 019901 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQL 97 (334)
Q Consensus 19 vaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi 97 (334)
||+|++..........+.+|+.+++.++||||+++++++..+...++||||+++++|..++.+ .+.+++..+..++.|+
T Consensus 47 v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi 126 (274)
T cd05076 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQL 126 (274)
T ss_pred EEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHH
Confidence 488988665433446788899999999999999999999999999999999999999988865 4668999999999999
Q ss_pred HHHHHHHHHCCceeCCCCCCcEEEcCCCC-----CCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccch
Q 019901 98 ISGVSYCHSMQVCHRDLKLENTLLDGSPA-----PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIAD 172 (334)
Q Consensus 98 l~~L~~LH~~~ivH~dlkp~NIli~~~~~-----~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D 172 (334)
+.||+|||++||+||||||+|||++..+. ..+|++|||++..... .....+++.|+|||.+.+....+.++|
T Consensus 127 ~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~---~~~~~~~~~~~aPe~~~~~~~~~~~~D 203 (274)
T cd05076 127 ASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS---REERVERIPWIAPECVPGGNSLSTAAD 203 (274)
T ss_pred HHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc---ccccccCCcccCchhhcCCCCCCcHHH
Confidence 99999999999999999999999975432 2489999998764322 123457888999999876443345599
Q ss_pred hhhhhHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 173 VWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 173 iwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
||||||++|+|+ +|..||........ .... ......+. ..++.+.++|.+||+.+|.+|||+.+++++
T Consensus 204 v~slG~~l~el~~~g~~p~~~~~~~~~-~~~~----~~~~~~~~--~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 204 KWSFGTTLLEICFDGEVPLKERTPSEK-ERFY----EKKHRLPE--PSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred HHHHHHHHHHHHhCCCCCccccChHHH-HHHH----HhccCCCC--CCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 999999999985 79999987654322 1111 11222222 346789999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=276.19 Aligned_cols=233 Identities=22% Similarity=0.315 Sum_probs=183.3
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +......+..+ |+|.+.... ...+.+.+|+.+++.++|||++++++++. ....++||||+.+++|.++
T Consensus 14 ig~g~~~~v~~~~~~~~~~~-~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 90 (260)
T cd05070 14 LGNGQFGEVWMGTWNGNTKV-AVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDF 90 (260)
T ss_pred eccccCceEEEEEecCCcee-EEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHH
Confidence 455554 32233455667 999988765 34567999999999999999999999875 4568999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 79 ICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 79 l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
+... ..+++..+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||++........ .....++..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 168 (260)
T cd05070 91 LKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLV--CKIADFGLARLIEDNEYTARQGAKFPIK 168 (260)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCce--EEeCCceeeeeccCcccccccCCCCCcc
Confidence 8753 35899999999999999999999999999999999999987654 99999999875432221 112235567
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||.+.+..++.+ +||||||+++|+|++ |.+||.+......... +. .....+.....+..+.+++.+||.+
T Consensus 169 y~aPE~~~~~~~~~~-~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05070 169 WTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMNNREVLEQ----VE-RGYRMPCPQDCPISLHELMLQCWKK 242 (260)
T ss_pred ccChHHHhcCCCcch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCcCCHHHHHHHHHHccc
Confidence 999999877776555 999999999999999 8999977554332222 21 2223334456789999999999999
Q ss_pred CCCCCCCHhHHh
Q 019901 234 DPAKRISIPEIR 245 (334)
Q Consensus 234 ~p~~R~s~~ell 245 (334)
+|.+|||+++++
T Consensus 243 ~p~~Rpt~~~l~ 254 (260)
T cd05070 243 DPEERPTFEYLQ 254 (260)
T ss_pred CcccCcCHHHHH
Confidence 999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=288.22 Aligned_cols=227 Identities=21% Similarity=0.327 Sum_probs=178.7
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEc-CCeEEEEEeccCCCChHHHHHhc-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNA------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------- 82 (334)
.+++.| |+|++..... .....+.+|+.+++++ +||||+++++++.. +..++++|||+.+++|.+++...
T Consensus 35 ~~~~~v-a~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~ 113 (337)
T cd05054 35 ASCRTV-AVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113 (337)
T ss_pred ccccee-eeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhcccccccc
Confidence 345677 9999875431 1234677899999999 79999999998764 46789999999999999988542
Q ss_pred ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 019901 83 ------------------------------------------------------GRFSEDEARFFFQQLISGVSYCHSMQ 108 (334)
Q Consensus 83 ------------------------------------------------------~~~~~~~~~~~~~qil~~L~~LH~~~ 108 (334)
.+++...+..++.|++.||.|||++|
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ 193 (337)
T cd05054 114 RNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRK 193 (337)
T ss_pred ccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 25788999999999999999999999
Q ss_pred ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh
Q 019901 109 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 185 (334)
Q Consensus 109 ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~ 185 (334)
|+||||||+|||++.++. ++|+|||+++....... .....++..|+|||++.+..++.+ +|||||||++|+|++
T Consensus 194 ivHrDikp~Nill~~~~~--vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~SlGv~l~el~t 270 (337)
T cd05054 194 CIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQ-SDVWSFGVLLWEIFS 270 (337)
T ss_pred eecCCCCcceEEEeCCCc--EEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCcc-ccHHHHHHHHHHHHH
Confidence 999999999999987654 99999999975432221 122345678999999988888766 999999999999998
Q ss_pred -CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 186 -GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 186 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
|..||.+......+...+. ...........++++.+++.+||+.+|.+||++.++++|
T Consensus 271 ~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 271 LGASPYPGVQIDEEFCRRLK----EGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred cCCCCCCCCCccHHHHHHHh----ccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999987544333322222 111222233568999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=278.81 Aligned_cols=238 Identities=22% Similarity=0.298 Sum_probs=179.1
Q ss_pred CCccee---e-ee--ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DR--CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~--~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| + ++ +..++..+ |+|.+..... .....+.+|+.+++.++||||+++++.+.+....++||||+.+|+
T Consensus 3 lg~G~~g~Vy~~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 3 IGNGWFGKVILGEVNSGYTPAQV-VVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred ccccCCceEEEEEEcCCCCceEE-EEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 566665 2 33 23445567 9998876542 223478889999999999999999999998889999999999999
Q ss_pred hHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---C
Q 019901 75 LFERICNAG-----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---P 146 (334)
Q Consensus 75 L~~~l~~~~-----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~ 146 (334)
|.+++.... .++...+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++....... .
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLT--VKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEECCccccccccCcceeecC
Confidence 999986532 3567788899999999999999999999999999999987654 99999999874322211 2
Q ss_pred CCccCCCccccchhhccCCC------CCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCC---C
Q 019901 147 KSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD---Y 216 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~ 216 (334)
....+++.|+|||++.+... .+.++||||||+++|+|++ |+.||............. .......+. .
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 236 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTV---REQQLKLPKPRLK 236 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHh---hcccCCCCCCccC
Confidence 23457788999999864321 2345999999999999996 999997665433322211 111111121 1
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
...++.+.+++.+|+ .+|.+|||+++|+.
T Consensus 237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 246788999999999 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=281.36 Aligned_cols=231 Identities=23% Similarity=0.362 Sum_probs=180.3
Q ss_pred cCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHhc-CCCCH
Q 019901 12 SYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNA-GRFSE 87 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 87 (334)
+.++..| |+|.+.... ......+.+|+.+++.++||||+++++++... ...++||||++|++|.+++.+. ..+++
T Consensus 30 ~~~~~~v-a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~ 108 (284)
T cd05079 30 DNTGEQV-AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINL 108 (284)
T ss_pred CCccceE-EEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCH
Confidence 5567777 999987553 23346789999999999999999999998775 5689999999999999998765 35899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~ 163 (334)
..+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||+++....... .....++..|+|||++.+
T Consensus 109 ~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~ 186 (284)
T cd05079 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCC--EEECCCccccccccCccceeecCCCCCCccccCHHHhcc
Confidence 999999999999999999999999999999999987654 99999999875433221 123446778999999987
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..++.+ +|||||||++|+|++++.|+..... ........ .........+....++..+.+|+.+||+
T Consensus 187 ~~~~~~-~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~ 264 (284)
T cd05079 187 SKFYIA-SDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLV-RVLEEGKRLPRPPNCPEEVYQLMRKCWE 264 (284)
T ss_pred CCCCcc-ccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHH-HHHHcCccCCCCCCCCHHHHHHHHHHcc
Confidence 777655 9999999999999998776532211 00011111 1122222334445689999999999999
Q ss_pred cCCCCCCCHhHHhcC
Q 019901 233 ADPAKRISIPEIRNH 247 (334)
Q Consensus 233 ~~p~~R~s~~ell~h 247 (334)
.+|.+|||+.+++.+
T Consensus 265 ~~p~~Rpt~~~il~~ 279 (284)
T cd05079 265 FQPSKRTTFQNLIEG 279 (284)
T ss_pred CCcccCcCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=283.52 Aligned_cols=223 Identities=22% Similarity=0.358 Sum_probs=178.5
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------- 82 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------- 82 (334)
..+ |+|.+..... .....+.+|+.+++.+ +||||+++++++..++.+++||||+.+++|..++...
T Consensus 43 ~~~-a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~ 121 (293)
T cd05053 43 STV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121 (293)
T ss_pred eeE-EEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccc
Confidence 445 9999876531 2234688899999999 8999999999999999999999999999999998642
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 83 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 83 -----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....++..
T Consensus 122 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 199 (293)
T cd05053 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV--MKIADFGLARDIHHIDYYRKTTNGRLPVK 199 (293)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe--EEeCccccccccccccceeccCCCCCCcc
Confidence 45889999999999999999999999999999999999987664 99999999875433221 112234567
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... .......+.....+..+.+|+.+||..
T Consensus 200 y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~li~~~l~~ 273 (293)
T cd05053 200 WMAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL-----LKEGYRMEKPQNCTQELYHLMRDCWHE 273 (293)
T ss_pred ccCHHHhccCCcCcc-cceeehhhHHHHHhcCCCCCCCCCCHHHHHHH-----HHcCCcCCCCCCCCHHHHHHHHHHccc
Confidence 999999887777655 999999999999997 9999987654332222 112222233445789999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+.+++++
T Consensus 274 ~p~~Rps~~eil~~ 287 (293)
T cd05053 274 VPSQRPTFKQLVED 287 (293)
T ss_pred CcccCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=285.45 Aligned_cols=243 Identities=27% Similarity=0.441 Sum_probs=187.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+.++.++..| |||.+.+... .....+.+|+.+++.++||||++++++|.. .+..|+|+||+ +++|...+
T Consensus 23 ~g~v~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~ 100 (328)
T cd07856 23 FGLVCSARDQLTGQNV-AIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLL 100 (328)
T ss_pred CeEEEEEEECCCCCEE-EEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHH
Confidence 3444 47788899999 9999876431 234678899999999999999999999876 56789999999 56888777
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.. .++++..+..++.|++.||.|||++||+||||+|+||+++.++. ++|+|||+++.... ......+++.|+|||
T Consensus 101 ~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~--~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE 175 (328)
T cd07856 101 TS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD--LKICDFGLARIQDP--QMTGYVSTRYYRAPE 175 (328)
T ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCC--EEeCccccccccCC--CcCCCcccccccCce
Confidence 54 46889999999999999999999999999999999999987654 99999999875422 223446788999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH--------------------hhc--cccCC---
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI--------------------LSV--QYSIP--- 214 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------------------~~~--~~~~~--- 214 (334)
.+.+....+.++|+|||||++|+|++|++||................ ... ....|
T Consensus 176 ~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (328)
T cd07856 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSE 255 (328)
T ss_pred eeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHH
Confidence 88664433455999999999999999999997654322111111000 000 00001
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+++.++++|.+||+.+|++|||+++++.||||...
T Consensus 256 ~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~ 294 (328)
T cd07856 256 KFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPY 294 (328)
T ss_pred HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccc
Confidence 112467899999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=280.63 Aligned_cols=224 Identities=20% Similarity=0.324 Sum_probs=179.5
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----------
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------- 82 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------- 82 (334)
+..+ |||.+..... ...+.+.+|+.+++.++||||+++++++...+..++++||+.+++|..++...
T Consensus 35 ~~~v-aiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~ 113 (283)
T cd05091 35 TQAV-AIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD 113 (283)
T ss_pred eeEE-EEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence 4566 9999875542 22356889999999999999999999999999999999999999999988532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 83 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 83 -----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
..++...+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+++.
T Consensus 114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 191 (283)
T cd05091 114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN--VKISDLGLFREVYAADYYKLMGNSLLPIR 191 (283)
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc--eEecccccccccccchheeeccCccCCcc
Confidence 34788899999999999999999999999999999999986654 99999999875432221 123346789
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....... ..+.... ..+.....+..+.+++.+||+.
T Consensus 192 y~aPE~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~----~~i~~~~-~~~~~~~~~~~~~~li~~cl~~ 265 (283)
T cd05091 192 WMSPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVI----EMIRNRQ-VLPCPDDCPAWVYTLMLECWNE 265 (283)
T ss_pred ccCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHHcCC-cCCCCCCCCHHHHHHHHHHhCC
Confidence 999999987777655 999999999999998 88899775543322 2222222 2223346799999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+||++.+++..
T Consensus 266 ~p~~RP~~~~i~~~ 279 (283)
T cd05091 266 FPSRRPRFKDIHSR 279 (283)
T ss_pred CcccCCCHHHHHHH
Confidence 99999999999853
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=280.13 Aligned_cols=223 Identities=19% Similarity=0.249 Sum_probs=179.0
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
+..+ |+|.+..... .....+.+|+.+++.++||||+++++++......++||||+.+++|.+++....
T Consensus 36 ~~~~-aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 114 (277)
T cd05032 36 ETRV-AIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG 114 (277)
T ss_pred ceeE-EEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCC
Confidence 3667 9999865541 223568899999999999999999999999999999999999999999986532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccccchh
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEV 160 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~ 160 (334)
.+++..+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++...... ......++..|+|||.
T Consensus 115 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 192 (277)
T cd05032 115 PPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192 (277)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCC--EEECCcccchhhccCcccccCCCCCccccccCHHH
Confidence 3677889999999999999999999999999999999987765 9999999987543222 1223456788999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
+.+..++.+ +|||||||++|+|++ |..||...+..... +.. . .....+.+...+..+.+++.+||+.+|++||
T Consensus 193 ~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~-~~~---~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 266 (277)
T cd05032 193 LKDGVFTTK-SDVWSFGVVLWEMATLAEQPYQGLSNEEVL-KFV---I-DGGHLDLPENCPDKLLELMRMCWQYNPKMRP 266 (277)
T ss_pred HhcCCCCcc-cchHHHHHHHHHhhccCCCCCccCCHHHHH-HHH---h-cCCCCCCCCCCCHHHHHHHHHHcCCChhhCC
Confidence 977776555 999999999999998 99999876543322 222 1 1112222334689999999999999999999
Q ss_pred CHhHHhc
Q 019901 240 SIPEIRN 246 (334)
Q Consensus 240 s~~ell~ 246 (334)
|+.++++
T Consensus 267 t~~~l~~ 273 (277)
T cd05032 267 TFLEIVS 273 (277)
T ss_pred CHHHHHH
Confidence 9999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=275.91 Aligned_cols=234 Identities=22% Similarity=0.309 Sum_probs=186.7
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ + +.+ ..+..+ |||.+.... ...+.+.+|+.+++.++||||+++++++......++||||+.+++|.+
T Consensus 14 ig~g~~~~v~~~~~-~~~~~~-~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 90 (261)
T cd05034 14 LGAGQFGEVWMGTW-NGTTKV-AVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD 90 (261)
T ss_pred eccCcceEEEEEEE-cCCceE-EEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence 455544 3 333 344566 999988665 345679999999999999999999999998899999999999999999
Q ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 78 RICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 78 ~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
++.... .++...+..++.|++.||.|||++|++|+||||+||+++.++. ++|+|||+++....... .....++.
T Consensus 91 ~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~ 168 (261)
T cd05034 91 FLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLV--CKIADFGLARLIEDDEYTAREGAKFPI 168 (261)
T ss_pred HHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCC--EEECccccceeccchhhhhhhccCCCc
Confidence 997643 6899999999999999999999999999999999999987765 99999999875432111 11223456
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||.+.+..++.+ +|+||||+++|+|++ |+.||.+......... +. .....+.....+..+.+++.+||.
T Consensus 169 ~y~~PE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~~i~~~l~ 242 (261)
T cd05034 169 KWTAPEAANYGRFTIK-SDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ----VE-RGYRMPRPPNCPEELYDLMLQCWD 242 (261)
T ss_pred cccCHHHhccCCcCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHHHHHHcc
Confidence 8999999987776544 999999999999998 9999987654333332 21 222333344568999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+||++++++.
T Consensus 243 ~~p~~Rp~~~~l~~ 256 (261)
T cd05034 243 KDPEERPTFEYLQS 256 (261)
T ss_pred cCcccCCCHHHHHH
Confidence 99999999999863
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=274.60 Aligned_cols=236 Identities=28% Similarity=0.383 Sum_probs=188.5
Q ss_pred CCccee----eeeecCCC----CeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSS----DLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~----~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ .+++...+ ..+ |+|.+...... ....+.+|+..++.++||||+++++++.+.+..+++|||+.+
T Consensus 7 lg~g~~g~v~~~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~ 85 (258)
T smart00219 7 LGEGAFGEVYKGTLKGLSGEKEVEV-AVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEG 85 (258)
T ss_pred eccCCCcceEEEEecCCCCCCCceE-EEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCC
Confidence 455544 35665555 667 99999766522 456889999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC--C
Q 019901 73 GELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--S 148 (334)
Q Consensus 73 ~~L~~~l~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~--~ 148 (334)
++|.+.+..... +++..+..++.|++.||.+||++|++||||+|+||+++.++. ++|+|||+++......... .
T Consensus 86 ~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 163 (258)
T smart00219 86 GDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLV--VKISDFGLSRDLYDDDYYKKKG 163 (258)
T ss_pred CCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCe--EEEcccCCceeccccccccccc
Confidence 999999976554 999999999999999999999999999999999999987764 9999999987544331111 1
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..+++.|+|||.+.+..++. ++|+||||+++|+|++ |++||........... +... ...+.....+.++.+++
T Consensus 164 ~~~~~~y~~Pe~~~~~~~~~-~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~i 237 (258)
T smart00219 164 GKLPIRWMAPESLKDGKFTS-KSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY----LKKG-YRLPKPENCPPEIYKLM 237 (258)
T ss_pred CCCcccccChHHhccCCCCc-chhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HhcC-CCCCCCCcCCHHHHHHH
Confidence 23678999999986666654 4999999999999998 8999987544332222 2221 22233345799999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
.+||..+|.+|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 238 LQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHCcCChhhCcCHHHHHh
Confidence 9999999999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=280.13 Aligned_cols=232 Identities=24% Similarity=0.347 Sum_probs=179.2
Q ss_pred ecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCChHHHHHhc-CCCCH
Q 019901 11 CSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNA-GRFSE 87 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~ 87 (334)
+..++..| |||.+........+.+.+|+.+++.++||||+++++++.. ...+++|+||+.+++|.+++.+. ..+++
T Consensus 29 ~~~~~~~v-~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~ 107 (284)
T cd05081 29 QDNTGEVV-AVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH 107 (284)
T ss_pred cCCCCcEE-EEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCH
Confidence 45677888 9999876553334678899999999999999999998754 34689999999999999998764 45899
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----CCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~----~~~~gt~~y~aPE~~~~ 163 (334)
..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++........ ....++..|+|||++.+
T Consensus 108 ~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 185 (284)
T cd05081 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR--VKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE 185 (284)
T ss_pred HHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCe--EEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence 999999999999999999999999999999999987664 999999998854332211 11123456999999987
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH-----------HHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..++.+ +|||||||++|+|++|..|+....... .....+..........+....++.++.+++.+||.
T Consensus 186 ~~~~~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 264 (284)
T cd05081 186 SKFSVA-SDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWN 264 (284)
T ss_pred CCcChH-HHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcc
Confidence 776554 999999999999999877764332110 00011111222233344445678999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|++|||+.++++
T Consensus 265 ~~p~~Rpt~~ei~~ 278 (284)
T cd05081 265 NDPSQRPSFSELAL 278 (284)
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=274.34 Aligned_cols=225 Identities=23% Similarity=0.352 Sum_probs=180.8
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHH
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 91 (334)
..+..+ |+|.+.... .....+.+|+.+++.++|||++++++++......++||||+.+++|.+++... +.+++..++
T Consensus 26 ~~~~~~-~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~ 103 (256)
T cd05112 26 LEKRKV-AIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL 103 (256)
T ss_pred eCCCeE-EEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHH
Confidence 346677 999987655 34567899999999999999999999999999999999999999999998764 468999999
Q ss_pred HHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchhhccCCCCCc
Q 019901 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGK 169 (334)
Q Consensus 92 ~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~ 169 (334)
.++.|++.||.+||++|++||||||+||+++.++. ++|+|||+++....... .....++..|+|||.+.+..++.+
T Consensus 104 ~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~ 181 (256)
T cd05112 104 GMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV--VKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181 (256)
T ss_pred HHHHHHHHHHHHHHHCCccccccccceEEEcCCCe--EEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChH
Confidence 99999999999999999999999999999986654 99999999875422211 122335678999999987776554
Q ss_pred cchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 170 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 170 ~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+||||||+++|+|++ |+.||.......... .+.. ..........+..+.+|+.+||+.+|.+|||+.+++++
T Consensus 182 -~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 182 -SDVWSFGVLMWEVFSEGKTPYENRSNSEVVE----TINA-GFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred -HHHHHHHHHHHHHHcCCCCCCCcCCHHHHHH----HHhC-CCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 999999999999998 999998655432222 2211 11222223468999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=275.07 Aligned_cols=234 Identities=21% Similarity=0.322 Sum_probs=185.8
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +.....+++.+ |+|.+.... .....+.+|+.+++.++||||+++++++. .+..++||||+.+++|.++
T Consensus 14 ig~G~~g~v~~~~~~~~~~~-a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05067 14 LGAGQFGEVWMGYYNGHTKV-AIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDF 90 (260)
T ss_pred eccCccceEEeeecCCCceE-EEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHH
Confidence 555555 43334566777 999987665 34568899999999999999999999874 4568999999999999998
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 79 ICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 79 l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
+... ..++...+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||++........ .....++..
T Consensus 91 ~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 168 (260)
T cd05067 91 LKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLC--CKIADFGLARLIEDNEYTAREGAKFPIK 168 (260)
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCC--EEEccCcceeecCCCCcccccCCccccc
Confidence 8653 35899999999999999999999999999999999999987665 99999999875432211 122345678
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +||||||+++|+|++ |++||.+.+........ ......+.....+.++.+++.+||..
T Consensus 169 y~~pe~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 169 WTAPEAINYGTFTIK-SDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-----ERGYRMPRPDNCPEELYELMRLCWKE 242 (260)
T ss_pred ccCHHHhccCCcCcc-cchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999987776554 999999999999999 99999876653332221 12223344445789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+++++.
T Consensus 243 ~p~~Rp~~~~l~~ 255 (260)
T cd05067 243 KPEERPTFEYLRS 255 (260)
T ss_pred ChhhCCCHHHHHH
Confidence 9999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=278.19 Aligned_cols=237 Identities=22% Similarity=0.341 Sum_probs=181.9
Q ss_pred CCccee---e-eeecCCCC--eeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEE
Q 019901 2 LGFHNF---Y-DRCSYSSD--LFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVM 67 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~--~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~ 67 (334)
||.|++ + ++...++. .+ |+|.+..... ...+.+.+|+.+++.++||||+++++.+... ...++||
T Consensus 7 ig~G~~g~V~~~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~ 85 (272)
T cd05075 7 LGEGEFGSVMEGQLNQDDSILKV-AVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85 (272)
T ss_pred cCcccCceEEEeEEccCCCeeeE-EEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEE
Confidence 555555 3 55555554 45 9999876531 2235788899999999999999999976432 2578999
Q ss_pred eccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC
Q 019901 68 EYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141 (334)
Q Consensus 68 e~~~~~~L~~~l~~------~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~ 141 (334)
||+.+|+|..++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 86 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~ 163 (272)
T cd05075 86 PFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMN--VCVADFGLSKKIY 163 (272)
T ss_pred EeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCC--EEECCCCcccccC
Confidence 99999999887742 234889999999999999999999999999999999999987654 9999999988643
Q ss_pred CCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 142 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 142 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
.... .....+++.|+|||.+.+..++.+ +|||||||++|+|++ |+.||.+........ .+.. ....+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~ 237 (272)
T cd05075 164 NGDYYRQGRIAKMPVKWIAIESLADRVYTTK-SDVWSFGVTMWEIATRGQTPYPGVENSEIYD----YLRQ-GNRLKQPP 237 (272)
T ss_pred cccceecCCcccCCcccCCHHHccCCCcChH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH----HHHc-CCCCCCCC
Confidence 3221 122346778999999987777655 999999999999999 899997755432222 1221 12223344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.++..+.++|.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=277.05 Aligned_cols=237 Identities=21% Similarity=0.328 Sum_probs=183.2
Q ss_pred CCccee---e-eeecC---CCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCe------EEEE
Q 019901 2 LGFHNF---Y-DRCSY---SSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTH------LAIV 66 (334)
Q Consensus 2 lG~g~~---~-~~~~~---~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~------~~lv 66 (334)
||.|+| + +.... ++..+ |||.+...... ....+.+|+..++.++||||+++++++..... .++|
T Consensus 7 lg~G~~g~v~~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v 85 (273)
T cd05035 7 LGEGEFGSVMEGQLSQDDGSQLKV-AVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVI 85 (273)
T ss_pred cCcCCCceEEEEEEecCCCCcceE-EEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEE
Confidence 566665 2 44333 34667 99998765422 23578899999999999999999998765543 7999
Q ss_pred EeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCC
Q 019901 67 MEYASGGELFERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140 (334)
Q Consensus 67 ~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~ 140 (334)
+||+.+++|..++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++..
T Consensus 86 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~ 163 (273)
T cd05035 86 LPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMT--VCVADFGLSKKI 163 (273)
T ss_pred EeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCe--EEECCccceeec
Confidence 9999999999888542 35899999999999999999999999999999999999987654 999999998754
Q ss_pred CCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCC
Q 019901 141 VLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDY 216 (334)
Q Consensus 141 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 216 (334)
..... .....++..|+|||.+.+..++.+ +|||||||++|+|++ |.+||.+......... ... ....+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~-~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~ 237 (273)
T cd05035 164 YSGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGQTPYPGVENHEIYDY----LRH-GNRLKQP 237 (273)
T ss_pred cccccccccccccCCccccCHhhcccCCCCcc-cchHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHc-CCCCCCC
Confidence 33221 112235678999999877777555 999999999999999 8999977654333222 111 1122233
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
..+++.+.+++.+||+.+|.+|||+.+++.+
T Consensus 238 ~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 238 EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4678999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=302.37 Aligned_cols=236 Identities=26% Similarity=0.400 Sum_probs=199.8
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEc-----CCeEEEEEeccCCCChHHHHHh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILT-----PTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
.++++++|+.. |+|+..... ..+++++.|..+|+.+ .|||++.++++|.. ++.+|||||||.||+..+++++
T Consensus 37 k~k~~~~~~~a-a~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn 114 (953)
T KOG0587|consen 37 KGRHVKTGQLA-AIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKN 114 (953)
T ss_pred EEeeeecCcee-eeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhh
Confidence 58899999999 999998887 7789999999999887 58999999999863 4689999999999999999986
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccc
Q 019901 82 A--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aP 158 (334)
. .++.|..+..|++.++.||.+||...++|||||-.|||++.++. |||+|||++....... ...+.+|||.||||
T Consensus 115 ~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~--VKLvDFGvSaQldsT~grRnT~iGtP~WMAP 192 (953)
T KOG0587|consen 115 TKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDSTVGRRNTFIGTPYWMAP 192 (953)
T ss_pred hcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCc--EEEeeeeeeeeeecccccccCcCCCcccccc
Confidence 4 56899999999999999999999999999999999999988775 9999999988655443 45567899999999
Q ss_pred hhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 159 EVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 159 E~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|++.. ..|+.. +|+||||++..||.-|.+|+-..-+...+ +.-+.+.+..+..+...+.++.+||..||.+
T Consensus 193 EViac~e~~d~tyd~R-~D~WsLGITaIEladG~PPl~DmHPmraL---F~IpRNPPPkLkrp~kWs~~FndFIs~cL~K 268 (953)
T KOG0587|consen 193 EVIACDESPDATYDYR-SDLWSLGITAIEMAEGAPPLCDMHPMRAL---FLIPRNPPPKLKRPKKWSKKFNDFISTCLVK 268 (953)
T ss_pred eeeecccCCCCCcccc-cchhhccceeehhcCCCCCccCcchhhhh---ccCCCCCCccccchhhHHHHHHHHHHHHHhh
Confidence 99853 345556 89999999999999999999765443222 2222233333444566799999999999999
Q ss_pred CCCCCCCHhHHhcCcccc
Q 019901 234 DPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~ 251 (334)
|..+||+..++|.|||++
T Consensus 269 d~e~RP~~~~ll~hpFi~ 286 (953)
T KOG0587|consen 269 DYEQRPSTEELLKHPFIT 286 (953)
T ss_pred ccccCcchhhhccCCccc
Confidence 999999999999999985
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=273.90 Aligned_cols=231 Identities=26% Similarity=0.379 Sum_probs=183.9
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.|++ +.....++..+ |+|.+.... ....+.+|+.+++.++||||+++++++..+ ..++||||+.+++|.+++
T Consensus 14 lg~g~~g~v~~~~~~~~~~-~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l 89 (254)
T cd05083 14 IGEGEFGAVLQGEYTGQKV-AVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFL 89 (254)
T ss_pred eccCCCCceEecccCCCce-EEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHH
Confidence 555655 34455678888 999986543 346788999999999999999999998765 479999999999999998
Q ss_pred HhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||+++..... ......+..|+|
T Consensus 90 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~--~kl~Dfg~~~~~~~~--~~~~~~~~~y~~ 165 (254)
T cd05083 90 RTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGV--AKVSDFGLARVGSMG--VDNSKLPVKWTA 165 (254)
T ss_pred HhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCc--EEECCCccceecccc--CCCCCCCceecC
Confidence 7643 4889999999999999999999999999999999999987664 999999998753221 223344678999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
||.+.+..++.+ +|+|||||++|+|++ |++||......... .. . ......+....++..+.+++.+||+.+|.
T Consensus 166 pe~~~~~~~~~~-~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-~~---~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 239 (254)
T cd05083 166 PEALKHKKFSSK-SDVWSYGVLLWEVFSYGRAPYPKMSLKEVK-EC---V-EKGYRMEPPEGCPADVYVLMTSCWETEPK 239 (254)
T ss_pred HHHhccCCcCch-hhHHHHHHHHHHHHhCCCCCCccCCHHHHH-HH---H-hCCCCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 999887777655 999999999999997 99999876543222 11 1 11222223345789999999999999999
Q ss_pred CCCCHhHHhc
Q 019901 237 KRISIPEIRN 246 (334)
Q Consensus 237 ~R~s~~ell~ 246 (334)
+|||+++++.
T Consensus 240 ~Rp~~~~l~~ 249 (254)
T cd05083 240 KRPSFHKLRE 249 (254)
T ss_pred hCcCHHHHHH
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=276.66 Aligned_cols=236 Identities=20% Similarity=0.357 Sum_probs=186.1
Q ss_pred CCccee----eeeecCCCC---eeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSD---LFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~---~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+..+.++. .| |||++.... ......+..|+.+++.++||||+++++++..++..++||||+.++
T Consensus 12 lg~g~~g~vy~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~ 90 (269)
T cd05065 12 IGAGEFGEVCRGRLKLPGKREIFV-AIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENG 90 (269)
T ss_pred ecCCCCCeEEEEEEecCCCCceeE-EEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCC
Confidence 454544 355666554 46 999987653 123457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCC---c
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS---T 149 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~---~ 149 (334)
+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++ .+||+|||++........... .
T Consensus 91 ~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~--~~kl~dfg~~~~~~~~~~~~~~~~~ 168 (269)
T cd05065 91 ALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL--VCKVSDFGLSRFLEDDTSDPTYTSS 168 (269)
T ss_pred cHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC--cEEECCCccccccccCccccccccc
Confidence 999988764 5689999999999999999999999999999999999998665 499999999874432221111 1
Q ss_pred c---CCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 150 V---GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 150 ~---gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
. .+..|+|||.+.+..++.+ +|||||||++|+|++ |..||.......... .+ ......+....++..+.+
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~-~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~----~i-~~~~~~~~~~~~~~~~~~ 242 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIN----AI-EQDYRLPPPMDCPTALHQ 242 (269)
T ss_pred cCCCcceeecCHhHhccCcccch-hhhhhhHHHHHHHhcCCCCCCCCCCHHHHHH----HH-HcCCcCCCcccCCHHHHH
Confidence 1 2457999999988777655 999999999999886 999998755432222 22 222344445567899999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 019901 226 LISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~ 246 (334)
++.+||..+|.+||++.+++.
T Consensus 243 li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 243 LMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=280.09 Aligned_cols=221 Identities=22% Similarity=0.344 Sum_probs=177.4
Q ss_pred eEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--------------
Q 019901 18 FVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-------------- 82 (334)
Q Consensus 18 vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------------- 82 (334)
++++|.+..... .....+.+|+.+++.++||||+++++.+...+..++|+||+.+++|.+++...
T Consensus 32 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 111 (290)
T cd05045 32 TVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNR 111 (290)
T ss_pred eEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCcccccccccccc
Confidence 349998876542 22357889999999999999999999999999999999999999999988642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 83 ----------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 83 ----------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
.+++...+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++....... ....
T Consensus 112 ~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 189 (290)
T cd05045 112 NSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRK--MKISDFGLSRDVYEEDSYVKRSKG 189 (290)
T ss_pred ccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCc--EEeccccccccccCccchhcccCC
Confidence 24788899999999999999999999999999999999987654 99999999875432221 2233
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.++..|+|||.+.+..++.+ +||||||+++|+|++ |..||.+...... ... .......+....++.++.+|+.
T Consensus 190 ~~~~~y~apE~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~i~ 263 (290)
T cd05045 190 RIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIAPERL-FNL----LKTGYRMERPENCSEEMYNLML 263 (290)
T ss_pred CCCccccCHHHHccCCcchH-hHHHHHHHHHHHHHhcCCCCCCCCCHHHH-HHH----HhCCCCCCCCCCCCHHHHHHHH
Confidence 45678999999877777655 999999999999998 9999977554322 222 1222233334467899999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||+.+|.+||+++++++
T Consensus 264 ~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 264 TCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHccCCcccCCCHHHHHH
Confidence 999999999999999874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=273.71 Aligned_cols=233 Identities=22% Similarity=0.324 Sum_probs=182.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ + +.+. .+..+ |+|.+.... ...+.+.+|+.+++.++|||++++++++. .+..++||||+.+++|.+
T Consensus 14 ig~g~~~~v~~~~~~-~~~~~-~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~ 89 (260)
T cd05069 14 LGQGCFGEVWMGTWN-GTTKV-AIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD 89 (260)
T ss_pred ecCcCCCeEEEEEEc-CCceE-EEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence 455555 3 3333 33456 999886554 34567899999999999999999998875 456899999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
++... ..++...+..++.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++....... .....++.
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~ 167 (260)
T cd05069 90 FLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLV--CKIADFGLARLIEDNEYTARQGAKFPI 167 (260)
T ss_pred HHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCe--EEECCCccceEccCCcccccCCCccch
Confidence 99764 34789999999999999999999999999999999999987665 99999999875432221 12234567
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||...+..++.+ +||||||+++|+|++ |..||.+......... + ......+.....+..+.+++.+||.
T Consensus 168 ~y~~Pe~~~~~~~~~~-~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~li~~~l~ 241 (260)
T cd05069 168 KWTAPEAALYGRFTIK-SDVWSFGILLTELVTKGRVPYPGMVNREVLEQ----V-ERGYRMPCPQGCPESLHELMKLCWK 241 (260)
T ss_pred hhCCHHHhccCCcChH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCcccCHHHHHHHHHHcc
Confidence 8999999887776555 999999999999999 9999987655433222 1 1122233344678999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
++|.+||+++++++
T Consensus 242 ~~p~~Rp~~~~i~~ 255 (260)
T cd05069 242 KDPDERPTFEYIQS 255 (260)
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=277.89 Aligned_cols=238 Identities=21% Similarity=0.344 Sum_probs=188.5
Q ss_pred CCccee----eeeecC-----CCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSY-----SSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~-----~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| +++.+. +.+.+ ++|.+...... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus 13 lg~g~~g~v~~~~~~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 91 (275)
T cd05046 13 LGRGEFGEVFLAKAKGIEEEGGETLV-LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTD 91 (275)
T ss_pred ecccceeEEEEEEeccCCcCCCcceE-EEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecC
Confidence 566666 355433 23455 99988765422 34678999999999999999999999998899999999999
Q ss_pred CCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC
Q 019901 72 GGELFERICNAG---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142 (334)
Q Consensus 72 ~~~L~~~l~~~~---------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~ 142 (334)
+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++..+. ++|+|||+++....
T Consensus 92 ~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~~~~~~~~~~~ 169 (275)
T cd05046 92 LGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQRE--VKVSLLSLSKDVYN 169 (275)
T ss_pred CCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCc--EEEcccccccccCc
Confidence 999999998765 6899999999999999999999999999999999999987665 99999999864322
Q ss_pred CC--CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 143 HS--QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 143 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
.. ......+++.|+|||.+.+..+..+ +||||||+++|+|++ |..||........ ...........+....+
T Consensus 170 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~~l~~~~~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~ 244 (275)
T cd05046 170 SEYYKLRNALIPLRWLAPEAVQEDDFSTK-SDVWSFGVLMWEVFTQGELPFYGLSDEEV----LNRLQAGKLELPVPEGC 244 (275)
T ss_pred ccccccCCceeEEeecChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCccccchHHH----HHHHHcCCcCCCCCCCC
Confidence 11 1223356778999999877766544 999999999999998 8899976554332 22232233333334467
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+..+.+++.+||+.+|.+|||+.+++..
T Consensus 245 ~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 245 PSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 8999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=279.20 Aligned_cols=227 Identities=18% Similarity=0.248 Sum_probs=178.5
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------C
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------R 84 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~ 84 (334)
..| |+|.+..... .....+.+|+.+++.++||||+++++++...+..|+||||+.+|+|.+++.+.+ .
T Consensus 37 ~~v-avK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 115 (288)
T cd05061 37 TRV-AVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115 (288)
T ss_pred eEE-EEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCC
Confidence 356 9998765431 223457789999999999999999999999999999999999999999997532 2
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhh
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 161 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~ 161 (334)
++...+..++.|++.||.|||++||+||||||+||+++.++. ++|+|||+++....... .....++..|+|||.+
T Consensus 116 ~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~--~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~ 193 (288)
T cd05061 116 PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESL 193 (288)
T ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCc--EEECcCCccccccccccccccCCCcccccccCHHHh
Confidence 466788999999999999999999999999999999987654 99999999875332211 1223456789999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
.+..++.+ +|+|||||++|+|++ |..||.+....... ..+.... ..+.....++.+.+++.+||+.+|.+|||
T Consensus 194 ~~~~~~~~-~DvwslG~~l~el~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps 267 (288)
T cd05061 194 KDGVFTTS-SDMWSFGVVLWEITSLAEQPYQGLSNEQVL----KFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPT 267 (288)
T ss_pred ccCCCChH-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 87777655 899999999999998 78999875543222 2222211 12223356899999999999999999999
Q ss_pred HhHHhc------Ccccc
Q 019901 241 IPEIRN------HEWFL 251 (334)
Q Consensus 241 ~~ell~------h~~~~ 251 (334)
+.++++ ||||.
T Consensus 268 ~~~ll~~l~~~~~~~~~ 284 (288)
T cd05061 268 FLEIVNLLKDDLHPSFP 284 (288)
T ss_pred HHHHHHHHHhhcCCCCC
Confidence 999986 77773
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=295.61 Aligned_cols=235 Identities=22% Similarity=0.346 Sum_probs=187.0
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +.+..+.| .| |||++...... .-+.+++|+..+++-+|-||+-|.+++..++. .||+.+|+|.+|+.
T Consensus 400 IGsGsFGtV~Rg~whG-dV-AVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~ 476 (678)
T KOG0193|consen 400 IGSGSFGTVYRGRWHG-DV-AVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYT 476 (678)
T ss_pred eccccccceeeccccc-ce-EEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhh
Confidence 788998 45555555 45 99999987743 34689999999999999999999999988877 99999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC---CCCCCCccCCC
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---HSQPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~---~~~~~~~~gt~ 153 (334)
++.-. .+|.....+.|++||+.|+.|||.++|||||||..|||+..++. |||+||||+..... ........|..
T Consensus 477 hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~k--VkIgDFGLatvk~~w~g~~q~~qp~gsi 554 (678)
T KOG0193|consen 477 HLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLK--VKIGDFGLATVKTRWSGEQQLEQPHGSL 554 (678)
T ss_pred hccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCc--EEEecccceeeeeeeccccccCCCccch
Confidence 98643 45899999999999999999999999999999999999987665 99999999864322 22234456888
Q ss_pred ccccchhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--c-cCCCCCCCCHHHHHHH
Q 019901 154 AYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--Y-SIPDYVHISPECRHLI 227 (334)
Q Consensus 154 ~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~-~~~~~~~~~~~~~~li 227 (334)
.|||||+++. .+| ++.+|||||||++|||+||..||....... ++..+..+. . ........+.++++|+
T Consensus 555 lwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dq----IifmVGrG~l~pd~s~~~s~~pk~mk~Ll 629 (678)
T KOG0193|consen 555 LWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQ----IIFMVGRGYLMPDLSKIRSNCPKAMKRLL 629 (678)
T ss_pred hhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhh----eEEEecccccCccchhhhccCHHHHHHHH
Confidence 9999999863 344 445999999999999999999998433322 221111110 1 1112234577999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
..||..++++||++.+||.
T Consensus 630 ~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 630 SDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHhcCcccCccHHHHHH
Confidence 9999999999999999886
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=312.60 Aligned_cols=239 Identities=31% Similarity=0.460 Sum_probs=185.1
Q ss_pred Cccee-eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEE----------------------
Q 019901 3 GFHNF-YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVIL---------------------- 58 (334)
Q Consensus 3 G~g~~-~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~---------------------- 58 (334)
|||.+ .++|+-+|..| |||.|.... ......+.+|+..|.+|+|||||+++..|.
T Consensus 491 GFG~VvkVRNKlDGr~Y-AIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs 569 (1351)
T KOG1035|consen 491 GFGSVVKVRNKLDGREY-AIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQS 569 (1351)
T ss_pred CCceEEEEeecccchhh-hhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhccc
Confidence 45555 49999999999 999997763 244568999999999999999999966542
Q ss_pred ----------------------------------c---------------------------------------------
Q 019901 59 ----------------------------------T--------------------------------------------- 59 (334)
Q Consensus 59 ----------------------------------~--------------------------------------------- 59 (334)
.
T Consensus 570 ~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess 649 (1351)
T KOG1035|consen 570 ASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESS 649 (1351)
T ss_pred CCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhh
Confidence 0
Q ss_pred ----------C--------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEE
Q 019901 60 ----------P--------THLAIVMEYASGGELFERICNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120 (334)
Q Consensus 60 ----------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIl 120 (334)
+ ..+||-||||+..++.+.+.++... ....++.++++|+.||.|+|++|||||||||.|||
T Consensus 650 ~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIF 729 (1351)
T KOG1035|consen 650 ESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIF 729 (1351)
T ss_pred hhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeE
Confidence 0 2479999999987777777666544 47789999999999999999999999999999999
Q ss_pred EcCCCCCCEEEeccCCccCCC-------------------CCCCCCCccCCCccccchhhccCC---CCCccchhhhhhH
Q 019901 121 LDGSPAPRLKICDFGYSKSSV-------------------LHSQPKSTVGTPAYIAPEVLLKKE---YDGKIADVWSCGV 178 (334)
Q Consensus 121 i~~~~~~~~kl~Dfgla~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwslG~ 178 (334)
++..+. |||+|||+|+... ..+..++.+||..|+|||++.+.. |+.+ +|||||||
T Consensus 730 Ld~~~~--VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~K-iDmYSLGI 806 (1351)
T KOG1035|consen 730 LDSRNS--VKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSK-IDMYSLGI 806 (1351)
T ss_pred EcCCCC--eeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccch-hhhHHHHH
Confidence 997765 9999999997411 111234557999999999998766 5555 99999999
Q ss_pred HHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 179 TLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 179 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
|++||+ .||...-+.. .++........+.+. +..--+.-..+|.+||+.||++||||.|||++.||-
T Consensus 807 VlFEM~---yPF~TsMERa---~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 807 VLFEML---YPFGTSMERA---SILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLP 875 (1351)
T ss_pred HHHHHh---ccCCchHHHH---HHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence 999998 4687543322 233333333333330 122345677899999999999999999999999984
|
|
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=281.65 Aligned_cols=222 Identities=21% Similarity=0.313 Sum_probs=176.3
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----------- 82 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------- 82 (334)
..+ |+|++..... .....+.+|+.+++.+ +||||+++++++...+.+++||||+.+|+|.+++...
T Consensus 45 ~~~-aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~ 123 (314)
T cd05099 45 VTV-AVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI 123 (314)
T ss_pred eEE-EEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence 456 9999875431 2235678899999999 6999999999999999999999999999999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 83 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 83 -----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
..++...+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++....... .....+++.
T Consensus 124 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~ 201 (314)
T cd05099 124 TKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNV--MKIADFGLARGVHDIDYYKKTSNGRLPVK 201 (314)
T ss_pred cCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCc--EEEccccccccccccccccccccCCCCcc
Confidence 24788999999999999999999999999999999999987664 99999999975432211 112234567
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+.. + .. .........++.++++++.+||..
T Consensus 202 y~aPE~~~~~~~~~~-~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~-~---~~-~~~~~~~~~~~~~l~~li~~cl~~ 275 (314)
T cd05099 202 WMAPEALFDRVYTHQ-SDVWSFGILMWEIFTLGGSPYPGIPVEELFKL-L---RE-GHRMDKPSNCTHELYMLMRECWHA 275 (314)
T ss_pred ccCHHHHccCCcCcc-chhhHHHHHHHHHHhCCCCCCCCCCHHHHHHH-H---Hc-CCCCCCCCCCCHHHHHHHHHHcCC
Confidence 999999987777655 999999999999999 8999976554322221 1 11 112222345788999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+.++++
T Consensus 276 ~p~~Rps~~~ll~ 288 (314)
T cd05099 276 VPTQRPTFKQLVE 288 (314)
T ss_pred CcccCcCHHHHHH
Confidence 9999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=284.12 Aligned_cols=246 Identities=28% Similarity=0.391 Sum_probs=194.4
Q ss_pred CCCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC--CC----cccceEEEEcCCeEEEEEecc
Q 019901 1 MLGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH--PN----IVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 1 ~lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h--p~----iv~~~~~~~~~~~~~lv~e~~ 70 (334)
.||.|+| + +.+..++..| |||+++--. ...++..-|+.+|.++.+ |+ +|.+.++|.-.++.|||+|.+
T Consensus 96 ~lGeGtFGkV~ec~D~~~~~~v-AlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell 173 (415)
T KOG0671|consen 96 LLGEGTFGKVVECWDRETKEHV-ALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL 173 (415)
T ss_pred hhcCCcccceEEEeecCCCcee-hHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc
Confidence 3677887 2 6677776666 999986544 456788889999999842 32 678888899999999999998
Q ss_pred CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC---------C---------CCCEE
Q 019901 71 SGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---------P---------APRLK 130 (334)
Q Consensus 71 ~~~~L~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~---------~---------~~~~k 130 (334)
|.++++.+.+++ +|+..+++.+.+|++.++++||+.+++|.||||+|||+.++ . ...++
T Consensus 174 -G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~ 252 (415)
T KOG0671|consen 174 -GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIK 252 (415)
T ss_pred -ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceE
Confidence 779999998764 59999999999999999999999999999999999998421 1 12589
Q ss_pred EeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc
Q 019901 131 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210 (334)
Q Consensus 131 l~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 210 (334)
++|||-|+...... .+.+.|..|+|||++.+-+|+.+ +||||+||||+||++|...|.+.++.+.+ ..+..++...
T Consensus 253 vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~p-CDvWSiGCIL~ElytG~~LFqtHen~EHL-aMMerIlGp~ 328 (415)
T KOG0671|consen 253 VIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQP-CDVWSIGCILVELYTGETLFQTHENLEHL-AMMERILGPI 328 (415)
T ss_pred EEecCCcceeccCc--ceeeeccccCCchheeccCcCCc-cCceeeeeEEEEeeccceecccCCcHHHH-HHHHHhhCCC
Confidence 99999987543332 56678999999999999999877 99999999999999999999988765544 3333332210
Q ss_pred ------------------ccCCC---------------C--------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 019901 211 ------------------YSIPD---------------Y--------VHISPECRHLISRIFVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 211 ------------------~~~~~---------------~--------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~ 249 (334)
...++ + ..-..++.+||++||..||.+|+|+.|+|.|||
T Consensus 329 P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpF 408 (415)
T KOG0671|consen 329 PSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPF 408 (415)
T ss_pred cHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHH
Confidence 00000 0 001245889999999999999999999999999
Q ss_pred cccc
Q 019901 250 FLKN 253 (334)
Q Consensus 250 ~~~~ 253 (334)
|+..
T Consensus 409 F~~~ 412 (415)
T KOG0671|consen 409 FARL 412 (415)
T ss_pred hhcC
Confidence 9754
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=275.55 Aligned_cols=236 Identities=21% Similarity=0.356 Sum_probs=186.5
Q ss_pred CCccee----eeeecCCCC---eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSD---LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~---~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|.| .++++.++. .+ |+|.+..... ...+.+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus 12 lg~g~~g~v~~~~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 90 (267)
T cd05066 12 IGAGEFGEVCSGRLKLPGKREIPV-AIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENG 90 (267)
T ss_pred ecccCCCceEEEEEecCCCCceEE-EEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCC
Confidence 455554 355555543 46 9999875431 23457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----CC
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP----KS 148 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~----~~ 148 (334)
+|.+++.+. +.++..++..++.|++.||.+||++|++||||||+|||++.++. ++|+|||+++........ ..
T Consensus 91 ~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~ 168 (267)
T cd05066 91 SLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTRG 168 (267)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCe--EEeCCCCcccccccccceeeecCC
Confidence 999998765 46899999999999999999999999999999999999987654 999999998754332211 11
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..++..|+|||.+.+..++.+ +|+|||||++|++++ |..||........... +. .....+....+++.+.+++
T Consensus 169 ~~~~~~y~~pe~~~~~~~~~~-~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li 242 (267)
T cd05066 169 GKIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWEMSNQDVIKA----IE-EGYRLPAPMDCPAALHQLM 242 (267)
T ss_pred CccceeecCHhHhccCccCch-hhhHHHHHHHHHHhcCCCCCcccCCHHHHHHH----Hh-CCCcCCCCCCCCHHHHHHH
Confidence 123567999999987777655 999999999999886 9999987654332222 21 2233444556789999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
.+||+.+|.+|||+.++++
T Consensus 243 ~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 243 LDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHcccCchhCCCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=290.38 Aligned_cols=238 Identities=23% Similarity=0.345 Sum_probs=186.1
Q ss_pred CCccee---e-eee-----cCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF---Y-DRC-----SYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~---~-~~~-----~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|+| + +++ ..++..| |||++...... ....+.+|+.++..+. ||||+++++++..++.+++|||||
T Consensus 45 lG~G~fG~Vy~~~~~~~~~~~~~~~v-avK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~ 123 (401)
T cd05107 45 LGSGAFGRVVEATAHGLSHSQSTMKV-AVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYC 123 (401)
T ss_pred ccCCCceeEEEEEEcCCCCCCCceEE-EEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEecc
Confidence 666665 3 442 2344566 99999865422 2346889999999997 999999999999999999999999
Q ss_pred CCCChHHHHHhcC-------------------------------------------------------------------
Q 019901 71 SGGELFERICNAG------------------------------------------------------------------- 83 (334)
Q Consensus 71 ~~~~L~~~l~~~~------------------------------------------------------------------- 83 (334)
.+|+|.+++.+.+
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 203 (401)
T cd05107 124 RYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYAD 203 (401)
T ss_pred CCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhh
Confidence 9999999886432
Q ss_pred -------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEe
Q 019901 84 -------------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132 (334)
Q Consensus 84 -------------------------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~ 132 (334)
.++...+..++.||+.||.|||++|++||||||+|||++..+. +||+
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~--~kL~ 281 (401)
T cd05107 204 IESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKL--VKIC 281 (401)
T ss_pred hhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCE--EEEE
Confidence 2567778899999999999999999999999999999987554 9999
Q ss_pred ccCCccCCCCCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhh
Q 019901 133 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 133 Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
|||+++...... ......+++.|+|||.+.+..+..+ +|||||||++|+|++ |..||............+ .
T Consensus 282 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~----~ 356 (401)
T cd05107 282 DFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTL-SDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI----K 356 (401)
T ss_pred ecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcH-hHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH----H
Confidence 999987532211 1223457889999999987777655 899999999999998 899997655433322221 2
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 209 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.....+.+..++.++.+++.+||..+|.+||++.+++..
T Consensus 357 ~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 357 RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 222333344578999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=275.07 Aligned_cols=236 Identities=21% Similarity=0.340 Sum_probs=186.6
Q ss_pred CCccee----eeeecCCCC---eeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSD---LFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~---~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|.+ .++.+.+++ .+ |+|.+.... ....+.+.+|+.+++.++||||+++.+++...+..++||||+.++
T Consensus 13 lg~g~~g~vy~~~~~~~~~~~~~~-~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 91 (268)
T cd05063 13 IGAGEFGEVFRGILKMPGRKEVAV-AIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENG 91 (268)
T ss_pred ecCCCCccEEEEEEecCCCCceEE-EEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCC
Confidence 455544 355655554 45 999987653 123457889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC----C
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK----S 148 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~----~ 148 (334)
+|..++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++. +||+|||++.......... .
T Consensus 92 ~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 169 (268)
T cd05063 92 ALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLE--CKVSDFGLSRVLEDDPEGTYTTSG 169 (268)
T ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCc--EEECCCccceecccccccceeccC
Confidence 999998764 56899999999999999999999999999999999999987654 9999999987543222111 1
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
...++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.......... .+. .....|.....++.+.+++
T Consensus 170 ~~~~~~y~~PE~~~~~~~~~~-~Dv~slG~il~ell~~g~~p~~~~~~~~~~~----~i~-~~~~~~~~~~~~~~~~~li 243 (268)
T cd05063 170 GKIPIRWTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMK----AIN-DGFRLPAPMDCPSAVYQLM 243 (268)
T ss_pred CCcCceecCHHHhhcCCcChH-hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHH----HHh-cCCCCCCCCCCCHHHHHHH
Confidence 123457999999987777655 999999999999997 999997665433222 222 2234444456789999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
.+||+.+|.+||++.++++
T Consensus 244 ~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 244 LQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHcCCCcccCcCHHHHHH
Confidence 9999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=269.16 Aligned_cols=241 Identities=40% Similarity=0.646 Sum_probs=200.9
Q ss_pred Ccceee-eeecCCCCeeEEEEEEecCcccc-cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 3 GFHNFY-DRCSYSSDLFVNIIIIVFHLWQI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 3 G~g~~~-~~~~~~~~~vvaiK~~~~~~~~~-~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
|+|.++ +.+..+|+.+ |+|++....... .+.+.+|+..++.++|+||+++++.+......++++||+.+++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~-~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLV-AIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEE-EEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 678775 7777788998 999998766333 5789999999999999999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchh
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 160 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~ 160 (334)
....++...+..++.+++.++.+||+.|++|+||+|.||+++.++ .++|+|||.+.............++..|+|||.
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~ 157 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG--HVKLADFGLARQLDPGGLLTTFVGTPEYMAPEV 157 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC--cEEEccccceeeeccccccccccCCcCCCCHHH
Confidence 776689999999999999999999999999999999999998765 499999999886555444455678999999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCC-CCCHHHHHHHHHhcccCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV-HISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~~p~~R~ 239 (334)
+.+..++. ++|+||||+++++|++|..||............ ............ .++.++.+++.+||..+|.+||
T Consensus 158 ~~~~~~~~-~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp 233 (244)
T smart00220 158 LLGKGYGK-AVDVWSLGVILYELLTGKPPFPGDDQLLELFKK---IGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRL 233 (244)
T ss_pred HccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH---HhccCCCCccccccCCHHHHHHHHHHccCCchhcc
Confidence 98777766 599999999999999999999874333322222 222222222111 1789999999999999999999
Q ss_pred CHhHHhcCccc
Q 019901 240 SIPEIRNHEWF 250 (334)
Q Consensus 240 s~~ell~h~~~ 250 (334)
++.++++||||
T Consensus 234 ~~~~~~~~~~~ 244 (244)
T smart00220 234 TAEEALQHPFF 244 (244)
T ss_pred CHHHHhhCCCC
Confidence 99999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=275.80 Aligned_cols=236 Identities=22% Similarity=0.302 Sum_probs=181.0
Q ss_pred CCccee----eeeecCCCCee---EEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLF---VNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~v---vaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+....++..+ +++|.+..... .....+..|+..++.++||||+++++++. +...++++||+.+|
T Consensus 15 lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~g 93 (279)
T cd05111 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLG 93 (279)
T ss_pred cCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCC
Confidence 566666 25555566642 26777643321 12256778888999999999999999875 45678999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++. +||+|||+++....... ....
T Consensus 94 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 171 (279)
T cd05111 94 SLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI--VQIADFGVADLLYPDDKKYFYSEH 171 (279)
T ss_pred cHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCc--EEEcCCccceeccCCCcccccCCC
Confidence 999999764 56899999999999999999999999999999999999987654 99999999975432221 1233
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+..... .... .......+.....+.++.+++.
T Consensus 172 ~~~~~y~~pE~~~~~~~~~~-~Dv~slG~il~el~t~g~~p~~~~~~~~-~~~~----~~~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05111 172 KTPIKWMALESILFGRYTHQ-SDVWSYGVTVWEMMSYGAEPYAGMRPHE-VPDL----LEKGERLAQPQICTIDVYMVMV 245 (279)
T ss_pred CCcccccCHHHhccCCcCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHH-HHHH----HHCCCcCCCCCCCCHHHHHHHH
Confidence 46778999999987777655 999999999999998 999998654322 2222 2222222333346788999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||..+|.+|||+.++++
T Consensus 246 ~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 246 KCWMIDENVRPTFKELAN 263 (279)
T ss_pred HHcCCCcccCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=280.20 Aligned_cols=224 Identities=20% Similarity=0.307 Sum_probs=179.2
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc----------
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---------- 82 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------- 82 (334)
+..+ |+|.+..... .....+.+|+.+++.+ +||||+++++++...+..|+||||+.+++|.+++.+.
T Consensus 47 ~~~v-~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 125 (304)
T cd05101 47 AVTV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 125 (304)
T ss_pred ceeE-EeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence 3456 9999875431 2335788999999999 8999999999999999999999999999999998764
Q ss_pred ------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCC
Q 019901 83 ------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTP 153 (334)
Q Consensus 83 ------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~ 153 (334)
..++...+..++.||+.||.|||++|++||||||+||+++.++. +||+|||+++....... .....+++
T Consensus 126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~--~kl~D~g~~~~~~~~~~~~~~~~~~~~~ 203 (304)
T cd05101 126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDVNNIDYYKKTTNGRLPV 203 (304)
T ss_pred cccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCc--EEECCCccceecccccccccccCCCCCc
Confidence 23678889999999999999999999999999999999987654 99999999875433221 12234567
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +||||||+++|+|++ |..||.+.+...... .+. ..........++..+.+++.+||.
T Consensus 204 ~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~cl~ 277 (304)
T cd05101 204 KWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFK----LLK-EGHRMDKPANCTNELYMMMRDCWH 277 (304)
T ss_pred eeeCchhhccCCCCch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHH-cCCcCCCCCCCCHHHHHHHHHHcc
Confidence 8999999988777655 999999999999998 888997655433222 221 222223334678999999999999
Q ss_pred cCCCCCCCHhHHhcC
Q 019901 233 ADPAKRISIPEIRNH 247 (334)
Q Consensus 233 ~~p~~R~s~~ell~h 247 (334)
.+|.+|||+.++++.
T Consensus 278 ~~p~~Rps~~e~l~~ 292 (304)
T cd05101 278 AIPSHRPTFKQLVED 292 (304)
T ss_pred cChhhCCCHHHHHHH
Confidence 999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-39 Score=293.87 Aligned_cols=221 Identities=27% Similarity=0.380 Sum_probs=187.1
Q ss_pred EEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHH
Q 019901 19 VNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEARFFF 94 (334)
Q Consensus 19 vaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~ 94 (334)
||||...-.. ......+.+|++++++++|||||+++|+......+++|||+|.||+|.++|.+.+. ++..+...++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~ 268 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC 268 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 4999987533 23446788999999999999999999999999999999999999999999999874 9999999999
Q ss_pred HHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc-cCCCccccchhhccCCCCCccchh
Q 019901 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADV 173 (334)
Q Consensus 95 ~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~Di 173 (334)
.+.+.||+|||+++++||||-.+|+|++.++. +||+|||+++........... .-...|+|||.+....|+.+ +||
T Consensus 269 ~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~--vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~k-TDV 345 (474)
T KOG0194|consen 269 YDAARGLEYLHSKNCIHRDIAARNCLYSKKGV--VKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFK-TDV 345 (474)
T ss_pred HHHHhHHHHHHHCCCcchhHhHHHheecCCCe--EEeCccccccCCcceeeccccccCcceecChhhhccCccccc-cch
Confidence 99999999999999999999999999987664 799999999876533333322 35678999999998877666 999
Q ss_pred hhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 174 WSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 174 wslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
||+||++||+++ |..||.+.... ....++....++.+.+...+.++..++.+||..+|++|||+.++.+
T Consensus 346 ~sfGV~~~Eif~~g~~Py~g~~~~----~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 346 WSFGVLLWEIFENGAEPYPGMKNY----EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred hheeeeEEeeeccCCCCCCCCCHH----HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 999999999998 78899987664 3333444555666666678999999999999999999999988764
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=308.36 Aligned_cols=134 Identities=26% Similarity=0.379 Sum_probs=118.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| ++.+..++..| |||++.+.... ....+.+|+.+++.++||||+++++++...+.+|+||||+.|++
T Consensus 12 LG~G~fg~Vy~a~~~~~~~~v-AiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~ 90 (669)
T cd05610 12 ISRGAFGKVYLGRKKNNSKLY-AVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGD 90 (669)
T ss_pred EecCCCeEEEEEEECCCCcEE-EEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCC
Confidence 555555 47788888998 99999865422 23578889999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 91 L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~--vkL~DFGls~ 152 (669)
T cd05610 91 VKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGH--IKLTDFGLSK 152 (669)
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCC--EEEEeCCCCc
Confidence 9999988888999999999999999999999999999999999999987654 9999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=281.33 Aligned_cols=223 Identities=21% Similarity=0.315 Sum_probs=177.8
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
..+ |+|.+..... .....+.+|+.+++.+ +||||+++++++...+..|+||||+.+++|.+++...+
T Consensus 51 ~~~-aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~ 129 (307)
T cd05098 51 TKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP 129 (307)
T ss_pred ceE-EEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence 456 9999976531 2234688899999999 79999999999999999999999999999999997642
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 84 ------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 84 ------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
.++...+..++.|++.||+|||++|++||||||+|||++.++. +||+|||+++....... .....+++.
T Consensus 130 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~--~kL~dfg~a~~~~~~~~~~~~~~~~~~~~ 207 (307)
T cd05098 130 TQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVK 207 (307)
T ss_pred ccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCc--EEECCCcccccccccchhhccccCCCccc
Confidence 3788999999999999999999999999999999999987654 99999999875432211 111234568
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|+|||||++|+|++ |..||..... ......+ ......+.+..++.++.+++.+||..
T Consensus 208 y~aPE~~~~~~~~~~-~DvwslG~~l~el~~~g~~p~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~ 281 (307)
T cd05098 208 WMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-EELFKLL----KEGHRMDKPSNCTNELYMMMRDCWHA 281 (307)
T ss_pred eeChHHhccCCCCcH-HHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH----HcCCCCCCCCcCCHHHHHHHHHHccc
Confidence 999999988777655 999999999999998 8899976543 2222221 12222233446789999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+.+++++
T Consensus 282 ~p~~Rps~~evl~~ 295 (307)
T cd05098 282 VPSQRPTFKQLVED 295 (307)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=279.05 Aligned_cols=226 Identities=23% Similarity=0.341 Sum_probs=176.5
Q ss_pred eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC------------
Q 019901 17 LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------------ 83 (334)
Q Consensus 17 ~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------ 83 (334)
.| |+|.+..... .....+.+|+.+++.++|||++++++++...+..++||||+.+++|.+++....
T Consensus 46 ~v-avK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 124 (295)
T cd05097 46 LV-AVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP 124 (295)
T ss_pred EE-EEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence 45 9999876531 223568899999999999999999999999999999999999999999886532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchh
Q 019901 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEV 160 (334)
Q Consensus 84 ~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~ 160 (334)
.++...+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++....... .....+++.|+|||+
T Consensus 125 ~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 202 (295)
T cd05097 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES 202 (295)
T ss_pred cccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCCc--EEecccccccccccCcceeccCcCcCceeecChhh
Confidence 3678889999999999999999999999999999999987654 99999999875432211 122345678999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHh--CCCCCCCCCchHHHHHHHHHHhh--ccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
+.+..++.+ +|+|||||++|+|++ +..||.................. ...........++.+.+++.+||+.+|.
T Consensus 203 ~~~~~~~~~-~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~ 281 (295)
T cd05097 203 ILLGKFTTA-SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIK 281 (295)
T ss_pred hccCCcCch-hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCch
Confidence 887777555 999999999999988 67888776543333322211111 1111222334689999999999999999
Q ss_pred CCCCHhHHhc
Q 019901 237 KRISIPEIRN 246 (334)
Q Consensus 237 ~R~s~~ell~ 246 (334)
+|||+.++++
T Consensus 282 ~RPs~~~i~~ 291 (295)
T cd05097 282 DRPTFNKIHH 291 (295)
T ss_pred hCcCHHHHHH
Confidence 9999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=273.59 Aligned_cols=232 Identities=22% Similarity=0.207 Sum_probs=180.6
Q ss_pred CCccee----eeeecCCCC----------eeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSD----------LFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~----------~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 67 (334)
||.|++ .+.++.++. .+ ++|.+...... ...+.+|+.+++.++||||+++++++.. ...++||
T Consensus 3 lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v-~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~ 79 (259)
T cd05037 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSV-VLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE 79 (259)
T ss_pred ccccccceEEEEEEeccCCccccCCccceee-eeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence 566665 355555552 34 78877655422 6788899999999999999999999887 7789999
Q ss_pred eccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC-----CEEEeccCCccCCC
Q 019901 68 EYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----RLKICDFGYSKSSV 141 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~-----~~kl~Dfgla~~~~ 141 (334)
||+.+++|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++..+.. .+||+|||++....
T Consensus 80 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~ 159 (259)
T cd05037 80 EYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL 159 (259)
T ss_pred EcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcccccc
Confidence 9999999999998766 68999999999999999999999999999999999999866521 49999999987543
Q ss_pred CCCCCCCccCCCccccchhhccC-CCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 142 LHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 142 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
. .....++..|+|||++.+. ...+.++||||||+++|+|++ |..||......... .... .....+. ..
T Consensus 160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-~~~~----~~~~~~~--~~ 229 (259)
T cd05037 160 S---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-RFYQ----DQHRLPM--PD 229 (259)
T ss_pred c---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-HHHh----cCCCCCC--CC
Confidence 3 2344577889999998776 233455999999999999999 68888765432211 1111 1111121 12
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+..+.+++.+||..+|.+|||+.++++
T Consensus 230 ~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 230 CAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred chHHHHHHHHHhccChhhCCCHHHHHH
Confidence 488999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=274.48 Aligned_cols=239 Identities=28% Similarity=0.395 Sum_probs=187.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---c--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---W--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ .+++..++..+ ++|+.+... . .....+.+|+.+++.++||||+++++.+......++|+||+.+
T Consensus 8 ig~g~~g~v~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 86 (260)
T cd08222 8 LGKGSFGTVYLVKDKKAVAEE-RLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEG 86 (260)
T ss_pred ecCCCCceEEEEEecCCCCcc-eEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCC
Confidence 455554 36677766666 777765432 1 1223567899999999999999999999988999999999999
Q ss_pred CChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCC
Q 019901 73 GELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPK 147 (334)
Q Consensus 73 ~~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~ 147 (334)
++|...+.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.+ .++|+|||+++...... ...
T Consensus 87 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~---~~~l~d~g~~~~~~~~~~~~~ 163 (260)
T cd08222 87 RDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNN---LLKIGDFGVSRLLMGSCDLAT 163 (260)
T ss_pred CCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecC---CEeecccCceeecCCCccccc
Confidence 999988753 3568999999999999999999999999999999999999743 39999999987543322 223
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
...|++.|+|||.+.+..++.+ +|+||+|+++|+|++|..||......... ........ ......++.++.++|
T Consensus 164 ~~~~~~~~~~pe~~~~~~~~~~-~Dv~slG~~~~~l~~~~~~~~~~~~~~~~----~~~~~~~~-~~~~~~~~~~~~~li 237 (260)
T cd08222 164 TFTGTPYYMSPEALKHQGYDSK-SDIWSLGCILYEMCCLAHAFEGQNFLSVV----LRIVEGPT-PSLPETYSRQLNSIM 237 (260)
T ss_pred CCCCCcCccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCCCCccHHHHH----HHHHcCCC-CCCcchhcHHHHHHH
Confidence 4468899999999877777655 99999999999999999999765432222 22222111 111235689999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.+||..+|.+||++.+++.||||
T Consensus 238 ~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 238 QSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHhcCChhhCcCHHHHhhCCCC
Confidence 99999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=276.83 Aligned_cols=228 Identities=24% Similarity=0.348 Sum_probs=178.5
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
+..+ |+|.+..... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|..++.+..
T Consensus 46 ~~~~-a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (296)
T cd05095 46 PVLV-AVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124 (296)
T ss_pred eeEE-EEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccc
Confidence 3355 9999876531 234678899999999999999999999999999999999999999999987643
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccch
Q 019901 84 -RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 159 (334)
Q Consensus 84 -~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE 159 (334)
.+++..+..++.|++.||+|||++|++||||||+|||++.++. ++|+|||+++....... .....+++.|+|||
T Consensus 125 ~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe 202 (296)
T cd05095 125 VTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYT--IKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE 202 (296)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCCC--EEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence 3667789999999999999999999999999999999986654 99999999875432221 12233467899999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCCCchHHHHHHHHHHh--hccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLV--GAYPFEDPEEPKNFRKTIHRIL--SVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+..+..++.+ +|+|||||++|+|++ |..||................. ......+....+++.+.+|+.+||+.+|
T Consensus 203 ~~~~~~~~~~-~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p 281 (296)
T cd05095 203 SILLGKFTTA-SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNA 281 (296)
T ss_pred HHhcCCccch-hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCc
Confidence 9877777555 999999999999998 7789976554333322211110 1112233444578999999999999999
Q ss_pred CCCCCHhHHhc
Q 019901 236 AKRISIPEIRN 246 (334)
Q Consensus 236 ~~R~s~~ell~ 246 (334)
.+|||+.++++
T Consensus 282 ~~Rp~~~~i~~ 292 (296)
T cd05095 282 KERPSFQEIHA 292 (296)
T ss_pred ccCCCHHHHHH
Confidence 99999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=271.33 Aligned_cols=234 Identities=21% Similarity=0.330 Sum_probs=183.2
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +......+..+ |+|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++|||+.+++|.++
T Consensus 14 lg~g~~~~vy~~~~~~~~~~-~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~ 90 (260)
T cd05073 14 LGAGQFGEVWMATYNKHTKV-AVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDF 90 (260)
T ss_pred ecCccceEEEEEEecCCccE-EEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHH
Confidence 455555 32233445566 999887654 334678899999999999999999999887 778999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 79 ICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 79 l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
+.+. ..++...+..++.|++.||.|||++|++||||+|+||+++..+. +||+|||++........ .....++..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~--~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 168 (260)
T cd05073 91 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIK 168 (260)
T ss_pred HHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCCcceeeccCCCcccccCCccccc
Confidence 9763 35788899999999999999999999999999999999987654 99999999875432211 122235677
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|+|||||++|++++ |+.||.+.+....... .......+.....+.++.+++.+||+.
T Consensus 169 y~~PE~~~~~~~~~~-~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~i~~~l~~ 242 (260)
T cd05073 169 WTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-----LERGYRMPRPENCPEELYNIMMRCWKN 242 (260)
T ss_pred ccCHhHhccCCcCcc-ccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH-----HhCCCCCCCcccCCHHHHHHHHHHccc
Confidence 999999987766555 899999999999998 9999987654332221 122233344456789999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+||++.++++
T Consensus 243 ~p~~Rp~~~~l~~ 255 (260)
T cd05073 243 RPEERPTFEYIQS 255 (260)
T ss_pred CcccCcCHHHHHH
Confidence 9999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=272.45 Aligned_cols=238 Identities=24% Similarity=0.364 Sum_probs=191.9
Q ss_pred eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEeccCCCChHHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELFERI 79 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~~~~~~L~~~l 79 (334)
.|-+..+++.| |+|...... ...-+...+|..++..++|+||++++.+|.-. ..+|+|||++ .++|...+
T Consensus 34 ~a~D~v~~~~v-~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi 111 (369)
T KOG0665|consen 34 AAFDQVLGRPV-AIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVI 111 (369)
T ss_pred ecchhhccCce-ehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHH
Confidence 36678888998 999876653 23457889999999999999999999998633 3589999999 56898887
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.. .++...+..++.|++.|++|||+.||+||||||+||++..... +||.|||+|+.........-.+.|..|+|||
T Consensus 112 ~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~--lKi~dfg~ar~e~~~~~mtpyVvtRyyrape 187 (369)
T KOG0665|consen 112 LM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCT--LKILDFGLARTEDTDFMMTPYVVTRYYRAPE 187 (369)
T ss_pred HH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhh--eeeccchhhcccCcccccCchhheeeccCch
Confidence 63 4788899999999999999999999999999999999987776 9999999998765554445567899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc---------------------------c
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------------------S 212 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------------------~ 212 (334)
++.+.++... +||||+||++.||++|+..|.+.+.-.++.+.......... .
T Consensus 188 vil~~~~ke~-vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~ 266 (369)
T KOG0665|consen 188 VILGMGYKEN-VDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSEL 266 (369)
T ss_pred heeccCCccc-chhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhh
Confidence 9999997766 89999999999999999999976655444444332211100 0
Q ss_pred CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 213 IPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 213 ~~~---------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+|. ...-+..+++++.+||..+|++|.|++++|.|||++-
T Consensus 267 fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~v 315 (369)
T KOG0665|consen 267 FPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKV 315 (369)
T ss_pred CCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeee
Confidence 111 0112467899999999999999999999999999973
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=276.60 Aligned_cols=224 Identities=21% Similarity=0.338 Sum_probs=178.5
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---------
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 83 (334)
++..+ |+|++..... .....+.+|+.+++.++||||+++++++..+...++||||+.+++|.+++....
T Consensus 34 ~~~~~-aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 112 (288)
T cd05050 34 PFTMV-AVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH 112 (288)
T ss_pred cceeE-EEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccc
Confidence 56677 9999876541 223568899999999999999999999999999999999999999999987432
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCC
Q 019901 84 -------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPK 147 (334)
Q Consensus 84 -------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~ 147 (334)
.+++..+..++.|++.||.|||++|++||||||+|||++.++. ++|+|||+++...... ...
T Consensus 113 ~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~ 190 (288)
T cd05050 113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKASE 190 (288)
T ss_pred cccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCc--eEECccccceecccCccccccC
Confidence 3678889999999999999999999999999999999987664 9999999987533221 122
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
....++.|+|||.+.+..++.+ +|||||||++|+|++ |..||.+....... ..+.... ..+....++.++.+|
T Consensus 191 ~~~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~el~~~~~~p~~~~~~~~~~----~~~~~~~-~~~~~~~~~~~l~~l 264 (288)
T cd05050 191 NDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI----YYVRDGN-VLSCPDNCPLELYNL 264 (288)
T ss_pred CCccChhhcCHHHHhcCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHH----HHHhcCC-CCCCCCCCCHHHHHH
Confidence 2345677999999988777655 999999999999997 88899765543322 2222222 122233578999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 019901 227 ISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~ 246 (334)
+.+||+.+|.+|||+.|+++
T Consensus 265 i~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 265 MRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=284.33 Aligned_cols=240 Identities=23% Similarity=0.328 Sum_probs=181.1
Q ss_pred CcceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-eEEEEEeccCCCChHHHHHh
Q 019901 3 GFHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEYASGGELFERICN 81 (334)
Q Consensus 3 G~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~ 81 (334)
|||.++.-...+|..| |||.+.........++.+|+.++.+++|||+|+++++|.+.+ ..+||+||+..|+|.+.+..
T Consensus 87 gfg~VYkG~l~~~~~v-AVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~ 165 (361)
T KOG1187|consen 87 GFGTVYKGVLSDGTVV-AVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHG 165 (361)
T ss_pred CCeEEEEEEECCCCEE-EEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCC
Confidence 4444454444455666 999877765221556999999999999999999999999988 59999999999999999987
Q ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCc-cCCCc
Q 019901 82 AG--RFSEDEARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKST-VGTPA 154 (334)
Q Consensus 82 ~~--~~~~~~~~~~~~qil~~L~~LH~~~---ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~-~gt~~ 154 (334)
.. ++++....+|+.+++.||+|||... ||||||||+|||+|.+.. .||+|||+|+.... .....+. .||..
T Consensus 166 ~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~--aKlsDFGLa~~~~~~~~~~~~~~~gt~g 243 (361)
T KOG1187|consen 166 KKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFN--AKLSDFGLAKLGPEGDTSVSTTVMGTFG 243 (361)
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCC--EEccCccCcccCCccccceeeecCCCCc
Confidence 54 7999999999999999999999843 999999999999997765 99999999976544 3332333 89999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCC--chHHHHHHHHHHhhc----cccCCCC--CCCC-----H
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--EPKNFRKTIHRILSV----QYSIPDY--VHIS-----P 221 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~----~~~~~~~--~~~~-----~ 221 (334)
|+|||.+.....+.+ +||||||+++.||++|+.+..... ....+.......... ...-|.. ...+ .
T Consensus 244 Y~~PEy~~~g~lt~K-sDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~ 322 (361)
T KOG1187|consen 244 YLAPEYASTGKLTEK-SDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVK 322 (361)
T ss_pred cCChhhhccCCcCcc-cccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHH
Confidence 999999987666555 999999999999999998887432 111122221111111 0001111 1222 2
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 222 ECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
.+..+..+|++.+|..||+..+++.
T Consensus 323 ~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 323 KLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 2567778999999999999999753
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=274.34 Aligned_cols=224 Identities=22% Similarity=0.349 Sum_probs=178.3
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-------CCCCH
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-------GRFSE 87 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~ 87 (334)
..+ |||.+.+... .....+.+|+.+++.++||||+++++++......++||||+.+++|.+++.+. ..++.
T Consensus 27 ~~~-~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~ 105 (269)
T cd05044 27 IRV-AVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTL 105 (269)
T ss_pred eee-hhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccH
Confidence 456 9999876531 23467889999999999999999999999999999999999999999998642 33788
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC---CCCEEEeccCCccCCCCCC---CCCCccCCCccccchhh
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVLHS---QPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~---~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~ 161 (334)
..+..++.|++.||.|||+++++|+||||+||+++.++ ...++|+|||+++...... ......++..|+|||.+
T Consensus 106 ~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~ 185 (269)
T cd05044 106 KELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESL 185 (269)
T ss_pred HHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHH
Confidence 99999999999999999999999999999999998755 1259999999987543221 11233457889999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
.+..++.+ +|||||||++|+|++ |..||.......... .+. ..........+|..+.++|.+||..+|.+||+
T Consensus 186 ~~~~~~~~-~Dv~slG~il~ellt~g~~p~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 259 (269)
T cd05044 186 LDGKFTTQ-SDVWSFGVLMWEILTLGQQPYPALNNQEVLQ----HVT-AGGRLQKPENCPDKIYQLMTNCWAQDPSERPT 259 (269)
T ss_pred ccCCcccc-hhHHHHHHHHHHHHHcCCCCCcccCHHHHHH----HHh-cCCccCCcccchHHHHHHHHHHcCCCcccCCC
Confidence 87777555 999999999999998 999997655432221 111 12222333457899999999999999999999
Q ss_pred HhHHhc
Q 019901 241 IPEIRN 246 (334)
Q Consensus 241 ~~ell~ 246 (334)
+.++++
T Consensus 260 ~~~i~~ 265 (269)
T cd05044 260 FDRIQE 265 (269)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=271.27 Aligned_cols=224 Identities=19% Similarity=0.254 Sum_probs=171.5
Q ss_pred EEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHH
Q 019901 20 NIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA----GRFSEDEARFFF 94 (334)
Q Consensus 20 aiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~ 94 (334)
++|.+.... ....+.+.+|+.+++.++||||+++++.+......|+||||+.+|+|.+++.+. ..++...++.++
T Consensus 26 ~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~ 105 (268)
T cd05086 26 VVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMA 105 (268)
T ss_pred EEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHH
Confidence 677766543 233468899999999999999999999999999999999999999999998754 236677888999
Q ss_pred HHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccchhhccCC------
Q 019901 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKE------ 165 (334)
Q Consensus 95 ~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------ 165 (334)
.||+.||+|||+++++||||||+|||++.++. ++|+|||++...... .......+++.|+|||++....
T Consensus 106 ~~i~~al~~lH~~~i~H~dikp~nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~ 183 (268)
T cd05086 106 CEIAAGVTHMHKHNFLHSDLALRNCFLTSDLT--VKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITA 183 (268)
T ss_pred HHHHHHHHHHHHCCeeccCCccceEEEcCCcc--EEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccC
Confidence 99999999999999999999999999987664 999999998642221 1223456888999999975321
Q ss_pred CCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHH
Q 019901 166 YDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244 (334)
Q Consensus 166 ~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~el 244 (334)
..+.++|||||||++|+|++ |..||........+...+...............+++.+.+++..|| .+|.+|||++++
T Consensus 184 ~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i 262 (268)
T cd05086 184 EQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262 (268)
T ss_pred CCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHH
Confidence 11345899999999999996 5778876655444444332211111111122347889999999999 679999999998
Q ss_pred hc
Q 019901 245 RN 246 (334)
Q Consensus 245 l~ 246 (334)
++
T Consensus 263 ~~ 264 (268)
T cd05086 263 HR 264 (268)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=272.72 Aligned_cols=221 Identities=24% Similarity=0.352 Sum_probs=177.0
Q ss_pred eeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHH
Q 019901 17 LFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFF 94 (334)
Q Consensus 17 ~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 94 (334)
.+ |||...... ....+.+.+|+.+++.++||||+++++++.. +..++||||+.+++|.+++.+.+ .+++..+..++
T Consensus 36 ~v-~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 113 (270)
T cd05056 36 AV-AVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYS 113 (270)
T ss_pred ce-EEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 45 999887654 2344678899999999999999999998875 45789999999999999997654 58999999999
Q ss_pred HHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchhhccCCCCCccch
Q 019901 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIAD 172 (334)
Q Consensus 95 ~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~D 172 (334)
.|++.||.|||+.|++||||||+||+++.++. ++|+|||+++....... .....+++.|+|||.+....++.+ +|
T Consensus 114 ~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~--~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~D 190 (270)
T cd05056 114 YQLSTALAYLESKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA-SD 190 (270)
T ss_pred HHHHHHHHHHHhCCeeccccChheEEEecCCC--eEEccCceeeecccccceecCCCCccccccChhhhccCCCCch-hh
Confidence 99999999999999999999999999987665 99999999875433221 112234568999999877777555 99
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 173 VWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 173 iwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
|||||+++|+|++ |..||........... +. .....+.+..+++.+.+++.+||..+|.+|||+.+++..
T Consensus 191 i~slG~il~el~~~g~~pf~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 191 VWMFGVCMWEILMLGVKPFQGVKNNDVIGR----IE-NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HH-cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999986 9999987655333222 11 222233445678999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=272.64 Aligned_cols=235 Identities=22% Similarity=0.350 Sum_probs=184.7
Q ss_pred CCccee---e-eeecCCCC----eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---Y-DRCSYSSD----LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~----~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|++ + +.++.+|. .+ |+|....... .....+.+|+.+++.++||||+++++++.. ...++||||+.+
T Consensus 15 ig~g~~g~v~~~~~~~~~~~~~~~~-aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~ 92 (279)
T cd05057 15 LGSGAFGTVYKGVWIPEGEKVKIPV-AIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPL 92 (279)
T ss_pred ecCCCCccEEEEEEecCCCCcceEE-EEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCC
Confidence 555555 3 55555554 35 9998876642 234678899999999999999999999887 788999999999
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC---C
Q 019901 73 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK---S 148 (334)
Q Consensus 73 ~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~---~ 148 (334)
|+|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||+++......... .
T Consensus 93 g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kL~dfg~~~~~~~~~~~~~~~~ 170 (279)
T cd05057 93 GCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLDVDEKEYHAEG 170 (279)
T ss_pred CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCe--EEECCCcccccccCcccceecCC
Confidence 9999998774 46899999999999999999999999999999999999987664 9999999997654322211 1
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..++..|+|||.+....++.+ +|+||||+++|++++ |+.||........ .. .+. .....+.+...+..+.+++
T Consensus 171 ~~~~~~y~~PE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~-~~---~~~-~~~~~~~~~~~~~~~~~~~ 244 (279)
T cd05057 171 GKVPIKWMALESILHRIYTHK-SDVWSYGVTVWELMTFGAKPYEGIPAVEI-PD---LLE-KGERLPQPPICTIDVYMVL 244 (279)
T ss_pred CcccccccCHHHhhcCCcCch-hhHHHHHHHHHHHhcCCCCCCCCCCHHHH-HH---HHh-CCCCCCCCCCCCHHHHHHH
Confidence 223567999999877777655 999999999999998 9999987654222 22 122 2223344445788999999
Q ss_pred HHhcccCCCCCCCHhHHhc
Q 019901 228 SRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~ 246 (334)
.+||..+|..|||+.++++
T Consensus 245 ~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 245 VKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHcCCChhhCCCHHHHHH
Confidence 9999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.39 Aligned_cols=237 Identities=29% Similarity=0.376 Sum_probs=188.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~~ 70 (334)
||.|+| .++|+.+|..+ |||.+.+.. ....+..-+|++++++++|||||+++++-++.. ...+|||||
T Consensus 21 LG~Ga~g~V~rgrnketG~~v-AvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC 99 (732)
T KOG4250|consen 21 LGKGAFGNVYRGRNKETGRLV-AVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYC 99 (732)
T ss_pred hcCCccceeeeecccccccch-hHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeec
Confidence 565655 48889999999 999998855 244567779999999999999999999865443 468999999
Q ss_pred CCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCCccCCCCCCC
Q 019901 71 SGGELFERICNA---GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 71 ~~~~L~~~l~~~---~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgla~~~~~~~~ 145 (334)
.||+|...+.+. ..+++.+++.++..++.||.|||.+|||||||||.||++... +....||+|||.|+.......
T Consensus 100 ~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~ 179 (732)
T KOG4250|consen 100 SGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSL 179 (732)
T ss_pred CCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCe
Confidence 999999999753 459999999999999999999999999999999999998543 333579999999999888888
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc----------------
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV---------------- 209 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------- 209 (334)
..+.+||+.|.+||.+..+.+++.-+|.|||||++|+.+||..||.....+.....++..+...
T Consensus 180 ~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgp 259 (732)
T KOG4250|consen 180 FTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGP 259 (732)
T ss_pred eeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCc
Confidence 8889999999999999854444455999999999999999999997655554333333332221
Q ss_pred ---cccCCCCCCCCHH----HHHHHHHhcccCCCCCC
Q 019901 210 ---QYSIPDYVHISPE----CRHLISRIFVADPAKRI 239 (334)
Q Consensus 210 ---~~~~~~~~~~~~~----~~~li~~~L~~~p~~R~ 239 (334)
...+|.+..+++. +..++..+|..+|.+|.
T Consensus 260 v~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 260 VEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred eeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1123333334433 45678889999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.27 Aligned_cols=230 Identities=25% Similarity=0.361 Sum_probs=182.3
Q ss_pred CCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCChHHHHHhcC-CCCHH
Q 019901 13 YSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAG-RFSED 88 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~ 88 (334)
.++..+ |||++...... ....+.+|+.+++.++||||+++++++.. ....++||||+.+++|.+++.... .++..
T Consensus 31 ~~~~~~-avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~ 109 (284)
T cd05038 31 NTGEQV-AVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK 109 (284)
T ss_pred CCceEE-EEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHH
Confidence 346777 99999876632 35689999999999999999999999877 557999999999999999997654 58999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhccC
Q 019901 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKK 164 (334)
Q Consensus 89 ~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~ 164 (334)
.+..++.|++.||+|||++|++||||||+||+++.++. ++|+|||++........ .....++..|+|||.+.+.
T Consensus 110 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~ 187 (284)
T cd05038 110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDL--VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS 187 (284)
T ss_pred HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCC--EEEcccccccccccCCcceeccCCCCCcccccCcHHHccC
Confidence 99999999999999999999999999999999987654 99999999876542211 1122345679999999877
Q ss_pred CCCCccchhhhhhHHHHHHHhCCCCCCCCCchH----------HHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 165 EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK----------NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 165 ~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
.+..+ +||||||+++|+|++|..||....... .....+..........+.....+.++.+++.+||..+
T Consensus 188 ~~~~~-~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~ 266 (284)
T cd05038 188 KFSSA-SDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAE 266 (284)
T ss_pred CCCcc-cchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccC
Confidence 76555 899999999999999999986543211 0112222223333344444567889999999999999
Q ss_pred CCCCCCHhHHhc
Q 019901 235 PAKRISIPEIRN 246 (334)
Q Consensus 235 p~~R~s~~ell~ 246 (334)
|.+|||+.++++
T Consensus 267 p~~Rpt~~ei~~ 278 (284)
T cd05038 267 PQDRPSFADLIL 278 (284)
T ss_pred hhhCCCHHHHHH
Confidence 999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=270.39 Aligned_cols=223 Identities=22% Similarity=0.283 Sum_probs=172.2
Q ss_pred CeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEE-cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHH
Q 019901 16 DLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARF 92 (334)
Q Consensus 16 ~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~ 92 (334)
..+ |||.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.+++|.+++.+. ..++...+..
T Consensus 24 ~~~-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~ 102 (262)
T cd05058 24 IHC-AVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG 102 (262)
T ss_pred EEE-EEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHH
Confidence 345 999875432 123457788999999999999999999765 456689999999999999998764 3467888899
Q ss_pred HHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCccCCCccccchhhccCCCC
Q 019901 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYD 167 (334)
Q Consensus 93 ~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~ 167 (334)
++.|++.||.|||+.|++||||||+|||++.++. +||+|||+++...... ......+++.|+|||.+.+..++
T Consensus 103 ~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 180 (262)
T cd05058 103 FGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT--VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFT 180 (262)
T ss_pred HHHHHHHHHHHHHhCCccccccCcceEEEcCCCc--EEECCccccccccCCcceeecccccCcCCccccChhHhccCccc
Confidence 9999999999999999999999999999987664 9999999987543211 11233457789999999877776
Q ss_pred CccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 168 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 168 ~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
.+ +|||||||++|+|++ |.+||......... ...... ...+....+++.+.+++.+||..+|++||++.+++.
T Consensus 181 ~~-~Di~slG~~l~el~~~~~~~~~~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 181 TK-SDVWSFGVLLWELMTRGAPPYPDVDSFDIT----VYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred hH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHH----HHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 55 999999999999999 56677654432221 112111 122223346899999999999999999999999985
Q ss_pred C
Q 019901 247 H 247 (334)
Q Consensus 247 h 247 (334)
.
T Consensus 255 ~ 255 (262)
T cd05058 255 R 255 (262)
T ss_pred H
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=280.96 Aligned_cols=223 Identities=21% Similarity=0.310 Sum_probs=178.0
Q ss_pred eeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-----------
Q 019901 17 LFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG----------- 83 (334)
Q Consensus 17 ~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------- 83 (334)
.+ |+|.+..... .....+.+|+.+++++ +||||+++++++..++..++|+||+.+|+|.+++.+..
T Consensus 46 ~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~ 124 (334)
T cd05100 46 TV-AVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC 124 (334)
T ss_pred eE-EEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence 56 9998875431 2235788999999999 79999999999999999999999999999999987532
Q ss_pred -----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCcc
Q 019901 84 -----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 155 (334)
Q Consensus 84 -----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y 155 (334)
.++...+..++.|++.||.|||++|++||||||+|||++.++. +||+|||+++....... .....++..|
T Consensus 125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y 202 (334)
T cd05100 125 KLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNV--MKIADFGLARDVHNIDYYKKTTNGRLPVKW 202 (334)
T ss_pred cCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCc--EEECCcccceecccccccccccCCCcCceE
Confidence 3677889999999999999999999999999999999987654 99999999875432211 1122345679
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +. .....+.....+.++.+++.+||+.+
T Consensus 203 ~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~cl~~~ 276 (334)
T cd05100 203 MAPEALFDRVYTHQ-SDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL----LK-EGHRMDKPANCTHELYMIMRECWHAV 276 (334)
T ss_pred cCHHHhccCCcCch-hhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH----HH-cCCCCCCCCCCCHHHHHHHHHHcccC
Confidence 99999988777665 999999999999998 8999977654332221 21 12222333457889999999999999
Q ss_pred CCCCCCHhHHhcCc
Q 019901 235 PAKRISIPEIRNHE 248 (334)
Q Consensus 235 p~~R~s~~ell~h~ 248 (334)
|.+|||+.+++.+-
T Consensus 277 p~~Rps~~ell~~l 290 (334)
T cd05100 277 PSQRPTFKQLVEDL 290 (334)
T ss_pred hhhCcCHHHHHHHH
Confidence 99999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=281.44 Aligned_cols=227 Identities=20% Similarity=0.334 Sum_probs=176.4
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEc-CCeEEEEEeccCCCChHHHHHhc-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNA------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------- 82 (334)
.+++.| |||++..... .....+.+|+.++..+ +||||+++++++.. ++.+++|||||.+|+|.+++...
T Consensus 35 ~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~ 113 (343)
T cd05103 35 ATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPY 113 (343)
T ss_pred ccceeE-EEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccc
Confidence 456677 9999976541 2235688999999999 68999999998765 45689999999999999988642
Q ss_pred ------------------------------------------------------------CCCCHHHHHHHHHHHHHHHH
Q 019901 83 ------------------------------------------------------------GRFSEDEARFFFQQLISGVS 102 (334)
Q Consensus 83 ------------------------------------------------------------~~~~~~~~~~~~~qil~~L~ 102 (334)
..++...+..++.|++.||.
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 193 (343)
T cd05103 114 KTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGME 193 (343)
T ss_pred cccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHH
Confidence 13677888999999999999
Q ss_pred HHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHH
Q 019901 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 179 (334)
Q Consensus 103 ~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i 179 (334)
|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||.+.+..++.+ +||||||++
T Consensus 194 ~lH~~~i~H~dikp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~~ 270 (343)
T cd05103 194 FLASRKCIHRDLAARNILLSENNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVL 270 (343)
T ss_pred HHHhCCeecCCCccCeEEEcCCCc--EEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCch-hhHHHHHHH
Confidence 999999999999999999987654 99999999875422211 122335678999999988777655 999999999
Q ss_pred HHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 180 LYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 180 l~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+|+|++ |..||............+. .....+.+...++++.+++.+||+.+|.+|||+.++++|
T Consensus 271 l~el~~~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 271 LWEIFSLGASPYPGVKIDEEFCRRLK----EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHCCCCCCCCccccHHHHHHHh----ccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999997 9999976544333222221 111222223468899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=270.26 Aligned_cols=238 Identities=29% Similarity=0.416 Sum_probs=185.6
Q ss_pred CCccee----eeeecC-CCCeeEEEEEEecCcc----------cccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEE
Q 019901 2 LGFHNF----YDRCSY-SSDLFVNIIIIVFHLW----------QIDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAI 65 (334)
Q Consensus 2 lG~g~~----~~~~~~-~~~~vvaiK~~~~~~~----------~~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~l 65 (334)
||.|.+ .+.+.. +++.+ |+|.+..... .....+.+|+.++++ ++||||+++++++..++..++
T Consensus 8 ig~G~~~~v~~~~~~~~~~~~~-avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~l 86 (269)
T cd08528 8 LGSGAFGCVYKVRKKNNGQNLL-ALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYI 86 (269)
T ss_pred hcCCCCceEEEEEEcCCCCcee-eeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEE
Confidence 555555 356666 45666 9999875431 112346678887764 799999999999999999999
Q ss_pred EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCC
Q 019901 66 VMEYASGGELFERICN----AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140 (334)
Q Consensus 66 v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~ 140 (334)
||||+.+++|.+++.. ...+++..++.++.|++.||.|||+ .|++||||+|+||+++.++. ++|+|||++...
T Consensus 87 v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~--~~l~dfg~~~~~ 164 (269)
T cd08528 87 VMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDK--VTITDFGLAKQK 164 (269)
T ss_pred EEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCc--EEEecccceeec
Confidence 9999999999888743 3468999999999999999999996 78999999999999987664 999999998765
Q ss_pred CCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCC
Q 019901 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 141 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (334)
..........|+..|+|||.+.+..++.+ +|+||||+++|+|++|++||.......... .+............++
T Consensus 165 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~-~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 239 (269)
T cd08528 165 QPESKLTSVVGTILYSCPEIVKNEPYGEK-ADVWAFGCILYQMCTLQPPFYSTNMLSLAT----KIVEAVYEPLPEGMYS 239 (269)
T ss_pred ccccccccccCcccCcChhhhcCCCCchH-HHHHHHHHHHHHHHhCCCcccccCHHHHHH----HHhhccCCcCCcccCC
Confidence 44433345568999999999987776555 999999999999999999997654432222 2222222222222578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+.+.+++.+||+.+|++||++.++..+
T Consensus 240 ~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 240 EDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=275.63 Aligned_cols=237 Identities=20% Similarity=0.341 Sum_probs=184.1
Q ss_pred CCccee----eeeecCCCCee---EEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLF---VNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~v---vaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+.+..+|..+ +|+|.+..... .....+.+|+.+++.++||||+++++++... ..+++++|+.+|
T Consensus 15 lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g 93 (303)
T cd05110 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHG 93 (303)
T ss_pred cccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCC
Confidence 566666 35566666532 38888765431 1223678999999999999999999998754 467999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 74 ELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 74 ~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+|.+++.... .+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... ....
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~ 171 (303)
T cd05110 94 CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNH--VKITDFGLARLLEGDEKEYNADGG 171 (303)
T ss_pred CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCc--eEEccccccccccCcccccccCCC
Confidence 9999987654 5899999999999999999999999999999999999976654 99999999975433222 1223
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.++..|+|||.+.+..++.+ +|||||||++|+|++ |..||.+... ..... ........+.....+..+.+++.
T Consensus 172 ~~~~~y~~PE~~~~~~~~~~-~DiwslG~~l~el~t~g~~p~~~~~~-~~~~~----~~~~~~~~~~~~~~~~~~~~li~ 245 (303)
T cd05110 172 KMPIKWMALECIHYRKFTHQ-SDVWSYGVTIWELMTFGGKPYDGIPT-REIPD----LLEKGERLPQPPICTIDVYMVMV 245 (303)
T ss_pred ccccccCCHHHhccCCCChH-HHHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH----HHHCCCCCCCCCCCCHHHHHHHH
Confidence 45678999999987777655 899999999999997 8999976543 22222 22223334444557899999999
Q ss_pred HhcccCCCCCCCHhHHhcC
Q 019901 229 RIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h 247 (334)
+||..+|.+||++++++..
T Consensus 246 ~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 246 KCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999998864
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=271.10 Aligned_cols=223 Identities=21% Similarity=0.287 Sum_probs=177.2
Q ss_pred CCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEeccCCCChHHHHHhc--------CC
Q 019901 15 SDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFERICNA--------GR 84 (334)
Q Consensus 15 ~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~ 84 (334)
+..+ ++|.+.... ......+.+|+.+++.++||||+++++++.. +...+++++|+.+++|..++... ..
T Consensus 35 ~~~v-~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~ 113 (280)
T cd05043 35 EEEV-FVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA 113 (280)
T ss_pred eeEE-EEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccC
Confidence 4555 999886543 1234668899999999999999999998765 46789999999999999998653 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhh
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVL 161 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~ 161 (334)
+++..+..++.|++.||.|||++|++||||||+||+++.++. +||+|||+++....... .....++..|+|||++
T Consensus 114 l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~--~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 191 (280)
T cd05043 114 LSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQ--VKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL 191 (280)
T ss_pred CCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCc--EEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence 899999999999999999999999999999999999987654 99999999975432211 1223456789999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
.+..++.+ +|||||||++|++++ |++||....... ... ........+....+++++.+++.+||..+|++|||
T Consensus 192 ~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 265 (280)
T cd05043 192 VNKEYSSA-SDVWSFGVLLWELMTLGQTPYVEIDPFE-MAA----YLKDGYRLAQPINCPDELFAVMACCWALDPEERPS 265 (280)
T ss_pred hcCCCCch-hhHHHhHHHHHHHhcCCCCCcCcCCHHH-HHH----HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCC
Confidence 87777655 999999999999998 999997654322 222 11222333344457899999999999999999999
Q ss_pred HhHHhc
Q 019901 241 IPEIRN 246 (334)
Q Consensus 241 ~~ell~ 246 (334)
+.+++.
T Consensus 266 ~~~~~~ 271 (280)
T cd05043 266 FSQLVQ 271 (280)
T ss_pred HHHHHH
Confidence 999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=301.03 Aligned_cols=220 Identities=25% Similarity=0.361 Sum_probs=186.4
Q ss_pred EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-------CCCCHHHH
Q 019901 19 VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-------GRFSEDEA 90 (334)
Q Consensus 19 vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~ 90 (334)
||||.+.+.. .+....+.+|..+|+.++|||||++++++.+.+..+|++|||+||+|..+|++. ..++..+.
T Consensus 725 vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dL 804 (1025)
T KOG1095|consen 725 VAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDL 804 (1025)
T ss_pred EEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHH
Confidence 3999988764 345578999999999999999999999999999999999999999999999876 23899999
Q ss_pred HHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCC
Q 019901 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYD 167 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~ 167 (334)
..++.||+.|++||+++++|||||..+|+|++... .|||+|||+|+....... .....-...|||||.+....++
T Consensus 805 l~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r--~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFt 882 (1025)
T KOG1095|consen 805 LAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR--VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFT 882 (1025)
T ss_pred HHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC--cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccc
Confidence 99999999999999999999999999999998764 499999999993322211 1112334589999999998888
Q ss_pred CccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 168 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 168 ~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
++ +|||||||++||+++ |..||.+....+.+.. ..... +++.+..++..+.+++..||+.+|.+||++..|++
T Consensus 883 sk-SDvWsFGVllWEifslG~~PY~~~~n~~v~~~----~~~gg-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 883 SK-SDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD----VLEGG-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred cc-cchhhhHHHHHHHHhCCCCCCCCcchHHHHHH----HHhCC-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 77 999999999999998 9999998776544332 33333 66777789999999999999999999999999987
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=263.41 Aligned_cols=244 Identities=23% Similarity=0.353 Sum_probs=192.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHH-HcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||-|.| ...++.+|+.. |||.+..... ....++..|.... ++-+.||||++|+....++..|+.||+|+ .+|
T Consensus 72 iG~G~fG~V~KM~hk~sg~~m-AVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~Sl 149 (361)
T KOG1006|consen 72 IGNGAFGTVNKMLHKPSGKLM-AVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISL 149 (361)
T ss_pred hcCCcchhhhhhhcCccCcEE-EEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhH
Confidence 565665 46789999999 9999988763 2335677777755 55578999999999999999999999994 466
Q ss_pred HHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 76 FERIC-----NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 76 ~~~l~-----~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
..+-+ ....++|.-+-.+....+.||.||.. .+|||||+||+|||++..|. +||||||++-.....-.....
T Consensus 150 DklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~--vKLCDFGIcGqLv~SiAkT~d 227 (361)
T KOG1006|consen 150 DKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGD--VKLCDFGICGQLVDSIAKTVD 227 (361)
T ss_pred HHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCC--EeeecccchHhHHHHHHhhhc
Confidence 43322 34568999899999999999999996 58999999999999988776 999999998765555555566
Q ss_pred cCCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-C--C-CCCCCCHHH
Q 019901 150 VGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-I--P-DYVHISPEC 223 (334)
Q Consensus 150 ~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~--~-~~~~~~~~~ 223 (334)
.|-..|||||.+.. .+|+-+ ||+||||++|||+.||..|+..... ..+.+..+.....+ + + ....++..+
T Consensus 228 aGCrpYmAPERi~p~~~gyDiR-SDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 228 AGCRPYMAPERIDPSDKGYDIR-SDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred cCCccccChhccCCccCCcchh-hhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 78899999999863 346666 9999999999999999999986443 23333333333222 1 1 224579999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 224 RHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..||.-||.+|-+.||...+|+.+||++..
T Consensus 304 ~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 999999999999999999999999999653
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=249.95 Aligned_cols=243 Identities=22% Similarity=0.408 Sum_probs=193.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcC--CeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTP--THLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~--~~~~lv~e~~~~~~ 74 (334)
+|-|.| -+.+..+++.+ +||+++.-. .+.+++|+.+|+.|. ||||++++++..++ ....+|+||++..+
T Consensus 46 ~GRGKYSEVFeg~~~~~~eK~-ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~D 121 (338)
T KOG0668|consen 46 VGRGKYSEVFEGINITNNEKC-VIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTD 121 (338)
T ss_pred HcCccHhhHhcccccCCCceE-EEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhcccc
Confidence 577777 27777888998 999987543 578999999999997 99999999998765 45789999998876
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
...+. +.++...++.++.+++.||.|+|+.||+|||+||.|+||+.... .++|+|+|+|...-....-...+.+..
T Consensus 122 fk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~r-kLrlIDWGLAEFYHp~~eYnVRVASRy 197 (338)
T KOG0668|consen 122 FKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELR-KLRLIDWGLAEFYHPGKEYNVRVASRY 197 (338)
T ss_pred HHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhc-eeeeeecchHhhcCCCceeeeeeehhh
Confidence 65544 44888999999999999999999999999999999999986543 699999999986544444445678889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCC-CCCCchHHHHHHHHHHhh---------ccccCC-C--------
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILS---------VQYSIP-D-------- 215 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~---------~~~~~~-~-------- 215 (334)
|--||.+..-+....+.|+|||||++..|+..+.|| .+.+..+++.++.+-... ....++ .
T Consensus 198 fKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~ 277 (338)
T KOG0668|consen 198 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRH 277 (338)
T ss_pred cCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhcc
Confidence 999999876555555589999999999999988886 555666666655432111 111111 0
Q ss_pred -------------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 -------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 -------------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
-.-+++++.+|+.++|..|-.+|+|+.|++.||||..
T Consensus 278 ~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~ 327 (338)
T KOG0668|consen 278 SRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP 327 (338)
T ss_pred ccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence 1124799999999999999999999999999999954
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=264.77 Aligned_cols=226 Identities=20% Similarity=0.340 Sum_probs=175.2
Q ss_pred CCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEeccCCCChHHHHHhc--
Q 019901 13 YSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASGGELFERICNA-- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~-- 82 (334)
.++..+ |||++..... ...+.+.+|+.+++.++||||+++++++.... ..+++++|+.+|+|..++...
T Consensus 25 ~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 103 (273)
T cd05074 25 GSFQKV-AVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRI 103 (273)
T ss_pred CCceEE-EEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcc
Confidence 456777 9999976542 22356889999999999999999999886532 357899999999998876432
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCcc
Q 019901 83 ----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 155 (334)
Q Consensus 83 ----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y 155 (334)
..++...+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+++...... ......+++.|
T Consensus 104 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 181 (273)
T cd05074 104 GEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMT--VCVADFGLSKKIYSGDYYRQGCASKLPVKW 181 (273)
T ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCC--EEECcccccccccCCcceecCCCccCchhh
Confidence 24788999999999999999999999999999999999986654 9999999988543221 11233456789
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
++||.+.+..++.+ +|||||||++|+|++ |++||........... +... ...+.....++.+.+++.+||+.+
T Consensus 182 ~~pe~~~~~~~~~~-sDi~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~l~~~~l~~~ 255 (273)
T cd05074 182 LALESLADNVYTTH-SDVWAFGVTMWEIMTRGQTPYAGVENSEIYNY----LIKG-NRLKQPPDCLEDVYELMCQCWSPE 255 (273)
T ss_pred cCHhHHhcCccchh-hhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHH----HHcC-CcCCCCCCCCHHHHHHHHHHcCCC
Confidence 99999987777655 999999999999999 8999976544222211 1111 112222356899999999999999
Q ss_pred CCCCCCHhHHhcC
Q 019901 235 PAKRISIPEIRNH 247 (334)
Q Consensus 235 p~~R~s~~ell~h 247 (334)
|.+|||+.+++.+
T Consensus 256 p~~Rps~~~~~~~ 268 (273)
T cd05074 256 PKCRPSFQHLRDQ 268 (273)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=271.44 Aligned_cols=253 Identities=25% Similarity=0.389 Sum_probs=198.2
Q ss_pred CCCcceee----eeecCCCCeeEEEEEEecCc-ccc------cHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEe
Q 019901 1 MLGFHNFY----DRCSYSSDLFVNIIIIVFHL-WQI------DENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVME 68 (334)
Q Consensus 1 ~lG~g~~~----~~~~~~~~~vvaiK~~~~~~-~~~------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e 68 (334)
+||-|+|. |.+.....+| |||+-.... +.. -+..-+|..+.+.|+||-||++|++|.- ...+|-|+|
T Consensus 470 LLGrGGFSEVyKAFDl~EqRYv-AvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLE 548 (775)
T KOG1151|consen 470 LLGRGGFSEVYKAFDLTEQRYV-AVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLE 548 (775)
T ss_pred HhccccHHHHHHhcccchhhee-eEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeee
Confidence 47888882 4455555555 999965443 211 1356689999999999999999999864 467899999
Q ss_pred ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--CceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCC
Q 019901 69 YASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 69 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~--~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~ 145 (334)
||+|.+|.-+++..+.+++.+++.|+.||+.||.||... .|||-||||.|||+.+. ..+.+||+||||++.+.....
T Consensus 549 YceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy 628 (775)
T KOG1151|consen 549 YCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSY 628 (775)
T ss_pred ecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCcc
Confidence 999999999999999999999999999999999999975 59999999999998543 335799999999986544332
Q ss_pred C--------CCccCCCccccchhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC
Q 019901 146 P--------KSTVGTPAYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214 (334)
Q Consensus 146 ~--------~~~~gt~~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 214 (334)
. ....||-||++||++.-. +.-+.++||||+|||+|..+.|+.||............-.-+......+|
T Consensus 629 ~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP 708 (775)
T KOG1151|consen 629 NSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 708 (775)
T ss_pred CcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence 2 234699999999988532 22244589999999999999999999865433222211111223455677
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.-+.+++++++||++||+.--++|....+|-.||||.-..
T Consensus 709 ~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~ 748 (775)
T KOG1151|consen 709 PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI 748 (775)
T ss_pred CCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence 7778999999999999999999999999999999996543
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=281.87 Aligned_cols=240 Identities=25% Similarity=0.360 Sum_probs=194.8
Q ss_pred Cccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC------CCCcccceEEEEcCCeEEEEEeccCC
Q 019901 3 GFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR------HPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 3 G~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
|.|.| .|++..-|+.| |||+|.... .....=++|+.+|+.|+ --|+++++..|...+++|||+|-+ .
T Consensus 441 GkGvFs~Vvra~D~~r~~~v-AiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-s 517 (752)
T KOG0670|consen 441 GKGVFSTVVRARDQARGQEV-AIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-S 517 (752)
T ss_pred ccceeeeeeeccccCCCCee-EEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-h
Confidence 55555 37888889998 999998776 44566778999999996 248999999999999999999988 5
Q ss_pred CChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 73 GELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 73 ~~L~~~l~~~~~---~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
-+|.+.|++.+. +....++.|+.|+..||..|...||+|.||||.|||++.+.. .+||||||.|.....+.. +..
T Consensus 518 lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~-iLKLCDfGSA~~~~enei-tPY 595 (752)
T KOG0670|consen 518 LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKN-ILKLCDFGSASFASENEI-TPY 595 (752)
T ss_pred chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcc-eeeeccCccccccccccc-cHH
Confidence 689999998764 888999999999999999999999999999999999986554 599999998865433322 223
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--------------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-------------- 215 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------------- 215 (334)
.-+..|.|||++.|-+|+.. .|+||+||+||||+||+..|.+.+....+.-.+.- ...+|.
T Consensus 596 LVSRFYRaPEIiLG~~yd~~-iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~----KGk~p~KmlRKgqF~dqHFD 670 (752)
T KOG0670|consen 596 LVSRFYRAPEIILGLPYDYP-IDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL----KGKFPNKMLRKGQFKDQHFD 670 (752)
T ss_pred HHHHhccCcceeecCcccCC-ccceeeceeeEEeeccceecCCCCcHHHHHHHHHh----cCCCcHHHhhhcchhhhhcc
Confidence 45678999999999999888 89999999999999999999998876555433321 111110
Q ss_pred --------------------------C-----------CCC-------CHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 216 --------------------------Y-----------VHI-------SPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 216 --------------------------~-----------~~~-------~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
+ ..+ -..+++||.+||..||.+|.|..++|.||||+
T Consensus 671 ~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~ 750 (752)
T KOG0670|consen 671 QDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFIT 750 (752)
T ss_pred cccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCccc
Confidence 0 001 25689999999999999999999999999996
Q ss_pred c
Q 019901 252 K 252 (334)
Q Consensus 252 ~ 252 (334)
.
T Consensus 751 ~ 751 (752)
T KOG0670|consen 751 E 751 (752)
T ss_pred C
Confidence 4
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=265.80 Aligned_cols=237 Identities=16% Similarity=0.158 Sum_probs=171.0
Q ss_pred CCccee---e-eeecCC---CCeeEEEEEEecCcccc--c---------HHHHHHHHHHHcCCCCCcccceEEEEcCC--
Q 019901 2 LGFHNF---Y-DRCSYS---SDLFVNIIIIVFHLWQI--D---------ENVQREIINHRSLRHPNIVRFKEVILTPT-- 61 (334)
Q Consensus 2 lG~g~~---~-~~~~~~---~~~vvaiK~~~~~~~~~--~---------~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-- 61 (334)
||.|+| + +++..+ +..+ |+|+........ . .....+...+..+.|+||+++++.+....
T Consensus 20 LG~G~fG~Vy~~~~~~~~~~~~~~-~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~ 98 (294)
T PHA02882 20 IGCGGFGCVYETQCASDHCINNQA-VAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCR 98 (294)
T ss_pred EecCCCceEEEEEEcCCcccccce-EEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCC
Confidence 555555 3 555555 4455 777754433111 0 11223334556678999999998765443
Q ss_pred --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 62 --HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 62 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
..+++++++ ..++.+.+.....+++..++.++.|++.||.|||++||+||||||+|||++.++. ++|+|||+|+.
T Consensus 99 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~--~~l~DFGla~~ 175 (294)
T PHA02882 99 MYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNR--GYIIDYGIASH 175 (294)
T ss_pred ceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCc--EEEEEcCCcee
Confidence 357888887 4467777766666789999999999999999999999999999999999986654 99999999975
Q ss_pred CCCCC--------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHH-----HHHHH
Q 019901 140 SVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK-----TIHRI 206 (334)
Q Consensus 140 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-----~~~~~ 206 (334)
..... ......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......... .+..+
T Consensus 176 ~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~ 254 (294)
T PHA02882 176 FIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-GDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRL 254 (294)
T ss_pred eccCCcccccccccccccCCCccccCHHHhCCCCCCcH-HHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHh
Confidence 43211 1123469999999999988877655 9999999999999999999987643222211 11222
Q ss_pred hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
....... ...++.+.+++..|+..+|.+||+++++++
T Consensus 255 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 255 HEGKIKI---KNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hhhhhcc---CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2222222 345899999999999999999999999874
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=276.40 Aligned_cols=236 Identities=23% Similarity=0.355 Sum_probs=192.7
Q ss_pred CCccee---e---eeec-CCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y---DRCS-YSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~---~~~~-~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||-|.| + +.+. +....-||||..+.+. ....+.+..|..+++.++||||+++++++.+ ...|||||++..|
T Consensus 397 iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~G 475 (974)
T KOG4257|consen 397 IGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLG 475 (974)
T ss_pred hcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccch
Confidence 676666 1 2233 3344555999988743 4567899999999999999999999999865 5679999999999
Q ss_pred ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc--c
Q 019901 74 ELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--V 150 (334)
Q Consensus 74 ~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~--~ 150 (334)
.|..+++.+. .++......++.||+.||.|||++++|||||-.+|||+.+..- |||+|||+++.......-... .
T Consensus 476 ELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C--VKLaDFGLSR~~ed~~yYkaS~~k 553 (974)
T KOG4257|consen 476 ELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQC--VKLADFGLSRYLEDDAYYKASRGK 553 (974)
T ss_pred hHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcce--eeecccchhhhccccchhhccccc
Confidence 9999998764 5899999999999999999999999999999999999987664 999999999976544432222 2
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
-...|||||.++-..+++. ||||-||+.+||++. |..||.+....+..- ......++|.++.+|+.+..++.+
T Consensus 554 LPIKWmaPESINfRrFTtA-SDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~-----~iEnGeRlP~P~nCPp~LYslmsk 627 (974)
T KOG4257|consen 554 LPIKWMAPESINFRRFTTA-SDVWMFGVCMWEILSLGVKPFQGVKNSDVIG-----HIENGERLPCPPNCPPALYSLMSK 627 (974)
T ss_pred cceeecCccccchhcccch-hhHHHHHHHHHHHHHhcCCccccccccceEE-----EecCCCCCCCCCCCChHHHHHHHH
Confidence 3557999999998888766 999999999999886 999998866543221 123455778888899999999999
Q ss_pred hcccCCCCCCCHhHHhc
Q 019901 230 IFVADPAKRISIPEIRN 246 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~ 246 (334)
||+.+|.+||++.++..
T Consensus 628 cWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 628 CWAYEPSKRPRFTEIKA 644 (974)
T ss_pred HhccCcccCCcHHHHHH
Confidence 99999999999887643
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=292.49 Aligned_cols=236 Identities=29% Similarity=0.384 Sum_probs=185.4
Q ss_pred ceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC
Q 019901 5 HNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83 (334)
Q Consensus 5 g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 83 (334)
|+++.+....|+.| |||.+-... ..-..+||..|+.- +|||||++++.-.+.+..||..|+| ..+|.+++...+
T Consensus 523 Gt~Vf~G~ye~R~V-AVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~ 597 (903)
T KOG1027|consen 523 GTVVFRGVYEGREV-AVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSG 597 (903)
T ss_pred CcEEEEEeeCCcee-hHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccc
Confidence 45678888888888 999875433 45788999999887 5999999999988999999999999 579999998741
Q ss_pred C----CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC---CCCCCEEEeccCCccCCCCCCC----CCCccCC
Q 019901 84 R----FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQ----PKSTVGT 152 (334)
Q Consensus 84 ~----~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~---~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt 152 (334)
. ......+..+.|++.||++||+.+||||||||+||||.. ++..+++|+|||+++....... ..+..||
T Consensus 598 ~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 598 LDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGT 677 (903)
T ss_pred cchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCc
Confidence 1 111346788999999999999999999999999999976 3545799999999986544332 2345699
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhhccccCCCCCC-CCHHHHHHHHHh
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISPECRHLISRI 230 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~ 230 (334)
-.|+|||++....... ++|||||||++|+.++| ..||...-.. -.++....+.+-.... ...++++||.+|
T Consensus 678 ~GW~APE~L~~~~~~~-avDiFslGCvfyYvltgG~HpFGd~~~R------~~NIl~~~~~L~~L~~~~d~eA~dLI~~m 750 (903)
T KOG1027|consen 678 SGWQAPEQLREDRKTQ-AVDIFSLGCVFYYVLTGGSHPFGDSLER------QANILTGNYTLVHLEPLPDCEAKDLISRM 750 (903)
T ss_pred ccccCHHHHhccccCc-ccchhhcCceEEEEecCCccCCCchHHh------hhhhhcCccceeeeccCchHHHHHHHHHh
Confidence 9999999998776644 59999999999999986 9999854321 1123344333222111 122899999999
Q ss_pred cccCCCCCCCHhHHhcCccccc
Q 019901 231 FVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~ 252 (334)
|.++|..||++.++|.||||..
T Consensus 751 l~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 751 LNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cCCCcccCCCHHHHhCCCccCC
Confidence 9999999999999999999964
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=278.15 Aligned_cols=243 Identities=24% Similarity=0.351 Sum_probs=199.5
Q ss_pred CCCcceeeee--ec---CCCC-eeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 1 MLGFHNFYDR--CS---YSSD-LFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 1 ~lG~g~~~~~--~~---~~~~-~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
+||.|+|-+. .. .+|+ .-||||++...... ...++.+|+.+|.+|+|||++++|++..+ ..+.+|||++..|
T Consensus 117 ~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 117 LLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLG 195 (1039)
T ss_pred HhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccc
Confidence 4788888222 11 2232 33599999887743 56899999999999999999999999887 6789999999999
Q ss_pred ChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc--
Q 019901 74 ELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 149 (334)
Q Consensus 74 ~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~-- 149 (334)
+|.+.|.+. ..|.......|+.||+.|+.||.++++|||||-..|+|+-.... |||+||||.+...........
T Consensus 196 SLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprt--VKI~DFGLmRaLg~ned~Yvm~p 273 (1039)
T KOG0199|consen 196 SLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRT--VKICDFGLMRALGENEDMYVMAP 273 (1039)
T ss_pred hHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccce--eeeecccceeccCCCCcceEecC
Confidence 999999873 44888999999999999999999999999999999999976554 999999999976555443322
Q ss_pred --cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 150 --VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 150 --~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
.-...|+|||.+....++.. ||+|++||++|||++ |..||.+......+ +++. ....++.+..+|.++.++
T Consensus 274 ~rkvPfAWCaPEsLrh~kFSha-SDvWmyGVTiWEMFtyGEePW~G~~g~qIL----~~iD-~~erLpRPk~csedIY~i 347 (1039)
T KOG0199|consen 274 QRKVPFAWCAPESLRHRKFSHA-SDVWMYGVTIWEMFTYGEEPWVGCRGIQIL----KNID-AGERLPRPKYCSEDIYQI 347 (1039)
T ss_pred CCcCcccccCHhHhcccccccc-chhhhhhhhHHhhhccCCCCCCCCCHHHHH----Hhcc-ccccCCCCCCChHHHHHH
Confidence 23457999999999999766 999999999999998 89999987764433 3333 455677777899999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+..||..+|.+|||+..|.+.-++..
T Consensus 348 mk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 348 MKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred HHHhccCCccccccHHHHHHhHHHHh
Confidence 99999999999999999876655544
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.47 Aligned_cols=247 Identities=25% Similarity=0.390 Sum_probs=197.1
Q ss_pred CCcceee----eeecCCCCeeEEEEEEecC--cccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-----eEEEEEecc
Q 019901 2 LGFHNFY----DRCSYSSDLFVNIIIIVFH--LWQIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~~----~~~~~~~~~vvaiK~~~~~--~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~ 70 (334)
||||.|- +.+..+|++| |+|.+..- .+...+.+.+|+++|...+|.|++..+++.+-.+ .+|+|+|++
T Consensus 61 IGYGAFGVVWsVTDPRdgrrv-alkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELm 139 (449)
T KOG0664|consen 61 IGYGAFGVVWSVTDPRSGKRV-ALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELM 139 (449)
T ss_pred ccccceeEEEeccCCCCccch-hHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHH
Confidence 7999882 4577889999 99987543 2345688999999999999999999999876543 478899998
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC--C
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--S 148 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~--~ 148 (334)
. .+|...+-+...++...++-+++||+.||+|||+.||.||||||.|.|++++.. +||||||+|+......... .
T Consensus 140 Q-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCv--LKICDFGLARvee~d~~~hMTq 216 (449)
T KOG0664|consen 140 Q-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCI--LKICDFGLARTWDQRDRLNMTH 216 (449)
T ss_pred H-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCce--EEecccccccccchhhhhhhHH
Confidence 4 578888888888999999999999999999999999999999999999988765 9999999999654443322 2
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHH-------------------Hhhc
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR-------------------ILSV 209 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-------------------~~~~ 209 (334)
.+-|..|+|||++.|...++.+.||||+|||+.||+..+..|......+++.-+..- ++..
T Consensus 217 EVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~ 296 (449)
T KOG0664|consen 217 EVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRA 296 (449)
T ss_pred HHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhcc
Confidence 357889999999998877777799999999999999999999877665555433221 1111
Q ss_pred cccCCCC---------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 210 QYSIPDY---------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 210 ~~~~~~~---------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
....|.. ..-.-+...++..+|..+|.+|.+.++++.|+++.+
T Consensus 297 ~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 297 GLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEE 348 (449)
T ss_pred CCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccc
Confidence 1111211 112346788999999999999999999999999864
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=270.49 Aligned_cols=240 Identities=23% Similarity=0.341 Sum_probs=192.3
Q ss_pred CCCccee--eeeecCCC-CeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 1 MLGFHNF--YDRCSYSS-DLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~-~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
.||.|.| +-.+...| ..| |+|.++...-. ...++.+||++|.+|+||||+.++++|..++.+++|+||++.|+|.
T Consensus 545 kiGeGqFGEVhLCeveg~lkV-AVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLn 623 (807)
T KOG1094|consen 545 KIGEGQFGEVHLCEVEGPLKV-AVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLN 623 (807)
T ss_pred hhcCcccceeEEEEecCceEE-EEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHH
Confidence 3788888 33333444 566 99999887633 3478999999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccC
Q 019901 77 ERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVG 151 (334)
Q Consensus 77 ~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~g 151 (334)
+++.+.. .+.-.....++.||+.|++||.+.++|||||.+.|+|++.+.+ +||+|||+++....... ....+-
T Consensus 624 qFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~--iKiadfgmsR~lysg~yy~vqgr~vl 701 (807)
T KOG1094|consen 624 QFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFT--IKIADFGMSRNLYSGDYYRVQGRAVL 701 (807)
T ss_pred HHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCccc--EEecCcccccccccCCceeeecceee
Confidence 9998763 2345556779999999999999999999999999999987765 99999999995443322 122345
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHH--hCCCCCCCCCchHHHHHHHHHHhhcc---ccCCCCCCCCHHHHHH
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML--VGAYPFEDPEEPKNFRKTIHRILSVQ---YSIPDYVHISPECRHL 226 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~--~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l 226 (334)
..+|||||.+.-..+++. ||+|++|+++||++ +...||...++.+...+ .......+ .-++.++-++..+.++
T Consensus 702 piRwmawEsillgkFtta-SDvWafgvTlwE~~~~C~e~Py~~lt~e~vven-~~~~~~~~~~~~~l~~P~~cp~~lyel 779 (807)
T KOG1094|consen 702 PIRWMAWESILLGKFTTA-SDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN-AGEFFRDQGRQVVLSRPPACPQGLYEL 779 (807)
T ss_pred eeeehhHHHHHhccccch-hhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh-hhhhcCCCCcceeccCCCcCcHHHHHH
Confidence 679999999999999777 99999999999986 57899987776444333 22222221 2244556789999999
Q ss_pred HHHhcccCCCCCCCHhHHh
Q 019901 227 ISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell 245 (334)
+.+||..+..+|||++++.
T Consensus 780 ml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 780 MLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred HHHHhchhhhcCCCHHHHH
Confidence 9999999999999999984
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=263.22 Aligned_cols=119 Identities=22% Similarity=0.318 Sum_probs=103.7
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-----C---CCcccceEEEEc----CCeEE
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-----H---PNIVRFKEVILT----PTHLA 64 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-----h---p~iv~~~~~~~~----~~~~~ 64 (334)
.||+|.| +|.++.+...| |+|+++-.. .-.+....||++|+++. | .+||++++.|.. +.++|
T Consensus 85 KLGWGHFSTVWLawDtq~~r~V-AlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC 162 (590)
T KOG1290|consen 85 KLGWGHFSTVWLAWDTQNKRYV-ALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC 162 (590)
T ss_pred eccccccceeEEEeeccCCeEE-EEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence 4899998 68888888888 999988766 66788999999999884 3 379999999974 46899
Q ss_pred EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEc
Q 019901 65 IVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLD 122 (334)
Q Consensus 65 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~ 122 (334)
+|+|++ |.+|..+|... +.++...++.|++|||.||.|||. .||||.||||+|||+.
T Consensus 163 MVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 163 MVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred EEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 999999 88999999865 459999999999999999999997 6999999999999984
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=269.12 Aligned_cols=234 Identities=22% Similarity=0.331 Sum_probs=195.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||-|.| + ...++..-.| |||.++... -..+.+.+|..+|+.++|||+|+++++|..+..+|||+|||..|+|.+
T Consensus 275 LGGGQYGeVYeGvWKkyslTv-AVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLd 352 (1157)
T KOG4278|consen 275 LGGGQYGEVYEGVWKKYSLTV-AVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLD 352 (1157)
T ss_pred cCCCcccceeeeeeeccceee-ehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHH
Confidence 565555 3 5566666677 999987666 345789999999999999999999999999999999999999999999
Q ss_pred HHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC--CccCCC
Q 019901 78 RICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK--STVGTP 153 (334)
Q Consensus 78 ~l~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~--~~~gt~ 153 (334)
+|.+..+ ++.-...+++.||..|+.||..+++|||||-..|+|+..+.. ||++||||++.+....... ...-..
T Consensus 353 YLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhi--VKvADFGLsRlMtgDTYTAHAGAKFPI 430 (1157)
T KOG4278|consen 353 YLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHI--VKVADFGLSRLMTGDTYTAHAGAKFPI 430 (1157)
T ss_pred HHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccce--EEeeccchhhhhcCCceecccCccCcc
Confidence 9987544 677778889999999999999999999999999999986655 9999999999654332211 112356
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|.|||.+....++.+ +|||+||++|||+.| |-.||.+.+-. .+...+...++...+..+++.+.+|+..||+
T Consensus 431 KWTAPEsLAyNtFSiK-SDVWAFGVLLWEIATYGMsPYPGidlS-----qVY~LLEkgyRM~~PeGCPpkVYeLMraCW~ 504 (1157)
T KOG4278|consen 431 KWTAPESLAYNTFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLS-----QVYGLLEKGYRMDGPEGCPPKVYELMRACWN 504 (1157)
T ss_pred cccCcccccccccccc-hhhHHHHHHHHHHHhcCCCCCCCccHH-----HHHHHHhccccccCCCCCCHHHHHHHHHHhc
Confidence 7999999998888777 999999999999997 88999886653 2334556677777777899999999999999
Q ss_pred cCCCCCCCHhHHh
Q 019901 233 ADPAKRISIPEIR 245 (334)
Q Consensus 233 ~~p~~R~s~~ell 245 (334)
++|.+||+++|+-
T Consensus 505 WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 505 WSPSDRPSFAEIH 517 (1157)
T ss_pred CCcccCccHHHHH
Confidence 9999999999874
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-35 Score=279.34 Aligned_cols=245 Identities=17% Similarity=0.159 Sum_probs=159.3
Q ss_pred CCccee----eeeecCC----CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEE------EEcCCeEEEEE
Q 019901 2 LGFHNF----YDRCSYS----SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEV------ILTPTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~----~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~------~~~~~~~~lv~ 67 (334)
||.|+| .+.+..+ +..| |||.+.... ..+....+ .++...+.++..+... ...+...++|+
T Consensus 140 LG~G~FG~VYka~~~~~~~~~~~~v-AvK~~~~~~--~~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ 214 (566)
T PLN03225 140 LGEGAFGVVYKASLVNKQSKKEGKY-VLKKATEYG--AVEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVW 214 (566)
T ss_pred EeeCCCeEEEEEEEcCCccccCcEE-EEEEecccc--hhHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEE
Confidence 555555 3677777 7888 999875432 11111111 1222223333332222 13456799999
Q ss_pred eccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC
Q 019901 68 EYASGGELFERICNAGR--------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 127 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~ 127 (334)
||+.+++|.+++..... .....+..++.||+.||.|||++||+||||||+|||++... +
T Consensus 215 ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~-~ 293 (566)
T PLN03225 215 RYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGS-G 293 (566)
T ss_pred EecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCC-C
Confidence 99999999998865321 12345678999999999999999999999999999997532 2
Q ss_pred CEEEeccCCccCCCCC--CCCCCccCCCccccchhhccCCCC---------------------CccchhhhhhHHHHHHH
Q 019901 128 RLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEVLLKKEYD---------------------GKIADVWSCGVTLYVML 184 (334)
Q Consensus 128 ~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~---------------------~~~~DiwslG~il~~l~ 184 (334)
.+||+|||+|+..... ......++++.|+|||.+...... ..++|||||||++|+|+
T Consensus 294 ~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~ 373 (566)
T PLN03225 294 SFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMA 373 (566)
T ss_pred cEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHH
Confidence 5999999999754322 223456789999999976432221 12369999999999999
Q ss_pred hCCCCCCCCCchHHHHHHHHHH----------hhcccc------CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 019901 185 VGAYPFEDPEEPKNFRKTIHRI----------LSVQYS------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 248 (334)
Q Consensus 185 ~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~------~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~ 248 (334)
++..++.. ....+...+... ...... +......+...++||.+||++||.+|||+.++|+||
T Consensus 374 ~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e~L~Hp 451 (566)
T PLN03225 374 FPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHP 451 (566)
T ss_pred hCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHHHhCCc
Confidence 87666532 112222211110 000000 000011234466999999999999999999999999
Q ss_pred cccccC
Q 019901 249 WFLKNL 254 (334)
Q Consensus 249 ~~~~~~ 254 (334)
||....
T Consensus 452 ff~~~~ 457 (566)
T PLN03225 452 YFDREG 457 (566)
T ss_pred CcCCCC
Confidence 997643
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=279.86 Aligned_cols=238 Identities=22% Similarity=0.396 Sum_probs=198.9
Q ss_pred CCccee--e--eeecCCC--CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF--Y--DRCSYSS--DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~--~--~~~~~~~--~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|.| + .+-+..| ...||||.++.... .....+..|+.+|-+.+||||+++.++......+.||+|||+.|+
T Consensus 637 IGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGs 716 (996)
T KOG0196|consen 637 IGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGS 716 (996)
T ss_pred EecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCc
Confidence 566666 2 2222222 34449999988763 345789999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccC-
Q 019901 75 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG- 151 (334)
Q Consensus 75 L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~g- 151 (334)
|..+|..+ +.|+.-+...+++.|+.|++||.+.|+|||||-..|||++++-. +|++||||++...... ...++.|
T Consensus 717 LDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLv--CKVsDFGLSRvledd~~~~ytt~GG 794 (996)
T KOG0196|consen 717 LDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEAAYTTLGG 794 (996)
T ss_pred HHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceE--EEeccccceeecccCCCccccccCC
Confidence 99999764 67999999999999999999999999999999999999988765 9999999999653333 2223332
Q ss_pred --CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 152 --TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 152 --t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
..+|.|||.+....+++. |||||+||+|||.+. |.-||+..++.+.+. .....+++|.+.+.|..+..|+.
T Consensus 795 KIPiRWTAPEAIa~RKFTsA-SDVWSyGIVmWEVmSyGERPYWdmSNQdVIk-----aIe~gyRLPpPmDCP~aL~qLMl 868 (996)
T KOG0196|consen 795 KIPIRWTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIK-----AIEQGYRLPPPMDCPAALYQLML 868 (996)
T ss_pred ccceeecChhHhhhcccCch-hhccccceEEEEecccCCCcccccchHHHHH-----HHHhccCCCCCCCCcHHHHHHHH
Confidence 468999999999999766 999999999999875 999999877754433 34667888988999999999999
Q ss_pred HhcccCCCCCCCHhHHhcC
Q 019901 229 RIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h 247 (334)
.||+++-..||.+.||+++
T Consensus 869 dCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 869 DCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHhhcCCCHHHHHHH
Confidence 9999999999999998863
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-34 Score=266.54 Aligned_cols=235 Identities=17% Similarity=0.212 Sum_probs=166.2
Q ss_pred CCeeEEEEEEecCccccc--------------HHHHHHHHHHHcCCCCCc-----ccceEEEEc--------CCeEEEEE
Q 019901 15 SDLFVNIIIIVFHLWQID--------------ENVQREIINHRSLRHPNI-----VRFKEVILT--------PTHLAIVM 67 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~--------------~~~~~Ei~~l~~l~hp~i-----v~~~~~~~~--------~~~~~lv~ 67 (334)
+..| |||.+........ +....|+.++..++|.++ +++++++.. .+..++|+
T Consensus 186 ~r~V-AVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~ 264 (507)
T PLN03224 186 KRRV-VLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVW 264 (507)
T ss_pred CceE-EEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEE
Confidence 4456 9999875431111 223346777777766544 566666542 35689999
Q ss_pred eccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC
Q 019901 68 EYASGGELFERICNAG------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG 123 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~------------------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~ 123 (334)
||+.+++|.+++.... .++...++.++.|++.||.|||+++|+||||||+|||++.
T Consensus 265 Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~ 344 (507)
T PLN03224 265 KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344 (507)
T ss_pred EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC
Confidence 9999999998886421 2356678899999999999999999999999999999987
Q ss_pred CCCCCEEEeccCCccCCCCCCCCC--CccCCCccccchhhccCCC--------------------C-CccchhhhhhHHH
Q 019901 124 SPAPRLKICDFGYSKSSVLHSQPK--STVGTPAYIAPEVLLKKEY--------------------D-GKIADVWSCGVTL 180 (334)
Q Consensus 124 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~gt~~y~aPE~~~~~~~--------------------~-~~~~DiwslG~il 180 (334)
++. +||+|||+++......... ...+|+.|+|||++..... . ....||||+||++
T Consensus 345 ~~~--~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil 422 (507)
T PLN03224 345 DGQ--VKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLL 422 (507)
T ss_pred CCc--EEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHH
Confidence 654 9999999987543322222 2245899999999854321 1 1236999999999
Q ss_pred HHHHhCCC-CCCCCCchHH----H---HHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC---CCCCCHhHHhcCcc
Q 019901 181 YVMLVGAY-PFEDPEEPKN----F---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP---AKRISIPEIRNHEW 249 (334)
Q Consensus 181 ~~l~~g~~-pf~~~~~~~~----~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p---~~R~s~~ell~h~~ 249 (334)
|+|+++.. ||........ . .............++.+...++..++|+.+||..+| .+|+|++|+|+|||
T Consensus 423 ~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 423 MQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred HHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 99999875 7754221110 0 011112222344455566789999999999999866 68999999999999
Q ss_pred ccc
Q 019901 250 FLK 252 (334)
Q Consensus 250 ~~~ 252 (334)
|..
T Consensus 503 f~~ 505 (507)
T PLN03224 503 FLP 505 (507)
T ss_pred cCC
Confidence 954
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-36 Score=274.34 Aligned_cols=247 Identities=26% Similarity=0.375 Sum_probs=207.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
+|.|+| .|+++.+++.. |+|+++...-.....+++||-+++.++|||||.+++.+.....++++||||.||+|.+
T Consensus 23 vgsgTygdvyKaRd~~s~ela-avkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQd 101 (829)
T KOG0576|consen 23 VGSGTYGDVYKARDKRSGELA-AVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQD 101 (829)
T ss_pred ecCCcccchhhhcccccCchh-hheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccc
Confidence 688888 59999999999 9999998875666789999999999999999999999999999999999999999998
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~ 156 (334)
.-.-.+++++.++....+..+.||+|||++|=+|||||-.||+++..+. +|++|||.+..... -......+|||.||
T Consensus 102 iy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gD--vklaDfgvsaqitati~KrksfiGtpywm 179 (829)
T KOG0576|consen 102 IYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGD--VKLADFGVSAQITATIAKRKSFIGTPYWM 179 (829)
T ss_pred eeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCc--eeecccCchhhhhhhhhhhhcccCCcccc
Confidence 8777889999999999999999999999999999999999999988876 99999998764332 33456789999999
Q ss_pred cchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 157 APEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 157 aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|||+.. ...|.. .+|||++|++..||-.-.+|-...-....+ ..+.+.......+......++.+.+|++.+|.+
T Consensus 180 apEvaaverkggynq-lcdiwa~gitAiel~eLqpplfdlhpmr~l-~LmTkS~~qpp~lkDk~kws~~fh~fvK~altk 257 (829)
T KOG0576|consen 180 APEVAAVERKGGYNQ-LCDIWALGITAIELGELQPPLFDLHPMRAL-FLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTK 257 (829)
T ss_pred chhHHHHHhcccccc-cccccccccchhhhhhcCCcccccchHHHH-HHhhccCCCCCcccCCccchHHHHHHHHHHhcC
Confidence 999863 445544 499999999999998888886544332222 222333333334445556799999999999999
Q ss_pred CCCCCCCHhHHhcCcccccc
Q 019901 234 DPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~~ 253 (334)
+|++|||++.+|.|||..+.
T Consensus 258 npKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 258 NPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CCccCCChhhheeceeeccc
Confidence 99999999999999999764
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=286.61 Aligned_cols=229 Identities=21% Similarity=0.218 Sum_probs=170.3
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.++ ++++.++..| |||.+.... .....|+..+++++|||||++++++.+.+..|+||||+++|+|.+++..
T Consensus 703 ~g~Vy~~~~~~~~~~v-avK~~~~~~----~~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~- 776 (968)
T PLN00113 703 KGASYKGKSIKNGMQF-VVKEINDVN----SIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN- 776 (968)
T ss_pred CeeEEEEEECCCCcEE-EEEEccCCc----cccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc-
Confidence 44443 6667788888 999986443 1224568899999999999999999999999999999999999999853
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHH---HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 83 GRFSEDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH---~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
+++..+..++.|++.||+||| +.+|+||||||+||+++.+.. .++. ||.+.... ......+|+.|+|||
T Consensus 777 --l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~--~~~~-~~~~~~~~---~~~~~~~t~~y~aPE 848 (968)
T PLN00113 777 --LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDE--PHLR-LSLPGLLC---TDTKCFISSAYVAPE 848 (968)
T ss_pred --CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCc--eEEE-eccccccc---cCCCccccccccCcc
Confidence 788999999999999999999 679999999999999987665 4444 55543221 122346889999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhc-------cccCCCC----CCCCHHHHHHH
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSV-------QYSIPDY----VHISPECRHLI 227 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~-------~~~~~~~----~~~~~~~~~li 227 (334)
++.+..++.+ +|||||||++|||++|+.||...... ............. ....+.. .....++.+++
T Consensus 849 ~~~~~~~~~~-sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 927 (968)
T PLN00113 849 TRETKDITEK-SDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLA 927 (968)
T ss_pred cccCCCCCcc-cchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHH
Confidence 9988877665 99999999999999999999543211 1111111111000 0000000 01123577899
Q ss_pred HHhcccCCCCCCCHhHHhcC
Q 019901 228 SRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h 247 (334)
.+||+.+|.+|||+.++++.
T Consensus 928 ~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 928 LHCTATDPTARPCANDVLKT 947 (968)
T ss_pred HhhCcCCchhCcCHHHHHHH
Confidence 99999999999999999864
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-32 Score=265.18 Aligned_cols=224 Identities=25% Similarity=0.433 Sum_probs=183.8
Q ss_pred CeeEEEEEEecCccc-ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 16 DLFVNIIIIVFHLWQ-IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
..-||||..+..... ..+.+..|+.+++.+ +||||+.+++++...+.+++|+|||..|+|..++...+
T Consensus 328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~ 407 (609)
T KOG0200|consen 328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV 407 (609)
T ss_pred eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence 444599999876632 346899999999998 59999999999999999999999999999999998766
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC--CCccC--CC
Q 019901 84 ------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG--TP 153 (334)
Q Consensus 84 ------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--~~~~g--t~ 153 (334)
.++..+...+++||+.|++||+++++|||||-.+|||+..+.. +||+|||+|+........ ....| ..
T Consensus 408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~--~kIaDFGlar~~~~~~~y~~~~~~~~LP~ 485 (609)
T KOG0200|consen 408 FPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV--IKIADFGLARDHYNKDYYRTKSSAGTLPV 485 (609)
T ss_pred CccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE--EEEccccceeccCCCCceEecCCCCccce
Confidence 3888999999999999999999999999999999999987754 999999999854332221 22222 34
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|||||.+....|+.+ |||||+||++||+++ |..||.+......+ .. ......+...+...++++.++++.||+
T Consensus 486 kWmApEsl~~~~ft~k-SDVWSfGI~L~EifsLG~~PYp~~~~~~~l---~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~ 560 (609)
T KOG0200|consen 486 KWMAPESLFDRVFTSK-SDVWSFGILLWEIFTLGGTPYPGIPPTEEL---LE-FLKEGNRMEQPEHCSDEIYDLMKSCWN 560 (609)
T ss_pred eecCHHHhccCccccc-chhhHHHHHHHHHhhCCCCCCCCCCcHHHH---HH-HHhcCCCCCCCCCCCHHHHHHHHHHhC
Confidence 5999999999888766 899999999999998 89999874422222 22 334445556666789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+||++.++.+
T Consensus 561 ~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 561 ADPEDRPTFSECVE 574 (609)
T ss_pred CCcccCCCHHHHHH
Confidence 99999999999873
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=282.73 Aligned_cols=201 Identities=17% Similarity=0.212 Sum_probs=149.1
Q ss_pred cCCC-CCcccceEEE-------EcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCC
Q 019901 44 SLRH-PNIVRFKEVI-------LTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 114 (334)
Q Consensus 44 ~l~h-p~iv~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dl 114 (334)
.+.| +||+++++.| .....+++++|++ +++|.+++.. ...+++.+++.+++||+.||.|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4556 6888888877 2334678889987 6799999975 345999999999999999999999999999999
Q ss_pred CCCcEEEcCC-----------------CCCCEEEeccCCccCCCCCC-----------------CCCCccCCCccccchh
Q 019901 115 KLENTLLDGS-----------------PAPRLKICDFGYSKSSVLHS-----------------QPKSTVGTPAYIAPEV 160 (334)
Q Consensus 115 kp~NIli~~~-----------------~~~~~kl~Dfgla~~~~~~~-----------------~~~~~~gt~~y~aPE~ 160 (334)
||+|||++.. ....+|++|||+++...... .....+||++|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 9999999542 22347788888776421100 0012358999999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
+.+..++.+ +|||||||++|||++|.+|+..... ......... ..+......+....++.+||.++|.+|||
T Consensus 187 ~~~~~~~~~-sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~L~~~P~~Rps 258 (793)
T PLN00181 187 DNGSSSNCA-SDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-----LPPQILLNWPKEASFCLWLLHPEPSCRPS 258 (793)
T ss_pred hccCCCCch-hhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-----cChhhhhcCHHHHHHHHHhCCCChhhCcC
Confidence 988888655 9999999999999999988764211 111111111 11111122566789999999999999999
Q ss_pred HhHHhcCcccccc
Q 019901 241 IPEIRNHEWFLKN 253 (334)
Q Consensus 241 ~~ell~h~~~~~~ 253 (334)
+.++++||||.+.
T Consensus 259 ~~eil~h~~~~~~ 271 (793)
T PLN00181 259 MSELLQSEFINEP 271 (793)
T ss_pred hHHHhhchhhhhh
Confidence 9999999999763
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=222.89 Aligned_cols=190 Identities=27% Similarity=0.373 Sum_probs=153.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHH-cCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHR-SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|.+ ..++..+|... |+|.+.... .+..+.+.+|+.+.. ...+|.+|.|++....++.+++.||.++ .+|
T Consensus 54 lGrGayG~vekmrh~~sg~im-AvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSl 131 (282)
T KOG0984|consen 54 LGRGAYGVVEKMRHIQSGTIM-AVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSL 131 (282)
T ss_pred hcCCccchhhheeeccCCeEE-EEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhH
Confidence 566655 58899999999 999997654 133456777887664 4579999999999999999999999995 466
Q ss_pred HH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 76 FE----RICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 76 ~~----~l~~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
.. .+.+.+.++|.-+-+++..++.||.|||++ .++|||+||+||||+..|. ||+||||++-.....-......
T Consensus 132 dkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~Gq--VKiCDFGIsG~L~dSiAkt~da 209 (282)
T KOG0984|consen 132 DKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQ--VKICDFGISGYLVDSIAKTMDA 209 (282)
T ss_pred HHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCc--EEEcccccceeehhhhHHHHhc
Confidence 43 344567799999999999999999999985 8999999999999987664 9999999987554443333356
Q ss_pred CCCccccchhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCch
Q 019901 151 GTPAYIAPEVLLK----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 196 (334)
Q Consensus 151 gt~~y~aPE~~~~----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 196 (334)
|-..|||||.+.. ..|+-+ |||||||++++||.+++.||.....+
T Consensus 210 GCkpYmaPEri~~e~n~~gY~vk-sDvWSLGItmiElA~lr~PY~~w~tp 258 (282)
T KOG0984|consen 210 GCKPYMAPERINPELNQKGYSVK-SDVWSLGITMIEMAILRFPYESWGTP 258 (282)
T ss_pred CCCccCChhhcCcccCcccceee-hhhhhhhhhhhhhhhccccccccCCH
Confidence 8889999999853 356555 99999999999999999999865544
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=241.42 Aligned_cols=246 Identities=22% Similarity=0.340 Sum_probs=185.4
Q ss_pred CCCcceee----eeecC--CCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 1 MLGFHNFY----DRCSY--SSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 1 ~lG~g~~~----~~~~~--~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
.+|.|+|- +.+.. +...+||+|.+.... ....+.+|+++|..+. +.||+++.+++..++++.+|+||++..
T Consensus 43 kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~ 120 (418)
T KOG1167|consen 43 KIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHD 120 (418)
T ss_pred cccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCcc
Confidence 47888882 33333 344455999987665 5677999999999985 899999999999999999999999998
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC--------------
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-------------- 139 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~-------------- 139 (334)
...++... ++..+++.+++.++.||.++|.+|||||||||+|+|.+... ++-.|+|||+|..
T Consensus 121 ~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t-~rg~LvDFgLA~~~d~~~~~~~s~~~~ 196 (418)
T KOG1167|consen 121 RFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRT-QRGVLVDFGLAQRYDGYQQTEHSRSYS 196 (418)
T ss_pred CHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccccccc-CCceEEechhHHHHHhhhhhhhhhhhh
Confidence 88777654 67899999999999999999999999999999999997543 4689999999861
Q ss_pred ---CCC-CC-----------------------C----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCC
Q 019901 140 ---SVL-HS-----------------------Q----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 188 (334)
Q Consensus 140 ---~~~-~~-----------------------~----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 188 (334)
... .+ . .....|||+|+|||++...+--+.++||||.|+|+..+++++.
T Consensus 197 ~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~ 276 (418)
T KOG1167|consen 197 GRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRY 276 (418)
T ss_pred cccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhcccc
Confidence 000 00 0 0113599999999999877766677999999999999999999
Q ss_pred CCCCCCch-HHHHHHH--------HHHhh--cc---------------------------c-------cCCCC-CCCCHH
Q 019901 189 PFEDPEEP-KNFRKTI--------HRILS--VQ---------------------------Y-------SIPDY-VHISPE 222 (334)
Q Consensus 189 pf~~~~~~-~~~~~~~--------~~~~~--~~---------------------------~-------~~~~~-~~~~~~ 222 (334)
||-...+. ..+..+. .+... .. . ....+ ...+..
T Consensus 277 PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~ 356 (418)
T KOG1167|consen 277 PFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPAL 356 (418)
T ss_pred ccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHH
Confidence 99643321 1111110 00000 00 0 00001 123558
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+.+|+.+||..||.+|.|++++|+||||..
T Consensus 357 ~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 357 LLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred HHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 999999999999999999999999999964
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=244.11 Aligned_cols=234 Identities=22% Similarity=0.275 Sum_probs=173.1
Q ss_pred CCCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHc--CCCCCcccceEEEEcCC----eEEEEEeccCC
Q 019901 1 MLGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~~----~~~lv~e~~~~ 72 (334)
++|.|+| +.+.+.+++.| |||++.... .+.++.|-.+.+. ++|+||++|++.-.... .++||++|.+.
T Consensus 217 li~~Grfg~V~KaqL~~~~V-AVKifp~~~---kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~k 292 (534)
T KOG3653|consen 217 LIGRGRFGCVWKAQLDNRLV-AVKIFPEQE---KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPK 292 (534)
T ss_pred HhhcCccceeehhhccCcee-EEEecCHHH---HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccC
Confidence 4788888 56677788888 999987554 4667777776655 58999999999866554 79999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHS---------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~---------~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~ 143 (334)
|+|.++|+.+ .++......++..++.||+|||+ ..|+|||||..|||+.++.. +.|+|||||......
T Consensus 293 GsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlT--ccIaDFGLAl~~~p~ 369 (534)
T KOG3653|consen 293 GSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLT--CCIADFGLALRLEPG 369 (534)
T ss_pred CcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCc--EEeeccceeEEecCC
Confidence 9999999775 58999999999999999999995 35999999999999988776 999999999764432
Q ss_pred ---CCCCCccCCCccccchhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCC-CC---------------CchHHH
Q 019901 144 ---SQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFE-DP---------------EEPKNF 199 (334)
Q Consensus 144 ---~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~-~~---------------~~~~~~ 199 (334)
+.....+||.+|||||++.+.-- .-+..||||+|.++|||++...-+. +. ...+.+
T Consensus 370 ~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~m 449 (534)
T KOG3653|consen 370 KPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEM 449 (534)
T ss_pred CCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHH
Confidence 22334689999999999965321 1234799999999999998643332 10 011112
Q ss_pred HHHHHHHhhccccCCC-C--CCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 200 RKTIHRILSVQYSIPD-Y--VHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 200 ~~~~~~~~~~~~~~~~-~--~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
+..+-. .+....+|. | ..-...+++.+..||+.||+.|.|+.
T Consensus 450 q~~VV~-kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 450 QELVVR-KKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHh-hccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhH
Confidence 221111 011111221 1 12346689999999999999999974
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-32 Score=239.03 Aligned_cols=237 Identities=24% Similarity=0.359 Sum_probs=181.9
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHc--CCCCCcccceEEEEcC----CeEEEEEeccCCC
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~----~~~~lv~e~~~~~ 73 (334)
||.|+| +.+.++.|+.| |||++.-.. +++..+|.++.+. |+|+||+.|+..-..+ .+++||++|-+.|
T Consensus 219 IGkGRyGEVwrG~wrGe~V-AVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~G 294 (513)
T KOG2052|consen 219 IGKGRFGEVWRGRWRGEDV-AVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHG 294 (513)
T ss_pred ecCccccceeeccccCCce-EEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCC
Confidence 789999 78889999999 999986443 5678888888755 6999999999875433 3699999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----C---CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC--
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHS-----M---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-- 143 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-----~---~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-- 143 (334)
+|+++|.+ ..++.....+++..++.||++||. + .|.|||||..|||+..++. +-|+|+|||......
T Consensus 295 SL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~--C~IADLGLAv~h~~~t~ 371 (513)
T KOG2052|consen 295 SLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSDTD 371 (513)
T ss_pred cHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc--EEEeeceeeEEecccCC
Confidence 99999988 568999999999999999999994 2 4999999999999988876 999999999643322
Q ss_pred ---CCCCCccCCCccccchhhccCCC-----CCccchhhhhhHHHHHHHhC----------CCCCCCCCchHHHHHHHHH
Q 019901 144 ---SQPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHR 205 (334)
Q Consensus 144 ---~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~ 205 (334)
......+||.+|||||++...-- +.+.+||||||.++||++.. .+||.+..+.+...+.+++
T Consensus 372 ~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrk 451 (513)
T KOG2052|consen 372 TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRK 451 (513)
T ss_pred cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhc
Confidence 23456789999999999854221 13448999999999999852 6888765544333344444
Q ss_pred Hhhc---cccCCCCCCCCH---HHHHHHHHhcccCCCCCCCHhHHh
Q 019901 206 ILSV---QYSIPDYVHISP---ECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 206 ~~~~---~~~~~~~~~~~~---~~~~li~~~L~~~p~~R~s~~ell 245 (334)
+.-. .+.+|+.-.-.+ .+..+++.||..||..|.|+-.+.
T Consensus 452 VVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 452 VVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred ceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence 3322 222333222233 355678999999999999987664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=229.01 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=188.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceE-EEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKE-VILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~-~~~~~~~~~lv~e~~~~~~L 75 (334)
||-|.| ++.|+.++..+ ++|.+.... ...+.+.+|...---| .|.||+.-|+ .|++.+.+++++||++.|+|
T Consensus 32 lgeG~FgkIlL~eHr~s~t~i-vlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL 109 (378)
T KOG1345|consen 32 LGEGRFGKILLAEHRQSKTRI-VLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDL 109 (378)
T ss_pred hcccceeeEEeeeccCCceEE-EeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchh
Confidence 566666 69999999999 999998877 5567888888766555 4899999777 47888999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
..-+...+ +.|...+.++.|+++|+.|+|++++||||||.+||||-.....+|||||||+.+..... -...--+..|
T Consensus 110 ~snv~~~G-igE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t--V~~~~~~~~y 186 (378)
T KOG1345|consen 110 RSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT--VKYLEYVNNY 186 (378)
T ss_pred hhhcCccc-ccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce--ehhhhhhccc
Confidence 98887654 88999999999999999999999999999999999997666668999999987743211 1122345679
Q ss_pred ccchhhccC---C-CCCccchhhhhhHHHHHHHhCCCCCCCCCc-hHHHHHHHHHHhhccccCC-CCCCCCHHHHHHHHH
Q 019901 156 IAPEVLLKK---E-YDGKIADVWSCGVTLYVMLVGAYPFEDPEE-PKNFRKTIHRILSVQYSIP-DYVHISPECRHLISR 229 (334)
Q Consensus 156 ~aPE~~~~~---~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~ 229 (334)
.+||.+... . ...+.+|+|.||+++|..+||++||..... ...+.+..+-........| .+..+++.+..+.++
T Consensus 187 ~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk 266 (378)
T KOG1345|consen 187 HAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKK 266 (378)
T ss_pred CCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHH
Confidence 999987532 1 123448999999999999999999974321 1222222222222223333 345679999999999
Q ss_pred hcccCCCCC---CCHhHHhcCccccc
Q 019901 230 IFVADPAKR---ISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R---~s~~ell~h~~~~~ 252 (334)
-|..+|++| .+++......|...
T Consensus 267 ~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 267 SLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hcCCcccccchhHHHHHHHHHHHHHh
Confidence 999999999 66777677777754
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=256.50 Aligned_cols=221 Identities=22% Similarity=0.367 Sum_probs=187.7
Q ss_pred eeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHH
Q 019901 17 LFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFF 94 (334)
Q Consensus 17 ~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 94 (334)
..||||++.... .+...++..|+-.|.+++|||++++++++.... +.||++|+++|+|.++++.. .++.......|.
T Consensus 726 ipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~ 804 (1177)
T KOG1025|consen 726 IPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWC 804 (1177)
T ss_pred ceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHH
Confidence 334999987655 345678999999999999999999999998765 88999999999999999864 458889999999
Q ss_pred HHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc---CCCccccchhhccCCCCCccc
Q 019901 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV---GTPAYIAPEVLLKKEYDGKIA 171 (334)
Q Consensus 95 ~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~~ 171 (334)
.||++|+.|||.+++|||||-.+|+|+..... +|+.|||+|+.........+.. -.+.|||-|.+....|+.. |
T Consensus 805 ~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~h--vkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thq-S 881 (1177)
T KOG1025|consen 805 YQIAKGMKYLEEQRLVHRDLAARNVLVKSPNH--VKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQ-S 881 (1177)
T ss_pred HHHHHHHHHHHhcchhhhhhhhhheeecCCCe--EEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCch-h
Confidence 99999999999999999999999999987665 9999999999765555443332 3567999999999988777 9
Q ss_pred hhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 172 DVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 172 DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
||||+||++||++| |..|+.+... +-+.+.+....+++.++..+-++.-++.+||..|+..||+++++..
T Consensus 882 DVWsfGVtiWElmTFGa~Py~gi~~-----~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 882 DVWSFGVTIWELMTFGAKPYDGIPA-----EEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred hhhhhhhhHHHHHhcCCCccCCCCH-----HHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 99999999999998 8999987654 2334455566668888889999999999999999999999999753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=247.48 Aligned_cols=187 Identities=29% Similarity=0.420 Sum_probs=164.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-----cc---HHHHHHHHHHHcCC---CCCcccceEEEEcCCeEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-----ID---ENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIV 66 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-----~~---~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv 66 (334)
||.|.| +|.++.+...| +||.+.|+..- .+ -.+-.||.+|..++ |+||++++++|++++.+||+
T Consensus 569 lG~GAyGkV~lai~K~n~~eV-ViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~ 647 (772)
T KOG1152|consen 569 LGEGAYGKVNLAIHKENNYEV-VIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLE 647 (772)
T ss_pred ccccccceEEEeeecccceEE-EeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEE
Confidence 577776 68999998888 99999998721 11 24668999999997 99999999999999999999
Q ss_pred Eecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 67 MEYA-SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 67 ~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
||-- +|.+|+++|...++++|.+++.|++|++.|+++||+.||||||||-+|+.++++|- +||+|||-|... ..+.
T Consensus 648 te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~--~klidfgsaa~~-ksgp 724 (772)
T KOG1152|consen 648 TEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGF--VKLIDFGSAAYT-KSGP 724 (772)
T ss_pred ecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCe--EEEeeccchhhh-cCCC
Confidence 9966 45699999999999999999999999999999999999999999999999998876 999999987543 3344
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 192 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 192 (334)
.....||..|.|||++.|.+|-.+.-|||+||+++|.+.....||.+
T Consensus 725 fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 725 FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 56778999999999999999999989999999999999999999864
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-30 Score=215.83 Aligned_cols=201 Identities=42% Similarity=0.614 Sum_probs=171.2
Q ss_pred eeeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 85 (334)
.+....+++.+ ++|++...... ....+.+|+..++.+.|++++++++++......++++|++.+++|..++... ..+
T Consensus 11 ~~~~~~~~~~~-~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~ 89 (215)
T cd00180 11 LARDKKTGKKV-AIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKL 89 (215)
T ss_pred EEEecCCCcEE-EEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCC
Confidence 36666668888 99999876622 2468999999999999999999999999989999999999999999998776 468
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhhcc
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~ 163 (334)
+...+..++.+++.+|.+||++|++|+||+|.||+++. .+ +++|+|||.+....... ......+...|++||.+..
T Consensus 90 ~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~--~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~ 167 (215)
T cd00180 90 SEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG--KVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLG 167 (215)
T ss_pred CHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC--cEEEecCCceEEccCCcchhhcccCCCCccChhHhcc
Confidence 99999999999999999999999999999999999987 44 49999999987543322 1233557889999999877
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhH
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~e 243 (334)
....+..+|+|++|+++++| ..+.+++.+|++.+|.+||++.+
T Consensus 168 ~~~~~~~~D~~~lg~~~~~l-------------------------------------~~~~~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 168 KGYYSEKSDIWSLGVILYEL-------------------------------------PELKDLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred cCCCCchhhhHHHHHHHHHH-------------------------------------HHHHHHHHHHhhCCcccCcCHHH
Confidence 62334458999999999999 56889999999999999999999
Q ss_pred HhcCc
Q 019901 244 IRNHE 248 (334)
Q Consensus 244 ll~h~ 248 (334)
+++|+
T Consensus 211 l~~~~ 215 (215)
T cd00180 211 ILEHL 215 (215)
T ss_pred HhhCC
Confidence 99874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=213.88 Aligned_cols=165 Identities=21% Similarity=0.219 Sum_probs=126.7
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 73 GELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
|+|.+++.+. .++++..++.++.|++.||.|||+++ ||+|||++.++. +|+ ||+++..... ...|
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~--~~~--fG~~~~~~~~----~~~g 66 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGL--LKL--DGSVAFKTPE----QSRV 66 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccc--eee--ccceEeeccc----cCCC
Confidence 6899999864 45999999999999999999999998 999999987664 888 9998754322 2368
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHH-HHHHHHHHhhcccc-CCCCCCCCH--HHHHHH
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILSVQYS-IPDYVHISP--ECRHLI 227 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~--~~~~li 227 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||........ +............. .+....++. .+++++
T Consensus 67 ~~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 67 DPYFMAPEVIQGQSYTEK-ADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred cccccChHHhcCCCCcch-hhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 999999999998888665 9999999999999999999976543222 22222111111000 011112333 699999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||..+|.+|||+.+++.|+|+..
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHH
Confidence 9999999999999999999999853
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=210.38 Aligned_cols=185 Identities=38% Similarity=0.629 Sum_probs=158.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+.+..+++.+ |+|.+...... ..+.+.+|+..++.++|+|++++++.+......++++|++.+++|.+++..
T Consensus 12 ~~~v~~~~~~~~~~~~-~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~ 90 (225)
T smart00221 12 FGKVYLARDKGTGELV-AVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRK 90 (225)
T ss_pred CeEEEEEEEcCCCcEE-EEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHh
Confidence 3444 46677778888 99999877644 567899999999999999999999999988999999999999999999988
Q ss_pred cCC-CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccc
Q 019901 82 AGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~~~-~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aP 158 (334)
... +++..+..++.+++.++.+||+.|++|+||+|.||+++.++ .++|+|||++....... ......++..|++|
T Consensus 91 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~--~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~p 168 (225)
T smart00221 91 KGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG--LVKLADFGLARFIHRDLAALLKTVKGTPFYLAP 168 (225)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC--CEEEeeCceeeEecCcccccccceeccCCcCCH
Confidence 766 89999999999999999999999999999999999998764 49999999987654332 23445688899999
Q ss_pred hhh-ccCCCCCccchhhhhhHHHHHHHhCCCCCCC
Q 019901 159 EVL-LKKEYDGKIADVWSCGVTLYVMLVGAYPFED 192 (334)
Q Consensus 159 E~~-~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 192 (334)
|.+ ....++. ++|+||||+++++|++|+.||..
T Consensus 169 e~~~~~~~~~~-~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 169 EVLLGGKGYGE-AVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred hHhcCCCCCCc-hhhHHHHHHHHHHHHHCCCCccc
Confidence 998 4555555 59999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=210.16 Aligned_cols=219 Identities=18% Similarity=0.248 Sum_probs=176.5
Q ss_pred EEEEEecCcccc-cHHHHHHHHHHHcCCCCCcccceEEEEcC-CeEEEEEeccCCCChHHHHHh--------cCCCCHHH
Q 019901 20 NIIIIVFHLWQI-DENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICN--------AGRFSEDE 89 (334)
Q Consensus 20 aiK~~~~~~~~~-~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~ 89 (334)
-+|.++.+..+. -..+..|--++..+.|||+.++.++..+. ...++++.+..-|+|..++.. .+.++..+
T Consensus 318 ~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~q 397 (563)
T KOG1024|consen 318 LVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQ 397 (563)
T ss_pred HHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHH
Confidence 556655544222 25677888899999999999999987654 456788889988999999872 23477788
Q ss_pred HHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccchhhccCCC
Q 019901 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~ 166 (334)
...++.|++.|++|||+.|+||.||-.+|++|+..- +|||+|-.+++..... ...........||+||.+....|
T Consensus 398 lV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L--qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y 475 (563)
T KOG1024|consen 398 LVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL--QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY 475 (563)
T ss_pred HHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe--eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh
Confidence 889999999999999999999999999999998764 5999999999854332 22333445678999999999988
Q ss_pred CCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 167 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
++. +|+||||+++|||+| |+.|+...++.+. ...+...+++..+.++|+++..++..||+..|++||+++|+.
T Consensus 476 ssa-sDvWsfGVllWELmtlg~~PyaeIDPfEm-----~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv 549 (563)
T KOG1024|consen 476 SSA-SDVWSFGVLLWELMTLGKLPYAEIDPFEM-----EHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLV 549 (563)
T ss_pred cch-hhhHHHHHHHHHHHhcCCCCccccCHHHH-----HHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence 766 999999999999998 8999987665432 233456677777888999999999999999999999999975
Q ss_pred c
Q 019901 246 N 246 (334)
Q Consensus 246 ~ 246 (334)
.
T Consensus 550 ~ 550 (563)
T KOG1024|consen 550 I 550 (563)
T ss_pred H
Confidence 3
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-29 Score=241.09 Aligned_cols=215 Identities=36% Similarity=0.581 Sum_probs=173.6
Q ss_pred HHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCC
Q 019901 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL 114 (334)
Q Consensus 35 ~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dl 114 (334)
+..|.-+-..+.|||++.....+.+....+-+||||++ +|+..+.+.+.++..++..+++|++.|++|+|+.||.|||+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 55666777888999998888777766666666999999 99999999888999999999999999999999999999999
Q ss_pred CCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCC
Q 019901 115 KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 189 (334)
Q Consensus 115 kp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 189 (334)
||+|+++..++. +||+|||.+........ ....+|+..|+|||++.+..|+....||||.|++++-|.+|+.|
T Consensus 447 K~enll~~~~g~--lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~ 524 (601)
T KOG0590|consen 447 KLENLLVTENGI--LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFP 524 (601)
T ss_pred ccccEEEecCCc--eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCc
Confidence 999999988775 99999998864333222 34567999999999999999999999999999999999999999
Q ss_pred CCCCCchHHHHHHHHHHhh---ccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 190 FEDPEEPKNFRKTIHRILS---VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 190 f~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
|......+........... .....+.+..++...+.+|.+||+.+|.+|.|+++|++.+||+.
T Consensus 525 Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~ 590 (601)
T KOG0590|consen 525 WKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS 590 (601)
T ss_pred cccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence 9765443221100000000 00011123357889999999999999999999999999999965
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=227.39 Aligned_cols=229 Identities=24% Similarity=0.360 Sum_probs=175.2
Q ss_pred CCcceee--eeecCCCCeeEEEEEEecCcccc----cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNFY--DRCSYSSDLFVNIIIIVFHLWQI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~~--~~~~~~~~~vvaiK~~~~~~~~~----~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.++|+ ++.+...+.+ +||++.+..... -.+...|++ .+..++||.+++.-+..++...|+|-+|+ ..+|
T Consensus 31 LGstRFlKv~r~k~~eG~v-VvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnL 107 (1431)
T KOG1240|consen 31 LGSTRFLKVARAKDREGLV-VVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNL 107 (1431)
T ss_pred cCchhhhhhhhccCCCceE-EEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhh
Confidence 7889995 6777777777 999998876322 233444555 56679999999999988888899999999 5699
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC--------
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK-------- 147 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~-------- 147 (334)
++.+..++.+...+.++|+.||+.||.-+|..||+|||||.+||||++-+. +.|+||.-.+.........
T Consensus 108 yDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW--~~LtDFAsFKPtYLPeDNPadf~fFFD 185 (1431)
T KOG1240|consen 108 YDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNW--LYLTDFASFKPTYLPEDNPADFTFFFD 185 (1431)
T ss_pred hhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeech--hhhhcccccCCccCCCCCcccceEEEe
Confidence 999988888999999999999999999999999999999999999998765 9999999776543332221
Q ss_pred CccCCCccccchhhccCC---------C-CCccchhhhhhHHHHHHHh-CCCCCCCCCc-------hHHHHHHHHHHhhc
Q 019901 148 STVGTPAYIAPEVLLKKE---------Y-DGKIADVWSCGVTLYVMLV-GAYPFEDPEE-------PKNFRKTIHRILSV 209 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~---------~-~~~~~DiwslG~il~~l~~-g~~pf~~~~~-------~~~~~~~~~~~~~~ 209 (334)
+.....+|.|||.+.... . -.++.||||+||+++||++ |++||.-..- .......+.++
T Consensus 186 TSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I--- 262 (1431)
T KOG1240|consen 186 TSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI--- 262 (1431)
T ss_pred cCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC---
Confidence 122445799999986422 1 2455899999999999998 7999963110 00011111111
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 210 ~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
-+..++++|..|++.+|++|.|+++.|+.
T Consensus 263 ---------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 263 ---------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred ---------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 14579999999999999999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6e-27 Score=216.00 Aligned_cols=225 Identities=29% Similarity=0.509 Sum_probs=189.3
Q ss_pred eeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCC
Q 019901 9 DRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
+.....|..| |+|+.++.... .......|..++..++ ||.+|+++..|+.++.+++++++..||.|...+.+...+
T Consensus 16 ~~g~da~~~y-amkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f 94 (612)
T KOG0603|consen 16 AGGADAGHLY-AMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMF 94 (612)
T ss_pred hccccccchh-hhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCch
Confidence 3445667888 99999887632 2235566788888887 999999999999999999999999999999999998889
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCC
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 165 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 165 (334)
.+.....+...++.+++++|+.+|+|||+|++||+++..|. +++.|||+++....... .|||..|||||++.+
T Consensus 95 ~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Gh--i~~tdfglske~v~~~~---~cgt~eymApEI~~g-- 167 (612)
T KOG0603|consen 95 DELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGH--IKLTDFGLSKEAVKEKI---ACGTYEYRAPEIING-- 167 (612)
T ss_pred HHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCc--cccCCchhhhHhHhhhh---cccchhhhhhHhhhc--
Confidence 99999999999999999999999999999999999998876 99999999886543332 299999999999982
Q ss_pred CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC-----
Q 019901 166 YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS----- 240 (334)
Q Consensus 166 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s----- 240 (334)
. ..++|.||+|+++++|++|..||.+ ..+..+.......|. .++..+++++..++..+|.+|.-
T Consensus 168 h-~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrLg~~~~~ 236 (612)
T KOG0603|consen 168 H-LSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRLGAGPDG 236 (612)
T ss_pred c-CCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHhccCcch
Confidence 3 3348999999999999999999987 344445554444444 57899999999999999999984
Q ss_pred HhHHhcCccccc
Q 019901 241 IPEIRNHEWFLK 252 (334)
Q Consensus 241 ~~ell~h~~~~~ 252 (334)
+.++++|+||..
T Consensus 237 ~~eik~h~f~~~ 248 (612)
T KOG0603|consen 237 VDEIKQHEFFQS 248 (612)
T ss_pred hHHHhccchhee
Confidence 578999999965
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.9e-24 Score=189.59 Aligned_cols=235 Identities=34% Similarity=0.530 Sum_probs=183.5
Q ss_pred CeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCC-CcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---CCCHH
Q 019901 16 DLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHP-NIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---RFSED 88 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp-~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~ 88 (334)
..+ ++|.+...... ....+.+|+.+++.+.|+ +|+++.+.+......+++++++.++++...+.... .++..
T Consensus 23 ~~~-~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 101 (384)
T COG0515 23 KLV-ALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSES 101 (384)
T ss_pred cEE-EEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHH
Confidence 666 99999887632 367899999999999988 79999999988888999999999999997777664 79999
Q ss_pred HHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-------CCCCccCCCccccchhh
Q 019901 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 89 ~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~ 161 (334)
.+..++.|++.++.++|+.|++|||+||+||+++..+. .++++|||+++...... ......||+.|+|||.+
T Consensus 102 ~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~ 180 (384)
T COG0515 102 EALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR-VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180 (384)
T ss_pred HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCC-eEEEeccCcceecCCCCccccccccccccccccccCCHHHh
Confidence 99999999999999999999999999999999986652 39999999987433322 23566799999999999
Q ss_pred ccC--CCCCccchhhhhhHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhhccccCCCCCCC----CHHHHHHHHHhcc
Q 019901 162 LKK--EYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSIPDYVHI----SPECRHLISRIFV 232 (334)
Q Consensus 162 ~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~li~~~L~ 232 (334)
.+. .......|+||+|++++++++|..||..... .......+..........+..... ...+.+++.+++.
T Consensus 181 ~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (384)
T COG0515 181 LGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLA 260 (384)
T ss_pred cCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHh
Confidence 874 3445559999999999999999999876653 222222222211110111111111 2579999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
.+|..|.+..+...+++...
T Consensus 261 ~~~~~r~~~~~~~~~~~~~~ 280 (384)
T COG0515 261 KDPKNRLSSSSDLSHDLLAH 280 (384)
T ss_pred cCchhcCCHHHHhhchHhhC
Confidence 99999999999888876654
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-23 Score=188.70 Aligned_cols=241 Identities=21% Similarity=0.148 Sum_probs=179.3
Q ss_pred CCccee---e-eeecCCC-CeeEEEEEEecCcccccHHHHHHHHHHHcCCC----CCcccceEEE-EcCCeEEEEEeccC
Q 019901 2 LGFHNF---Y-DRCSYSS-DLFVNIIIIVFHLWQIDENVQREIINHRSLRH----PNIVRFKEVI-LTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~-~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h----p~iv~~~~~~-~~~~~~~lv~e~~~ 71 (334)
||.|+| + +.+..++ ..+ |+|+...........+..|+.++..+.. +++..+++.+ ..+..-|+||+.+
T Consensus 26 iG~G~fG~V~~v~~~~~~~~~~-a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~- 103 (322)
T KOG1164|consen 26 IGEGGFGAVYLVSDKSEKNKEY-AKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL- 103 (322)
T ss_pred ccccCCceEEEEEecCCCCeeE-EEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-
Confidence 455555 4 5555554 456 9999887653333378999999988863 6899999998 4777899999998
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-C--CCEEEeccCCcc--CCCCCC
Q 019901 72 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-A--PRLKICDFGYSK--SSVLHS 144 (334)
Q Consensus 72 ~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~--~~~kl~Dfgla~--~~~~~~ 144 (334)
|.+|.++.... +.|+..++..++.|++.+|.+||+.|++||||||+|+++.... . ..+.|.|||+|+ ......
T Consensus 104 G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~ 183 (322)
T KOG1164|consen 104 GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDS 183 (322)
T ss_pred CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCC
Confidence 88999987554 5799999999999999999999999999999999999997653 1 359999999998 321111
Q ss_pred ------C---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC
Q 019901 145 ------Q---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD 215 (334)
Q Consensus 145 ------~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (334)
. .....||..|+++.+..+...... .|+||++.++.+++.|..||..........+........... +.
T Consensus 184 ~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~-DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~-~~ 261 (322)
T KOG1164|consen 184 GGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRR-DDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTD-RF 261 (322)
T ss_pred CcccccCCCCccCCCCccccccHHHhCCCccCCc-hhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccc-cc
Confidence 1 122449999999999888877555 899999999999999999997765433322222111111111 01
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 216 YVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 216 ~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
....+.++..+...+-..+...+|....+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 262 GDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred cCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 2234678888888888889999998877654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4e-24 Score=175.83 Aligned_cols=255 Identities=18% Similarity=0.189 Sum_probs=194.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC-CCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| ++.+..+|..| |||+-.... .-..+..|.++.+.|++ ..|..+..++.+...-.+||+++ |.+|.
T Consensus 23 iGsGSFGdIy~~~~i~~ge~V-AiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE 98 (341)
T KOG1163|consen 23 IGSGSFGDIYLGISITSGEEV-AIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE 98 (341)
T ss_pred ecCCchhheeeeeeccCCceE-EEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence 788888 69999999999 999976655 23568889999999976 78888888888888999999998 88998
Q ss_pred HHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCC--------CCC
Q 019901 77 ERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH--------SQP 146 (334)
Q Consensus 77 ~~l~-~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~--------~~~ 146 (334)
+++. ..+.|+..++..++-|++.-++|+|.+++|||||||+|.|..-+.. .++.|+|||+|+..... ...
T Consensus 99 dLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~ 178 (341)
T KOG1163|consen 99 DLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYRED 178 (341)
T ss_pred HHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccC
Confidence 8876 3466999999999999999999999999999999999999853322 25899999999853322 223
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC---CCCCCHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHISPEC 223 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~ 223 (334)
....||..|.+-....+...+.+ -|+=|+|.++.++..|..||.+....... +-..++.....+.|. +...|.++
T Consensus 179 r~ltGTaRYASinAh~g~eqSRR-DDmeSvgYvLmYfnrG~LPWQglka~tk~-QKyEkI~EkK~s~~ie~LC~G~P~EF 256 (341)
T KOG1163|consen 179 RNLTGTARYASINAHLGIEQSRR-DDMESVGYVLMYFNRGSLPWQGLKAATKK-QKYEKISEKKMSTPIEVLCKGFPAEF 256 (341)
T ss_pred Cccceeeeehhhhhhhhhhhhhh-hhhhhhcceeeeeecCCCcccccchhhHH-HHHHHHHHhhcCCCHHHHhCCCcHHH
Confidence 34579999999877766555444 89999999999999999999986543222 222333333333332 35678999
Q ss_pred HHHHHHhcccCCCCCCC---HhHHhcCccccccCCCccccCC
Q 019901 224 RHLISRIFVADPAKRIS---IPEIRNHEWFLKNLPADLVVDN 262 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s---~~ell~h~~~~~~~~~~~~~~~ 262 (334)
.-.+..|-..--.+-|. +.++..--|+..+...+.+.+.
T Consensus 257 ~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW 298 (341)
T KOG1163|consen 257 AMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDW 298 (341)
T ss_pred HHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeH
Confidence 99999998888788786 3555555555555555555443
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-22 Score=174.36 Aligned_cols=235 Identities=19% Similarity=0.216 Sum_probs=182.1
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
.||-|+| ..++..+++.| |||.-.... ...++..|.+..+.|. .++|..+|.+.+++.+-.+|+|++ |.+|
T Consensus 35 KIGeGsFG~lf~G~Nl~nne~V-AIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSL 110 (449)
T KOG1165|consen 35 KIGEGSFGVLFLGKNLYNNEPV-AIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSL 110 (449)
T ss_pred ccccCcceeeecccccccCceE-EEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCH
Confidence 3788887 48888999999 999976555 3467899999999986 599999999999999999999999 8899
Q ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC---CCEEEeccCCccCCCCCC-------
Q 019901 76 FERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS------- 144 (334)
Q Consensus 76 ~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~---~~~kl~Dfgla~~~~~~~------- 144 (334)
.+++.-. ++|+...+..++.|++.-++++|++.+|+|||||+|+||...+. ..+.++|||+|+......
T Consensus 111 EDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPY 190 (449)
T KOG1165|consen 111 EDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPY 190 (449)
T ss_pred HHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcc
Confidence 9988754 45999999999999999999999999999999999999964332 258999999998543332
Q ss_pred -CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC---CCCCC
Q 019901 145 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD---YVHIS 220 (334)
Q Consensus 145 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~ 220 (334)
...+..||.+||+-....+...+.+ -|+=|||-++++.+.|..||.+.... .......++....-..|. ...+|
T Consensus 191 rE~KSLsGTARYMSINTHlGrEQSRR-DDLEaLGHvFmYFLRGsLPWQGLKA~-tnK~kYeKIGe~Kr~T~i~~Lc~g~P 268 (449)
T KOG1165|consen 191 REHKSLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAD-TNKEKYEKIGETKRSTPIEVLCEGFP 268 (449)
T ss_pred ccccccccceeeeEeeccccchhhhh-hhHHHhhhhhhhhccCCCccccccCc-chHHHHHHhccccccCCHHHHHhcCH
Confidence 2344579999999998888877655 89999999999999999999876542 222333344333222221 22456
Q ss_pred HHHHHHHHHhcccCCCCCCCH
Q 019901 221 PECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~ 241 (334)
.++...+...-..+-.+-|..
T Consensus 269 ~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 269 EEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred HHHHHHHHHHHhcCcccCCCH
Confidence 677776666666666666653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.3e-23 Score=188.60 Aligned_cols=149 Identities=16% Similarity=0.107 Sum_probs=109.4
Q ss_pred CCccee---e-eeecC-CCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF---Y-DRCSY-SSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~---~-~~~~~-~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| + |.++. ++..+ |||.+..... .....+.+|+.+|+.++|+|++..+.. .+..|+|||||.
T Consensus 26 IG~G~fg~Vy~a~~~~~~~~~v-AiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~ 101 (365)
T PRK09188 26 LKRDVFSTVERGYFAGDPGTAR-AVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTE 101 (365)
T ss_pred EeecCcEEEEEEEEcCCCCeEE-EEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccC
Confidence 455544 4 66666 55555 9998764311 124568999999999999999863322 246799999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCC-CCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----- 145 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dl-kp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----- 145 (334)
|++|.. +.. .. ...++.|++.||.|||++||+|||| ||+|||++.++ ++||+|||+|+.....+.
T Consensus 102 G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~--~ikLiDFGlA~~~~~~~~~~~~~ 172 (365)
T PRK09188 102 GVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG--EAAVIDFQLASVFRRRGALYRIA 172 (365)
T ss_pred CCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC--CEEEEECccceecccCcchhhhh
Confidence 999963 211 11 2568899999999999999999999 99999997655 499999999985433221
Q ss_pred ----CCCccCCCccccchhhcc
Q 019901 146 ----PKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 146 ----~~~~~gt~~y~aPE~~~~ 163 (334)
..+..+++.|+|||.+..
T Consensus 173 ~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 173 AYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred hhhhhhhhhccCccCCcccCCh
Confidence 134468888999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=170.29 Aligned_cols=227 Identities=22% Similarity=0.315 Sum_probs=178.9
Q ss_pred eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC-
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR- 84 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~- 84 (334)
+.+.+.+|..+ +.|++..... ...+.+..|.-.|+-..||||+.+++.+..+.++.++..|++.|+|+..+.....
T Consensus 206 lwrgrwqgndi-vakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~v 284 (448)
T KOG0195|consen 206 LWRGRWQGNDI-VAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSV 284 (448)
T ss_pred cccccccCcch-hhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccE
Confidence 44566778888 8888877653 3457888999999999999999999999999999999999999999999987543
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 85 -FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 85 -~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
.+..++..++.+++.|++|||+.. |.---|....++|+.+-..++-.+|--++. ......-.|.||+||.+
T Consensus 285 vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf------qe~gr~y~pawmspeal 358 (448)
T KOG0195|consen 285 VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF------QEVGRAYSPAWMSPEAL 358 (448)
T ss_pred EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee------eccccccCcccCCHHHH
Confidence 677889999999999999999864 444468888999988776556666644332 22344568899999999
Q ss_pred ccCCCC--CccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 162 LKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 162 ~~~~~~--~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
...+.+ .+++|+|||.+++|||.|...||....+.+--.+ +.-...+...++.++..+..+++-|+..||.+||
T Consensus 359 qrkped~n~raadmwsfaillwel~trevpfadlspmecgmk----ialeglrv~ippgis~hm~klm~icmnedpgkrp 434 (448)
T KOG0195|consen 359 QRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK----IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRP 434 (448)
T ss_pred hcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh----hhhccccccCCCCccHHHHHHHHHHhcCCCCcCC
Confidence 876654 4568999999999999999999987665432222 2222334444567899999999999999999999
Q ss_pred CHhHHh
Q 019901 240 SIPEIR 245 (334)
Q Consensus 240 s~~ell 245 (334)
.+..++
T Consensus 435 kfdmiv 440 (448)
T KOG0195|consen 435 KFDMIV 440 (448)
T ss_pred Ccceeh
Confidence 987764
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.3e-23 Score=199.02 Aligned_cols=205 Identities=30% Similarity=0.496 Sum_probs=151.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
+|.+ +++|+.+.+++ |+|+ .++.+ +.|- ++.....|.+| |+-...++..
T Consensus 96 ygavylvrh~~trqrf-a~ki-Nkq~l-----ilRn--ilt~a~npfvv---------------------gDc~tllk~~ 145 (1205)
T KOG0606|consen 96 YGAVYLVRHKETRQRF-AMKI-NKQNL-----ILRN--ILTFAGNPFVV---------------------GDCATLLKNI 145 (1205)
T ss_pred CCceeeeeccccccch-hhcc-cccch-----hhhc--cccccCCccee---------------------chhhhhcccC
Confidence 3444 58888899999 8854 33331 1111 33333444444 4555666666
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC----------------CCC
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----------------SQP 146 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----------------~~~ 146 (334)
++++... +.+++|||+.||+|||+||.|.+|+.-|. +|++|||+++..... ...
T Consensus 146 g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGh--iKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~d 215 (1205)
T KOG0606|consen 146 GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGH--IKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQD 215 (1205)
T ss_pred CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccc--ccccchhhhhhhhhhccchhhhcchHHHHHHhhh
Confidence 6666654 77999999999999999999999987665 999999998742211 112
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
+..+|||.|+|||++..++|. +.+|+|++|+|+|+.+-|+.||.+.+..+.+...+........ ....++++++++
T Consensus 216 KqvcgTPeyiaPeVilrqgyg-kpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE---~dea~p~Ea~dl 291 (1205)
T KOG0606|consen 216 KQVCGTPEYIAPEVILRQGYG-KPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE---EDEALPPEAQDL 291 (1205)
T ss_pred ccccCCccccChhhhhhhccC-CCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc---cCcCCCHHHHHH
Confidence 456899999999999988885 4499999999999999999999998776655554433222221 233578999999
Q ss_pred HHHhcccCCCCCC---CHhHHhcCccccc
Q 019901 227 ISRIFVADPAKRI---SIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~R~---s~~ell~h~~~~~ 252 (334)
|.++|+.+|..|. .+-++.+|+||+.
T Consensus 292 i~~LL~qnp~~Rlgt~ga~evk~h~ff~~ 320 (1205)
T KOG0606|consen 292 IEQLLRQNPLCRLGTGGALEVKQHGFFQL 320 (1205)
T ss_pred HHHHHHhChHhhcccchhhhhhhccceee
Confidence 9999999999996 5778899999964
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=171.67 Aligned_cols=190 Identities=29% Similarity=0.419 Sum_probs=140.7
Q ss_pred CCCCcccceEEEEc---------------------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 019901 46 RHPNIVRFKEVILT---------------------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 98 (334)
Q Consensus 46 ~hp~iv~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil 98 (334)
+|||||++..+|.+ +..+|+||... ..+|..++..+ ..+.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~-~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR-HRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC-CCchHHHHHHHHHHH
Confidence 59999999888752 23689999877 46899988664 467788889999999
Q ss_pred HHHHHHHHCCceeCCCCCCcEEE--cCCCCCCEEEeccCCccCCCCCC-------CCCCccCCCccccchhhccCCC---
Q 019901 99 SGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHS-------QPKSTVGTPAYIAPEVLLKKEY--- 166 (334)
Q Consensus 99 ~~L~~LH~~~ivH~dlkp~NIli--~~~~~~~~kl~Dfgla~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--- 166 (334)
+|+.|||+.||.|||+|..|||+ +.+..+.+.++|||++-.....+ ......|.-.-||||+....+-
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 99999999999999999999998 44555689999999875322211 1123357788999999864332
Q ss_pred --CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 167 --DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 167 --~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
+..++|.|+.|.+.||+++...||....+.-.-....+ ..+ ..+-+..+++.+++++..+|+.+|++|+|+
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yq---e~q-LPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQ---ESQ-LPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhh---hhh-CCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 23348999999999999999999987332110000000 111 112234589999999999999999999984
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.9e-21 Score=161.95 Aligned_cols=131 Identities=19% Similarity=0.179 Sum_probs=100.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--c------------------------cHHHHHHHHHHHcCCCCCcc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--I------------------------DENVQREIINHRSLRHPNIV 51 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~------------------------~~~~~~Ei~~l~~l~hp~iv 51 (334)
||.|++ .|.+. +|+.| |||+++..... . .....+|+..+..+.++++.
T Consensus 5 ig~G~~~~Vy~a~~~-~g~~v-AvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 5 ISTGKEANVYHATTA-NGEER-AIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred cccccceEEEEEECC-CCCEE-EEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 566666 35555 88888 99999875311 1 01234599999999888875
Q ss_pred cceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeCCCCCCcEEEcCCCCCCEE
Q 019901 52 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRDLKLENTLLDGSPAPRLK 130 (334)
Q Consensus 52 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~L-H~~~ivH~dlkp~NIli~~~~~~~~k 130 (334)
....+... . .++||||+.|+++.......++++...+..++.|++.+|.++ |+.||+||||||+|||++. + +++
T Consensus 83 ~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~-~--~v~ 157 (190)
T cd05147 83 CPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHD-G--KLY 157 (190)
T ss_pred CCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEEC-C--cEE
Confidence 54433222 2 389999999887766545567799999999999999999999 7999999999999999973 3 499
Q ss_pred EeccCCccC
Q 019901 131 ICDFGYSKS 139 (334)
Q Consensus 131 l~Dfgla~~ 139 (334)
|+|||+|..
T Consensus 158 LiDFG~a~~ 166 (190)
T cd05147 158 IIDVSQSVE 166 (190)
T ss_pred EEEcccccc
Confidence 999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=165.47 Aligned_cols=157 Identities=13% Similarity=0.166 Sum_probs=117.2
Q ss_pred CcceeeeeecCCCCeeEEEEEEecCcccccH---------HHHHHHHHHHcCCCCCcccceEEEEcC--------CeEEE
Q 019901 3 GFHNFYDRCSYSSDLFVNIIIIVFHLWQIDE---------NVQREIINHRSLRHPNIVRFKEVILTP--------THLAI 65 (334)
Q Consensus 3 G~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~---------~~~~Ei~~l~~l~hp~iv~~~~~~~~~--------~~~~l 65 (334)
|||.++..+. ++..+ |||++......... .+.+|+..+.++.||+|..+.+++... +..++
T Consensus 43 ~f~~v~l~~~-~~~~~-iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~l 120 (232)
T PRK10359 43 DDTKVSLIDT-DYGKY-ILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIM 120 (232)
T ss_pred CceEEEEEec-CCCcE-EEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEE
Confidence 6777766666 56678 99999765522222 268999999999999999999886633 35899
Q ss_pred EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 66 VMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 66 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
||||++|.+|.+.. .+++ ....+++.+|..+|+.|++|||+||+||+++.++ ++|+|||.++.......
T Consensus 121 vmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g---i~liDfg~~~~~~e~~a 189 (232)
T PRK10359 121 LIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG---LRIIDLSGKRCTAQRKA 189 (232)
T ss_pred EEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC---EEEEECCCcccccchhh
Confidence 99999999997763 2333 2456999999999999999999999999998654 99999998764321111
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHH
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 184 (334)
. ...+....+.. ++|+||||+++..+.
T Consensus 190 ~-----------d~~vler~y~~-~~di~~lg~~~~~~~ 216 (232)
T PRK10359 190 K-----------DRIDLERHYGI-KNEIKDLGYYLLIYK 216 (232)
T ss_pred H-----------HHHHHHhHhcc-cccccceeEeehHHH
Confidence 0 11334455664 489999999987664
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.8e-21 Score=159.59 Aligned_cols=132 Identities=19% Similarity=0.174 Sum_probs=103.2
Q ss_pred CCCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-----CCCCcccceEEEEcCC---eEE-EEEec
Q 019901 1 MLGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-----RHPNIVRFKEVILTPT---HLA-IVMEY 69 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-----~hp~iv~~~~~~~~~~---~~~-lv~e~ 69 (334)
+||.|++ +..++.++. . +||++........+.+.+|+.+++.+ .||||++++++++++. .++ +|+||
T Consensus 9 ~LG~G~~~~Vy~hp~~~~-k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~ 86 (210)
T PRK10345 9 PLGTGRHRKCYAHPEDAQ-R-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADF 86 (210)
T ss_pred eecCCCceEEEECCCCcC-e-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecC
Confidence 4788888 234665544 3 68888776444567899999999999 5799999999999873 434 78999
Q ss_pred --cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCCc
Q 019901 70 --ASGGELFERICNAGRFSEDEARFFFQQLISGV-SYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYS 137 (334)
Q Consensus 70 --~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L-~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgla 137 (334)
+.+++|.+++.+. .+++. ..++.|++.++ +|||+.+|+||||||+|||++.. +..+++|+||+.+
T Consensus 87 ~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 87 DGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred CCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 5579999999764 56666 46688888888 99999999999999999999743 2336999996543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.5e-20 Score=155.60 Aligned_cols=177 Identities=16% Similarity=0.126 Sum_probs=125.8
Q ss_pred CcceeeeeecCCCCeeEEEEEEecCcccc----cHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 3 GFHNFYDRCSYSSDLFVNIIIIVFHLWQI----DENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 3 G~g~~~~~~~~~~~~vvaiK~~~~~~~~~----~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
|||+++-... .+..+ +.+.+.-...-. ...+.+|+.+|++|. |+++++++++ +..+++|+|+.|.+|..
T Consensus 14 ~f~~v~~~~~-~~~k~-~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~ 87 (218)
T PRK12274 14 TFGRILLVRG-GERKF-VRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQ 87 (218)
T ss_pred CcceEEEeec-CCcee-eecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHh
Confidence 5666663333 55565 666665544211 125789999999995 4889998886 34699999999999865
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCC-CCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----------
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDL-KLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---------- 146 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dl-kp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---------- 146 (334)
.+.. ....++.|++.+|.++|++||+|||| ||+|||++.++. ++|+|||+|.........
T Consensus 88 ~~~~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~--i~LIDFG~A~~~~~~~~~~r~L~~rDl~ 158 (218)
T PRK12274 88 RPPR-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS--PAVIDFQLAVRGNPRARWMRLLAREDLR 158 (218)
T ss_pred hhhh-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC--EEEEECCCceecCCcchHHHHHHHHHHH
Confidence 4321 12457889999999999999999999 799999986654 999999999854433321
Q ss_pred ----CCccCCCccccchhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCCC
Q 019901 147 ----KSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194 (334)
Q Consensus 147 ----~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 194 (334)
.....++.|++|+.-.-- ..+-...++++.|+-+|.++|+..++.+..
T Consensus 159 ~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 159 HLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 011257888888754322 122123588899999999999999986543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=176.31 Aligned_cols=202 Identities=26% Similarity=0.354 Sum_probs=154.7
Q ss_pred HHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeCCCCCCcE
Q 019901 42 HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQV-CHRDLKLENT 119 (334)
Q Consensus 42 l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~i-vH~dlkp~NI 119 (334)
|+.+.|.|+.++++.+.++...++|.+||..|+|.+.+.. ...++......++++|+.||.|||...| +|+.++..|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 3457888889999999999999998776 9999999999
Q ss_pred EEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccchhhccCCC------CCccchhhhhhHHHHHHHhCCCCC
Q 019901 120 LLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEY------DGKIADVWSCGVTLYVMLVGAYPF 190 (334)
Q Consensus 120 li~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l~~g~~pf 190 (334)
+++.... +||+|||+....... ...........|.|||.+.+... .+++.||||+|++++|+++...||
T Consensus 81 lvd~~w~--lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 81 LVDSRWV--LKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred eeeeeEE--EEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 9987765 999999987654220 11111224457999999976422 245589999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhh-cc----ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 191 EDPEEPKNFRKTIHRILS-VQ----YSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
..........+.+..+.. .. +.+......++++..++..||..+|..||+++++-
T Consensus 159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~ 218 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIR 218 (484)
T ss_pred ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHH
Confidence 864332221333333333 11 11111124567899999999999999999998874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=163.72 Aligned_cols=214 Identities=18% Similarity=0.210 Sum_probs=132.1
Q ss_pred eeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCC----------CCcccceEEEE---------cC---C--
Q 019901 9 DRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRH----------PNIVRFKEVIL---------TP---T-- 61 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~h----------p~iv~~~~~~~---------~~---~-- 61 (334)
+.+..||+.+ |+|++..... ...+++++|.-....+.+ -.++..++... .. +
T Consensus 31 v~d~~t~~~~-avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~ 109 (288)
T PF14531_consen 31 VTDVETGEEF-AVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIY 109 (288)
T ss_dssp EEETTTTEEE-EEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEE
T ss_pred EEEccCCceE-EEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccc
Confidence 8899999999 9999877652 223566666655544322 12333333322 11 1
Q ss_pred ---eEEEEEeccCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEE
Q 019901 62 ---HLAIVMEYASGGELFERIC---NAGRF----SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKI 131 (334)
Q Consensus 62 ---~~~lv~e~~~~~~L~~~l~---~~~~~----~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl 131 (334)
..+++|+-+ .++|.+.+. ..... .......+..|++..+++||+.|+||+||+|+|++++.+|. +.|
T Consensus 110 ~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~--v~L 186 (288)
T PF14531_consen 110 WVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGG--VFL 186 (288)
T ss_dssp EEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS---EEE
T ss_pred eeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCC--EEE
Confidence 236788877 568877654 22222 12223445689999999999999999999999999998775 999
Q ss_pred eccCCccCCCCCCCCCCccCCCccccchhhccC-------CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHH
Q 019901 132 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204 (334)
Q Consensus 132 ~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 204 (334)
+||+........... ...+..|.+||..... ...+.+.|.|+||+++|.|+|++.||.......
T Consensus 187 g~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~------- 257 (288)
T PF14531_consen 187 GDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEA------- 257 (288)
T ss_dssp --GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGS-------
T ss_pred cChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccc-------
Confidence 999876543221111 3345779999976432 112445899999999999999999998654321
Q ss_pred HHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 205 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
.....+..+.++|..++.+|..+|+.+|.+|
T Consensus 258 ---~~~~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 258 ---DPEWDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp ---TSGGGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred ---cccccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 1111344445789999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=155.30 Aligned_cols=132 Identities=16% Similarity=0.161 Sum_probs=101.6
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccc--------------------------cHHHHHHHHHHHcCCCCCcc
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQI--------------------------DENVQREIINHRSLRHPNIV 51 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~--------------------------~~~~~~Ei~~l~~l~hp~iv 51 (334)
||.|++ + |.+. +|+.| |||++....... ....++|...+..+.|+++.
T Consensus 5 ig~G~~~~Vy~a~~~-~g~~v-avKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 5 ISTGKEANVYHARTG-DGEEL-AVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred eecCCCcEEEEEEcC-CCCEE-EEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 455555 3 5555 88998 999998763110 11246789999999999886
Q ss_pred cceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEE
Q 019901 52 RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLK 130 (334)
Q Consensus 52 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~k 130 (334)
....+.... .++||||+.|+++........+++...+..++.|++.+|.++|+ +||+||||||+|||++ ++ +++
T Consensus 83 ~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~--~~~ 157 (190)
T cd05145 83 VPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG--KPY 157 (190)
T ss_pred CceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC--CEE
Confidence 655544333 38999999988665443345668889999999999999999999 9999999999999997 43 499
Q ss_pred EeccCCccCC
Q 019901 131 ICDFGYSKSS 140 (334)
Q Consensus 131 l~Dfgla~~~ 140 (334)
|+|||+|+..
T Consensus 158 liDFG~a~~~ 167 (190)
T cd05145 158 IIDVSQAVEL 167 (190)
T ss_pred EEEcccceec
Confidence 9999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.6e-21 Score=176.97 Aligned_cols=175 Identities=27% Similarity=0.350 Sum_probs=133.0
Q ss_pred eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 62 HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 62 ~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.+||.|++|...+|.+++.+... .+....+.++.|+..|++| +|.+|||+||.||+...+. ++||.|||+..
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~--q~kIgDFgl~t 404 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD--QLKIGDFGLVT 404 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch--hhhhhhhhhee
Confidence 58999999999999999975433 5677899999999999999 9999999999999997665 49999999987
Q ss_pred CCCCCC-------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhcc
Q 019901 139 SSVLHS-------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQ 210 (334)
Q Consensus 139 ~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 210 (334)
...... ......||++||+||.+.++.|..+ +||||||+|++||+. -..+|.. ......+....
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~k-vdIyaLGlil~EL~~~f~T~~er-------~~t~~d~r~g~ 476 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEK-VDIYALGLILAELLIQFSTQFER-------IATLTDIRDGI 476 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhh-cchhhHHHHHHHHHHHhccHHHH-------HHhhhhhhcCC
Confidence 554443 2345579999999999999999776 999999999999996 2223321 11122222222
Q ss_pred ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 211 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 211 ~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
++.....+ .+.-..|+.+||.+.|.+||++.+.-.|+|.
T Consensus 477 ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 477 IPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred CChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 22111112 3556789999999999999987777667664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.5e-22 Score=189.20 Aligned_cols=249 Identities=30% Similarity=0.471 Sum_probs=196.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|.+ .+.+..+....+|.|.+.... ......+..|..+.+.+. |+|++.+++........+++++|..|++
T Consensus 28 ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~ 107 (601)
T KOG0590|consen 28 IGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGS 107 (601)
T ss_pred ccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccc
Confidence 455555 344444455555777776654 233456677999988887 9999999999999999999999999999
Q ss_pred hHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCC---CC
Q 019901 75 LFERI-CNAG-RFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQ---PK 147 (334)
Q Consensus 75 L~~~l-~~~~-~~~~~~~~~~~~qil~~L~~LH-~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~---~~ 147 (334)
++..+ .... ..+...+..++.|+..++.|+| ..++.|||+||+|.+++..+. .++++|||+|..... .+. ..
T Consensus 108 ~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~-~l~~~df~~At~~~~~~g~~~~~~ 186 (601)
T KOG0590|consen 108 LFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGS-ALKIADFGLATAYRNKNGAERSLK 186 (601)
T ss_pred cccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCC-cccCCCchhhccccccCCcceeee
Confidence 99988 5554 5778889999999999999999 999999999999999988773 499999999986554 222 23
Q ss_pred CccC-CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 148 STVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 148 ~~~g-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
..+| ++.|+|||...+..+..+..|+||.|+++.-+++|..||................ ........+..++....++
T Consensus 187 ~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 265 (601)
T KOG0590|consen 187 DRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSN-KGRFTQLPWNSISDQAHDL 265 (601)
T ss_pred cccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccc-ccccccCccccCChhhhhc
Confidence 3468 9999999999887787777999999999999999999998655433211111111 1122244566789999999
Q ss_pred HHHhcccCCCCCCCHhHHhcCccccc
Q 019901 227 ISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+.++|..+|..|.+.+++..++|+..
T Consensus 266 l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 266 LHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ccccccCCchhccccccccccccccc
Confidence 99999999999999999999999977
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.7e-18 Score=145.04 Aligned_cols=132 Identities=17% Similarity=0.134 Sum_probs=98.1
Q ss_pred CCccee---e-ee-ecCCCCeeEEEEEEecCccc------------------------ccHHHHHHHHHHHcCCCCCccc
Q 019901 2 LGFHNF---Y-DR-CSYSSDLFVNIIIIVFHLWQ------------------------IDENVQREIINHRSLRHPNIVR 52 (334)
Q Consensus 2 lG~g~~---~-~~-~~~~~~~vvaiK~~~~~~~~------------------------~~~~~~~Ei~~l~~l~hp~iv~ 52 (334)
||.|++ + |. +..+|..| |||++...... ....+.+|+..++.+.+.+ +.
T Consensus 36 Lg~G~~g~Vy~a~~~~~~g~~v-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~-i~ 113 (237)
T smart00090 36 ISTGKEANVYHALDFDGSGKER-AVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG-VP 113 (237)
T ss_pred eccCcceeEEEEEecCCCCcEE-EEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC-CC
Confidence 455554 3 55 56789998 99999865311 0123578999999997633 22
Q ss_pred ceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeCCCCCCcEEEcCCCCCCEEE
Q 019901 53 FKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKI 131 (334)
Q Consensus 53 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~-ivH~dlkp~NIli~~~~~~~~kl 131 (334)
+..++.. +..++||||+.|++|.........+....+..++.|++.+|.+||+.| ++||||||+||+++ .+ .++|
T Consensus 114 ~p~~~~~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~--~i~L 189 (237)
T smart00090 114 VPKPIAW-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DG--KVVI 189 (237)
T ss_pred CCeeeEe-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CC--CEEE
Confidence 2233322 235899999999888766544555677778899999999999999999 99999999999998 33 4999
Q ss_pred eccCCccC
Q 019901 132 CDFGYSKS 139 (334)
Q Consensus 132 ~Dfgla~~ 139 (334)
+|||.|..
T Consensus 190 iDFg~a~~ 197 (237)
T smart00090 190 IDVSQSVE 197 (237)
T ss_pred EEChhhhc
Confidence 99998763
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.6e-18 Score=165.35 Aligned_cols=180 Identities=24% Similarity=0.295 Sum_probs=140.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCc-c--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHL-W--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~-~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
+|-|+| + |.+.. |+.| |||+-+... + -+..++...++ .+ --+.|..+..++...+.-++|++|.+.|+
T Consensus 706 ~G~g~y~~vy~a~~~~-~~~~-alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt 780 (974)
T KOG1166|consen 706 IGEGSYGSVYVATHSN-GKLV-ALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASVLVSEYSPYGT 780 (974)
T ss_pred eccccceEEEEeecCC-CcEE-EEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcceeeeecccccc
Confidence 455555 4 44444 8888 999988765 2 22344444433 11 13456666666666778899999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-----CCCCCEEEeccCCccCCCCCCC---C
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSKSSVLHSQ---P 146 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-----~~~~~~kl~Dfgla~~~~~~~~---~ 146 (334)
|.+++...+.+++..+..++.|++..+++||..+||||||||.|.||.. .+...++|+|||.|..+..... .
T Consensus 781 lld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F 860 (974)
T KOG1166|consen 781 LLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKF 860 (974)
T ss_pred HHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEE
Confidence 9999998888999999999999999999999999999999999999942 2233599999998875443332 2
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCC
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA 187 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 187 (334)
...++|-.+-.+|+..|.+|+.. .|.|.|+.+++-|+.|+
T Consensus 861 ~~~~~td~f~C~EM~~grpWtYq-~DyfGlAa~~h~mLFG~ 900 (974)
T KOG1166|consen 861 KAVWHTDLFDCIEMREGRPWTYQ-IDYFGLAATVHVMLFGK 900 (974)
T ss_pred eeeeccccchhHHHhcCCCCchh-hhhHHHHHHHHHHHHHH
Confidence 34568899999999999999877 89999999999999886
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=4.3e-17 Score=138.45 Aligned_cols=130 Identities=21% Similarity=0.197 Sum_probs=104.4
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccc--------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQI--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~--------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|++ +.+....|..+ ++|+........ ...+.+|+.++..+.|+++.....++...+..++||||++
T Consensus 4 l~~G~~~~vy~~~~~~~~~-~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 82 (211)
T PRK14879 4 IKRGAEAEIYLGDFLGIKA-VIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIE 82 (211)
T ss_pred cccCceEEEEEEeeCCCce-EEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeC
Confidence 566666 33334478888 999865433211 1357789999999999999887777777788899999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
|++|.+.+.... . ....++.+++.+|.++|+.|++|||++|.|||++ .+ .++|+|||+++.
T Consensus 83 G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~--~~~liDf~~a~~ 143 (211)
T PRK14879 83 GEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG--KIYLIDFGLAEF 143 (211)
T ss_pred CcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC--CEEEEECCcccC
Confidence 999999886543 2 7889999999999999999999999999999998 33 499999998764
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.4e-17 Score=137.12 Aligned_cols=128 Identities=20% Similarity=0.175 Sum_probs=100.1
Q ss_pred CCCccee--eeeecCCCCeeEEEEEEecCcccc--------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 1 MLGFHNF--YDRCSYSSDLFVNIIIIVFHLWQI--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~--------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
+||.|++ +.+...+|..+ ++|......... .+.+.+|+.+++.+.|+++....-++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~-viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKA-VIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecCCccE-EEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4677777 33444677777 999865432111 245778999999999988766665666667789999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
+|++|.+.+..... .++.+++.+|.+||+.|++|||++|.||+++ .+ +++++|||+++.
T Consensus 80 ~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~--~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD--KLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC--cEEEEECCCCcC
Confidence 99999988755321 8899999999999999999999999999998 33 499999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.69 E-value=2e-16 Score=152.48 Aligned_cols=127 Identities=21% Similarity=0.206 Sum_probs=98.8
Q ss_pred CCCccee--eeeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 1 MLGFHNF--YDRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
+||.|++ +.+....+..+ ++|........ ..+.+.+|+.+++.++|++++....++......++||||+
T Consensus 340 ~iG~G~~g~Vy~~~~~~~~~-v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~ 418 (535)
T PRK09605 340 LIGKGAEADIKKGEYLGRDA-VIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYI 418 (535)
T ss_pred eeccCCcEEEEEEeecCccc-eeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEec
Confidence 3677777 33444555555 55543322111 1246789999999999999988877777777789999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
+|++|.+.+. ....++.+++.+|.+||+.|++||||||+|||++ ++ .++|+|||+++.
T Consensus 419 ~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~--~~~liDFGla~~ 476 (535)
T PRK09605 419 GGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD--RLYLIDFGLGKY 476 (535)
T ss_pred CCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC--cEEEEeCccccc
Confidence 9999998875 4577899999999999999999999999999994 33 499999999874
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.4e-15 Score=131.18 Aligned_cols=128 Identities=17% Similarity=0.133 Sum_probs=94.3
Q ss_pred CcceeeeeecCCCCeeEEEEEEecCcc-------------cccHHHHHHHHHHHcCCCCCc--ccceEEEEcC-C---eE
Q 019901 3 GFHNFYDRCSYSSDLFVNIIIIVFHLW-------------QIDENVQREIINHRSLRHPNI--VRFKEVILTP-T---HL 63 (334)
Q Consensus 3 G~g~~~~~~~~~~~~vvaiK~~~~~~~-------------~~~~~~~~Ei~~l~~l~hp~i--v~~~~~~~~~-~---~~ 63 (334)
|.|++..... .+..+ +||.+..... .....+.+|+.++..+.|++| ++.+++.... + ..
T Consensus 44 g~gtv~~v~~-~~~~~-vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~ 121 (239)
T PRK01723 44 GRGTTWFVQT-PGVNW-VLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRA 121 (239)
T ss_pred CCccEEEEEe-CCceE-EEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceee
Confidence 5666643333 36777 8998854220 123568889999999998875 5666654332 2 23
Q ss_pred EEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 64 AIVMEYASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 64 ~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
++|||+++| .+|.+++.. ..+++.. +.+++.+|.+||++||+||||||.|||++.++ .++|+|||.++.
T Consensus 122 ~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~--~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG--KFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC--CEEEEECCCccc
Confidence 599999997 688887754 4566543 56899999999999999999999999998655 499999998763
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.3e-15 Score=126.63 Aligned_cols=125 Identities=18% Similarity=0.202 Sum_probs=92.0
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCccc----------------------ccHHHHHHHHHHHcCCCCC--cccce
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQ----------------------IDENVQREIINHRSLRHPN--IVRFK 54 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~----------------------~~~~~~~Ei~~l~~l~hp~--iv~~~ 54 (334)
||.|++ +.....+|..+ |||++...... ......+|+.++..+.|++ ++..+
T Consensus 23 i~~G~~g~Vy~~~~~~g~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~ 101 (198)
T cd05144 23 IGVGKESDVYLALDPDGNPV-ALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI 101 (198)
T ss_pred cccCcceEEEEEEcCCCCEE-EEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee
Confidence 556655 32233478888 99997754300 1123678899999888774 33333
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEecc
Q 019901 55 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 134 (334)
Q Consensus 55 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Df 134 (334)
+ .+..++||||++|++|...... .....++.+++.++.++|+.|++||||||+||+++.++ .++|+||
T Consensus 102 ~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~--~~~liDf 169 (198)
T cd05144 102 D----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE--KIYIIDW 169 (198)
T ss_pred e----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC--cEEEEEC
Confidence 2 2445899999999998765321 34667889999999999999999999999999998655 4999999
Q ss_pred CCccC
Q 019901 135 GYSKS 139 (334)
Q Consensus 135 gla~~ 139 (334)
|++..
T Consensus 170 g~~~~ 174 (198)
T cd05144 170 PQMVS 174 (198)
T ss_pred Ccccc
Confidence 99864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.63 E-value=7.1e-15 Score=137.71 Aligned_cols=166 Identities=16% Similarity=0.251 Sum_probs=131.3
Q ss_pred eecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHH
Q 019901 10 RCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89 (334)
Q Consensus 10 ~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 89 (334)
..+.++..+ .|..++...-.....+.+.++.|+.++||||+++++.++.++++|+|+|.+. .|..++++. +...
T Consensus 32 t~k~~~~~v-sVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~ 105 (690)
T KOG1243|consen 32 TRKADGGPV-SVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEE 105 (690)
T ss_pred ceeccCCce-EEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHH
Confidence 456677777 9999887764445678899999999999999999999999999999999984 677788764 3778
Q ss_pred HHHHHHHHHHHHHHHH-HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhhccCCCC
Q 019901 90 ARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVLLKKEYD 167 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH-~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~ 167 (334)
+...++||+.||.||| +++++|++|....|+++..|. .||++|.++........ .....---.|..|+.+....++
T Consensus 106 v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~Ge--WkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~~s 183 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGE--WKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSEWS 183 (690)
T ss_pred HHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCc--EEEeeeEEEeccccCCcccccchhhhcccChhhcCccccc
Confidence 8899999999999998 678999999999999988776 99999998764433322 1112222346677765433321
Q ss_pred CccchhhhhhHHHHHHHhC
Q 019901 168 GKIADVWSCGVTLYVMLVG 186 (334)
Q Consensus 168 ~~~~DiwslG~il~~l~~g 186 (334)
.|.|-|||++++++.|
T Consensus 184 ---~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 184 ---IDSWGLGCLIEELFNG 199 (690)
T ss_pred ---hhhhhHHHHHHHHhCc
Confidence 6999999999999998
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.1e-15 Score=131.75 Aligned_cols=201 Identities=18% Similarity=0.288 Sum_probs=140.8
Q ss_pred HHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC--Cc
Q 019901 41 NHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSM--QV 109 (334)
Q Consensus 41 ~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qil~~L~~LH~~--~i 109 (334)
.|-.+.|.|||+++.++.+. ....+++||+..|++..+|++. ..+.....++|+-||+.||.|||+. -|
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 44556799999999998653 3589999999999999999764 3488889999999999999999986 49
Q ss_pred eeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-----CCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHH
Q 019901 110 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-----LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184 (334)
Q Consensus 110 vH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~ 184 (334)
+|+++.+.-|++..++. +|+.--.-..... .........+-+.|.|||.=....-... +|||++|+...+|.
T Consensus 200 ihgnlTc~tifiq~ngL--Ikig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a-~dIy~fgmcAlema 276 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGL--IKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA-SDIYKFGMCALEMA 276 (458)
T ss_pred ccCCcchhheeecCCce--EEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc-hhhhhhhHHHHHHH
Confidence 99999999999986664 5554322111000 0000111246788999996544444444 89999999999998
Q ss_pred hCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 185 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 185 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+..--...+........+.+..- .+. .+--+.++.+||+-.|..||++..++.||.+.+
T Consensus 277 ilEiq~tnseS~~~~ee~ia~~i~---~le-----n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 277 ILEIQSTNSESKVEVEENIANVII---GLE-----NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HheeccCCCcceeehhhhhhhhee---ecc-----CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 877653333322222222222111 111 223357899999999999999999999998865
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.4e-15 Score=141.03 Aligned_cols=229 Identities=20% Similarity=0.166 Sum_probs=174.8
Q ss_pred cCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC-CCH
Q 019901 12 SYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSE 87 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~ 87 (334)
..++..+ |+|.-+... ......=.+|+...+.++ |++.++.+..++..+.+++-+|+| +.+|..+...... +++
T Consensus 140 ~~s~~~~-a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~ 217 (524)
T KOG0601|consen 140 SESPHKF-AVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPD 217 (524)
T ss_pred ccCCccc-ccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCc
Confidence 7888888 888844433 133344556777777774 899999999999999999999999 4677777665444 889
Q ss_pred HHHHHHHHHHHH----HHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC------CCccCCCcccc
Q 019901 88 DEARFFFQQLIS----GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------KSTVGTPAYIA 157 (334)
Q Consensus 88 ~~~~~~~~qil~----~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~------~~~~gt~~y~a 157 (334)
..++..+.+... ||.++|+.+++|-|+||.||+...+. ..++++|||+.......... ....|...|++
T Consensus 218 ~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~-~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ 296 (524)
T KOG0601|consen 218 NLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW-TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAA 296 (524)
T ss_pred hhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc-ceeecCCcceeEEccCCccccceeeeecCCCCceEeC
Confidence 999999999999 99999999999999999999998773 35999999998755444322 12257788999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCC--CchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP--EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
||...+-. +..+|++++|.++.+..++..++... ..+..++.. ..........+..+...+..|++.+|
T Consensus 297 ke~~~~l~--~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~-------~ip~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 297 KELLNGLA--TFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG-------YIPLEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred hhhhcccc--chHhhhcchhhhhHhhHhhcccccCCCCCCccccccc-------cCchhhhcCcchhhhhHHHHhcCcch
Confidence 99875433 44589999999999999887777654 333322221 11112233457788889999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
..|++++.+++|+++..
T Consensus 368 ~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIHS 384 (524)
T ss_pred hhhhHHHHHhccccccc
Confidence 99999999999999865
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.58 E-value=6.4e-16 Score=150.47 Aligned_cols=236 Identities=27% Similarity=0.391 Sum_probs=177.1
Q ss_pred eeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCC
Q 019901 9 DRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
++-..+|... ++|...+... ...+.+..+-.++-...+|.++...--+......+++++|..+++|...+.+.+..
T Consensus 823 ~~pa~sgh~~-~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~ 901 (1205)
T KOG0606|consen 823 ASPAGSGHTR-PSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCL 901 (1205)
T ss_pred CCcccccccc-chhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCc
Confidence 4445566666 6666555441 11233334444443445577776655555667899999999999999999998888
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC-CCC-----C----------------
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVL-----H---------------- 143 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~-~~~-----~---------------- 143 (334)
+..-++.++..+..++++||+..+.|+|++|.|+++...+. .+++|||.... ... .
T Consensus 902 saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh--~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~ 979 (1205)
T KOG0606|consen 902 SAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGH--RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSE 979 (1205)
T ss_pred ccccccchhHHHHhhhhccccchhhcccccccchhhcccCC--cccCccccccccccccCcCCcccccccCccccccccc
Confidence 88899999999999999999999999999999999977665 89999984321 000 0
Q ss_pred ----------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC
Q 019901 144 ----------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213 (334)
Q Consensus 144 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 213 (334)
.......||+.|.+||...+...... +|+|++|+++++.++|.+||...+....++ ++.+.....
T Consensus 980 ~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~-ad~~~~g~~l~e~l~g~pp~na~tpq~~f~----ni~~~~~~~ 1054 (1205)
T KOG0606|consen 980 RRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA-ADWWSSGVCLFEVLTGIPPFNAETPQQIFE----NILNRDIPW 1054 (1205)
T ss_pred cccccccchhhccccccCCCcccCCcccccccCCCc-chhhhhhhhhhhhhcCCCCCCCcchhhhhh----ccccCCCCC
Confidence 00122358999999999988877555 899999999999999999999877755443 344444443
Q ss_pred CC-CCCCCHHHHHHHHHhcccCCCCCCCHh---HHhcCccccc
Q 019901 214 PD-YVHISPECRHLISRIFVADPAKRISIP---EIRNHEWFLK 252 (334)
Q Consensus 214 ~~-~~~~~~~~~~li~~~L~~~p~~R~s~~---ell~h~~~~~ 252 (334)
|. ....++.+++++.+.|..+|.+|..+. ++..|+||+.
T Consensus 1055 p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~ 1097 (1205)
T KOG0606|consen 1055 PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQD 1097 (1205)
T ss_pred CCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCC
Confidence 33 345789999999999999999999877 8899999965
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.9e-14 Score=114.88 Aligned_cols=125 Identities=22% Similarity=0.184 Sum_probs=98.9
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC--CCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|.+ +.+-...+..+ ++|+...... ...+.+|+..++.+.+ +++++++..+...+..+++|||+.|+.+..
T Consensus 6 i~~g~~~~v~~~~~~~~~~-~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~ 82 (155)
T cd05120 6 LKGGLTNRVYLLGTKDEDY-VLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDE 82 (155)
T ss_pred cccccccceEEEEecCCeE-EEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeeccc
Confidence 455555 22223344677 9999866542 5679999999999976 588999888887788999999999887754
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~---~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
. +......++.+++.+|..+|.. +++|+|++|.||+++..+ .++++|||.++
T Consensus 83 ~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~--~~~l~Df~~~~ 137 (155)
T cd05120 83 V-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK--ILGIIDWEYAG 137 (155)
T ss_pred C-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc--EEEEEeccccc
Confidence 3 4567778899999999999984 799999999999998644 49999999876
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.54 E-value=7.8e-14 Score=116.05 Aligned_cols=128 Identities=16% Similarity=0.213 Sum_probs=85.4
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccc---cHH---------------------HHHHHHHHHcCCCCC--cc
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQI---DEN---------------------VQREIINHRSLRHPN--IV 51 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~---~~~---------------------~~~Ei~~l~~l~hp~--iv 51 (334)
||.|++ + +.+. +|+.| |||++....... ... ...|...+..+.+.+ +.
T Consensus 5 lg~G~~g~Vy~a~~~-~~~~v-avKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 5 IGTGKEADVYLALDG-DGEPV-AVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccceeEEEEECC-CCCEE-EEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 555555 3 4444 78888 999987654111 111 134555565554433 33
Q ss_pred cceEEEEcCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCE
Q 019901 52 RFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRL 129 (334)
Q Consensus 52 ~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~ 129 (334)
+++.. ...++||||+.++.+.. .+.... .. ..+..++.+++.++.++|. .||+||||||+||+++ ++ .+
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~--~~ 153 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG--KV 153 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC--cE
Confidence 34332 23589999999854321 121111 11 6788999999999999999 9999999999999998 44 49
Q ss_pred EEeccCCccCC
Q 019901 130 KICDFGYSKSS 140 (334)
Q Consensus 130 kl~Dfgla~~~ 140 (334)
+|+|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.1e-13 Score=126.67 Aligned_cols=227 Identities=19% Similarity=0.169 Sum_probs=163.3
Q ss_pred CCCCeeEEEEEEecCccccc--HHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHH
Q 019901 13 YSSDLFVNIIIIVFHLWQID--ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~--~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 89 (334)
.++-.| ++|-......... ..-..|+.+...+ .|.++++.+..|......|+-.|||+++++...+.-...+.+..
T Consensus 289 ~~~~~Y-~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 289 EGDCIY-AAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred CCCceE-eChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcch
Confidence 556677 8877766542222 2334566666655 58999998888888888889999999999877765555688899
Q ss_pred HHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc-cchhhccCCCCC
Q 019901 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI-APEVLLKKEYDG 168 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~ 168 (334)
.+.+..|++.++.++|++.++|+|+||+||++..++ ...++.|||+.+.... ........-+++ .+|++.......
T Consensus 368 ~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~-~~~~~~~~~~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~ 444 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDG-FFSKLGDFGCWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHL 444 (524)
T ss_pred hhhhHHHHHhccccccchhhhcccccccceeeccch-hhhhccccccccccce--ecccccccccccccchhhccccccc
Confidence 999999999999999999999999999999998754 3489999998764211 112223344455 255555444444
Q ss_pred ccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 019901 169 KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 248 (334)
Q Consensus 169 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~ 248 (334)
.+.|++|||..+.+.+++.+.-....... .+... ..|.......++..+.+.++.+++..|+++.++..|+
T Consensus 445 ~~~~~~sl~~~~~e~~~~~~ls~~~~~~~-------~i~~~--~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~ 515 (524)
T KOG0601|consen 445 SKADIFSLGLSVDEAITGSPLSESGVQSL-------TIRSG--DTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS 515 (524)
T ss_pred cccccccccccccccccCcccCcccccce-------eeecc--cccCCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence 55899999999999998875544322211 11111 2233334558899999999999999999999998887
Q ss_pred cccc
Q 019901 249 WFLK 252 (334)
Q Consensus 249 ~~~~ 252 (334)
-|..
T Consensus 516 ~~~~ 519 (524)
T KOG0601|consen 516 EFYR 519 (524)
T ss_pred hhhh
Confidence 7643
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.36 E-value=8.4e-12 Score=103.43 Aligned_cols=97 Identities=14% Similarity=0.208 Sum_probs=72.7
Q ss_pred HHHHHHHcCCC--CCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HHCCceeCC
Q 019901 37 REIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYC-HSMQVCHRD 113 (334)
Q Consensus 37 ~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~L-H~~~ivH~d 113 (334)
+|.+.|+++.. -++.+++.+ ..-+|||||+.++.+....-+...+++..+..+..+++.+|..| |..|+||||
T Consensus 75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGD 150 (197)
T cd05146 75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHAD 150 (197)
T ss_pred HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 79999988864 345555544 34589999997654432222233466677788899999999998 899999999
Q ss_pred CCCCcEEEcCCCCCCEEEeccCCccCC
Q 019901 114 LKLENTLLDGSPAPRLKICDFGYSKSS 140 (334)
Q Consensus 114 lkp~NIli~~~~~~~~kl~Dfgla~~~ 140 (334)
|+|.|||+.. + .+.|+|||.|...
T Consensus 151 Ls~~NIL~~~-~--~v~iIDF~qav~~ 174 (197)
T cd05146 151 LSEYNMLWHD-G--KVWFIDVSQSVEP 174 (197)
T ss_pred CCHHHEEEEC-C--cEEEEECCCceeC
Confidence 9999999974 3 3999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.36 E-value=4.1e-12 Score=103.87 Aligned_cols=112 Identities=21% Similarity=0.261 Sum_probs=82.1
Q ss_pred cCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcc-cceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHH
Q 019901 12 SYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 90 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 90 (334)
...++.| ++|+..... .......+|+..++.+.+.+++ +++... ...-++||||++|.++... ....
T Consensus 18 ~~~~~~~-~lK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~--------~~~~ 85 (170)
T cd05151 18 EVANKKY-VVRIPGNGT-ELLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE--------DFSD 85 (170)
T ss_pred EECCeEE-EEEeCCCCc-ccccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc--------cccC
Confidence 3457788 999976543 2234578999999988765544 455443 2334899999999887543 1112
Q ss_pred HHHHHHHHHHHHHHHHCCc-----eeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 91 RFFFQQLISGVSYCHSMQV-----CHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~~i-----vH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
..++.+++.+|..||+.++ +|+|++|.||+++ ++ +++++|||.+.
T Consensus 86 ~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~--~~~liDf~~a~ 135 (170)
T cd05151 86 PENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG--RLWLIDWEYAG 135 (170)
T ss_pred HHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC--eEEEEeccccc
Confidence 3456789999999999885 9999999999998 33 49999999765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.33 E-value=1e-11 Score=116.37 Aligned_cols=76 Identities=16% Similarity=0.162 Sum_probs=57.2
Q ss_pred CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCc
Q 019901 60 PTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLIS-GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137 (334)
Q Consensus 60 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~-~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla 137 (334)
.+..++||||++|++|.+..... .... ...++.+++. .+..+|..|++|+|+||.||+++.++ +++++|||++
T Consensus 230 ~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g--~i~liDfG~~ 304 (437)
T TIGR01982 230 TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDG--KIIALDFGIV 304 (437)
T ss_pred cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCC--cEEEEeCCCe
Confidence 34569999999999998776432 1122 2345555555 46789999999999999999997665 4999999998
Q ss_pred cCC
Q 019901 138 KSS 140 (334)
Q Consensus 138 ~~~ 140 (334)
...
T Consensus 305 ~~l 307 (437)
T TIGR01982 305 GRL 307 (437)
T ss_pred eEC
Confidence 643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.32 E-value=7.8e-11 Score=107.85 Aligned_cols=210 Identities=18% Similarity=0.243 Sum_probs=150.9
Q ss_pred ceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccCC-CChHHHH
Q 019901 5 HNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASG-GELFERI 79 (334)
Q Consensus 5 g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l 79 (334)
.+|.+-...+|..| ++|.++-.........-.-++.++++.|+|+|++.++|.+ +..+++|++|.++ ++|.++.
T Consensus 291 Ttyk~~s~~DG~~Y-vLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 291 TTYKATSNVDGNAY-VLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred eeEeeeeccCCcee-eeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 35568888999999 9999855553444455667889999999999999999974 4579999999976 5666543
Q ss_pred H---------------hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC
Q 019901 80 C---------------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 80 ~---------------~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~ 144 (334)
- .....+|..+|.++.||..||.++|+.|...+-|.|.+|+++++. +++|+.-|+........
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~--RIriS~C~i~Dvl~~d~ 447 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM--RIRISGCGIMDVLQEDP 447 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc--eEEEecccceeeecCCC
Confidence 2 123478899999999999999999999999999999999997654 58887766544322211
Q ss_pred CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 019901 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (334)
+ +.+.+. +.-|.=.||.++..|.||..--...+..... .+..+ ...++.+++
T Consensus 448 ------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s--~~~~I---------~~~yS~D~r 499 (655)
T KOG3741|consen 448 ------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSS--HLTRI---------TTTYSTDLR 499 (655)
T ss_pred ------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHH--HHHHh---------hhhhhHHHH
Confidence 0 112222 2269999999999999997442222221111 11111 113689999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 019901 225 HLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~ 246 (334)
++|..+...+++. -++.+++.
T Consensus 500 n~v~yl~s~~~~~-ksI~~llp 520 (655)
T KOG3741|consen 500 NVVEYLESLNFRE-KSIQDLLP 520 (655)
T ss_pred HHHHHHHhcCccc-ccHHHHHH
Confidence 9999999999886 67777764
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-12 Score=123.14 Aligned_cols=87 Identities=25% Similarity=0.354 Sum_probs=59.4
Q ss_pred CCCcccceEEEEc-CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcE
Q 019901 47 HPNIVRFKEVILT-PTHLAIVMEYASGGELFER--ICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENT 119 (334)
Q Consensus 47 hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~--l~~~~----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NI 119 (334)
+.+.+.+-.++.+ .+..++||||+.|+.+.+. +...+ .+.+..+..++.|++ ..|++|+|+||.||
T Consensus 219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNI 291 (537)
T PRK04750 219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNI 291 (537)
T ss_pred CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHe
Confidence 3333444444432 3456899999999999764 33333 244555555556654 58999999999999
Q ss_pred EEcCCC--CCCEEEeccCCccCC
Q 019901 120 LLDGSP--APRLKICDFGYSKSS 140 (334)
Q Consensus 120 li~~~~--~~~~kl~Dfgla~~~ 140 (334)
+++.++ .++++++|||++...
T Consensus 292 lv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 292 FVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred EEecCCCCCCeEEEEecceEEEC
Confidence 998655 235999999988644
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=4.6e-11 Score=96.08 Aligned_cols=97 Identities=25% Similarity=0.282 Sum_probs=78.2
Q ss_pred HHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeC
Q 019901 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHR 112 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~ 112 (334)
....+|.++++.+.--.|....=++.+.....|+|||++|..|.+.+... ...+++.+-.-+.-||..||||+
T Consensus 44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHG 116 (204)
T COG3642 44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHG 116 (204)
T ss_pred HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecC
Confidence 46778999999887666666555666777889999999998888888765 24556666667777999999999
Q ss_pred CCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 113 DLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 113 dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
||.++||++.+.+ +.++||||+..
T Consensus 117 DLTtsNiIl~~~~---i~~IDfGLg~~ 140 (204)
T COG3642 117 DLTTSNIILSGGR---IYFIDFGLGEF 140 (204)
T ss_pred CCccceEEEeCCc---EEEEECCcccc
Confidence 9999999997554 99999999863
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=6.3e-10 Score=89.27 Aligned_cols=131 Identities=18% Similarity=0.159 Sum_probs=95.5
Q ss_pred eeeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC-CChHHH
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG-GELFER 78 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~~L~~~ 78 (334)
+.+....|+.+ .||.=....+. .....++|++.|.++.--.|....=+|.+...-.|+|||++| .++.++
T Consensus 23 v~~~~~~Ge~~-iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~ 101 (229)
T KOG3087|consen 23 VPRGSFSGEAA-IIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDF 101 (229)
T ss_pred EeeeccCCcee-EEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHH
Confidence 44566788887 66664332211 235788899999888766666555566666677899999977 467777
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC-CEEEeccCCccC
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKS 139 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~-~~kl~Dfgla~~ 139 (334)
+.... .........++++|-..+.-||..+|||+||..+||++.+.+.+ .+.++|||++..
T Consensus 102 i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 102 ILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred HHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 76532 22333347888999999999999999999999999999876653 248999999764
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.15 E-value=8.2e-10 Score=96.57 Aligned_cols=126 Identities=13% Similarity=0.066 Sum_probs=90.5
Q ss_pred cCCCCeeEEEEEEecCccc-----------ccHHHHHHHHHHHcCCCCCccc--ceEEEEc-----CCeEEEEEeccCCC
Q 019901 12 SYSSDLFVNIIIIVFHLWQ-----------IDENVQREIINHRSLRHPNIVR--FKEVILT-----PTHLAIVMEYASGG 73 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~~-----------~~~~~~~Ei~~l~~l~hp~iv~--~~~~~~~-----~~~~~lv~e~~~~~ 73 (334)
...|+.| .||........ ......+|...+..|..-+|.. ++.+++. ...-++|||++++.
T Consensus 42 ~~~g~~~-~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~ 120 (268)
T PRK15123 42 ELAGKSY-FLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPT 120 (268)
T ss_pred EECCEEE-EEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCC
Confidence 4456677 88876433210 1124788998888775444333 3334432 23578999999875
Q ss_pred -ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-----CCCCCEEEeccCCcc
Q 019901 74 -ELFERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-----SPAPRLKICDFGYSK 138 (334)
Q Consensus 74 -~L~~~l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-----~~~~~~kl~Dfgla~ 138 (334)
+|.+++.. ..+.+......++.+++..+..||..||+|+|++++|||++. .+...+.|+||+.++
T Consensus 121 ~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 121 ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 78888753 344667788899999999999999999999999999999974 234469999999775
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=4.2e-11 Score=113.11 Aligned_cols=154 Identities=18% Similarity=0.293 Sum_probs=109.3
Q ss_pred HHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--------CCCC--ccCCCccccchhhc
Q 019901 94 FQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------QPKS--TVGTPAYIAPEVLL 162 (334)
Q Consensus 94 ~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--------~~~~--~~gt~~y~aPE~~~ 162 (334)
+.+.+.||.|+|. .++||+.|.|++|.++.++. +||+.|+.+....... .... ......|.|||.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~--wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGD--WKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcc--eeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 4455699999996 68999999999999988776 9999999876433311 1111 12456799999998
Q ss_pred cCCCCCccchhhhhhHHHHHHH-hCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 163 KKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
+..- +.++|++|+|+++|.+. .|+..+............ .. ......+-....+++++++=+.++|..++..||++
T Consensus 183 ~~~~-~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~-~~-~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~ 259 (700)
T KOG2137|consen 183 GTTN-TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFS-RN-LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTL 259 (700)
T ss_pred cccc-cccccceeeeeEEEEEecCCcchhhccCCcchhhhh-hc-ccccccccccccCcHHHHHHHHHHhcCCcccCcch
Confidence 7544 45599999999999999 566666543222111110 00 01111111224689999999999999999999999
Q ss_pred hHHhcCccccc
Q 019901 242 PEIRNHEWFLK 252 (334)
Q Consensus 242 ~ell~h~~~~~ 252 (334)
.+++.-|||..
T Consensus 260 ~~l~~~~ff~D 270 (700)
T KOG2137|consen 260 DLLLSIPFFSD 270 (700)
T ss_pred hhhhcccccCC
Confidence 99999999965
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.7e-09 Score=89.38 Aligned_cols=98 Identities=24% Similarity=0.366 Sum_probs=65.3
Q ss_pred HHHHHHHHHHHcCCCC--CcccceEEEEcCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHC
Q 019901 33 ENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYAS--GGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSM 107 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~-LH~~ 107 (334)
...++|.+.|..+..- ++.+++++ ..+ +|||||+. |..+..+ .... ++......++.+++..+.. +|..
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~--~~~--~ivME~I~~~G~~~~~l-~~~~-~~~~~~~~~~~~il~~~~~~~~~~ 126 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDY--NRN--VIVMEYIGEDGVPLPRL-KDVD-LSPEEPKELLEEILEEIIKMLHKA 126 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEE--ETT--EEEEE--EETTEEGGCH-HHCG-GGGSTHHHHHHHHHHHHHHHHHCT
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEE--eCC--EEEEEecCCCccchhhH-Hhcc-ccchhHHHHHHHHHHHHHHHHHhc
Confidence 4577899999999866 45556544 232 79999998 6555443 3221 2245567778888885555 6899
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
||+||||.+.|||++.+ .+.++|||.+..
T Consensus 127 givHGDLs~~NIlv~~~---~~~iIDf~qav~ 155 (188)
T PF01163_consen 127 GIVHGDLSEYNILVDDG---KVYIIDFGQAVD 155 (188)
T ss_dssp TEEESS-STTSEEEETT---CEEE--GTTEEE
T ss_pred CceecCCChhhEEeecc---eEEEEecCccee
Confidence 99999999999999865 399999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.02 E-value=2.2e-09 Score=91.52 Aligned_cols=123 Identities=20% Similarity=0.202 Sum_probs=89.9
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCC--CcccceEEEEcC---CeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHP--NIVRFKEVILTP---THLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.|..+ ++|+...... .....+.+|+.+++.+.+. .+.+++.+.... +..++||||++|.++...+.. ..+++
T Consensus 21 ~g~~~-ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~ 98 (223)
T cd05154 21 GGRRL-VLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSP 98 (223)
T ss_pred CCcce-EEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCH
Confidence 35788 9999876542 2456789999999999764 456677665543 367899999999888765432 34667
Q ss_pred HHHHHHHHHHHHHHHHHHH--------------------------------------------------------CCcee
Q 019901 88 DEARFFFQQLISGVSYCHS--------------------------------------------------------MQVCH 111 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~--------------------------------------------------------~~ivH 111 (334)
.....++.+++.+|..||+ ..++|
T Consensus 99 ~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H 178 (223)
T cd05154 99 EERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVH 178 (223)
T ss_pred HHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEE
Confidence 7777777777777777773 23689
Q ss_pred CCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 112 RDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 112 ~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+|++|.||+++.+..+.+.|+||+.+.
T Consensus 179 gD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 179 GDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred CCCCcccEEEcCCCCcEEEEEeccccc
Confidence 999999999987322347899999765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.95 E-value=8.6e-09 Score=87.08 Aligned_cols=107 Identities=19% Similarity=0.200 Sum_probs=83.2
Q ss_pred HHHHHHHHHHHcCCCCCc--ccceEEEEcC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019901 33 ENVQREIINHRSLRHPNI--VRFKEVILTP----THLAIVMEYASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCH 105 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp~i--v~~~~~~~~~----~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH 105 (334)
....+|...+..|..-+| ++.+.+.+.. ...++|+|++++. +|.+.+......+......++.+++..+.-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 467888888777754333 3444444432 2468999999884 78888877555777888999999999999999
Q ss_pred HCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccC
Q 019901 106 SMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKS 139 (334)
Q Consensus 106 ~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~ 139 (334)
..||+|+|++|.|||++..+ ...+.++||+-++.
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999998764 33599999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.82 E-value=4.4e-08 Score=88.14 Aligned_cols=179 Identities=16% Similarity=0.177 Sum_probs=117.1
Q ss_pred eEEEEEeccCCCChHHHHH----h---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEecc
Q 019901 62 HLAIVMEYASGGELFERIC----N---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 134 (334)
Q Consensus 62 ~~~lv~e~~~~~~L~~~l~----~---~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Df 134 (334)
.+.++|..+.|-.=-..+. + ...+.........+.|+.+.+.||..|.+-+|+.++|+|+...+. |.|.|-
T Consensus 84 ~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~--V~LVds 161 (637)
T COG4248 84 VIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSK--VVLVDS 161 (637)
T ss_pred eeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCce--EEEEcc
Confidence 3788888887642212221 1 223667778889999999999999999999999999999976665 888875
Q ss_pred CCccCCCCCCCCCCccCCCccccchhhc-----cCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCc----hHHHHHHHH
Q 019901 135 GYSKSSVLHSQPKSTVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEE----PKNFRKTIH 204 (334)
Q Consensus 135 gla~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~----~~~~~~~~~ 204 (334)
.-.............+|.+.|.+||.-. +..-+.. +|.|.||+++|+|+.| +.||.+... +..+...+.
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~-hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTAN-HDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCcc-ccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 4322222222223456899999999764 2223334 7999999999999986 999975321 111111110
Q ss_pred --------HHhh---ccccCCCCCCCCHHHHHHHHHhcccC--CCCCCCHhH
Q 019901 205 --------RILS---VQYSIPDYVHISPECRHLISRIFVAD--PAKRISIPE 243 (334)
Q Consensus 205 --------~~~~---~~~~~~~~~~~~~~~~~li~~~L~~~--p~~R~s~~e 243 (334)
+... ....-+.+.-+++++..+..+|+... +.-|||++.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 0000 00111123457899999999998753 568998753
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.63 E-value=7.3e-09 Score=97.42 Aligned_cols=206 Identities=21% Similarity=0.190 Sum_probs=144.6
Q ss_pred HHHHHHHHHHHcCCCCC-cccceEEEEcCCeEEEEEeccCCC-ChHHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 019901 33 ENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGG-ELFER-ICNAGRFSEDEARFFFQQLISGVSYCHSMQV 109 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~~~~-~L~~~-l~~~~~~~~~~~~~~~~qil~~L~~LH~~~i 109 (334)
....-++++|.+++||| .+..++-++.+...+++++++.++ +.... -...-.+.+.+...+.+.-+.+|+++|+.-=
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 56777899999999999 677777777778899999999887 22111 1111224555666777888899999999877
Q ss_pred eeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCC
Q 019901 110 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 189 (334)
Q Consensus 110 vH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 189 (334)
+|+| ||+..... .+..+|+............+..+++.++|||+.....+... .|.|++|.-..++.-|-+|
T Consensus 358 ~~~d----~~l~s~~~---~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~-p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILGSEEE---VKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGC-PDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccccccc---cccccccCCcccCcccccccCCCCCCCCCchhhcccccccC-CCccCCCcchhhcCCCCCC
Confidence 8998 88876533 89999998877665556677789999999999998888877 8999999877777777766
Q ss_pred CCCCCchHHHHHHHHHHhhcc--ccCCCCCCCCHHHH-HHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 190 FEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECR-HLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 190 f~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~-~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
-..... .. ..+.... ..+......++... ++...|+...|..|+....++.|.+|..
T Consensus 430 r~~P~~--~~----~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 430 RSSPPA--VL----PMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCCCcc--cc----CCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 543111 00 0000000 00000001112222 4778899999999999999999999965
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.61 E-value=1.1e-06 Score=73.38 Aligned_cols=122 Identities=11% Similarity=0.106 Sum_probs=87.5
Q ss_pred CCeeEEEEEEecCc------ccccHHHHHHHHHHHcCCCCC--cccceEEEE---cC--CeEEEEEeccCC-CChHHHHH
Q 019901 15 SDLFVNIIIIVFHL------WQIDENVQREIINHRSLRHPN--IVRFKEVIL---TP--THLAIVMEYASG-GELFERIC 80 (334)
Q Consensus 15 ~~~vvaiK~~~~~~------~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~---~~--~~~~lv~e~~~~-~~L~~~l~ 80 (334)
|+.+ -+|...... .-....+.+|+..+..+..-+ +.++. ++. .+ -.-+||+|-+.| -+|.+.+.
T Consensus 41 g~~~-ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~ 118 (216)
T PRK09902 41 GKKL-YVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYA 118 (216)
T ss_pred CcEE-EEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHh
Confidence 3456 677654221 124578999999998885433 33433 222 11 247899997754 57777775
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 81 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 81 ~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+. .+.++.....++.+++..+.-||+.|+.|+|+.+.||+++..+...++++||.-++
T Consensus 119 ~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 119 QHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred cCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 52 34577788899999999999999999999999999999985554459999998655
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.58 E-value=3.6e-07 Score=76.47 Aligned_cols=67 Identities=22% Similarity=0.336 Sum_probs=52.2
Q ss_pred CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 61 THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 61 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
...++||||++|..|.+... +++. +...+..++.-||+.|++|+|.+|.|++++.++ ++++||+..+
T Consensus 116 ~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~---i~iID~~~k~ 182 (229)
T PF06176_consen 116 SSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG---IRIIDTQGKR 182 (229)
T ss_pred eEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc---EEEEECcccc
Confidence 34578999999988866431 3332 335567788999999999999999999998554 9999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.58 E-value=2.5e-07 Score=92.66 Aligned_cols=202 Identities=21% Similarity=0.240 Sum_probs=142.8
Q ss_pred HHHHHHHHHcCCCCCcccceEEEEcCCe----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 019901 35 VQREIINHRSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVC 110 (334)
Q Consensus 35 ~~~Ei~~l~~l~hp~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~iv 110 (334)
...|+..+..+.|+|++.++.+...... +.+..++|.+.++...+..-+.++...++.+..+++.||.++|+....
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~ 308 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLE 308 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccc
Confidence 4456677788899999999888665432 345668999999999999989999999999999999999999998554
Q ss_pred eCCCCCC---cEEEcCCCCCCEEEe--ccCCccCCCCCCCCCCccCCCccccchhhccCCCCCc-cchhhhhhHHHHHHH
Q 019901 111 HRDLKLE---NTLLDGSPAPRLKIC--DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK-IADVWSCGVTLYVML 184 (334)
Q Consensus 111 H~dlkp~---NIli~~~~~~~~kl~--Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~DiwslG~il~~l~ 184 (334)
|.-+..+ +--.+ +.+.+..+ ||+.++............-+..+.+||......+... ..|+|++|.....+.
T Consensus 309 ~v~L~~s~~~~~~~~--~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 309 HVVLSASSSKESTVD--GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eeEEecccccccccC--ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 4444333 11122 22235555 8887776655555555566778889988766555422 369999999999998
Q ss_pred hCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 185 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 185 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.|..+-..... ....+. . .......+.+.+|+.-++++|+++.+++.|+|....
T Consensus 387 ~~~~i~~~~~~-------~~~~l~------~--~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 387 QGEDISEKSAV-------PVSLLD------V--LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred hcCcccccccc-------hhhhhc------c--ccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 77644221110 000000 0 112267889999999999999999999999998653
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.55 E-value=8.9e-07 Score=75.86 Aligned_cols=125 Identities=16% Similarity=0.184 Sum_probs=89.2
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCc----------------------ccccHHHHHHHHHHHcCCCC--Ccccce
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHL----------------------WQIDENVQREIINHRSLRHP--NIVRFK 54 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~----------------------~~~~~~~~~Ei~~l~~l~hp--~iv~~~ 54 (334)
||.|.= +..-...|..+ |||+=.... .......++|..+|..|... .+.+.+
T Consensus 99 IGvGKEsdVY~~~~~~g~~~-~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~ 177 (304)
T COG0478 99 IGVGKESDVYVAIDPKGRKV-AVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPI 177 (304)
T ss_pred cccCccceEEEEECCCCCEE-EEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcc
Confidence 455543 34444568888 999844322 01235678899999999755 666666
Q ss_pred EEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEecc
Q 019901 55 EVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 134 (334)
Q Consensus 55 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Df 134 (334)
++ +.-.+||||++|..|...- ++......++..|+.-+..+-..||||+|+.+-||+++.++. +.++||
T Consensus 178 ~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~--~~vIDw 246 (304)
T COG0478 178 AW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD--IVVIDW 246 (304)
T ss_pred cc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC--EEEEeC
Confidence 54 5668999999997775431 235556666677777777777999999999999999998765 999999
Q ss_pred CCcc
Q 019901 135 GYSK 138 (334)
Q Consensus 135 gla~ 138 (334)
-.+.
T Consensus 247 PQ~v 250 (304)
T COG0478 247 PQAV 250 (304)
T ss_pred cccc
Confidence 7554
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.33 E-value=2e-05 Score=65.68 Aligned_cols=126 Identities=20% Similarity=0.203 Sum_probs=89.0
Q ss_pred CCCccee--eeeecCCCCeeEEEEEEecCc----------------ccccHHHHHHHHHHHcCC------CCCcccceEE
Q 019901 1 MLGFHNF--YDRCSYSSDLFVNIIIIVFHL----------------WQIDENVQREIINHRSLR------HPNIVRFKEV 56 (334)
Q Consensus 1 ~lG~g~~--~~~~~~~~~~vvaiK~~~~~~----------------~~~~~~~~~Ei~~l~~l~------hp~iv~~~~~ 56 (334)
+||.|+- +..|..+... .||+..... ........+|+.....+. +.+|.+++++
T Consensus 8 ~i~~G~~R~cy~HP~dp~~--cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~ 85 (199)
T PF10707_consen 8 LIAQGGERDCYQHPDDPNL--CIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGF 85 (199)
T ss_pred ccccCCCceEEECCCCCCe--EEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEE
Confidence 3666766 4555555554 689887765 123466777777666665 7899999999
Q ss_pred EEcCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC--C
Q 019901 57 ILTPTHLAIVMEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP--R 128 (334)
Q Consensus 57 ~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~--~ 128 (334)
.+++.-..+|+|.+.. -+|.+++.+ +.++. .....+. .-..+|-+.+|+.+|++|.||++.....+ +
T Consensus 86 veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~ 160 (199)
T PF10707_consen 86 VETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFR 160 (199)
T ss_pred EecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceE
Confidence 9999888999998743 367777744 44666 4444433 34557889999999999999999655433 4
Q ss_pred EEEec
Q 019901 129 LKICD 133 (334)
Q Consensus 129 ~kl~D 133 (334)
+.|+|
T Consensus 161 lvlID 165 (199)
T PF10707_consen 161 LVLID 165 (199)
T ss_pred EEEEe
Confidence 78888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=68.90 Aligned_cols=58 Identities=12% Similarity=0.127 Sum_probs=43.8
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccceEEEEcCCeEEEEEeccCCCC
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
.|..+ ++|...... ....+.+|.++++.+..-+ +.+.+.+...++...+||++++|.+
T Consensus 21 ~~~~~-VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 21 KTGKW-MLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred cCCCE-EEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 36677 888876533 3467899999999886443 4667778777888899999999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.18 E-value=2.6e-05 Score=67.64 Aligned_cols=60 Identities=10% Similarity=-0.055 Sum_probs=42.3
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
.+..+ .||+..... ...+.+|+.+++.+. +--+.+++.+...++..++||++++|.++..
T Consensus 21 ~~~~~-~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 21 KNPGL-YLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred CCCcE-EEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 34566 788864332 346788999988874 3345567777766667899999999987754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=3.8e-07 Score=93.48 Aligned_cols=208 Identities=13% Similarity=0.065 Sum_probs=143.5
Q ss_pred HHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-
Q 019901 36 QREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNA----GRFSEDEARFFFQQLISGVSYCHSMQ- 108 (334)
Q Consensus 36 ~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qil~~L~~LH~~~- 108 (334)
..|...++...|+++.....-... ....+.+++||.+|.+++.+.+. +++.+.-+.-...+.+.+..-+|+..
T Consensus 1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344445566789998887665542 34579999999999999998764 23444434444444477777777542
Q ss_pred ----ceeCCCCCCcEEEcCCCCCCEEEeccCCcc-CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHH
Q 019901 109 ----VCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 183 (334)
Q Consensus 109 ----ivH~dlkp~NIli~~~~~~~~kl~Dfgla~-~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 183 (334)
.+|+++|+-|.+|..+.. +|+.++|+.+ ............+++.|++|++.+.-.++.+ +|+|..|+-+|.+
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny~--v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~r-sdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNYN--VKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKR-SDILRRSLSLYLR 1433 (2724)
T ss_pred CCccchhhhhhhhccceecCCc--ccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhH-HHHHHHHHHHHHH
Confidence 689999999999986654 9999999998 3333333455678899999999988888666 9999999999999
Q ss_pred HhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 184 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 184 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
..|..+|. ...+..++.+.............|.++......+|-..-..||.-...+.-+.|.
T Consensus 1434 s~~n~~fi-----~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1434 SDGNAYFI-----FFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred hcccHHHH-----HHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence 98887774 2333333333332222222223355666666666777778899888887777663
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.7e-05 Score=75.40 Aligned_cols=76 Identities=16% Similarity=0.166 Sum_probs=53.4
Q ss_pred CCeEEEEEeccCCCChHHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCc
Q 019901 60 PTHLAIVMEYASGGELFER--ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137 (334)
Q Consensus 60 ~~~~~lv~e~~~~~~L~~~--l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla 137 (334)
.+.-.++|||++|..+.+. +.. ..++...+...+.++ -+..+-..|+.|.|.+|.||+++.++. +.+.|||+.
T Consensus 238 t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dgffHaDpHpGNi~v~~~g~--i~~lDfGi~ 312 (517)
T COG0661 238 TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDGFFHADPHPGNILVRSDGR--IVLLDFGIV 312 (517)
T ss_pred cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcCccccCCCccceEEecCCc--EEEEcCcce
Confidence 4566999999999888776 444 335544433332222 122333489999999999999987764 999999987
Q ss_pred cCC
Q 019901 138 KSS 140 (334)
Q Consensus 138 ~~~ 140 (334)
...
T Consensus 313 g~l 315 (517)
T COG0661 313 GRL 315 (517)
T ss_pred ecC
Confidence 643
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.6e-05 Score=65.45 Aligned_cols=118 Identities=15% Similarity=0.138 Sum_probs=76.2
Q ss_pred CCCCeeEEEEEEecCcccc---------c---------------HHHHHHHHHHHcCCCC--CcccceEEEEcCCeEEEE
Q 019901 13 YSSDLFVNIIIIVFHLWQI---------D---------------ENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIV 66 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~---------~---------------~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~~~~~lv 66 (334)
.++..+ |+|+++...... + .=..+|...|+++..- .+.+.+.+. .-.||
T Consensus 70 ~~~~~~-avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLv 144 (268)
T COG1718 70 GDGRYV-AVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLV 144 (268)
T ss_pred CCCceE-EEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEE
Confidence 456677 999998754110 0 1133466666666433 333444432 34899
Q ss_pred EeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 67 MEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 67 ~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
|||+..... ...|.. -++...++..+..+++..+.-|-. .|+||+||+.-|||+. .+. +.++|||-|..
T Consensus 145 MEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~--p~iID~~QaV~ 215 (268)
T COG1718 145 MEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE--PYIIDVSQAVT 215 (268)
T ss_pred EEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe--EEEEECccccc
Confidence 999954311 112221 123344688888899999888877 8999999999999998 333 89999997764
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.94 E-value=0.00011 Score=74.73 Aligned_cols=123 Identities=17% Similarity=0.277 Sum_probs=74.5
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcCC-CCCc--ccceEEEEcC---CeEEEEEeccCCCChHH-----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSLR-HPNI--VRFKEVILTP---THLAIVMEYASGGELFE----------- 77 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~-hp~i--v~~~~~~~~~---~~~~lv~e~~~~~~L~~----------- 77 (334)
..+ ++|+...... .....+.+|..+++.+. |+++ .+++.++.+. +..|+||||++|..+.+
T Consensus 66 ~~~-VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~~~~~~~~~~~~~r 144 (822)
T PLN02876 66 KRY-VLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIFVDPKLPGVAPERR 144 (822)
T ss_pred eeE-EEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcccCCccCCCCCHHHH
Confidence 356 7776544331 22357899999999995 6665 6667666553 46799999998864321
Q ss_pred ---------HHH---hc----------CC---CCHHHHHHHHHH---------------HHHHHHHHHH-----------
Q 019901 78 ---------RIC---NA----------GR---FSEDEARFFFQQ---------------LISGVSYCHS----------- 106 (334)
Q Consensus 78 ---------~l~---~~----------~~---~~~~~~~~~~~q---------------il~~L~~LH~----------- 106 (334)
.+. .- +. +...++..|..+ +...+.+|..
T Consensus 145 ~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~ 224 (822)
T PLN02876 145 RAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNPKMLELIDWLRENIPAEDSTGAG 224 (822)
T ss_pred HHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCChhHHHHHHHHHhcCCCccccCCC
Confidence 111 10 00 112233333222 1223455632
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
..+||+|+++.|+|++..+...+-|.||+++..
T Consensus 225 ~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 225 TGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred cceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 249999999999999754333357999998764
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00016 Score=68.73 Aligned_cols=77 Identities=18% Similarity=0.185 Sum_probs=52.9
Q ss_pred CeEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCC
Q 019901 61 THLAIVMEYASGGELFE--RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGY 136 (334)
Q Consensus 61 ~~~~lv~e~~~~~~L~~--~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgl 136 (334)
..-.|+||||+|..+.+ .+.+.+ ++...+..-+.+... .-|=..|++|+|-+|.||+++.+ +..++.+.|||+
T Consensus 275 t~RVLtME~~~G~~i~Dl~~i~~~g-i~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl 351 (538)
T KOG1235|consen 275 TKRVLTMEYVDGIKINDLDAIDKRG-ISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGL 351 (538)
T ss_pred cceEEEEEecCCccCCCHHHHHHcC-CCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccc
Confidence 45699999999987754 454443 666644443333221 22335789999999999999853 345799999998
Q ss_pred ccCC
Q 019901 137 SKSS 140 (334)
Q Consensus 137 a~~~ 140 (334)
....
T Consensus 352 ~~~i 355 (538)
T KOG1235|consen 352 YAVI 355 (538)
T ss_pred cccc
Confidence 7643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.85 E-value=8.9e-05 Score=63.91 Aligned_cols=58 Identities=10% Similarity=-0.111 Sum_probs=35.8
Q ss_pred CeeEEEEEEecCcccccHHHHHHHHHHHcCCCC---CcccceEEEEcC---CeEEEEEeccCCCChH
Q 019901 16 DLFVNIIIIVFHLWQIDENVQREIINHRSLRHP---NIVRFKEVILTP---THLAIVMEYASGGELF 76 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~~~---~~~~lv~e~~~~~~L~ 76 (334)
..+ ++|+..... ....+.+|...++.+... .+.+++...... ...+++|++++|.++.
T Consensus 19 ~~~-VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 19 DDM-SVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred Cce-EEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 456 778754422 345799999999887532 233444333221 2348899999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.85 E-value=9.8e-05 Score=63.07 Aligned_cols=59 Identities=19% Similarity=0.171 Sum_probs=40.2
Q ss_pred CeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccceEEEE---cCCeEEEEEeccCCCChHH
Q 019901 16 DLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFKEVIL---TPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~---~~~~~~lv~e~~~~~~L~~ 77 (334)
+.+ ++|+.... .....+.+|..+++.+.... +.+++.... .....+++|++++|..+..
T Consensus 21 ~~~-vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 21 GRY-VLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp SEE-EEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred cEE-EEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 578 99997554 24567889999888875433 455665332 2345799999999987766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.71 E-value=0.00011 Score=68.64 Aligned_cols=166 Identities=16% Similarity=0.204 Sum_probs=103.8
Q ss_pred HHHHHHHHHHHcCCCCCcccceEEEEcC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 019901 33 ENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 111 (334)
Q Consensus 33 ~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH 111 (334)
.++.-....++.+.|+|...++++.... .+..+|+|++ +-+|.+.+.... +-..... ..|+.|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~ 90 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH 90 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence 4677788899999999999999887543 4588999999 568888876543 2111111 112221
Q ss_pred CCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019901 112 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 191 (334)
Q Consensus 112 ~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 191 (334)
.|| ++.+| -++.. . .+..| +++||||+|.++.++.-|...+.
T Consensus 91 -----~~~---------~~~td-~~~t~----~--~~~~~-----------------pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 91 -----LNI---------IYITD-HFLTK----Y--PSPIG-----------------PKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred -----ehh---------hhccc-ccccc----C--CCCCC-----------------cchhhhhHHHHHHHHHHhhHHHH
Confidence 122 33444 11110 0 11111 24999999999999999988876
Q ss_pred CCCchHHHHHHHHHHhhccccCC-------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 192 DPEEPKNFRKTIHRILSVQYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.....+...... +......... .....+..+..+..+|+-..|..||...++.+++-|...
T Consensus 133 ~~~~s~~l~~i~-k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILL-KYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHH-HhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 554433332221 1111110000 001246778889999999999999999999999998753
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.65 E-value=0.00039 Score=60.73 Aligned_cols=118 Identities=15% Similarity=0.095 Sum_probs=67.1
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCChHHH----------H--
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELFER----------I-- 79 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L~~~----------l-- 79 (334)
.++..+ ++|..........-...+|..+++.+...++ .+++... . -++|++|++|..+... +
T Consensus 17 ~~~~~~-vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~~~~~~~~~~~~~~~la~ 91 (256)
T TIGR02721 17 HPGISF-VWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEVITLDQFVALDLLLELAA 91 (256)
T ss_pred eCCccE-EEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcccccccccCchhHHHHHH
Confidence 556677 8888655431221246889999988865444 3344332 2 2689999998665311 1
Q ss_pred --H---hc----CCCCHH-HHHHHHHHH---------HHHHHHHHH--------CCceeCCCCCCcEEEcCCCCCCEEEe
Q 019901 80 --C---NA----GRFSED-EARFFFQQL---------ISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKIC 132 (334)
Q Consensus 80 --~---~~----~~~~~~-~~~~~~~qi---------l~~L~~LH~--------~~ivH~dlkp~NIli~~~~~~~~kl~ 132 (334)
. .. .+++.. .+..+..++ ...+..+-. ..++|+|+.|.||+++.++ +.++
T Consensus 92 ~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~~~~---~~lI 168 (256)
T TIGR02721 92 LLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVTPQG---LKLI 168 (256)
T ss_pred HHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEeCCC---CEEE
Confidence 1 11 112211 222222222 111222221 2489999999999998654 7899
Q ss_pred ccCCcc
Q 019901 133 DFGYSK 138 (334)
Q Consensus 133 Dfgla~ 138 (334)
||..|.
T Consensus 169 DwE~a~ 174 (256)
T TIGR02721 169 DWEYAS 174 (256)
T ss_pred eccccC
Confidence 999765
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0014 Score=58.56 Aligned_cols=58 Identities=12% Similarity=0.036 Sum_probs=40.8
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCC---CCcccceEEEEc---CCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRH---PNIVRFKEVILT---PTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h---p~iv~~~~~~~~---~~~~~lv~e~~~~~~L 75 (334)
++.+ ++|..+.. .....+.+|...|+.+.. -.+.++++++.. .+..++|||+++|+++
T Consensus 37 ~~~~-~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~ 100 (297)
T PRK10593 37 QGNP-MPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV 100 (297)
T ss_pred CCCE-EEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence 3456 77875321 134689999999988853 356777776654 3668999999998764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0013 Score=56.48 Aligned_cols=55 Identities=15% Similarity=0.247 Sum_probs=35.0
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
++.| ++|+..... ...-...+|+.+++.+...++ ++++..+. + .+||||++|.++
T Consensus 24 ~~~~-vlR~~~~~~-~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i~G~~l 79 (235)
T cd05157 24 QDAV-LVRVYGNKT-ELIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFIPGRTL 79 (235)
T ss_pred CCeE-EEEEccCCc-cceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEeeCCCcC
Confidence 5677 899876543 222345689988888854444 34444332 2 479999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00052 Score=56.93 Aligned_cols=97 Identities=14% Similarity=0.090 Sum_probs=75.3
Q ss_pred HHHHHHHHcCCC-CCcccceEEEEcCCeEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CC
Q 019901 36 QREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFE---RICNAGRFSEDEARFFFQQLISGVSYCHS---MQ 108 (334)
Q Consensus 36 ~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~qil~~L~~LH~---~~ 108 (334)
..|.-+++.+.+ +++++++|.+ ++ ++|+||...+++.. .+...-..+.....+++.+++..+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C---G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC---GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC---CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999997 33 66889997766542 11122235788899999999999999997 34
Q ss_pred ceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 109 VCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 109 ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+.-.|++|+|+-++.++. +|++|...+.
T Consensus 83 ~~lcDv~~~nfgv~~~~~--lk~iDld~v~ 110 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGR--LKLIDLDDVF 110 (188)
T ss_pred EEEeecchHHeEEeCCCc--EEEEechhcc
Confidence 788999999999987655 9999998654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0013 Score=58.70 Aligned_cols=119 Identities=18% Similarity=0.154 Sum_probs=67.5
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccceE------EEEcCCeEEEEEeccCCCChHH--------
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFKE------VILTPTHLAIVMEYASGGELFE-------- 77 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~------~~~~~~~~~lv~e~~~~~~L~~-------- 77 (334)
.++.+ ++|+... .....+..|+.+++.+.+.+ +.+++. +...++..++|+++++|..+..
T Consensus 36 ~~~~~-vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~ 111 (296)
T cd05153 36 DSGRY-VLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQ 111 (296)
T ss_pred CCCcE-EEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHH
Confidence 44567 8898754 23466788888887775332 334333 1233456789999999866421
Q ss_pred ---HH---Hhc-CCCCH------------HHHH--------HHHHHHHHHHHHHHH-------CCceeCCCCCCcEEEcC
Q 019901 78 ---RI---CNA-GRFSE------------DEAR--------FFFQQLISGVSYCHS-------MQVCHRDLKLENTLLDG 123 (334)
Q Consensus 78 ---~l---~~~-~~~~~------------~~~~--------~~~~qil~~L~~LH~-------~~ivH~dlkp~NIli~~ 123 (334)
.+ ... ..+.. .... .....+..++.++.. .+++|+|+.|.||+++.
T Consensus 112 lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~ 191 (296)
T cd05153 112 IGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLFDG 191 (296)
T ss_pred HHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEEeC
Confidence 01 000 00100 0000 011112233444443 47999999999999986
Q ss_pred CCCCCEEEeccCCcc
Q 019901 124 SPAPRLKICDFGYSK 138 (334)
Q Consensus 124 ~~~~~~kl~Dfgla~ 138 (334)
++. +.|+||+.+.
T Consensus 192 ~~~--~~iIDfe~a~ 204 (296)
T cd05153 192 DEL--SGVIDFYFAC 204 (296)
T ss_pred Cce--EEEeehhhhc
Confidence 542 5799998654
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.38 E-value=0.0023 Score=57.46 Aligned_cols=30 Identities=33% Similarity=0.453 Sum_probs=25.3
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.++||+|+++.||+++.++ .+.|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~~~~~--~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLFDGDS--VKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEEECCc--eEEEeeccccc
Confidence 6899999999999998654 26899999754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0018 Score=58.02 Aligned_cols=56 Identities=11% Similarity=0.144 Sum_probs=37.2
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCChH
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
++.+ ++|+..... .......+|..+++.+...++ .+++..+. + .+|++|++|.++.
T Consensus 29 ~~~~-vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v~e~i~G~~l~ 85 (302)
T cd05156 29 PRKV-LLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GRIEEFIPSRTLT 85 (302)
T ss_pred CCeE-EEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC-C---CchhheeCCCcCC
Confidence 5778 899976654 334567888888888754333 34555543 2 3589999887664
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.0045 Score=50.13 Aligned_cols=116 Identities=15% Similarity=0.101 Sum_probs=80.3
Q ss_pred eeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCccc-ceEEEEcCCeEEEEEeccCCCChHHHHHhcCC
Q 019901 6 NFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVR-FKEVILTPTHLAIVMEYASGGELFERICNAGR 84 (334)
Q Consensus 6 ~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 84 (334)
+|+......|..+ |+|+-..+. ...+++.|+++|..+.--++-+ ++.+. ..++.|||+.|.+|.......
T Consensus 36 s~Vyl~~~~~~~~-a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~L~~~~~~~-- 106 (201)
T COG2112 36 SVVYLGEWRGGEV-ALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRPLGKLEIGG-- 106 (201)
T ss_pred cEEEEeeccCceE-EEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcchhhhhhcc--
Confidence 3455556677777 999976555 5688999999999998766644 44442 235569999998887664321
Q ss_pred CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCC--CcEEEcCCCCCCEEEeccCCcc
Q 019901 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKL--ENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 85 ~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp--~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+ ++-+..+++.-.-|-..||-|+.|.- .||++.. + .+.|+||.-|+
T Consensus 107 -~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~-~--~~~iIDFd~At 154 (201)
T COG2112 107 -D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVND-R--DVYIIDFDSAT 154 (201)
T ss_pred -c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecC-C--cEEEEEccchh
Confidence 2 23334456665667889999999975 4666643 3 39999999765
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0071 Score=54.68 Aligned_cols=124 Identities=21% Similarity=0.252 Sum_probs=83.6
Q ss_pred eeeecCCCCeeEEEEEEecCcc---------------------cccH-----HHHHHHHHHHcCCCCCcccceEEEEcCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLW---------------------QIDE-----NVQREIINHRSLRHPNIVRFKEVILTPT 61 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~---------------------~~~~-----~~~~Ei~~l~~l~hp~iv~~~~~~~~~~ 61 (334)
+-.....|..+ |||+++.+.+ ...+ =..+|++.|++++...|.-.--+....
T Consensus 161 YHat~~dG~~~-AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk~- 238 (520)
T KOG2270|consen 161 YHATEEDGSEF-AIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLKN- 238 (520)
T ss_pred EeeecCCCceE-EEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec-
Confidence 44455678888 9999876531 0111 134678888888776654433333322
Q ss_pred eEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 62 HLAIVMEYASGGEL-FERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 62 ~~~lv~e~~~~~~L-~~~l~~~~~~~~~~~~~~~~qil~~L~~LH-~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
-+|||+|+.+..- ...| +.-.++...+..+-.|++.-+.-|- ..++||.||.--|+|+... .+.++|.+.+.
T Consensus 239 -hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~LyhdG---~lyiIDVSQSV 312 (520)
T KOG2270|consen 239 -HVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHDG---KLYIIDVSQSV 312 (520)
T ss_pred -ceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEECC---EEEEEEccccc
Confidence 3799999954222 1222 2335788888888888888887775 4799999999999999743 39999988654
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.99 E-value=0.027 Score=50.82 Aligned_cols=30 Identities=30% Similarity=0.392 Sum_probs=24.5
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.++||+|++|.||+++++. ..-++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~~~--~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDR--LSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEEECCc--eEEEEeccccc
Confidence 4899999999999997543 24799999764
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.017 Score=48.17 Aligned_cols=111 Identities=16% Similarity=0.242 Sum_probs=73.5
Q ss_pred eeeeeecCCCCeeEEEEEEecCc---c-------c-----------ccHHHHHHHHHHHcC---CCCCc--ccceEEEEc
Q 019901 6 NFYDRCSYSSDLFVNIIIIVFHL---W-------Q-----------IDENVQREIINHRSL---RHPNI--VRFKEVILT 59 (334)
Q Consensus 6 ~~~~~~~~~~~~vvaiK~~~~~~---~-------~-----------~~~~~~~Ei~~l~~l---~hp~i--v~~~~~~~~ 59 (334)
+++.+-.-.|..| |||++..-. . . ...-+..|.+...+| .+.++ |+++++..-
T Consensus 52 ~~V~kv~I~g~~Y-ALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L 130 (207)
T PF13095_consen 52 GYVFKVEIDGRIY-ALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLL 130 (207)
T ss_pred eEEEEEEECCeEE-EEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEE
Confidence 4566777889999 999943311 0 0 012355666666555 45566 889988631
Q ss_pred C------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEE
Q 019901 60 P------------------THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121 (334)
Q Consensus 60 ~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli 121 (334)
. ....||.||+.... .++...+ .++++-+..+|..||+-+|+++.|..
T Consensus 131 ~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~~----~~~~~dl~~~~k~gI~~~Dv~~~ny~- 196 (207)
T PF13095_consen 131 TEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRDI----PQMLRDLKILHKLGIVPRDVKPRNYR- 196 (207)
T ss_pred chHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhHH----HHHHHHHHHHHHCCeeeccCcccccc-
Confidence 1 13578888876643 2344444 45566677799999999999999986
Q ss_pred cCCCCCCEEEeccCCc
Q 019901 122 DGSPAPRLKICDFGYS 137 (334)
Q Consensus 122 ~~~~~~~~kl~Dfgla 137 (334)
+ -||+|||.+
T Consensus 197 --~----G~lvDfs~~ 206 (207)
T PF13095_consen 197 --G----GKLVDFSSS 206 (207)
T ss_pred --C----CEEEecccC
Confidence 2 489999853
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.054 Score=50.28 Aligned_cols=56 Identities=11% Similarity=0.003 Sum_probs=35.7
Q ss_pred CeeEEEEEEecCc------c-cccHHHHHHHHHHHcCC---CCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 16 DLFVNIIIIVFHL------W-QIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 16 ~~vvaiK~~~~~~------~-~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
+.+ +||.-.... + -..+....|...|+.+. ..++++++.+ +....++|||++++..
T Consensus 52 ~sv-IVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lVME~L~~~~ 117 (401)
T PRK09550 52 KSV-IVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTVMEDLSDHK 117 (401)
T ss_pred eEE-EEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEEEecCCCcc
Confidence 367 999854211 1 13356777888887763 2356666666 4456789999998744
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.54 E-value=0.024 Score=51.53 Aligned_cols=53 Identities=9% Similarity=0.114 Sum_probs=33.9
Q ss_pred eeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 17 LFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 17 ~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
.| ++|+..... ...-.-.+|..+++.+..-++ .+++.++. ++ +|.+|++|.+|
T Consensus 44 ~~-v~Ri~g~~t-~~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~g~~l 97 (330)
T PLN02421 44 SV-TVRLFGPNT-DYVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFINARTL 97 (330)
T ss_pred eE-EEEEecCCc-CeEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---EeehhhcCCCC
Confidence 67 889876544 222234678888888865555 34565553 32 48899987665
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.019 Score=52.44 Aligned_cols=117 Identities=16% Similarity=0.205 Sum_probs=67.1
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcc-cceEEEEcCCeEEEEEeccCCCChHHH----------H----
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELFER----------I---- 79 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~L~~~----------l---- 79 (334)
+..| ++|+..... ...-+..+|..+++.+..-++- ++++.+..+ .|.+|+++.++... +
T Consensus 65 ~~~~-v~Ri~g~~t-~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~g~~l~~~~l~~~~~~~~ia~~L 138 (344)
T PLN02236 65 GRKV-LVRIYGEGV-ELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIHARTLSAADLRDPEISALIAAKL 138 (344)
T ss_pred CCeE-EEEEccCCC-CeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeCCCCCCHHHcCChHHHHHHHHHH
Confidence 3567 889886654 2222347888888888654443 456665332 47899988666321 1
Q ss_pred H---hcC------CCCHHHHHHHHHHHH-----------------HHHHHH----H----HCCceeCCCCCCcEEEcCCC
Q 019901 80 C---NAG------RFSEDEARFFFQQLI-----------------SGVSYC----H----SMQVCHRDLKLENTLLDGSP 125 (334)
Q Consensus 80 ~---~~~------~~~~~~~~~~~~qil-----------------~~L~~L----H----~~~ivH~dlkp~NIli~~~~ 125 (334)
. +.. ......+..++.++. ..+..| . ...++|+|+++.|||++...
T Consensus 139 ~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~ 218 (344)
T PLN02236 139 REFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQEIGFCHNDLQYGNIMIDEET 218 (344)
T ss_pred HHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCCCceEEeCCCCcCcEEEeCCC
Confidence 1 100 011223334432221 111111 1 22579999999999997532
Q ss_pred CCCEEEeccCCcc
Q 019901 126 APRLKICDFGYSK 138 (334)
Q Consensus 126 ~~~~kl~Dfgla~ 138 (334)
+.+.++||..|.
T Consensus 219 -~~~~lID~Eya~ 230 (344)
T PLN02236 219 -RAITIIDYEYAS 230 (344)
T ss_pred -CcEEEEeehhcc
Confidence 359999998765
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.47 E-value=0.0034 Score=55.76 Aligned_cols=93 Identities=14% Similarity=0.182 Sum_probs=63.8
Q ss_pred HHHHHHHHHHcCCCC--CcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 019901 34 NVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCH 111 (334)
Q Consensus 34 ~~~~Ei~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH 111 (334)
+..+|...|+.|... -+.+.+++ ++-++|||++.|-.|...-. ...+..+...+..-+--|...|+||
T Consensus 156 aa~kEfafmkaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIH 225 (465)
T KOG2268|consen 156 AATKEFAFMKALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIH 225 (465)
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccc----cceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCcee
Confidence 566788888887532 23344433 56699999999988755421 1123334444445556688999999
Q ss_pred CCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 112 RDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 112 ~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+|..--||+++.++. ++++||--..
T Consensus 226 gDFNEFNimv~dd~~--i~vIDFPQmv 250 (465)
T KOG2268|consen 226 GDFNEFNIMVKDDDK--IVVIDFPQMV 250 (465)
T ss_pred cccchheeEEecCCC--EEEeechHhh
Confidence 999999999986554 9999997443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.14 Score=46.33 Aligned_cols=65 Identities=9% Similarity=-0.072 Sum_probs=39.4
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccce---E--EEEcCCeEEEEEeccCCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFK---E--VILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~---~--~~~~~~~~~lv~e~~~~~~ 74 (334)
+.....+|..+ ++|+..... .....+..|+..+..|.... ++... + +...++..+.|+++++|..
T Consensus 42 y~v~~~~~~~~-vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 42 YQFGDEDGRRV-VAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred EEEecCCCCEE-EEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 33444556778 999986444 34567888888887664221 22211 1 2233567788999998754
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.014 Score=52.71 Aligned_cols=88 Identities=25% Similarity=0.241 Sum_probs=61.0
Q ss_pred CCCCCcccceEEEEcC-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEc
Q 019901 45 LRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLD 122 (334)
Q Consensus 45 l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~ 122 (334)
.-.++..+.+-+-.++ ...|++|++- |+++.- +. .-..+++..++++.+..+.-+..+ ..-||++...||||+
T Consensus 282 ~g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-ik---~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId 356 (488)
T COG5072 282 CGSVFLETLKVVSLDETLYLYLHFKDH-GTPISI-IK---ADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID 356 (488)
T ss_pred ccchhhhcceEEecCCceEEEEEEecC-Cceeee-ee---cccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee
Confidence 3344444443333222 3578888876 556532 21 134678899999998888777764 578999999999998
Q ss_pred CCCCCCEEEeccCCccCC
Q 019901 123 GSPAPRLKICDFGYSKSS 140 (334)
Q Consensus 123 ~~~~~~~kl~Dfgla~~~ 140 (334)
.|. |.|+||-+++..
T Consensus 357 -~Gn--vtLIDfklsRl~ 371 (488)
T COG5072 357 -EGN--VTLIDFKLSRLS 371 (488)
T ss_pred -cCc--eEEEEeeeeecc
Confidence 554 999999999843
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.024 Score=50.07 Aligned_cols=30 Identities=23% Similarity=0.325 Sum_probs=23.7
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.++|+|++|.|||++.++. .+-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~-~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILIDEDAR-VTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEEeCCCC-EEEEECcHhcc
Confidence 4899999999999985332 24699999765
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.22 E-value=0.048 Score=48.92 Aligned_cols=31 Identities=16% Similarity=0.290 Sum_probs=26.7
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCccCC
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~ 140 (334)
.++|+|+++.|++++..+. +-+.||+++...
T Consensus 199 ~lvHGD~~~gNlii~~~~~--~gVlDwe~~~lG 229 (321)
T COG3173 199 VLVHGDYRPGNLIIDPGRP--TGVLDWELATLG 229 (321)
T ss_pred eeeeCCcccCCEEEeCCCe--eEEEeccccccC
Confidence 4899999999999987765 899999988743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.045 Score=46.16 Aligned_cols=55 Identities=13% Similarity=0.032 Sum_probs=33.6
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
++.| +||+..... ..--....|..+++.+...++ .++++.+.. + .|.+|++|.+|
T Consensus 2 ~~~~-~~Ri~g~~t-~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~-g---~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKY-LVRIPGEGT-ENFIDRENENEALKLLSEAGLGPKIIYFFEN-G---RVEEFIEGRTL 57 (211)
T ss_dssp TSEE-EEEEEESCG-CSHHHHHHHHHHHHHHHHTTSSS-EEEEETT-E---EEEE--SSEE-
T ss_pred CCEE-EEEeCCCCc-ccccCHHHHHHHHHHHHHcCCCCeEEEEcCC-C---cEEEEeccccc
Confidence 4566 899987774 444577788888888865555 445555432 2 46699977654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.63 E-value=0.063 Score=45.34 Aligned_cols=98 Identities=17% Similarity=0.076 Sum_probs=61.8
Q ss_pred EEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 019901 20 NIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI 98 (334)
Q Consensus 20 aiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil 98 (334)
.+|.+...... ....++.+.+++.++. .|+++..- .+..+.++.|+|...... + ..++.-=+
T Consensus 89 ~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~---------~----~N~i~agi 151 (308)
T PF07387_consen 89 FLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN---------F----SNFITAGI 151 (308)
T ss_pred hhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc---------h----hHHHHHhH
Confidence 34444433323 3456677777776654 46666522 334578999999643221 0 11111114
Q ss_pred HHHHHHHH--CCceeCCCCCCcEEEcCCCCCCEEEeccCC
Q 019901 99 SGVSYCHS--MQVCHRDLKLENTLLDGSPAPRLKICDFGY 136 (334)
Q Consensus 99 ~~L~~LH~--~~ivH~dlkp~NIli~~~~~~~~kl~Dfgl 136 (334)
.+|.-.|+ .+.+|||-.|+|||-++.|. +||.|-+.
T Consensus 152 ~~L~~fH~~~~~~lHGD~np~NiM~D~~G~--lKlVDP~~ 189 (308)
T PF07387_consen 152 KDLMDFHSENQHCLHGDCNPDNIMCDKFGY--LKLVDPVC 189 (308)
T ss_pred HHHHHhhccCCCeecCCCChhheeecCCCC--EEecChhh
Confidence 56777884 57999999999999998876 99999763
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.21 Score=45.61 Aligned_cols=29 Identities=17% Similarity=0.228 Sum_probs=23.9
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
..++|||+.+.|||++..+ ++++|+.++.
T Consensus 192 ~~llHGDl~~gNi~~~~~~---~~~iD~e~~~ 220 (370)
T TIGR01767 192 ETLLHGDLHSGSIFVSEHE---TKVIDPEFAF 220 (370)
T ss_pred ceeeeccCCcccEEEcCCC---CEEEcCcccc
Confidence 4589999999999997544 7899998654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.39 Score=50.39 Aligned_cols=32 Identities=34% Similarity=0.484 Sum_probs=25.7
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEE-EeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLK-ICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~k-l~Dfgla~ 138 (334)
+++||+|+.+.|||++.++..++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 579999999999999866422354 99999765
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.76 E-value=0.32 Score=45.12 Aligned_cols=39 Identities=10% Similarity=0.058 Sum_probs=27.7
Q ss_pred HHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCChH
Q 019901 34 NVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 34 ~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
.-.+|+.+++.+...++ .++++.+.. ++|.||++|.+|.
T Consensus 98 dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 98 DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEWVEGNTMG 137 (383)
T ss_pred ccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEEeccccCC
Confidence 34678999999876555 445666532 6899999987663
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.71 E-value=0.073 Score=47.71 Aligned_cols=29 Identities=31% Similarity=0.620 Sum_probs=24.3
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.+++|+|+++.||+++. + .+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~--~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-N--EVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-C--cEEEEECcccc
Confidence 57899999999999986 3 38999999643
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.13 Score=46.12 Aligned_cols=76 Identities=25% Similarity=0.265 Sum_probs=44.7
Q ss_pred EEEEeccC--CCChHH-HHHhcCCCCHH-HHHHHHHHHHHHHHHHH----HCCceeCCCCCCcEEEcCCCCC--------
Q 019901 64 AIVMEYAS--GGELFE-RICNAGRFSED-EARFFFQQLISGVSYCH----SMQVCHRDLKLENTLLDGSPAP-------- 127 (334)
Q Consensus 64 ~lv~e~~~--~~~L~~-~l~~~~~~~~~-~~~~~~~qil~~L~~LH----~~~ivH~dlkp~NIli~~~~~~-------- 127 (334)
.+|+.+.. ...+.. ...+.|-.|.. -++.++.|++.-.-.+- ..+.+|.||||.|||+-.+...
T Consensus 251 IIIfPLArcSadkv~~~~~~e~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~ 330 (444)
T PHA03111 251 IIIFPLARCSADKVTEENAAELGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDA 330 (444)
T ss_pred EEEEehhhcccccCCHHHHHHcCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCe
Confidence 56666542 223322 22333433433 36778888865442332 2468999999999999654321
Q ss_pred --------CEEEeccCCccC
Q 019901 128 --------RLKICDFGYSKS 139 (334)
Q Consensus 128 --------~~kl~Dfgla~~ 139 (334)
+++|.||.+|+.
T Consensus 331 ~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 331 TYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred EEEeccchhhhhcccCHHHH
Confidence 456777777664
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.24 E-value=0.046 Score=45.06 Aligned_cols=28 Identities=25% Similarity=0.410 Sum_probs=23.9
Q ss_pred ceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 109 VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 109 ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
.+|+|+.|.|++++.++ ++|+||+.|..
T Consensus 79 p~H~D~~~~N~~~~~~~---~~lIDwe~a~~ 106 (188)
T PRK10271 79 PLHMDVHAGNLVHSASG---LRLIDWEYAGD 106 (188)
T ss_pred eecCCCCCccEEEECCC---EEEEeCCcccC
Confidence 58999999999997554 89999998753
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=94.22 E-value=0.041 Score=49.34 Aligned_cols=52 Identities=29% Similarity=0.363 Sum_probs=34.6
Q ss_pred HHHHHHHHHHHHHHHH---H-HCCceeCCCCCCcEEEcCCCCC----------------CEEEeccCCccCC
Q 019901 89 EARFFFQQLISGVSYC---H-SMQVCHRDLKLENTLLDGSPAP----------------RLKICDFGYSKSS 140 (334)
Q Consensus 89 ~~~~~~~qil~~L~~L---H-~~~ivH~dlkp~NIli~~~~~~----------------~~kl~Dfgla~~~ 140 (334)
-++.++.|++.-.--+ - ..+.+|.||||.|||+-.+... +++|.||.+|+..
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 3666777875432112 1 3468999999999999543321 4678888887643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=93.90 E-value=0.15 Score=42.52 Aligned_cols=32 Identities=22% Similarity=0.264 Sum_probs=25.5
Q ss_pred CCceeCCCCCCcEEEcCCCCC---CEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~---~~kl~Dfgla~ 138 (334)
..++|||+.+.||++..++.+ .+.++||..++
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 458999999999999754322 58999999765
|
subfamily of choline kinases |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=93.55 E-value=0.85 Score=42.29 Aligned_cols=62 Identities=16% Similarity=0.111 Sum_probs=43.6
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHCCceeCCCCCCcEEEcCC
Q 019901 62 HLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY-CHSMQVCHRDLKLENTLLDGS 124 (334)
Q Consensus 62 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~-LH~~~ivH~dlkp~NIli~~~ 124 (334)
...++-+|..|.++..++.... .+++..+.++.--+.||-- |---+++|.|++|.||++.-+
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~~~-~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKWKS-QPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred cceeeeeccccccHHhhhhccc-ChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 4577778998988888886543 4555555555555555433 445789999999999999543
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=93.11 E-value=0.73 Score=43.60 Aligned_cols=55 Identities=13% Similarity=0.052 Sum_probs=33.8
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcc-cceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
++.| .+|+.....-.. -...+|..+++.+...+|- ++++.+. + +.|.+|++|.+|
T Consensus 138 ~~~~-lvRiyG~~te~l-IdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I~efi~g~~l 193 (442)
T PTZ00296 138 RRRV-LFRIYGKDVDEL-YNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRIEEWLYGDPL 193 (442)
T ss_pred CceE-EEEecCCCccce-eCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEEEEeeCCccC
Confidence 4567 888876654111 2456788888777654553 4555553 2 457899988644
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=92.92 E-value=0.92 Score=42.29 Aligned_cols=29 Identities=14% Similarity=0.264 Sum_probs=23.2
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
...+||||+|.|||++.++ .+++|..++.
T Consensus 230 ~~L~HGDl~~g~i~~~~~~---~~~id~ef~~ 258 (418)
T PLN02756 230 QALVHGDLHTGSVMVTPDS---TQVIDPEFAF 258 (418)
T ss_pred cceeecCCCCCcEEEcCCC---ceEecchhhc
Confidence 3589999999999998654 7889876543
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 334 | ||||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-154 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-153 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 1e-153 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-153 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-145 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-142 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 7e-51 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-48 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-48 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-47 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-44 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-44 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-44 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-44 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-44 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-43 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-43 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-43 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-43 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-43 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-43 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 9e-43 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-42 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 5e-42 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-36 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-36 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-36 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-36 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-36 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-35 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-35 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-35 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-35 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-35 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-35 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-35 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-35 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-35 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-35 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-35 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-35 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-35 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 5e-35 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-35 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-34 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-34 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-34 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-34 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 2e-34 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-34 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-34 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-34 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-33 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-33 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-33 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-33 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-33 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-33 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 6e-33 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 9e-33 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-32 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-32 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-32 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-32 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-32 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-32 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-32 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 3e-32 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-32 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 4e-32 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-32 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-32 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-31 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-31 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 1e-31 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-31 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-31 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-31 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-31 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-31 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 1e-31 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-31 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-31 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-31 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-31 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-31 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-31 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-31 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-31 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-31 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-31 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-31 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-31 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-31 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-31 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-31 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-31 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-31 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-31 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-31 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-31 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-31 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-31 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-31 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-31 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-31 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-31 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-31 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 3e-31 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 3e-31 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 3e-31 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-31 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-31 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-31 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-31 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-31 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 8e-31 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 8e-31 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-30 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-30 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-30 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-30 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 4e-30 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 5e-30 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-30 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-30 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-30 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-30 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-30 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-29 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-29 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-29 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-29 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-29 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 3e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 3e-29 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 3e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 3e-29 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-29 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 3e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 3e-29 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-29 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 3e-29 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 3e-29 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 4e-29 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 4e-29 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 4e-29 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-29 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-29 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 6e-29 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-28 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-28 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-28 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-28 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-28 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-28 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-28 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-28 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-28 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-28 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 3e-28 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-28 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-28 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 5e-28 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 5e-28 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-28 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-28 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-28 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-28 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 9e-28 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-28 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-28 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-28 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-27 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-27 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-27 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-27 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 1e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-27 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-27 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-27 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-27 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-27 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 1e-27 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-27 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-27 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-27 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-27 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 3e-27 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-27 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-27 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 4e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-27 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 5e-27 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 5e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-27 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-27 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 8e-27 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-27 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 9e-27 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-26 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 3e-26 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-26 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-25 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-25 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-25 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-25 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 4e-25 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-25 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 4e-25 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-25 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-25 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-25 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-24 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-24 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-24 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-24 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-24 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-24 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-24 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-23 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-23 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-22 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 4e-22 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-22 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 5e-22 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 5e-22 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-22 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-22 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 6e-22 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 6e-22 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 6e-22 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-22 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-22 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-22 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 8e-22 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-22 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 9e-22 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-21 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-21 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-21 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-21 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-21 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-21 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-21 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-21 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-21 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-21 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-21 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-21 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-21 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-21 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-21 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-21 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-21 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-21 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-21 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-21 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-21 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-21 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-21 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-21 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-21 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-21 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-21 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-21 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 4e-21 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 4e-21 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 4e-21 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 4e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 7e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 7e-21 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-21 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-21 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 8e-21 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-20 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-20 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-20 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-20 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-19 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-19 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-19 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-19 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 6e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 6e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 6e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 6e-19 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 3e-18 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-18 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-18 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-17 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-17 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-17 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-17 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 2e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-17 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-17 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-17 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-17 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-17 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-17 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-17 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-17 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 7e-17 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 9e-17 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-16 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-16 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 2e-16 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-16 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 5e-16 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-16 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-16 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-16 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 7e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-16 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 8e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-16 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 8e-16 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 9e-16 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 9e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-16 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-16 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-16 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 9e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-16 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-16 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 9e-16 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 9e-16 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-16 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-15 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-15 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-15 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-15 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-15 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-15 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-15 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-15 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-15 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 4e-15 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-15 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-14 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-13 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 1e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-13 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-13 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-13 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-13 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-13 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-13 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-13 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 3e-13 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-13 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-13 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 3e-13 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-13 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 3e-13 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-13 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-13 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-13 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-13 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-13 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 4e-13 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-13 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-13 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-13 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-13 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 4e-13 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-13 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-13 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 4e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-13 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-13 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 4e-13 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 4e-13 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-13 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-13 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-13 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 5e-13 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-13 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-13 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-13 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-13 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 5e-13 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-13 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-13 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-13 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-13 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 5e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-13 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-13 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 5e-13 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 5e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 6e-13 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 6e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-13 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 6e-13 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 6e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 6e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 7e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-12 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 1e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-12 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 1e-12 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-12 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-12 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-12 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-12 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-12 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-12 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 2e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-12 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-12 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-12 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-12 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-12 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-12 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-12 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 3e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-12 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-12 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-12 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-12 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-12 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-12 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-12 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-12 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-12 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-12 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 6e-12 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-12 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 6e-12 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-12 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-12 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 7e-12 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 7e-12 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-12 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 8e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-11 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 2e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-11 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-11 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-11 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-11 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-11 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 4e-11 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-11 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-11 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-11 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-11 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-11 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 7e-11 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 8e-11 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 8e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 8e-11 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-11 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-11 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-11 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 9e-11 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 9e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 9e-11 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 9e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-10 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-10 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-10 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-10 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-10 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 3e-10 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 3e-10 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 3e-10 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 3e-10 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 3e-10 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 3e-10 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 3e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-10 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-10 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-10 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 3e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 4e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-10 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-10 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 4e-10 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-10 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 4e-10 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-10 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-10 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-10 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 6e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 6e-10 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 6e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 7e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 7e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 7e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-10 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 7e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 7e-10 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 8e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 8e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 9e-10 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-09 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-09 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-09 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-09 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-09 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-09 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-09 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-09 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-09 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-09 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 4e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 4e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-09 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-09 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 6e-09 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 6e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 6e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-09 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 7e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 7e-09 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-09 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-09 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-08 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-08 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-08 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-08 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-08 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-08 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-08 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 3e-08 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-08 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-08 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-08 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-08 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-08 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 4e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-08 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-08 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 5e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-08 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 6e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 6e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-08 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-08 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 6e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-08 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-08 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 9e-08 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 9e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-07 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-07 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-07 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 1e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-07 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-07 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-07 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-07 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-07 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-07 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-07 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 4e-07 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 4e-07 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 4e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-07 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-07 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-07 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-07 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-07 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-07 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 7e-07 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-07 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 8e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 9e-07 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-06 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-06 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 4e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 5e-06 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 6e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 7e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 7e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 7e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 8e-06 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-05 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-05 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-05 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 1e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-05 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-05 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-05 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-05 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-05 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-05 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 3e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 5e-05 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 5e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 5e-05 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 5e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 5e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 5e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 5e-05 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 5e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 5e-05 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-05 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 6e-05 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 6e-05 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-05 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-05 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 8e-05 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 9e-05 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 9e-05 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-05 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-04 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 1e-04 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-04 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-04 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-04 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-04 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 2e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 2e-04 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 2e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 2e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 2e-04 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-04 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 3e-04 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-04 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-04 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-04 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-04 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-04 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-04 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-04 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 4e-04 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 4e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-04 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 4e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-04 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 6e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 6e-04 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 8e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 8e-04 |
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 513 bits (1323), Expect = 0.0
Identities = 250/304 (82%), Positives = 282/304 (92%), Gaps = 1/304 (0%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 90
IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI+MEYASGGEL+ERICNAGRFSEDEA
Sbjct: 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEA 118
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
RFFFQQL+SGVSYCHSMQ+CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV
Sbjct: 119 RFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 178
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTPAYIAPEVLL++EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP+++RKTI RILSV+
Sbjct: 179 GTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK 238
Query: 211 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEE 270
YSIPD + ISPEC HLISRIFVADPA RISIPEI+ H WFLKNLPADL+ ++ T +QF+E
Sbjct: 239 YSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQE 298
Query: 271 PDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDIDSSGEI 330
P+QPMQS+D IMQII+EATIPA + L+ + +LD+DD+M +D D++ ++DIDSSGEI
Sbjct: 299 PEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDM-DDFDSESEIDIDSSGEI 357
Query: 331 VYAM 334
VYA+
Sbjct: 358 VYAL 361
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-134
Identities = 83/273 (30%), Positives = 135/273 (49%), Gaps = 14/273 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
EN+++EI ++ L H N+V+F + +EY SGGELF+RI E +A+
Sbjct: 50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 149
FF QL++GV Y H + + HRD+K EN LLD LKI DFG + +++
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKM 167
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILS 208
GT Y+APE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKE 223
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 268
+ + + I L+ +I V +P+ RI+IP+I+ W+ K L T+
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGV 283
Query: 269 EEP----DQPMQSIDEIMQIIAEATIPAAGTQS 297
E + +QS + + + + P +G
Sbjct: 284 SESPSGFSKHIQSNLDFSPVNSASRTPGSGWSK 316
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 371 bits (954), Expect = e-130
Identities = 77/230 (33%), Positives = 121/230 (52%), Gaps = 10/230 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
EN+++EI ++ L H N+V+F + +EY SGGELF+RI E +A+
Sbjct: 50 ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQR 109
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KST 149
FF QL++GV Y H + + HRD+K EN LLD LKI DFG + +++
Sbjct: 110 FFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFRYNNRERLLNKM 167
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILS 208
GT Y+APE+L ++E+ + DVWSCG+ L ML G P++ P + + +
Sbjct: 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKE 223
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
+ + + I L+ +I V +P+ RI+IP+I+ W+ K L
Sbjct: 224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-105
Identities = 99/226 (43%), Positives = 132/226 (58%), Gaps = 8/226 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++REI N + RHP+I++ +VI TPT +VMEY SGGELF+ IC GR E EAR
Sbjct: 56 GKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARR 115
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
FQQ++S V YCH V HRDLK EN LLD KI DFG S +++ G+
Sbjct: 116 LFQQILSAVDYCHRHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGS 173
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P Y APEV+ + Y G D+WSCGV LY +L G PF+D P F+K I +
Sbjct: 174 PNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK----IRGGVFY 229
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
IP+ +++ L+ + DP KR +I +IR HEWF ++LP+ L
Sbjct: 230 IPE--YLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL 273
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 310 bits (796), Expect = e-103
Identities = 100/258 (38%), Positives = 144/258 (55%), Gaps = 8/258 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++REI N + RHP+I++ +VI TP+ + +VMEY SGGELF+ IC GR E E+R
Sbjct: 61 GKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRR 120
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
FQQ++SGV YCH V HRDLK EN LLD KI DFG S +++ G+
Sbjct: 121 LFQQILSGVDYCHRHMVVHRDLKPENVLLDAH--MNAKIADFGLSNMMSDGEFLRTSCGS 178
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P Y APEV+ + Y G D+WS GV LY +L G PF+D P F+K I +
Sbjct: 179 PNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK----ICDGIFY 234
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPD 272
P +++P L+ + DP KR +I +IR HEWF ++LP L ++ + + D
Sbjct: 235 TPQ--YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDD 292
Query: 273 QPMQSIDEIMQIIAEATI 290
+ ++ + E + E +
Sbjct: 293 EALKEVCEKFECSEEEVL 310
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 304 bits (781), Expect = e-103
Identities = 93/251 (37%), Positives = 133/251 (52%), Gaps = 12/251 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ + RE+ + L HPNIV+ EVI T L ++MEYASGGE+F+ + GR E EAR
Sbjct: 59 QKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
F+Q++S V YCH ++ HRDLK EN LLD +KI DFG+S + + + G
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDAD--MNIKIADFGFSNEFTVGGKLDAFCGA 176
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P Y APE+ K+YDG DVWS GV LY ++ G+ PF+ + + +L +Y
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER----VLRGKYR 232
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPD 272
IP Y+ S +C +L+ R V +P KR ++ +I W D + E D
Sbjct: 233 IPFYM--STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDEL----KPFVEPELD 286
Query: 273 QPMQSIDEIMQ 283
Q +IM
Sbjct: 287 ISDQKRIDIMV 297
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 301 bits (774), Expect = e-102
Identities = 84/228 (36%), Positives = 116/228 (50%), Gaps = 11/228 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI HRSL H ++V F + +V+E L E +E EAR+
Sbjct: 60 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-G 151
+ +Q++ G Y H +V HRDLKL N L+ +KI DFG + + K + G
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP YIAPEVL KK + + DVWS G +Y +LVG PFE ++T RI +Y
Sbjct: 178 TPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEY 232
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 258
SIP HI+P LI ++ DP R +I E+ N E+F +PA L
Sbjct: 233 SIPK--HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 278
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-101
Identities = 110/258 (42%), Positives = 148/258 (57%), Gaps = 10/258 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
V+REI + LRHP+I++ +VI TPT + +V+EYA GGELF+ I R +EDE R
Sbjct: 54 MRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRR 112
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
FFQQ+I + YCH ++ HRDLK EN LLD + +KI DFG S + K++ G+
Sbjct: 113 FFQQIICAIEYCHRHKIVHRDLKPENLLLDDN--LNVKIADFGLSNIMTDGNFLKTSCGS 170
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P Y APEV+ K Y G DVWSCG+ LYVMLVG PF+D P F+K + S Y
Sbjct: 171 PNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK----VNSCVYV 226
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPD 272
+PD +SP + LI R+ VADP +RI+I EIR WF NLP L + +
Sbjct: 227 MPD--FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSR 284
Query: 273 QPMQSIDEIMQIIAEATI 290
+ + E M + +
Sbjct: 285 I-VSKLGEAMGFSEDYIV 301
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-101
Identities = 84/228 (36%), Positives = 116/228 (50%), Gaps = 11/228 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI HRSL H ++V F + +V+E L E +E EAR+
Sbjct: 86 EKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARY 145
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-G 151
+ +Q++ G Y H +V HRDLKL N L+ +KI DFG + + K + G
Sbjct: 146 YLRQIVLGCQYLHRNRVIHRDLKLGNLFLNED--LEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP YIAPEVL KK + + DVWS G +Y +LVG PFE ++T RI +Y
Sbjct: 204 TPNYIAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFET----SCLKETYLRIKKNEY 258
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 258
SIP HI+P LI ++ DP R +I E+ N E+F +PA L
Sbjct: 259 SIPK--HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARL 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = e-101
Identities = 86/229 (37%), Positives = 121/229 (52%), Gaps = 20/229 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEA 90
E V +EI + L HPN+V+ EV+ P HL +V E + G + E + SED+A
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQA 139
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS-----KSSVLHSQ 145
RF+FQ LI G+ Y H ++ HRD+K N L+ +KI DFG S ++L
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGED--GHIKIADFGVSNEFKGSDALLS-- 195
Query: 146 PKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
+TVGTPA++APE L +K + GK DVW+ GVTLY + G PF D K
Sbjct: 196 --NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK-- 251
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
I S PD I+ + + LI+R+ +P RI +PEI+ H W +
Sbjct: 252 --IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = e-101
Identities = 79/263 (30%), Positives = 123/263 (46%), Gaps = 18/263 (6%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGG--ELFERICNAGRFS 86
+ NV++EI R LRH N+++ +V+ + +VMEY G E+ + + RF
Sbjct: 49 GEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFP 107
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+A +F QLI G+ Y HS + H+D+K N LL LKI G +++ +
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTG--GTLKISALGVAEALHPFAAD 165
Query: 147 ---KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202
+++ G+PA+ PE+ + G D+WS GVTLY + G YPFE N K
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD----NIYKL 221
Query: 203 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV-VD 261
I Y+IP P L+ + +PAKR SI +IR H WF K P V
Sbjct: 222 FENIGKGSYAIPGD--CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVP 279
Query: 262 NTTNNQFEEPDQPMQSIDEIMQI 284
+ ++ + M + + +
Sbjct: 280 IPPSPDTKDRWRSMTVVPYLEDL 302
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = e-100
Identities = 70/225 (31%), Positives = 119/225 (52%), Gaps = 11/225 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEAR 91
+ VQ E+ H L+HP+I+ ++ +V+E GE+ + N FSE+EAR
Sbjct: 56 QRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEAR 115
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV- 150
F Q+I+G+ Y HS + HRDL L N LL + +KI DFG + + + T+
Sbjct: 116 HFMHQIITGMLYLHSHGILHRDLTLSNLLLTRN--MNIKIADFGLATQLKMPHEKHYTLC 173
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP YI+PE+ + + + +DVWS G Y +L+G PF+ + T+++++
Sbjct: 174 GTPNYISPEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDT----DTVKNTLNKVVLAD 228
Query: 211 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
Y +P +S E + LI ++ +PA R+S+ + +H + +N
Sbjct: 229 YEMPS--FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSS 271
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 289 bits (743), Expect = 7e-98
Identities = 71/223 (31%), Positives = 113/223 (50%), Gaps = 10/223 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++REI LRHPNI+R + +++E+A GEL++ + GRF E +
Sbjct: 59 HQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSAT 118
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
F ++L + YCH +V HRD+K EN L+ LKI DFG+S + + ++ GT
Sbjct: 119 FMEELADALHYCHERKVIHRDIKPENLLMGYK--GELKIADFGWSVHAP-SLRRRTMCGT 175
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
Y+ PE++ K +D K D+W GV Y LVG PF+ P + R+ I++V
Sbjct: 176 LDYLPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRR----IVNVDLK 230
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
P ++ S + LIS++ P +R+ + + H W N
Sbjct: 231 FPPFL--SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 287 bits (737), Expect = 6e-97
Identities = 75/223 (33%), Positives = 116/223 (52%), Gaps = 10/223 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
++RE+ LRHPNI+R T + +++EYA G ++ + +F E
Sbjct: 54 HQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTAT 113
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ +L + +SYCHS +V HRD+K EN LL + LKI DFG+S S+ GT
Sbjct: 114 YITELANALSYCHSKRVIHRDIKPENLLLGSA--GELKIADFGWSV-HAPSSRRTDLCGT 170
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
Y+ PE++ + +D K D+WS GV Y LVG PFE +++T RI V+++
Sbjct: 171 LDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFT 225
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
PD ++ R LISR+ +P++R + E+ H W N
Sbjct: 226 FPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 266
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 279 bits (715), Expect = 4e-93
Identities = 71/233 (30%), Positives = 104/233 (44%), Gaps = 24/233 (10%)
Query: 33 ENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASG-GELFERICNAGRFSEDE 89
V E++ + + ++R + P +++E +LF+ I G E+
Sbjct: 91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 150
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHSQP 146
AR FF Q++ V +CH+ V HRD+K EN L+D + LK+ DFG K +V
Sbjct: 151 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG-ELKLIDFGSGALLKDTVYT--- 206
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
GT Y PE + Y G+ A VWS G+ LY M+ G PFE E I
Sbjct: 207 -DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EI 255
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADL 258
+ Q +S EC+HLI P+ R + EI+NH W LP +
Sbjct: 256 IRGQVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 306
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 5e-93
Identities = 66/235 (28%), Positives = 95/235 (40%), Gaps = 25/235 (10%)
Query: 33 ENVQREIINHRSLR----HPNIVRFKEVILTPTHLAIVMEYA-SGGELFERICNAGRFSE 87
E+ + HP ++R + T +V+E +LF+ I G E
Sbjct: 79 VTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE 138
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS---KSSVLHS 144
+R FF Q+++ + +CHS V HRD+K EN L+D K+ DFG
Sbjct: 139 GPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLIDFGSGALLHDEPYT- 196
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
GT Y PE + + +Y A VWS G+ LY M+ G PFE
Sbjct: 197 ---DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER----------DQ 243
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 259
IL + P H+SP+C LI R P+ R S+ EI W +
Sbjct: 244 EILEAELHFPA--HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPL 296
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 277 bits (711), Expect = 4e-92
Identities = 51/256 (19%), Positives = 96/256 (37%), Gaps = 39/256 (15%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------R 84
++ + E+ +++ + + +I + I+ EY + +
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 85 FSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SS 140
+ + +++ SY H+ +CHRD+K N L+D + R+K+ DFG S+
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKN--GRVKLSDFGESEYMVDK 205
Query: 141 VLHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
+ + GT ++ PE + Y+G D+WS G+ LYVM PF +
Sbjct: 206 KIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI---SL 258
Query: 200 RKTIHRILSVQYSIPDYV-----------------HISPECRHLISRIFVADPAKRISIP 242
+ + I + P +S E + +PA+RI+
Sbjct: 259 VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318
Query: 243 EIRNHEWFLKNLPADL 258
+ HEW DL
Sbjct: 319 DALKHEWLADTNIEDL 334
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 5e-92
Identities = 63/224 (28%), Positives = 98/224 (43%), Gaps = 15/224 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVME-YASGGELFERICNAGRFSEDEAR 91
V EI + H NI++ ++ +VME + SG +LF I R E A
Sbjct: 74 GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ F+QL+S V Y + HRD+K EN ++ +K+ DFG + + G
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAED--FTIKLIDFGSAAYLERGKLFYTFCG 191
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T Y APEVL+ Y G ++WS GVTLY ++ PF + EE +
Sbjct: 192 TIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEAAI 241
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
P V S E L+S + P +R ++ ++ W + +
Sbjct: 242 HPPYLV--SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVN 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 255 bits (655), Expect = 1e-84
Identities = 84/227 (37%), Positives = 124/227 (54%), Gaps = 9/227 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ ++EI +SL HPNI+R E T + +VME +GGELFER+ + F E +A
Sbjct: 51 DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR 110
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ ++S V+YCH + V HRDLK EN L SP LK+ DFG + ++ VG
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP Y++P+V L+ Y G D WS GV +YV+L G PF P + + K I +
Sbjct: 171 TPYYVSPQV-LEGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTF 224
Query: 212 SI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256
+ D++++SP+ LI R+ P +RI+ + HEWF K L +
Sbjct: 225 TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 1e-81
Identities = 74/235 (31%), Positives = 108/235 (45%), Gaps = 11/235 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
NV+ EI + L HP I++ K + IV+E GGELF+++ R E +
Sbjct: 60 LNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKL 118
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+F Q++ V Y H + HRDLK EN LL +KI DFG+SK S ++ G
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 178
Query: 152 TPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHRILS 208
TP Y+APEVL+ + D WS GV L++ L G PF + + + I S
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQ----ITS 234
Query: 209 VQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
+Y+ V +S + L+ ++ V DP R + E H W D
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 247 bits (634), Expect = 2e-81
Identities = 76/231 (32%), Positives = 119/231 (51%), Gaps = 8/231 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ ++RE R L+HPNIVR + I + +V + +GGELFE I +SE +A
Sbjct: 50 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 109
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
QQ++ ++YCHS + HR+LK EN LL + +K+ DFG + G
Sbjct: 110 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP Y++PEVL K Y K D+W+CGV LY++LVG PF D ++ + + + I + Y
Sbjct: 170 TPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAY 224
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 260
P++ ++PE + LI + +P KRI+ + W +
Sbjct: 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAI 275
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 7e-81
Identities = 73/224 (32%), Positives = 112/224 (50%), Gaps = 12/224 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----NAGRFSED 88
E ++ EI +SL HPNI++ EV ++ IVME GGEL ERI SE
Sbjct: 65 EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG 124
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPK 147
+Q+++ ++Y HS V H+DLK EN L SP +KI DFG ++
Sbjct: 125 YVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHST 184
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
+ GT Y+APEV K++ K D+WS GV +Y +L G PF + +K
Sbjct: 185 NAAGTALYMAPEV-FKRDVTFK-CDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----AT 238
Query: 208 SVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ + + ++P+ L+ ++ DP +R S ++ +HEWF
Sbjct: 239 YKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 2e-80
Identities = 55/236 (23%), Positives = 92/236 (38%), Gaps = 22/236 (9%)
Query: 33 ENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 90
++ + EI L+ + I+R + +T ++ +VME +L + E
Sbjct: 71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 129
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 147
+ +++ ++ V H + H DLK N L+ LK+ DFG +
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD 186
Query: 148 STVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
S VGT Y+ PE + +DVWS G LY M G PF+
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ---II 243
Query: 198 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
N +H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 244 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 299
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 245 bits (626), Expect = 8e-80
Identities = 54/260 (20%), Positives = 102/260 (39%), Gaps = 39/260 (15%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSE 87
+ RE + L H NIV+ + T H ++ME+ G L+ + NA E
Sbjct: 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQ 145
E + ++ G+++ + HR++K N + + K+ DFG ++ Q
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 146 PKSTVGTPAYIAPEVL--------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
S GT Y+ P++ +K+Y D+WS GVT Y G+ PF E P+
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 198 NFRKTIHRILSVQYS-------------------IPDYVHISPECR----HLISRIFVAD 234
++ +++I++ + S +P +S + +++ I AD
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 235 PAKRISIPEIRNHEWFLKNL 254
K + + +
Sbjct: 291 QEKCWGFDQFFAETSDILHR 310
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 8e-80
Identities = 58/288 (20%), Positives = 106/288 (36%), Gaps = 28/288 (9%)
Query: 33 ENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 90
++ + EI L+ + I+R + +T ++ +VME +L + E
Sbjct: 52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 110
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPK 147
+ +++ ++ V H + H DLK N L+ LK+ DFG +
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD 167
Query: 148 STVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
S VGT Y+ PE + +DVWS G LY M G PF+
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 227
Query: 198 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
+ +H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 228 S---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 284
Query: 258 LVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGS 305
+ T + + + +++ + + +I A G
Sbjct: 285 NQMAKGTTEEMK------YVLGQLVGLNSPNSILKAAKTLYEHYSGGE 326
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 246 bits (631), Expect = 3e-79
Identities = 72/223 (32%), Positives = 108/223 (48%), Gaps = 9/223 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
NV+ EI + L HP I++ K + IV+E GGELF+++ R E +
Sbjct: 185 LNVETEIEILKKLNHPCIIKIKNFFDAEDYY-IVLELMEGGELFDKVVGNKRLKEATCKL 243
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+F Q++ V Y H + HRDLK EN LL +KI DFG+SK S ++ G
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG 303
Query: 152 TPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
TP Y+APEVL+ + D WS GV L++ L G PF + + + +I S
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKD---QITSG 360
Query: 210 QYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+Y+ + +S + L+ ++ V DP R + E H W
Sbjct: 361 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 4e-79
Identities = 54/263 (20%), Positives = 99/263 (37%), Gaps = 22/263 (8%)
Query: 33 ENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEA 90
++ + EI L+ + I+R + +T ++ +VME +L + E
Sbjct: 99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWER 157
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---K 147
+ +++ ++ V H + H DLK N L+ LK+ DFG + +
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDG---MLKLIDFGIANQMQPDTTSVVKD 214
Query: 148 STVGTPAYIAPEVLLKKEYD----------GKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
S VG Y+ PE + +DVWS G LY M G PF+
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI 274
Query: 198 NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
+ +H I+ + I + + ++ DP +RISIPE+ H +
Sbjct: 275 S---KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV 331
Query: 258 LVVDNTTNNQFEEPDQPMQSIDE 280
+ T + + + ++
Sbjct: 332 NQMAKGTTEEMKYVLGQLVGLNS 354
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 241 bits (617), Expect = 1e-78
Identities = 72/234 (30%), Positives = 113/234 (48%), Gaps = 14/234 (5%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
E +E+ I + HPNI++ K+ T T +V + GELF+ + SE E R
Sbjct: 68 EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETR 127
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ L+ + H + + HRDLK EN LLD +K+ DFG+S + + G
Sbjct: 128 KIMRALLEVICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLREVCG 185
Query: 152 TPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
TP+Y+APE++ D GK D+WS GV +Y +L G+ PF ++ R I
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----I 241
Query: 207 LSVQYSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
+S Y P++ S + L+SR V P KR + E H +F + + ++
Sbjct: 242 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 243 bits (622), Expect = 3e-78
Identities = 58/304 (19%), Positives = 112/304 (36%), Gaps = 39/304 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVI--LTPTHLAIVMEYASGGELFERIC---NAGRFSE 87
+ RE + L H NIV+ + T H ++ME+ G L+ + NA E
Sbjct: 52 DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE 111
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFGYSKSSVLHSQ 145
E + ++ G+++ + HR++K N + + K+ DFG ++ Q
Sbjct: 112 SEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ 171
Query: 146 PKSTVGTPAYIAPEVL--------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
S GT Y+ P++ +K+Y D+WS GVT Y G+ PF E P+
Sbjct: 172 FVSLYGTEEYLHPDMYERAVLRKDHQKKYGAT-VDLWSIGVTFYHAATGSLPFRPFEGPR 230
Query: 198 NFRKTIHRILSVQYS-------------------IPDYVHISP----ECRHLISRIFVAD 234
++ +++I++ + S +P +S +++ I AD
Sbjct: 231 RNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD 290
Query: 235 PAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAG 294
K + + + V + + +++ + T +
Sbjct: 291 QEKCWGFDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISS 350
Query: 295 TQSL 298
Q L
Sbjct: 351 NQEL 354
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 3e-78
Identities = 76/228 (33%), Positives = 118/228 (51%), Gaps = 8/228 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ ++RE R L+HPNIVR + I + +V + +GGELFE I +SE +A
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
QQ++ ++YCHS + HR+LK EN LL + +K+ DFG + G
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 192
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP Y++PEVL K Y K D+W+CGV LY++LVG PF D ++ + + + I + Y
Sbjct: 193 TPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQ----IKAGAY 247
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
P++ ++PE + LI + +P KRI+ + W
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 295
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 2e-77
Identities = 68/228 (29%), Positives = 109/228 (47%), Gaps = 14/228 (6%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
E +RE I + HP+I+ + + + + +V + GELF+ + SE E R
Sbjct: 144 EATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETR 203
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ L+ VS+ H+ + HRDLK EN LLD + +++ DFG+S + + G
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDN-MQ-IRLSDFGFSCHLEPGEKLRELCG 261
Query: 152 TPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
TP Y+APE+L + GK D+W+CGV L+ +L G+ PF + R I
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----I 317
Query: 207 LSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ QY S + LISR+ DP R++ + H +F +
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 2e-77
Identities = 81/243 (33%), Positives = 122/243 (50%), Gaps = 11/243 (4%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
D +++ EI + ++H NIV +++ + TH +VM+ SGGELF+RI G ++E +A
Sbjct: 50 DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS 109
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KST 149
QQ++S V Y H + HRDLK EN L ++ I DFG SK + + +
Sbjct: 110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK--MEQNGIMSTA 167
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
GTP Y+APEVL +K Y K D WS GV Y++L G PF + E K F K I
Sbjct: 168 CGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEG 222
Query: 210 QYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 267
Y P + IS + I + DP +R + + +H W N + + + Q
Sbjct: 223 YYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQ 282
Query: 268 FEE 270
++
Sbjct: 283 IQK 285
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-77
Identities = 80/224 (35%), Positives = 120/224 (53%), Gaps = 9/224 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ RE+ + L HPNI++ E++ + IV E +GGELF+ I RFSE +A
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+Q+ SG++Y H + HRDLK EN LL+ +KI DFG S +++ K +G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T YIAPEV L+ YD K DVWS GV LY++L G PF E ++ + + +Y
Sbjct: 186 TAYYIAPEV-LRGTYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKR----VETGKY 239
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ +P + IS + + LI ++ P+ RI+ + H W K
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 247 bits (631), Expect = 1e-76
Identities = 74/328 (22%), Positives = 121/328 (36%), Gaps = 34/328 (10%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERIC---NAG 83
E EI + L HPN+V +EV LA + MEY GG+L + + N
Sbjct: 57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC 116
Query: 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVL 142
E R + S + Y H ++ HRDLK EN +L G KI D GY+K
Sbjct: 117 GLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202
VGT Y+APE+L +K+Y D WS G + + G PF +P +
Sbjct: 177 GELCTEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGK 235
Query: 203 IHR--------------ILSVQYSIPDYVHISPECRHLISRIF----VADPAKRISIPEI 244
+ + +P H+S + R + +R + P+
Sbjct: 236 VREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295
Query: 245 RNHEWF-----LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLN 299
N F + +L V++ + P +++ + + + T Q L
Sbjct: 296 PNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTENENLQNLKSWLQQDTGIPEEEQELL 355
Query: 300 QCLNGSLDIDDEMDEDIDTDPDLDIDSS 327
Q +L+ + + + +D
Sbjct: 356 QASGLALNSAQPLTQYVIDCTVIDGRQG 383
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 1e-76
Identities = 72/224 (32%), Positives = 107/224 (47%), Gaps = 8/224 (3%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
+ EI I R +HPNI+ K+V ++ +V E GGEL ++I FSE EA
Sbjct: 60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREAS 119
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST 149
+ V Y H+ V HRDLK N L ++ICDFG++K + T
Sbjct: 120 AVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT 179
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
T ++APEVL ++ YD D+WS GV LY ML G PF + + RI S
Sbjct: 180 PCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGS 237
Query: 209 VQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
++S+ +S + L+S++ DP +R++ + H W
Sbjct: 238 GKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI 281
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-76
Identities = 66/269 (24%), Positives = 106/269 (39%), Gaps = 52/269 (19%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-------- 84
E ++ E+ + L HPNI R EV ++ +VME GG L +++
Sbjct: 73 ERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAM 132
Query: 85 --------------------------------FSEDEARFFFQQLISGVSYCHSMQVCHR 112
E +Q+ S + Y H+ +CHR
Sbjct: 133 DVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHR 192
Query: 113 DLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-----KSTVGTPAYIAPEVLLKKEYD 167
D+K EN L + + +K+ DFG SK + + GTP ++APEVL
Sbjct: 193 DIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES 252
Query: 168 -GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECR 224
G D WS GV L+++L+GA PF + + +L+ + P+Y +SP R
Sbjct: 253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQ----VLNKKLCFENPNYNVLSPLAR 308
Query: 225 HLISRIFVADPAKRISIPEIRNHEWFLKN 253
L+S + + +R H W +
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 3e-76
Identities = 84/232 (36%), Positives = 119/232 (51%), Gaps = 9/232 (3%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
N Q+EI HPNIV+ EV H +VME +GGELFERI FSE EA
Sbjct: 50 ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEAS 109
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQP-KST 149
+ ++L+S VS+ H + V HRDLK EN L D + +KI DFG+++ +QP K+
Sbjct: 110 YIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTP 169
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI---HRI 206
T Y APE+L + YD + D+WS GV LY ML G PF+ + + +I
Sbjct: 170 CFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKI 228
Query: 207 LSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256
+S + ++S E + LI + DP KR+ + +R +EW
Sbjct: 229 KKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 233 bits (598), Expect = 5e-76
Identities = 75/222 (33%), Positives = 121/222 (54%), Gaps = 9/222 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E ++RE+ R +RHPNI+ ++ T + +++E SGGELF+ + +EDEA
Sbjct: 53 EEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQ 112
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +Q++ GV Y HS ++ H DLK EN +L P PR+K+ DFG + ++ K+
Sbjct: 113 FLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF 172
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APE++ + G AD+WS GV Y++L GA PF + + I +V
Sbjct: 173 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVN 227
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
Y + + + S + I R+ V DP +R++I + H W
Sbjct: 228 YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWI 269
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 6e-76
Identities = 76/234 (32%), Positives = 127/234 (54%), Gaps = 10/234 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+++RE+ + ++HPN++ EV T + +++E +GGELF+ + +E+EA
Sbjct: 59 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 118
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +Q+++GV Y HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+
Sbjct: 119 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 178
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APE++ + G AD+WS GV Y++L GA PF + + + +V
Sbjct: 179 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVN 233
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 262
Y D + + S + I R+ V DP KR++I + H W +K +
Sbjct: 234 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW-IKPKDTQQALSR 286
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 7e-76
Identities = 73/235 (31%), Positives = 119/235 (50%), Gaps = 9/235 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E ++RE+ R + H N++ +V T + +++E SGGELF+ + SE+EA
Sbjct: 60 EEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +Q++ GV+Y H+ ++ H DLK EN +L P P +K+ DFG + + K+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APE++ + G AD+WS GV Y++L GA PF + + I SV
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITSVS 234
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 263
Y + + H S + I ++ V + KR++I E H W +V
Sbjct: 235 YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 235 bits (602), Expect = 1e-75
Identities = 73/235 (31%), Positives = 119/235 (50%), Gaps = 9/235 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E ++RE+ R + HPNI+ +V T + +++E SGGELF+ + SE+EA
Sbjct: 60 EEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATS 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +Q++ GV+Y H+ ++ H DLK EN +L P P +K+ DFG + + K+
Sbjct: 120 FIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF 179
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APE++ + G AD+WS GV Y++L GA PF + + I +V
Sbjct: 180 GTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLAN----ITAVS 234
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNT 263
Y + + S + I ++ V + KR++I E H W +V
Sbjct: 235 YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 4e-75
Identities = 91/294 (30%), Positives = 141/294 (47%), Gaps = 19/294 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ RE+ + L HPNI++ E++ + IV E +GGELF+ I RFSE +A
Sbjct: 66 STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR 125
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+Q+ SG++Y H + HRDLK EN LL+ +KI DFG S +++ K +G
Sbjct: 126 IIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG 185
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--V 209
T YIAPEV L+ YD K DVWS GV LY++L G PF KN + R+ +
Sbjct: 186 TAYYIAPEV-LRGTYDEK-CDVWSAGVILYILLSGTPPFYG----KNEYDILKRVETGKY 239
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+ +P + IS + + LI ++ P+ RI+ + H W K + + + +
Sbjct: 240 AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLE-- 297
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 321
++ I Q AE + A + L + E+ +DT+ D
Sbjct: 298 ------SAMTNIRQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNND 345
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 233 bits (597), Expect = 5e-75
Identities = 86/241 (35%), Positives = 129/241 (53%), Gaps = 8/241 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ V+ EI L HPNI++ KE+ TPT +++V+E +GGELF+RI G +SE +A
Sbjct: 93 KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAAD 152
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+Q++ V+Y H + HRDLK EN L +P LKI DFG SK K+ G
Sbjct: 153 AVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG 212
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP Y APE+L Y G D+WS G+ Y++L G PF D + + RIL+ +Y
Sbjct: 213 TPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYD---ERGDQFMFRRILNCEY 268
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
P + +S + L+ ++ V DP KR++ + H W + A+ V +T + +
Sbjct: 269 YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPW-VTGKAANFVHMDTAQKKLQ 327
Query: 270 E 270
E
Sbjct: 328 E 328
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-74
Identities = 89/296 (30%), Positives = 140/296 (47%), Gaps = 24/296 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI +SL HPNI++ +V + +V E+ GGELFE+I N +F E +A
Sbjct: 91 EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAAN 150
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+Q++SG+ Y H + HRD+K EN LL + + +KI DFG S + + +G
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG 210
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--V 209
T YIAPEV LKK+Y+ K DVWSCGV +Y++L G PF +N + I ++
Sbjct: 211 TAYYIAPEV-LKKKYNEK-CDVWSCGVIMYILLCGYPPFGG----QNDQDIIKKVEKGKY 264
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+ D+ +IS E + LI + D KR + E N W K N
Sbjct: 265 YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKY-----------ANNIN 313
Query: 270 EPDQPMQS--IDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDD--EMDEDIDTDPD 321
+ DQ + + + + A + L + + ++ + +D + D
Sbjct: 314 KSDQKTLCGALSNMRKFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGD 369
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 236 bits (603), Expect = 2e-74
Identities = 81/238 (34%), Positives = 123/238 (51%), Gaps = 9/238 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++ RE+ + L HPNI++ E + +V E +GGELF+ I + RFSE +A
Sbjct: 71 ESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR 130
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+Q++SG++Y H ++ HRDLK EN LL+ S ++I DFG S + K +G
Sbjct: 131 IIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG 190
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--V 209
T YIAPEV L YD K DVWS GV LY++L G PF N + ++
Sbjct: 191 TAYYIAPEV-LHGTYDEK-CDVWSTGVILYILLSGCPPFNG----ANEYDILKKVEKGKY 244
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 267
+ +P + +S + LI ++ P+ RIS + +HEW + VD + +
Sbjct: 245 TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDN 302
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-74
Identities = 95/323 (29%), Positives = 153/323 (47%), Gaps = 35/323 (10%)
Query: 22 IIIVFHLWQID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80
II L D + ++RE R L+HPNIVR + I H ++ + +GGELFE I
Sbjct: 43 IINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIV 102
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGY 136
+SE +A QQ++ V +CH M V HR+LK EN LL G+ +K+ DFG
Sbjct: 103 AREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAA---VKLADFGL 159
Query: 137 SKSSVLHSQP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 195
+ Q GTP Y++PEVL K Y GK D+W+CGV LY++LVG PF D ++
Sbjct: 160 AIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQ 218
Query: 196 PKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ +++ I + Y P++ ++PE + LI+++ +P+KRI+ E H W
Sbjct: 219 HRLYQQ----IKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274
Query: 254 LPADLVVDNTTNNQFEEPDQPMQS--IDEIMQIIAEATIPAAGTQSLNQCLNGSL---DI 308
+ +D + + A + A + N S+ +I
Sbjct: 275 STV--------------ASCMHRQETVDCLKKFNARRKLKGAILTVMLATRNFSVRKQEI 320
Query: 309 DDEMDEDIDTDPDLDIDSSGEIV 331
++ I+ + D +S ++
Sbjct: 321 IKVTEQLIEAISNGDFESYTKMC 343
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 7e-74
Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 10/282 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEAR 91
V+ EI L HP ++ + + +++E+ SGGELF+RI + SE E
Sbjct: 93 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ +Q G+ + H + H D+K EN + + A +KI DFG + K T
Sbjct: 153 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 212
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T + APE++ ++ G D+W+ GV YV+L G PF ++ +T+ + +
Sbjct: 213 TAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDW 267
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+ +SPE + I + +P KR+++ + H W + ++
Sbjct: 268 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKI 327
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDE 311
+ D A I A SL + I D
Sbjct: 328 RQKIKEKYADWPAPQPAIGRI--ANFSSLRKHRPQEYQIYDS 367
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 8e-74
Identities = 75/228 (32%), Positives = 120/228 (52%), Gaps = 9/228 (3%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
+ + E+ + L HPNI++ + + +VME GGELF+ I + +F+E +A
Sbjct: 80 NSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA 139
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
+Q++SGV+Y H + HRDLK EN LL +KI DFG S + K +
Sbjct: 140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL 199
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GT YIAPEV L+K+YD K DVWS GV L+++L G PF + ++ + ++ +
Sbjct: 200 GTAYYIAPEV-LRKKYDEK-CDVWSIGVILFILLAGYPPFGG----QTDQEILRKVEKGK 253
Query: 211 YS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256
Y+ P++ ++S + LI ++ D +RIS + H W +
Sbjct: 254 YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK 301
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 1e-73
Identities = 65/249 (26%), Positives = 99/249 (39%), Gaps = 39/249 (15%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVIL-------------TPTHLAIVMEYASGGELFERI 79
+ E++ SL H +VR+ L + L I MEY G L++ I
Sbjct: 47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI 106
Query: 80 CNAGRF-SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
+ DE F+Q++ +SY HS + HRDLK N +D S +KI DFG +K
Sbjct: 107 HSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDES--RNVKIGDFGLAK 164
Query: 139 S---------------SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVM 183
+ S +GT Y+A EVL + + D++S G+ + M
Sbjct: 165 NVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 184 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISI 241
+ YPF E N K ++ SV P + + +I + DP KR
Sbjct: 225 I---YPFSTGMERVNILK---KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGA 278
Query: 242 PEIRNHEWF 250
+ N W
Sbjct: 279 RTLLNSGWL 287
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 3e-73
Identities = 69/241 (28%), Positives = 116/241 (48%), Gaps = 8/241 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEAR 91
E V+ EI L H N+++ + + + +VMEY GGELF+RI + +E +
Sbjct: 131 EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI 190
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
F +Q+ G+ + H M + H DLK EN L A ++KI DFG ++ + K G
Sbjct: 191 LFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFG 250
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP ++APEV + ++ D+WS GV Y++L G PF + + IL+ ++
Sbjct: 251 TPEFLAPEV-VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNN----ILACRW 305
Query: 212 S--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
++ IS E + IS++ + + + RIS E H W + + N+
Sbjct: 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGS 365
Query: 270 E 270
+
Sbjct: 366 D 366
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-73
Identities = 57/239 (23%), Positives = 99/239 (41%), Gaps = 8/239 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEAR 91
V++EI RH NI+ E + L ++ E+ SG ++FERI + +E E
Sbjct: 46 VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIV 105
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ Q+ + + HS + H D++ EN + + +KI +FG ++ +
Sbjct: 106 SYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT 165
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
P Y APEV D+WS G +YV+L G PF + I++ +Y
Sbjct: 166 APEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEY 220
Query: 212 SIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 268
+ + + IS E + R+ V + R++ E H W + + T
Sbjct: 221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHR 279
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 4e-73
Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 11/233 (4%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC--NAGRFSEDE 89
+ EI + + P ++ EV + + +++EYA+GGE+F A SE++
Sbjct: 73 AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEND 132
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHSQPKS 148
+Q++ GV Y H + H DLK +N LL P +KI DFG S+ + +
Sbjct: 133 VIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELRE 192
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
+GTP Y+APE+L D+W+ G+ Y++L PF + + + I
Sbjct: 193 IMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN----ISQ 247
Query: 209 VQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 259
V + + +S I + V +P KR + +H W + +L
Sbjct: 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLF 300
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 230 bits (588), Expect = 5e-73
Identities = 84/264 (31%), Positives = 132/264 (50%), Gaps = 11/264 (4%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 85
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 158
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 144
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 159 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 218
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 277
Query: 205 RILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 262
RI QY P+ +S E + LI + +P +R++I E NH W +++ +
Sbjct: 278 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 337
Query: 263 TTNNQFEEPDQPMQSIDEIMQIIA 286
T+ E+ ++ +E+ +A
Sbjct: 338 TSRVLKEDKERWEDVKEEMTSALA 361
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-72
Identities = 72/235 (30%), Positives = 113/235 (48%), Gaps = 14/235 (5%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLA----IVMEYASGGELFERICNAG--RF 85
++E+ + ++ P+IV +V H I+ME GGELF RI G F
Sbjct: 66 PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAF 125
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 144
+E EA + + + + + HS + HRD+K EN L LK+ DFG++K
Sbjct: 126 TEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQ 183
Query: 145 QP-KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
++ TP Y+APEVL ++YD K D+WS GV +Y++L G PF
Sbjct: 184 NALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK 242
Query: 204 HRILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256
RI QY P+ +S + + LI + DP +R++I + NH W +++
Sbjct: 243 RRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVV 297
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 1e-71
Identities = 70/229 (30%), Positives = 112/229 (48%), Gaps = 14/229 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSED 88
E+++RE L+HP+IV E + L +V E+ G +L I +SE
Sbjct: 71 EDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEA 130
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQP- 146
A + +Q++ + YCH + HRD+K LL + +K+ FG +
Sbjct: 131 VASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
VGTP ++APEV+ ++ Y GK DVW CGV L+++L G PF +E + I
Sbjct: 191 GGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKE-----RLFEGI 244
Query: 207 LSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ +Y + HIS + L+ R+ + DPA+RI++ E NH W +
Sbjct: 245 IKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 221 bits (566), Expect = 9e-71
Identities = 68/251 (27%), Positives = 104/251 (41%), Gaps = 29/251 (11%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
V RE+ + ++ H N++ E +V E GG + I F+E EA
Sbjct: 55 SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS 114
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSK--------SSV 141
Q + S + + H+ + HRDLK EN L + +P +KICDF S +
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSP-VKICDFDLGSGIKLNGDCSPI 173
Query: 142 LHSQPKSTVGTPAYIAPEVLLKKEYD----GKIADVWSCGVTLYVMLVGAYPF------- 190
+ + G+ Y+APEV+ + K D+WS GV LY++L G PF
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233
Query: 191 ----EDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEI 244
P I +Y D+ HIS + LIS++ V D +R+S ++
Sbjct: 234 CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQV 293
Query: 245 RNHEWFLKNLP 255
H W P
Sbjct: 294 LQHPWVQGCAP 304
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 3e-70
Identities = 70/224 (31%), Positives = 111/224 (49%), Gaps = 8/224 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEAR 91
E V++EI LRHP +V + + ++ E+ SGGELFE++ + + SEDEA
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 258
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ +Q+ G+ + H H DLK EN + + LK+ DFG + K T G
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 318
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T + APEV K G D+WS GV Y++L G PF +N +T+ + S +
Sbjct: 319 TAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDW 373
Query: 212 SIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
++ D + IS + + I ++ +ADP R++I + H W
Sbjct: 374 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 219 bits (559), Expect = 9e-70
Identities = 57/241 (23%), Positives = 94/241 (39%), Gaps = 25/241 (10%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERI----CNAGR 84
E QRE HR HPNI+R L +++ + G L+ I
Sbjct: 71 EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144
+ED+ + + G+ H+ HRDLK N LL + + D G + +H
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDE--GQPVLMDLGSMNQACIHV 188
Query: 145 QPKST----------VGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVMLVGAYPFED 192
+ T +Y APE+ + + + DVWS G LY M+ G P++
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 193 PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ + ++ + Q SIP S L++ + DP +R IP + + L+
Sbjct: 249 VFQKGD---SVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
Query: 253 N 253
Sbjct: 306 P 306
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 5e-67
Identities = 70/270 (25%), Positives = 132/270 (48%), Gaps = 19/270 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSEDEA 90
E +RE+ +++HPNIV+++E L IVM+Y GG+LF+RI F ED+
Sbjct: 68 EESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI 127
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKST 149
+F Q+ + + H ++ HRD+K +N L +++ DFG ++ + ++
Sbjct: 128 LDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD--GTVQLGDFGIARVLNSTVELARAC 185
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
+GTP Y++PE+ K Y+ K +D+W+ G LY + + FE + + + +I+S
Sbjct: 186 IGTPYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEA----GSMKNLVLKIISG 240
Query: 210 QYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 268
+ + H S + R L+S++F +P R S+ I + K + + + Q
Sbjct: 241 SFPPVSL--HYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRI------EKFLSPQL 292
Query: 269 EEPDQPMQSIDEIMQIIAEATIPAAGTQSL 298
+ +++ + A PA+G S+
Sbjct: 293 IAEEFCLKTFSKFGSQPIPAKRPASGQNSI 322
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 3e-66
Identities = 71/235 (30%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGR----FS 86
+ + E+ R L+HPNIVR+ + I+ T L IVMEY GG+L I +
Sbjct: 50 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 109
Query: 87 EDEARFFFQQLISGVSYCHSM-----QVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-S 140
E+ QL + CH V HRDLK N LDG +K+ DFG ++ +
Sbjct: 110 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILN 167
Query: 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 200
S K+ VGTP Y++PE + + Y+ K +D+WS G LY + PF + +
Sbjct: 168 HDTSFAKTFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQK 222
Query: 201 KTIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254
+ +I ++ IP S E +I+R+ R S+ EI + L++
Sbjct: 223 ELAGKIREGKFRRIPY--RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 205 bits (525), Expect = 5e-65
Identities = 56/241 (23%), Positives = 92/241 (38%), Gaps = 31/241 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTH----------------LAIVMEYASGGELF 76
E +RE+ L H NIV + + L I ME+ G L
Sbjct: 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLE 108
Query: 77 ERI--CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 134
+ I + + A F+Q+ GV Y HS ++ +RDLK N L + ++KI DF
Sbjct: 109 QWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT--KQVKIGDF 166
Query: 135 GYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
G S + + GT Y++PE + ++Y + D+++ G+ L +L
Sbjct: 167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDT---AF 222
Query: 195 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254
E F + I D + + L+ ++ P R + EI K
Sbjct: 223 ETSKFFTDLRDG-----IISD--IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275
Query: 255 P 255
P
Sbjct: 276 P 276
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-64
Identities = 76/264 (28%), Positives = 118/264 (44%), Gaps = 32/264 (12%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFERICNAG--RF 85
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 55 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 114
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSKSSVLHS 144
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG
Sbjct: 115 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG--------- 165
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
A E ++YD K D+WS GV +Y++L G PF
Sbjct: 166 -----------FAKET-TGEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 212
Query: 205 RILSVQYSIPDYV--HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 262
RI QY P+ +S E + LI + +P +R++I E NH W +++ +
Sbjct: 213 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272
Query: 263 TTNNQFEEPDQPMQSIDEIMQIIA 286
T+ E+ ++ +E+ +A
Sbjct: 273 TSRVLKEDKERWEDVKEEMTSALA 296
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 7e-64
Identities = 64/251 (25%), Positives = 102/251 (40%), Gaps = 38/251 (15%)
Query: 33 ENVQREIINHRSLR-HPNIVRF-------KEVILTPTHLAIVMEYASGGELFERICNA-- 82
+ +E+ + L HPNIV+F KE T +++ G+L E +
Sbjct: 70 RAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMES 129
Query: 83 -GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139
G S D F Q V + H + + HRDLK+EN LL +K+CDFG + +
Sbjct: 130 RGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG--TIKLCDFGSATT 187
Query: 140 SVLHSQPKST-------------VGTPAYIAPEV--LLKKEYDGKIADVWSCGVTLYVML 184
+ + TP Y PE+ L G+ D+W+ G LY++
Sbjct: 188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
Query: 185 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+PFED RI++ +YSIP + LI + +P +R+SI E+
Sbjct: 248 FRQHPFEDG--------AKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299
Query: 245 RNHEWFLKNLP 255
+ +
Sbjct: 300 VHQLQEIAAAR 310
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 207 bits (528), Expect = 8e-64
Identities = 64/295 (21%), Positives = 110/295 (37%), Gaps = 43/295 (14%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED--- 88
+ EI + S HPN++R+ T L I +E L + + + E+
Sbjct: 53 DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKL 111
Query: 89 ----EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-----------RLKICD 133
+Q+ SGV++ HS+++ HRDLK +N L+ S R+ I D
Sbjct: 112 QKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISD 171
Query: 134 FGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYD------GKIADVWSCGVTLYV 182
FG K S + + GT + APE+L + + D++S G Y
Sbjct: 172 FGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY 231
Query: 183 MLVGAY-PFEDPEEPKNFRKTIHRILSVQYSIPDYV-----HISPECRHLISRIFVADPA 236
+L PF D I+ +S+ + + E LIS++ DP
Sbjct: 232 ILSKGKHPFGDKYS------RESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPL 285
Query: 237 KRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIP 291
KR + ++ H F + ++ E P ++ ++ IP
Sbjct: 286 KRPTAMKVLRHPLFWPKSKKLEFLLKVSDRLEIENRDPPSALLMKFDAGSDFVIP 340
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (512), Expect = 1e-62
Identities = 66/226 (29%), Positives = 108/226 (47%), Gaps = 20/226 (8%)
Query: 34 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF 93
+R++++ L HP V+ L + YA GEL + I G F E RF+
Sbjct: 78 TRERDVMS--RLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY 135
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---V 150
+++S + Y H + HRDLK EN LL+ ++I DFG +K S+ V
Sbjct: 136 TAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSFV 193
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GT Y++PE+L +K K +D+W+ G +Y ++ G PF E F+K I+ ++
Sbjct: 194 GTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQK----IIKLE 248
Query: 211 YSIPDYVHISPECRHLISRIFVADPAKRISIP------EIRNHEWF 250
Y P+ P+ R L+ ++ V D KR+ ++ H +F
Sbjct: 249 YDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFF 292
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 64/233 (27%), Positives = 104/233 (44%), Gaps = 12/233 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSED 88
+ +EI + L HPN++++ + L IV+E A G+L I + + E
Sbjct: 77 ADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPER 136
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPK 147
+F QL S + + HS +V HRD+K N + + +K+ D G + S +
Sbjct: 137 TVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITAT--GVVKLGDLGLGRFFSSKTTAAH 194
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
S VGTP Y++PE + + Y+ K +D+WS G LY M PF + N +I
Sbjct: 195 SLVGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIE 251
Query: 208 SVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 259
Y +P H S E R L++ DP KR + + + + A +
Sbjct: 252 QCDYPPLPS-DHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSL 303
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 3e-60
Identities = 47/220 (21%), Positives = 84/220 (38%), Gaps = 14/220 (6%)
Query: 33 ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEA 90
E+ +H + +HP VR ++ L + E G L + G E +
Sbjct: 101 ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQV 159
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
+ + + +++ HS + H D+K N L P R K+ DFG +
Sbjct: 160 WGYLRDTLLALAHLHSQGLVHLDVKPANIFLG--PRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
G P Y+APE+ L+ Y ADV+S G+T+ + P + +++ L +
Sbjct: 218 GDPRYMAPEL-LQGSYGTA-ADVFSLGLTILEVACNMEL---PHGGEGWQQLRQGYLPPE 272
Query: 211 YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+S E R ++ + DP R + +
Sbjct: 273 --FTA--GLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 198 bits (504), Expect = 3e-60
Identities = 60/251 (23%), Positives = 95/251 (37%), Gaps = 21/251 (8%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEA 90
RE+ + S HPN++R+ I +E L E + E
Sbjct: 62 SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEP 120
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSK----SSVLH 143
QQ SG+++ HS+ + HRDLK N L+ + + I DFG K
Sbjct: 121 ITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 144 SQPKSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAY-PFEDPEEPKNF 199
S+ GT +IAPE+L K+ D++S G Y ++ PF +
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQ---- 235
Query: 200 RKTIHRILSVQYSIPDY-VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
R+ + + H R LI ++ DP KR S + H +F +L L
Sbjct: 236 RQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF-WSLEKQL 294
Query: 259 VVDNTTNNQFE 269
+++ E
Sbjct: 295 QFFQDVSDRIE 305
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 188 bits (481), Expect = 7e-58
Identities = 71/215 (33%), Positives = 121/215 (56%), Gaps = 19/215 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
+ HP IV+ T L +++++ GG+LF R+ F+E++ +F+ +L + +
Sbjct: 82 EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 104 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 160
HS+ + +RDLK EN LLD G +K+ DFG SK S+ H + + GT Y+APEV
Sbjct: 142 LHSLGIIYRDLKPENILLDEEG----HIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
+ ++ + + AD WS GV ++ ML G PF+ K+ ++T+ IL + +P + +S
Sbjct: 198 VNRRGH-TQSADWWSFGVLMFEMLTGTLPFQG----KDRKETMTMILKAKLGMPQF--LS 250
Query: 221 PECRHLISRIFVADPAKRI-SIP----EIRNHEWF 250
PE + L+ +F +PA R+ + P EI+ H +F
Sbjct: 251 PEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 4e-57
Identities = 27/226 (11%), Positives = 57/226 (25%), Gaps = 33/226 (14%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEY--------ASGGELFERICNAGRFSEDEARFFF 94
+ + ++R + L+ Y G L
Sbjct: 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT 212
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
Q+I ++ H + H L+ + +LD + + F V + +
Sbjct: 213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQR--GGVFLTGFE---HLVRDGARVVSSVSRG 267
Query: 155 YIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ PE+ ++ D W+ G+ +Y + P I
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW-IF 326
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
R +I R L+ R+ + +
Sbjct: 327 R---------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 186 bits (473), Expect = 4e-57
Identities = 57/257 (22%), Positives = 94/257 (36%), Gaps = 39/257 (15%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILT------------PTHLAIVMEYASGGELFERI- 79
E V RE+ L HP IVR+ L +L I M+ L + +
Sbjct: 48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN 107
Query: 80 --CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137
C F Q+ V + HS + HRDLK N +K+ DFG
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLV 165
Query: 138 K-------------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML 184
+++ VGT Y++PE + Y K D++S G+ L+ +L
Sbjct: 166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELL 224
Query: 185 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
YPF E +T+ + ++++ P + P ++ + P +R I
Sbjct: 225 ---YPFSTQMERV---RTLTDVRNLKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINI 277
Query: 245 RNHEWFLK-NLPADLVV 260
+ F + P V+
Sbjct: 278 IENAVFEDLDFPGKTVL 294
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 5e-57
Identities = 71/215 (33%), Positives = 114/215 (53%), Gaps = 19/215 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
++HP IV T L +++EY SGGELF ++ G F ED A F+ ++ + +
Sbjct: 77 EVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGH 136
Query: 104 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 160
H + +RDLK EN +L+ G +K+ DFG K S+ T GT Y+APE+
Sbjct: 137 LHQKGIIYRDLKPENIMLNHQG----HVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEI 192
Query: 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
L++ + + D WS G +Y ML GA PF +N +KTI +IL + ++P Y ++
Sbjct: 193 LMRSGH-NRAVDWWSLGALMYDMLTGAPPFTG----ENRKKTIDKILKCKLNLPPY--LT 245
Query: 221 PECRHLISRIFVADPAKRI-SIP----EIRNHEWF 250
E R L+ ++ + A R+ + P E++ H +F
Sbjct: 246 QEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFF 280
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 2e-56
Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 12/223 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
NV +E+ + L HP +V + +V++ GG+L + F E+ +
Sbjct: 60 RNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +L+ + Y + ++ HRD+K +N LLD G + I DF + +Q +
Sbjct: 120 FICELVMALDYLQNQRIIHRDMKPDNILLDEHG----HVHITDFNIAAMLPRETQITTMA 175
Query: 151 GTPAYIAPEVLLKKEYDG--KIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
GT Y+APE+ ++ G D WS GVT Y +L G P+ + ++ +H +
Sbjct: 176 GTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS-TSSKEIVHTFET 234
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRI-SIPEIRNHEWF 250
+ P S E L+ ++ +P +R + +++N +
Sbjct: 235 TVVTYPSA--WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM 275
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 185 bits (471), Expect = 3e-56
Identities = 75/212 (35%), Positives = 109/212 (51%), Gaps = 15/212 (7%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
+ HP + T +L VMEY +GG+L I + +F A F+ ++I G+
Sbjct: 73 LAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQ 132
Query: 103 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 159
+ HS + +RDLKL+N LLD G +KI DFG K ++L +T GTP YIAPE
Sbjct: 133 FLHSKGIVYRDLKLDNILLDKDG----HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPE 188
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219
+LL ++Y D WS GV LY ML+G PF +E + F I P + +
Sbjct: 189 ILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS----IRMDNPFYPRW--L 241
Query: 220 SPECRHLISRIFVADPAKRI-SIPEIRNHEWF 250
E + L+ ++FV +P KR+ +IR H F
Sbjct: 242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 273
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 4e-56
Identities = 71/214 (33%), Positives = 110/214 (51%), Gaps = 20/214 (9%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
+ HP I+R + ++M+Y GGELF + + RF A+F+ ++ + Y
Sbjct: 62 IVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEY 121
Query: 104 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161
HS + +RDLK EN LLD G +KI DFG++K + + GTP YIAPEV+
Sbjct: 122 LHSKDIIYRDLKPENILLDKNG----HIKITDFGFAK--YVPDVTYTLCGTPDYIAPEVV 175
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
K Y K D WS G+ +Y ML G PF D K + K IL+ + P +
Sbjct: 176 STKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK----ILNAELRFPP--FFNE 228
Query: 222 ECRHLISRIFVADPAKRI-SIP----EIRNHEWF 250
+ + L+SR+ D ++R+ ++ +++NH WF
Sbjct: 229 DVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 262
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 6e-56
Identities = 67/215 (31%), Positives = 108/215 (50%), Gaps = 16/215 (7%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
+ P +V T T L ++++Y +GGELF + RF+E E + + +++ + + H
Sbjct: 117 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLH 176
Query: 106 SMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVL 161
+ + +RD+KLEN LLD G + + DFG SK V ++ GT Y+AP+++
Sbjct: 177 KLGIIYRDIKLENILLDSNG----HVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 162 LKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
+ K D WS GV +Y +L GA PF E + + RIL + P +S
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQE--MS 290
Query: 221 PECRHLISRIFVADPAKRI-SIP----EIRNHEWF 250
+ LI R+ + DP KR+ P EI+ H +F
Sbjct: 291 ALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 325
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-55
Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 18/215 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++++HP +V T L V++Y +GGELF + F E ARF+ ++ S +
Sbjct: 94 KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALG 153
Query: 103 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 159
Y HS+ + +RDLK EN LLD G + + DFG K ++ H+ ST GTP Y+APE
Sbjct: 154 YLHSLNIVYRDLKPENILLDSQG----HIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPE 209
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219
VL K+ Y + D W G LY ML G PF +N + IL+ + +I
Sbjct: 210 VLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYS----RNTAEMYDNILNKPLQLKP--NI 262
Query: 220 SPECRHLISRIFVADPAKRISIP----EIRNHEWF 250
+ RHL+ + D KR+ EI++H +F
Sbjct: 263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-55
Identities = 70/214 (32%), Positives = 114/214 (53%), Gaps = 20/214 (9%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
++ P +V+ + ++L +VMEY +GGE+F + GRFSE ARF+ Q++ Y
Sbjct: 97 AVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 104 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161
HS+ + +RDLK EN L+D G +++ DFG++K + + + GTP +APE++
Sbjct: 157 LHSLDLIYRDLKPENLLIDQQG----YIQVTDFGFAK--RVKGRTWTLCGTPEALAPEII 210
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
L K Y K D W+ GV +Y M G PF + + + K I+S + P H S
Sbjct: 211 LSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK----IVSGKVRFPS--HFSS 263
Query: 222 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
+ + L+ + D KR + +I+NH+WF
Sbjct: 264 DLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 182 bits (463), Expect = 4e-55
Identities = 76/215 (35%), Positives = 110/215 (51%), Gaps = 19/215 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
+ RHP + K T L VMEYA+GGELF + F+E+ ARF+ +++S + Y
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEY 120
Query: 104 CHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEV 160
HS V +RD+KLEN +LD G +KI DFG K + T GTP Y+APEV
Sbjct: 121 LHSRDVVYRDIKLENLMLDKDG----HIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176
Query: 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220
L +Y G+ D W GV +Y M+ G PF + + + F IL + P +S
Sbjct: 177 LEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL----ILMEEIRFPRT--LS 229
Query: 221 PECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
PE + L++ + DP +R+ E+ H +F
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 1e-54
Identities = 69/215 (32%), Positives = 100/215 (46%), Gaps = 16/215 (7%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
+ HP + + TP L VME+ +GG+L I + RF E ARF+ ++IS +
Sbjct: 79 LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVL 161
+ H + +RDLKL+N LLD K+ DFG K + + +T GTP YIAPE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHE--GHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEIL 196
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
+ Y G D W+ GV LY ML G PFE E F IL+ + P +
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA----ILNDEVVYPT--WLHE 249
Query: 222 ECRHLISRIFVADPAKRI------SIPEIRNHEWF 250
+ ++ +P R+ I H +F
Sbjct: 250 DATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFF 284
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 19/216 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 76 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 135
Query: 103 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 159
+ S + +RDLKL+N +LD G +KI DFG K ++ T GTP YIAPE
Sbjct: 136 FLQSKGIIYRDLKLDNVMLDSEG----HIKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219
++ + Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +
Sbjct: 192 IIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--M 244
Query: 220 SPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
S E + + P KR+ +I+ H +F
Sbjct: 245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 280
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 187 bits (475), Expect = 6e-54
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 11/213 (5%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
+ P IV TP L+ +++ +GG+L + G FSE + RF+ ++I G+
Sbjct: 247 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 306
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 162
+ H+ V +RDLK N LLD ++I D G + +P ++VGT Y+APEVL
Sbjct: 307 HMHNRFVVYRDLKPANILLDEH--GHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQ 363
Query: 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222
K AD +S G L+ +L G PF + K+ + L++ +PD SPE
Sbjct: 364 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQ-HKTKDKHEIDRMTLTMAVELPDS--FSPE 420
Query: 223 CRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
R L+ + D +R+ E++ +F
Sbjct: 421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 2e-53
Identities = 64/222 (28%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 65 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 124
Query: 103 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 159
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 125 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIP 214
+L ++Y G D W+ GV ++ M+ G PF+ IL Q IP
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239
Query: 215 DYVHISPECRHLISRIFVADPAKRI------SIPEIRNHEWF 250
+S + ++ DP +R+ +I+ H +F
Sbjct: 240 RS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 279
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 3e-53
Identities = 34/257 (13%), Positives = 61/257 (23%), Gaps = 42/257 (16%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVI--------------------------LTPTHLAIV 66
E + L + ++ + ++
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 67 MEYASG------GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTL 120
M AS L G QLI + S + H +N
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLF 226
Query: 121 LDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGV 178
+ RL + D + P AP L + W G+
Sbjct: 227 IMPD--GRLMLGDVS---ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281
Query: 179 TLYVMLVGAYPFEDPEEPKNF---RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235
++Y + PF R ++ + + + + LI R D
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDR 341
Query: 236 AKRISIPEIRNHEWFLK 252
+R+ E FL+
Sbjct: 342 RRRLLPLEAMETPEFLQ 358
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 6e-53
Identities = 80/212 (37%), Positives = 108/212 (50%), Gaps = 16/212 (7%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
RHP + K T L VMEYA+GGELF + FSED ARF+ +++S + Y H
Sbjct: 206 RHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 106 SMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVLLK 163
S + V +RDLKLEN +LD +KI DFG K + T GTP Y+APEVL
Sbjct: 266 SEKNVVYRDLKLENLMLDKD--GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323
Query: 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223
+Y G+ D W GV +Y M+ G PF + + K F IL + P + PE
Sbjct: 324 NDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL----ILMEEIRFPRT--LGPEA 376
Query: 224 RHLISRIFVADPAKRI-SIP----EIRNHEWF 250
+ L+S + DP +R+ EI H +F
Sbjct: 377 KSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 2e-52
Identities = 65/222 (29%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
++ HP +V T + L V+EY +GG+L + + E+ ARF+ ++ ++
Sbjct: 108 QASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALN 167
Query: 103 YCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPE 159
Y H + +RDLKL+N LLD G +K+ D+G K + ST GTP YIAPE
Sbjct: 168 YLHERGIIYRDLKLDNVLLDSEG----HIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 223
Query: 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR-----KTIHRILSVQYSIP 214
+L ++Y G D W+ GV ++ M+ G PF+ N IL Q IP
Sbjct: 224 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 215 DYVHISPECRHLISRIFVADPAKRI------SIPEIRNHEWF 250
+S + ++ DP +R+ +I+ H +F
Sbjct: 283 R--SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFF 322
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 4e-51
Identities = 72/215 (33%), Positives = 103/215 (47%), Gaps = 18/215 (8%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH 105
P +V+ +L +VMEY GG+L + + E ARF+ +++ + H
Sbjct: 127 NSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTAEVVLALDAIH 185
Query: 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLLK 163
SM HRD+K +N LLD S LK+ DFG + VGTP YI+PEVL
Sbjct: 186 SMGFIHRDVKPDNMLLDKS--GHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 164 KEYD---GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDYVH 218
+ D G+ D WS GV LY MLVG PF + T +I++ + PD
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLTFPDDND 299
Query: 219 ISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 250
IS E ++LI F+ D R+ + EI+ H +F
Sbjct: 300 ISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFF 333
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 4e-51
Identities = 59/244 (24%), Positives = 93/244 (38%), Gaps = 37/244 (15%)
Query: 33 ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----FSE 87
+N RE+ H L +H ++VR+ H+ I EY +GG L + I R F E
Sbjct: 55 QNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE 114
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-----------------GSPAPRLK 130
E + Q+ G+ Y HSM + H D+K N + S K
Sbjct: 115 AELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFK 174
Query: 131 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYP 189
I D G+ S P+ G ++A EVL + K AD+++ +T+
Sbjct: 175 IGDLGHVTR---ISSPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPL 230
Query: 190 FEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 248
+ ++ H I + IP +S E L+ + DP +R S + H
Sbjct: 231 PRNGDQ-------WHEIRQGRLPRIPQ--VLSQEFTELLKVMIHPDPERRPSAMALVKHS 281
Query: 249 WFLK 252
L
Sbjct: 282 VLLS 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 178 bits (452), Expect = 7e-51
Identities = 69/214 (32%), Positives = 102/214 (47%), Gaps = 15/214 (7%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS 102
+ P + + T L VMEY +GG+L I GRF E A F+ ++ G+
Sbjct: 397 LPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLF 456
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV-GTPAYIAPEVL 161
+ S + +RDLKL+N +LD +KI DFG K ++ T GTP YIAPE++
Sbjct: 457 FLQSKGIIYRDLKLDNVMLD--SEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEII 514
Query: 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
+ Y GK D W+ GV LY ML G PFE +E + F+ I+ + P +S
Sbjct: 515 AYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS----IMEHNVAYPKS--MSK 567
Query: 222 ECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
E + + P KR+ +I+ H +F
Sbjct: 568 EAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF 601
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 1e-50
Identities = 60/212 (28%), Positives = 95/212 (44%), Gaps = 12/212 (5%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSY 103
+V T L +V+ +GG+L I + G+ F E A F+ ++ G+
Sbjct: 242 NSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLED 301
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK 163
H ++ +RDLK EN LLD ++I D G + K VGT Y+APEV+
Sbjct: 302 LHRERIVYRDLKPENILLDDH--GHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKN 359
Query: 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223
+ Y D W+ G LY M+ G PF+ ++ + + V + SP+
Sbjct: 360 ERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER--FSPQA 416
Query: 224 RHLISRIFVADPAKRI-----SIPEIRNHEWF 250
R L S++ DPA+R+ S E++ H F
Sbjct: 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLF 448
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 174 bits (444), Expect = 2e-50
Identities = 66/217 (30%), Positives = 95/217 (43%), Gaps = 19/217 (8%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN----AGRFSEDEARFFFQQLISGV 101
IV T T L +VM +GG++ I N F E A F+ Q++SG+
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 102 SYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAP 158
+ H + +RDLK EN LLD G ++I D G + GTP ++AP
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDG----NVRISDLGLAVELKAGQTKTKGYAGTPGFMAP 358
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 218
E+LL +EY D ++ GVTLY M+ PF E ++ R+L + PD
Sbjct: 359 ELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDK-- 415
Query: 219 ISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
SP + + DP KR+ S +R H F
Sbjct: 416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-50
Identities = 59/235 (25%), Positives = 90/235 (38%), Gaps = 11/235 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+++ E++ L P IV + + I ME GG L + I G ED
Sbjct: 92 RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR 151
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLH 143
A ++ Q + G+ Y H+ ++ H D+K +N LL R +CDFG++
Sbjct: 152 ALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSD-GSRAALCDFGHALCLQPDGLGKSL 210
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
GT ++APEV++ K D K D+WS + ML G +P+ K I
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLK-I 268
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
IP +P I +P R S E+R L
Sbjct: 269 ASEPPPIREIPP--SCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGL 321
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-50
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 22/220 (10%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEARFFFQQLISGVSYC 104
I + +L +VMEY GG+L + G R + ARF+ +++ +
Sbjct: 119 DRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSV 178
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 162
H + HRD+K +N LLD +++ DFG +S VGTP Y++PE+L
Sbjct: 179 HRLGYVHRDIKPDNILLDRC--GHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236
Query: 163 KKEYD------GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIP 214
G D W+ GV Y M G PF + +T +I+ S+P
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA----DSTAETYGKIVHYKEHLSLP 292
Query: 215 DY-VHISPECRHLISRIFVADPAKRI---SIPEIRNHEWF 250
+ E R I R + P R+ + R H +F
Sbjct: 293 LVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFF 331
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 5e-50
Identities = 61/231 (26%), Positives = 103/231 (44%), Gaps = 27/231 (11%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYC 104
I +L +VM+Y GG+L + R E+ ARF+ +++ +
Sbjct: 132 DSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSV 191
Query: 105 HSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VGTPAYIAPEVLL 162
H + HRD+K +N L+D + +++ DFG + +S+ VGTP YI+PE+L
Sbjct: 192 HQLHYVHRDIKPDNILMDMN--GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 163 KKEYD----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS--VQYSIPDY 216
E G D WS GV +Y ML G PF ++ +T +I++ ++ P
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA----ESLVETYGKIMNHKERFQFPTQ 305
Query: 217 V-HISPECRHLISRIFVADPAKRI---SIPEIRNHEWF-------LKNLPA 256
V +S + LI R + R+ I + + H +F ++N A
Sbjct: 306 VTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEA 355
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-49
Identities = 31/239 (12%), Positives = 64/239 (26%), Gaps = 30/239 (12%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS-----------GGELFERICNAGRF 85
R I ++ P + V L + ++ + G L
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLH 143
Q+I ++ H + H L+ + +LD + + F + +
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD--QRGGVFLTGFEHLVRDGASAV 266
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
S P A +L ++ + D W+ G+ +Y + P D
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326
Query: 200 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
+I R L+ R+ + + + L +L
Sbjct: 327 EWIFRSC----------KNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEY-EQLRTEL 374
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 167 bits (423), Expect = 6e-49
Identities = 47/271 (17%), Positives = 89/271 (32%), Gaps = 44/271 (16%)
Query: 28 LWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-----NA 82
W+ + + + ++F L +V E S G L I
Sbjct: 108 PWEF-YIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166
Query: 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---------LKICD 133
+ F +++ + H ++ H D+K +N +L + L + D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226
Query: 134 FGYSKSSVLHSQPKSTV-----GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 188
G S + PK T+ T + E+L K ++ +I D + T+Y ML G Y
Sbjct: 227 LGQSID--MKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTY 283
Query: 189 PF-EDPEEPKNFRKTIHR---------ILSVQYSIPDYVHIS--PECRHLISRIFVADPA 236
++ R V +IPD H+ R + ++F
Sbjct: 284 MKVKNEGGECKPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343
Query: 237 KRISIPEIRNHEWFLKNLPADLVVDNTTNNQ 267
+I L+N L+++ + +
Sbjct: 344 NKIRA---------LRNRLIVLLLECKRSRK 365
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-47
Identities = 66/225 (29%), Positives = 110/225 (48%), Gaps = 15/225 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG---ELFERICNAGRFSEDE 89
+ + EI H+ L+H NIV++ + I ME GG L + +E
Sbjct: 64 QPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT 123
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKS 148
F+ +Q++ G+ Y H Q+ HRD+K +N L++ + + LKI DFG SK + ++ ++
Sbjct: 124 IGFYTKQILEGLKYLHDNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKRLAGINPCTET 182
Query: 149 TVGTPAYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
GT Y+APE++ K Y AD+WS G T+ M G PF + EP+ + ++
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQ---AAMFKV 238
Query: 207 LSVQYS--IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ IP+ +S E + I + F DP KR ++ E+
Sbjct: 239 GMFKVHPEIPE--SMSAEAKAFILKCFEPDPDKRACANDLLVDEF 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 161 bits (408), Expect = 4e-47
Identities = 45/231 (19%), Positives = 83/231 (35%), Gaps = 26/231 (11%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI---CNAGRFSEDEARF 92
+I N V + +L I M+ L + + C+
Sbjct: 109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLH 168
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 149
F Q+ V + HS + HRDLK N +K+ DFG + + ++
Sbjct: 169 IFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD--DVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 150 ----------VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
VGT Y++PE + Y K D++S G+ L+ +L Y F E
Sbjct: 227 MPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLILFELL---YSFSTQMERV-- 280
Query: 200 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ I + ++++ + P+ ++ + P +R +I + F
Sbjct: 281 -RIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 34/269 (12%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+ E+ + HPNIV+ L P + +VMEYA GG L+ + A
Sbjct: 43 SERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYT 100
Query: 90 ARFFFQQLI---SGVSYCHSMQ---VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143
A + GV+Y HSMQ + HRDLK N LL LKICDFG + +
Sbjct: 101 AAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAG-GTVLKICDFGTAC--DIQ 157
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP------- 196
+ + G+ A++APEV Y K DV+S G+ L+ ++ PF++ P
Sbjct: 158 THMTNNKGSAAWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
Query: 197 --KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKN 253
R + + L++R + DP++R S+ EI ++
Sbjct: 217 VHNGTRPP----------LIKNLP--KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRY 264
Query: 254 LPADLVVDNTTNNQFEEPDQPMQSIDEIM 282
P P + + +
Sbjct: 265 FPGADEPLQYPCQHSLPPGEDGRVEPYVD 293
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 3e-41
Identities = 56/225 (24%), Positives = 103/225 (45%), Gaps = 15/225 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
+ + E + L+HPNIVRF + + + +V E + G L +
Sbjct: 70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK 129
Query: 89 EARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
R + +Q++ G+ + H+ + HRDLK +N + G P +KI D G + S
Sbjct: 130 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFA 187
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN-FRKTIHR 205
K+ +GTP ++APE+ +++YD DV++ G+ + M YP+ + + +R+
Sbjct: 188 KAVIGTPEFMAPEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG 245
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ S PE + +I + +R SI ++ NH +F
Sbjct: 246 VKPA--SFDK--VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 286
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 3e-39
Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR---FSEDE 89
RE+ + LRHPNIV F + P +L+IV EY S G L+ + +G E
Sbjct: 79 NEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR 138
Query: 90 ARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP- 146
+ G++Y H+ + HR+LK N L+D +K+CDFG S+ + S
Sbjct: 139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKK--YTVKVCDFGLSR--LKASTFL 194
Query: 147 --KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
KS GTP ++APEVL + + K +DV+S GV L+ + P+ + N + +
Sbjct: 195 SSKSAAGTPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGN----LNPAQVVA 249
Query: 205 RILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ IP ++ P+ +I + +P KR S I
Sbjct: 250 AVGFKCKRLEIPRNLN--PQVAAIIEGCWTNEPWKRPSFATI 289
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 6e-39
Identities = 64/223 (28%), Positives = 95/223 (42%), Gaps = 20/223 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
ENV++E L+HPNI+ + V L +L +VME+A GG L + R D
Sbjct: 51 ENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVN 109
Query: 93 FFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPR------LKICDFGYSKSSVLH 143
+ Q+ G++Y H + HRDLK N L+ LKI DFG ++
Sbjct: 110 WAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-EWHR 168
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
+ S G A++APEV+ + +DVWS GV L+ +L G PF +
Sbjct: 169 TTKMSAAGAYAWMAPEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRG----IDGLAVA 223
Query: 204 HRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+ + + IP L+ + DP R S I
Sbjct: 224 YGVAMNKLALPIPSTCP--EPFAKLMEDCWNPDPHSRPSFTNI 264
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-37
Identities = 49/225 (21%), Positives = 87/225 (38%), Gaps = 22/225 (9%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAGRFSE 87
+ + E R HPN++ +P H ++ + G L+ + F
Sbjct: 49 RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV 108
Query: 88 DEARF--FFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143
D+++ F + G+++ H+++ + L + ++D +I S
Sbjct: 109 DQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM--TARISMADVKFSF--- 163
Query: 144 SQPKSTVGTPAYIAPEVLLKKEYDGKI--ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK 201
Q + PA++APE L KK D AD+WS V L+ ++ PF D + +
Sbjct: 164 -QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD----LSNME 218
Query: 202 TIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
++ +IP ISP L+ DPAKR I
Sbjct: 219 IGMKVALEGLRPTIPP--GISPHVSKLMKICMNEDPAKRPKFDMI 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 22/228 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E++Q+EI P + ++ L T L I+MEY GG + + G E +
Sbjct: 65 EDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIAT 123
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 151
++++ G+ Y HS + HRD+K N LL +K+ DFG + ++T VG
Sbjct: 124 ILREILKGLDYLHSEKKIHRDIKAANVLLSEH--GEVKLADFGVAGQLTDTQIKRNTFVG 181
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP ++APEV+ + YD K AD+WS G+T + G P + P + V +
Sbjct: 182 TPFWMAPEVIKQSAYDSK-ADIWSLGITAIELARGEPPHSE-LHP----------MKVLF 229
Query: 212 SIPDYV------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
IP + S + + +P+ R + E+ H++ L+N
Sbjct: 230 LIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 7e-37
Identities = 71/232 (30%), Positives = 111/232 (47%), Gaps = 29/232 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ R ++PNIV + + L L +VMEY +GG L + + E +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAA 120
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKST 149
++ + + + HS QV HRD+K +N LL DG +K+ DFG+ + + S+ +
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMDG----SVKLTDFGFCAQITPEQSKRSTM 176
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTP ++APEV+ +K Y K D+WS G+ M+ G P+ + E P L
Sbjct: 177 VGTPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLN-ENP----------LRA 224
Query: 210 QYSIP--------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
Y I + +S R ++R D KR S E+ H+ FLK
Sbjct: 225 LYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQ-FLKI 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 8e-37
Identities = 57/225 (25%), Positives = 95/225 (42%), Gaps = 25/225 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEAR 91
+ QRE+ +L HPNIV+ ++ P +VME+ G+L+ R+ +
Sbjct: 68 QEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKL 125
Query: 92 FFFQQLISGVSYCHSM--QVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLHSQP 146
+ G+ Y + + HRDL+ N L + K+ DFG S+
Sbjct: 126 RLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSV 183
Query: 147 KSTVGTPAYIAPEVLL--KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+G ++APE + ++ Y K AD +S + LY +L G PF++ K I
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGK-----IK 237
Query: 205 RILSVQY-----SIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
I ++ +IP+ P R++I + DP KR I
Sbjct: 238 FINMIREEGLRPTIPEDCP--PRLRNVIELCWSGDPKKRPHFSYI 280
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-36
Identities = 64/232 (27%), Positives = 113/232 (48%), Gaps = 29/232 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + E++ R +H N+V + L L ++ME+ GG L + I + R +E++
Sbjct: 87 ELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIAT 145
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKST 149
+ ++ ++Y H+ V HRD+K ++ LL DG R+K+ DFG+ + S + KS
Sbjct: 146 VCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG----RVKLSDFGFCAQISKDVPKRKSL 201
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGTP ++APEV+ + Y + D+WS G+ + M+ G P+ + P +
Sbjct: 202 VGTPYWMAPEVISRSLYATE-VDIWSLGIMVIEMVDGEPPYFS-DSP----------VQA 249
Query: 210 QYSIP--------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+ + +SP R + R+ V DP +R + E+ +H FL
Sbjct: 250 MKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHP-FLLQ 300
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 48/246 (19%), Positives = 99/246 (40%), Gaps = 41/246 (16%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEAR 91
+ +RE++ +R RH N+V F ++P HLAI+ G L+ + +A ++ R
Sbjct: 74 KAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR 133
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVLHSQ 145
Q+++ G+ Y H+ + H+DLK +N D ++ I DFG + +
Sbjct: 134 QIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNG---KVVITDFGLFSISGVLQAGRREDK 190
Query: 146 PKSTVGTPAYIAPEVL---------LKKEYDGKIADVWSCGVTLYVMLVGAYPFED--PE 194
+ G ++APE++ K + +DV++ G Y + +PF+ E
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH-SDVFALGTIWYELHAREWPFKTQPAE 249
Query: 195 E-----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ + + E ++ + + +R + ++ +
Sbjct: 250 AIIWQMGTGMKPNL---------SQI--GMGKEISDILLFCWAFEQEERPTFTKLMDM-- 296
Query: 250 FLKNLP 255
L+ LP
Sbjct: 297 -LEKLP 301
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 3e-36
Identities = 60/241 (24%), Positives = 103/241 (42%), Gaps = 28/241 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEAR 91
+ + +EI + P++V++ T L IVMEY G + + I +EDE
Sbjct: 69 QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIA 128
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKS 148
Q + G+ Y H M+ HRD+K N LL +G K+ DFG + + + ++ +
Sbjct: 129 TILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG----HAKLADFGVAGQLTDTMAKRNT 184
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
+GTP ++APEV+ + Y+ AD+WS G+T M G P+ D P +
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYAD-IHP----------MR 232
Query: 209 VQYSIP--------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVV 260
+ IP S + + V P +R + ++ H + ++
Sbjct: 233 AIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILR 292
Query: 261 D 261
D
Sbjct: 293 D 293
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-36
Identities = 57/233 (24%), Positives = 99/233 (42%), Gaps = 22/233 (9%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFF 94
+ E+ R RH NI+ F T LAIV ++ G L+ + + +F +
Sbjct: 68 KNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIA 126
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVG 151
+Q G+ Y H+ + HRDLK N L +KI DFG + Q + G
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLHED--NTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 152 TPAYIAPEVLLKKE---YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
+ ++APEV+ ++ Y + +DV++ G+ LY ++ G P+ + N R I ++
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQ-SDVYAFGIVLYELMTGQLPYSN----INNRDQIIEMVG 239
Query: 209 VQYSIPDYVHISPEC----RHLISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
PD + C + L++ +R S P I ++ L +
Sbjct: 240 RGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAE---IEELARE 289
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-35
Identities = 71/256 (27%), Positives = 105/256 (41%), Gaps = 48/256 (18%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQ 96
RE+ + L+H NI+ K VI L ++ EYA +L + + S + F Q
Sbjct: 82 REVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQ 140
Query: 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPR---LKICDFGYSKSSVLHSQPKST-VGT 152
LI+GV++CHS + HRDLK +N LL S A LKI DFG +++ + + + + T
Sbjct: 141 LINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIIT 200
Query: 153 PAYIAPEVLL-KKEYDGKIADVWSCGVTLYVML--------------------------- 184
Y PE+LL + Y + D+WS ML
Sbjct: 201 LWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDD 259
Query: 185 -----VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239
V A P PK KT+ R+L + E L++ + DP KRI
Sbjct: 260 TTWPGVTALPDWKQSFPKFRGKTLKRVLG--------ALLDDEGLDLLTAMLEMDPVKRI 311
Query: 240 SIPEIRNHEWFLKNLP 255
S H +F +
Sbjct: 312 SAKNALEHPYF-SHND 326
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 56/256 (21%), Positives = 108/256 (42%), Gaps = 14/256 (5%)
Query: 30 QIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
+ ++ + ++ + +S P IV+ +T T + I ME + G E
Sbjct: 65 EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPER 124
Query: 89 EARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
++ + Y V HRD+K N LLD ++K+CDFG S V
Sbjct: 125 ILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDER--GQIKLCDFGISGRLVDDKAKD 182
Query: 148 STVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKT 202
+ G AY+APE + K +YD + ADVWS G++L + G +P+++ K +
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIR-ADVWSLGISLVELATGQFPYKN---CKTDFEV 238
Query: 203 IHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVD 261
+ ++L + +P ++ S + + + D KR ++ H + + ++ V
Sbjct: 239 LTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLEVDVA 298
Query: 262 NTTNNQFEEPDQPMQS 277
+ + + + P
Sbjct: 299 SWFKDVMAKTESPRSG 314
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-35
Identities = 63/254 (24%), Positives = 103/254 (40%), Gaps = 39/254 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEY-----ASGGELFERICNAGRFSEDEAR 91
REI + L+H NIVR +VI T L +V E+ + + +
Sbjct: 52 REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 150
+F QL+ G+++CH ++ HRDLK +N L++ +LK+ DFG +++ + S+ V
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKR--GQLKLGDFGLARAFGIPVNTFSSEV 169
Query: 151 GTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YP 189
T Y AP+VL+ + Y I D+WSCG L M+ G P
Sbjct: 170 VTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTP 228
Query: 190 FED--------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241
E P+ N ++ R L + + + +P R+S
Sbjct: 229 NESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288
Query: 242 PEIRNHEWFLKNLP 255
+ +H WF
Sbjct: 289 KQALHHPWF-AEYY 301
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-34
Identities = 62/271 (22%), Positives = 108/271 (39%), Gaps = 45/271 (16%)
Query: 22 IIIVFHLWQIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80
+I + I + RE+ + H P IV F + ++I ME+ GG L + +
Sbjct: 65 LIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK 123
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139
AGR E +I G++Y ++ HRD+K N L++ +K+CDFG S
Sbjct: 124 KAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFGVSGQ 181
Query: 140 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
+ S S VGT +Y++PE L Y + +D+WS G++L M VG YP P+ +
Sbjct: 182 LI-DSMANSFVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELE 239
Query: 200 RKTIHRILSVQYSIPDYVHI--------------------------------------SP 221
++ P S
Sbjct: 240 LMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 299
Query: 222 ECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
E + +++ + +PA+R + ++ H + +
Sbjct: 300 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR 330
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 65/250 (26%), Positives = 102/250 (40%), Gaps = 50/250 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + L+H NIV+ +VI T L +V E+ +L + G A+ F
Sbjct: 49 REISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSFL 106
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
QL++G++YCH +V HRDLK +N L++ LKI DFG +++ + + + + T
Sbjct: 107 LQLLNGIAYCHDRRVLHRDLKPQNLLINRE--GELKIADFGLARAFGIPVRKYTHEIVTL 164
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVML---------------------------- 184
Y AP+VL+ K+Y I D+WS G M+
Sbjct: 165 WYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSK 223
Query: 185 ----VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240
V P DP L + L+S++ DP +RI+
Sbjct: 224 NWPNVTELPKYDPNFTVYEPLPWESFLK---------GLDESGIDLLSKMLKLDPNQRIT 274
Query: 241 IPEIRNHEWF 250
+ H +F
Sbjct: 275 AKQALEHAYF 284
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-34
Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 48/255 (18%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + L+H NIVR +V+ + L +V E+ + F+ G + + F
Sbjct: 50 REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS--CNGDLDPEIVKSFL 107
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
QL+ G+ +CHS V HRDLK +N L++ + LK+ +FG +++ + + S V T
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRN--GELKLANFGLARAFGIPVRCYSAEVVTL 165
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRILS 208
Y P+VL K Y I D+WS G + P + ++ + RI
Sbjct: 166 WYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQ-------LKRIFR 217
Query: 209 V-----------QYSIPDYV----------------HISPECRHLISRIFVADPAKRISI 241
+ +PDY ++ R L+ + +P +RIS
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277
Query: 242 PEIRNHEWFLKNLPA 256
E H +F +
Sbjct: 278 EEALQHPYF-SDFCP 291
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 6e-34
Identities = 66/252 (26%), Positives = 109/252 (43%), Gaps = 44/252 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + L HPNIV +VI + L +V E+ ++ + N + + + +
Sbjct: 68 REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
QL+ GV++CH ++ HRDLK +N L++ LK+ DFG +++ + + + V T
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSD--GALKLADFGLARAFGIPVRSYTHEVVTL 183
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED 192
Y AP+VL+ K+Y + D+WS G M+ G P
Sbjct: 184 WYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPR 242
Query: 193 --PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243
P+ + + F+ + S E L+S + DP KRIS +
Sbjct: 243 EWPQVQELPLWKQRTFQVFEKKPWSSIIP-----GFCQEGIDLLSNMLCFDPNKRISARD 297
Query: 244 IRNHEWFLKNLP 255
NH +F K+L
Sbjct: 298 AMNHPYF-KDLD 308
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-34
Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 21/236 (8%)
Query: 31 IDENVQREI-----INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICN-A 82
++ Q+ + I+ R++ P V F + + I ME + ++++ +
Sbjct: 44 VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKG 103
Query: 83 GRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
ED ++ + + HS + V HRD+K N L++ ++K+CDFG S V
Sbjct: 104 QTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINAL--GQVKMCDFGISGYLV 161
Query: 142 LHSQPKST-VGTPAYIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 196
K G Y+APE + +K Y K +D+WS G+T+ + + +P++ P
Sbjct: 162 -DDVAKDIDAGCKPYMAPERINPELNQKGYSVK-SDIWSLGITMIELAILRFPYDSWGTP 219
Query: 197 KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
F+ + +++ S E S+ + +R + PE+ H +F
Sbjct: 220 --FQ-QLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 33/246 (13%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91
E+ EI + HP IV+ L I++E+ GG + + +E + +
Sbjct: 61 EDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ 120
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYS-KSSVLHSQPKS 148
+Q++ +++ HS ++ HRDLK N L+ +G +++ DFG S K+ + S
Sbjct: 121 VVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD----IRLADFGVSAKNLKTLQKRDS 176
Query: 149 TVGTPAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
+GTP ++APEV++ YD K AD+WS G+TL M P + P
Sbjct: 177 FIGTPYWMAPEVVMCETMKDTPYDYK-ADIWSLGITLIEMAQIEPPHHE-LNP------- 227
Query: 204 HRILSVQYSIP--------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
+ V I S E R + +P R S ++ H +
Sbjct: 228 ---MRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284
Query: 256 ADLVVD 261
+ +
Sbjct: 285 NKALRE 290
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-33
Identities = 64/251 (25%), Positives = 108/251 (43%), Gaps = 28/251 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF--------ERICNAGR 84
+ + +EI HPNIV + + L +VM+ SGG + + +G
Sbjct: 58 DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV 117
Query: 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS------K 138
E ++++ G+ Y H HRD+K N LL + ++I DFG S
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGG 175
Query: 139 SSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-- 195
+ K+ VGTP ++APEV+ + + YD K AD+WS G+T + GA P+
Sbjct: 176 DITRNKVRKTFVGTPCWMAPEVMEQVRGYDFK-ADIWSFGITAIELATGAAPYHKYPPMK 234
Query: 196 -----PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+N ++ + + + Y R +IS DP KR + E+ H++F
Sbjct: 235 VLMLTLQNDPPSLETGVQDKEMLKKY---GKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
Query: 251 LKNLPADLVVD 261
K + + +
Sbjct: 292 QKAKNKEFLQE 302
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 60/255 (23%), Positives = 103/255 (40%), Gaps = 44/255 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
RE+ + L+H NIV ++I T L +V EY + + + + F
Sbjct: 49 REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFL 106
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
QL+ G++YCH +V HRDLK +N L++ LK+ DFG +++ + ++ V T
Sbjct: 107 FQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTL 164
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA--------------------YPFED 192
Y P++LL +Y +I D+W G Y M G P E+
Sbjct: 165 WYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223
Query: 193 --------PE-EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243
E + N+ K L + + L++++ + RIS +
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRISAED 278
Query: 244 IRNHEWFLKNLPADL 258
H +F +L +
Sbjct: 279 AMKHPFF-LSLGERI 292
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 61/288 (21%), Positives = 103/288 (35%), Gaps = 72/288 (25%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + L+HPN+V EV L +V EY +R E +
Sbjct: 51 REIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSIT 108
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-T--VG 151
Q + V++CH HRD+K EN L+ +K+CDFG+++ L V
Sbjct: 109 WQTLQAVNFCHKHNCIHRDVKPENILITKH--SVIKLCDFGFARL--LTGPSDYYDDEVA 164
Query: 152 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG------------------------ 186
T Y +PE+L+ +Y + DVW+ G +L G
Sbjct: 165 TRWYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI 223
Query: 187 --------------AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232
DPE+ + +IS L+
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFP-------------NISYPALGLLKGCLH 270
Query: 233 ADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDE 280
DP +R++ ++ +H +F +N+ + +E D+P +++
Sbjct: 271 MDPTERLTCEQLLHHPYF-ENIRE-------IEDLAKEHDKPAENLYF 310
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 63/242 (26%), Positives = 102/242 (42%), Gaps = 31/242 (12%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
+++ +E+ + LRHPN ++++ L +VMEY G + E E
Sbjct: 98 WQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIA 157
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSKSSVLHSQPKST 149
+ G++Y HS + HRD+K N LL G +K+ DFG + + S
Sbjct: 158 AVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG----LVKLGDFGSASI---MAPANSF 210
Query: 150 VGTPAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
VGTP ++APEV+L + +YDGK DVWS G+T + P +
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFN-MNA---------- 258
Query: 207 LSVQYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLV 259
+S Y I H S R+ + P R + + H + L+ P ++
Sbjct: 259 MSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVI 318
Query: 260 VD 261
+D
Sbjct: 319 MD 320
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-32
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 38/252 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + LRH N+V EV +V E+ + E N + +
Sbjct: 73 REIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG--LDYQVVQKYL 130
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTP 153
Q+I+G+ +CHS + HRD+K EN L+ S +K+CDFG++++ + V T
Sbjct: 131 FQIINGIGFCHSHNIIHRDIKPENILVSQS--GVVKLCDFGFARTLAAPGEVYDDEVATR 188
Query: 154 AYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFE-DPEEPKNFRKTIHRIL---- 207
Y APE+L+ +Y + DVW+ G + M +G F D + + + I L
Sbjct: 189 WYRAPELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDSDIDQLYH--IMMCLGNLI 245
Query: 208 -SVQ---YSIPDYV------------------HISPECRHLISRIFVADPAKRISIPEIR 245
Q P + +S L + DP KR E+
Sbjct: 246 PRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305
Query: 246 NHEWFLKNLPAD 257
+H++F + A+
Sbjct: 306 HHDFFQMDGFAE 317
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-32
Identities = 59/283 (20%), Positives = 96/283 (33%), Gaps = 60/283 (21%)
Query: 31 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAI--VMEYAS--------GGELFERIC 80
I + REI R L+HPN++ ++V L+ + + +YA +
Sbjct: 61 ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANK 120
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR--LKICDFG--- 135
+ + Q++ G+ Y H+ V HRDLK N L+ G R +KI D G
Sbjct: 121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 180
Query: 136 -YSKSSVLHSQPKSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVML--------- 184
++ + V T Y APE+LL + Y I D+W+ G +L
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCR 239
Query: 185 --------------------------------VGAYPFEDPEEPKNFRKTIHRILSVQYS 212
+ P R T ++Y
Sbjct: 240 QEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM 299
Query: 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
V + HL+ ++ DP KRI+ + +F P
Sbjct: 300 EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF-LEDP 341
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-32
Identities = 71/307 (23%), Positives = 120/307 (39%), Gaps = 49/307 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH------LAIVMEYASG---GELFERICNAGRFSE 87
RE+ R ++HPN+V K + L +V+EY
Sbjct: 81 RELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPM 140
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+ + QL+ ++Y HS+ +CHRD+K +N LLD LK+ DFG +K +L +
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSAK--ILIAGEP 197
Query: 148 ST--VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE------- 195
+ + + Y APE++ Y I D+WS G + ++ G +P E +
Sbjct: 198 NVSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK 256
Query: 196 ----PKNFRKTIHRILS--VQYSIPDYV----------HISPECRHLISRIFVADPAKRI 239
P R+ I + +++ P P+ LISR+ P+ R+
Sbjct: 257 VLGTPS--REQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314
Query: 240 SIPEIRNHEWF--LKN----LPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAA 293
+ E H +F L+ +P + N EE I ++ AEA + +
Sbjct: 315 TAIEALCHPFFDELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHAEAELLSR 374
Query: 294 GTQSLNQ 300
G N
Sbjct: 375 GIDVHNF 381
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-32
Identities = 54/233 (23%), Positives = 98/233 (42%), Gaps = 13/233 (5%)
Query: 30 QIDENVQREI-INHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--ELFERICNA--GR 84
+ + + ++ + RS P IV+F + I ME S + ++ + +
Sbjct: 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDV 121
Query: 85 FSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143
E+ + +++ +++ HRD+K N LLD S +K+CDFG S V
Sbjct: 122 IPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRS--GNIKLCDFGISGQLVDS 179
Query: 144 SQPKSTVGTPAYIAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
G Y+APE + ++ YD + +DVWS G+TLY + G +P+ +
Sbjct: 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVR-SDVWSLGITLYELATGRFPYPKWNSVFDQ 238
Query: 200 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+ + Q S + SP + ++ D +KR E+ H + L
Sbjct: 239 LTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILM 291
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-32
Identities = 53/270 (19%), Positives = 93/270 (34%), Gaps = 55/270 (20%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEA 90
+Q E+ + HPNIV ++ + L +V + + G + IC +E
Sbjct: 71 TFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAI 130
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS--------KSSVL 142
+ Q ++ + Y H M HR +K + L+ + + + + V+
Sbjct: 131 AYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVV 188
Query: 143 HSQPKSTVGTPAYIAPEVL--LKKEYDGKIADVWSCGVTLYVMLVGAYPFED-------- 192
H PK +V +++PEVL + YD K +D++S G+T + G PF+D
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLL 247
Query: 193 --------------------------------PEEPKNFRKTIHRILSVQYSIPDYVHIS 220
T S P + S
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 221 PECRHLISRIFVADPAKRISIPEIRNHEWF 250
P H + + +P R S + NH +F
Sbjct: 308 PHFHHFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-32
Identities = 76/311 (24%), Positives = 118/311 (37%), Gaps = 53/311 (17%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASG---GELFERICNAGRFSE 87
RE+ R L H NIVR + + +L +V++Y
Sbjct: 96 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV 155
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+ + QL ++Y HS +CHRD+K +N LLD A LK+CDFG +K L
Sbjct: 156 IYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAK--QLVRGEP 212
Query: 148 ST--VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFEDPEE------- 195
+ + + Y APE++ +Y I DVWS G L +L+G +P + +
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 271
Query: 196 ----PKNFRKTIHRILS--VQYSIPDYV----------HISPECRHLISRIFVADPAKRI 239
P R+ I + ++ P PE L SR+ P R+
Sbjct: 272 VLGTPT--REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 329
Query: 240 SIPEIRNHEWF--LKN----LPADLVVDNTTNNQFEE----PDQPMQSIDEIMQIIAEAT 289
+ E H +F L++ LP N +E P I +I A A+
Sbjct: 330 TPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAAS 389
Query: 290 IPAAGTQSLNQ 300
P T + +
Sbjct: 390 TPTNATAASDA 400
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 62/255 (24%), Positives = 105/255 (41%), Gaps = 52/255 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG--GELFERICNAGRFSEDEARFFF 94
REI + L HPNI+ + +++++V ++ + + N+ + + +
Sbjct: 61 REIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYM 118
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKST-VG 151
+ G+ Y H + HRDLK N LLD G LK+ DFG +KS ++ + V
Sbjct: 119 LMTLQGLEYLHQHWILHRDLKPNNLLLDENG----VLKLADFGLAKSFGSPNRAYTHQVV 174
Query: 152 TPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPF----EDPEEPKNFRKTIHRI 206
T Y APE+L + Y + D+W+ G L +L+ PF D ++ + RI
Sbjct: 175 TRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRV-PFLPGDSDLDQ-------LTRI 225
Query: 207 LSV-----------QYSIPDYV---------------HISPECRHLISRIFVADPAKRIS 240
S+PDYV + LI +F+ +P RI+
Sbjct: 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285
Query: 241 IPEIRNHEWFLKNLP 255
+ ++F N P
Sbjct: 286 ATQALKMKYF-SNRP 299
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 3e-31
Identities = 61/250 (24%), Positives = 108/250 (43%), Gaps = 41/250 (16%)
Query: 30 QIDENVQREIINHRSL-RHPNIVRF------KEVILTPTHLAIVMEYASGGELFE--RIC 80
+E +++EI + H NI + K L +VME+ G + + +
Sbjct: 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNT 121
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL--DGSPAPRLKICDFGYSK 138
E+ + ++++ G+S+ H +V HRD+K +N LL + +K+ DFG S
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA----EVKLVDFGVSA 177
Query: 139 SSVLHSQPKST-VGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFED 192
++T +GTP ++APEV+ E YD K +D+WS G+T M GA P D
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCD 236
Query: 193 PEEPKNFRKTIHRILSVQYSIP-------DYVHISPECRHLISRIFVADPAKRISIPEIR 245
P + + IP S + + I V + ++R + ++
Sbjct: 237 -MHP----------MRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLM 285
Query: 246 NHEWFLKNLP 255
H F+++ P
Sbjct: 286 KHP-FIRDQP 294
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 3e-31
Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 33/280 (11%)
Query: 20 NIIIIVFHLWQIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75
++++ L + DE QR + R L HPN+++F V+ L + EY GG L
Sbjct: 35 GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 76 FERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDF 134
I + + + F + + SG++Y HSM + HRDL N L+ + + + DF
Sbjct: 95 RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN--KNVVVADF 152
Query: 135 GYSK---------------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVT 179
G ++ + + VG P ++APE++ + YD K DV+S G+
Sbjct: 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIV 211
Query: 180 LYVMLVGAYPFEDPEEPKN--FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237
L ++ D P+ F + L P P + R DP K
Sbjct: 212 LCEIIGRVNADPDY-LPRTMDFGLNVRGFL--DRYCPPNCP--PSFFPITVRCCDLDPEK 266
Query: 238 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQS 277
R S ++ E +L+ L L Q E+ D+
Sbjct: 267 RPSFVKL---EHWLETLRMHLAGHLPLGPQLEQLDRGFWE 303
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 58/258 (22%), Positives = 91/258 (35%), Gaps = 51/258 (19%)
Query: 37 REIINHRSLR---HPNIVRFKEVILTPTH-----LAIVMEYASG--GELFERICNAGRFS 86
RE+ R L HPN+VR +V T + +V E+ ++
Sbjct: 60 REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDK-APPPGLP 118
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+ + +Q + G+ + H+ + HRDLK EN L+ +K+ DFG ++ +S
Sbjct: 119 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSG--GTVKLADFGLARI---YSYQ 173
Query: 147 K---STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA---------------- 187
V T Y APEVLL+ Y + D+WS G M
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNSEADQLGKIF 232
Query: 188 ----YPFED--PEEPK----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237
P ED P + F R + + L+ + +P K
Sbjct: 233 DLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVP-----EMEESGAQLLLEMLTFNPHK 287
Query: 238 RISIPEIRNHEWFLKNLP 255
RIS H + K+
Sbjct: 288 RISAFRALQHSYLHKDEG 305
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 64/268 (23%), Positives = 105/268 (39%), Gaps = 54/268 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA--------IVMEYASG--GELFERICNAGRFS 86
REI + L+H N+V E+ T +V ++ L + +F+
Sbjct: 65 REIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFT 122
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVL 142
E + Q L++G+ Y H ++ HRD+K N L+ LK+ DFG +S +
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRD--GVLKLADFGLARAFSLAKNS 180
Query: 143 HSQP-KSTVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGA------------- 187
+ V T Y PE+LL +++Y I D+W G + M +
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNTEQHQLA 239
Query: 188 -------YPFED--PE-------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231
+ P E K R + + YV P LI ++
Sbjct: 240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRL--KAYV-RDPYALDLIDKLL 296
Query: 232 VADPAKRISIPEIRNHEWFLKN-LPADL 258
V DPA+RI + NH++F + +P+DL
Sbjct: 297 VLDPAQRIDSDDALNHDFFWSDPMPSDL 324
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 2e-29
Identities = 44/206 (21%), Positives = 73/206 (35%), Gaps = 39/206 (18%)
Query: 44 SLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEARFFFQQLI 98
+ HP+IV+ + IVMEY G L + EA + +++
Sbjct: 135 EVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAEAIAYLLEIL 192
Query: 99 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 158
+SY HS+ + + DLK EN +L +LK+ D G + GTP + AP
Sbjct: 193 PALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSR---INSFGYLYGTPGFQAP 246
Query: 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED------PEEPKNFRKTIHRILSVQYS 212
E++ D+++ G TL + + PE+ +
Sbjct: 247 EIVRTGPTVA--TDIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK------------ 292
Query: 213 IPDYVHISPECRHLISRIFVADPAKR 238
L+ R DP +R
Sbjct: 293 ------TYDSYGRLLRRAIDPDPRQR 312
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 52/254 (20%), Positives = 89/254 (35%), Gaps = 57/254 (22%)
Query: 37 REIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+ N LRH NI+ F + T L ++ Y G L++ +
Sbjct: 51 TELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLR 109
Query: 93 FFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----S 139
+ SG+++ H + HRDLK +N L+ + + I D G + +
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG--QCCIADLGLAVMHSQST 167
Query: 140 SVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAY----- 188
+ L VGT Y+APEVL + + D+W+ G+ L+ +
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKR-VDIWAFGLVLWEVARRMVSNGIV 226
Query: 189 -----PFED--PEEP-----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230
PF D P +P R I ++ + EC +
Sbjct: 227 EDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWY----- 281
Query: 231 FVADPAKRISIPEI 244
+P+ R++ I
Sbjct: 282 --QNPSARLTALRI 293
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-29
Identities = 63/257 (24%), Positives = 102/257 (39%), Gaps = 50/257 (19%)
Query: 37 REI---INHRSLRHPNIVRFKEVILTP-----THLAIVMEYASG--GELFERICNAGRFS 86
RE+ + + HPN+VR +V T L +V E+ ++
Sbjct: 60 REVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-VPEPGVP 118
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+ + QL+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++ Q
Sbjct: 119 TETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARI--YSFQM 174
Query: 147 KST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA----------------- 187
T V T Y APEVLL+ Y + D+WS G M
Sbjct: 175 ALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 188 ---YPFED--PEE---PK-NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238
P E+ P + P+ F + + + I + L+ + +PAKR
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT-----DIDELGKDLLLKCLTFNPAKR 288
Query: 239 ISIPEIRNHEWFLKNLP 255
IS +H +F ++L
Sbjct: 289 ISAYSALSHPYF-QDLE 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 59/158 (37%), Positives = 81/158 (51%), Gaps = 5/158 (3%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
+RE+ N L H NIV +V +VMEY G L E I + G S D A F
Sbjct: 59 EREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTN 118
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKSTVGTP 153
Q++ G+ + H M++ HRD+K +N L+D LKI DFG +K S +Q +GT
Sbjct: 119 QILDGIKHAHDMRIVHRDIKPQNILID--SNKTLKIFDFGIAKALSETSLTQTNHVLGTV 176
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 191
Y +PE + D D++S G+ LY MLVG PF
Sbjct: 177 QYFSPEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFN 213
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-28
Identities = 48/248 (19%), Positives = 93/248 (37%), Gaps = 43/248 (17%)
Query: 37 REIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
EI +RH NI+ F + + T L ++ +Y G L++ + +
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLK 138
Query: 93 FFQQLISGVSYCHSMQ--------VCHRDLKLENTLLDGSPAPRLKICDFGYSK-----S 139
+SG+ + H+ + HRDLK +N L+ + I D G + +
Sbjct: 139 LAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVKFISDT 196
Query: 140 SVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 193
+ + P + VGT Y+ PEVL + AD++S G+ L+ +
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIM-ADMYSFGLILWEVARRCVSGGIV 255
Query: 194 EEPKN-FRKTIHRILSVQY------------SIPDYVH---ISPECRHLISRIFVADPAK 237
EE + + + S + S P+ + L++ + +PA
Sbjct: 256 EEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPAS 315
Query: 238 RISIPEIR 245
R++ ++
Sbjct: 316 RLTALRVK 323
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 53/252 (21%), Positives = 100/252 (39%), Gaps = 45/252 (17%)
Query: 37 REIINHRSLR-HPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFF 93
REI +LR PNI+ +++ P A+V E+ + + + ++ + RF+
Sbjct: 79 REIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFY 135
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--VG 151
+++ + YCHSM + HRD+K N ++D +L++ D+G ++ H + V
Sbjct: 136 MYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFY--HPGQEYNVRVA 192
Query: 152 TPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPF-------------------- 190
+ + PE+L+ + YD + D+WS G L M+ PF
Sbjct: 193 SRYFKGPELLVDYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTE 251
Query: 191 ------------EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238
DP + + + +SPE + ++ D R
Sbjct: 252 DLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSR 311
Query: 239 ISIPEIRNHEWF 250
++ E H +F
Sbjct: 312 LTAREAMEHPYF 323
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 34/218 (15%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQ 95
QRE L+ P++V + L + M +G +L + G + A +
Sbjct: 82 QREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVR 141
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQPKSTVGTP 153
Q+ S + H+ HRD+K EN L+ S + DFG + + +Q +TVGT
Sbjct: 142 QIGSALDAAHAAGATHRDVKPENILV--SADDFAYLVDFGIASATTDEKLTQLGNTVGTL 199
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-------------EDPEEPKNFR 200
Y+APE + + AD+++ LY L G+ P+ + P R
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVR 258
Query: 201 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238
P I +I+R +P R
Sbjct: 259 -------------PG---IPVAFDAVIARGMAKNPEDR 280
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-27
Identities = 54/249 (21%), Positives = 94/249 (37%), Gaps = 43/249 (17%)
Query: 37 REIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
EI LRH NI+ F + T T L +V +Y G LF+ + N + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIK 143
Query: 93 FFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----S 139
SG+++ H + HRDLK +N L+ + I D G + +
Sbjct: 144 LALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG--TCCIADLGLAVRHDSAT 201
Query: 140 SVLHSQPKSTVGTPAYIAPEVLLK------KEYDGKIADVWSCGVTLYVMLVGAYPFEDP 193
+ P VGT Y+APEVL E + AD+++ G+ + +
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKR-ADIYAMGLVFWEIARRCSIGGIH 260
Query: 194 EEPKN-FRKTIHRILSVQY------------SIPDYVHISPECR---HLISRIFVADPAK 237
E+ + + + SV+ +IP+ R ++ + A+ A
Sbjct: 261 EDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAA 320
Query: 238 RISIPEIRN 246
R++ I+
Sbjct: 321 RLTALRIKK 329
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-27
Identities = 65/259 (25%), Positives = 93/259 (35%), Gaps = 51/259 (19%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG--------ELFE----RICNAGR 84
REI R L H NIV+ E++ + E E + G
Sbjct: 57 REIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP 116
Query: 85 FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144
E+ AR F QL+ G+ Y HS V HRDLK N ++ + LKI DFG ++ H
Sbjct: 117 LLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN-TEDLVLKIGDFGLARIMDPHY 175
Query: 145 QPKST----VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
K + T Y +P +LL Y I D+W+ G ML G F +
Sbjct: 176 SHKGHLSEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAG----AHE 230
Query: 200 RKTIHRILSV------------QYSIPDYV----------------HISPECRHLISRIF 231
+ + IL IP Y+ IS E + +I
Sbjct: 231 LEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQIL 290
Query: 232 VADPAKRISIPEIRNHEWF 250
P R++ E +H +
Sbjct: 291 TFSPMDRLTAEEALSHPYM 309
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 55/225 (24%), Positives = 85/225 (37%), Gaps = 41/225 (18%)
Query: 36 QREIINHRSLRHPNIVR---FKEVILTPTHLA-IVMEYASGGELFERICNAGRFSEDEAR 91
+RE N +L HP IV E L IVMEY G L + + G + A
Sbjct: 60 RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 147
+++ H + HRD+K N ++ S +K+ DFG + S +Q
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMI--SATNAVKVMDFGIARAIADSGNSVTQTA 177
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--------------EDP 193
+ +GT Y++PE D + +DV+S G LY +L G PF EDP
Sbjct: 178 AVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP 236
Query: 194 EEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238
P +S + ++ + +P R
Sbjct: 237 IPPSARH-------------EG---LSADLDAVVLKALAKNPENR 265
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-26
Identities = 59/254 (23%), Positives = 99/254 (38%), Gaps = 43/254 (16%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYASGGELFERICNAGR----F 85
+ + + L HPNIV+ + T L +VMEY L N R
Sbjct: 68 QIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAP 126
Query: 86 SEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143
+ F QLI + H S+ VCHRD+K N L++ + LK+CDFG +K
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCDFGSAKKLSPS 185
Query: 144 SQPKSTVGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGA--YPFED-------- 192
+ + + Y APE++ + Y + D+WS G M++G + ++
Sbjct: 186 EPNVAYICSRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 193 -------PEE------PKNFRKTIHRILSVQYS--IPDYV-HISPECRHLISRIFVADPA 236
E P + ++ + +S D+ + E L+S + P
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 237 KRISIPEIRNHEWF 250
+R+ E H +F
Sbjct: 305 ERMKPYEALCHPYF 318
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-26
Identities = 61/287 (21%), Positives = 106/287 (36%), Gaps = 45/287 (15%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERI-CNAGRFSEDEA 90
REI HPNI+ +++ + L +V E +L + I S
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHI 136
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
++F ++ G+ H V HRDL N LL + + ICDF ++ + V
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN--NDITICDFNLAREDTADANKTHYV 194
Query: 151 GTPAYIAPEVLLK-KEYDGKIADVWSCG---------------------VTLYVMLVGAY 188
Y APE++++ K + + D+WS G + V +VG
Sbjct: 195 THRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 189 PFEDPEEPKNF--RKTIHRILSVQYSIP---DYVHISPECRHLISRIFVADPAKRISIPE 243
ED + R + LS + P LI+++ +P +RIS +
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ 313
Query: 244 IRNHEWFLKNL--PADLVVDNTTNNQFEEPDQPMQSI-----DEIMQ 283
H + ++L P DL + F+E + + E+ +
Sbjct: 314 ALRHP-YFESLFDPLDLTEGLSERFHFDESVTDVYDMHKIFTAEVER 359
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 8e-26
Identities = 63/286 (22%), Positives = 116/286 (40%), Gaps = 54/286 (18%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE+ + +RH N++ +V L +VM + G +L ++ + ED
Sbjct: 73 RELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRI 130
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
+F Q++ G+ Y H+ + HRDLK N ++ LKI DFG ++ + + T
Sbjct: 131 QFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKILDFGLARQ----ADSEMTG 184
Query: 150 -VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
V T Y APEV+L Y + D+WS G + M+ G F+ + + I+
Sbjct: 185 YVVTRWYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKG----SDHLDQLKEIM 239
Query: 208 SV------------------QY--SIPD---------YVHISPECRHLISRIFVADPAKR 238
V Y +P+ + SP +L+ ++ V D +R
Sbjct: 240 KVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQR 299
Query: 239 ISIPEIRNHEWFLKNL--PADLVVDNTTNNQFEEPDQPMQSIDEIM 282
++ E H + ++L D ++ F++ D+ + +
Sbjct: 300 VTAGEALAHP-YFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 344
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-25
Identities = 62/286 (21%), Positives = 109/286 (38%), Gaps = 54/286 (18%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE+ + ++H N++ +V L +V G +L I + ++D
Sbjct: 77 RELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADL-NNIVKCQKLTDDHV 134
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
+F Q++ G+ Y HS + HRDLK N ++ LKI DFG ++ + + T
Sbjct: 135 QFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED--CELKILDFGLARH----TADEMTG 188
Query: 150 -VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
V T Y APE++L Y+ + D+WS G + +L G F + + IL
Sbjct: 189 YVATRWYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPG----TDHIDQLKLIL 243
Query: 208 SV------------------QY--SIPD---------YVHISPECRHLISRIFVADPAKR 238
+ Y S+ ++ +P L+ ++ V D KR
Sbjct: 244 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 303
Query: 239 ISIPEIRNHEWFLKNL--PADLVVDNTTNNQFEEPDQPMQSIDEIM 282
I+ + H + P D V + + E D + +
Sbjct: 304 ITAAQALAHA-YFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLT 348
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 61/256 (23%), Positives = 97/256 (37%), Gaps = 48/256 (18%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE++ + + H NI+ V L IVME L ++ +
Sbjct: 73 RELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQM-ELDHERM 129
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
+ Q++ G+ + HS + HRDLK N ++ LKI DFG ++++ V
Sbjct: 130 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLARTAGTSFMMTPYV 187
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE------------------D 192
T Y APEV+L Y + D+WS G + M+ G F
Sbjct: 188 VTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 246
Query: 193 PEE---------------PKNFRKTIHRILSVQYSIPDYVH---ISPECRHLISRIFVAD 234
PE PK + ++ D H + + R L+S++ V D
Sbjct: 247 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVID 306
Query: 235 PAKRISIPEIRNHEWF 250
+KRIS+ E H +
Sbjct: 307 ASKRISVDEALQHPYI 322
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 1e-24
Identities = 63/252 (25%), Positives = 111/252 (44%), Gaps = 52/252 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE++ + ++H N++ +V + L +VM + +L + + +FSE++
Sbjct: 72 RELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKI 128
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
++ Q++ G+ Y HS V HRDLK N ++ LKI DFG ++ + + T
Sbjct: 129 QYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED--CELKILDFGLARH----ADAEMTG 182
Query: 150 -VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
V T Y APEV+L Y+ + D+WS G + ML G F+ K++ + +IL
Sbjct: 183 YVVTRWYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKG----KDYLDQLTQIL 237
Query: 208 SV------------------QY--SIPD---------YVHISPECRHLISRIFVADPAKR 238
V Y S+P + SP+ L+ ++ D KR
Sbjct: 238 KVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKR 297
Query: 239 ISIPEIRNHEWF 250
++ + H +F
Sbjct: 298 LTAAQALTHPFF 309
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 68/254 (26%), Positives = 104/254 (40%), Gaps = 50/254 (19%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGELFERICNAGRFSEDEAR 91
REI RH NI+ ++I PT + IV + +L ++ S D
Sbjct: 74 REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDL-YKLLKTQHLSNDHIC 131
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-- 149
+F Q++ G+ Y HS V HRDLK N LL+ + LKICDFG ++ +
Sbjct: 132 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT--CDLKICDFGLARVADPDHDHTGFLT 189
Query: 150 --VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHR 205
V T Y APE++L K Y I D+WS G L ML F P K++ ++
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIF-----PGKHYLDQLNH 243
Query: 206 ILSV------------------QY--SIPD---------YVHISPECRHLISRIFVADPA 236
IL + Y S+P + + + L+ ++ +P
Sbjct: 244 ILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPH 303
Query: 237 KRISIPEIRNHEWF 250
KRI + + H +
Sbjct: 304 KRIEVEQALAHPYL 317
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 5e-24
Identities = 71/306 (23%), Positives = 120/306 (39%), Gaps = 71/306 (23%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEAR 91
REI + +H NI+ + + I+ E +L R+ + S+D +
Sbjct: 58 REIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQ 115
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG----YSKSSVLHSQPK 147
+F Q + V H V HRDLK N L++ + LK+CDFG +S+ +S+P
Sbjct: 116 YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSN--CDLKVCDFGLARIIDESAADNSEPT 173
Query: 148 ST-------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KN 198
V T Y APEV+L +Y + DVWSCG L + + F P ++
Sbjct: 174 GQQSGMVEFVATRWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIF-----PGRD 227
Query: 199 FRKTIHRILSV-------------------QY--SIPD---------YVHISPECRHLIS 228
+R + I + +Y S+P + ++P+ L+
Sbjct: 228 YRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ 287
Query: 229 RIFVADPAKRISIPEIRNHEWFLKNL-------PADLVVDNTTNNQFEEPDQPMQSI--- 278
R+ V DPAKRI+ E H +L+ + + + + + +
Sbjct: 288 RMLVFDPAKRITAKEALEHP-YLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKL 346
Query: 279 --DEIM 282
+EI
Sbjct: 347 IWNEIF 352
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 6e-24
Identities = 61/259 (23%), Positives = 95/259 (36%), Gaps = 54/259 (20%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA------IVMEYASGGELFERICNAGRFSEDEA 90
RE++ + + H NI+ V L +VME L + I +
Sbjct: 110 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERM 166
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST- 149
+ Q++ G+ + HS + HRDLK N ++ LKI DFG +++ + T
Sbjct: 167 SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKILDFGLART--AGTSFMMTP 222
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF------------------ 190
V T Y APEV+L Y + D+WS G + M+ F
Sbjct: 223 YVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGT 281
Query: 191 ---ED----------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231
E F K L S + + + R L+S++
Sbjct: 282 PCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNK-LKASQARDLLSKML 340
Query: 232 VADPAKRISIPEIRNHEWF 250
V DPAKRIS+ + H +
Sbjct: 341 VIDPAKRISVDDALQHPYI 359
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 99.1 bits (247), Expect = 6e-24
Identities = 47/257 (18%), Positives = 79/257 (30%), Gaps = 52/257 (20%)
Query: 37 REIINHRSLRHPNIVRF-----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
+ I + H NI RF + +VMEY G L + + + +
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSC 114
Query: 92 FFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSK---- 138
+ G++Y H+ + HRDL N L+ I DFG S
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKND--GTCVISDFGLSMRLTG 172
Query: 139 -----SSVLHSQPKSTVGTPAYIAPEVL------LKKEYDGKIADVWSCGVTLYVML--- 184
+ S VGT Y+APEVL E K D+++ G+ + +
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232
Query: 185 VGAYPFEDPEE---------PKNFRKTIHRILSVQY----SIPDYVHISPECRHLISRIF 231
+P E E + ++L + P+ + +
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292
Query: 232 V----ADPAKRISIPEI 244
D R++
Sbjct: 293 EDCWDQDAEARLTAQXA 309
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 99.4 bits (248), Expect = 1e-23
Identities = 58/307 (18%), Positives = 100/307 (32%), Gaps = 73/307 (23%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------------- 83
RE+ + L H NI++ + T N G
Sbjct: 49 RELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPS 108
Query: 84 ----------------------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 115
+ + QL V + HS+ +CHRD+K
Sbjct: 109 QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168
Query: 116 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK-KEYDGKIADVW 174
+N L++ LK+CDFG +K + + + + Y APE++L EY I D+W
Sbjct: 169 PQNLLVNSKDN-TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-DLW 226
Query: 175 SCGVTLYVMLVGA--YPFEDPEE-----------PKNFRKTIHRILS--VQYSIPDYVHI 219
S G +++G + E + P ++ + R+ + P
Sbjct: 227 SIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPT--KEQMIRMNPHYTEVRFPTLKAK 284
Query: 220 S----------PECRHLISRIFVADPAKRISIPEIRNHEWF--LKNLPADLVVDNTTNNQ 267
L+ +I +P RI+ E H +F L+N V +N+
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPH 344
Query: 268 FEEPDQP 274
+ P
Sbjct: 345 GVNQNIP 351
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 40/182 (21%), Positives = 74/182 (40%), Gaps = 26/182 (14%)
Query: 37 REIINHRSLRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+ + ++H NI++F K L ++ + G L + + A S +E
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCH 125
Query: 93 FFQQLISGVSYCHSMQ----------VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
+ + G++Y H + HRD+K +N LL + I DFG +
Sbjct: 126 IAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTA--CIADFGLALKFEA 183
Query: 143 HSQPKST---VGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
T VGT Y+APEVL +++ + D+++ G+ L+ + + P
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLR-IDMYAMGLVLWELASRCTAADGPV 242
Query: 195 EP 196
+
Sbjct: 243 DE 244
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 56/263 (21%), Positives = 84/263 (31%), Gaps = 61/263 (23%)
Query: 49 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--RFSEDEARFFFQQLISGVSYCHS 106
N++ E H+ + E S L+E I FS R F ++ + H
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHK 218
Query: 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLKKE 165
++ H DLK EN LL +K+ DFG SS Q T + + Y APEV+L
Sbjct: 219 NRIIHCDLKPENILLKQQGRSGIKVIDFG---SSCYEHQRVYTYIQSRFYRAPEVILGAR 275
Query: 166 YDGKIADVWSCGVTLYVMLVGAYPF----------------------------------- 190
Y I D+WS G L +L G
Sbjct: 276 YGMPI-DMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVS 334
Query: 191 -------------EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH-----LISRIFV 232
D N ++ L ++ + C + +
Sbjct: 335 SKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLE 394
Query: 233 ADPAKRISIPEIRNHEWFLKNLP 255
DPA R++ + H W + LP
Sbjct: 395 WDPAVRMTPGQALRHPWLRRRLP 417
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 8e-21
Identities = 61/281 (21%), Positives = 95/281 (33%), Gaps = 72/281 (25%)
Query: 37 REIINHRSLR-HPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNAGRFSEDEARFF 93
REI+ L H NIV V+ + +V +Y +L + A ++
Sbjct: 57 REIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDL-HAVIRANILEPVHKQYV 114
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST---- 149
QLI + Y HS + HRD+K N LL+ +K+ DFG S+S V + +
Sbjct: 115 VYQLIKVIKYLHSGGLLHRDMKPSNILLNAE--CHVKVADFGLSRSFVNIRRVTNNIPLS 172
Query: 150 ------------------VGTPAYIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG---- 186
V T Y APE+LL +Y I D+WS G L +L G
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIF 231
Query: 187 -------------------------------------AYPFEDPEEPKNFRKTIHRILSV 209
+ + N R + ++
Sbjct: 232 PGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNL 291
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
I + E L+ ++ +P KRIS + H +
Sbjct: 292 LLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV 332
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 9e-21
Identities = 50/272 (18%), Positives = 89/272 (32%), Gaps = 61/272 (22%)
Query: 41 NHRSLRHPNIVRFKEV----ILTPTHLAIVMEYASGGELFE--RICNAGRFSEDEARFFF 94
S+ +I++ + H+ +V E G L + +
Sbjct: 79 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYVKQIS 137
Query: 95 QQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPR----LKICDFGYSKSSVLHSQPKST 149
+QL+ G+ Y H + H D+K EN L++ +P +KI D G + ++
Sbjct: 138 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG--NACWYDEHYTNS 195
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-------------- 195
+ T Y +PEVLL + D+WS ++ ++ G + FE E
Sbjct: 196 IQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254
Query: 196 ------PKNF------------------------RKTIHRILSVQYSIPDYVHISPECRH 225
P + +L+ +Y + E
Sbjct: 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK--DEAKEISD 312
Query: 226 LISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
+S + DP KR + NH W L +
Sbjct: 313 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 60/304 (19%), Positives = 101/304 (33%), Gaps = 94/304 (30%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYASGGELFERICNAGRFSEDEAR 91
REI L H ++V+ ++++ L +V+E A + + +E +
Sbjct: 101 REIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIK 159
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
L+ GV Y HS + HRDLK N L++ +K+CDFG +++ S +
Sbjct: 160 TLLYNLLVGVKYVHSAGILHRDLKPANCLVNQD--CSVKVCDFGLARTVDYPENGNSQLP 217
Query: 152 TPA----------------------------YIAPEVLL-KKEYDGKIADVWSCGVTLYV 182
Y APE++L ++ Y I DVWS G
Sbjct: 218 ISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAE 276
Query: 183 ML------------------------VGAYPFEDPEEPKNFRKTIH---RILSV------ 209
+L + + + R I ++
Sbjct: 277 LLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSE 336
Query: 210 ------------QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRN 246
+Y P + S + HL+ R+ V +P KRI+I E
Sbjct: 337 EDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLA 396
Query: 247 HEWF 250
H +F
Sbjct: 397 HPFF 400
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 1e-20
Identities = 57/296 (19%), Positives = 98/296 (33%), Gaps = 86/296 (29%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSEDEAR 91
REI L+ I+R ++I+ L IV+E A +L + +E+ +
Sbjct: 74 REITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIK 132
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
L+ G ++ H + HRDLK N LL+ +K+CDFG +++
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQD--CSVKVCDFGLARTINSEKDTNIVND 190
Query: 152 TPA-----------------------YIAPEVLLK-KEYDGKIADVWSCGVTLYVMLVG- 186
Y APE++L + Y I D+WS G +L
Sbjct: 191 LEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNML 249
Query: 187 -----------------------AYPFEDPEEPKNFRKTIHRILSV-------------- 209
K+ R ++ I ++
Sbjct: 250 QSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK 309
Query: 210 ----QY--SIPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+Y P Y IS + +L+ + +P KRI+I + +H +
Sbjct: 310 PEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYL 365
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 63/270 (23%), Positives = 90/270 (33%), Gaps = 68/270 (25%)
Query: 49 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 106
IV K + HL +V E S L++ + N S + R F QQ+ + + + +
Sbjct: 117 YIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLAT 175
Query: 107 --MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VGTPAYIAPEVLLK 163
+ + H DLK EN LL +KI DFG SS Q + + Y +PEVLL
Sbjct: 176 PELSIIHCDLKPENILLCNPKRSAIKIVDFG---SSCQLGQRIYQYIQSRFYRSPEVLLG 232
Query: 164 KEYDGKIADVWSCGVTLYVMLVG------------------------------------- 186
YD I D+WS G L M G
Sbjct: 233 MPYDLAI-DMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKF 291
Query: 187 -------AYPFEDPEEPKN-----FRKTIHRILSVQYSIP---DYVHISPECR------H 225
+ + ++ K + +H IL V+ P
Sbjct: 292 FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKD 351
Query: 226 LISRIFVADPAKRISIPEIRNHEWFLKNLP 255
LI R+ DP RI H +F K
Sbjct: 352 LILRMLDYDPKTRIQPYYALQHSFFKKTAD 381
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 4e-19
Identities = 33/206 (16%), Positives = 55/206 (26%), Gaps = 34/206 (16%)
Query: 35 VQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFF 94
+ + P + R +V+ T +V E+ GG L E S A
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA--DTSPSPVGAIRAM 135
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
Q L + H V + S + + PA
Sbjct: 136 QSLAAAADAAHRAGVALSIDHPSRVRV--SIDGDVV-------------------LAYPA 174
Query: 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP 214
+ D+ G +LY +LV +P + R + Q P
Sbjct: 175 TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA-PAERDTAGQPIEP 225
Query: 215 DYVH--ISPECRHLISRIFVADPAKR 238
+ I + + +R D R
Sbjct: 226 ADIDRDIPFQISAVAARSVQGDGGIR 251
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 4e-19
Identities = 53/275 (19%), Positives = 85/275 (30%), Gaps = 63/275 (22%)
Query: 49 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 106
V + H+ I E G FE + + R QL + + H
Sbjct: 83 LCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHE 141
Query: 107 MQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQPKST 149
Q+ H DLK EN L S +++ DFG S+ + +T
Sbjct: 142 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG---SATFDHEHHTT 198
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA--YPFED-------------- 192
V T Y PEV+L+ + DVWS G L+ G + +
Sbjct: 199 IVATRHYRPPEVILELGWAQPC-DVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 257
Query: 193 ----------------------PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230
E + R ++ + + L+ R+
Sbjct: 258 IPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317
Query: 231 FVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTN 265
DPA+RI++ E H +F P + + N
Sbjct: 318 LEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRN 352
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 4e-18
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARF 92
+REI +SL+H NIV++K V + L ++MEY G L + + + R +
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ Q+ G+ Y + + HRDL N L+ + R+KI DFG +K + + V
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEFFKVKE 175
Query: 153 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
P APE L + ++ +DVWS GV LY
Sbjct: 176 PGESPIFWYAPESLTESKFSVA-SDVWSFGVVLY 208
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 62/260 (23%), Positives = 87/260 (33%), Gaps = 63/260 (24%)
Query: 49 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 106
V+ E H+ IV E G ++ I G F D R Q+ V++ HS
Sbjct: 78 RCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 107 MQVCHRDLKLENTLLDGSPA-----------------PRLKICDFGYSKSSVLHSQPKST 149
++ H DLK EN L S P +K+ DFG S+ + ST
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG---SATYDDEHHST 193
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLY---------------------VMLVGA 187
V T Y APEV+L + DVWS G L ++G
Sbjct: 194 LVSTRHYRAPEVILALGWSQPC-DVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGP 252
Query: 188 YP------------FED-----PEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230
P F E R ++ + LI ++
Sbjct: 253 LPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKM 312
Query: 231 FVADPAKRISIPEIRNHEWF 250
DPAKRI++ E H +F
Sbjct: 313 LEYDPAKRITLREALKHPFF 332
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 4e-18
Identities = 46/163 (28%), Positives = 64/163 (39%), Gaps = 12/163 (7%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQ 95
+E + HPNIVR V + IVME GG+ + R
Sbjct: 161 QEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155
+G+ Y S HRDL N L+ LKI DFG S+ + G
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSR--EEADGVYAASGGLRQ 276
Query: 156 I-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+ APE L Y + +DVWS G+ L+ +GA P+ +
Sbjct: 277 VPVKWTAPEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPN 318
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 82.4 bits (204), Expect = 5e-18
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 12/154 (7%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARF 92
+REI +SL+H NIV++K V + L ++MEY G L + + + R +
Sbjct: 90 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 149
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ Q+ G+ Y + + HRDL N L+ + R+KI DFG +K + + V
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILV-ENEN-RVKIGDFGLTK-VLPQDKEYYKVKE 206
Query: 153 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
P APE L + ++ +DVWS GV LY
Sbjct: 207 PGESPIFWYAPESLTESKFSVA-SDVWSFGVVLY 239
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 2e-17
Identities = 51/185 (27%), Positives = 75/185 (40%), Gaps = 15/185 (8%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARF 92
QREI ++L IV+++ V P L +VMEY G L + + + R
Sbjct: 72 QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVG 151
+ Q+ G+ Y S + HRDL N L+ S A +KI DFG +K +L V
Sbjct: 132 YSSQICKGMEYLGSRRCVHRDLAARNILV-ESEA-HVKIADFGLAK--LLPLDKDYYVVR 187
Query: 152 TPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 205
P APE L + + +DVWS GV LY + E
Sbjct: 188 EPGQSPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERD 246
Query: 206 ILSVQ 210
+ ++
Sbjct: 247 VPALS 251
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 46/157 (29%), Positives = 67/157 (42%), Gaps = 14/157 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
SL H N++R V+LTP + +V E A G L +R+ + G F + Q+ G+
Sbjct: 77 SLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 156
Y S + HRDL N LL + +KI DFG + L
Sbjct: 136 YLESKRFIHRDLAARNLLL-ATRD-LVKIGDFGLMR--ALPQNDDHYVMQEHRKVPFAWC 191
Query: 157 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE L + + +D W GVTL+ + G P+
Sbjct: 192 APESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIG 227
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-17
Identities = 51/273 (18%), Positives = 86/273 (31%), Gaps = 81/273 (29%)
Query: 49 NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHS 106
NIV++ + H+ ++ E G L+E I F ++ + + +++ ++Y
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRK 155
Query: 107 MQVCHRDLKLENTLLDGSPA-----------------------PRLKICDFGYSKSSVLH 143
M + H DLK EN LLD +K+ DFG +
Sbjct: 156 MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG---CATFK 212
Query: 144 SQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG---------------- 186
S + + T Y APEV+L +D D+WS G L + G
Sbjct: 213 SDYHGSIINTRQYRAPEVILNLGWDVSS-DMWSFGCVLAELYTGSLLFRTHEHMEHLAMM 271
Query: 187 -----------------------------AYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217
+ + N K + + L + I
Sbjct: 272 ESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH-- 329
Query: 218 HISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ I DP R S E+ H++
Sbjct: 330 ---ELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 4e-17
Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
S+ +P++ R + LT T + ++ + G L + + + + Q+ G++
Sbjct: 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPE 159
Y ++ HRDL N L+ +P +KI DFG +K + G P ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 5e-17
Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 14/155 (9%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERI-CNAGRFSEDEARF 92
++EI R+L H NIV++K + + ++ME+ G L E + N + + +
Sbjct: 71 KKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLK 130
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS-TVG 151
+ Q+ G+ Y S Q HRDL N L+ S ++KI DFG +K + + + TV
Sbjct: 131 YAVQICKGMDYLGSRQYVHRDLAARNVLV-ESEH-QVKIGDFGLTK--AIETDKEYYTVK 186
Query: 152 TPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
APE L++ ++ +DVWS GVTL+
Sbjct: 187 DDRDSPVFWYAPECLMQSKFYIA-SDVWSFGVTLH 220
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 7e-17
Identities = 39/155 (25%), Positives = 65/155 (41%), Gaps = 8/155 (5%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
+ ++HPN+V+ V I+ E+ + G L + R CN S + Q+ S
Sbjct: 271 KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY--IAP 158
+ Y HR+L N L+ + +K+ DFG S+ + AP
Sbjct: 331 MEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPIKWTAP 388
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E L ++ K +DVW+ GV L+ + G P+
Sbjct: 389 ESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 422
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 10/155 (6%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 101
++HPN+V+ V I+ E+ + G L + R CN S + Q+ S +
Sbjct: 65 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAP 158
Y HRDL N L+ + +K+ DFG S+ + + G P + AP
Sbjct: 125 EYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAP 181
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E L ++ K +DVW+ GV L+ + G P+
Sbjct: 182 ESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPG 215
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 4e-16
Identities = 43/156 (27%), Positives = 64/156 (41%), Gaps = 13/156 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSY 103
L +P IVR + + + +VME A G L + + + Q+ G+ Y
Sbjct: 74 QLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 132
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYIA 157
HRDL N LL + KI DFG SK L + K+ P + A
Sbjct: 133 LEESNFVHRDLAARNVLL-VTQH-YAKISDFGLSK--ALRADENYYKAQTHGKWPVKWYA 188
Query: 158 PEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
PE + ++ K +DVWS GV ++ G P+
Sbjct: 189 PECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG 223
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 5e-16
Identities = 44/157 (28%), Positives = 66/157 (42%), Gaps = 14/157 (8%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
L +P IVR V + +VME A GG L + + Q+ G+
Sbjct: 66 QLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK 124
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGT--P-AYI 156
Y HRDL N LL + KI DFG SK L + + P +
Sbjct: 125 YLEEKNFVHRDLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKWY 180
Query: 157 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE + +++ + +DVWS GVT++ + G P++
Sbjct: 181 APECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 216
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 6e-16
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 11/154 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
L HP +V+ V L + +V E+ G L + R G F+ + + G++
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLR-TQRGLFAAETLLGMCLDVCEGMA 118
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APE 159
Y V HRDL N L+ + +K+ DFG ++ VL Q S+ GT + +PE
Sbjct: 119 YLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPE 175
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
V Y K +DVWS GV ++ V G P+E+
Sbjct: 176 VFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYEN 208
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-16
Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 36 QREIINHRSLRHPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDEARFF 93
++EI R+L H +I+++K L +VMEY G L + + + F
Sbjct: 81 KQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLF 139
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153
QQ+ G++Y H+ HRDL N LL + +KI DFG +K+ V V
Sbjct: 140 AQQICEGMAYLHAQHYIHRDLAARNVLL-DNDR-LVKIGDFGLAKA-VPEGHEYYRVRED 196
Query: 154 AYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
APE L + ++ +DVWS GVTLY
Sbjct: 197 GDSPVFWYAPECLKEYKFYYA-SDVWSFGVTLY 228
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 40/154 (25%), Positives = 75/154 (48%), Gaps = 9/154 (5%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
S+ +P++ R + LT T + ++ + G L + + + + Q+ G++
Sbjct: 73 SVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN 131
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--P-AYIAPE 159
Y ++ HRDL N L+ +P +KI DFG +K + G P ++A E
Sbjct: 132 YLEDRRLVHRDLAARNVLV-KTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+L + Y + +DVWS GVT++ +M G+ P++
Sbjct: 190 SILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDG 222
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-15
Identities = 54/255 (21%), Positives = 101/255 (39%), Gaps = 31/255 (12%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 101
SL H +IVR + + L +V +Y G L + + + G + Q+ G+
Sbjct: 70 GSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI----- 156
Y + HR+L N LL SP+ ++++ DFG + +L K + + A
Sbjct: 129 YYLEEHGMVHRNLAARNVLL-KSPS-QVQVADFGVAD--LLPPDDKQLLYSEAKTPIKWM 184
Query: 157 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHRI-----LSVQ 210
A E + +Y + +DVWS GVT++ +M GA P+ + + L+
Sbjct: 185 ALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAG----LRLAEVPDLLEKGERLAQP 239
Query: 211 YSIPDYVH-ISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTNNQF 268
V+ + +C D R + E+ N ++ P LV+ +
Sbjct: 240 QICTIDVYMVMVKCWM-------IDENIRPTFKELANEFTRMARDPPRYLVIKRESGPGI 292
Query: 269 EEPDQPMQSIDEIMQ 283
+P ++ ++
Sbjct: 293 APGPEPHGLTNKKLE 307
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 2e-15
Identities = 45/155 (29%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
HPNI+R + V+ IV EY G L F R + G+F+ + + + +G+
Sbjct: 107 FDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR-THDGQFTIMQLVGMLRGVGAGMR 165
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 158
Y + HRDL N L+D + K+ DFG S+ +T G I AP
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAP 223
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + + + +DVWS GV ++ V+ G P+ +
Sbjct: 224 EAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWN 257
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 42/158 (26%), Positives = 65/158 (41%), Gaps = 14/158 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGV 101
L +P IVR V + +VME A GG L + + Q+ G+
Sbjct: 391 HQLDNPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI-- 156
Y HR+L N LL + KI DFG SK L + + +
Sbjct: 450 KYLEEKNFVHRNLAARNVLL-VNRH-YAKISDFGLSK--ALGADDSYYTARSAGKWPLKW 505
Query: 157 -APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE + +++ + +DVWS GVT++ + G P++
Sbjct: 506 YAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK 542
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 4e-15
Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 11/154 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
L HP +V+F V + IV EY S G L + R + + + G++
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLR-SHGKGLEPSQLLEMCYDVCEGMA 118
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APE 159
+ S Q HRDL N L+D +K+ DFG ++ VL Q S+VGT + APE
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTR-YVLDDQYVSSVGTKFPVKWSAPE 175
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
V +Y K +DVW+ G+ ++ V +G P++
Sbjct: 176 VFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDL 208
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 4e-15
Identities = 47/157 (29%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
HPNI+R + V+ + IV EY G L F R + +F+ + + + SG+
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR-KHDAQFTVIQLVGMLRGIASGMK 161
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---KSTVGTPAYI--- 156
Y M HRDL N L++ + K+ DFG + VL P +T G I
Sbjct: 162 YLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGR--VLEDDPEAAYTTRGGKIPIRWT 217
Query: 157 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+PE + +++ +DVWS G+ L+ VM G P+ +
Sbjct: 218 SPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWE 253
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 45/155 (29%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
H NI+R + VI + I+ EY G L F R G FS + + + +G+
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDGEFSVLQLVGMLRGIAAGMK 161
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPAYI---AP 158
Y +M HRDL N L++ + K+ DFG S+ + +T G I AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 219
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + +++ +DVWS G+ ++ VM G P+ +
Sbjct: 220 EAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWE 253
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 7e-15
Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 9/161 (5%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 94
+E + LRH +V+ V+ + + IV EY S G L F + +
Sbjct: 311 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 369
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ +
Sbjct: 370 AQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFP 427
Query: 155 Y--IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE L + K +DVWS G+ L + G P+
Sbjct: 428 IKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 467
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 7e-15
Identities = 43/157 (27%), Positives = 64/157 (40%), Gaps = 15/157 (9%)
Query: 43 RSLRHPNIVRFKEVILT-PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS 99
LRH N+V+ VI+ L IV EY + G L + R D F +
Sbjct: 241 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 300
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI--- 156
+ Y HRDL N L+ K+ DFG +K + + +
Sbjct: 301 AMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEAS-----STQDTGKLPVKWT 353
Query: 157 APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE L +K++ K +DVWS G+ L+ + G P+
Sbjct: 354 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 389
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 9e-15
Identities = 42/161 (26%), Positives = 66/161 (40%), Gaps = 9/161 (5%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 94
+E + LRH +V+ V+ + + IV EY S G L F + +
Sbjct: 228 QEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMA 286
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ +
Sbjct: 287 AQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFP 344
Query: 155 Y--IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
APE L + K +DVWS G+ L + G P+
Sbjct: 345 IKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPG 384
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 9e-15
Identities = 43/154 (27%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
L H +V+ V + I+ EY + G L + R RF + + + +
Sbjct: 76 LSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLR-EMRHRFQTQQLLEMCKDVCEAME 134
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APE 159
Y S Q HRDL N L++ +K+ DFG S+ VL + S+VG+ + PE
Sbjct: 135 YLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSR-YVLDDEYTSSVGSKFPVRWSPPE 191
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
VL+ ++ K +D+W+ GV ++ + +G P+E
Sbjct: 192 VLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYER 224
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 44/155 (28%), Positives = 65/155 (41%), Gaps = 15/155 (9%)
Query: 45 LRHPNIVRFKEVILTPT-HLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 101
LRH N+V+ VI+ L IV EY + G L + R D F + +
Sbjct: 71 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 158
Y HRDL N L+ S K+ DFG +K + + + AP
Sbjct: 131 EYLEGNNFVHRDLAARNVLV--SEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAP 183
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E L +K++ K +DVWS G+ L+ + G P+
Sbjct: 184 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPR 217
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 2e-14
Identities = 39/155 (25%), Positives = 71/155 (45%), Gaps = 11/155 (7%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 101
L+H +VR V+ T + I+ EY G L F + + + + ++ Q+ G+
Sbjct: 64 QLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---AP 158
++ HRDL+ N L+ + + KI DFG ++ + ++ + G I AP
Sbjct: 123 AFIEERNYIHRDLRAANILVSDTLS--CKIADFGLAR-LIEDNEYTAREGAKFPIKWTAP 179
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + + K +DVWS G+ L ++ G P+
Sbjct: 180 EAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPG 213
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-14
Identities = 41/160 (25%), Positives = 61/160 (38%), Gaps = 17/160 (10%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 98
H NIVR V L I+ME +GG+L + + L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 99 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 156
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRASYYRKGGCAML 207
Query: 157 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
PE ++ + K D WS GV L+ + +G P+
Sbjct: 208 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPY 246
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 9e-14
Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 37 REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 94
E ++L+H +V+ V+ T + I+ E+ + G L F + + + F
Sbjct: 232 AEANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS 290
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
Q+ G+++ HRDL+ N L+ S KI DFG ++ + ++ + G
Sbjct: 291 AQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLAR-VIEDNEYTAREGAKF 347
Query: 155 YI---APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
I APE + + K +DVWS G+ L ++ G P+
Sbjct: 348 PIKWTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPG 388
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 53/246 (21%), Positives = 89/246 (36%), Gaps = 39/246 (15%)
Query: 43 RSLRHPNIVRF------KEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFF 94
+ HP++ + +++ + G+L F A R E+
Sbjct: 80 KEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLL---ASRIGENPFNLPL 136
Query: 95 QQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
Q L+ G+ Y S HRDL N +L + + DFG S+ ++S
Sbjct: 137 QTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSR--KIYSGDY 192
Query: 148 STVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNF 199
G + + A E L Y +DVW+ GVT++ +M G Y + E N+
Sbjct: 193 YRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNY 251
Query: 200 RKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADL 258
+R+ P E L+ + + ADP +R S +R E L +L
Sbjct: 252 LIGGNRL-----KQPPEC--MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS 304
Query: 259 VVDNTT 264
+
Sbjct: 305 TSQDPL 310
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 69.9 bits (171), Expect = 1e-13
Identities = 49/282 (17%), Positives = 82/282 (29%), Gaps = 96/282 (34%)
Query: 61 THLAIVMEYA--SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLE 117
TH+ +V E + + N + QQ++ G+ Y H+ ++ H D+K E
Sbjct: 118 THICMVFEVLGHHLLKWIIK-SNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPE 176
Query: 118 NTLLD-----------------------------------------------GSPAPRLK 130
N LL + ++K
Sbjct: 177 NILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVK 236
Query: 131 ICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 190
I D G + +H + T Y + EVL+ Y+ AD+WS + + G Y F
Sbjct: 237 IADLG--NACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMAFELATGDYLF 293
Query: 191 E--DPEE------------------PKNF----------------RKTIHRI--LSVQYS 212
E EE P+ K I ++ +
Sbjct: 294 EPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEV 353
Query: 213 IPDYVHISPE----CRHLISRIFVADPAKRISIPEIRNHEWF 250
+ + S E + + P KR + E H W
Sbjct: 354 LVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWL 395
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-13
Identities = 52/252 (20%), Positives = 88/252 (34%), Gaps = 32/252 (12%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLI------ 98
H NIVR V L I++E +GG+L + + L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 99 -SGVSYCHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYI 156
G Y HRD+ N LL R+ KI DFG ++ ++ G A +
Sbjct: 191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR--DIYRAGYYRKGGCAML 248
Query: 157 -----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRILS 208
PE ++ + K D WS GV L+ + +G YP + +E F + R+
Sbjct: 249 PVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM-- 305
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 268
P + ++++ + P R + I ++ D + N
Sbjct: 306 ---DPPK--NCPGPVYRIMTQCWQHQPEDRPNFAIIL---ERIEYCTQD---PDVINTAL 354
Query: 269 EEPDQPMQSIDE 280
P+ +E
Sbjct: 355 PIEYGPLVEEEE 366
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 12/155 (7%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGV 101
HP+IV+ VI I+ME + GEL F + + QL + +
Sbjct: 72 QFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQ-VRKYSLDLASLILYAYQLSTAL 129
Query: 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT--PA-YIAP 158
+Y S + HRD+ N L+ + +K+ DFG S+ + S P ++AP
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRY-MEDSTYYKASKGKLPIKWMAP 186
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + + + +DVW GV ++ +++ G PF+
Sbjct: 187 ESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 220
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 2e-13
Identities = 52/236 (22%), Positives = 88/236 (37%), Gaps = 38/236 (16%)
Query: 43 RSLRHPNIVR-----FKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQ 95
+ HPN++R + +++ + G+L + R Q
Sbjct: 91 KDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS---RLETGPKHIPLQ 147
Query: 96 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
L+ G+ Y + HRDL N +L + + DFG SK ++S
Sbjct: 148 TLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSK--KIYSGDYY 203
Query: 149 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFR 200
G A + A E L + Y K +DVW+ GVT++ + G YP E ++
Sbjct: 204 RQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYL 262
Query: 201 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLP 255
HR+ P+ E ++ + DP R + +R E L++LP
Sbjct: 263 LHGHRL-----KQPE--DCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP 311
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 2e-13
Identities = 37/154 (24%), Positives = 64/154 (41%), Gaps = 10/154 (6%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
+L HP+IV+ +I I+ME GEL + N + Q+ ++
Sbjct: 69 NLDHPHIVKLIGIIEEEPTW-IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI---APE 159
Y S+ HRD+ + N L+ +K+ DFG S+ + T I +PE
Sbjct: 128 YLESINCVHRDIAVRNILVASPEC--VKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPE 184
Query: 160 VLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
+ + + +DVW V ++ ++ G PF
Sbjct: 185 SINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFW 217
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 4e-13
Identities = 40/155 (25%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 44 SLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEARFFFQQLISGVS 102
HP+IV+ VI I+ME + GEL + + QL + ++
Sbjct: 447 QFDHPHIVKLIGVITENPVW-IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALA 505
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--KSTVG-TPA-YIAP 158
Y S + HRD+ N L+ + +K+ DFG S+ + K++ G P ++AP
Sbjct: 506 YLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSR--YMEDSTYYKASKGKLPIKWMAP 561
Query: 159 EVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFED 192
E + + + +DVW GV ++ +++ G PF+
Sbjct: 562 ESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQG 595
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 7e-13
Identities = 30/161 (18%), Positives = 58/161 (36%), Gaps = 21/161 (13%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISGVS 102
L H ++V V + +V E+ G L + + N + +QL + +
Sbjct: 69 LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWKLEVAKQLAAAMH 127
Query: 103 YCHSMQVCHRDLKLENTLLDGSPAPRL------KICDFGYSKSSVLHSQPKSTVGTPAYI 156
+ + H ++ +N LL + K+ D G S + + + + ++
Sbjct: 128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI---PWV 184
Query: 157 APEVLLKKEYDGKI----ADVWSCGVTLY-VMLVGAYPFED 192
PE + + K D WS G TL+ + G P
Sbjct: 185 PPECIE----NPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 7e-13
Identities = 45/249 (18%), Positives = 92/249 (36%), Gaps = 31/249 (12%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL--FERICNAGRFSEDEAR--------FFF 94
++VR V+ ++ME + G+L + R +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154
++ G++Y ++ + HRDL N ++ + +KI DFG ++ ++ G
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMV--AEDFTVKIGDFGMTR--DIYETDYYRKGGKG 200
Query: 155 YI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRKTIHRI 206
+ +PE L + +DVWS GV L+ + + Y E+ F +
Sbjct: 201 LLPVRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTN 265
PD + L+ + +P R S EI + + ++ ++ +
Sbjct: 260 -----DKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 312
Query: 266 NQFEEPDQP 274
N+ EP++
Sbjct: 313 NKLPEPEEL 321
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 1e-12
Identities = 54/231 (23%), Positives = 93/231 (40%), Gaps = 37/231 (16%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 96
+H NI+ L +++EYAS G L + E + F+
Sbjct: 145 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 204
Query: 97 LIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 205 LVSCTYQLARGMEYLASQKCIHRDLAARNVLV--TENNVMKIADFGLAR--DINNIDYYK 260
Query: 150 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEEPKNFRK 201
T + APE L + Y + +DVWS GV ++ + +G YP EE K
Sbjct: 261 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319
Query: 202 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFL 251
HR+ P + + E ++ + A P++R + ++ + L
Sbjct: 320 EGHRM-----DKPA--NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL 363
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 64.9 bits (159), Expect = 3e-12
Identities = 43/158 (27%), Positives = 69/158 (43%), Gaps = 26/158 (16%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE---------RICNAGRFSEDEARFFFQ 95
L+H +IV+F V L +V EY G+L + I G+ + +
Sbjct: 74 LQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS 133
Query: 96 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
Q++ SG+ Y S HRDL N L+ +KI DFG S+ ++S
Sbjct: 134 QMLHIASQIASGMVYLASQHFVHRDLATRNCLV--GANLLVKIGDFGMSR--DVYSTDYY 189
Query: 149 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
VG + PE ++ +++ + +DVWS GV L+
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSFGVILW 226
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 5e-12
Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 29/168 (17%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------FERICNAGRFSEDEARFFF 94
H NIV ++ EY G+L + +DE
Sbjct: 85 NHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDL 144
Query: 95 QQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
+ L+S G+++ S HRDL N LL KICDFG ++ + +
Sbjct: 145 EDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLAR--DIKNDSN 200
Query: 148 STVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 189
V A + APE + Y + +DVWS G+ L+ + +G+ P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-11
Identities = 46/167 (27%), Positives = 69/167 (41%), Gaps = 26/167 (15%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--------RICNAGRFSEDEARFFFQQ 96
L+H +IVRF V L +V EY G+L AG Q
Sbjct: 100 LQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ 159
Query: 97 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+ +G+ Y + HRDL N L+ +KI DFG S+ ++S
Sbjct: 160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLV--GQGLVVKIGDFGMSR--DIYSTDYYR 215
Query: 150 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
VG + PE +L +++ + +DVWS GV L+ + G P+
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 1e-11
Identities = 36/168 (21%), Positives = 68/168 (40%), Gaps = 27/168 (16%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQ 95
L+HPN+V V+ L+++ Y S G+L + + ++
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 96 QLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
+ +G+ Y S V H+DL N L+ +KI D G + +++
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV--YDKLNVKISDLGLFR--EVYAADYY 184
Query: 149 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+ + + APE ++ ++ +D+WS GV L+ V G P+
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPY 231
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 1e-11
Identities = 43/166 (25%), Positives = 62/166 (37%), Gaps = 30/166 (18%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 96
HPNI+ +L + +EYA G L E + + QQ
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 97 LI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+ G+ Y Q HRDL N L+ + KI DFG S+ ++
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSRGQEVY-----V 196
Query: 150 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 189
T + A E L Y +DVWS GV L+ ++ +G P
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTP 241
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 44/156 (28%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 44 SLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLISG 100
HPN++ + L +V+ Y G+L F R + + F Q+ G
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAKG 140
Query: 101 VSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT-PA-Y 155
+ Y S + HRDL N +LD +K+ DFG ++ +S T P +
Sbjct: 141 MKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKW 198
Query: 156 IAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
+A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 199 MALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 233
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 3e-11
Identities = 42/157 (26%), Positives = 68/157 (43%), Gaps = 13/157 (8%)
Query: 43 RSLRHPNIVRFKEVILTPTH-LAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLIS 99
+ HPN++ + L +V+ Y G+L F R + + F Q+
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-NETHNPTVKDLIGFGLQVAK 203
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI--- 156
G+ + S + HRDL N +LD +K+ DFG ++ T A +
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261
Query: 157 --APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
A E L +++ K +DVWS GV L+ +M GA P+
Sbjct: 262 WMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPY 297
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 3e-11
Identities = 37/164 (22%), Positives = 64/164 (39%), Gaps = 25/164 (15%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFE-------RICNAGRFSEDEARFFFQQLI 98
+H NIV + ++ EY G+L + F+ + + L+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 99 S-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
G+++ S HRD+ N LL + KI DFG ++ + + V
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLL--TNGHVAKIGDFGLARD--IMNDSNYIVK 223
Query: 152 TPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 189
A + APE + Y + +DVWS G+ L+ + +G P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNP 266
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 4e-11
Identities = 41/157 (26%), Positives = 63/157 (40%), Gaps = 26/157 (16%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 96
+H NI+ L +++EYAS G L + E + +
Sbjct: 133 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 192
Query: 97 LIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +H
Sbjct: 193 LVSCAYQVARGMEYLASKKCIHRDLAARNVLV--TEDNVMKIADFGLAR--DIHHIDYYK 248
Query: 150 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY 181
T + APE L + Y + +DVWS GV L+
Sbjct: 249 KTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLW 284
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 42/166 (25%), Positives = 69/166 (41%), Gaps = 27/166 (16%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQQ 96
+H NI+ L +++EYAS G L + E + F+
Sbjct: 99 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKD 158
Query: 97 LIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
L+S G+ Y S + HRDL N L+ + +KI DFG ++ +++
Sbjct: 159 LVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLAR--DINNIDYYK 214
Query: 150 VGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 189
T + APE L + Y + +DVWS GV ++ + +G P
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSP 259
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 2e-10
Identities = 45/165 (27%), Positives = 72/165 (43%), Gaps = 17/165 (10%)
Query: 43 RSLRHPNIVRFKEVILT--PTHLAIVMEYASGGEL--FERICNAGRFSEDEARFFFQQLI 98
R L HPN++ ++L +++ Y G+L F R + + F Q+
Sbjct: 77 RGLNHPNVLALIGIMLPPEGLPH-VLLPYMCHGDLLQFIR-SPQRNPTVKDLISFGLQVA 134
Query: 99 SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGT-PA 154
G+ Y + HRDL N +LD S +K+ DFG ++ +S + P
Sbjct: 135 RGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 155 -YIAPEVLLKKEYDGKIADVWSCGVTLY-VMLVGA--YPFEDPEE 195
+ A E L + K +DVWS GV L+ ++ GA Y DP +
Sbjct: 193 KWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 2e-10
Identities = 42/176 (23%), Positives = 69/176 (39%), Gaps = 35/176 (19%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 87
+ HP++++ L +++EYA G L ++
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 88 DEARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140
DE LIS G+ Y M++ HRDL N L+ +KI DFG S+
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRD- 199
Query: 141 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
++ + + I A E L Y + +DVWS GV L+ ++ +G P+
Sbjct: 200 -VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPY 253
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 41/168 (24%), Positives = 65/168 (38%), Gaps = 28/168 (16%)
Query: 46 RHPNIVRFKEVILTP-THLAIVMEYASGGEL---------FERICNAGRFSEDEARFFFQ 95
H N+V P L +++E+ G L + +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 96 QLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
LI G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLAR--DIYKDPDY 204
Query: 149 TVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
A + APE + + Y + +DVWS GV L+ + +GA P+
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPY 251
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 38/176 (21%), Positives = 65/176 (36%), Gaps = 35/176 (19%)
Query: 45 LRHPNIVRFKEVILTPTHLAIVMEYASGGEL-----------------FERICNAGRFSE 87
+PNIV+ V + ++ EY + G+L + A S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 88 DEARFFFQQLI-------SGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140
+ + +G++Y + HRDL N L+ +KI DFG S++
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV--GENMVVKIADFGLSRN- 223
Query: 141 VLHSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPF 190
++S I PE + Y + +DVW+ GV L+ + G P+
Sbjct: 224 -IYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPY 277
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 1e-09
Identities = 42/173 (24%), Positives = 62/173 (35%), Gaps = 34/173 (19%)
Query: 46 RHPNIVRFKEVILTPTHLAIVMEYASGGEL----------------FERICNAGRFSEDE 89
H NIV + ++ EY G+L ED
Sbjct: 107 SHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 90 ARFFFQQLIS-------GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
F+ L+ G+ + HRDL N L+ +KICDFG ++ +
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARD--I 222
Query: 143 HSQPKSTVGTPAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYP 189
S V A + APE L + Y K +DVWS G+ L+ + +G P
Sbjct: 223 MSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNP 274
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 1e-09
Identities = 34/106 (32%), Positives = 53/106 (50%), Gaps = 15/106 (14%)
Query: 100 GVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-SSVLHSQPKST--VGTPAYI 156
G+++ H HRD+K N LLD + KI DFG ++ S ++ VGT AY+
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTA--KISDFGLARASEKFAQTVMTSRIVGTTAYM 202
Query: 157 APEVLLKKEY-DGKI---ADVWSCGVTLYVMLVGAYPFEDPEEPKN 198
AP E G+I +D++S GV L ++ G ++ EP+
Sbjct: 203 AP------EALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQL 242
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 53.7 bits (130), Expect = 2e-08
Identities = 48/166 (28%), Positives = 67/166 (40%), Gaps = 44/166 (26%)
Query: 45 LRHPNIVRF----KEVILTPTHLAIVMEYASGGELFERICNAGRFSE------------D 88
RHP++V E + ++ +Y G L + + +
Sbjct: 92 CRHPHLVSLIGFCDE----RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK- 147
AR G+ Y H+ + HRD+K N LLD + P KI DFG SK Q
Sbjct: 148 AAR--------GLHYLHTRAIIHRDVKSINILLDENFVP--KITDFGISKKGTELDQTHL 197
Query: 148 STV--GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTLYVMLVG 186
STV GT YI PE L +K +DV+S GV L+ +L
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEK------SDVYSFGVVLFEVLCA 237
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 51.1 bits (122), Expect = 2e-07
Identities = 33/119 (27%), Positives = 56/119 (47%), Gaps = 11/119 (9%)
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ Q+ G+ + S + HRDL N LL +KICDFG ++ ++ P
Sbjct: 198 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARD--IYKDPDYVRKG 253
Query: 153 PAYI-----APEVLLKKEYDGKIADVWSCGVTLY-VMLVGAYPFEDPEEPKNFRKTIHR 205
A + APE + + Y + +DVWS GV L+ + +GA P+ + + F + +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 45/168 (26%), Positives = 65/168 (38%), Gaps = 46/168 (27%)
Query: 38 EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG----ELFERICNAGRFS------- 86
E+I+ H N++R + +TPT +V Y + G L ER +
Sbjct: 79 EMISM--AVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136
Query: 87 -EDEARFFFQQLISGVSYCH---SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142
AR G++Y H ++ HRD+K N LLD + DFG +K L
Sbjct: 137 ALGSAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEA--VVGDFGLAK---L 183
Query: 143 HSQPKSTV-----GTPAYIAPE-----VLLKKEYDGKIADVWSCGVTL 180
+ V GT +IAPE +K DV+ GV L
Sbjct: 184 MDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEK------TDVFGYGVML 225
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 7e-07
Identities = 22/82 (26%), Positives = 34/82 (41%), Gaps = 2/82 (2%)
Query: 57 ILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLK 115
L IV+E+ GG E++ S A+ QL + ++ S++ HRDL
Sbjct: 131 FFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLH 189
Query: 116 LENTLLDGSPAPRLKICDFGYS 137
N LL + +L G S
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGKS 211
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 20/140 (14%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+VM+ S +LF C+ + S Q+I+ V + HS HRD+K +N L+
Sbjct: 79 VLVMDLLGPSLEDLF-NFCS-RKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136
Query: 122 D-GSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLKKEY---DGK 169
G A ++ I DFG +K S+ H + K+ GT Y + L E D
Sbjct: 137 GLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRD-- 194
Query: 170 IADVWSCGVTLYVMLVGAYP 189
D+ S G L L G+ P
Sbjct: 195 --DLESLGYVLMYFLRGSLP 212
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 32/142 (22%), Positives = 59/142 (41%), Gaps = 22/142 (15%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+V++ S +L +C +FS +Q+++ V H + +RD+K +N L+
Sbjct: 82 VLVIDLLGPSLEDLL-DLCG-RKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI 139
Query: 122 ---DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLKKEY---D 167
+ A + + DFG K + H + K+ GT Y++ L +E D
Sbjct: 140 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRD 199
Query: 168 GKIADVWSCGVTLYVMLVGAYP 189
D+ + G L G+ P
Sbjct: 200 ----DLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 9e-06
Identities = 40/142 (28%), Positives = 60/142 (42%), Gaps = 22/142 (15%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
A+V+E S +LF +C+ FS QLIS + Y HS + +RD+K EN L+
Sbjct: 81 AMVLELLGPSLEDLF-DLCD-RTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138
Query: 122 DGSPAPRLKIC---DFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLKKEY---D 167
++ DF +K + H + KS GT Y++ L KE D
Sbjct: 139 GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRD 198
Query: 168 GKIADVWSCGVTLYVMLVGAYP 189
D+ + G L G+ P
Sbjct: 199 ----DLEALGHMFMYFLRGSLP 216
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 4e-05
Identities = 41/140 (29%), Positives = 59/140 (42%), Gaps = 20/140 (14%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+VME S +LF C+ +FS Q+IS + Y HS HRD+K +N L+
Sbjct: 81 VMVMELLGPSLEDLF-NFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138
Query: 122 -DGSPAPRLKICDFGYSK-----SSVLH---SQPKSTVGTPAYIAPEVLLKKEY---DGK 169
G + I DFG +K + H + K+ GT Y + L E D
Sbjct: 139 GLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRD-- 196
Query: 170 IADVWSCGVTLYVMLVGAYP 189
D+ S G L +G+ P
Sbjct: 197 --DLESLGYVLMYFNLGSLP 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 15/103 (14%), Positives = 33/103 (32%), Gaps = 11/103 (10%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+V+ S + SE +L+ + + H + H ++ EN +
Sbjct: 134 FLVLPSLGRSLQSALDV-SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
Query: 122 DGSPAPRLKICDFGYSK---SSVLH-----SQPKSTVGTPAYI 156
D ++ + +G++ S H G +I
Sbjct: 193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 9e-05
Identities = 17/77 (22%), Positives = 31/77 (40%), Gaps = 5/77 (6%)
Query: 64 AIVMEY--ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL 121
+VME ++ N G F + +++ + Y H + H D+K N LL
Sbjct: 128 FMVMERLGIDLQKISG--QN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL 184
Query: 122 DGSPAPRLKICDFGYSK 138
++ + D+G S
Sbjct: 185 GYKNPDQVYLADYGLSY 201
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 41.7 bits (98), Expect = 2e-04
Identities = 10/43 (23%), Positives = 22/43 (51%)
Query: 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
+++ + Y H + H D+K N LL+ ++ + D+G +
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.0 bits (95), Expect = 4e-04
Identities = 50/366 (13%), Positives = 105/366 (28%), Gaps = 125/366 (34%)
Query: 34 NVQR-----EIINH-RSLR-HPNIVRF------KEVILTPTHLAIVMEYASGGELFERIC 80
NV R ++ LR N++ K +A+
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW------VAL--------------- 168
Query: 81 NAGRFSEDEARFFFQQL-ISGVSYCHS-------MQ-VCHRDLKLENTLLDGSPAPRLKI 131
+ + + + F+ ++ + C+S +Q + ++ + D S +L+I
Sbjct: 169 DVCLSYKVQCKMDFKIFWLN-LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 132 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKI-ADVWS----------C---- 176
+L S+P Y LL + +V + C
Sbjct: 228 HSIQAELRRLLKSKP--------Y--ENCLL-------VLLNVQNAKAWNAFNLSCKILL 270
Query: 177 -----GVTLYVMLVGAY---------PFEDPEEPKNFRKTIHRILSVQYSIPDYVH-ISP 221
VT ++ E K + Q +P V +P
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD--CRPQ-DLPREVLTTNP 327
Query: 222 --------ECRHLISRIFVADPAKRISIPEIRNH-EWFLKNL-PADLVVDNTTNNQFEE- 270
R ++ D K ++ ++ E L L PA+ F+
Sbjct: 328 RRLSIIAESIRDGLATW---DNWKHVNCDKLTTIIESSLNVLEPAEY------RKMFDRL 378
Query: 271 ---PDQ---PMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDIDTDPDLDI 324
P P ++ +I I + +N+ SL ++ + E + P + +
Sbjct: 379 SVFPPSAHIPTI----LLSLIWFDVIKSDVMVVVNKLHKYSL-VEKQPKESTISIPSIYL 433
Query: 325 DSSGEI 330
+ ++
Sbjct: 434 ELKVKL 439
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.94 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.87 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.77 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.58 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.09 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.91 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.56 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.49 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.4 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.17 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.98 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.95 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.92 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.92 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.8 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.37 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.28 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.17 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.07 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.95 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.93 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.65 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 96.5 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.46 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.45 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.65 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 95.41 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.78 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 89.56 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.97 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 82.46 |
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-63 Score=434.11 Aligned_cols=245 Identities=42% Similarity=0.710 Sum_probs=200.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|+++.+|+.| |||++.+... .....+.+|+.+++.++|||||++++++.+++.+|+||||| +|+
T Consensus 21 lG~G~fg~V~~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~ 98 (275)
T 3hyh_A 21 LGEGSFGKVKLAYHTTTGQKV-ALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 98 (275)
T ss_dssp EEC---CCEEEEECTTTCCEE-EEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEE
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCC
Confidence 566665 48889999999 9999987652 23467899999999999999999999999999999999999 789
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.........+.+||+.
T Consensus 99 L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~~~~~~~~~GT~~ 176 (275)
T 3hyh_A 99 LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLN--VKIADFGLSNIMTDGNFLKTSCGSPN 176 (275)
T ss_dssp HHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCC--EEECCSSCC---------------CT
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCC--EEEeecCCCeecCCCCccCCeeECcc
Confidence 9999999999999999999999999999999999999999999999987765 99999999987665555667899999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||||++.+..+++.++|||||||++|+|++|++||.+.+... ....+......+|. .+|+++++||.+||++|
T Consensus 177 Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 250 (275)
T 3hyh_A 177 YAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPV----LFKNISNGVYTLPK--FLSPGAAGLIKRMLIVN 250 (275)
T ss_dssp TSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHHHHTCCCCCT--TSCHHHHHHHHHHSCSS
T ss_pred cCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHcCCCCCCC--CCCHHHHHHHHHHccCC
Confidence 9999999998887767999999999999999999998765433 33344444555543 58999999999999999
Q ss_pred CCCCCCHhHHhcCccccccCCC
Q 019901 235 PAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~~~ 256 (334)
|.+|||++|+++||||+..+|.
T Consensus 251 P~~R~s~~eil~hpw~k~~~p~ 272 (275)
T 3hyh_A 251 PLNRISIHEIMQDDWFKVDLPE 272 (275)
T ss_dssp GGGSCCHHHHHHCHHHHTTCCG
T ss_pred hhHCcCHHHHHcCcccccCCCh
Confidence 9999999999999999877654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=450.74 Aligned_cols=330 Identities=77% Similarity=1.251 Sum_probs=230.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +++++.+++.| |||++.... ...+.+.+|+.+++.++||||+++++++.+++.+|+||||+.+|+|.+
T Consensus 28 lG~G~~g~V~~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~ 105 (361)
T 3uc3_A 28 IGSGNFGVARLMRDKLTKELV-AVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE 105 (361)
T ss_dssp ESSSTTSSEEEEEETTTCCEE-EEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred eccCCCEEEEEEEECCCCcEE-EEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence 555554 58888899999 999998766 556889999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
++.+.+++++..++.++.||+.||.|||++||+||||||+|||++.++.+++||+|||+|+...........+||+.|+|
T Consensus 106 ~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~a 185 (361)
T 3uc3_A 106 RICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 185 (361)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCC
Confidence 99888899999999999999999999999999999999999999877666799999999986555555566789999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++++++|||||||++|+|++|+.||.+......+...+..+.......|....+++++++||.+||+.+|.+
T Consensus 186 PE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~ 265 (361)
T 3uc3_A 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPAT 265 (361)
T ss_dssp HHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTT
T ss_pred hhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhH
Confidence 99999888877778999999999999999999998776666677777777777777777789999999999999999999
Q ss_pred CCCHhHHhcCccccccCCCccccCCCCCCCCCCCCCCCCCHHHHHHHHHHhCCCCCCCcchhhhcCCCCCCCcccccCCC
Q 019901 238 RISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDEMDEDID 317 (334)
Q Consensus 238 R~s~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~ 317 (334)
|||++++++||||.+..+.+..........+..+.++.+.++.+.+.+.+..++........+...+..|.||+ ++|+|
T Consensus 266 Rps~~ell~hp~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~d~~-~~~~d 344 (361)
T 3uc3_A 266 RISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATIPAVRNRCLDDFMTDNLDLDDD-MDDFD 344 (361)
T ss_dssp SCCHHHHHTSHHHHTTCCCC------------------CCHHHHHHHHHHHTCC--------------------------
T ss_pred CcCHHHHHhCcchhcCCchhhhccccccccccCCcccccCHHHHHHHHhhccCcccccccchhccccccccccc-ccccc
Confidence 99999999999999988877766555666777788889999999999999999887776666666666665554 33355
Q ss_pred CCCCCCCCCCCceeecC
Q 019901 318 TDPDLDIDSSGEIVYAM 334 (334)
Q Consensus 318 ~~~~~~~d~~~~~~~~~ 334 (334)
++++.|.|++|+|.||+
T Consensus 345 ~~~~~d~d~~g~~~~~~ 361 (361)
T 3uc3_A 345 SESEIDIDSSGEIVYAL 361 (361)
T ss_dssp -----------------
T ss_pred chhhhccCCCCcEEecC
Confidence 66778999999999996
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-62 Score=442.09 Aligned_cols=246 Identities=25% Similarity=0.428 Sum_probs=211.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.| +|+++.+|+.| |||++.+......+.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+++.+
T Consensus 87 fG~V~~a~~~~tg~~v-AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~- 164 (346)
T 4fih_A 87 TGIVCIATVRSSGKLV-AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH- 164 (346)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-
T ss_pred CeEEEEEEECCCCCEE-EEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-
Confidence 4444 48899999999 99999887656667899999999999999999999999999999999999999999998876
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aPE~~ 161 (334)
+++++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.|||||++
T Consensus 165 ~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl 242 (346)
T 4fih_A 165 TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELI 242 (346)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCC--EEEecCcCceecCCCCCcccccccCcCcCCHHHH
Confidence 56999999999999999999999999999999999999987765 999999999865433 334567899999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+..|+.+ +|||||||++|+|++|++||.+.+....+..+.. .....++.+..+|+++++||.+||++||.+|||+
T Consensus 243 ~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta 318 (346)
T 4fih_A 243 SRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATA 318 (346)
T ss_dssp TTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred CCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCCccccCCHHHHHHHHHHcCCChhHCcCH
Confidence 98888655 9999999999999999999988765444433221 1222344455789999999999999999999999
Q ss_pred hHHhcCccccccCCCc
Q 019901 242 PEIRNHEWFLKNLPAD 257 (334)
Q Consensus 242 ~ell~h~~~~~~~~~~ 257 (334)
+|+|+||||++..+..
T Consensus 319 ~e~l~Hp~~~~~~~p~ 334 (346)
T 4fih_A 319 AELLKHPFLAKAGPPA 334 (346)
T ss_dssp HHHTTCGGGGGCCCGG
T ss_pred HHHhcCHhhcCCCCCc
Confidence 9999999998865543
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-62 Score=434.16 Aligned_cols=241 Identities=30% Similarity=0.507 Sum_probs=208.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +|+++.+|+.| |||++.+... ...+.+.+|+.+|++++|||||+++++|++++.+|||||||+||+
T Consensus 40 lG~G~fg~V~~a~~~~~~~~~-AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~ 118 (311)
T 4aw0_A 40 LGEGSFSTVVLARELATSREY-AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118 (311)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEE
T ss_pred EecccCeEEEEEEECCCCCEE-EEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCC
Confidence 455544 48899999999 9999987542 334679999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVG 151 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~g 151 (334)
|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+|
T Consensus 119 L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~~~G 196 (311)
T 4aw0_A 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVG 196 (311)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTTTCCCBCCCCS
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCC--EEEEEcCCceecCCCCCcccccCccc
Confidence 9999999999999999999999999999999999999999999999987765 999999999865322 23456789
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
||.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+.... ..++....+.+|. .+|+++++||.+||
T Consensus 197 Tp~YmAPEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~dli~~lL 269 (311)
T 4aw0_A 197 TAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEGLI----FAKIIKLEYDFPE--KFFPKARDLVEKLL 269 (311)
T ss_dssp CGGGCCHHHHHHSCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHTCCCCCT--TCCHHHHHHHHHHS
T ss_pred CcccCCHHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCCCCCCc--ccCHHHHHHHHHHc
Confidence 999999999999888655 9999999999999999999988665433 3445555555554 58999999999999
Q ss_pred ccCCCCCCCHhH------HhcCccccc
Q 019901 232 VADPAKRISIPE------IRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~~e------ll~h~~~~~ 252 (334)
++||.+|||++| +++||||+.
T Consensus 270 ~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 270 VLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp CSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred cCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 999999999988 588999954
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-61 Score=441.80 Aligned_cols=247 Identities=26% Similarity=0.438 Sum_probs=212.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +|+++.+|+.| |||++.+......+.+.+|+.+|+.++|||||+++++|.+++.+|||||||+||+|.+
T Consensus 159 iG~G~fG~V~~a~~~~tg~~v-AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~ 237 (423)
T 4fie_A 159 IGEGSTGIVCIATVRSSGKLV-AVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 237 (423)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred eccCcCcEEEEEEECCCCCEE-EEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHH
Confidence 454544 48899999999 9999988775666789999999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~ 156 (334)
++.. +++++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+.||
T Consensus 238 ~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GTp~Ym 314 (423)
T 4fie_A 238 IVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGR--VKLSDFGFCAQVSKEVPRRKSLVGTPYWM 314 (423)
T ss_dssp HHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCC--EEECCCTTCEECCSSCCCBCCCEECTTTC
T ss_pred HHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEecCccceECCCCCccccccccCcCcC
Confidence 8865 56999999999999999999999999999999999999987765 999999999865433 3345678999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..+.. .....++.+..+|+++++||.+||++||.
T Consensus 315 APEvl~~~~y~~~-~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~---~~~~~~~~~~~~s~~~~dli~~~L~~dP~ 390 (423)
T 4fie_A 315 APELISRLPYGPE-VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDRLLVRDPA 390 (423)
T ss_dssp CHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSCTTSSCHHHHHHHHHHSCSSTT
T ss_pred CHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHc---CCCCCCcccccCCHHHHHHHHHHcCCChh
Confidence 9999998888665 9999999999999999999988765444433221 12233455567899999999999999999
Q ss_pred CCCCHhHHhcCccccccCCC
Q 019901 237 KRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~~~ 256 (334)
+|||++|+|+||||++..+.
T Consensus 391 ~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 391 QRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp TSCCHHHHTTCGGGGGCCCG
T ss_pred HCcCHHHHhcCHHhcCCCCC
Confidence 99999999999999886544
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-61 Score=437.19 Aligned_cols=244 Identities=29% Similarity=0.489 Sum_probs=204.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| +|+++.+|+.| |||++.+.... ..+.+.+|+.++++++|||||+++++|++++.+|||||||+||+|
T Consensus 32 lG~G~fg~V~~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L 110 (350)
T 4b9d_A 32 IGEGSFGKAILVKSTEDGRQY-VIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL 110 (350)
T ss_dssp C------CEEEEEETTTCCEE-EEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcH
Confidence 666666 58899999999 99999876532 246789999999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCC
Q 019901 76 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt 152 (334)
.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+.+||
T Consensus 111 ~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~GT 188 (350)
T 4b9d_A 111 FKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGT--VQLGDFGIARVLNSTVELARACIGT 188 (350)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCC--EEECSTTEESCCCHHHHHHHHHHSC
T ss_pred HHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCC--EEEcccccceeecCCcccccccCCC
Confidence 9999754 35799999999999999999999999999999999999987765 9999999998653322 12345799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+....+.+ +...... +.+..+|+++++||.+||+
T Consensus 189 ~~YmAPE~l~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~~~----i~~~~~~-~~~~~~s~~~~~li~~~L~ 262 (350)
T 4b9d_A 189 PYYLSPEICENKPYNNK-SDIWALGCVLYELCTLKHAFEAGSMKNLVLK----IISGSFP-PVSLHYSYDLRSLVSQLFK 262 (350)
T ss_dssp CTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCC-CCCTTSCHHHHHHHHHHTC
T ss_pred ccccCHHHHCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHHHH----HHcCCCC-CCCccCCHHHHHHHHHHcc
Confidence 99999999999888655 9999999999999999999998765444433 3333322 3345689999999999999
Q ss_pred cCCCCCCCHhHHhcCccccccC
Q 019901 233 ADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+||.+|||++|+|+||||++..
T Consensus 263 ~dP~~R~s~~e~l~hp~~~~~~ 284 (350)
T 4b9d_A 263 RNPRDRPSVNSILEKGFIAKRI 284 (350)
T ss_dssp SSGGGSCCHHHHHTSHHHHTTG
T ss_pred CChhHCcCHHHHhcCHHhhcCC
Confidence 9999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-60 Score=420.90 Aligned_cols=240 Identities=23% Similarity=0.379 Sum_probs=198.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (334)
||.| .|.++.++..| |||++.+.... ..+.+.+|+.++++++|||||+++++|++ ++.+|||||||+||+|.
T Consensus 39 fg~Vy~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~ 117 (290)
T 3fpq_A 39 FKTVYKGLDTETTVEV-AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHH
T ss_pred CcEEEEEEECCCCeEE-EEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHH
Confidence 4444 47889999999 99999876522 23578999999999999999999999875 35689999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+++.+.+.+++..++.|+.||+.||+|||++| ||||||||+|||+++ ++ .+||+|||+|+... .....+.+|||
T Consensus 118 ~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g--~vKl~DFGla~~~~-~~~~~~~~GTp 194 (290)
T 3fpq_A 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKR-ASFAKAVIGTP 194 (290)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS--CEEECCTTGGGGCC-TTSBEESCSSC
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC--CEEEEeCcCCEeCC-CCccCCcccCc
Confidence 99999899999999999999999999999998 999999999999974 34 49999999997532 23345678999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|||||++.+ .|+.+ +|||||||++|+|+||++||.+......+.. .+.....+......+++++++||.+||++
T Consensus 195 ~YmAPE~~~~-~y~~~-~DiwSlGvilyelltg~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~li~~~L~~ 269 (290)
T 3fpq_A 195 EFMAPEMYEE-KYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp CCCCGGGGGT-CCCTH-HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred cccCHHHcCC-CCCcH-HHHHHHHHHHHHHHHCCCCCCCCCcHHHHHH---HHHcCCCCCCCCccCCHHHHHHHHHHccC
Confidence 9999999865 57655 9999999999999999999987655443332 23222222222345789999999999999
Q ss_pred CCCCCCCHhHHhcCccccc
Q 019901 234 DPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~ 252 (334)
||.+|||++|+|+||||++
T Consensus 270 dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 270 NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHTSGGGC-
T ss_pred ChhHCcCHHHHhcCccccC
Confidence 9999999999999999975
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-61 Score=424.67 Aligned_cols=241 Identities=30% Similarity=0.544 Sum_probs=198.9
Q ss_pred CCccee----eeee---cCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRC---SYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~---~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| +|++ +.+++.| |||++.+... .....+.+|+.++++++|||||+++++|++++.+|+|||||+|
T Consensus 32 lG~G~fg~Vy~a~~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g 110 (304)
T 3ubd_A 32 LGQGSFGKVFLVKKISGSDARQLY-AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRG 110 (304)
T ss_dssp EECGGGCEEEEEEECSSTTTTCEE-EEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTT
T ss_pred EecCCCeEEEEEEEccCCCCCEEE-EEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCC
Confidence 555555 3555 3467778 9999987652 2345788999999999999999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~g 151 (334)
|+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... .....+.+|
T Consensus 111 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~--vKl~DFGla~~~~~~~~~~~~~~G 188 (304)
T 3ubd_A 111 GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGH--IKLTDFGLSKESIDHEKKAYSFCG 188 (304)
T ss_dssp CEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSC--EEEESSEEEEC-----CCCCSCCC
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCC--EEecccccceeccCCCcccccccc
Confidence 999999999999999999999999999999999999999999999999987765 99999999986433 334456789
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|||||++.+..|+.+ +|||||||++|+|++|++||.+.+....+ ..+......+|. .+|+++++||.+||
T Consensus 189 T~~YmAPE~~~~~~y~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~~L 261 (304)
T 3ubd_A 189 TVEYMAPEVVNRRGHTQS-ADWWSFGVLMFEMLTGTLPFQGKDRKETM----TMILKAKLGMPQ--FLSPEAQSLLRMLF 261 (304)
T ss_dssp CGGGCCHHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred CcccCCHHHhccCCCCCC-CcccchHHHHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCCC--cCCHHHHHHHHHHc
Confidence 999999999999888765 99999999999999999999987654433 334444544443 58999999999999
Q ss_pred ccCCCCCCC-----HhHHhcCccccc
Q 019901 232 VADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s-----~~ell~h~~~~~ 252 (334)
++||.+||| ++|+++||||+.
T Consensus 262 ~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 262 KRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp CSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred ccCHHHCCCCCcCCHHHHHcCccccC
Confidence 999999998 479999999954
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=421.55 Aligned_cols=237 Identities=24% Similarity=0.345 Sum_probs=199.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.| .|+++.+|+.| |||++.+... ..+|+.+++.++|||||+++++|.+++.+|||||||+||+|.+++.+.
T Consensus 71 fG~Vy~a~~~~~g~~v-AiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~ 144 (336)
T 4g3f_A 71 FGEVHRMKDKQTGFQC-AVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQM 144 (336)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHc
Confidence 4444 48899999999 9999987652 247999999999999999999999999999999999999999999998
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC------CCCccCCCccc
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------PKSTVGTPAYI 156 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~------~~~~~gt~~y~ 156 (334)
+++++..++.++.||+.||+|||++|||||||||+|||++.++. ++||+|||+|+....... ....+||+.||
T Consensus 145 ~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~Ym 223 (336)
T 4g3f_A 145 GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGS-RAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHM 223 (336)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSC-CEEECCCTTCEEC------------CCCCCCGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCC-EEEEeeCCCCeEccCCCcccceecCCccccCcccc
Confidence 99999999999999999999999999999999999999987653 499999999986433221 23457999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC-CCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..+.. ....+ ..+..+|+++++||.+||++||
T Consensus 224 APE~~~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~----~~~~~~~~~~~~s~~~~~li~~~L~~dP 298 (336)
T 4g3f_A 224 APEVVMGKPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS----EPPPIREIPPSCAPLTAQAIQEGLRKEP 298 (336)
T ss_dssp CHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH----SCCGGGGSCTTSCHHHHHHHHHHTCSSG
T ss_pred CHHHHCCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc----CCCCchhcCccCCHHHHHHHHHHccCCH
Confidence 9999999888766 9999999999999999999988766554444332 22221 2234689999999999999999
Q ss_pred CCCCCHhHH-------------hcCccccc
Q 019901 236 AKRISIPEI-------------RNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~el-------------l~h~~~~~ 252 (334)
.+|||+.|+ |+|||+.+
T Consensus 299 ~~R~sa~el~~~l~~~l~~~~~l~hPw~~~ 328 (336)
T 4g3f_A 299 VHRASAMELRRKVGKALQEVGGLKSPWKGE 328 (336)
T ss_dssp GGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred hHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence 999999997 56888754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-57 Score=418.54 Aligned_cols=249 Identities=24% Similarity=0.358 Sum_probs=206.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc------CCeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT------PTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~~~~~lv~e~ 69 (334)
||.|+| .|+++.+|+.| |||++.+... ...+.+.+|+.+|+.++|||||++++++.. .+.+||||||
T Consensus 62 lG~G~fG~V~~a~~~~t~~~v-AiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~ 140 (398)
T 4b99_A 62 IGNGAYGVVSSARRRLTGQQV-AIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDL 140 (398)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEEC
T ss_pred EecccCeEEEEEEECCCCCEE-EEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeC
Confidence 455554 48899999999 9999976542 223568899999999999999999999764 3679999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-----CC
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-----HS 144 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-----~~ 144 (334)
|. |+|.+++.+.+++++..++.+++||+.||.|||++|||||||||+|||++.++. +||+|||+|+.... ..
T Consensus 141 ~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~--~Ki~DFGla~~~~~~~~~~~~ 217 (398)
T 4b99_A 141 ME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCE--LKIGDFGMARGLCTSPAEHQY 217 (398)
T ss_dssp CS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCC-------CC
T ss_pred CC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCC--EEEeecceeeecccCcccccc
Confidence 95 689999999899999999999999999999999999999999999999987765 99999999985432 22
Q ss_pred CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc------------
Q 019901 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS------------ 212 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~------------ 212 (334)
...+.+||+.|||||++.+..+.+.++||||+||++|+|++|++||.+.+....+..+..........
T Consensus 218 ~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~ 297 (398)
T 4b99_A 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA 297 (398)
T ss_dssp CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 33467899999999999887776677999999999999999999999887766666554432221110
Q ss_pred ----CCC---------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 213 ----IPD---------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 213 ----~~~---------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
++. ...+++++.+||.+||.+||.+|||++|+|+||||++..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 010 235789999999999999999999999999999998754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=403.90 Aligned_cols=244 Identities=21% Similarity=0.359 Sum_probs=191.3
Q ss_pred CCccee----eeeec---CCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCS---YSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~---~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| +|+++ .+++.| |||.+.+.. ....+.+|+.+|+.+ +||||++++++|.+.+++|+|||||+||
T Consensus 29 lG~G~fg~Vy~a~~~~~~~~~~~v-AiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~ 105 (361)
T 4f9c_A 29 IGEGTFSSVYLATAQLQVGPEEKI-ALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHE 105 (361)
T ss_dssp EEECSSEEEEEEEEEBTTSCEEEE-EEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCC
T ss_pred EecccCcEEEEEEEcccCCCCCEE-EEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcc
Confidence 455555 36554 356677 999987654 346788999999988 6999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---------
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--------- 144 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--------- 144 (334)
+|.+++. .+++.+++.+++||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+......
T Consensus 106 ~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~-~~~kl~DFGla~~~~~~~~~~~~~~~~ 181 (361)
T 4f9c_A 106 SFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRL-KKYALVDFGLAQGTHDTKIELLKFVQS 181 (361)
T ss_dssp CHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECTTCSCGGGGGC--
T ss_pred cHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCC-CeEEECcCCCCcccCCccccccccccc
Confidence 9999883 599999999999999999999999999999999999998652 359999999997432211
Q ss_pred --------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHH
Q 019901 145 --------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTI 203 (334)
Q Consensus 145 --------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~ 203 (334)
...+.+||+.|+|||++.+....+.++||||+||++|+|++|++||....+. ..+..+.
T Consensus 182 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~ 261 (361)
T 4f9c_A 182 EAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIM 261 (361)
T ss_dssp ------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHH
Confidence 1234579999999999988765566699999999999999999999655432 2222221
Q ss_pred HHH----------------------------------hhc--------------cccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 204 HRI----------------------------------LSV--------------QYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 204 ~~~----------------------------------~~~--------------~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
... ... ....+.+..+|+++++||.+||+.||
T Consensus 262 ~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP 341 (361)
T 4f9c_A 262 TIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNP 341 (361)
T ss_dssp HHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCT
T ss_pred HhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCCh
Confidence 100 000 00112345689999999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
.+|||++|+|+||||++
T Consensus 342 ~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 342 ASRITAEEALLHPFFKD 358 (361)
T ss_dssp TTSCCHHHHHTSGGGTT
T ss_pred hHCcCHHHHhcCcccCC
Confidence 99999999999999964
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-56 Score=396.57 Aligned_cols=240 Identities=24% Similarity=0.370 Sum_probs=185.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-ccHHHHHHHHHHHcCCCCCcccceEEEEcCC------------eEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-IDENVQREIINHRSLRHPNIVRFKEVILTPT------------HLA 64 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------------~~~ 64 (334)
||.|+| .|+++.+|..| |||++...... ..+.+.+|+.+|++++|||||+++++|.+.+ .+|
T Consensus 13 lG~G~fg~V~~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ 91 (299)
T 4g31_A 13 LGRGGFGVVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91 (299)
T ss_dssp EEECC--EEEEEEETTTCCEE-EEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEE
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEE
Confidence 455555 48889999999 99999876522 3467899999999999999999999987544 479
Q ss_pred EEEeccCCCChHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC
Q 019901 65 IVMEYASGGELFERICNAGRF---SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141 (334)
Q Consensus 65 lv~e~~~~~~L~~~l~~~~~~---~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~ 141 (334)
+|||||.||+|.+++...+.+ +...++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+...
T Consensus 92 ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~--vKl~DFGla~~~~ 169 (299)
T 4g31_A 92 IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMD 169 (299)
T ss_dssp EEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCCCC----
T ss_pred EEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCc--EEEccCccceecC
Confidence 999999999999999876553 45668999999999999999999999999999999987765 9999999998543
Q ss_pred CCCC-------------CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh
Q 019901 142 LHSQ-------------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 142 ~~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
.... ..+.+||+.|||||++.+..|+.+ +|||||||++|+|++ ||.+... ....+..+..
T Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~-~DiwSlGvilyell~---Pf~~~~~---~~~~~~~~~~ 242 (299)
T 4g31_A 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHK-VDIFSLGLILFELLY---PFSTQME---RVRTLTDVRN 242 (299)
T ss_dssp ----------------------CCCTTSCHHHHTTCCCCTH-HHHHHHHHHHHHHHS---CCSSHHH---HHHHHHHHHT
T ss_pred CCccccccccccccccccCCcccCccccCHHHHcCCCCCCH-HHHHHHHHHHHHHcc---CCCCccH---HHHHHHHHhc
Confidence 3221 233579999999999999888765 999999999999995 7864221 1122222222
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 209 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+ +.+...++.+.+||.+||++||.+|||+.|+|+||||+.
T Consensus 243 ~~~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~ 285 (299)
T 4g31_A 243 LKFP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFED 285 (299)
T ss_dssp TCCC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCC
T ss_pred CCCC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCC
Confidence 2211 122235678899999999999999999999999999964
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-56 Score=429.00 Aligned_cols=246 Identities=28% Similarity=0.501 Sum_probs=212.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .|+++.+|+.| |||++.+......+.+.+|+.+|+.++|||||+++++|.+++.+|+|||||+||+|.+
T Consensus 165 lG~G~fg~V~~~~~~~tg~~~-AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~ 243 (573)
T 3uto_A 165 LGTGAFGVVHRVTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 243 (573)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred EeeccCeEEEEEEECCCCCEE-EEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHH
Confidence 455544 48899999999 9999988764456789999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
++.+ .+.+++.+++.+++||+.||.|||++||+||||||+|||++.+..+.+||+|||+|+.........+.+||+.||
T Consensus 244 ~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~ 323 (573)
T 3uto_A 244 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 323 (573)
T ss_dssp HHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGC
T ss_pred HHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECcccc
Confidence 9864 467999999999999999999999999999999999999986654569999999998766555556678999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHHHhcccC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||++.+..|+.+ +|||||||++|+|++|++||.+.+....+ ..+......+ +.+..+|+++++||.+||++|
T Consensus 324 APEv~~~~~y~~~-~DiWSlGvilyeml~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~d 398 (573)
T 3uto_A 324 APEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETL----RNVKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 398 (573)
T ss_dssp CHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHH----HHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred CHHHhCCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCcCHHHHH----HHHHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 9999999888655 99999999999999999999987664443 3344444333 334578999999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 019901 235 PAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~ 253 (334)
|.+|||++|+|+||||+..
T Consensus 399 p~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 399 PNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp GGGSCCHHHHHHSTTTSCC
T ss_pred hhHCcCHHHHhcCcCcCCC
Confidence 9999999999999999763
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-55 Score=424.16 Aligned_cols=243 Identities=28% Similarity=0.442 Sum_probs=202.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHH---HHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~---Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| +|+++.+|+.| |||++.+... .....+.+ ++.+++.++|||||+++++|++.+.+|||||||.
T Consensus 197 LG~G~fG~V~la~~~~tg~~~-AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~ 275 (689)
T 3v5w_A 197 IGRGGFGEVYGCRKADTGKMY-AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 275 (689)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EecccCeEEEEEEECCCCCEE-EEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCC
Confidence 455555 58899999999 9999987642 22233334 4667778899999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
||+|..++.+.+.|++..++.|+.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.... ....+.+|
T Consensus 276 GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~--vKL~DFGlA~~~~~-~~~~t~~G 352 (689)
T 3v5w_A 276 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSK-KKPHASVG 352 (689)
T ss_dssp SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS-CCCCSCCS
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCC--EEecccceeeecCC-CCCCCccC
Confidence 9999999999999999999999999999999999999999999999999987775 99999999986533 34467799
Q ss_pred CCccccchhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
||.|||||++.+. .|+ .++|||||||++|+|++|++||.+..... ...+...+......+|. .+|+++++||.+|
T Consensus 353 Tp~YmAPEvl~~~~~y~-~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~~i~~~i~~~~~~~p~--~~S~~a~dLI~~l 428 (689)
T 3v5w_A 353 THGYMAPEVLQKGVAYD-SSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTMAVELPD--SFSPELRSLLEGL 428 (689)
T ss_dssp CGGGCCHHHHSTTCCCC-THHHHHHHHHHHHHHHHSSCTTCGGGCCC-HHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred CcCccCHHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHhhcCCCCCCCc--cCCHHHHHHHHHH
Confidence 9999999999754 554 55999999999999999999997644322 22344445555555543 5899999999999
Q ss_pred cccCCCCCCC-----HhHHhcCccccc
Q 019901 231 FVADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~s-----~~ell~h~~~~~ 252 (334)
|++||.+|++ ++|+++||||+.
T Consensus 429 L~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 429 LQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp TCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred ccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 9999999998 799999999964
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-55 Score=392.84 Aligned_cols=240 Identities=23% Similarity=0.355 Sum_probs=195.2
Q ss_pred CCccee---e-eeec-----CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF---Y-DRCS-----YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~~-----~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| + +++. .++..| |||+++.......+.+.+|+.++++++|||||++++++.+++.+|+|||||++
T Consensus 21 lG~G~fG~Vy~a~~~~~~~~~~~~~v-AvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~ 99 (299)
T 4asz_A 21 LGEGAFGKVFLAECYNLCPEQDKILV-AVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKH 99 (299)
T ss_dssp EEC--CCCEEEEEECSCC----CEEE-EEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTT
T ss_pred EeeCCCcEEEEEEECCcccCCCCEEE-EEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCC
Confidence 566665 3 4433 345666 99999876544557899999999999999999999999999999999999999
Q ss_pred CChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 73 GELFERICNA-------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 73 ~~L~~~l~~~-------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
|+|.+++.+. ..+++.++..++.||+.||.|||+++||||||||+|||++.++. +||+|||+|+.
T Consensus 100 G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~--~Ki~DFGla~~ 177 (299)
T 4asz_A 100 GDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL--VKIGDFGMSRD 177 (299)
T ss_dssp CBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHH
T ss_pred CcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc--EEECCccccee
Confidence 9999999764 35999999999999999999999999999999999999987765 99999999975
Q ss_pred CCCCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCC
Q 019901 140 SVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPD 215 (334)
Q Consensus 140 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (334)
..... ......||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+.+..+.... +.... ..+.
T Consensus 178 ~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k-~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~~~-~~~~ 251 (299)
T 4asz_A 178 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE-SDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC----ITQGR-VLQR 251 (299)
T ss_dssp HTGGGCEEETTTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHHTC-CCCC
T ss_pred cCCCCceeecCceecChhhcCHHHHcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcCC-CCCC
Confidence 33222 2234569999999999999888765 999999999999998 8999998765443332 22222 2334
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 ~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+..+|+++.+|+.+||+.+|.+|||++++ ++|+.+
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~ 286 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence 45689999999999999999999999998 456643
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=386.61 Aligned_cols=242 Identities=21% Similarity=0.320 Sum_probs=187.4
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +.+... ...| |||+++.... ...+.+.+|+.++++++|||||++++++.. +.+|||||||+||+|.+
T Consensus 44 iG~G~fG~Vy~~~~-~~~v-AvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~ 120 (307)
T 3omv_A 44 IGSGSFGTVYKGKW-HGDV-AVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYK 120 (307)
T ss_dssp CCCCSSSEEEEEES-SSEE-EEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHH
T ss_pred EeeCCCcEEEEEEE-CCcE-EEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHH
Confidence 677776 222222 2357 9999876542 223678999999999999999999998754 56899999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCC
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~ 153 (334)
++... +++++..+..++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+..... ....+.+||+
T Consensus 121 ~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 198 (307)
T 3omv_A 121 HLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLT--VKIGDFGLATVKSRWSGSQQVEQPTGSV 198 (307)
T ss_dssp HHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEE--EEECCCSSCBC------------CCCCT
T ss_pred HHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCc--EEEeeccCceecccCCcceeecccccCC
Confidence 99764 57999999999999999999999999999999999999987765 999999999854332 2234568999
Q ss_pred ccccchhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 154 AYIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 154 ~y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
.|||||++.+. .|+ .++|||||||++|||+||+.||.+.+........+......+.....+..+|+++.+|+.+|
T Consensus 199 ~ymAPE~l~~~~~~~y~-~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~c 277 (307)
T 3omv_A 199 LWMAPEVIRMQDNNPFS-FQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADC 277 (307)
T ss_dssp TSCCHHHHHCCSSCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHH
T ss_pred CccCHHHhhccCCCCCC-cHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHH
Confidence 99999999753 354 45999999999999999999998876654444333221111111122346899999999999
Q ss_pred cccCCCCCCCHhHHhcCcc
Q 019901 231 FVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~ 249 (334)
|+.+|.+|||+.+++++..
T Consensus 278 l~~dP~~RPs~~ei~~~Le 296 (307)
T 3omv_A 278 VKKVKEERPLFPQILSSIE 296 (307)
T ss_dssp TCSSSTTSCCHHHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHHHH
Confidence 9999999999999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-54 Score=390.28 Aligned_cols=226 Identities=23% Similarity=0.343 Sum_probs=184.0
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc----------
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------- 82 (334)
.++..| |||+++.......+.+.+|+.+|++++|||||++++++.+++.+|||||||++|+|.+++.+.
T Consensus 69 ~~~~~v-AvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~ 147 (329)
T 4aoj_A 69 QDKMLV-AVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGG 147 (329)
T ss_dssp --CEEE-EEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-------
T ss_pred CCCeEE-EEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCccccccccc
Confidence 356677 999998765445578999999999999999999999999999999999999999999999753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCc
Q 019901 83 -----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 154 (334)
Q Consensus 83 -----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~ 154 (334)
+++++.++..|+.||+.||.|||+++||||||||+|||++.++. +||+|||+|+...... .....+||+.
T Consensus 148 ~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ 225 (329)
T 4aoj_A 148 EDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV--VKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225 (329)
T ss_dssp ----CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC----------------CCCCGG
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc--EEEcccccceeccCCCcceecCccccccc
Confidence 35899999999999999999999999999999999999987765 9999999998543322 2234679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|||||++.+..++.+ +|||||||++|||+| |+.||.+.+..+.+.. +... ...+.+..+|+++.+|+.+||+.
T Consensus 226 ymAPE~~~~~~~~~~-sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~----i~~g-~~~~~p~~~~~~~~~li~~cl~~ 299 (329)
T 4aoj_A 226 WMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDC----ITQG-RELERPRACPPEVYAIMRGCWQR 299 (329)
T ss_dssp GCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHH----HHHT-CCCCCCTTCCHHHHHHHHHHCCS
T ss_pred ccChhhhcCCCCCcc-ccccchHHHHHHHHcCCCCCCCCCCHHHHHHH----HHcC-CCCCCcccccHHHHHHHHHHcCc
Confidence 999999999888655 999999999999998 8999998765443332 2222 23344456899999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
||.+|||++|++++
T Consensus 300 dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 300 EPQQRHSIKDVHAR 313 (329)
T ss_dssp STTTSCCHHHHHHH
T ss_pred ChhHCcCHHHHHHH
Confidence 99999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-54 Score=382.56 Aligned_cols=226 Identities=20% Similarity=0.329 Sum_probs=188.7
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc---------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------- 82 (334)
.++..| |||++..... ...+.+.+|+.++++++|||||++++++.+++.+++|||||++|+|.++|...
T Consensus 54 ~~~~~V-AvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~ 132 (308)
T 4gt4_A 54 EQTQAV-AIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST 132 (308)
T ss_dssp --CEEE-EEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC--
T ss_pred CCCeEE-EEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccc
Confidence 355667 9999976542 33478999999999999999999999999999999999999999999999653
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCC
Q 019901 83 -------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGT 152 (334)
Q Consensus 83 -------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt 152 (334)
..+++..+..++.||+.||.|||+++||||||||+|||++.++. +||+|||+|+..... ......+||
T Consensus 133 ~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--~Ki~DFGlar~~~~~~~~~~~~~~~gt 210 (308)
T 4gt4_A 133 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN--VKISDLGLFREVYAADYYKLLGNSLLP 210 (308)
T ss_dssp ---CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred ccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC--EEECCcccceeccCCCceeEecccccC
Confidence 35899999999999999999999999999999999999987765 999999999854332 223456799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+.|||||++.+..++.+ +|||||||++|||+| |..||.+.+..+... .+.. ....|.+..+|+++.+|+.+||
T Consensus 211 ~~ymAPE~l~~~~~s~k-sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~~~~li~~C~ 284 (308)
T 4gt4_A 211 IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE----MIRN-RQVLPCPDDCPAWVYALMIECW 284 (308)
T ss_dssp GGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHHT
T ss_pred CcccCHHHHhCCCCCcc-chhhhHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCcccchHHHHHHHHHHc
Confidence 99999999998888655 999999999999998 899999876543332 2222 2334555678999999999999
Q ss_pred ccCCCCCCCHhHHhcC
Q 019901 232 VADPAKRISIPEIRNH 247 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h 247 (334)
+.+|.+|||+.+++++
T Consensus 285 ~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 285 NEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CSSGGGSCCHHHHHHH
T ss_pred CCChhHCcCHHHHHHH
Confidence 9999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-52 Score=373.50 Aligned_cols=245 Identities=38% Similarity=0.647 Sum_probs=211.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| +|++..+|+.| |||++.+... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||+++++|
T Consensus 23 lG~G~~g~V~~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L 101 (328)
T 3fe3_A 23 IGKGNFAKVKLARHILTGREV-AIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101 (328)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBH
T ss_pred EeeCCCEEEEEEEECCCCCEE-EEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcH
Confidence 444544 48888999999 9999987652 2235688999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
.+++...+++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........+||+.|
T Consensus 102 ~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y 179 (328)
T 3fe3_A 102 FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMN--IKIADFGFSNEFTVGGKLDAFCGAPPY 179 (328)
T ss_dssp HHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTCCGGGSSSCGGGTTSSSGGG
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCC--EEEeeccCceecCCCCccccccCCcce
Confidence 999998889999999999999999999999999999999999999987765 999999999866555555667899999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.... ...+.......|. .+++++.+||.+||..||
T Consensus 180 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP 253 (328)
T 3fe3_A 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKEL----RERVLRGKYRIPF--YMSTDCENLLKRFLVLNP 253 (328)
T ss_dssp CCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHCCSST
T ss_pred eCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHH----HHHHHhCCCCCCC--CCCHHHHHHHHHHCCCCh
Confidence 9999999988877779999999999999999999988665332 3334444444443 479999999999999999
Q ss_pred CCCCCHhHHhcCccccccCC
Q 019901 236 AKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~~ 255 (334)
.+|||++|+++||||.....
T Consensus 254 ~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 254 IKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp TTSCCHHHHTTCTTTTTTCT
T ss_pred hHCcCHHHHhcCHhhcCCCc
Confidence 99999999999999976543
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-52 Score=379.43 Aligned_cols=238 Identities=20% Similarity=0.317 Sum_probs=192.4
Q ss_pred CCccee---e-eeecCCC-----CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCC-CCcccceEEEEc-CCeEEEEEec
Q 019901 2 LGFHNF---Y-DRCSYSS-----DLFVNIIIIVFHLW-QIDENVQREIINHRSLRH-PNIVRFKEVILT-PTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~-----~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~-~~~~~lv~e~ 69 (334)
||.|+| + |.+..++ +.| |||.+..... ...+.+.+|+.+|+++.| ||||++++++.. ++.+|+||||
T Consensus 72 LG~G~fG~Vy~a~~~~~~~~~~~k~V-AvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey 150 (353)
T 4ase_A 72 LGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 150 (353)
T ss_dssp EEECSSEEEEEEEEETSSSTTCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEEC
T ss_pred EecCCCeEEEEEEEcCCCcccCCeEE-EEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEc
Confidence 455555 3 5544433 455 9999976552 224578999999999965 899999999866 4679999999
Q ss_pred cCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEec
Q 019901 70 ASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 133 (334)
Q Consensus 70 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~D 133 (334)
|++|+|.++|.+. ..+++.++..++.||+.||.|||+++||||||||+|||++.++. +||+|
T Consensus 151 ~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~--vKi~D 228 (353)
T 4ase_A 151 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICD 228 (353)
T ss_dssp CTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECC
T ss_pred CCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCC--EEECc
Confidence 9999999999753 34899999999999999999999999999999999999987765 99999
Q ss_pred cCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhc
Q 019901 134 FGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSV 209 (334)
Q Consensus 134 fgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 209 (334)
||+|+....... ..+.+||+.|||||++.+..|+.+ +|||||||++|||+| |+.||.+......+...+. .
T Consensus 229 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~k-sDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~----~ 303 (353)
T 4ase_A 229 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK----E 303 (353)
T ss_dssp CGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----H
T ss_pred chhhhhcccCCCceeeccccccccccCHHHHhcCCCCCc-ccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHH----c
Confidence 999986533322 234579999999999999888655 999999999999998 9999988765554443332 2
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 210 ~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
...++.+..+++++.+++.+||+.||.+|||+.++++|
T Consensus 304 g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 304 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 23334445689999999999999999999999999987
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=368.73 Aligned_cols=243 Identities=30% Similarity=0.517 Sum_probs=207.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .++++.+|..| |||++.+.... ..+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+|.
T Consensus 25 fg~V~~~~~~~~~~~~-avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~ 103 (361)
T 2yab_A 25 FAIVKKCREKSTGLEY-AAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELF 103 (361)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHH
Confidence 3444 48888999999 99999886532 2367999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC--CCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++...........+||+.
T Consensus 104 ~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~ 183 (361)
T 2yab_A 104 DFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183 (361)
T ss_dssp HHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCcc
Confidence 99988888999999999999999999999999999999999999976552 2599999999987655555566789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~ 232 (334)
|+|||++.+..++.+ +|||||||++|+|++|.+||.+.+....+. .+......++ .+..+++.+++||.+||.
T Consensus 184 y~aPE~~~~~~~~~~-~DiwslGvil~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 258 (361)
T 2yab_A 184 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITAVSYDFDEEFFSQTSELAKDFIRKLLV 258 (361)
T ss_dssp GCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTSCHHHHHHHHHHSC
T ss_pred EECchHHcCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhcCCCCCchhccCCCHHHHHHHHHHCC
Confidence 999999988877655 999999999999999999998866543333 3333333332 235689999999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
.||.+|||+.++++||||..
T Consensus 259 ~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 259 KETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp SSTTTSCCHHHHHTSTTTSC
T ss_pred CChhHCcCHHHHhcCcCcCC
Confidence 99999999999999999964
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-50 Score=362.11 Aligned_cols=239 Identities=33% Similarity=0.575 Sum_probs=204.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+|+.| |||++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+|..++
T Consensus 18 fg~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l 96 (337)
T 1o6l_A 18 FGKVILVREKATGRYY-AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHL 96 (337)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHH
Confidence 4444 48888899999 999998753 234467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCccccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aP 158 (334)
.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .....+.+||+.|+||
T Consensus 97 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aP 174 (337)
T 1o6l_A 97 SRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTPEYLAP 174 (337)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECGGGCCG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCC--EEEeeccchhhcccCCCcccccccChhhCCh
Confidence 98889999999999999999999999999999999999999987765 99999999986433 2334566899999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+......+|. .+++++++||.+||+.+|.+|
T Consensus 175 E~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R 247 (337)
T 1o6l_A 175 EVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLF----ELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQR 247 (337)
T ss_dssp GGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHTCSSTTTS
T ss_pred hhhcCCCCCch-hhcccchhHHHHHhcCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHHh
Confidence 99988887655 99999999999999999999876553333 333344444443 589999999999999999999
Q ss_pred C-----CHhHHhcCccccc
Q 019901 239 I-----SIPEIRNHEWFLK 252 (334)
Q Consensus 239 ~-----s~~ell~h~~~~~ 252 (334)
| +++++++||||..
T Consensus 248 ~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 248 LGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp TTCSTTTHHHHHTSGGGTT
T ss_pred cCCCCCCHHHHHcCCCcCC
Confidence 9 8999999999964
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=354.73 Aligned_cols=243 Identities=25% Similarity=0.383 Sum_probs=205.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||++ .+++..+|+.| |||++........+.+.+|+.+++.++||||+++++++..++..|+||||+.|++|.+++.+.
T Consensus 33 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 111 (297)
T 3fxz_A 33 SGTVYTAMDVATGQEV-AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET 111 (297)
T ss_dssp TEEEEEEEBTTTCCEE-EEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS
T ss_pred CeEEEEEEECCCCcEE-EEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc
Confidence 4444 47788999999 999998776556678999999999999999999999999999999999999999999998765
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~y~aPE~~ 161 (334)
.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... ....+||+.|+|||++
T Consensus 112 -~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 188 (297)
T 3fxz_A 112 -CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188 (297)
T ss_dssp -CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHH
T ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCC--EEEeeCCCceecCCcccccCCccCCcCccChhhh
Confidence 6999999999999999999999999999999999999987765 99999999876543332 3445799999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCH
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISI 241 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~ 241 (334)
.+..++.+ +|||||||++|+|++|+.||.+............ ......+....+++.+.+||.+||+.||.+|||+
T Consensus 189 ~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~ 264 (297)
T 3fxz_A 189 TRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSA 264 (297)
T ss_dssp HCSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred cCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---CCCCCCCCccccCHHHHHHHHHHccCChhHCcCH
Confidence 98888655 9999999999999999999987665443332221 2222333344689999999999999999999999
Q ss_pred hHHhcCccccccC
Q 019901 242 PEIRNHEWFLKNL 254 (334)
Q Consensus 242 ~ell~h~~~~~~~ 254 (334)
+++++||||+...
T Consensus 265 ~ell~h~~~~~~~ 277 (297)
T 3fxz_A 265 KELLQHQFLKIAK 277 (297)
T ss_dssp HHHTTCGGGGGCC
T ss_pred HHHhhChhhcccC
Confidence 9999999997644
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-50 Score=363.54 Aligned_cols=243 Identities=44% Similarity=0.748 Sum_probs=206.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .|.+..+|+.| |||++.+.. ......+.+|+.+++.++||||+++++++.+++..++||||+ +|+|.+++
T Consensus 22 ~g~V~~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l 99 (336)
T 3h4j_B 22 FGKVKLATHYKTQQKV-ALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYI 99 (336)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHH
Confidence 3444 48888999999 999998653 234568999999999999999999999999999999999999 78999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
...+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...........+||+.|+|||
T Consensus 100 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE 177 (336)
T 3h4j_B 100 VEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLN--VKIADFGLSNIMTDGNFLKTSCGSPNYAAPE 177 (336)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCC--EEECCSSCTBTTTTSBTTCCCTTSTTTSCGG
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCC--EEEEEeccceeccCCcccccccCCcCcCCHH
Confidence 88889999999999999999999999999999999999999987765 9999999998766555566778999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..+.+.++|||||||++|+|++|+.||.+........ .+....... +..+|+++.+||.+||+.||.+||
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~Rp 251 (336)
T 3h4j_B 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFK----KVNSCVYVM--PDFLSPGAQSLIRRMIVADPMQRI 251 (336)
T ss_dssp GSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBC----CCCSSCCCC--CTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred HHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHH----HHHcCCCCC--cccCCHHHHHHHHHHcCCChhHCc
Confidence 99888876667999999999999999999998654322111 111122222 335799999999999999999999
Q ss_pred CHhHHhcCccccccCCC
Q 019901 240 SIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 240 s~~ell~h~~~~~~~~~ 256 (334)
|++|+++||||+...+.
T Consensus 252 t~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 252 TIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp CHHHHTTCHHHHTTCCG
T ss_pred CHHHHHhChhhccCCcc
Confidence 99999999999876653
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=374.15 Aligned_cols=245 Identities=34% Similarity=0.598 Sum_probs=206.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .+.++.+|+.+ |+|++.+.... ..+.+.+|+.+++.++||||+++++++.+++..|+|||||.||+|
T Consensus 19 LG~G~fg~V~~~~~~~~~~~~-a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L 97 (444)
T 3soa_A 19 LGKGAFSVVRRCVKVLAGQEY-AAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97 (444)
T ss_dssp EEEC--CEEEEEEETTTTEEE-EEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBH
T ss_pred eccCCCeEEEEEEECCCCcEE-EEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCH
Confidence 455555 37788999999 99999876532 235788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCC-CCCccCCC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQ-PKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~ 153 (334)
.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+....... ....+||+
T Consensus 98 ~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~ 177 (444)
T 3soa_A 98 FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTP 177 (444)
T ss_dssp HHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCG
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCc
Confidence 9999998999999999999999999999999999999999999999753 234699999999976543332 34567999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L 231 (334)
.|+|||++.+..++.+ +|||||||++|+|++|.+||.+......+.. +.... ...+.+..+++++++||.+||
T Consensus 178 ~Y~APE~l~~~~~~~~-~DIwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L 252 (444)
T 3soa_A 178 GYLSPEVLRKDPYGKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQ----IKAGAYDFPSPEWDTVTPEAKDLINKML 252 (444)
T ss_dssp GGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH----HHHTCCCCCTTTTTTSCHHHHHHHHHHS
T ss_pred ccCCHHHhcCCCCCCc-cccHHHHHHHHHHHhCCCCCCCccHHHHHHH----HHhCCCCCCccccccCCHHHHHHHHHHc
Confidence 9999999988888655 9999999999999999999988665443333 33333 334445678999999999999
Q ss_pred ccCCCCCCCHhHHhcCccccc
Q 019901 232 VADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~ 252 (334)
+.||.+|||+.|+|+||||..
T Consensus 253 ~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 253 TINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp CSSTTTSCCHHHHHHSCTTHH
T ss_pred CCChhHCCCHHHHhcCccccC
Confidence 999999999999999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=364.37 Aligned_cols=243 Identities=33% Similarity=0.567 Sum_probs=206.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||.+ .+.++.+|..| |||++...... ..+.+.+|+.+++.++||||+++++++.+++..|+||||+.||+|.+.+.
T Consensus 42 ~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~ 120 (362)
T 2bdw_A 42 FSVVRRCVHKTTGLEF-AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120 (362)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHT
T ss_pred CeEEEEEEECCCCCEE-EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHH
Confidence 4444 37888899999 99999876532 23578899999999999999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
..+.+++..++.++.||+.||.|||++||+||||||+|||++..+. ..+||+|||+++...........+||+.|+|||
T Consensus 121 ~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE 200 (362)
T 2bdw_A 121 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 200 (362)
T ss_dssp TCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHH
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHH
Confidence 8888999999999999999999999999999999999999976432 459999999998765554455678999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
++.+..++.+ +|||||||++|+|++|++||.+.+...... .+...... .+.+..+++++++||.+||+.||.+
T Consensus 201 ~~~~~~~~~~-~DiwslG~il~~ll~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 275 (362)
T 2bdw_A 201 VLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYA----QIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKK 275 (362)
T ss_dssp HHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGG
T ss_pred HHccCCCCch-hhHHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhh
Confidence 9988877655 999999999999999999998766533332 23333333 3334568999999999999999999
Q ss_pred CCCHhHHhcCccccc
Q 019901 238 RISIPEIRNHEWFLK 252 (334)
Q Consensus 238 R~s~~ell~h~~~~~ 252 (334)
|||+.++|+||||..
T Consensus 276 R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 276 RITADQALKVPWICN 290 (362)
T ss_dssp SCCHHHHTTSHHHHT
T ss_pred CcCHHHHhcCcccCC
Confidence 999999999999965
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-50 Score=365.34 Aligned_cols=239 Identities=31% Similarity=0.507 Sum_probs=201.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.+|+.| |||++.+.. ....+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||+.||+|..+
T Consensus 36 fg~V~~~~~~~~~~~~-AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 114 (353)
T 3txo_A 36 FGKVMLARVKETGDLY-AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFH 114 (353)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CEEEEEEEEcCCCCEE-EEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 4444 47888899999 999998753 13346788999999988 799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|+|
T Consensus 115 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 192 (353)
T 3txo_A 115 IQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGH--CKLADFGMCKEGICNGVTTATFCGTPDYIA 192 (353)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCC---------CCGGGCC
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCC--EEEccccceeecccCCccccccCCCcCeEC
Confidence 999889999999999999999999999999999999999999987765 999999999854332 33445689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|++||.+.+....+ ..+......+|. .+++++.+||.+||+++|.+
T Consensus 193 PE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~~~~~~~li~~lL~~dP~~ 265 (353)
T 3txo_A 193 PEILQEMLYGPA-VDWWAMGVLLYEMLCGHAPFEAENEDDLF----EAILNDEVVYPT--WLHEDATGILKSFMTKNPTM 265 (353)
T ss_dssp HHHHHHHHCTTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHTCSSGGG
T ss_pred hhhcCCCCcCCc-cCCCcchHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCC--CCCHHHHHHHHHHhhhCHHH
Confidence 999988888655 99999999999999999999887654433 334444555554 47999999999999999999
Q ss_pred CCCH------hHHhcCccccc
Q 019901 238 RISI------PEIRNHEWFLK 252 (334)
Q Consensus 238 R~s~------~ell~h~~~~~ 252 (334)
||++ +++++||||..
T Consensus 266 R~~~~~~~~~~~il~hp~f~~ 286 (353)
T 3txo_A 266 RLGSLTQGGEHAILRHPFFKE 286 (353)
T ss_dssp STTSGGGTCTHHHHTSGGGTT
T ss_pred ccCCcccCCHHHHhhCCcccC
Confidence 9998 89999999964
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=364.72 Aligned_cols=243 Identities=24% Similarity=0.407 Sum_probs=205.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .+.++.++..| |+|++.... .....+.+|+.+++.++||||+++++++.+.+.+++|||||+|++|.+++...
T Consensus 18 ~g~Vy~~~~~~~~~~~-a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~ 95 (321)
T 1tki_A 18 FGIVHRCVETSSKKTY-MAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS 95 (321)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSS
T ss_pred CeEEEEEEECCCCcEE-EEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhc
Confidence 3444 47888889998 999997655 44567899999999999999999999999999999999999999999999765
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 83 G-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
+ .+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+++............||+.|+|||++
T Consensus 96 ~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 175 (321)
T 1tki_A 96 AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175 (321)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHh
Confidence 3 699999999999999999999999999999999999998744456999999999865544444456799999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
.+..++. ++|||||||++|+|++|..||.+......... +......++ .+..+|+++.+||.+||..||.+||
T Consensus 176 ~~~~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp 250 (321)
T 1tki_A 176 QHDVVST-ATDMWSLGTLVYVLLSGINPFLAETNQQIIEN----IMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM 250 (321)
T ss_dssp TTCEECH-HHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCc-hhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHH----HHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc
Confidence 8876654 49999999999999999999988765443333 333333322 2346899999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
|+.|+|+||||++.
T Consensus 251 t~~e~l~hp~~~~~ 264 (321)
T 1tki_A 251 TASEALQHPWLKQK 264 (321)
T ss_dssp CHHHHHHSHHHHSC
T ss_pred CHHHHhcChhhccC
Confidence 99999999999764
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=366.77 Aligned_cols=243 Identities=27% Similarity=0.480 Sum_probs=202.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.+++.| |||++.+... ...+.+.+|+.+++++ +||||++++++|.+.+.+|+||||+.||+|..+
T Consensus 65 fG~V~~~~~~~~~~~~-AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 143 (396)
T 4dc2_A 65 YAKVLLVRLKKTDRIY-AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 143 (396)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHH
Confidence 4444 47888888888 9999987652 2335688999999876 899999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-CCCCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+... ......+.+||+.|+|
T Consensus 144 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~gt~~Y~a 221 (396)
T 4dc2_A 144 MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221 (396)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCBCGGGCC
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCC--EEEeecceeeecccCCCccccccCCcccCC
Confidence 998889999999999999999999999999999999999999987765 9999999998633 3334456789999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH-----HHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----NFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
||++.+..++.+ +|||||||++|+|++|++||....... ........+......+|. .+++++++||.+||+
T Consensus 222 PE~l~~~~~~~~-~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 298 (396)
T 4dc2_A 222 PEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLN 298 (396)
T ss_dssp HHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred chhhcCCCCChH-HHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCC--cCCHHHHHHHHHHhc
Confidence 999998888655 999999999999999999997432211 112233344444555544 589999999999999
Q ss_pred cCCCCCCCH------hHHhcCccccc
Q 019901 233 ADPAKRISI------PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~------~ell~h~~~~~ 252 (334)
.||.+||++ +++++||||+.
T Consensus 299 ~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 299 KDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCHhHcCCCCCCCCHHHHhcCccccC
Confidence 999999985 79999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=358.97 Aligned_cols=245 Identities=31% Similarity=0.565 Sum_probs=206.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .++++.+|..| |||++.+.... ..+.+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 19 lG~G~~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 97 (326)
T 2y0a_A 19 LGSGQFAVVKKCREKSTGLQY-AAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97 (326)
T ss_dssp EECCSSEEEEEEEETTTCCEE-EEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EeeCCCeEEEEEEECCCCcEE-EEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCC
Confidence 454544 47888899999 99999876522 24679999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC--CCCEEEeccCCccCCCCCCCCCCc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~--~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++...........
T Consensus 98 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 177 (326)
T 2y0a_A 98 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 177 (326)
T ss_dssp SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCC
T ss_pred CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccc
Confidence 999999998888899999999999999999999999999999999999997655 125999999999866554455567
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLI 227 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 227 (334)
+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+.. +.......+ .+..+++.+.+||
T Consensus 178 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li 252 (326)
T 2y0a_A 178 FGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLAN----VSAVNYEFEDEYFSNTSALAKDFI 252 (326)
T ss_dssp CSCTTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHTCCCCCHHHHTTSCHHHHHHH
T ss_pred cCCcCcCCceeecCCCCCcH-HHHHHHHHHHHHHHHCcCCCCCCCHHHHHHH----HHhcCCCcCccccccCCHHHHHHH
Confidence 89999999999988777655 9999999999999999999987665433332 222222222 2346799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||+.+|.+|||++++|+||||+.
T Consensus 253 ~~~L~~dP~~Rpt~~e~l~hp~~~~ 277 (326)
T 2y0a_A 253 RRLLVKDPKKRMTIQDSLQHPWIKP 277 (326)
T ss_dssp HHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred HHHccCChhhCCCHHHHhcCCCccC
Confidence 9999999999999999999999964
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=354.41 Aligned_cols=237 Identities=30% Similarity=0.566 Sum_probs=204.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+|+.| |||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+|.+++
T Consensus 19 ~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l 97 (318)
T 1fot_A 19 FGRVHLIRSRHNGRYY-AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLL 97 (318)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHH
Confidence 3444 47888899999 999998754 234467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ...+.+||+.|+|||
T Consensus 98 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE 173 (318)
T 1fot_A 98 RKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTYTLCGTPDYIAPE 173 (318)
T ss_dssp HHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBCCCCSCTTTCCHH
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCC--EEEeecCcceecCC--ccccccCCccccCHh
Confidence 99889999999999999999999999999999999999999987765 99999999985432 334568999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+......+| ..++++++++|.+||..+|.+||
T Consensus 174 ~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~ 246 (318)
T 1fot_A 174 VVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTYE----KILNAELRFP--PFFNEDVKDLLSRLITRDLSQRL 246 (318)
T ss_dssp HHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHHHHHHTCSCTTTCT
T ss_pred HhcCCCCCcc-cchhhhHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHHHHHHhccCHHHcC
Confidence 9988888655 999999999999999999998766543333 3444444444 35799999999999999999999
Q ss_pred -----CHhHHhcCccccc
Q 019901 240 -----SIPEIRNHEWFLK 252 (334)
Q Consensus 240 -----s~~ell~h~~~~~ 252 (334)
+++++++||||+.
T Consensus 247 ~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 247 GNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp TSSTTTTHHHHTSGGGSS
T ss_pred CCcCCCHHHHhcCccccC
Confidence 8999999999964
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=373.63 Aligned_cols=246 Identities=40% Similarity=0.739 Sum_probs=211.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .+++..+|+.| |||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+
T Consensus 24 LG~G~fg~V~~a~~~~~g~~v-AvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~ 102 (476)
T 2y94_A 24 LGVGTFGKVKVGKHELTGHKV-AVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102 (476)
T ss_dssp EECCSSSCEEEEEETTTCCEE-EEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEE
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCc
Confidence 455554 48888899999 9999987542 234678999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.........+.+||+.
T Consensus 103 L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~--vkL~DFG~a~~~~~~~~~~~~~gt~~ 180 (476)
T 2y94_A 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPN 180 (476)
T ss_dssp HHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCC--EEECCCSSCEECCTTCCBCCCCSCST
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCC--eEEEeccchhhccccccccccCCCcC
Confidence 9999988888999999999999999999999999999999999999987765 99999999987655555566789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..+.+.++|||||||++|+|++|+.||.+........ .+.......| ..+++++.+||.+||+.|
T Consensus 181 y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~s~~~~~Li~~~L~~d 254 (476)
T 2y94_A 181 YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK----KICDGIFYTP--QYLNPSVISLLKHMLQVD 254 (476)
T ss_dssp TCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH----HHHTTCCCCC--TTCCHHHHHHHHHHTCSS
T ss_pred eEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH----HHhcCCcCCC--ccCCHHHHHHHHHHcCCC
Confidence 9999999988877777999999999999999999998766544333 3333333333 357999999999999999
Q ss_pred CCCCCCHhHHhcCccccccCCC
Q 019901 235 PAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~~~ 256 (334)
|.+|||++++++||||++..+.
T Consensus 255 P~~Rpt~~eil~hp~~~~~~~~ 276 (476)
T 2y94_A 255 PMKRATIKDIREHEWFKQDLPK 276 (476)
T ss_dssp TTTSCCHHHHHTCHHHHTTCCT
T ss_pred chhCcCHHHHHhCHHhhhcCcc
Confidence 9999999999999999876543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=360.59 Aligned_cols=241 Identities=22% Similarity=0.268 Sum_probs=176.2
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC----eEEEEEeccCCCCh
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e~~~~~~L 75 (334)
||.|+| +.+...+|+.| |||++.... ......+.|+..+.+++|||||++++++..++ .+|||||||++|+|
T Consensus 11 iG~G~fG~Vy~~~~~g~~V-AvK~l~~~~-~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL 88 (303)
T 3hmm_A 11 IGKGRFGEVWRGKWRGEEV-AVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp EEECSSSEEEEEEETTEEE-EEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred EeeCCCeEEEEEEECCEEE-EEEEECccc-hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcH
Confidence 455555 33444578888 999997654 22233445667778899999999999998653 68999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC--------CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 144 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~--------~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--- 144 (334)
.+++.+. ++++..+..++.|++.||+|||++ |||||||||+|||++.++. +||+|||+|+......
T Consensus 89 ~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~--~Ki~DFGla~~~~~~~~~~ 165 (303)
T 3hmm_A 89 FDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp HHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEE
T ss_pred HHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCC--EEEEeCCCCccccCCCCce
Confidence 9999764 589999999999999999999987 9999999999999987765 9999999997543322
Q ss_pred --CCCCccCCCccccchhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCCCCCc----------hH-HHHHHHHHH
Q 019901 145 --QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEE----------PK-NFRKTIHRI 206 (334)
Q Consensus 145 --~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~-~~~~~~~~~ 206 (334)
...+.+||+.|||||++.+... .+.++|||||||++|||+||.+||..... .. ........+
T Consensus 166 ~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 245 (303)
T 3hmm_A 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp SCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHH
Confidence 2234579999999999976421 13459999999999999999877643221 10 111222222
Q ss_pred hhcccc--CCCC---CCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 207 LSVQYS--IPDY---VHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 207 ~~~~~~--~~~~---~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.....+ +|.. ...++.+.+|+.+||+.||.+|||+.|+++.
T Consensus 246 ~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 222221 2211 1123578899999999999999999999853
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=365.52 Aligned_cols=244 Identities=25% Similarity=0.442 Sum_probs=206.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .+.++.+|+.| |+|++..........+.+|+.+++.++||||+++++++.+.+.+++||||+.|++|.+++...
T Consensus 64 ~g~Vy~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 142 (387)
T 1kob_A 64 FGVVHRCVEKATGRVF-VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE 142 (387)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCT
T ss_pred CEEEEEEEECCCCCEE-EEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhh
Confidence 4444 47888899988 999998765344567899999999999999999999999999999999999999999998765
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 83 G-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+.+||+|||+++...........+||+.|+|||++
T Consensus 143 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~ 222 (387)
T 1kob_A 143 DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV 222 (387)
T ss_dssp TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhc
Confidence 4 699999999999999999999999999999999999998655556999999999866544444456799999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
.+..++.+ +|||||||++|+|++|..||.+......+.. +...... .+.+..+++++.+||.+||+.||.+||
T Consensus 223 ~~~~~~~~-~DiwSlG~il~elltg~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp 297 (387)
T 1kob_A 223 DREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL 297 (387)
T ss_dssp TTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCCc-ccEeeHhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCc
Confidence 88777655 9999999999999999999988665433332 2232222 233456899999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
|+.++|+||||+..
T Consensus 298 t~~ell~hp~~~~~ 311 (387)
T 1kob_A 298 TVHDALEHPWLKGD 311 (387)
T ss_dssp CHHHHHTSTTTSSC
T ss_pred CHHHHhhCccccCC
Confidence 99999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=365.38 Aligned_cols=245 Identities=29% Similarity=0.494 Sum_probs=205.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .+++..+|..| |||++........+.+.+|+.+++.++||||+++++++...+.+++||||+++++|.+
T Consensus 97 lG~G~~g~Vy~a~~~~~g~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~ 175 (373)
T 2x4f_A 97 LGGGRFGQVHKCEETATGLKL-AAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD 175 (373)
T ss_dssp CC-----CEEEEEETTTCCEE-EEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHH
T ss_pred EecCcCEEEEEEEEcCCCcEE-EEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHH
Confidence 676666 47788899998 9999987664556789999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+..+++||+|||+++...........+||+.|+
T Consensus 176 ~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~ 255 (373)
T 2x4f_A 176 RIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFL 255 (373)
T ss_dssp HHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEe
Confidence 88654 46999999999999999999999999999999999999954444469999999998765555555667999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHHHhcccC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||++.+..++.+ +|||||||++|+|++|+.||.+......+..+ ......+ +.+..+++++++||.+||+.+
T Consensus 256 aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~~~~~~~li~~~L~~d 330 (373)
T 2x4f_A 256 APEVVNYDFVSFP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNI----LACRWDLEDEEFQDISEEAKEFISKLLIKE 330 (373)
T ss_dssp CHHHHTTCBCCHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH----HHTCCCSCSGGGTTSCHHHHHHHHTTSCSS
T ss_pred ChhhccCCCCCcH-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HhccCCCChhhhccCCHHHHHHHHHHcCCC
Confidence 9999987776544 99999999999999999999987665444433 2222222 233568999999999999999
Q ss_pred CCCCCCHhHHhcCccccc
Q 019901 235 PAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~ 252 (334)
|.+|||+.++|+||||..
T Consensus 331 p~~Rps~~e~l~hp~~~~ 348 (373)
T 2x4f_A 331 KSWRISASEALKHPWLSD 348 (373)
T ss_dssp GGGSCCHHHHHHSHHHHC
T ss_pred hhhCCCHHHHhcCcCcCC
Confidence 999999999999999965
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=359.09 Aligned_cols=239 Identities=33% Similarity=0.554 Sum_probs=203.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.+|+.| |||++.+.. ....+.+.+|..+++.+ +||||+++++++.+.+.+|+||||+.||+|.++
T Consensus 30 fg~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 108 (345)
T 1xjd_A 30 FGKVFLAEFKKTNQFF-AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYH 108 (345)
T ss_dssp SSEEEEEEETTTTEEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 4444 48888899998 999998754 13346788899999876 999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .......+||+.|+|
T Consensus 109 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 186 (345)
T 1xjd_A 109 IQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186 (345)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCC--EEEeEChhhhhcccCCCcccCCCCCcccCC
Confidence 998888999999999999999999999999999999999999987765 99999999986432 233456689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ ..+......+|. .+++++++||.+||..+|.+
T Consensus 187 PE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~lL~~dp~~ 259 (345)
T 1xjd_A 187 PEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNPFYPR--WLEKEAKDLLVKLFVREPEK 259 (345)
T ss_dssp HHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHSCSSGGG
T ss_pred hhhhcCCCCCCh-hhhHHHHHHHHHHhcCCCCCCCCCHHHHH----HHHHhCCCCCCc--ccCHHHHHHHHHHhcCCHhH
Confidence 999988887655 99999999999999999999876654333 333344444443 47999999999999999999
Q ss_pred CCCHh-HHhcCccccc
Q 019901 238 RISIP-EIRNHEWFLK 252 (334)
Q Consensus 238 R~s~~-ell~h~~~~~ 252 (334)
||++. ++++||||..
T Consensus 260 R~~~~~~i~~hp~f~~ 275 (345)
T 1xjd_A 260 RLGVRGDIRQHPLFRE 275 (345)
T ss_dssp SBTTBSCGGGSGGGTT
T ss_pred cCCChHHHHcCccccC
Confidence 99998 9999999964
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=355.91 Aligned_cols=243 Identities=27% Similarity=0.480 Sum_probs=201.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.+++.| |||++.+.... ..+.+.+|+.+++.+ +||||+++++++.+.+.+|+||||+.||+|..+
T Consensus 22 fg~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~ 100 (345)
T 3a8x_A 22 YAKVLLVRLKKTDRIY-AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100 (345)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 3444 47888889988 99999876532 234678899999887 899999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .......+||+.|+|
T Consensus 101 l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFG~a~~~~~~~~~~~~~~gt~~y~a 178 (345)
T 3a8x_A 101 MQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGH--IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178 (345)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCGGGCBCSCCTTCCBCCCCSCGGGCC
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEEeccccccccCCCCcccccCCCccccC
Confidence 998888999999999999999999999999999999999999987765 99999999986432 233455689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-----HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
||++.+..++.+ +|||||||++|+|++|+.||...... .........+......+|. .+++++++||.+||+
T Consensus 179 PE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 255 (345)
T 3a8x_A 179 PEILRGEDYGFS-VDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFLN 255 (345)
T ss_dssp HHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTC
T ss_pred ccccCCCCCChH-HhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhc
Confidence 999988887655 99999999999999999999753211 1112223334444444443 589999999999999
Q ss_pred cCCCCCCCH------hHHhcCccccc
Q 019901 233 ADPAKRISI------PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~------~ell~h~~~~~ 252 (334)
.+|.+||++ +++++||||..
T Consensus 256 ~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 256 KDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 999999995 89999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-49 Score=361.15 Aligned_cols=242 Identities=23% Similarity=0.396 Sum_probs=204.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+++.| |||++.+.. ......+.+|+.+++.++||||++++++|.+.+.+|+||||+.||+|..++
T Consensus 28 fG~V~~~~~~~~~~~~-AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l 106 (384)
T 4fr4_A 28 FGKVCIVQKNDTKKMY-AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL 106 (384)
T ss_dssp TCCEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHH
Confidence 3444 48888899999 999998754 233467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...........+||+.|+|||
T Consensus 107 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 107 QQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH--VHITDFNIAAMLPRETQITTMAGTKPYMAPE 184 (384)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCCCCSCGGGCCGG
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCC--EEEeccceeeeccCCCceeccCCCccccCCe
Confidence 98889999999999999999999999999999999999999987765 9999999998765555556778999999999
Q ss_pred hhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 160 VLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 160 ~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
++.+ ..++. ++|||||||++|+|++|+.||....... .......+.......| ..+++.+.+||.+||+.+|.
T Consensus 185 ~~~~~~~~~~~~-~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~~~~~~~~~~~~p--~~~s~~~~~li~~lL~~dP~ 260 (384)
T 4fr4_A 185 MFSSRKGAGYSF-AVDWWSLGVTAYELLRGRRPYHIRSSTS-SKEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPD 260 (384)
T ss_dssp GTCCCSSCCBCT-THHHHHHHHHHHHHHHSSCSSCCCTTSC-HHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSSGG
T ss_pred eeccCCCCCCCc-cceeechHHHHHHHHhCCCCCCCCCCcc-HHHHHHHHhhcccCCC--CcCCHHHHHHHHHHhcCCHh
Confidence 9964 33544 4999999999999999999998644322 2233333333333333 35799999999999999999
Q ss_pred CCCC-HhHHhcCccccc
Q 019901 237 KRIS-IPEIRNHEWFLK 252 (334)
Q Consensus 237 ~R~s-~~ell~h~~~~~ 252 (334)
+||+ ++++++||||..
T Consensus 261 ~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 261 QRFSQLSDVQNFPYMND 277 (384)
T ss_dssp GSCCSHHHHHTSGGGTT
T ss_pred HhcccHHHHHcChhhhc
Confidence 9998 899999999964
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=356.15 Aligned_cols=246 Identities=32% Similarity=0.560 Sum_probs=203.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .+++..+++.| |||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+|||||.+++|.+++..
T Consensus 20 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (323)
T 3tki_A 20 YGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (323)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBT
T ss_pred CEEEEEEEECCCCcEE-EEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhh
Confidence 4444 47888899999 9999976542 3346789999999999999999999999999999999999999999999988
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccc
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aP 158 (334)
...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.|+||
T Consensus 99 ~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP 176 (323)
T 3tki_A 99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176 (323)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCSCCSCGGGSCH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCC--EEEEEeeccceeccCCcccccCCCccCcCccCc
Confidence 888999999999999999999999999999999999999987665 999999999743222 223456799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..+.+.++|||||||++|+|++|+.||........... .........+.+..+++.+.+||.+||+.+|.+|
T Consensus 177 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 253 (323)
T 3tki_A 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (323)
T ss_dssp HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HHhcccccCCccccCCHHHHHHHHHHccCChhhC
Confidence 9998887766669999999999999999999987655332222 1222233334445689999999999999999999
Q ss_pred CCHhHHhcCccccccCC
Q 019901 239 ISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 239 ~s~~ell~h~~~~~~~~ 255 (334)
||++|+++||||.+...
T Consensus 254 ~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 254 ITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp CCHHHHTTCTTTTCCCC
T ss_pred cCHHHHhhChhhccccc
Confidence 99999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.39 Aligned_cols=237 Identities=30% Similarity=0.538 Sum_probs=204.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+|+.| |||++.+... ...+.+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+|.+++
T Consensus 54 ~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l 132 (350)
T 1rdq_E 54 FGRVMLVKHKESGNHY-AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHL 132 (350)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CcEEEEEEECCCCCEE-EEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHH
Confidence 4444 48888899999 9999987542 34467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ...+.+||+.|+|||
T Consensus 133 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~--~kL~DFg~a~~~~~--~~~~~~gt~~y~aPE 208 (350)
T 1rdq_E 133 RRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTWTLCGTPEALAPE 208 (350)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBCCCEECGGGCCHH
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCC--EEEcccccceeccC--CcccccCCccccCHH
Confidence 98889999999999999999999999999999999999999987765 99999999985432 234568999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++.+ +|||||||++|+|++|++||.+......+ ..+......+| ..+++++.++|.+||+.+|.+||
T Consensus 209 ~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~~~~~~~li~~lL~~dp~~R~ 281 (350)
T 1rdq_E 209 IILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp HHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHHHHHHHSCSCTTTCT
T ss_pred HhcCCCCCCc-CCEecccHhHhHHhhCCCCCCCCCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHhhcCHHhcc
Confidence 9988887655 99999999999999999999876654333 33444444444 35899999999999999999999
Q ss_pred C-----HhHHhcCccccc
Q 019901 240 S-----IPEIRNHEWFLK 252 (334)
Q Consensus 240 s-----~~ell~h~~~~~ 252 (334)
+ ++++++||||..
T Consensus 282 ~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 282 GNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TSSTTTTHHHHTSGGGTT
T ss_pred CCccCCHHHHHhCcCcCC
Confidence 8 999999999954
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=344.37 Aligned_cols=246 Identities=22% Similarity=0.388 Sum_probs=194.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||++ .++++.+|+.| |||++...... ....+.+|+.+++.++||||+++++++.+++.+++||||+.+ ++...+.
T Consensus 15 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 92 (292)
T 3o0g_A 15 YGTVFKAKNRETHEIV-ALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFD 92 (292)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHH
T ss_pred CeEEEEEEECCCCceE-EEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHH
Confidence 3444 48888899999 99999876522 236788999999999999999999999999999999999976 5555554
Q ss_pred -hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccccc
Q 019901 81 -NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAP 158 (334)
Q Consensus 81 -~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aP 158 (334)
..+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+||
T Consensus 93 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 170 (292)
T 3o0g_A 93 SCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLWYRPP 170 (292)
T ss_dssp HTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCSCCSCCCSCCSCGGGCCH
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEeecccceecCCccccccCCccccCCcCh
Confidence 4678999999999999999999999999999999999999987765 999999999754332 223455789999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCC-CCCCchHHHHHHHHHHhhcccc-----------------------CC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF-EDPEEPKNFRKTIHRILSVQYS-----------------------IP 214 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-----------------------~~ 214 (334)
|++.+....+.++|||||||++|+|++|..|| .+......+............. ..
T Consensus 171 E~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (292)
T 3o0g_A 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVN 250 (292)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTT
T ss_pred HHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhh
Confidence 99987774455699999999999999887775 4443333333333221111000 01
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+++.+++||.+||+.||.+|||++|+++||||.+.
T Consensus 251 ~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 251 VVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp TSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred cccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 122478999999999999999999999999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.46 Aligned_cols=239 Identities=30% Similarity=0.511 Sum_probs=203.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.+|+.| |||++.+... ...+.+.+|..+++.+ +||||+++++++.+.+.+|+||||+.||+|.++
T Consensus 33 fg~V~~~~~~~~~~~~-AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 111 (353)
T 2i0e_A 33 FGKVMLSERKGTDELY-AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYH 111 (353)
T ss_dssp TEEEEEEEETTEEEEE-EEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHH
Confidence 4444 47888888888 9999987541 3346788999999988 799999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .......+||+.|+|
T Consensus 112 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--vkL~DFG~a~~~~~~~~~~~~~~gt~~y~a 189 (353)
T 2i0e_A 112 IQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGTPDYIA 189 (353)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSCGGGCC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCc--EEEEeCCcccccccCCcccccccCCccccC
Confidence 998888999999999999999999999999999999999999987765 99999999986432 233456689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|++||.+.+....+ ..+......+|. .+++++++||.+||..+|.+
T Consensus 190 PE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~ 262 (353)
T 2i0e_A 190 PEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDELF----QSIMEHNVAYPK--SMSKEAVAICKGLMTKHPGK 262 (353)
T ss_dssp HHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHTCSCTTS
T ss_pred hhhhcCCCcCCc-ccccchHHHHHHHHcCCCCCCCCCHHHHH----HHHHhCCCCCCC--CCCHHHHHHHHHHhhcCHHH
Confidence 999988888655 99999999999999999999876654333 334444444443 58999999999999999999
Q ss_pred CCC-----HhHHhcCccccc
Q 019901 238 RIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 238 R~s-----~~ell~h~~~~~ 252 (334)
||+ ++++++||||+.
T Consensus 263 R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 263 RLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CTTCSTTHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHhcCccccC
Confidence 995 699999999964
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=364.67 Aligned_cols=243 Identities=30% Similarity=0.424 Sum_probs=203.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+++.| |+|++.+.. ....+.+.+|+.+++.++||||++++++|.+++.+|+|||||+||+|.+++
T Consensus 82 fG~V~~~~~~~~~~~~-AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l 160 (410)
T 3v8s_A 82 FGEVQLVRHKSTRKVY-AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLM 160 (410)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CEEEEEEEECCCCcEE-EEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHH
Confidence 4444 48888899998 999998743 133456889999999999999999999999999999999999999999988
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCcccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~a 157 (334)
.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... ...+.+||+.|+|
T Consensus 161 ~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~--ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~A 237 (410)
T 3v8s_A 161 SN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGH--LKLADFGTCMKMNKEGMVRCDTAVGTPDYIS 237 (410)
T ss_dssp HH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSEEECCSCCSCGGGCC
T ss_pred Hc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCC--EEEeccceeEeeccCCcccccCCcCCccccC
Confidence 76 46999999999999999999999999999999999999987765 9999999997644332 2346789999999
Q ss_pred chhhccCCC---CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 158 PEVLLKKEY---DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 158 PE~~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
||++.+... .+.++|||||||++|+|++|++||.+.+....+.+++... ....+|....+|+++++||.+||..+
T Consensus 238 PE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~s~~~~~li~~lL~~~ 315 (410)
T 3v8s_A 238 PEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--NSLTFPDDNDISKEAKNLICAFLTDR 315 (410)
T ss_dssp HHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCCTTCCCCHHHHHHHHHHSSCG
T ss_pred HHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc--ccccCCCcccccHHHHHHHHHHccCh
Confidence 999986551 2345999999999999999999999876655544443321 22345655678999999999999999
Q ss_pred CCC--CCCHhHHhcCccccc
Q 019901 235 PAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~--R~s~~ell~h~~~~~ 252 (334)
|.+ |++++++++||||+.
T Consensus 316 ~~rlgR~~~~ei~~Hp~f~~ 335 (410)
T 3v8s_A 316 EVRLGRNGVEEIKRHLFFKN 335 (410)
T ss_dssp GGCTTSSCHHHHHTSGGGCC
T ss_pred hhhCCCCCHHHHhcCccccC
Confidence 988 999999999999965
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=348.37 Aligned_cols=249 Identities=24% Similarity=0.385 Sum_probs=198.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+.++.+|..| |||++..... .....+.+|+.+++.++||||+++++++..++.+++||||+. ++|.
T Consensus 13 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~ 90 (317)
T 2pmi_A 13 LGNGTYATVYKGLNKTTGVYV-ALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLK 90 (317)
T ss_dssp ------CEEEEEECSSSCCEE-EEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHH
T ss_pred ECCCCCEEEEEEEECCCCcEE-EEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHH
Confidence 566655 47788889998 9999987642 345788999999999999999999999999999999999997 5899
Q ss_pred HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCc
Q 019901 77 ERICNA------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKST 149 (334)
Q Consensus 77 ~~l~~~------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~ 149 (334)
+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......
T Consensus 91 ~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~ 168 (317)
T 2pmi_A 91 KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ--LKLGDFGLARAFGIPVNTFSSE 168 (317)
T ss_dssp HHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCSSCEETTSCCCCCCCC
T ss_pred HHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCC--EEECcCccceecCCCcccCCCC
Confidence 988754 35899999999999999999999999999999999999987765 999999999764332 223455
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------c----------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------S---------- 212 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~---------- 212 (334)
.||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+............ .
T Consensus 169 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (317)
T 2pmi_A 169 VVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248 (317)
T ss_dssp CSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCC
T ss_pred cccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccccccc
Confidence 79999999999977544445599999999999999999999987765555444332211100 0
Q ss_pred -----------CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 213 -----------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 213 -----------~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
......+++++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 301 (317)
T 2pmi_A 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYY 301 (317)
T ss_dssp CCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred ccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhccc
Confidence 001124788999999999999999999999999999998754
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=358.16 Aligned_cols=248 Identities=26% Similarity=0.314 Sum_probs=192.8
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCC-CCCcccceEEEEcCC--eEEEEEeccC
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLR-HPNIVRFKEVILTPT--HLAIVMEYAS 71 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~--~~~lv~e~~~ 71 (334)
.||.|+| .|.++.+|+.| |||++.+... .....+.+|+.+++.+. ||||+++++++..++ .+|+|||||.
T Consensus 16 ~lG~G~~g~V~~~~~~~~~~~v-aiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~ 94 (388)
T 3oz6_A 16 KLGKGAYGIVWKSIDRRTGEVV-AVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME 94 (388)
T ss_dssp C-------CEEEEEETTTCCEE-EEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS
T ss_pred EeeeCCCeEEEEEEECCCCCEE-EEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC
Confidence 3677666 47889999999 9999876531 23356789999999997 999999999998654 7999999996
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC--------
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-------- 143 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-------- 143 (334)
++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.....
T Consensus 95 -~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~ 170 (388)
T 3oz6_A 95 -TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH--VKVADFGLSRSFVNIRRVTNNIP 170 (388)
T ss_dssp -EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEESSSCCCCCCCGG
T ss_pred -cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCC--EEecCCccccccccccccccccc
Confidence 689888866 57999999999999999999999999999999999999987765 999999999753221
Q ss_pred --------------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc
Q 019901 144 --------------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209 (334)
Q Consensus 144 --------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 209 (334)
......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..++......
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p 250 (388)
T 3oz6_A 171 LSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFP 250 (388)
T ss_dssp GCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 112335799999999999875444556999999999999999999999877666555544222110
Q ss_pred cc-----------------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 019901 210 QY-----------------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHE 248 (334)
Q Consensus 210 ~~-----------------------------------------~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~ 248 (334)
.. .......+++++.+||.+||+.||.+|||++|+|+||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp 330 (388)
T 3oz6_A 251 SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHP 330 (388)
T ss_dssp CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTST
T ss_pred CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCH
Confidence 00 0011225789999999999999999999999999999
Q ss_pred ccccc
Q 019901 249 WFLKN 253 (334)
Q Consensus 249 ~~~~~ 253 (334)
||..-
T Consensus 331 ~~~~~ 335 (388)
T 3oz6_A 331 FVSIF 335 (388)
T ss_dssp TTTTT
T ss_pred HHHHh
Confidence 99764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=370.94 Aligned_cols=244 Identities=34% Similarity=0.546 Sum_probs=205.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| +++++.++..| |||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+|||||.+|+|
T Consensus 45 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L 123 (494)
T 3lij_A 45 LGSGAYGEVLLCRDKVTHVER-AIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123 (494)
T ss_dssp EECC---EEEEEEETTTCCEE-EEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred EecCCCEEEEEEEECCCCcEE-EEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcH
Confidence 455555 48888899999 9999987652 3457899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
.+.+....++++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+|+...........+||+.
T Consensus 124 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~ 203 (494)
T 3lij_A 124 FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAY 203 (494)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTT
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcC
Confidence 99998888999999999999999999999999999999999999997543 24599999999986655555566789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~ 232 (334)
|+|||++.+ .++.+ +|||||||++|+|++|++||.+......+.. +.... ...+.+..+|+.+++||.+||+
T Consensus 204 y~aPE~l~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 277 (494)
T 3lij_A 204 YIAPEVLRK-KYDEK-CDVWSIGVILFILLAGYPPFGGQTDQEILRK----VEKGKYTFDSPEWKNVSEGAKDLIKQMLQ 277 (494)
T ss_dssp TCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCSGGGTTSCHHHHHHHHHHTC
T ss_pred eeCHHHHcc-cCCCc-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCchhcccCCHHHHHHHHHHCC
Confidence 999999864 46544 9999999999999999999998766444333 33333 2334456789999999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
.+|.+|||+.++|+||||++
T Consensus 278 ~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 278 FDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SSTTTSCCHHHHHTCHHHHH
T ss_pred CChhhCccHHHHhcCccccc
Confidence 99999999999999999976
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=342.10 Aligned_cols=242 Identities=34% Similarity=0.573 Sum_probs=205.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .+.+..++..+ |+|++........+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~~-a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 100 (277)
T 3f3z_A 22 WGEVKIAVQKGTRIRR-AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHK 100 (277)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred CEEEEEEEeCCCCcEE-EEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHc
Confidence 4444 47888888888 999998876566688999999999999999999999999999999999999999999999988
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEE---cCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli---~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
+.+++..++.++.|++.||.|||++||+||||||+|||+ +.++ .+||+|||++.............||+.|+|||
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~--~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE 178 (277)
T 3f3z_A 101 RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS--PLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ 178 (277)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC--CEEECCCTTCEECCTTSCBCCCCSCTTTCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC--cEEEEecccceeccCccchhccCCCCCccChH
Confidence 889999999999999999999999999999999999999 4443 59999999998665555556678999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCHHHHHHHHHhcccCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~~p~~ 237 (334)
++.+. ++. ++||||||+++|+|++|+.||........... +.......+. +..+++.+.++|.+||+.+|.+
T Consensus 179 ~~~~~-~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 252 (277)
T 3f3z_A 179 VLEGL-YGP-ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK----IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQ 252 (277)
T ss_dssp HHTTC-BCT-THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTT
T ss_pred Hhccc-CCc-hhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCchhhhcCCHHHHHHHHHHccCChhh
Confidence 98654 544 49999999999999999999988665443332 3333333332 2357999999999999999999
Q ss_pred CCCHhHHhcCccccccC
Q 019901 238 RISIPEIRNHEWFLKNL 254 (334)
Q Consensus 238 R~s~~ell~h~~~~~~~ 254 (334)
|||+.++++||||++..
T Consensus 253 R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 253 RITSLQALEHEWFEKQL 269 (277)
T ss_dssp SCCHHHHTTSHHHHHHH
T ss_pred CcCHHHHhcCHHHhccc
Confidence 99999999999998754
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=355.82 Aligned_cols=242 Identities=29% Similarity=0.547 Sum_probs=199.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.+ .+.++.+|+.| |||++.+... ...+.+.+|+.+++.++||||+++++++.+++.+|+|||||+|++|.+
T Consensus 37 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~ 115 (351)
T 3c0i_A 37 FSVVRRCINRETGQQF-AVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCF 115 (351)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHH
Confidence 3444 47788999999 9999976431 134679999999999999999999999999999999999999999988
Q ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCC-CCCccC
Q 019901 78 RICNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQ-PKSTVG 151 (334)
Q Consensus 78 ~l~~~----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~-~~~~~g 151 (334)
.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++....... ....+|
T Consensus 116 ~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~g 195 (351)
T 3c0i_A 116 EIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195 (351)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCS
T ss_pred HHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcC
Confidence 77643 3589999999999999999999999999999999999997643 23599999999976543332 345679
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHH
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISR 229 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ 229 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+... .....+.......+ .+..+++++++||.+
T Consensus 196 t~~y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 269 (351)
T 3c0i_A 196 TPHFMAPEVVKREPYGKP-VDVWGCGVILFILLSGCLPFYGTKE-----RLFEGIIKGKYKMNPRQWSHISESAKDLVRR 269 (351)
T ss_dssp CGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCSSHH-----HHHHHHHHTCCCCCHHHHTTSCHHHHHHHHH
T ss_pred CcCccCHHHHcCCCCCch-HhhHHHHHHHHHHHHCCCCCCCcHH-----HHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 999999999988877655 9999999999999999999987432 22222333332222 234689999999999
Q ss_pred hcccCCCCCCCHhHHhcCccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||+.||.+|||+.++++||||+.
T Consensus 270 ~L~~dP~~R~s~~e~l~hp~~~~ 292 (351)
T 3c0i_A 270 MLMLDPAERITVYEALNHPWLKE 292 (351)
T ss_dssp HTCSSTTTSCCHHHHHTSHHHHT
T ss_pred HCCCChhHCcCHHHHhcChhhcC
Confidence 99999999999999999999975
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=354.78 Aligned_cols=243 Identities=33% Similarity=0.552 Sum_probs=187.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .+++..+++.| |||++.... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...
T Consensus 66 ~g~Vy~~~~~~~~~~v-avK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 142 (349)
T 2w4o_A 66 TSIVYRCKQKGTQKPY-ALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEK 142 (349)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTC
T ss_pred CEEEEEEEECCCCcEE-EEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhc
Confidence 3444 47788888888 999998654 3467889999999999999999999999999999999999999999999888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
+.+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+++...........+||+.|+|||++
T Consensus 143 ~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~ 222 (349)
T 2w4o_A 143 GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEIL 222 (349)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHh
Confidence 88999999999999999999999999999999999999975 22345999999999865544444566799999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
.+..++.+ +|||||||++|+|++|..||.......... ..+...... .+.+..++.++.+||.+||+.||.+||
T Consensus 223 ~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp 298 (349)
T 2w4o_A 223 RGCAYGPE-VDMWSVGIITYILLCGFEPFYDERGDQFMF---RRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL 298 (349)
T ss_dssp TTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCTTCHHHHH---HHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC
T ss_pred cCCCCCcc-cchHHHHHHHHHHHhCCCCCCCCcccHHHH---HHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc
Confidence 88877655 999999999999999999998765543222 223333222 233457899999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
|+.++++||||...
T Consensus 299 t~~e~l~hp~~~~~ 312 (349)
T 2w4o_A 299 TTFQALQHPWVTGK 312 (349)
T ss_dssp CHHHHHHSTTTTST
T ss_pred CHHHHhcCcccCCC
Confidence 99999999999754
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=353.41 Aligned_cols=247 Identities=36% Similarity=0.588 Sum_probs=186.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .++++.+|+.| |||++.+.. ...+.+|+.+++.+. ||||+++++++.+++..|+||||+.+++|.
T Consensus 19 lG~G~~g~V~~~~~~~~~~~v-avK~~~~~~---~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~ 94 (325)
T 3kn6_A 19 LGEGSFSICRKCVHKKSNQAF-AVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF 94 (325)
T ss_dssp SEEETTEEEEEEEETTTCCEE-EEEEEEGGG---HHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred cccCCCeEEEEEEECCCCCEE-EEEEEChhh---hhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence 565555 47888899999 999997543 467889999999997 999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++..+. ..+||+|||+++...... .....+||+.
T Consensus 95 ~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~ 174 (325)
T 3kn6_A 95 ERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLH 174 (325)
T ss_dssp HHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-------------
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcC
Confidence 99999889999999999999999999999999999999999999976442 259999999997543322 2345678999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhhccccCCC--CCCCCHHHHHHHHH
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPD--YVHISPECRHLISR 229 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~ 229 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+.... .........+......++. +..+++++++||.+
T Consensus 175 y~aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 253 (325)
T 3kn6_A 175 YAAPELLNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQG 253 (325)
T ss_dssp ---------CCCCHH-HHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHH
T ss_pred ccCHHHhcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHH
Confidence 999999988887655 99999999999999999999864431 1122334444444433332 23579999999999
Q ss_pred hcccCCCCCCCHhHHhcCcccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
||+.||.+|||++++++||||+..
T Consensus 254 ~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 254 LLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp HHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred HCCCChhHCCCHHHHhcChhhccC
Confidence 999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=339.19 Aligned_cols=247 Identities=32% Similarity=0.546 Sum_probs=207.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
+|.+ .+.++.+|..| |+|++...... ..+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+.+.
T Consensus 19 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~ 97 (284)
T 3kk8_A 19 FSVVRRCVHKTTGLEF-AAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 97 (284)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CeEEEEEEEcCCCceE-EEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHH
Confidence 4444 37788889998 99999876522 23578899999999999999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
..+.+++..+..++.|++.||.|||++||+||||||+||+++.++. ..+||+|||++.............||+.|+|||
T Consensus 98 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE 177 (284)
T 3kk8_A 98 AREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPE 177 (284)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCch
Confidence 8888999999999999999999999999999999999999975442 359999999997665555555678999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++.+ +||||||+++|+|++|+.||.+............ .......+.+..+++++.+||.+||+.+|.+||
T Consensus 178 ~~~~~~~~~~-~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 254 (284)
T 3kk8_A 178 VLKKDPYSKP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA--GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 254 (284)
T ss_dssp HHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred hhcCCCCCcc-cchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh--ccccCCchhhcccCHHHHHHHHHHcccChhhCC
Confidence 9988877655 9999999999999999999987665433332221 122233344457899999999999999999999
Q ss_pred CHhHHhcCccccccC
Q 019901 240 SIPEIRNHEWFLKNL 254 (334)
Q Consensus 240 s~~ell~h~~~~~~~ 254 (334)
|++++++||||.+..
T Consensus 255 s~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 255 TADQALKVPWICNRE 269 (284)
T ss_dssp CHHHHTTSHHHHSCC
T ss_pred CHHHHhcCccccCCh
Confidence 999999999997653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=348.46 Aligned_cols=251 Identities=29% Similarity=0.451 Sum_probs=199.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+++..+++.| |||++..........+.+|+.+++++ +||||+++++++.+++.+|+||||+.+++|.
T Consensus 21 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 99 (316)
T 2ac3_A 21 LGEGAHARVQTCINLITSQEY-AVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSIL 99 (316)
T ss_dssp CCCCSSEEEEEEECSSSCCEE-EEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred ecCCceEEEEEEEEcCCCcEE-EEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHH
Confidence 566665 47788899998 99999877645567899999999885 7999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCC--------CCC
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHS--------QPK 147 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~--------~~~ 147 (334)
+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++...... ...
T Consensus 100 ~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 179 (316)
T 2ac3_A 100 SHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELL 179 (316)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----------------
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccc
Confidence 99998888999999999999999999999999999999999999976543 349999999987543211 122
Q ss_pred CccCCCccccchhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH-----------HHHHHHHHHhhccc
Q 019901 148 STVGTPAYIAPEVLLK-----KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK-----------NFRKTIHRILSVQY 211 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-----------~~~~~~~~~~~~~~ 211 (334)
..+||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+..... ........+.....
T Consensus 180 ~~~gt~~y~aPE~~~~~~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~ 258 (316)
T 2ac3_A 180 TPCGSAEYMAPEVVEAFSEEASIYDK-RCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258 (316)
T ss_dssp --CCSGGGCCHHHHHHTSHHHHHHTT-THHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCC
T ss_pred cccCCcCccChHHhhcccccccCCCc-ccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCc
Confidence 3469999999999875 34544 4999999999999999999998654211 11122233333333
Q ss_pred cCCC--CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 212 SIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 212 ~~~~--~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.+|. +..+++.+++||.+||+.||.+|||++++++||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 3332 245799999999999999999999999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=346.91 Aligned_cols=243 Identities=34% Similarity=0.562 Sum_probs=197.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--------------------------ccHHHHHHHHHHHcCCCCCcc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--------------------------IDENVQREIINHRSLRHPNIV 51 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--------------------------~~~~~~~Ei~~l~~l~hp~iv 51 (334)
||.|+| .+++..+++.| |||++.+.... ..+.+.+|+.+++.++||||+
T Consensus 21 lG~G~~g~Vy~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv 99 (298)
T 2zv2_A 21 IGKGSYGVVKLAYNENDNTYY-AMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVV 99 (298)
T ss_dssp EEC--CCEEEEEEETTTTEEE-EEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBC
T ss_pred EeecCCEEEEEEEECCCCcEE-EEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCC
Confidence 454444 47788889888 99999875421 125688999999999999999
Q ss_pred cceEEEEc--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCE
Q 019901 52 RFKEVILT--PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRL 129 (334)
Q Consensus 52 ~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~ 129 (334)
++++++.. .+.+|+||||+++++|.+++ ..+++++..++.++.||+.||.|||++||+||||||+|||++.++. +
T Consensus 100 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~ 176 (298)
T 2zv2_A 100 KLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGH--I 176 (298)
T ss_dssp CEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--E
T ss_pred eEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCC--E
Confidence 99999987 56899999999999998754 3457999999999999999999999999999999999999987665 9
Q ss_pred EEeccCCccCCCCCC-CCCCccCCCccccchhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHH
Q 019901 130 KICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206 (334)
Q Consensus 130 kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 206 (334)
||+|||+++...... ......||+.|+|||++.+... .+.++|||||||++|+|++|+.||....... ....+
T Consensus 177 kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~----~~~~~ 252 (298)
T 2zv2_A 177 KIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC----LHSKI 252 (298)
T ss_dssp EECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH----HHHHH
T ss_pred EEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH----HHHHH
Confidence 999999997543322 2244579999999999976553 3556899999999999999999998754422 22333
Q ss_pred hhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 207 ~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.......+....+++++.+||.+||+.||.+|||+.++++||||++
T Consensus 253 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred hcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 4444555666678999999999999999999999999999999953
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=355.08 Aligned_cols=242 Identities=30% Similarity=0.485 Sum_probs=199.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .++++.+|+.| |||++.+.. ....+|+.++.++ +||||+++++++.+++.+|+|||||.||+|.+.+.+
T Consensus 35 ~g~V~~~~~~~~~~~~-avK~~~~~~----~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~ 109 (342)
T 2qr7_A 35 YSVCKRCIHKATNMEF-AVKIIDKSK----RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILR 109 (342)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEETTT----CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHT
T ss_pred CEEEEEEEECCCCCEE-EEEEEEccc----CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHH
Confidence 3444 48888899998 999998765 2345788888777 799999999999999999999999999999999998
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC--CCEEEeccCCccCCCCC-CCCCCccCCCccccc
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~--~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aP 158 (334)
.+.+++..++.++.||+.||.|||++||+||||||+|||+..... ..+||+|||+++..... ....+.+||+.|+||
T Consensus 110 ~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aP 189 (342)
T 2qr7_A 110 QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAP 189 (342)
T ss_dssp CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCH
Confidence 889999999999999999999999999999999999999854321 35999999999854333 233456899999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|++.+..++.+ +|||||||++|+|++|..||.+... .........+......++ .+..+|+++++||.+||..||.
T Consensus 190 E~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 267 (342)
T 2qr7_A 190 EVLERQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPH 267 (342)
T ss_dssp HHHHHHHHHHH-HHHHHHHHHHHHHHHSSCSSCSSTT-SCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTT
T ss_pred HHhcCCCCCCc-cCeeeHhHHHHHHhcCCCCCCCCCc-CCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChh
Confidence 99987777544 9999999999999999999986432 122233344444444333 3457899999999999999999
Q ss_pred CCCCHhHHhcCccccc
Q 019901 237 KRISIPEIRNHEWFLK 252 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~ 252 (334)
+|||+.++++||||..
T Consensus 268 ~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 268 QRLTAALVLRHPWIVH 283 (342)
T ss_dssp TSCCHHHHTTSHHHHT
T ss_pred HCcCHHHHhcCCeecC
Confidence 9999999999999965
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-48 Score=369.32 Aligned_cols=248 Identities=33% Similarity=0.550 Sum_probs=206.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc--ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL--WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~--~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .++++.+++.| |||++.+.. ......+.+|+.+++.++||||+++++++.+.+.+|+|||||.+++|
T Consensus 30 lG~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L 108 (486)
T 3mwu_A 30 LGKGSFGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108 (486)
T ss_dssp EECCSSSEEEEEEETTTCCEE-EEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred EeecCCEEEEEEEECCCCCEE-EEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcH
Confidence 454444 47888899999 999997653 13456889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+|+...........+||+.
T Consensus 109 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~ 188 (486)
T 3mwu_A 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAY 188 (486)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGG
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCC
Confidence 99998888999999999999999999999999999999999999996532 24599999999986655555566789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+. ++ .++|||||||++|+|++|++||.+......+..... .......|.+..+|+++++||.+||+.+
T Consensus 189 y~aPE~~~~~-~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~li~~~L~~d 264 (486)
T 3mwu_A 189 YIAPEVLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET--GKYAFDLPQWRTISDDAKDLIRKMLTFH 264 (486)
T ss_dssp GCCGGGGGSC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCSCSGGGGGSCHHHHHHHHHHTCSS
T ss_pred CCCHHHhCCC-CC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCCcccCCCCHHHHHHHHHHcCCC
Confidence 9999998763 54 459999999999999999999988766444333221 1222344555678999999999999999
Q ss_pred CCCCCCHhHHhcCccccccC
Q 019901 235 PAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~ 254 (334)
|.+|||+.++|+||||++..
T Consensus 265 p~~R~t~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 265 PSLRITATQCLEHPWIQKYS 284 (486)
T ss_dssp TTTSCCHHHHHHCHHHHHTC
T ss_pred hhhCcCHHHHhcCHhhccCc
Confidence 99999999999999998653
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=356.50 Aligned_cols=246 Identities=22% Similarity=0.384 Sum_probs=197.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
+|++ .++++.+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++.+++.+|+|||||.+++|.+++.
T Consensus 40 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 118 (389)
T 3gni_B 40 LMTVNLARYKPTGEYV-TVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118 (389)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHH
T ss_pred ceEEEEEEEcCCCCEE-EEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHh
Confidence 4444 58888899999 9999987652 223678889999999999999999999999999999999999999999998
Q ss_pred hc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC--------CCCCCCcc
Q 019901 81 NA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--------HSQPKSTV 150 (334)
Q Consensus 81 ~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~--------~~~~~~~~ 150 (334)
.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .......+
T Consensus 119 ~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 196 (389)
T 3gni_B 119 THFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSV 196 (389)
T ss_dssp HTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCGGGCEECEETTEECSCBCCCCTTCT
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC--EEEcccccceeecccccccccccccccccc
Confidence 75 67999999999999999999999999999999999999987664 99999998753221 12233457
Q ss_pred CCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------------------
Q 019901 151 GTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------- 209 (334)
Q Consensus 151 gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------- 209 (334)
||+.|+|||++.+ ..++. ++|||||||++|+|++|+.||.+.................
T Consensus 197 gt~~y~aPE~~~~~~~~~~~-~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (389)
T 3gni_B 197 KVLPWLSPEVLQQNLQGYDA-KSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRS 275 (389)
T ss_dssp TTGGGSCHHHHSTTSSCBCT-HHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC--------------------------
T ss_pred ccccccCHHHHhccCCCCCc-HhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccccccccccccccccccc
Confidence 9999999999987 45654 4999999999999999999998766544443322111100
Q ss_pred ---------------------cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 210 ---------------------QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 210 ---------------------~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+....+++++.+||.+||+.||.+|||++++|+||||++.
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~ 340 (389)
T 3gni_B 276 VANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 340 (389)
T ss_dssp ------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred ccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence 00111234578999999999999999999999999999999763
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=345.63 Aligned_cols=244 Identities=27% Similarity=0.412 Sum_probs=193.4
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||+++ +++ .+|+.| |||++..... .....+.+|+.+++.++||||+++++++.+++.+++||||+.+ +|.+.+.
T Consensus 34 ~g~V~~~~~-~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 110 (311)
T 3niz_A 34 YGVVYKAKD-SQGRIV-ALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLD 110 (311)
T ss_dssp SCEEEEEEE-TTSCEE-EEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHH
T ss_pred CeEEEEEEE-CCCCEE-EEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHH
Confidence 34444 555 457888 9999976542 2236788999999999999999999999999999999999975 7878776
Q ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccccc
Q 019901 81 NA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAP 158 (334)
Q Consensus 81 ~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aP 158 (334)
.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+||
T Consensus 111 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aP 188 (311)
T 3niz_A 111 ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA--LKLADFGLARAFGIPVRSYTHEVVTLWYRAP 188 (311)
T ss_dssp TCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEETTSCCC---CCCCCCTTCCH
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCC--EEEccCcCceecCCCcccccCCcccCCcCCH
Confidence 64 45999999999999999999999999999999999999987765 999999999864332 223445789999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-CC-----------------------
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IP----------------------- 214 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~----------------------- 214 (334)
|++.+....+.++|||||||++|+|++|+.||.+.................... .+
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSS 268 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHH
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHH
Confidence 999775544555999999999999999999999877766655544332211100 00
Q ss_pred CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 215 DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 215 ~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
....+++++.+||.+||+.||.+|||++|+|+||||++
T Consensus 269 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 306 (311)
T 3niz_A 269 IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKD 306 (311)
T ss_dssp HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTT
T ss_pred hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCccccc
Confidence 01246889999999999999999999999999999965
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=345.09 Aligned_cols=241 Identities=25% Similarity=0.440 Sum_probs=202.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .++++.+|+.| |||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.+
T Consensus 58 ~g~V~~a~~~~~g~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 135 (321)
T 2c30_A 58 TGIVCLAREKHSGRQV-AVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ- 135 (321)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-
T ss_pred CeEEEEEEECCCCcEE-EEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-
Confidence 4444 47778899999 99999877645567899999999999999999999999999999999999999999998764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~~ 161 (334)
..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++
T Consensus 136 ~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~ 213 (321)
T 2c30_A 136 VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR--VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI 213 (321)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc--EEEeeeeeeeecccCccccccccCCccccCHhhh
Confidence 56999999999999999999999999999999999999987664 9999999987544332 23456799999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
.+..++.+ +|||||||++|+|++|+.||........... +... .........+++.+.++|.+||+.+|.+|||
T Consensus 214 ~~~~~~~~-~Dv~slG~il~el~~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps 288 (321)
T 2c30_A 214 SRSLYATE-VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR----LRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERAT 288 (321)
T ss_dssp TTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCC
T ss_pred cCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcC
Confidence 88777655 9999999999999999999987655333322 2221 1122333457899999999999999999999
Q ss_pred HhHHhcCcccccc
Q 019901 241 IPEIRNHEWFLKN 253 (334)
Q Consensus 241 ~~ell~h~~~~~~ 253 (334)
+.++++||||.+.
T Consensus 289 ~~ell~hp~~~~~ 301 (321)
T 2c30_A 289 AQELLDHPFLLQT 301 (321)
T ss_dssp HHHHHTSGGGGGC
T ss_pred HHHHhcChhhccC
Confidence 9999999999764
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=363.06 Aligned_cols=243 Identities=24% Similarity=0.444 Sum_probs=201.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+++.| |||++.+... .....+.+|+.+++.++||||++++++|.+++.+|+|||||.||+|.+++
T Consensus 87 fG~V~~~~~~~~~~~v-AvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l 165 (437)
T 4aw2_A 87 FGEVAVVKLKNADKVF-AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLL 165 (437)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CEEEEEEEEcCCCcEE-EEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHH
Confidence 4444 47788888888 9999987431 23345899999999999999999999999999999999999999999999
Q ss_pred Hh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccc
Q 019901 80 CN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYI 156 (334)
Q Consensus 80 ~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~ 156 (334)
.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....... ....+||+.|+
T Consensus 166 ~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~ 243 (437)
T 4aw2_A 166 SKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGH--IRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243 (437)
T ss_dssp HTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECCSCCSCGGGC
T ss_pred HHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCC--EEEcchhhhhhcccCCCcccccccCCcCee
Confidence 87 467999999999999999999999999999999999999987765 99999999975443322 23468999999
Q ss_pred cchhhc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCC-CCCCHHHHHHHHHh
Q 019901 157 APEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDY-VHISPECRHLISRI 230 (334)
Q Consensus 157 aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~ 230 (334)
|||++. ...++ .++|||||||++|+|++|++||.+.+....+.+++.... ...+|.. ..+|+++++||.+|
T Consensus 244 APE~l~~~~~~~~~~~-~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~p~~~~~~s~~~~dLi~~l 320 (437)
T 4aw2_A 244 SPEILQAMEGGKGRYG-PECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE--RFQFPTQVTDVSENAKDLIRRL 320 (437)
T ss_dssp CHHHHHHHHTSCCEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHH--HCCCCSSCCCSCHHHHHHHHTT
T ss_pred ChHHHhhcccCCCCCC-CcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccc--cccCCcccccCCHHHHHHHHHH
Confidence 999997 34454 459999999999999999999998776555554433221 2233332 45899999999999
Q ss_pred cccCCCC--CCCHhHHhcCccccc
Q 019901 231 FVADPAK--RISIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~--R~s~~ell~h~~~~~ 252 (334)
|..+|.+ |++++++++||||..
T Consensus 321 L~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 321 ICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp SSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred hcccccccCCCCHHHHhCCCccCC
Confidence 9988888 999999999999964
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=371.93 Aligned_cols=243 Identities=26% Similarity=0.394 Sum_probs=205.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .++++.+|+.| |||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||||+.||+|..++
T Consensus 197 fG~Vy~a~~~~tg~~v-AvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l 275 (576)
T 2acx_A 197 FGEVCACQVRATGKMY-ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHI 275 (576)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHH
Confidence 4444 47888899999 9999987542 33467889999999999999999999999999999999999999999999
Q ss_pred HhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcccc
Q 019901 80 CNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~a 157 (334)
...+. +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...........+||+.|+|
T Consensus 276 ~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~--vKL~DFGla~~~~~~~~~~~~~GT~~Y~A 353 (576)
T 2acx_A 276 YHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGH--IRISDLGLAVHVPEGQTIKGRVGTVGYMA 353 (576)
T ss_dssp HSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCEECCCSCGGGCC
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCC--eEEEecccceecccCccccccCCCccccC
Confidence 87544 999999999999999999999999999999999999987765 99999999986554444455689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|++||.+.............+......++ ..+|+++++||.+||+.||.+
T Consensus 354 PEvl~~~~~~~~-~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI~~lL~~dP~~ 430 (576)
T 2acx_A 354 PEVVKNERYTFS-PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLCSQLLCKDPAE 430 (576)
T ss_dssp HHHHTTCEESSH-HHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGG
T ss_pred HHHHcCCCCCcc-chHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHHHHhccCCHHH
Confidence 999988877655 99999999999999999999876543222333333444443343 458999999999999999999
Q ss_pred CC-----CHhHHhcCccccc
Q 019901 238 RI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 238 R~-----s~~ell~h~~~~~ 252 (334)
|| +++++++||||+.
T Consensus 431 R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 431 RLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp STTCSSSHHHHHHTSGGGTT
T ss_pred cCCCCCCCHHHHHhChhhcc
Confidence 99 7899999999975
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=369.65 Aligned_cols=246 Identities=35% Similarity=0.567 Sum_probs=205.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-------------cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-------------QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLA 64 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-------------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~ 64 (334)
||.|+| .|+++.++..| |||++.+... ...+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 44 lG~G~~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 122 (504)
T 3q5i_A 44 LGSGAYGEVLLCKEKNGHSEK-AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122 (504)
T ss_dssp EEC--CEEEEEEEETTTCCEE-EEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred ecccCCeEEEEEEECCCCcEE-EEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 455555 47888899999 9999987542 22467899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCC
Q 019901 65 IVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLH 143 (334)
Q Consensus 65 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~ 143 (334)
+|||||.||+|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+|+.....
T Consensus 123 lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC
Confidence 99999999999999998889999999999999999999999999999999999999986653 25999999999866555
Q ss_pred CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCH
Q 019901 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISP 221 (334)
Q Consensus 144 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 221 (334)
......+||+.|+|||++.+ .++.+ +|||||||++|+|++|.+||.+......+.. +...... .+.+..+|+
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~-~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~ 276 (504)
T 3q5i_A 203 YKLRDRLGTAYYIAPEVLKK-KYNEK-CDVWSCGVIMYILLCGYPPFGGQNDQDIIKK----VEKGKYYFDFNDWKNISD 276 (504)
T ss_dssp SCBCCCCSCTTTCCHHHHTT-CBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCHHHHTTSCH
T ss_pred CccccccCCcCCCCHHHhcc-CCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHcCCCCCCccccCCCCH
Confidence 55566789999999999864 46544 9999999999999999999998766443333 3333322 233457899
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 222 ECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
++++||.+||+.+|.+|||++++|+||||++..
T Consensus 277 ~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 277 EAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 999999999999999999999999999998754
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=355.30 Aligned_cols=239 Identities=31% Similarity=0.528 Sum_probs=195.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHH-HHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIIN-HRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~-l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ +++++.++..| |||++.+.... ....+.+|..+ ++.++||||+++++++.+.+.+|+||||+.||+|..+
T Consensus 51 fg~V~~~~~~~~~~~~-AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~ 129 (373)
T 2r5t_A 51 FGKVLLARHKAEEVFY-AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYH 129 (373)
T ss_dssp TCEEEEEEETTTCCEE-EEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHH
T ss_pred CeEEEEEEEcCCCCEE-EEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHH
Confidence 4444 48888899998 99999886522 23456677776 5778999999999999999999999999999999999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC-CCCCCCCccCCCcccc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIA 157 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~-~~~~~~~~~gt~~y~a 157 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++... ........+||+.|+|
T Consensus 130 l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~--ikL~DFG~a~~~~~~~~~~~~~~gt~~y~a 207 (373)
T 2r5t_A 130 LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGH--IVLTDFGLCKENIEHNSTTSTFCGTPEYLA 207 (373)
T ss_dssp HHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCBCGGGBCCCCCCCSBSCCCCCCC
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCC--EEEeeCccccccccCCCccccccCCccccC
Confidence 998889999999999999999999999999999999999999987765 9999999998533 2334456789999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|..||.+.+....+. .+......++ ..+++++++||.+||+.+|.+
T Consensus 208 PE~~~~~~~~~~-~DiwslG~il~ell~G~~Pf~~~~~~~~~~----~i~~~~~~~~--~~~~~~~~~li~~lL~~dp~~ 280 (373)
T 2r5t_A 208 PEVLHKQPYDRT-VDWWCLGAVLYEMLYGLPPFYSRNTAEMYD----NILNKPLQLK--PNITNSARHLLEGLLQKDRTK 280 (373)
T ss_dssp HHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSBHHHHHH----HHHHSCCCCC--SSSCHHHHHHHHHHTCSSGGG
T ss_pred HHHhCCCCCCch-hhhHHHHHHHHHHHcCCCCCCCCCHHHHHH----HHHhcccCCC--CCCCHHHHHHHHHHcccCHHh
Confidence 999988887655 999999999999999999998766544333 3334444433 358999999999999999999
Q ss_pred CCCH----hHHhcCccccc
Q 019901 238 RISI----PEIRNHEWFLK 252 (334)
Q Consensus 238 R~s~----~ell~h~~~~~ 252 (334)
||++ .++++||||..
T Consensus 281 R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 281 RLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp STTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHhCCccccC
Confidence 9986 69999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=371.03 Aligned_cols=244 Identities=33% Similarity=0.547 Sum_probs=206.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .++++.+|+.| |||++.+... ...+.+.+|+.+++.++||||+++++++.+.+..|+|||||.+++|.+.+
T Consensus 39 ~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 117 (484)
T 3nyv_A 39 FGEVILCKDKITGQEC-AVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEI 117 (484)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CEEEEEEEECCCCCEE-EEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHH
Confidence 4444 47888899999 9999987642 34568999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCCCCCccCCCccccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aP 158 (334)
...+.+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||+|+...........+||+.|+||
T Consensus 118 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP 197 (484)
T 3nyv_A 118 ISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197 (484)
T ss_dssp HTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCc
Confidence 998899999999999999999999999999999999999999532 2345999999999765444444456799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|++.+ .++. ++|||||||++|+|++|++||.+......+.. +.... ...|.+..+|+++++||.+||+.+|.
T Consensus 198 E~~~~-~~~~-~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~ 271 (484)
T 3nyv_A 198 EVLHG-TYDE-KCDVWSTGVILYILLSGCPPFNGANEYDILKK----VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 271 (484)
T ss_dssp HHHHT-CCCT-HHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGG
T ss_pred eeecC-CCCC-cceeHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCCcccccCCHHHHHHHHHHCCCChh
Confidence 99876 4654 49999999999999999999998766444333 33332 33455567899999999999999999
Q ss_pred CCCCHhHHhcCccccccC
Q 019901 237 KRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~ 254 (334)
+|||+.++|+||||+...
T Consensus 272 ~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 272 MRISARDALDHEWIQTYT 289 (484)
T ss_dssp GSCCHHHHHTSHHHHHHT
T ss_pred HCcCHHHHhhChhhcccc
Confidence 999999999999998654
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=341.48 Aligned_cols=244 Identities=26% Similarity=0.410 Sum_probs=194.1
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||+++ +++ .+|+.| |||++..... .....+.+|+.+++.++||||+++++++..++..++||||+.+ +|.+++.
T Consensus 15 ~g~V~~~~~-~~~~~~-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 91 (288)
T 1ob3_A 15 YGVVYKAQN-NYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLD 91 (288)
T ss_dssp TEEEEEEEE-TTSCEE-EEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHH
T ss_pred CEEEEEEEc-CCCCEE-EEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHH
Confidence 44444 555 678888 9999976542 2347889999999999999999999999999999999999975 8988887
Q ss_pred hc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCccccc
Q 019901 81 NA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAYIAP 158 (334)
Q Consensus 81 ~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~aP 158 (334)
.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+||
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 92 VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLWYRAP 169 (288)
T ss_dssp TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCTTCCH
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEeECccccccCccccccccccccccccCc
Confidence 64 67999999999999999999999999999999999999987665 999999998754322 223345789999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--------------cCC---------C
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------SIP---------D 215 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~---------~ 215 (334)
|++.+....+.++|||||||++|+|++|++||.+................... ..+ .
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (288)
T 1ob3_A 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESF 249 (288)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGT
T ss_pred hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHH
Confidence 99977554455599999999999999999999987765555444432211100 000 1
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 ~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+++++.+||.+||+.||.+|||++++++||||++
T Consensus 250 ~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 286 (288)
T 1ob3_A 250 LKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (288)
T ss_dssp CCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence 1347899999999999999999999999999999965
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=361.15 Aligned_cols=244 Identities=33% Similarity=0.540 Sum_probs=191.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHH-HcCCCCCcccceEEEEc----CCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~ 77 (334)
||++ .+.++.+|+.| |||++.. ...+.+|+.++ +..+||||+++++++.. .+.+|+|||||.||+|.+
T Consensus 75 ~g~V~~~~~~~~~~~v-AiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~ 148 (400)
T 1nxk_A 75 NGKVLQIFNKRTQEKF-ALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 148 (400)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHH
Confidence 4444 47888899999 9999853 35678899887 55689999999999875 567999999999999999
Q ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 78 RICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 78 ~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
++...+ .+++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+++...........+||+.
T Consensus 149 ~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~ 228 (400)
T 1nxk_A 149 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPY 228 (400)
T ss_dssp HHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CT
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCC
Confidence 998753 599999999999999999999999999999999999998632 34599999999986655555566789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~ 232 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+.............+....+ ..+.+..+++++.+||.+||+
T Consensus 229 y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~ 307 (400)
T 1nxk_A 229 YVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 307 (400)
T ss_dssp TCCGGGSCCCCSSSH-HHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSC
T ss_pred ccCHhhcCCCCCCCc-ccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCC
Confidence 999999988887655 99999999999999999999765432211111122223333 333456789999999999999
Q ss_pred cCCCCCCCHhHHhcCccccccC
Q 019901 233 ADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.||.+|||+.++++||||.+..
T Consensus 308 ~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 308 TEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp SSGGGSCCHHHHHHSHHHHTTT
T ss_pred CChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999997643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=362.03 Aligned_cols=249 Identities=24% Similarity=0.355 Sum_probs=184.3
Q ss_pred CCCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc-----CCeEEEEEec
Q 019901 1 MLGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAIVMEY 69 (334)
Q Consensus 1 ~lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~ 69 (334)
.||.|+| .++++.+|+.| |||++.+... ...+.+.+|+.+++.++||||+++++++.. .+.+|+||||
T Consensus 60 ~lG~G~~g~V~~~~~~~~~~~v-aiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~ 138 (458)
T 3rp9_A 60 LIGTGSYGHVCEAYDKLEKRVV-AIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI 138 (458)
T ss_dssp C-------CEEEEEECC--CEE-EEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECC
T ss_pred EeeecCCeEEEEEEECCCCcEE-EEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEec
Confidence 3677766 47888999999 9999976531 223678899999999999999999999843 3579999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----- 144 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----- 144 (334)
+ +++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 139 ~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~--~kl~DFGla~~~~~~~~~~~~ 215 (458)
T 3rp9_A 139 A-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCS--VKVCDFGLARTVDYPENGNSQ 215 (458)
T ss_dssp C-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCC--EEECCCTTCBCTTSCTTCCCC
T ss_pred c-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCC--EeecccccchhccCccccccc
Confidence 8 5799999988888999999999999999999999999999999999999987765 9999999998643221
Q ss_pred -----------------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-----------CCCCC
Q 019901 145 -----------------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-----------GAYPF 190 (334)
Q Consensus 145 -----------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-----------g~~pf 190 (334)
.....+||++|+|||++......+.++|||||||++|+|++ |+++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f 295 (458)
T 3rp9_A 216 LPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295 (458)
T ss_dssp CC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSC
T ss_pred cccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccC
Confidence 12334789999999987544433455999999999999998 77777
Q ss_pred CCCCc--------------------hHHHHHHHHHHhhcc----------------cc---------CCCCCCCCHHHHH
Q 019901 191 EDPEE--------------------PKNFRKTIHRILSVQ----------------YS---------IPDYVHISPECRH 225 (334)
Q Consensus 191 ~~~~~--------------------~~~~~~~~~~~~~~~----------------~~---------~~~~~~~~~~~~~ 225 (334)
.+... ...+..+........ .. ...+..+++++.+
T Consensus 296 ~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 375 (458)
T 3rp9_A 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIH 375 (458)
T ss_dssp C--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHH
T ss_pred CCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHH
Confidence 66431 111111111000000 00 0112456999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
||.+||..||.+|||++|+|+||||+.-
T Consensus 376 Ll~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 376 LLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 9999999999999999999999999764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=347.58 Aligned_cols=239 Identities=28% Similarity=0.505 Sum_probs=191.6
Q ss_pred cceee-eeec---CCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 4 FHNFY-DRCS---YSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~~-~~~~---~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.++ +++. .+|+.| |||++.+... .....+.+|+.+++.++||||+++++++..++.+|+||||+.|++|
T Consensus 30 ~g~V~~~~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 108 (327)
T 3a62_A 30 YGKVFQVRKVTGANTGKIF-AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108 (327)
T ss_dssp TEEEEEEEECSSTTTTCEE-EEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEH
T ss_pred CEEEEEEEEeccCCCCcEE-EEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcH
Confidence 44443 4443 678888 9999987642 2345678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~ 154 (334)
.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... ......+||+.
T Consensus 109 ~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~ 186 (327)
T 3a62_A 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGH--VKLTDFGLCKESIHDGTVTHTFCGTIE 186 (327)
T ss_dssp HHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSC--EEECCCSCC----------CTTSSCCT
T ss_pred HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCc--EEEEeCCcccccccCCccccccCCCcC
Confidence 999998888999999999999999999999999999999999999987665 999999998754322 22345679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+........ .+......+| ..+++++++||.+||..+
T Consensus 187 y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~L~~d 259 (327)
T 3a62_A 187 YMAPEILMRSGHNRA-VDWWSLGALMYDMLTGAPPFTGENRKKTID----KILKCKLNLP--PYLTQEARDLLKKLLKRN 259 (327)
T ss_dssp TSCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHHHHHHHSCSC
T ss_pred ccCHhhCcCCCCCCc-ccchhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCC--CCCCHHHHHHHHHHHhcC
Confidence 999999988777555 999999999999999999998766544333 3333333333 357999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 019901 235 PAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~-----s~~ell~h~~~~~ 252 (334)
|.+|| +++++++||||..
T Consensus 260 p~~R~~~~~~~~~e~l~hp~f~~ 282 (327)
T 3a62_A 260 AASRLGAGPGDAGEVQAHPFFRH 282 (327)
T ss_dssp GGGSTTSSTTTHHHHHHSGGGSS
T ss_pred HhhccCCCCCCHHHHHcCCcccC
Confidence 99999 8899999999964
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=342.73 Aligned_cols=247 Identities=25% Similarity=0.355 Sum_probs=200.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCC---CCCcccceEEEEcCC-----eEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLR---HPNIVRFKEVILTPT-----HLA 64 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~-----~~~ 64 (334)
||.|++ .+++..+|+.| |||++..... .....+.+|+.+++.++ ||||+++++++.... .++
T Consensus 17 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~ 95 (308)
T 3g33_A 17 IGVGAYGTVYKARDPHSGHFV-ALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95 (308)
T ss_dssp ECCSSSCCEEEEECTTTCCEE-EEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEE
T ss_pred EecCCCeEEEEEEECCCCcEE-EEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEE
Confidence 555555 47888999999 9999986441 23457888888887775 999999999998765 589
Q ss_pred EEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC
Q 019901 65 IVMEYASGGELFERICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL 142 (334)
Q Consensus 65 lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~ 142 (334)
+||||+. ++|.+++..... +++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....
T Consensus 96 lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~ 172 (308)
T 3g33_A 96 LVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT--VKLADFGLARIYSY 172 (308)
T ss_dssp EEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSC--EEECSCSCTTTSTT
T ss_pred EEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCC--EEEeeCccccccCC
Confidence 9999996 599999987654 999999999999999999999999999999999999987665 99999999987655
Q ss_pred CCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cCC-------
Q 019901 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIP------- 214 (334)
Q Consensus 143 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~------- 214 (334)
.......+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+................... ..+
T Consensus 173 ~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 251 (308)
T 3g33_A 173 QMALTPVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPR 251 (308)
T ss_dssp CCCSGGGGCCCSSCCHHHHHTSCCCST-HHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCG
T ss_pred CcccCCccccccccCchHHcCCCCCch-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccc
Confidence 555566789999999999988888665 99999999999999999999987776655554443221110 000
Q ss_pred -------------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 -------------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 -------------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+++.+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 252 GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 013578999999999999999999999999999999764
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=347.73 Aligned_cols=243 Identities=30% Similarity=0.521 Sum_probs=205.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .++++.+|..| |||++.+.... ..+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.
T Consensus 25 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 103 (321)
T 2a2a_A 25 FAIVKKCREKSTGLEY-AAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELF 103 (321)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred CEEEEEEEECCCCeEE-EEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHH
Confidence 4444 47888899999 99999876522 2467999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC--CCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~--~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++............||+.
T Consensus 104 ~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~ 183 (321)
T 2a2a_A 104 DFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPE 183 (321)
T ss_dssp HHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCC
Confidence 99998888999999999999999999999999999999999999986652 1599999999986655545556679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~ 232 (334)
|+|||++.+..++.+ +|||||||++|+|++|..||.+........ .+.......+. +..+++.+.+||.+||+
T Consensus 184 y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~~~~~~~li~~~l~ 258 (321)
T 2a2a_A 184 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NITSVSYDFDEEFFSHTSELAKDFIRKLLV 258 (321)
T ss_dssp GCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTCCHHHHHHHHTTSC
T ss_pred ccCcccccCCCCCCc-cccHHHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhcccccChhhhcccCHHHHHHHHHHcC
Confidence 999999988777655 999999999999999999998766543332 23332222221 24579999999999999
Q ss_pred cCCCCCCCHhHHhcCccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~ 252 (334)
.+|.+|||++++++||||..
T Consensus 259 ~dp~~Rps~~e~l~hp~~~~ 278 (321)
T 2a2a_A 259 KETRKRLTIQEALRHPWITP 278 (321)
T ss_dssp SSTTTSCCHHHHHHSTTTSC
T ss_pred CChhhCcCHHHHhcCccccC
Confidence 99999999999999999964
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=364.07 Aligned_cols=239 Identities=34% Similarity=0.566 Sum_probs=194.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .++++.+|..| |||++.+... .....+.+|+.+++.++||||+++++++...+.+|+||||+.+|+|..++
T Consensus 161 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l 239 (446)
T 4ejn_A 161 FGKVILVKEKATGRYY-AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239 (446)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHH
T ss_pred CEEEEEEEEcCCCCEE-EEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHH
Confidence 4444 47888999999 9999987531 23356788999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCcccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~a 157 (334)
.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.++. +||+|||+|+.... .......+||+.|+|
T Consensus 240 ~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~~y~a 317 (446)
T 4ejn_A 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH--IKITDFGLCKEGIKDGATMKTFCGTPEYLA 317 (446)
T ss_dssp HHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSC--EEECCCCCCCTTCC-----CCSSSCGGGCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCC--EEEccCCCceeccCCCcccccccCCccccC
Confidence 988899999999999999999999998 99999999999999987765 99999999986333 233455689999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|+.||.+........ .+......+| ..+++++.+||.+||+.||.+
T Consensus 318 PE~~~~~~~~~~-~DiwslG~il~ell~g~~Pf~~~~~~~~~~----~i~~~~~~~p--~~~~~~~~~li~~~L~~dP~~ 390 (446)
T 4ejn_A 318 PEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHEKLFE----LILMEEIRFP--RTLGPEAKSLLSGLLKKDPKQ 390 (446)
T ss_dssp HHHHHTSCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCC--TTSCHHHHHHHHHHTCSSTTT
T ss_pred HhhcCCCCCCCc-cchhhhHHHHHHHhhCCCCCCCCCHHHHHH----HHHhCCCCCC--ccCCHHHHHHHHHHcccCHHH
Confidence 999988888655 999999999999999999998766543332 3333444444 357999999999999999999
Q ss_pred CC-----CHhHHhcCccccc
Q 019901 238 RI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 238 R~-----s~~ell~h~~~~~ 252 (334)
|| |++++++||||..
T Consensus 391 R~~~~~~t~~ell~hp~f~~ 410 (446)
T 4ejn_A 391 RLGGGSEDAKEIMQHRFFAG 410 (446)
T ss_dssp STTCSTTTHHHHHTSGGGTT
T ss_pred hCCCCCCCHHHHHhCccccC
Confidence 99 9999999999964
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=350.22 Aligned_cols=238 Identities=27% Similarity=0.397 Sum_probs=203.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 69 (334)
||.|+| .++++.++..| |||++.+.... ....+.+|+.+++.++||||+++++++.+.+..++||||
T Consensus 32 lG~G~~g~Vy~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~ 110 (335)
T 3dls_A 32 LGSGAFGFVWTAVDKEKNKEV-VVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK 110 (335)
T ss_dssp CSSSSSCSEEEEEETTTTEEE-EEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred EEecCCEEEEEEEECCCCcEE-EEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEe
Confidence 566655 47788899998 99999876521 234678899999999999999999999999999999999
Q ss_pred cCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCC
Q 019901 70 ASGG-ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 70 ~~~~-~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~ 148 (334)
+.+| +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..........
T Consensus 111 ~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~ 188 (335)
T 3dls_A 111 HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFT--IKLIDFGSAAYLERGKLFYT 188 (335)
T ss_dssp CTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECCTTCCBCE
T ss_pred CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCc--EEEeecccceECCCCCceec
Confidence 9766 99999998889999999999999999999999999999999999999987664 99999999986655555556
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||..... .... ....+..+++++.+||.
T Consensus 189 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----------~~~~--~~~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 189 FCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE----------TVEA--AIHPPYLVSKELMSLVS 256 (335)
T ss_dssp ECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------GTTT--CCCCSSCCCHHHHHHHH
T ss_pred cCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------HHhh--ccCCCcccCHHHHHHHH
Confidence 67999999999999888866669999999999999999999975322 1111 22223357999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccccC
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+||+.+|.+|||++++++||||++..
T Consensus 257 ~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 257 GLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHccCChhhCcCHHHHhcCccccCCc
Confidence 99999999999999999999997643
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=338.24 Aligned_cols=242 Identities=31% Similarity=0.483 Sum_probs=193.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ +++++.++..+ |+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+.+..
T Consensus 35 ~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 113 (285)
T 3is5_A 35 FGDVHLVEERSSGLER-VIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVS 113 (285)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHH
T ss_pred CeEEEEEEEccCCceE-EEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHh
Confidence 4444 47788889998 9999987652 2347899999999999999999999999999999999999999999998854
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 82 ----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 82 ----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
...+++..++.++.|++.||.|||++||+||||||+|||++.. ..+.+||+|||+++............||+.|+
T Consensus 114 ~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~ 193 (285)
T 3is5_A 114 AQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYM 193 (285)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGC
T ss_pred hhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcC
Confidence 3679999999999999999999999999999999999999542 23469999999998655555556678999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-CCCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||++.+ .++ .++|||||||++|+|++|+.||.+......... ....... ......+++++.+||.+||+.+|
T Consensus 194 aPE~~~~-~~~-~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 267 (285)
T 3is5_A 194 APEVFKR-DVT-FKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK----ATYKEPNYAVECRPLTPQAVDLLKQMLTKDP 267 (285)
T ss_dssp CHHHHTT-CCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHCCCCCCC--CCCCHHHHHHHHHHTCSCT
T ss_pred ChHHhcc-CCC-cccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh----hccCCcccccccCcCCHHHHHHHHHHccCCh
Confidence 9999854 454 459999999999999999999987654332222 2212211 12223479999999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
.+|||+.|+|+||||++
T Consensus 268 ~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 268 ERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp TTSCCHHHHHTSGGGGC
T ss_pred hhCcCHHHHhcCHHhhc
Confidence 99999999999999975
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-48 Score=357.67 Aligned_cols=242 Identities=25% Similarity=0.422 Sum_probs=199.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ +++++.+|+.| |||++.+... ...+.+.+|+.++..++||||++++++|.+.+.+|+||||+.||+|.+++
T Consensus 74 fG~V~~~~~~~~~~~v-AiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l 152 (412)
T 2vd5_A 74 FSEVAVVKMKQTGQVY-AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLL 152 (412)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHH
Confidence 4444 48888899999 9999987431 23356889999999999999999999999999999999999999999999
Q ss_pred HhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccc
Q 019901 80 CNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYI 156 (334)
Q Consensus 80 ~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~ 156 (334)
.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....... ....+||+.|+
T Consensus 153 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~--vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~ 230 (412)
T 2vd5_A 153 SKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGH--IRLADFGSCLKLRADGTVRSLVAVGTPDYL 230 (412)
T ss_dssp HHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCTTSCEECSSCCSCGGGC
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCC--EEEeechhheeccCCCccccceeccccCcC
Confidence 8754 7999999999999999999999999999999999999987765 99999999976543332 23468999999
Q ss_pred cchhhcc-------CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC-CCCCCHHHHHHHH
Q 019901 157 APEVLLK-------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD-YVHISPECRHLIS 228 (334)
Q Consensus 157 aPE~~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~ 228 (334)
|||++.. ..++ .++|||||||++|+|++|+.||.+.+....+.++.... ....+|. ...+|+++++||.
T Consensus 231 APE~l~~~~~~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~~~p~~~~~~s~~~~dli~ 307 (412)
T 2vd5_A 231 SPEILQAVGGGPGTGSYG-PECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK--EHLSLPLVDEGVPEEARDFIQ 307 (412)
T ss_dssp CHHHHHHHHTCTTCSEEC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH--HHCCCC----CCCHHHHHHHH
T ss_pred CHHHHhhcccCcCCCCCC-hHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc--cCcCCCccccCCCHHHHHHHH
Confidence 9999973 3454 45999999999999999999998876655444433221 1122332 2468999999999
Q ss_pred HhcccCCCCC---CCHhHHhcCccccc
Q 019901 229 RIFVADPAKR---ISIPEIRNHEWFLK 252 (334)
Q Consensus 229 ~~L~~~p~~R---~s~~ell~h~~~~~ 252 (334)
+||. +|.+| ++++++++||||..
T Consensus 308 ~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 308 RLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp TTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 9999 99998 59999999999964
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=363.14 Aligned_cols=246 Identities=24% Similarity=0.357 Sum_probs=192.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|+| .|++..+|+.| |||++.+... .....+.+|+.+++.++||||+++++++... ..+|+||||
T Consensus 70 lG~G~~g~V~~a~~~~~~~~v-AiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~ 148 (464)
T 3ttj_A 70 IGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148 (464)
T ss_dssp EEECSSCEEEEEEETTTTEEE-EEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred eecCCCeEEEEEEECCCCCEE-EEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeC
Confidence 455554 47888999998 9999987531 2346788999999999999999999999654 468999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+.+ +|...+.. .+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...........
T Consensus 149 ~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~ 223 (464)
T 3ttj_A 149 MDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 223 (464)
T ss_dssp CSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCCC-----CCCC---
T ss_pred CCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCC--EEEEEEEeeeecCCCcccCCC
Confidence 965 56666643 4899999999999999999999999999999999999987765 999999999876555555667
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc---------------cCC
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY---------------SIP 214 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~---------------~~~ 214 (334)
+||+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+....+..++........ ..+
T Consensus 224 ~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~ 302 (464)
T 3ttj_A 224 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 302 (464)
T ss_dssp -CCCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSC
T ss_pred cccccccCHHHHcCCCCCHH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhccc
Confidence 89999999999999888755 99999999999999999999987766665555443221100 000
Q ss_pred CCCC---------------------CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 DYVH---------------------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ~~~~---------------------~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.... .++++++||.+||..||.+|||++|+|+||||....
T Consensus 303 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 303 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred ccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 0000 156799999999999999999999999999998643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=365.46 Aligned_cols=243 Identities=28% Similarity=0.407 Sum_probs=204.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .++++.+|+.| |||++.+... .....+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|..++
T Consensus 198 fG~Vy~a~~~~tg~~v-AiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l 276 (543)
T 3c4z_A 198 FGEVFACQMKATGKLY-ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHI 276 (543)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CeEEEEEEECCCCcEE-EEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHH
Confidence 4444 47888899999 9999987542 23467889999999999999999999999999999999999999999998
Q ss_pred Hhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC-CCccCCCc
Q 019901 80 CNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVGTPA 154 (334)
Q Consensus 80 ~~~----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~-~~~~gt~~ 154 (334)
.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........ ...+||+.
T Consensus 277 ~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~GT~~ 354 (543)
T 3c4z_A 277 YNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN--VRISDLGLAVELKAGQTKTKGYAGTPG 354 (543)
T ss_dssp HTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCTTCCCBCCCCSCTT
T ss_pred HHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCC--EEEeecceeeeccCCCcccccccCCcc
Confidence 764 36999999999999999999999999999999999999987765 999999999865443332 34589999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|++||.+.............+......+| ..+|+++++||.+||+++
T Consensus 355 Y~APE~l~~~~~~~~-~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~d 431 (543)
T 3c4z_A 355 FMAPELLLGEEYDFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP--DKFSPASKDFCEALLQKD 431 (543)
T ss_dssp TSCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHHHHHSCSS
T ss_pred ccChhhhcCCCCChH-HhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC--cccCHHHHHHHHHhccCC
Confidence 999999998888655 99999999999999999999876443233344444444444444 368999999999999999
Q ss_pred CCCCCC-----HhHHhcCccccc
Q 019901 235 PAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~s-----~~ell~h~~~~~ 252 (334)
|.+||+ ++++++||||+.
T Consensus 432 P~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 432 PEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp GGGSCCCBTTBSHHHHTSGGGTT
T ss_pred HhHCCCCcccCHHHHHcCccccC
Confidence 999996 589999999975
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=340.96 Aligned_cols=247 Identities=25% Similarity=0.360 Sum_probs=196.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
+|++ .+++..+|+.| |||++...... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+++|..++.
T Consensus 16 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 94 (311)
T 4agu_A 16 YGVVFKCRNRDTGQIV-AIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR 94 (311)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHH
T ss_pred CeEEEEEEeCCCCcEE-EEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHh
Confidence 4444 47888889999 99998765521 23567899999999999999999999999999999999999999999888
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccch
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPE 159 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE 159 (334)
..+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||
T Consensus 95 ~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE 172 (311)
T 4agu_A 95 YQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSV--IKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172 (311)
T ss_dssp TSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECC------------GGGCCHH
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCC--EEEeeCCCchhccCcccccCCCcCCccccChH
Confidence 8888999999999999999999999999999999999999987664 9999999997544222 234557999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCCC---------
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD--------- 215 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~--------- 215 (334)
++.+....+.++||||||+++|+|++|++||.+................ .....+.
T Consensus 173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (311)
T 4agu_A 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252 (311)
T ss_dssp HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHH
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhh
Confidence 9987544455699999999999999999999887765544333222110 0001111
Q ss_pred -CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 -YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 -~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+++.+.+||.+||+.||.+|||++++++||||++.
T Consensus 253 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 291 (311)
T 4agu_A 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291 (311)
T ss_dssp HCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTC
T ss_pred hcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhc
Confidence 13578999999999999999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-48 Score=348.70 Aligned_cols=248 Identities=28% Similarity=0.386 Sum_probs=192.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||++ .+++..+++.| |||++..... .....+.+|+.+++.++||||+++++++..++.+++||||+. ++|.+++.
T Consensus 47 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 124 (329)
T 3gbz_A 47 YGEVYKAIDTVTNETV-AIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMD 124 (329)
T ss_dssp SSEEEEEEETTTTEEE-EEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHH
T ss_pred CeEEEEEEECCCCceE-EEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHh
Confidence 3444 47788899988 9999976542 224567899999999999999999999999999999999997 59999999
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC---CCCEEEeccCCccCCCCC-CCCCCccCCCccc
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP---APRLKICDFGYSKSSVLH-SQPKSTVGTPAYI 156 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~---~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y~ 156 (334)
..+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++..... ......+||+.|+
T Consensus 125 ~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~ 204 (329)
T 3gbz_A 125 KNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204 (329)
T ss_dssp HCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCcccc
Confidence 988999999999999999999999999999999999999995432 235999999998754322 2234457899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cC------CCC-------------
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI------PDY------------- 216 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~------~~~------------- 216 (334)
|||++.+....+.++|||||||++|+|++|+.||.+......+............ .. +.+
T Consensus 205 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (329)
T 3gbz_A 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK 284 (329)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHH
T ss_pred CHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHh
Confidence 9999987654455599999999999999999999987766555554433211110 00 000
Q ss_pred ----CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 217 ----VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 217 ----~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..+++++.+||.+||+.||.+|||++|+|+||||+..
T Consensus 285 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 285 RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp HHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 0168999999999999999999999999999999653
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=336.08 Aligned_cols=244 Identities=41% Similarity=0.723 Sum_probs=197.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+.+..+|+.| |||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++
T Consensus 24 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (276)
T 2h6d_A 24 FGKVKIGEHQLTGHKV-AVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYI 102 (276)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CeEEEEEEECCCCceE-EEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHH
Confidence 3444 47778889998 999997653 234468899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++.............||+.|+|||
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 103 CKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMN--AKIADFGLSNMMSDGEFLRTSCGSPNYAAPE 180 (276)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSC--EEECCCCGGGCCCC-------------CCTG
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCC--EEEeecccccccCCCcceecccCCccccCHH
Confidence 98888999999999999999999999999999999999999987665 9999999998665544445567999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..+.+.++||||||+++|+|++|+.||......... ..+.......| ..+++.+.++|.+||+.+|.+||
T Consensus 181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~----~~~~~~~~~~~--~~~~~~l~~li~~~l~~~p~~Rp 254 (276)
T 2h6d_A 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLF----KKIRGGVFYIP--EYLNRSVATLLMHMLQVDPLKRA 254 (276)
T ss_dssp GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSSGGGSC
T ss_pred HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHH----HHhhcCcccCc--hhcCHHHHHHHHHHccCChhhCC
Confidence 9988776666699999999999999999999876543322 22333333333 35789999999999999999999
Q ss_pred CHhHHhcCccccccCCC
Q 019901 240 SIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 240 s~~ell~h~~~~~~~~~ 256 (334)
|++++++||||++..+.
T Consensus 255 s~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 255 TIKDIREHEWFKQDLPS 271 (276)
T ss_dssp CHHHHHHSHHHHTTCCG
T ss_pred CHHHHHhChhhccCchh
Confidence 99999999999886643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=345.60 Aligned_cols=246 Identities=23% Similarity=0.406 Sum_probs=191.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||++ .+++..+++.| |||++..... .....+.+|+.+++.++||||+++++++..++..++||||+. ++|.+++..
T Consensus 15 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~ 92 (324)
T 3mtl_A 15 YATVYKGKSKLTDNLV-ALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDD 92 (324)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHH
T ss_pred CEEEEEEEECCCCcEE-EEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHh
Confidence 3444 47788899998 9999976542 222355689999999999999999999999999999999996 588888876
Q ss_pred cC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccch
Q 019901 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPE 159 (334)
Q Consensus 82 ~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE 159 (334)
.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||
T Consensus 93 ~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE 170 (324)
T 3mtl_A 93 CGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGE--LKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170 (324)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCC--EEECSSSEEECC------------CGGGCCHH
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCC--EEEccCcccccccCCccccccccCcccccChh
Confidence 54 5999999999999999999999999999999999999987765 9999999987543322 233457899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cC-----------------------CC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI-----------------------PD 215 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~-----------------------~~ 215 (334)
++.+....+.++|||||||++|+|++|+.||.+................... .. +.
T Consensus 171 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (324)
T 3mtl_A 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH 250 (324)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH
T ss_pred hhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh
Confidence 9987544455599999999999999999999987765555444332211100 00 01
Q ss_pred CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 ~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 251 ~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 288 (324)
T 3mtl_A 251 APRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSL 288 (324)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGG
T ss_pred cCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhc
Confidence 23468999999999999999999999999999999764
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=339.53 Aligned_cols=244 Identities=34% Similarity=0.551 Sum_probs=199.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
+|.+ .+++..+|+.| |||++..........+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...
T Consensus 22 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 100 (304)
T 2jam_A 22 FSEVFLVKQRLTGKLF-ALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100 (304)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred CceEEEEEECCCCCEE-EEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHc
Confidence 3444 47888899998 999998765445567899999999999999999999999999999999999999999999888
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL 161 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~ 161 (334)
+.+++..++.++.|++.||.|||++||+||||||+||++.. +..+.+||+|||+++..... ......||+.|+|||++
T Consensus 101 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~ 179 (304)
T 2jam_A 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVL 179 (304)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTB
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHh
Confidence 88999999999999999999999999999999999999932 12235999999998753322 22345699999999999
Q ss_pred ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 162 LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 162 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
.+..++. ++|||||||++|+|++|+.||........... +..... ..+.+..+++.+.+||.+||..+|.+||
T Consensus 180 ~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp 254 (304)
T 2jam_A 180 AQKPYSK-AVDCWSIGVITYILLCGYPPFYEETESKLFEK----IKEGYYEFESPFWDDISESAKDFICHLLEKDPNERY 254 (304)
T ss_dssp SSCSCCH-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC
T ss_pred ccCCCCc-hhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHH----HHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCc
Confidence 8877754 49999999999999999999987665433332 222222 2233456899999999999999999999
Q ss_pred CHhHHhcCccccccC
Q 019901 240 SIPEIRNHEWFLKNL 254 (334)
Q Consensus 240 s~~ell~h~~~~~~~ 254 (334)
|++++++||||....
T Consensus 255 s~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 255 TCEKALSHPWIDGNT 269 (304)
T ss_dssp CHHHHHTSHHHHSSC
T ss_pred CHHHHhcCccccCCC
Confidence 999999999997643
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=352.62 Aligned_cols=246 Identities=24% Similarity=0.327 Sum_probs=189.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCCh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L 75 (334)
||.+ .|+++.+|+.| |||++..... .....+.+|+.+++.++||||+++++++... +.+|+||||+. ++|
T Consensus 39 ~g~V~~a~~~~~~~~v-AiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L 116 (432)
T 3n9x_A 39 YGYVYLAYDKNTEKNV-AIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDL 116 (432)
T ss_dssp TEEEEEEEETTTTEEE-EEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEH
T ss_pred CEEEEEEEECCCCcEE-EEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCH
Confidence 3444 48888899998 9999976531 2336788999999999999999999999766 57999999995 699
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----------
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----------- 144 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----------- 144 (334)
.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+......
T Consensus 117 ~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~ 194 (432)
T 3n9x_A 117 KKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCS--VKVCDFGLARTINSEKDTNIVNDLEEN 194 (432)
T ss_dssp HHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEEC---------------
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCC--EEEccCCCccccccccccccccccccc
Confidence 999988888999999999999999999999999999999999999987765 9999999998543321
Q ss_pred ------------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-----------CCCCCCCCCc------
Q 019901 145 ------------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-----------GAYPFEDPEE------ 195 (334)
Q Consensus 145 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-----------g~~pf~~~~~------ 195 (334)
.....+||++|+|||++......+.++|||||||++|+|++ |+++|.+...
T Consensus 195 ~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~ 274 (432)
T 3n9x_A 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPD 274 (432)
T ss_dssp ----------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----
T ss_pred ccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcc
Confidence 12456799999999997555444556999999999999998 4444544321
Q ss_pred -----------hHHHHHHHHHH--------------------hhccccCC-----CCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 196 -----------PKNFRKTIHRI--------------------LSVQYSIP-----DYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 196 -----------~~~~~~~~~~~--------------------~~~~~~~~-----~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
..++..++... .......+ .+..+++++.+||.+||+.||.+||
T Consensus 275 ~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 354 (432)
T 3n9x_A 275 RNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRI 354 (432)
T ss_dssp ------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC
T ss_pred cccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC
Confidence 11111111100 00000001 1245799999999999999999999
Q ss_pred CHhHHhcCcccccc
Q 019901 240 SIPEIRNHEWFLKN 253 (334)
Q Consensus 240 s~~ell~h~~~~~~ 253 (334)
|++|+|+||||..-
T Consensus 355 ta~e~L~Hp~f~~~ 368 (432)
T 3n9x_A 355 TIDQALDHPYLKDV 368 (432)
T ss_dssp CHHHHHTCGGGTTT
T ss_pred CHHHHhcChhhhhc
Confidence 99999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=348.40 Aligned_cols=246 Identities=22% Similarity=0.351 Sum_probs=196.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~ 69 (334)
||.|+| .+.++.+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++...+ .+|+||||
T Consensus 33 lG~G~~g~V~~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~ 111 (367)
T 1cm8_A 33 VGSGAYGAVCSAVDGRTGAKV-AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111 (367)
T ss_dssp C------CEEEEEETTTCCEE-EEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred eeecCCeEEEEEEECCCCCEE-EEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEec
Confidence 566665 47888999999 9999866441 22357889999999999999999999998653 46999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .....
T Consensus 112 ~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~--~~~~~ 185 (367)
T 1cm8_A 112 M-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS--EMTGY 185 (367)
T ss_dssp C-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS--SCCSS
T ss_pred C-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCC--EEEEeeeccccccc--ccCcC
Confidence 9 8899998876 57999999999999999999999999999999999999987765 99999999986432 23456
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-------------------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------- 210 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 210 (334)
+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+........
T Consensus 186 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~ 265 (367)
T 1cm8_A 186 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 265 (367)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhC
Confidence 7999999999998743334559999999999999999999998776555554433211100
Q ss_pred c-----cC-CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 Y-----SI-PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 ~-----~~-~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
. .+ .....+++.+.+||.+||..||.+|||++++|+||||....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 266 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 00 01235789999999999999999999999999999997643
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=333.80 Aligned_cols=245 Identities=32% Similarity=0.563 Sum_probs=203.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+.++.+++.| |||++..... ...+.+.+|+.+++.++||||+++++++.+++..|+||||+++++|.+++..
T Consensus 20 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 98 (276)
T 2yex_A 20 YGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 98 (276)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT
T ss_pred CcEEEEEEECCCCcEE-EEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhh
Confidence 4444 47788899998 9999976542 3347889999999999999999999999999999999999999999999987
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccc
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aP 158 (334)
...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|+||
T Consensus 99 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 176 (276)
T 2yex_A 99 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176 (276)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGCCG
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCC--EEEeeCCCccccCCCcchhcccCCccccCccCh
Confidence 778999999999999999999999999999999999999987665 999999998753222 223455799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..+.+.++||||||+++|+|++|+.||........... .........+.+..+++.+.++|.+||+.+|.+|
T Consensus 177 E~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 253 (276)
T 2yex_A 177 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 253 (276)
T ss_dssp GGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH---HHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred HHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH---HhhhcccccCchhhcCHHHHHHHHHHCCCCchhC
Confidence 9998877766669999999999999999999987654322221 1222222333345689999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 019901 239 ISIPEIRNHEWFLKNL 254 (334)
Q Consensus 239 ~s~~ell~h~~~~~~~ 254 (334)
||++++++||||++..
T Consensus 254 ps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 254 ITIPDIKKDRWYNKPL 269 (276)
T ss_dssp CCHHHHTTCTTTTCCC
T ss_pred CCHHHHhcCccccChh
Confidence 9999999999997653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=347.22 Aligned_cols=241 Identities=29% Similarity=0.515 Sum_probs=201.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
+|.+ .|+++.+|+.| |||++...... ..+.+.+|+.+++.+ +||||+++++++...+..|+||||+.|+
T Consensus 107 ~g~Vy~a~~~~~g~~v-avK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~ 185 (365)
T 2y7j_A 107 SSVVRRCVHRATGHEF-AVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKG 185 (365)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTC
T ss_pred CEEEEEEEECCCCcEE-EEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCC
Confidence 4444 37778889999 99999876421 135678999999998 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++. +||+|||++............+||+
T Consensus 186 ~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~--ikl~DfG~~~~~~~~~~~~~~~gt~ 263 (365)
T 2y7j_A 186 ELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ--IRLSDFGFSCHLEPGEKLRELCGTP 263 (365)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSCG
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC--EEEEecCcccccCCCcccccCCCCC
Confidence 99999998888999999999999999999999999999999999999987665 9999999998665555555678999
Q ss_pred ccccchhhccC------CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCHHHHH
Q 019901 154 AYIAPEVLLKK------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECRH 225 (334)
Q Consensus 154 ~y~aPE~~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 225 (334)
.|+|||++.+. .++ .++|||||||++|+|++|+.||........... +...... .+.+..+++.+.+
T Consensus 264 ~y~aPE~~~~~~~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~~~~~~~ 338 (365)
T 2y7j_A 264 GYLAPEILKCSMDETHPGYG-KEVDLWACGVILFTLLAGSPPFWHRRQILMLRM----IMEGQYQFSSPEWDDRSSTVKD 338 (365)
T ss_dssp GGCCHHHHHHTTCTTSCCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCHHHHSSSCHHHHH
T ss_pred CccChhhccccccccCcCCC-chhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH----HHhCCCCCCCcccccCCHHHHH
Confidence 99999998643 344 449999999999999999999987655333322 2222222 2334567999999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||.+||+.+|.+|||++++++||||++
T Consensus 339 li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 339 LISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999963
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-47 Score=343.89 Aligned_cols=248 Identities=25% Similarity=0.372 Sum_probs=196.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc--------CCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT--------PTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--------~~~~~lv~ 67 (334)
||.|++ .+++..+|+.| |||++..... .....+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus 25 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~ 103 (351)
T 3mi9_A 25 IGQGTFGEVFKARHRKTGQKV-ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103 (351)
T ss_dssp CSSCSTTSEEEEEETTTCCEE-EEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEE
T ss_pred EecCCCcEEEEEEECCCCCEE-EEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEE
Confidence 566655 48888999999 9999876652 234678899999999999999999999886 45789999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC----
Q 019901 68 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL---- 142 (334)
Q Consensus 68 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~---- 142 (334)
||+.+ +|...+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 104 e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~ 180 (351)
T 3mi9_A 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNS 180 (351)
T ss_dssp ECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECCCCSSS
T ss_pred eccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCC--EEEccchhcccccccccc
Confidence 99975 777776654 56999999999999999999999999999999999999987765 99999999975431
Q ss_pred -CCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-CCCCC---
Q 019901 143 -HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYV--- 217 (334)
Q Consensus 143 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~--- 217 (334)
........||+.|+|||++.+....+.++|||||||++|+|++|++||.+.................... .+...
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 2223445789999999999875544556999999999999999999999877655544433322111111 01100
Q ss_pred ----------------------CCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 218 ----------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 218 ----------------------~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 026789999999999999999999999999999764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=334.36 Aligned_cols=240 Identities=32% Similarity=0.583 Sum_probs=199.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+++..++..| |||++.+... .....+.+|+.+++.++||||+++++++.+.+..++||||+.+++|.+.+
T Consensus 22 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l 100 (279)
T 3fdn_A 22 FGNVYLAREKQSKFIL-ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL 100 (279)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CeEEEEEEEccCCcEE-EEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHH
Confidence 3444 47788888888 9999976542 33567899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..... .......||+.|+|||
T Consensus 101 ~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~--~~l~Dfg~~~~~~~-~~~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRTDLCGTLDYLPPE 177 (279)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSC--EEECSCCEESCC---------CCCCTTCCHH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCC--EEEEeccccccCCc-ccccccCCCCCccCHh
Confidence 98888999999999999999999999999999999999999987665 99999998864332 2234567999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++.+ +||||||+++|+|++|..||.......... .+.......| ..+++.+.+||.+||+.+|.+||
T Consensus 178 ~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp 250 (279)
T 3fdn_A 178 MIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYK----RISRVEFTFP--DFVTEGARDLISRLLKHNPSQRP 250 (279)
T ss_dssp HHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHHHHHHHCCSSGGGSC
T ss_pred HhccCCCCcc-chhHhHHHHHHHHHHCCCCCCCCcHHHHHH----HHHhCCCCCC--CcCCHHHHHHHHHHhccChhhCC
Confidence 9988777655 999999999999999999998765533332 2333333333 34799999999999999999999
Q ss_pred CHhHHhcCccccccC
Q 019901 240 SIPEIRNHEWFLKNL 254 (334)
Q Consensus 240 s~~ell~h~~~~~~~ 254 (334)
|+.++++||||+...
T Consensus 251 s~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 251 MLREVLEHPWITANS 265 (279)
T ss_dssp CHHHHHHCHHHHHHC
T ss_pred CHHHHhhCccccCCc
Confidence 999999999997754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=357.74 Aligned_cols=243 Identities=31% Similarity=0.523 Sum_probs=190.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.+ .|.+..+++.| |||++.+.... ....+.+|+.++++++||||+++++++.. +..|+||||+.+++
T Consensus 148 ~g~V~~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~ 225 (419)
T 3i6u_A 148 CGEVKLAFERKTCKKV-AIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGE 225 (419)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCB
T ss_pred CeEEEEEEECCCCcEE-EEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCc
Confidence 4444 47889999999 99999875421 12358899999999999999999999854 56899999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++..+ ...+||+|||+|+...........+||+
T Consensus 226 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~ 305 (419)
T 3i6u_A 226 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305 (419)
T ss_dssp GGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------C
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCC
Confidence 999998888899999999999999999999999999999999999997543 2359999999998765555556678999
Q ss_pred ccccchhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHH
Q 019901 154 AYIAPEVLLK---KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLIS 228 (334)
Q Consensus 154 ~y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 228 (334)
.|+|||++.+ ..+ +.++|||||||++|+|++|++||........+...+. ...... +.+..+++.+.+||.
T Consensus 306 ~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~li~ 381 (419)
T 3i6u_A 306 TYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---SGKYNFIPEVWAEVSEKALDLVK 381 (419)
T ss_dssp TTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---TTCCCCCHHHHTTSCHHHHHHHH
T ss_pred CccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---cCCCCCCchhhcccCHHHHHHHH
Confidence 9999999864 333 4459999999999999999999987654433333222 222211 223467999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+||+.+|.+|||++++|+||||+.
T Consensus 382 ~~L~~dP~~Rps~~e~l~hp~~~~ 405 (419)
T 3i6u_A 382 KLLVVDPKARFTTEEALRHPWLQD 405 (419)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHccCChhHCcCHHHHhCCcccCC
Confidence 999999999999999999999964
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=347.83 Aligned_cols=246 Identities=27% Similarity=0.456 Sum_probs=196.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCc-----ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHL-----WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~-----~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.+ .+++..++..| |||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++|||||+||+|.+
T Consensus 39 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~ 117 (345)
T 3hko_A 39 YGVVRVAIENQTRAIR-AIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLD 117 (345)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred CeEEEEEEECCCCceE-EEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHH
Confidence 3444 47888899998 999997653 1334688999999999999999999999999999999999999999999
Q ss_pred HHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCC
Q 019901 78 RICN----------------------------------------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLE 117 (334)
Q Consensus 78 ~l~~----------------------------------------~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~ 117 (334)
++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 118 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~ 197 (345)
T 3hko_A 118 KLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPE 197 (345)
T ss_dssp HEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChh
Confidence 8842 112467889999999999999999999999999999
Q ss_pred cEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCccCCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCC
Q 019901 118 NTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPF 190 (334)
Q Consensus 118 NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf 190 (334)
|||++.++...+||+|||+++...... ......||+.|+|||++.+ ..++ .++|||||||++|+|++|+.||
T Consensus 198 NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf 276 (345)
T 3hko_A 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG-PKCDAWSAGVLLHLLLMGAVPF 276 (345)
T ss_dssp GEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCC-THHHHHHHHHHHHHHHHSSCSS
T ss_pred hEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCC-cHHHHHHHHHHHHHHHHCCCCC
Confidence 999987664469999999997532211 1245579999999999975 4444 4599999999999999999999
Q ss_pred CCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 191 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.+............. ......+....+++.+.+||.+||+.+|.+|||+.++++||||++.
T Consensus 277 ~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~ 337 (345)
T 3hko_A 277 PGVNDADTISQVLNK--KLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF 337 (345)
T ss_dssp CCSSHHHHHHHHHHC--CCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred CCCChHHHHHHHHhc--ccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence 887765444433222 1112223334579999999999999999999999999999999763
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=335.45 Aligned_cols=244 Identities=31% Similarity=0.558 Sum_probs=200.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+++..+|+.| |+|++...... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.
T Consensus 18 ~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (283)
T 3bhy_A 18 FAIVRKCRQKGTGKEY-AAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELF 96 (283)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHH
T ss_pred ceEEEEEEEcCCCCee-ehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHH
Confidence 4444 47788889999 99999876522 2467999999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC--CCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP--APRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~--~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
+++.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++ ...+||+|||++.............||+.
T Consensus 97 ~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 176 (283)
T 3bhy_A 97 DFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPE 176 (283)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGG
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcC
Confidence 9998888899999999999999999999999999999999999997654 22599999999986554444455679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~ 232 (334)
|+|||++.+..++.+ +||||||+++|+|++|..||.+......... +.......+ .+..+++.+.++|.+||.
T Consensus 177 y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 251 (283)
T 3bhy_A 177 FVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGETKQETLTN----ISAVNYDFDEEYFSNTSELAKDFIRRLLV 251 (283)
T ss_dssp GCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH----HHTTCCCCCHHHHTTCCHHHHHHHHTTSC
T ss_pred ccCcceecCCCCCcc-hhhhhHHHHHHHHHHCCCCCCCcchHHHHHH----hHhcccCCcchhcccCCHHHHHHHHHHcc
Confidence 999999988777655 9999999999999999999987665333322 222222221 224578999999999999
Q ss_pred cCCCCCCCHhHHhcCcccccc
Q 019901 233 ADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~ 253 (334)
.+|.+|||+.++++||||+..
T Consensus 252 ~dp~~Rps~~~~l~h~~~~~~ 272 (283)
T 3bhy_A 252 KDPKRRMTIAQSLEHSWIKAI 272 (283)
T ss_dssp SSGGGSCCHHHHHHCHHHHHH
T ss_pred CCHhHCcCHHHHHhCHHHHHH
Confidence 999999999999999999753
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-47 Score=371.23 Aligned_cols=241 Identities=30% Similarity=0.507 Sum_probs=207.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| +++++.+++.| |||++.+.. ....+.+.+|..++..+ +||+|+++++++.+.+.+|+||||+.||
T Consensus 349 LG~G~fG~V~~~~~~~~~~~v-AvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg 427 (674)
T 3pfq_A 349 LGKGSFGKVMLSERKGTDELY-AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGG 427 (674)
T ss_dssp SSBTTTBCEEEEEESSSCCEE-EEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSC
T ss_pred EccCCCEEEEEEEECCCCcEE-EEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCC
Confidence 566655 48888899999 999998753 23456788999999887 7999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt 152 (334)
+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .....+.+||
T Consensus 428 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~--ikL~DFGla~~~~~~~~~~~~~~GT 505 (674)
T 3pfq_A 428 DLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH--IKIADFGMCKENIWDGVTTKTFCGT 505 (674)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSC--EEECCCTTCEECCCTTCCBCCCCSC
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCc--EEEeecceeeccccCCcccccccCC
Confidence 99999999889999999999999999999999999999999999999987765 99999999985332 3334566899
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|++||.+.+.... ...+......+|. .+++++++||.+||+
T Consensus 506 ~~Y~APE~l~~~~~~~~-~DvwSlGvilyelltG~~Pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~~li~~lL~ 578 (674)
T 3pfq_A 506 PDYIAPEIIAYQPYGKS-VDWWAFGVLLYEMLAGQAPFEGEDEDEL----FQSIMEHNVAYPK--SMSKEAVAICKGLMT 578 (674)
T ss_dssp SSSCCHHHHTCCCBSTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHSSCCCCCT--TSCHHHHHHHHHHSC
T ss_pred CcccCHhhhcCCCCCcc-ceEechHHHHHHHHcCCCCCCCCCHHHH----HHHHHhCCCCCCc--cCCHHHHHHHHHHcc
Confidence 99999999988888655 9999999999999999999998665433 3344555555554 589999999999999
Q ss_pred cCCCCCCCH-----hHHhcCccccc
Q 019901 233 ADPAKRISI-----PEIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~-----~ell~h~~~~~ 252 (334)
+||.+||++ +++++||||..
T Consensus 579 ~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 579 KHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCHHHCCCCCCCcHHHHhcCccccC
Confidence 999999997 99999999964
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-47 Score=341.62 Aligned_cols=246 Identities=24% Similarity=0.432 Sum_probs=199.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..+|+.| |||++.+... .....+.+|+.+++.+. ||||+++++++...+..++||||+.+++|.+++
T Consensus 42 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 120 (327)
T 3lm5_A 42 FAVVRQCISKSTGQEY-AAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLC 120 (327)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGG
T ss_pred CeEEEEEEECCCCCEE-EEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHH
Confidence 3444 47788899999 9999987552 23468899999999995 699999999999999999999999999999988
Q ss_pred Hhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 80 CNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 80 ~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
... +.+++..++.++.||+.||.|||++||+||||||+|||++... .+.+||+|||+++............||+.|+
T Consensus 121 ~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~ 200 (327)
T 3lm5_A 121 LPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYL 200 (327)
T ss_dssp SSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGC
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCcc
Confidence 553 6699999999999999999999999999999999999997621 2359999999998665554455668999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|||||||++|+|++|+.||.+............ .......+.+..+++.+.+||.+||+.+|.
T Consensus 201 aPE~~~~~~~~~~-~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 277 (327)
T 3lm5_A 201 APEILNYDPITTA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ--VNVDYSEETFSSVSQLATDFIQSLLVKNPE 277 (327)
T ss_dssp CHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH--TCCCCCTTTTTTSCHHHHHHHHHHSCSSGG
T ss_pred CCeeecCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh--cccccCchhhcccCHHHHHHHHHHcCCChh
Confidence 9999988877655 9999999999999999999988765444333221 122233344457899999999999999999
Q ss_pred CCCCHhHHhcCcccccc
Q 019901 237 KRISIPEIRNHEWFLKN 253 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~ 253 (334)
+|||++++|+||||++.
T Consensus 278 ~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 278 KRPTAEICLSHSWLQQW 294 (327)
T ss_dssp GSCCHHHHTTCGGGCCC
T ss_pred hCcCHHHHhCCHhhccc
Confidence 99999999999999653
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=343.06 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=198.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .+++..+|+.| |||++...... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus 33 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l 111 (331)
T 4aaa_A 33 VGEGSYGMVMKCRNKDTGRIV-AIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTIL 111 (331)
T ss_dssp GGGGTTSSEEEEEETTTCCEE-EEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EeecCCEEEEEEEECCCCceE-EEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchH
Confidence 455544 47888889999 99999766522 235678999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~ 154 (334)
..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.
T Consensus 112 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~t~~ 189 (331)
T 4aaa_A 112 DDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGV--VKLCDFGFARTLAAPGEVYDDEVATRW 189 (331)
T ss_dssp HHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCTTC------------CCCCCT
T ss_pred HHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCc--EEEEeCCCceeecCCccccCCCcCCcc
Confidence 888877788999999999999999999999999999999999999987764 999999999754332 22345579999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh---------------ccccCCC----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS---------------VQYSIPD---- 215 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------~~~~~~~---- 215 (334)
|+|||++.+....+.++|||||||++|+|++|++||.+................ .....+.
T Consensus 190 y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (331)
T 4aaa_A 190 YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKER 269 (331)
T ss_dssp TCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSC
T ss_pred ccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCcccccc
Confidence 999999987644455699999999999999999999987765554443322110 0011111
Q ss_pred ------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 ------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 ------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+++.+.+||.+||+.||.+|||++|+|+||||+.
T Consensus 270 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 312 (331)
T 4aaa_A 270 EPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQM 312 (331)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHG
T ss_pred chhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhcc
Confidence 2357899999999999999999999999999999965
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=349.05 Aligned_cols=249 Identities=24% Similarity=0.362 Sum_probs=182.4
Q ss_pred CCCccee----eeeec--CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCC
Q 019901 1 MLGFHNF----YDRCS--YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASG 72 (334)
Q Consensus 1 ~lG~g~~----~~~~~--~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~ 72 (334)
+||.|+| .++++ .++..| |||++.... ....+.+|+.+++.++||||+++++++.. ...+|+||||+.
T Consensus 28 ~lG~G~~g~Vy~~~~~~~~~~~~v-aiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~- 103 (405)
T 3rgf_A 28 KVGRGTYGHVYKAKRKDGKDDKDY-ALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE- 103 (405)
T ss_dssp CCC-----EEEEEEESSSSCCCCE-EEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred EeeecCCeEEEEEEEccCCCCeEE-EEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence 3677777 35543 567788 999987554 45678999999999999999999999954 678999999996
Q ss_pred CChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC--CCCCEEEeccCCccCCC
Q 019901 73 GELFERICNA---------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS--PAPRLKICDFGYSKSSV 141 (334)
Q Consensus 73 ~~L~~~l~~~---------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~--~~~~~kl~Dfgla~~~~ 141 (334)
++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||+... ..+.+||+|||+|+...
T Consensus 104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~ 183 (405)
T 3rgf_A 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183 (405)
T ss_dssp EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC---
T ss_pred CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecC
Confidence 5888877532 249999999999999999999999999999999999999421 22359999999998543
Q ss_pred CC----CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---------HHHHHHHHHHhh
Q 019901 142 LH----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---------KNFRKTIHRILS 208 (334)
Q Consensus 142 ~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---------~~~~~~~~~~~~ 208 (334)
.. ......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.... ..+..+......
T Consensus 184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~ 263 (405)
T 3rgf_A 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 263 (405)
T ss_dssp -------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCC
T ss_pred CCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCC
Confidence 32 22344679999999999987664556699999999999999999999765431 222222221110
Q ss_pred cccc-C-------------------------------CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 209 VQYS-I-------------------------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 209 ~~~~-~-------------------------------~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.... . ......++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 264 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~ 340 (405)
T 3rgf_A 264 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED 340 (405)
T ss_dssp CCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred CChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence 0000 0 0011237889999999999999999999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=350.09 Aligned_cols=244 Identities=23% Similarity=0.357 Sum_probs=196.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc------------------
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT------------------ 59 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------------------ 59 (334)
||.|+| .|.+..+|+.| |||++.... ....+|+.+++.++||||+++++++..
T Consensus 15 lG~G~fg~V~~a~~~~~~~~v-AiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~ 89 (383)
T 3eb0_A 15 LGTGSFGIVCEVFDIESGKRF-ALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKL 89 (383)
T ss_dssp EECC-CEEEEEEEETTTCCEE-EEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------
T ss_pred EEeccCEEEEEEEECCCCCEE-EEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccc
Confidence 455555 47788999999 999987654 223479999999999999999999844
Q ss_pred --------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCC
Q 019901 60 --------------------PTHLAIVMEYASGGELFERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLK 115 (334)
Q Consensus 60 --------------------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlk 115 (334)
...+++||||+. ++|.+.+. ..+.+++..++.++.||+.||.|||++||+|||||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dik 168 (383)
T 3eb0_A 90 GGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIK 168 (383)
T ss_dssp --------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCC
T ss_pred cccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccC
Confidence 334899999997 57766554 45679999999999999999999999999999999
Q ss_pred CCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc
Q 019901 116 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 195 (334)
Q Consensus 116 p~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 195 (334)
|+|||++... +.+||+|||+|+............||+.|+|||++.+....+.++|||||||++|+|++|++||.+...
T Consensus 169 p~Nil~~~~~-~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 247 (383)
T 3eb0_A 169 PQNLLVNSKD-NTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247 (383)
T ss_dssp GGGEEEETTT-TEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHEEEcCCC-CcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCCh
Confidence 9999997422 259999999998765555566778999999999998766445559999999999999999999998877
Q ss_pred hHHHHHHHHHHhhc-------------cccCC----------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 196 PKNFRKTIHRILSV-------------QYSIP----------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 196 ~~~~~~~~~~~~~~-------------~~~~~----------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+...+...... ...+| ....+++++.+||.+||+.+|.+|||+.|+++||||..
T Consensus 248 ~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~ 327 (383)
T 3eb0_A 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327 (383)
T ss_dssp HHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred HHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence 66665554322111 00111 12247899999999999999999999999999999975
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=332.14 Aligned_cols=240 Identities=31% Similarity=0.590 Sum_probs=202.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+++..++..| |||++.+... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++
T Consensus 27 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 105 (284)
T 2vgo_A 27 FGNVYLAREKQNKFIM-ALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKEL 105 (284)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CeEEEEEEEcCCCcEE-EEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHH
Confidence 3444 47778888888 9999976531 23467899999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+.+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... ......|++.|+|||
T Consensus 106 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 106 QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGE--LKIADFGWSVHAPSL-RRRTMCGTLDYLPPE 182 (284)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCC--EEECCCTTCEECSSS-CBCCCCSCGGGCCHH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCC--EEEecccccccCccc-ccccccCCCCcCCHH
Confidence 98888999999999999999999999999999999999999987665 999999998654322 234567999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++.+ +||||||+++|+|++|..||......... ..+......+| ..+++.++++|.+||+.+|.+||
T Consensus 183 ~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~----~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rp 255 (284)
T 2vgo_A 183 MIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETH----RRIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRL 255 (284)
T ss_dssp HHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHTTCCCCC--TTSCHHHHHHHHHHSCSSGGGSC
T ss_pred HhccCCCCcc-cchhhHHHHHHHHHHCCCCCCCCCHhHHH----HHHhccccCCC--CcCCHHHHHHHHHHhhcCHhhCC
Confidence 9988877655 99999999999999999999876553332 22333333333 35799999999999999999999
Q ss_pred CHhHHhcCccccccC
Q 019901 240 SIPEIRNHEWFLKNL 254 (334)
Q Consensus 240 s~~ell~h~~~~~~~ 254 (334)
|++++++||||+...
T Consensus 256 s~~~ll~h~~~~~~~ 270 (284)
T 2vgo_A 256 PLKGVMEHPWVKANS 270 (284)
T ss_dssp CHHHHHTCHHHHHHC
T ss_pred CHHHHhhCHHHHhhc
Confidence 999999999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.48 Aligned_cols=236 Identities=19% Similarity=0.216 Sum_probs=184.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHc-CCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRS-LRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~-l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||++ .+++..+|..| |||++...... ......+|+..+.. .+||||+++++++.+++.+|+||||+ +++|.+.+
T Consensus 70 ~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~ 147 (311)
T 3p1a_A 70 YGEVFKVRSKEDGRLY-AVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHC 147 (311)
T ss_dssp TEEEEEEEETTTSCEE-EEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHH
T ss_pred CeEEEEEEECCCCeEE-EEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHH
Confidence 4444 47788899998 99998765422 22344455555544 48999999999999999999999999 67888887
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccc
Q 019901 80 CNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aP 158 (334)
... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++............||+.|+||
T Consensus 148 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~gt~~y~aP 225 (311)
T 3p1a_A 148 EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGR--CKLGDFGLLVELGTAGAGEVQEGDPRYMAP 225 (311)
T ss_dssp HHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGC--EEECCCTTCEECC------CCCCCGGGCCG
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCC--EEEccceeeeecccCCCCcccCCCccccCH
Confidence 764 45999999999999999999999999999999999999987765 999999999866555555566799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+ .++. ++|||||||++|+|++|..||.+... . ..+............+++++.+||.+||+.+|.+|
T Consensus 226 E~~~~-~~~~-~~DiwslG~il~el~~g~~~~~~~~~---~----~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R 296 (311)
T 3p1a_A 226 ELLQG-SYGT-AADVFSLGLTILEVACNMELPHGGEG---W----QQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLR 296 (311)
T ss_dssp GGGGT-CCST-HHHHHHHHHHHHHHHHTCCCCSSHHH---H----HHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTS
T ss_pred hHhcC-CCCc-hhhHHHHHHHHHHHHhCCCCCCCccH---H----HHHhccCCCcccccCCCHHHHHHHHHHcCCChhhC
Confidence 99876 5554 49999999999999999777654321 1 11222111111233579999999999999999999
Q ss_pred CCHhHHhcCccccc
Q 019901 239 ISIPEIRNHEWFLK 252 (334)
Q Consensus 239 ~s~~ell~h~~~~~ 252 (334)
||++++++||||++
T Consensus 297 pt~~ell~hp~~~~ 310 (311)
T 3p1a_A 297 ATAEALLALPVLRQ 310 (311)
T ss_dssp CCHHHHHTSGGGSC
T ss_pred cCHHHHHhCccccC
Confidence 99999999999965
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=340.83 Aligned_cols=246 Identities=23% Similarity=0.353 Sum_probs=197.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.+ .+++..+|+.| |||++..... .....+.+|+.+++.++||||+++++++...+..++||||+.+ +|..
T Consensus 23 ~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~ 100 (346)
T 1ua2_A 23 FATVYKARDKNTNQIV-AIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEV 100 (346)
T ss_dssp TEEEEEEECSSCCSEE-EEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHH
T ss_pred CEEEEEEEECCCCcEE-EEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHH
Confidence 3444 47788889998 9999976442 1235788999999999999999999999999999999999975 8888
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCcc
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y 155 (334)
.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|
T Consensus 101 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~t~~y 178 (346)
T 1ua2_A 101 IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVVTRWY 178 (346)
T ss_dssp HHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCCCCTT
T ss_pred HHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCC--EEEEecccceeccCCcccCCcccccccc
Confidence 88764 45999999999999999999999999999999999999987765 9999999998653332 33456799999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cCCC-------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPD------------------- 215 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~------------------- 215 (334)
+|||++.+....+.++|||||||++|+|++|.+||.+......+............ ..+.
T Consensus 179 ~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (346)
T 1ua2_A 179 RAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLH 258 (346)
T ss_dssp CCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHH
T ss_pred cCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChH
Confidence 99999976654456699999999999999999999987776655555443221110 0000
Q ss_pred --CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 --YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 --~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+++++.+||.+||+.||.+|||++|+|+||||...
T Consensus 259 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~ 298 (346)
T 1ua2_A 259 HIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 298 (346)
T ss_dssp HHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred HhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence 13467899999999999999999999999999999764
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=346.58 Aligned_cols=246 Identities=21% Similarity=0.367 Sum_probs=183.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~ 69 (334)
||.|+| .+.+..+|+.| |||++..... .....+.+|+.+++.++||||+++++++... +.+|+|+|+
T Consensus 37 lG~G~~g~V~~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~ 115 (367)
T 2fst_X 37 VGSGAYGSVCAAFDTKTGLRV-AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 115 (367)
T ss_dssp CC----CCEEEEEETTTTEEE-EEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEEC
T ss_pred EeecCCeEEEEEEECCCCCEE-EEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEecc
Confidence 666665 47788899998 9999876431 2345788999999999999999999998754 568999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... .....
T Consensus 116 ~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~--~~~~~ 189 (367)
T 2fst_X 116 M-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTAD--EMTGY 189 (367)
T ss_dssp C-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECC----------------
T ss_pred c-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCC--EEEeeccccccccc--cCCCc
Confidence 9 7899888865 67999999999999999999999999999999999999987665 99999999985432 23456
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-------------------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------------- 210 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------- 210 (334)
.||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..+........
T Consensus 190 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 269 (367)
T 2fst_X 190 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 269 (367)
T ss_dssp -CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTS
T ss_pred CcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhcc
Confidence 7999999999998744445559999999999999999999998776555554443221100
Q ss_pred ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 ~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
...+ .....++.+.+||.+||+.||.+|||++++|+||||.+..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 270 TQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp CCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred CCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 0001 0134689999999999999999999999999999998653
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=333.24 Aligned_cols=242 Identities=31% Similarity=0.500 Sum_probs=201.7
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---------cccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---------QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---------~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
+|.+ .+.++.+|+.| |||++..... ...+.+.+|+.+++++. ||||+++++++..++..++||||+.+
T Consensus 30 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 108 (298)
T 1phk_A 30 SSVVRRCIHKPTCKEY-AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKK 108 (298)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred ceEEEEEEEcCcCceE-EEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCC
Confidence 3444 47788889988 9999986541 12356789999999995 99999999999999999999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.............||
T Consensus 109 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~ 186 (298)
T 1phk_A 109 GELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLREVCGT 186 (298)
T ss_dssp CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBCCCCSC
T ss_pred CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCc--EEEecccchhhcCCCcccccccCC
Confidence 999999998888999999999999999999999999999999999999987665 999999999866555455566799
Q ss_pred Cccccchhhc------cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCCCHHHH
Q 019901 153 PAYIAPEVLL------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECR 224 (334)
Q Consensus 153 ~~y~aPE~~~------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 224 (334)
+.|+|||++. ...+ +.++||||||+++|+|++|+.||........... +..... ..+.+..+++.+.
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~l~ 261 (298)
T 1phk_A 187 PSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM----IMSGNYQFGSPEWDDYSDTVK 261 (298)
T ss_dssp GGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCCCTTTGGGSCHHHH
T ss_pred ccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHH----HhcCCcccCcccccccCHHHH
Confidence 9999999985 2334 3459999999999999999999987655433322 222222 2333456899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 225 HLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
++|.+||+.+|.+|||+.++++||||++.
T Consensus 262 ~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (298)
T 1phk_A 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQY 290 (298)
T ss_dssp HHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence 99999999999999999999999999764
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=344.50 Aligned_cols=246 Identities=25% Similarity=0.365 Sum_probs=185.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~ 69 (334)
||.|+| .+.+..+++.| |||++..... .....+.+|+.+++.++||||+++++++...+ .+|+||||
T Consensus 33 lG~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~ 111 (371)
T 2xrw_A 33 IGSGAQGIVCAAYDAILERNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 111 (371)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEEC
T ss_pred eEecCCEEEEEEEECCCCceE-EEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEc
Confidence 444444 47788889888 9999986542 22357889999999999999999999997664 78999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+. ++|.+.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 112 ~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~ 186 (371)
T 2xrw_A 112 MD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 186 (371)
T ss_dssp CS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCC-------------
T ss_pred CC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCC--EEEEEeecccccccccccCCc
Confidence 96 57888875 35899999999999999999999999999999999999987665 999999999865544444556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc---------------ccCC
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------YSIP 214 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------~~~~ 214 (334)
+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+...+....... ...+
T Consensus 187 ~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (371)
T 2xrw_A 187 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRP 265 (371)
T ss_dssp ---CTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSC
T ss_pred eecCCccCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCc
Confidence 89999999999998877655 9999999999999999999998766544443322110000 0001
Q ss_pred CCC---------------------CCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 DYV---------------------HISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ~~~---------------------~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
... ..++++++||.+||+.||.+|||++++|+||||....
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 326 (371)
T 2xrw_A 266 KYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326 (371)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred cccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence 000 0156899999999999999999999999999997643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.07 Aligned_cols=243 Identities=33% Similarity=0.569 Sum_probs=204.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
+|.+ .+++..+++.| |||++..... .....+.+|+.++++++||||+++++++...+..++||||+.+++|.+.+.
T Consensus 35 ~g~V~~~~~~~~~~~v-alK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 113 (287)
T 2wei_A 35 FGEVLKCKDRITQQEY-AVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEII 113 (287)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred CEEEEEEEEcCCCcEE-EEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHH
Confidence 4444 47788899998 9999987542 334688999999999999999999999999999999999999999999998
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 81 ~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
+.+.+++..++.++.||+.||.|||++||+||||||+||+++.++ ...+||+|||+++............||+.|+|||
T Consensus 114 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE 193 (287)
T 2wei_A 114 KRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193 (287)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHH
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChH
Confidence 888899999999999999999999999999999999999997643 2369999999998655444445557899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--ccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--YSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
++.+. ++ .++||||||+++|+|++|..||.+........ .+.... ...+.+..+++++.++|.+||+.+|.+
T Consensus 194 ~~~~~-~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~ 267 (287)
T 2wei_A 194 VLRGT-YD-EKCDVWSAGVILYILLSGTPPFYGKNEYDILK----RVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267 (287)
T ss_dssp HHTTC-CC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGG
T ss_pred HhcCC-CC-CchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH----HHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhh
Confidence 98764 54 44999999999999999999998766543322 222222 233444678999999999999999999
Q ss_pred CCCHhHHhcCcccccc
Q 019901 238 RISIPEIRNHEWFLKN 253 (334)
Q Consensus 238 R~s~~ell~h~~~~~~ 253 (334)
|||+.++++||||++.
T Consensus 268 Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 268 RITATQCLEHPWIQKY 283 (287)
T ss_dssp SCCHHHHHHSHHHHHH
T ss_pred CcCHHHHhcCHHHhcc
Confidence 9999999999999764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-46 Score=341.70 Aligned_cols=242 Identities=22% Similarity=0.369 Sum_probs=194.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-----CCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-----HPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-----hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.+ .+++..++..| |||++.... .......+|+.+++.+. ||||+++++++...+..++||||+ +++|.+
T Consensus 48 ~g~V~~~~~~~~~~~v-avK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~ 124 (360)
T 3llt_A 48 FGRVLLCQHIDNKKYY-AVKVVRNIK-KYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYE 124 (360)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECSCH-HHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHH
T ss_pred CeEEEEEEECCCCeEE-EEEEeccch-hhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHH
Confidence 3444 47888899998 999997544 44567888999999986 999999999999999999999999 899999
Q ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-----------------------CCCCEEEe
Q 019901 78 RICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------------------PAPRLKIC 132 (334)
Q Consensus 78 ~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-----------------------~~~~~kl~ 132 (334)
++.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+
T Consensus 125 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~ 204 (360)
T 3llt_A 125 IITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204 (360)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEEC
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEE
Confidence 998754 49999999999999999999999999999999999999751 23459999
Q ss_pred ccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc--
Q 019901 133 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-- 210 (334)
Q Consensus 133 Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-- 210 (334)
|||+|+.... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+...........
T Consensus 205 DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~ 281 (360)
T 3llt_A 205 DFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKN 281 (360)
T ss_dssp CCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHH
T ss_pred eccCceecCC--CCcCccCcccccCcHHHcCCCCCCc-cchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHH
Confidence 9999975332 3345679999999999998888655 9999999999999999999987665444333221110000
Q ss_pred --------------------ccCCCC------------------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 211 --------------------YSIPDY------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 211 --------------------~~~~~~------------------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
...|.. ...++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 282 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 282 MLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 000000 01247788999999999999999999999999994
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=344.59 Aligned_cols=245 Identities=25% Similarity=0.392 Sum_probs=198.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .+++..++..| |+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++.+
T Consensus 46 ~g~V~~~~~~~~~~~v-a~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 124 (360)
T 3eqc_A 46 GGVVFKVSHKPSGLVM-ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK 124 (360)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHH
T ss_pred CeEEEEEEECCCCcEE-EEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHH
Confidence 3444 47888889998 9999987641 2346789999999999999999999999999999999999999999999998
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchh
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 160 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~ 160 (334)
.+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++.... .......||+.|+|||+
T Consensus 125 ~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~-~~~~~~~gt~~y~aPE~ 201 (360)
T 3eqc_A 125 AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSYMSPER 201 (360)
T ss_dssp HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HC----CCCCTTCCHHH
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCC--EEEEECCCCccccc-ccccCCCCCCCeECHHH
Confidence 88899999999999999999999996 9999999999999987765 99999999864322 12345579999999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHH--------------------------------------HH
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR--------------------------------------KT 202 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--------------------------------------~~ 202 (334)
+.+..++.+ +|||||||++|+|++|+.||.......... ..
T Consensus 202 ~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (360)
T 3eqc_A 202 LQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFEL 280 (360)
T ss_dssp HTTCCCSHH-HHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHH
T ss_pred HcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhh
Confidence 988877654 999999999999999999998655322111 11
Q ss_pred HHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 203 IHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 203 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+............++.++.+||.+||+.+|.+|||++++|+||||+..
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 331 (360)
T 3eqc_A 281 LDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331 (360)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred hhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence 111112222212223478999999999999999999999999999999764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=336.90 Aligned_cols=241 Identities=35% Similarity=0.540 Sum_probs=203.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..+++.| |+|++.+... ...+.+.+|+.+++.++||||+++++++.+.+..|+||||+.+++|.+++
T Consensus 54 ~g~Vy~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 132 (335)
T 2owb_A 54 FAKCFEISDADTKEVF-AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 132 (335)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHH
Confidence 4444 47788888888 9999987642 23467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aP 158 (334)
...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+||
T Consensus 133 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aP 210 (335)
T 2owb_A 133 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAP 210 (335)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCH
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCC--EEEeeccCceecccCcccccccCCCccccCH
Confidence 88888999999999999999999999999999999999999987665 9999999997654322 23445799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..++.+ +||||||+++|+|++|+.||.......... .+......++ ..+++.+.+||.+||+.||.+|
T Consensus 211 E~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~dp~~R 283 (335)
T 2owb_A 211 EVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIP--KHINPVAASLIQKMLQTDPTAR 283 (335)
T ss_dssp HHHHTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCC--TTSCHHHHHHHHHHTCSSGGGS
T ss_pred HHhccCCCCch-hhHHHHHHHHHHHHHCcCCCCCCCHHHHHH----HHhcCCCCCC--ccCCHHHHHHHHHHccCChhHC
Confidence 99988777555 999999999999999999998765433322 2333333333 3579999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 019901 239 ISIPEIRNHEWFLKNL 254 (334)
Q Consensus 239 ~s~~ell~h~~~~~~~ 254 (334)
||++++++||||....
T Consensus 284 ps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 284 PTINELLNDEFFTSGY 299 (335)
T ss_dssp CCGGGGGGSHHHHTSC
T ss_pred cCHHHHhcCccccCCC
Confidence 9999999999998753
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=330.20 Aligned_cols=241 Identities=35% Similarity=0.540 Sum_probs=203.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..+++.+ |+|++.+... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++
T Consensus 28 ~g~Vy~~~~~~~~~~~-a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 106 (294)
T 2rku_A 28 FAKCFEISDADTKEVF-AGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELH 106 (294)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHH
T ss_pred CEEEEEEEECCCCceE-EEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHH
Confidence 4444 47788888888 9999987642 23467889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aP 158 (334)
...+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+||
T Consensus 107 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP 184 (294)
T 2rku_A 107 KRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLE--VKIGDFGLATKVEYDGERKKVLCGTPNYIAP 184 (294)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCCSSCCH
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCC--EEEEeccCceecccCccccccccCCCCcCCc
Confidence 88888999999999999999999999999999999999999987665 9999999997644322 23445799999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..++.+ +||||||+++|+|++|+.||.......... .+.......| ..+++.+.++|.+||+.+|.+|
T Consensus 185 E~~~~~~~~~~-~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R 257 (294)
T 2rku_A 185 EVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYL----RIKKNEYSIP--KHINPVAASLIQKMLQTDPTAR 257 (294)
T ss_dssp HHHTTSCBCTH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHTTCCCCC--TTSCHHHHHHHHHHTCSSGGGS
T ss_pred chhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HHhhccCCCc--cccCHHHHHHHHHHcccChhhC
Confidence 99988777555 999999999999999999998765533322 2333333333 3579999999999999999999
Q ss_pred CCHhHHhcCccccccC
Q 019901 239 ISIPEIRNHEWFLKNL 254 (334)
Q Consensus 239 ~s~~ell~h~~~~~~~ 254 (334)
||++++++||||....
T Consensus 258 ps~~~ll~~~~~~~~~ 273 (294)
T 2rku_A 258 PTINELLNDEFFTSGY 273 (294)
T ss_dssp CCGGGGGGSHHHHTSC
T ss_pred cCHHHHhhChheecCC
Confidence 9999999999998653
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=338.80 Aligned_cols=239 Identities=26% Similarity=0.381 Sum_probs=196.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||++ .+++..+|..| |||++...... ..+.+.+|+.+++.++||||+++++++..++..++||||+. |+|.+.+
T Consensus 67 ~g~Vy~a~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l 144 (348)
T 1u5q_A 67 FGAVYFARDVRNSEVV-AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLL 144 (348)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHH
T ss_pred CEEEEEEEEccCCeEE-EEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHH
Confidence 3444 37778888888 99999875422 22568899999999999999999999999999999999997 5787777
Q ss_pred H-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccc
Q 019901 80 C-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAP 158 (334)
Q Consensus 80 ~-~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aP 158 (334)
. ...++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.... .....||+.|+||
T Consensus 145 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~---~~~~~gt~~y~aP 219 (348)
T 1u5q_A 145 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANSFVGTPYWMAP 219 (348)
T ss_dssp HHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCCCCSCGGGCCH
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCC--EEEeeccCceecCC---CCcccCCcceeCH
Confidence 5 4567999999999999999999999999999999999999987664 99999999975432 2356799999999
Q ss_pred hhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 159 EVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 159 E~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|++. +..++. ++|||||||++|+|++|+.||.+......... +............+++.+++||.+||+.+|
T Consensus 220 E~~~~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP 294 (348)
T 1u5q_A 220 EVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYH----IAQNESPALQSGHWSEYFRNFVDSCLQKIP 294 (348)
T ss_dssp HHHHTTSSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHHHHHHHHHTCSSG
T ss_pred hhhccccCCCCCc-HHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHcccCh
Confidence 9985 345544 49999999999999999999987665443332 222222222334679999999999999999
Q ss_pred CCCCCHhHHhcCccccccC
Q 019901 236 AKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~ 254 (334)
.+|||++++++||||....
T Consensus 295 ~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 295 QDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp GGSCCHHHHTTCHHHHSCC
T ss_pred hhCcCHHHHhhChhhhccC
Confidence 9999999999999997644
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=341.63 Aligned_cols=240 Identities=22% Similarity=0.329 Sum_probs=189.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCC---------------
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPT--------------- 61 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--------------- 61 (334)
||.|+| .|+++.+|..| |||++..... ...+.+.+|+.+++.++||||+++++++.+..
T Consensus 14 lG~G~~g~V~~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~ 92 (332)
T 3qd2_B 14 MGRGGFGVVFEAKNKVDDCNY-AIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKD 92 (332)
T ss_dssp EECC-CSEEEEEEETTTCCEE-EEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----
T ss_pred ecCCCCeEEEEEEEcCCCcEE-EEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcc
Confidence 455554 47888899999 9999986552 34578999999999999999999999986543
Q ss_pred ------------------------------------------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHH
Q 019901 62 ------------------------------------------HLAIVMEYASGGELFERICNAGR---FSEDEARFFFQQ 96 (334)
Q Consensus 62 ------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~q 96 (334)
.+++|||||++++|.+++.+... .++..++.++.|
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~q 172 (332)
T 3qd2_B 93 ESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ 172 (332)
T ss_dssp ---------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHH
T ss_pred ccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHH
Confidence 38999999999999999987644 566678999999
Q ss_pred HHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-------------CCCCccCCCccccchhhcc
Q 019901 97 LISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-------------QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 97 il~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-------------~~~~~~gt~~y~aPE~~~~ 163 (334)
|+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||+.|+|||++.+
T Consensus 173 i~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 250 (332)
T 3qd2_B 173 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDV--VKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHG 250 (332)
T ss_dssp HHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHC
T ss_pred HHHHHHHHHhCCeeecCCCcccEEEeCCCC--EEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcC
Confidence 999999999999999999999999987664 9999999998544331 2234579999999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhH
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~e 243 (334)
..++.+ +|||||||++|+|++|..|+.. .............. ......++++.+||.+||+.+|.+|||+++
T Consensus 251 ~~~~~~-~Di~slG~il~el~~~~~~~~~------~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 322 (332)
T 3qd2_B 251 NNYSHK-VDIFSLGLILFELLYSFSTQME------RVRIITDVRNLKFP-LLFTQKYPQEHMMVQDMLSPSPTERPEATD 322 (332)
T ss_dssp CCCCTH-HHHHHHHHHHHHHHSCCCCHHH------HHHHHHHHHTTCCC-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHH
T ss_pred CCCcch-hhHHHHHHHHHHHHHcCCChhH------HHHHHHHhhccCCC-cccccCChhHHHHHHHHccCCCCcCCCHHH
Confidence 887655 9999999999999998776532 11222222222111 111235788999999999999999999999
Q ss_pred HhcCccccc
Q 019901 244 IRNHEWFLK 252 (334)
Q Consensus 244 ll~h~~~~~ 252 (334)
+++||||++
T Consensus 323 ~l~~~~f~~ 331 (332)
T 3qd2_B 323 IIENAIFEN 331 (332)
T ss_dssp HHHSTTCCC
T ss_pred Hhhchhhhc
Confidence 999999954
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=351.34 Aligned_cols=247 Identities=23% Similarity=0.294 Sum_probs=196.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC------CCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL------RHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l------~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+.+..+++.| |||++.... .....+.+|+.+++.+ +||||+++++++...+.+++||||+. ++|.
T Consensus 110 fg~V~~a~~~~~~~~v-AvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~ 186 (429)
T 3kvw_A 110 FGQVVKAYDHKVHQHV-ALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLY 186 (429)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHH
T ss_pred cEEEEEEEECCCCcEE-EEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHH
Confidence 3444 47788888888 999997654 3446777888888776 57899999999999999999999995 6899
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 77 ERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 77 ~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
+++.... .+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+|+... ....+.+||+.
T Consensus 187 ~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~--~~~~~~~gt~~ 264 (429)
T 3kvw_A 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH--QRVYTYIQSRF 264 (429)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETT--CCCCSSCSCGG
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecC--CcccccCCCCC
Confidence 9887754 4999999999999999999999999999999999999987765559999999987532 23345689999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc----------------cC-----
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------SI----- 213 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------~~----- 213 (334)
|+|||++.+..++.+ +|||||||++|+|++|++||.+......+............ ..
T Consensus 265 y~aPE~~~~~~~~~~-~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (429)
T 3kvw_A 265 YRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCT 343 (429)
T ss_dssp GCCHHHHHTBCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSC
T ss_pred ccChHHHhCCCCCch-HHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCccccc
Confidence 999999998888655 99999999999999999999987766555444432111000 00
Q ss_pred ------------------------CC--------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCCC
Q 019901 214 ------------------------PD--------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPA 256 (334)
Q Consensus 214 ------------------------~~--------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~~ 256 (334)
+. ....++.+.+||.+||+.||.+|||++|+|+||||++..+.
T Consensus 344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~ 418 (429)
T 3kvw_A 344 VTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK 418 (429)
T ss_dssp EECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred ccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence 00 01237889999999999999999999999999999876543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=348.42 Aligned_cols=243 Identities=27% Similarity=0.411 Sum_probs=193.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+++..+|+.| |||++.... ....+|+.+++.++||||+++++++... ..+++||||+.+ +|.
T Consensus 67 fg~Vy~~~~~~~~~~v-aiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~ 140 (420)
T 1j1b_A 67 FGVVYQAKLCDSGELV-AIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVY 140 (420)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHH
T ss_pred CEEEEEEEECCCCcEE-EEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHH
Confidence 3444 47788899999 999987544 2345799999999999999999998542 247899999975 666
Q ss_pred HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 77 ERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 77 ~~l~----~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
..+. ....+++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+++...........+||
T Consensus 141 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~t 219 (420)
T 1j1b_A 141 RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVSYICS 219 (420)
T ss_dssp HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSC
T ss_pred HHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCC-eEEeccchhhhhcccCCCceeeeeC
Confidence 5554 3467999999999999999999999999999999999999985432 4899999999866555555667899
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------------cccCCC----
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIPD---- 215 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~---- 215 (334)
+.|+|||++.+....+.++|||||||++|+|++|++||.+......+.+++...... .+.+|.
T Consensus 220 ~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~ 299 (420)
T 1j1b_A 220 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAH 299 (420)
T ss_dssp TTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCC
T ss_pred CCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCC
Confidence 999999999776434455999999999999999999999877666665554422110 111111
Q ss_pred ------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 ------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 ------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+++++.+||.+||..||.+|||+.|+++||||...
T Consensus 300 ~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 300 PWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 343 (420)
T ss_dssp CHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred CHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence 12468999999999999999999999999999999764
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=329.57 Aligned_cols=240 Identities=29% Similarity=0.510 Sum_probs=178.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+++..+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++
T Consensus 24 ~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (278)
T 3cok_A 24 FAGVYRAESIHTGLEV-AIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYL 102 (278)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHH
T ss_pred ceEEEEEEEccCCceE-EEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHH
Confidence 3444 47778899998 9999976541 23467899999999999999999999999999999999999999999999
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCcccc
Q 019901 80 CNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~a 157 (334)
... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|
T Consensus 103 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y~a 180 (278)
T 3cok_A 103 KNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMN--IKIADFGLATQLKMPHEKHYTLCGTPNYIS 180 (278)
T ss_dssp HTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCC--EEECCCTTCEECC-----------------
T ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCC--EEEEeecceeeccCCCCcceeccCCCCcCC
Confidence 875 56999999999999999999999999999999999999987665 9999999987543222 2334579999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +||||||+++|+|++|+.||.......... ......... +..+++++.++|.+||+.+|.+
T Consensus 181 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~ 253 (278)
T 3cok_A 181 PEIATRSAHGLE-SDVWSLGCMFYTLLIGRPPFDTDTVKNTLN----KVVLADYEM--PSFLSIEAKDLIHQLLRRNPAD 253 (278)
T ss_dssp -----------C-THHHHHHHHHHHHHHSSCSSCCCSCC---------CCSSCCCC--CTTSCHHHHHHHHHHSCSSGGG
T ss_pred cchhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCChhHHHHHH----HHhhcccCC--ccccCHHHHHHHHHHcccCHhh
Confidence 999987777555 999999999999999999998765433222 222222222 3357999999999999999999
Q ss_pred CCCHhHHhcCcccccc
Q 019901 238 RISIPEIRNHEWFLKN 253 (334)
Q Consensus 238 R~s~~ell~h~~~~~~ 253 (334)
|||++++++||||.+.
T Consensus 254 Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 254 RLSLSSVLDHPFMSRN 269 (278)
T ss_dssp SCCHHHHTTSTTTC--
T ss_pred CCCHHHHhcCccccCC
Confidence 9999999999999654
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=338.14 Aligned_cols=244 Identities=23% Similarity=0.348 Sum_probs=191.4
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCC--CCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRH--PNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +.....+++.| |||++...... ..+.+.+|+.+++.++| |||+++++++..++.+|+|||+ .+++
T Consensus 17 lG~G~~g~Vy~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~ 94 (343)
T 3dbq_A 17 IGSGGSSKVFQVLNEKKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNID 94 (343)
T ss_dssp ESCCSSEEEEEEECTTSCEE-EEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEE
T ss_pred EecCCCeEEEEEEeCCCCEE-EEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCC
Confidence 455555 43333567777 99999876522 23678899999999976 9999999999999999999995 5889
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVG 151 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~g 151 (334)
|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++....... ....+|
T Consensus 95 L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~g 171 (343)
T 3dbq_A 95 LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVG 171 (343)
T ss_dssp HHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCCC------------CC
T ss_pred HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEEC-C--cEEEeecccccccCcccccccCCCCcC
Confidence 9999999889999999999999999999999999999999999999973 3 499999999986533322 235579
Q ss_pred CCccccchhhcc-----------CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCC
Q 019901 152 TPAYIAPEVLLK-----------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 152 t~~y~aPE~~~~-----------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (334)
|+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||....... ..+................+
T Consensus 172 t~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 247 (343)
T 3dbq_A 172 TVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPE 247 (343)
T ss_dssp CCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHH---HHHHHHHCTTSCCCCCCCSC
T ss_pred CcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHH---HHHHHHhcCCcccCCcccCC
Confidence 999999999865 334 445999999999999999999998654422 11222233333333334567
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+++.+||.+||+.+|.+|||+.++++||||+...
T Consensus 248 ~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 8999999999999999999999999999997643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=339.30 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=197.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+++..++..| |||++..... .....+.+|+.+++.++||||+++++++... ...|+||||+. ++|.
T Consensus 40 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~ 117 (364)
T 3qyz_A 40 YGMVCSAYDNLNKVRV-AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLY 117 (364)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHH
T ss_pred CeEEEEEEECCCCeEE-EEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHH
Confidence 3444 47788888888 9999975441 2236788999999999999999999999755 46899999996 5898
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCC
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGT 152 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt 152 (334)
+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||
T Consensus 118 ~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~gt 194 (364)
T 3qyz_A 118 KLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLTEYVAT 194 (364)
T ss_dssp HHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTCCCCSC
T ss_pred HHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCC--EEEEeCcceEecCCCCCccccccccccc
Confidence 88866 46999999999999999999999999999999999999987665 9999999997543322 12445799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc----------------ccCC--
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------YSIP-- 214 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~~~~-- 214 (334)
+.|+|||++.+....+.++|||||||++|+|++|++||.+......+........... ...+
T Consensus 195 ~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (364)
T 3qyz_A 195 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274 (364)
T ss_dssp GGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCC
T ss_pred cCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCc
Confidence 9999999987655445569999999999999999999998776665555432211100 0000
Q ss_pred -------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 215 -------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 215 -------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
....+++++.+||.+||+.||.+|||++++|+||||.+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 275 NKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp CCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred cCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 01357899999999999999999999999999999987643
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=335.44 Aligned_cols=242 Identities=20% Similarity=0.365 Sum_probs=194.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEc--CCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..+++.| |||++.... .+.+.+|+.+++.++ ||||+++++++.. ....++||||+.+++|..++
T Consensus 49 ~g~V~~~~~~~~~~~v-avK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~ 124 (330)
T 3nsz_A 49 YSEVFEAINITNNEKV-VVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY 124 (330)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHG
T ss_pred CeEEEEEEECCCCcEE-EEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHH
Confidence 3444 47788899998 999987433 578999999999997 9999999999987 67899999999999998887
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.. +++..++.++.||+.||.|||++||+||||||+|||++.++. .+||+|||+|+............||+.|+|||
T Consensus 125 ~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE 200 (330)
T 3nsz_A 125 QT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRYFKGPE 200 (330)
T ss_dssp GG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCCTTCEECCTTCCCCSCCSCGGGCCHH
T ss_pred Hh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCC-EEEEEeCCCceEcCCCCccccccccccccChh
Confidence 43 899999999999999999999999999999999999986552 59999999998665555556678999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHh---------hcccc-----------------
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRIL---------SVQYS----------------- 212 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~---------~~~~~----------------- 212 (334)
++.+....+.++|||||||++|+|++|+.||...... ..+........ .....
T Consensus 201 ~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (330)
T 3nsz_A 201 LLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRW 280 (330)
T ss_dssp HHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCG
T ss_pred hhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccch
Confidence 9987444455599999999999999999999654432 22222111100 00000
Q ss_pred -----CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 213 -----IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 213 -----~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
......+++++.+||.+||+.||.+|||++|+|+||||+.-
T Consensus 281 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~ 326 (330)
T 3nsz_A 281 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 326 (330)
T ss_dssp GGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred hhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence 01112278999999999999999999999999999999753
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-46 Score=329.29 Aligned_cols=240 Identities=23% Similarity=0.360 Sum_probs=194.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+.+..++..| |+|++..... ...+.+.+|+.+++.++||||+++++++.. ...+++||||+++++|.
T Consensus 39 ~g~Vy~~~~~~~~~~v-a~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 117 (290)
T 1t4h_A 39 FKTVYKGLDTETTVEV-AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLK 117 (290)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHH
T ss_pred CeEEEEeEecCCceEE-EEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHH
Confidence 3444 47788888888 9999986552 234578899999999999999999999875 45689999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEc-CCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~-~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
+++.+.+.+++..++.++.||+.||.|||++| |+||||||+|||++ .++ .+||+|||++..... .......||+
T Consensus 118 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~kl~Dfg~~~~~~~-~~~~~~~~t~ 194 (290)
T 1t4h_A 118 TYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRA-SFAKAVIGTP 194 (290)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCT-TSBEESCSSC
T ss_pred HHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC--CEEEeeCCCcccccc-cccccccCCc
Confidence 99998888999999999999999999999999 99999999999997 344 499999999864322 2234457999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+ .++ .++|||||||++|+|++|+.||............ ..............++++.++|.+||+.
T Consensus 195 ~y~aPE~~~~-~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~ 269 (290)
T 1t4h_A 195 EFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---VTSGVKPASFDKVAIPEVKEIIEGCIRQ 269 (290)
T ss_dssp CCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH---HTTTCCCGGGGGCCCHHHHHHHHHHSCS
T ss_pred CcCCHHHHhc-cCC-CcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHH---HhccCCccccCCCCCHHHHHHHHHHccC
Confidence 9999998864 454 4599999999999999999999876554433322 2222222222334679999999999999
Q ss_pred CCCCCCCHhHHhcCccccc
Q 019901 234 DPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~ 252 (334)
+|.+|||++++++||||++
T Consensus 270 dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 270 NKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp SGGGSCCHHHHHTSGGGC-
T ss_pred ChhhCCCHHHHhhCccccc
Confidence 9999999999999999965
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=339.94 Aligned_cols=248 Identities=23% Similarity=0.330 Sum_probs=194.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCe-------EEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTH-------LAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-------~~lv~e~~ 70 (334)
||.|+| .+++..+|..| |||++.... .......+++..++.++||||+++++++...+. +++||||+
T Consensus 31 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~ 108 (360)
T 3e3p_A 31 AGQGTFGTVQLGKEKSTGMSV-AIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV 108 (360)
T ss_dssp --------CEEEEETTTCCEE-EEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECC
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecc
Confidence 666666 47888899998 999987665 445677888899999999999999999875433 89999999
Q ss_pred CCCChHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHH--HCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCC
Q 019901 71 SGGELFERI----CNAGRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLH 143 (334)
Q Consensus 71 ~~~~L~~~l----~~~~~~~~~~~~~~~~qil~~L~~LH--~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~ 143 (334)
.+ +|...+ .....+++..++.++.|++.||.||| ++||+||||||+|||++. ++ .+||+|||+++.....
T Consensus 109 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~--~~kl~Dfg~a~~~~~~ 185 (360)
T 3e3p_A 109 PD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG--TLKLCDFGSAKKLSPS 185 (360)
T ss_dssp SC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT--EEEECCCTTCBCCCTT
T ss_pred cc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC--cEEEeeCCCceecCCC
Confidence 76 444433 34567999999999999999999999 999999999999999985 44 5999999999876655
Q ss_pred CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-------------
Q 019901 144 SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ------------- 210 (334)
Q Consensus 144 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------- 210 (334)
.......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+......+...........
T Consensus 186 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (360)
T 3e3p_A 186 EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD 265 (360)
T ss_dssp SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCC
T ss_pred CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhh
Confidence 5556678999999999997766445569999999999999999999998776555555443211100
Q ss_pred cc-------------CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 YS-------------IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 ~~-------------~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.. .......++++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 322 (360)
T 3e3p_A 266 VDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELH 322 (360)
T ss_dssp GGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred ccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccC
Confidence 00 001122568899999999999999999999999999998753
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=336.48 Aligned_cols=242 Identities=24% Similarity=0.379 Sum_probs=194.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCC--eEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++...+ ..++||||+.+++|.+++
T Consensus 22 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 100 (319)
T 4euu_A 22 TANVFRGRHKKTGDLF-AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100 (319)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHH
T ss_pred CeEEEEEEECCCCcEE-EEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHH
Confidence 3444 47888889998 9999986542 33467889999999999999999999998765 789999999999999999
Q ss_pred HhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEE----cCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 80 CNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 80 ~~~~~---~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli----~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
..... +++..++.++.||+.||.|||++||+||||||+|||+ +..+ .+||+|||+++............||
T Consensus 101 ~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~gt 178 (319)
T 4euu_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGT 178 (319)
T ss_dssp HSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE--EEEECCCTTCEECCTTCCBCCCCSC
T ss_pred HHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc--eEEEccCCCceecCCCCceeecccC
Confidence 86543 9999999999999999999999999999999999998 4333 4999999999876555555567899
Q ss_pred Cccccchhhc--------cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------------
Q 019901 153 PAYIAPEVLL--------KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------- 211 (334)
Q Consensus 153 ~~y~aPE~~~--------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 211 (334)
+.|+|||++. +..++ .++|||||||++|+|++|+.||............+..+.....
T Consensus 179 ~~y~aPE~~~~~~~~~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 257 (319)
T 4euu_A 179 EEYLHPDMYERAVLRKDHQKKYG-ATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257 (319)
T ss_dssp GGGCCHHHHHHHTSCCCCCCCBC-TTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTC
T ss_pred CCccCHHHhhhccccccccCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCC
Confidence 9999999986 34554 4499999999999999999999765544444444444433221
Q ss_pred ------cCCCC----CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 019901 212 ------SIPDY----VHISPECRHLISRIFVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 212 ------~~~~~----~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~ 249 (334)
..+.. ..++..+.++|.+||+.||.+|||++|+|+||-
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred ccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 11111 123567899999999999999999999999984
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.39 Aligned_cols=244 Identities=24% Similarity=0.366 Sum_probs=200.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..+|..| |||++.... ..+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+
T Consensus 37 lg~G~~g~Vy~~~~~~~~~~v-aiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 113 (314)
T 3com_A 37 LGEGSYGSVYKAIHKETGQIV-AIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSD 113 (314)
T ss_dssp CC----CEEEEEEETTTCCEE-EEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred eccCCCeEEEEEEECCCCCEE-EEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHH
Confidence 565555 47788889998 999998654 45789999999999999999999999999999999999999999999
Q ss_pred HHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 78 RIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~-~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
++. ....+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||++...... .......||+.|
T Consensus 114 ~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~y 191 (314)
T 3com_A 114 IIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGH--AKLADFGVAGQLTDTMAKRNTVIGTPFW 191 (314)
T ss_dssp HHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECBTTBSCBCCCCSCGGG
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCC--EEEeecccchhhhhhccccCccCCCCCc
Confidence 987 4567999999999999999999999999999999999999987665 999999998754332 223445799999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+|||++.+..++.+ +||||||+++|+|++|+.||............ .............+++.+.++|.+||..+|
T Consensus 192 ~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 267 (314)
T 3com_A 192 MAPEVIQEIGYNCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTNPPPTFRKPELWSDNFTDFVKQCLVKSP 267 (314)
T ss_dssp CCHHHHSSSCBCTT-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHSCCCCCSSGGGSCHHHHHHHHHHTCSCT
T ss_pred cChhhcCCCCCCcc-ccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcCCCcccCCcccCCHHHHHHHHHHccCCh
Confidence 99999988877655 99999999999999999999876543322211 111122222334578999999999999999
Q ss_pred CCCCCHhHHhcCccccccC
Q 019901 236 AKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~~~ 254 (334)
.+|||+.++++||||....
T Consensus 268 ~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 268 EQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TTSCCHHHHTTSHHHHTCC
T ss_pred hhCcCHHHHHhCHHHhcCC
Confidence 9999999999999997643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=338.24 Aligned_cols=243 Identities=31% Similarity=0.520 Sum_probs=193.3
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--------cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--------QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.+ .+++..+++.| |||++..... .....+.+|+.+++.++||||+++++++..++ .|+||||+.+++
T Consensus 23 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~ 100 (322)
T 2ycf_A 23 CGEVKLAFERKTCKKV-AIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGE 100 (322)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEE
T ss_pred CEEEEEEEEcCCCcEE-EEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCc
Confidence 4444 47788888888 9999976542 12246889999999999999999999987665 899999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+++............||+
T Consensus 101 L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~ 180 (322)
T 2ycf_A 101 LFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180 (322)
T ss_dssp THHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCC
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCc
Confidence 999998888899999999999999999999999999999999999997644 2359999999987543322223456999
Q ss_pred ccccchhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHH
Q 019901 154 AYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLIS 228 (334)
Q Consensus 154 ~y~aPE~~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~ 228 (334)
.|+|||++. ...+ +.++|||||||++|+|++|..||........+...+.. ..... ..+..+++.+.+||.
T Consensus 181 ~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~li~ 256 (322)
T 2ycf_A 181 TYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS---GKYNFIPEVWAEVSEKALDLVK 256 (322)
T ss_dssp TTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHH---TCCCCCHHHHTTSCHHHHHHHH
T ss_pred CccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHh---CccccCchhhhhcCHHHHHHHH
Confidence 999999974 3344 44599999999999999999999876544333332222 11111 112457999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+||+.+|.+|||++++++||||..
T Consensus 257 ~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 257 KLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp HHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred HHcccCHhhCCCHHHHhhCcCcCC
Confidence 999999999999999999999964
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=327.02 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=192.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|++ .+++..+++.| |||++..... .....+.+|+..+..+ +||||+++++++.+++..++||||+++++|.+++
T Consensus 24 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 102 (289)
T 1x8b_A 24 FGSVFKCVKRLDGCIY-AIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAI 102 (289)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHH
T ss_pred ceEEEEEEEcCCCceE-EEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHH
Confidence 4444 47888899999 9999987542 2346788999999998 9999999999999999999999999999999999
Q ss_pred Hhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-----------------CCCEEEeccCCcc
Q 019901 80 CNA----GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------------APRLKICDFGYSK 138 (334)
Q Consensus 80 ~~~----~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-----------------~~~~kl~Dfgla~ 138 (334)
... +.+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||++.
T Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 182 (289)
T 1x8b_A 103 SENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182 (289)
T ss_dssp HHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCE
T ss_pred HhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccccccc
Confidence 765 6699999999999999999999999999999999999997432 2359999999987
Q ss_pred CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCC
Q 019901 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH 218 (334)
Q Consensus 139 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (334)
.... .....||+.|+|||++.+....+.++|||||||++|+|++|.+|+..... ... +..... ...+..
T Consensus 183 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~----~~~~~~-~~~~~~ 251 (289)
T 1x8b_A 183 RISS---PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---WHE----IRQGRL-PRIPQV 251 (289)
T ss_dssp ETTC---SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHH----HHTTCC-CCCSSC
T ss_pred ccCC---ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---HHH----HHcCCC-CCCCcc
Confidence 5433 23456999999999998765555569999999999999999988754322 111 122111 122346
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 219 ~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+++++.++|.+||+.+|.+|||+.++++||||...
T Consensus 252 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 252 LSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred cCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 89999999999999999999999999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=341.58 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=191.6
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCC--CCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.++ +.+. +++.| |||++..... ...+.+.+|+.+++.+. ||||+++++++..++.+|+||| +.+++|.++
T Consensus 69 fg~Vy~~~~~-~~~~v-aiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~ 145 (390)
T 2zmd_A 69 SSKVFQVLNE-KKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 145 (390)
T ss_dssp SEEEEEEECT-TCCEE-EEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHH
T ss_pred CeEEEEEEcC-CCCEE-EEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHH
Confidence 34444 4444 47787 9999987652 23367899999999996 5999999999999999999999 568899999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCcc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y 155 (334)
+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++. + .+||+|||+++...... .....+||+.|
T Consensus 146 l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~-~--~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y 222 (390)
T 2zmd_A 146 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGAVNY 222 (390)
T ss_dssp HHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESS-S--CEEECCCSSSCCC---------CCSCCCGGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEEC-C--eEEEEecCccccccCCCccccCCCCCcCCCc
Confidence 999889999999999999999999999999999999999999963 3 49999999998653322 23456799999
Q ss_pred ccchhhccC----------CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 156 IAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 156 ~aPE~~~~~----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
+|||++.+. ...+.++|||||||++|+|++|+.||....... ..+..+.......+.....+.++.+
T Consensus 223 ~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 299 (390)
T 2zmd_A 223 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI---SKLHAIIDPNHEIEFPDIPEKDLQD 299 (390)
T ss_dssp CCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH---HHHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred cChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH---HHHHHHhCccccCCCCccchHHHHH
Confidence 999998652 123455999999999999999999998654321 1222333333333333345889999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
||.+||+.+|.+|||+.++|+||||+...
T Consensus 300 li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 300 VLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 99999999999999999999999997643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=341.17 Aligned_cols=244 Identities=28% Similarity=0.491 Sum_probs=198.0
Q ss_pred cceee-eeec---CCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 4 FHNFY-DRCS---YSSDLFVNIIIIVFHLW----QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 4 ~g~~~-~~~~---~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.++ +++. .+|+.| |||++.+... ...+.+.+|+.+++.+ +||||+++++++..++.+++||||+.+++
T Consensus 67 ~g~Vy~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 145 (355)
T 1vzo_A 67 YGKVFLVRKISGHDTGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145 (355)
T ss_dssp TEEEEEEEECSSTTTTCEE-EEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCB
T ss_pred CEEEEEEEEcccCCCCeEE-EEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCC
Confidence 44443 5552 578888 9999976431 3346778899999999 69999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGT 152 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt 152 (334)
|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... .....+||
T Consensus 146 L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~gt 223 (355)
T 1vzo_A 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAYDFCGT 223 (355)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGCGGGSC
T ss_pred HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCc--EEEeeCCCCeecccCCCCcccCcccC
Confidence 9999998888999999999999999999999999999999999999987664 9999999987543221 22345799
Q ss_pred CccccchhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 153 PAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 153 ~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+.|+|||++.+.. ..+.++|||||||++|+|++|+.||...............+....... +..+++.+.+||.+||
T Consensus 224 ~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L 301 (355)
T 1vzo_A 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKDLIQRLL 301 (355)
T ss_dssp CTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCC--CTTSCHHHHHHHHHHT
T ss_pred cCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCC--CcccCHHHHHHHHHHh
Confidence 9999999997532 234559999999999999999999986544333333444444333333 3457999999999999
Q ss_pred ccCCCCCC-----CHhHHhcCccccc
Q 019901 232 VADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
..+|.+|| |++++++||||.+
T Consensus 302 ~~dP~~R~~~~~~s~~ell~h~~f~~ 327 (355)
T 1vzo_A 302 MKDPKKRLGCGPRDADEIKEHLFFQK 327 (355)
T ss_dssp CSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred hhCHHHhcCCCCCCHHHHHcCcchhc
Confidence 99999999 9999999999964
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=336.30 Aligned_cols=248 Identities=21% Similarity=0.329 Sum_probs=186.0
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccc-----------cHHHHHHHHHHHcCCCCCcccceEEEEc-----CCeEEEEE
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQI-----------DENVQREIINHRSLRHPNIVRFKEVILT-----PTHLAIVM 67 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~-----------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~ 67 (334)
||.++.....+|..| |||++....... .+.+.+|+.+++.++||||+++++++.. ...+|+||
T Consensus 35 ~g~V~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~ 113 (362)
T 3pg1_A 35 YGAVCAGVDSEGIPV-AIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVT 113 (362)
T ss_dssp TEEEEEEECTTSCEE-EEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEE
T ss_pred CEEEEEEECCCCCeE-EEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEE
Confidence 444443333458888 999997644211 1678999999999999999999999853 34789999
Q ss_pred eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC
Q 019901 68 EYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146 (334)
Q Consensus 68 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~ 146 (334)
||+. |+|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 114 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~ 190 (362)
T 3pg1_A 114 ELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNND--ITICDFNLAREDTADANK 190 (362)
T ss_dssp ECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCTTC----------
T ss_pred ccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCC--EEEEecCccccccccccc
Confidence 9997 5888877654 46999999999999999999999999999999999999987665 999999999865555555
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc----------------
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---------------- 210 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---------------- 210 (334)
....||+.|+|||++.+....+.++|||||||++|+|++|+.||.+..................
T Consensus 191 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 270 (362)
T 3pg1_A 191 THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYL 270 (362)
T ss_dssp -----CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHT
T ss_pred ceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHH
Confidence 5678999999999998744445559999999999999999999998776555544433211100
Q ss_pred ----ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 211 ----YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 211 ----~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
...+ .....++.+.+||.+||+.+|.+|||++++++||||+....
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 271 RNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp TTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 0000 12346889999999999999999999999999999987543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=329.53 Aligned_cols=242 Identities=21% Similarity=0.300 Sum_probs=179.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||.+ .+++..+|+.| |||++...... ..+.+.++...++.++||||+++++++..++..++||||+. ++|.+++.
T Consensus 20 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~ 97 (290)
T 3fme_A 20 YGVVEKMRHVPSGQIM-AVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYK 97 (290)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHH
T ss_pred CeEEEEEEecCCCeEE-EEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHH
Confidence 3444 47888899998 99999765411 12334455556888999999999999999999999999997 58777664
Q ss_pred h----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 81 N----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 81 ~----~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
. .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++............||+.|
T Consensus 98 ~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~t~~y 175 (290)
T 3fme_A 98 QVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQ--VKMCDFGISGYLVDDVAKDIDAGCKPY 175 (290)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCC--EEBCCC---------------CCCCCC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCC--EEEeecCCcccccccccccccCCCccc
Confidence 3 56799999999999999999999998 9999999999999987664 999999999866555555556899999
Q ss_pred ccchhh----ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 156 IAPEVL----LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 156 ~aPE~~----~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+|||++ .+..+ +.++|||||||++|+|++|+.||......... +...............+++++.++|.+||
T Consensus 176 ~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l 251 (290)
T 3fme_A 176 MAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQ---LKQVVEEPSPQLPADKFSAEFVDFTSQCL 251 (290)
T ss_dssp SCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH---HHHHHHSCCCCCCTTTSCHHHHHHHHHHT
T ss_pred cChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHH---HHHHhccCCCCcccccCCHHHHHHHHHHh
Confidence 999997 33444 45599999999999999999999864433221 11222222222223457999999999999
Q ss_pred ccCCCCCCCHhHHhcCcccccc
Q 019901 232 VADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+.+|.+|||++++++||||+..
T Consensus 252 ~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 252 KKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp CSSGGGSCCHHHHTTSHHHHHH
T ss_pred hcChhhCcCHHHHHhCcccccC
Confidence 9999999999999999999754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=345.00 Aligned_cols=241 Identities=24% Similarity=0.389 Sum_probs=189.0
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEeccCCCChH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~~~~~~L~ 76 (334)
||.++ +++..++. + |+|.+.... ....+|+.+++.++||||+++++++...+ .+++||||+.++ +.
T Consensus 53 ~g~V~~a~~~~~~~-~-aikk~~~~~----~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~ 125 (394)
T 4e7w_A 53 FGVVFQAKLVESDE-V-AIKKVLQDK----RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VY 125 (394)
T ss_dssp TEEEEEEEETTTEE-E-EEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HH
T ss_pred CeEEEEEEECCCCe-E-EEEEEecCc----chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HH
Confidence 44444 55555555 6 888776543 22347999999999999999999996543 389999999764 43
Q ss_pred HHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc-CCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 77 ERIC----NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 77 ~~l~----~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~-~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
..+. ....+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+|+............|
T Consensus 126 ~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~--~~kL~DFG~a~~~~~~~~~~~~~~ 203 (394)
T 4e7w_A 126 RASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPNVSYIC 203 (394)
T ss_dssp HHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT--EEEECCCTTCEECCTTCCCCSSCS
T ss_pred HHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC--cEEEeeCCCcccccCCCCCccccc
Confidence 3332 356799999999999999999999999999999999999998 444 499999999987655555667789
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------------cccCCC---
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIPD--- 215 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~~--- 215 (334)
|+.|+|||++.+....+.++|||||||++|+|++|++||.+......+..++...... ...++.
T Consensus 204 t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~ 283 (394)
T 4e7w_A 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRP 283 (394)
T ss_dssp CGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCC
T ss_pred CcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccC
Confidence 9999999999776544555999999999999999999999887666655554422110 011111
Q ss_pred -------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 216 -------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 216 -------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...+++++.+||.+||+.+|.+|||+.++++||||...
T Consensus 284 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (394)
T 4e7w_A 284 HPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL 328 (394)
T ss_dssp CCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred CcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence 12478999999999999999999999999999999764
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-45 Score=325.43 Aligned_cols=244 Identities=28% Similarity=0.382 Sum_probs=194.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.+ .+++..++..| |||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++...
T Consensus 35 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 113 (295)
T 2clq_A 35 YGIVYAGRDLSNQVRI-AIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK 113 (295)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHT
T ss_pred cEEEEEEEECCCCeEE-EEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhh
Confidence 3444 47788888888 999998776455678999999999999999999999999999999999999999999999865
Q ss_pred C---CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCC-CCCCccCCCcccc
Q 019901 83 G---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIA 157 (334)
Q Consensus 83 ~---~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~a 157 (334)
. .+++..++.++.|++.||.|||++||+||||||+||+++. ++ .+||+|||+++...... ......||+.|+|
T Consensus 114 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~a 191 (295)
T 2clq_A 114 WGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSG--VLKISDFGTSKRLAGINPCTETFTGTLQYMA 191 (295)
T ss_dssp TCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTC--CEEECCTTTCEESCC-----CCCCCCGGGCC
T ss_pred ccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCC--CEEEeecccccccCCCCCcccccCCCccccC
Confidence 2 4679999999999999999999999999999999999986 44 49999999987543322 2345579999999
Q ss_pred chhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 158 PEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 158 PE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
||++.+.. ..+.++||||||+++|+|++|+.||.......... ............+..+++++.++|.+||+.+|.
T Consensus 192 PE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~ 268 (295)
T 2clq_A 192 PEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM---FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPD 268 (295)
T ss_dssp HHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH---HHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTT
T ss_pred hhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH---HhhccccccccccccCCHHHHHHHHHHccCChh
Confidence 99997643 12455999999999999999999997654332211 111111222223346799999999999999999
Q ss_pred CCCCHhHHhcCcccccc
Q 019901 237 KRISIPEIRNHEWFLKN 253 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~ 253 (334)
+|||++++++||||+..
T Consensus 269 ~Rps~~~ll~~~~~~~~ 285 (295)
T 2clq_A 269 KRACANDLLVDEFLKVS 285 (295)
T ss_dssp TSCCHHHHHTSGGGCC-
T ss_pred hCCCHHHHhcChhhhhc
Confidence 99999999999999653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=330.83 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=191.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEc------CCeEEEEEeccCCCCh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILT------PTHLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~------~~~~~lv~e~~~~~~L 75 (334)
+|.+ .+++..+|+.| |||++.... ...+.+.+|+.+++.+ +||||+++++++.. .+.+++||||+.+++|
T Consensus 37 ~g~Vy~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L 114 (326)
T 2x7f_A 37 YGQVYKGRHVKTGQLA-AIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV 114 (326)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEH
T ss_pred CEEEEEEEECCCCCeE-EEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcH
Confidence 4444 47788899998 999998765 5567899999999998 79999999999986 4689999999999999
Q ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCC
Q 019901 76 FERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGT 152 (334)
Q Consensus 76 ~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt 152 (334)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++...... .......||
T Consensus 115 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 192 (326)
T 2x7f_A 115 TDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAE--VKLVDFGVSAQLDRTVGRRNTFIGT 192 (326)
T ss_dssp HHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCTTTC-------------CC
T ss_pred HHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCC--EEEeeCcCceecCcCccccccccCC
Confidence 9999864 56999999999999999999999999999999999999987665 999999998754332 223445799
Q ss_pred Cccccchhhc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 153 PAYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 153 ~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
+.|+|||++. +..++ .++|||||||++|+|++|..||........... +............+++.+.+||
T Consensus 193 ~~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li 267 (326)
T 2x7f_A 193 PYWMAPEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPRNPAPRLKSKKWSKKFQSFI 267 (326)
T ss_dssp GGGCCHHHHC--------CC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSCCCCCSCSCSCHHHHHHH
T ss_pred ccccChhhhccccccCcCCC-ccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH----hhcCccccCCccccCHHHHHHH
Confidence 9999999986 34454 449999999999999999999987655333222 2222222223346799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCcccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.+||..+|.+|||++++++||||...
T Consensus 268 ~~~l~~dp~~Rps~~~ll~hp~~~~~ 293 (326)
T 2x7f_A 268 ESCLVKNHSQRPATEQLMKHPFIRDQ 293 (326)
T ss_dssp HHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred HHHhccChhhCCCHHHHhhChHHhhC
Confidence 99999999999999999999999653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=328.01 Aligned_cols=242 Identities=29% Similarity=0.360 Sum_probs=192.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+++..++..| |||++...... ..+.+.+|+.+++.++||||+++++++..++..|+||||++|++|.+++
T Consensus 24 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 102 (294)
T 4eqm_A 24 MSTVYLAEDTILNIKV-AIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYI 102 (294)
T ss_dssp TEEEEEEEETTTCSEE-EEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHH
T ss_pred CEEEEEEEECCCCCeE-EEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHH
Confidence 4444 47888899999 99999765522 2357889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCcccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~a 157 (334)
.+.+++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|
T Consensus 103 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a 180 (294)
T 4eqm_A 103 ESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKT--LKIFDFGIAKALSETSLTQTNHVLGTVQYFS 180 (294)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCSSSTTC-------------CCSSCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC--EEEEeCCCccccccccccccCccccCccccC
Confidence 98889999999999999999999999999999999999999987765 9999999998643332 2234579999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +|||||||++|+|++|+.||.+..........+.... ..........+|+.+.++|.+||+++|.+
T Consensus 181 PE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 258 (294)
T 4eqm_A 181 PEQAKGEATDEC-TDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKAN 258 (294)
T ss_dssp HHHHHTCCCCTT-HHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCC-CCHHHHSCTTSCHHHHHHHHHHSCSSGGG
T ss_pred HhHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccC-CCcchhcccCCCHHHHHHHHHHhcCCHhH
Confidence 999988877655 9999999999999999999988765433322221100 00011123468999999999999999999
Q ss_pred CCCHhHHhcCccc
Q 019901 238 RISIPEIRNHEWF 250 (334)
Q Consensus 238 R~s~~ell~h~~~ 250 (334)
||+..+.+.+.|.
T Consensus 259 R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 259 RYKTIQEMKDDLS 271 (294)
T ss_dssp SCSSHHHHHHHHH
T ss_pred ccccHHHHHHHHH
Confidence 9966666666654
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-47 Score=348.48 Aligned_cols=231 Identities=12% Similarity=0.135 Sum_probs=182.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHH---HHHHcCCCCCcccce-------EEEEcCC--------
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREI---INHRSLRHPNIVRFK-------EVILTPT-------- 61 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei---~~l~~l~hp~iv~~~-------~~~~~~~-------- 61 (334)
||.+ .++++.+|+.| |||++.+... ...+.+.+|+ ..++.++||||++++ +++...+
T Consensus 86 ~g~V~~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (377)
T 3byv_A 86 PYAYLEATDQETGESF-EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 164 (377)
T ss_dssp TEEEEEEEC-CCCCEE-EEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC-
T ss_pred CEEEEEEEECCCCcEE-EEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccc
Confidence 4444 47778889998 9999986532 2346788999 555666899999998 7776654
Q ss_pred ---------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC
Q 019901 62 ---------HLAIVMEYASGGELFERICNAGRFSE-------DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 125 (334)
Q Consensus 62 ---------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~ 125 (334)
..|+||||+ +|+|.+++.+.+.+++ ..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 165 ~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 243 (377)
T 3byv_A 165 LDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 243 (377)
T ss_dssp -----CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred cCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 389999999 6899999987655665 77888999999999999999999999999999998776
Q ss_pred CCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccC-----------CCCCccchhhhhhHHHHHHHhCCCCCCCCC
Q 019901 126 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194 (334)
Q Consensus 126 ~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 194 (334)
. +||+|||+|+.... .....+| +.|+|||++.+. .++ .++|||||||++|+|++|+.||.+..
T Consensus 244 ~--~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~-~~~DvwSlG~il~elltg~~Pf~~~~ 317 (377)
T 3byv_A 244 G--VFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMT-FSFDAWALGLVIYWIWCADLPITKDA 317 (377)
T ss_dssp C--EEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECC-HHHHHHHHHHHHHHHHHSSCCC----
T ss_pred C--EEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCC-hhhhHHHHHHHHHHHHHCCCCCcccc
Confidence 4 99999999985322 2334567 999999999877 665 45999999999999999999997644
Q ss_pred chHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 195 EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
..... ....+....+++++.+||.+||+.||.+|||+.++++||||++
T Consensus 318 ~~~~~----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 318 ALGGS----------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp --CCS----------GGGGSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred cccch----------hhhhhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 32111 1112233468999999999999999999999999999999964
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=337.36 Aligned_cols=243 Identities=21% Similarity=0.293 Sum_probs=192.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHHHcCCCCCcccceEEEEcCC----eEEEEEeccCCCCh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e~~~~~~L 75 (334)
||.+ .+++..+++.| |||++....... ...+.+|+.+++.++||||+++++++.... ..|+||||++|++|
T Consensus 25 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L 103 (311)
T 3ork_A 25 MSEVHLARDLRDHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL 103 (311)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEH
T ss_pred CEEEEEEEECCCCceE-EEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCH
Confidence 4444 47888899988 999998765222 246889999999999999999999987643 35999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccC
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVG 151 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~g 151 (334)
.+++...+++++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......|
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~g 181 (311)
T 3ork_A 104 RDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQTAAVIG 181 (311)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSC--EEECCCSCC------------------
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCC--EEEeeccCcccccccccccccccccCc
Confidence 999998889999999999999999999999999999999999999987765 9999999997543322 1233568
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.............. ..........+++++.++|.+||
T Consensus 182 t~~y~aPE~~~~~~~~~~-~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l 258 (311)
T 3ork_A 182 TAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED--PIPPSARHEGLSADLDAVVLKAL 258 (311)
T ss_dssp CCTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC--CCCHHHHSTTCCHHHHHHHHHHT
T ss_pred CcccCCHHHhcCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC--CCCcccccCCCCHHHHHHHHHHH
Confidence 999999999988877655 999999999999999999998766543333222111 01111123457999999999999
Q ss_pred ccCCCCCCCHhHHhcCccccc
Q 019901 232 VADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~ 252 (334)
+.||.+||++.+++.|+|+..
T Consensus 259 ~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 259 AKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CSSGGGSCSSHHHHHHHHHHH
T ss_pred hcCHhhChhhHHHHHHHHHHH
Confidence 999999999999999999965
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-45 Score=329.17 Aligned_cols=242 Identities=24% Similarity=0.345 Sum_probs=192.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN- 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~- 81 (334)
+|.+ .+++..++..+ |+|++........+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++..
T Consensus 32 ~g~V~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 110 (302)
T 2j7t_A 32 FGKVYKAKNKETGALA-AAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLEL 110 (302)
T ss_dssp TCCEEEEEETTTCCEE-EEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHH
T ss_pred CeEEEEEEEcCCCcEE-EEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhh
Confidence 3444 47888889988 99999876645567899999999999999999999999999999999999999999998875
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-CCCCCCccCCCccccchh
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-HSQPKSTVGTPAYIAPEV 160 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~-~~~~~~~~gt~~y~aPE~ 160 (334)
...+++..++.++.|++.||.|||++|++||||||+||+++.++. +||+|||++..... ........||+.|+|||+
T Consensus 111 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 188 (302)
T 2j7t_A 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGD--IRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188 (302)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSC--EEECCCHHHHHHHHHHHC-----CCGGGCCHHH
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCC--EEEEECCCCccccccccccccccCChhhcCCee
Confidence 466999999999999999999999999999999999999987665 99999998753211 112234579999999999
Q ss_pred hc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 161 LL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 161 ~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
+. +..++ .++||||||+++|+|++|..||.............. ...........++..+.++|.+||+.+|
T Consensus 189 ~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dp 264 (302)
T 2j7t_A 189 VMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK---SDPPTLLTPSKWSVEFRDFLKIALDKNP 264 (302)
T ss_dssp HHHHHTTSTTTT-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---SCCCCCSSGGGSCHHHHHHHHHHSCSCT
T ss_pred eccccCCCCCCc-hhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhc---cCCcccCCccccCHHHHHHHHHHcccCh
Confidence 84 44444 459999999999999999999987665433322211 1111222334578999999999999999
Q ss_pred CCCCCHhHHhcCccccc
Q 019901 236 AKRISIPEIRNHEWFLK 252 (334)
Q Consensus 236 ~~R~s~~ell~h~~~~~ 252 (334)
.+|||+.++++||||..
T Consensus 265 ~~Rps~~~ll~h~~~~~ 281 (302)
T 2j7t_A 265 ETRPSAAQLLEHPFVSS 281 (302)
T ss_dssp TTSCCHHHHTTSTTTTT
T ss_pred hhCCCHHHHhcChHHhh
Confidence 99999999999999965
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=324.85 Aligned_cols=241 Identities=26% Similarity=0.403 Sum_probs=200.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+.+..+++.| |||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++..
T Consensus 35 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 113 (303)
T 3a7i_A 35 FGEVFKGIDNRTQKVV-AIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP 113 (303)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT
T ss_pred CeEEEEEEECCCCcEE-EEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc
Confidence 4444 47788889998 9999987652 3347899999999999999999999999999999999999999999998865
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccccchh
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYIAPEV 160 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~aPE~ 160 (334)
+++++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||++....... ......||+.|+|||+
T Consensus 114 -~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~ 190 (303)
T 3a7i_A 114 -GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE--VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEV 190 (303)
T ss_dssp -SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECBTTBCCBCCCCSCGGGCCHHH
T ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCC--EEEeecccceecCccccccCccCCCcCccCHHH
Confidence 57999999999999999999999999999999999999987664 9999999997543322 2344579999999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRIS 240 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s 240 (334)
+.+..++.+ +||||||+++|+|++|+.||........... +.... .......++..+.++|.+||+.+|.+|||
T Consensus 191 ~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps 264 (303)
T 3a7i_A 191 IKQSAYDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFL----IPKNN-PPTLEGNYSKPLKEFVEACLNKEPSFRPT 264 (303)
T ss_dssp HTTCCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH----HHHSC-CCCCCSSCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HhcCCCCch-hhhHHHHHHHHHHccCCCCCCCcCHHHHHHH----hhcCC-CCCCccccCHHHHHHHHHHcCCChhhCcC
Confidence 988877655 9999999999999999999987654332221 11111 11223457999999999999999999999
Q ss_pred HhHHhcCccccccC
Q 019901 241 IPEIRNHEWFLKNL 254 (334)
Q Consensus 241 ~~ell~h~~~~~~~ 254 (334)
+.++++||||....
T Consensus 265 ~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 265 AKELLKHKFILRNA 278 (303)
T ss_dssp HHHHTTCHHHHHHC
T ss_pred HHHHhhChhhhcCC
Confidence 99999999997653
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=332.96 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=178.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|++ .+.+..+++.| |||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.
T Consensus 23 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 101 (303)
T 2vwi_A 23 IGSGATAVVQAAYCAPKKEKV-AIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101 (303)
T ss_dssp CC---CCCEEEEEC----CEE-EEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHH
T ss_pred eccccceEEEEEEECCCCcEE-EEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchH
Confidence 566655 36677788888 999987654 233467889999999999999999999999999999999999999999
Q ss_pred HHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----
Q 019901 77 ERICN--------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---- 144 (334)
Q Consensus 77 ~~l~~--------~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---- 144 (334)
+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||++.......
T Consensus 102 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 179 (303)
T 2vwi_A 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS--VQIADFGVSAFLATGGDITR 179 (303)
T ss_dssp HHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCC--EEECCCHHHHHCC-------
T ss_pred HHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCC--EEEEeccchheeccCCCccc
Confidence 99874 456999999999999999999999999999999999999987665 9999999886433221
Q ss_pred --CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc----ccCCCCCC
Q 019901 145 --QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----YSIPDYVH 218 (334)
Q Consensus 145 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 218 (334)
......||+.|+|||++.+....+.++|||||||++|+|++|+.||.................... ........
T Consensus 180 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (303)
T 2vwi_A 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKK 259 (303)
T ss_dssp --------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCC
T ss_pred hhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhh
Confidence 123457999999999987633234559999999999999999999988766544332221110000 00112245
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 219 ~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+++++.++|.+||+.+|.+|||+.++++||||++..
T Consensus 260 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 789999999999999999999999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=330.41 Aligned_cols=243 Identities=27% Similarity=0.442 Sum_probs=188.0
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +.+...+|..| |||++...... ..+.+.+|+.++++++||||+++++++...+.+++||||+.+++|.+
T Consensus 45 lG~G~~g~V~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 123 (309)
T 3p86_A 45 IGAGSFGTVHRAEWHGSDV-AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 123 (309)
T ss_dssp EEECSSEEEEEEEETTEEE-EEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHH
T ss_pred eecCCCeEEEEEEECCCcE-EEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHH
Confidence 455555 22333467777 99999876532 23578899999999999999999999999999999999999999999
Q ss_pred HHHhcCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccC
Q 019901 78 RICNAGR---FSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 151 (334)
Q Consensus 78 ~l~~~~~---~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~g 151 (334)
++.+.+. +++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|||+++...... ......|
T Consensus 124 ~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~~~~~~~~~~g 201 (309)
T 3p86_A 124 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYT--VKVCDFGLSRLKASTFLSSKSAAG 201 (309)
T ss_dssp HHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCC--EEECCCC-----------------
T ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCc--EEECCCCCCccccccccccccCCC
Confidence 9987654 999999999999999999999999 999999999999987664 9999999997543322 2345679
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......... ........+....+++++.+||.+||
T Consensus 202 t~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~Pf~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l 276 (309)
T 3p86_A 202 TPEWMAPEVLRDEPSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAA----VGFKCKRLEIPRNLNPQVAAIIEGCW 276 (309)
T ss_dssp CCTTSCHHHHTTCCCCTT-HHHHHHHHHHHHHHHCCCTTTTSCHHHHHHH----HHHSCCCCCCCTTSCHHHHHHHHHHT
T ss_pred CccccChhhhcCCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhcCCCCCCCccCCHHHHHHHHHHc
Confidence 999999999988877655 9999999999999999999987665433222 22222233334568999999999999
Q ss_pred ccCCCCCCCHhHHhc--Cccccc
Q 019901 232 VADPAKRISIPEIRN--HEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s~~ell~--h~~~~~ 252 (334)
+.+|.+|||++++++ ++++..
T Consensus 277 ~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 277 TNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp CSSGGGSCCHHHHHHHHHHHHC-
T ss_pred cCChhhCcCHHHHHHHHHHHHHh
Confidence 999999999999987 455544
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=330.74 Aligned_cols=247 Identities=28% Similarity=0.364 Sum_probs=193.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEE--------------cCCeE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVIL--------------TPTHL 63 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--------------~~~~~ 63 (334)
||.|++ .+.+..+|+.| |||++........+.+.+|+.+++.++||||+++++++. ..+..
T Consensus 19 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~ 97 (320)
T 2i6l_A 19 LGCGGNGLVFSAVDNDCDKRV-AIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSV 97 (320)
T ss_dssp CC-----CEEEEEETTTTEEE-EEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEE
T ss_pred eccCCCeEEEEEEECCCCeEE-EEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCce
Confidence 566655 47888889998 999998765444577899999999999999999999874 34689
Q ss_pred EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC
Q 019901 64 AIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143 (334)
Q Consensus 64 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~ 143 (334)
|+||||+. |+|.+++.+ +++++..++.++.|++.||.|||++||+||||||+|||++..+ ..+||+|||+++.....
T Consensus 98 ~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~kl~Dfg~~~~~~~~ 174 (320)
T 2i6l_A 98 YIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTED-LVLKIGDFGLARIMDPH 174 (320)
T ss_dssp EEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-TEEEECCCTTCBCC---
T ss_pred eEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CeEEEccCccccccCCC
Confidence 99999997 699988854 5799999999999999999999999999999999999997433 25999999999854322
Q ss_pred ----CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh-----------
Q 019901 144 ----SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS----------- 208 (334)
Q Consensus 144 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~----------- 208 (334)
.......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+................
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (320)
T 2i6l_A 175 YSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLS 254 (320)
T ss_dssp -----CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHT
T ss_pred cccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhh
Confidence 12234467999999999876444456699999999999999999999987765444433322100
Q ss_pred -------ccccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 209 -------VQYSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 209 -------~~~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.....+ ....+++++++||.+||+.||.+|||++++++||||+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 311 (320)
T 2i6l_A 255 VIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311 (320)
T ss_dssp TSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHT
T ss_pred cCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccc
Confidence 000000 12357999999999999999999999999999999975
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=335.08 Aligned_cols=244 Identities=28% Similarity=0.463 Sum_probs=170.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ .++++.+|+.| |||++.... .........++.+.||||+++++++.. ...+++||||+.||+|.++
T Consensus 42 ~g~V~~~~~~~~~~~v-avK~~~~~~----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~ 116 (336)
T 3fhr_A 42 NGKVLECFHRRTGQKC-ALKLLYDSP----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSR 116 (336)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEESSH----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEecCcH----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHH
Confidence 3444 48888899999 999986533 222333344677899999999999876 4568999999999999999
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+.+||+|||+++.... .......||+.|
T Consensus 117 l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~t~~y 195 (336)
T 3fhr_A 117 IQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYY 195 (336)
T ss_dssp HHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc-cccccCCCCcCc
Confidence 98764 699999999999999999999999999999999999997533 34599999999975432 233456789999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--cccCCCCCCCCHHHHHHHHHhccc
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV--QYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
+|||++.+..++.+ +|||||||++|+|++|+.||...............+... ....+.+..+++++.+||.+||+.
T Consensus 196 ~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 274 (336)
T 3fhr_A 196 VAPEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKT 274 (336)
T ss_dssp --------CHHHHH-HHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCS
T ss_pred cChhhhCCCCCCch-hhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCC
Confidence 99999977777544 999999999999999999997655433222222222222 223344567899999999999999
Q ss_pred CCCCCCCHhHHhcCccccccC
Q 019901 234 DPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~~~ 254 (334)
+|.+|||++++++||||++..
T Consensus 275 dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 275 DPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp SGGGSCCHHHHHHSHHHHTGG
T ss_pred ChhHCcCHHHHhcCccccccc
Confidence 999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=333.13 Aligned_cols=242 Identities=24% Similarity=0.359 Sum_probs=190.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeE------EEEEeccCCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHL------AIVMEYASGGE 74 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~------~lv~e~~~~~~ 74 (334)
||.+ .+.++.+|+.| |||++..... .....+.+|+.+++.++||||+++++++...+.. |+||||+. ++
T Consensus 55 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 132 (371)
T 4exu_A 55 YGSVCSAIDKRSGEKV-AIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TD 132 (371)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EE
T ss_pred CeEEEEEEECCCCCEE-EEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-cc
Confidence 3444 47788899998 9999987542 1236788999999999999999999999877654 99999996 68
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|...+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ......||+.
T Consensus 133 l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~a~~~~~--~~~~~~~t~~ 206 (371)
T 4exu_A 133 LQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRW 206 (371)
T ss_dssp HHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSTTCC----------CTTCCCT
T ss_pred HHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCC--EEEEecCccccccc--CcCCcccCcc
Confidence 877763 34999999999999999999999999999999999999987765 99999999975432 2345678999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-------------------ccCC-
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-------------------YSIP- 214 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~~- 214 (334)
|+|||++.+....+.++|||||||++|+|++|+.||.+......+........... ...+
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (371)
T 4exu_A 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 286 (371)
T ss_dssp TSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCC
T ss_pred ccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcc
Confidence 99999998743334559999999999999999999998776555544433211100 0000
Q ss_pred -----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 -----DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 -----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
....+++.+.+||.+||+.+|.+|||++++|+||||+..
T Consensus 287 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 287 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF 330 (371)
T ss_dssp CCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred hhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence 123568999999999999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=325.88 Aligned_cols=245 Identities=26% Similarity=0.355 Sum_probs=195.6
Q ss_pred cceee-eeec-CCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC---CCCCcccceEEEE-----cCCeEEEEEeccC
Q 019901 4 FHNFY-DRCS-YSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL---RHPNIVRFKEVIL-----TPTHLAIVMEYAS 71 (334)
Q Consensus 4 ~g~~~-~~~~-~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~-----~~~~~~lv~e~~~ 71 (334)
+|.++ +++. .+|..| |||++..... .....+.+|+.+++.+ +||||+++++++. .....++||||+.
T Consensus 24 ~g~V~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 102 (326)
T 1blx_A 24 YGKVFKARDLKNGGRFV-ALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD 102 (326)
T ss_dssp TEEEEEEEETTTTTEEE-EEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS
T ss_pred cEEEEEEEecCCCCEEE-EEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC
Confidence 44443 6665 455666 9999976542 2335677888877766 8999999999987 5568999999997
Q ss_pred CCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 72 GGELFERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 72 ~~~L~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 103 -~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 179 (326)
T 1blx_A 103 -QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSV 179 (326)
T ss_dssp -CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCC
T ss_pred -CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCC--EEEecCcccccccCCCCcccc
Confidence 69999998753 4999999999999999999999999999999999999987665 999999999865444444556
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc-ccC---------------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ-YSI--------------- 213 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~--------------- 213 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+......+........... ...
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (326)
T 1blx_A 180 VVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 258 (326)
T ss_dssp CCCCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCC
T ss_pred ccccceeCHHHHhcCCCCcc-hhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccC
Confidence 79999999999988877655 9999999999999999999998776555554443221110 000
Q ss_pred -----CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 214 -----PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 214 -----~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.....+++.+++||.+||+.+|.+|||+.++++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 303 (326)
T 1blx_A 259 AQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 303 (326)
T ss_dssp CCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccccc
Confidence 0123578999999999999999999999999999999653
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=328.46 Aligned_cols=237 Identities=24% Similarity=0.358 Sum_probs=191.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .+.+..++..| |+|++........+.+.+|+.+++.++||||+++++++.+++..++||||+.+++|.+
T Consensus 18 lG~G~~g~V~~~~~~~~~~~v-a~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 96 (310)
T 3s95_A 18 LGKGCFGQAIKVTHRETGEVM-VMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRG 96 (310)
T ss_dssp EECCSSEEEEEEEETTTCCEE-EEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred ecCCCCEEEEEEEECCCCcEE-EEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHH
Confidence 455554 47788889998 9999866554456789999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC----------
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP---------- 146 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~---------- 146 (334)
++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 97 ~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 174 (310)
T 3s95_A 97 IIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKN--VVVADFGLARLMVDEKTQPEGLRSLKKP 174 (310)
T ss_dssp HHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSC--EEECCCTTCEECC---------------
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCC--EEEeecccceeccccccccccccccccc
Confidence 9987 567999999999999999999999999999999999999987665 999999999754322211
Q ss_pred -----CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHH-HHHHHHHhhccccCCCCCCCC
Q 019901 147 -----KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF-RKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 147 -----~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 220 (334)
...+||+.|+|||++.+..++.+ +||||||+++|+|++|..||......... ......... ......++
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 249 (310)
T 3s95_A 175 DRKKRYTVVGNPYWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLD----RYCPPNCP 249 (310)
T ss_dssp -----CCCCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHH----HTCCTTCC
T ss_pred ccccccccCCCcceeCHHHhcCCCCCcH-HHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccc----ccCCCCCC
Confidence 14579999999999988877655 99999999999999999998753321100 000001111 11123578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+.+.++|.+||+.+|.+|||+.++++
T Consensus 250 ~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 250 PSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp TTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999999999985
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=335.01 Aligned_cols=242 Identities=22% Similarity=0.397 Sum_probs=198.4
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCccccc-----------------HHHHHHHHHHHcCCCCCcccceEEEEcC
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQID-----------------ENVQREIINHRSLRHPNIVRFKEVILTP 60 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~-----------------~~~~~Ei~~l~~l~hp~iv~~~~~~~~~ 60 (334)
||.|++ + +.+ +|+.| |||++........ +.+.+|+.+++.++||||+++++++...
T Consensus 39 lg~G~~g~V~~~~~--~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 115 (348)
T 2pml_X 39 LNQGKFNKIILCEK--DNKFY-ALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY 115 (348)
T ss_dssp EECCSSCCEEEEEE--TTEEE-EEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS
T ss_pred EcCCCCeEEEEEEc--CCceE-EEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC
Confidence 455544 3 555 88888 9999987642211 7899999999999999999999999999
Q ss_pred CeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEE
Q 019901 61 THLAIVMEYASGGELFER------ICN--AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKI 131 (334)
Q Consensus 61 ~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl 131 (334)
+..++||||+++++|.++ +.+ ...+++..++.++.|++.||.|||+ +||+||||||+|||++.++. +||
T Consensus 116 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~--~kl 193 (348)
T 2pml_X 116 DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR--VKL 193 (348)
T ss_dssp SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTSC--EEE
T ss_pred CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCCc--EEE
Confidence 999999999999999988 665 5679999999999999999999999 99999999999999987664 999
Q ss_pred eccCCccCCCCCCCCCCccCCCccccchhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc
Q 019901 132 CDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKK-EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210 (334)
Q Consensus 132 ~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 210 (334)
+|||++...... ......||+.|+|||++.+. .++..++|||||||++|+|++|+.||......... ...+....
T Consensus 194 ~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~i~~~~ 269 (348)
T 2pml_X 194 SDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL---FNNIRTKN 269 (348)
T ss_dssp CCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH---HHHHTSCC
T ss_pred eccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH---HHHHhccC
Confidence 999998754332 33456799999999999877 45453699999999999999999999876653222 22233333
Q ss_pred ccCCCC-----------------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 211 YSIPDY-----------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 211 ~~~~~~-----------------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...|.. ..+++++.+||.+||+.+|.+|||++++++||||..
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 328 (348)
T 2pml_X 270 IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328 (348)
T ss_dssp CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTT
T ss_pred cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccC
Confidence 333321 458999999999999999999999999999999964
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=330.14 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=192.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+.+..+|+.| |||++..... .....+.+|+.+++.++||||+++++++... +..++||||+. ++|.
T Consensus 24 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~ 101 (353)
T 2b9h_A 24 YGVVCSATHKPTGEIV-AIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLH 101 (353)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHH
T ss_pred CeEEEEEEECCCCcEE-EEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHH
Confidence 3444 47788889888 9999975431 2235678999999999999999999987654 67999999996 6898
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----------
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----------- 145 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----------- 145 (334)
+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 102 ~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~ 178 (353)
T 2b9h_A 102 RVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD--LKVCDFGLARIIDESAADNSEPTGQQSG 178 (353)
T ss_dssp HHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECC---------------
T ss_pred HHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCc--EEEEecccccccccccccccCccccccc
Confidence 88876 56999999999999999999999999999999999999987665 99999999975432211
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc---------------
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ--------------- 210 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--------------- 210 (334)
....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+......+...........
T Consensus 179 ~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (353)
T 2b9h_A 179 MVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRARE 258 (353)
T ss_dssp -CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHH
T ss_pred hhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhH
Confidence 12347899999999987644445669999999999999999999988765444333222111100
Q ss_pred -----ccCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 -----YSIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 -----~~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
...+ .+..+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (353)
T 2b9h_A 259 YIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH 313 (353)
T ss_dssp HHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence 0000 0235789999999999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=329.89 Aligned_cols=242 Identities=27% Similarity=0.320 Sum_probs=191.5
Q ss_pred cceee-eee-cCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCC------CcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 4 FHNFY-DRC-SYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHP------NIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~~-~~~-~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp------~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.++ +.+ ..++..| |||++.... ...+.+.+|+.+++.++|+ +++++++++...+..++||||+ +++|
T Consensus 27 ~g~V~~~~~~~~~~~~v-avK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l 103 (339)
T 1z57_A 27 FGKVVECIDHKAGGRHV-AVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLST 103 (339)
T ss_dssp TEEEEEEEETTTTTEEE-EEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred CeEEEEEEecCCCCcEE-EEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCH
Confidence 34443 666 4456666 999997654 3456788999999888765 4999999999999999999999 8899
Q ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-----------------CCCEEEeccCC
Q 019901 76 FERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------------APRLKICDFGY 136 (334)
Q Consensus 76 ~~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-----------------~~~~kl~Dfgl 136 (334)
.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++..+ .+.+||+|||+
T Consensus 104 ~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~ 183 (339)
T 1z57_A 104 YDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGS 183 (339)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSS
T ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcc
Confidence 99998765 689999999999999999999999999999999999997643 34599999999
Q ss_pred ccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-----
Q 019901 137 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----- 211 (334)
Q Consensus 137 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----- 211 (334)
++.... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...+......... .......
T Consensus 184 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~-~~~~~~p~~~~~ 259 (339)
T 1z57_A 184 ATYDDE--HHSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMME-RILGPLPKHMIQ 259 (339)
T ss_dssp CEETTS--CCCSSCSCGGGCCHHHHTTSCCCTH-HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHH-HHHCSCCHHHHH
T ss_pred cccCcc--ccccccCCccccChHHhhCCCCCcc-hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCCCCHHHHh
Confidence 875332 2345679999999999988887655 999999999999999999998766544332221 1111000
Q ss_pred ----------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 212 ----------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 212 ----------------------------------~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
........++++.+||.+||+.||.+|||++|+++||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~ 334 (339)
T 1z57_A 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334 (339)
T ss_dssp HCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred hccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence 00001123577899999999999999999999999999965
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=323.69 Aligned_cols=242 Identities=32% Similarity=0.499 Sum_probs=194.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCCCCcccceEEEE--cCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+.+..++..| |||++.+... ...+.+.+|+.+++.++||||+++++++. ..+..++||||+.++ |.
T Consensus 18 ~g~V~~~~~~~~~~~~-avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~ 95 (305)
T 2wtk_C 18 YGKVKEVLDSETLCRR-AVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQ 95 (305)
T ss_dssp SCEEEEEEBTTTCCEE-EEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HH
T ss_pred CeEEEEEEECCCCcEE-EEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HH
Confidence 3444 37788899998 9999987541 33468999999999999999999999984 456899999999876 77
Q ss_pred HHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccC
Q 019901 77 ERICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVG 151 (334)
Q Consensus 77 ~~l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~g 151 (334)
+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....... ......|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~ 173 (305)
T 2wtk_C 96 EMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGT--LKISALGVAEALHPFAADDTCRTSQG 173 (305)
T ss_dssp HHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCSSCEECCCCS
T ss_pred HHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCc--EEeeccccccccCccccccccccCCC
Confidence 77765 356999999999999999999999999999999999999987665 9999999987543221 2234569
Q ss_pred CCccccchhhccCCC-CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEY-DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
|+.|+|||++.+... .+.++||||||+++|+|++|+.||.+...... ...+.......+ ..+++.+.+||.+|
T Consensus 174 ~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~i~~~~~~~~--~~~~~~l~~li~~~ 247 (305)
T 2wtk_C 174 SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKL----FENIGKGSYAIP--GDCGPPLSDLLKGM 247 (305)
T ss_dssp CGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH----HHHHHHCCCCCC--SSSCHHHHHHHHHH
T ss_pred CCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHH----HHHHhcCCCCCC--CccCHHHHHHHHHH
Confidence 999999999876432 34559999999999999999999987654332 223333333333 35799999999999
Q ss_pred cccCCCCCCCHhHHhcCccccccCC
Q 019901 231 FVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
|+.||.+|||++++++||||++..+
T Consensus 248 l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 248 LEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp TCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ccCChhhCCCHHHHhcCcccccCCC
Confidence 9999999999999999999987654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-45 Score=335.50 Aligned_cols=244 Identities=27% Similarity=0.315 Sum_probs=193.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CC-----CcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HP-----NIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp-----~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.+ .+++..+++.| |||++.... .....+.+|+.+++.++ |+ +|+++++++...+..|+||||+. ++|.
T Consensus 67 ~g~V~~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~ 143 (382)
T 2vx3_A 67 FGQVVKAYDRVEQEWV-AIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLY 143 (382)
T ss_dssp TEEEEEEEETTTTEEE-EEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred CEEEEEEEEcCCCcEE-EEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHH
Confidence 4444 47788888888 999997554 34467788888888875 44 49999999999999999999995 5999
Q ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 77 ERICNA--GRFSEDEARFFFQQLISGVSYCH--SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 77 ~~l~~~--~~~~~~~~~~~~~qil~~L~~LH--~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
+++... +.+++..++.++.|++.||.||| +.||+||||||+|||++.+..+.+||+|||+|+.... .....+||
T Consensus 144 ~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~--~~~~~~~t 221 (382)
T 2vx3_A 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ--RIYQYIQS 221 (382)
T ss_dssp HHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSC
T ss_pred HHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc--ccccccCC
Confidence 999875 45999999999999999999999 5799999999999999654445699999999975432 33456899
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--------------cCC----
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------SIP---- 214 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~---- 214 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|++||.+......+..+......... ..+
T Consensus 222 ~~y~aPE~~~~~~~~~~-~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (382)
T 2vx3_A 222 RFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTW 300 (382)
T ss_dssp GGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCE
T ss_pred ccccChHHHcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhcccccc
Confidence 99999999998887655 99999999999999999999987766555554432211000 000
Q ss_pred ---------------CCCC-------------------------CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 215 ---------------DYVH-------------------------ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 215 ---------------~~~~-------------------------~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.... .++++.+||.+||+.||.+|||++|+|+||||++.
T Consensus 301 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 301 NLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp EECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0000 01378999999999999999999999999999764
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=327.66 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=190.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCe------EEEEEeccCCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTH------LAIVMEYASGGE 74 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~------~~lv~e~~~~~~ 74 (334)
||.+ .+.++.+|+.| |||++..... .....+.+|+.+++.++||||+++++++...+. .|+||||+. ++
T Consensus 37 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 114 (353)
T 3coi_A 37 YGSVCSAIDKRSGEKV-AIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TD 114 (353)
T ss_dssp SEEEEEEEETTTTEEE-EEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EE
T ss_pred CeEEEEEEECCCCCEE-EEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CC
Confidence 4444 47788899998 9999976542 123578899999999999999999999987654 599999996 68
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.... ......||+.
T Consensus 115 l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~--~~~~~~~t~~ 188 (353)
T 3coi_A 115 LQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCE--LKILDFGLARHADA--EMTGYVVTRW 188 (353)
T ss_dssp GGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCC--EEECSTTCTTC----------CCSBC
T ss_pred HHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCc--EEEeecccccCCCC--CccccccCcC
Confidence 877764 35999999999999999999999999999999999999987665 99999999875432 2344578999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc------------------------c
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV------------------------Q 210 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------------------------~ 210 (334)
|+|||++.+....+.++|||||||++|+|++|+.||.+......+.......... .
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (353)
T 3coi_A 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPR 268 (353)
T ss_dssp CSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSS
T ss_pred cCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCC
Confidence 9999999874444455999999999999999999999876554444433221100 0
Q ss_pred ccC-CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 211 YSI-PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 211 ~~~-~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
..+ .....+++++.+||.+||+.||.+|||++++++||||+...
T Consensus 269 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 269 KDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred ccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 000 11235789999999999999999999999999999997643
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=322.78 Aligned_cols=240 Identities=28% Similarity=0.405 Sum_probs=185.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc-------------CCeEEEEEec
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT-------------PTHLAIVMEY 69 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-------------~~~~~lv~e~ 69 (334)
||.+ .+++..+|..| |||++.... ...+.+.+|+.+++.++||||+++++++.. .+..|+||||
T Consensus 19 ~g~V~~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 96 (303)
T 1zy4_A 19 FGQVVKARNALDSRYY-AIKKIRHTE-EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEY 96 (303)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEEEH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEEC
T ss_pred cEEEEEEEEcCCCeEE-EEEEEeccH-HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEec
Confidence 3444 47788899998 999997644 345678999999999999999999998864 3578999999
Q ss_pred cCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----
Q 019901 70 ASGGELFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----- 143 (334)
Q Consensus 70 ~~~~~L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----- 143 (334)
+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 97 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~ 174 (303)
T 1zy4_A 97 CENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRN--VKIGDFGLAKNVHRSLDILK 174 (303)
T ss_dssp CCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCCCCCSCTTC------
T ss_pred CCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCC--EEEeeCcchhhcccccchhc
Confidence 99999999998654 5889999999999999999999999999999999999987665 999999998754321
Q ss_pred ----------CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC
Q 019901 144 ----------SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213 (334)
Q Consensus 144 ----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 213 (334)
.......||+.|+|||++.+....+.++|||||||++|+|++ ||...... ......+......+
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~---~~~~~~~~~~~~~~ 248 (303)
T 1zy4_A 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER---VNILKKLRSVSIEF 248 (303)
T ss_dssp -------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH---HHHHHHHHSTTCCC
T ss_pred cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH---HHHHHhcccccccc
Confidence 122345689999999999866444555999999999999998 55432221 22222333222222
Q ss_pred C--CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 214 P--DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 214 ~--~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
| .....++.+.++|.+||+.||.+|||+.++++||||...
T Consensus 249 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 249 PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 2 223567889999999999999999999999999999653
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=340.34 Aligned_cols=242 Identities=22% Similarity=0.326 Sum_probs=187.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC--------CCCcccceEEEE----cCCeEEEEEecc
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR--------HPNIVRFKEVIL----TPTHLAIVMEYA 70 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~--------hp~iv~~~~~~~----~~~~~~lv~e~~ 70 (334)
||.+ .+++..+++.| |||++.... ...+.+.+|+.+++.++ ||||+++++++. ....+|+||||+
T Consensus 50 ~g~V~~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~ 127 (397)
T 1wak_A 50 FSTVWLSWDIQGKKFV-AMKVVKSAE-HYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL 127 (397)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECSCH-HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC
T ss_pred CeeEEEEEecCCCeEE-EEEEEecCC-cchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc
Confidence 3444 47788888888 999997654 44567889999999885 788999999988 556899999999
Q ss_pred CCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCC----------------------
Q 019901 71 SGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP---------------------- 125 (334)
Q Consensus 71 ~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~---------------------- 125 (334)
+++|.+.+... +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 128 -~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~ 206 (397)
T 1wak_A 128 -GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206 (397)
T ss_dssp -CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-----------
T ss_pred -CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCC
Confidence 56676766554 4699999999999999999999998 999999999999997653
Q ss_pred -------------------------CCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHH
Q 019901 126 -------------------------APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTL 180 (334)
Q Consensus 126 -------------------------~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il 180 (334)
...+||+|||+|+.... .....+||+.|+|||++.+..++.+ +|||||||++
T Consensus 207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il 283 (397)
T 1wak_A 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLEVLIGSGYNTP-ADIWSTACMA 283 (397)
T ss_dssp ----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHHHHHTSCCCTH-HHHHHHHHHH
T ss_pred CCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCChhhcCCCCCcH-HHHHHHHHHH
Confidence 02599999999975432 2345679999999999998887655 9999999999
Q ss_pred HHHHhCCCCCCCCCch------HHHHHHHHHHhhc--------ccc----------------------------CCCCCC
Q 019901 181 YVMLVGAYPFEDPEEP------KNFRKTIHRILSV--------QYS----------------------------IPDYVH 218 (334)
Q Consensus 181 ~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~--------~~~----------------------------~~~~~~ 218 (334)
|+|++|+.||...... ............. ... ......
T Consensus 284 ~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 363 (397)
T 1wak_A 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQE 363 (397)
T ss_dssp HHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHH
T ss_pred HHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchh
Confidence 9999999999865422 1111111110000 000 000112
Q ss_pred CCHHHHHHHHHhcccCCCCCCCHhHHhcCcccc
Q 019901 219 ISPECRHLISRIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 219 ~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
.++.+.+||.+||+.||.+|||++|+|+||||+
T Consensus 364 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 364 EAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred hHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 246788999999999999999999999999995
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=338.48 Aligned_cols=241 Identities=14% Similarity=0.108 Sum_probs=174.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHH---HHHHcCCCCCcccce-------EEEEcC---------
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREI---INHRSLRHPNIVRFK-------EVILTP--------- 60 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei---~~l~~l~hp~iv~~~-------~~~~~~--------- 60 (334)
||.+ .+++..+|+.| |||++..... ...+.+.+|+ ..++. +||||++++ +++...
T Consensus 75 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~ 152 (371)
T 3q60_A 75 RSVVFLVRDVERLEDF-ALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152 (371)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCS
T ss_pred CEEEEEEEECCCCcee-EEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeecc
Confidence 3444 47788889988 9999998652 2235677784 55555 799977754 555433
Q ss_pred --------CeEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC
Q 019901 61 --------THLAIVMEYASGGELFERICNA-GRFSEDEA------RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 125 (334)
Q Consensus 61 --------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~------~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~ 125 (334)
..+|+||||+. ++|.+++... ..++.... ..++.||+.||+|||++||+||||||+|||++.++
T Consensus 153 ~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~ 231 (371)
T 3q60_A 153 PGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG 231 (371)
T ss_dssp CC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS
T ss_pred CCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC
Confidence 34899999998 8999999864 23444444 56779999999999999999999999999998776
Q ss_pred CCCEEEeccCCccCCCCCCCCCCccCCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHH--HH
Q 019901 126 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RK 201 (334)
Q Consensus 126 ~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~ 201 (334)
. +||+|||+|+..... .....+|+.|+|||++.+ ..++ .++|||||||++|+|++|+.||.+....... ..
T Consensus 232 ~--~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 306 (371)
T 3q60_A 232 R--LMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFT-HALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKR 306 (371)
T ss_dssp C--EEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECC-HHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCB
T ss_pred C--EEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcC-ccccHHHHHHHHHHHHhCCCCCCCcCcccccchhh
Confidence 5 999999999854321 124567799999999976 5565 5599999999999999999999876331100 00
Q ss_pred -HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 202 -TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 202 -~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
............+....+++.+.+||.+||+.||.+|||+.++++||||++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~ 358 (371)
T 3q60_A 307 PSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ 358 (371)
T ss_dssp CCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred hhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence 000011123334445578999999999999999999999999999999965
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=316.59 Aligned_cols=234 Identities=21% Similarity=0.336 Sum_probs=191.3
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA- 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 82 (334)
||.++.....+++.| |||++.... ...+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...
T Consensus 23 ~g~V~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (269)
T 4hcu_A 23 FGLVHLGYWLNKDKV-AIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 100 (269)
T ss_dssp SCEEEEEEETTTEEE-EEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT
T ss_pred ccEEEEEEecCCCeE-EEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC
Confidence 444443333356677 999998766 45578999999999999999999999999999999999999999999999654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccchh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEV 160 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~ 160 (334)
+.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... ......+|+.|+|||+
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 178 (269)
T 4hcu_A 101 GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 178 (269)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCC--EEeccccccccccccccccccCcccccccCCHHH
Confidence 45999999999999999999999999999999999999987654 9999999987543221 2234457889999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
+.+..++.+ +||||||+++|+|++ |+.||........... +.. ..........++.+.+++.+||+.+|.+||
T Consensus 179 ~~~~~~~~~-~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 252 (269)
T 4hcu_A 179 FSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVYQIMNHCWRERPEDRP 252 (269)
T ss_dssp HHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcCCCCCch-hhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHH----Hhc-CccCCCCCcCCHHHHHHHHHHccCCcccCc
Confidence 988777655 999999999999999 9999987665433322 222 223333445799999999999999999999
Q ss_pred CHhHHhcC
Q 019901 240 SIPEIRNH 247 (334)
Q Consensus 240 s~~ell~h 247 (334)
|+.++++|
T Consensus 253 s~~~ll~~ 260 (269)
T 4hcu_A 253 AFSRLLRQ 260 (269)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999876
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=315.60 Aligned_cols=234 Identities=21% Similarity=0.278 Sum_probs=191.3
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 83 (334)
||.++.....++..| |||++.... ...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...+
T Consensus 21 ~g~V~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 98 (268)
T 3sxs_A 21 FGVVKLGKWKGQYDV-AVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG 98 (268)
T ss_dssp TEEEEEEEETTTEEE-EEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG
T ss_pred CceEEEEEecCceeE-EEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC
Confidence 444443344455567 999998766 445779999999999999999999999999999999999999999999998754
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchh
Q 019901 84 -RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEV 160 (334)
Q Consensus 84 -~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~ 160 (334)
.+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... .....+|+.|+|||+
T Consensus 99 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (268)
T 3sxs_A 99 KGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLC--VKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEV 176 (268)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCC--EEECCTTCEEECCTTCEEECCSCCCCGGGCCHHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCC--EEEccCccceecchhhhhcccCCCcCcccCCHHH
Confidence 4999999999999999999999999999999999999987765 99999999875433221 233456778999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
+.+..++.+ +||||||+++|+|++ |+.||........... +.. ......+...++.+.++|.+||+.+|.+||
T Consensus 177 ~~~~~~~~~-~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 250 (268)
T 3sxs_A 177 FHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLK----VSQ-GHRLYRPHLASDTIYQIMYSCWHELPEKRP 250 (268)
T ss_dssp HHHSEEETT-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHHHHTTCSSGGGSC
T ss_pred HhccCCchh-hhhHHHHHHHHHHHcCCCCCccccChHHHHHH----HHc-CCCCCCCCcChHHHHHHHHHHcCCChhhCc
Confidence 988777655 999999999999999 9999987665433322 222 222233345799999999999999999999
Q ss_pred CHhHHhcC
Q 019901 240 SIPEIRNH 247 (334)
Q Consensus 240 s~~ell~h 247 (334)
|+.+++++
T Consensus 251 s~~~ll~~ 258 (268)
T 3sxs_A 251 TFQQLLSS 258 (268)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999976
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=328.36 Aligned_cols=245 Identities=23% Similarity=0.293 Sum_probs=190.6
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC------cccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN------IVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~------iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.++ +.+..+++..||||++.... ...+.+.+|+.+++.++|++ ++.+++++...+..++||||+ +++|.
T Consensus 32 ~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~ 109 (355)
T 2eu9_A 32 FGKVVECLDHARGKSQVALKIIRNVG-KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTF 109 (355)
T ss_dssp TEEEEEEEETTTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred CeEEEEEEecCCCceEEEEEEEcccc-cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChH
Confidence 44444 77777775444999997654 44567889999999987665 899999999999999999999 66777
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-----------------CCCCEEEeccCCc
Q 019901 77 ERICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-----------------PAPRLKICDFGYS 137 (334)
Q Consensus 77 ~~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-----------------~~~~~kl~Dfgla 137 (334)
+.+.... .+++..++.++.||+.||.|||++||+||||||+|||++.. ..+.+||+|||++
T Consensus 110 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~ 189 (355)
T 2eu9_A 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189 (355)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTC
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcc
Confidence 7776653 69999999999999999999999999999999999999432 2335999999999
Q ss_pred cCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc------
Q 019901 138 KSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------ 211 (334)
Q Consensus 138 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------ 211 (334)
+... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.....................
T Consensus 190 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~ 266 (355)
T 2eu9_A 190 TFDH--EHHTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRT 266 (355)
T ss_dssp EETT--SCCCSSCSCGGGCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHC
T ss_pred cccc--ccccCCcCCCcccCCeeeecCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhc
Confidence 7532 23345679999999999988887655 99999999999999999999877654433322211100000
Q ss_pred --------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 --------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 --------------------------------~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
........++++.+||.+||+.||.+|||++++++||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 267 RKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp SCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred cchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence 000011124578999999999999999999999999999764
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=324.84 Aligned_cols=243 Identities=20% Similarity=0.309 Sum_probs=177.0
Q ss_pred cceee-eeecCCCC---eeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeE------EEEEeccC
Q 019901 4 FHNFY-DRCSYSSD---LFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHL------AIVMEYAS 71 (334)
Q Consensus 4 ~g~~~-~~~~~~~~---~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~------~lv~e~~~ 71 (334)
||.++ +++..+++ .| |||++..... ...+.+.+|+.+++.++||||+++++++...... ++||||+.
T Consensus 36 ~g~Vy~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~ 114 (323)
T 3qup_A 36 FGSVREAQLKQEDGSFVKV-AVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMK 114 (323)
T ss_dssp TEEEEEEEC-------CEE-EEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCT
T ss_pred CeEEEEEEEcccCCcceeE-EEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEecc
Confidence 34443 66666654 56 9999976542 2346789999999999999999999999877654 99999999
Q ss_pred CCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 72 GGELFERICNAG------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 72 ~~~L~~~l~~~~------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 115 ~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~--~kl~Dfg~a~~~~~~~~ 192 (323)
T 3qup_A 115 HGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT--VCVADFGLSRKIYSGDY 192 (323)
T ss_dssp TCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC---------
T ss_pred CCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC--EEEeecccccccccccc
Confidence 999999986543 5999999999999999999999999999999999999987664 99999999975433222
Q ss_pred ---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCH
Q 019901 146 ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221 (334)
Q Consensus 146 ---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 221 (334)
.....+++.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........... . ....+....+++
T Consensus 193 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~~~~~ 266 (323)
T 3qup_A 193 YRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----G-GNRLKQPPECME 266 (323)
T ss_dssp --------CCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH----T-TCCCCCCTTCCH
T ss_pred ccccccccCcccccCchhhcCCCCCCc-cchhhHHHHHHHHHhCCCCCccccChHHHHHHHh----c-CCCCCCCCccCH
Confidence 223456789999999988877644 999999999999999 999998877654433321 1 222334456899
Q ss_pred HHHHHHHHhcccCCCCCCC-------HhHHhcCccccccCC
Q 019901 222 ECRHLISRIFVADPAKRIS-------IPEIRNHEWFLKNLP 255 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s-------~~ell~h~~~~~~~~ 255 (334)
++.++|.+||+.+|.+||| +++++.|||+....+
T Consensus 267 ~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 267 EVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 9999999999999999999 788899999976543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=324.80 Aligned_cols=234 Identities=22% Similarity=0.330 Sum_probs=189.7
Q ss_pred ccee-eeeecCCCCe---eEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDL---FVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~---vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ .+++..+++. | |||++..... ...+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.++
T Consensus 62 ~g~V~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 140 (325)
T 3kul_A 62 SGEVCYGRLRVPGQRDVPV-AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140 (325)
T ss_dssp TEEEEEEEECCTTSCCEEE-EEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHH
T ss_pred CcEEEEEEEecCCCCCceE-EEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHH
Confidence 4444 4667666654 6 9999986541 2346789999999999999999999999999999999999999999999
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCC
Q 019901 79 ICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTP 153 (334)
Q Consensus 79 l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~ 153 (334)
+... +.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+
T Consensus 141 l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~ 218 (325)
T 3kul_A 141 LRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV--CKVSDFGLSRVLEDDPDAAYTTTGGKIPI 218 (325)
T ss_dssp HHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCSSCEECC----CCEECC---CCG
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCC--EEECCCCcccccccCccceeeccCCCCcc
Confidence 9754 57999999999999999999999999999999999999987664 99999999985433221 12234677
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... + ......+....+++.+.++|.+||.
T Consensus 219 ~y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~l~~li~~~l~ 292 (325)
T 3kul_A 219 RWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISS----V-EEGYRLPAPMGCPHALHQLMLDCWH 292 (325)
T ss_dssp GGSCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHH----H-HTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccCHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----H-HcCCCCCCCCCcCHHHHHHHHHHcc
Confidence 8999999988877655 999999999999999 9999987665433322 2 2223444555789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 293 ~dp~~Rps~~eil~ 306 (325)
T 3kul_A 293 KDRAQRPRFSQIVS 306 (325)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999985
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=319.62 Aligned_cols=243 Identities=23% Similarity=0.321 Sum_probs=180.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-c-cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-I-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-~-~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ .++++.+|+.| |||++...... . .+.+..+..+++.++||||+++++++..++..++||||+ ++.+
T Consensus 33 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~ 110 (318)
T 2dyl_A 33 MGSGTCGQVWKMRFRKTGHVI-AVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCA 110 (318)
T ss_dssp C------CEEEEEETTTCCEE-EEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEH
T ss_pred eeecCCeeEEEEEEecCCeEE-EEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcH
Confidence 566555 47788899998 99999876521 1 233444556788899999999999999999999999999 5556
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 76 FERICN-AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
...... .+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++............||+
T Consensus 111 ~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~ 188 (318)
T 2dyl_A 111 EKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQ--IKLCDFGISGRLVDDKAKDRSAGCA 188 (318)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSC--EEECCCTTC--------------CC
T ss_pred HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCC--EEEEECCCchhccCCccccccCCCc
Confidence 555543 46799999999999999999999996 9999999999999987665 9999999997655444445567999
Q ss_pred ccccchhhc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh-ccccCCCCCCCCHHHHHHH
Q 019901 154 AYIAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS-VQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 154 ~y~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li 227 (334)
.|+|||++. ...++ .++|||||||++|+|++|+.||.......... ..+.. .....+....+++++.++|
T Consensus 189 ~y~aPE~~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li 264 (318)
T 2dyl_A 189 AYMAPERIDPPDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVL---TKVLQEEPPLLPGHMGFSGDFQSFV 264 (318)
T ss_dssp TTCCHHHHC--------CC-THHHHHHHHHHHHHHHHSSCTTTTCCSHHHHH---HHHHHSCCCCCCSSSCCCHHHHHHH
T ss_pred cccChhhcccccccccCCc-cccchhhHHHHHHHHHhCCCCCCCCCccHHHH---HHHhccCCCCCCccCCCCHHHHHHH
Confidence 999999985 33444 45999999999999999999998754332222 22222 2233444456899999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||+.+|.+|||++++++||||++
T Consensus 265 ~~~l~~dp~~Rps~~~ll~h~~~~~ 289 (318)
T 2dyl_A 265 KDCLTKDHRKRPKYNKLLEHSFIKR 289 (318)
T ss_dssp HHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred HHHccCChhHCcCHHHHhhCHHHHh
Confidence 9999999999999999999999975
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=326.72 Aligned_cols=237 Identities=30% Similarity=0.464 Sum_probs=197.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCC--CCCcccceEEEEcCCeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 69 (334)
||.|+| .+++..++..| |||++...... ....+.+|+.+++.+. ||||+++++++..++..++|||+
T Consensus 51 lg~G~~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~ 129 (320)
T 3a99_A 51 LGSGGFGSVYSGIRVSDNLPV-AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129 (320)
T ss_dssp CSSSSSCEEEEEEETTTTEEE-EEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EeeCCCeEEEEEEECCCCcEE-EEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEc
Confidence 555554 37778888888 99999876522 2356788999999996 59999999999999999999999
Q ss_pred cCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc-CCCCCCEEEeccCCccCCCCCCCCC
Q 019901 70 ASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPK 147 (334)
Q Consensus 70 ~~~-~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~-~~~~~~~kl~Dfgla~~~~~~~~~~ 147 (334)
+.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++ .++ .+||+|||+++..... ...
T Consensus 130 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~--~~kL~Dfg~~~~~~~~-~~~ 206 (320)
T 3a99_A 130 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG--ELKLIDFGSGALLKDT-VYT 206 (320)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT--EEEECCCTTCEECCSS-CBC
T ss_pred CCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCC--CEEEeeCccccccccc-ccc
Confidence 976 89999999888899999999999999999999999999999999999998 344 4999999998754332 234
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
...||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... . ....... ....+++++.+||
T Consensus 207 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~----~~~~~~~--~~~~~~~~~~~li 274 (320)
T 3a99_A 207 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E----IIRGQVF--FRQRVSSECQHLI 274 (320)
T ss_dssp CCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHCCCC--CSSCCCHHHHHHH
T ss_pred CCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------h----hhccccc--ccccCCHHHHHHH
Confidence 45799999999999887776676899999999999999999997521 1 1122222 2235799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccccC
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.+||+.+|.+|||++++++||||++..
T Consensus 275 ~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 275 RWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp HHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 999999999999999999999997643
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-45 Score=333.14 Aligned_cols=245 Identities=19% Similarity=0.256 Sum_probs=195.5
Q ss_pred CCccee----eee-----ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDR-----CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~-----~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .++ +..++..| |||++..... .....+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus 79 LG~G~fg~Vy~~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 157 (367)
T 3l9p_A 79 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMA 157 (367)
T ss_dssp CCCCSSSCEEEEEECC-----CCEEE-EEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred eeeCCCEEEEEEEEccCCCCCcceeE-EEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCC
Confidence 566666 344 34556677 9999875431 234578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCC--
Q 019901 72 GGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSV-- 141 (334)
Q Consensus 72 ~~~L~~~l~~~~-------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~-- 141 (334)
+|+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++ ...+||+|||+|+...
T Consensus 158 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~ 237 (367)
T 3l9p_A 158 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 237 (367)
T ss_dssp TEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHH
T ss_pred CCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccc
Confidence 999999998653 489999999999999999999999999999999999998543 2359999999987421
Q ss_pred -CCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 142 -LHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 142 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
.........||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.......... .+.. ....+....+
T Consensus 238 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~pf~~~~~~~~~~----~i~~-~~~~~~~~~~ 311 (367)
T 3l9p_A 238 GYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTS-GGRMDPPKNC 311 (367)
T ss_dssp SSCTTCCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHT-TCCCCCCTTC
T ss_pred cccccCCCcCCcccEECHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCccC
Confidence 1222344568999999999988877655 999999999999998 999998766543322 2222 2223334468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
++.+.+||.+||+.+|.+|||+.+++++.++...
T Consensus 312 ~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 312 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 9999999999999999999999999999887543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=319.58 Aligned_cols=242 Identities=29% Similarity=0.418 Sum_probs=193.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEE--cCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~ 78 (334)
+|.+ .++++.+|+.| |+|++..... ...+.+.+|+.+++.++||||+++++++. .++..++||||+++++|.++
T Consensus 19 ~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 97 (279)
T 2w5a_A 19 YGRCQKIRRKSDGKIL-VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASV 97 (279)
T ss_dssp SSEEEEEEETTTCCEE-EEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHH
T ss_pred CcEEEEEEECCCCcEE-EEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHH
Confidence 4444 47788889998 9999987652 23457889999999999999999999875 36789999999999999999
Q ss_pred HHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCC
Q 019901 79 ICNA----GRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKS 148 (334)
Q Consensus 79 l~~~----~~~~~~~~~~~~~qil~~L~~LH~~~-----ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~ 148 (334)
+... ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. +||+|||+++....... ...
T Consensus 98 l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 175 (279)
T 2w5a_A 98 ITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDTSFAKT 175 (279)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSC--EEECCCCHHHHC---CHHHHH
T ss_pred HHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCC--EEEecCchheeeccccccccc
Confidence 8753 34999999999999999999999999 999999999999987665 99999999875432211 123
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
..||+.|+|||++.+..++.+ +||||||+++|+|++|+.||.......... .+..... .+....+++++.++|.
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~----~i~~~~~-~~~~~~~~~~l~~li~ 249 (279)
T 2w5a_A 176 FVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAG----KIREGKF-RRIPYRYSDELNEIIT 249 (279)
T ss_dssp HHSCCTTCCHHHHHCC-CCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHHTCC-CCCCTTSCHHHHHHHH
T ss_pred cCCCccccChHHhccCCCCch-hhHHHHHHHHHHHHHCCCCCcccCHHHHHH----HHhhccc-ccCCcccCHHHHHHHH
Confidence 468999999999988777544 999999999999999999998765432222 2222222 1223357999999999
Q ss_pred HhcccCCCCCCCHhHHhcCccccccC
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+||+.+|.+|||+.++++|+|+....
T Consensus 250 ~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 250 RMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp HHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred HHcCCCcccCCCHHHHHhChhhhhhc
Confidence 99999999999999999999997643
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=327.34 Aligned_cols=242 Identities=23% Similarity=0.316 Sum_probs=171.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHH-HHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREII-NHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC 80 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~-~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 80 (334)
||.+ .+.++.+|+.| |||++..... .....+.+|+. +++.++||||+++++++..++..++||||+.+ +|.+++.
T Consensus 35 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~ 112 (327)
T 3aln_A 35 YGSVNKMVHKPSGQIM-AVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYK 112 (327)
T ss_dssp SEEEEEEEETTTTEEE-EEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHH
T ss_pred CEEEEEEEEcCCCCEE-EEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHH
Confidence 4444 37788889888 9999987542 22345556665 77888999999999999999999999999975 7877776
Q ss_pred h-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 81 N-----AGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 81 ~-----~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
. ...+++..+..++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++............||+.
T Consensus 113 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~--~kl~Dfg~~~~~~~~~~~~~~~gt~~ 190 (327)
T 3aln_A 113 YVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN--IKLCDFGISGQLVDSIAKTRDAGCRP 190 (327)
T ss_dssp HHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTE--EEECCCSSSCC---------------
T ss_pred HHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCC--EEEccCCCceecccccccccCCCCcc
Confidence 3 56799999999999999999999998 9999999999999987664 99999999986554444445579999
Q ss_pred cccchhhc----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc---ccCCCCCCCCHHHHHHH
Q 019901 155 YIAPEVLL----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ---YSIPDYVHISPECRHLI 227 (334)
Q Consensus 155 y~aPE~~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~li 227 (334)
|+|||++. +..++ .++|||||||++|+|++|+.||....... ..+....... ........+++.+.+||
T Consensus 191 y~aPE~~~~~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 266 (327)
T 3aln_A 191 YMAPERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVF---DQLTQVVKGDPPQLSNSEEREFSPSFINFV 266 (327)
T ss_dssp ---------------CC-SHHHHHHHHHHHHHHHHSCCCSSCC----------CCCCCSCCCCCCCCSSCCCCHHHHHHH
T ss_pred ccCceeeccccCcCCCC-chhhHHHHHHHHHHHHHCCCCCCCcchHH---HHHHHHhcCCCCCCCCcccccCCHHHHHHH
Confidence 99999983 44454 44999999999999999999997643211 1111111111 11112245799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCcccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.+||+.+|.+|||+.++++||||...
T Consensus 267 ~~~l~~dp~~Rps~~ell~hp~~~~~ 292 (327)
T 3aln_A 267 NLCLTKDESKRPKYKELLKHPFILMY 292 (327)
T ss_dssp HHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHhhCChhhCcCHHHHHhChHHHHh
Confidence 99999999999999999999999753
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=329.85 Aligned_cols=224 Identities=21% Similarity=0.320 Sum_probs=184.6
Q ss_pred CCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---------
Q 019901 15 SDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------- 83 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 83 (334)
+..| |||++..... ...+.+.+|+.+++.+ +||||+++++++...+.+|+||||+.+|+|.+++...+
T Consensus 113 ~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~ 191 (370)
T 2psq_A 113 AVTV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD 191 (370)
T ss_dssp EEEE-EEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-------
T ss_pred ceeE-EEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccc
Confidence 3456 9999976542 2235789999999999 89999999999999999999999999999999998653
Q ss_pred -------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCC
Q 019901 84 -------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTP 153 (334)
Q Consensus 84 -------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~ 153 (334)
.++...++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+
T Consensus 192 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~t~ 269 (370)
T 2psq_A 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRLPV 269 (370)
T ss_dssp ----CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCSSCEETTCCCTTCTTTTTTSCG
T ss_pred ccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCC--EEEccccCCcccCcccceecccCCCccc
Confidence 4789999999999999999999999999999999999987765 9999999998543322 223345788
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... + ......+.+..+++++.++|.+||+
T Consensus 270 ~y~aPE~~~~~~~~~~-~DvwslG~il~ellt~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~l~~li~~~l~ 343 (370)
T 2psq_A 270 KWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL----L-KEGHRMDKPANCTNELYMMMRDCWH 343 (370)
T ss_dssp GGCCHHHHHTCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH----H-HTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred ceECHhHhcCCCCCcH-HHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----H-hcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 9999999988877655 999999999999999 9999987665433322 1 1222233344689999999999999
Q ss_pred cCCCCCCCHhHHhcC
Q 019901 233 ADPAKRISIPEIRNH 247 (334)
Q Consensus 233 ~~p~~R~s~~ell~h 247 (334)
.+|.+|||+.+++++
T Consensus 344 ~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 344 AVPSQRPTFKQLVED 358 (370)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999864
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=338.20 Aligned_cols=239 Identities=24% Similarity=0.328 Sum_probs=183.0
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||+++++...+|+.| |||++.... ...+.+|+.+++.+ +||||+++++++.+.+..|+|||||. |+|.+++...
T Consensus 37 ~G~V~~~~~~~~~~v-AvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~ 111 (432)
T 3p23_A 37 EGTIVYRGMFDNRDV-AVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQK 111 (432)
T ss_dssp GGCEEEEEESSSSEE-EEEEECTTT---EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSS
T ss_pred CEEEEEEEEeCCeEE-EEEEECHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhc
Confidence 445567888899998 999997644 23467899999999 79999999999999999999999995 6999998765
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC---CCCCCEEEeccCCccCCCCC----CCCCCccCCCc
Q 019901 83 G-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---SPAPRLKICDFGYSKSSVLH----SQPKSTVGTPA 154 (334)
Q Consensus 83 ~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~---~~~~~~kl~Dfgla~~~~~~----~~~~~~~gt~~ 154 (334)
. .+++..++.++.||+.||.|||++||+||||||+|||++. .+..++||+|||+|+..... ......+||+.
T Consensus 112 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~ 191 (432)
T 3p23_A 112 DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191 (432)
T ss_dssp SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTT
T ss_pred CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcC
Confidence 4 4666678899999999999999999999999999999953 33335889999999865432 22344579999
Q ss_pred cccchhhcc---CCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhcccc-CCCCCCCCHHHHHHHHH
Q 019901 155 YIAPEVLLK---KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYS-IPDYVHISPECRHLISR 229 (334)
Q Consensus 155 y~aPE~~~~---~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~ 229 (334)
|+|||++.+ ..+ +.++|||||||++|+|++ |..||....... ... . ....... .......+..+++||.+
T Consensus 192 y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-~~~-~--~~~~~~~~~~~~~~~~~~~~~li~~ 266 (432)
T 3p23_A 192 WIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-ANI-L--LGACSLDCLHPEKHEDVIARELIEK 266 (432)
T ss_dssp SCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-HHH-H--TTCCCCTTSCTTCHHHHHHHHHHHH
T ss_pred ccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-HHH-H--hccCCccccCccccccHHHHHHHHH
Confidence 999999974 333 345999999999999999 999996544321 111 1 1111111 11112235668999999
Q ss_pred hcccCCCCCCCHhHHhcCccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
||+.||.+|||++++++||||..
T Consensus 267 ~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 267 MIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHhCCHhhCCCHHHHHhCccccC
Confidence 99999999999999999999964
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=316.87 Aligned_cols=237 Identities=19% Similarity=0.271 Sum_probs=191.4
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|++ +.....++..| |||++.... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.++
T Consensus 32 lg~G~~g~V~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 109 (283)
T 3gen_A 32 LGTGQFGVVKYGKWRGQYDV-AIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNY 109 (283)
T ss_dssp CC---CEEEEEEEETTTEEE-EEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHH
T ss_pred cCCCCCceEEEEEEcCCCeE-EEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHH
Confidence 566555 33333455567 999998766 4457899999999999999999999999999999999999999999999
Q ss_pred HHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCcc
Q 019901 79 ICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAY 155 (334)
Q Consensus 79 l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y 155 (334)
+.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|
T Consensus 110 l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 187 (283)
T 3gen_A 110 LREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVRW 187 (283)
T ss_dssp HHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSC--EEECSTTGGGGBCCHHHHSTTSTTSCGGG
T ss_pred HHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCC--EEEccccccccccccccccccCCccCccc
Confidence 976 467999999999999999999999999999999999999987664 9999999987543221 12334578899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||++.+..++. ++||||||+++|+|++ |+.||........... +.. ..........++.+.++|.+||+.+
T Consensus 188 ~aPE~~~~~~~~~-~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~l~~~ 261 (283)
T 3gen_A 188 SPPEVLMYSKFSS-KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH----IAQ-GLRLYRPHLASEKVYTIMYSCWHEK 261 (283)
T ss_dssp CCHHHHHHCCCSH-HHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred CCHHHhccCCCCc-hhhHHHHHHHHHHHHhCCCCCccccChhHHHHH----Hhc-ccCCCCCCcCCHHHHHHHHHHccCC
Confidence 9999998877754 4999999999999998 9999987665433322 222 2222333457899999999999999
Q ss_pred CCCCCCHhHHhcCc
Q 019901 235 PAKRISIPEIRNHE 248 (334)
Q Consensus 235 p~~R~s~~ell~h~ 248 (334)
|.+|||++++++|-
T Consensus 262 p~~Rps~~~ll~~L 275 (283)
T 3gen_A 262 ADERPTFKILLSNI 275 (283)
T ss_dssp GGGSCCHHHHHHHH
T ss_pred hhHCcCHHHHHHHH
Confidence 99999999999763
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=322.76 Aligned_cols=239 Identities=21% Similarity=0.238 Sum_probs=190.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .+++..+|+.| |||++.... ..+.+.+|+.+++.+ +||||+++++++..++..++||||+ +++|.
T Consensus 17 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~ 92 (330)
T 2izr_A 17 IGCGNFGELRLGKNLYTNEYV-AIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLE 92 (330)
T ss_dssp CCC-CTTSEEEEEETTTTEEE-EEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred eeccCCceEEEEEECCCCcEE-EEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHH
Confidence 566655 47788899988 999987654 345789999999999 9999999999999999999999999 99999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC---CCEEEeccCCccCCCCCCC-------
Q 019901 77 ERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHSQ------- 145 (334)
Q Consensus 77 ~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~---~~~kl~Dfgla~~~~~~~~------- 145 (334)
+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++.......
T Consensus 93 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~ 172 (330)
T 2izr_A 93 DLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYR 172 (330)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCC
T ss_pred HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCcccccc
Confidence 999863 67999999999999999999999999999999999999976542 1399999999985433221
Q ss_pred -CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCHH
Q 019901 146 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPE 222 (334)
Q Consensus 146 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 222 (334)
....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+...... ......+.......+. .....++
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~Pf~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~p~ 250 (330)
T 2izr_A 173 EHKSLTGTARYMSINTHLGKEQSRR-DDLEALGHMFMYFLRGSLPWQGLKADTL-KERYQKIGDTKRATPIEVLCENFPE 250 (330)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTTTCCCSSH-HHHHHHHHHHHHHSCHHHHTTTCHH
T ss_pred ccCCcCCCccccChHHHcCCCCCch-hHHHHHHHHHHHHhcCCCCccccccccH-HHHHHHHHhhhccCCHHHHhccChH
Confidence 245679999999999988877544 9999999999999999999987543222 2222222221111111 1112349
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+.+++.+||+.+|.+||++.++++
T Consensus 251 ~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhCCCCCCCCHHHHHH
Confidence 999999999999999999988775
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=329.91 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=189.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-----------CCCcccceEEEEcCC----eEEEEE
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-----------HPNIVRFKEVILTPT----HLAIVM 67 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv~~~~~~~~~~----~~~lv~ 67 (334)
||.+ .+++..+++.| |||++.... ...+.+.+|+.+++.+. ||||+++++++...+ .+++||
T Consensus 32 ~g~V~~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~ 109 (373)
T 1q8y_A 32 FSTVWLAKDMVNNTHV-AMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVF 109 (373)
T ss_dssp SEEEEEEEETTTTEEE-EEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEE
T ss_pred CeEEEEEEecCCCcEE-EEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEE
Confidence 4444 47788889888 999997654 34567889999998876 899999999988654 799999
Q ss_pred eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCC----CCCEEEeccCCccCC
Q 019901 68 EYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSP----APRLKICDFGYSKSS 140 (334)
Q Consensus 68 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~----~~~~kl~Dfgla~~~ 140 (334)
||+ +++|.+++... ..+++..++.++.||+.||.|||++ ||+||||||+|||++..+ ...+||+|||+++..
T Consensus 110 e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~ 188 (373)
T 1q8y_A 110 EVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188 (373)
T ss_dssp CCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred ecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEccccccccc
Confidence 999 89999999864 4599999999999999999999998 999999999999995322 225999999999754
Q ss_pred CCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc------hHHHHHHHHHHhhccc---
Q 019901 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------PKNFRKTIHRILSVQY--- 211 (334)
Q Consensus 141 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~--- 211 (334)
.. ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... ...+............
T Consensus 189 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 265 (373)
T 1q8y_A 189 DE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 265 (373)
T ss_dssp TB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHH
T ss_pred CC--CCCCCCCCccccCcHHHhCCCCCch-HhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHH
Confidence 32 2345579999999999998887655 9999999999999999999986542 1112221111100000
Q ss_pred ---------------------------------cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 212 ---------------------------------SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 212 ---------------------------------~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
........++++.+||.+||+.||.+|||++++|+||||++...
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 266 RNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp HHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred hccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccC
Confidence 00011124578899999999999999999999999999987543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-44 Score=317.97 Aligned_cols=232 Identities=22% Similarity=0.315 Sum_probs=183.8
Q ss_pred ecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHhcC-CCCH
Q 019901 11 CSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAG-RFSE 87 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~ 87 (334)
+..++..| |||++........+.+.+|+.+++.++||||+++++++... ..+++||||+.+++|.+++...+ ++++
T Consensus 35 ~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 113 (295)
T 3ugc_A 35 QDNTGEVV-AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113 (295)
T ss_dssp CSSCCEEE-EEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCH
T ss_pred cCCCCcEE-EEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCH
Confidence 55677788 99999866534456789999999999999999999998653 56899999999999999998754 4999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~ 163 (334)
..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+
T Consensus 114 ~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 191 (295)
T 3ugc_A 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191 (295)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCSCC-------------CTTCGGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCe--EEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC
Confidence 999999999999999999999999999999999987764 9999999998543322 1223357778999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..++.+ +||||||+++|+|++|..||...... .................+.+..+++++.++|.+||+
T Consensus 192 ~~~~~~-~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 270 (295)
T 3ugc_A 192 SKFSVA-SDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN 270 (295)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred CCCChH-HHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcC
Confidence 887655 99999999999999999998643210 111111222223333445556789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 271 ~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 271 NNVNQRPSFRDLAL 284 (295)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCCCHHHHHH
Confidence 99999999999875
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=334.14 Aligned_cols=237 Identities=25% Similarity=0.354 Sum_probs=180.5
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||+++.++..+|+.| |||++.... .+.+.+|+.+++.+ +||||+++++++.+++.+|+|||||. |+|.+++...
T Consensus 28 ~g~V~~~~~~~g~~v-AvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~ 102 (434)
T 2rio_A 28 SGTVVFQGSFQGRPV-AVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESK 102 (434)
T ss_dssp TTCEEEEEESSSSEE-EEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC
T ss_pred CeEEEEEEEECCeEE-EEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhcc
Confidence 444556778889988 999987543 35678999999875 89999999999999999999999995 6999999875
Q ss_pred CCC-------CHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-----------CCCEEEeccCCccCCCCCC
Q 019901 83 GRF-------SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-----------APRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 83 ~~~-------~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-----------~~~~kl~Dfgla~~~~~~~ 144 (334)
+.. ++..++.++.||+.||.|||++||+||||||+|||++..+ ...+||+|||+|+......
T Consensus 103 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~ 182 (434)
T 2rio_A 103 NVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQ 182 (434)
T ss_dssp ------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--
T ss_pred CCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCC
Confidence 432 2334578999999999999999999999999999997532 3369999999998644322
Q ss_pred C-----CCCccCCCccccchhhcc-------CCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccc
Q 019901 145 Q-----PKSTVGTPAYIAPEVLLK-------KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQY 211 (334)
Q Consensus 145 ~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 211 (334)
. ....+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |+.||....... .. +.....
T Consensus 183 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~----i~~~~~ 255 (434)
T 2rio_A 183 SSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SN----IIRGIF 255 (434)
T ss_dssp ------------CCTTSCHHHHSCCCTTSCCCCC-CTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HH----HHHTCC
T ss_pred ccceeeecCCCCCCCccCHHHhccccccccccCc-chhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HH----HhcCCC
Confidence 1 234579999999999975 334 455999999999999999 999997654322 11 122222
Q ss_pred cCCCC-----CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 212 SIPDY-----VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 212 ~~~~~-----~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
..+.. ..+++++.++|.+||+.+|.+|||+.++++||||..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 22221 124578999999999999999999999999999954
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=313.09 Aligned_cols=237 Identities=16% Similarity=0.139 Sum_probs=189.8
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+++..+|+.| |||++.... ..+.+.+|+.+++.+ +|||++++++++..+...++||||+ +++|.+++..
T Consensus 23 ~g~V~~~~~~~~~~~v-avK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~ 98 (298)
T 1csn_A 23 FGVIFEGTNLLNNQQV-AIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL 98 (298)
T ss_dssp SCEEEEEEETTTTEEE-EEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH
T ss_pred CEEEEEEEECCCCcEE-EEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHH
Confidence 3444 47778889888 999987554 446789999999999 7999999999999999999999999 9999999987
Q ss_pred cC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC---CCEEEeccCCccCCCCCC--------CCCCc
Q 019901 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS--------QPKST 149 (334)
Q Consensus 82 ~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~---~~~kl~Dfgla~~~~~~~--------~~~~~ 149 (334)
.+ ++++..++.++.||+.||.|||++||+||||||+|||++.++. ..+||+|||+++...... .....
T Consensus 99 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 178 (298)
T 1csn_A 99 CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 178 (298)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCC
Confidence 54 5999999999999999999999999999999999999975432 249999999997543322 23455
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH---HHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
.||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+..... .+........... .......+++++.++
T Consensus 179 ~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~l 256 (298)
T 1csn_A 179 SGTARYMSINTHLGREQSR-RDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP-LRELCAGFPEEFYKY 256 (298)
T ss_dssp CSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC-HHHHTTTSCHHHHHH
T ss_pred CCCcccCCchhhcCCCCCh-HHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc-HHHHHhhCcHHHHHH
Confidence 7999999999998877754 4999999999999999999998754322 1222111111111 111123579999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 019901 227 ISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~ 246 (334)
|.+||+.+|.+|||++++++
T Consensus 257 i~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 257 MHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcccCCCHHHHHH
Confidence 99999999999999999875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=315.93 Aligned_cols=241 Identities=23% Similarity=0.332 Sum_probs=188.2
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCC--CCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.++ +.+ .+++.| |||++..... ...+.+.+|+.+++.++ ||||+++++++..++..++||| +.+++|.++
T Consensus 41 ~g~Vy~~~~-~~~~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~ 117 (313)
T 3cek_A 41 SSKVFQVLN-EKKQIY-AIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSW 117 (313)
T ss_dssp SEEEEEEEC-TTCCEE-EEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHH
T ss_pred CEEEEEEEc-CCCcEE-EEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHH
Confidence 34444 444 457777 9999987652 23367889999999997 5999999999999999999999 558899999
Q ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCcc
Q 019901 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y 155 (334)
+.+.+.+++..++.++.|++.||.|||++||+||||||+|||++. + .+||+|||+++....... .....||+.|
T Consensus 118 l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~--~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y 194 (313)
T 3cek_A 118 LKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-G--MLKLIDFGIANQMQPDTTSVVKDSQVGTVNY 194 (313)
T ss_dssp HHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-T--EEEECCCSSSCC--------------CCGGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-C--eEEEeeccccccccCccccccccCCCCCCCc
Confidence 999889999999999999999999999999999999999999964 3 599999999975433221 2345799999
Q ss_pred ccchhhccC----------CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 156 IAPEVLLKK----------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 156 ~aPE~~~~~----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
+|||++.+. ...+.++|||||||++|+|++|+.||........ ............+.....++++.+
T Consensus 195 ~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~ 271 (313)
T 3cek_A 195 MPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS---KLHAIIDPNHEIEFPDIPEKDLQD 271 (313)
T ss_dssp CCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH---HHHHHHCTTSCCCCCCCSCHHHHH
T ss_pred CCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHH---HHHHHHhcccccCCcccchHHHHH
Confidence 999998652 2234559999999999999999999986544221 122223333333333456899999
Q ss_pred HHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 226 LISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+|.+||+.+|.+|||++++++||||+..
T Consensus 272 li~~~l~~dp~~Rps~~ell~h~~~~~~ 299 (313)
T 3cek_A 272 VLKCCLKRDPKQRISIPELLAHPYVQIQ 299 (313)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred HHHHHccCCcccCcCHHHHhcCccccCC
Confidence 9999999999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=323.10 Aligned_cols=234 Identities=29% Similarity=0.481 Sum_probs=189.6
Q ss_pred cceee-eeecCCCCeeEEEEEEecCcc------cccHHHHHHHHHHHcC----CCCCcccceEEEEcCCeEEEEEec-cC
Q 019901 4 FHNFY-DRCSYSSDLFVNIIIIVFHLW------QIDENVQREIINHRSL----RHPNIVRFKEVILTPTHLAIVMEY-AS 71 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~vvaiK~~~~~~~------~~~~~~~~Ei~~l~~l----~hp~iv~~~~~~~~~~~~~lv~e~-~~ 71 (334)
||.++ +++..+++.| |||++..... .....+.+|+.+++.+ +||||+++++++...+..++|||+ +.
T Consensus 44 ~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~ 122 (312)
T 2iwi_A 44 FGTVFAGHRLTDRLQV-AIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLP 122 (312)
T ss_dssp TEEEEEEECTTTCCEE-EEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSS
T ss_pred CEEEEEEEEccCCeEE-EEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCC
Confidence 44443 7778888888 9999977642 1234566799999888 899999999999999999999999 78
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc-CCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD-GSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~-~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
+++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||+++ .++ .+||+|||+++..... ......
T Consensus 123 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~kl~dfg~~~~~~~~-~~~~~~ 199 (312)
T 2iwi_A 123 AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG--CAKLIDFGSGALLHDE-PYTDFD 199 (312)
T ss_dssp EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT--EEEECCCSSCEECCSS-CBCCCC
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC--eEEEEEcchhhhcccC-cccccC
Confidence 999999999888899999999999999999999999999999999999998 444 4999999998754332 234557
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... . +......++ ..+++.+.++|.+|
T Consensus 200 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~----~~~~~~~~~--~~~~~~~~~li~~~ 267 (312)
T 2iwi_A 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------E----ILEAELHFP--AHVSPDCCALIRRC 267 (312)
T ss_dssp SCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------H----HHHTCCCCC--TTSCHHHHHHHHHH
T ss_pred CcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------H----HhhhccCCc--ccCCHHHHHHHHHH
Confidence 99999999999887776656999999999999999999997521 1 112222222 35799999999999
Q ss_pred cccCCCCCCCHhHHhcCcccccc
Q 019901 231 FVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
|+.+|.+|||++++++||||+..
T Consensus 268 l~~~p~~Rps~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 268 LAPKPSSRPSLEEILLDPWMQTP 290 (312)
T ss_dssp TCSSTTTSCCHHHHHHSTTTCC-
T ss_pred ccCChhhCcCHHHHhcChhhcCc
Confidence 99999999999999999999754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=320.21 Aligned_cols=238 Identities=23% Similarity=0.315 Sum_probs=191.0
Q ss_pred CCccee----eeeecCCCCee-EEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLF-VNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~v-vaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .++++.+|..+ +|||.+.... ....+.+.+|+.+++++ +||||+++++++...+..|+||||+++++
T Consensus 33 lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 112 (327)
T 1fvr_A 33 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112 (327)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred eecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCC
Confidence 455544 47777777642 4889887543 23456789999999999 89999999999999999999999999999
Q ss_pred hHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 75 LFERICNAG----------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 75 L~~~l~~~~----------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++
T Consensus 113 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~--~kL~Dfg~~~ 190 (327)
T 1fvr_A 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSR 190 (327)
T ss_dssp HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEE
T ss_pred HHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCe--EEEcccCcCc
Confidence 999997654 6999999999999999999999999999999999999987664 9999999998
Q ss_pred CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 139 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
............+++.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+........ .+ ......+...
T Consensus 191 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~-~~~~~~~~~~ 264 (327)
T 1fvr_A 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYE----KL-PQGYRLEKPL 264 (327)
T ss_dssp SSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HG-GGTCCCCCCT
T ss_pred cccccccccCCCCCccccChhhhccccCCch-hcchHHHHHHHHHHcCCCCCCCCCcHHHHHH----Hh-hcCCCCCCCC
Confidence 5544444455567899999999987777554 999999999999998 999998766533222 22 2222334445
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.+++.+.++|.+||+.+|.+|||+++++++
T Consensus 265 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 265 NCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 689999999999999999999999999875
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=328.00 Aligned_cols=229 Identities=20% Similarity=0.343 Sum_probs=187.2
Q ss_pred ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCC-eEEEEEeccCCCChHHHHHhcCC---
Q 019901 11 CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPT-HLAIVMEYASGGELFERICNAGR--- 84 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--- 84 (334)
+..+++.| |||++..... ...+.+.+|+.+++.+ +||||+++++++...+ .+++|||||.+|+|.+++.....
T Consensus 48 ~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~ 126 (359)
T 3vhe_A 48 KTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 126 (359)
T ss_dssp STTCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBC
T ss_pred ccccceEE-EEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccc
Confidence 45566777 9999986542 2235789999999999 7899999999998754 48999999999999999976543
Q ss_pred ---------------------------------------------------------------CCHHHHHHHHHHHHHHH
Q 019901 85 ---------------------------------------------------------------FSEDEARFFFQQLISGV 101 (334)
Q Consensus 85 ---------------------------------------------------------------~~~~~~~~~~~qil~~L 101 (334)
+++..++.++.||+.||
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL 206 (359)
T 3vhe_A 127 PYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206 (359)
T ss_dssp SCC------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHH
T ss_pred ccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHH
Confidence 89999999999999999
Q ss_pred HHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhH
Q 019901 102 SYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGV 178 (334)
Q Consensus 102 ~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 178 (334)
.|||++||+||||||+|||++.++. +||+|||+++....... .....||+.|+|||++.+..++.+ +|||||||
T Consensus 207 ~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~ 283 (359)
T 3vhe_A 207 EFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGV 283 (359)
T ss_dssp HHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHH-HHHHHHHH
T ss_pred HHHHHCCcccCCCChhhEEEcCCCc--EEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCch-hhhhhHHH
Confidence 9999999999999999999987664 99999999975433221 234568899999999988877654 99999999
Q ss_pred HHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 179 TLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 179 il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
++|+|++ |..||.+..........+.. ....+.+..+++++.++|.+||+.+|.+|||++++++|
T Consensus 284 il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 284 LLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHhcCCCCCCccchhHHHHHHHHc----CCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 9999998 99999887655444333322 22233344579999999999999999999999999976
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-44 Score=312.76 Aligned_cols=227 Identities=29% Similarity=0.407 Sum_probs=176.7
Q ss_pred CCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHH
Q 019901 13 YSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 88 (334)
.+|+.+ |||++..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++. .+++++.
T Consensus 28 ~~~~~v-avK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~ 105 (271)
T 3dtc_A 28 WIGDEV-AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPD 105 (271)
T ss_dssp ETTEEE-EEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHH
T ss_pred EcCCeE-EEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHH
Confidence 357777 9999876542 223678899999999999999999999999999999999999999988875 4579999
Q ss_pred HHHHHHHHHHHHHHHHHHCC---ceeCCCCCCcEEEcCC------CCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 89 EARFFFQQLISGVSYCHSMQ---VCHRDLKLENTLLDGS------PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 89 ~~~~~~~qil~~L~~LH~~~---ivH~dlkp~NIli~~~------~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.++.++.|++.||.|||++| |+||||||+|||++.. ..+.+||+|||+++..... ......||+.|+|||
T Consensus 106 ~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE 184 (271)
T 3dtc_A 106 ILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRT-TKMSAAGAYAWMAPE 184 (271)
T ss_dssp HHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHH
T ss_pred HHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccc-cccCCCCccceeCHH
Confidence 99999999999999999999 8999999999999752 1345999999999754332 223557999999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
++.+..++. ++||||||+++|+|++|+.||.+........ .........+....+++.+.++|.+||+.+|.+||
T Consensus 185 ~~~~~~~~~-~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 259 (271)
T 3dtc_A 185 VIRASMFSK-GSDVWSYGVLLWELLTGEVPFRGIDGLAVAY----GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP 259 (271)
T ss_dssp HHHHCCCSH-HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHH----HHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhccCCCCc-hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----hhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCc
Confidence 998877754 4999999999999999999998766533222 22333334444557899999999999999999999
Q ss_pred CHhHHhcC
Q 019901 240 SIPEIRNH 247 (334)
Q Consensus 240 s~~ell~h 247 (334)
|+.+++++
T Consensus 260 s~~e~l~~ 267 (271)
T 3dtc_A 260 SFTNILDQ 267 (271)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999875
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-44 Score=315.18 Aligned_cols=235 Identities=21% Similarity=0.307 Sum_probs=195.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ .+.+..++..| |||++.... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.+
T Consensus 21 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~ 98 (288)
T 3kfa_A 21 LGGGQYGEVYEGVWKKYSLTV-AVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98 (288)
T ss_dssp SGGGTTCSEEEEEEGGGTEEE-EEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred cCCCCceeEEEeEecCCCEEE-EEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence 455554 47788888888 999998665 455789999999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
++... ..+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... .....+|+
T Consensus 99 ~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~~l~Dfg~~~~~~~~~~~~~~~~~~~~ 176 (288)
T 3kfa_A 99 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI 176 (288)
T ss_dssp HHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGC--EEECCCCGGGTSCSSSSEEETTEEECG
T ss_pred HHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCC--EEEccCccceeccCCccccccCCcccc
Confidence 99874 44999999999999999999999999999999999999987664 99999999975443321 22345788
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +||||||+++|+|++ |..||........... .......+....+++.+.++|.+||.
T Consensus 177 ~y~aPE~~~~~~~~~~-~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~~l~ 250 (288)
T 3kfa_A 177 KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPEKVYELMRACWQ 250 (288)
T ss_dssp GGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CcCChhhhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HhccCCCCCCCCCCHHHHHHHHHHhC
Confidence 9999999988877544 999999999999999 9999987665433322 12223334445689999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||++++++
T Consensus 251 ~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 251 WNPSDRPSFAEIHQ 264 (288)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=310.71 Aligned_cols=228 Identities=24% Similarity=0.321 Sum_probs=190.9
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc----------------CCeEEEEEeccC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT----------------PTHLAIVMEYAS 71 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----------------~~~~~lv~e~~~ 71 (334)
.+++..+|+.| |||++.... +.+.+|+.+++.++||||+++++++.. ...+++||||++
T Consensus 29 ~~~~~~~~~~v-avK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~ 103 (284)
T 2a19_B 29 KAKHRIDGKTY-VIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD 103 (284)
T ss_dssp EEEETTTCCEE-EEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCC
T ss_pred EEEEcCCCeEE-EEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccC
Confidence 47788889999 999997654 567899999999999999999998864 456899999999
Q ss_pred CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 72 GGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 72 ~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
+++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...........
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~ 181 (284)
T 2a19_B 104 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQ--VKIGDFGLVTSLKNDGKRTRS 181 (284)
T ss_dssp SCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEESSCCSCCCCC
T ss_pred CCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCC--EEECcchhheecccccccccc
Confidence 99999999754 57999999999999999999999999999999999999987664 999999999876555555566
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.||+.|+|||++.+..++.+ +||||||+++|+|++|..||... ........... . ...+++.+.++|.+
T Consensus 182 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~~~~~~~~~------~~~~~~~~~~~--~--~~~~~~~~~~li~~ 250 (284)
T 2a19_B 182 KGTLRYMSPEQISSQDYGKE-VDLYALGLILAELLHVCDTAFET------SKFFTDLRDGI--I--SDIFDKKEKTLLQK 250 (284)
T ss_dssp CSCCTTSCHHHHHCSCCCTH-HHHHHHHHHHHHHHSCCSSHHHH------HHHHHHHHTTC--C--CTTSCHHHHHHHHH
T ss_pred CCcccccChhhhccCCCcch-hhhHHHHHHHHHHHhcCCcchhH------HHHHHHhhccc--c--cccCCHHHHHHHHH
Confidence 79999999999988777655 99999999999999999887421 11112221111 1 23478999999999
Q ss_pred hcccCCCCCCCHhHHhcCcccccc
Q 019901 230 IFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
||+.+|.+|||+.++++|.+..+.
T Consensus 251 ~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 251 LLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp HTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred HccCChhhCcCHHHHHHHHHHHhh
Confidence 999999999999999999887654
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-44 Score=329.80 Aligned_cols=234 Identities=24% Similarity=0.336 Sum_probs=190.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .++++.++..| |||++..... ...+.+.+|+.+++.++||||+++++++..++.+|+||||+++|+|.+++..
T Consensus 127 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 205 (377)
T 3cbl_A 127 FGEVFSGRLRADNTLV-AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT 205 (377)
T ss_dssp TEEEEEEEETTTCCEE-EEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHH
T ss_pred CCeEEEEEEecCCeEE-EEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHh
Confidence 4444 37777788888 9999875531 2235688999999999999999999999999999999999999999999976
Q ss_pred cC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCcccc
Q 019901 82 AG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIA 157 (334)
Q Consensus 82 ~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~a 157 (334)
.+ .+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|
T Consensus 206 ~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~--~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~a 283 (377)
T 3cbl_A 206 EGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNV--LKISDFGMSREEADGVYAASGGLRQVPVKWTA 283 (377)
T ss_dssp HGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECTTSEEECCSSCCEEEGGGSC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCc--EEECcCCCceecCCCceeecCCCCCCCcCcCC
Confidence 54 5999999999999999999999999999999999999987665 9999999987532211 1112235778999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
||++.+..++.+ +|||||||++|+|++ |..||.+....... . ........+.+..+++.+.++|.+||+.+|.
T Consensus 284 PE~~~~~~~~~~-~DvwslG~il~el~t~g~~p~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 357 (377)
T 3cbl_A 284 PEALNYGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTR-E----FVEKGGRLPCPELCPDAVFRLMEQCWAYEPG 357 (377)
T ss_dssp HHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCSSTTSCHHHHH-H----HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred HhHhccCCCCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHH-H----HHHcCCCCCCCCCCCHHHHHHHHHHcCCCch
Confidence 999988777554 999999999999998 99999876653322 1 1222333444556899999999999999999
Q ss_pred CCCCHhHHhc
Q 019901 237 KRISIPEIRN 246 (334)
Q Consensus 237 ~R~s~~ell~ 246 (334)
+|||++++++
T Consensus 358 ~Rps~~~i~~ 367 (377)
T 3cbl_A 358 QRPSFSTIYQ 367 (377)
T ss_dssp GSCCHHHHHH
T ss_pred hCcCHHHHHH
Confidence 9999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=318.60 Aligned_cols=226 Identities=21% Similarity=0.326 Sum_probs=186.0
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCC-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR------- 84 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------- 84 (334)
.++..| |||++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+++.....
T Consensus 51 ~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 129 (314)
T 2ivs_A 51 AGYTTV-AVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLG 129 (314)
T ss_dssp SSEEEE-EEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC-
T ss_pred cCcceE-EEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccc
Confidence 344666 9999976541 2336788999999999999999999999999999999999999999999987543
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---
Q 019901 85 -----------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 144 (334)
Q Consensus 85 -----------------~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--- 144 (334)
+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++......
T Consensus 130 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~ 207 (314)
T 2ivs_A 130 SGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRK--MKISDFGLSRDVYEEDSYV 207 (314)
T ss_dssp ---------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTE--EEECCCTTCEECTTTSCEE
T ss_pred ccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCC--EEEccccccccccccccce
Confidence 899999999999999999999999999999999999987664 9999999987543322
Q ss_pred CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHH
Q 019901 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (334)
......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... + ......+....+++.+
T Consensus 208 ~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~ 281 (314)
T 2ivs_A 208 KRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL-L----KTGHRMERPDNCSEEM 281 (314)
T ss_dssp CSSCCCSCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-H----HTTCCCCCCTTCCHHH
T ss_pred eccCCCCcccccChhhhcCCCcCch-hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-h----hcCCcCCCCccCCHHH
Confidence 1233457889999999988777655 999999999999999 9999987765433322 1 1222233345689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcC
Q 019901 224 RHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.++|.+||+.+|.+|||+.+++++
T Consensus 282 ~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 282 YRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999865
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=315.64 Aligned_cols=233 Identities=17% Similarity=0.158 Sum_probs=186.5
Q ss_pred ccee-eeeecCCCC-------eeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 4 FHNF-YDRCSYSSD-------LFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~-~~~~~~~~~-------~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||++ .+++..+++ .| |+|++........+.+.+|+.+++.++||||+++++++..++..++||||+.+++|
T Consensus 21 ~g~V~~~~~~~~~~~~~~~~~~v-a~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L 99 (289)
T 4fvq_A 21 FTKIFKGVRREVGDYGQLHETEV-LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSL 99 (289)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEE-EEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBH
T ss_pred CceEEEEEEecccccccccchhh-hhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCH
Confidence 4444 477777774 46 99999776645567899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC------CEEEeccCCccCCCCCCCCCC
Q 019901 76 FERICNAGR-FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP------RLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 76 ~~~l~~~~~-~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~------~~kl~Dfgla~~~~~~~~~~~ 148 (334)
.+++.+.+. +++..++.++.||+.||.|||++||+||||||+|||++.++.. .+||+|||++..... ...
T Consensus 100 ~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~---~~~ 176 (289)
T 4fvq_A 100 DTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP---KDI 176 (289)
T ss_dssp HHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSC---HHH
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccC---ccc
Confidence 999987654 9999999999999999999999999999999999999765531 299999999864322 233
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..||+.|+|||++.+....+.++|||||||++|+|++|. +||..... ...... .......+ ...++++.++|
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~-~~~~~~----~~~~~~~~--~~~~~~l~~li 249 (289)
T 4fvq_A 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDS-QRKLQF----YEDRHQLP--APKAAELANLI 249 (289)
T ss_dssp HHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHHHHH----HHTTCCCC--CCSSCTTHHHH
T ss_pred cCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccch-HHHHHH----hhccCCCC--CCCCHHHHHHH
Confidence 468999999999987444455699999999999999955 55544333 222221 11222222 24588999999
Q ss_pred HHhcccCCCCCCCHhHHhcC
Q 019901 228 SRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h 247 (334)
.+||+.+|.+|||+.++++|
T Consensus 250 ~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 250 NNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHSCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhHCcCHHHHHHH
Confidence 99999999999999999975
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=331.27 Aligned_cols=232 Identities=24% Similarity=0.361 Sum_probs=188.8
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC-eEEEEEeccCCCChHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT-HLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~ 78 (334)
||.|+| +.+....|..| |||+++... ..+.+.+|+.++++++||||+++++++.... .+|+||||+.+|+|.++
T Consensus 201 lG~G~fg~V~~~~~~~~~v-avK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~ 277 (450)
T 1k9a_A 201 IGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 277 (450)
T ss_dssp EEECSSEEEEEEEETTEEE-EEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHH
T ss_pred ecCcCCeeEEEEEecCCeE-EEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHH
Confidence 455555 22333457777 999997654 5678999999999999999999999987654 79999999999999999
Q ss_pred HHhcCC--CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 79 ICNAGR--FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 79 l~~~~~--~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
+.+.+. +++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .....+++.|+
T Consensus 278 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~--~~~~~~~~~y~ 353 (450)
T 1k9a_A 278 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWT 353 (450)
T ss_dssp HHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSC--EEECCCTTCEECC--------CCCTTTS
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCC--EEEeeCCCccccccc--ccCCCCCccee
Confidence 987654 799999999999999999999999999999999999987664 999999999854322 23346788999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||++.+..++.+ +|||||||++|+|++ |+.||.+.......... ......+.+..+++.+.++|.+||+.+|
T Consensus 354 aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~p~~~~~~l~~li~~cl~~dp 427 (450)
T 1k9a_A 354 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV-----EKGYKMDAPDGCPPAVYDVMKNCWHLDA 427 (450)
T ss_dssp CHHHHHSSCCCHH-HHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHH-----HTTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CHHHhcCCCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCcCCHHHHHHHHHHcCCCh
Confidence 9999988887655 999999999999998 99999877654433322 1223344455789999999999999999
Q ss_pred CCCCCHhHHhc
Q 019901 236 AKRISIPEIRN 246 (334)
Q Consensus 236 ~~R~s~~ell~ 246 (334)
.+|||+.+++.
T Consensus 428 ~~Rpt~~~l~~ 438 (450)
T 1k9a_A 428 ATRPTFLQLRE 438 (450)
T ss_dssp GGSCCHHHHHH
T ss_pred hHCcCHHHHHH
Confidence 99999999875
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=322.07 Aligned_cols=228 Identities=23% Similarity=0.347 Sum_probs=186.9
Q ss_pred CCCeeEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC--------
Q 019901 14 SSDLFVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------- 83 (334)
++..| |||++.... ....+.+.+|+.+++.+ +||||+++++++...+..++||||+++|+|.+++....
T Consensus 74 ~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~ 152 (344)
T 1rjb_A 74 VSIQV-AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 152 (344)
T ss_dssp CEEEE-EEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred cceEE-EEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence 44566 999997653 23457899999999999 89999999999999999999999999999999997653
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---
Q 019901 84 ---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 145 (334)
Q Consensus 84 ---------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--- 145 (334)
.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++.......
T Consensus 153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~ 230 (344)
T 1rjb_A 153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV--VKICDFGLARDIMSDSNYVV 230 (344)
T ss_dssp ----------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE--EEECCCGGGSCGGGCTTSEE
T ss_pred chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCc--EEeCCCccCcccccCcccee
Confidence 3799999999999999999999999999999999999987664 99999999975433322
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (334)
.....||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......+...+. .....+....+++++.
T Consensus 231 ~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~ 305 (344)
T 1rjb_A 231 RGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQ----NGFKMDQPFYATEEIY 305 (344)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHH----TTCCCCCCTTCCHHHH
T ss_pred ccCccCccCccCHHHhccCCCChh-HhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHh----cCCCCCCCCCCCHHHH
Confidence 223457889999999988777654 999999999999998 9999988766554443332 2233344456799999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCcc
Q 019901 225 HLISRIFVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~h~~ 249 (334)
++|.+||+.+|.+|||+.++++|..
T Consensus 306 ~li~~~l~~dp~~Rps~~~l~~~l~ 330 (344)
T 1rjb_A 306 IIMQSCWAFDSRKRPSFPNLTSFLG 330 (344)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCCchhCcCHHHHHHHHH
Confidence 9999999999999999999998653
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=323.36 Aligned_cols=242 Identities=16% Similarity=0.149 Sum_probs=186.6
Q ss_pred CCccee----eeeecC---CCCeeEEEEEEecCccc-----------ccHHHHHHHHHHHcCCCCCcccceEEEEc----
Q 019901 2 LGFHNF----YDRCSY---SSDLFVNIIIIVFHLWQ-----------IDENVQREIINHRSLRHPNIVRFKEVILT---- 59 (334)
Q Consensus 2 lG~g~~----~~~~~~---~~~~vvaiK~~~~~~~~-----------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~---- 59 (334)
||.|+| .+++.. ++..+ |||++...... ....+.+|+..++.++||||+++++++..
T Consensus 45 lg~G~~g~Vy~~~~~~~~~~~~~~-aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~ 123 (345)
T 2v62_A 45 IGSGGFGLIYLAFPTNKPEKDARH-VVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123 (345)
T ss_dssp C------CEEEEEESSSCGGGCCE-EEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSS
T ss_pred EeecCCeEEEEEEecCCCCccceE-EEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCC
Confidence 566665 466666 77888 99999876411 22456788899999999999999999987
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 60 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 60 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
....|+||||+ +++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+.+||+|||+|+.
T Consensus 124 ~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~ 202 (345)
T 2v62_A 124 RSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202 (345)
T ss_dssp CEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEE
T ss_pred CcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCcee
Confidence 77899999999 99999999887789999999999999999999999999999999999999877644699999999975
Q ss_pred CCCCCC--------CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhcc
Q 019901 140 SVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQ 210 (334)
Q Consensus 140 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~ 210 (334)
...... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||...... ..............
T Consensus 203 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 281 (345)
T 2v62_A 203 YCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRR-SDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL 281 (345)
T ss_dssp SSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT
T ss_pred cccccccccchhccccccCCCccccCHHHhcCCCCCch-hhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccc
Confidence 432211 134579999999999988777544 99999999999999999999653222 22222211111110
Q ss_pred c----cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 211 Y----SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 211 ~----~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
. .......+++++.++|.+||+.+|.+|||++++++
T Consensus 282 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 282 PQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp THHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 00111257999999999999999999999999885
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=324.03 Aligned_cols=223 Identities=21% Similarity=0.329 Sum_probs=185.0
Q ss_pred CeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC----------
Q 019901 16 DLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG---------- 83 (334)
Q Consensus 16 ~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------- 83 (334)
..| |||++..... .....+.+|+.+++.+ +||||+++++++..++..++||||+.+|+|.+++....
T Consensus 102 ~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~ 180 (382)
T 3tt0_A 102 TKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNP 180 (382)
T ss_dssp EEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCC
T ss_pred eEE-EEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccccc
Confidence 456 9999976642 2236788999999999 89999999999999999999999999999999998754
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCc
Q 019901 84 ------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPA 154 (334)
Q Consensus 84 ------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~ 154 (334)
.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... ......+|+.
T Consensus 181 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~t~~ 258 (382)
T 3tt0_A 181 SHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIADFGLARDIHHIDYYKKTTNGRLPVK 258 (382)
T ss_dssp CSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECSCSCCCCSSCCCTTCCCTTCCCGGG
T ss_pred ccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCc--EEEcccCcccccccccccccccCCCCCcc
Confidence 4999999999999999999999999999999999999987664 9999999998543322 2233457889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ .+ ......+....+++++.+||.+||+.
T Consensus 259 y~aPE~~~~~~~~~~-~DiwslG~il~ellt~g~~p~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~l~~li~~~l~~ 332 (382)
T 3tt0_A 259 WMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFK----LL-KEGHRMDKPSNCTNELYMMMRDCWHA 332 (382)
T ss_dssp GSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HH-HTTCCCCCCSSCCHHHHHHHHHHTCS
T ss_pred eeCHHHhcCCCCCch-hHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH----HH-HcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 999999988777655 999999999999999 999998765433222 22 22223333456899999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+++++++
T Consensus 333 dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 333 VPSQRPTFKQLVED 346 (382)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999875
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=308.43 Aligned_cols=237 Identities=25% Similarity=0.379 Sum_probs=189.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc-------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI-------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~-------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|++ .+++..+++.| |||++....... .+.+.+|+.+++.++||||+++++++.+.. ++||||+
T Consensus 27 lg~G~~g~V~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~ 103 (287)
T 4f0f_A 27 IGKGGFGLVHKGRLVKDKSVV-AIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFV 103 (287)
T ss_dssp CCCCSSSCEEEEEETTTCCEE-EEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECC
T ss_pred cccCCceeEEEEEEcCCceEE-EEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEec
Confidence 565555 47788899998 999997655222 167899999999999999999999987665 7999999
Q ss_pred CCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCC---CCEEEeccCCccCCCCCC
Q 019901 71 SGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPA---PRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 71 ~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~---~~~kl~Dfgla~~~~~~~ 144 (334)
.+++|.+.+.+. ..+++..++.++.|++.||.|||++| |+||||||+|||++.++. ..+||+|||+++....
T Consensus 104 ~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-- 181 (287)
T 4f0f_A 104 PCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-- 181 (287)
T ss_dssp TTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--
T ss_pred CCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--
Confidence 999998888654 46999999999999999999999999 999999999999975442 2389999999974332
Q ss_pred CCCCccCCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHH
Q 019901 145 QPKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222 (334)
Q Consensus 145 ~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (334)
......||+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||......... ............+....+++.
T Consensus 182 ~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 258 (287)
T 4f0f_A 182 SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIK--FINMIREEGLRPTIPEDCPPR 258 (287)
T ss_dssp CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH--HHHHHHHSCCCCCCCTTSCHH
T ss_pred cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHH--HHHHHhccCCCCCCCcccCHH
Confidence 2344679999999999843 333 44599999999999999999999876543321 112222233333344568999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+.++|.+||+.+|.+|||++++++
T Consensus 259 l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 259 LRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999999985
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=316.87 Aligned_cols=228 Identities=23% Similarity=0.337 Sum_probs=189.3
Q ss_pred cCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC------
Q 019901 12 SYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------ 83 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------ 83 (334)
..++..| |||++..... ...+.+.+|+.+++.+ +||||+++++++..++..++||||+.+|+|.+++....
T Consensus 50 ~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 128 (313)
T 1t46_A 50 SDAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICS 128 (313)
T ss_dssp TTCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC---
T ss_pred cchhhhh-HHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccc
Confidence 4456677 9999986642 2346789999999999 99999999999999999999999999999999998654
Q ss_pred ------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCC
Q 019901 84 ------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKS 148 (334)
Q Consensus 84 ------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~ 148 (334)
.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... ...
T Consensus 129 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 206 (313)
T 1t46_A 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGN 206 (313)
T ss_dssp -----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSS
T ss_pred cccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCC--EEEccccccccccccccceeccC
Confidence 4899999999999999999999999999999999999987664 99999999976543322 233
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
..+|+.|+|||++.+..++.+ +||||||+++|+|++ |+.||.+..........+.. ....+....+++.+.++|
T Consensus 207 ~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li 281 (313)
T 1t46_A 207 ARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE----GFRMLSPEHAPAEMYDIM 281 (313)
T ss_dssp SEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH----TCCCCCCTTSCHHHHHHH
T ss_pred CCCcceeeChHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc----CCCCCCcccCCHHHHHHH
Confidence 457889999999988777544 999999999999998 99999887655444443322 223333446899999999
Q ss_pred HHhcccCCCCCCCHhHHhcC
Q 019901 228 SRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h 247 (334)
.+||+.+|.+|||+.+++++
T Consensus 282 ~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 282 KTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCchhCcCHHHHHHH
Confidence 99999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=324.93 Aligned_cols=244 Identities=21% Similarity=0.222 Sum_probs=190.4
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|++ + ++ ..+|..| |||++........+.+.+|+.+++.++||||+++++++...+..++||||+.+++|.+
T Consensus 47 lg~G~~g~Vy~~~-~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 124 (321)
T 2qkw_B 47 IGHGVFGKVYKGV-LRDGAKV-ALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR 124 (321)
T ss_dssp SCBCSSSEEEEEE-CTTCCEE-EEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred eecCCCeeEEEEE-ECCCCEE-EEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence 566555 3 44 3467888 9999877654555789999999999999999999999999999999999999999999
Q ss_pred HHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCcc
Q 019901 78 RICNAG----RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTV 150 (334)
Q Consensus 78 ~l~~~~----~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~ 150 (334)
++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......
T Consensus 125 ~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~ 202 (321)
T 2qkw_B 125 HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFV--PKITDFGISKKGTELDQTHLSTVVK 202 (321)
T ss_dssp GSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCC--EEECCCTTCEECSSSSCCCCBCCCE
T ss_pred HHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCC--EEEeecccccccccccccccccccC
Confidence 886543 4899999999999999999999999999999999999987664 9999999997533221 123345
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHH--HHHH-HHHhhccc--------cCCCCCCC
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF--RKTI-HRILSVQY--------SIPDYVHI 219 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--~~~~-~~~~~~~~--------~~~~~~~~ 219 (334)
||+.|+|||++.+..++.+ +|||||||++|+|++|+.||......... .... ........ ........
T Consensus 203 gt~~y~aPE~~~~~~~~~~-~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 281 (321)
T 2qkw_B 203 GTLGYIDPEYFIKGRLTEK-SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPES 281 (321)
T ss_dssp EETTTCCHHHHHHCBCCTH-HHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHH
T ss_pred CCccccCHHHhcCCCCCcc-cchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHH
Confidence 8999999999988877655 99999999999999999999765432211 1100 01111100 00011123
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+..+.+++.+||+.+|.+|||+.+++++..-
T Consensus 282 ~~~l~~li~~~l~~dP~~Rps~~ell~~L~~ 312 (321)
T 2qkw_B 282 LRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312 (321)
T ss_dssp HHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCcccCcCHHHHHHHHHH
Confidence 5678999999999999999999999987543
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-43 Score=312.67 Aligned_cols=232 Identities=22% Similarity=0.312 Sum_probs=184.7
Q ss_pred ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHh-cCCCC
Q 019901 11 CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICN-AGRFS 86 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~-~~~~~ 86 (334)
+..+++.| |||++..... ...+.+.+|+.+++.++||||+++++++... +.+++||||+.+++|.+++.. ...++
T Consensus 46 ~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 124 (302)
T 4e5w_A 46 GDNTGEQV-AVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124 (302)
T ss_dssp SSSCSEEE-EEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCC
T ss_pred cCccCeEE-EEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCC
Confidence 56778888 9999986542 2347899999999999999999999999876 679999999999999999954 45699
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhc
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~ 162 (334)
+..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.
T Consensus 125 ~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 202 (302)
T 4e5w_A 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQ--VKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM 202 (302)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCC--EEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence 9999999999999999999999999999999999987764 9999999997544332 233456888999999998
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCC----------chHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE----------EPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+..++.+ +|||||||++|+|++|..|+.... ...................+.+..+++.+.++|.+||+
T Consensus 203 ~~~~~~~-~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 281 (302)
T 4e5w_A 203 QSKFYIA-SDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWE 281 (302)
T ss_dssp HCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTC
T ss_pred CCCCCcc-hhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcC
Confidence 8877644 999999999999999999874321 01111111222223333445556789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 282 ~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 282 FQPSNRTSFQNLIE 295 (302)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHH
Confidence 99999999999885
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=319.51 Aligned_cols=235 Identities=20% Similarity=0.308 Sum_probs=182.8
Q ss_pred cceee-eeecCCCCee---EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNFY-DRCSYSSDLF---VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~~-~~~~~~~~~v---vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||+++ +++..+++.+ ||+|.+.... ....+.+.+|+.++++++||||+++++++..++ .++|++|+.+|+|.++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~ 106 (327)
T 3poz_A 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 106 (327)
T ss_dssp TEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHH
T ss_pred CeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHH
Confidence 44443 6777777665 3666654332 234468999999999999999999999998765 7899999999999999
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 79 ICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 79 l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+....... .....+|+.
T Consensus 107 l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 184 (327)
T 3poz_A 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIK 184 (327)
T ss_dssp HHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTHHHHHTTTCC-------CCCGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCC--EEEccCcceeEccCCcccccccCCCcccc
Confidence 9874 56999999999999999999999999999999999999987665 99999999875432222 223356889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |+.||.+....... .. .......+.....+.++.+++.+||+.
T Consensus 185 y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~li~~~l~~ 258 (327)
T 3poz_A 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SI----LEKGERLPQPPICTIDVYMIMVKCWMI 258 (327)
T ss_dssp GSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHH-HH----HHTTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred ccChHHhccCCCCch-hhhhhhHHHHHHHHhcCCCCccCCCHHHHH-HH----HHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 999999988877655 999999999999999 99999876654322 22 222333444556899999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+.+++++
T Consensus 259 ~p~~Rps~~ell~~ 272 (327)
T 3poz_A 259 DADSRPKFRELIIE 272 (327)
T ss_dssp CGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=321.54 Aligned_cols=235 Identities=21% Similarity=0.320 Sum_probs=188.7
Q ss_pred cceee-eeec-----CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 4 FHNFY-DRCS-----YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 4 ~g~~~-~~~~-----~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.++ +++. .++..| |||++..... ...+.+.+|+.+++.++||||+++++++..++..++||||+.+++|.
T Consensus 60 ~g~Vy~~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 138 (343)
T 1luf_A 60 FGRVFQARAPGLLPYEPFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138 (343)
T ss_dssp SCEEEEEEEETSSTTSSEEEE-EEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred CeeEEEEEecCcCCCCCceeE-EEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHH
Confidence 34443 5555 344667 9999986542 23467899999999999999999999999999999999999999999
Q ss_pred HHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEe
Q 019901 77 ERICNA------------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132 (334)
Q Consensus 77 ~~l~~~------------------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~ 132 (334)
+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+
T Consensus 139 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~--~kl~ 216 (343)
T 1luf_A 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIA 216 (343)
T ss_dssp HHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEEC
T ss_pred HHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCe--EEEe
Confidence 999764 56999999999999999999999999999999999999987664 9999
Q ss_pred ccCCccCCCCC---CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhh
Q 019901 133 DFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 133 Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
|||+++..... .......+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ .+..
T Consensus 217 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~----~~~~ 291 (343)
T 1luf_A 217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY----YVRD 291 (343)
T ss_dssp CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HHHT
T ss_pred ecCCCcccccCccccccCCCcccceecChhhhccCCcCcc-cccHHHHHHHHHHHhcCCCcCCCCChHHHHH----HHhC
Confidence 99998743222 22334568899999999988777654 999999999999999 999998765533222 2222
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 209 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.. ..+....+++.+.++|.+||+.+|.+|||+.+++++
T Consensus 292 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 292 GN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 22 122334689999999999999999999999999853
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-43 Score=307.41 Aligned_cols=234 Identities=21% Similarity=0.327 Sum_probs=190.4
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA- 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 82 (334)
+|.++.....+++.| |+|++.... ...+.+.+|+.+++.++||||+++++++..++..++||||+++++|.+++...
T Consensus 21 ~g~V~~~~~~~~~~v-aiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 98 (267)
T 3t9t_A 21 FGLVHLGYWLNKDKV-AIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR 98 (267)
T ss_dssp TEEEEEEEETTTEEE-EEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT
T ss_pred ceeEEEEEecCCCeE-EEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc
Confidence 444443333366677 999998766 44578999999999999999999999999999999999999999999999875
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC--CCCCCccCCCccccchh
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPEV 160 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~--~~~~~~~gt~~y~aPE~ 160 (334)
+.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... .......+++.|+|||+
T Consensus 99 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~--~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~ 176 (267)
T 3t9t_A 99 GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEV 176 (267)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGC--EEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCC--EEEcccccccccccccccccccccccccccChhh
Confidence 56899999999999999999999999999999999999987664 999999998754221 12234457889999999
Q ss_pred hccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCC
Q 019901 161 LLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRI 239 (334)
Q Consensus 161 ~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~ 239 (334)
+.+..++. ++||||||+++|+|++ |+.||........... +.. ..........++.+.+++.+||+.+|.+||
T Consensus 177 ~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp 250 (267)
T 3t9t_A 177 FSFSRYSS-KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVYQIMNHCWRERPEDRP 250 (267)
T ss_dssp HHHCCCCH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHT-TCCCCCCTTSCHHHHHHHHHHTCSSGGGSC
T ss_pred hcCCCccc-hhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH----Hhc-CCcCCCCccCcHHHHHHHHHHccCChhhCc
Confidence 98777754 4999999999999999 8999987655333222 222 222233345799999999999999999999
Q ss_pred CHhHHhcC
Q 019901 240 SIPEIRNH 247 (334)
Q Consensus 240 s~~ell~h 247 (334)
|+.+++++
T Consensus 251 s~~~ll~~ 258 (267)
T 3t9t_A 251 AFSRLLRQ 258 (267)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999864
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=336.57 Aligned_cols=235 Identities=21% Similarity=0.305 Sum_probs=195.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .+.++.++..| |||++.... ...+.+.+|+.+++.++||||+++++++...+.+|+||||+.+|+|.+
T Consensus 228 lG~G~fg~Vy~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~ 305 (495)
T 1opk_A 228 LGGGQYGEVYEGVWKKYSLTV-AVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 305 (495)
T ss_dssp SGGGTTSSEEEEEEGGGTEEE-EEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred ecCCCCeEEEEEEEcCCCeEE-EEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHH
Confidence 555555 47777778888 999998765 446789999999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~ 153 (334)
++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+++
T Consensus 306 ~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~ 383 (495)
T 1opk_A 306 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI 383 (495)
T ss_dssp HHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEECCTTCCEECCTTCCCCG
T ss_pred HHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCc--EEEeecccceeccCCceeecCCCcCCc
Confidence 99864 45899999999999999999999999999999999999987664 9999999998643221 122345678
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... .......+.+..+++.+.+||.+||+
T Consensus 384 ~y~aPE~~~~~~~~~~-sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~ 457 (495)
T 1opk_A 384 KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-----LEKDYRMERPEGCPEKVYELMRACWQ 457 (495)
T ss_dssp GGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-----HHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred ceeCHhHHhcCCCCcH-HhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-----HHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 8999999988877655 999999999999999 9999988765433322 22233444455789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 458 ~dP~~RPs~~el~~ 471 (495)
T 1opk_A 458 WNPSDRPSFAEIHQ 471 (495)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred cChhHCcCHHHHHH
Confidence 99999999999975
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=329.65 Aligned_cols=240 Identities=25% Similarity=0.401 Sum_probs=189.6
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCC--eEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l 79 (334)
||++ .+++..+|+.| |||++..... ...+.+.+|+.+++.++||||+++++++...+ ..++|||||.+|+|.+++
T Consensus 22 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 100 (396)
T 4eut_A 22 TANVFRGRHKKTGDLF-AIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVL 100 (396)
T ss_dssp SEEEEEEEETTTCCEE-EEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHT
T ss_pred CeEEEEEEECCCCcEE-EEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHH
Confidence 3444 48888899999 9999986542 33467889999999999999999999998755 789999999999999998
Q ss_pred HhcCC---CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEE----cCCCCCCEEEeccCCccCCCCCCCCCCccCC
Q 019901 80 CNAGR---FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL----DGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152 (334)
Q Consensus 80 ~~~~~---~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli----~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt 152 (334)
..... +++..++.++.||+.||.|||++||+||||||+|||+ +..+ .+||+|||+++............||
T Consensus 101 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~--~~kL~DFG~a~~~~~~~~~~~~~gt 178 (396)
T 4eut_A 101 EEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS--VYKLTDFGAARELEDDEQFVSLYGT 178 (396)
T ss_dssp TSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE--EEEECCGGGCEECCCGGGSSCSSSC
T ss_pred HhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce--eEEEecCCCceEccCCCccccccCC
Confidence 76433 9999999999999999999999999999999999998 4333 4999999999866555445567899
Q ss_pred Cccccchhhcc--------CCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------------
Q 019901 153 PAYIAPEVLLK--------KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------- 211 (334)
Q Consensus 153 ~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------- 211 (334)
+.|+|||++.+ ..+ +.++|||||||++|+|++|+.||............+..+.....
T Consensus 179 ~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 257 (396)
T 4eut_A 179 EEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG 257 (396)
T ss_dssp CTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTC
T ss_pred ccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCC
Confidence 99999999865 333 34589999999999999999999764433333333433333221
Q ss_pred ------cCCCCC----CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 212 ------SIPDYV----HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 212 ------~~~~~~----~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
..+... .++..+.++|.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 258 PIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred CcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 111111 235678899999999999999999998653
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=314.09 Aligned_cols=236 Identities=20% Similarity=0.286 Sum_probs=182.9
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
+|.+ .+.+..+++.| |||++...... ..+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++
T Consensus 47 ~g~Vy~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 125 (309)
T 2h34_A 47 MGDVYEAEDTVRERIV-ALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAML 125 (309)
T ss_dssp SSEEEEEEETTTTEEE-EEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHH
T ss_pred CeeEEEEEEcCCCeEE-EEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHH
Confidence 4444 47778888888 99999765422 2367889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCcccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIA 157 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~a 157 (334)
.+.+.+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||++....... ......||+.|+|
T Consensus 126 ~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~a 203 (309)
T 2h34_A 126 RRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDF--AYLVDFGIASATTDEKLTQLGNTVGTLYYMA 203 (309)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSCCC----------------CCGGGCC
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCC--EEEecCccCccccccccccccccCCCcCccC
Confidence 98888999999999999999999999999999999999999987664 9999999987543322 1234579999999
Q ss_pred chhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 158 PEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 158 PE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
||++.+..++.+ +||||||+++|+|++|+.||...... .....+... ..........+|+.+.++|.+||+.+|.+
T Consensus 204 PE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 279 (309)
T 2h34_A 204 PERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA--IPRPSTVRPGIPVAFDAVIARGMAKNPED 279 (309)
T ss_dssp GGGTCC----CC-CHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC--CCCGGGTSTTCCTHHHHHHHHHTCSSGGG
T ss_pred HHHHcCCCCCch-HhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC--CCCccccCCCCCHHHHHHHHHhccCCHHH
Confidence 999988777655 99999999999999999999875432 221211111 11111223468999999999999999999
Q ss_pred CC-CHhHHhc
Q 019901 238 RI-SIPEIRN 246 (334)
Q Consensus 238 R~-s~~ell~ 246 (334)
|| |+++++.
T Consensus 280 Rp~s~~~l~~ 289 (309)
T 2h34_A 280 RYVTCGDLSA 289 (309)
T ss_dssp SCSSHHHHHH
T ss_pred HHHhHHHHHH
Confidence 99 7888764
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=317.43 Aligned_cols=237 Identities=21% Similarity=0.286 Sum_probs=187.2
Q ss_pred CCccee----eeeecCCCCee---EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLF---VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~v---vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .+++..++..+ ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..++||||+.+|
T Consensus 21 lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~ 99 (325)
T 3kex_A 21 LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLG 99 (325)
T ss_dssp EECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTC
T ss_pred eeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCC
Confidence 455544 47777888774 2666664433 233467889999999999999999999886 45689999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... ....
T Consensus 100 ~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~ 177 (325)
T 3kex_A 100 SLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQ--VQVADFGVADLLPPDDKQLLYSEA 177 (325)
T ss_dssp BSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSC--EEECSCSGGGGSCCCTTCCC----
T ss_pred CHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCe--EEECCCCcccccCcccccccccCC
Confidence 999999764 57999999999999999999999999999999999999987665 99999999986433322 2334
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+....+++++.++|.
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~~~li~ 251 (325)
T 3kex_A 178 KTPIKWMALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-L----EKGERLAQPQICTIDVYMVMV 251 (325)
T ss_dssp -CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-H----HTTCBCCCCTTBCTTTTHHHH
T ss_pred CCcccccChHHhccCCCChh-hHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-H----HcCCCCCCCCcCcHHHHHHHH
Confidence 57889999999988877654 999999999999999 9999987665333221 1 122233333457889999999
Q ss_pred HhcccCCCCCCCHhHHhcC
Q 019901 229 RIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h 247 (334)
+||..+|.+|||+.+++++
T Consensus 252 ~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 252 KCWMIDENIRPTFKELANE 270 (325)
T ss_dssp HHTCSCTTTSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999986
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=309.44 Aligned_cols=222 Identities=22% Similarity=0.328 Sum_probs=184.6
Q ss_pred CCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcC--CeEEEEEeccCCCChHHHHHhcC--CCCH
Q 019901 14 SSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTP--THLAIVMEYASGGELFERICNAG--RFSE 87 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~ 87 (334)
++..+ |||++..... ...+.+.+|+.+++.++||||+++++++.+. +..++||||+++++|.+++.+.+ .+++
T Consensus 32 ~~~~~-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 110 (271)
T 3kmu_A 32 QGNDI-VVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQ 110 (271)
T ss_dssp TTEEE-EEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCH
T ss_pred CCeeE-EEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCH
Confidence 47777 9999987652 2235789999999999999999999999887 78999999999999999998765 4899
Q ss_pred HHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCC
Q 019901 88 DEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKE 165 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 165 (334)
..++.++.|++.||.|||++| |+||||||+|||++.++. ++|+|||++... ......||+.|+|||++.+..
T Consensus 111 ~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~--~~l~~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~ 184 (271)
T 3kmu_A 111 SQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMT--ARISMADVKFSF----QSPGRMYAPAWVAPEALQKKP 184 (271)
T ss_dssp HHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSC--EEEEGGGSCCTT----SCTTCBSCGGGSCHHHHHSCG
T ss_pred HHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcc--eeEEeccceeee----cccCccCCccccChhhhccCC
Confidence 999999999999999999999 999999999999987765 899888876542 223457899999999998765
Q ss_pred CCCc--cchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhH
Q 019901 166 YDGK--IADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243 (334)
Q Consensus 166 ~~~~--~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~e 243 (334)
+... ++|||||||++|+|++|+.||........... ........+.+..+++++.++|.+||+.+|.+|||+++
T Consensus 185 ~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 260 (271)
T 3kmu_A 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK----VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDM 260 (271)
T ss_dssp GGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH----HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred CCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH----HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 5442 58999999999999999999987665433322 22233333344568999999999999999999999999
Q ss_pred Hhc
Q 019901 244 IRN 246 (334)
Q Consensus 244 ll~ 246 (334)
+++
T Consensus 261 il~ 263 (271)
T 3kmu_A 261 IVP 263 (271)
T ss_dssp HHH
T ss_pred HHH
Confidence 985
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=323.07 Aligned_cols=225 Identities=20% Similarity=0.338 Sum_probs=176.1
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-CCCHHHH
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEA 90 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~ 90 (334)
.++..| |||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.+.+ .+++..+
T Consensus 71 ~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~ 149 (373)
T 2qol_A 71 KKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL 149 (373)
T ss_dssp SCBCCE-EEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHH
T ss_pred CCceeE-EEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHH
Confidence 356667 9999976541 234578999999999999999999999999999999999999999999998754 6999999
Q ss_pred HHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhccCCC
Q 019901 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~ 166 (334)
..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+..+
T Consensus 150 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 227 (373)
T 2qol_A 150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV--CKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227 (373)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC----------------------CTTSCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCC--EEECcCccccccccCCccceeccCCCcCCCccChhhhccCCc
Confidence 999999999999999999999999999999987664 99999999975433221 112235778999999988877
Q ss_pred CCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 167 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
+.+ +|||||||++|+|++ |+.||........... + ......+....++..+.+++.+||+.+|.+|||+.+++
T Consensus 228 ~~~-~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~ 301 (373)
T 2qol_A 228 TSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA----V-DEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIV 301 (373)
T ss_dssp CHH-HHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH----H-HTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred Cch-hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHH
Confidence 655 999999999999998 9999987665332222 2 22233444556899999999999999999999999987
Q ss_pred c
Q 019901 246 N 246 (334)
Q Consensus 246 ~ 246 (334)
+
T Consensus 302 ~ 302 (373)
T 2qol_A 302 S 302 (373)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=318.29 Aligned_cols=232 Identities=23% Similarity=0.345 Sum_probs=188.2
Q ss_pred ecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEE--cCCeEEEEEeccCCCChHHHHHh-cCCCCH
Q 019901 11 CSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGGELFERICN-AGRFSE 87 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~ 87 (334)
+..++..| |||++........+.+.+|+.+++.++||||+++++++. ..+.+++||||+++++|.+++.. ...+++
T Consensus 48 ~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 126 (327)
T 3lxl_A 48 GDNTGALV-AVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 126 (327)
T ss_dssp SSSCSEEE-EEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCH
T ss_pred CCCcceEE-EEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCH
Confidence 46677788 999998765444567999999999999999999999987 45679999999999999999976 356999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~ 163 (334)
..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......||+.|+|||++.+
T Consensus 127 ~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 204 (327)
T 3lxl_A 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAH--VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD 204 (327)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCC--EEEcccccceecccCCccceeeccCCccccccCHHHhcc
Confidence 999999999999999999999999999999999987665 9999999997543322 2233468888999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..++. ++|||||||++|+|++|+.||...... ..... ...........+....+++.+.++|.+||+
T Consensus 205 ~~~~~-~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 282 (327)
T 3lxl_A 205 NIFSR-QSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSR-LLELLEEGQRLPAPPACPAEVHELMKLCWA 282 (327)
T ss_dssp CEEEH-HHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHH-HHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCh-HHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHH-HHHHhhcccCCCCCCcccHHHHHHHHHHcC
Confidence 77754 499999999999999999999653221 01111 122223333445556789999999999999
Q ss_pred cCCCCCCCHhHHhcC
Q 019901 233 ADPAKRISIPEIRNH 247 (334)
Q Consensus 233 ~~p~~R~s~~ell~h 247 (334)
.+|.+|||+.+++++
T Consensus 283 ~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 283 PSPQDRPSFSALGPQ 297 (327)
T ss_dssp SSGGGSCCHHHHHHH
T ss_pred CChhhCcCHHHHHHH
Confidence 999999999999764
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=310.32 Aligned_cols=234 Identities=21% Similarity=0.333 Sum_probs=177.2
Q ss_pred cceee-eeecCCC---CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNFY-DRCSYSS---DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~~-~~~~~~~---~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.++ +.+..++ ..| |||.+..... ...+.+.+|+.+++.++||||+++++++. ++..|+||||+.+++|.++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~ 105 (281)
T 1mp8_A 28 FGDVHQGIYMSPENPALAV-AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSF 105 (281)
T ss_dssp SSEEEEEEECCC--CCEEE-EEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHH
T ss_pred CeeEEEEEEecCCCCceEE-EEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHH
Confidence 34443 5554433 345 9999876431 23467889999999999999999999984 5678999999999999999
Q ss_pred HHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCcc
Q 019901 79 ICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAY 155 (334)
Q Consensus 79 l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y 155 (334)
+...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|
T Consensus 106 l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y 183 (281)
T 1mp8_A 106 LQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKLPIKW 183 (281)
T ss_dssp HHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------CCGGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCC--EEECccccccccCcccccccccCCCcccc
Confidence 98654 6999999999999999999999999999999999999987664 99999999975433222 2233567899
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
+|||++.+..++.+ +|||||||++|+|++ |..||.+.......... .. ....+....+++.+.++|.+||+.+
T Consensus 184 ~aPE~~~~~~~~~~-~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i----~~-~~~~~~~~~~~~~l~~li~~~l~~~ 257 (281)
T 1mp8_A 184 MAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPTLYSLMTKCWAYD 257 (281)
T ss_dssp CCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred cChhhcccCCCCCc-cCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHHHHHHccCC
Confidence 99999987777554 999999999999996 99999887664433322 11 1223344568999999999999999
Q ss_pred CCCCCCHhHHhcC
Q 019901 235 PAKRISIPEIRNH 247 (334)
Q Consensus 235 p~~R~s~~ell~h 247 (334)
|.+|||+.+++++
T Consensus 258 p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 258 PSRRPRFTELKAQ 270 (281)
T ss_dssp GGGSCCHHHHHHH
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-44 Score=321.41 Aligned_cols=239 Identities=19% Similarity=0.235 Sum_probs=179.9
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC----eEEEEEeccCCCCh
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e~~~~~~L 75 (334)
||.|+| +.+....++.| |||++.... .......+|+.+++.++||||+++++++.... .+++||||+++|+|
T Consensus 32 lg~G~~g~Vy~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L 109 (322)
T 3soc_A 32 KARGRFGCVWKAQLLNEYV-AVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL 109 (322)
T ss_dssp EECSTTCEEEEEEETTEEE-EEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred ecccCceEEEEEEECCCEE-EEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCH
Confidence 455554 22223346777 999997655 33456677999999999999999999998743 47999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC----------CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSM----------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS- 144 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~----------~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~- 144 (334)
.+++.. +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+|+......
T Consensus 110 ~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~--~kL~DFg~a~~~~~~~~ 186 (322)
T 3soc_A 110 SDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLT--ACIADFGLALKFEAGKS 186 (322)
T ss_dssp HHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCC--EEECCCTTCEEECTTSC
T ss_pred HHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCe--EEEccCCcccccccccC
Confidence 999976 4599999999999999999999999 9999999999999987664 9999999997533222
Q ss_pred --CCCCccCCCccccchhhccCCC----CCccchhhhhhHHHHHHHhCCCCCCCCCchH------------HHHHHHHHH
Q 019901 145 --QPKSTVGTPAYIAPEVLLKKEY----DGKIADVWSCGVTLYVMLVGAYPFEDPEEPK------------NFRKTIHRI 206 (334)
Q Consensus 145 --~~~~~~gt~~y~aPE~~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~~~~~~~~ 206 (334)
......||+.|+|||++.+... .+.++|||||||++|+|++|+.||.+..... .........
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (322)
T 3soc_A 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVV 266 (322)
T ss_dssp CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHH
T ss_pred ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhh
Confidence 2334579999999999976322 1334899999999999999999997643211 111111111
Q ss_pred hhccccCCCCC------CCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 207 LSVQYSIPDYV------HISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 207 ~~~~~~~~~~~------~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
.. ....|... ..++++.+||.+||+.||.+|||+.++++
T Consensus 267 ~~-~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 267 VH-KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp TT-SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hc-ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 11 11111111 12345999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-43 Score=330.30 Aligned_cols=234 Identities=21% Similarity=0.325 Sum_probs=189.8
Q ss_pred CCccee---eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF---YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~---~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|+| +.....++..| |||++.... ...+.+.+|+.+++.++||||+++++++. .+.+|+||||+.+|+|.++
T Consensus 196 lG~G~fg~V~~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~ 272 (454)
T 1qcf_A 196 LGAGQFGEVWMATYNKHTKV-AVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDF 272 (454)
T ss_dssp EECCSSEEEEEEEETTTEEE-EEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHH
T ss_pred cccCCceEEEEEEECCccEE-EEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHH
Confidence 454544 43223345666 999998765 45678999999999999999999999986 5678999999999999999
Q ss_pred HHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC--CCCCCccCCCc
Q 019901 79 ICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPA 154 (334)
Q Consensus 79 l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~--~~~~~~~gt~~ 154 (334)
+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++..... .......+|+.
T Consensus 273 l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~ 350 (454)
T 1qcf_A 273 LKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLV--CKIADFGLARVIEDNEYTAREGAKFPIK 350 (454)
T ss_dssp HHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCC--EEECSTTGGGGBCCHHHHTTCSSSSCGG
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCc--EEEeeCCCceEcCCCceeccCCCccccc
Confidence 9754 36899999999999999999999999999999999999987665 999999999854321 11233456788
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |+.||.+.......... ......+.+..+++++.++|.+||+.
T Consensus 351 y~aPE~~~~~~~~~~-~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i-----~~~~~~~~~~~~~~~l~~li~~cl~~ 424 (454)
T 1qcf_A 351 WTAPEAINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL-----ERGYRMPRPENCPEELYNIMMRCWKN 424 (454)
T ss_dssp GSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-----HHTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred ccCHHHhccCCCCcH-HHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-----HcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 999999988777655 999999999999999 99999887654433322 12234455567899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+++++.
T Consensus 425 dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 425 RPEERPTFEYIQS 437 (454)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999874
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=309.46 Aligned_cols=227 Identities=20% Similarity=0.246 Sum_probs=182.8
Q ss_pred eecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 10 RCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 10 ~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
.+..++..| |||++..... ...+.+.+|+.+++.++||||+++++++ ..+..++||||+.+++|.+++...+.+++
T Consensus 39 ~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 116 (291)
T 1xbb_A 39 QMKKVVKTV-AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKD 116 (291)
T ss_dssp ECSSSEEEE-EEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCH
T ss_pred cCCCceeeE-EEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCH
Confidence 345566777 9999986642 2246789999999999999999999998 56678999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~ 163 (334)
..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+
T Consensus 117 ~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 194 (291)
T 1xbb_A 117 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 194 (291)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCc--EEEccCCcceeeccCCCcccccccCCCCceeeChHHhcc
Confidence 999999999999999999999999999999999987664 99999999875433221 122346788999999987
Q ss_pred CCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 164 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
..++. ++||||||+++|+|++ |+.||.+........ .+.. ....+....+++.+.++|.+||+.+|.+|||+.
T Consensus 195 ~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 268 (291)
T 1xbb_A 195 YKFSS-KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEK-GERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 268 (291)
T ss_dssp CEEEH-HHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCh-hhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHH----HHHc-CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHH
Confidence 77754 4999999999999999 999998766533222 1211 222233446899999999999999999999999
Q ss_pred HHhc
Q 019901 243 EIRN 246 (334)
Q Consensus 243 ell~ 246 (334)
++++
T Consensus 269 ~l~~ 272 (291)
T 1xbb_A 269 AVEL 272 (291)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9875
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=318.50 Aligned_cols=240 Identities=26% Similarity=0.381 Sum_probs=188.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEE----cCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVIL----TPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~----~~~~~~lv~e~~~~~ 73 (334)
||.|++ .+++..+|+.| |||++........+.+.+|+.+++.++||||+++++++. ..+..++||||+.++
T Consensus 37 lg~G~~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~ 115 (317)
T 2buj_A 37 LGEGGFSYVDLVEGLHDGHFY-ALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRG 115 (317)
T ss_dssp EEC--CEEEEEEEETTTCCEE-EEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTC
T ss_pred ecCCCCeEEEEEEecCCCcEE-EEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCC
Confidence 455554 47788899998 999997765445678899999999999999999999987 345789999999999
Q ss_pred ChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC---
Q 019901 74 ELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP--- 146 (334)
Q Consensus 74 ~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~--- 146 (334)
+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++........
T Consensus 116 ~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~--~kl~dfg~~~~~~~~~~~~~~ 193 (317)
T 2buj_A 116 TLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ--PVLMDLGSMNQACIHVEGSRQ 193 (317)
T ss_dssp BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCSSCEESCEEEESHHH
T ss_pred cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCC--EEEEecCcchhcccccccccc
Confidence 99998876 467999999999999999999999999999999999999987665 999999988753221111
Q ss_pred -------CCccCCCccccchhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCCCch-HHHHHHHHHHhhccccCCCC
Q 019901 147 -------KSTVGTPAYIAPEVLLKKEY--DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-KNFRKTIHRILSVQYSIPDY 216 (334)
Q Consensus 147 -------~~~~gt~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~ 216 (334)
....||+.|+|||++.+... .+.++|||||||++|+|++|+.||...... ..... ........+..
T Consensus 194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~~~~~~~~~~~ 269 (317)
T 2buj_A 194 ALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL----AVQNQLSIPQS 269 (317)
T ss_dssp HHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH----HHHCC--CCCC
T ss_pred cccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH----HhhccCCCCcc
Confidence 12347999999999875442 234599999999999999999999531110 01111 11223344555
Q ss_pred CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCc
Q 019901 217 VHISPECRHLISRIFVADPAKRISIPEIRNHE 248 (334)
Q Consensus 217 ~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~ 248 (334)
..+++.+.++|.+||+.+|.+|||+.+++++-
T Consensus 270 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L 301 (317)
T 2buj_A 270 PRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301 (317)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred ccCCHHHHHHHHHHhhcChhhCCCHHHHHHHh
Confidence 67899999999999999999999999999863
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.05 Aligned_cols=234 Identities=19% Similarity=0.296 Sum_probs=182.9
Q ss_pred ccee-eeeecCCCCee---EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 4 FHNF-YDRCSYSSDLF---VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~v---vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
||.+ .+++..+++.+ ||+|.+.... ......+.+|+.+++.++||||+++++++..+. .++|++|+.+|+|.++
T Consensus 28 ~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~ 106 (327)
T 3lzb_A 28 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDY 106 (327)
T ss_dssp SEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHH
T ss_pred CeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHH
Confidence 4444 47778888776 2444443322 234578999999999999999999999998765 7899999999999999
Q ss_pred HHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCc
Q 019901 79 ICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPA 154 (334)
Q Consensus 79 l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~ 154 (334)
+... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.
T Consensus 107 l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kL~DfG~a~~~~~~~~~~~~~~~~~t~~ 184 (327)
T 3lzb_A 107 VREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGGKVPIK 184 (327)
T ss_dssp HHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCTTC----------------CCCGG
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCC--EEEccCcceeEccCccccccccCCCcccc
Confidence 9864 56999999999999999999999999999999999999987664 99999999975433222 223346789
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|+|++ |..||.+........ . .......+....+++++.++|.+||..
T Consensus 185 y~aPE~~~~~~~~~~-~Di~slG~il~ell~~g~~p~~~~~~~~~~~-~----~~~~~~~~~~~~~~~~l~~li~~~l~~ 258 (327)
T 3lzb_A 185 WMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISS-I----LEKGERLPQPPICTIDVYMIMRKCWMI 258 (327)
T ss_dssp GSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHH-H----HHTTCCCCCCTTBCHHHHHHHHHHTCS
T ss_pred ccCHHHHcCCCCChH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH-H----HHcCCCCCCCccCCHHHHHHHHHHcCC
Confidence 999999988887655 999999999999999 999998776543322 2 222333444556899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
+|.+|||+.++++
T Consensus 259 dp~~Rps~~ell~ 271 (327)
T 3lzb_A 259 DADSRPKFRELII 271 (327)
T ss_dssp SGGGSCCHHHHHH
T ss_pred ChhHCcCHHHHHH
Confidence 9999999999986
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-43 Score=319.01 Aligned_cols=235 Identities=12% Similarity=0.159 Sum_probs=185.2
Q ss_pred cceee-eeecCC--------CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCccc---------------ceEEEEc
Q 019901 4 FHNFY-DRCSYS--------SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVR---------------FKEVILT 59 (334)
Q Consensus 4 ~g~~~-~~~~~~--------~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~---------------~~~~~~~ 59 (334)
||.++ +++..+ ++.| |||++... ..+.+|+.+++.++||||++ +++++..
T Consensus 55 ~g~Vy~~~~~~t~~~~~~~~~~~v-avK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~ 128 (352)
T 2jii_A 55 QGILYEAAPTSTLTCDSGPQKQKF-SLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH 128 (352)
T ss_dssp TEEEEEEEECC-----------CE-EEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEE
T ss_pred CeEEEEEeecCCccccccccCceE-EEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhcccc
Confidence 44443 666663 7777 99998754 46889999999999999887 5677765
Q ss_pred -CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCC
Q 019901 60 -PTHLAIVMEYASGGELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 136 (334)
Q Consensus 60 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgl 136 (334)
++..|+||||+ +++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++...+||+|||+
T Consensus 129 ~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~ 207 (352)
T 2jii_A 129 QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207 (352)
T ss_dssp TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGG
T ss_pred CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcc
Confidence 78899999999 99999999876 779999999999999999999999999999999999999876523599999999
Q ss_pred ccCCCCCC--------CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCC-chHHHHHHHHHHh
Q 019901 137 SKSSVLHS--------QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE-EPKNFRKTIHRIL 207 (334)
Q Consensus 137 a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~ 207 (334)
++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.... .............
T Consensus 208 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 286 (352)
T 2jii_A 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR-SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFV 286 (352)
T ss_dssp CBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred eeeccCCCccccccccccccccCCccccCHHHHccCCCCch-hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhcc
Confidence 97543221 1133479999999999988777554 999999999999999999998764 3233333333222
Q ss_pred hccccCC----CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 208 SVQYSIP----DYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 208 ~~~~~~~----~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
.....++ .+..+++++.+||.+||+.+|.+|||++++++
T Consensus 287 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 287 DKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp HSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 2222211 12357999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=317.71 Aligned_cols=242 Identities=14% Similarity=0.162 Sum_probs=182.8
Q ss_pred CCccee----eeeecCC-----CCeeEEEEEEecCcc-----------cccHHHHHHHHHHHcCCCCCcccceEEEEcC-
Q 019901 2 LGFHNF----YDRCSYS-----SDLFVNIIIIVFHLW-----------QIDENVQREIINHRSLRHPNIVRFKEVILTP- 60 (334)
Q Consensus 2 lG~g~~----~~~~~~~-----~~~vvaiK~~~~~~~-----------~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~- 60 (334)
||.|+| .+.+..+ +..| |||++..... .......+|+..++.++||||+++++++...
T Consensus 43 lG~G~~g~Vy~~~~~~~~~~~~~~~v-avK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 121 (364)
T 3op5_A 43 IGQGGFGCIYLADMNSSESVGSDAPC-VVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDK 121 (364)
T ss_dssp CCCC-CCEEEEEEECCSSCCCTTCSE-EEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEE
T ss_pred EecCCCeEEEEeeecCccccccccce-EEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeecc
Confidence 566665 3555544 4677 9999876541 0113344566677788899999999998764
Q ss_pred ---CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCC
Q 019901 61 ---THLAIVMEYASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGY 136 (334)
Q Consensus 61 ---~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgl 136 (334)
...|+||||+ |++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||++....+.+||+|||+
T Consensus 122 ~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~ 200 (364)
T 3op5_A 122 NGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGL 200 (364)
T ss_dssp TTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTT
T ss_pred CCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCc
Confidence 5689999999 99999999876 679999999999999999999999999999999999999843344699999999
Q ss_pred ccCCCCCCC--------CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh
Q 019901 137 SKSSVLHSQ--------PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 137 a~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
|+....... .....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+................
T Consensus 201 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~ 279 (364)
T 3op5_A 201 AYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRR-GDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYR 279 (364)
T ss_dssp CEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHH
T ss_pred ceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhh
Confidence 975432211 133459999999999988877544 99999999999999999999864433322222211111
Q ss_pred ccc-----cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 209 VQY-----SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 209 ~~~-----~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
... .......+++++.+++..||..+|.+|||+.++++
T Consensus 280 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 280 ENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 000 00011357999999999999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=308.46 Aligned_cols=240 Identities=26% Similarity=0.398 Sum_probs=182.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|++ .+.+..+|..| |||++..... .....+.+|+.+++.++||||+++++++...+..++||||+.+++
T Consensus 40 lg~G~~g~Vy~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 118 (310)
T 2wqm_A 40 IGRGQFSEVYRAACLLDGVPV-ALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGD 118 (310)
T ss_dssp EECC--CEEEEEEETTTCCEE-EEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCB
T ss_pred ecCCCCceEEEEEEcCCCceE-EEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCC
Confidence 454544 37778889998 9999986442 234578899999999999999999999999999999999999999
Q ss_pred hHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCc
Q 019901 75 LFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKST 149 (334)
Q Consensus 75 L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~ 149 (334)
|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... .....
T Consensus 119 L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~ 196 (310)
T 2wqm_A 119 LSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGV--VKLGDLGLGRFFSSKTTAAHSL 196 (310)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCC----------------
T ss_pred HHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCC--EEEEeccceeeecCCCcccccc
Confidence 9998864 456999999999999999999999999999999999999987664 9999999987543322 22345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISR 229 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 229 (334)
.|++.|+|||++.+..++.+ +||||||+++|+|++|..||.+..... ......+............+++++.++|.+
T Consensus 197 ~~~~~y~aPE~~~~~~~~~~-~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 273 (310)
T 2wqm_A 197 VGTPYYMSPERIHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNL--YSLCKKIEQCDYPPLPSDHYSEELRQLVNM 273 (310)
T ss_dssp --CCSSCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTC---CCH--HHHHHHHHTTCSCCCCTTTSCHHHHHHHHH
T ss_pred CCCeeEeChHHhCCCCCCch-hhHHHHHHHHHHHHhCCCCCcccchhH--HHHHHHhhcccCCCCcccccCHHHHHHHHH
Confidence 68999999999988777554 999999999999999999997643221 122222322222222234679999999999
Q ss_pred hcccCCCCCCCHhHHhcC
Q 019901 230 IFVADPAKRISIPEIRNH 247 (334)
Q Consensus 230 ~L~~~p~~R~s~~ell~h 247 (334)
||+.||.+|||+.+++++
T Consensus 274 ~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 274 CINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999853
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-43 Score=309.99 Aligned_cols=226 Identities=23% Similarity=0.341 Sum_probs=171.5
Q ss_pred CeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHH
Q 019901 16 DLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEARF 92 (334)
Q Consensus 16 ~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~ 92 (334)
..+ |||++..... ...+.+.+|+.+++.++||||++++++. ..+..++||||+.+++|.+++.. ...+++..++.
T Consensus 47 ~~v-avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 124 (289)
T 3og7_A 47 GDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID 124 (289)
T ss_dssp SEE-EEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHH
T ss_pred Cce-EEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHH
Confidence 357 9999976652 2236788999999999999999999964 55678999999999999999864 35699999999
Q ss_pred HHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccchhhc---cCCC
Q 019901 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLL---KKEY 166 (334)
Q Consensus 93 ~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aPE~~~---~~~~ 166 (334)
++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... .......||+.|+|||++. +..+
T Consensus 125 i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 202 (289)
T 3og7_A 125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNT--VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202 (289)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE--EEECCCC------------------CCCTTCCHHHHC----CCS
T ss_pred HHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEEccceeccccccccccccccccCCCccccCchhhcccCCCCC
Confidence 9999999999999999999999999999987764 999999998754321 2223456999999999986 3444
Q ss_pred CCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 167 DGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+ .++||||||+++|+|++|+.||............................+++.+.+||.+||+.+|.+|||+.++++
T Consensus 203 ~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 203 S-FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp C-HHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-cccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3 459999999999999999999988766554444333221111111122357899999999999999999999999985
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-43 Score=316.16 Aligned_cols=245 Identities=20% Similarity=0.268 Sum_probs=192.1
Q ss_pred CCccee---e-ee-----ecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF---Y-DR-----CSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~---~-~~-----~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|++ + ++ +..++..| |||++..... .....+.+|+.+++.++||||+++++++...+..|+||||+.
T Consensus 38 lg~G~~g~Vy~~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 116 (327)
T 2yfx_A 38 LGHGAFGEVYEGQVSGMPNDPSPLQV-AVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMA 116 (327)
T ss_dssp CC--CSSCEEEEEC--------CCEE-EEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred EcCCCCeeEEEEEEcCCCCCCccceE-EEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCC
Confidence 566655 2 44 45677788 9999975431 234578899999999999999999999999999999999999
Q ss_pred CCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCC
Q 019901 72 GGELFERICNAG-------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLH 143 (334)
Q Consensus 72 ~~~L~~~l~~~~-------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~ 143 (334)
+++|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++..+ ...+||+|||+++.....
T Consensus 117 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~ 196 (327)
T 2yfx_A 117 GGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196 (327)
T ss_dssp TEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-
T ss_pred CCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccc
Confidence 999999998753 489999999999999999999999999999999999998433 235999999998643221
Q ss_pred ---CCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCC
Q 019901 144 ---SQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHI 219 (334)
Q Consensus 144 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (334)
.......||+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.......... .+... ...+....+
T Consensus 197 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~----~~~~~-~~~~~~~~~ 270 (327)
T 2yfx_A 197 SYYRKGGCAMLPVKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE----FVTSG-GRMDPPKNC 270 (327)
T ss_dssp -----CCGGGSCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHH----HHHTT-CCCCCCTTC
T ss_pred cccccCCCcCCCcceeCHhHhcCCCCCch-hhHHHHHHHHHHHHcCCCCCCCCcCHHHHHH----HHhcC-CCCCCCCCC
Confidence 22234568999999999988777554 999999999999998 999998765433222 22221 222334468
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
++.+.++|.+||+.+|.+|||+.++++|.|+...
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~ 304 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 304 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence 9999999999999999999999999999987543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-43 Score=316.63 Aligned_cols=236 Identities=20% Similarity=0.315 Sum_probs=191.3
Q ss_pred cceee-eeecCCCC-----eeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 4 FHNFY-DRCSYSSD-----LFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 4 ~g~~~-~~~~~~~~-----~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.++ +.+..+++ .| |+|++..... ...+.+.+|+.+++.+ +||||+++++++..++..++||||+.+|+|
T Consensus 59 ~g~Vy~~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 137 (333)
T 2i1m_A 59 FGKVVEATAFGLGKEDAVLKV-AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDL 137 (333)
T ss_dssp SEEEEEEEETTCSSSCCCCEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEH
T ss_pred CcceEEEEecCCCcccchhHH-HHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcH
Confidence 44443 66665554 56 9999976542 2346788999999999 899999999999999999999999999999
Q ss_pred HHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC
Q 019901 76 FERICNA--------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141 (334)
Q Consensus 76 ~~~l~~~--------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~ 141 (334)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 138 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~--~kl~Dfg~~~~~~ 215 (333)
T 2i1m_A 138 LNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHV--AKIGDFGLARDIM 215 (333)
T ss_dssp HHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGE--EEBCCCGGGCCGG
T ss_pred HHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCe--EEECccccccccc
Confidence 9998753 35899999999999999999999999999999999999987664 9999999997543
Q ss_pred CCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 142 LHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 142 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
.... .....+|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+............ .....+.+.
T Consensus 216 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~----~~~~~~~~~ 290 (333)
T 2i1m_A 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQ-SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVK----DGYQMAQPA 290 (333)
T ss_dssp GCTTSEECSSCEECGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHH----HTCCCCCCT
T ss_pred cccceeecCCCCCCccccCHHHhccCCCChH-HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHh----cCCCCCCCC
Confidence 3222 233457889999999988777644 999999999999998 9999987765544443332 223333344
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
..++.+.++|.+||+.+|.+|||+.+++++
T Consensus 291 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 291 FAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 579999999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=312.32 Aligned_cols=235 Identities=21% Similarity=0.333 Sum_probs=183.1
Q ss_pred cceee-eeecCCCC----eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 4 FHNFY-DRCSYSSD----LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~~-~~~~~~~~----~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.++ +.+..++. .| |||++..... .....+.+|+.+++.++||||+++++++...+..++||||+.+++|.+
T Consensus 57 ~g~Vy~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 135 (333)
T 1mqb_A 57 FGEVYKGMLKTSSGKKEVPV-AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135 (333)
T ss_dssp SSEEEEEEEEC---CCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred CeEEEEEEEecCCCCccccE-EEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHH
Confidence 34443 55554443 36 9999976542 223578899999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCC
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGT 152 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt 152 (334)
++... +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|
T Consensus 136 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~ 213 (333)
T 1mqb_A 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSGGKIP 213 (333)
T ss_dssp HHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-----------------CCC
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCc--EEECCCCcchhhccccccccccCCCCcc
Confidence 99765 56999999999999999999999999999999999999987664 99999999975433221 1223467
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
+.|+|||++.+..++.+ +|||||||++|+|++ |+.||.......... .+. .....+....+++.+.++|.+||
T Consensus 214 ~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~pf~~~~~~~~~~----~~~-~~~~~~~~~~~~~~l~~li~~~l 287 (333)
T 1mqb_A 214 IRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMK----AIN-DGFRLPTPMDCPSAIYQLMMQCW 287 (333)
T ss_dssp GGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TTCCCCCCTTCBHHHHHHHHHHT
T ss_pred ccccCchhcccCCCCch-hhhHHHHHHHHHHHcCCCCCcccCCHHHHHH----HHH-CCCcCCCcccCCHHHHHHHHHHc
Confidence 88999999988777654 999999999999998 999998765533222 222 22334445568999999999999
Q ss_pred ccCCCCCCCHhHHhcC
Q 019901 232 VADPAKRISIPEIRNH 247 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h 247 (334)
+.+|.+|||+.+++++
T Consensus 288 ~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 288 QQERARRPKFADIVSI 303 (333)
T ss_dssp CSSTTTSCCHHHHHHH
T ss_pred CCChhhCcCHHHHHHH
Confidence 9999999999999864
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=305.02 Aligned_cols=235 Identities=18% Similarity=0.173 Sum_probs=185.2
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEE-EcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+++..+|+.| |||++.... ..+.+.+|+.+++.++|++++..+..+ ..++..++||||+ +++|.+++..
T Consensus 22 ~g~V~~~~~~~~~~~v-avK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~ 97 (296)
T 3uzp_A 22 FGDIYLGTDIAAGEEV-AIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF 97 (296)
T ss_dssp TEEEEEEEETTTTEEE-EEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH
T ss_pred CeEEEEEEEcCCCcEE-EEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHh
Confidence 4444 47788899988 999987655 345799999999999998876665554 6678899999999 8999999974
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc---CCCCCCEEEeccCCccCCCCCCC--------CCCc
Q 019901 82 -AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ--------PKST 149 (334)
Q Consensus 82 -~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~---~~~~~~~kl~Dfgla~~~~~~~~--------~~~~ 149 (334)
.+.+++..++.++.|++.||.|||++||+||||||+|||++ .++ .+||+|||+++....... ....
T Consensus 98 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~--~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 3uzp_A 98 CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC--eEEEeeCCCccccccccccccccccccccc
Confidence 45799999999999999999999999999999999999994 444 499999999975433322 2455
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc---hHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE---PKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
.||+.|+|||++.+..++. ++|||||||++|+|++|+.||..... ...+............. .....+|+++.++
T Consensus 176 ~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~l 253 (296)
T 3uzp_A 176 TGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-VLCKGYPSEFATY 253 (296)
T ss_dssp CSCTTTCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-HHTTTSCHHHHHH
T ss_pred ccccccCChhhhcCCCCCc-chhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-HHHhhCCHHHHHH
Confidence 7999999999998877754 49999999999999999999986432 22232222222111110 0123578999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 019901 227 ISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~ 246 (334)
|.+||+.+|.+|||++++++
T Consensus 254 i~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 254 LNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcCcCcCCCHHHHHH
Confidence 99999999999999999875
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=313.71 Aligned_cols=226 Identities=20% Similarity=0.314 Sum_probs=183.6
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------- 83 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 83 (334)
.++..| |||++..... .....+.+|+.+++.+ +||||+++++++...+.+++||||+.+++|.+++....
T Consensus 65 ~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 143 (334)
T 2pvf_A 65 KEAVTV-AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 143 (334)
T ss_dssp ---CEE-EEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSC
T ss_pred ccceEE-EEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhcccccccc
Confidence 355667 9999976542 2235788999999999 89999999999999999999999999999999998654
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccC
Q 019901 84 ---------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVG 151 (334)
Q Consensus 84 ---------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~g 151 (334)
.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+
T Consensus 144 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~ 221 (334)
T 2pvf_A 144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNV--MKIADFGLARDINNIDYYKKTTNGRL 221 (334)
T ss_dssp C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECTTTSSEECCSCCCC
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCC--EEEccccccccccccccccccCCCCc
Confidence 3899999999999999999999999999999999999987664 9999999997543322 1233457
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +.. ....+....+++.+.++|.+|
T Consensus 222 ~~~y~aPE~~~~~~~~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~l~~li~~~ 295 (334)
T 2pvf_A 222 PVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL----LKE-GHRMDKPANCTNELYMMMRDC 295 (334)
T ss_dssp CGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHH-TCCCCCCTTCCHHHHHHHHHH
T ss_pred ccceeChHHhcCCCcChH-HHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH----Hhc-CCCCCCCccCCHHHHHHHHHH
Confidence 889999999988777554 999999999999999 9999987654332222 111 122233456899999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 019901 231 FVADPAKRISIPEIRNH 247 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h 247 (334)
|+.+|.+|||+.+++++
T Consensus 296 l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 296 WHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-43 Score=316.99 Aligned_cols=241 Identities=20% Similarity=0.238 Sum_probs=184.8
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 82 (334)
||.++.....+|..| |||++..... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++...
T Consensus 43 ~g~V~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 121 (326)
T 3uim_A 43 FGKVYKGRLADGTLV-AVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRER 121 (326)
T ss_dssp SSEEEEECCSSSCCE-EEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCC
T ss_pred CcEEEEEEecCCCEE-EEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhc
Confidence 344443334567888 9999987652 23347899999999999999999999999999999999999999999999864
Q ss_pred C----CCCHHHHHHHHHHHHHHHHHHHHC---CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 83 G----RFSEDEARFFFQQLISGVSYCHSM---QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 83 ~----~~~~~~~~~~~~qil~~L~~LH~~---~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
. .+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++....... .....||+
T Consensus 122 ~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~gt~ 199 (326)
T 3uim_A 122 PESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE--AVVGDFGLAKLMDYKDTHVTTAVRGTI 199 (326)
T ss_dssp STTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC--EEECCCSSCEECCSSSSCEECCCCSCG
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC--EEeccCccccccCcccccccccccCCc
Confidence 3 399999999999999999999999 9999999999999987664 99999999975433222 23345999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC----CCchHHHHHHHHHHhhccccCCC----------CCCC
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED----PEEPKNFRKTIHRILSVQYSIPD----------YVHI 219 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~----~~~~~~~~~~~~~~~~~~~~~~~----------~~~~ 219 (334)
.|+|||++.+..++.+ +|||||||++|+|++|+.||.. .................. .... ....
T Consensus 200 ~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~ 277 (326)
T 3uim_A 200 GHIAPEYLSTGKSSEK-TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK-KLEALVDVDLQGNYKDEE 277 (326)
T ss_dssp GGCCHHHHHHSEECHH-HHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSC-CSTTSSCTTCTTSCCHHH
T ss_pred CccCHHHhccCCCCcc-ccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhch-hhhhhcChhhccccCHHH
Confidence 9999999988777554 9999999999999999999952 111111111111111100 0000 1112
Q ss_pred CHHHHHHHHHhcccCCCCCCCHhHHhcCcc
Q 019901 220 SPECRHLISRIFVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 220 ~~~~~~li~~~L~~~p~~R~s~~ell~h~~ 249 (334)
+..+.+++.+||+.+|.+|||+.++++|..
T Consensus 278 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 278 VEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 477999999999999999999999998754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=303.88 Aligned_cols=232 Identities=19% Similarity=0.298 Sum_probs=186.6
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 83 (334)
+|.++.....++..| |||++.... ...+.+.+|+.+++.++||||+++++++. .+..++||||+.+++|.+++....
T Consensus 26 ~g~Vy~~~~~~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~ 102 (279)
T 1qpc_A 26 FGEVWMGYYNGHTKV-AVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPS 102 (279)
T ss_dssp TEEEEEEEETTTEEE-EEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHH
T ss_pred CeEEEEEEEcCCcEE-EEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCC
Confidence 444443333455566 999998765 45678999999999999999999999986 456899999999999999987543
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccch
Q 019901 84 --RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPE 159 (334)
Q Consensus 84 --~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE 159 (334)
.+++..+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++...... ......+++.|+|||
T Consensus 103 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE 180 (279)
T 1qpc_A 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180 (279)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCC--EEECCCcccccccCcccccccCCCCccCccChh
Confidence 6999999999999999999999999999999999999987654 9999999997543322 123345788999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
++.+..++.+ +||||||+++|+|++ |+.||.+......... +. .....+....+++++.++|.+||+.+|.+|
T Consensus 181 ~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~l~~li~~~l~~~p~~R 254 (279)
T 1qpc_A 181 AINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LE-RGYRMVRPDNCPEELYQLMRLCWKERPEDR 254 (279)
T ss_dssp HHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred hhccCCCCch-hhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH----Hh-cccCCCCcccccHHHHHHHHHHhccChhhC
Confidence 9987777544 999999999999999 9999987665433222 21 222333345689999999999999999999
Q ss_pred CCHhHHhc
Q 019901 239 ISIPEIRN 246 (334)
Q Consensus 239 ~s~~ell~ 246 (334)
||+.++++
T Consensus 255 ps~~~l~~ 262 (279)
T 1qpc_A 255 PTFDYLRS 262 (279)
T ss_dssp CCHHHHHH
T ss_pred CCHHHHHH
Confidence 99999875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=306.35 Aligned_cols=227 Identities=24% Similarity=0.309 Sum_probs=184.5
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHH
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEA 90 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~ 90 (334)
.++..| |||++..... ...+.+.+|+.+++.++||||+++++++ ..+..++||||+.+++|.+++... ..+++..+
T Consensus 35 ~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 112 (287)
T 1u59_A 35 KKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV 112 (287)
T ss_dssp -CCEEE-EEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHH
T ss_pred CCcceE-EEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHH
Confidence 456667 9999987541 2346788999999999999999999999 456689999999999999998654 45999999
Q ss_pred HHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhccCCC
Q 019901 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLKKEY 166 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~ 166 (334)
+.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..+
T Consensus 113 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 190 (287)
T 1u59_A 113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190 (287)
T ss_dssp HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCC--EEECcccceeeeccCcceeeccccccccccccCHHHhccCCC
Confidence 999999999999999999999999999999987664 9999999997543222 1233456889999999987777
Q ss_pred CCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 167 DGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 167 ~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
+.+ +|||||||++|+|++ |+.||........... +.. ....+.+..+++++.++|.+||+.+|.+|||+.+++
T Consensus 191 ~~~-~Di~slG~il~ellt~g~~p~~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~ 264 (287)
T 1u59_A 191 SSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 264 (287)
T ss_dssp CHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHH
T ss_pred Cch-hhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH----Hhc-CCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHH
Confidence 554 999999999999998 9999987765433222 222 122233446899999999999999999999999999
Q ss_pred cCcc
Q 019901 246 NHEW 249 (334)
Q Consensus 246 ~h~~ 249 (334)
++.+
T Consensus 265 ~~l~ 268 (287)
T 1u59_A 265 QRMR 268 (287)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-43 Score=313.36 Aligned_cols=228 Identities=20% Similarity=0.349 Sum_probs=186.1
Q ss_pred cCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCC-eEEEEEeccCCCChHHHHHhcCC----
Q 019901 12 SYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPT-HLAIVMEYASGGELFERICNAGR---- 84 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---- 84 (334)
..+++.| |||++..... ...+.+.+|+.+++.+ +||||+++++++...+ .+++||||+.+++|.+++.....
T Consensus 54 ~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 132 (316)
T 2xir_A 54 TATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 132 (316)
T ss_dssp TTCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEEC
T ss_pred cccceEE-EEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccc
Confidence 3566777 9999987542 2235788999999999 7899999999987654 59999999999999999987654
Q ss_pred ------------CCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 85 ------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 85 ------------~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... ....
T Consensus 133 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 210 (316)
T 2xir_A 133 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICDFGLARDIYKDPDYVRKGDA 210 (316)
T ss_dssp C-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCGGGSCTTTCTTSEEETTE
T ss_pred ccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCC--EEECCCccccccccCccceeccCC
Confidence 899999999999999999999999999999999999986664 99999999975433222 2234
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+..........+.. ....+....+++.+.++|.
T Consensus 211 ~~t~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~li~ 285 (316)
T 2xir_A 211 RLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE----GTRMRAPDYTTPEMYQTML 285 (316)
T ss_dssp EECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH----TCCCCCCTTCCHHHHHHHH
T ss_pred CcceeecCchhhccccccch-hHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhcc----CccCCCCCCCCHHHHHHHH
Confidence 57889999999988877654 999999999999998 99999877654444333222 1222333457999999999
Q ss_pred HhcccCCCCCCCHhHHhcC
Q 019901 229 RIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h 247 (334)
+||+.+|.+|||+.++++|
T Consensus 286 ~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 286 DCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCChhhCcCHHHHHHH
Confidence 9999999999999999976
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.25 Aligned_cols=226 Identities=18% Similarity=0.224 Sum_probs=184.9
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc---------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--------- 82 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------- 82 (334)
.++..| |||++..... .....+.+|+.+++.++||||+++++++..++..++||||+.+++|.+++...
T Consensus 53 ~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 131 (322)
T 1p4o_A 53 EPETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPV 131 (322)
T ss_dssp EEEEEE-EEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTT
T ss_pred CCceEE-EEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCC
Confidence 356677 9999976542 23356889999999999999999999999999999999999999999998753
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccc
Q 019901 83 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAP 158 (334)
Q Consensus 83 -~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aP 158 (334)
..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+||
T Consensus 132 ~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 209 (322)
T 1p4o_A 132 LAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 209 (322)
T ss_dssp CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCH
T ss_pred CCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCe--EEECcCccccccccccccccccCCCCCCCccCh
Confidence 35799999999999999999999999999999999999987664 99999999875432221 2234578999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
|++.+..++.+ +|||||||++|+|++ |..||.+......... +.... ..+....+++.+.++|.+||+.+|.+
T Consensus 210 E~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~ 283 (322)
T 1p4o_A 210 ESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEGG-LLDKPDNCPDMLFELMRMCWQYNPKM 283 (322)
T ss_dssp HHHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGG
T ss_pred hhhccCCCCch-hhHHHHHHHHHHHHhcCCCccccCCHHHHHHH----HHcCC-cCCCCCCCCHHHHHHHHHHcCCCccc
Confidence 99988777554 999999999999999 8999987655333222 22222 22334468999999999999999999
Q ss_pred CCCHhHHhcC
Q 019901 238 RISIPEIRNH 247 (334)
Q Consensus 238 R~s~~ell~h 247 (334)
|||+.++++|
T Consensus 284 Rps~~e~l~~ 293 (322)
T 1p4o_A 284 RPSFLEIISS 293 (322)
T ss_dssp SCCHHHHHHH
T ss_pred CcCHHHHHHH
Confidence 9999999976
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=310.71 Aligned_cols=232 Identities=24% Similarity=0.333 Sum_probs=185.1
Q ss_pred eecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCCChHHHHHhcCCCC
Q 019901 10 RCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGGELFERICNAGRFS 86 (334)
Q Consensus 10 ~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~ 86 (334)
.+..+++.| |||++..... ...+.+.+|+.+++.++||||+++++++.. ...+++||||+++++|.+++.+. .++
T Consensus 55 ~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~ 132 (318)
T 3lxp_A 55 TNDGTGEMV-AVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIG 132 (318)
T ss_dssp CC--CCEEE-EEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCC
T ss_pred CCCCCCcEE-EEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCC
Confidence 355577888 9999987641 234678999999999999999999999987 46899999999999999998765 499
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhc
Q 019901 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLL 162 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~ 162 (334)
+..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.
T Consensus 133 ~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 210 (318)
T 3lxp_A 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRL--VKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 210 (318)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCC--EEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence 9999999999999999999999999999999999987664 9999999997544332 123446888999999998
Q ss_pred cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch----------HHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 163 KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP----------KNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 163 ~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+..++.+ +|||||||++|+|++|+.||...... ......+..........+....+++++.+||.+||+
T Consensus 211 ~~~~~~~-~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 289 (318)
T 3lxp_A 211 EYKFYYA-SDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWE 289 (318)
T ss_dssp HCEEEHH-HHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCCCcH-HHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcC
Confidence 8777644 99999999999999999999753211 011111222223333445556789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 290 ~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 290 TEASFRPTFENLIP 303 (318)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CCcccCcCHHHHHH
Confidence 99999999999984
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=306.88 Aligned_cols=235 Identities=18% Similarity=0.174 Sum_probs=183.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEE-EcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVI-LTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
+|.+ .+++..+++.| |||++.... ....+.+|+.+++.++|++++..+..+ ..++..++||||+ +++|.+++..
T Consensus 22 ~g~V~~~~~~~~~~~v-avK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~ 97 (296)
T 4hgt_A 22 FGDIYLGTDIAAGEEV-AIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNF 97 (296)
T ss_dssp SSEEEEEEETTTTEEE-EEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH
T ss_pred CeEEEEEEEcCCCceE-EEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHH
Confidence 3444 47788889988 999976654 345689999999999988877766554 6778899999999 9999999875
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEE---cCCCCCCEEEeccCCccCCCCCC--------CCCCc
Q 019901 82 -AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHS--------QPKST 149 (334)
Q Consensus 82 -~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli---~~~~~~~~kl~Dfgla~~~~~~~--------~~~~~ 149 (334)
.+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++ .+||+|||+++...... .....
T Consensus 98 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~--~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 4hgt_A 98 CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN--LVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC--eEEEecCccceeccCcccCccCCCCccccc
Confidence 4569999999999999999999999999999999999999 5544 49999999997543322 22355
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch---HHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP---KNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
.||+.|+|||++.+..++. ++|||||||++|+|++|+.||.+.... ............... ......+|+++.++
T Consensus 176 ~gt~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l 253 (296)
T 4hgt_A 176 TGTARYASINTHLGIEQSR-RDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-EVLCKGYPSEFATY 253 (296)
T ss_dssp CSCGGGCCHHHHTTCCCCH-HHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-HHHTTTSCHHHHHH
T ss_pred CCCccccchHHhcCCCCCc-hhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh-hhhhccCCHHHHHH
Confidence 7999999999998887754 499999999999999999999865432 222222222111111 00123578999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 019901 227 ISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~ 246 (334)
|.+||+.+|.+|||++++++
T Consensus 254 i~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 254 LNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHHhcCCCCCCCHHHHHH
Confidence 99999999999999999875
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=314.42 Aligned_cols=238 Identities=23% Similarity=0.324 Sum_probs=177.7
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHc--CCCCCcccceEEEEc----CCeEEEEEeccCCC
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRS--LRHPNIVRFKEVILT----PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~ 73 (334)
||.|+| +.+...+|+.| |||++.... .....+|.+++.. ++||||+++++++.. ...+++||||+++|
T Consensus 16 lg~G~~g~V~~~~~~~~~v-avK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g 91 (301)
T 3q4u_A 16 VGKGRYGEVWRGSWQGENV-AVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMG 91 (301)
T ss_dssp EEECSSEEEEEEEETTEEE-EEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTC
T ss_pred eccCCCcEEEEEEECCEEE-EEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCC
Confidence 455554 23334478888 999986543 3455566666655 899999999998654 35689999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ 145 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH--------~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~ 145 (334)
+|.+++.. ..+++..++.++.|++.||.||| ++||+||||||+|||++.++. +||+|||+|+.......
T Consensus 92 ~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~~~~~~~ 168 (301)
T 3q4u_A 92 SLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQ--CCIADLGLAVMHSQSTN 168 (301)
T ss_dssp BHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTT
T ss_pred CHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCC--EEEeeCCCeeecccccc
Confidence 99999954 57999999999999999999999 999999999999999987664 99999999864322221
Q ss_pred -----CCCccCCCccccchhhccCCCC-----CccchhhhhhHHHHHHHhC----------CCCCCCCCchHHHHHHHHH
Q 019901 146 -----PKSTVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHR 205 (334)
Q Consensus 146 -----~~~~~gt~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~ 205 (334)
.....||+.|+|||++.+.... +.++|||||||++|+|++| ..||...............
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~ 248 (301)
T 3q4u_A 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRK 248 (301)
T ss_dssp EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHH
T ss_pred cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhH
Confidence 2344799999999999776322 2458999999999999999 8898654332211222222
Q ss_pred HhhccccCCCC------CCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 206 ILSVQYSIPDY------VHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 206 ~~~~~~~~~~~------~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
........+.. ...++.+.++|.+||+.+|.+|||+.++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 249 VVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22221111111 124578999999999999999999999985
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.26 Aligned_cols=249 Identities=27% Similarity=0.342 Sum_probs=195.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEc------CCeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILT------PTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~~~~~lv~e~~ 70 (334)
||.|+| .+.+..+|..| |||++.... ....+.+.+|+.+++.++||||+++++++.. ++..++|||||
T Consensus 22 LG~G~fG~Vyla~~~~tg~~V-AVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~ 100 (676)
T 3qa8_A 22 LGTGGFGYVLRWIHQDTGEQV-AIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYC 100 (676)
T ss_dssp CCBCSSSBCCCCCCTTTTCCE-EECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECC
T ss_pred EeeCCCeEEEEEEECCCCcEE-EEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeC
Confidence 666666 37788889998 999987653 1234678899999999999999999998765 67789999999
Q ss_pred CCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC-CCEEEeccCCccCCCCCCCC
Q 019901 71 SGGELFERICNAG---RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA-PRLKICDFGYSKSSVLHSQP 146 (334)
Q Consensus 71 ~~~~L~~~l~~~~---~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~-~~~kl~Dfgla~~~~~~~~~ 146 (334)
+||+|.+++.... .+++..++.++.|++.||.|||++||+||||||+|||++.++. ..+||+|||+++........
T Consensus 101 ~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~ 180 (676)
T 3qa8_A 101 EGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELC 180 (676)
T ss_dssp SSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCC
T ss_pred CCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccccc
Confidence 9999999998754 5999999999999999999999999999999999999986543 24899999999876655555
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHH-----HHH-----hhccc----c
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI-----HRI-----LSVQY----S 212 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~-----~~~-----~~~~~----~ 212 (334)
....||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+......+.... ... ..... .
T Consensus 181 ~~~~gt~~Y~APE~l~~~~~s~k-sDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~ 259 (676)
T 3qa8_A 181 TEFVGTLQYLAPELLEQKKYTVT-VDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSV 259 (676)
T ss_dssp CCCCSCCTTCSSCSSCCSCCSTT-HHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSS
T ss_pred ccccCCcccCChHHhccCCCCch-hHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccc
Confidence 66789999999999988877655 999999999999999999997643221110000 000 00000 1
Q ss_pred CCCC----CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 213 IPDY----VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 213 ~~~~----~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+.+ ..+++.+.+||.+||..||.+|||++++++||||..
T Consensus 260 lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 260 LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp SCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred cCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 1111 125688999999999999999999999999999975
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=325.58 Aligned_cols=233 Identities=22% Similarity=0.329 Sum_probs=184.6
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| + +.+. .+..| |||++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+.+|+|.+
T Consensus 192 lG~G~fg~Vy~~~~~-~~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~ 267 (452)
T 1fmk_A 192 LGQGCFGEVWMGTWN-GTTRV-AIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 267 (452)
T ss_dssp EEECSSCEEEEEEET-TTEEE-EEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred ecCCCCeEEEEEEEC-CCceE-EEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence 444444 3 4433 34456 999998765 445789999999999999999999999866 67899999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~ 153 (334)
++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+++
T Consensus 268 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~ 345 (452)
T 1fmk_A 268 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 345 (452)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCG
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCC--EEECCCccceecCCCceecccCCcccc
Confidence 99743 56999999999999999999999999999999999999987654 9999999998543222 122345678
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
.|+|||++.+..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..+++.+.++|.+||+
T Consensus 346 ~y~aPE~~~~~~~~~~-sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~ 419 (452)
T 1fmk_A 346 KWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLHDLMCQCWR 419 (452)
T ss_dssp GGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTSCHHHHHHHHHHTC
T ss_pred cccCHhHHhcCCCCcc-ccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 9999999988877655 999999999999999 9999987665433322 2 2233444455789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||++++++
T Consensus 420 ~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 420 KEPEERPTFEYLQA 433 (452)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999885
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=309.28 Aligned_cols=223 Identities=32% Similarity=0.546 Sum_probs=174.0
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHH-HcCCCCCcccceEEEEc----CCeEEEEEeccCCCChHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINH-RSLRHPNIVRFKEVILT----PTHLAIVMEYASGGELFE 77 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~~~L~~ 77 (334)
+|.+ .+.++.+++.| |||++.. .....+|+.++ +.++||||+++++++.. .+.+++||||+.+++|.+
T Consensus 31 ~g~V~~~~~~~~~~~v-aiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 104 (299)
T 3m2w_A 31 NGKVLQIFNKRTQEKF-ALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFS 104 (299)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHH
T ss_pred CeEEEEEEEcCCCcEE-EEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHH
Confidence 3444 47888899999 9999853 45678899988 66799999999999886 678999999999999999
Q ss_pred HHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 78 RICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 78 ~l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
++...+ .+++..++.++.|++.||.|||++||+||||||+|||++..+ .+.+||+|||++....
T Consensus 105 ~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~------------- 171 (299)
T 3m2w_A 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT------------- 171 (299)
T ss_dssp HHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-------------
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-------------
Confidence 998764 699999999999999999999999999999999999998632 3459999999886421
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFV 232 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~ 232 (334)
+..++ .++|||||||++|+|++|+.||.+.............+.......+ .+..+++++.+||.+||+
T Consensus 172 --------~~~~~-~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 242 (299)
T 3m2w_A 172 --------GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLK 242 (299)
T ss_dssp --------TCGGG-GHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTC
T ss_pred --------cccCC-chhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcc
Confidence 12343 4499999999999999999999765432111000001111111111 124579999999999999
Q ss_pred cCCCCCCCHhHHhcCccccccC
Q 019901 233 ADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 233 ~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.+|.+|||++++++||||.+..
T Consensus 243 ~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 243 TEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SSTTTSCCHHHHHTSHHHHTGG
T ss_pred cChhhCCCHHHHhcChhhcccc
Confidence 9999999999999999997754
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=309.35 Aligned_cols=241 Identities=22% Similarity=0.307 Sum_probs=187.4
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCc----ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHL----WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~----~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ +.+...++..| |||++.... ....+.+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus 39 lg~G~~g~Vy~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 117 (307)
T 2nru_A 39 MGEGGFGVVYKGYVNNTTV-AVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSL 117 (307)
T ss_dssp EEECSSEEEEEEESSSCEE-EEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred cccCCCeEEEEEEECCceE-EEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcH
Confidence 455555 23334477888 999997643 12346789999999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 76 FERICN---AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 76 ~~~l~~---~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
.+++.. ..++++..++.++.|++.||.|||++||+||||||+||+++.++. +||+|||+++....... ....
T Consensus 118 ~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~ 195 (307)
T 2nru_A 118 LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFT--AKISDFGLARASEKFAQTVMTSRI 195 (307)
T ss_dssp HHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECCSCSSCEECSSC
T ss_pred HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCc--EEEeeccccccccccccccccccc
Confidence 999874 346999999999999999999999999999999999999987664 99999999875433221 2345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--------cC-CCCCCCC
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------SI-PDYVHIS 220 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------~~-~~~~~~~ 220 (334)
.||+.|+|||++.+. ++. ++||||||+++|+|++|..||..................... .. +.....+
T Consensus 196 ~g~~~y~aPE~~~~~-~~~-~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (307)
T 2nru_A 196 VGTTAYMAPEALRGE-ITP-KSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSV 273 (307)
T ss_dssp CSCGGGCCHHHHTTE-ECT-HHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHH
T ss_pred CCCcCcCChHHhcCC-CCc-cchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHH
Confidence 799999999998654 544 499999999999999999999876543322222222211111 00 1111235
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
..+.+++.+||+.+|.+|||+.+++++
T Consensus 274 ~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 274 EAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 678999999999999999999999864
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=308.06 Aligned_cols=237 Identities=20% Similarity=0.304 Sum_probs=179.9
Q ss_pred CCccee---e-eeecC---CCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcCC-----eEEEEE
Q 019901 2 LGFHNF---Y-DRCSY---SSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVM 67 (334)
Q Consensus 2 lG~g~~---~-~~~~~---~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~ 67 (334)
||.|++ + +.... ++..| |||++...... ..+.+.+|+.+++.++||||+++++++...+ ..++||
T Consensus 42 lg~G~~g~V~~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~ 120 (313)
T 3brb_A 42 LGEGEFGSVMEGNLKQEDGTSLKV-AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVIL 120 (313)
T ss_dssp EEC-CCCCEEEEEEECTTSCEEEE-EEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEE
T ss_pred eeecCCeEEEEEEEeccCCceeEE-EEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEE
Confidence 455554 3 44443 44467 99999766422 2356889999999999999999999998754 359999
Q ss_pred eccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCC
Q 019901 68 EYASGGELFERICN------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141 (334)
Q Consensus 68 e~~~~~~L~~~l~~------~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~ 141 (334)
||+.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...
T Consensus 121 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kl~Dfg~~~~~~ 198 (313)
T 3brb_A 121 PFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMT--VCVADFGLSKKIY 198 (313)
T ss_dssp ECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSC--EEECSCSCC----
T ss_pred ecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEEeecCcceecc
Confidence 99999999999843 356999999999999999999999999999999999999987664 9999999987543
Q ss_pred CCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 142 LHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 142 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
... ......+++.|+|||++.+..++.+ +|||||||++|+|++ |..||............. . ....+...
T Consensus 199 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~----~-~~~~~~~~ 272 (313)
T 3brb_A 199 SGDYYRQGRIAKMPVKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL----H-GHRLKQPE 272 (313)
T ss_dssp ------------CCGGGSCHHHHHSSCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH----T-TCCCCCBT
T ss_pred cccccCcccccCCCccccCchhhcCCCccch-hhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH----c-CCCCCCCc
Confidence 322 1233457889999999988777655 999999999999999 999998876644333221 1 12233345
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.+++.+.++|.+||..+|.+|||+.+++++
T Consensus 273 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 273 DCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 689999999999999999999999999864
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-42 Score=304.27 Aligned_cols=221 Identities=21% Similarity=0.283 Sum_probs=179.3
Q ss_pred eeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHH
Q 019901 17 LFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFF 94 (334)
Q Consensus 17 ~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~ 94 (334)
.| |||++.... ....+.+.+|+.+++.++||||+++++++..+ ..++||||+.+++|.+++.+. ..+++..+..++
T Consensus 42 ~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 119 (281)
T 3cc6_A 42 NV-AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119 (281)
T ss_dssp EE-EEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHH
T ss_pred eE-EEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHH
Confidence 46 999998764 23346789999999999999999999998654 568999999999999999765 459999999999
Q ss_pred HHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCccccchhhccCCCCCccch
Q 019901 95 QQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPAYIAPEVLLKKEYDGKIAD 172 (334)
Q Consensus 95 ~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~D 172 (334)
.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..++.+ +|
T Consensus 120 ~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~D 196 (281)
T 3cc6_A 120 LQICKAMAYLESINCVHRDIAVRNILVASPEC--VKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA-SD 196 (281)
T ss_dssp HHHHHHHHHHHHTTCCCCCCSGGGEEEEETTE--EEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHH-HH
T ss_pred HHHHHHHHHHHHCCcccCCCccceEEECCCCc--EEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCch-hc
Confidence 99999999999999999999999999987664 99999999875433221 233457889999999987777554 99
Q ss_pred hhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 173 VWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 173 iwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
|||||+++|+|++ |+.||............ . .....+....+++.+.++|.+||+.+|.+|||+.+++++
T Consensus 197 i~slG~il~~llt~g~~p~~~~~~~~~~~~~-~----~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 197 VWMFAVCMWEILSFGKQPFFWLENKDVIGVL-E----KGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHHHHHHTTTCCTTTTSCGGGHHHHH-H----HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHHhCCCCCcccCChHHHHHHH-h----cCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 9999999999998 99999876654433221 1 122333445689999999999999999999999999865
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.54 Aligned_cols=228 Identities=21% Similarity=0.379 Sum_probs=173.5
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHc--CCCCCcccceEEEEcC----CeEEEEEeccCCCChHHHHHhcCCCC
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRS--LRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAGRFS 86 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~ 86 (334)
.+|..| |||++.... .....+|..++.. ++||||+++++++... +..++||||+.+|+|.+++... .++
T Consensus 58 ~~~~~v-avK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~ 132 (337)
T 3mdy_A 58 WRGEKV-AVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLD 132 (337)
T ss_dssp ETTEEE-EEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBC
T ss_pred ECCceE-EEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCC
Confidence 447777 999986544 3445556666555 4899999999999877 7899999999999999999664 699
Q ss_pred HHHHHHHHHHHHHHHHHHHHC--------CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----CCCccCCC
Q 019901 87 EDEARFFFQQLISGVSYCHSM--------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PKSTVGTP 153 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH~~--------~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~~~~~gt~ 153 (334)
+..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+++....... .....||+
T Consensus 133 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~ 210 (337)
T 3mdy_A 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVKFISDTNEVDIPPNTRVGTK 210 (337)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSC--EEECCCTTCEECC---------CCSSCSCG
T ss_pred HHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCC--EEEEeCCCceeeccccccccCCCCCCccCc
Confidence 999999999999999999998 9999999999999987664 99999999965433222 23457999
Q ss_pred ccccchhhccCCCCCc-----cchhhhhhHHHHHHHhC----------CCCCCCCCchHHHHHHHHHHhhccc---cCCC
Q 019901 154 AYIAPEVLLKKEYDGK-----IADVWSCGVTLYVMLVG----------AYPFEDPEEPKNFRKTIHRILSVQY---SIPD 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~-----~~DiwslG~il~~l~~g----------~~pf~~~~~~~~~~~~~~~~~~~~~---~~~~ 215 (334)
.|+|||++.+...... ++|||||||++|+|++| ..||..................... ..+.
T Consensus 211 ~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (337)
T 3mdy_A 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPN 290 (337)
T ss_dssp GGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred ceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccc
Confidence 9999999987665443 38999999999999999 7777654322211122222221111 1111
Q ss_pred ---CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 216 ---YVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 216 ---~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
...+++++.++|.+||+.+|.+|||+.++++|
T Consensus 291 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 291 RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11346779999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=303.40 Aligned_cols=236 Identities=24% Similarity=0.348 Sum_probs=184.8
Q ss_pred CCccee---e-eeecCCCC---eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeE-EEEEeccCC
Q 019901 2 LGFHNF---Y-DRCSYSSD---LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHL-AIVMEYASG 72 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~---~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~-~lv~e~~~~ 72 (334)
||.|++ + +.+..++. .+ |+|++..... ...+.+.+|+.+++.++||||+++++++.+.+.. ++||||+.+
T Consensus 29 lg~G~~g~Vy~~~~~~~~~~~~~~-aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~ 107 (298)
T 3pls_A 29 IGKGHFGVVYHGEYIDQAQNRIQC-AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCH 107 (298)
T ss_dssp EEEETTEEEEEEEEECSSSCEEEE-EEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTT
T ss_pred eccCCCceEEEEEEecCCCceeee-eeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccC
Confidence 444444 3 55444443 56 9999876441 2346788999999999999999999999876654 999999999
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-----CCC
Q 019901 73 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQP 146 (334)
Q Consensus 73 ~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-----~~~ 146 (334)
++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++..... ...
T Consensus 108 ~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~~ 185 (298)
T 3pls_A 108 GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFT--VKVADFGLARDILDREYYSVQQH 185 (298)
T ss_dssp CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECCTTSSCTTTTGGGGCSCCS
T ss_pred CCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCc--EEeCcCCCcccccCCcccccccC
Confidence 999999976 456899999999999999999999999999999999999987664 999999999743221 223
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
....+|+.|+|||++.+..++.+ +|||||||++|+|++|. +||..... ......+. .....+....+++.+.+
T Consensus 186 ~~~~~~~~y~aPE~~~~~~~~~~-~Di~slG~il~~l~~g~~~~~~~~~~-~~~~~~~~----~~~~~~~~~~~~~~l~~ 259 (298)
T 3pls_A 186 RHARLPVKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDP-FDLTHFLA----QGRRLPQPEYCPDSLYQ 259 (298)
T ss_dssp SCTTCGGGGSCHHHHTTCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCG-GGHHHHHH----TTCCCCCCTTCCHHHHH
T ss_pred cCCCCCccccChhhhccCCCChh-hchhhHHHHHHHHhhCCCCCCccCCH-HHHHHHhh----cCCCCCCCccchHHHHH
Confidence 34567889999999988777654 99999999999999955 55554443 33322221 22233444568999999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 019901 226 LISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~ 246 (334)
+|.+||+.+|.+|||+.++++
T Consensus 260 li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 260 VMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCChhhCcCHHHHHH
Confidence 999999999999999999885
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=305.66 Aligned_cols=221 Identities=24% Similarity=0.374 Sum_probs=175.9
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC-CeEEEEEeccCCCChHHHHHhcCC--CCHHH
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR--FSEDE 89 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~ 89 (334)
.+|..| |||++.... ..+.+.+|+.+++.++||||+++++++... +..++||||+.+++|.+++.+.+. +++..
T Consensus 42 ~~~~~v-avK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 118 (278)
T 1byg_A 42 YRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC 118 (278)
T ss_dssp ETTEEE-EEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHH
T ss_pred EcCCEE-EEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHH
Confidence 457777 999987554 457899999999999999999999987654 578999999999999999976543 89999
Q ss_pred HHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCc
Q 019901 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 169 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 169 (334)
+..++.|++.||.|||++||+||||||+||+++.++. +||+|||+++..... .....+++.|+|||++.+..++.+
T Consensus 119 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~--~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~ 194 (278)
T 1byg_A 119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTK 194 (278)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCc--EEEeecccccccccc--ccCCCccccccCHHHhCCCCCCch
Confidence 9999999999999999999999999999999987664 999999998754322 234467899999999988777554
Q ss_pred cchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 170 IADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 170 ~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+||||||+++|+|++ |+.||........... + ......+....+++.+.++|.+||+.+|.+|||+.++++
T Consensus 195 -~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~----~-~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 195 -SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----V-EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -HHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----H-TTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -hcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-hcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 999999999999998 9999987665433222 2 122233344568999999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=309.69 Aligned_cols=232 Identities=22% Similarity=0.317 Sum_probs=185.2
Q ss_pred ecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC--eEEEEEeccCCCChHHHHHhc-CCCCH
Q 019901 11 CSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT--HLAIVMEYASGGELFERICNA-GRFSE 87 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~ 87 (334)
+..+|..| |||++........+.+.+|+.+++.++||||+++++++...+ .+++||||+++++|.+++.+. ..+++
T Consensus 66 ~~~~~~~v-avK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~ 144 (326)
T 2w1i_A 66 QDNTGEVV-AVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144 (326)
T ss_dssp SSSCCEEE-EEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCH
T ss_pred cCCCceEE-EEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCH
Confidence 45677787 999998765444568999999999999999999999987654 789999999999999999876 45999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~ 163 (334)
..++.++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+++.|+|||++.+
T Consensus 145 ~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~ 222 (326)
T 2w1i_A 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENR--VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 222 (326)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCc--EEEecCcchhhccccccccccccCCCCceeEECchhhcC
Confidence 999999999999999999999999999999999987664 99999999975433321 223457788999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHhCCCCCCCCCc-----------hHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 164 KEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE-----------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
..++. ++|||||||++|+|++|..||..... .......+..........+....+++++.++|.+||+
T Consensus 223 ~~~~~-~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 301 (326)
T 2w1i_A 223 SKFSV-ASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWN 301 (326)
T ss_dssp CEEEH-HHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSC
T ss_pred CCCCc-hhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcC
Confidence 77754 49999999999999999999864211 0111111222222233344556789999999999999
Q ss_pred cCCCCCCCHhHHhc
Q 019901 233 ADPAKRISIPEIRN 246 (334)
Q Consensus 233 ~~p~~R~s~~ell~ 246 (334)
.+|.+|||+.++++
T Consensus 302 ~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 302 NNVNQRPSFRDLAL 315 (326)
T ss_dssp SSGGGSCCHHHHHH
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=312.98 Aligned_cols=234 Identities=26% Similarity=0.408 Sum_probs=171.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEE--------cCCeEEEEEeccCCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVIL--------TPTHLAIVMEYASGG 73 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~--------~~~~~~lv~e~~~~~ 73 (334)
||.+ .+++..+++.| |||++........+.+.+|+.+++.+. ||||+++++++. ....+++||||+. |
T Consensus 41 ~g~V~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g 118 (337)
T 3ll6_A 41 FAFVYEAQDVGSGREY-ALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-G 118 (337)
T ss_dssp SEEEEEEEETTTCCEE-EEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-E
T ss_pred ceEEEEEEECCCCcEE-EEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-C
Confidence 3434 47788899999 999987765445578899999999996 999999999984 3446899999995 7
Q ss_pred ChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---
Q 019901 74 ELFERICN---AGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--- 145 (334)
Q Consensus 74 ~L~~~l~~---~~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--- 145 (334)
+|.+++.. .+++++..++.++.||+.||.|||++| |+||||||+|||++.++. +||+|||+++.......
T Consensus 119 ~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~--~kl~Dfg~~~~~~~~~~~~~ 196 (337)
T 3ll6_A 119 QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT--IKLCDFGSATTISHYPDYSW 196 (337)
T ss_dssp EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC--EEBCCCTTCBCCSSCC----
T ss_pred CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC--EEEecCccceeccccCcccc
Confidence 89888765 466999999999999999999999999 999999999999987664 99999999975433221
Q ss_pred ----------CCCccCCCccccchhh---ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc
Q 019901 146 ----------PKSTVGTPAYIAPEVL---LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212 (334)
Q Consensus 146 ----------~~~~~gt~~y~aPE~~---~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 212 (334)
.....||+.|+|||++ .+..+ +.++|||||||++|+|++|+.||....... .......
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~--------~~~~~~~ 267 (337)
T 3ll6_A 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLR--------IVNGKYS 267 (337)
T ss_dssp ---------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------------------CC
T ss_pred cccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHH--------hhcCccc
Confidence 1144689999999998 34444 445999999999999999999997644321 1222333
Q ss_pred CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 213 IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 213 ~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
.+.....++.+.+||.+||+.+|.+|||+.++++|..-
T Consensus 268 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 268 IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 44445678899999999999999999999999987543
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=308.68 Aligned_cols=234 Identities=29% Similarity=0.444 Sum_probs=179.8
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.|++ +.+....++.| |||++.... ..+.+.+|+.++++++||||+++++++.+ ..++||||+++++|.+++
T Consensus 16 lg~G~~g~V~~~~~~~~~v-avK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l 90 (307)
T 2eva_A 16 VGRGAFGVVCKAKWRAKDV-AIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVL 90 (307)
T ss_dssp EECCSSSEEEEEEETTEEE-EEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHH
T ss_pred eecCCCceEEEEEECCeeE-EEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHH
Confidence 455554 23333456777 999986443 45678999999999999999999998763 479999999999999999
Q ss_pred HhcC---CCCHHHHHHHHHHHHHHHHHHHH---CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCC
Q 019901 80 CNAG---RFSEDEARFFFQQLISGVSYCHS---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153 (334)
Q Consensus 80 ~~~~---~~~~~~~~~~~~qil~~L~~LH~---~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~ 153 (334)
.... .++...+..++.|++.||.|||+ +||+||||||+|||++.++. .+||+|||++...... .....||+
T Consensus 91 ~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~-~~kl~Dfg~~~~~~~~--~~~~~gt~ 167 (307)
T 2eva_A 91 HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGT-VLKICDFGTACDIQTH--MTNNKGSA 167 (307)
T ss_dssp HCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTT-EEEECCCCC--------------CCT
T ss_pred hccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCC-EEEEcccccccccccc--cccCCCCC
Confidence 8765 37899999999999999999999 89999999999999986553 3799999998754322 23456999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +||||||+++|+|++|+.||........ ....... .....+....+++.+.++|.+||+.
T Consensus 168 ~y~aPE~~~~~~~~~~-~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~ 243 (307)
T 2eva_A 168 AWMAPEVFEGSNYSEK-CDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVH-NGTRPPLIKNLPKPIESLMTRCWSK 243 (307)
T ss_dssp TSSCHHHHTCCCCCTH-HHHHHHHHHHHHHHHTCCTTTTTCSSHH--HHHHHHH-TTCCCCCBTTCCHHHHHHHHHHTCS
T ss_pred ceEChhhhCCCCCCcH-HHHHHHHHHHHHHHHCCCCchhhCccHH--HHHHHHh-cCCCCCcccccCHHHHHHHHHHhcC
Confidence 9999999988777655 9999999999999999999986543221 1111111 1222333456899999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||+++++++
T Consensus 244 dp~~Rps~~ell~~ 257 (307)
T 2eva_A 244 DPSQRPSMEEIVKI 257 (307)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999863
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=335.50 Aligned_cols=227 Identities=20% Similarity=0.251 Sum_probs=184.2
Q ss_pred eecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 10 RCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 10 ~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
..+.++..| |||+++.... ...+.+.+|+.+++.++||||+++++++.. +..++||||+.+|+|.+++...+.+++
T Consensus 391 ~~~~~~~~v-AvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~ 468 (635)
T 4fl3_A 391 QMKKVVKTV-AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKD 468 (635)
T ss_dssp ECSSCEEEE-EEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCH
T ss_pred cCCCcceEE-EEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCH
Confidence 344566777 9999987542 234689999999999999999999999865 458999999999999999998888999
Q ss_pred HHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCccCCCccccchhhcc
Q 019901 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKSTVGTPAYIAPEVLLK 163 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~gt~~y~aPE~~~~ 163 (334)
..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... ......+|+.|+|||++.+
T Consensus 469 ~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~--~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~ 546 (635)
T 4fl3_A 469 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 546 (635)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCTTHHHHTTC-------------CGGGSCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCC--EEEEEcCCccccccCccccccccCCCCceeeeChhhhcC
Confidence 999999999999999999999999999999999987764 9999999997543222 1223346789999999988
Q ss_pred CCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHh
Q 019901 164 KEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIP 242 (334)
Q Consensus 164 ~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ 242 (334)
..++.+ +|||||||++|+|++ |+.||.+......... + ......+.+..+++++.++|.+||+.+|.+|||++
T Consensus 547 ~~~~~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i-~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ 620 (635)
T 4fl3_A 547 YKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM----L-EKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFA 620 (635)
T ss_dssp CCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCcH-HHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHH
Confidence 887655 999999999999998 9999988765432222 2 22223334456899999999999999999999999
Q ss_pred HHhc
Q 019901 243 EIRN 246 (334)
Q Consensus 243 ell~ 246 (334)
++++
T Consensus 621 ~l~~ 624 (635)
T 4fl3_A 621 AVEL 624 (635)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9874
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-42 Score=305.54 Aligned_cols=236 Identities=25% Similarity=0.394 Sum_probs=182.5
Q ss_pred CCccee----eeeecC-CCC--eeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSY-SSD--LFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~-~~~--~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|++ .+++.. ++. .| |||++..... ...+.+.+|+.+++.++||||+++++++..++ .++||||+.
T Consensus 26 lg~G~~g~Vy~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~ 103 (291)
T 1u46_A 26 LGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAP 103 (291)
T ss_dssp CC----CCCEEEEEECTTSCEEEE-EEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCT
T ss_pred ecCCCceeEEEEEeccCCCceeEE-EEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEeccc
Confidence 566665 344433 333 45 9999986542 23467889999999999999999999998765 899999999
Q ss_pred CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----C
Q 019901 72 GGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 146 (334)
Q Consensus 72 ~~~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~ 146 (334)
+++|.+++... +.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .
T Consensus 104 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~--~kl~Dfg~~~~~~~~~~~~~~~ 181 (291)
T 1u46_A 104 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQ 181 (291)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-
T ss_pred CCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCC--EEEccccccccccccccchhhh
Confidence 99999998764 56999999999999999999999999999999999999987664 99999999875433321 2
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
....+|+.|+|||++.+..++. ++||||||+++|+|++ |+.||.+...... ...+.......+....+++.+.+
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~-~~Di~slG~il~~l~~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~l~~ 256 (291)
T 1u46_A 182 EHRKVPFAWCAPESLKTRTFSH-ASDTWMFGVTLWEMFTYGQEPWIGLNGSQI----LHKIDKEGERLPRPEDCPQDIYN 256 (291)
T ss_dssp ----CCGGGCCHHHHHHCEEEH-HHHHHHHHHHHHHHHTTSCCTTTTCCHHHH----HHHHHTSCCCCCCCTTCCHHHHH
T ss_pred ccCCCCceeeCchhhcCCCCCc-hhhHHHHHHHHHHHHhCCCCCcccCCHHHH----HHHHHccCCCCCCCcCcCHHHHH
Confidence 2345788999999998877754 4999999999999999 9999987665333 23333344445555678999999
Q ss_pred HHHHhcccCCCCCCCHhHHhc
Q 019901 226 LISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell~ 246 (334)
+|.+||..+|.+|||+.++++
T Consensus 257 li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 257 VMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHccCCcccCcCHHHHHH
Confidence 999999999999999999986
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-42 Score=313.47 Aligned_cols=221 Identities=15% Similarity=0.137 Sum_probs=175.6
Q ss_pred ecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC---CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh-----c
Q 019901 11 CSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-----A 82 (334)
Q Consensus 11 ~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~ 82 (334)
+..+++.| |||++.... ...+.+|+.+++.++ |+||+++++++...+..|+|||||++|+|.+++.. .
T Consensus 91 ~~~~~~~v-avK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~ 166 (365)
T 3e7e_A 91 DAKNKQKF-VLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPE 166 (365)
T ss_dssp ---CCCCE-EEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTT
T ss_pred ccccCcEE-EEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccc
Confidence 67788888 999987543 457888888888887 89999999999999999999999999999999974 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcC---------CCCCCEEEeccCCccCCC---CCCCCCCcc
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG---------SPAPRLKICDFGYSKSSV---LHSQPKSTV 150 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~---------~~~~~~kl~Dfgla~~~~---~~~~~~~~~ 150 (334)
+.+++..++.++.||+.||.|||++||+||||||+|||++. ...+.+||+|||+|+... ........+
T Consensus 167 ~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 246 (365)
T 3e7e_A 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246 (365)
T ss_dssp CSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSS
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeec
Confidence 56999999999999999999999999999999999999976 112359999999996432 222234567
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ......++.. ..++.+.+++..|
T Consensus 247 gt~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~pf~~~~~~~---------~~~~~~~~~~-~~~~~~~~~~~~~ 315 (365)
T 3e7e_A 247 ETSGFQCVEMLSNKPWNYQ-IDYFGVAATVYCMLFGTYMKVKNEGGE---------CKPEGLFRRL-PHLDMWNEFFHVM 315 (365)
T ss_dssp CTTSCCCHHHHTTCCBSTH-HHHHHHHHHHHHHHHSSCCCEEEETTE---------EEECSCCTTC-SSHHHHHHHHHHH
T ss_pred CCCCCCChHHhcCCCCCcc-ccHHHHHHHHHHHHhCCCccccCCCCc---------eeechhcccc-CcHHHHHHHHHHH
Confidence 9999999999998887655 999999999999999999996533210 0011111111 2477899999999
Q ss_pred cccCCCCCCCHhHHhc
Q 019901 231 FVADPAKRISIPEIRN 246 (334)
Q Consensus 231 L~~~p~~R~s~~ell~ 246 (334)
|+.+|.+|++..+.+.
T Consensus 316 l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 316 LNIPDCHHLPSLDLLR 331 (365)
T ss_dssp HCCCCTTCCCCHHHHH
T ss_pred cCCCCCCcchHHHHHH
Confidence 9999999976544444
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=301.52 Aligned_cols=220 Identities=21% Similarity=0.267 Sum_probs=176.3
Q ss_pred EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEE-cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHH
Q 019901 19 VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ 95 (334)
Q Consensus 19 vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 95 (334)
+|+|.+.... ....+.+.+|+.++++++||||+++++++. .++..++||||+.+++|.+++.+. ..+++..++.++.
T Consensus 56 ~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ 135 (298)
T 3f66_A 56 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 135 (298)
T ss_dssp EEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHH
T ss_pred EEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHH
Confidence 3999987644 123467889999999999999999999854 556889999999999999999764 4589999999999
Q ss_pred HHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCccCCCccccchhhccCCCCCcc
Q 019901 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKI 170 (334)
Q Consensus 96 qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~ 170 (334)
|++.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..++.+
T Consensus 136 ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~--~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 212 (298)
T 3f66_A 136 QVAKGMKYLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTK- 212 (298)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHH-
T ss_pred HHHHHHHHHHhCCccCCCCchheEEECCCCC--EEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChH-
Confidence 9999999999999999999999999987664 9999999997543221 2234467889999999988877655
Q ss_pred chhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 171 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 171 ~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+||||||+++|+|++ |.+||............ ... ........+++.+.++|.+||+.+|.+|||+.++++
T Consensus 213 ~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 213 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcC-CCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999 67777765554333222 111 122233457999999999999999999999999885
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=331.30 Aligned_cols=222 Identities=24% Similarity=0.318 Sum_probs=179.7
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHH
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~ 91 (334)
++..| |||+++.... ...+.+.+|+.+++.++||||+++++++.. +.+++||||+.+|+|.+++... ..+++..+.
T Consensus 362 ~~~~v-AvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~ 439 (613)
T 2ozo_A 362 KQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 439 (613)
T ss_dssp CEEEE-EEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHH
T ss_pred CcEEE-EEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHH
Confidence 44456 9999987542 345789999999999999999999999976 5689999999999999998754 459999999
Q ss_pred HHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCccCCCccccchhhccCCCC
Q 019901 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKSTVGTPAYIAPEVLLKKEYD 167 (334)
Q Consensus 92 ~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~ 167 (334)
.++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+|+.|+|||++.+..++
T Consensus 440 ~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~--vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~ 517 (613)
T 2ozo_A 440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517 (613)
T ss_dssp HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCSTTTTCC--------------CCTTSCHHHHHHCCCC
T ss_pred HHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCc--EEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCC
Confidence 99999999999999999999999999999987664 99999999986433221 1223456899999999888776
Q ss_pred CccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 168 GKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 168 ~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
.+ +|||||||++|+|++ |+.||.+......... +.. ....+.+..+++++.++|.+||+.+|.+|||+.+++
T Consensus 518 ~~-sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 518 SR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF----IEQ-GKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp HH-HHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH----HHT-TCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred cH-HHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHc-CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 55 999999999999998 9999998776443322 222 223344456899999999999999999999999975
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=326.68 Aligned_cols=221 Identities=22% Similarity=0.322 Sum_probs=183.4
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHH
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA--GRFSEDEARF 92 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 92 (334)
+..| |||++.... ...+.+.+|+.+++.++||||+++++++.. +.+|+||||+.+|+|.+++... ..+++..+..
T Consensus 291 ~~~v-avK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~ 367 (535)
T 2h8h_A 291 TTRV-AIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD 367 (535)
T ss_dssp TEEE-EEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHH
T ss_pred CceE-EEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHH
Confidence 4456 999998765 445789999999999999999999999866 6789999999999999999753 5699999999
Q ss_pred HHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccchhhccCCCCCcc
Q 019901 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPEVLLKKEYDGKI 170 (334)
Q Consensus 93 ~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~ 170 (334)
++.||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+++.|+|||++.+..++.+
T Consensus 368 i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 444 (535)
T 2h8h_A 368 MAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK- 444 (535)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHH-
T ss_pred HHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCc--EEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCch-
Confidence 9999999999999999999999999999987654 9999999997543211 1233456789999999988777655
Q ss_pred chhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 171 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 171 ~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
+|||||||++|+|++ |+.||.+......... + ......+....+++.+.+||.+||+.+|.+|||+++|++
T Consensus 445 sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~----i-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 445 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----V-ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp HHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH----H-HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH----H-HcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999 9999987665433322 2 223334445578999999999999999999999999885
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=313.34 Aligned_cols=221 Identities=21% Similarity=0.263 Sum_probs=171.1
Q ss_pred EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEE-cCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHH
Q 019901 19 VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNA-GRFSEDEARFFFQ 95 (334)
Q Consensus 19 vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~ 95 (334)
||||.+.... ....+.+.+|+.+++.++||||+++++++. .++..++||||+.+|+|.+++.+. ..+++..+..++.
T Consensus 120 vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~ 199 (373)
T 3c1x_A 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199 (373)
T ss_dssp EEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHH
T ss_pred EEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHH
Confidence 3999986543 123467889999999999999999999865 456789999999999999999765 4589999999999
Q ss_pred HHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCccCCCccccchhhccCCCCCcc
Q 019901 96 QLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTPAYIAPEVLLKKEYDGKI 170 (334)
Q Consensus 96 qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~ 170 (334)
||+.||.|||++||+||||||+|||++.++. +||+|||+++...... ......+|+.|+|||++.+..++.+
T Consensus 200 qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~- 276 (373)
T 3c1x_A 200 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK- 276 (373)
T ss_dssp HHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC---------------------CCGGGSCHHHHHHCCCCHH-
T ss_pred HHHHHHHHHHHCCEecCccchheEEECCCCC--EEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcH-
Confidence 9999999999999999999999999987664 9999999997543221 1223457889999999988877654
Q ss_pred chhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 171 ADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 171 ~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
+|||||||++|+|++ |.+||............ ... ...+.+..+++.+.+++.+||+.+|.+|||+.+++++
T Consensus 277 ~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~-~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 277 SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQG-RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999 78888776554333221 111 1223334679999999999999999999999999864
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=316.26 Aligned_cols=237 Identities=19% Similarity=0.198 Sum_probs=186.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC-CCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .+++..++..| |||++.... ....+.+|+.+++.+.| +++..+..++...+..++||||+ +++|.
T Consensus 15 LG~G~fG~Vy~a~~~~~~~~v-AvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~ 90 (483)
T 3sv0_A 15 IGSGSFGEIYLGTNIQTNEEV-AIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLE 90 (483)
T ss_dssp CEECSSCEEEEEEETTTCCEE-EEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EeeCCCEEEEEEEECCCCcEE-EEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHH
Confidence 555554 47778889998 999987665 34568999999999987 55666666777888999999999 99999
Q ss_pred HHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEc---CCCCCCEEEeccCCccCCCCCCC-------
Q 019901 77 ERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLD---GSPAPRLKICDFGYSKSSVLHSQ------- 145 (334)
Q Consensus 77 ~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~---~~~~~~~kl~Dfgla~~~~~~~~------- 145 (334)
+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++ ..+ .+||+|||+++.......
T Consensus 91 ~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~--~vkL~DFGla~~~~~~~~~~~~~~~ 168 (483)
T 3sv0_A 91 DLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN--QVYIIDFGLAKKYRDTSTHQHIPYR 168 (483)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT--CEEECCCTTCEECBCTTTCCBCCCC
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC--eEEEEeCCcceeccCCccccccccc
Confidence 99975 46799999999999999999999999999999999999993 444 499999999975433222
Q ss_pred -CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchH---HHHHHHHHHhhccccCCCCCCCCH
Q 019901 146 -PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK---NFRKTIHRILSVQYSIPDYVHISP 221 (334)
Q Consensus 146 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 221 (334)
.....||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+..... .+............ ......+++
T Consensus 169 ~~~~~~gt~~Y~aPE~~~~~~~s~~-sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~-~~l~~~~p~ 246 (483)
T 3sv0_A 169 ENKNLTGTARYASVNTHLGIEQSRR-DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI-EALCRGYPT 246 (483)
T ss_dssp CCCCCCSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH-HHHHTTSCH
T ss_pred cccccCCCccccCHHHhcCCCCChH-HHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH-HHHhcCCcH
Confidence 225679999999999988887655 999999999999999999998754422 22222211111110 011135789
Q ss_pred HHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 222 ECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 222 ~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
++.+||.+||+.+|.+||++.+|++
T Consensus 247 ~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 247 EFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999999999999999988764
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=307.37 Aligned_cols=228 Identities=22% Similarity=0.306 Sum_probs=177.8
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHc--CCCCCcccceEEEEcCC----eEEEEEeccCCCChHHHHHhcCCCC
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRS--LRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFS 86 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~--l~hp~iv~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~ 86 (334)
.+|+.| |||++.... ...+.+|+.+++. ++||||+++++++.... ..++||||+.+|+|.+++.+ ..++
T Consensus 63 ~~~~~v-avK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~ 137 (342)
T 1b6c_B 63 WRGEEV-AVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVT 137 (342)
T ss_dssp ETTEEE-EEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBC
T ss_pred EcCccE-EEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCcc
Confidence 367788 999986543 4567888888877 78999999999998876 89999999999999999976 4699
Q ss_pred HHHHHHHHHHHHHHHHHHH--------HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-----CCCCccCCC
Q 019901 87 EDEARFFFQQLISGVSYCH--------SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-----QPKSTVGTP 153 (334)
Q Consensus 87 ~~~~~~~~~qil~~L~~LH--------~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-----~~~~~~gt~ 153 (334)
+..++.++.|++.||.||| ++||+||||||+|||++.++. +||+|||+++...... ......||+
T Consensus 138 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~--~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~ 215 (342)
T 1b6c_B 138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215 (342)
T ss_dssp HHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSC--EEECCCTTCEEEETTTTEEEECCCSCCCCG
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCC--EEEEECCCceeccccccccccccccCCcCc
Confidence 9999999999999999999 899999999999999987664 9999999997543332 234557999
Q ss_pred ccccchhhccCCCCC-----ccchhhhhhHHHHHHHhC----------CCCCCCCCchH-HHHHHHHHHhhcccc--CCC
Q 019901 154 AYIAPEVLLKKEYDG-----KIADVWSCGVTLYVMLVG----------AYPFEDPEEPK-NFRKTIHRILSVQYS--IPD 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~-----~~~DiwslG~il~~l~~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~--~~~ 215 (334)
.|+|||++.+..... .++|||||||++|+|++| ..||....... ........+...... ++.
T Consensus 216 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (342)
T 1b6c_B 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPN 295 (342)
T ss_dssp GGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCG
T ss_pred ccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcc
Confidence 999999997653221 458999999999999999 78887653221 111222222222111 111
Q ss_pred ---CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 216 ---YVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 216 ---~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
....++.+.++|.+||+.+|.+|||+.++++|
T Consensus 296 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 296 RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 11234679999999999999999999999875
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=305.32 Aligned_cols=234 Identities=22% Similarity=0.354 Sum_probs=183.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|++ + +++. ..+ |+|++..... ...+.+.+|+.+++.++||||+++++++...+..++||||+.+++|
T Consensus 41 lg~G~~g~V~~~~~~---~~~-avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L 116 (319)
T 2y4i_B 41 IGKGRFGQVYHGRWH---GEV-AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTL 116 (319)
T ss_dssp CCCSSSSEEEEEEES---SSE-EEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEH
T ss_pred eccCCceEEEEEEEc---CeE-EEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcH
Confidence 566655 3 3332 347 9999976542 2345688999999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC------CCCCCC
Q 019901 76 FERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL------HSQPKS 148 (334)
Q Consensus 76 ~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~------~~~~~~ 148 (334)
.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++ ++ .+||+|||+++.... ......
T Consensus 117 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~--~~~l~Dfg~~~~~~~~~~~~~~~~~~~ 193 (319)
T 2y4i_B 117 YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG--KVVITDFGLFSISGVLQAGRREDKLRI 193 (319)
T ss_dssp HHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC-----CCEECCCSCCC----------CCSCBC
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC--CEEEeecCCcccccccccccccccccc
Confidence 99997754 699999999999999999999999999999999999997 33 499999999864321 112233
Q ss_pred ccCCCccccchhhccCC--------CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCC
Q 019901 149 TVGTPAYIAPEVLLKKE--------YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHIS 220 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~--------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 220 (334)
..||+.|+|||++.+.. ..+.++|||||||++|+|++|+.||.......... .+............++
T Consensus 194 ~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~ 269 (319)
T 2y4i_B 194 QNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIW----QMGTGMKPNLSQIGMG 269 (319)
T ss_dssp CSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHH----HHHTTCCCCCCCSSCC
T ss_pred CCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH----HhccCCCCCCCcCCCC
Confidence 45899999999987522 22455999999999999999999998765533322 2222222222233578
Q ss_pred HHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 221 PECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 221 ~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
.++.++|.+||..+|.+|||+.++++
T Consensus 270 ~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 270 KEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp TTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999999999986
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=309.20 Aligned_cols=237 Identities=21% Similarity=0.283 Sum_probs=169.2
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHH--HHHHHcCCCCCcccceEEEEc-----CCeEEEEEeccCC
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQRE--IINHRSLRHPNIVRFKEVILT-----PTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~E--i~~l~~l~hp~iv~~~~~~~~-----~~~~~lv~e~~~~ 72 (334)
||.|+| +.+.+.+++.| |||++.... ......| +..++.++||||+++++.+.. ...+++||||+++
T Consensus 21 lg~G~~g~Vy~~~~~~~~v-avK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 96 (336)
T 3g2f_A 21 IGRGRYGAVYKGSLDERPV-AVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPN 96 (336)
T ss_dssp EEECSSEEEEEEEETTEEE-EEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTT
T ss_pred cccCCCeEEEEEEECCeEE-EEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCC
Confidence 455555 23334577787 999997554 2333444 444556899999999986542 2367999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---------CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSM---------QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 143 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~---------~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~ 143 (334)
|+|.+++.... .++..++.++.||+.||.|||++ ||+||||||+|||++.++. +||+|||+++.....
T Consensus 97 g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~--~kL~DFG~a~~~~~~ 173 (336)
T 3g2f_A 97 GSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGT--CVISDFGLSMRLTGN 173 (336)
T ss_dssp CBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSC--EEECCCTTCEECSSS
T ss_pred CcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCc--EEEeeccceeecccc
Confidence 99999997654 58999999999999999999999 9999999999999987664 999999999754321
Q ss_pred ---------CCCCCccCCCccccchhhccC-------CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHH--------
Q 019901 144 ---------SQPKSTVGTPAYIAPEVLLKK-------EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF-------- 199 (334)
Q Consensus 144 ---------~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------- 199 (334)
......+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||.........
T Consensus 174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 252 (336)
T 3g2f_A 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252 (336)
T ss_dssp SCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred cccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence 112345799999999999763 23 34589999999999999997766432211000
Q ss_pred -----HHHHHHHhhcc---ccCCC----CCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 200 -----RKTIHRILSVQ---YSIPD----YVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 200 -----~~~~~~~~~~~---~~~~~----~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
........... ..+|. ....++.+.+||.+||+.+|.+|||++++++
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 00011111111 11111 1113457999999999999999999999954
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=315.99 Aligned_cols=232 Identities=18% Similarity=0.212 Sum_probs=173.0
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCccc--------ccHHHHHHHHHHHcCC---------CCCcccceEE----
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQ--------IDENVQREIINHRSLR---------HPNIVRFKEV---- 56 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~--------~~~~~~~Ei~~l~~l~---------hp~iv~~~~~---- 56 (334)
||.|+| + +++ +|+.| |||++.+.... ..+.+.+|+.+++.++ ||||+++.++
T Consensus 28 lG~G~~g~V~~~~~--~~~~v-AvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~ 104 (336)
T 2vuw_A 28 IGEGVFGEVFQTIA--DHTPV-AIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQ 104 (336)
T ss_dssp EEEETTEEEEEEEE--TTEEE-EEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEE
T ss_pred ecccCceEEEEEEe--CCceE-EEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEec
Confidence 455544 3 544 67777 99999876421 2277899999998886 6666665554
Q ss_pred -------------EEc-------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCc
Q 019901 57 -------------ILT-------------PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQV 109 (334)
Q Consensus 57 -------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH-~~~i 109 (334)
|.+ .+.+|+|||||.+|++.+.+.+ +.+++..++.++.||+.||.||| ++||
T Consensus 105 ~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~i 183 (336)
T 2vuw_A 105 GSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRF 183 (336)
T ss_dssp SSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_pred CCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCE
Confidence 333 6789999999999987777644 56899999999999999999999 9999
Q ss_pred eeCCCCCCcEEEcCCCC------------------CCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccc
Q 019901 110 CHRDLKLENTLLDGSPA------------------PRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIA 171 (334)
Q Consensus 110 vH~dlkp~NIli~~~~~------------------~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 171 (334)
+||||||+|||++.++. ..+||+|||+|+.... ...+||+.|+|||++.+.. +.++
T Consensus 184 vHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~g~~--~~~~ 257 (336)
T 2vuw_A 184 EHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFTGDG--DYQF 257 (336)
T ss_dssp BCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGCCCS--SHHH
T ss_pred eECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhcCCC--ccce
Confidence 99999999999987651 1599999999985432 3458999999999998765 4559
Q ss_pred hhhhhhHH-HHHHHhCCCCCCCCCchHHHHHHHHHHhhc-cccC----CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHh
Q 019901 172 DVWSCGVT-LYVMLVGAYPFEDPEEPKNFRKTIHRILSV-QYSI----PDYVHISPECRHLISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 172 DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell 245 (334)
||||||++ .+++++|..||.... ........+... .... +.+..+|+++++||.+||+.+ |++|+|
T Consensus 258 Diwsl~~~~~~~~~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l 329 (336)
T 2vuw_A 258 DIYRLMKKENNNRWGEYHPYSNVL---WLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLL 329 (336)
T ss_dssp HHHHHHHHHHTTCTTSCCTHHHHH---HHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred ehhhhhCCCCcccccccCCCcchh---hhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence 99998777 777888999985311 001111122211 1111 112246889999999999976 999999
Q ss_pred -cCcccc
Q 019901 246 -NHEWFL 251 (334)
Q Consensus 246 -~h~~~~ 251 (334)
+||||+
T Consensus 330 ~~Hp~f~ 336 (336)
T 2vuw_A 330 CQHSLFK 336 (336)
T ss_dssp HHCGGGC
T ss_pred hcCCCcC
Confidence 999994
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-41 Score=311.26 Aligned_cols=231 Identities=13% Similarity=0.127 Sum_probs=176.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCC-CCc---------ccceEE------------E
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRH-PNI---------VRFKEV------------I 57 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~h-p~i---------v~~~~~------------~ 57 (334)
||.+ .+.+..+|+.| |||++..... ...+.+.+|+.+++.+.| +|. +...+. +
T Consensus 91 fG~Vy~a~~~~~g~~v-AvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (413)
T 3dzo_A 91 PYAYLEATDQETGESF-EVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVR 169 (413)
T ss_dssp TEEEEEEEETTTCCEE-EEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--------
T ss_pred CEEEEEEEecCCCCce-EEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCcccccc
Confidence 4444 48888999999 9999885431 235789999999999987 321 111111 1
Q ss_pred Ec-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC
Q 019901 58 LT-----PTHLAIVMEYASGGELFERICN-------AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 125 (334)
Q Consensus 58 ~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~ 125 (334)
.. ...++++|+++ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 170 ~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~ 248 (413)
T 3dzo_A 170 LDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG 248 (413)
T ss_dssp -------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC
T ss_pred CCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC
Confidence 11 22467888876 6899988841 23477888999999999999999999999999999999998776
Q ss_pred CCCEEEeccCCccCCCCCCCCCCccCCCccccchhh----------ccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCc
Q 019901 126 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVL----------LKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 195 (334)
Q Consensus 126 ~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 195 (334)
. +||+|||+++..... ....+| +.|+|||++ .+..++ .++|||||||++|+|++|+.||.....
T Consensus 249 ~--~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~DvwSlGvil~elltg~~Pf~~~~~ 322 (413)
T 3dzo_A 249 G--VFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMT-FAFDTWTLGLAIYWIWCADLPNTDDAA 322 (413)
T ss_dssp C--EEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEEC-HHHHHHHHHHHHHHHHHSSCCCCTTGG
T ss_pred e--EEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCC-chhhHHHHHHHHHHHHHCCCCCCCcch
Confidence 5 999999998754333 345577 999999999 333454 459999999999999999999986543
Q ss_pred hHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 196 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
... ....++....+|+.+.+||.+||+.+|.+|||+.++++||||++
T Consensus 323 ~~~----------~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~ 369 (413)
T 3dzo_A 323 LGG----------SEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369 (413)
T ss_dssp GSC----------SGGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred hhh----------HHHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence 221 11123334468999999999999999999999999999999965
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=321.90 Aligned_cols=236 Identities=22% Similarity=0.353 Sum_probs=184.4
Q ss_pred CCccee---e-eeecCCC--CeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCSYSS--DLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~--~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| + +.+..++ ...||||.+..... ...+.+.+|+.+++.++||||+++++++. ++..|+||||+.+|+
T Consensus 398 LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~ 476 (656)
T 2j0j_A 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE 476 (656)
T ss_dssp EECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCB
T ss_pred EeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCc
Confidence 455554 3 5554433 23339998865431 23367889999999999999999999984 566899999999999
Q ss_pred hHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... .....+
T Consensus 477 L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~--vkL~DFG~a~~~~~~~~~~~~~~~~ 554 (656)
T 2j0j_A 477 LRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKL 554 (656)
T ss_dssp HHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECCCCCCCSCCC----------C
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCC--EEEEecCCCeecCCCcceeccCCCC
Confidence 999998654 6999999999999999999999999999999999999987664 99999999986533222 123356
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
|+.|+|||++.+..++.+ +|||||||++|+|++ |..||.+......... +.. ....+.+..+++.+.++|.+|
T Consensus 555 t~~y~aPE~~~~~~~~~~-~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~----i~~-~~~~~~~~~~~~~l~~li~~~ 628 (656)
T 2j0j_A 555 PIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR----IEN-GERLPMPPNCPPTLYSLMTKC 628 (656)
T ss_dssp CGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHH-TCCCCCCTTCCHHHHHHHHHH
T ss_pred CcceeCHHHhcCCCCCch-hhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HHc-CCCCCCCccccHHHHHHHHHH
Confidence 789999999988877654 999999999999997 9999987665433322 222 122334456899999999999
Q ss_pred cccCCCCCCCHhHHhc
Q 019901 231 FVADPAKRISIPEIRN 246 (334)
Q Consensus 231 L~~~p~~R~s~~ell~ 246 (334)
|..+|.+|||+.++++
T Consensus 629 l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 629 WAYDPSRRPRFTELKA 644 (656)
T ss_dssp TCSSGGGSCCHHHHHH
T ss_pred cCCChhHCcCHHHHHH
Confidence 9999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=325.46 Aligned_cols=226 Identities=21% Similarity=0.228 Sum_probs=179.2
Q ss_pred Ccceee-eeecC-CCCeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCe-----EEEEEeccCCCC
Q 019901 3 GFHNFY-DRCSY-SSDLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTH-----LAIVMEYASGGE 74 (334)
Q Consensus 3 G~g~~~-~~~~~-~~~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~-----~~lv~e~~~~~~ 74 (334)
|||.++ +.+.. +|..| |||++.... ......+.+|+.+++.++||||+++++++...+. .|+||||+.|++
T Consensus 92 ~~g~Vy~a~~~~~~~~~v-aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~ 170 (681)
T 2pzi_A 92 GLGWIYLALDRNVNGRPV-VLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQS 170 (681)
T ss_dssp TTEEEEEEEEGGGTTEEE-EEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEE
T ss_pred CCeEEEEEEEcCCCCcEE-EEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCc
Confidence 344444 66765 56777 999987543 1233568899999999999999999999987654 799999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+.+.. ++++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++..... ...+||+.
T Consensus 171 L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~---~~kl~DFG~a~~~~~~---~~~~gt~~ 242 (681)
T 2pzi_A 171 LKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE---QLKLIDLGAVSRINSF---GYLYGTPG 242 (681)
T ss_dssp CC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS---CEEECCCTTCEETTCC---SCCCCCTT
T ss_pred HHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC---cEEEEecccchhcccC---CccCCCcc
Confidence 9987755 69999999999999999999999999999999999999864 4999999999864332 45679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+.. +.++|||||||++|+|++|.+||.+...... .........++.+.++|.+||+.+
T Consensus 243 y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------------~~~~~~~~~~~~l~~li~~~l~~d 308 (681)
T 2pzi_A 243 FQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------------PEDDPVLKTYDSYGRLLRRAIDPD 308 (681)
T ss_dssp TSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------------CTTCHHHHHCHHHHHHHHHHTCSS
T ss_pred ccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCcccccccc------------cccccccccCHHHHHHHhhhccCC
Confidence 99999987654 4559999999999999999999875321100 000000123688999999999999
Q ss_pred CCCCCCHhHHhcCcccc
Q 019901 235 PAKRISIPEIRNHEWFL 251 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~ 251 (334)
|.+||+..+.+.|+|+.
T Consensus 309 P~~R~~~~~~l~~~l~~ 325 (681)
T 2pzi_A 309 PRQRFTTAEEMSAQLTG 325 (681)
T ss_dssp GGGSCSSHHHHHHHHHH
T ss_pred hhhCCCHHHHHHHHHHH
Confidence 99999999999999874
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=280.97 Aligned_cols=210 Identities=15% Similarity=0.081 Sum_probs=165.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||.+ .+.+..+|+.| |||++....... .+.+.+|+..++.++||||+++++++..++..|+||||++|++|.+++
T Consensus 44 ~g~Vy~a~~~~~~~~v-avK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l 122 (286)
T 3uqc_A 44 PLQFWQALDTALDRQV-ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA 122 (286)
T ss_dssp TCEEEEEEETTTTEEE-EEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHH
T ss_pred CeEEEEEEecCCCceE-EEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHH
Confidence 3444 48888889998 999998765222 267899999999999999999999999999999999999999999998
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccccch
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 159 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE 159 (334)
.+. ....++..++.|++.||.|||++||+||||||+|||++.++. +||+++| |++|
T Consensus 123 ~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~--~kl~~~~-------------------~~~~- 178 (286)
T 3uqc_A 123 DTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGD--VVLAYPA-------------------TMPD- 178 (286)
T ss_dssp TTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSC--EEECSCC-------------------CCTT-
T ss_pred hcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCC--EEEEecc-------------------ccCC-
Confidence 543 466788999999999999999999999999999999987765 8998554 2332
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC--CCCCCCCHHHHHHHHHhcccCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI--PDYVHISPECRHLISRIFVADPAK 237 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~~p~~ 237 (334)
+ +.++|||||||++|+|++|+.||.+.+....+.... ......... .....+++++.++|.+||+.||.+
T Consensus 179 ------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 250 (286)
T 3uqc_A 179 ------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE-RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGI 250 (286)
T ss_dssp ------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC-BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSC
T ss_pred ------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH-HHhccCCCChhhcccCCCHHHHHHHHHHcccCCcc
Confidence 3 455999999999999999999998765422110000 000011100 112458999999999999999999
Q ss_pred CCCHhHHhcC
Q 019901 238 RISIPEIRNH 247 (334)
Q Consensus 238 R~s~~ell~h 247 (334)
| |+.++++.
T Consensus 251 R-s~~el~~~ 259 (286)
T 3uqc_A 251 R-SASTLLNL 259 (286)
T ss_dssp C-CHHHHHHH
T ss_pred C-CHHHHHHH
Confidence 9 99999863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=293.51 Aligned_cols=172 Identities=12% Similarity=0.074 Sum_probs=131.5
Q ss_pred eeecCCCCeeEEEEEEecCcc----------cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 9 DRCSYSSDLFVNIIIIVFHLW----------QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~----------~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
++....|+.| |||++.+... ...+.+.+|+.+|+++ .|+||+++++++++++.+|||||||+|++|.+
T Consensus 253 ~rr~~fg~~~-~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d 331 (569)
T 4azs_A 253 SRRYFFGEDY-VCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSD 331 (569)
T ss_dssp CEEEEECSSE-EEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHH
T ss_pred ccccccccee-EEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHH
Confidence 5667789999 9999987641 1125688999999999 69999999999999999999999999999999
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
+|.+.+++++. .++.||+.||+|+|++|||||||||+|||++.++. +||+|||+|+...... ...+.+||+.||
T Consensus 332 ~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~--vKL~DFGlAr~~~~~~~~~~t~vGTp~Ym 406 (569)
T 4azs_A 332 MLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQH--ARLIDFGSIVTTPQDCSWPTNLVQSFFVF 406 (569)
T ss_dssp HHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSC--EEECCCTTEESCC---CCSHHHHHHHHHH
T ss_pred HHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCC--EEEeecccCeeCCCCCccccCceechhhc
Confidence 99999888875 47899999999999999999999999999987765 9999999998654332 334567999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAY 188 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 188 (334)
|||++.+.. . ..+|+||+|++++.|.++..
T Consensus 407 APE~l~g~~-~-~~~d~~s~g~~~~~l~~~~~ 436 (569)
T 4azs_A 407 VNELFAENK-S-WNGFWRSAPVHPFNLPQPWS 436 (569)
T ss_dssp HHHHC-------------------CCCCTTHH
T ss_pred cHHHhCCCC-C-Ccccccccccchhhhccccc
Confidence 999997653 3 34899999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-28 Score=233.78 Aligned_cols=176 Identities=21% Similarity=0.135 Sum_probs=137.8
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccc--------cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQI--------DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~--------~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| +.+....+..+ ++|......... .+.+.+|+.++++++||||+++..++...+..|+||||++
T Consensus 344 LG~G~fg~Vy~~~~~~~~~-~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ 422 (540)
T 3en9_A 344 IGKGAEADIKRDSYLDFDV-IIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYIN 422 (540)
T ss_dssp ----CCEEEEEEECSSCEE-EEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCC
T ss_pred EeeCCCEEEEEEEECCCeE-EEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCC
Confidence 677776 33446678888 998876543211 2347899999999999999966666556777799999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC------
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ------ 145 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~------ 145 (334)
|++|.+++.+ +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.......
T Consensus 423 ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~----~~kL~DFGla~~~~~~~~~~~~~~ 490 (540)
T 3en9_A 423 GKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK----DLYIIDFGLGKISNLDEDKAVDLI 490 (540)
T ss_dssp SEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS----SEEECCCTTCEECCCHHHHHHHHH
T ss_pred CCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC----eEEEEECccCEECCCccccccchh
Confidence 9999999865 6789999999999999999999999999999986 499999999986543221
Q ss_pred --CCCccCCCccccchhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019901 146 --PKSTVGTPAYIAPEVLLK--KEYDGKIADVWSCGVTLYVMLVGAYPFE 191 (334)
Q Consensus 146 --~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~ 191 (334)
..+.+||+.|||||++.. ..|... +|+||..+-..+...++.+|.
T Consensus 491 ~~~~~~~GT~~y~APEv~~~~~~~Y~~~-~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 491 VFKKAVLSTHHEKFDEIWERFLEGYKSV-YDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHCGGGHHHHHHHHHHHHHHH-CTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhcCCCCcCCHHHHHHHHHHHHHH-HhHHHHHHHHHHHHHhccccC
Confidence 124579999999999976 556444 899999988888887777663
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1e-22 Score=179.48 Aligned_cols=127 Identities=16% Similarity=0.088 Sum_probs=99.9
Q ss_pred eeeecCCCCeeEEEEEEecCccc------------------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEec
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQ------------------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 69 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~------------------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 69 (334)
.+.+ .+|+.| |||++...... ....+.+|+.+++.++ | +++.+++.. +..|+||||
T Consensus 108 ~~~~-~~g~~v-alK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~ 181 (282)
T 1zar_A 108 NCYS-EKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMEL 181 (282)
T ss_dssp EEEE-TTTEEE-EEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEEC
T ss_pred EEEe-CCCCEE-EEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEe
Confidence 3666 778888 99999754311 2356889999999999 5 666666544 456999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
++|++|.+ +. ......++.|++.||.|||++||+||||||+|||++ ++ .+||+|||+|+.
T Consensus 182 ~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~--~vkl~DFG~a~~---------- 241 (282)
T 1zar_A 182 IDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE--GIWIIDFPQSVE---------- 241 (282)
T ss_dssp CCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT--EEEECCCTTCEE----------
T ss_pred cCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC--cEEEEECCCCeE----------
Confidence 99999987 42 134567999999999999999999999999999998 54 499999999863
Q ss_pred cCCCccccchhhc
Q 019901 150 VGTPAYIAPEVLL 162 (334)
Q Consensus 150 ~gt~~y~aPE~~~ 162 (334)
+..++|||.+.
T Consensus 242 --~~~~~a~e~l~ 252 (282)
T 1zar_A 242 --VGEEGWREILE 252 (282)
T ss_dssp --TTSTTHHHHHH
T ss_pred --CCCCCHHHHHH
Confidence 45678999874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=4.6e-19 Score=154.10 Aligned_cols=126 Identities=13% Similarity=0.148 Sum_probs=92.8
Q ss_pred CCccee---e-eeecCCCCe--eEEEEEEecCcccc------------------------cHHHHHHHHHHHcCCCCCc-
Q 019901 2 LGFHNF---Y-DRCSYSSDL--FVNIIIIVFHLWQI------------------------DENVQREIINHRSLRHPNI- 50 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~--vvaiK~~~~~~~~~------------------------~~~~~~Ei~~l~~l~hp~i- 50 (334)
||.|++ + +.+..+|.. | |||++....... ...+.+|+.+++.+.|+++
T Consensus 55 ig~G~~g~Vy~a~~~~~g~~~~v-AvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 133 (258)
T 1zth_A 55 ISTGKEANVFYADGVFDGKPVAM-AVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVS 133 (258)
T ss_dssp EEECSSEEEEEEEEEETTEEEEE-EEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EeecceEEEEEEEEcCCCcEeeE-EEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 455544 3 556568888 8 999986542110 1268899999999988865
Q ss_pred -ccceEEEEcCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HCCceeCCCCCCcEEEcC
Q 019901 51 -VRFKEVILTPTHLAIVMEYASG-G----ELFERICNAGRFSEDEARFFFQQLISGVSYCH-SMQVCHRDLKLENTLLDG 123 (334)
Q Consensus 51 -v~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH-~~~ivH~dlkp~NIli~~ 123 (334)
+.++.. +..++||||+.+ | +|.+.... .++..+..++.|++.||.||| +.||+||||||+|||++.
T Consensus 134 ~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~ 206 (258)
T 1zth_A 134 VPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID 206 (258)
T ss_dssp CCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS
T ss_pred CCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC
Confidence 333332 345899999932 3 66665432 235578899999999999999 999999999999999976
Q ss_pred CCCCCEEEeccCCccC
Q 019901 124 SPAPRLKICDFGYSKS 139 (334)
Q Consensus 124 ~~~~~~kl~Dfgla~~ 139 (334)
.++|+|||+|..
T Consensus 207 ----~~~liDFG~a~~ 218 (258)
T 1zth_A 207 ----KVYFIDMGQAVT 218 (258)
T ss_dssp ----SEEECCCTTCEE
T ss_pred ----cEEEEECccccc
Confidence 499999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.58 E-value=3.6e-15 Score=135.33 Aligned_cols=127 Identities=13% Similarity=0.028 Sum_probs=84.9
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCccc------------c--cH--------HHHHHHHHHHcCCCCCcccceE
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQ------------I--DE--------NVQREIINHRSLRHPNIVRFKE 55 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~------------~--~~--------~~~~Ei~~l~~l~hp~iv~~~~ 55 (334)
||.|++ + |.+ .+|+.| |||+++..... . .. ...+|...|.++.++++....-
T Consensus 103 IG~Gk~a~VY~a~d-~~G~~v-AvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p 180 (397)
T 4gyi_A 103 IGVGKESDIMIVAD-EKGKQK-VLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEP 180 (397)
T ss_dssp EEECSSEEEEEEEC-TTCCEE-EEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCE
T ss_pred eeeCCceEEEEEEC-CCCCEE-EEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCee
Confidence 455554 4 444 578888 99998653210 0 01 1235666666665544432222
Q ss_pred EEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC--------
Q 019901 56 VILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-------- 127 (334)
Q Consensus 56 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~-------- 127 (334)
+.... .+|||||++|++|.... ....+..++.||+.+|.+||+.|||||||||.|||++.++.+
T Consensus 181 ~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~ 252 (397)
T 4gyi_A 181 IAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITL 252 (397)
T ss_dssp EEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEE
T ss_pred eeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccccccc
Confidence 22222 27999999998885542 223456788999999999999999999999999999765532
Q ss_pred CEEEeccCCcc
Q 019901 128 RLKICDFGYSK 138 (334)
Q Consensus 128 ~~kl~Dfgla~ 138 (334)
.+.|+||+-+.
T Consensus 253 ~~~iID~~Q~V 263 (397)
T 4gyi_A 253 TPIIIXFPQMV 263 (397)
T ss_dssp EEEECCCTTCE
T ss_pred ceEEEEeCCcc
Confidence 37899999654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.35 E-value=5.4e-12 Score=109.36 Aligned_cols=118 Identities=15% Similarity=0.073 Sum_probs=92.5
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHH
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 91 (334)
..++.+ ++|+...........+.+|+.+++.+. +..+.++++++...+..|+||||++|.+|.+.+. +.....
T Consensus 35 ~~~~~~-vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~ 108 (263)
T 3tm0_A 35 GENENL-YLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPE 108 (263)
T ss_dssp CSSCEE-EEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHH
T ss_pred CCCCcE-EEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHH
Confidence 346788 999987643233457999999999885 6778889999988899999999999999876531 223345
Q ss_pred HHHHHHHHHHHHHHH-----------------------------------------------------------CCceeC
Q 019901 92 FFFQQLISGVSYCHS-----------------------------------------------------------MQVCHR 112 (334)
Q Consensus 92 ~~~~qil~~L~~LH~-----------------------------------------------------------~~ivH~ 112 (334)
.++.+++.+|..||+ ..++|+
T Consensus 109 ~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~Hg 188 (263)
T 3tm0_A 109 KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHG 188 (263)
T ss_dssp HHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECS
T ss_pred HHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECC
Confidence 788899999999998 458999
Q ss_pred CCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 113 DLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 113 dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|++|.|||++.+. .+.|+||+.+.
T Consensus 189 Dl~~~Nil~~~~~--~~~lIDwe~a~ 212 (263)
T 3tm0_A 189 DLGDSNIFVKDGK--VSGFIDLGRSG 212 (263)
T ss_dssp SCCTTSEEEETTE--EEEECCCTTCE
T ss_pred CCCcCcEEEECCc--EEEEEEchhcc
Confidence 9999999997532 25699999654
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=4.2e-11 Score=103.29 Aligned_cols=117 Identities=12% Similarity=0.116 Sum_probs=85.6
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
+.....+|..+ ++|+.... ....+.+|+.+++.+.+.+ +.+++.+...++..++||||++|.+|. .. ..
T Consensus 37 ~~~~~~~g~~~-vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~ 107 (264)
T 1nd4_A 37 FRLSAQGRPVL-FVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HL 107 (264)
T ss_dssp EEEECTTSCCE-EEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CC
T ss_pred EEEecCCCCeE-EEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cC
Confidence 43444567778 99997543 2356889999998886544 556888888888899999999998884 21 12
Q ss_pred CHHHHHHHHHHHHHHHHHHHHCC---------------------------------------------------------
Q 019901 86 SEDEARFFFQQLISGVSYCHSMQ--------------------------------------------------------- 108 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~~~--------------------------------------------------------- 108 (334)
+ ...++.+++..|..||+..
T Consensus 108 ~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ 184 (264)
T 1nd4_A 108 A---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL 184 (264)
T ss_dssp C---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred C---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCe
Confidence 2 2356677777778887643
Q ss_pred -ceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 109 -VCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 109 -ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
++|+|++|.|||++.++ .+.|+|||.+.
T Consensus 185 ~l~HgDl~~~Nil~~~~~--~~~liD~~~a~ 213 (264)
T 1nd4_A 185 VVTHGDACLPNIMVENGR--FSGFIDCGRLG 213 (264)
T ss_dssp EEECSSCCGGGEEEETTE--EEEECCCTTCE
T ss_pred EEECCCCCCCcEEEECCc--EEEEEcchhcc
Confidence 99999999999997543 25699999764
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.09 E-value=3.4e-10 Score=102.69 Aligned_cols=122 Identities=15% Similarity=0.233 Sum_probs=90.7
Q ss_pred CCCeeEEEEEEe--cCc-ccccHHHHHHHHHHHcCCC--CCcccceEEEEcC---CeEEEEEeccCCCChHHHHHhcCCC
Q 019901 14 SSDLFVNIIIIV--FHL-WQIDENVQREIINHRSLRH--PNIVRFKEVILTP---THLAIVMEYASGGELFERICNAGRF 85 (334)
Q Consensus 14 ~~~~vvaiK~~~--~~~-~~~~~~~~~Ei~~l~~l~h--p~iv~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~ 85 (334)
.++.+ ++|+.. ... ......+.+|+.+++.+.. ..+++++.++.+. +..|+||||++|..+.+. ....+
T Consensus 60 ~~~~~-vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l 136 (359)
T 3dxp_A 60 PGQTY-VMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGM 136 (359)
T ss_dssp SSCEE-EEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTC
T ss_pred CCceE-EEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccC
Confidence 34677 888865 332 1234578999999999874 5578888887765 458999999999877442 12347
Q ss_pred CHHHHHHHHHHHHHHHHHHHH----------------------------------------------------------C
Q 019901 86 SEDEARFFFQQLISGVSYCHS----------------------------------------------------------M 107 (334)
Q Consensus 86 ~~~~~~~~~~qil~~L~~LH~----------------------------------------------------------~ 107 (334)
++.....++.+++..|..||+ .
T Consensus 137 ~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 216 (359)
T 3dxp_A 137 SPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLT 216 (359)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCC
T ss_pred CHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCc
Confidence 788889999999999999997 3
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+++|||++|.|||++.++...+.|+||+.+.
T Consensus 217 ~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 217 SIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp EEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred eEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 5899999999999986543336899999876
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.91 E-value=1.3e-09 Score=96.43 Aligned_cols=168 Identities=16% Similarity=0.101 Sum_probs=106.9
Q ss_pred CeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCC--cccceEEEEcCC---eEEEEEeccCCCChHHHHHhcCCCCHHH
Q 019901 16 DLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPN--IVRFKEVILTPT---HLAIVMEYASGGELFERICNAGRFSEDE 89 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~--iv~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 89 (334)
..+ ++|+-... .....+.+|..+++.+. +.. +.+++......+ ..|+||++++|.+|..... ..++..+
T Consensus 41 ~~~-vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~ 115 (304)
T 3sg8_A 41 RDF-IFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQS 115 (304)
T ss_dssp TSE-EEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHH
T ss_pred CEE-EEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHH
Confidence 456 88885422 23467899999998873 333 334443332222 3589999999998875433 2467888
Q ss_pred HHHHHHHHHHHHHHHHH----------------------------------------------------------CCcee
Q 019901 90 ARFFFQQLISGVSYCHS----------------------------------------------------------MQVCH 111 (334)
Q Consensus 90 ~~~~~~qil~~L~~LH~----------------------------------------------------------~~ivH 111 (334)
...++.+++..|..||+ ..++|
T Consensus 116 ~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~H 195 (304)
T 3sg8_A 116 QNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIH 195 (304)
T ss_dssp HHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEEC
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEe
Confidence 88889999999999986 13699
Q ss_pred CCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc---ccchhhcc--CCCCCc-----------cchhhh
Q 019901 112 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY---IAPEVLLK--KEYDGK-----------IADVWS 175 (334)
Q Consensus 112 ~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y---~aPE~~~~--~~~~~~-----------~~Diws 175 (334)
+|++|.||+++.+....+.|+||+.+........ ....... ..|+.... ..|... -.+.|+
T Consensus 196 gD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D---l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~ 272 (304)
T 3sg8_A 196 NDFSSDHILFDTEKNTICGIIDFGDAAISDPDND---FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWS 272 (304)
T ss_dssp SCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH---HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred CCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH---HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999864222478999998764221100 0000011 22222110 001000 158999
Q ss_pred hhHHHHHHHhCCCCCC
Q 019901 176 CGVTLYVMLVGAYPFE 191 (334)
Q Consensus 176 lG~il~~l~~g~~pf~ 191 (334)
+|.++|.+.+|..+|.
T Consensus 273 l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 273 FEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHcCCHHHH
Confidence 9999999999987763
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=1.7e-06 Score=74.78 Aligned_cols=120 Identities=18% Similarity=0.160 Sum_probs=82.9
Q ss_pred eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCH
Q 019901 9 DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSE 87 (334)
Q Consensus 9 ~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~ 87 (334)
......+..+ ++|+-... ....+.+|...|+.+. +--+.+++.++.+++..++||++++|.++.+..... .
T Consensus 44 l~~~~~~~~~-~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~ 115 (272)
T 4gkh_A 44 LYGKPNAPEL-FLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----P 115 (272)
T ss_dssp EECCTTCCCE-EEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----G
T ss_pred EEecCCCeEE-EEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----H
Confidence 3344455677 89986533 2456889999998874 223667888888889999999999998887655432 1
Q ss_pred HHHHHHHHHHHHHHHHHHHC----------------------------------------------------------Cc
Q 019901 88 DEARFFFQQLISGVSYCHSM----------------------------------------------------------QV 109 (334)
Q Consensus 88 ~~~~~~~~qil~~L~~LH~~----------------------------------------------------------~i 109 (334)
.....+..++...|..||+. .+
T Consensus 116 ~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l 195 (272)
T 4gkh_A 116 DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVV 195 (272)
T ss_dssp GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEE
T ss_pred HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEE
Confidence 22334455555555555531 16
Q ss_pred eeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 110 CHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 110 vH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+|+|++|.|||++..+ .+-|+||+.+.
T Consensus 196 ~HGDl~~~Nil~~~~~--~~~viDwe~a~ 222 (272)
T 4gkh_A 196 THGDFSLDNLIFDEGK--LIGCIDVGRVG 222 (272)
T ss_dssp ECSCCCTTSEEEETTE--EEEECCCTTCE
T ss_pred EcCCCCCCeEEEECCe--EEEEEECcccc
Confidence 8999999999998643 25699999764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.40 E-value=3.6e-06 Score=74.36 Aligned_cols=120 Identities=18% Similarity=0.098 Sum_probs=80.5
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCC---CcccceEEEE-cCCeEEEEEeccCCCChHHHHHhcCCCCHHHH
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHP---NIVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGRFSEDEA 90 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~ 90 (334)
|..+ ++|+-... .....+.+|..+++.+.+. .+.+++.+.. ..+..++||++++|.++....- ..++....
T Consensus 39 g~~~-VlR~~~~~--~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~ 113 (306)
T 3tdw_A 39 NGDW-VFRFPKSQ--QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAK 113 (306)
T ss_dssp TTTE-EEEEESSH--HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHH
T ss_pred CCEE-EEEecCCc--hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHH
Confidence 5677 88884211 2346789999999998753 3556666654 4456789999999988866321 22455555
Q ss_pred HHHHHHHHHHHHHHHHC------------------------------------------------------------Cce
Q 019901 91 RFFFQQLISGVSYCHSM------------------------------------------------------------QVC 110 (334)
Q Consensus 91 ~~~~~qil~~L~~LH~~------------------------------------------------------------~iv 110 (334)
..++.++...|..||+. .++
T Consensus 114 ~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~ 193 (306)
T 3tdw_A 114 DRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLI 193 (306)
T ss_dssp HHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEE
T ss_pred HHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeE
Confidence 55666666666666542 359
Q ss_pred eCCCCCCcEEEcCC--CCCCEEEeccCCccC
Q 019901 111 HRDLKLENTLLDGS--PAPRLKICDFGYSKS 139 (334)
Q Consensus 111 H~dlkp~NIli~~~--~~~~~kl~Dfgla~~ 139 (334)
|+|++|.|||++.. ....+.|+||+.+..
T Consensus 194 HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 194 HGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp CSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred eCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 99999999999861 112248999997653
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.98 E-value=4.3e-06 Score=75.33 Aligned_cols=60 Identities=10% Similarity=-0.022 Sum_probs=40.3
Q ss_pred CCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCC---CCcccceEEEEcC---CeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHL---WQIDENVQREIINHRSLRH---PNIVRFKEVILTP---THLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~h---p~iv~~~~~~~~~---~~~~lv~e~~~~~~L 75 (334)
+..+ ++|+..... ......+.+|+.+++.+.. -.+.+++.+..+. +..++|||+++|.++
T Consensus 52 ~~~~-vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l 120 (357)
T 3ats_A 52 QQKL-VARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVP 120 (357)
T ss_dssp EEEE-EEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCC
T ss_pred CceE-EEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCCh
Confidence 5567 888765432 1123578899999888742 3466777776554 356899999998654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.92 E-value=0.00016 Score=59.65 Aligned_cols=122 Identities=16% Similarity=0.082 Sum_probs=76.9
Q ss_pred CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 73 GELFERICN-AGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 73 ~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
.+|.+.|.. ..+++|+++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|. |-..+ +.+. .
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~--V~f~~-~~s~-----------~ 98 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGA--VTLAP-AADD-----------A 98 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSC--EEECC-C---------------
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCc--eeccc-cccc-----------c
Confidence 378888875 4679999999999999999887632 22223445568999987776 65553 1110 1
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
....+.|||... ...+.+.=|||||+++|.-+--..|= .....+|+.+..||..|
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------------~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------------NEERELSPPLEQLIDHM 153 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------------TEEECCCHHHHHHHHHH
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------------ccchhhCHHHHHHHHHH
Confidence 233456888653 22234468999999999887422221 12235899999999999
Q ss_pred ccc
Q 019901 231 FVA 233 (334)
Q Consensus 231 L~~ 233 (334)
..-
T Consensus 154 t~~ 156 (229)
T 2yle_A 154 ANT 156 (229)
T ss_dssp TTC
T ss_pred Hhc
Confidence 866
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.92 E-value=5.1e-05 Score=67.55 Aligned_cols=30 Identities=27% Similarity=0.442 Sum_probs=25.1
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.+++|+|+++.|||++.++. +.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~--~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQ--IWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGC--EEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCc--EEEEehhhcc
Confidence 57999999999999965443 9999999654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.80 E-value=0.0001 Score=67.32 Aligned_cols=59 Identities=15% Similarity=-0.081 Sum_probs=34.5
Q ss_pred cCCCCeeEEEEEEecCcc-------cccHHHHHHHHHHHcCCC--CC-cccceEEEEcCCeEEEEEeccCCC
Q 019901 12 SYSSDLFVNIIIIVFHLW-------QIDENVQREIINHRSLRH--PN-IVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~-------~~~~~~~~Ei~~l~~l~h--p~-iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
..++..+ +||....... ...+.+..|..+++.+.. |. +.+++.+ +....++|||++.|.
T Consensus 52 ~~~~~~~-vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~ 120 (397)
T 2olc_A 52 QEHDRAL-IIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL 120 (397)
T ss_dssp ----CEE-EEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred CCCCcEE-EEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence 4456777 9998653221 123567889998887742 43 3455543 344458999999774
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.00077 Score=58.98 Aligned_cols=56 Identities=14% Similarity=0.096 Sum_probs=32.0
Q ss_pred CeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEecc-CCCCh
Q 019901 16 DLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYA-SGGEL 75 (334)
Q Consensus 16 ~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~-~~~~L 75 (334)
+.+ ++|+..... ...-...+|+.+++.+...++ .+++.+ ....-++|++|+ +|.++
T Consensus 38 ~~~-vlR~~~~~~-~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l 95 (301)
T 3dxq_A 38 GDL-CLRIPGKGT-EEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTM 95 (301)
T ss_dssp TTE-EEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEEC
T ss_pred eeE-EEECCCCCc-cceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccC
Confidence 556 888876543 112234678887777643333 355544 333347899999 66555
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.28 E-value=0.00089 Score=61.57 Aligned_cols=31 Identities=16% Similarity=0.245 Sum_probs=26.2
Q ss_pred HCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 106 SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 106 ~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
...++|||++|.|||++.++ ++++||+.+..
T Consensus 231 ~~~liHGDl~~~Nil~~~~~---~~lID~e~a~~ 261 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS---TQVIDPEFSFY 261 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC---EEECCCTTCEE
T ss_pred CCeEEecCCCCCcEEEeCCC---CEEEeCccccc
Confidence 46799999999999997543 99999998763
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.17 E-value=0.002 Score=56.90 Aligned_cols=61 Identities=8% Similarity=-0.014 Sum_probs=37.8
Q ss_pred CCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC--cccceEE-----EEcCCeEEEEEeccCCCCh
Q 019901 13 YSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN--IVRFKEV-----ILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~--iv~~~~~-----~~~~~~~~lv~e~~~~~~L 75 (334)
.+|+.+ ++|+..... .....+..|..+++.+.... +++++.. ...++..++||++++|.++
T Consensus 47 ~~g~~~-vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~~ 114 (328)
T 1zyl_A 47 EDRRRF-VVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 114 (328)
T ss_dssp TTCCCE-EEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEE-EEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCCC
Confidence 346678 999987443 23467778888887664222 3333332 2235567899999988543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.07 E-value=0.00097 Score=58.78 Aligned_cols=119 Identities=17% Similarity=0.145 Sum_probs=64.5
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCC-----CCCcccce-E--EEEcCCeEEEEEeccCCCChH----------
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLR-----HPNIVRFK-E--VILTPTHLAIVMEYASGGELF---------- 76 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-----hp~iv~~~-~--~~~~~~~~~lv~e~~~~~~L~---------- 76 (334)
++.+ ++|+..... ..+.+..|+.+++.+. -|.++... + +....+..+++++|++|..+.
T Consensus 45 ~g~~-vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~ 121 (322)
T 2ppq_A 45 KDPL-ILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREV 121 (322)
T ss_dssp SCCE-EEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHH
T ss_pred CccE-EEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHH
Confidence 3467 899886531 2356777888776663 23333211 0 112346679999999986531
Q ss_pred -H---HHHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHH-------CCceeCCCCCCcEEE
Q 019901 77 -E---RICNA-GRF--------SEDEARFF---------------FQQLISGVSYCHS-------MQVCHRDLKLENTLL 121 (334)
Q Consensus 77 -~---~l~~~-~~~--------~~~~~~~~---------------~~qil~~L~~LH~-------~~ivH~dlkp~NIli 121 (334)
. .+... ..+ ........ ...+...+..+.. .+++|+|+++.|||+
T Consensus 122 g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~ 201 (322)
T 2ppq_A 122 GKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFF 201 (322)
T ss_dssp HHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEE
T ss_pred HHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEE
Confidence 0 11110 011 11100000 0113334455542 468999999999999
Q ss_pred cCCCCCCEEEeccCCcc
Q 019901 122 DGSPAPRLKICDFGYSK 138 (334)
Q Consensus 122 ~~~~~~~~kl~Dfgla~ 138 (334)
+.++ .+.++||+.+.
T Consensus 202 ~~~~--~~~lIDf~~a~ 216 (322)
T 2ppq_A 202 LGDE--LSGLIDFYFAC 216 (322)
T ss_dssp ETTE--EEEECCCTTCE
T ss_pred eCCc--eEEEecchhcc
Confidence 8643 24799998654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0014 Score=59.38 Aligned_cols=118 Identities=18% Similarity=0.178 Sum_probs=70.8
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC-cccceEEEEcCCeEEEEEeccCCCChHH--------------HH
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFE--------------RI 79 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~l 79 (334)
+..+ ++|+..... .....+.+|..+++.+..-+ ..++++.+.. .+||||++|.+|.. .+
T Consensus 82 ~~~~-vlR~~g~~~-~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L 155 (379)
T 3feg_A 82 PREV-LLRLYGAIL-QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKM 155 (379)
T ss_dssp CSEE-EEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHH
T ss_pred CCeE-EEEECCCcc-chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHH
Confidence 4677 888864322 33466779999998875322 3556666543 28999999865421 11
Q ss_pred H---hc----C-CCC--HHHHHHHHHHHHH-------------------HHHHHH----H----CCceeCCCCCCcEEEc
Q 019901 80 C---NA----G-RFS--EDEARFFFQQLIS-------------------GVSYCH----S----MQVCHRDLKLENTLLD 122 (334)
Q Consensus 80 ~---~~----~-~~~--~~~~~~~~~qil~-------------------~L~~LH----~----~~ivH~dlkp~NIli~ 122 (334)
. .. + ... ..++..|..++-. .+..|. . ..++|+|+.+.|||++
T Consensus 156 a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~ 235 (379)
T 3feg_A 156 AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLL 235 (379)
T ss_dssp HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEE
T ss_pred HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEc
Confidence 1 11 1 111 3556666655432 223332 2 2489999999999998
Q ss_pred CC--CCCCEEEeccCCcc
Q 019901 123 GS--PAPRLKICDFGYSK 138 (334)
Q Consensus 123 ~~--~~~~~kl~Dfgla~ 138 (334)
.+ ..+.+.++||..|.
T Consensus 236 ~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 236 SEPENADSLMLVDFEYSS 253 (379)
T ss_dssp SCC---CCEEECCCTTCE
T ss_pred CCCCccCcEEEEecccCC
Confidence 65 12359999999764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.95 E-value=0.0068 Score=53.31 Aligned_cols=58 Identities=10% Similarity=-0.055 Sum_probs=44.6
Q ss_pred CCCeeEEEEEEecCcccccHHHHHHHHHHHcCC---CCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 14 SSDLFVNIIIIVFHLWQIDENVQREIINHRSLR---HPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~---hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
.++.+ ++|+.... ....+.+|...|+.|. ...+++++.+....+..++||||++|..+
T Consensus 58 ~~~~~-vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 58 EVQTV-FVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp SSCEE-EEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred CCCeE-EEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 46677 88887543 2456888998888874 35677888888878889999999998764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.93 E-value=0.0083 Score=53.04 Aligned_cols=32 Identities=31% Similarity=0.414 Sum_probs=25.6
Q ss_pred CCceeCCCCCCcEEEcCCC--CCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSP--APRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~--~~~~kl~Dfgla~ 138 (334)
..++|||+++.|||++.+. ...+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 4689999999999997531 1358999999876
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.0027 Score=57.20 Aligned_cols=28 Identities=36% Similarity=0.646 Sum_probs=23.2
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
+++|+|+++.|||++.+ .+.++||..+.
T Consensus 213 ~l~HgDl~~~Nil~~~~---~~~lID~e~a~ 240 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNK---CLRLIDFEYSG 240 (369)
T ss_dssp EEECSCCCGGGEEECC----CEEECCCTTCE
T ss_pred EEEeCCCCcccEEecCC---cEEEEEecCCC
Confidence 58999999999999743 28999998764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=96.50 E-value=0.019 Score=49.59 Aligned_cols=63 Identities=10% Similarity=0.015 Sum_probs=41.0
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCC---CcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHP---NIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp---~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+.....+|+.| ++|+...........+.+|...|+.|..- -+++++.+ .. -++||||+.++..
T Consensus 32 yrv~l~DG~~~-~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 32 YRVELADGTPL-FVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDERPP 97 (288)
T ss_dssp EEEEETTSCEE-EEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCCCCC
T ss_pred EEEEECCCCEE-EEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecccCC
Confidence 34445678888 99986655434456788999999887422 23444443 22 3789999987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.46 E-value=0.059 Score=47.77 Aligned_cols=30 Identities=23% Similarity=0.475 Sum_probs=24.9
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
..++|+|+.+.||+++.++. +.|+||+.+.
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~--~~~iD~e~~~ 235 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEES--IYIIDWDEPM 235 (339)
T ss_dssp CEEECSCCCGGGEEECGGGC--EEECCCSSCE
T ss_pred ceeEeCCCCcCCEEEeCCCe--EEEEECCCCe
Confidence 35899999999999975443 8999998765
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.45 E-value=0.0041 Score=57.31 Aligned_cols=54 Identities=9% Similarity=0.103 Sum_probs=34.7
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+..+ ++|+..... ..+.+.+|..+++.+...++ .++++.+.. .+|++|++|.+|
T Consensus 105 ~~~~-vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 105 PNKV-LLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp CSEE-EEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CceE-EEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 4677 899874321 11566789998888754344 556665532 389999987443
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=95.41 E-value=0.073 Score=49.34 Aligned_cols=55 Identities=18% Similarity=0.071 Sum_probs=34.8
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+..+ ++|+..... ...-...+|..+++.|...++ .++++.+. + .+|++|++|.+|
T Consensus 133 ~~~~-vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 133 QAKY-LIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp TEEE-EEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred CceE-EEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 3677 899875432 111223689999988875555 45776662 2 259999987544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.78 E-value=0.065 Score=49.13 Aligned_cols=55 Identities=18% Similarity=0.104 Sum_probs=34.2
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCC-cccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~-iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+..+ ++|+..... ...-...+|..+++.+...+ ..++++.+ .+ ++|++|++|.+|
T Consensus 102 ~~~~-vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~I~efI~G~~l 157 (424)
T 3mes_A 102 HPRI-LFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--GRIEEFIDGEPL 157 (424)
T ss_dssp CSEE-EEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEEC
T ss_pred CCeE-EEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CEEEEEeCCccC
Confidence 5677 888865433 22234578888888775333 34555543 22 789999998654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=89.56 E-value=0.69 Score=37.85 Aligned_cols=116 Identities=9% Similarity=0.077 Sum_probs=76.4
Q ss_pred CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC
Q 019901 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 125 (334)
Q Consensus 46 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~ 125 (334)
.||+++.. .+-.+++.+.+.++.-+.+.-+..+. ..+....+.++.+|+....+++ .-+|--|+|+||+++.++
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik---~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~ 116 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK---SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDG 116 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG---GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTS
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH---hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCC
Confidence 58888877 57677777777776654333333343 3678889999999888774443 347888999999998776
Q ss_pred CCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019901 126 APRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFE 191 (334)
Q Consensus 126 ~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 191 (334)
. +++.--|+-.. ++|. .. +...=.-.+=|++..+++++..|.
T Consensus 117 ~--p~i~~RGik~~----------------l~P~-----~~-~ee~fL~qyKAliiall~~K~~Fe 158 (215)
T 4ann_A 117 L--PIAKTRGLQNV----------------VDPL-----PV-SEAEFLTRYKALVICAFNEKQSFD 158 (215)
T ss_dssp C--EEESCCEETTT----------------BSCC-----CC-CHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred C--EEEEEccCccC----------------CCCC-----CC-CHHHHHHHHHHHHHHHHcCCCCHH
Confidence 5 88887664221 2222 11 121123345678888888888874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.97 E-value=4 Score=33.42 Aligned_cols=114 Identities=15% Similarity=0.151 Sum_probs=75.0
Q ss_pred CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHCCceeCCCCCCcEEEcCC
Q 019901 46 RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVS-YCHSMQVCHRDLKLENTLLDGS 124 (334)
Q Consensus 46 ~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~-~LH~~~ivH~dlkp~NIli~~~ 124 (334)
.||++ -..+-.+++.+.+.++.-+++.-+..+.+ ++....+.++.+|+.... ++ ..-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~~---~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIRK---TTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHHT---SCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHHh---cCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 57888 44455677888888877655555555543 678888888888877554 33 445788899999999877
Q ss_pred CCCCEEEeccCCccCCCCCCCCCCccCCCccccchhhccCCCCCccchh-hhhhHHHHHHHhCCCCCC
Q 019901 125 PAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADV-WSCGVTLYVMLVGAYPFE 191 (334)
Q Consensus 125 ~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~ 191 (334)
+. +++.-.|+-. -++|.-+ +. .|. -++=|++..++.++..|.
T Consensus 121 ~~--p~i~hRGi~~----------------~lpP~e~------~e-e~fl~qyKali~all~~K~~Fe 163 (219)
T 4ano_A 121 LE--PFFLHVGVKE----------------SLPPDEW------DD-ERLLREVKATVLALTEGEYRFD 163 (219)
T ss_dssp CC--EEESCCEETT----------------TBSSCSC------CH-HHHHHHHHHHHHHHTTCSSCHH
T ss_pred Cc--EEEEEcCCcc----------------cCCCCCC------CH-HHHHHHHHHHHHHHHcCCCCHH
Confidence 65 8888777522 1233211 11 233 345577777887777663
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=82.46 E-value=0.69 Score=41.85 Aligned_cols=30 Identities=40% Similarity=0.606 Sum_probs=23.7
Q ss_pred ceeCCCCCCcEEEcC----CCCCCEEEeccCCcc
Q 019901 109 VCHRDLKLENTLLDG----SPAPRLKICDFGYSK 138 (334)
Q Consensus 109 ivH~dlkp~NIli~~----~~~~~~kl~Dfgla~ 138 (334)
++|+|+.+.|||+.. +....+.++||.+|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 679999999999943 122359999999875
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 334 | ||||
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-69 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 4e-68 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-66 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-64 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-64 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-63 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-63 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 6e-62 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-61 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-61 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-60 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-58 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-56 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 7e-56 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 5e-55 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-54 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 5e-53 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-51 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-50 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 2e-50 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-50 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-48 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-46 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-45 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-45 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-45 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 8e-45 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-44 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-44 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 1e-43 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 1e-43 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-43 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-43 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 6e-42 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-41 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-41 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-40 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-39 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-37 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-35 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-34 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-34 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 8e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-10 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 216 bits (550), Expect = 2e-69
Identities = 78/237 (32%), Positives = 124/237 (52%), Gaps = 8/237 (3%)
Query: 22 IIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81
I+ + EN+++EI ++ L H N+V+F + +EY SGGELF+RI
Sbjct: 37 IVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 96
Query: 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
E +A+ FF QL++GV Y H + + HRD+K EN LLD LKI DFG +
Sbjct: 97 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER--DNLKISDFGLATVFR 154
Query: 142 LHSQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKN 198
+++ + GT Y+APE+L ++E+ + DVWSCG+ L ML G P++ P +
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS-- 212
Query: 199 FRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
+ + + + I L+ +I V +P+ RI+IP+I+ W+ K L
Sbjct: 213 -CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (540), Expect = 4e-68
Identities = 75/224 (33%), Positives = 120/224 (53%), Gaps = 10/224 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
++ ++RE+ LRHPNI+R T + +++EYA G ++ + +F E
Sbjct: 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQR 107
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
+ +L + +SYCHS +V HRD+K EN LL + LKI DFG+S + S+ +
Sbjct: 108 TATYITELANALSYCHSKRVIHRDIKPENLLLGSA--GELKIADFGWSVHAP-SSRRTTL 164
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
GT Y+ PE++ + +D K D+WS GV Y LVG PFE +++T RI V
Sbjct: 165 CGTLDYLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRV 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253
+++ PD ++ R LISR+ +P++R + E+ H W N
Sbjct: 220 EFTFPD--FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 211 bits (538), Expect = 1e-66
Identities = 65/282 (23%), Positives = 120/282 (42%), Gaps = 10/282 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG-RFSEDEAR 91
V+ EI L HP ++ + + +++E+ SGGELF+RI + SE E
Sbjct: 71 YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 130
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ +Q G+ + H + H D+K EN + + A +KI DFG + K T
Sbjct: 131 NYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA 190
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T + APE++ ++ D+W+ GV YV+L G PF ++ +T+ + +
Sbjct: 191 TAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDW 245
Query: 212 SIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+ + +SPE + I + +P KR+++ + H W + + ++++
Sbjct: 246 EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN--LTSRIPSSRYN 303
Query: 270 EPDQPMQSIDEIMQIIAEATIPAAGTQSLNQCLNGSLDIDDE 311
+ Q ++ A A SL + I D
Sbjct: 304 KIRQKIKEKYADWPAPQPAIGRIANFSSLRKHRPQEYQIYDS 345
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 207 bits (527), Expect = 4e-65
Identities = 73/262 (27%), Positives = 123/262 (46%), Gaps = 18/262 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91
E V++EI LRHP +V + + ++ E+ SGGELFE++ + + SEDEA
Sbjct: 68 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 127
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151
+ +Q+ G+ + H H DLK EN + + LK+ DFG + K T G
Sbjct: 128 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTG 187
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
T + APEV K D+WS GV Y++L G PF +N +T+ + S +
Sbjct: 188 TAEFAAPEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGG----ENDDETLRNVKSCDW 242
Query: 212 SIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK-NLPADLV--------- 259
++ D + IS + + I ++ +ADP R++I + H W N P
Sbjct: 243 NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 302
Query: 260 VDNTTNNQFEEPDQPMQSIDEI 281
+ ++ +++ +P+ + I
Sbjct: 303 IRDSIKTKYDAWPEPLPPLGRI 324
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 204 bits (519), Expect = 2e-64
Identities = 79/242 (32%), Positives = 120/242 (49%), Gaps = 8/242 (3%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEAR 91
+ +++ EI ++HPNIV ++ + HL ++M+ SGGELF+RI G ++E +A
Sbjct: 51 EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS 110
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP-RLKICDFGYSKSSVLHSQPKSTV 150
Q++ V Y H + + HRDLK EN L ++ I DFG SK S +
Sbjct: 111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTAC 170
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP Y+APEVL +K Y D WS GV Y++L G PF D +N K +IL +
Sbjct: 171 GTPGYVAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAE 225
Query: 211 YSI--PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQF 268
Y P + IS + I + DP KR + + H W + D + + + Q
Sbjct: 226 YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQI 285
Query: 269 EE 270
++
Sbjct: 286 KK 287
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (519), Expect = 3e-64
Identities = 58/227 (25%), Positives = 102/227 (44%), Gaps = 8/227 (3%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI-CNAGRFSEDEA 90
V++EI RH NI+ E + L ++ E+ SG ++FERI +A +E E
Sbjct: 45 QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI 104
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150
+ Q+ + + HS + H D++ EN + + +KI +FG ++ +
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
P Y APEV D+WS G +YV+L G PF + ++ I I++ +
Sbjct: 165 TAPEYYAPEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAE 219
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
Y+ + + IS E + R+ V + R++ E H W + +
Sbjct: 220 YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (513), Expect = 3e-63
Identities = 83/265 (31%), Positives = 132/265 (49%), Gaps = 11/265 (4%)
Query: 33 ENVQREI-INHRSLRHPNIVRFKEVILTP----THLAIVMEYASGGELFERICNAG--RF 85
+RE+ ++ R+ + P+IVR +V L IVME GGELF RI + G F
Sbjct: 49 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF 108
Query: 86 SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHS 144
+E EA + + + Y HS+ + HRD+K EN L P LK+ DFG++K + H+
Sbjct: 109 TEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN 168
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ TP Y+APEVL ++YD D+WS GV +Y++L G PF
Sbjct: 169 SLTTPCYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT 227
Query: 205 RILSVQYSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDN 262
RI QY P+ + +S E + LI + +P +R++I E NH W +++ +
Sbjct: 228 RIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 287
Query: 263 TTNNQFEEPDQPMQSIDEIMQIIAE 287
T+ E+ ++ +E+ +A
Sbjct: 288 TSRVLKEDKERWEDVKEEMTSALAT 312
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 200 bits (510), Expect = 6e-63
Identities = 62/252 (24%), Positives = 109/252 (43%), Gaps = 18/252 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+++ +E+ + LRHPN ++++ L +VMEY G + E E
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAA 119
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ G++Y HS + HRD+K N LL +K+ DFG + + + S VGT
Sbjct: 120 VTHGALQGLAYLHSHNMIHRDVKAGNILLSEP--GLVKLGDFGSAS---IMAPANSFVGT 174
Query: 153 PAYIAPEVLL---KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
P ++APEV+L + +YDGK DVWS G+T + P + N ++ I
Sbjct: 175 PYWMAPEVILAMDEGQYDGK-VDVWSLGITCIELAERKPPLFN----MNAMSALYHIAQN 229
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFE 269
+ H S R+ + P R + + H + L+ P +++D +
Sbjct: 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD-----LIQ 284
Query: 270 EPDQPMQSIDEI 281
++ +D +
Sbjct: 285 RTKDAVRELDNL 296
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 6e-62
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 12/223 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
V RE L HP V+ L + YA GEL + I G F E RF
Sbjct: 53 PYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF 112
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST--- 149
+ +++S + Y H + HRDLK EN LL+ ++I DFG +K S+
Sbjct: 113 YTAEIVSALEYLHGKGIIHRDLKPENILLNED--MHIQITDFGTAKVLSPESKQARANSF 170
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
VGT Y++PE+L +K +D+W+ G +Y ++ G PF N +I+ +
Sbjct: 171 VGTAQYVSPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKL 225
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252
+Y P+ P+ R L+ ++ V D KR+ E+ +
Sbjct: 226 EYDFPE--KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 195 bits (497), Expect = 2e-61
Identities = 70/227 (30%), Positives = 111/227 (48%), Gaps = 10/227 (4%)
Query: 30 QIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
++ E +E+ R + HPNI++ K+ T T +V + GELF+ + SE
Sbjct: 51 ELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEK 110
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
E R + L+ + H + + HRDLK EN LLD +K+ DFG+S + +
Sbjct: 111 ETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD--MNIKLTDFGFSCQLDPGEKLRE 168
Query: 149 TVGTPAYIAPEVLLKKEYD-----GKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 203
GTP+Y+APE++ D GK D+WS GV +Y +L G+ PF ++ R +
Sbjct: 169 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 228
Query: 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
+ Q+ P++ S + L+SR V P KR + E H +F
Sbjct: 229 SG--NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-61
Identities = 63/224 (28%), Positives = 104/224 (46%), Gaps = 8/224 (3%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E + EI+ R ++PNIV + + L L +VMEY +GG L + + E +
Sbjct: 62 ELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAA 120
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-VG 151
++ + + + HS QV HRD+K +N LL +K+ DFG+ +ST VG
Sbjct: 121 VCRECLQALEFLHSNQVIHRDIKSDNILLGMD--GSVKLTDFGFCAQITPEQSKRSTMVG 178
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP ++APEV+ +K Y K D+WS G+ M+ G P+ + + +
Sbjct: 179 TPYWMAPEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYL---IATNGTP 234
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255
+ + +S R ++R D KR S E+ H++ P
Sbjct: 235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP 278
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 1e-60
Identities = 54/233 (23%), Positives = 103/233 (44%), Gaps = 13/233 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR-FSEDEAR 91
E+ EI S HPNIV+ + +L I++E+ +GG + + R +E + +
Sbjct: 54 EDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQ 113
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST-V 150
+Q + ++Y H ++ HRDLK N L +K+ DFG S + Q + + +
Sbjct: 114 VVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD--GDIKLADFGVSAKNTRTIQRRDSFI 171
Query: 151 GTPAYIAPEVLLKKEYDGKI----ADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
GTP ++APEV++ + + ADVWS G+TL M P + N + + +I
Sbjct: 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHE----LNPMRVLLKI 227
Query: 207 LSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
+ ++ S + + + + R + ++ H + + +
Sbjct: 228 AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPI 280
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-60
Identities = 61/263 (23%), Positives = 106/263 (40%), Gaps = 43/263 (16%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
I + RE+ P IV F + ++I ME+ GG L + + AGR E
Sbjct: 46 AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 90 ARFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
+I G++Y + HRD+K N L++ +K+CDFG S ++ S S
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSR--GEIKLCDFGVSG-QLIDSMANS 162
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE------------- 195
VGT +Y++PE L Y + +D+WS G++L M VG YP P+
Sbjct: 163 FVGTRSYMSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG 221
Query: 196 -------------------------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230
P + + I++ S E + +++
Sbjct: 222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 281
Query: 231 FVADPAKRISIPEIRNHEWFLKN 253
+ +PA+R + ++ H + ++
Sbjct: 282 LIKNPAERADLKQLMVHAFIKRS 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 1e-58
Identities = 75/222 (33%), Positives = 125/222 (56%), Gaps = 9/222 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+++RE+ + ++HPN++ EV T + +++E +GGELF+ + +E+EA
Sbjct: 58 EDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATE 117
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPKSTV 150
F +Q+++GV Y HS+Q+ H DLK EN +L P PR+KI DFG + ++ K+
Sbjct: 118 FLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF 177
Query: 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ 210
GTP ++APE++ + AD+WS GV Y++L GA PF ++T+ + +V
Sbjct: 178 GTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVN 232
Query: 211 YSIPD--YVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
Y D + + S + I R+ V DP KR++I + H W
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-58
Identities = 57/224 (25%), Positives = 103/224 (45%), Gaps = 13/224 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGELFERICNAGRFSED 88
+ + E + L+HPNIVRF + + + +V E + G L +
Sbjct: 53 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIK 112
Query: 89 EARFFFQQLISGVSYCHSM--QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
R + +Q++ G+ + H+ + HRDLK +N + G P +KI D G + S
Sbjct: 113 VLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITG-PTGSVKIGDLGLATLKR-ASFA 170
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
K+ +GTP ++APE+ +++YD DV++ G+ + M YP+ + +N + R+
Sbjct: 171 KAVIGTPEFMAPEM-YEEKYDES-VDVYAFGMCMLEMATSEYPYSE---CQNAAQIYRRV 225
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
S PE + +I + +R SI ++ NH +F
Sbjct: 226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 3e-56
Identities = 66/229 (28%), Positives = 101/229 (44%), Gaps = 20/229 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVIL--TPTHLAIVMEYASGGELFERICNAGR----FS 86
+ + E+ R L+HPNIVR+ + I+ T T L IVMEY GG+L I +
Sbjct: 48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLD 107
Query: 87 EDEARFFFQQLISGVSYCH-----SMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 141
E+ QL + CH V HRDLK N LDG +K+ DFG ++
Sbjct: 108 EEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ--NVKLGDFGLARILN 165
Query: 142 LHSQPKSTVG-TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 200
+ TP Y++PE + + Y+ K +D+WS G LY + PF + +
Sbjct: 166 HDTSFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTA----FSQK 220
Query: 201 KTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ +I ++ Y S E +I+R+ R S+ EI +
Sbjct: 221 ELAGKIREGKFRRIPY-RYSDELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 7e-56
Identities = 73/223 (32%), Positives = 114/223 (51%), Gaps = 11/223 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
++ + + + + HP + T +L VMEY +GG+L I + +F
Sbjct: 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR 104
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
A F+ ++I G+ + HS + +RDLKL+N LLD +KI DFG K ++L +T
Sbjct: 105 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD--GHIKIADFGMCKENMLGDAKTNT 162
Query: 150 -VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
GTP YIAPE+LL ++Y+ D WS GV LY ML+G PF ++ + H I
Sbjct: 163 FCGTPDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRM 217
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIP-EIRNHEWF 250
P + E + L+ ++FV +P KR+ + +IR H F
Sbjct: 218 DNPFYPR--WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 5e-55
Identities = 55/253 (21%), Positives = 102/253 (40%), Gaps = 10/253 (3%)
Query: 10 RCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEY 69
+ + D+ V ++ + Q + + E+ R RH NI+ F T LAIV ++
Sbjct: 26 KGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQW 84
Query: 70 ASGGELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 128
G L+ + +F + +Q G+ Y H+ + HRDLK N L
Sbjct: 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL--T 142
Query: 129 LKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYD--GKIADVWSCGVTLYVM 183
+KI DFG + Q + G+ ++APEV+ ++ + +DV++ G+ LY +
Sbjct: 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYEL 202
Query: 184 LVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPE 243
+ G P+ + + R + + L++ +R P+
Sbjct: 203 MTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQ 262
Query: 244 IRNH-EWFLKNLP 255
I E ++LP
Sbjct: 263 ILASIELLARSLP 275
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-54
Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 17/221 (7%)
Query: 33 ENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEYASGG-ELFERICNAGRFSEDE 89
V E++ + + ++R + P +++E +LF+ I G E+
Sbjct: 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEEL 111
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
AR FF Q++ V +CH+ V HRD+K EN L+D + LK+ DFG + +
Sbjct: 112 ARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGAL-LKDTVYTDF 169
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
GT Y PE + Y G+ A VWS G+ LY M+ G PFE EE I+
Sbjct: 170 DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----------IIRG 219
Query: 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 250
Q +S EC+HLI P+ R + EI+NH W
Sbjct: 220 QVFFRQ--RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 176 bits (447), Expect = 5e-53
Identities = 72/272 (26%), Positives = 118/272 (43%), Gaps = 28/272 (10%)
Query: 34 NVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFF 93
N + + + P IV TP L+ +++ +GG+L + G FSE + RF+
Sbjct: 53 NERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY 112
Query: 94 FQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTP 153
++I G+ + H+ V +RDLK N LLD ++I D G + +P ++VGT
Sbjct: 113 AAEIILGLEHMHNRFVVYRDLKPANILLD--EHGHVRISDLGLACDFS-KKKPHASVGTH 169
Query: 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI 213
Y+APEVL K AD +S G L+ +L G PF + K+ + L++ +
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF-RQHKTKDKHEIDRMTLTMAVEL 228
Query: 214 PDYVHISPECRHLISRIFVADPAKRISIP-----EIRNHEWF---------LKNLPADLV 259
PD SPE R L+ + D +R+ E++ +F L+ P L+
Sbjct: 229 PD--SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLI 286
Query: 260 --------VDNTTNNQFEEPDQPMQSIDEIMQ 283
D F+E D + + Q
Sbjct: 287 PPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQ 318
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 171 bits (434), Expect = 1e-51
Identities = 72/223 (32%), Positives = 113/223 (50%), Gaps = 16/223 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+ E + + HP I+R + ++M+Y GGELF + + RF A+F
Sbjct: 49 EHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKF 108
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ ++ + Y HS + +RDLK EN LLD + +KI DFG++K + + GT
Sbjct: 109 YAAEVCLALEYLHSKDIIYRDLKPENILLDKN--GHIKITDFGFAK--YVPDVTYTLCGT 164
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P YIAPEV+ K Y+ D WS G+ +Y ML G PF D N KT +IL+ +
Sbjct: 165 PDYIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELR 219
Query: 213 IPDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF 250
P + + + L+SR+ D ++R+ +++NH WF
Sbjct: 220 FPP--FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 2e-50
Identities = 68/292 (23%), Positives = 104/292 (35%), Gaps = 35/292 (11%)
Query: 28 LWQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASGG---ELFER 78
+ Q RE+ R L H NIVR + + +L +V++Y
Sbjct: 53 VLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY 112
Query: 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
+ + QL ++Y HS +CHRD+K +N LLD A K+CDFG +K
Sbjct: 113 SRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVL-KLCDFGSAK 171
Query: 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--- 195
V S + + Y APE++ DVWS G L +L+G F
Sbjct: 172 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 231
Query: 196 --------------------PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235
P +I + ++ PE L SR+ P
Sbjct: 232 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 236 AKRISIPEIRNHEWF--LKNLPADLVVDNTTNNQFEEPDQPMQSIDEIMQII 285
R++ E H +F L++ L T F Q + S + I+
Sbjct: 292 TARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATIL 343
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 2e-50
Identities = 46/223 (20%), Positives = 83/223 (37%), Gaps = 9/223 (4%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFERICNAGRFSED 88
+RE N +L HP IV + T IVMEY G L + + G +
Sbjct: 52 LRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPK 111
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG--YSKSSVLHSQP 146
A +++ H + HRD+K N ++ + A ++ + S +Q
Sbjct: 112 RAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 171
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+ +GT Y++PE D + +DV+S G LY +L G PF + +
Sbjct: 172 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRED 230
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEW 249
+ + +S + ++ + +P R +
Sbjct: 231 PIPPSARHE--GLSADLDAVVLKALAKNPENRYQTAAEMRADL 271
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 3e-50
Identities = 57/250 (22%), Positives = 97/250 (38%), Gaps = 26/250 (10%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
I+ REI + L HPNI+ + +++++V ++ N+ +
Sbjct: 42 GINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSH 101
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS-SVLHSQPKS 148
+ + + G+ Y H + HRDLK N LLD + LK+ DFG +KS +
Sbjct: 102 IKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDEN--GVLKLADFGLAKSFGSPNRAYTH 159
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
V T Y APE+L G D+W+ G L +L+ + + + +
Sbjct: 160 QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT 219
Query: 209 V-------QYSIPDYV---------------HISPECRHLISRIFVADPAKRISIPEIRN 246
S+PDYV + LI +F+ +P RI+ +
Sbjct: 220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279
Query: 247 HEWFLKNLPA 256
++F N P
Sbjct: 280 MKYF-SNRPG 288
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 4e-49
Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 12/221 (5%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFERICNAGR--FS 86
+ E LRH N+V+ VI+ L IV EY + G L + + + GR
Sbjct: 42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLG 101
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
D F + + Y HRDL N L+ K+ DFG +K S
Sbjct: 102 GDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSED--NVAKVSDFGLTKE--ASSTQ 157
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+ + APE L +K++ K +DVWS G+ L+ + K+ + +
Sbjct: 158 DTGKLPVKWTAPEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK- 215
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ PD P ++ + D A R S ++R
Sbjct: 216 -GYKMDAPD--GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (413), Expect = 2e-48
Identities = 74/224 (33%), Positives = 111/224 (49%), Gaps = 15/224 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ E ++ RHP + K T L VMEYA+GGELF + F+E+ ARF
Sbjct: 50 AHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF 109
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP-KSTVG 151
+ +++S + Y HS V +RD+KLEN +LD +KI DFG K + K+ G
Sbjct: 110 YGAEIVSALEYLHSRDVVYRDIKLENLMLDKD--GHIKITDFGLCKEGISDGATMKTFCG 167
Query: 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY 211
TP Y+APEVL +Y D W GV +Y M+ G PF + ++ + IL +
Sbjct: 168 TPEYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEI 222
Query: 212 SIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRNHEWF 250
P +SPE + L++ + DP +R+ E+ H +F
Sbjct: 223 RFPR--TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 3e-46
Identities = 59/284 (20%), Positives = 106/284 (37%), Gaps = 50/284 (17%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT--------HLAIVMEYA 70
+ +++ REI + L+H N+V E+ T + +V ++
Sbjct: 40 LKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC 99
Query: 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLK 130
+F+ E + Q L++G+ Y H ++ HRD+K N L+ LK
Sbjct: 100 EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG--VLK 157
Query: 131 ICDFGYSK-----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV 185
+ DFG ++ + ++ + V T Y PE+LL + G D+W G + M
Sbjct: 158 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 217
Query: 186 GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVH--------------------------- 218
+ + + + I + SI V
Sbjct: 218 RSPIMQG----NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLK 273
Query: 219 ---ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN-LPADL 258
P LI ++ V DPA+RI + NH++F + +P+DL
Sbjct: 274 AYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 4e-46
Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 12/223 (5%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC-NAGRFSED 88
+ ++ RE+ SL H N++R V+LTP + +V E A G L +R+ + G F
Sbjct: 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLG 111
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHS 144
+ Q+ G+ Y S + HRDL N LL +KI DFG + + +
Sbjct: 112 TLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR--DLVKIGDFGLMRALPQNDDHYV 169
Query: 145 QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIH 204
+ A+ APE L + + +D W GVTL+ M P N + +H
Sbjct: 170 MQEHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQE---PWIGLNGSQILH 225
Query: 205 RILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+I +P + +++ + + P R + +R+
Sbjct: 226 KIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDF 268
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-45
Identities = 58/296 (19%), Positives = 112/296 (37%), Gaps = 38/296 (12%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASG 72
+ + F + RE+ + +RH N++ +V T +VM +
Sbjct: 48 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105
Query: 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132
G ++ + ED +F Q++ G+ Y H+ + HRDLK N ++ LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED--CELKIL 163
Query: 133 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 192
DFG ++ S+ V T Y APEV+L + D+WS G + M+ G F+
Sbjct: 164 DFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKG 221
Query: 193 PEEPKNFRKTIHRILSVQYSIPDYV-------------------------HISPECRHLI 227
+ ++ + + + + SP +L+
Sbjct: 222 SDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLL 281
Query: 228 SRIFVADPAKRISIPEIRNHEWFLK-NLPADLVVDNTTNNQFEEPDQPMQSIDEIM 282
++ V D +R++ E H +F + D ++ F++ D+ + +
Sbjct: 282 EKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVT 337
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 2e-45
Identities = 70/300 (23%), Positives = 115/300 (38%), Gaps = 46/300 (15%)
Query: 22 IIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTH----LAIVMEYASGGELFE 77
I F + REI RH NI+ ++I PT ++ + G +L++
Sbjct: 40 KISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYK 99
Query: 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137
+ S D +F Q++ G+ Y HS V HRDLK N LL+ + LKICDFG +
Sbjct: 100 LL-KTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC--DLKICDFGLA 156
Query: 138 K----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDP 193
+ V T Y APE++L + K D+WS G L ML F
Sbjct: 157 RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPG- 215
Query: 194 EEPKNFRKTIHRILSVQYSIPD-----------------------------YVHISPECR 224
K++ ++ IL + S + + +
Sbjct: 216 ---KHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKAL 272
Query: 225 HLISRIFVADPAKRISIPEIRNHEWFLKNL-PADLVVDNTTNN-QFEEPDQPMQSIDEIM 282
L+ ++ +P KRI + + H + + P+D + E D P + + E++
Sbjct: 273 DLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDMELDDLPKEKLKELI 332
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 154 bits (389), Expect = 2e-45
Identities = 62/256 (24%), Positives = 102/256 (39%), Gaps = 26/256 (10%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78
+ I + I REI + L+H NIV+ +VI T L +V E+
Sbjct: 31 LKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLL 90
Query: 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
G A+ F QL++G++YCH +V HRDLK +N L++ LKI DFG ++
Sbjct: 91 DVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE--GELKIADFGLAR 148
Query: 139 SSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
+ + + + + T Y AP+VL+ + D+WS G M+ G F E
Sbjct: 149 AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD 208
Query: 198 NFRKTIHRILSVQYSIPDYV-----------------------HISPECRHLISRIFVAD 234
+ + + V + L+S++ D
Sbjct: 209 QLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLD 268
Query: 235 PAKRISIPEIRNHEWF 250
P +RI+ + H +F
Sbjct: 269 PNQRITAKQALEHAYF 284
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 155 bits (393), Expect = 3e-45
Identities = 76/270 (28%), Positives = 129/270 (47%), Gaps = 30/270 (11%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
E+ E +++ P +V+ + ++L +VMEY +GGE+F + GRFSE ARF
Sbjct: 86 EHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGT 152
+ Q++ Y HS+ + +RDLK EN L+D +++ DFG++K + + GT
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ--GYIQVTDFGFAKRV--KGRTWTLCGT 201
Query: 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS 212
P +APE++L K Y+ D W+ GV +Y M G PF + +I+S +
Sbjct: 202 PEALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVR 256
Query: 213 IPDYVHISPECRHLISRIFVADPAKRI-----SIPEIRNHEWF---------LKNLPADL 258
P H S + + L+ + D KR + +I+NH+WF + + A
Sbjct: 257 FPS--HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314
Query: 259 V-----VDNTTNNQFEEPDQPMQSIDEIMQ 283
+ +T+N E ++ SI+E
Sbjct: 315 IPKFKGPGDTSNFDDYEEEEIRVSINEKCG 344
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 7e-45
Identities = 41/222 (18%), Positives = 83/222 (37%), Gaps = 12/222 (5%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSED 88
++ E +L H +V+ V + I+ EY + G L + RF
Sbjct: 41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQ 100
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
+ + + + Y S Q HRDL N L++ +K+ DFG S+ + S
Sbjct: 101 QLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG--VVKVSDFGLSRYVLDDEYTSS 158
Query: 149 T--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHR 205
+ PEVL+ ++ K +D+W+ GV ++ + +G P+E +
Sbjct: 159 VGSKFPVRWSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 217
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ S + ++ + +R + + ++
Sbjct: 218 -----LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 153 bits (388), Expect = 8e-45
Identities = 50/253 (19%), Positives = 102/253 (40%), Gaps = 39/253 (15%)
Query: 33 ENVQREIINHRSLR-HPNIVRFKEVILTPTH--LAIVMEYASGGELFERICNAGRFSEDE 89
+ ++REI +LR PNI+ +++ P A+V E+ + + + ++ +
Sbjct: 74 KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYD 130
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149
RF+ +++ + YCHSM + HRD+K N ++D +L++ D+G ++ +
Sbjct: 131 IRFYMYEILKALDYCHSMGIMHRDVKPHNVMID-HEHRKLRLIDWGLAEFYHPGQEYNVR 189
Query: 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV 209
V + + PE+L+ + D+WS G L M+ PF + + I ++L
Sbjct: 190 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 249
Query: 210 QY--------------------------------SIPDYVHISPECRHLISRIFVADPAK 237
+ + +SPE + ++ D
Sbjct: 250 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 309
Query: 238 RISIPEIRNHEWF 250
R++ E H +F
Sbjct: 310 RLTAREAMEHPYF 322
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 1e-44
Identities = 53/228 (23%), Positives = 84/228 (36%), Gaps = 20/228 (8%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA-GRFSEDEAR 91
E + RE L +P IVR V L +VME A GG L + +
Sbjct: 54 EEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA 112
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPK 147
Q+ G+ Y HRDL N LL + I DFG SK ++
Sbjct: 113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAK--ISDFGLSKALGADDSYYTARS 170
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRI 206
+ + APE + +++ + +DVWS GVT++ L G P++ + + I
Sbjct: 171 AGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKK----MKGPEVMAFI 225
Query: 207 LSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIR---NHEWF 250
+ P PE L+S ++ R + ++
Sbjct: 226 EQGKRMECPP--ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 46/231 (19%), Positives = 79/231 (34%), Gaps = 18/231 (7%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARF 92
+ + E + L +P IVR + + + +VME A G L + + +
Sbjct: 53 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 93 FFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS----SVLHSQPKS 148
Q+ G+ Y HRDL N LL KI DFG SK+ +
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLLV--TQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRIL 207
+ APE + ++ K +DVWS GV ++ G P+ + +
Sbjct: 170 GKWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRG----MKGSEVTAMLE 224
Query: 208 SVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRN--HEWFLKNLP 255
+ P E L++ + D R + ++ +
Sbjct: 225 KGERMGCPA--GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN 273
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 2e-44
Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 9/228 (3%)
Query: 30 QIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSED 88
+ E+ + E +R P +V T T L ++++Y +GGELF + RF+E
Sbjct: 70 KTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH 129
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
E + + +++ + + H + + +RD+KLEN LLD + L + +
Sbjct: 130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYD 189
Query: 149 TVGTPAYIAPEVLL-KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
GT Y+AP+++ K D WS GV +Y +L GA PF E + + RIL
Sbjct: 190 FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 249
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRIS-----IPEIRNHEWF 250
+ P +S + LI R+ + DP KR+ EI+ H +F
Sbjct: 250 KSEPPYPQ--EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-44
Identities = 66/257 (25%), Positives = 106/257 (41%), Gaps = 27/257 (10%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS-GGELFE 77
+ I + + REI + L HPNIV+ +VI T L +V E+ + F
Sbjct: 32 LKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFM 91
Query: 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYS 137
+ + QL+ G+++CHS +V HRDLK +N L++ +K+ DFG +
Sbjct: 92 DASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG--AIKLADFGLA 149
Query: 138 KSSVLHSQPKST-VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP 196
++ + + + V T Y APE+LL +Y D+WS G M+ F E
Sbjct: 150 RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI 209
Query: 197 KNFRKTIH-------RILSVQYSIPDYV----------------HISPECRHLISRIFVA 233
+ + S+PDY + + R L+S++
Sbjct: 210 DQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHY 269
Query: 234 DPAKRISIPEIRNHEWF 250
DP KRIS H +F
Sbjct: 270 DPNKRISAKAALAHPFF 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-44
Identities = 47/243 (19%), Positives = 89/243 (36%), Gaps = 35/243 (14%)
Query: 33 ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI------------ 79
E + E+ L H NIV + ++ EY G+L +
Sbjct: 85 EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI 144
Query: 80 -----------CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPR 128
+ + ++ F Q+ G+ + HRDL N L+
Sbjct: 145 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHG--KV 202
Query: 129 LKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML- 184
+KICDFG ++ S + + ++APE L + Y K +DVWS G+ L+ +
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFS 261
Query: 185 VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
+G P+ ++++ + + + + E ++ + D KR S P +
Sbjct: 262 LGVNPYPG----IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317
Query: 245 RNH 247
+
Sbjct: 318 TSF 320
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (378), Expect = 1e-43
Identities = 49/233 (21%), Positives = 94/233 (40%), Gaps = 17/233 (7%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSED 88
+ + E HPN++ + V+ T + I+ E+ G L N G+F+
Sbjct: 69 KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVI 128
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK------SSVL 142
+ + + +G+ Y M HRDL N L++ + K+ DFG S+ S
Sbjct: 129 QLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN--LVCKVSDFGLSRFLEDDTSDPT 186
Query: 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRK 201
++ + APE + +++ +DVWS G+ ++ ++ G P+ D +
Sbjct: 187 YTSALGGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWD----MTNQD 241
Query: 202 TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKN 253
I+ I Y +P + L+ + D R +I N + ++N
Sbjct: 242 VINAIEQ-DYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 1e-43
Identities = 47/249 (18%), Positives = 90/249 (36%), Gaps = 11/249 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDE 89
+ ++ + E S+ +P++ R + LT T I G L +
Sbjct: 53 KANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQY 112
Query: 90 ARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQP 146
+ Q+ G++Y ++ HRDL N L+ +KI DFG +K +
Sbjct: 113 LLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTP--QHVKITDFGLAKLLGAEEKEYHA 170
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+ ++A E +L + Y + +DVWS GVT++ ++ D I I
Sbjct: 171 EGGKVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASE----ISSI 225
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH-EWFLKNLPADLVVDNTTN 265
L +P + + ++ + ++ D R E+ ++ LV+
Sbjct: 226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDER 285
Query: 266 NQFEEPDQP 274
P
Sbjct: 286 MHLPSPTDS 294
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 2e-43
Identities = 48/232 (20%), Positives = 88/232 (37%), Gaps = 14/232 (6%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE--RICNAGRFSE 87
E +E + LRH +V+ V+ + + IV EY S G L + +
Sbjct: 54 MSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRL 112
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQ 145
+ Q+ SG++Y M HRDL+ N L+ + K+ DFG ++ ++
Sbjct: 113 PQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN--LVCKVADFGLARLIEDNEYTA 170
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
+ + APE L + K +DVWS G+ L + + + R
Sbjct: 171 RQGAKFPIKWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 229
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN--HEWFLKNLP 255
Y +P L+ + + +P +R + ++ ++F P
Sbjct: 230 ----GYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEP 277
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 45/221 (20%), Positives = 85/221 (38%), Gaps = 10/221 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE-RICNAGRFSED 88
+E+ E L HP +V+ V L + +V E+ G L + G F+ +
Sbjct: 42 MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAE 101
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQP 146
+ G++Y V HRDL N L+ + +K+ DFG ++ ++
Sbjct: 102 TLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ--VIKVSDFGMTRFVLDDQYTSS 159
Query: 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
T + +PEV Y K +DVWS GV ++ + P E ++ + + I
Sbjct: 160 TGTKFPVKWASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKI---PYENRSNSEVVEDI 215
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ + + S +++ + P R + +
Sbjct: 216 ST-GFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (373), Expect = 4e-43
Identities = 51/221 (23%), Positives = 97/221 (43%), Gaps = 11/221 (4%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSED 88
+ E +E + R HP+IV+ VI T + I+ME + GEL +
Sbjct: 50 SVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLA 108
Query: 89 EARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148
+ QL + ++Y S + HRD+ N L+ + +K+ DFG S+ + K+
Sbjct: 109 SLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSN--DCVKLGDFGLSRYMEDSTYYKA 166
Query: 149 T--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 206
+ ++APE + + + +DVW GV ++ +L+ P + I RI
Sbjct: 167 SKGKLPIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVK---PFQGVKNNDVIGRI 222
Query: 207 LSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ + +P + P L+++ + DP++R E++
Sbjct: 223 ENGER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-43
Identities = 63/251 (25%), Positives = 94/251 (37%), Gaps = 33/251 (13%)
Query: 30 QIDENVQREIINHRSL---RHPNIVRFKEVILTP-----THLAIVMEYASGGEL-FERIC 80
+ + RE+ R L HPN+VR +V T L +V E+ +
Sbjct: 49 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV 108
Query: 81 NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS 140
+ + QL+ G+ + HS +V HRDLK +N L+ S ++K+ DFG ++
Sbjct: 109 PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS--GQIKLADFGLARIY 166
Query: 141 VLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFR 200
S V T Y APEVLL+ Y D+WS G M F +
Sbjct: 167 SFQMALTSVVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLG 225
Query: 201 KTIHRIL---------------------SVQYSIPDYVHISPECRHLISRIFVADPAKRI 239
K + I S Q I + L+ + +PAKRI
Sbjct: 226 KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
Query: 240 SIPEIRNHEWF 250
S +H +F
Sbjct: 286 SAYSALSHPYF 296
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-43
Identities = 62/262 (23%), Positives = 105/262 (40%), Gaps = 27/262 (10%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFER 78
+ + + + + REI + L+H NIVR +V+ + L +V E+
Sbjct: 32 LKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYF 91
Query: 79 ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138
G + + F QL+ G+ +CHS V HRDLK +N L++ + LK+ +FG ++
Sbjct: 92 DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN--GELKLANFGLAR 149
Query: 139 SSVLHSQPKS-TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPK 197
+ + + S V T Y P+VL + D+WS G + P +
Sbjct: 150 AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 209
Query: 198 NFRKTIHRIL--------SVQYSIPDYV----------------HISPECRHLISRIFVA 233
+ K I R+L +PDY ++ R L+ +
Sbjct: 210 DQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKC 269
Query: 234 DPAKRISIPEIRNHEWFLKNLP 255
+P +RIS E H +F P
Sbjct: 270 NPVQRISAEEALQHPYFSDFCP 291
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-42
Identities = 43/227 (18%), Positives = 84/227 (37%), Gaps = 14/227 (6%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI--CNAGRFSE 87
+ E + L+H +VR V+ T + I+ EY G L + + + + +
Sbjct: 50 MSPDAFLAEANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTI 108
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
++ Q+ G+++ HRDL+ N L+ KI DFG ++ +
Sbjct: 109 NKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVS--DTLSCKIADFGLARLIEDNEYTA 166
Query: 148 ST--VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
+ APE + + K +DVWS G+ L ++ + + R
Sbjct: 167 REGAKFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN--HEWF 250
Y + + E L+ + P R + +R+ ++F
Sbjct: 226 ----GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 6e-42
Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 11/217 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR--FSEDEA 90
E +E + ++HPN+V+ V I+ E+ + G L + + R S
Sbjct: 58 EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL 117
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK--SSVLHSQPKS 148
+ Q+ S + Y HRDL N L+ + +K+ DFG S+ + ++
Sbjct: 118 LYMATQISSAMEYLEKKNFIHRDLAARNCLVGEN--HLVKVADFGLSRLMTGDTYTAHAG 175
Query: 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS 208
+ APE L ++ K +DVW+ GV L+ + + ++ +L
Sbjct: 176 AKFPIKWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLE 230
Query: 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIR 245
Y + + L+ + +P+ R S EI
Sbjct: 231 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 8e-42
Identities = 49/232 (21%), Positives = 83/232 (35%), Gaps = 24/232 (10%)
Query: 33 ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERI------------ 79
+ E+ L HPNI+ +L + +EYA G L + +
Sbjct: 55 RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAF 114
Query: 80 ----CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFG 135
A S + F + G+ Y Q HRDL N L+ + KI DFG
Sbjct: 115 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGEN--YVAKIADFG 172
Query: 136 YSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 195
S+ ++ + ++A E L Y +DVWS GV L+ ++ P
Sbjct: 173 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGT---PYC 228
Query: 196 PKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ ++ Y + ++ E L+ + + P +R S +I
Sbjct: 229 GMTCAELYEKLPQ-GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-41
Identities = 56/281 (19%), Positives = 108/281 (38%), Gaps = 36/281 (12%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLA-----IVMEYASGGELFERICNAGRFSE 87
+ RE+ + ++H N++ +V L ++ + G I + ++
Sbjct: 62 KRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTD 120
Query: 88 DEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147
D +F Q++ G+ Y HS + HRDLK N ++ LKI DFG ++ +
Sbjct: 121 DHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVN--EDCELKILDFGLARH--TDDEMT 176
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
V T Y APE++L + + D+WS G + +L G F + + + +
Sbjct: 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVG 236
Query: 208 SVQYSIPD-------------------------YVHISPECRHLISRIFVADPAKRISIP 242
+ + ++ +P L+ ++ V D KRI+
Sbjct: 237 TPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAA 296
Query: 243 EIRNHEWFLK-NLPADLVVDNTTNNQFEEPDQPMQSIDEIM 282
+ H +F + + P D V + + FE D + +
Sbjct: 297 QALAHAYFAQYHDPDDEPVADPYDQSFESRDLLIDEWKSLT 337
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 142 bits (359), Expect = 9e-41
Identities = 48/253 (18%), Positives = 88/253 (34%), Gaps = 18/253 (7%)
Query: 25 VFHLWQIDENVQREIINHRSLRHPN-IVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83
+ + + E ++ ++ I + + +VME +
Sbjct: 39 LECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSR 98
Query: 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLL-DGSPAPRLKICDFGYSK---- 138
+FS Q+IS + Y HS HRD+K +N L+ G + I DFG +K
Sbjct: 99 KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158
Query: 139 ----SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPE 194
+ + + K+ GT Y + L E + D+ S G L +G+ P++ +
Sbjct: 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLK 217
Query: 195 EPKNFRKTIHRILSVQYSIPDYV---HISPECRHLISRIFVADPAKRISIPEIRN---HE 248
+K RI + S P V E ++ + +R +
Sbjct: 218 AATKRQK-YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 249 WFLKNLPADLVVD 261
+ + D V D
Sbjct: 277 FHRQGFSYDYVFD 289
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 140 bits (354), Expect = 4e-40
Identities = 50/243 (20%), Positives = 91/243 (37%), Gaps = 36/243 (14%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGR----- 84
+ + QRE +PNIV+ V + ++ EY + G+L E + +
Sbjct: 58 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 117
Query: 85 -------------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP 125
S E +Q+ +G++Y + HRDL N L+ +
Sbjct: 118 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 177
Query: 126 APRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYV 182
+KI DFG S+ S+ + + ++ PE + Y + +DVW+ GV L+
Sbjct: 178 --VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWE 234
Query: 183 MLVGAYPFEDPEEPKNFRKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISI 241
+ P + I+ + + P+ + E +L+ + PA R S
Sbjct: 235 IFSYGLQ---PYYGMAHEEVIYYVRDGNILACPE--NCPLELYNLMRLCWSKLPADRPSF 289
Query: 242 PEI 244
I
Sbjct: 290 CSI 292
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 1e-39
Identities = 47/231 (20%), Positives = 87/231 (37%), Gaps = 12/231 (5%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN-AGRFSEDEAR 91
+ E H NI+R + VI + I+ EY G L + + G FS +
Sbjct: 54 VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLV 113
Query: 92 FFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK----SSVLHSQPK 147
+ + +G+ Y +M HRDL N L++ + K+ DFG S+
Sbjct: 114 GMLRGIAAGMKYLANMNYVHRDLAARNILVNSN--LVCKVSDFGLSRVLEDDPEATYTTS 171
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRIL 207
+ APE + +++ +DVWS G+ ++ ++ K I+
Sbjct: 172 GGKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND-- 228
Query: 208 SVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADL 258
+ +P + L+ + + + A+R +I + L P L
Sbjct: 229 --GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDSL 277
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 7e-39
Identities = 40/222 (18%), Positives = 79/222 (35%), Gaps = 14/222 (6%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVIL-TPTHLAIVMEYASGGELFE-RICNAGRFSEDEA 90
E I + HPN++ + L + +V+ Y G+L + +
Sbjct: 73 SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132
Query: 91 RFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK-----SSVLHSQ 145
F Q+ G+ + S + HRDL N +LD +K+ DFG ++
Sbjct: 133 IGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEK--FTVKVADFGLARDMYDKEFDSVHN 190
Query: 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHR 205
++A E L +++ K +DVWS GV L+ ++ P + + +
Sbjct: 191 KTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 206 ILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ + ++ + + R S E+ +
Sbjct: 250 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 3e-38
Identities = 47/234 (20%), Positives = 81/234 (34%), Gaps = 28/234 (11%)
Query: 33 ENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERIC----------- 80
E + E+ L H NIV ++ EY G+L +
Sbjct: 71 EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT 130
Query: 81 -------NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 133
+ ++ F Q+ G+++ S HRDL N LL KICD
Sbjct: 131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG--RITKICD 188
Query: 134 FGYSKSSVLHSQPKST---VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF 190
FG ++ S ++APE + Y + +DVWS G+ L+ +
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSP 247
Query: 191 EDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEI 244
++++ + + H E ++ + ADP KR + +I
Sbjct: 248 YPGM---PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 133 bits (334), Expect = 3e-37
Identities = 37/237 (15%), Positives = 76/237 (32%), Gaps = 17/237 (7%)
Query: 25 VFHLWQIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG 83
++ E ++ L I H +V++
Sbjct: 37 FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGR 96
Query: 84 RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP---RLKICDFGYSK-- 138
+FS +Q+++ V H + +RD+K +N L+ + + + DFG K
Sbjct: 97 KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156
Query: 139 ------SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 192
+ + + K+ GT Y++ L +E + D+ + G L G+ P++
Sbjct: 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQG 215
Query: 193 PEEPKNFRKTIHRILSVQYSIPDYV---HISPECRHLISRIFVADPAKRISIPEIRN 246
+ N +K RI + S P E + ++
Sbjct: 216 LKAATNKQK-YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 3e-36
Identities = 46/263 (17%), Positives = 99/263 (37%), Gaps = 26/263 (9%)
Query: 2 LGFHNFYDRCSYSSDLFVNIIIIVFHLWQID-ENVQREIINHRSL-RHPNIVRFKEVILT 59
L D+ + V + ++ + D ++ E+ + + +H NI+
Sbjct: 31 LAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 90
Query: 60 PTHLAIVMEYASGGELFERI----------------CNAGRFSEDEARFFFQQLISGVSY 103
L +++EYAS G L E + + S + Q+ G+ Y
Sbjct: 91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 150
Query: 104 CHSMQVCHRDLKLENTLLDGSPAPRL-KICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 162
S + HRDL N L+ ++ + + + ++APE L
Sbjct: 151 LASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALF 210
Query: 163 KKEYDGKIADVWSCGVTLYVML-VGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISP 221
+ Y + +DVWS GV L+ + +G P+ + + ++L + + + +
Sbjct: 211 DRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPV-----EELFKLLKEGHRMDKPSNCTN 264
Query: 222 ECRHLISRIFVADPAKRISIPEI 244
E ++ + A P++R + ++
Sbjct: 265 ELYMMMRDCWHAVPSQRPTFKQL 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 4e-35
Identities = 60/309 (19%), Positives = 109/309 (35%), Gaps = 48/309 (15%)
Query: 19 VNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYASG 72
+ + F + RE++ + + H NI+ V + +VME
Sbjct: 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106
Query: 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132
+ + Q++ G+ + HS + HRDLK N ++ LKI
Sbjct: 107 NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD--CTLKIL 161
Query: 133 DFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFED 192
DFG ++++ V T Y APEV+L Y + D+WS G + M+ F
Sbjct: 162 DFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPG 220
Query: 193 PEEPKNFRKTIHRILSVQYSIPDYVH---------------------------------- 218
+ + K I ++ + +
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 219 --ISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLPADLVVDNTTNNQFEEPDQPMQ 276
+ + R L+S++ V DPAKRIS+ + H + V ++ D+
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREH 340
Query: 277 SIDEIMQII 285
+I+E ++I
Sbjct: 341 TIEEWKELI 349
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 7e-35
Identities = 52/252 (20%), Positives = 88/252 (34%), Gaps = 41/252 (16%)
Query: 32 DENVQREIINHRSLRHPNIVRFKEVI----LTPTHLAIVMEYASGGELFERICNAGRFSE 87
+ EI LRH NI+ F T T L +V +Y G LF+ + N +
Sbjct: 41 SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTV 99
Query: 88 DEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFG---- 135
+ SG+++ H + HRDLK +N L+ + I D G
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKN--GTCCIADLGLAVR 157
Query: 136 -YSKSSVLHSQPKSTVGTPAYIAPEVL-----LKKEYDGKIADVWSCGVTLYVMLVGAYP 189
S + + P VGT Y+APEVL +K K AD+++ G+ + +
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217
Query: 190 FEDPEEPKNFRKTIHRILSVQYSIPDYV----------------HISPECRHLISRIFVA 233
E+ + + + V ++ + A
Sbjct: 218 GGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYA 277
Query: 234 DPAKRISIPEIR 245
+ A R++ I+
Sbjct: 278 NGAARLTALRIK 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 1e-34
Identities = 45/238 (18%), Positives = 85/238 (35%), Gaps = 26/238 (10%)
Query: 30 QIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIVMEYASGGELFERICNAGR---- 84
+ + I H N+V P L +++E+ G L + +
Sbjct: 59 EHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVP 118
Query: 85 ------------FSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132
+ + + Q+ G+ + S + HRDL N LL +KIC
Sbjct: 119 YKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK--NVVKIC 176
Query: 133 DFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYP 189
DFG ++ + + ++APE + + Y + +DVWS GV L+ +
Sbjct: 177 DFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGAS 235
Query: 190 FEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
P + R L + + +PE + + +P++R + E+ H
Sbjct: 236 ---PYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 4e-34
Identities = 41/229 (17%), Positives = 85/229 (37%), Gaps = 22/229 (9%)
Query: 33 ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRF------- 85
E + ++VR V+ ++ME + G+L + +
Sbjct: 68 IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127
Query: 86 ---SEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---S 139
S + ++ G++Y ++ + HRDL N ++ +KI DFG ++
Sbjct: 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAED--FTVKIGDFGMTRDIYE 185
Query: 140 SVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNF 199
+ + + + +++PE L + DVWS GV L+ + A P + +
Sbjct: 186 TDYYRKGGKGLLPVRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQ---PYQGLSN 241
Query: 200 RKTIHRILSVQY-SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247
+ + ++ PD + L+ + +P R S EI +
Sbjct: 242 EQVLRFVMEGGLLDKPD--NCPDMLFELMRMCWQYNPKMRPSFLEIISS 288
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 109 bits (272), Expect = 8e-28
Identities = 48/272 (17%), Positives = 90/272 (33%), Gaps = 51/272 (18%)
Query: 36 QREIINHRSLRHPNIVR----FKEVILTPTHLAIVMEYASGGEL-FERICNAGRFSEDEA 90
+ S+ +I++ F H+ +V E L +
Sbjct: 68 DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127
Query: 91 RFFFQQLISGVSYCHSMQ-VCHRDLKLENTLLD--GSPAPRLKICDFGYSKSSVLHSQPK 147
+ +QL+ G+ Y H + H D+K EN L++ SP ++I +
Sbjct: 128 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 187
Query: 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPF--EDPEEPKNFRKTIHR 205
+++ T Y +PEVLL + AD+WS ++ ++ G + F ++ I +
Sbjct: 188 NSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ 246
Query: 206 ILSVQYSIPDYV----------------------------------------HISPECRH 225
I+ + +P Y+ + E
Sbjct: 247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISD 306
Query: 226 LISRIFVADPAKRISIPEIRNHEWFLKNLPAD 257
+S + DP KR + NH W L +
Sbjct: 307 FLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 338
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 57.5 bits (138), Expect = 2e-10
Identities = 21/154 (13%), Positives = 42/154 (27%), Gaps = 27/154 (17%)
Query: 27 HLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFS 86
+ + E + L+ + + A++ME R
Sbjct: 53 FSVLAIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMEL-------IDAKELYRVR 101
Query: 87 EDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 146
+ ++ V+ + + H DL N L+ + I DF SV +
Sbjct: 102 VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSE---EGIWIIDFP---QSVEVGEE 155
Query: 147 KSTVGTPAYIAPEVL-----LKKEYDGKIADVWS 175
+ +V + Y D+ S
Sbjct: 156 GW----REILERDVRNIITYFSRTY-RTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 334 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.86 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.39 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.91 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.67 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.53 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.44 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.43 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-61 Score=420.23 Aligned_cols=246 Identities=32% Similarity=0.561 Sum_probs=206.5
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||++ .|+++.+|+.| |||++.+... ...+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.+++.+
T Consensus 18 fg~V~~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~ 96 (271)
T d1nvra_ 18 YGEVQLAVNRVTEEAV-AVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEP 96 (271)
T ss_dssp TEEEEEEEETTTCCEE-EEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBT
T ss_pred CeEEEEEEECCCCCEE-EEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhc
Confidence 4444 48899999999 9999987652 3456799999999999999999999999999999999999999999999988
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CCCCCccCCCccccc
Q 019901 82 AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAP 158 (334)
Q Consensus 82 ~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~~~~~~gt~~y~aP 158 (334)
.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|+||
T Consensus 97 ~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~--~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~AP 174 (271)
T d1nvra_ 97 DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDN--LKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174 (271)
T ss_dssp TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCC--EEECCCTTCEECEETTEECCBCCCCSCGGGSCT
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCC--EEEccchhheeeccCCccccccceeeCcCccCH
Confidence 888999999999999999999999999999999999999987765 999999999854322 223456899999999
Q ss_pred hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 159 EVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 159 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
|++.+..++++++|||||||++|+|++|++||............ ........+.+..+|+++++||.+||+.||.+|
T Consensus 175 E~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 251 (271)
T d1nvra_ 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD---WKEKKTYLNPWKKIDSAPLALLHKILVENPSAR 251 (271)
T ss_dssp HHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH---HHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTS
T ss_pred hHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH---HhcCCCCCCccccCCHHHHHHHHHHcCCChhHC
Confidence 99998888777799999999999999999999876543332222 222233334445689999999999999999999
Q ss_pred CCHhHHhcCccccccCC
Q 019901 239 ISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 239 ~s~~ell~h~~~~~~~~ 255 (334)
||++|+|+||||++.++
T Consensus 252 ~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 252 ITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp CCHHHHTTCTTTTCCCC
T ss_pred cCHHHHhcCHhhCcCCC
Confidence 99999999999987654
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-59 Score=413.91 Aligned_cols=245 Identities=25% Similarity=0.386 Sum_probs=209.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .|+++.+|+.| |||++.+......+.+.+|+.+++.++|||||+++++|.+++.+|+|||||+||+|.+
T Consensus 28 iG~G~fg~Vy~a~~~~~~~~v-AvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~ 106 (293)
T d1yhwa1 28 IGQGASGTVYTAMDVATGQEV-AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD 106 (293)
T ss_dssp CCCSSSCEEEEEEBTTTCCEE-EEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHH
T ss_pred EecCcCcEEEEEEECCCCCEE-EEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHH
Confidence 666665 58889999999 9999988765556789999999999999999999999999999999999999999998
Q ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCccc
Q 019901 78 RICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~y~ 156 (334)
++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... .....+||+.|+
T Consensus 107 ~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~ 183 (293)
T d1yhwa1 107 VVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGS--VKLTDFGFCAQITPEQSKRSTMVGTPYWM 183 (293)
T ss_dssp HHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSTTCCBCCCCSCGGGC
T ss_pred Hhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCc--EeeccchhheeeccccccccccccCCCcc
Confidence 8765 56999999999999999999999999999999999999987664 9999999998654333 345567999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|||||||++|+|++|++||.+......+..... .....++.+..+|+++++||.+||++||.
T Consensus 184 aPE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~ 259 (293)
T d1yhwa1 184 APEVVTRKAYGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT---NGTPELQNPEKLSAIFRDFLNRCLDMDVE 259 (293)
T ss_dssp CHHHHSSSCBCTH-HHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH---HCSCCCSSGGGSCHHHHHHHHHHTCSSTT
T ss_pred ChhhhcCCCCCch-hceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHh---CCCCCCCCcccCCHHHHHHHHHHccCChh
Confidence 9999999888665 9999999999999999999988765444433222 22333444456899999999999999999
Q ss_pred CCCCHhHHhcCccccccC
Q 019901 237 KRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 237 ~R~s~~ell~h~~~~~~~ 254 (334)
+|||++|+|+||||+...
T Consensus 260 ~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 260 KRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp TSCCHHHHTTCGGGGGCC
T ss_pred HCcCHHHHhcCHhhCCCC
Confidence 999999999999997543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-60 Score=409.99 Aligned_cols=241 Identities=33% Similarity=0.589 Sum_probs=208.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|+++.+|+.| |||++.+.. ....+.+.+|+.+++.++|||||++++++.+++.+|+|||||++|+
T Consensus 14 iG~G~fg~Vy~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~ 92 (263)
T d2j4za1 14 LGKGKFGNVYLAREKQSKFIL-ALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGT 92 (263)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EecCCCcEEEEEEECCCCcEE-EEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCc
Confidence 455544 48889999999 999998654 2345678999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.... ......+||+.
T Consensus 93 L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--~kl~DFG~a~~~~~-~~~~~~~Gt~~ 169 (263)
T d2j4za1 93 VYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGE--LKIADFGWSVHAPS-SRRTTLCGTLD 169 (263)
T ss_dssp HHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEECCCCSCSCCCC-CCCEETTEEGG
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCC--EeecccceeeecCC-CcccccCCCCc
Confidence 9999999889999999999999999999999999999999999999987765 99999999976433 23345679999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+... ....+......+|. .+|+++++||.+||++|
T Consensus 170 Y~APE~~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~----~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 242 (263)
T d2j4za1 170 YLPPEMIEGRMHDEK-VDLWSLGVLCYEFLVGKPPFEANTYQE----TYKRISRVEFTFPD--FVTEGARDLISRLLKHN 242 (263)
T ss_dssp GCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHH----HHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred ccCHHHHcCCCCCch-hhhhhHhHHHHHHhcCCCCCCCCCHHH----HHHHHHcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 999999998888655 999999999999999999998765533 33344444544443 58999999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 019901 235 PAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~ 253 (334)
|.+|||++|+|+||||+.+
T Consensus 243 p~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 243 PSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp GGGSCCHHHHHTCHHHHHH
T ss_pred HhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-59 Score=416.83 Aligned_cols=246 Identities=34% Similarity=0.582 Sum_probs=193.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .|+++.+|+.| |||++.+... .....+.+|+.+++.++|||||++++++.+++.+|+|||||+||+|.
T Consensus 17 lG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~ 95 (307)
T d1a06a_ 17 LGTGAFSEVILAEDKRTQKLV-AIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 95 (307)
T ss_dssp SBSGGGGGEEEEEETTTCCEE-EEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred EeeccCeEEEEEEECCCCCEE-EEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence 677776 58889999999 9999987653 23457889999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC-CCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS-PAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~-~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+++.+.+++++..++.++.||+.||+|||++||+||||||+|||+... ..+.+||+|||+|+.........+.+||+.|
T Consensus 96 ~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y 175 (307)
T d1a06a_ 96 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGY 175 (307)
T ss_dssp HHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTT
T ss_pred HhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccc
Confidence 999998899999999999999999999999999999999999999642 2346999999999876555555677899999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--cCCCCCCCCHHHHHHHHHhccc
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--SIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~ 233 (334)
+|||++.+..++.+ +|||||||++|+|++|++||.+........ .+..... ..+.+..+|+++++||.+||++
T Consensus 176 ~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 250 (307)
T d1a06a_ 176 VAPEVLAQKPYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFE----QILKAEYEFDSPYWDDISDSAKDFIRHLMEK 250 (307)
T ss_dssp SCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHH----HHHTTCCCCCTTTTTTSCHHHHHHHHHHSCS
T ss_pred cCcHHHcCCCCCcH-HHhhhhhHHHHHHHhCCCCCCCCCHHHHHH----HHhccCCCCCCccccCCCHHHHHHHHHHccC
Confidence 99999998888665 999999999999999999998766543333 3333333 3344567899999999999999
Q ss_pred CCCCCCCHhHHhcCcccccc
Q 019901 234 DPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 234 ~p~~R~s~~ell~h~~~~~~ 253 (334)
||.+|||++|+++||||+..
T Consensus 251 dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 251 DPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp SGGGSCCHHHHHHSTTTTSS
T ss_pred CHhHCcCHHHHhcCHhhCCC
Confidence 99999999999999999653
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-58 Score=406.79 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=204.9
Q ss_pred CCcce---e-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHN---F-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~---~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+ + .|+++.+|..| |||++.+......+.+.+|+.++++++|||||++++++.+++.+|+|||||+||+|.+
T Consensus 20 iG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~ 98 (288)
T d2jfla1 20 LGDGAFGKVYKAQNKETSVLA-AAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 98 (288)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHH
T ss_pred EeeCCCcEEEEEEECCCCeEE-EEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHH
Confidence 45554 4 48889999998 9999988765566789999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCCcc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTPAY 155 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~~y 155 (334)
++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+||+.|
T Consensus 99 ~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y 176 (288)
T d2jfla1 99 VMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGD--IKLADFGVSAKNTRTIQRRDSFIGTPYW 176 (288)
T ss_dssp HHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECHHHHHHHTCCCSCCTT
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCC--EEEEechhhhccCCCccccccccccccc
Confidence 8765 456999999999999999999999999999999999999987765 999999999754322 123456799999
Q ss_pred ccchhhc-----cCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 156 IAPEVLL-----KKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 156 ~aPE~~~-----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
+|||++. +..|+ .++|||||||++|+|++|++||.+.+..+.+...... ....++.+..+|+++++||.+|
T Consensus 177 ~APE~l~~~~~~~~~y~-~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~---~~~~~~~~~~~s~~~~~li~~~ 252 (288)
T d2jfla1 177 MAPEVVMCETSKDRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS---EPPTLAQPSRWSSNFKDFLKKC 252 (288)
T ss_dssp CCHHHHTTCSTTTSSTT-THHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHS---CCCCCSSGGGSCHHHHHHHHHH
T ss_pred CCHHHHhhcccCCCCCC-hhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC---CCCCCCccccCCHHHHHHHHHH
Confidence 9999985 33344 4599999999999999999999987765554443221 1223344456899999999999
Q ss_pred cccCCCCCCCHhHHhcCccccc
Q 019901 231 FVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h~~~~~ 252 (334)
|++||.+|||++|+|+||||+.
T Consensus 253 L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 253 LEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp SCSSTTTSCCHHHHTTSGGGCC
T ss_pred ccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999964
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.9e-58 Score=416.55 Aligned_cols=246 Identities=25% Similarity=0.457 Sum_probs=211.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +|+++.+|+.| |||++.+........+.+|+.++++++|||||+++++|.+++.+|+|||||+||+|.+
T Consensus 37 lG~G~fg~V~~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 115 (352)
T d1koba_ 37 LGSGAFGVVHRCVEKATGRVF-VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD 115 (352)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHH
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHH
Confidence 455554 48889999999 9999987764445678899999999999999999999999999999999999999998
Q ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
.+.+.+ ++++.+++.++.||+.||+|||++||+||||||+|||++....+++||+|||+|+.........+..||+.|+
T Consensus 116 ~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~ 195 (352)
T d1koba_ 116 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFA 195 (352)
T ss_dssp HTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGC
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCccccc
Confidence 876654 6999999999999999999999999999999999999985555579999999998766655556678999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~ 234 (334)
|||++.+..++.+ +|||||||++|+|++|++||.+.+....+.. +......++ .+..+|+++++||.+||++|
T Consensus 196 aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 270 (352)
T d1koba_ 196 APEIVDREPVGFY-TDMWAIGVLGYVLLSGLSPFAGEDDLETLQN----VKRCDWEFDEDAFSSVSPEAKDFIKNLLQKE 270 (352)
T ss_dssp CHHHHTTCCBCHH-HHHHHHHHHHHHHHHSCCSSCCSSHHHHHHH----HHHCCCCCCSSTTTTSCHHHHHHHHTTSCSS
T ss_pred CHHHHcCCCCCCc-cchHHHHHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 9999998888655 9999999999999999999988766444333 333333333 34578999999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 019901 235 PAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~ 253 (334)
|.+|||++|+|+||||+..
T Consensus 271 p~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 271 PRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp GGGSCCHHHHHTSTTTSSC
T ss_pred hhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999764
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2e-58 Score=417.29 Aligned_cols=246 Identities=29% Similarity=0.506 Sum_probs=210.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .|+++.+|+.| |||++.+......+.+.+|+.++++++|||||++++++.+++.+|+|||||+||+|.+
T Consensus 34 lG~G~fg~Vy~~~~~~~g~~v-AvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~ 112 (350)
T d1koaa2 34 LGTGAFGVVHRVTERATGNNF-AAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE 112 (350)
T ss_dssp EEEETTEEEEEEEETTTTEEE-EEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHH
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHH
Confidence 455554 48889999999 9999987764455788999999999999999999999999999999999999999999
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
++.+ .+++++..++.++.||+.||.|||++|||||||||+|||++.+..+.+||+|||+|+.........+.+||+.||
T Consensus 113 ~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~ 192 (350)
T d1koaa2 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 192 (350)
T ss_dssp HHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTC
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCccccc
Confidence 9854 467999999999999999999999999999999999999976544569999999998765555556678999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~ 234 (334)
|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+.. +......++ .+..+|+++++||.+||+.|
T Consensus 193 aPEv~~~~~~~~~-~DiwSlGvilyell~G~~Pf~~~~~~~~~~~----i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 267 (350)
T d1koaa2 193 APEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRN----VKSCDWNMDDSAFSGISEDGKDFIRKLLLAD 267 (350)
T ss_dssp CHHHHHTCCBCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH----HHHTCCCSCCGGGGGCCHHHHHHHHHHCCSS
T ss_pred CHHHHcCCCCChh-HhhhhhhHHHHHHHhCCCCCCCCCHHHHHHH----HHhCCCCCCcccccCCCHHHHHHHHHHccCC
Confidence 9999998888655 9999999999999999999987765444433 333333322 23468999999999999999
Q ss_pred CCCCCCHhHHhcCcccccc
Q 019901 235 PAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~ 253 (334)
|.+|||++|+|+||||+..
T Consensus 268 P~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 268 PNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp GGGSCCHHHHHHSTTTSCT
T ss_pred hhHCcCHHHHhcCcccCCC
Confidence 9999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-58 Score=407.05 Aligned_cols=245 Identities=31% Similarity=0.565 Sum_probs=210.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .|+++.+|+.| |||++.+.... ..+.+.+|+.++++++|||||+++++|.+++.+|+|||||+
T Consensus 18 lG~G~fg~Vy~~~~~~~~~~~-AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~ 96 (293)
T d1jksa_ 18 LGSGQFAVVKKCREKSTGLQY-AAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96 (293)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCC
Confidence 455554 48889999999 99999876522 23679999999999999999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCC--CCEEEeccCCccCCCCCCCCCCc
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPA--PRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~--~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++. ..+||+|||+|+.........+.
T Consensus 97 gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~ 176 (293)
T d1jksa_ 97 GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNI 176 (293)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCC
T ss_pred CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCcccccc
Confidence 9999999998889999999999999999999999999999999999999976553 25999999999876666666677
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLI 227 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li 227 (334)
.||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..+.+. .+......++ .+..+|+++++||
T Consensus 177 ~~t~~y~APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li 251 (293)
T d1jksa_ 177 FGTPEFVAPEIVNYEPLGLE-ADMWSIGVITYILLSGASPFLGDTKQETLA----NVSAVNYEFEDEYFSNTSALAKDFI 251 (293)
T ss_dssp CCCGGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHH----HHHTTCCCCCHHHHTTSCHHHHHHH
T ss_pred CCCCcccCHHHHcCCCCCCc-ccchhhhHHHHHHHcCCCCCCCCCHHHHHH----HHHhcCCCCCchhcCCCCHHHHHHH
Confidence 89999999999988878655 999999999999999999999866544333 3333333322 2346899999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccc
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.+||+.||.+|||++|+|+||||+.
T Consensus 252 ~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 252 RRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp HTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred HHHccCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999964
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=413.25 Aligned_cols=247 Identities=26% Similarity=0.404 Sum_probs=201.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .|+++.+|+.| |+|++.+... .....+.+|+.+|+.++|||||+++++|.+++.+|+|||||+||+|.
T Consensus 14 iG~G~fg~V~~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~ 92 (322)
T d1s9ja_ 14 LGAGNGGVVFKVSHKPSGLVM-ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 92 (322)
T ss_dssp EECCSSCCEEEEEETTTTEEE-EEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHH
T ss_pred EecCCCeEEEEEEECCCCcEE-EEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHH
Confidence 566665 48888899998 9999987642 33467899999999999999999999999999999999999999999
Q ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC-CceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCcc
Q 019901 77 ERICNAGRFSEDEARFFFQQLISGVSYCHSM-QVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAY 155 (334)
Q Consensus 77 ~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~-~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y 155 (334)
+++.+.+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++. +||+|||+|+.... ....+.+||+.|
T Consensus 93 ~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~--vkl~DFGla~~~~~-~~~~~~~GT~~Y 169 (322)
T d1s9ja_ 93 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGE--IKLCDFGVSGQLID-SMANSFVGTRSY 169 (322)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCC--EEECCCCCCHHHHH-HTC---CCSSCC
T ss_pred HHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCC--EEEeeCCCccccCC-CccccccCCccc
Confidence 9999988999999999999999999999975 9999999999999987765 99999999985432 233466899999
Q ss_pred ccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHH----------------------------------
Q 019901 156 IAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRK---------------------------------- 201 (334)
Q Consensus 156 ~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---------------------------------- 201 (334)
+|||++.+..|+.+ +||||+||++|+|++|+.||.+.+.......
T Consensus 170 ~APEvl~~~~y~~~-~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (322)
T d1s9ja_ 170 MSPERLQGTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPM 248 (322)
T ss_dssp CCHHHHHCSCCCTT-HHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCC
T ss_pred cCchHHcCCCCCcH-HHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccch
Confidence 99999999888766 9999999999999999999986543221100
Q ss_pred ----HHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 202 ----TIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 202 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
.................+|+++++||.+||+.||.+|||++|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~ 304 (322)
T d1s9ja_ 249 AIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304 (322)
T ss_dssp CHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred hHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence 0000111111101112368999999999999999999999999999999764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-58 Score=403.49 Aligned_cols=239 Identities=31% Similarity=0.514 Sum_probs=202.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHH
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERI 79 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 79 (334)
||++ .|+++.+|+.| |||++.+... ...+.+.+|+.++++++||||++++++|.+++.+|+|||||+||+|.+++
T Consensus 21 fg~Vy~a~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~ 99 (288)
T d1uu3a_ 21 FSTVVLARELATSREY-AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYI 99 (288)
T ss_dssp SCEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhh
Confidence 4444 48889999999 9999987542 33467999999999999999999999999999999999999999999999
Q ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCCccc
Q 019901 80 CNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYI 156 (334)
Q Consensus 80 ~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~~y~ 156 (334)
...+.+++..++.++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+...... ...+.+||+.|+
T Consensus 100 ~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~ 177 (288)
T d1uu3a_ 100 RKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMH--IQITDFGTAKVLSPESKQARANSFVGTAQYV 177 (288)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECC----------CCCCGGGC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCce--EEecccccceecccCCcccccccccCCcccc
Confidence 99999999999999999999999999999999999999999987765 9999999998653322 234567999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPA 236 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~ 236 (334)
|||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ .++......+|. .+|+++++||.+||++||.
T Consensus 178 APE~~~~~~~~~~-~DiwSlGvilyell~g~~Pf~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~~li~~~L~~dP~ 250 (288)
T d1uu3a_ 178 SPELLTEKSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIF----QKIIKLEYDFPE--KFFPKARDLVEKLLVLDAT 250 (288)
T ss_dssp CHHHHHTCCCCHH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHTTCCCCCT--TCCHHHHHHHHTTSCSSGG
T ss_pred CceeeccCCCCcc-cceehhhHHHHHHhhCCCCCCCcCHHHHH----HHHHcCCCCCCc--cCCHHHHHHHHHHccCCHh
Confidence 9999998888654 99999999999999999999986654333 334455555543 5899999999999999999
Q ss_pred CCCCHhH------HhcCccccc
Q 019901 237 KRISIPE------IRNHEWFLK 252 (334)
Q Consensus 237 ~R~s~~e------ll~h~~~~~ 252 (334)
+|||++| +++||||..
T Consensus 251 ~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 251 KRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp GSTTSGGGTCHHHHHTSGGGTT
T ss_pred HCcCHHHHcCCHHHHcCCccCC
Confidence 9999988 578888854
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-57 Score=405.78 Aligned_cols=242 Identities=26% Similarity=0.374 Sum_probs=204.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccc---cHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQI---DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~---~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|+++.+|+.| |||++.+..... .+.+.+|+.++++++|||||++++++.+++.+|+|||||.+|+
T Consensus 23 lG~G~fg~Vy~a~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~ 101 (309)
T d1u5ra_ 23 IGHGSFGAVYFARDVRNSEVV-AIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSA 101 (309)
T ss_dssp EEECSSSEEEEEEETTTTEEE-EEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred EecCCCeEEEEEEECCCCcEE-EEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCc
Confidence 455554 47888999988 999998765322 2468899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|..++...+++++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.... ....+||+.
T Consensus 102 l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~--~Kl~DFG~a~~~~~---~~~~~GT~~ 176 (309)
T d1u5ra_ 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL--VKLGDFGSASIMAP---ANSFVGTPY 176 (309)
T ss_dssp HHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE--EEECCCTTCBSSSS---BCCCCSCGG
T ss_pred hHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC--EEEeecccccccCC---CCccccCcc
Confidence 9888888888999999999999999999999999999999999999987765 99999999986433 345689999
Q ss_pred cccchhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 155 YIAPEVLLKK---EYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 155 y~aPE~~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+|||++.+. .|+. ++|||||||++|+|++|+.||.+......+. .+.......+....+|+++++||.+||
T Consensus 177 Y~APE~~~~~~~~~y~~-~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~s~~~~~li~~~L 251 (309)
T d1u5ra_ 177 WMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY----HIAQNESPALQSGHWSEYFRNFVDSCL 251 (309)
T ss_dssp GCCHHHHTTTTSCCBCT-HHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH----HHHHSCCCCCSCTTSCHHHHHHHHHHT
T ss_pred ccCHHHHhccCCCCcCc-hhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH----HHHhCCCCCCCCCCCCHHHHHHHHHHC
Confidence 9999998643 3544 4999999999999999999998766544333 333333333344568999999999999
Q ss_pred ccCCCCCCCHhHHhcCccccccC
Q 019901 232 VADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
+.||.+|||++|+|+||||.+..
T Consensus 252 ~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 252 QKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp CSSGGGSCCHHHHTTCHHHHSCC
T ss_pred cCChhHCcCHHHHHhCHHhcCCC
Confidence 99999999999999999997654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=407.17 Aligned_cols=241 Identities=33% Similarity=0.576 Sum_probs=209.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| +|+++.+|+.| |||++.+... ...+.+.+|+.+|+.++||||++++++|++++.+|+|||||+||+
T Consensus 13 lG~G~fg~V~~~~~~~~~~~~-AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~ 91 (337)
T d1o6la_ 13 LGKGTFGKVILVREKATGRYY-AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 91 (337)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCc
Confidence 455544 48899999999 9999987642 334678899999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+..... ....+.+||+
T Consensus 92 L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~--vkl~DFG~a~~~~~~~~~~~~~~GT~ 169 (337)
T d1o6la_ 92 LFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH--IKITDFGLCKEGISDGATMKTFCGTP 169 (337)
T ss_dssp HHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCSCCTTCCBCCCEECG
T ss_pred hhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCC--EEEeecccccccccCCcccccceeCH
Confidence 9999999999999999999999999999999999999999999999987765 999999999865443 3345678999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+.... ...+......+|. .+|+++++||.+||++
T Consensus 170 ~Y~aPE~~~~~~y~~~-~DiwSlGvilyeml~G~~pf~~~~~~~~----~~~i~~~~~~~p~--~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 170 EYLAPEVLEDNDYGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERL----FELILMEEIRFPR--TLSPEAKSLLAGLLKK 242 (337)
T ss_dssp GGCCGGGGSSSCBCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHH----HHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred HHhhhhhccCCCCChh-hcccchhhHHHHHHHCCCCCCCcCHHHH----HHHHhcCCCCCCc--cCCHHHHHHHHhhccC
Confidence 9999999999998665 9999999999999999999998765433 3334444555443 5899999999999999
Q ss_pred CCCCCCC-----HhHHhcCccccc
Q 019901 234 DPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 234 ~p~~R~s-----~~ell~h~~~~~ 252 (334)
||.+|++ ++++++||||..
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CchhhcccccccHHHHHcCccccc
Confidence 9999994 899999999964
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-57 Score=396.51 Aligned_cols=241 Identities=24% Similarity=0.379 Sum_probs=198.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc----CCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT----PTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~----~~~~~lv~e~~~ 71 (334)
||.|+| .|.++.++..| |+|.+..... ...+.+.+|++++++++|||||++++++.+ ++.+|+|||||+
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~v-a~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~ 95 (270)
T d1t4ha_ 17 IGRGSFKTVYKGLDTETTVEV-AWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 95 (270)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCC
T ss_pred EecCcCcEEEEEEECCCCeEE-EEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCC
Confidence 455554 47888899998 9999987652 223578899999999999999999999875 456899999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeCCCCCCcEEEcC-CCCCCEEEeccCCccCCCCCCCCCC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQ--VCHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~--ivH~dlkp~NIli~~-~~~~~~kl~Dfgla~~~~~~~~~~~ 148 (334)
+|+|.+++.+.+.+++..++.++.||+.||+|||++| |+||||||+|||+++ ++ .+||+|||+|+.... ....+
T Consensus 96 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~--~~Kl~DFGla~~~~~-~~~~~ 172 (270)
T d1t4ha_ 96 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG--SVKIGDLGLATLKRA-SFAKA 172 (270)
T ss_dssp SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS--CEEECCTTGGGGCCT-TSBEE
T ss_pred CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCC--CEEEeecCcceeccC-CccCC
Confidence 9999999999889999999999999999999999998 999999999999964 34 499999999975322 23345
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+||+.|+|||++.+ .++. ++|||||||++|+|++|+.||.+......... .+.....+.......++++++||.
T Consensus 173 ~~GT~~Y~aPE~~~~-~~~~-~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~~~li~ 247 (270)
T d1t4ha_ 173 VIGTPEFMAPEMYEE-KYDE-SVDVYAFGMCMLEMATSEYPYSECQNAAQIYR---RVTSGVKPASFDKVAIPEVKEIIE 247 (270)
T ss_dssp SCSSCCCCCGGGGGT-CCCT-HHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHH---HHTTTCCCGGGGGCCCHHHHHHHH
T ss_pred cccCccccCHHHhCC-CCCC-cCchhhHHHHHHHHHHCCCCCCCcccHHHHHH---HHHcCCCCcccCccCCHHHHHHHH
Confidence 689999999999865 4654 49999999999999999999987655443332 233222222223457899999999
Q ss_pred HhcccCCCCCCCHhHHhcCcccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFL 251 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~ 251 (334)
+||++||++|||++|+|+||||+
T Consensus 248 ~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 248 GCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHccCCHhHCcCHHHHhCCcccC
Confidence 99999999999999999999995
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=408.47 Aligned_cols=246 Identities=24% Similarity=0.421 Sum_probs=211.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .|.++.+|+.| |||++.+.. .....+.+|+.+|+.++|||||+++++|++++.+|+|||||+||+|.+
T Consensus 13 lG~G~fg~Vy~~~~~~~~~~~-AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~ 90 (321)
T d1tkia_ 13 LGRGEFGIVHRCVETSSKKTY-MAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFE 90 (321)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHH
T ss_pred EecCCCeEEEEEEECCCCcEE-EEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHH
Confidence 455554 48889999999 999998766 445678899999999999999999999999999999999999999999
Q ss_pred HHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 78 RICNAG-RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 78 ~l~~~~-~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
++...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.++..++||+|||+++...........+||+.|+
T Consensus 91 ~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ 170 (321)
T d1tkia_ 91 RINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYY 170 (321)
T ss_dssp HHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGS
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccc
Confidence 998765 6999999999999999999999999999999999999987666679999999998765555555668999999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC--CCCCCCHHHHHHHHHhcccC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP--DYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~~ 234 (334)
|||.+.+..++.+ +|||||||++|+|++|+.||.+.+....+. .+......++ .+..+|+++++||.+||.+|
T Consensus 171 ape~~~~~~~~~~-~DiWSlGvily~ll~G~~Pf~~~~~~~~~~----~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 245 (321)
T d1tkia_ 171 APEVHQHDVVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIE----NIMNAEYTFDEEAFKEISIEAMDFVDRLLVKE 245 (321)
T ss_dssp CHHHHTTCEECHH-HHHHHHHHHHHHHHHSSCTTCCSSHHHHHH----HHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSS
T ss_pred cchhccCCCCCch-hhcccHHHHHHHHHhCCCCCCCCCHHHHHH----HHHhCCCCCChhhccCCCHHHHHHHHHHccCC
Confidence 9999988887654 999999999999999999999876644333 3444444333 23468999999999999999
Q ss_pred CCCCCCHhHHhcCccccccC
Q 019901 235 PAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 235 p~~R~s~~ell~h~~~~~~~ 254 (334)
|.+|||++|+++||||++..
T Consensus 246 p~~R~s~~eil~hp~~~~~~ 265 (321)
T d1tkia_ 246 RKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp GGGSCCHHHHHHSHHHHSCG
T ss_pred hhHCcCHHHHhcCHhhccCc
Confidence 99999999999999997653
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.3e-56 Score=398.76 Aligned_cols=239 Identities=31% Similarity=0.564 Sum_probs=207.1
Q ss_pred CCcce---e-eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHN---F-YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~---~-~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+ + +|+++.+|+.| |||++.+.. ....+.+.+|+.+++.++|||||++++++.+++.+|+|||||.||+
T Consensus 12 lG~G~fg~Vy~a~~~~~g~~v-AvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~ 90 (316)
T d1fota_ 12 LGTGSFGRVHLIRSRHNGRYY-AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGE 90 (316)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred EecCcCcEEEEEEECCCCCEE-EEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcc
Confidence 45555 4 48889999999 999998654 2334678999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... ...+.+||+.
T Consensus 91 l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~--vkL~DFG~a~~~~~--~~~~~~Gt~~ 166 (316)
T d1fota_ 91 LFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH--IKITDFGFAKYVPD--VTYTLCGTPD 166 (316)
T ss_dssp HHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSC--EEECCCSSCEECSS--CBCCCCSCTT
T ss_pred ccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCC--EEEecCccceEecc--ccccccCccc
Confidence 9999999999999999999999999999999999999999999999987665 99999999986433 3346789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+......+| ..+|++++++|.+||.++
T Consensus 167 Y~APE~l~~~~y~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 167 YIAPEVVSTKPYNKS-IDWWSFGILIYEMLAGYTPFYDSNTMKTY----EKILNAELRFP--PFFNEDVKDLLSRLITRD 239 (316)
T ss_dssp TCCHHHHTTCCBCTT-HHHHHHHHHHHHHHHSSCTTCCSSHHHHH----HHHHHCCCCCC--TTSCHHHHHHHHHHTCSC
T ss_pred ccCHHHHcCCCCCch-hhccccchhHHHHHhCCCCCCCcCHHHHH----HHHHcCCCCCC--CCCCHHHHHHHHHHhhhC
Confidence 999999998888765 99999999999999999999886654433 33444444444 358999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 019901 235 PAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~-----s~~ell~h~~~~~ 252 (334)
|.+|+ |++++++||||++
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSS
T ss_pred HHhccccchhhHHHHHcCccccc
Confidence 99996 8999999999965
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.9e-56 Score=391.96 Aligned_cols=246 Identities=30% Similarity=0.469 Sum_probs=207.5
Q ss_pred CCcce---e-eeeecCCCCeeEEEEEEecCccc---------ccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEE
Q 019901 2 LGFHN---F-YDRCSYSSDLFVNIIIIVFHLWQ---------IDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVM 67 (334)
Q Consensus 2 lG~g~---~-~~~~~~~~~~vvaiK~~~~~~~~---------~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~ 67 (334)
||.|+ + .|+++.+|+.| |||++.+.... ..+.+.+|+.++++++ ||||+++++++.+++.+|+||
T Consensus 11 iG~G~~g~V~~~~~~~~~~~~-AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivm 89 (277)
T d1phka_ 11 LGRGVSSVVRRCIHKPTCKEY-AVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 89 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEE
Confidence 56444 4 48888899998 99999886522 1246889999999997 999999999999999999999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCC
Q 019901 68 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 147 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~ 147 (334)
|||+||+|.+++...+++++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+.........
T Consensus 90 E~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~--~kl~DFG~a~~~~~~~~~~ 167 (277)
T d1phka_ 90 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMN--IKLTDFGFSCQLDPGEKLR 167 (277)
T ss_dssp ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCC--EEECCCTTCEECCTTCCBC
T ss_pred EcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCC--eEEccchheeEccCCCcee
Confidence 99999999999999899999999999999999999999999999999999999987665 9999999998766555556
Q ss_pred CccCCCccccchhhccCC-----CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHH
Q 019901 148 STVGTPAYIAPEVLLKKE-----YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPE 222 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (334)
..+||+.|+|||++.+.. ..+.++||||+||++|+|++|+.||.+.+.......+... ......+....+|++
T Consensus 168 ~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s~~ 245 (277)
T d1phka_ 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG--NYQFGSPEWDDYSDT 245 (277)
T ss_dssp CCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT--CCCCCTTTGGGSCHH
T ss_pred eeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC--CCCCCCcccccCCHH
Confidence 678999999999986422 2244599999999999999999999987664443332221 122334445578999
Q ss_pred HHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 223 CRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 223 ~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
+++||.+||+.+|.+|||++|+|+||||++
T Consensus 246 ~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 246 VKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred HHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 999999999999999999999999999965
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-57 Score=393.14 Aligned_cols=240 Identities=29% Similarity=0.421 Sum_probs=189.1
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEc--CCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILT--PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--~~~~~lv~e~~~~~ 73 (334)
||.|+| .++++.+|+.| |||++.+.... ..+.+.+|+.++++++|||||++++++.+ ++.+|+|||||+||
T Consensus 12 iG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g 90 (269)
T d2java1 12 IGTGSYGRCQKIRRKSDGKIL-VWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGG 90 (269)
T ss_dssp EEECSSEEEEEEEETTTCCEE-EEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTE
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCC
Confidence 455554 48889999999 99999876532 23568899999999999999999999865 46789999999999
Q ss_pred ChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC-----ceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC
Q 019901 74 ELFERICN----AGRFSEDEARFFFQQLISGVSYCHSMQ-----VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS 144 (334)
Q Consensus 74 ~L~~~l~~----~~~~~~~~~~~~~~qil~~L~~LH~~~-----ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~ 144 (334)
+|.+++.+ .+.+++..++.++.||+.||+|||++| |+||||||+|||++.++. +||+|||+|+......
T Consensus 91 ~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~--vkl~DFG~a~~~~~~~ 168 (269)
T d2java1 91 DLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQN--VKLGDFGLARILNHDT 168 (269)
T ss_dssp EHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSC--EEECCHHHHHHC----
T ss_pred cHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCc--EEEeeccceeecccCC
Confidence 99998864 457999999999999999999999976 999999999999987765 9999999998654332
Q ss_pred -CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHH
Q 019901 145 -QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPEC 223 (334)
Q Consensus 145 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (334)
.....+||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+...... +.+..+|+++
T Consensus 169 ~~~~~~~gt~~Y~APE~l~~~~~~~~-~DIwSlGvilyel~tg~~Pf~~~~~~~~~----~~i~~~~~~-~~~~~~s~~l 242 (269)
T d2java1 169 SFAKAFVGTPYYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELA----GKIREGKFR-RIPYRYSDEL 242 (269)
T ss_dssp -------CCCSCCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHH----HHHHHTCCC-CCCTTSCHHH
T ss_pred CccccCCCCcccCCHHHHcCCCCChH-HHHHhhCHHHHHHhhCCCCCCCCCHHHHH----HHHHcCCCC-CCCcccCHHH
Confidence 3345689999999999988888655 99999999999999999999876553332 233333322 2234689999
Q ss_pred HHHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 224 RHLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
++||.+||+.||.+|||++|+|+|||+
T Consensus 243 ~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 243 NEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999995
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-56 Score=397.07 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=202.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc-----ccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ-----IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~-----~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 72 (334)
||.|+| .|+++.+|+.| |||++.+.... ..+.+.+|+.+++.++|||||++++++..++.+|+|||||.+
T Consensus 6 lG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~ 84 (299)
T d1ua2a_ 6 LGEGQFATVYKARDKNTNQIV-AIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 84 (299)
T ss_dssp EEEETTEEEEEEECSSCCSEE-EEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE
T ss_pred eccCcCeEEEEEEECCCCcEE-EEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcc
Confidence 565554 48888999999 99999765421 235789999999999999999999999999999999999998
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccC
Q 019901 73 GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~g 151 (334)
+++.......+.+++..++.+++||+.||+|||++||+||||||+|||++..+. +||+|||+|+...... ...+.+|
T Consensus 85 ~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~--~KL~DFG~a~~~~~~~~~~~~~~g 162 (299)
T d1ua2a_ 85 DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV--LKLADFGLAKSFGSPNRAYTHQVV 162 (299)
T ss_dssp EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCCGGGSTTTSCCCCCCCSCC
T ss_pred hHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc--cccccCccccccCCCcccccceec
Confidence 888777766778999999999999999999999999999999999999987765 9999999998654433 3345679
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc-C---------------CC
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS-I---------------PD 215 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~---------------~~ 215 (334)
|+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+..+.......... . +.
T Consensus 163 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (299)
T d1ua2a_ 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242 (299)
T ss_dssp CCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCC
T ss_pred ChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCC
Confidence 9999999999776655666999999999999999999999887766655554332211100 0 00
Q ss_pred ------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 ------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 ------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 243 ~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~ 285 (299)
T d1ua2a_ 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN 285 (299)
T ss_dssp CCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred CChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence 1246899999999999999999999999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-57 Score=404.34 Aligned_cols=246 Identities=33% Similarity=0.533 Sum_probs=202.8
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHH-cCCCCCcccceEEEEc----CCeEEEEEeccCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHR-SLRHPNIVRFKEVILT----PTHLAIVMEYASG 72 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~-~l~hp~iv~~~~~~~~----~~~~~lv~e~~~~ 72 (334)
||.|+| .|+++.+|+.| |||++.. ...+.+|+.++. .++|||||+++++|++ .+.+|+|||||+|
T Consensus 20 lG~G~fg~Vy~a~~~~~~~~v-AiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g 93 (335)
T d2ozaa1 20 LGLGINGKVLQIFNKRTQEKF-ALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 93 (335)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred eeeccCeEEEEEEECCCCCEE-EEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence 555655 48899999999 9999853 456889999865 5689999999999875 4679999999999
Q ss_pred CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCCCCCCc
Q 019901 73 GELFERICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 73 ~~L~~~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
|+|.+++.+. .++++.+++.++.||+.||+|||++||+||||||+|||++..+ .+.+||+|||+|+...........
T Consensus 94 g~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~ 173 (335)
T d2ozaa1 94 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP 173 (335)
T ss_dssp EEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCC
T ss_pred CcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCCccccc
Confidence 9999999874 3699999999999999999999999999999999999997533 346999999999877666666778
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCC--CCCCCHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPD--YVHISPECRHLI 227 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li 227 (334)
+||+.|+|||++.+..|+.+ +|||||||++|+|+||++||.+.............+......+|. +..+|+++++||
T Consensus 174 ~gt~~y~aPE~~~~~~y~~~-~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li 252 (335)
T d2ozaa1 174 CYTPYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLI 252 (335)
T ss_dssp SCCCSSCCCCCCCGGGGSHH-HHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHH
T ss_pred cCCcccCCcHHHcCCCCCHH-HHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHH
Confidence 89999999999988888655 999999999999999999998766544444444444434444332 235799999999
Q ss_pred HHhcccCCCCCCCHhHHhcCccccccC
Q 019901 228 SRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.+||+.||++|||+.|+++||||.+..
T Consensus 253 ~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 253 RNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp HHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred HHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 999999999999999999999997654
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=9e-56 Score=400.09 Aligned_cols=239 Identities=31% Similarity=0.549 Sum_probs=206.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCc---ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHL---WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~---~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|+++.+|+.| |||++.+.. ....+.+.+|+.+++.++|||||++++++...+.+++||||+.||+
T Consensus 49 lG~G~fg~Vy~a~~~~~g~~~-AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~ 127 (350)
T d1rdqe_ 49 LGTGSFGRVMLVKHKESGNHY-AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGE 127 (350)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCB
T ss_pred eecCcCcEEEEEEECCCCCEE-EEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccc
Confidence 455554 48899999999 999998654 2334678999999999999999999999999999999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|..++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+.... ...+.+||+.
T Consensus 128 l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~--ikL~DFG~a~~~~~--~~~~~~Gt~~ 203 (350)
T d1rdqe_ 128 MFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGY--IQVTDFGFAKRVKG--RTWTLCGTPE 203 (350)
T ss_dssp HHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSC--EEECCCTTCEECSS--CBCCCEECGG
T ss_pred hhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCC--EEeeeceeeeeccc--ccccccCccc
Confidence 9999999899999999999999999999999999999999999999987764 99999999986533 3346789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccC
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVAD 234 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~ 234 (334)
|||||++.+..++.+ +|||||||++|+|++|+.||.+.+....+ ..+.......| ..+|+++.+||.+||++|
T Consensus 204 Y~APE~~~~~~~~~~-~DiwSlGvilyemltG~~Pf~~~~~~~~~----~~i~~~~~~~p--~~~s~~~~~li~~~L~~d 276 (350)
T d1rdqe_ 204 ALAPEIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIY----EKIVSGKVRFP--SHFSSDLKDLLRNLLQVD 276 (350)
T ss_dssp GCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCC--TTCCHHHHHHHHHHSCSC
T ss_pred cCCHHHHcCCCCCcc-ccccchhHHHHHHHhCCCCCCCcCHHHHH----HHHhcCCCCCC--ccCCHHHHHHHHHHhhhC
Confidence 999999999888755 99999999999999999999876654333 33444444443 368999999999999999
Q ss_pred CCCCC-----CHhHHhcCccccc
Q 019901 235 PAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 235 p~~R~-----s~~ell~h~~~~~ 252 (334)
|.+|+ |++++++||||+.
T Consensus 277 P~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 277 LTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGTT
T ss_pred HHhccccccccHHHHHcCccccC
Confidence 99995 8999999999954
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-55 Score=399.64 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=200.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHH---HHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~---Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .|+++.+|+.| |||++.+... .....+.+ ++.+++.++|||||+++++|.+++.+|+|||||+
T Consensus 12 lG~G~fg~Vy~~~~~~t~~~v-AiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~ 90 (364)
T d1omwa3 12 IGRGGFGEVYGCRKADTGKMY-AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 90 (364)
T ss_dssp EEECSSCEEEEEEETTTCCEE-EEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCC
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecC
Confidence 455554 48889999999 9999976542 22233444 4777888899999999999999999999999999
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
||+|.+++.+.+.+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+..... .....+|
T Consensus 91 gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~--iKl~DFGla~~~~~~-~~~~~~G 167 (364)
T d1omwa3 91 GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH--VRISDLGLACDFSKK-KPHASVG 167 (364)
T ss_dssp SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSC--EEECCCTTCEECSSS-CCCSCCS
T ss_pred CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCc--EEEeeeceeeecCCC-ccccccc
Confidence 9999999999999999999999999999999999999999999999999987765 999999999854432 3456689
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
|+.|+|||++......+.++|||||||++|+|++|+.||.+...... ............. .+..+|+++++||.+||
T Consensus 168 T~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~-~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L 244 (364)
T d1omwa3 168 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVE--LPDSFSPELRSLLEGLL 244 (364)
T ss_dssp CGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCH-HHHHHHSSSCCCC--CCSSSCHHHHHHHHHHT
T ss_pred ccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcccCCCC--CCCCCCHHHHHHHHHHc
Confidence 99999999997554434559999999999999999999987654322 2223333333333 33468999999999999
Q ss_pred ccCCCCCCC-----HhHHhcCccccc
Q 019901 232 VADPAKRIS-----IPEIRNHEWFLK 252 (334)
Q Consensus 232 ~~~p~~R~s-----~~ell~h~~~~~ 252 (334)
++||.+||| ++++++||||+.
T Consensus 245 ~~dP~~R~t~~~~~a~eil~Hp~f~~ 270 (364)
T d1omwa3 245 QRDVNRRLGCLGRGAQEVKESPFFRS 270 (364)
T ss_dssp CSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred ccCHHHhCCCcccCHHHHHcCccccC
Confidence 999999999 799999999964
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-55 Score=391.15 Aligned_cols=241 Identities=34% Similarity=0.560 Sum_probs=203.9
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc---cccHHHHHHHHHH-HcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW---QIDENVQREIINH-RSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~---~~~~~~~~Ei~~l-~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| .|+++.+|+.| |||++.+... ...+.+.+|+.++ +.++|||||++++++.+++.+|+|||||+||
T Consensus 10 iG~G~fg~Vy~~~~~~t~~~v-AvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g 88 (320)
T d1xjda_ 10 LGKGSFGKVFLAEFKKTNQFF-AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGG 88 (320)
T ss_dssp EEECSSSEEEEEEETTTTEEE-EEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EecCCCcEEEEEEECCCCCEE-EEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCC
Confidence 455544 58899999999 9999987531 2334566777766 4789999999999999999999999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCC
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGT 152 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt 152 (334)
+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++..+. +||+|||+|+....... ....+||
T Consensus 89 ~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt 166 (320)
T d1xjda_ 89 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGH--IKIADFGMCKENMLGDAKTNTFCGT 166 (320)
T ss_dssp BHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSC--EEECCCTTCBCCCCTTCCBCCCCSC
T ss_pred cHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCc--eeccccchhhhcccccccccccCCC
Confidence 99999999999999999999999999999999999999999999999987665 99999999986543333 3446799
Q ss_pred CccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcc
Q 019901 153 PAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFV 232 (334)
Q Consensus 153 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 232 (334)
+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+..... ..+......+|. .+|+++++||.+||+
T Consensus 167 ~~y~aPE~~~~~~~~~~-~DiwSlGvilyemltG~~PF~~~~~~~~~----~~i~~~~~~~p~--~~s~~~~dli~~~L~ 239 (320)
T d1xjda_ 167 PDYIAPEILLGQKYNHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELF----HSIRMDNPFYPR--WLEKEAKDLLVKLFV 239 (320)
T ss_dssp GGGCCHHHHTTCCBCTH-HHHHHHHHHHHHHHHSSCSSCCSSHHHHH----HHHHHCCCCCCT--TSCHHHHHHHHHHSC
T ss_pred CCcCCHHHHcCCCCCch-hhhhhhhHHHHHHHhCCCCCCCCCHHHHH----HHHHcCCCCCCc--cCCHHHHHHHHHhcc
Confidence 99999999999888765 99999999999999999999987654333 333444444443 579999999999999
Q ss_pred cCCCCCCCHh-HHhcCccccc
Q 019901 233 ADPAKRISIP-EIRNHEWFLK 252 (334)
Q Consensus 233 ~~p~~R~s~~-ell~h~~~~~ 252 (334)
+||.+|||+. ++++||||++
T Consensus 240 ~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 240 REPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SSGGGSBTTBSCGGGSGGGTT
T ss_pred cCCCCCcCHHHHHHhCchhcc
Confidence 9999999995 8999999964
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-54 Score=381.69 Aligned_cols=248 Identities=27% Similarity=0.390 Sum_probs=199.2
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| .|+++.+|+.| |||++..... ...+.+.+|+.++++++|||||+++++|.+++.+|+|||||.++.+
T Consensus 10 lG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~ 88 (298)
T d1gz8a_ 10 IGEGTYGVVYKARNKLTGEVV-ALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLK 88 (298)
T ss_dssp EEECSSSEEEEEEETTTCCEE-EEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHH
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchh
Confidence 455554 48899999998 9999976542 2457899999999999999999999999999999999999976544
Q ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC-CCCCCccCCC
Q 019901 76 FERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTVGTP 153 (334)
Q Consensus 76 ~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~-~~~~~~~gt~ 153 (334)
...... ...+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+..... .......||+
T Consensus 89 ~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~--~kl~DFG~a~~~~~~~~~~~~~~gt~ 166 (298)
T d1gz8a_ 89 KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGA--IKLADFGLARAFGVPVRTYTHEVVTL 166 (298)
T ss_dssp HHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECSTTHHHHHCCCSBCTTCCBCCC
T ss_pred hhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCc--ceeccCCcceeccCCcccceeecccc
Confidence 333333 456999999999999999999999999999999999999987665 999999999754332 3344567999
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc--------------cCCC----
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY--------------SIPD---- 215 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--------------~~~~---- 215 (334)
.|+|||++....+.+.++|||||||++|+|++|+.||.+.+....+............ ..+.
T Consensus 167 ~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (298)
T d1gz8a_ 167 WYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246 (298)
T ss_dssp TTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCC
T ss_pred eeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccccccccc
Confidence 9999999988887777799999999999999999999987765555544432211110 0000
Q ss_pred -----CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 216 -----YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 216 -----~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+|+++++||.+||+.||.+|||++|+|+||||++
T Consensus 247 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~ 288 (298)
T d1gz8a_ 247 DFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288 (298)
T ss_dssp CHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred chhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhcc
Confidence 1246899999999999999999999999999999964
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=381.58 Aligned_cols=237 Identities=30% Similarity=0.463 Sum_probs=199.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc------ccHHHHHHHHHHHcCC--CCCcccceEEEEcCCeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ------IDENVQREIINHRSLR--HPNIVRFKEVILTPTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~------~~~~~~~Ei~~l~~l~--hp~iv~~~~~~~~~~~~~lv~e~ 69 (334)
||.|+| .|+++.+|+.| |||++.+.... ....+.+|+.++++++ |||||++++++.+++..|+||||
T Consensus 12 lG~G~fg~Vy~a~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~ 90 (273)
T d1xwsa_ 12 LGSGGFGSVYSGIRVSDNLPV-AIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 90 (273)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEEC
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEe
Confidence 455554 48889999999 99999875421 2245779999999986 89999999999999999999999
Q ss_pred cCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCC
Q 019901 70 ASG-GELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 70 ~~~-~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~ 148 (334)
+.+ +++.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+. +.+||+|||+|+.... ....+
T Consensus 91 ~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~-~~vkl~DFG~a~~~~~-~~~~~ 168 (273)
T d1xwsa_ 91 PEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR-GELKLIDFGSGALLKD-TVYTD 168 (273)
T ss_dssp CSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTT-TEEEECCCTTCEECCS-SCBCC
T ss_pred ccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCC-CeEEECccccceeccc-ccccc
Confidence 976 67888888888999999999999999999999999999999999999998543 2599999999975432 23345
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.+||+.|+|||++.+..++++++|||||||++|+|++|+.||.+.. .+......++ ..+|+++++||.
T Consensus 169 ~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~----------~i~~~~~~~~--~~~s~~~~~li~ 236 (273)
T d1xwsa_ 169 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------EIIRGQVFFR--QRVSSECQHLIR 236 (273)
T ss_dssp CCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----------HHHHCCCCCS--SCCCHHHHHHHH
T ss_pred cccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch----------HHhhcccCCC--CCCCHHHHHHHH
Confidence 6899999999999988887777899999999999999999997521 1223333333 358999999999
Q ss_pred HhcccCCCCCCCHhHHhcCcccccc
Q 019901 229 RIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
+||+.||.+|||++|+|+||||++.
T Consensus 237 ~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 237 WCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp HHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred HHccCCHhHCcCHHHHhcCHhhCCC
Confidence 9999999999999999999999654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=378.18 Aligned_cols=246 Identities=26% Similarity=0.327 Sum_probs=197.1
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcC---CCCCcccceEEEEc-----CCeEEEEEeccCC
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSL---RHPNIVRFKEVILT-----PTHLAIVMEYASG 72 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l---~hp~iv~~~~~~~~-----~~~~~lv~e~~~~ 72 (334)
||++ .|++..+++.+||||++.+... .....+.+|+.+++.+ +||||++++++|.. ...++++|||+.+
T Consensus 20 fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~ 99 (305)
T d1blxa_ 20 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ 99 (305)
T ss_dssp TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC
T ss_pred CeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccC
Confidence 4444 4778777665559999977542 2344677888877665 79999999999863 3578999999988
Q ss_pred CChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccC
Q 019901 73 GELFERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG 151 (334)
Q Consensus 73 ~~L~~~l~-~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~g 151 (334)
+.+..... ....+++..++.++.|++.||+|||++|||||||||+|||++..+. +||+|||+++............|
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~--~kl~dfg~~~~~~~~~~~~~~~g 177 (305)
T d1blxa_ 100 DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ--IKLADFGLARIYSFQMALTSVVV 177 (305)
T ss_dssp BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECSCCSCCCCCGGGGGCCCCC
T ss_pred CchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCC--eeecchhhhhhhcccccCCCccc
Confidence 87754443 3456999999999999999999999999999999999999987765 99999999987666656667789
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-cC-----------------
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-SI----------------- 213 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~----------------- 213 (334)
|+.|+|||++.+..|+.+ +|||||||++|+|++|++||.+.+....+..+......... ..
T Consensus 178 T~~Y~APE~~~~~~y~~~-~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (305)
T d1blxa_ 178 TLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ 256 (305)
T ss_dssp CCTTCCHHHHTTCCCCTH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCC
T ss_pred ChhhcCcchhcCCCCChh-ehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccccc
Confidence 999999999999888766 99999999999999999999988776665554433211100 00
Q ss_pred ---CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 214 ---PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 214 ---~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.....+++.+++||.+||++||.+|||++|+|+||||++
T Consensus 257 ~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~ 298 (305)
T d1blxa_ 257 PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298 (305)
T ss_dssp CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTT
T ss_pred chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcC
Confidence 012357899999999999999999999999999999964
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=4.9e-53 Score=372.41 Aligned_cols=236 Identities=20% Similarity=0.260 Sum_probs=197.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| .|.++.+|..| |||++.... ...+.+.+|+.++++++|||||++++++.+++.+++|||||++|+|..
T Consensus 25 iG~G~fg~Vy~a~~~~~~~~v-AvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~ 102 (287)
T d1opja_ 25 LGGGQYGEVYEGVWKKYSLTV-AVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 102 (287)
T ss_dssp TTTTTTSSEEEEEEGGGTEEE-EEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EeeCCCeEEEEEEECCCCeEE-EEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHH
Confidence 566665 47788889888 999998765 456789999999999999999999999999999999999999999999
Q ss_pred HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCC
Q 019901 78 RICNA--GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTP 153 (334)
Q Consensus 78 ~l~~~--~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~ 153 (334)
++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... .....||+
T Consensus 103 ~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFG~a~~~~~~~~~~~~~~~g~~ 180 (287)
T d1opja_ 103 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHL--VKVADFGLSRLMTGDTYTAHAGAKFPI 180 (287)
T ss_dssp HHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCCTTTCCSSSSEEETTEEECG
T ss_pred HhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCc--EEEccccceeecCCCCceeeccccccc
Confidence 98764 56899999999999999999999999999999999999987765 99999999986543322 22345899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|+|++|..||..........+. .......+.+..+|+++.+||.+||+.
T Consensus 181 ~y~aPE~~~~~~~~~k-~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~----i~~~~~~~~~~~~~~~l~~li~~cl~~ 255 (287)
T d1opja_ 181 KWTAPESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL----LEKDYRMERPEGCPEKVYELMRACWQW 255 (287)
T ss_dssp GGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH----HHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred cccChHHHcCCCCCch-hhhhhHHHHHHHHHhCCCCCCCcchHHHHHHH----HhcCCCCCCCccchHHHHHHHHHHcCC
Confidence 9999999998888654 99999999999999977666554443333332 233344455557899999999999999
Q ss_pred CCCCCCCHhHHhc
Q 019901 234 DPAKRISIPEIRN 246 (334)
Q Consensus 234 ~p~~R~s~~ell~ 246 (334)
||.+|||++++++
T Consensus 256 dP~~Rps~~ei~~ 268 (287)
T d1opja_ 256 NPSDRPSFAEIHQ 268 (287)
T ss_dssp SGGGSCCHHHHHH
T ss_pred CHhHCcCHHHHHH
Confidence 9999999999975
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-53 Score=370.88 Aligned_cols=242 Identities=21% Similarity=0.284 Sum_probs=187.4
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| +.+.+ .+..| |||+++.... ...+.+.+|+.++++++|||||++++++. ++.+++|||||++|+|.+
T Consensus 16 lG~G~fg~Vy~~~-~~~~v-AvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~ 92 (276)
T d1uwha_ 16 IGSGSFGTVYKGK-WHGDV-AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYH 92 (276)
T ss_dssp EEECSSCEEEEEE-SSSEE-EEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHH
T ss_pred EeeCCCcEEEEEE-ECCEE-EEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHH
Confidence 566665 22222 23457 9999976542 23467889999999999999999999864 456899999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---CCCCccCCC
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTP 153 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~---~~~~~~gt~ 153 (334)
++... .++++..+..++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...+..||+
T Consensus 93 ~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 170 (276)
T d1uwha_ 93 HLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLT--VKIGDFGLATVKSRWSGSHQFEQLSGSI 170 (276)
T ss_dssp HHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSS--EEECCCCCSCC------------CCCCG
T ss_pred HHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCC--EEEccccceeeccccCCcccccccccCc
Confidence 99764 56999999999999999999999999999999999999987765 9999999997543322 234557999
Q ss_pred ccccchhhccCC--CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhc
Q 019901 154 AYIAPEVLLKKE--YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIF 231 (334)
Q Consensus 154 ~y~aPE~~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 231 (334)
.|||||++.+.. ..+.++|||||||++|||+||+.||.+.+........+...............+|+++.+||.+||
T Consensus 171 ~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl 250 (276)
T d1uwha_ 171 LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECL 250 (276)
T ss_dssp GGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHT
T ss_pred ccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHc
Confidence 999999997533 124559999999999999999999998776555444433321111111223467999999999999
Q ss_pred ccCCCCCCCHhHHhcCc
Q 019901 232 VADPAKRISIPEIRNHE 248 (334)
Q Consensus 232 ~~~p~~R~s~~ell~h~ 248 (334)
+.+|.+|||+++++++-
T Consensus 251 ~~dp~~RPt~~~il~~L 267 (276)
T d1uwha_ 251 KKKRDERPLFPQILASI 267 (276)
T ss_dssp CSSGGGSCCHHHHHHHH
T ss_pred CCCHhHCcCHHHHHHHH
Confidence 99999999999999873
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.7e-52 Score=369.42 Aligned_cols=247 Identities=26% Similarity=0.384 Sum_probs=198.7
Q ss_pred CCcce---ee-eeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHN---FY-DRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~---~~-~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+ |+ |++ .+|+.| |||++..... ...+.+.+|+.++++++||||+++++++..++..+++|+|+.++.+
T Consensus 10 iG~G~fg~Vy~~~~-~~~~~v-AvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~ 87 (286)
T d1ob3a_ 10 IGEGTYGVVYKAQN-NYGETF-ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK 87 (286)
T ss_dssp EEEETTEEEEEEEE-TTSCEE-EEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred EecCCCcEEEEEEe-CCCCEE-EEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence 45555 44 555 478888 9999977642 2357899999999999999999999999999999999999988777
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC-CCCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS-QPKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~-~~~~~~gt~~ 154 (334)
..+....+.+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|....... ......|++.
T Consensus 88 ~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~~~ 165 (286)
T d1ob3a_ 88 KLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGE--LKIADFGLARAFGIPVRKYTHEIVTLW 165 (286)
T ss_dssp HHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSC--EEECCTTHHHHHCC---------CCCT
T ss_pred HHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCC--EEecccccceecccCccccceecccch
Confidence 777777788999999999999999999999999999999999999987765 9999999987543322 2344569999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------cC--------------
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY-------SI-------------- 213 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-------~~-------------- 213 (334)
|+|||.+.+..+.+.++|||||||++|+|++|++||.+......+............ ..
T Consensus 166 y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (286)
T d1ob3a_ 166 YRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245 (286)
T ss_dssp TCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCC
T ss_pred hhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcc
Confidence 999999987777667799999999999999999999887765555444332211100 00
Q ss_pred --CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 214 --PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 214 --~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
.....+++.+++||.+||+.||++|||++|+|+||||++
T Consensus 246 ~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp GGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 012346899999999999999999999999999999964
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-52 Score=380.06 Aligned_cols=247 Identities=27% Similarity=0.386 Sum_probs=197.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcC------CeEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTP------THLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~------~~~~lv~e~~~ 71 (334)
||.|+| +|+++.+|+.| |||++.+.. ....+|+.+|+.++||||++++++|... .++|+|||||.
T Consensus 28 LG~G~fg~Vy~a~~~~~~~~v-AiK~i~~~~----~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~ 102 (350)
T d1q5ka_ 28 IGNGSFGVVYQAKLCDSGELV-AIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP 102 (350)
T ss_dssp EEEETTEEEEEEEETTTCCEE-EEEEEECCS----SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred EeeCcCeEEEEEEECCCCCEE-EEEEECccc----hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence 565544 48899999999 999998655 2234799999999999999999998543 35899999997
Q ss_pred CCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCC
Q 019901 72 GGELFER---ICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 148 (334)
Q Consensus 72 ~~~L~~~---l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~ 148 (334)
++.+... ......+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+|+.........+
T Consensus 103 ~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~-~~kl~DFG~a~~~~~~~~~~~ 181 (350)
T d1q5ka_ 103 ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA-VLKLCDFGSAKQLVRGEPNVS 181 (350)
T ss_dssp EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTC-CEEECCCTTCEECCTTSCCCS
T ss_pred CccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCC-ceeEecccchhhccCCccccc
Confidence 6543322 234567999999999999999999999999999999999999986652 499999999987666666677
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc-------------cccCC-
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------QYSIP- 214 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~~~- 214 (334)
.+||+.|+|||++.+....+.++||||+||++|+|++|++||...+....+.......... ...++
T Consensus 182 ~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~ 261 (350)
T d1q5ka_ 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQ 261 (350)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCC
T ss_pred ccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccc
Confidence 8899999999998876555566999999999999999999998877655555443221100 00111
Q ss_pred ---------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 215 ---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 215 ---------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
....+++++.+||.+||..||.+|||+.|+|+||||++-.
T Consensus 262 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 262 IKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred cccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 1234789999999999999999999999999999997643
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-53 Score=370.67 Aligned_cols=239 Identities=21% Similarity=0.266 Sum_probs=190.1
Q ss_pred CCccee---e-ee--ecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DR--CSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~--~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| + +. .+.+++.| |||++..... ...+.+.+|+.++++++|||||++++++..+ ..++|||||++|
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~v-AvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~~g 92 (277)
T d1xbba_ 15 LGSGNFGTVKKGYYQMKKVVKTV-AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELG 92 (277)
T ss_dssp EEECSSEEEEEEEEECSSSEEEE-EEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCTTE
T ss_pred cccCCCeEEEEEEEccCCcCeEE-EEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCCCC
Confidence 555655 3 43 33455667 9999976542 2246789999999999999999999998754 578999999999
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCCc
Q 019901 74 ELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKST 149 (334)
Q Consensus 74 ~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~~ 149 (334)
+|.+++.+..++++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... ....
T Consensus 93 ~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~--~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 93 PLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHY--AKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTE--EEECCCTTCEECCTTCSEEEC----
T ss_pred cHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCc--ccccchhhhhhcccccccccccccc
Confidence 99999999899999999999999999999999999999999999999987765 99999999985433221 2334
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.||+.|+|||++.+..++.+ +|||||||++|||++ |++||.+.+..+... .+.. ....+.+..+|+++.+||.
T Consensus 171 ~gt~~y~APE~l~~~~~~~~-sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~~~~li~ 244 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTA----MLEK-GERMGCPAGCPREMYDLMN 244 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred CCCceecCchhhcCCCCCch-hhhccchhhhhHHhhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCcccCHHHHHHHH
Confidence 68999999999988887655 999999999999998 899999876533222 2222 2333444578999999999
Q ss_pred HhcccCCCCCCCHhHH---hcCccc
Q 019901 229 RIFVADPAKRISIPEI---RNHEWF 250 (334)
Q Consensus 229 ~~L~~~p~~R~s~~el---l~h~~~ 250 (334)
+||+.+|.+|||++++ |+|+|+
T Consensus 245 ~cl~~dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 245 LCWTYDVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHhhCHHh
Confidence 9999999999999998 456554
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=361.19 Aligned_cols=235 Identities=22% Similarity=0.355 Sum_probs=183.9
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| + ++. .+++.| |||++.+.. ...+.+.+|+.++++++|||||++++++..++.+++|||||++|+|.+
T Consensus 13 iG~G~fg~Vy~~~~-~~~~~v-AvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~ 89 (263)
T d1sm2a_ 13 IGSGQFGLVHLGYW-LNKDKV-AIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSD 89 (263)
T ss_dssp EECCSSCCEEEEEE-TTTEEE-EEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EeeCCCeEEEEEEE-CCCCEE-EEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHH
Confidence 455655 3 443 456667 999998766 556789999999999999999999999999999999999999999999
Q ss_pred HHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 78 RICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 78 ~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... .....||+.
T Consensus 90 ~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~ 167 (263)
T d1sm2a_ 90 YLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQV--IKVSDFGMTRFVLDDQYTSSTGTKFPVK 167 (263)
T ss_dssp HHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGC--EEECSCC------------------CTT
T ss_pred HhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCC--eEecccchheeccCCCceeecceecCcc
Confidence 88765 55899999999999999999999999999999999999987765 99999999986543322 234568999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|||+| |.+||........... +.. ....+.+...++++.+|+.+||+.
T Consensus 168 y~aPE~l~~~~~~~k-~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~-~~~~~~p~~~~~~l~~li~~cl~~ 241 (263)
T d1sm2a_ 168 WASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----IST-GFRLYKPRLASTHVYQIMNHCWKE 241 (263)
T ss_dssp SCCHHHHTTCCCCHH-HHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH----HHH-TCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cCChHHhcCCCCCch-hhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH----HHh-cCCCCCccccCHHHHHHHHHHccC
Confidence 999999998888655 999999999999999 5666665544332222 222 223333446799999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|.+|||++++++|
T Consensus 242 ~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 242 RPEDRPAFSRLLRQ 255 (263)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999976
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.9e-52 Score=365.37 Aligned_cols=241 Identities=22% Similarity=0.329 Sum_probs=190.6
Q ss_pred CCcce---e-eeeecCCCCeeEEEEEEecCccc---ccHHHHHHHHHHHcCCCCCcccceEEEEcCC----eEEEEEecc
Q 019901 2 LGFHN---F-YDRCSYSSDLFVNIIIIVFHLWQ---IDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYA 70 (334)
Q Consensus 2 lG~g~---~-~~~~~~~~~~vvaiK~~~~~~~~---~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e~~ 70 (334)
||.|+ + .|+++.+|+.| |||++.+.... ....+.+|+.+++.++||||+++++++...+ .+|+|||||
T Consensus 15 lG~G~fg~Vy~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~ 93 (277)
T d1o6ya_ 15 LGFGGMSEVHLARDLRLHRDV-AVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 93 (277)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECC
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECC
Confidence 45554 4 48888999999 99999876532 2346889999999999999999999987643 489999999
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC----CCC
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH----SQP 146 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~----~~~ 146 (334)
+|++|..++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++. ++|+|||.++..... ...
T Consensus 94 ~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~--~~l~d~~~~~~~~~~~~~~~~~ 171 (277)
T d1o6ya_ 94 DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA--VKVMDFGIARAIADSGNSVTQT 171 (277)
T ss_dssp CEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSC--EEECCCTTCEECC---------
T ss_pred CCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccc--ceeehhhhhhhhcccccccccc
Confidence 99999999999899999999999999999999999999999999999999987765 999999988643222 223
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcccc--CCCCCCCCHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYS--IPDYVHISPECR 224 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 224 (334)
...+||+.|+|||++.+..++.+ +|||||||++|+|+||++||.+.+....+...+ ..... ......+|+++.
T Consensus 172 ~~~~Gt~~Y~aPE~~~~~~~~~~-~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~~~s~~l~ 246 (277)
T d1o6ya_ 172 AAVIGTAQYLSPEQARGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV----REDPIPPSARHEGLSADLD 246 (277)
T ss_dssp -------TTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH----HCCCCCGGGTSSSCCHHHH
T ss_pred ccccCcccccCHHHHcCCCCCcc-eecccchHHHHHHHhCCCCCCCcCHHHHHHHHH----hcCCCCCchhccCCCHHHH
Confidence 45679999999999988888655 999999999999999999998876544443332 22222 223456899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhcCccc
Q 019901 225 HLISRIFVADPAKRISIPEIRNHEWF 250 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~h~~~ 250 (334)
+||.+||++||.+||+..+.+.|+|.
T Consensus 247 ~li~~~L~~dp~~R~~sa~~l~~~l~ 272 (277)
T d1o6ya_ 247 AVVLKALAKNPENRYQTAAEMRADLV 272 (277)
T ss_dssp HHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred HHHHHHccCCHhHCHhHHHHHHHHHH
Confidence 99999999999999954444556665
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=372.39 Aligned_cols=245 Identities=22% Similarity=0.361 Sum_probs=195.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCC------eEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPT------HLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~------~~~lv~e~ 69 (334)
||.|+| .|.++.+|+.| |||++.+... ...+.+.+|+.+|+.++|||||+++++|...+ .+|+||||
T Consensus 26 lG~G~fg~V~~~~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~ 104 (346)
T d1cm8a_ 26 VGSGAYGAVCSAVDGRTGAKV-AIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 104 (346)
T ss_dssp C------CEEEEEETTTCCEE-EEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEec
Confidence 677777 58889999999 9999986542 12357889999999999999999999998654 57999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
| +.+|...+ +.+++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .....
T Consensus 105 ~-~~~l~~~~-~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~--~kl~Dfg~a~~~~~--~~~~~ 178 (346)
T d1cm8a_ 105 M-GTDLGKLM-KHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCE--LKILDFGLARQADS--EMTGY 178 (346)
T ss_dssp C-SEEHHHHH-HHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCS--SCCSS
T ss_pred c-cccHHHHH-HhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccc--cccccccceeccCC--ccccc
Confidence 9 66676655 4567999999999999999999999999999999999999987765 99999999986433 33566
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc--------------------
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV-------------------- 209 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------- 209 (334)
.||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+....+..........
T Consensus 179 ~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (346)
T d1cm8a_ 179 VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGL 258 (346)
T ss_dssp CSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHS
T ss_pred cccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccC
Confidence 899999999999887666666999999999999999999998876554443332211100
Q ss_pred -ccc----CCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 210 -QYS----IPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 210 -~~~----~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
... ......+++++.+||.+||..||.+|||++|+|+||||+.-
T Consensus 259 ~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 259 PELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred CcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 000 01123578999999999999999999999999999999763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=8.4e-52 Score=371.95 Aligned_cols=243 Identities=21% Similarity=0.386 Sum_probs=197.0
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEc--CCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILT--PTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~--~~~~~lv~e~~~~~~ 74 (334)
||.|+| +|+++.+|+.| |||++++.. .+.+.+|+.+|+.++ ||||++++++|.. ...+++|||||.+++
T Consensus 43 LG~G~fg~V~~a~~~~~~~~v-AiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~ 118 (328)
T d3bqca1 43 LGRGKYSEVFEAINITNNEKV-VVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTD 118 (328)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCB
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCc
Confidence 566655 48888999998 999997544 467899999999995 9999999999984 457999999999999
Q ss_pred hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCc
Q 019901 75 LFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 154 (334)
Q Consensus 75 L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~ 154 (334)
|.... +.+++..++.+++||+.||+|||++||+||||||+|||++.++. .+||+|||+|+...........++|+.
T Consensus 119 L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~-~vkl~DFG~a~~~~~~~~~~~~~~t~~ 194 (328)
T d3bqca1 119 FKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHR-KLRLIDWGLAEFYHPGQEYNVRVASRY 194 (328)
T ss_dssp GGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTT-EEEECCGGGCEECCTTCCCCSCCSCGG
T ss_pred HHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCC-eeeecccccceeccCCCcccccccCcc
Confidence 87653 46999999999999999999999999999999999999986543 489999999987666666677789999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhc----------c--------------
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSV----------Q-------------- 210 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----------~-------------- 210 (334)
|+|||++.+....+.++||||+||++|+|++|+.||............+...... .
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (328)
T d3bqca1 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRH 274 (328)
T ss_dssp GCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCC
T ss_pred ccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccc
Confidence 9999998876655566999999999999999999998765433222111111100 0
Q ss_pred --------ccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccc
Q 019901 211 --------YSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLK 252 (334)
Q Consensus 211 --------~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~ 252 (334)
...+....+++++++||++||..||.+|||++|+|+||||+.
T Consensus 275 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~ 324 (328)
T d3bqca1 275 SRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324 (328)
T ss_dssp CCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred cccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 001112346899999999999999999999999999999965
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=372.78 Aligned_cols=238 Identities=23% Similarity=0.357 Sum_probs=193.6
Q ss_pred CCccee---e-eeecCCCC-----eeEEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEecc
Q 019901 2 LGFHNF---Y-DRCSYSSD-----LFVNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~-----~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~ 70 (334)
||.|+| + |++..+++ .| |+|.+.... ......+.+|+.+++++ +|||||++++++.+.+.+|+|||||
T Consensus 45 lG~G~fG~Vy~a~~~~~~~~~~~~~v-avK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~ 123 (325)
T d1rjba_ 45 LGSGAFGKVMNATAYGISKTGVSIQV-AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYC 123 (325)
T ss_dssp EEECSSEEEEEEEEESCSSSSCEEEE-EEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred EeeCCCeEEEEEEEcCCCcccceeEE-EEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcC
Confidence 455554 3 55555443 35 999987653 23456889999999988 8999999999999999999999999
Q ss_pred CCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCC
Q 019901 71 SGGELFERICNA-----------------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAP 127 (334)
Q Consensus 71 ~~~~L~~~l~~~-----------------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~ 127 (334)
++|+|.+++.+. +.+++..++.++.||+.||+|||++|||||||||+|||++.++.
T Consensus 124 ~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~- 202 (325)
T d1rjba_ 124 CYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV- 202 (325)
T ss_dssp TTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTE-
T ss_pred CCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCe-
Confidence 999999999754 24899999999999999999999999999999999999987765
Q ss_pred CEEEeccCCccCCCCCCC---CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHH
Q 019901 128 RLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTI 203 (334)
Q Consensus 128 ~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 203 (334)
+||+|||+|+....... ..+..||+.|||||++.+..++.+ +|||||||++|||+| |++||.+......+.+.+
T Consensus 203 -~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~ 280 (325)
T d1rjba_ 203 -VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLI 280 (325)
T ss_dssp -EEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred -EEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcc-eeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 99999999986544332 224568999999999988888655 999999999999997 899998876655544433
Q ss_pred HHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 204 HRILSVQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.....++.+..+|+++++||.+||+.+|++|||++||++|
T Consensus 281 ----~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 281 ----QNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ----HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----hcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3344455556789999999999999999999999999976
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.9e-52 Score=366.42 Aligned_cols=238 Identities=21% Similarity=0.351 Sum_probs=183.7
Q ss_pred CCccee----eeeecCCCCe--eEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDL--FVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~--vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .++++.+++. +||||.+..... ...+.+.+|+.+|++++|||||++++++..++.+++|||||++|+
T Consensus 34 lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~ 113 (299)
T d1jpaa_ 34 IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGS 113 (299)
T ss_dssp EEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEE
T ss_pred EeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCc
Confidence 455555 3667666653 338888766542 234578999999999999999999999999999999999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCC------C
Q 019901 75 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP------K 147 (334)
Q Consensus 75 L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~------~ 147 (334)
|.+++... +.+++.++..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+........ .
T Consensus 114 L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~ 191 (299)
T d1jpaa_ 114 LDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLV--CKVSDFGLSRFLEDDTSDPTYTSAL 191 (299)
T ss_dssp HHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCC-------------------
T ss_pred ceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCc--EEECCcccceEccCCCCcceeeecc
Confidence 99988774 56999999999999999999999999999999999999987765 999999999854332221 1
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
...||+.|+|||++.+..++.+ +|||||||++|||+| |++||.+........ .+. .....+.+..+++++.+|
T Consensus 192 ~~~~t~~y~aPE~~~~~~~~~~-sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~----~i~-~~~~~~~~~~~~~~l~~l 265 (299)
T d1jpaa_ 192 GGKIPIRWTAPEAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVIN----AIE-QDYRLPPPMDCPSALHQL 265 (299)
T ss_dssp ----CGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH----HHH-TTCCCCCCTTCCHHHHHH
T ss_pred cccCCccccCHHHHhcCCCCcc-cccccchHHHHHHHhCCCCCCCCCCHHHHHH----HHH-cCCCCCCCccchHHHHHH
Confidence 2357899999999988887655 999999999999998 899998876543322 222 233445556789999999
Q ss_pred HHHhcccCCCCCCCHhHHhcC
Q 019901 227 ISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~h 247 (334)
+.+||+.+|.+|||+.+++++
T Consensus 266 i~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 266 MLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999998864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-51 Score=367.22 Aligned_cols=249 Identities=24% Similarity=0.341 Sum_probs=194.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEc--------CCeEEEEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILT--------PTHLAIVM 67 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~--------~~~~~lv~ 67 (334)
||.|+| .|+++.+|+.| |||++.+... .....+.+|+.+|+.++||||+++++++.. ++.+|+||
T Consensus 18 LG~G~fg~Vy~a~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~ 96 (318)
T d3blha1 18 IGQGTFGEVFKARHRKTGQKV-ALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 96 (318)
T ss_dssp EEECSSSEEEEEEETTTCCEE-EEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEE
T ss_pred EecCcCeEEEEEEECCCCCEE-EEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEE
Confidence 555555 48888999999 9999876542 345678999999999999999999999865 35689999
Q ss_pred eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC-----
Q 019901 68 EYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL----- 142 (334)
Q Consensus 68 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~----- 142 (334)
|||.++.+.........+++..++.+++||+.||.|||++||+||||||+|||++.++. +||+|||+|+....
T Consensus 97 e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~--~kl~dfg~~~~~~~~~~~~ 174 (318)
T d3blha1 97 DFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV--LKLADFGLARAFSLAKNSQ 174 (318)
T ss_dssp ECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSC--EEECCCTTCEECCC-----
T ss_pred eccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCc--EEeeecceeeecccccccc
Confidence 99988777666566678999999999999999999999999999999999999987765 99999999974332
Q ss_pred CCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccC-CCC-----
Q 019901 143 HSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSI-PDY----- 216 (334)
Q Consensus 143 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~----- 216 (334)
.....+.+||+.|+|||++.+....+.++|||||||++|+|++|++||.+..................... ...
T Consensus 175 ~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 254 (318)
T d3blha1 175 PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYEL 254 (318)
T ss_dssp CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC--
T ss_pred cccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhh
Confidence 22334567999999999998765445569999999999999999999988766544443333221111100 000
Q ss_pred --------------------CCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 217 --------------------VHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 217 --------------------~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
...++++.+||.+||+.||++|||++|+|+||||+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 255 YEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp -----CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred hhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 0136788999999999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-51 Score=360.87 Aligned_cols=250 Identities=23% Similarity=0.373 Sum_probs=203.5
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc--cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW--QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~--~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
||.|+| +|+++.+|+.| |||+++.... .....+.+|+.+++.++||||+++++++......++|++++.+++|
T Consensus 10 LG~G~fg~V~~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l 88 (292)
T d1unla_ 10 IGEGTYGTVFKAKNRETHEIV-ALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLK 88 (292)
T ss_dssp EEECSSSEEEEEEETTTCCEE-EEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHH
T ss_pred EecCcCeEEEEEEECCCCcEE-EEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccc
Confidence 555554 58889999998 9999987652 2346889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-CCCccCCCc
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-PKSTVGTPA 154 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-~~~~~gt~~ 154 (334)
..++...+.+++..++.++.|++.||+|||++||+||||||+|||++..+. +||+|||.|+....... .....+++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~--~kl~DFG~a~~~~~~~~~~~~~~~~~~ 166 (292)
T d1unla_ 89 KYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGE--LKLANFGLARAFGIPVRCYSAEVVTLW 166 (292)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC--EEECCCTTCEECCSCCSCCCSCCSCGG
T ss_pred ccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCc--eeeeecchhhcccCCCccceeeccccc
Confidence 998888889999999999999999999999999999999999999987665 99999999986544332 334457889
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-----------------------
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY----------------------- 211 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------- 211 (334)
|+|||++.+..+.+.++|||||||++|+|++|+.||............+........
T Consensus 167 ~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T d1unla_ 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT 246 (292)
T ss_dssp GCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTC
T ss_pred hhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccc
Confidence 999999988776666699999999999999999987554443332222222111100
Q ss_pred -cCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 212 -SIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 212 -~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.......+++.+++||.+||+.||.+|||++|+|+||||++-.
T Consensus 247 ~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 247 SLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred hhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0011235688999999999999999999999999999997643
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=363.07 Aligned_cols=240 Identities=25% Similarity=0.318 Sum_probs=192.3
Q ss_pred CCccee---e-eeecCC--CCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCSYS--SDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~~~--~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| + +.++.+ +..| |||+++.... ...+.+.+|+.++++++|||||++++++.++ .+|+|||||++|+
T Consensus 17 iG~G~fg~Vy~~~~~~~~~~~~v-AvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~lvmE~~~~g~ 94 (285)
T d1u59a_ 17 LGCGNFGSVRQGVYRMRKKQIDV-AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALMLVMEMAGGGP 94 (285)
T ss_dssp EECCTTEEEEEEEEC---CCEEE-EEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTEE
T ss_pred EecccCeEEEEEEEecCCCcEEE-EEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEEEEEEeCCCCc
Confidence 566655 3 444433 3345 9999976542 2346789999999999999999999998754 5899999999999
Q ss_pred hHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCCCc
Q 019901 75 LFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPKST 149 (334)
Q Consensus 75 L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~~~ 149 (334)
|.+++... +.+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...... .....
T Consensus 95 L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~ 172 (285)
T d1u59a_ 95 LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHY--AKISDFGLSKALGADDSYYTARSAG 172 (285)
T ss_dssp HHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTE--EEECCCTTCEECTTCSCEECCCCSS
T ss_pred HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCc--eeeccchhhhccccccccccccccc
Confidence 99987654 56999999999999999999999999999999999999987765 9999999998543322 22345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.||+.|+|||++.+..++.+ +|||||||++|||+| |+.||.+....+... .+.. ....+.+..+|+++.+||.
T Consensus 173 ~gt~~y~aPE~~~~~~~~~k-sDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 173 KWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA----FIEQ-GKRMECPPECPPELYALMS 246 (285)
T ss_dssp CCCGGGCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCTHHHHH----HHHT-TCCCCCCTTCCHHHHHHHH
T ss_pred ccCccccChHHHhCCCCCcc-chhhcchHHHHHHHhCCCCCCCCCCHHHHHH----HHHc-CCCCCCCCcCCHHHHHHHH
Confidence 68999999999988888655 999999999999998 999998876543322 2222 2233444578999999999
Q ss_pred HhcccCCCCCCCHhHH---hcCcccc
Q 019901 229 RIFVADPAKRISIPEI---RNHEWFL 251 (334)
Q Consensus 229 ~~L~~~p~~R~s~~el---l~h~~~~ 251 (334)
+||+.+|.+|||+.++ |+|+|+.
T Consensus 247 ~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 247 DCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999887 6688774
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-51 Score=361.10 Aligned_cols=237 Identities=19% Similarity=0.290 Sum_probs=189.4
Q ss_pred cceeeeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc-
Q 019901 4 FHNFYDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA- 82 (334)
Q Consensus 4 ~g~~~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~- 82 (334)
||.++....+++..| |||++.... ...+.+.+|+.++++++|||||++++++.+ +.+++|||||++|+|.+++...
T Consensus 26 fg~Vy~~~~~~~~~v-AvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~ 102 (272)
T d1qpca_ 26 FGEVWMGYYNGHTKV-AVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPS 102 (272)
T ss_dssp TEEEEEEEETTTEEE-EEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHH
T ss_pred CcEEEEEEECCCCEE-EEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcC
Confidence 444442223355666 999998766 456789999999999999999999998754 5679999999999999877543
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCCccccch
Q 019901 83 -GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTPAYIAPE 159 (334)
Q Consensus 83 -~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~~y~aPE 159 (334)
.++++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+...... ......||+.|+|||
T Consensus 103 ~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE 180 (272)
T d1qpca_ 103 GIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLS--CKIADFGLARLIEDNEYTAREGAKFPIKWTAPE 180 (272)
T ss_dssp HHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSC--EEECCCTTCEECSSSCEECCTTCCCCTTTSCHH
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccc--eeeccccceEEccCCccccccccCCcccccChH
Confidence 35999999999999999999999999999999999999987765 9999999998654322 234557899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
++.+..++.+ +|||||||++|||+|| .+||......... ..+. .....+.+..+|+++.+|+.+||+.+|.+|
T Consensus 181 ~~~~~~~~~~-sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~----~~i~-~~~~~~~p~~~~~~l~~li~~cl~~~P~~R 254 (272)
T d1qpca_ 181 AINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVI----QNLE-RGYRMVRPDNCPEELYQLMRLCWKERPEDR 254 (272)
T ss_dssp HHHHCEECHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHH----HHHH-TTCCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHhCCCCCch-hhhhhhHHHHHHHHhCCCCCCCCCCHHHHH----HHHH-hcCCCCCcccChHHHHHHHHHHcCCCHhHC
Confidence 9988887655 9999999999999995 5555554433222 2222 223344455789999999999999999999
Q ss_pred CCHhHHhc--Ccccc
Q 019901 239 ISIPEIRN--HEWFL 251 (334)
Q Consensus 239 ~s~~ell~--h~~~~ 251 (334)
||++++++ |+||.
T Consensus 255 pt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 255 PTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCHHHHHHHHHHHHH
T ss_pred cCHHHHHHHhhhhhh
Confidence 99999988 78885
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-51 Score=355.67 Aligned_cols=235 Identities=20% Similarity=0.299 Sum_probs=196.6
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| + +++ +++..| |||.+++.. ...+.+.+|+.++++++||||+++++++.+++.+++||||+++|+|..
T Consensus 12 iG~G~fg~Vy~~~~-~~~~~v-AvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~ 88 (258)
T d1k2pa_ 12 LGTGQFGVVKYGKW-RGQYDV-AIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN 88 (258)
T ss_dssp CCEETTEEEEEEEE-TTTEEE-EEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred EecCCCeEEEEEEE-CCCCEE-EEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence 666666 2 444 456667 999999876 456789999999999999999999999999999999999999999998
Q ss_pred HHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccCCCc
Q 019901 78 RICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVGTPA 154 (334)
Q Consensus 78 ~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~gt~~ 154 (334)
++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+|+....... .....||+.
T Consensus 89 ~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~--~kl~DfG~a~~~~~~~~~~~~~~~~t~~ 166 (258)
T d1k2pa_ 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGV--VKVSDFGLSRYVLDDEYTSSVGSKFPVR 166 (258)
T ss_dssp HHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCC--EEECCCSSCCBCSSSSCCCCCCSCCCGG
T ss_pred hhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCc--EEECcchhheeccCCCceeecccCCCCC
Confidence 8665 456999999999999999999999999999999999999987665 99999999975433322 233568999
Q ss_pred cccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 155 YIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 155 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
|+|||++.+..++.+ +|||||||++|||+| |+.||.+.+..+... .+.. ....+.+...++++.+||.+||+.
T Consensus 167 y~aPE~~~~~~~~~k-sDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~----~i~~-~~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 167 WSPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAE----HIAQ-GLRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp GCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCHHHHHH----HHHT-TCCCCCCTTCCHHHHHHHHHTTCS
T ss_pred cCCcHHhcCCCCCcc-eeecccchhhHhHHhcCCCCCCCCCHHHHHH----HHHh-CCCCCCcccccHHHHHHHHHHccC
Confidence 999999998888655 999999999999998 899999877544332 2322 233444557899999999999999
Q ss_pred CCCCCCCHhHHhcC
Q 019901 234 DPAKRISIPEIRNH 247 (334)
Q Consensus 234 ~p~~R~s~~ell~h 247 (334)
+|++|||++++++|
T Consensus 241 dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 241 KADERPTFKILLSN 254 (258)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred CHhHCcCHHHHHHH
Confidence 99999999999987
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-51 Score=367.96 Aligned_cols=249 Identities=26% Similarity=0.384 Sum_probs=195.3
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCC-----eEEEEEeccC
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPT-----HLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~-----~~~lv~e~~~ 71 (334)
||.|+| .|+++.+|+.| |||++.+... ...+.+.+|+.+|++++||||+++++++.... .+|++ +|+.
T Consensus 16 LG~G~fg~Vy~~~~~~~~~~v-AvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~-~~~~ 93 (345)
T d1pmea_ 16 IGEGAYGMVCSAYDNVNKVRV-AIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV-THLM 93 (345)
T ss_dssp CC---CCCEEEEEETTTCSEE-EEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEE-EECC
T ss_pred EeeccCeEEEEEEECCCCcEE-EEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEE-Eeec
Confidence 677776 58889999999 9999976542 22457889999999999999999999987543 34555 5566
Q ss_pred CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC----CCC
Q 019901 72 GGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS----QPK 147 (334)
Q Consensus 72 ~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~----~~~ 147 (334)
+|+|.+++.. +++++..++.++.||+.||+|||++|||||||||+|||++.++. +||+|||+|+...... ...
T Consensus 94 ~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~--~kl~DfG~a~~~~~~~~~~~~~~ 170 (345)
T d1pmea_ 94 GADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD--LKICDFGLARVADPDHDHTGFLT 170 (345)
T ss_dssp CEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCC--EEECCCTTCEECCGGGCBCCTTC
T ss_pred CCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCC--EEEcccCceeeccCCCccceeec
Confidence 9999999865 46999999999999999999999999999999999999987664 9999999997543322 234
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhcc----------------c
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQ----------------Y 211 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----------------~ 211 (334)
..+||+.|+|||++......+.++||||+||++|+|++|++||.+.+................ .
T Consensus 171 ~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (345)
T d1pmea_ 171 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250 (345)
T ss_dssp CCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHH
T ss_pred cccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccc
Confidence 567999999999987666656669999999999999999999988765444433322111000 0
Q ss_pred cCC---------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccCC
Q 019901 212 SIP---------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNLP 255 (334)
Q Consensus 212 ~~~---------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~~ 255 (334)
..+ ....+++++++||.+||+.||.+|||++|+|+||||++...
T Consensus 251 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp TSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred cCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCC
Confidence 000 12357899999999999999999999999999999986543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=370.16 Aligned_cols=246 Identities=24% Similarity=0.334 Sum_probs=187.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEc------CCeEEEEEec
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILT------PTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~------~~~~~lv~e~ 69 (334)
||.|+| +|+++.+|+.| |||++.+.... ....+.+|+.++++++||||++++++|.. .+.+|+||||
T Consensus 25 LG~G~fg~V~~~~d~~t~~~v-AvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey 103 (355)
T d2b1pa1 25 IGSGAQGIVCAAYDAVLDRNV-AIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103 (355)
T ss_dssp CSCC--CEEEEEEETTTTEEE-EEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEEC
T ss_pred eecCcCeEEEEEEECCCCCEE-EEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEec
Confidence 677776 58899999999 99999876522 23468899999999999999999999964 3689999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCc
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST 149 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~ 149 (334)
|.++ +...+ ...+++..++.+++||+.||.|||++||+||||||+|||++.++. +|++|||+++...........
T Consensus 104 ~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~--~kl~df~~~~~~~~~~~~~~~ 178 (355)
T d2b1pa1 104 MDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT--LKILDFGLARTAGTSFMMTPY 178 (355)
T ss_dssp CSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC-------------
T ss_pred cchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccc--eeeechhhhhccccccccccc
Confidence 9665 44544 356999999999999999999999999999999999999987765 999999999877666666777
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhh------------------ccc
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILS------------------VQY 211 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~------------------~~~ 211 (334)
+||+.|+|||++.+..++.+ +||||+||++|+|++|++||.+.+........+..... ...
T Consensus 179 ~~t~~y~aPE~l~~~~~~~~-~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (355)
T d2b1pa1 179 VVTRYYRAPEVILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257 (355)
T ss_dssp --CCTTCCHHHHTTCCCCTT-HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSC
T ss_pred cccccccChhhhcCCCCCCC-cccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCc
Confidence 89999999999998887665 99999999999999999999887665544443322211 000
Q ss_pred cCCC------------------CCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 212 SIPD------------------YVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 212 ~~~~------------------~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
.... ....++++++||++||..||++|||++|+|+||||+...
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp CCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred cccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 0000 011367899999999999999999999999999998754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-51 Score=369.84 Aligned_cols=246 Identities=21% Similarity=0.350 Sum_probs=195.7
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCccc--ccHHHHHHHHHHHcCCCCCcccceEEEEcC-----CeEEEEEecc
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQ--IDENVQREIINHRSLRHPNIVRFKEVILTP-----THLAIVMEYA 70 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~--~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~-----~~~~lv~e~~ 70 (334)
||.|+| +|+++.+|+.| |||++.+.... ..+.+.+|+.+|++++|||||++++++... ...++|++|+
T Consensus 26 LG~G~fg~Vy~a~~~~~~~~v-AiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~ 104 (348)
T d2gfsa1 26 VGSGAYGSVCAAFDTKTGLRV-AVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL 104 (348)
T ss_dssp CGGGTTSSEEEEEETTTTEEE-EEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEEC
T ss_pred EecCCCeEEEEEEECCCCCEE-EEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEee
Confidence 666665 58889999999 99999876522 235788999999999999999999998643 3345666777
Q ss_pred CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCcc
Q 019901 71 SGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV 150 (334)
Q Consensus 71 ~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 150 (334)
.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.++. +|++|||+|..... ...+..
T Consensus 105 ~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~--~kl~dfg~a~~~~~--~~~~~~ 179 (348)
T d2gfsa1 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE--LKILDFGLARHTDD--EMTGYV 179 (348)
T ss_dssp CSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC--EEECCC----CCTG--GGSSSC
T ss_pred cCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccccccccc--ccccccchhcccCc--cccccc
Confidence 89999998854 57999999999999999999999999999999999999987765 99999999875432 334567
Q ss_pred CCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccc-------------------
Q 019901 151 GTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQY------------------- 211 (334)
Q Consensus 151 gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~------------------- 211 (334)
||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+.......+.........
T Consensus 180 g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (348)
T d2gfsa1 180 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259 (348)
T ss_dssp HHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSC
T ss_pred ccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcc
Confidence 9999999999888777666799999999999999999999987765554444332211100
Q ss_pred cCC------CCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCcccccc
Q 019901 212 SIP------DYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKN 253 (334)
Q Consensus 212 ~~~------~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~ 253 (334)
..+ ....+++++++||.+||+.||.+|||++|+|+||||++.
T Consensus 260 ~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~ 307 (348)
T d2gfsa1 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307 (348)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred cCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence 000 023578999999999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-51 Score=366.74 Aligned_cols=246 Identities=30% Similarity=0.519 Sum_probs=203.7
Q ss_pred CCccee---e-eee---cCCCCeeEEEEEEecCcc----cccHHHHHHHHHHHcCCC-CCcccceEEEEcCCeEEEEEec
Q 019901 2 LGFHNF---Y-DRC---SYSSDLFVNIIIIVFHLW----QIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEY 69 (334)
Q Consensus 2 lG~g~~---~-~~~---~~~~~~vvaiK~~~~~~~----~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~ 69 (334)
||.|+| + |++ +.+|+.| |||++.+... ...+.+.+|+.++++++| |||+++++++.+...+++||||
T Consensus 32 IG~G~fg~Vy~~~~~~~~~~g~~v-AvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~ 110 (322)
T d1vzoa_ 32 LGTGAYGKVFLVRKISGHDTGKLY-AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDY 110 (322)
T ss_dssp EEETTTEEEEEEEECSSTTTTCEE-EEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECC
T ss_pred EecCCCeEEEEEEECccCCCCcEE-EEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeec
Confidence 455554 3 554 4568888 9999976542 234678899999999976 8999999999999999999999
Q ss_pred cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCC--CCCCC
Q 019901 70 ASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPK 147 (334)
Q Consensus 70 ~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~--~~~~~ 147 (334)
+.+|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+|+.... .....
T Consensus 111 ~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~--vkL~DFG~a~~~~~~~~~~~~ 188 (322)
T d1vzoa_ 111 INGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGH--VVLTDFGLSKEFVADETERAY 188 (322)
T ss_dssp CCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSC--EEESCSSEEEECCGGGGGGGC
T ss_pred ccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCC--EEEeeccchhhhccccccccc
Confidence 999999999999999999999999999999999999999999999999999987765 99999999975432 22334
Q ss_pred CccCCCccccchhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKE-YDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHL 226 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 226 (334)
+..|++.|+|||.+.+.. +.+.++|||||||++|+|++|+.||.+.....................| ..+|+++.+|
T Consensus 189 ~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~~~~l 266 (322)
T d1vzoa_ 189 DFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSALAKDL 266 (322)
T ss_dssp GGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHH
T ss_pred ccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHHHHHH
Confidence 567999999999997654 3345599999999999999999999887665555555554444444333 3689999999
Q ss_pred HHHhcccCCCCCC-----CHhHHhcCccccc
Q 019901 227 ISRIFVADPAKRI-----SIPEIRNHEWFLK 252 (334)
Q Consensus 227 i~~~L~~~p~~R~-----s~~ell~h~~~~~ 252 (334)
|.+||++||.+|| |++|+++||||++
T Consensus 267 i~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 267 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999999999999 4899999999964
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=352.64 Aligned_cols=241 Identities=21% Similarity=0.290 Sum_probs=187.3
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHH
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFE 77 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~ 77 (334)
||.|+| + ++++ +++.| |||++.... ...+.+.+|+.++++++|||||++++++.+ +..++|||||.+|+|..
T Consensus 25 iG~G~fg~Vy~~~~~-~~~~v-AiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~ 100 (285)
T d1fmka3 25 LGQGCFGEVWMGTWN-GTTRV-AIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD 100 (285)
T ss_dssp EEECSSCEEEEEEET-TTEEE-EEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred EeeCCCeEEEEEEEC-CCCEE-EEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhh
Confidence 455554 4 5444 34566 999997665 556789999999999999999999999854 56799999999999998
Q ss_pred HHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC--CCCCccCCC
Q 019901 78 RICN--AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--QPKSTVGTP 153 (334)
Q Consensus 78 ~l~~--~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--~~~~~~gt~ 153 (334)
++.. .+.+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+...... ......||+
T Consensus 101 ~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~--~kl~DfGla~~~~~~~~~~~~~~~gt~ 178 (285)
T d1fmka3 101 FLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLV--CKVADFGLARLIEDNEYTARQGAKFPI 178 (285)
T ss_dssp HHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCCTTC--------------CCG
T ss_pred hhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCc--EEEcccchhhhccCCCceeeccccccc
Confidence 8764 356999999999999999999999999999999999999987765 9999999998543222 223456899
Q ss_pred ccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhccc
Q 019901 154 AYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVA 233 (334)
Q Consensus 154 ~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 233 (334)
.|+|||++.+..++.+ +|||||||++|||++|..||............ +. .....+....+|+++++||.+||+.
T Consensus 179 ~y~aPE~~~~~~~~~k-sDI~S~Giil~el~t~~~p~~~~~~~~~~~~~---i~-~~~~~~~~~~~~~~l~~li~~cl~~ 253 (285)
T d1fmka3 179 KWTAPEAALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQ---VE-RGYRMPCPPECPESLHDLMCQCWRK 253 (285)
T ss_dssp GGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH-TTCCCCCCTTSCHHHHHHHHHHTCS
T ss_pred cccChHHHhCCCCCcH-HhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH---HH-hcCCCCCCcccCHHHHHHHHHHccc
Confidence 9999999988888655 99999999999999965554443333322222 22 2233445567899999999999999
Q ss_pred CCCCCCCHhHHhc--Ccccccc
Q 019901 234 DPAKRISIPEIRN--HEWFLKN 253 (334)
Q Consensus 234 ~p~~R~s~~ell~--h~~~~~~ 253 (334)
+|++|||++++++ ++||...
T Consensus 254 dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 254 EPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp SGGGSCCHHHHHHHHHTTTSCS
T ss_pred CHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999987 7787543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-50 Score=351.28 Aligned_cols=238 Identities=21% Similarity=0.301 Sum_probs=183.0
Q ss_pred CCccee---e-eeecCCCC---eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCSYSSD---LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~---~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| + |+.+.++. ..||||++..... .....+.+|+.++++++|||||++++++.+.+..++|||||.++
T Consensus 15 iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~ 94 (283)
T d1mqba_ 15 IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 94 (283)
T ss_dssp EEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTE
T ss_pred EeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccC
Confidence 566655 3 55555442 2349999976542 22346889999999999999999999999999999999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----CCC
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----PKS 148 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~~~ 148 (334)
++.+.+... +.+++.++..++.||+.||+|||++||+||||||+|||++.++. +||+|||+|+....... ...
T Consensus 95 ~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~--~Kl~DFGla~~~~~~~~~~~~~~~ 172 (283)
T d1mqba_ 95 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLV--CKVSDFGLSRVLEDDPEATYTTSG 172 (283)
T ss_dssp EHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCC--EEECCCCC----------------
T ss_pred cchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCe--EEEcccchhhcccCCCccceEecc
Confidence 999887655 56999999999999999999999999999999999999987765 99999999985433221 223
Q ss_pred ccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 149 TVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 149 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
..||+.|+|||++.+..++.+ +|||||||++|||+++..||............ .......+.+..+++.+.++|.
T Consensus 173 ~~gt~~Y~APE~l~~~~~~~~-sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~~~~~~~~~~~~~l~~li~ 247 (283)
T d1mqba_ 173 GKIPIRWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKA----INDGFRLPTPMDCPSAIYQLMM 247 (283)
T ss_dssp -CCCGGGSCHHHHHSCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH----HHTTCCCCCCTTCBHHHHHHHH
T ss_pred CCCCccccCHHHHccCCCCCc-ccccccHHHHHHHHhCCCCccccCCHHHHHHH----HhccCCCCCchhhHHHHHHHHH
Confidence 458999999999988888665 99999999999999965555443333322222 2233444555678999999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||+.+|.+|||+.++++
T Consensus 248 ~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 248 QCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTCSSTTTSCCHHHHHH
T ss_pred HHCcCCHhHCcCHHHHHH
Confidence 999999999999999986
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-49 Score=348.49 Aligned_cols=237 Identities=22% Similarity=0.348 Sum_probs=180.7
Q ss_pred CCccee---e-eeecCCCC--eeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF---Y-DRCSYSSD--LFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~--~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| + |++..+++ ..||||.+..... ...+.+.+|+.++++++||||+++++++. ++.+|+|||||++|+
T Consensus 15 iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~ 93 (273)
T d1mp8a_ 15 IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGE 93 (273)
T ss_dssp EEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEE
T ss_pred EeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCc
Confidence 555555 3 66655543 2238888765431 22467899999999999999999999985 567899999999999
Q ss_pred hHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC--CCCccC
Q 019901 75 LFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ--PKSTVG 151 (334)
Q Consensus 75 L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~--~~~~~g 151 (334)
|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++. +||+|||+|+....... .....|
T Consensus 94 l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~--~Kl~DfG~a~~~~~~~~~~~~~~~g 171 (273)
T d1mp8a_ 94 LRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDC--VKLGDFGLSRYMEDSTYYKASKGKL 171 (273)
T ss_dssp HHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTE--EEECC-------------------C
T ss_pred HHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCc--EEEccchhheeccCCcceeccceec
Confidence 9988765 456999999999999999999999999999999999999987765 99999999986433222 234468
Q ss_pred CCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHh
Q 019901 152 TPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRI 230 (334)
Q Consensus 152 t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 230 (334)
|+.|+|||++.+..++.+ +|||||||++|||++ |.+||.+.........+ .. ....+.+..+|+++.+||.+|
T Consensus 172 t~~y~apE~l~~~~~~~~-~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i----~~-~~~~~~~~~~~~~~~~li~~c 245 (273)
T d1mp8a_ 172 PIKWMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI----EN-GERLPMPPNCPPTLYSLMTKC 245 (273)
T ss_dssp CGGGCCHHHHHHCCCSHH-HHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH----HT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred CcccchhhHhccCCCCCc-cccccchHHHHHHHhcCCCCCCCCCHHHHHHHH----Hc-CCCCCCCCCCCHHHHHHHHHH
Confidence 999999999988888655 999999999999998 89999887765444332 22 223345567899999999999
Q ss_pred cccCCCCCCCHhHHhcC
Q 019901 231 FVADPAKRISIPEIRNH 247 (334)
Q Consensus 231 L~~~p~~R~s~~ell~h 247 (334)
|+.||.+|||+.++++|
T Consensus 246 l~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 246 WAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TCSSGGGSCCHHHHHHH
T ss_pred cCCCHhHCcCHHHHHHH
Confidence 99999999999999876
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-49 Score=352.08 Aligned_cols=238 Identities=22% Similarity=0.300 Sum_probs=192.4
Q ss_pred CCccee----eeeecCCCCee-EEEEEEecCc-ccccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCC
Q 019901 2 LGFHNF----YDRCSYSSDLF-VNIIIIVFHL-WQIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~v-vaiK~~~~~~-~~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~ 74 (334)
||.|+| .|.++.+|..+ ||||.+.... ....+.+.+|+.+|+++ +|||||++++++.+++.+++||||+++|+
T Consensus 18 iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~ 97 (309)
T d1fvra_ 18 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97 (309)
T ss_dssp EECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCB
T ss_pred EeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCc
Confidence 555555 46777777643 4788876543 23456799999999998 79999999999999999999999999999
Q ss_pred hHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 75 LFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 75 L~~~l~~~----------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++..+. +||+|||+|+
T Consensus 98 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~--~kl~DfG~a~ 175 (309)
T d1fvra_ 98 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV--AKIADFGLSR 175 (309)
T ss_dssp HHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGC--EEECCTTCEE
T ss_pred HHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCc--eEEccccccc
Confidence 99998654 56999999999999999999999999999999999999987765 9999999998
Q ss_pred CCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhhccccCCCCC
Q 019901 139 SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYV 217 (334)
Q Consensus 139 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (334)
............||+.|+|||.+.+..++.+ +|||||||++|+|++|. +||.+.+..... ..+.. ...++.+.
T Consensus 176 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-sDvwSfGvil~ell~~~~~p~~~~~~~~~~----~~i~~-~~~~~~~~ 249 (309)
T d1fvra_ 176 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLPQ-GYRLEKPL 249 (309)
T ss_dssp SSCEECCC----CCTTTCCHHHHHHCEECHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHGGG-TCCCCCCT
T ss_pred cccccccccceecCCcccchHHhccCCCCcc-ceeehhHHHHHHHHhcCCCCCCCCCHHHHH----HHHHh-cCCCCCCc
Confidence 7665555556679999999999998888655 99999999999999965 677766543322 22222 23444555
Q ss_pred CCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 218 HISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 218 ~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
.+++++++||.+||+.+|++|||+.++++|
T Consensus 250 ~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 250 NCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 789999999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-49 Score=345.99 Aligned_cols=233 Identities=23% Similarity=0.342 Sum_probs=182.5
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEeccCCCChHHH
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGGELFER 78 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~~L~~~ 78 (334)
||.|+| +.+...+|..| |||++++.. ..+.+.+|+.++++++||||+++++++.+ .+.+|+||||+++|+|.++
T Consensus 15 lG~G~fg~Vy~~~~~~~~v-AvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~ 91 (262)
T d1byga_ 15 IGKGEFGDVMLGDYRGNKV-AVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDY 91 (262)
T ss_dssp EEECSSCEEEEEEETTEEE-EEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHH
T ss_pred EecCCCeEEEEEEECCeEE-EEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHH
Confidence 455555 33333467777 999997654 45789999999999999999999998854 4678999999999999999
Q ss_pred HHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCCCCCccCCCccc
Q 019901 79 ICNAG--RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 156 (334)
Q Consensus 79 l~~~~--~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~~~~~~gt~~y~ 156 (334)
+.+.+ .+++..+..++.||+.||.|||+++|+||||||+|||++.++. +||+|||+++.... ......+|+.|+
T Consensus 92 l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~--~kl~dfg~s~~~~~--~~~~~~~~~~y~ 167 (262)
T d1byga_ 92 LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--AKVSDFGLTKEASS--TQDTGKLPVKWT 167 (262)
T ss_dssp HHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC--EEECCCCC--------------CCTTTS
T ss_pred HHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCC--EeecccccceecCC--CCccccccccCC
Confidence 87643 4899999999999999999999999999999999999987765 99999999985432 334557899999
Q ss_pred cchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCC
Q 019901 157 APEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADP 235 (334)
Q Consensus 157 aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p 235 (334)
|||++.+..++. ++|||||||++|||+| |++||...+....... +. .....+.+..+++++++||.+||+.||
T Consensus 168 aPE~l~~~~~t~-~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~----i~-~~~~~~~~~~~~~~~~~li~~cl~~dP 241 (262)
T d1byga_ 168 APEALREKKFST-KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR----VE-KGYKMDAPDGCPPAVYEVMKNCWHLDA 241 (262)
T ss_dssp CHHHHHHCCCCH-HHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH----HT-TTCCCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred ChHHHhCCCCCh-HHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HH-cCCCCCCCccCCHHHHHHHHHHcccCH
Confidence 999998888754 4999999999999998 7898887665443332 22 223334445689999999999999999
Q ss_pred CCCCCHhHHhcC
Q 019901 236 AKRISIPEIRNH 247 (334)
Q Consensus 236 ~~R~s~~ell~h 247 (334)
.+|||+.+++++
T Consensus 242 ~~Rps~~~l~~~ 253 (262)
T d1byga_ 242 AMRPSFLQLREQ 253 (262)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999864
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-49 Score=351.87 Aligned_cols=239 Identities=19% Similarity=0.297 Sum_probs=186.9
Q ss_pred CCccee---e-eeecCCCCee---EEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCSYSSDLF---VNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~v---vaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 73 (334)
||.|+| + +++..+|+.+ ||+|.+.... ....+.+.+|+.++++++|||||++++++.++ ..+++++|+.+|
T Consensus 17 lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~ 95 (317)
T d1xkka_ 17 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFG 95 (317)
T ss_dssp EEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTC
T ss_pred EecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCC
Confidence 455554 3 6777777642 3777776543 23457899999999999999999999999875 467888999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
+|.+.+... ..+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|||+|+....... ....
T Consensus 96 ~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~--~kl~DFGla~~~~~~~~~~~~~~~ 173 (317)
T d1xkka_ 96 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQH--VKITDFGLAKLLGAEEKEYHAEGG 173 (317)
T ss_dssp BHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTE--EEECCCSHHHHTTTTCC-------
T ss_pred cccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCC--eEeeccccceeccccccccccccc
Confidence 998887764 56999999999999999999999999999999999999987765 99999999986443322 2234
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
.||+.|+|||++.+..++.+ +|||||||++|||+| |.+||.+.+..+.. ..+ .....++.+..+++++.+|+.
T Consensus 174 ~gt~~y~APE~l~~~~~~~~-sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i----~~~~~~~~p~~~~~~~~~li~ 247 (317)
T d1xkka_ 174 KVPIKWMALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEIS-SIL----EKGERLPQPPICTIDVYMIMV 247 (317)
T ss_dssp -CCTTTSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHH----HHTCCCCCCTTBCHHHHHHHH
T ss_pred ccCccccChHHHhcCCCChh-hhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHH----HcCCCCCCCcccCHHHHHHHH
Confidence 58999999999998888655 999999999999998 89999877654432 222 222334455578999999999
Q ss_pred HhcccCCCCCCCHhHHhcCcc
Q 019901 229 RIFVADPAKRISIPEIRNHEW 249 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~h~~ 249 (334)
+||+.+|.+|||+.+++.|..
T Consensus 248 ~cl~~dP~~RPs~~eil~~l~ 268 (317)
T d1xkka_ 248 KCWMIDADSRPKFRELIIEFS 268 (317)
T ss_dssp HHTCSSGGGSCCHHHHHHHHH
T ss_pred HhCCCChhhCcCHHHHHHHHH
Confidence 999999999999999998843
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-49 Score=344.71 Aligned_cols=235 Identities=25% Similarity=0.379 Sum_probs=183.1
Q ss_pred CCccee----eeeec-CCCC--eeEEEEEEecCcc---cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccC
Q 019901 2 LGFHNF----YDRCS-YSSD--LFVNIIIIVFHLW---QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYAS 71 (334)
Q Consensus 2 lG~g~~----~~~~~-~~~~--~vvaiK~~~~~~~---~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~ 71 (334)
||.|+| .|+.. .+++ .| |||++.+... ...+.+.+|+.++++++||||+++++++.+ +.+++|||||+
T Consensus 16 iG~G~fg~Vy~~~~~~~~~~~~~v-AiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~ 93 (273)
T d1u46a_ 16 LGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAP 93 (273)
T ss_dssp CC----CCCEEEEEECTTSCEEEE-EEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred EecCCCeEEEEEEEECCCCcEEEE-EEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeec
Confidence 676666 34433 3333 45 9999987642 223578999999999999999999999976 46789999999
Q ss_pred CCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC----C
Q 019901 72 GGELFERICN-AGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ----P 146 (334)
Q Consensus 72 ~~~L~~~l~~-~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~----~ 146 (334)
+|++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||+++....... .
T Consensus 94 ~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~--vkl~DfGl~~~~~~~~~~~~~~ 171 (273)
T d1u46a_ 94 LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDL--VKIGDFGLMRALPQNDDHYVMQ 171 (273)
T ss_dssp TCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTE--EEECCCTTCEECCC-CCEEEC-
T ss_pred CcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccc--eeeccchhhhhcccCCCcceec
Confidence 9999987765 456999999999999999999999999999999999999987764 99999999986533322 2
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRH 225 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (334)
....|++.|+|||++.+..++.+ +|||||||++|||+| |++||.+.+..... ..+......++.+..+|+++++
T Consensus 172 ~~~~~~~~~~aPE~~~~~~~~~~-~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~----~~i~~~~~~~~~~~~~~~~l~~ 246 (273)
T d1u46a_ 172 EHRKVPFAWCAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQIL----HKIDKEGERLPRPEDCPQDIYN 246 (273)
T ss_dssp ----CCGGGCCHHHHHHCEEEHH-HHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTSCCCCCCCTTCCHHHHH
T ss_pred CccccCcccCCHHHHhCCCCCcc-hhhhhhHHHHHHHHhCCCCCCCCcCHHHHH----HHHHhCCCCCCCcccccHHHHH
Confidence 23457889999999998877554 999999999999998 89999887664433 3444555556666788999999
Q ss_pred HHHHhcccCCCCCCCHhHHh
Q 019901 226 LISRIFVADPAKRISIPEIR 245 (334)
Q Consensus 226 li~~~L~~~p~~R~s~~ell 245 (334)
+|.+||+.||++|||+++++
T Consensus 247 li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 247 VMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHH
Confidence 99999999999999999986
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-48 Score=347.15 Aligned_cols=238 Identities=20% Similarity=0.325 Sum_probs=179.8
Q ss_pred CCccee---e-eeecC-----CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcC-CeEEEEEec
Q 019901 2 LGFHNF---Y-DRCSY-----SSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTP-THLAIVMEY 69 (334)
Q Consensus 2 lG~g~~---~-~~~~~-----~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~-~~~~lv~e~ 69 (334)
||.|+| + |.+.. +++.| |||++..... ...+.+.+|+..+.++ +||||+.+++++... +.+++||||
T Consensus 21 iG~G~fG~Vy~a~~~~~~~~~~~~~v-AvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~ 99 (299)
T d1ywna1 21 LGRGAFGQVIEADAFGIDKTATCRTV-AVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99 (299)
T ss_dssp EEECSSCEEEEEEEESTTSSSCEEEE-EEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEEC
T ss_pred EeecCCeEEEEEEEcCCCcccCCeEE-EEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEe
Confidence 555555 3 54433 33456 9999876542 2335677788777666 689999999987654 568999999
Q ss_pred cCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEec
Q 019901 70 ASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICD 133 (334)
Q Consensus 70 ~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~D 133 (334)
|++|+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||++.++. +||+|
T Consensus 100 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~--~Kl~D 177 (299)
T d1ywna1 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNV--VKICD 177 (299)
T ss_dssp CTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGC--EEECC
T ss_pred cCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCc--EEEcc
Confidence 9999999999753 24899999999999999999999999999999999999987765 99999
Q ss_pred cCCccCCCCCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhhc
Q 019901 134 FGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSV 209 (334)
Q Consensus 134 fgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~ 209 (334)
||+|+...... ......||+.|+|||++.+..++.+ +|||||||++|+|++| .+||.+......+...+..
T Consensus 178 FGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~---- 252 (299)
T d1ywna1 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ-SDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE---- 252 (299)
T ss_dssp ------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHH----
T ss_pred CcchhhccccccccccCceeeCccccchhHhhcCCCCcc-cceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc----
Confidence 99998543322 2334579999999999998887655 9999999999999986 5788876655544443332
Q ss_pred cccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 210 QYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 210 ~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
...++.+..+++++.++|.+||+.||.+|||++|+++|
T Consensus 253 ~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 253 GTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22333444689999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-48 Score=342.22 Aligned_cols=236 Identities=22% Similarity=0.320 Sum_probs=189.4
Q ss_pred CCccee----eeeecCCCC-------eeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEe
Q 019901 2 LGFHNF----YDRCSYSSD-------LFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVME 68 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~-------~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e 68 (334)
||.|+| .|++..+++ .| |||++.+... .....+.+|...+.++ +|||||++++++.+++.+++|||
T Consensus 21 iG~G~fg~Vy~~~~~~~~~~~~~~~~~v-AvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e 99 (299)
T d1fgka_ 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKV-AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVE 99 (299)
T ss_dssp CC-----CEEEEEEECC----CCCEEEE-EEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred EeecCCcEEEEEEEcCCCcccccCceEE-EEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEE
Confidence 677777 355544432 45 9999987652 2336788898888887 79999999999999999999999
Q ss_pred ccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEe
Q 019901 69 YASGGELFERICNA----------------GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKIC 132 (334)
Q Consensus 69 ~~~~~~L~~~l~~~----------------~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~ 132 (334)
||++|+|.+++... ..+++..++.++.||+.||+|||++|||||||||+|||++.++. +||+
T Consensus 100 ~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~--~kl~ 177 (299)
T d1fgka_ 100 YASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNV--MKIA 177 (299)
T ss_dssp CCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEEC
T ss_pred ccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCC--eEec
Confidence 99999999999754 34899999999999999999999999999999999999987765 9999
Q ss_pred ccCCccCCCCCC---CCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhh
Q 019901 133 DFGYSKSSVLHS---QPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILS 208 (334)
Q Consensus 133 Dfgla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 208 (334)
|||+++...... ......||+.|+|||++.+..++.+ +|||||||++|+|++ |.+||.+.+....+ . .+ .
T Consensus 178 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k-~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~-~---~i-~ 251 (299)
T d1fgka_ 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELF-K---LL-K 251 (299)
T ss_dssp STTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSSTTCCHHHHH-H---HH-H
T ss_pred cchhhccccccccccccccCCCChhhhhhhHhcCCCCCch-hhhHHhHHHHHHhccCCCCCCCCCCHHHHH-H---HH-H
Confidence 999998654332 2334578999999999998888655 999999999999998 79999876653322 2 22 2
Q ss_pred ccccCCCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhc
Q 019901 209 VQYSIPDYVHISPECRHLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 209 ~~~~~~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~ 246 (334)
....++.+..+|+++.+||.+||+.+|++|||+.|+++
T Consensus 252 ~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 252 EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 23344455578999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.1e-48 Score=341.96 Aligned_cols=224 Identities=21% Similarity=0.309 Sum_probs=183.5
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC---------
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG--------- 83 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------- 83 (334)
++..| |||++..... ...+.+.+|+.++++++||||+++++++...+..++||||+.+|+|.+++....
T Consensus 42 ~~~~v-AvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~ 120 (301)
T d1lufa_ 42 PFTMV-AVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120 (301)
T ss_dssp SEEEE-EEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred CCeEE-EEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccc
Confidence 44566 9999876542 234679999999999999999999999999999999999999999999986532
Q ss_pred ---------------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCC---CC
Q 019901 84 ---------------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQ 145 (334)
Q Consensus 84 ---------------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~---~~ 145 (334)
.+++..+..++.|++.||+|||++|||||||||+|||++.++. +||+|||+|+..... ..
T Consensus 121 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~--~Kl~DFGls~~~~~~~~~~~ 198 (301)
T d1lufa_ 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMV--VKIADFGLSRNIYSADYYKA 198 (301)
T ss_dssp --------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC--EEECCCSCHHHHTGGGCBC-
T ss_pred cccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCc--EEEccchhheeccCCccccc
Confidence 3889999999999999999999999999999999999987665 999999999743222 22
Q ss_pred CCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCC-CCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHH
Q 019901 146 PKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGA-YPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECR 224 (334)
Q Consensus 146 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (334)
..+..||+.|+|||++.+..++.+ +|||||||++|||++|. +||.+....+... .+.... ..+.+..+++++.
T Consensus 199 ~~~~~~~~~y~aPE~~~~~~~t~k-sDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~----~v~~~~-~~~~p~~~~~~~~ 272 (301)
T d1lufa_ 199 DGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY----YVRDGN-ILACPENCPLELY 272 (301)
T ss_dssp ---CCBCGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HHHTTC-CCCCCTTCCHHHH
T ss_pred cCCCCcCcCcCCHHHHccCCCChh-hhhccchhhHHHHHccCCCCCCCCCHHHHHH----HHHcCC-CCCCCccchHHHH
Confidence 335578999999999998888755 99999999999999985 6788766544333 232222 2334456899999
Q ss_pred HHHHHhcccCCCCCCCHhHHhc
Q 019901 225 HLISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 225 ~li~~~L~~~p~~R~s~~ell~ 246 (334)
+||.+||+.+|.+|||+.|+++
T Consensus 273 ~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 273 NLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999864
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-47 Score=336.07 Aligned_cols=239 Identities=19% Similarity=0.245 Sum_probs=184.8
Q ss_pred CCccee---e-eeecCCC--CeeEEEEEEecCc-ccccHHHHHHHHHHHcCCCCCcccceEEEEc-CCeEEEEEeccCCC
Q 019901 2 LGFHNF---Y-DRCSYSS--DLFVNIIIIVFHL-WQIDENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIVMEYASGG 73 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~--~~vvaiK~~~~~~-~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~~~ 73 (334)
||.|+| + +....++ ...||||.+.+.. ....+.+.+|+.++++++||||+++++++.. ++..++|||||++|
T Consensus 35 iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g 114 (311)
T d1r0pa_ 35 IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114 (311)
T ss_dssp EEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTC
T ss_pred EeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecC
Confidence 455554 3 4554433 2334999997543 1234679999999999999999999999765 57899999999999
Q ss_pred ChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC-----CC
Q 019901 74 ELFERICNA-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ-----PK 147 (334)
Q Consensus 74 ~L~~~l~~~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~-----~~ 147 (334)
+|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||+++....... ..
T Consensus 115 ~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~--~kL~DFG~~~~~~~~~~~~~~~~~ 192 (311)
T d1r0pa_ 115 DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFT--VKVADFGLARDMYDKEFDSVHNKT 192 (311)
T ss_dssp BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCC--EEECSSGGGCCTTTTTCCCTTCTT
T ss_pred chhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCC--EEEecccchhhccccccccceecc
Confidence 999988754 35788899999999999999999999999999999999987665 99999999986433322 22
Q ss_pred CccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHH
Q 019901 148 STVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLI 227 (334)
Q Consensus 148 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (334)
...||+.|+|||.+.+..++.+ +||||||+++|||+||..||........... .+... ...+.+..+++++.+||
T Consensus 193 ~~~gt~~y~aPE~~~~~~~~~k-sDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g-~~~~~p~~~~~~l~~li 267 (311)
T d1r0pa_ 193 GAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQG-RRLLQPEYCPDPLYEVM 267 (311)
T ss_dssp CSSCCGGGSCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTT-CCCCCCTTCCHHHHHHH
T ss_pred cccccccccChHHHhcCCCCCh-hHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH---HHHcC-CCCCCcccCcHHHHHHH
Confidence 3468999999999988887655 9999999999999997777765433222222 22222 23334456899999999
Q ss_pred HHhcccCCCCCCCHhHHhcC
Q 019901 228 SRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 228 ~~~L~~~p~~R~s~~ell~h 247 (334)
.+||+.+|++|||+.|+++|
T Consensus 268 ~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 268 LKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999987
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-47 Score=338.32 Aligned_cols=224 Identities=18% Similarity=0.219 Sum_probs=184.1
Q ss_pred CCCeeEEEEEEecCcc-cccHHHHHHHHHHHcCCCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhc----------
Q 019901 14 SSDLFVNIIIIVFHLW-QIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNA---------- 82 (334)
Q Consensus 14 ~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------- 82 (334)
++..| |||++..... .....+.+|+.++++++||||+++++++..++..++|||||.+|+|.+++...
T Consensus 49 ~~~~V-AvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~ 127 (308)
T d1p4oa_ 49 PETRV-AIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 127 (308)
T ss_dssp EEEEE-EEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred CCcEE-EEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccccc
Confidence 34566 9999976542 22346889999999999999999999999999999999999999999988642
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCccCCCccccch
Q 019901 83 GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPE 159 (334)
Q Consensus 83 ~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~~gt~~y~aPE 159 (334)
..++...+..++.|++.||.|||+++|+||||||+|||++.++. +||+|||+|+....... .....||+.|+|||
T Consensus 128 ~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~--~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe 205 (308)
T d1p4oa_ 128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT--VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205 (308)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCC--EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCce--EEEeecccceeccCCcceeeccceecccccCCHH
Confidence 24688999999999999999999999999999999999987765 99999999985433322 23346899999999
Q ss_pred hhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHHHhcccCCCCC
Q 019901 160 VLLKKEYDGKIADVWSCGVTLYVMLVG-AYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLISRIFVADPAKR 238 (334)
Q Consensus 160 ~~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~R 238 (334)
.+.+..++.+ +|||||||++|||+|| .+||.+.+....+.. +... ...+.+..+|+.+.++|.+||+.+|.+|
T Consensus 206 ~l~~~~~~~~-~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~----i~~~-~~~~~p~~~~~~l~~li~~cl~~~P~~R 279 (308)
T d1p4oa_ 206 SLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF----VMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMR 279 (308)
T ss_dssp HHHHCCCCHH-HHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHH----HHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred HHccCCCCcc-cccccHHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhC-CCCCCcccchHHHHHHHHHHcCCChhHC
Confidence 9988888655 9999999999999998 578877665443332 2222 2334445689999999999999999999
Q ss_pred CCHhHHhc
Q 019901 239 ISIPEIRN 246 (334)
Q Consensus 239 ~s~~ell~ 246 (334)
||++++++
T Consensus 280 Ps~~~il~ 287 (308)
T d1p4oa_ 280 PSFLEIIS 287 (308)
T ss_dssp CCHHHHHH
T ss_pred cCHHHHHH
Confidence 99999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-46 Score=333.92 Aligned_cols=250 Identities=18% Similarity=0.173 Sum_probs=188.4
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcc-cceEEEEcCCeEEEEEeccCCCChH
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIV-RFKEVILTPTHLAIVMEYASGGELF 76 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv-~~~~~~~~~~~~~lv~e~~~~~~L~ 76 (334)
||.|+| .|++..+|+.| |||++.... ....+.+|+.+++.++|++++ .+..++.+++..++||||+. ++|.
T Consensus 15 iG~G~fG~Vy~a~~~~~~~~v-AvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~ 90 (299)
T d1ckia_ 15 IGSGSFGDIYLGTDIAAGEEV-AIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLE 90 (299)
T ss_dssp EEECSSSEEEEEEETTTTEEE-EEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred EeeCCCcEEEEEEECCCCCEE-EEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchh
Confidence 455554 47888999988 999988765 345689999999999876655 55666678889999999994 5665
Q ss_pred HHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCC-CCCEEEeccCCccCCCCCC--------CC
Q 019901 77 ERIC-NAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSP-APRLKICDFGYSKSSVLHS--------QP 146 (334)
Q Consensus 77 ~~l~-~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~-~~~~kl~Dfgla~~~~~~~--------~~ 146 (334)
..+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++..+ ...+||+|||+|+...... ..
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~ 170 (299)
T d1ckia_ 91 DLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170 (299)
T ss_dssp HHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBC
T ss_pred hhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceecccc
Confidence 5554 456799999999999999999999999999999999999986432 2359999999998543222 22
Q ss_pred CCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC---CCCCCCHHH
Q 019901 147 KSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPEC 223 (334)
Q Consensus 147 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~ 223 (334)
.+..||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.............. ........+ ....+|+++
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~p~~~ 248 (299)
T d1ckia_ 171 KNLTGTARYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYER-ISEKKMSTPIEVLCKGYPSEF 248 (299)
T ss_dssp CSCCCCSSSCCHHHHTTBCCCHH-HHHHHHHHHHHHHHHSSCTTCCCC-------HHH-HHHHHHHSCHHHHTTTSCHHH
T ss_pred CCcCCCccccCHHHHhCCCCCCh-hhEEecCHHHHHHHhCCCcccccchHHHHHHHHH-hhcccCCCChhHhccCCCHHH
Confidence 34579999999999998887655 9999999999999999999987654333222211 111111111 123579999
Q ss_pred HHHHHHhcccCCCCCCCHh---HHhcCccccccCCCc
Q 019901 224 RHLISRIFVADPAKRISIP---EIRNHEWFLKNLPAD 257 (334)
Q Consensus 224 ~~li~~~L~~~p~~R~s~~---ell~h~~~~~~~~~~ 257 (334)
.+||.+||+.+|.+||+++ ++|+|+|.++..+.+
T Consensus 249 ~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~~ 285 (299)
T d1ckia_ 249 ATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYD 285 (299)
T ss_dssp HHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCCS
T ss_pred HHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCCC
Confidence 9999999999999999986 457888876665444
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6e-47 Score=337.41 Aligned_cols=226 Identities=23% Similarity=0.336 Sum_probs=187.0
Q ss_pred CCCCeeEEEEEEecCcc-cccHHHHHHHHHHHcC-CCCCcccceEEEEcCCeEEEEEeccCCCChHHHHHhcC-------
Q 019901 13 YSSDLFVNIIIIVFHLW-QIDENVQREIINHRSL-RHPNIVRFKEVILTPTHLAIVMEYASGGELFERICNAG------- 83 (334)
Q Consensus 13 ~~~~~vvaiK~~~~~~~-~~~~~~~~Ei~~l~~l-~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------- 83 (334)
.++..| |||++++... .....+.+|+.+++.+ +|||||++++++.+++.+++|||||++|+|.+++.+..
T Consensus 51 ~~~~~v-AvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~ 129 (311)
T d1t46a_ 51 DAAMTV-AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK 129 (311)
T ss_dssp TCEEEE-EEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC----
T ss_pred CCCeEE-EEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence 455567 9999987552 2345788999999998 69999999999999999999999999999999987543
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCCC---CCCc
Q 019901 84 -----------RFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKST 149 (334)
Q Consensus 84 -----------~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~~---~~~~ 149 (334)
.+++..+..++.||+.||+|||++|||||||||+|||++.++. +||+|||+++....... ....
T Consensus 130 ~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~--~ki~DfG~~~~~~~~~~~~~~~~~ 207 (311)
T d1t46a_ 130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRI--TKICDFGLARDIKNDSNYVVKGNA 207 (311)
T ss_dssp ----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTE--EEECCCGGGSCTTSCTTSEECSSS
T ss_pred cccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCc--ccccccchheeccCCCcceEeeec
Confidence 5899999999999999999999999999999999999987664 99999999986443222 2345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCCCchHHHHHHHHHHhhccccCCCCCCCCHHHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLV-GAYPFEDPEEPKNFRKTIHRILSVQYSIPDYVHISPECRHLIS 228 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 228 (334)
+||+.|+|||++.+..++.+ +|||||||++|+|+| |.+||.+......+.+.+. .....+.+..+|+.+.+||.
T Consensus 208 ~gt~~y~aPE~~~~~~~~~~-~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~----~~~~~~~~~~~~~~l~~Li~ 282 (311)
T d1t46a_ 208 RLPVKWMAPESIFNCVYTFE-SDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK----EGFRMLSPEHAPAEMYDIMK 282 (311)
T ss_dssp EECGGGCCHHHHHHCCCCHH-HHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHH----HTCCCCCCTTSCHHHHHHHH
T ss_pred ccChHHcCHHHhcCCCCCCc-ccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHh----cCCCCCCcccccHHHHHHHH
Confidence 78999999999988777655 999999999999998 6777776665555444433 23333444568999999999
Q ss_pred HhcccCCCCCCCHhHHhc
Q 019901 229 RIFVADPAKRISIPEIRN 246 (334)
Q Consensus 229 ~~L~~~p~~R~s~~ell~ 246 (334)
+||+.||.+|||++++++
T Consensus 283 ~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 283 TCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHTCSSGGGSCCHHHHHH
T ss_pred HHcCCChhHCcCHHHHHH
Confidence 999999999999999985
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=6.3e-45 Score=321.58 Aligned_cols=237 Identities=18% Similarity=0.160 Sum_probs=187.4
Q ss_pred ccee-eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCC-CCcccceEEEEcCCeEEEEEeccCCCChHHHHHh
Q 019901 4 FHNF-YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRH-PNIVRFKEVILTPTHLAIVMEYASGGELFERICN 81 (334)
Q Consensus 4 ~g~~-~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~h-p~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 81 (334)
||.+ .|+++.+|+.| |||++.... ....+.+|++.++.+.| +|++.+++++..+...++||||+ +++|.+.+..
T Consensus 18 fG~Vy~a~~~~~~~~v-AvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~ 93 (293)
T d1csna_ 18 FGVIFEGTNLLNNQQV-AIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDL 93 (293)
T ss_dssp SCEEEEEEETTTTEEE-EEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHH
T ss_pred CeEEEEEEECCCCCEE-EEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHh
Confidence 4444 48888999998 999987654 34568899999999976 89999999999999999999999 7899988876
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCC---CCCCEEEeccCCccCCCCC--------CCCCCc
Q 019901 82 A-GRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGS---PAPRLKICDFGYSKSSVLH--------SQPKST 149 (334)
Q Consensus 82 ~-~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~---~~~~~kl~Dfgla~~~~~~--------~~~~~~ 149 (334)
. ..++...+..++.|++.||.|||++||+||||||+|||++.. ..+.+||+|||+|+..... ....+.
T Consensus 94 ~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (293)
T d1csna_ 94 CGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173 (293)
T ss_dssp TTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCC
T ss_pred hccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCce
Confidence 5 469999999999999999999999999999999999999642 2346999999999753321 123345
Q ss_pred cCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCchHHHHHHHHHHhhccccCC---CCCCCCHHHHHH
Q 019901 150 VGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILSVQYSIP---DYVHISPECRHL 226 (334)
Q Consensus 150 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l 226 (334)
+||+.|||||++.+..++.+ +|||||||++|+|++|+.||.+.......... ..+.......+ ....+|+++.++
T Consensus 174 ~GT~~y~aPE~~~~~~~~~~-~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~-~~i~~~~~~~~~~~l~~~~p~~l~~i 251 (293)
T d1csna_ 174 SGTARYMSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKY-ERIGEKKQSTPLRELCAGFPEEFYKY 251 (293)
T ss_dssp CSCTTTCCHHHHTTCCCCHH-HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHH-HHHHHHHHHSCHHHHTTTSCHHHHHH
T ss_pred EEchhhcCHHHhcCCCCChH-HHHHHhhHHHHHHHhCCCcCCCccchhHHHHH-HHHHhccCCCChHHhcCCCCHHHHHH
Confidence 79999999999998887655 99999999999999999999865443222111 11111111111 123578999999
Q ss_pred HHHhcccCCCCCCCHhHHhc
Q 019901 227 ISRIFVADPAKRISIPEIRN 246 (334)
Q Consensus 227 i~~~L~~~p~~R~s~~ell~ 246 (334)
+..|+..+|.+||+++.+.+
T Consensus 252 i~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 252 MHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHhcCCcccCcCHHHHHH
Confidence 99999999999999877643
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-46 Score=329.30 Aligned_cols=241 Identities=22% Similarity=0.261 Sum_probs=175.6
Q ss_pred CCccee--eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCcccceEEEEcCC----eEEEEEeccCCCCh
Q 019901 2 LGFHNF--YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNIVRFKEVILTPT----HLAIVMEYASGGEL 75 (334)
Q Consensus 2 lG~g~~--~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~~~----~~~lv~e~~~~~~L 75 (334)
||.|+| +.+.+.+|+.| |||++.... ......+.|+..++.++||||+++++++.+.+ .+|+|||||++|+|
T Consensus 11 iG~G~fg~Vy~~~~~g~~v-AvK~~~~~~-~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L 88 (303)
T d1vjya_ 11 IGKGRFGEVWRGKWRGEEV-AVKIFSSRE-ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL 88 (303)
T ss_dssp EECCSSSEEEEEEETTEEE-EEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBH
T ss_pred EeeCCCeEEEEEEECCEEE-EEEEECccc-hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCH
Confidence 566665 34445678888 999986554 22233445566667889999999999987653 68999999999999
Q ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------CCceeCCCCCCcEEEcCCCCCCEEEeccCCccCCCCCC---
Q 019901 76 FERICNAGRFSEDEARFFFQQLISGVSYCHS--------MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS--- 144 (334)
Q Consensus 76 ~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~--------~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~~~~~~--- 144 (334)
.+++.+. .++...+..++.|++.||.|||+ +|||||||||+|||++.++. +||+|||+++......
T Consensus 89 ~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~--~Kl~DFGl~~~~~~~~~~~ 165 (303)
T d1vjya_ 89 FDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT--CCIADLGLAVRHDSATDTI 165 (303)
T ss_dssp HHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSC--EEECCCTTCEEEETTTTEE
T ss_pred HHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCC--eEEEecCccccccCCCcce
Confidence 9999775 58999999999999999999996 69999999999999987765 9999999997543322
Q ss_pred --CCCCccCCCccccchhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCCCCCch-----------HHHHHHHHHH
Q 019901 145 --QPKSTVGTPAYIAPEVLLKKEY-----DGKIADVWSCGVTLYVMLVGAYPFEDPEEP-----------KNFRKTIHRI 206 (334)
Q Consensus 145 --~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----------~~~~~~~~~~ 206 (334)
......||+.|+|||++.+... .+.++|||||||++|||+||.+||...... ..........
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (303)
T d1vjya_ 166 DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVV 245 (303)
T ss_dssp CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHH
T ss_pred eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHH
Confidence 2334679999999999875432 134589999999999999999887432211 0111111112
Q ss_pred hhcccc--CCCC---CCCCHHHHHHHHHhcccCCCCCCCHhHHhcC
Q 019901 207 LSVQYS--IPDY---VHISPECRHLISRIFVADPAKRISIPEIRNH 247 (334)
Q Consensus 207 ~~~~~~--~~~~---~~~~~~~~~li~~~L~~~p~~R~s~~ell~h 247 (334)
...... +|.. ...+..+.+++.+||+.||.+|||+.|++++
T Consensus 246 ~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 246 CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 221211 1111 1123458999999999999999999999763
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.9e-43 Score=320.19 Aligned_cols=248 Identities=22% Similarity=0.339 Sum_probs=182.6
Q ss_pred CCccee----eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-----------CCCcccceEEEEc--CCeEE
Q 019901 2 LGFHNF----YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-----------HPNIVRFKEVILT--PTHLA 64 (334)
Q Consensus 2 lG~g~~----~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-----------hp~iv~~~~~~~~--~~~~~ 64 (334)
||.|+| .|+++.+|+.| |||++.+.. ...+.+.+|+.+++.++ ||||+++++++.. ....+
T Consensus 21 LG~G~fg~Vy~~~~~~~g~~v-AvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~ 98 (362)
T d1q8ya_ 21 LGWGHFSTVWLAKDMVNNTHV-AMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVH 98 (362)
T ss_dssp EEECSSEEEEEEEETTTTEEE-EEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEE
T ss_pred EeeCCCeEEEEEEECCCCCEE-EEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeecccccee
Confidence 566655 48889999999 999998765 33567888999888775 5789999998764 45667
Q ss_pred EEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHH-CCceeCCCCCCcEEEcCCCC----CCEEEeccCC
Q 019901 65 IVMEYASGGELFERI---CNAGRFSEDEARFFFQQLISGVSYCHS-MQVCHRDLKLENTLLDGSPA----PRLKICDFGY 136 (334)
Q Consensus 65 lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~qil~~L~~LH~-~~ivH~dlkp~NIli~~~~~----~~~kl~Dfgl 136 (334)
+++.++..+...... .....+++..++.+++||+.||.|||+ .||+||||||+|||++..+. ..++++|||.
T Consensus 99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~ 178 (362)
T d1q8ya_ 99 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGN 178 (362)
T ss_dssp EEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTT
T ss_pred eeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccc
Confidence 777776555433322 234569999999999999999999998 89999999999999975443 1489999999
Q ss_pred ccCCCCCCCCCCccCCCccccchhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCCCch------HHHHHHHHHHhhc-
Q 019901 137 SKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEP------KNFRKTIHRILSV- 209 (334)
Q Consensus 137 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------~~~~~~~~~~~~~- 209 (334)
|..... .....+||+.|+|||++.+..++.+ +||||+||++++|++|+.||...... ......+......
T Consensus 179 s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~ 255 (362)
T d1q8ya_ 179 ACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELP 255 (362)
T ss_dssp CEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH-HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCC
T ss_pred cccccc--ccccccccccccChhhccccCCCcc-ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCC
Confidence 875432 3356789999999999998888765 99999999999999999999754321 1111111100000
Q ss_pred ---------------c----ccC----------------CCCCCCCHHHHHHHHHhcccCCCCCCCHhHHhcCccccccC
Q 019901 210 ---------------Q----YSI----------------PDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWFLKNL 254 (334)
Q Consensus 210 ---------------~----~~~----------------~~~~~~~~~~~~li~~~L~~~p~~R~s~~ell~h~~~~~~~ 254 (334)
. ... ......++++++||.+||..||.+|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 256 SYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence 0 000 00112367899999999999999999999999999998543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.86 E-value=7.1e-22 Score=162.10 Aligned_cols=123 Identities=15% Similarity=0.097 Sum_probs=93.2
Q ss_pred CCccee---e-eeecCCCCeeEEEEEEecCccc------------------ccHHHHHHHHHHHcCCCCCcccceEEEEc
Q 019901 2 LGFHNF---Y-DRCSYSSDLFVNIIIIVFHLWQ------------------IDENVQREIINHRSLRHPNIVRFKEVILT 59 (334)
Q Consensus 2 lG~g~~---~-~~~~~~~~~vvaiK~~~~~~~~------------------~~~~~~~Ei~~l~~l~hp~iv~~~~~~~~ 59 (334)
||.|+| + |.+ .+|+.| |||++...... ......+|...+.++.|++++..+++.
T Consensus 8 IG~G~~g~Vy~a~~-~~g~~v-AvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-- 83 (191)
T d1zara2 8 MGEGKESAVFNCYS-EKFGEC-VVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-- 83 (191)
T ss_dssp EEECSSEEEEEEEE-TTTEEE-EEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--
T ss_pred eeeCcceEEEEEEC-CCCCEE-EEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--
Confidence 455554 4 444 578888 99997643210 013445688899999999999887663
Q ss_pred CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeCCCCCCcEEEcCCCCCCEEEeccCCccC
Q 019901 60 PTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHSMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKS 139 (334)
Q Consensus 60 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qil~~L~~LH~~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~~ 139 (334)
. .+++|||+.+..+.. ++...+..++.|++.+|.|||++||+||||||+|||++.++ ++|+|||+|+.
T Consensus 84 ~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~---~~liDFG~a~~ 151 (191)
T d1zara2 84 G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG---IWIIDFPQSVE 151 (191)
T ss_dssp T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE---EEECCCTTCEE
T ss_pred C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC---EEEEECCCccc
Confidence 2 279999998866532 45666788999999999999999999999999999998543 89999999875
Q ss_pred C
Q 019901 140 S 140 (334)
Q Consensus 140 ~ 140 (334)
.
T Consensus 152 ~ 152 (191)
T d1zara2 152 V 152 (191)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.39 E-value=1.1e-06 Score=73.41 Aligned_cols=66 Identities=12% Similarity=-0.046 Sum_probs=49.3
Q ss_pred cCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCC-CCCcccceEEEEcCCeEEEEEeccCCCChHHH
Q 019901 12 SYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIVMEYASGGELFER 78 (334)
Q Consensus 12 ~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 78 (334)
..+++.+ +||+...........+.+|...++.+. +--+.+++.+...++..++||++++|.++...
T Consensus 34 ~~~~~~~-vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 34 VGENENL-YLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp ECSSCEE-EEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred EeCCCeE-EEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 3566777 889887665445567889999887764 33356778888888999999999998877544
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.91 E-value=1.7e-05 Score=65.55 Aligned_cols=64 Identities=9% Similarity=0.052 Sum_probs=44.8
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCC--CcccceEEEEcCCeEEEEEeccCCCCh
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHP--NIVRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp--~iv~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+-.....+..+ ++|...... ...+.+|...++.+... .+.+++.+..+++..++||++++|.++
T Consensus 28 ~r~~~~~~~~~-vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 28 FRLSAQGRPVL-FVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp EEEECTTSCCE-EEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EEEEeCCCCEE-EEEeCCccC---HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 33344556667 889865443 34578888888776432 356678888888889999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.67 E-value=0.00012 Score=64.67 Aligned_cols=28 Identities=18% Similarity=0.239 Sum_probs=24.1
Q ss_pred CceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 108 QVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 108 ~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.++|||++|.|||++.++ ++|+||..|.
T Consensus 224 ~LiHGDl~~gNIlv~~~~---~~vID~E~a~ 251 (392)
T d2pula1 224 TLIHGDLHTGSIFASEHE---TKVIDPEFAF 251 (392)
T ss_dssp EEECSCCCGGGEEECSSC---EEECCCTTCE
T ss_pred ceeccCCcCCceeEcCCc---eEEechhhcc
Confidence 589999999999997543 8999998765
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.53 E-value=0.00032 Score=60.11 Aligned_cols=65 Identities=12% Similarity=0.091 Sum_probs=42.7
Q ss_pred eeeecCCCCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-----ccc--eEEEEcCCeEEEEEeccCCCC
Q 019901 8 YDRCSYSSDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-----VRF--KEVILTPTHLAIVMEYASGGE 74 (334)
Q Consensus 8 ~~~~~~~~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-----v~~--~~~~~~~~~~~lv~e~~~~~~ 74 (334)
+-....+|..| ++|+..... ...+.+..|+..+..|...++ +.. -..+..++..+.+++++.|..
T Consensus 39 y~v~~~dg~~~-VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 39 YQFQDEDRRRF-VVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp EEECCTTCCCE-EEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred EEEEcCCCCEE-EEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 33445678888 999987765 456778899988877642222 111 112345677899999998743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.44 E-value=0.0025 Score=53.82 Aligned_cols=30 Identities=27% Similarity=0.349 Sum_probs=24.9
Q ss_pred CCceeCCCCCCcEEEcCCCCCCEEEeccCCcc
Q 019901 107 MQVCHRDLKLENTLLDGSPAPRLKICDFGYSK 138 (334)
Q Consensus 107 ~~ivH~dlkp~NIli~~~~~~~~kl~Dfgla~ 138 (334)
.|+||+|+.+.||+++++.. .-++||+.+.
T Consensus 183 ~giIHgDl~~dNvl~~~~~v--~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDEL--SGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEEETTEE--EEECCCTTCE
T ss_pred cccccCCcchhhhhcccccc--eeEecccccc
Confidence 57999999999999986542 5899999754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.43 E-value=0.0031 Score=55.26 Aligned_cols=54 Identities=9% Similarity=0.103 Sum_probs=35.5
Q ss_pred CCeeEEEEEEecCcccccHHHHHHHHHHHcCCCCCc-ccceEEEEcCCeEEEEEeccCCCCh
Q 019901 15 SDLFVNIIIIVFHLWQIDENVQREIINHRSLRHPNI-VRFKEVILTPTHLAIVMEYASGGEL 75 (334)
Q Consensus 15 ~~~vvaiK~~~~~~~~~~~~~~~Ei~~l~~l~hp~i-v~~~~~~~~~~~~~lv~e~~~~~~L 75 (334)
+..| .+++..... ..-...+|..+++.+.-.++ .+++.++.. .+|++|++|.++
T Consensus 74 ~~~v-llRi~g~~~--~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 74 PNKV-LLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp CSEE-EEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred CCcE-EEEecCCcc--hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 3455 777766322 33467789999988854344 467777642 688999987554
|